Citrus Sinensis ID: 013686

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------44
Protein Sequence
MIIAGKNGFSTGAGIGIALGSAAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKWVSSSNPSSSF
Secondary Structure (PSIPRED)
ccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEccccccHHHHHHHHHHHHHHHccccccccEEccccccccEEEEEEEEcccccHHHHccccccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccccEEEcccccccccccHHHccccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccHHHEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHccccccccccEEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEcccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcHHHcEEEccccccccccccccEEEccEEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHcccccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccccEccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
miiagkngfstgAGIGIALGSAAAVILGLIFFCIIRRRRKTAAYaksrdlktppssasgatattsaatttttnssqsipsypysitdlergssyfgakvfscseleeatdnfnsskqlgdggfgAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTklqhpnlvklygctsrqSRELLLVYEyipngtvadhlhnrqpnscllpwpVRLSIAIETAGALAYLHASDVIhrdvksnnilldnnfrvkvadfglsrlfptdvthvstapqgtpgyvdpdyfqcykltdksdvySFGVVLIELISGleavdtsrhrhdinlsnmatnkiqngalnelvdpslgfekdyAVRNMVTSVAELAFRCVqqdrdmrpTMKEVLEILRETkdsnlgtskakvVDIRIADDaallkkdspslspddsgtdkwvsssnpsssf
Flexible Loop (DISEMBL)
MIIAGKNGFSTGAGIGIALGSAAAVILGLIFFCIIRRRRKTAAyaksrdlktppssasgatattsaatttttnssqsipsYPYSITDLERGSSYFGAKVFSCSELEEATDNfnsskqlgdgGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVThvstapqgtpgyvdPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAfrcvqqdrdmrPTMKEVLEILretkdsnlgtskakvvdIRIADDaallkkdspslspddsgtdkwvsssnpsssf
Low Complexity Region (SEG)
MIIAGKNGFSTgagigialgsaaavilgliFFCIIRRRRKTAAYAKSRDLKtppssasgatattsaatttttnssqsipsypysiTDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAAllkkdspslspddsGTDKWVSSSNPSSSF
Disordered region (IsUnstruct)
******NGFSTGAGIGIALGSAAAVILGLIFFCIIRRRRKT***************************************************SYFGAKVF********************GGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD*********VLEIL*************KVVDIRIA*********************************
Disordered Region (DISOPRED)
**************IGIALGSAAAVILGLIFFCIIRR**********************************************************GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLY*N****IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV*****RHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE****************************************************
Disordered Region (DISEMBL)
MIIAGKNGFSTGAGIGIALGSAAAVILGLIFFCIIRRRRKT************************************IPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKD************************
Disordered Region (DISPRO)
*******GFSTGAGIGIALGSAAAVILGLIFFCIIRRRRK*****************************************************YFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE****************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MIIAGKNGFSTGAGIGIALGSAAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKWVSSSNPSSSF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	438	2.2.26 [Sep-21-2011]
P0C5E2	654	Probable serine/threonine	no	no	0.874	0.585	0.564	1e-124
Q8RY67	708	Wall-associated receptor	no	no	0.721	0.446	0.463	7e-82
Q8GYF5	622	Wall-associated receptor	no	no	0.673	0.474	0.465	3e-73
Q9C9L5	792	Wall-associated receptor	no	no	0.634	0.351	0.456	1e-66
Q7X8C5	748	Wall-associated receptor	no	no	0.652	0.382	0.457	1e-65
Q8VYA3	769	Wall-associated receptor	no	no	0.691	0.394	0.425	2e-65
Q9M342	639	Wall-associated receptor	no	no	0.646	0.442	0.471	5e-65
Q8RY17	751	Wall-associated receptor	no	no	0.673	0.392	0.450	6e-65
Q9S9M2	761	Wall-associated receptor	no	no	0.652	0.375	0.451	7e-65
Q9SA25	720	Wall-associated receptor	no	no	0.666	0.405	0.456	9e-64

>sp|P0C5E2|Y1839_ARATH Probable serine/threonine-protein kinase At1g18390 OS=Arabidopsis thaliana GN=At1g18390 PE=1 SV=2

 Score =  445 bits (1144), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 236/418 (56%), Positives = 285/418 (68%), Gaps = 35/418 (8%)

Query: 15  IGIALGSAAAVILGLI---FFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTT 71
           I  ++  A+A ++GLI    F  +  RRKT +Y  S                 SA     
Sbjct: 265 ITKSISGASAAVVGLIAASIFWYVYHRRKTKSYRNS-----------------SALLPRN 307

Query: 72  TNSSQSIPSYPYSITDLERGSSYF-GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI 130
            +S  S  S+     D+E+      G  +FS  ELEEAT+NF+ SK+LGDGGFG VY G 
Sbjct: 308 ISSDPSAKSF-----DIEKAEELLVGVHIFSYEELEEATNNFDPSKELGDGGFGTVYYGK 362

Query: 131 LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP 190
           L+DGR VAVKRLY+NNFKR EQF NEVEILT L+HPNLV L+GC+S+QSR+LLLVYEY+ 
Sbjct: 363 LKDGRSVAVKRLYDNNFKRAEQFRNEVEILTGLRHPNLVALFGCSSKQSRDLLLVYEYVA 422

Query: 191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV 250
           NGT+ADHLH  Q N   LPW +RL IA+ETA AL YLHAS +IHRDVKSNNILLD NF V
Sbjct: 423 NGTLADHLHGPQANPSSLPWSIRLKIAVETASALKYLHASKIIHRDVKSNNILLDQNFNV 482

Query: 251 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLE 310
           KVADFGLSRLFP D THVSTAPQGTPGYVDPDY  CY+L++KSDVYSF VVL+ELIS L 
Sbjct: 483 KVADFGLSRLFPMDKTHVSTAPQGTPGYVDPDYHLCYQLSNKSDVYSFAVVLMELISSLP 542

Query: 311 AVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD 370
           AVD +R R +INLSNMA  KIQN  L ++VDPSLGF+ D  VR  V +VAELAF+C+Q D
Sbjct: 543 AVDITRPRQEINLSNMAVVKIQNHELRDMVDPSLGFDTDTRVRQTVIAVAELAFQCLQSD 602

Query: 371 RDMRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKW 428
           +D+RP M  V + L   +++  G S+  VVD+   + +  L   SP     DS   KW
Sbjct: 603 KDLRPCMSHVQDTLTRIQNNGFG-SEMDVVDV---NKSGPLVAQSP-----DSVIVKW 651

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RY67|WAKLO_ARATH Wall-associated receptor kinase-like 14 OS=Arabidopsis thaliana GN=WAKL14 PE=2 SV=2

 Score =  305 bits (780), Expect = 7e-82,   Method: Compositional matrix adjust.
 Identities = 157/339 (46%), Positives = 226/339 (66%), Gaps = 23/339 (6%)

Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI 159
           F   E+E+ATD F+  ++LG G +G VY G L++   VA+KRL   + + ++Q MNE+++
Sbjct: 336 FPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKL 395

Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
           L+ + HPNLV+L GC   Q  + +LVYEY+PNGT+++HL   + +   LPW +RL++A +
Sbjct: 396 LSSVSHPNLVRLLGCCIEQG-DPVLVYEYMPNGTLSEHLQRDRGSG--LPWTLRLTVATQ 452

Query: 220 TAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
           TA A+AYLH+S    + HRD+KS NILLD +F  KVADFGLSRL  T+ +H+STAPQGTP
Sbjct: 453 TAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTP 512

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
           GY+DP Y QC+ L+DKSDVYSFGVVL E+I+GL+ VD +R   +INL+ +A +KI +G +
Sbjct: 513 GYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCI 572

Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSK 396
           +E++DP L  + D    + + +VAELAFRC+    DMRPTM EV + L +          
Sbjct: 573 DEIIDPILDLDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQ---------- 622

Query: 397 AKVVDIRIADDAALLKKDSP--SLSPDDSGTDKWVSSSN 433
                IR++     +  DSP  SL   D G+++ V  S+
Sbjct: 623 -----IRLSGWIPSMSLDSPAGSLRSSDRGSERSVKQSS 656

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2

 Score =  276 bits (705), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 143/307 (46%), Positives = 207/307 (67%), Gaps = 12/307 (3%)

Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI 159
           ++  E+E+ATD+F+    LG G +G VY G   +   VA+KRL   +   I+Q +NE+++
Sbjct: 302 YTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKL 361

Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL-HNR-QPNSCLLPWPVRLSIA 217
           L+ + HPNLV+L GC      E  LVYE++PNGT+  HL H R QP    L W +RL+IA
Sbjct: 362 LSSVSHPNLVRLLGCCFADG-EPFLVYEFMPNGTLYQHLQHERGQPP---LSWQLRLAIA 417

Query: 218 IETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRL-FPTD--VTHVSTA 271
            +TA A+A+LH+S    + HRD+KS+NILLD+ F  K++DFGLSRL   TD   +H+STA
Sbjct: 418 CQTANAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHISTA 477

Query: 272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI 331
           PQGTPGY+DP Y Q ++L+DKSDVYSFGVVL+E+ISG + +D +R   ++NL+++A ++I
Sbjct: 478 PQGTPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVDRI 537

Query: 332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN 391
             G + +++DP L  E +  +   + ++AELAFRC+   R+MRPTM E+ E L   K  +
Sbjct: 538 GRGRVVDIIDPCLNKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRIKLMH 597

Query: 392 LGTSKAK 398
            GT   K
Sbjct: 598 YGTESGK 604

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1

 Score =  253 bits (647), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 130/285 (45%), Positives = 193/285 (67%), Gaps = 7/285 (2%)

Query: 99  VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVE 158
           VFS  ELE+AT+NF+S++ LG GG G VY G+L DGRIVAVK+    +  ++E+F+NEV 
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493

Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           IL+++ H N+VKL GC   +++  +LVYE+IPNG + +HLH+    + +  W +RL IAI
Sbjct: 494 ILSQINHRNIVKLLGCC-LETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAI 552

Query: 219 ETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           + AGAL+YLH+S    + HRDVKS NI+LD  +R KV+DFG SR    D TH++T   GT
Sbjct: 553 DIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGT 612

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA 335
            GY+DP+YFQ  + TDKSDVYSFGVVL+ELI+G +++   R + +  L+      ++   
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENK 672

Query: 336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           L +++D  +   +D  + + VT+ A++A +C+      RP+M+EV
Sbjct: 673 LFDIIDARI---RDGCMLSQVTATAKVARKCLNLKGRKRPSMREV 714

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  250 bits (639), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 136/297 (45%), Positives = 191/297 (64%), Gaps = 11/297 (3%)

Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNE 156
           +++FS  ELE+ATDNFN ++ LG GG G VY G+L DGRIVAVKR    +  R+E+F+NE
Sbjct: 401 SRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINE 460

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           V +L ++ H N+VKL GC   ++   +LVYE++PNG +   LH+ + +   + W VRL I
Sbjct: 461 VVVLAQINHRNIVKLLGCC-LETEVPVLVYEFVPNGDLCKRLHD-ESDDYTMTWEVRLHI 518

Query: 217 AIETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           AIE AGAL+YLH++    + HRD+K+ NILLD   R KV+DFG SR    D TH++T   
Sbjct: 519 AIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVA 578

Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
           GT GYVDP+YFQ  K T+KSDVYSFGVVL+EL++G +     R   +  L+      ++ 
Sbjct: 579 GTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKE 638

Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV---LEILRET 387
             + ++VD  +   KD    + V SVA LA RC+ +    RP M+EV   LE++R +
Sbjct: 639 NRVLDIVDDRI---KDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1

 Score =  250 bits (638), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 137/322 (42%), Positives = 203/322 (63%), Gaps = 19/322 (5%)

Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           +VF+  ELE+AT+NF+ ++ LG+GG G VY G+L DGRIVAVK+    +  ++E+F+NEV
Sbjct: 419 RVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 478

Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL+++ H N+VKL GC   ++   +LVYE+IPNG + +HLH+   +  +  W VRL IA
Sbjct: 479 VILSQINHRNIVKLLGCC-LETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIA 537

Query: 218 IETAGALAYLHA---SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG 274
           ++ AGAL+YLH+   S + HRD+KS NI+LD   R KV+DFG SR    D TH++T   G
Sbjct: 538 VDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSG 597

Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
           T GY+DP+YFQ  + TDKSDVYSFGVVL ELI+G ++V   R +    L+   T  ++  
Sbjct: 598 TVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKEN 657

Query: 335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV---LEILR------ 385
            L++++D  +   +D    N VT+ A++A +C+      RP+M++V   LE +R      
Sbjct: 658 RLSDIIDARI---RDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDM 714

Query: 386 ---ETKDSNLGTSKAKVVDIRI 404
              E    N    K  +VD+ +
Sbjct: 715 QPYEYASENEEEKKETLVDVNV 736

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2

 Score =  248 bits (634), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 142/301 (47%), Positives = 189/301 (62%), Gaps = 18/301 (5%)

Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           ++F+  E+ +ATDNF  S  LG GGFG V+ G L DG  VAVKR    N K I Q +NEV
Sbjct: 340 RIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEV 399

Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL----PWPVR 213
           +IL ++ H NLVKL GC       +L VYE++PNGT+ +H++        L    P   R
Sbjct: 400 QILCQVSHKNLVKLLGCCIELEMPVL-VYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRR 458

Query: 214 LSIAIETAGALAYLHASD---VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST 270
           L IA +TA  L YLH+S    + HRDVKS+NILLD N  VKVADFGLSRL  +DV+HV+T
Sbjct: 459 LMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTT 518

Query: 271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK 330
             QGT GY+DP+Y+  ++LTDKSDVYSFGVVL EL++  +A+D +R   D+NL       
Sbjct: 519 CAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKA 578

Query: 331 IQNGALNELVDPSLGF---EKDYAVRNMVTSVAELAFRCVQQDRDMRPTM----KEVLEI 383
           ++ G L +++DP +G    EK+      +  +AEL   CV++ R  RPTM    KE+  I
Sbjct: 579 LKEGRLMDVIDPVIGIGATEKEIESMKALGVLAEL---CVKETRQCRPTMQVAAKEIENI 635

Query: 384 L 384
           L
Sbjct: 636 L 636

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  248 bits (633), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 138/306 (45%), Positives = 194/306 (63%), Gaps = 11/306 (3%)

Query: 90  RGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR 149
           RG +   +K+FS  ELE+ATDNFN ++ LG GG G VY G+L DGRIVAVKR    +  +
Sbjct: 399 RGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDK 458

Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
           +E+F+NEV +L+++ H N+VKL GC   ++   +LVYE+IPNG +   LH+   +   + 
Sbjct: 459 VEEFINEVGVLSQINHRNIVKLMGCC-LETEVPILVYEHIPNGDLFKRLHHDSDDY-TMT 516

Query: 210 WPVRLSIAIETAGALAYLHA---SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
           W VRL I++E AGALAYLH+   + V HRDVK+ NILLD  +R KV+DFG SR    D T
Sbjct: 517 WDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQT 576

Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
           H++T   GT GY+DP+YFQ  + TDKSDVYSFGVVL+ELI+G +     R   +  L + 
Sbjct: 577 HLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSH 636

Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV---LEI 383
               ++   + ++VD  +   K+      V +VA+LA RC+      RP M+EV   LE 
Sbjct: 637 FNEAMKQNRVLDIVDSRI---KEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELER 693

Query: 384 LRETKD 389
           +R + +
Sbjct: 694 IRSSPE 699

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  248 bits (633), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 134/297 (45%), Positives = 192/297 (64%), Gaps = 11/297 (3%)

Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNE 156
           +K+FS +ELE+ATDNFN+++ LG GG G VY G+L DGRIVAVKR    +  ++E+F+NE
Sbjct: 409 SKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINE 468

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           V +L ++ H N+VKL GC   ++   +LVYE++PNG +   L + + +  ++ W VRL I
Sbjct: 469 VVVLAQINHRNIVKLLGCC-LETEVPVLVYEFVPNGDLCKRLRD-ECDDYIMTWEVRLHI 526

Query: 217 AIETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           AIE AGAL+YLH++    + HRD+K+ NILLD  ++VKV+DFG SR    D TH++T   
Sbjct: 527 AIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVA 586

Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
           GT GYVDP+YFQ  K TDKSDVYSFGVVL+ELI+G       +   +   +      ++ 
Sbjct: 587 GTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKE 646

Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV---LEILRET 387
               ++VD  +   KD    + V +VA+LA RC+ +    RP M+EV   LE +R +
Sbjct: 647 NRFLDIVDERI---KDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSS 700

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1

 Score =  244 bits (623), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 137/300 (45%), Positives = 189/300 (63%), Gaps = 8/300 (2%)

Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           KVFS ++LE ATD FN+S+ LG GG G VY G+L DG IVAVK+      + +E+F+NE+
Sbjct: 376 KVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEI 435

Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            +L+++ H N+VK+ GC   ++   +LVYE+IPN  + DHLHN   +   + W VRL IA
Sbjct: 436 ILLSQINHRNVVKILGCC-LETEVPILVYEFIPNRNLFDHLHNPSEDF-PMSWEVRLCIA 493

Query: 218 IETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG 274
            E A AL+YLH++    + HRDVKS NILLD   R KV+DFG+SR    D TH++T  QG
Sbjct: 494 CEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQG 553

Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
           T GYVDP+Y Q    T KSDVYSFGV+LIEL++G + V   R +    L       ++N 
Sbjct: 554 TIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRND 613

Query: 335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGT 394
            L+E++D  +  E D   R  V +VA+LA RC+  + + RPTM++V   L   +    GT
Sbjct: 614 RLHEILDARIKEECD---REEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGT 670

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	438
255551438	685	wall-associated kinase, putative [Ricinu	0.947	0.605	0.665	1e-163
359488166	648	PREDICTED: probable serine/threonine-pro	0.961	0.649	0.649	1e-161
449465603	680	PREDICTED: probable serine/threonine-pro	0.938	0.604	0.623	1e-150
449519988	607	PREDICTED: LOW QUALITY PROTEIN: probable	0.936	0.675	0.624	1e-150
357508173	1182	Ser/Thr protein kinase [Medicago truncat	0.926	0.343	0.651	1e-148
357508169	1205	Ser/Thr protein kinase [Medicago truncat	0.924	0.336	0.651	1e-148
357508171	1178	Ser/Thr protein kinase [Medicago truncat	0.924	0.343	0.651	1e-148
224079347	308	predicted protein [Populus trichocarpa]	0.684	0.974	0.8	1e-144
449442072	705	PREDICTED: probable serine/threonine-pro	0.968	0.601	0.609	1e-143
356567262	1476	PREDICTED: probable receptor-like protei	0.929	0.275	0.636	1e-142

>gi|255551438|ref|XP_002516765.1| wall-associated kinase, putative [Ricinus communis] gi|223544138|gb|EEF45663.1| wall-associated kinase, putative [Ricinus communis]

 Score =  579 bits (1493), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 286/430 (66%), Positives = 338/430 (78%), Gaps = 15/430 (3%)

Query: 5   GKNGFSTG----AGIGIALGSAAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGA 60
           G + FS G    +G+GIA      + LG   F  ++R+++ AA  K++DL TPPSS S  
Sbjct: 254 GPDPFSCGRSQSSGVGIAGAVVIGIGLGCWIFLYVQRKKRIAAQTKNKDLPTPPSSKSQP 313

Query: 61  TATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGD 120
                       N SQ+ PSY  S +DLE+GS+YFG KVFS  EL EATDNF+ SK+LGD
Sbjct: 314 APVI--------NFSQTTPSYSSSKSDLEKGSTYFGTKVFSYEELVEATDNFDPSKELGD 365

Query: 121 GGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR 180
           GGFG VY GIL DGR+VAVKRL+ENN KR EQFMNE+EILT+L+H NLV LYGCTS++SR
Sbjct: 366 GGFGTVYYGILSDGRVVAVKRLFENNMKRAEQFMNEIEILTRLRHKNLVTLYGCTSKRSR 425

Query: 181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSN 240
           EL+LVYEYIPNGT+ADH+H  +  S LL W VRLSIAIETA ALAYLHASDVIHRDVK+N
Sbjct: 426 ELVLVYEYIPNGTLADHIHGNRSKSGLLTWKVRLSIAIETADALAYLHASDVIHRDVKTN 485

Query: 241 NILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGV 300
           NILLDNNFRVKVADFGLSRLFP D THVSTAPQGTPGYVDP+Y+QCY+LTDKSDVYSFGV
Sbjct: 486 NILLDNNFRVKVADFGLSRLFPNDCTHVSTAPQGTPGYVDPEYYQCYQLTDKSDVYSFGV 545

Query: 301 VLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA 360
           VL+ELIS L+AVDT+RHR DINL+NMA NKIQN A+NELVDP LG++KDYAVR M TSVA
Sbjct: 546 VLVELISSLQAVDTNRHRLDINLANMAVNKIQNHAINELVDPMLGYDKDYAVRKMTTSVA 605

Query: 361 ELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSP 420
           ELAFRC+QQ++DMRPTM EVLE L++ +  + G+ K + +DI+  DD  LL   +P  SP
Sbjct: 606 ELAFRCLQQEKDMRPTMAEVLEALKKIESEDYGSEKTEALDIK-EDDVVLLNHVAP-FSP 663

Query: 421 DDS-GTDKWV 429
           D+S  TDKWV
Sbjct: 664 DESVTTDKWV 673

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488166|ref|XP_003633713.1| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Vitis vinifera]

 Score =  575 bits (1483), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 285/439 (64%), Positives = 342/439 (77%), Gaps = 18/439 (4%)

Query: 6   KNGFS--------TGAGIGIALGSAAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSA 57
           +NG+S        + +G  +       + LG +F+ + +RRR+ A+ AKS+DL TPPSS 
Sbjct: 219 RNGYSPSTCQNTTSASGYSVLGAVLLGIFLGCLFYFLAQRRRR-ASKAKSKDLPTPPSSK 277

Query: 58  SGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQ 117
             A + T          S+SIPSYPY+ +D+E+GS+YFG +VFS  ELEEAT+NF+ S++
Sbjct: 278 GIAPSLTGF--------SESIPSYPYTKSDIEKGSTYFGVQVFSYMELEEATNNFDPSRE 329

Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR 177
           LGDGGFG VY G L+DGR+VAVKRLYENNFKR+EQFMNEV+ILT+LQH NLVKLYGCTSR
Sbjct: 330 LGDGGFGTVYYGKLQDGRVVAVKRLYENNFKRVEQFMNEVQILTRLQHQNLVKLYGCTSR 389

Query: 178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDV 237
           +SRELLLVYEYIPNGTVADHLH +Q NS  + WPVRLSIAIETA ALAYLH S++IHRDV
Sbjct: 390 RSRELLLVYEYIPNGTVADHLHGKQANSGSITWPVRLSIAIETANALAYLHESEIIHRDV 449

Query: 238 KSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYS 297
           K+NNILLDNNF+VKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP+Y QCY+LT KSDVYS
Sbjct: 450 KTNNILLDNNFQVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYHQCYQLTSKSDVYS 509

Query: 298 FGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVT 357
           FGVVL+ELIS  +AVDT+RHRHDINL+NMA NKI N  L+ELVDPSLGFE D  VR  +T
Sbjct: 510 FGVVLMELISSKQAVDTNRHRHDINLANMAVNKILNHTLHELVDPSLGFESDSLVRRKIT 569

Query: 358 SVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPS 417
            VAELAFRC+Q +RDMRPTM EVL+ LR  ++      KA+ VDI  ++D  LLK + P 
Sbjct: 570 LVAELAFRCLQHERDMRPTMGEVLKALRRIENEESDVQKAEEVDIN-SEDIGLLKSNPPP 628

Query: 418 LSPDDSGTDKWVSSSNPSS 436
           +SPD    DK V+ + P S
Sbjct: 629 VSPDSVVADKGVNPTTPYS 647

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449465603|ref|XP_004150517.1| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Cucumis sativus]

 Score =  537 bits (1383), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 263/422 (62%), Positives = 324/422 (76%), Gaps = 11/422 (2%)

Query: 15  IGIALGSAA--AVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTT 72
           +G+++G A    + LG   FC  +R +K     KS+DL +PPSS    T +T  +++  +
Sbjct: 264 VGLSIGGATVLGLCLGCFVFCTTQRNKKRVMKLKSKDLPSPPSSGGIPTPSTFRSSSIPS 323

Query: 73  NSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILR 132
                        +++E GSSYFGA+VF+ +ELEEAT NF+ S++LGDGG+G VY G L+
Sbjct: 324 YPYSR--------SNIENGSSYFGAQVFTYAELEEATHNFDRSRELGDGGYGTVYFGTLK 375

Query: 133 DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG 192
           DGR VAVKRLYENN+KR++QF NEVEIL+KLQHPNLVKLYGCTSRQS+ LLLVYEYI NG
Sbjct: 376 DGRTVAVKRLYENNYKRVQQFTNEVEILSKLQHPNLVKLYGCTSRQSQGLLLVYEYISNG 435

Query: 193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKV 252
           TVADHLH +Q NS LL W VRL IAIETA ALAYLH  D+IHRDVK+NNILLDNNF+VKV
Sbjct: 436 TVADHLHGKQANSGLLTWSVRLKIAIETANALAYLHRKDIIHRDVKTNNILLDNNFKVKV 495

Query: 253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV 312
           ADFGLSRLFP +VTHVSTAPQGTPGYVDP+Y+QCY+LTDKSDVYSFGVVL+ELIS L+AV
Sbjct: 496 ADFGLSRLFPINVTHVSTAPQGTPGYVDPEYYQCYQLTDKSDVYSFGVVLVELISSLQAV 555

Query: 313 DTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRD 372
           D +R+R DINLSNMA N+I N AL +LVDP LGFE+DYAVR+M+ SVAELA+RC+QQ RD
Sbjct: 556 DVNRNRDDINLSNMAINRIHNQALADLVDPDLGFERDYAVRSMIKSVAELAYRCLQQTRD 615

Query: 373 MRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSG-TDKWVSS 431
            RP+M EV+E LRE ++  +   KA+V+    +D+  LL+  S   SP+    TDKW+  
Sbjct: 616 ARPSMDEVVEALRELENEEVAARKAEVLVDLGSDNVRLLRNTSSPQSPESGPVTDKWMKV 675

Query: 432 SN 433
            N
Sbjct: 676 LN 677

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449519988|ref|XP_004167016.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase At1g18390-like [Cucumis sativus]

 Score =  536 bits (1382), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 264/423 (62%), Positives = 325/423 (76%), Gaps = 13/423 (3%)

Query: 15  IGIALGSAA--AVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTT 72
           +G+++G A    + LG   FC  +R +      KS+DL +PPSS    T +T  +++  +
Sbjct: 191 VGLSIGGATVLGLCLGCFVFCTTQRNKNVXMKLKSKDLPSPPSSGGIPTPSTFRSSSIPS 250

Query: 73  NSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILR 132
                        +++E GSSYFGA+VF+ +ELEEAT NF+ S++LGDGG+G VY G L+
Sbjct: 251 YPYSR--------SNIENGSSYFGAQVFTYAELEEATHNFDRSRELGDGGYGTVYFGTLK 302

Query: 133 DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG 192
           DGR VAVKRLYENN+KR++QF NEVEIL+KLQHPNLVKLYGCTSRQS+ LLLVYEYI NG
Sbjct: 303 DGRTVAVKRLYENNYKRVQQFTNEVEILSKLQHPNLVKLYGCTSRQSQGLLLVYEYISNG 362

Query: 193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKV 252
           TVADHLH +Q NS LL W VRL IAIETA ALAYLH  D+IHRDVK+NNILLDNNF+VKV
Sbjct: 363 TVADHLHGKQANSGLLTWSVRLKIAIETANALAYLHRKDIIHRDVKTNNILLDNNFKVKV 422

Query: 253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV 312
           ADFGLSRLFP +VTHVSTAPQGTPGYVDP+Y+QCY+LTDKSDVYSFGVVL+ELIS L+AV
Sbjct: 423 ADFGLSRLFPINVTHVSTAPQGTPGYVDPEYYQCYQLTDKSDVYSFGVVLVELISSLQAV 482

Query: 313 DTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRD 372
           D +R+R DINLSNMA N+I N AL +LVDP LGFE+DYAVR+M+ SVAELA+RC+QQ RD
Sbjct: 483 DVNRNRDDINLSNMAINRIHNQALADLVDPDLGFERDYAVRSMIKSVAELAYRCLQQTRD 542

Query: 373 MRPTMKEVLEILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSG--TDKWVS 430
            RP+M EV+E LRE ++  +   KA+V+    +D+  LL+  S   SP +SG  TDKW+ 
Sbjct: 543 ARPSMDEVVEALRELENEEVAARKAEVLVDLGSDNVRLLRNTSSPQSP-ESGPVTDKWMK 601

Query: 431 SSN 433
             N
Sbjct: 602 VLN 604

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508173|ref|XP_003624375.1| Ser/Thr protein kinase [Medicago truncatula] gi|355499390|gb|AES80593.1| Ser/Thr protein kinase [Medicago truncatula]

 Score =  531 bits (1368), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 266/408 (65%), Positives = 321/408 (78%), Gaps = 2/408 (0%)

Query: 22   AAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSY 81
            AA  +LG +   ++RRRRK A    S DL  PPSS    + T +   T+TTNSSQSIPSY
Sbjct: 768  AALCLLGFVACFVVRRRRKNAKKPISNDLYMPPSST--TSGTNTGTLTSTTNSSQSIPSY 825

Query: 82   PYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKR 141
            P S T     S YFG +VF+  ELEEAT+NF++SK+LG+GGFG VY G L+DGR+VAVKR
Sbjct: 826  PSSKTSTMPKSFYFGVQVFTYEELEEATNNFHTSKELGEGGFGTVYKGDLKDGRVVAVKR 885

Query: 142  LYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR 201
             YE+NFKR+ QFMNEVEIL +L+H NLV LYGCTS+ SRELLLVYEYI NGTVADHLH  
Sbjct: 886  HYESNFKRVAQFMNEVEILARLRHKNLVTLYGCTSKHSRELLLVYEYISNGTVADHLHGD 945

Query: 202  QPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
            + +SCLLPW VRL IA+ETA ALAYLHASDV+HRDVKSNNILLD  F VKVADFGLSRLF
Sbjct: 946  RSSSCLLPWSVRLDIALETAEALAYLHASDVMHRDVKSNNILLDEKFHVKVADFGLSRLF 1005

Query: 262  PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
            P DVTHVSTAPQGTPGYVDP+Y+QCY+LTDKSDVYSFGVVL+ELIS L+AVD +RHR+D+
Sbjct: 1006 PNDVTHVSTAPQGTPGYVDPEYYQCYQLTDKSDVYSFGVVLVELISSLQAVDITRHRNDV 1065

Query: 322  NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            NL+NMA NKIQ+  L +LVDP+LG+EKD +V+ M T+VAELAFRC+QQ RD+RP+M E++
Sbjct: 1066 NLANMAVNKIQSQELYDLVDPNLGYEKDNSVKRMTTAVAELAFRCLQQQRDLRPSMDEIV 1125

Query: 382  EILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKWV 429
            E+LR  K     T ++KV+D+ +  D  +L K  P  +  DS  +KWV
Sbjct: 1126 EVLRAIKSDEPETQESKVLDVVVRTDELVLLKKGPYPTSPDSVAEKWV 1173

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508169|ref|XP_003624373.1| Ser/Thr protein kinase [Medicago truncatula] gi|355499388|gb|AES80591.1| Ser/Thr protein kinase [Medicago truncatula]

 Score =  530 bits (1364), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 265/407 (65%), Positives = 320/407 (78%), Gaps = 2/407 (0%)

Query: 22   AAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSY 81
            AA  +LG +   ++RRRRK A    S DL  PPSS    + T +   T+TTNSSQSIPSY
Sbjct: 768  AALCLLGFVACFVVRRRRKNAKKPISNDLYMPPSST--TSGTNTGTLTSTTNSSQSIPSY 825

Query: 82   PYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKR 141
            P S T     S YFG +VF+  ELEEAT+NF++SK+LG+GGFG VY G L+DGR+VAVKR
Sbjct: 826  PSSKTSTMPKSFYFGVQVFTYEELEEATNNFHTSKELGEGGFGTVYKGDLKDGRVVAVKR 885

Query: 142  LYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR 201
             YE+NFKR+ QFMNEVEIL +L+H NLV LYGCTS+ SRELLLVYEYI NGTVADHLH  
Sbjct: 886  HYESNFKRVAQFMNEVEILARLRHKNLVTLYGCTSKHSRELLLVYEYISNGTVADHLHGD 945

Query: 202  QPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
            + +SCLLPW VRL IA+ETA ALAYLHASDV+HRDVKSNNILLD  F VKVADFGLSRLF
Sbjct: 946  RSSSCLLPWSVRLDIALETAEALAYLHASDVMHRDVKSNNILLDEKFHVKVADFGLSRLF 1005

Query: 262  PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
            P DVTHVSTAPQGTPGYVDP+Y+QCY+LTDKSDVYSFGVVL+ELIS L+AVD +RHR+D+
Sbjct: 1006 PNDVTHVSTAPQGTPGYVDPEYYQCYQLTDKSDVYSFGVVLVELISSLQAVDITRHRNDV 1065

Query: 322  NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            NL+NMA NKIQ+  L +LVDP+LG+EKD +V+ M T+VAELAFRC+QQ RD+RP+M E++
Sbjct: 1066 NLANMAVNKIQSQELYDLVDPNLGYEKDNSVKRMTTAVAELAFRCLQQQRDLRPSMDEIV 1125

Query: 382  EILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKW 428
            E+LR  K     T ++KV+D+ +  D  +L K  P  +  DS  +KW
Sbjct: 1126 EVLRAIKSDEPETQESKVLDVVVRTDELVLLKKGPYPTSPDSVAEKW 1172

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508171|ref|XP_003624374.1| Ser/Thr protein kinase [Medicago truncatula] gi|355499389|gb|AES80592.1| Ser/Thr protein kinase [Medicago truncatula]

 Score =  530 bits (1364), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 265/407 (65%), Positives = 320/407 (78%), Gaps = 2/407 (0%)

Query: 22   AAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSY 81
            AA  +LG +   ++RRRRK A    S DL  PPSS    + T +   T+TTNSSQSIPSY
Sbjct: 768  AALCLLGFVACFVVRRRRKNAKKPISNDLYMPPSST--TSGTNTGTLTSTTNSSQSIPSY 825

Query: 82   PYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKR 141
            P S T     S YFG +VF+  ELEEAT+NF++SK+LG+GGFG VY G L+DGR+VAVKR
Sbjct: 826  PSSKTSTMPKSFYFGVQVFTYEELEEATNNFHTSKELGEGGFGTVYKGDLKDGRVVAVKR 885

Query: 142  LYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR 201
             YE+NFKR+ QFMNEVEIL +L+H NLV LYGCTS+ SRELLLVYEYI NGTVADHLH  
Sbjct: 886  HYESNFKRVAQFMNEVEILARLRHKNLVTLYGCTSKHSRELLLVYEYISNGTVADHLHGD 945

Query: 202  QPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
            + +SCLLPW VRL IA+ETA ALAYLHASDV+HRDVKSNNILLD  F VKVADFGLSRLF
Sbjct: 946  RSSSCLLPWSVRLDIALETAEALAYLHASDVMHRDVKSNNILLDEKFHVKVADFGLSRLF 1005

Query: 262  PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
            P DVTHVSTAPQGTPGYVDP+Y+QCY+LTDKSDVYSFGVVL+ELIS L+AVD +RHR+D+
Sbjct: 1006 PNDVTHVSTAPQGTPGYVDPEYYQCYQLTDKSDVYSFGVVLVELISSLQAVDITRHRNDV 1065

Query: 322  NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            NL+NMA NKIQ+  L +LVDP+LG+EKD +V+ M T+VAELAFRC+QQ RD+RP+M E++
Sbjct: 1066 NLANMAVNKIQSQELYDLVDPNLGYEKDNSVKRMTTAVAELAFRCLQQQRDLRPSMDEIV 1125

Query: 382  EILRETKDSNLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKW 428
            E+LR  K     T ++KV+D+ +  D  +L K  P  +  DS  +KW
Sbjct: 1126 EVLRAIKSDEPETQESKVLDVVVRTDELVLLKKGPYPTSPDSVAEKW 1172

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224079347|ref|XP_002305829.1| predicted protein [Populus trichocarpa] gi|222848793|gb|EEE86340.1| predicted protein [Populus trichocarpa]

 Score =  518 bits (1335), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 240/300 (80%), Positives = 272/300 (90%)

Query: 86  TDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN 145
           +DL++GS+Y G +VFS +ELEEAT+ F+SSK+LGDGGFG VY G+LRDGR+VAVKRLYE+
Sbjct: 4   SDLDKGSTYLGVRVFSYNELEEATNCFDSSKELGDGGFGTVYYGVLRDGRVVAVKRLYES 63

Query: 146 NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
           N +R EQFMNE+EIL  L+H NLV+LYGCTSR SRELLLVYEY+PNGTVADHLH RQ NS
Sbjct: 64  NMRRAEQFMNEIEILAHLRHKNLVELYGCTSRHSRELLLVYEYLPNGTVADHLHGRQSNS 123

Query: 206 CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV 265
            LL WPVRLSIAIETA ALAYLHASDVIHRDVK+NNILLDN+F VKVADFGLSRLFPTDV
Sbjct: 124 GLLTWPVRLSIAIETASALAYLHASDVIHRDVKTNNILLDNDFHVKVADFGLSRLFPTDV 183

Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN 325
           THVSTAPQGTPGYVDP+Y+QCY LT+KSDVYS+GVVLIELIS LEAVD +RHRHDINLSN
Sbjct: 184 THVSTAPQGTPGYVDPEYYQCYHLTNKSDVYSYGVVLIELISALEAVDITRHRHDINLSN 243

Query: 326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
           MA NKIQN ALNELVDP LGF+KD+ VR MV+SVAELAF C+Q +R+MRPTM+EVLE+LR
Sbjct: 244 MAVNKIQNHALNELVDPFLGFDKDFVVREMVSSVAELAFMCLQHEREMRPTMEEVLEVLR 303

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449442072|ref|XP_004138806.1| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Cucumis sativus] gi|449490207|ref|XP_004158537.1| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Cucumis sativus]

 Score =  513 bits (1322), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 262/430 (60%), Positives = 317/430 (73%), Gaps = 6/430 (1%)

Query: 15  IGIALGSA--AAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTT 72
           IG+++G A  AA I+G   F   R+++K            P    S +T+          
Sbjct: 276 IGVSIGGACLAATIIGCCIFLCFRKKKKQYPIGSVSKEAGPSPRVSDSTSNKDLPPAPLL 335

Query: 73  NS--SQSIPSYPYSITDLERGSSYFGA-KVFSCSELEEATDNFNSSKQLGDGGFGAVYLG 129
           NS  SQSIPSYP S +D+E  ++   A +VF+ +ELE AT+ F+ S++LGDGGFG VY G
Sbjct: 336 NSFQSQSIPSYPSSKSDIETPTTTNHAIRVFNYAELETATNKFDRSRELGDGGFGTVYYG 395

Query: 130 ILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI 189
            L DGR VAVKRLYE+N KR+EQFMNEV+IL  LQH NLVKLYGCTSR S+ LLLVYEYI
Sbjct: 396 KLVDGREVAVKRLYEHNCKRVEQFMNEVDILAHLQHDNLVKLYGCTSRYSQGLLLVYEYI 455

Query: 190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR 249
           PNGTVADHLH  +    LL WP+RL IAIETA AL YLH S++IHRDVK+ NILLDNNF 
Sbjct: 456 PNGTVADHLHGSRMKLGLLSWPIRLRIAIETANALMYLHHSEIIHRDVKTTNILLDNNFT 515

Query: 250 VKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           VKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP+Y+QCY+LT KSDVYSFGVVLIELIS L
Sbjct: 516 VKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYYQCYQLTTKSDVYSFGVVLIELISSL 575

Query: 310 EAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQ 369
            AVDT R RHDINLSNMA +KI++ AL+ELVDP LGF +++ VR+  TSVAELAF C+QQ
Sbjct: 576 RAVDTDRTRHDINLSNMAISKIRSQALDELVDPKLGFNENHEVRSATTSVAELAFLCLQQ 635

Query: 370 DRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIR-IADDAALLKKDSPSLSPDDSGTDKW 428
           +RD+RPTM EV+E+LR+ ++    +  AKV+DI  + DD  L+KK  PS SP+    + W
Sbjct: 636 ERDLRPTMDEVVEVLRKIENEKSNSEMAKVIDIGVVGDDIELIKKAPPSFSPNSVIANNW 695

Query: 429 VSSSNPSSSF 438
           VSSS  + S 
Sbjct: 696 VSSSTTTGSL 705

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567262|ref|XP_003551840.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max]

 Score =  512 bits (1319), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 268/421 (63%), Positives = 333/421 (79%), Gaps = 14/421 (3%)

Query: 4    AGKNGFSTGAGIGIALGSAAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATAT 63
            + K G + GA IG  +  A  VILG ++F +++RRRKT AY K R ++   + +SG T  
Sbjct: 1051 SSKVGVAIGASIGAVV--ALVVILGCVYF-VMQRRRKT-AYNKQRSMELFIAPSSGDTFA 1106

Query: 64   TSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGF 123
            ++  T+ + +S QS  + P     +   S YFG +VF+  ELEEAT NF+SS++LG+GGF
Sbjct: 1107 STTNTSQSLSSYQSSNTDP-----MPPRSYYFGVQVFTYEELEEATKNFDSSRELGEGGF 1161

Query: 124  GAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL 183
            G VY G L+DGR+VAVKR YE+N +RIEQFMNEV+IL +L+H +LV L+GCTSR SRELL
Sbjct: 1162 GTVYKGQLKDGRVVAVKRHYESNSRRIEQFMNEVQILARLRHKSLVTLFGCTSRHSRELL 1221

Query: 184  LVYEYIPNGTVADHLHNRQPNSC-LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNI 242
            LVYE+IPNGTVADHL  R  NS  LLPWPVRL+IA+ETA ALAYLHA+DVIHRDVK+NNI
Sbjct: 1222 LVYEFIPNGTVADHLQGRSSNSTNLLPWPVRLNIAVETAEALAYLHANDVIHRDVKTNNI 1281

Query: 243  LLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVL 302
            LLD+NFRVKVADFGLSR FP  VTHVSTAPQGTPGYVDP+Y+QCY+LTDKSDVYSFGVVL
Sbjct: 1282 LLDDNFRVKVADFGLSRDFPNHVTHVSTAPQGTPGYVDPEYYQCYQLTDKSDVYSFGVVL 1341

Query: 303  IELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAEL 362
            +ELIS L+AVD +R+R D+NL+NMA NKIQN  L+ELVDP LGFE+DYA+R M T VAEL
Sbjct: 1342 VELISSLQAVDINRNRSDVNLANMAINKIQNQELHELVDPYLGFERDYAIRRMTTGVAEL 1401

Query: 363  AFRCVQQDRDMRPTMKEVLEILRETK-DSNLGT-SKAKVVDIRIADDAALLKKDSPSLSP 420
            AFRC+QQ+R++RP+M EV+EILR  K D  LG   + +V+++RI D+A LLKK SP +SP
Sbjct: 1402 AFRCLQQEREIRPSMNEVVEILRGIKSDDGLGAREETEVLEVRI-DEARLLKKVSP-VSP 1459

Query: 421  D 421
            D
Sbjct: 1460 D 1460

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	438
TAIR|locus:2176667	686	AT5G38210 [Arabidopsis thalian	0.908	0.580	0.567	9.4e-114
TAIR|locus:2204465	1296	AT1G66880 [Arabidopsis thalian	0.913	0.308	0.562	5.2e-113
TAIR|locus:2014154	654	AT1G18390 [Arabidopsis thalian	0.719	0.481	0.665	6.1e-110
TAIR|locus:2031230	629	AT1G25390 [Arabidopsis thalian	0.684	0.476	0.677	4.4e-107
TAIR|locus:2046728	708	AT2G23450 [Arabidopsis thalian	0.652	0.403	0.5	1.2e-74
TAIR|locus:2174994	622	AT5G66790 [Arabidopsis thalian	0.673	0.474	0.465	3e-69
TAIR|locus:2205040	792	AT1G69730 [Arabidopsis thalian	0.634	0.351	0.456	1.4e-62
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.664	0.389	0.455	3e-62
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.673	0.392	0.450	4.8e-62
TAIR|locus:2019843	769	WAKL10 "WALL ASSOCIATED KINASE	0.636	0.362	0.451	1e-61

TAIR|locus:2176667 AT5G38210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1122 (400.0 bits), Expect = 9.4e-114, P = 9.4e-114
 Identities = 232/409 (56%), Positives = 285/409 (69%)

Query:    33 CI-IRRRRKTAAYAKSRDLKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTDLERG 91
             CI IRRR+K A    ++ L                                   ++L  G
Sbjct:   283 CIFIRRRKKLATQYTNKGLSTTTPYSSNYTMSNTPTSTTISGSNHSLVPSI---SNLGNG 339

Query:    92 SSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE 151
             S Y G +VFS  ELEEAT+NF  SK+LGDGGFG VY G L+DGR VAVKRL+E + KR+E
Sbjct:   340 SVYSGIQVFSYEELEEATENF--SKELGDGGFGTVYYGTLKDGRAVAVKRLFERSLKRVE 397

Query:   152 QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
             QF NE++IL  L+HPNLV LYGCT+R SRELLLVYEYI NGT+A+HLH  Q  S  + WP
Sbjct:   398 QFKNEIDILKSLKHPNLVILYGCTTRHSRELLLVYEYISNGTLAEHLHGNQAQSRPICWP 457

Query:   212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA 271
              RL IAIETA AL+YLHAS +IHRDVK+ NILLD+N++VKVADFGLSRLFP D TH+STA
Sbjct:   458 ARLQIAIETASALSYLHASGIIHRDVKTTNILLDSNYQVKVADFGLSRLFPMDQTHISTA 517

Query:   272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI 331
             PQGTPGYVDP+Y+QCY+L +KSDVYSFGVVL ELIS  EAVD +RHRHDINL+NMA +KI
Sbjct:   518 PQGTPGYVDPEYYQCYRLNEKSDVYSFGVVLSELISSKEAVDITRHRHDINLANMAISKI 577

Query:   332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN 391
             QN A++EL D SLGF +D +V+ M++SVAELAFRC+QQ+RD+RP+M E++E+LR  +   
Sbjct:   578 QNDAVHELADLSLGFARDPSVKKMMSSVAELAFRCLQQERDVRPSMDEIVEVLRVIQKDG 637

Query:   392 LGTSKAKVVDIRI--ADDAAXXXXXXXXXXXXXXGTDKWV-SSSNPSSS 437
             +  SK  VV+I +   DD                 TDK   SSSN ++S
Sbjct:   638 ISDSKDVVVEIDVNGGDDVGLLKHGVPPPLSPE--TDKTTASSSNTTAS 684

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2204465 AT1G66880 [Arabidopsis thaliana (taxid:3702)]

 Score = 1115 (397.6 bits), Expect = 5.2e-113, P = 5.2e-113
 Identities = 231/411 (56%), Positives = 278/411 (67%)

Query:    31 FFCIIRRRRKTA-AYAKSRDLKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTDLE 89
             F CI RRRRKT  A   S+ L                                   ++L 
Sbjct:   892 FLCI-RRRRKTQDAQYTSKSLPITSYSSRDTSRNPTSTTISSSSNHSLLPSI----SNLA 946

Query:    90 RGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR 149
               S Y G +VFS  ELEEAT+NF  S++LGDGGFG VY G+L+DGR VAVKRLYE + KR
Sbjct:   947 NRSDYCGVQVFSYEELEEATENF--SRELGDGGFGTVYYGVLKDGRAVAVKRLYERSLKR 1004

Query:   150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
             +EQF NE+EIL  L+HPNLV LYGCTSR SRELLLVYEYI NGT+A+HLH  +  +  L 
Sbjct:  1005 VEQFKNEIEILKSLKHPNLVILYGCTSRHSRELLLVYEYISNGTLAEHLHGNRAEARPLC 1064

Query:   210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS 269
             W  RL+IAIETA AL++LH   +IHRD+K+ NILLD+N++VKVADFGLSRLFP D TH+S
Sbjct:  1065 WSTRLNIAIETASALSFLHIKGIIHRDIKTTNILLDDNYQVKVADFGLSRLFPMDQTHIS 1124

Query:   270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN 329
             TAPQGTPGYVDP+Y+QCY+L +KSDVYSFGVVL ELIS  EAVD +RHRHDINL+NMA +
Sbjct:  1125 TAPQGTPGYVDPEYYQCYQLNEKSDVYSFGVVLTELISSKEAVDITRHRHDINLANMAVS 1184

Query:   330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD 389
             KIQN AL+ELVD SLG++ D  VR  + +VAELAFRC+QQ+RD+RP M E++EILR  KD
Sbjct:  1185 KIQNNALHELVDSSLGYDNDPEVRRKMMAVAELAFRCLQQERDVRPAMDEIVEILRGIKD 1244

Query:   390 SNLGTSKAK---VVDIRIADDAAXXXXXXXXXXXXXXGTDKWVSSSNPSSS 437
                     K   VVDI                      TDKW SSS+ ++S
Sbjct:  1245 DEKKRVLVKSPDVVDIECGGGDDVGLLRNSVPPPISPETDKWTSSSDTAAS 1295

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2014154 AT1G18390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
 Identities = 211/317 (66%), Positives = 249/317 (78%)

Query:    87 DLERGSSYF-GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN 145
             D+E+      G  +FS  ELEEAT+NF+ SK+LGDGGFG VY G L+DGR VAVKRLY+N
Sbjct:   318 DIEKAEELLVGVHIFSYEELEEATNNFDPSKELGDGGFGTVYYGKLKDGRSVAVKRLYDN 377

Query:   146 NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
             NFKR EQF NEVEILT L+HPNLV L+GC+S+QSR+LLLVYEY+ NGT+ADHLH  Q N 
Sbjct:   378 NFKRAEQFRNEVEILTGLRHPNLVALFGCSSKQSRDLLLVYEYVANGTLADHLHGPQANP 437

Query:   206 CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV 265
               LPW +RL IA+ETA AL YLHAS +IHRDVKSNNILLD NF VKVADFGLSRLFP D 
Sbjct:   438 SSLPWSIRLKIAVETASALKYLHASKIIHRDVKSNNILLDQNFNVKVADFGLSRLFPMDK 497

Query:   266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN 325
             THVSTAPQGTPGYVDPDY  CY+L++KSDVYSF VVL+ELIS L AVD +R R +INLSN
Sbjct:   498 THVSTAPQGTPGYVDPDYHLCYQLSNKSDVYSFAVVLMELISSLPAVDITRPRQEINLSN 557

Query:   326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
             MA  KIQN  L ++VDPSLGF+ D  VR  V +VAELAF+C+Q D+D+RP M  V + L 
Sbjct:   558 MAVVKIQNHELRDMVDPSLGFDTDTRVRQTVIAVAELAFQCLQSDKDLRPCMSHVQDTLT 617

Query:   386 ETKDSNLGTSKAKVVDI 402
               +++  G S+  VVD+
Sbjct:   618 RIQNNGFG-SEMDVVDV 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006984 "ER-nucleus signaling pathway" evidence=RCA

GO:0009407 "toxin catabolic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010583 "response to cyclopentenone" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2031230 AT1G25390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1059 (377.8 bits), Expect = 4.4e-107, P = 4.4e-107
 Identities = 204/301 (67%), Positives = 244/301 (81%)

Query:    86 TDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN 145
             +D+E    +F   +FS  EL+ ATDNF+  + LGDGGFG VY G +RDGR VAVKRLYE+
Sbjct:   265 SDVEFSQVFFKIPIFSYKELQAATDNFSKDRLLGDGGFGTVYYGKVRDGREVAVKRLYEH 324

Query:   146 NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ-PN 204
             N++R+EQFMNE+EILT+L H NLV LYGCTSR+SRELLLVYE+IPNGTVADHL+    P+
Sbjct:   325 NYRRLEQFMNEIEILTRLHHKNLVSLYGCTSRRSRELLLVYEFIPNGTVADHLYGENTPH 384

Query:   205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD 264
                L W +RLSIAIETA ALAYLHASD+IHRDVK+ NILLD NF VKVADFGLSRL P+D
Sbjct:   385 QGFLTWSMRLSIAIETASALAYLHASDIIHRDVKTTNILLDRNFGVKVADFGLSRLLPSD 444

Query:   265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS 324
             VTHVSTAPQGTPGYVDP+Y +CY LTDKSDVYSFGVVL+ELIS   AVD SR + +INLS
Sbjct:   445 VTHVSTAPQGTPGYVDPEYHRCYHLTDKSDVYSFGVVLVELISSKPAVDISRCKSEINLS 504

Query:   325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
             ++A NKIQN A +EL+D +LG+  +  VR M T VAELAF+C+QQD  MRPTM++V+  L
Sbjct:   505 SLAINKIQNHATHELIDQNLGYATNEGVRKMTTMVAELAFQCLQQDNTMRPTMEQVVHEL 564

Query:   385 R 385
             +
Sbjct:   565 K 565

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
 Identities = 146/292 (50%), Positives = 209/292 (71%)

Query:   100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI 159
             F   E+E+ATD F+  ++LG G +G VY G L++   VA+KRL   + + ++Q MNE+++
Sbjct:   336 FPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKL 395

Query:   160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
             L+ + HPNLV+L GC   Q  + +LVYEY+PNGT+++HL   + +   LPW +RL++A +
Sbjct:   396 LSSVSHPNLVRLLGCCIEQG-DPVLVYEYMPNGTLSEHLQRDRGSG--LPWTLRLTVATQ 452

Query:   220 TAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
             TA A+AYLH+S    + HRD+KS NILLD +F  KVADFGLSRL  T+ +H+STAPQGTP
Sbjct:   453 TAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTP 512

Query:   277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
             GY+DP Y QC+ L+DKSDVYSFGVVL E+I+GL+ VD +R   +INL+ +A +KI +G +
Sbjct:   513 GYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCI 572

Query:   337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK 388
             +E++DP L  + D    + + +VAELAFRC+    DMRPTM EV + L + +
Sbjct:   573 DEIIDPILDLDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQIR 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2174994 AT5G66790 [Arabidopsis thaliana (taxid:3702)]

 Score = 702 (252.2 bits), Expect = 3.0e-69, P = 3.0e-69
 Identities = 143/307 (46%), Positives = 207/307 (67%)

Query:   100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI 159
             ++  E+E+ATD+F+    LG G +G VY G   +   VA+KRL   +   I+Q +NE+++
Sbjct:   302 YTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKL 361

Query:   160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL-HNR-QPNSCLLPWPVRLSIA 217
             L+ + HPNLV+L GC      E  LVYE++PNGT+  HL H R QP    L W +RL+IA
Sbjct:   362 LSSVSHPNLVRLLGCCFADG-EPFLVYEFMPNGTLYQHLQHERGQPP---LSWQLRLAIA 417

Query:   218 IETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRL-FPTD--VTHVSTA 271
              +TA A+A+LH+S    + HRD+KS+NILLD+ F  K++DFGLSRL   TD   +H+STA
Sbjct:   418 CQTANAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHISTA 477

Query:   272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI 331
             PQGTPGY+DP Y Q ++L+DKSDVYSFGVVL+E+ISG + +D +R   ++NL+++A ++I
Sbjct:   478 PQGTPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVDRI 537

Query:   332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN 391
               G + +++DP L  E +  +   + ++AELAFRC+   R+MRPTM E+ E L   K  +
Sbjct:   538 GRGRVVDIIDPCLNKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRIKLMH 597

Query:   392 LGTSKAK 398
              GT   K
Sbjct:   598 YGTESGK 604

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 130/285 (45%), Positives = 193/285 (67%)

Query:    99 VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVE 158
             VFS  ELE+AT+NF+S++ LG GG G VY G+L DGRIVAVK+    +  ++E+F+NEV 
Sbjct:   434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493

Query:   159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
             IL+++ H N+VKL GC   +++  +LVYE+IPNG + +HLH+    + +  W +RL IAI
Sbjct:   494 ILSQINHRNIVKLLGCCL-ETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAI 552

Query:   219 ETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
             + AGAL+YLH+S    + HRDVKS NI+LD  +R KV+DFG SR    D TH++T   GT
Sbjct:   553 DIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGT 612

Query:   276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA 335
              GY+DP+YFQ  + TDKSDVYSFGVVL+ELI+G +++   R + +  L+      ++   
Sbjct:   613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENK 672

Query:   336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
             L +++D  +   +D  + + VT+ A++A +C+      RP+M+EV
Sbjct:   673 LFDIIDARI---RDGCMLSQVTATAKVARKCLNLKGRKRPSMREV 714

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 636 (228.9 bits), Expect = 3.0e-62, P = 3.0e-62
 Identities = 138/303 (45%), Positives = 194/303 (64%)

Query:    97 AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNE 156
             +++FS  ELE+ATDNFN ++ LG GG G VY G+L DGRIVAVKR    +  R+E+F+NE
Sbjct:   401 SRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINE 460

Query:   157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
             V +L ++ H N+VKL GC   ++   +LVYE++PNG +   LH+ + +   + W VRL I
Sbjct:   461 VVVLAQINHRNIVKLLGCCL-ETEVPVLVYEFVPNGDLCKRLHD-ESDDYTMTWEVRLHI 518

Query:   217 AIETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             AIE AGAL+YLH++    + HRD+K+ NILLD   R KV+DFG SR    D TH++T   
Sbjct:   519 AIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVA 578

Query:   274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
             GT GYVDP+YFQ  K T+KSDVYSFGVVL+EL++G +     R   +  L+      ++ 
Sbjct:   579 GTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKE 638

Query:   334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV---LEILRETK-D 389
               + ++VD  +   KD    + V SVA LA RC+ +    RP M+EV   LE++R +  D
Sbjct:   639 NRVLDIVDDRI---KDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYD 695

Query:   390 SNL 392
             S +
Sbjct:   696 SGI 698

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
 Identities = 138/306 (45%), Positives = 194/306 (63%)

Query:    90 RGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR 149
             RG +   +K+FS  ELE+ATDNFN ++ LG GG G VY G+L DGRIVAVKR    +  +
Sbjct:   399 RGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDK 458

Query:   150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
             +E+F+NEV +L+++ H N+VKL GC   ++   +LVYE+IPNG +   LH+   +   + 
Sbjct:   459 VEEFINEVGVLSQINHRNIVKLMGCCL-ETEVPILVYEHIPNGDLFKRLHH-DSDDYTMT 516

Query:   210 WPVRLSIAIETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
             W VRL I++E AGALAYLH++    V HRDVK+ NILLD  +R KV+DFG SR    D T
Sbjct:   517 WDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQT 576

Query:   267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
             H++T   GT GY+DP+YFQ  + TDKSDVYSFGVVL+ELI+G +     R   +  L + 
Sbjct:   577 HLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSH 636

Query:   327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV---LEI 383
                 ++   + ++VD  +   K+      V +VA+LA RC+      RP M+EV   LE 
Sbjct:   637 FNEAMKQNRVLDIVDSRI---KEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELER 693

Query:   384 LRETKD 389
             +R + +
Sbjct:   694 IRSSPE 699

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 631 (227.2 bits), Expect = 1.0e-61, P = 1.0e-61
 Identities = 129/286 (45%), Positives = 191/286 (66%)

Query:    98 KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
             +VF+  ELE+AT+NF+ ++ LG+GG G VY G+L DGRIVAVK+    +  ++E+F+NEV
Sbjct:   419 RVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 478

Query:   158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
              IL+++ H N+VKL GC   ++   +LVYE+IPNG + +HLH+   +  +  W VRL IA
Sbjct:   479 VILSQINHRNIVKLLGCCL-ETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIA 537

Query:   218 IETAGALAYLHA---SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG 274
             ++ AGAL+YLH+   S + HRD+KS NI+LD   R KV+DFG SR    D TH++T   G
Sbjct:   538 VDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSG 597

Query:   275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
             T GY+DP+YFQ  + TDKSDVYSFGVVL ELI+G ++V   R +    L+   T  ++  
Sbjct:   598 TVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKEN 657

Query:   335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              L++++D  +   +D    N VT+ A++A +C+      RP+M++V
Sbjct:   658 RLSDIIDARI---RDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQV 700

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006182 "cGMP biosynthetic process" evidence=IDA

GO:0006952 "defense response" evidence=IEP

GO:0009617 "response to bacterium" evidence=IEP

GO:0009620 "response to fungus" evidence=IEP

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009723 "response to ethylene stimulus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	438
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-56
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-55
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-52
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-51
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-43
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-38
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-38
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-36
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-36
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-35
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-35
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-35
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-34
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-33
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-33
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-33
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-32
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-32
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-31
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-31
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-30
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-30
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-30
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-29
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-29
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-28
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-28
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-28
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-27
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-27
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-27
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-27
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-27
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-27
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-26
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-26
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-24
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-23
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-23
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-23
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-23
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-23
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-22
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-22
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-21
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-21
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-21
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-21
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-20
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-20
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-20
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-20
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-20
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-19
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-19
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-19
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-18
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-18
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-18
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-17
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-17
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-16
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-14
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-13
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-04

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  185 bits (471), Expect = 2e-56
 Identities = 90/271 (33%), Positives = 133/271 (49%), Gaps = 60/271 (22%)

Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           LG+GGFG VYL   +  G+ VA+K +  E++   +E+ + E+EIL KL HPN+VKLYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV- 59

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
                 L LV EY   G++ D L   +     L     L I ++    L YLH++ +IHR
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 236 DVKSNNILLDN-NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-YFQCYKLTDKS 293
           D+K  NILLD+ N +VK+ADFGLS+L  +D + + T   GTP Y+ P+        ++KS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKS 175

Query: 294 DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR 353
           D++S GV+L EL                                                
Sbjct: 176 DIWSLGVILYEL------------------------------------------------ 187

Query: 354 NMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                + +L  + +Q+D + RP+ KE+LE L
Sbjct: 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  184 bits (470), Expect = 1e-55
 Identities = 80/271 (29%), Positives = 129/271 (47%), Gaps = 29/271 (10%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           ++LG+G FG VYL    + G++VA+K +  +   K  E+ + E++IL KL+HPN+V+LY 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
                  +L LV EY   G + D L  R      L          +   AL YLH+  ++
Sbjct: 65  VF-EDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSKGIV 119

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+K  NILLD +  VK+ADFGL+R         +    GTP Y+ P+           
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKAV 177

Query: 294 DVYSFGVVLIELISGLEAVDTSRH--RHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           D++S GV+L EL++G       +     D  L  +   KI      +   P   ++    
Sbjct: 178 DIWSLGVILYELLTG-------KPPFPGDDQLLELF-KKIGKP---KPPFPPPEWDISPE 226

Query: 352 VRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            ++++        + + +D + R T +E L+
Sbjct: 227 AKDLIR-------KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  181 bits (461), Expect = 2e-54
 Identities = 88/285 (30%), Positives = 130/285 (45%), Gaps = 47/285 (16%)

Query: 116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLV 169
           K+LG+G FG VY G L+         VAVK L E   +   E+F+ E  I+ KL HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           +L G CT  Q   L +V EY+P G + D L         L     L +A++ A  + YL 
Sbjct: 65  RLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLE 119

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD-----PDY 283
           + + +HRD+ + N L+  N  VK++DFGLSR    D+       +   G +      P+ 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 284 FQCYKLTDKSDVYSFGVVLIELISG----LEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            +  K T KSDV+SFGV+L E+ +        +                  +++G    L
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLELLEDG--YRL 223

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
             P           N    + EL  +C   D + RPT  E++E L
Sbjct: 224 PRP----------ENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  178 bits (453), Expect = 3e-53
 Identities = 88/285 (30%), Positives = 135/285 (47%), Gaps = 46/285 (16%)

Query: 115 SKQLGDGGFGAVYLGILRD-----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
            K+LG+G FG VY G L+         VAVK L E+ + ++IE+F+ E  I+ KL HPN+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           VKL G    +   L +V EY+  G +  +L   +P    L     LS A++ A  + YL 
Sbjct: 64  VKLLGV-CTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLE 119

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS--------TAPQGTPGYV 279
           + + IHRD+ + N L+  N  VK++DFGLSR L+  D              AP+      
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES----- 174

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
                +  K T KSDV+SFGV+L E+ +        +    ++   +    ++NG     
Sbjct: 175 ----LKEGKFTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEEVL-EYLKNGYRLPQ 224

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                         N    + +L  +C  +D + RPT  E++EIL
Sbjct: 225 PP------------NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (449), Expect = 2e-52
 Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 45/284 (15%)

Query: 116 KQLGDGGFGAVYLGILRDG-----RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           K+LG+G FG VY G L+         VAVK L E+ + ++IE+F+ E  I+ KL HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           KL G    +   L++V EY+P G + D+L   +P    L     LS A++ A  + YL +
Sbjct: 65  KLLGV-CTEEEPLMIVMEYMPGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLES 121

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS--------TAPQGTPGYVD 280
            + IHRD+ + N L+  N  VK++DFGLSR L+  D   V          AP+       
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES------ 175

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
               +  K T KSDV+SFGV+L E+ +             ++ + +    ++ G      
Sbjct: 176 ---LKEGKFTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAEVL-EYLKKGYRLPK- 225

Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            P           N    + +L  +C  +D + RPT  E++EIL
Sbjct: 226 -PP----------NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  175 bits (446), Expect = 4e-52
 Identities = 86/275 (31%), Positives = 132/275 (48%), Gaps = 23/275 (8%)

Query: 112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLY--ENNFKRIEQFMNEVEILTKLQHPNL 168
           +   ++LG G FG VY    +  G+IVAVK L       K+ +    E+ IL +L HPN+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V+L          L LV EY   G + D+L    P    L       IA++    L YLH
Sbjct: 61  VRLID-AFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLH 115

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-YFQCY 287
           ++ +IHRD+K  NILLD N  VK+ADFGL++      + ++T   GTP Y+ P+      
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGN 174

Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE 347
               K DV+S GV+L EL++G           +  L  +         +  ++ P L F+
Sbjct: 175 GYGPKVDVWSLGVILYELLTG-----KPPFSGENILDQLQL-------IRRILGPPLEFD 222

Query: 348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +     +      +L  +C+ +D   RPT +E+L+
Sbjct: 223 EPK-WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  173 bits (442), Expect = 2e-51
 Identities = 65/198 (32%), Positives = 112/198 (56%), Gaps = 9/198 (4%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           + LG G FG+VYL + +D G ++AVK   L  ++ + +E    E+ IL+ LQHPN+V+ Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 173 GC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           G     +   L +  EY+  G+++  L         LP PV      +    LAYLH++ 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLAYLHSNG 121

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
           ++HRD+K  NIL+D++  VK+ADFG ++ L   +    + + +GTP ++ P+  +  +  
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 291 DKSDVYSFGVVLIELISG 308
             +D++S G  +IE+ +G
Sbjct: 182 RAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  173 bits (440), Expect = 3e-51
 Identities = 87/288 (30%), Positives = 132/288 (45%), Gaps = 44/288 (15%)

Query: 116 KQLGDGGFGAVYLGILRDG----RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG+G FG VY G L+        VAVK L E+ + +  + F+ E  ++ KL HPN+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-----LPWPVRLSIAIETAGALA 225
           L G    +   L LV EY+  G + D+L   +P         L     LS AI+ A  + 
Sbjct: 61  LLGV-CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYF 284
           YL +   +HRD+ + N L+  +  VK++DFGLSR    D  +        P  ++ P+  
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 285 QCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKIQNGALN 337
           +    T KSDV+SFGV+L E+ +       GL   +   +             ++ G   
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-------------LRKG--Y 224

Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
            L  P    ++ Y          EL   C Q D + RPT  E++E L 
Sbjct: 225 RLPKPEYCPDELY----------ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  154 bits (393), Expect = 3e-44
 Identities = 83/276 (30%), Positives = 131/276 (47%), Gaps = 34/276 (12%)

Query: 116 KQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNFKRIEQ--FMNEVEILTKLQHPNLVKLY 172
           KQ+G G FG VYL     DG++  +K +  +N    E+   +NEV+IL KL HPN++K Y
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
                + + L +V EY   G ++  +  ++      P    L   ++   AL YLH+  +
Sbjct: 66  ESFEEKGK-LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           +HRD+K  NI L +N  VK+ DFG+S++  + V    T   GTP Y+ P+  Q      K
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNKPYNYK 183

Query: 293 SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT--NKIQNG---ALNELVDPSLGFE 347
           SD++S G VL EL +          +H     N+     KI  G    +       L   
Sbjct: 184 SDIWSLGCVLYELCTL---------KHPFEGENLLELALKILKGQYPPIPSQYSSEL--- 231

Query: 348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI 383
                RN+V          +Q+D + RP++ ++L+ 
Sbjct: 232 -----RNLV-------SSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  151 bits (385), Expect = 3e-43
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 29/205 (14%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G GGFG VY     R G+ VA+K +   + ++ E+ +NE++IL K +HPN+VK YG 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETAGALAYLH 228
             ++  EL +V E+   G++ D L +             L+      +  E    L YLH
Sbjct: 66  YLKKD-ELWIVMEFCSGGSLKDLLKST---------NQTLTESQIAYVCKELLKGLEYLH 115

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDY 283
           ++ +IHRD+K+ NILL ++  VK+ DFGLS         +S         GTP ++ P+ 
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLS-------AQLSDTKARNTMVGTPYWMAPEV 168

Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
                   K+D++S G+  IEL  G
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  139 bits (353), Expect = 3e-38
 Identities = 70/207 (33%), Positives = 106/207 (51%), Gaps = 12/207 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLG---ILRD--GRIVAVKRL-YENNFKRIEQFMNEVEILTKL 163
            +    KQLG+G FG V L     L D  G  VAVK L +    +    F  E+EIL  L
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 164 QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
            H N+VK  G C     R L L+ EY+P+G++ D+L   +     +     L  + +   
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPG-YVD 280
            + YL +   IHRD+ + NIL+++   VK++DFGL+++ P D   +    P  +P  +  
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
           P+  +  K +  SDV+SFGV L EL +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  141 bits (356), Expect = 4e-38
 Identities = 93/339 (27%), Positives = 152/339 (44%), Gaps = 26/339 (7%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHP- 166
           ++   ++LG+G FG VYL   RD ++VA+K L    E+  K +E+F+ E++IL  L HP 
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N+VKLY     +   L LV EY+  G++ D L        L      L I  +   AL Y
Sbjct: 59  NIVKLYDFFQDEGS-LYLVMEYVDGGSLEDLLKKIGRKGPLSE-SEALFILAQILSALEY 116

Query: 227 LHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVD 280
           LH+  +IHRD+K  NILLD +   VK+ DFGL++L P   +  S         GTPGY+ 
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 281 PDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN 337
           P+          +  SD++S G+ L EL++GL   +  ++    + +     ++   +L 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKA 397
             + PS       A  +++        + + +D   R +     ++  +           
Sbjct: 237 SPLSPSNPELISKAASDLLK-------KLLAKDPKNRLSSSS--DLSHDLLAHLKLKESD 287

Query: 398 KVVDIRIADDAALLKKDSPSLSPDDSGTDKWVSSSNPSS 436
               ++  D A L     PSL    S  +    S +   
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLK 326

Length = 384

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  138 bits (349), Expect = 5e-38
 Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 33/274 (12%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V+LG  R    VA+K + E      + F+ E +++ KL HPNLV+LYG  
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           ++Q R + +V EY+ NG + ++L  R+    +  L     L +  +   A+ YL ++  I
Sbjct: 69  TKQ-RPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLESNGFI 122

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPDYFQCYKLT 290
           HRD+ + N L+  +  VKV+DFGL+R    D     T+ QGT     +  P+ F   + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 291 DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            KSDV+SFGV++ E+ S                  M   +  N  + E V  S G+ + Y
Sbjct: 180 SKSDVWSFGVLMWEVFSE---------------GKMPYERFSNSEVVESV--SAGY-RLY 221

Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
             +   T V  + + C  +  + RP  K++L  L
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 1e-36
 Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 11/202 (5%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHPN 167
           N+     +G G FG VY G+ L  G  VA+K++     K   ++  M E+++L  L+HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VK  G     S  L ++ EY  NG+    L          P  +      +    LAYL
Sbjct: 61  IVKYIGSI-ETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           H   VIHRD+K+ NIL   +  VK+ADFG++ +L   DV+    +  GTP ++ P+  + 
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEM 173

Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              +  SD++S G  +IEL++G
Sbjct: 174 SGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 8e-36
 Identities = 70/200 (35%), Positives = 105/200 (52%), Gaps = 18/200 (9%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           LG G FG V L   +D G++ A+K L        K +E  + E  IL+++ HP +VKL+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 174 CTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
             + Q+ E L LV EY P G +  HL              R   A E   AL YLH+  +
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSKE---GRFSEERARFYAA-EIVLALEYLHSLGI 114

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ--CYKLT 290
           I+RD+K  NILLD +  +K+ DFGL++   ++ +  +T   GTP Y+ P+      Y   
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY--- 170

Query: 291 DKS-DVYSFGVVLIELISGL 309
            K+ D +S GV+L E+++G 
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  131 bits (332), Expect = 3e-35
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 29/223 (13%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL-Q 164
           D+F   K +G+G F  V L   +   +  A+K L        K+++    E E+LT+L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP ++KLY  T +    L  V EY PNG +  ++        L         A E   AL
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRK---YGSL-DEKCTRFYAAEILLAL 115

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ----------- 273
            YLH+  +IHRD+K  NILLD +  +K+ DFG +++   + +  S               
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 274 --------GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                   GT  YV P+          SD+++ G ++ ++++G
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  131 bits (330), Expect = 3e-35
 Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 43/275 (15%)

Query: 117 QLGDGGFGAVYLGIL-RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+  +    VAVK L E+    +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +R+     ++ E++  G + D+L  R+ N   +   V L +A + + A+ YL   + IHR
Sbjct: 72  TREP-PFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPDYFQCYKLTDK 292
           D+ + N L+  N  VKVADFGLSRL   D     TA  G      +  P+     K + K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 293 SDVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK 348
           SDV++FGV+L E+    +S    +D S+    +                         EK
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------------------EK 220

Query: 349 DYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
            Y +         V EL   C Q +   RP+  E+
Sbjct: 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  129 bits (327), Expect = 7e-35
 Identities = 69/196 (35%), Positives = 107/196 (54%), Gaps = 12/196 (6%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG-C 174
           ++LG G FG V++G       VAVK L        E F+ E +I+ KL+H  LV+LY  C
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +  +   + +V EY+  G++ D L +       L  P  + +A + A  +AYL + + IH
Sbjct: 71  S--EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT--P-GYVDPDYFQCYKLTD 291
           RD+ + NIL+  N   K+ADFGL+RL   D     TA +G   P  +  P+     + T 
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEAANYGRFTI 183

Query: 292 KSDVYSFGVVLIELIS 307
           KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  129 bits (325), Expect = 3e-34
 Identities = 76/200 (38%), Positives = 111/200 (55%), Gaps = 11/200 (5%)

Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V L     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             G C S   R L LV EY+P G++ D+L   Q +   L     L  A +    + YL +
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGY-VDPDYFQCY 287
              +HRD+ + NIL+++  RVK+ DFGL+++ P D   +    P  +P +   P+     
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K +  SDV+SFGVVL EL +
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  126 bits (319), Expect = 1e-33
 Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 6/193 (3%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG-C 174
           ++LG G FG V+ G+  +   VAVK L        + F+ E +I+ KL+HP L++LY  C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           T      + +V E +  G++ ++L      +  LP  +   +A + A  +AYL A + IH
Sbjct: 71  T--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQNYIH 126

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+ + N+L+  N   KVADFGL+R+   D+       +    +  P+     + + KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 295 VYSFGVVLIELIS 307
           V+SFG++L E+++
Sbjct: 187 VWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  126 bits (317), Expect = 2e-33
 Identities = 81/269 (30%), Positives = 135/269 (50%), Gaps = 29/269 (10%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++ KL H  LV+LYG  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 176 SRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           ++Q R + +V EY+ NG + ++L  H ++     L     L +  +    +AYL +   I
Sbjct: 69  TKQ-RPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESKQFI 122

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDK 292
           HRD+ + N L+D+   VKV+DFGLSR +  D  + S+     P  +  P+     K + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 293 SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAV 352
           SDV++FGV++ E+ S        +  ++   ++    K+  G    L  P L  EK YA+
Sbjct: 182 SDVWAFGVLMWEVYS------LGKMPYERFNNSETVEKVSQG--LRLYRPHLASEKVYAI 233

Query: 353 RNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
                      + C  +  + RPT +++L
Sbjct: 234 ----------MYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  125 bits (316), Expect = 2e-33
 Identities = 67/198 (33%), Positives = 111/198 (56%), Gaps = 5/198 (2%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
                 +++G G FG V+LG   + R VA+K + E      E F+ E +++ KL HP LV
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLV 62

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +LYG  + +S  + LV+E++ +G ++D+L  ++           L + ++    +AYL +
Sbjct: 63  QLYGVCTERS-PICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLES 118

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           S+VIHRD+ + N L+  N  VKV+DFG++R    D    ST  +    +  P+ F   K 
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178

Query: 290 TDKSDVYSFGVVLIELIS 307
           + KSDV+SFGV++ E+ S
Sbjct: 179 SSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  125 bits (315), Expect = 3e-33
 Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 26/271 (9%)

Query: 118 LGDGGFG-AVYLGILRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           LG G FG A       D  +V  K   L   + K     +NE+ IL+ LQHPN++  Y  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN- 66

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
                  LL+  EY   GT+ D +  ++    L    + L    +   A++Y+H + ++H
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQ--LFEEEMVLWYLFQIVSAVSYIHKAGILH 124

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+K+ NI L     +K+ DFG+S++  ++ +   T   GTP Y+ P+  Q  K   KSD
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFKSD 183

Query: 295 VYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRN 354
           +++ G VL EL++     D +      N  N+   KI  G    +V           + +
Sbjct: 184 IWALGCVLYELLTLKRTFDAT------NPLNLV-VKIVQGNYTPVVSVY-----SSELIS 231

Query: 355 MVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
           +V S        +QQD + RPT  EVL+   
Sbjct: 232 LVHS-------LLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  125 bits (316), Expect = 3e-33
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 34/281 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPN 167
            +    K LG G  G VY    +  G+I A+K+++ + + +  +Q + E++ L   + P 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VK YG   ++  E+ +V EY+  G++AD L  +      +P PV   IA +    L YL
Sbjct: 61  VVKCYGAFYKEG-EISIVLEYMDGGSLAD-LLKKVGK---IPEPVLAYIARQILKGLDYL 115

Query: 228 HA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           H    +IHRD+K +N+L+++   VK+ADFG+S++    +   +T   GT  Y+ P+  Q 
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQG 174

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT-----NKIQNGALNELVD 341
              +  +D++S G+ L+E   G         +         +       I +G    L  
Sbjct: 175 ESYSYAADIWSLGLTLLECALG---------KFPFLPPGQPSFFELMQAICDGPPPSL-- 223

Query: 342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           P+  F  ++  R+ ++        C+Q+D   RP+  E+L+
Sbjct: 224 PAEEFSPEF--RDFIS-------ACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  125 bits (316), Expect = 6e-33
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 29/212 (13%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
            + + + +++G+G  G VY    R  G+ VA+K++     +  E  +NE+ I+   +HPN
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVRLS------IAIET 220
           +V  Y        EL +V EY+  G++ D          ++    VR++      +  E 
Sbjct: 77  IVDYYDSY-LVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVCREV 125

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG----LSRLFPTDVTHVSTAPQGTP 276
              L YLH+ +VIHRD+KS+NILL  +  VK+ADFG    L++      + V     GTP
Sbjct: 126 LQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-----GTP 180

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            ++ P+  +      K D++S G++ IE+  G
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  124 bits (314), Expect = 9e-33
 Identities = 71/211 (33%), Positives = 109/211 (51%), Gaps = 21/211 (9%)

Query: 116 KQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNL 168
           ++LG+G FG V+LG         D  +VAVK L E       + F  E E+LT  QH N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 169 VKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----------LSIA 217
           VK YG CT  +    ++V+EY+ +G +   L +  P++  L  P            L IA
Sbjct: 71  VKFYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTP 276
           ++ A  + YL +   +HRD+ + N L+  +  VK+ DFG+SR ++ TD   V        
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            ++ P+     K T +SDV+SFGVVL E+ +
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 1e-32
 Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 23/200 (11%)

Query: 115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
              +G G FG V LG  R G+ VAVK L +++    + F+ E  ++T L+HPNLV+L G 
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLG- 67

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
              Q   L +V EY+  G++ D+L +R     ++    +L  A++    + YL   + +H
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKNFVH 125

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS-------TAPQGTPGYVDPDYFQCY 287
           RD+ + N+L+  +   KV+DFGL++         S       TAP+           +  
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWTAPEA---------LREK 174

Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFG++L E+ S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  122 bits (308), Expect = 4e-32
 Identities = 86/271 (31%), Positives = 138/271 (50%), Gaps = 27/271 (9%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG-C 174
           K+LG G FG V+LG  R    VA+K + E      E F+ E +++ KL HP LV+LYG C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           T  Q + L +V E++ NG + ++L  RQ     L   + LS+  +    + YL  +  IH
Sbjct: 69  T--QQKPLYIVTEFMENGCLLNYLRQRQGK---LSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKS 293
           RD+ + N L+ +   VKV+DFG++R +  D  + S++    P  +  P+ F   K + KS
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 294 DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR 353
           DV+SFGV++ E+ +                  M   K  N  + E++  S GF + Y  +
Sbjct: 183 DVWSFGVLMWEVFTE---------------GKMPFEKKSNYEVVEMI--SRGF-RLYRPK 224

Query: 354 NMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
               +V E+ + C  +  + RPT  E+L  +
Sbjct: 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 1e-31
 Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 20/219 (9%)

Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           L + T  F   + +G+G +G VY     + G++VA+K + +      E+   E  IL K 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKY 59

Query: 164 -QHPNLVKLYGCTSRQSR-----ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
             HPN+   YG   +++      +L LV E    G+V D +   +     L       I 
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---G 274
            ET   LAYLH + VIHRD+K  NILL  N  VK+ DFG+S      +           G
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIG 175

Query: 275 TPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISG 308
           TP ++ P+   C          +SDV+S G+  IEL  G
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  119 bits (299), Expect = 7e-31
 Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 116 KQLGDGGFGAVYLGILRD--GRI--VAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVK 170
           K+LGDG FG V  G      G++  VAVK L  +    I + F+ E  I+  L H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           LYG        L++V E  P G++ D L                  A++ A  + YL + 
Sbjct: 61  LYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGH--FLISTLCDYAVQIANGMRYLESK 116

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTP-GYVDPDYFQCYK 288
             IHRD+ + NILL ++ +VK+ DFGL R  P +  H         P  +  P+  +   
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 289 LTDKSDVYSFGVVLIELIS 307
            +  SDV+ FGV L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 7e-31
 Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLYG- 173
           +++G G FG VY G+L+    VAVK         +  +F+ E EIL +  HPN+VKL G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR--LSIAIETAGALAYLHASD 231
           C   Q + + +V E +P G++   L  R+  + L    V+  L ++++ A  + YL + +
Sbjct: 61  CV--QKQPIYIVMELVPGGSLLTFL--RKKKNRL---TVKKLLQMSLDAAAGMEYLESKN 113

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLT 290
            IHRD+ + N L+  N  +K++DFG+SR     +  VS   +  P  +  P+     + T
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 291 DKSDVYSFGVVLIELISG 308
            +SDV+S+G++L E  S 
Sbjct: 174 SESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  118 bits (298), Expect = 8e-31
 Identities = 63/195 (32%), Positives = 107/195 (54%), Gaps = 11/195 (5%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V++G       VA+K L + +    E F+ E  ++ +LQHP LV+LY   
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +++   + ++ EY+ NG++ D L  + P    L     + +A + A  +A++   + IHR
Sbjct: 71  TQEP--IYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPDYFQCYKLTDK 292
           D+++ NIL+      K+ADFGL+RL   +     TA +G      +  P+       T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 293 SDVYSFGVVLIELIS 307
           SDV+SFG++L E+++
Sbjct: 184 SDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (298), Expect = 1e-30
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 8/198 (4%)

Query: 112 FNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           F   ++LG G FG V+ G+ ++   VA+K L  ++  + + F  EV+ L +L+H +L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           +   S     + ++ E +  G++   L  R P   +LP    + +A + A  +AYL   +
Sbjct: 68  FAVCSV-GEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
            IHRD+ + NIL+  +   KVADFGL+RL   DV  +     P     +  P+       
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGTF 181

Query: 290 TDKSDVYSFGVVLIELIS 307
           + KSDV+SFG++L E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  117 bits (295), Expect = 3e-30
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 42/283 (14%)

Query: 115 SKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
             ++G G FG VY  + L  G ++AVK  R+ +N+ K I++  +E+++L  L+HPNLVK 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           YG    +  ++ +  EY   GT+ + L + +    +L   V     ++    LAYLH+  
Sbjct: 65  YGVEVHRE-KVYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVDPDYFQCYK 288
           ++HRD+K  NI LD+N  +K+ DFG +     + T +    Q   GTP Y+ P+     K
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 289 LTDK---SDVYSFGVVLIELISGLEAVDTSR--HRHDINLSNM----ATNKIQNGALNEL 339
                  +D++S G V++E+ +G       R     D     M    A +K       +L
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATG------KRPWSELDNEFQIMFHVGAGHKPPIPDSLQL 233

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                 F                  RC++ D   RPT  E+L+
Sbjct: 234 SPEGKDFLD----------------RCLESDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 5e-30
 Identities = 83/295 (28%), Positives = 131/295 (44%), Gaps = 45/295 (15%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYEN-NFKRIEQFMNEVEILTK 162
           +     ++LG G FG VY G+ +          VA+K + EN + +   +F+NE  ++ +
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP---NSCLLPWPVRLSI--- 216
               ++V+L G  S     L+ V E +  G +  +L +R+P   N+  L  P        
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLV-VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGT 275
           A E A  +AYL A   +HRD+ + N ++  +  VK+ DFG++R ++ TD           
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ--N 333
             ++ P+  +    T KSDV+SFGVVL E                     MAT   Q   
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWE---------------------MATLAEQPYQ 223

Query: 334 GALNELVDPSLGFEKDYAVRNMVTS----VAELAFRCVQQDRDMRPTMKEVLEIL 384
           G  NE V   L F  D    ++  +    + EL   C Q +  MRPT  E++  L
Sbjct: 224 GLSNEEV---LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  116 bits (291), Expect = 7e-30
 Identities = 71/205 (34%), Positives = 110/205 (53%), Gaps = 11/205 (5%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH 165
           E   ++    K+LG+G FG V++G       VAVK L        E F+ E +I+ KL+H
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRH 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             LV+LY   S     + +V EY+  G++ D L + +  +  LP  V   +A + A  +A
Sbjct: 61  DKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMA 116

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPD 282
           Y+   + IHRD++S NIL+ +    K+ADFGL+RL   +     TA QG      +  P+
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPE 173

Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
                + T KSDV+SFG++L EL++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  116 bits (291), Expect = 1e-29
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 18/280 (6%)

Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G +VAVK L  E   +    +  E+ IL  L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 170 KLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  GC S Q  + L L+ EY+P G++ D+L   + N   L     L  A +    +AYLH
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLH 124

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG-TPGY-VDPDYFQC 286
           +   IHRD+ + N+LLDN+  VK+ DFGL++  P    +      G +P +    +  + 
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K +  SDV+SFGV L EL++  ++  +   +    +      ++    L EL++     
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERG--- 240

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
            +    +N    V  L   C + +   RPT + ++ IL+E
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  115 bits (289), Expect = 2e-29
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 30/276 (10%)

Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQ--FMNEVEILTKLQHPN 167
           +F    ++G G FG V+  + + D R+ A+K++  +   R E+   ++E  +L KL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR--QPNSCLLPWPVRLSIAIETAGALA 225
           +++ Y     + + L +V EY  NG +   L  +  +P      W       I+    LA
Sbjct: 61  IIRYYESFLDKGK-LNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           +LH+  ++HRD+KS N+ LD    VK+ D G+++L   +    +T   GTP Y+ P+  +
Sbjct: 116 HLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCE 174

Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                +KSDV++ GVVL E  +G       +H  D N       KI  G    +   S  
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTG-------KHPFDANNQGALILKIIRGVFPPV---SQM 224

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           + +          +A+L  +C+ +D   RP   ++L
Sbjct: 225 YSQQ---------LAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  115 bits (290), Expect = 2e-29
 Identities = 75/221 (33%), Positives = 115/221 (52%), Gaps = 30/221 (13%)

Query: 115 SKQLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQ-FMNEVEILTKLQHPN 167
            ++LG+G FG VY G L           VA+K L EN   +++Q F  E E+++ LQHPN
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69

Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL------------LPWPVRL 214
           +V L G CT  + +   +++EY+ +G + + L    P+S +            L     L
Sbjct: 70  IVCLLGVCT--KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL-FPTD---VTHVST 270
            IAI+ A  + YL +   +HRD+ + N L+     VK++DFGLSR  +  D   V   S 
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLE 310
            P     ++ P+     K T +SD++SFGVVL E+ S GL+
Sbjct: 188 LPV---RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ 225

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 6e-29
 Identities = 78/285 (27%), Positives = 130/285 (45%), Gaps = 52/285 (18%)

Query: 116 KQLGDGGFGAVYLGILR-DGR----IVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLV 169
           K LG G FG VY G+   +G      VA+K L E    K  ++ ++E  ++  + HP++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALA 225
           +L G C S Q   + L+ + +P G + D++ N + N     LL W V++      A  ++
Sbjct: 73  RLLGICLSSQ---VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMS 123

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYF 284
           YL    ++HRD+ + N+L+     VK+ DFGL++L   D           P  ++  +  
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 285 QCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKIQNGALN 337
                T KSDV+S+GV + EL++       G+ AV+                 ++ G   
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-------------LEKG--E 228

Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            L  P +     Y V  +V        +C   D + RPT KE++ 
Sbjct: 229 RLPQPPICTIDVYMV--LV--------KCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  114 bits (286), Expect = 6e-29
 Identities = 71/210 (33%), Positives = 112/210 (53%), Gaps = 21/210 (10%)

Query: 117 QLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +LG+G FG V+L         +D  +VAVK L E +    + F  E E+LT LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL-------PWPVRLS----IAI 218
            YG CT  + R LL+V+EY+ +G +   L +  P++ +L       P  + L     IA 
Sbjct: 72  FYGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPG 277
           + A  + YL +   +HRD+ + N L+     VK+ DFG+SR ++ TD   V         
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++ P+     K T +SD++SFGVVL E+ +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  113 bits (284), Expect = 1e-28
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 18/204 (8%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRL-YEN-NFKRIEQFMNEVEILTKLQHPNLVKLYG- 173
           +G G FG V       DG+I+  K + Y N   K  +Q ++EV IL +L+HPN+V+ Y  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH----- 228
              R ++ L +V EY   G +A  +   +     +       I  +   AL   H     
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV----THVSTAPQGTPGYVDPDYF 284
            + V+HRD+K  NI LD N  VK+ DFGL+++   D     T+V     GTP Y+ P+  
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPEQL 182

Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
                 +KSD++S G ++ EL + 
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCAL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  112 bits (283), Expect = 2e-28
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 32/277 (11%)

Query: 117 QLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
            +G G    VY  I L +   VA+KR+  E     +++   EV+ +++  HPN+VK Y  
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY-T 66

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +     EL LV  Y+  G++ D + +  P    L   +  ++  E    L YLH++  IH
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLHSNGQIH 125

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLF--PTDVTH-VSTAPQGTPGYVDPDYF-QCYKLT 290
           RD+K+ NILL  +  VK+ADFG+S       D T  V     GTP ++ P+   Q +   
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 291 DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            K+D++SFG+  IEL +G                 +    +QN        PSL    DY
Sbjct: 186 FKADIWSFGITAIELATGAAPY------SKYPPMKVLMLTLQNDP------PSLETGADY 233

Query: 351 -----AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                + R M++        C+Q+D   RPT +E+L+
Sbjct: 234 KKYSKSFRKMISL-------CLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  112 bits (282), Expect = 3e-28
 Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 20/211 (9%)

Query: 116 KQLGDGGFGAVYLG------ILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++LG+G FG V+L         +D  +VAVK L +      + F  E E+LT LQH ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL----PWPVR--------LSIA 217
           K YG        L++V+EY+ +G +   L    P++ +L    P   +        L IA
Sbjct: 71  KFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTP 276
            + A  + YL +   +HRD+ + N L+  N  VK+ DFG+SR ++ TD   V        
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            ++ P+     K T +SDV+SFGV+L E+ +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  110 bits (278), Expect = 5e-28
 Identities = 76/276 (27%), Positives = 128/276 (46%), Gaps = 30/276 (10%)

Query: 111 NFNSSKQLGDGGFGAVYL-GILRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPN 167
           +F   K+LG G +G+VY    L D +  A+K   L   + K  E  +NE+ IL  + HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           ++  Y        +L +V EY P G ++  +  R+    L+P      I I+    L  L
Sbjct: 61  IIS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H   ++HRD+KS NILL  N  VK+ D G+S++   ++        GTP Y+ P+ ++  
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGR 176

Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA--TNKIQNGALNELVDPSLG 345
             + KSD++S G +L E+ +                 +M     K+Q G    +  P + 
Sbjct: 177 PYSYKSDIWSLGCLLYEMATF---------APPFEARSMQDLRYKVQRGKYPPI--PPI- 224

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           + +D  ++N + S        +Q    +RP   ++L
Sbjct: 225 YSQD--LQNFIRS-------MLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 5e-28
 Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 63/225 (28%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF----MNEVEILTKLQHPNLVK 170
            Q+G+G +G VY     + G +VA+K++   N K  E F    + E+++L KL+HPN+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADH-----LHNRQPNSCLLPWPVRLSIA------- 217
           L    TS+    + +V+EY+      DH     L + +         V+ + +       
Sbjct: 63  LKEIVTSKGKGSIYMVFEYM------DHDLTGLLDSPE---------VKFTESQIKCYMK 107

Query: 218 --IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF----PTDVT-HVST 270
             +E    L YLH++ ++HRD+K +NIL++N+  +K+ADFGL+R +      D T  V T
Sbjct: 108 QLLE---GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT 164

Query: 271 ----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                P+   G   Y             + D++S G +L EL  G
Sbjct: 165 LWYRPPELLLGATRY-----------GPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (278), Expect = 5e-28
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKR--LYENNFKR---IEQFMNEVEILTKLQHPNLVKL 171
           LG G FG+VY G+ L DG   AVK   L ++       ++Q   E+ +L+KLQHPN+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
            G T R+   L +  E +P G++A  L          P PV      +    L YLH  +
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLEYLHDRN 122

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF-QCYKLT 290
            +HRD+K  NIL+D N  VK+ADFG+++         S   +G+P ++ P+   Q     
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF--KGSPYWMAPEVIAQQGGYG 180

Query: 291 DKSDVYSFGVVLIELISG 308
             +D++S G  ++E+ +G
Sbjct: 181 LAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 7e-28
 Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 30/206 (14%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN--EVEILTKLQ-HPNLVKL 171
           KQLGDG FG+VYL   ++ G +VA+K++ +  F   E+ MN  EV+ L KL  HPN+VKL
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
                R++ EL  V+EY+  G +   + +R+         V  SI  +    LA++H   
Sbjct: 64  KE-VFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKHG 119

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVST----APQGTPGYV---DP 281
             HRD+K  N+L+     VK+ADFGL+R     P    +VST    AP+     +     
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPE-----ILLRST 174

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELIS 307
            Y      +   D+++ G ++ EL +
Sbjct: 175 SY------SSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  110 bits (277), Expect = 1e-27
 Identities = 68/197 (34%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 119 GDGGFGAVYLGILRDGRIV-AVKRLYENNFKRIEQ-----FMNEVEILTKLQHPNLVKLY 172
           G G FG V +   RD + + A+K  Y N  K +E+      +NE  IL +L HP LV L+
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMK--YMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 173 GCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
              S Q  E + LV + +  G +  HL  +   S      V+  I  E   AL YLH+  
Sbjct: 67  --YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWIC-EIVLALEYLHSKG 120

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           +IHRD+K +NILLD    V + DF ++     D    ST+  GTPGY+ P+       + 
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQGYSV 178

Query: 292 KSDVYSFGVVLIELISG 308
             D +S GV   E + G
Sbjct: 179 AVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  110 bits (276), Expect = 1e-27
 Identities = 59/192 (30%), Positives = 103/192 (53%), Gaps = 4/192 (2%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V++G   +   VAVK L       ++ F+ E  ++  LQH  LV+LY   
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +++   + ++ EY+  G++ D L + +    LLP  +  S  I  A  +AY+   + IHR
Sbjct: 71  TKE-EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIERKNYIHR 127

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+++ N+L+  +   K+ADFGL+R+   +        +    +  P+       T KSDV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 296 YSFGVVLIELIS 307
           +SFG++L E+++
Sbjct: 188 WSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 2e-27
 Identities = 83/281 (29%), Positives = 134/281 (47%), Gaps = 30/281 (10%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
            D +    +LGDG FG VY    ++ G   A K +   + + +E FM E++IL++ +HPN
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVAD-HLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           +V LY     +++ L ++ E+   G +    L   +     L  P    +  +   AL +
Sbjct: 64  IVGLYEAYFYENK-LWILIEFCDGGALDSIMLELERG----LTEPQIRYVCRQMLEALNF 118

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           LH+  VIHRD+K+ NILL  +  VK+ADFG+S    + +    T   GTP ++ P+   C
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVAC 177

Query: 287 YKLTD-----KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD 341
               D     K+D++S G+ LIEL     A     H H++N   +   KI       L  
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL-----AQMEPPH-HELNPMRVLL-KILKSEPPTLDQ 230

Query: 342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           PS  +   +   + +         C+ +D D RPT  E+L+
Sbjct: 231 PS-KWSSSF--NDFLK-------SCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  110 bits (277), Expect = 2e-27
 Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 15/204 (7%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           D+F   K LG G FG V L   +  G+  A+K L +      K++E  +NE  IL  ++H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P LV LYG   +    L LV EY+P G +  HL          P PV    A +   AL 
Sbjct: 61  PFLVNLYGSF-QDDSNLYLVMEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALE 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+ D+++RD+K  N+LLD++  +K+ DFG ++        +     GTP Y+ P+   
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIIL 171

Query: 286 CYKLTDKS-DVYSFGVVLIELISG 308
             K   K+ D ++ G+++ E+++G
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  109 bits (273), Expect = 2e-27
 Identities = 64/192 (33%), Positives = 103/192 (53%), Gaps = 7/192 (3%)

Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE-QFMNEVEILTKLQHPNLVKLYG-CT 175
           LG G FG V+ G L+D   VAVK   E+  + ++ +F++E  IL +  HPN+VKL G CT
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
            RQ   + +V E +P G     L  ++     L     +  A++ A  +AYL + + IHR
Sbjct: 63  QRQP--IYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N L+  N  +K++DFG+SR     +   S   Q    +  P+     + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 296 YSFGVVLIELIS 307
           +S+G++L E  S
Sbjct: 178 WSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  109 bits (274), Expect = 3e-27
 Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 16/199 (8%)

Query: 121 GGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNLVKLYGCTS 176
           G +G V+L      G I A+K + + +  R   ++Q + E +IL++ Q P +VKLY  + 
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62

Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
           +  + L LV EY+P G +A  L N      L     R+ IA E   AL YLH++ +IHRD
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENV---GSLDEDVARIYIA-EIVLALEYLHSNGIIHRD 118

Query: 237 VKSNNILLDNNFRVKVADFGLSR-------LFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +K +NIL+D+N  +K+ DFGLS+       +   D         GTP Y+ P+       
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 290 TDKSDVYSFGVVLIELISG 308
           +   D +S G +L E + G
Sbjct: 179 SKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  108 bits (272), Expect = 4e-27
 Identities = 77/275 (28%), Positives = 139/275 (50%), Gaps = 28/275 (10%)

Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQF--MNEVEILTKLQHPN 167
            +   + +G G FG V+L   + D ++V +K++      + E+    NE ++L  L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +++ Y     + + L++V EY P GT+A+++  ++ NS LL     L   ++   AL ++
Sbjct: 61  IIEYYE-NFLEDKALMIVMEYAPGGTLAEYI-QKRCNS-LLDEDTILHFFVQILLALHHV 117

Query: 228 HASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           H   ++HRD+K+ NILLD +   VK+ DFG+S++  +     +    GTP Y+ P+  + 
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCEG 175

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
                KSD+++ G VL EL S   A + +      NL  +   KI +G    + D    +
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAA------NLPALVL-KIMSGTFAPISDR---Y 225

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
             D  +R ++ S+  L       D   RP + +++
Sbjct: 226 SPD--LRQLILSMLNL-------DPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 5e-27
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 116 KQLGDGGFGAVYLGILR--DGRI--VAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNLVK 170
           K+LG G FG+V  G+     G+   VAVK L + +    ++ F+ E  ++ +L HP +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAIETAGALAYLH 228
           L G    +   L+LV E  P G +  +L  R+  P S L         A + A  +AYL 
Sbjct: 61  LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE 112

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT-P-GYVDPDYFQC 286
           +   +HRD+ + N+LL N  + K++DFG+SR       +      G  P  +  P+    
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 287 YKLTDKSDVYSFGVVLIELIS 307
            K + KSDV+S+GV L E  S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  108 bits (272), Expect = 6e-27
 Identities = 77/282 (27%), Positives = 143/282 (50%), Gaps = 22/282 (7%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKR--LYE-NNFKRIEQFMNEVEILTKLQ 164
             NF   K++G G F  VY  I L DGR+VA+K+  ++E  + K  +  + E+++L +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HPN++K    +  ++ EL +V E    G ++  + + +    L+P        ++   AL
Sbjct: 61  HPNVIKYLA-SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
            ++H+  ++HRD+K  N+ +     VK+ D GL R F +  T   +   GTP Y+ P+  
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERI 178

Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
                  KSD++S G +L E    + A+ +  +   +NL ++   KI+      L  P+ 
Sbjct: 179 HENGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLYSLC-KKIEKCDYPPL--PAD 231

Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
            + ++  +R++V+       RC+  D + RP +  VL++ +E
Sbjct: 232 HYSEE--LRDLVS-------RCINPDPEKRPDISYVLQVAKE 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  109 bits (272), Expect = 6e-27
 Identities = 81/287 (28%), Positives = 135/287 (47%), Gaps = 37/287 (12%)

Query: 116 KQLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++LG+G FG V+L         +D  +VAVK L + +    + F  E E+LT LQH ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW---PVRLS------IAIE 219
           K YG C   +   L++V+EY+ +G +   L    P++ L+     P  L+      IA +
Sbjct: 71  KFYGVCV--EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGY 278
            A  + YL +   +HRD+ + N L+  N  VK+ DFG+SR ++ TD   V         +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+     K T +SDV+S GVVL E+ +                      ++ N  + E
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT---------------YGKQPWYQLSNNEVIE 233

Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
            +      ++    R     V +L   C Q++  MR  +KE+  +L+
Sbjct: 234 CITQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  108 bits (271), Expect = 8e-27
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLY-----ENNFKR----IEQFMNEVEILTKLQHPN 167
           +G G FG+VYLG+    G ++AVK++       ++  R    ++    E+ +L +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +V+  G +   +  L +  EY+P G+VA  L+N           +  +   +    L YL
Sbjct: 68  IVQYLGSSL-DADHLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYL 122

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP-----QGTPGYVDPD 282
           H   +IHRD+K  NIL+DN   +K++DFG+S+    +     T       QG+  ++ P+
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
             +    T K+D++S G +++E+++G
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 8e-27
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 40/281 (14%)

Query: 116 KQLGDGGFGAVYLGIL----RDGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNL 168
           K +G G FG V  G L    +    VA+K L     +  +    F+ E  I+ +  HPN+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNI 67

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHL-HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           ++L G  ++ SR ++++ EY+ NG++   L  N             + +    A  + YL
Sbjct: 68  IRLEGVVTK-SRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYL 122

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQC 286
              + +HRD+ + NIL+++N   KV+DFGLSR         +T     P  +  P+    
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN-MATNKIQNG-ALNELVD-PS 343
            K T  SDV+SFG+V+ E++S  E       R   ++SN      +++G  L   +D PS
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGE-------RPYWDMSNQDVIKAVEDGYRLPPPMDCPS 235

Query: 344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                          + +L   C Q+DR+ RPT  +++  L
Sbjct: 236 A--------------LYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 3e-26
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 13/205 (6%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF-----KRIEQFMNEVEILTKLQ 164
           N+   K LG G FG VYL    D GR +AVK++  +       K +     E+++L  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           H  +V+ YGC  R    L +  EY+P G+V D L         L   V      +    +
Sbjct: 63  HERIVQYYGCL-RDDETLSIFMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGV 117

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPD 282
            YLH++ ++HRD+K  NIL D+   VK+ DFG S+   T  +  +      GTP ++ P+
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
                    K+DV+S G  ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  106 bits (266), Expect = 3e-26
 Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 28/202 (13%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           LG+G +G+VY  I ++ G++VA+K +     + +++ + E+ IL +   P +VK YG   
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS---IAIETAGA---LAYLHAS 230
           + + +L +V EY   G+V+D +               L+   IA         L YLH++
Sbjct: 69  KNT-DLWIVMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHSN 118

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ----GTPGYVDPDYFQC 286
             IHRD+K+ NILL+   + K+ADFG+S      +T  + A +    GTP ++ P+  Q 
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS----GQLTD-TMAKRNTVIGTPFWMAPEVIQE 173

Query: 287 YKLTDKSDVYSFGVVLIELISG 308
               +K+D++S G+  IE+  G
Sbjct: 174 IGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  106 bits (265), Expect = 4e-26
 Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 11/194 (5%)

Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         L  P  + +A + A  +AY+   + +HRD
Sbjct: 72  EEP--IYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPDYFQCYKLTDKS 293
           +++ NIL+  N   KVADFGL+RL   +     TA QG      +  P+     + T KS
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 294 DVYSFGVVLIELIS 307
           DV+SFG++L EL +
Sbjct: 185 DVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 30/207 (14%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN--EVEILTKLQHPNLVKLY 172
            ++G+G +G VY       G IVA+K++               E+++L +L HPN++KL 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
                +   L LV+E++      D     +     LP  +  S   +    LA+ H+  +
Sbjct: 65  DVFRHKGD-LYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV---TH-VST----APQ---GTPGYVDP 281
           +HRD+K  N+L++    +K+ADFGL+R F + V   TH V T    AP+   G  GY   
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY--- 176

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
                   +   D++S G +  EL+S 
Sbjct: 177 --------STPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  105 bits (265), Expect = 8e-26
 Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 20/205 (9%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
             ++  ++G+G  G V +      GR VAVK++     +R E   NEV I+   QHPN+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHL-HNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++Y  +     EL +V E++  G + D + H R      +      ++ +    AL++LH
Sbjct: 80  EMYS-SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLH 132

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDY 283
           A  VIHRD+KS++ILL ++ RVK++DFG       +V      P+     GTP ++ P+ 
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPEV 186

Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
                   + D++S G+++IE++ G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  104 bits (261), Expect = 1e-25
 Identities = 66/194 (34%), Positives = 106/194 (54%), Gaps = 11/194 (5%)

Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +I+ KL+H  LV LY   S
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V E++  G++ D L  ++ +   L  P  + +A + A  +AY+   + IHRD
Sbjct: 72  EEP--IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPDYFQCYKLTDKS 293
           +++ NIL+ +N   K+ADFGL+RL   +     TA QG      +  P+     + T KS
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 294 DVYSFGVVLIELIS 307
           DV+SFG++L EL++
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 15/196 (7%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +G G FG VY  I  R  ++VA+K +  E     IE    E++ L++ + P + K YG  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
            + S+ L ++ EY   G+  D L         L       I  E    L YLH    IHR
Sbjct: 69  LKGSK-LWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVDPDYFQCYKLTDK 292
           D+K+ NILL     VK+ADFG+S      +T   +      GTP ++ P+  +     +K
Sbjct: 123 DIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178

Query: 293 SDVYSFGVVLIELISG 308
           +D++S G+  IEL  G
Sbjct: 179 ADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  103 bits (259), Expect = 2e-25
 Identities = 84/278 (30%), Positives = 144/278 (51%), Gaps = 33/278 (11%)

Query: 116 KQLGDGGFGAVYLGILR-DGR---IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVK 170
           K +G G FG V+ GIL+  GR    VA+K L      K+ + F++E  I+ +  H N+++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           L G  ++  +  +++ EY+ NG +  +L  H+ + +S  L   +R       A  + YL 
Sbjct: 71  LEGVVTK-FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYLS 124

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD--VTHVSTAPQGTPGYVDPDYFQC 286
             + +HRD+ + NIL+++N   KV+DFGLSR+   D   T+ ++  +    +  P+    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K T  SDV+SFG+V+ E++S  E       R   ++SN    K    A+N+      GF
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGE-------RPYWDMSNHEVMK----AIND------GF 227

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
               A  +  ++V +L  +C QQDR  RP   +++ +L
Sbjct: 228 RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  103 bits (259), Expect = 3e-25
 Identities = 81/279 (29%), Positives = 133/279 (47%), Gaps = 39/279 (13%)

Query: 118 LGDGGFGAVYLGILRDGRIVAVKR--LYENNF----KRIEQFMNEVEILTKLQHPNLVKL 171
           LG G +G VY G+   G+++AVK+  L  +N     K  E+   EV++L  L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
            G T      + +  E++P G+++  L+   P    LP PV      +    +AYLH + 
Sbjct: 68  LG-TCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNNC 122

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP-----QGTPGYVDPDYFQC 286
           V+HRD+K NN++L  N  +K+ DFG +R       H + +       GTP ++ P+    
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 287 YKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS 343
                KSD++S G  + E+ +G   L ++D         L+ M       GA   L+ P 
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMD--------RLAAM----FYIGAHRGLM-PR 229

Query: 344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           L      A  + VTS       C+ +D+  RP+  ++L 
Sbjct: 230 LPDSFSAAAIDFVTS-------CLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  104 bits (260), Expect = 4e-25
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 27/224 (12%)

Query: 110 DNFNSSKQLGDGGFGAVY----LGIL--RDGRIVAVKRLYENNFKRIE-QFMNEVEILTK 162
           +N    + +G G FG V+     G+L      +VAVK L E     ++  F  E  ++ +
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP------------------N 204
             HPN+VKL G  +   + + L++EY+  G + + L +R P                  N
Sbjct: 65  FDHPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPT 263
              L    +L IA + A  +AYL     +HRD+ + N L+  N  VK+ADFGLSR ++  
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           D    S        ++ P+     + T +SDV+++GVVL E+ S
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 44/214 (20%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF--------MNEVEILTKLQHP 166
           ++LG+G +G VY     + G IVA+K++      R++          + E+ +L +L+HP
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKI------RLDNEEEGIPSTALREISLLKELKHP 58

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N+VKL        R+L LV+EY     +  +L  R      L   +  SI  +    LAY
Sbjct: 59  NIVKLL-DVIHTERKLYLVFEYCDM-DLKKYLDKRPGP---LSPNLIKSIMYQLLRGLAY 113

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV---TH-VST----APQ---GT 275
            H+  ++HRD+K  NIL++ +  +K+ADFGL+R F   +   TH V T    AP+   G+
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 276 PGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
             Y              + D++S G +  E+I+G
Sbjct: 174 KHY------------STAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (254), Expect = 2e-24
 Identities = 84/298 (28%), Positives = 143/298 (47%), Gaps = 50/298 (16%)

Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQF 153
           SC ++EE          +G G FG V  G L+  G+    VA+K L   Y    +R   F
Sbjct: 4   SCVKIEEV---------IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DF 52

Query: 154 MNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
           ++E  I+ +  HPN++ L G  ++ SR ++++ E++ NG +   L  RQ +       + 
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTK-SRPVMIITEFMENGALDSFL--RQNDGQFTVIQL- 108

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVST 270
           + +    A  + YL   + +HRD+ + NIL+++N   KV+DFGLSR      +D T+ S+
Sbjct: 109 VGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168

Query: 271 APQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN 329
                P  +  P+     K T  SDV+S+G+V+ E++S  E       R   ++SN    
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-------RPYWDMSNQ--- 218

Query: 330 KIQNGALNELVDPSLGFEKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                      D     E+DY +    +  T++ +L   C Q+DR+ RP   +++  L
Sbjct: 219 -----------DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 2e-24
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 25/202 (12%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVK--RLYE-NNFKRIEQFMNEVEILTKLQHPNLVKL 171
           +++G G +G VY    +  G +VA+K  +L   ++F+ I+Q   E+ +L + +HPN+V  
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ---EISMLKECRHPNIVAY 65

Query: 172 YGCTSRQSR-ELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +G  S   R +L +V EY   G++ D     R P    L       +  ET   LAYLH 
Sbjct: 66  FG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP----LSELQIAYVCRETLKGLAYLHE 119

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVDPDYFQC 286
           +  IHRD+K  NILL  +  VK+ADFG+S      +T      +   GTP ++ P+    
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 287 YKLTD---KSDVYSFGVVLIEL 305
            +      K D+++ G+  IEL
Sbjct: 176 ERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  102 bits (255), Expect = 2e-24
 Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 45/236 (19%)

Query: 102 CSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF----MNE 156
           CS+L     ++    +LG+G FG VY    ++ GR+VA+K++  +N K  + F    + E
Sbjct: 4   CSKL----RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALRE 57

Query: 157 VEILTKLQHPNLVKL----YGCTSRQSRELLLVYEYIPNGTVADH-----LHNRQPNSCL 207
           ++IL KL+HPN+V L         +  R+   VY   P     DH     L N  P+  L
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP---YMDHDLSGLLEN--PSVKL 112

Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
               ++  +     G + YLH + ++HRD+K+ NIL+DN   +K+ADFGL+R +      
Sbjct: 113 TESQIKCYMLQLLEG-INYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGP--- 168

Query: 268 VSTAPQGTPGYVDPDYFQC-----YK-----LTDKS-----DVYSFGVVLIELISG 308
               P+G  G     Y        Y+     L ++      D++  G V  E+ + 
Sbjct: 169 -PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  101 bits (253), Expect = 3e-24
 Identities = 89/304 (29%), Positives = 146/304 (48%), Gaps = 51/304 (16%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF--KRIEQFMNEV 157
           E + +     ++LG G FG VY G  RD   G     VAVK + E+    +RIE F+NE 
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEA 60

Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP---NSCLLPWPV-- 212
            ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   N+   P P   
Sbjct: 61  SVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119

Query: 213 -RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA 271
             + +A E A  +AYL+A   +HRD+ + N ++ ++F VK+ DFG++R    D+      
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYY 175

Query: 272 PQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
            +G  G     ++ P+  +    T  SD++SFGVVL E+                  +++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------------TSL 217

Query: 327 ATNKIQNGALNELVDPSLGFEKD--YAVR--NMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           A    Q G  NE V   L F  D  Y  +  N    V +L   C Q +  MRPT  E++ 
Sbjct: 218 AEQPYQ-GLSNEQV---LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Query: 383 ILRE 386
           +L++
Sbjct: 274 LLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 13/197 (6%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYE----NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G+G +G V     +  G IVA+K+  E     + K+    + EV++L +L+H N+V L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNLK 66

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
               R+ R L LV+EY+   T+ + L    P   L P  VR  I  +   A+AY H+ ++
Sbjct: 67  EAFRRKGR-LYLVFEYVER-TLLELL-EASPGG-LPPDAVRSYI-WQLLQAIAYCHSHNI 121

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           IHRD+K  NIL+  +  +K+ DFG +R          T    T  Y  P+         K
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 293 S-DVYSFGVVLIELISG 308
             DV++ G ++ EL+ G
Sbjct: 182 PVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  101 bits (253), Expect = 4e-24
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 15/199 (7%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN-----EVEILTKLQHPNLV 169
           K+LG+G +  VY       GRIVA+K++     K  +  +N     E+++L +L+HPN++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
            L      +S  + LV+E++   T  + +  +  +  L P  ++ S  + T   L YLH+
Sbjct: 66  GLLDVFGHKSN-INLVFEFME--TDLEKVI-KDKSIVLTPADIK-SYMLMTLRGLEYLHS 120

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG-TPGYVDPD-YFQCY 287
           + ++HRD+K NN+L+ ++  +K+ADFGL+R F +    ++   Q  T  Y  P+  F   
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT--HQVVTRWYRAPELLFGAR 178

Query: 288 KLTDKSDVYSFGVVLIELI 306
                 D++S G +  EL+
Sbjct: 179 HYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 99.7 bits (248), Expect = 7e-24
 Identities = 56/192 (29%), Positives = 103/192 (53%), Gaps = 5/192 (2%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V++        VAVK +   +   +E F+ E  ++  LQH  LVKL+   
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +++   + ++ E++  G++ D L + + +   LP  +  S  I  A  +A++   + IHR
Sbjct: 71  TKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRNYIHR 126

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+++ NIL+  +   K+ADFGL+R+   +        +    +  P+       T KSDV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 296 YSFGVVLIELIS 307
           +SFG++L+E+++
Sbjct: 187 WSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  100 bits (250), Expect = 8e-24
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)

Query: 118 LGDGGFGAVYL-GILRDGRIVAVKRLYENNFKRIE-----QFMNEVEILTKLQHPNLVKL 171
           +G+G  G V+       G  VA+K++     +R+E     Q + E++ L   QHP +VKL
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHN-RQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
                  S   +LV EY+P   +++ L +  +P    LP     S        +AY+HA+
Sbjct: 65  LDVFPHGSG-FVLVMEYMP-SDLSEVLRDEERP----LPEAQVKSYMRMLLKGVAYMHAN 118

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-YFQCYKL 289
            ++HRD+K  N+L+  +  +K+ADFGL+RLF  +   + +    T  Y  P+  +   K 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 290 TDKSDVYSFGVVLIELISG 308
               D+++ G +  EL++G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 99.3 bits (247), Expect = 9e-24
 Identities = 61/190 (32%), Positives = 104/190 (54%), Gaps = 9/190 (4%)

Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR 177
           +G G FG V LG  R G  VAVK +   N    + F+ E  ++T+L+H NLV+L G    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDV 237
           +   L +V EY+  G++ D+L +R     +L     L  +++   A+ YL A++ +HRD+
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128

Query: 238 KSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYS 297
            + N+L+  +   KV+DFGL++    + +      +    +  P+  +  K + KSDV+S
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 298 FGVVLIELIS 307
           FG++L E+ S
Sbjct: 185 FGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPN 167
            +   K++G+G FG +YL   + D     +K   L +   K  E    EV +L K++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ-----PNSCLLPWPVRLSIAIETAG 222
           +V  +       R L +V EY   G +   + NRQ         +L W V++S+      
Sbjct: 61  IVTFFASFQENGR-LFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLG----- 113

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            L ++H   ++HRD+KS NI L  N  V K+ DFG++R    D   ++    GTP Y+ P
Sbjct: 114 -LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSP 171

Query: 282 DYFQCYKLTDKSDVYSFGVVLIEL 305
           +  Q     +K+D++S G VL EL
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 34/208 (16%)

Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRLYEN----NFKRIEQFMNEVEILTKLQHPNLVKL 171
           ++G+G +G V+    R+ G+IVA+K+  E+      K+I   + E+ +L +L+HPNLV L
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNL 65

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
                R+ R+L LV+EY  + TV + L  + P    +P  +   I  +T  A+ + H  +
Sbjct: 66  IE-VFRRKRKLHLVFEYCDH-TVLNEL-EKNPRG--VPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVT-HVST----APQ---GTPGYVD 280
            IHRDVK  NIL+    ++K+ DFG +R+      D T +V+T    AP+   G   Y  
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P            DV++ G V  EL++G
Sbjct: 181 P-----------VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 99.0 bits (246), Expect = 2e-23
 Identities = 84/302 (27%), Positives = 143/302 (47%), Gaps = 47/302 (15%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYENNF--KRIEQFMNE 156
           E A +    S++LG G FG VY GI + G +       VA+K + E     +RIE F+NE
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP----NSCLLPWPV 212
             ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P    N    P  +
Sbjct: 60  ASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 213 R--LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST 270
           +  + +A E A  +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R    D+     
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174

Query: 271 APQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN 325
             +G  G     ++ P+  +    T  SDV+SFGVVL E+ +  E            +SN
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-------MSN 227

Query: 326 MATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
               + +  G L +  D            N    + EL   C Q +  MRP+  E++  +
Sbjct: 228 EQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Query: 385 RE 386
           +E
Sbjct: 276 KE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 41/228 (17%)

Query: 113 NSSKQLGDGGFGAVYL-----------------GILRDGRIVAVKRLYEN-NFKRIEQFM 154
           N  ++LG+G FG V+L                        +VAVK L  + +    E F+
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 155 NEVEILTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQP-------NSC 206
            EV+IL++L  PN+ +L G CT      L ++ EY+ NG +   L            NS 
Sbjct: 68  KEVKILSRLSDPNIARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV 265
            L +   L +A + A  + YL + + +HRD+ + N L+  N+ +K+ADFG+SR L+ +D 
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 266 THVSTAPQGTPGYVDP------DYFQCYKLTDKSDVYSFGVVLIELIS 307
             V    QG      P      +     K T KSDV++FGV L E+++
Sbjct: 186 YRV----QGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 98.4 bits (245), Expect = 2e-23
 Identities = 67/284 (23%), Positives = 126/284 (44%), Gaps = 35/284 (12%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRL-YENNFKR-----IEQFMNEVEILT 161
            +   +QLG G F + Y    RD   G ++AVK++ Y  N        +E    E+ ++ 
Sbjct: 1   EWLKGQQLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA 58

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           +L HP+++++ G T  +     L  E++  G+V+  L             V ++   +  
Sbjct: 59  RLNHPHIIRMLGAT-CEDSHFNLFVEWMAGGSVSHLLSKYGAFK----EAVIINYTEQLL 113

Query: 222 GALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRLFPTDVTHVSTAPQ---GTPG 277
             L+YLH + +IHRDVK  N+L+D+   R+++ADFG +       T          GT  
Sbjct: 114 RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN 337
           ++ P+  +  +     DV+S G V+IE+ +     +  +H + + L     +     ++ 
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233

Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           E + P L                ++  RC++   + RP  +E+L
Sbjct: 234 EHLSPGL---------------RDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.7 bits (243), Expect = 3e-23
 Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 17/195 (8%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLY 172
           + +G+G FGAV  G    G+ VAVK     N K     + F+ E  ++TKL H NLV+L 
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLL 65

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G        L +V E +  G + + L  R     L+     L  +++ A  + YL +  +
Sbjct: 66  GVILHNG--LYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           +HRD+ + NIL+  +   KV+DFGL+R+    V +     + T     P+  +  K + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSSK 177

Query: 293 SDVYSFGVVLIELIS 307
           SDV+S+GV+L E+ S
Sbjct: 178 SDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 66/216 (30%), Positives = 112/216 (51%), Gaps = 22/216 (10%)

Query: 116 KQLGDGGFGAVYLGIL-----RDGRIVAVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLV 169
           ++LG+  FG +Y G L        ++VA+K L + NN ++  +F  E  ++ +L HPN+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-------------LPWPVRLSI 216
            L G  + Q + + +++EY+  G + + L  R P+S +             L     L I
Sbjct: 71  CLLGVVT-QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGT 275
           AI+ A  + YL +   +H+D+ + NIL+     VK++D GLSR ++  D   V       
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLE 310
             ++ P+     K +  SD++SFGVVL E+ S GL+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ 225

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 98.2 bits (244), Expect = 4e-23
 Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 21/200 (10%)

Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LGDG FG VY    ++ G + A K +   + + +E +M E+EIL    HP +VKL G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
               + L ++ E+ P G V   +         L  P    I  +   AL YLH+  +IHR
Sbjct: 79  YWDGK-LWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSMKIIHR 134

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDYFQCYKLT 290
           D+K+ N+LL  +  +K+ADFG+S        +V T  +     GTP ++ P+   C  + 
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 291 D-----KSDVYSFGVVLIEL 305
           D     K+D++S G+ LIE+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.4 bits (243), Expect = 5e-23
 Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 10/196 (5%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
            +LG G  G V   + R  G+I+AVK +  E N    +Q + E++IL K   P +V  YG
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DV 232
                  ++ +  EY+ +G   D +         +P  +   IA+     L YLH    +
Sbjct: 67  AFYNNG-DISICMEYM-DGGSLDKILKEVQGR--IPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           IHRDVK +NIL+++  ++K+ DFG+S      V  ++    GT  Y+ P+  Q    + K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQGNDYSVK 179

Query: 293 SDVYSFGVVLIELISG 308
           SD++S G+ LIEL +G
Sbjct: 180 SDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 97.0 bits (241), Expect = 7e-23
 Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 32/256 (12%)

Query: 111 NFNSSKQLGDGGFGAVYL--GILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
            +N  + +G+G FG   L   +  D +    +     +   +E    E  +L K++HPN+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 169 VKLYGCTSRQSRE----LLLVYEYIPNGTVADHLHNRQ----PNSCLLPWPVRLSIAIET 220
           V       ++S E    L +V EY   G +   +  ++    P   +L W V++ + ++ 
Sbjct: 61  V-----AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ- 114

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
                ++H   V+HRD+KS NI L  N +VK+ DFG +RL  +   +  T   GTP YV 
Sbjct: 115 -----HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVP 168

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
           P+ ++     +KSD++S G +L EL        T +H    N       K+  G+   L 
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELC-------TLKHPFQANSWKNLILKVCQGSYKPL- 220

Query: 341 DPS-LGFEKDYAVRNM 355
            PS   +E    ++ M
Sbjct: 221 -PSHYSYELRSLIKQM 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 97.4 bits (242), Expect = 8e-23
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 11/200 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           DNF    ++G+G  G V +  ++  G++VAVK++     +R E   NEV I+   QH N+
Sbjct: 23  DNF---IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V++Y  +     EL +V E++  G + D + + + N   +      ++ +    AL+ LH
Sbjct: 80  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           A  VIHRD+KS++ILL ++ RVK++DFG       +V    +   GTP ++ P+      
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISRLP 192

Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D++S G+++IE++ G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.9 bits (243), Expect = 9e-23
 Identities = 93/297 (31%), Positives = 150/297 (50%), Gaps = 50/297 (16%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF---MNEVEILTKLQHPN 167
           F   +++G G FGAVY    +R   +VA+K++  +  +  E++   + EV+ L +++HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGAL-- 224
            ++  GC  R+     LV EY   G+ +D L  +++P          + IA  T GAL  
Sbjct: 87  SIEYKGCYLRE-HTAWLVMEYCL-GSASDLLEVHKKPLQ-------EVEIAAITHGALQG 137

Query: 225 -AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
            AYLH+ ++IHRD+K+ NILL    +VK+ADFG + +     + V     GTP ++ P+ 
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192

Query: 284 FQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
                  +   K DV+S G+  IEL          R     N++ M+   + + A NE  
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSA--LYHIAQNE-- 240

Query: 341 DPSLGFEK--DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSNL 392
            P+L   +  DY  RN V S       C+Q+    RPT +E+L+   +LRE  ++ L
Sbjct: 241 SPTLQSNEWSDY-FRNFVDS-------CLQKIPQDRPTSEELLKHMFVLRERPETVL 289

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 96.5 bits (241), Expect = 9e-23
 Identities = 65/199 (32%), Positives = 96/199 (48%), Gaps = 19/199 (9%)

Query: 118 LGDGGFGAVYLGIL-RDGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           LG GGFG V L  +    R  A+K +   +     + E   +E EIL +  HP +VKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP-WPVRLSIA--IETAGALAYLHAS 230
            T +  + + ++ EY   G +   L +R     L   +  R  IA  +    A  YLH  
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRG----LFDEYTARFYIACVVL---AFEYLHNR 112

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
            +I+RD+K  N+LLD+N  VK+ DFG ++ L     T       GTP YV P+       
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGY 169

Query: 290 TDKSDVYSFGVVLIELISG 308
               D +S G++L EL++G
Sbjct: 170 DFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 39/289 (13%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++   P + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----LSIAIETAGALA 225
           K YG   + ++ L ++ EY+  G+  D L          P P+      +I  E    L 
Sbjct: 66  KYYGSYLKDTK-LWIIMEYLGGGSALDLLE---------PGPLDETQIATILREILKGLD 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+   IHRD+K+ N+LL  +  VK+ADFG++    TD         GTP ++ P+  +
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIK 174

Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                 K+D++S G+  IEL  G E   +  H   +       N            P+L 
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG-EPPHSELHPMKVLFLIPKNNP-----------PTL- 221

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSN 391
            E +Y+       + E    C+ ++   RPT KE+L+   I+R  K ++
Sbjct: 222 -EGNYS-----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTS 264

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 27/210 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGR---------IVAVKRLYENNFKRIEQFMNEVEIL 160
           D+    K +G G FG V+L   R            I  V RL     K+ +   NE  +L
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-----KQEQHVHNEKRVL 55

Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAI 218
            ++ HP +++L+  T    R L ++ EY+P G +  +L N     NS        L  A 
Sbjct: 56  KEVSHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS------TGLFYAS 108

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E   AL YLH+ ++++RD+K  NILLD    +K+ DFG    F   +   +    GTP Y
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDRTWTLCGTPEY 164

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  Q        D ++ G+++ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 95.4 bits (237), Expect = 3e-22
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 116 KQLGDGGFGAVYLGIL-----RDGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G  VAVK L  E+    I     E+EIL  L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  G CT      + L+ E++P+G++ ++L  R  N   L    +L  A++    + YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLK--QQLKYAVQICKGMDYLG 126

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTP--GYVDPDYFQ 285
           +   +HRD+ + N+L+++  +VK+ DFGL++   TD  + +      +P   Y      Q
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             K    SDV+SFGV L EL++
Sbjct: 187 S-KFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.9 bits (238), Expect = 4e-22
 Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 18/202 (8%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIV----AVKRLYENNFKRIE-QFMNEVEILTKLQHPNLV 169
           K LG G FG VY GI + +G  V    A+K L E    +   +FM+E  I+  + HP+LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAY 226
           +L G     S  + LV + +P+G + D++H  + N     LL W V++      A  + Y
Sbjct: 73  RLLGVC--LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMY 124

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQ 285
           L    ++HRD+ + N+L+ +   VK+ DFGL+RL   D    +      P  ++  +   
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             K T +SDV+S+GV + EL++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 95.4 bits (237), Expect = 4e-22
 Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 48/302 (15%)

Query: 116 KQLGDGGFGAVYL----GILR---------DGR--IVAVKRLYENNFKRIEQ-FMNEVEI 159
           ++LG+G FG V+L    G+           DG+  +VAVK L  +  K     F+ E++I
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-----LPWPVR- 213
           +++L++PN+++L          L ++ EY+ NG +   L  R+  S       +P     
Sbjct: 71  MSRLKNPNIIRLL-GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 214 --LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVST 270
             L +A++ A  + YL + + +HRD+ + N L+ N++ +K+ADFG+SR L+  D   +  
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI-- 187

Query: 271 APQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS 324
             QG    V P  +  +      K T  SDV++FGV L E+ +  +    S    +  + 
Sbjct: 188 --QGRA--VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243

Query: 325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           N        G    L    L            + V +L  RC  +D   RPT  ++   L
Sbjct: 244 NTGEFFRNQGRQIYLSQTPL----------CPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293

Query: 385 RE 386
           RE
Sbjct: 294 RE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYE---NNFKRIEQFMNEVEIL-TKLQHPNLVK 170
           K LG G FG V L  L+    + AVK L +        +E  M E  +L    +HP L +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L+ C   + R L  V EY+  G +  H+      S     P     A E    L +LH  
Sbjct: 61  LHSCFQTKDR-LFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
            +I+RD+K +N+LLD+   +K+ADFG+ +  +     T       GTP Y+ P+      
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC---GTPDYIAPEILSYQP 172

Query: 289 LTDKSDVYSFGVVLIELISG 308
                D ++ GV+L E+++G
Sbjct: 173 YGPAVDWWALGVLLYEMLAG 192

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 29/207 (14%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF---MNEVEILTKLQHPN 167
           F   +++G G FGAVY    +R   +VA+K++  +  +  E++   + EV  L +L+HPN
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVR-LSIAIETAGAL 224
            ++  GC  R+     LV EY   G+ +D L  H +         P++ + IA    GAL
Sbjct: 77  TIEYKGCYLREH-TAWLVMEYCL-GSASDILEVHKK---------PLQEVEIAAICHGAL 125

Query: 225 ---AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
              AYLH+ + IHRD+K+ NILL     VK+ADFG + L     + V     GTP ++ P
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAP 180

Query: 282 DYFQCY---KLTDKSDVYSFGVVLIEL 305
           +        +   K DV+S G+  IEL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 94.4 bits (234), Expect = 7e-22
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 13/206 (6%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLY-----ENNFKRIEQFMNEVEILTKLQ 164
           N+   K LG G FG VYL    D GR +A K++          K +     E+++L  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 165 HPNLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           H  +V+ YGC   R  + L +  EY+P G+V D L         L   V      +    
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEG 118

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDP 281
           ++YLH++ ++HRD+K  NIL D+   VK+ DFG S+   T     +   +  GTP ++ P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELIS 307
           +         K+DV+S G  ++E+++
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 94.1 bits (234), Expect = 7e-22
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 118 LGDGGFGAVYLGILRDG----RIVAVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L D        AVK L    + + +EQF+ E  I+    HPN++ L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR--LSIAIETAGALAYLHAS 230
           G         L+V  Y+ +G + + + +   N       V+  +   ++ A  + YL + 
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT-----VKDLIGFGLQVAKGMEYLASK 117

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-------THVSTAPQGTPGYVDPDY 283
             +HRD+ + N +LD +F VKVADFGL+R    D+        H  T  +    ++  + 
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
            Q  K T KSDV+SFGV+L EL++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 93.7 bits (233), Expect = 8e-22
 Identities = 76/277 (27%), Positives = 141/277 (50%), Gaps = 40/277 (14%)

Query: 116 KQLGDGGFG-AVYLGILRDGRIVAVKRLYENNFKRI-----EQFMNEVEILTKLQHPNLV 169
           K++G+G FG A+ +    DG+   +K   E N  ++     E+   EV +L+ ++HPN+V
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIK---EINISKMSPKEREESRKEVAVLSNMKHPNIV 62

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ----PNSCLLPWPVRLSIAIETAGALA 225
           + Y  +  ++  L +V +Y   G +   ++ ++    P   +L W V++ +A      L 
Sbjct: 63  Q-YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LK 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           ++H   ++HRD+KS NI L  +  +K+ DFG++R+  + V    T   GTP Y+ P+  +
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICE 174

Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                +KSD+++ G VL E+ +   A +        N+ N+   KI  G+      P + 
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NMKNLVL-KIIRGSY-----PPVS 222

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
               Y +RN+V+ +    F+  +  RD RP++  +LE
Sbjct: 223 SHYSYDLRNLVSQL----FK--RNPRD-RPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 94.6 bits (235), Expect = 1e-21
 Identities = 70/233 (30%), Positives = 112/233 (48%), Gaps = 49/233 (21%)

Query: 116 KQLGDGGFGAVYLGI---------------LRDGR--IVAVKRLYENNFKRIEQ-FMNEV 157
           ++LG+G FG V+L                 +R GR  +VAVK L  +  K     F+ EV
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 158 EILTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQ-------------P 203
           +IL++L+ PN+++L G C       L ++ EY+ NG +   L +               P
Sbjct: 71  KILSRLKDPNIIRLLGVCV--DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 204 NSCLL--PWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-L 260
             CL    +   L +A++ A  + YL + + +HRD+ + N L+  N  +K+ADFG+SR L
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 261 FPTDVTHVSTAPQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELIS 307
           +  D   +    QG    V P  +  +      K T  SDV++FGV L E++ 
Sbjct: 189 YAGDYYRI----QGRA--VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 39/290 (13%)

Query: 112 FNSSKQLGDGGFGAVYLGIL-RDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG VY GI  R   +VA+K +  E     IE    E+ +L++   P + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----LSIAIETAGALA 225
           + YG   + ++ L ++ EY+  G+  D L          P P+      +I  E    L 
Sbjct: 66  RYYGSYLKGTK-LWIIMEYLGGGSALDLLK---------PGPLEETYIATILREILKGLD 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+   IHRD+K+ N+LL     VK+ADFG++    TD         GTP ++ P+  +
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIK 174

Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                 K+D++S G+  IEL  G E  ++  H   + L  +  N            P+L 
Sbjct: 175 QSAYDFKADIWSLGITAIELAKG-EPPNSDLHPMRV-LFLIPKNS----------PPTLE 222

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSNL 392
            +     +  V +       C+ +D   RPT KE+L+   I R TK ++ 
Sbjct: 223 GQYSKPFKEFVEA-------CLNKDPRFRPTAKELLKHKFITRYTKKTSF 265

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)

Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LGDG FG VY    ++  ++A  ++ +   +  +E +M E++IL    HPN+VKL    
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 176 SRQSRELLLVYEYIPNGTV-ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
             ++   +L+ E+   G V A  L   +P    L  P    +  +T  AL YLH + +IH
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD--- 291
           RD+K+ NIL   +  +K+ADFG+S    T       +  GTP ++ P+   C    D   
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 292 --KSDVYSFGVVLIEL 305
             K+DV+S G+ LIE+
Sbjct: 186 DYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 25/208 (12%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVK------RLYENNFKR----IEQFMNEVEILTKLQHP 166
           +G G +G VYL + +  G ++AVK       +   +  R    ++   +E+E L  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N+V+  G        L +  EY+P G++   L             +      +    LAY
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR----FEEQLVRFFTEQVLEGLAY 123

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSR----LFPTDVTHVSTAPQGTPGYVDPD 282
           LH+  ++HRD+K++N+L+D +   K++DFG+S+    ++  D      + QG+  ++ P+
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWMAPE 180

Query: 283 YFQCYK--LTDKSDVYSFGVVLIELISG 308
               Y    + K D++S G V++E+ +G
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 17/204 (8%)

Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHP 166
           +F   + LG G FG V +   +  G   A+K L +      K+++    E  IL +L HP
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN--RQPNSCLLPWPVRLSIAIETAGAL 224
            +V +  C+ +    +  + E++  G +  HL    R PN     +   L +A E     
Sbjct: 79  FIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----- 132

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
            YLH+ D+I+RD+K  N+LLDN   VKV DFG    F   V   +    GTP Y+ P+  
Sbjct: 133 -YLHSKDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFTLCGTPEYLAPEVI 187

Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           Q        D ++ GV+L E I+G
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 21/201 (10%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQH---PNLVKLY 172
           +G G +GAVY G  +  GR+VA+K +  +     +     EV +L++L+    PN+ K Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPV-RLSIAI---ETAGALAYLH 228
           G    +   L ++ EY   G+V          + +   P+    I++   E   AL Y+H
Sbjct: 69  GSY-LKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
              VIHRD+K+ NIL+ N   VK+ DFG++ L   + +  ST   GTP ++ P+     K
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVITEGK 177

Query: 289 LTD-KSDVYSFGVVLIELISG 308
             D K+D++S G+ + E+ +G
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 84/283 (29%), Positives = 135/283 (47%), Gaps = 43/283 (15%)

Query: 116 KQLGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNL 168
           K +G G FG V  G L+  G+    VA+K L   Y    +R   F++E  I+ +  HPN+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR--DFLSEASIMGQFDHPNI 67

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAY 226
           + L G  ++ S+ +++V EY+ NG++   L  H+ Q     L   +R       A  + Y
Sbjct: 68  IHLEGVVTK-SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKY 121

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT-P-GYVDPDYF 284
           L     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G  P  +  P+  
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
              K T  SDV+S+G+V+ E++S  E       R    +SN               D   
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGE-------RPYWEMSNQ--------------DVIK 220

Query: 345 GFEKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
             E+ Y   A  +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 221 AIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 31/285 (10%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++   P + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           K YG   + ++ L ++ EY+  G+  D L     +   +      ++  E    L YLH+
Sbjct: 66  KYYGSYLKGTK-LWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 119

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
              IHRD+K+ N+LL     VK+ADFG++    TD         GTP ++ P+  Q    
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             K+D++S G+  IEL  G E  ++  H   + L  +  N            P+L     
Sbjct: 179 DSKADIWSLGITAIELAKG-EPPNSDMHPMRV-LFLIPKNN----------PPTL----- 221

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSN 391
                      E    C+ +D   RPT KE+L+   I++  K ++
Sbjct: 222 --TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 40/288 (13%)

Query: 116 KQLGDGGFGAVYLG----ILRDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVK 170
            ++G+G FG V LG     +   R+V VK L  +        F+ EV+   +L HPN+++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP-VRLSIAIETAGALAYLH 228
             G C   +S   LLV E+ P G + ++L + +     +    V   +A E A  L +LH
Sbjct: 60  CLGQCI--ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSR------LFPTDVTHVSTAPQGTPGYVDP- 281
            +D IH D+   N  L  +  VK+ D+GL+        + T   H        P  V+  
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 282 -DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
                    T KS+++S GV + EL        T+  +   +LS+          L ++V
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELF-------TAADQPYPDLSDEQV-------LKQVV 223

Query: 341 -DPSLGFEKDYAVRNMVTSVAELAFRCVQ---QDRDMRPTMKEVLEIL 384
            +  +   K      +    ++  +  +Q    D + RPT +EV E+L
Sbjct: 224 REQDIKLPKP----QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 83/276 (30%), Positives = 125/276 (45%), Gaps = 33/276 (11%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKL 171
           +++G G FG V+ G LR D   VAVK   E    + K   +F+ E  IL +  HPN+V+L
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRL 58

Query: 172 YG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
            G CT +Q   + +V E +  G     L    P    L     + +    A  + YL + 
Sbjct: 59  IGVCTQKQP--IYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLESK 113

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKL 289
             IHRD+ + N L+     +K++DFG+SR     V   +   +  P  +  P+     + 
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK-IQNGALNELVDPSLGFEK 348
           + +SDV+SFG++L E  S L AV  +      NLSN  T + I+ G    L  P L  + 
Sbjct: 174 SSESDVWSFGILLWEAFS-LGAVPYA------NLSNQQTREAIEQGV--RLPCPELCPDA 224

Query: 349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            Y           L  RC + D   RP+   V + L
Sbjct: 225 VY----------RLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 20/220 (9%)

Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEI 159
           S L +    F   + +G+G +G VY G  ++ G++ A+K   + E+  + I+    E+ +
Sbjct: 9   SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINM 65

Query: 160 LTKL-QHPNLVKLYGCTSRQS-----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
           L K   H N+   YG   ++S      +L LV E+   G+V D + N + N+    W   
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA- 124

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             I  E    LA+LHA  VIHRD+K  N+LL  N  VK+ DFG+S      V   +T   
Sbjct: 125 -YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI- 182

Query: 274 GTPGYVDPDYFQCYKLTD-----KSDVYSFGVVLIELISG 308
           GTP ++ P+   C +  D     +SD++S G+  IE+  G
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.8 bits (230), Expect = 4e-21
 Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 25/205 (12%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHPN 167
           F+  +++G G FGAVY    +R+  +VA+K++    + + ++ +  + EV  L KL+HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGAL-- 224
            ++  GC  R+     LV EY   G+ +D L  +++P          + IA  T GAL  
Sbjct: 77  TIQYRGCYLRE-HTAWLVMEYCL-GSASDLLEVHKKPLQ-------EVEIAAVTHGALQG 127

Query: 225 -AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
            AYLH+ ++IHRDVK+ NILL     VK+ DFG + +       V     GTP ++ P+ 
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182

Query: 284 FQCY---KLTDKSDVYSFGVVLIEL 305
                  +   K DV+S G+  IEL
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 16/209 (7%)

Query: 110 DNFNSSKQLGDGGFGAVY----LGILRDGRI--VAVKRLYEN-NFKRIEQFMNEVEILTK 162
           +N +  K LG G FG V      G+ +   +  VAVK L    +    E  M+E++I++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 163 L-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           L  H N+V L G CT      +L++ EY   G + + L  R+  S L    + LS + + 
Sbjct: 95  LGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDL-LSFSYQV 150

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYV 279
           A  +A+L + + IHRD+ + N+LL +   VK+ DFGL+R    D  +V       P  ++
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210

Query: 280 DPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
            P+  F C   T +SDV+S+G++L E+ S
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 61/194 (31%), Positives = 103/194 (53%), Gaps = 10/194 (5%)

Query: 117 QLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           ++G+G  G V +   +  GR VAVK +     +R E   NEV I+   QH N+V++Y  +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK-S 86

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA-GALAYLHASDVIH 234
                EL ++ E++  G + D +   + N        +++   E+   AL YLH+  VIH
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQTRLNE------EQIATVCESVLQALCYLHSQGVIH 140

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+KS++ILL  + RVK++DFG       DV    +   GTP ++ P+         + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRTPYGTEVD 199

Query: 295 VYSFGVVLIELISG 308
           ++S G+++IE++ G
Sbjct: 200 IWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 92.3 bits (229), Expect = 5e-21
 Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 8/194 (4%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G G  G VY  I +  G+ VA+K++      + E  +NE+ ++ + +HPN+V  Y  
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN-YLD 83

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +     EL +V EY+  G++ D +     +   +    R     E   AL +LH++ VIH
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQVIH 138

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+KS+NILL  +  VK+ DFG       + +  ST   GTP ++ P+         K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVD 197

Query: 295 VYSFGVVLIELISG 308
           ++S G++ IE++ G
Sbjct: 198 IWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 91.2 bits (226), Expect = 8e-21
 Identities = 74/279 (26%), Positives = 133/279 (47%), Gaps = 22/279 (7%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHP 166
           NF   K++G G F  VY    L DG  VA+K++   +    K     + E+++L +L HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N++K Y  +  +  EL +V E    G ++  + + +    L+P        ++   AL +
Sbjct: 63  NVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           +H+  V+HRD+K  N+ +     VK+ D GL R F +  T  + +  GTP Y+ P+    
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE 180

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
                KSD++S G +L E    + A+ +  +   +NL ++   KI+      L  PS  +
Sbjct: 181 NGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLYSLC-KKIEQCDYPPL--PSDHY 233

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
            ++  +R +V         C+  D + RP +  V ++ +
Sbjct: 234 SEE--LRQLVN-------MCINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 69/233 (29%), Positives = 105/233 (45%), Gaps = 41/233 (17%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQ---FMNEVEILTKL 163
           D+F   K +G G FG V+L  +RD   G++ A+K L +++  +  Q      E +IL   
Sbjct: 1   DDFEVIKVIGRGAFGEVWL--VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
             P +VKLY  + +    L LV EY+P G + + L  +           R  IA E   A
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIA-ELVLA 113

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS------------------RLFPTDV 265
           L  +H    IHRD+K +NIL+D +  +K+ADFGL                    LF  +V
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 266 THVSTAPQ----------GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                  +          GTP Y+ P+  +      + D +S GV+L E++ G
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 11/211 (5%)

Query: 99  VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEV 157
           V S  +  E  D+F    ++G+G  G V +   +  G+ VAVK++     +R E   NEV
Sbjct: 14  VVSPGDPREYLDSF---IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 70

Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            I+    H N+V +Y  +     EL +V E++  G + D + + + N   +      ++ 
Sbjct: 71  VIMRDYHHENVVDMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVC 124

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
           +    AL+YLH   VIHRD+KS++ILL ++ R+K++DFG       +V    +   GTP 
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL-VGTPY 183

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           ++ P+         + D++S G+++IE+I G
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYEN-----NFKRIEQFMNEVEILTKLQ 164
           N+   K LG G FG VYL    D GR +AVK++  +       K +     E+++L  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 165 HPNLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           H  +V+ YGC      R L +  E++P G++ D L +       L   V      +    
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEG 118

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR------LFPTDVTHVSTAPQGTPG 277
           ++YLH++ ++HRD+K  NIL D+   VK+ DFG S+      L  T +  V+    GTP 
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPY 174

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++ P+         K+D++S G  ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 25/218 (11%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRI-VAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F + K + +G +GAVYL   ++ R   A+K++ + N     +I+Q   E +ILT  ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP-VRLSIAIETAGAL 224
           P +V ++ C+    R L +V EY+  G  A  L N       LP    R+  A ET  AL
Sbjct: 61  PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFA-ETVLAL 114

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT------HVSTAPQ----- 273
            YLH   ++HRD+K +N+L+ +   +K+ DFGLS++    +T      H+    +     
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 274 ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
              GTP Y+ P+           D ++ G++L E + G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 15/207 (7%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL-----YENNFKRIEQFMNEVEILTKLQ 164
           N+   K LG G FG VYL    D GR +AVK++      +   K +     E+++L  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 165 HPNLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           H  +V+ YGC    + ++L +  EY+P G++ D L         L   V      +    
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQG 118

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT---DVTHVSTAPQGTPGYVD 280
           ++YLH++ ++HRD+K  NIL D+   VK+ DFG S+   T     T + +   GTP ++ 
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV-TGTPYWMS 177

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
           P+         K+DV+S    ++E+++
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 6/202 (2%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKR-LYENNFKRIEQFMNEVEILTKLQHPN 167
           +      +LG+G  G+V    L++ G I A+K    + N    +Q + E+EI    + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           +VK YG      S  + +  EY   G++       +     +   V   IA      L+Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           LH+  +IHRD+K +NILL    +VK+ DFG+S      V  ++    GT  Y+ P+  Q 
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFTGTSFYMAPERIQG 177

Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              +  SDV+S G+ L+E+   
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 26/212 (12%)

Query: 116 KQLGDGGFGAVYLGILR--DGRI--VAVKRLYENNFKR--IEQFMNEVEILTKLQHPNLV 169
           K LG+G FG+V  G L   DG    VAVK +  +      IE+F++E   +    HPN++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 170 KLYG-CTSRQSREL----LLVYEYIPNGTVADHL-HNR-QPNSCLLPWPVRLSIAIETAG 222
           KL G C    S +     +++  ++ +G +   L ++R       LP    L   ++ A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV---THVSTAP---QGT 275
            + YL   + IHRD+ + N +L  +  V VADFGLS+ ++  D      ++  P      
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
               D  Y      T KSDV++FGV + E+ +
Sbjct: 185 ESLADRVY------TSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 58/271 (21%)

Query: 50  LKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEAT 109
           L  PP S+S +++++S+A       S S PS   S+++LER                   
Sbjct: 45  LPLPPPSSSSSSSSSSSA-------SGSAPSAAKSLSELERV------------------ 79

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE-QFMNEVEILTKLQHPN 167
                  ++G G  G VY  I R  GR+ A+K +Y N+   +  Q   E+EIL  + HPN
Sbjct: 80  ------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPN 133

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS-IAIETAGALAY 226
           +VK +      + E+ ++ E++  G++       +           L+ +A +    +AY
Sbjct: 134 VVKCHD-MFDHNGEIQVLLEFMDGGSLEGTHIADEQ---------FLADVARQILSGIAY 183

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           LH   ++HRD+K +N+L+++   VK+ADFG+SR+    +   +++  GT  Y+ P+    
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERIN- 241

Query: 287 YKLTD---------KSDVYSFGVVLIELISG 308
              TD           D++S GV ++E   G
Sbjct: 242 ---TDLNHGAYDGYAGDIWSLGVSILEFYLG 269

Length = 353

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 90.7 bits (225), Expect = 3e-20
 Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 19/200 (9%)

Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR---IEQFMNEVEILT-KLQHPNLVKLY 172
           LG G FG V L  L+  GR+ AVK L ++   +   +E  M E  IL+    HP L +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNR----QPNSCLLPWPVRLSIAIETAGALAYLH 228
            C     R L  V E++  G +  H+       +  +           A E   AL +LH
Sbjct: 63  CCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFY--------AAEITSALMFLH 113

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
              +I+RD+K +N+LLD+    K+ADFG+ +    +    ST   GTP Y+ P+  Q   
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEML 172

Query: 289 LTDKSDVYSFGVVLIELISG 308
                D ++ GV+L E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 30/217 (13%)

Query: 116 KQLGDGGFGAVYLGIL-----RDGRI-VAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG+G FG V           +    VAVK L ++   K +   ++E+E++  + +H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP----NSCLLPWPVR--------LS 215
           ++ L G  + Q   L +V EY  +G + D L  R+P     S   P P          +S
Sbjct: 78  IINLLGVCT-QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
            A + A  + +L +   IHRD+ + N+L+  +  +K+ADFGL+R    D+ H+    + T
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTT 192

Query: 276 PGYVDPDYFQCYKLTDK-----SDVYSFGVVLIELIS 307
            G +   +     L D+     SDV+SFGV+L E+ +
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 74/205 (36%), Positives = 104/205 (50%), Gaps = 23/205 (11%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQ--FMNEVEILTK-LQHPNLVK 170
           K +G G FG V L   + DG+  AVK L +    K+ EQ   M E  +L K ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 171 LYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           L+   S Q+ + L  V +Y+  G +  HL   Q          R   A E A AL YLH+
Sbjct: 61  LH--YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARF-YAAEIASALGYLHS 114

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYF--Q 285
            ++I+RD+K  NILLD+   V + DFGL +     + H  T     GTP Y+ P+    Q
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 286 CYKLTDKS-DVYSFGVVLIELISGL 309
            Y   D++ D +  G VL E++ GL
Sbjct: 172 PY---DRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 76/282 (26%), Positives = 135/282 (47%), Gaps = 22/282 (7%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKR--LYEN-NFKRIEQFMNEVEILTKLQHP 166
           NF   K++G G F  VY    L D + VA+K+  ++E  + K  +  + E+++L +L HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N++K Y  +  +  EL +V E    G ++  +   +    L+P        ++   A+ +
Sbjct: 63  NVIK-YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           +H+  V+HRD+K  N+ +     VK+ D GL R F +  T  + +  GTP Y+ P+    
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE 180

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
                KSD++S G +L E    + A+ +  +   +NL ++   KI+         P L  
Sbjct: 181 NGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLFSLC-QKIEQCDY-----PPLPT 230

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK 388
           E  Y+ +     + EL   C+  D D RP +  V +I ++  
Sbjct: 231 EH-YSEK-----LRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 16/219 (7%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILT-KLQHPNLVK 170
           K LG G FG V+L  L+   +  A+K L ++       +E  M E  +L+   +HP L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC-LLPWPVRLSIAIETAGALAYLHA 229
           LY CT +    L  V EY+  G +  H+      SC     P     A E    L +LH+
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHS 114

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
             +++RD+K +NILLD +  +K+ADFG+ +          T   GTP Y+ P+     K 
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173

Query: 290 TDKSDVYSFGVVLIELISG---LEAVDTSRHRHDINLSN 325
               D +SFGV+L E++ G       D       I + N
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 89.0 bits (220), Expect = 5e-20
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLV 169
           F   + +G+G +G VY G  ++ G++ A+K + +      E+   E+ +L K   H N+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 170 KLYGCTSRQS-----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
             YG   +++      +L LV E+   G+V D + N + N+    W     I  E    L
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGL 124

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           ++LH   VIHRD+K  N+LL  N  VK+ DFG+S      V   +T   GTP ++ P+  
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 183

Query: 285 QCYKLTD-----KSDVYSFGVVLIELISG 308
            C +  D     KSD++S G+  IE+  G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 6e-20
 Identities = 68/201 (33%), Positives = 96/201 (47%), Gaps = 23/201 (11%)

Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEV-------EILTKLQHPNL 168
           Q+G GG+G V+L   +D G IVA+KR+     K +   +NEV       +ILT  +   L
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILTTTKSEWL 63

Query: 169 VKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           VKL    + Q  E L L  EY+P G     L+N      L     R  +A E   A+  L
Sbjct: 64  VKLL--YAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMA-EMFEAVDAL 117

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H    IHRD+K  N L+D +  +K+ DFGLS+   T    V     G+P Y+ P+  +  
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGK 173

Query: 288 KLTDKSDVYSFGVVLIELISG 308
                 D +S G +L E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 89.0 bits (220), Expect = 9e-20
 Identities = 80/287 (27%), Positives = 141/287 (49%), Gaps = 27/287 (9%)

Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNE 156
           K+ S   + +    +   +++G G  G VY  I +  G+ VA+K++      + E  +NE
Sbjct: 7   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           + ++ + ++PN+V  Y  +     EL +V EY+  G++ D +      +C+    +  ++
Sbjct: 67  ILVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIA-AV 120

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
             E   AL +LH++ VIHRD+KS+NILL  +  VK+ DFG       + +  ST   GTP
Sbjct: 121 CRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTP 179

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
            ++ P+         K D++S G++ IE++ G            + L  +ATN       
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IATN-----GT 232

Query: 337 NELVDPSLGFEKDYAV-RNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            EL +P    E+  AV R+ +        RC++ D D R + KE+L+
Sbjct: 233 PELQNP----ERLSAVFRDFLN-------RCLEMDVDRRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 21/201 (10%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMN---EVEIL-TKLQHPNLVK 170
           K +  G FG+VYL   R  G   A+K L +++     Q  N   E  I+  + + P + K
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 171 LYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLP--WPVRLSIAIETAGALAYL 227
           LY   S QS++ L LV EY+  G  A  +         LP  W  +  IA E    +  L
Sbjct: 62  LY--YSFQSKDYLYLVMEYLNGGDCASLIKTLGG----LPEDW-AKQYIA-EVVLGVEDL 113

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H   +IHRD+K  N+L+D    +K+ DFGLSR         +    GTP Y+ P+     
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGV 168

Query: 288 KLTDKSDVYSFGVVLIELISG 308
                SD +S G V+ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 13/198 (6%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLY--------ENNFKRIEQFMNEVEILTKLQHPN 167
           ++LG G FG VYL  ++D + VA +RL         E N     Q   E ++L+KL HP 
Sbjct: 6   QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VK +     +     ++ EY     +   L   +     L         I+    + Y+
Sbjct: 64  IVKFHASFLERD-AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H   ++HRD+K+ NI L NN  +K+ DFG+SRL       ++T   GTP Y+ P+  +  
Sbjct: 123 HQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 288 KLTDKSDVYSFGVVLIEL 305
               KSD++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 14/194 (7%)

Query: 117 QLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
            LG G  G VY    L   RI+AVK +  +   +  +Q M+E+EIL K   P ++  YG 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
              ++R + +  E++  G++   ++ +      +P  V   IA+     L YL +  ++H
Sbjct: 68  FFVENR-ISICTEFMDGGSL--DVYRK------IPEHVLGRIAVAVVKGLTYLWSLKILH 118

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RDVK +N+L++   +VK+ DFG+S      V  ++    GT  Y+ P+     +    SD
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIHSD 175

Query: 295 VYSFGVVLIELISG 308
           V+S G+  +EL  G
Sbjct: 176 VWSLGISFMELALG 189

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 29/225 (12%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD--GR----IVAVKRLYEN-NFKRIEQFMNEVEILTKL 163
           N    K LG+G FG V         GR     VAVK L EN +   +   ++E  +L ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH------------NRQPNSCLLPWP 211
            HP+++KLYG  S Q   LLL+ EY   G++   L             +   NS  L  P
Sbjct: 61  NHPHVIKLYGACS-QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 212 -VR-------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT 263
             R       +S A + +  + YL    ++HRD+ + N+L+    ++K++DFGLSR    
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 264 DVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           + ++V  +    P  ++  +    +  T +SDV+SFGV+L E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 74/202 (36%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQ--FMNEVEILTK-LQHPNLVK 170
           K +G G FG V L   + DG   AVK L +    K+ EQ   M E  +L K L+HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 171 LYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           L+   S Q+ E L  V +Y+  G +  HL   Q   C L    R   A E A A+ YLH+
Sbjct: 61  LH--YSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARF-YAAEVASAIGYLHS 114

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
            ++I+RD+K  NILLD+   V + DFGL +  + P + T       GTP Y+ P+  +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLAPEVLRKE 171

Query: 288 KLTDKSDVYSFGVVLIELISGL 309
                 D +  G VL E++ GL
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.4 bits (227), Expect = 1e-19
 Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 24/298 (8%)

Query: 94  YFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQ 152
           +F +KV     + +   +      +  G  GA Y G      +   VK +  N+   I  
Sbjct: 674 FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS 731

Query: 153 FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPV 212
             +E+  + KLQHPN+VKL G   R  +   L++EYI    +++ L N       L W  
Sbjct: 732 --SEIADMGKLQHPNIVKLIG-LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWER 781

Query: 213 RLSIAIETAGALAYLH---ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS 269
           R  IAI  A AL +LH   +  V+  ++    I++D      +    L  L  TD     
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840

Query: 270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN 329
           ++      YV P+  +   +T+KSD+Y FG++LIEL++G    D     H  ++   A  
Sbjct: 841 SS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARY 894

Query: 330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET 387
              +  L+  +DPS+  +       +V  V  LA  C   D   RP   +VL+ L   
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIV-EVMNLALHCTATDPTARPCANDVLKTLESA 951

Length = 968

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 35/274 (12%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVE--ILTKLQHPNLVKLY 172
           + +G G +G V L   R DG+   +K+L   N  R E+   E E  +L++L+HPN+V   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV--- 62

Query: 173 GCTSRQSRE-----LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
               R+S E     L +V  +   G +   L  ++    LLP    +   ++ A AL YL
Sbjct: 63  --AYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H   ++HRD+K+ N+ L     +KV D G++R+        ST   GTP Y+ P+ F   
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNK 177

Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE 347
               KSDV++ G  + E+        T +H  +    N    +I  G L  +        
Sbjct: 178 PYNYKSDVWALGCCVYEMA-------TLKHAFNAKDMNSLVYRIIEGKLPPM-------P 223

Query: 348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           KDY+       + EL    + +  + RP++K +L
Sbjct: 224 KDYS-----PELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 85/293 (29%), Positives = 141/293 (48%), Gaps = 44/293 (15%)

Query: 117 QLGDGGFGAVYLGI-LRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           ++G G FGAVY         +VAVK++    +   ++ +  + EV+ L +L+HPN ++  
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGAL---AYLH 228
           GC  ++     LV EY   G+ +D L  +++P          + IA  T GAL   AYLH
Sbjct: 88  GCYLKE-HTAWLVMEYCL-GSASDLLEVHKKPLQ-------EVEIAAITHGALQGLAYLH 138

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY- 287
           + ++IHRD+K+ NILL    +VK+ADFG         +  + +  GTP ++ P+      
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEVILAMD 193

Query: 288 --KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN----LSNMATNKIQNGALNELVD 341
             +   K DV+S G+  IEL      +       ++N    L ++A N       NE  D
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQNDSPTLQSNEWTD 247

Query: 342 PSLGFEKDYAVRNM----VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS 390
              GF  DY ++ +      S   L    V++DR  R     ++++++ TKD+
Sbjct: 248 SFRGF-VDYCLQKIPQERPASAELLRHDFVRRDRPARV----LIDLIQRTKDA 295

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)

Query: 118 LGDGGFGAVYLGI---LRDGRI-VAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG VY G+     + +I VAVK      +    E+F+ E  I+ +  HP++VKL 
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + +V E  P G +  +L   Q N   L     +  + + + ALAYL +   
Sbjct: 74  GVITENP--VWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESKRF 128

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           +HRD+ + N+L+ +   VK+ DFGLSR    +  + ++  +    ++ P+     + T  
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 293 SDVYSFGVVLIELIS 307
           SDV+ FGV + E++ 
Sbjct: 189 SDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 71/230 (30%), Positives = 107/230 (46%), Gaps = 15/230 (6%)

Query: 91  GSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVY-LGILRDGRIVAVKRLYENNFKR 149
           G   + + +     L + TD +   + +G G +G VY +   +DG + AVK L  +    
Sbjct: 3   GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISD 60

Query: 150 I-EQFMNEVEILTKL-QHPNLVKLYGCTSRQSR----ELLLVYEYIPNGTVADHLHNRQP 203
           + E+   E  IL  L  HPN+VK YG   +  +    +L LV E    G+V + +     
Sbjct: 61  VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120

Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT 263
               L   +   I       L +LH + +IHRDVK NNILL     VK+ DFG+S    +
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKS-----DVYSFGVVLIELISG 308
                +T+  GTP ++ P+   C +  D S     DV+S G+  IEL  G
Sbjct: 181 TRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 11/197 (5%)

Query: 117 QLGDGGFGAVYLGI--LRDGRI-VAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +LG G FG V  G+  +R  +I VA+K L   N K + ++ M E EI+ +L +P +V++ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G    ++  L+LV E    G +   L  ++     +     + +  + +  + YL   + 
Sbjct: 62  GVC--EAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH--VSTAPQGTPGYVDPDYFQCYKLT 290
           +HRD+ + N+LL N    K++DFGLS+    D ++    +A +    +  P+     K +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 291 DKSDVYSFGVVLIELIS 307
            +SDV+S+G+ + E  S
Sbjct: 177 SRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 47/155 (30%), Positives = 91/155 (58%), Gaps = 13/155 (8%)

Query: 117 QLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFM-NEVEILTKLQ---HPNLVK 170
           ++G+G +G VY    L  GR VA+K++    + + I      E+ +L +L+   HPN+V+
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 171 LY----GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           L     G  + +  +L LV+E++ +  +A +L ++ P   L P  ++  +  +    + +
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIK-DLMRQLLRGVDF 122

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           LH+  ++HRD+K  NIL+ ++ +VK+ADFGL+R++
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 49/290 (16%)

Query: 110 DNFNSSKQLGDGGFGAVY-LGILRDGRIVAVKRLY-----ENNFKRIEQFMNEVEILTKL 163
           ++  +  ++G G  G VY +   + G ++AVK++      E N KRI   + +++++ K 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRI---LMDLDVVLK- 69

Query: 164 QH--PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL--SIAIE 219
            H  P +VK YG     S ++ +  E +   T  D L  R       P P  +   + + 
Sbjct: 70  SHDCPYIVKCYGYFITDS-DVFICMELM--STCLDKLLKRIQG----PIPEDILGKMTVA 122

Query: 220 TAGALAYL---HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
              AL YL   H   VIHRDVK +NILLD +  VK+ DFG+S           +A  G  
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCA 178

Query: 277 GYVDPDYFQCYKLTDK----SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
            Y+ P+         K    +DV+S G+ L+EL +G       +   ++ L+     KI 
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LT-----KIL 232

Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                 L  P+ GF  D+               C+ +D   RP  +E+L+
Sbjct: 233 QEEPPSL-PPNEGFSPDF---------CSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILT-KLQHPNLVK 170
           K LG G FG V L  L+      A+K L ++       +E  M E  +L    +HP L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI-AIETAGALAYLHA 229
           L+ CT +    L  V EY+  G +  H+      S       R    A E    L +LH 
Sbjct: 61  LF-CTFQTKEHLFFVMEYLNGGDLMFHIQ-----SSGRFDEARARFYAAEIICGLQFLHK 114

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
             +I+RD+K +N+LLD +  +K+ADFG+ +         ST   GTP Y+ P+  +  K 
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKY 173

Query: 290 TDKSDVYSFGVVLIELISG 308
            +  D +SFGV+L E++ G
Sbjct: 174 NESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 86/298 (28%), Positives = 123/298 (41%), Gaps = 43/298 (14%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRI------VAVKRLYENNFKRIEQ-FMNEVE 158
           E   D+    + LG G FG VY G+ R          VAVK L E+  ++ E  F+ E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 159 ILTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHL---HNRQPNSCLLPWPVRL 214
           I++K  H N+V+L G    R  R +LL  E +  G +   L     R      L     L
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILL--ELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119

Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLDNN--FRV-KVADFGLSRLFPTDVTHVSTA 271
             A + A    YL  +  IHRD+ + N LL      RV K+ADFG++R    D+   S  
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYY 175

Query: 272 PQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
            +G        ++ P+ F     T K+DV+SFGV+L E+ S               L  M
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYM 220

Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                 N  + E V  + G   D   +     V  +   C Q   + RP    +LE +
Sbjct: 221 PYPGRTNQEVMEFV--TGGGRLDPP-KGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 60/175 (34%), Positives = 81/175 (46%), Gaps = 15/175 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL------YENNFKRIEQFMNEVEILTK 162
            +F   K LG G  G V+L  L+  G++ A+K L        N  KR+     E EIL  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL---TEQEILAT 57

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HP L  LY  + +    L LV +Y P G +   L  RQP  CL     R   A E   
Sbjct: 58  LDHPFLPTLY-ASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAA-EVLL 114

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
           AL YLH   +++RD+K  NILL  +  + ++DF LS    +DV     +     G
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS--KQSDVEPPPVSKALRKG 167

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 17/199 (8%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQ------FMNEVEILTKLQHPNLVK 170
           LG GGFG V    ++  G++ A K+L   + KR+++       +NE +IL K+    +V 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL---DKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57

Query: 171 L-YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           L Y   ++   +L LV   +  G +  H++N        P    +  A +    L +LH 
Sbjct: 58  LAYAFETKD--DLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ 113

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
             +++RD+K  N+LLD++  V+++D GL+               GTPGY+ P+  Q    
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVY 171

Query: 290 TDKSDVYSFGVVLIELISG 308
               D ++ G  L E+I+G
Sbjct: 172 DFSVDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.3 bits (213), Expect = 7e-19
 Identities = 58/198 (29%), Positives = 106/198 (53%), Gaps = 8/198 (4%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +   +++G G  G V+  I +  G+ VA+K++      + E  +NE+ ++ +L++PN+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
               +     EL +V EY+  G++ D +      +C+    +  ++  E   AL +LHA+
Sbjct: 81  FLD-SFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIA-AVCRECLQALEFLHAN 134

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
            VIHRD+KS+N+LL  +  VK+ DFG       + +  ST   GTP ++ P+        
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 193

Query: 291 DKSDVYSFGVVLIELISG 308
            K D++S G++ IE++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 36/216 (16%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQ--------FMNEVEI 159
            F    ++G+G +G VY    RD   G IVA+K++      R++          + E+ +
Sbjct: 8   EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKV------RMDNERDGIPISSLREITL 59

Query: 160 LTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           L  L+HPN+V+L      +    + LV EY     +A  L N               + +
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLML 115

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           +    L YLH + +IHRD+K +N+LL +   +K+ADFGL+R +      +      TP  
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM------TPKV 169

Query: 279 VDPDY------FQCYKLTDKSDVYSFGVVLIELISG 308
           V   Y        C   T   D+++ G +L EL++ 
Sbjct: 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 86.6 bits (214), Expect = 9e-19
 Identities = 76/254 (29%), Positives = 119/254 (46%), Gaps = 28/254 (11%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQHPNLVK 170
           K +G G FG V L   + + +  AVK L +      K  +  M+E  +L K ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L+       + L  V +YI  G +  HL   Q   C L    R   A E A AL YLH+ 
Sbjct: 61  LHFSFQTADK-LYFVLDYINGGELFYHL---QRERCFLEPRARF-YAAEIASALGYLHSL 115

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYFQCYK 288
           ++++RD+K  NILLD+   + + DFGL +    ++ H  T     GTP Y+ P+      
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 289 LTDKSDVYSFGVVLIELISGLE---AVDTSRHRHDI---------NLSNMATNKIQNGAL 336
                D +  G VL E++ GL    + +T+    +I         N++N A + ++ G L
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE-GLL 231

Query: 337 NELVDPSLGFEKDY 350
            +     LG + D+
Sbjct: 232 QKDRTKRLGAKDDF 245

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 86.6 bits (214), Expect = 9e-19
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 116 KQLGDGGFGAVYLGIL-RDGRIVAVKRLYEN---NFKRIEQFMNEVEILTK-LQHPNLVK 170
           K +G G FG V L     DG+  AVK L +    N K  +  M E  +L K ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L+  + + + +L  V +++  G +  HL   +      P P     A E A AL YLH+ 
Sbjct: 61  LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSI 115

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           ++++RD+K  NILLD+   V + DFGL +  +  +D T   T   GTP Y+ P+  +   
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQP 172

Query: 289 LTDKSDVYSFGVVLIELISGL 309
             +  D +  G VL E++ GL
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)

Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR-IEQFMNEV 157
           F+  +L++         ++G G FG V   + +  G I+AVKR+     ++  ++ + ++
Sbjct: 1   FTAEDLKDL-------GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53

Query: 158 EILTKLQH-PNLVKLYG----------CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           +++ +    P +VK YG          C       L   Y+Y+         +     S 
Sbjct: 54  DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV---------YEVL-KSV 103

Query: 207 LLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV 265
           + P  +   IA+ T  AL YL     +IHRDVK +NILLD N  +K+ DFG+S      +
Sbjct: 104 I-PEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162

Query: 266 THVSTA---PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                A   P   P  +DP     Y +  +SDV+S G+ L E+ +G
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDV--RSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 14/198 (7%)

Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRL-YENNFKRIEQF-MNEVEILTKLQHPNLVKLYG 173
           ++G+G +G V+    R+   IVA+KR+  +++ + +    + E+ +L +L+H N+V+LY 
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC--LLPWPVRLSIAIETAGALAYLHASD 231
                 ++L LV+EY       D    +  +SC   +   +  S   +    LA+ H+ +
Sbjct: 67  VL-HSDKKLTLVFEY------CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           V+HRD+K  N+L++ N  +K+ADFGL+R F   V   S A   T  Y  PD     KL  
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS-AEVVTLWYRPPDVLFGAKLYS 178

Query: 292 KS-DVYSFGVVLIELISG 308
            S D++S G +  EL + 
Sbjct: 179 TSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 40/292 (13%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI-EQFMNEVEILTKLQ 164
           + +D +   + +G G +G V+  +  ++G   AVK L  +    I E+   E  IL  L 
Sbjct: 15  DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILKALS 72

Query: 165 -HPNLVKLYGCTSRQSR----ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
            HPN+VK YG   ++      +L LV E    G+V D +         +  P+   I  E
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
               L +LH +  IHRDVK NNILL     VK+ DFG+S    T          GTP ++
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWM 191

Query: 280 DPDYFQCYKLTDKS-----DVYSFGVVLIELISGLEAVDTSRHRHDINLSNM----ATNK 330
            P+   C +  D +     DV+S G+  IEL  G           D  L+++    A  K
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG-----------DPPLADLHPMRALFK 240

Query: 331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           I       L  P L +  ++          +   +C+ +D + RPT+ ++L+
Sbjct: 241 IPRNPPPTLHQPEL-WSNEF---------NDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 70/278 (25%), Positives = 131/278 (47%), Gaps = 35/278 (12%)

Query: 117 QLGDGGFGAVYLGILRDG--RIVAVKRLYENNF----------KRIEQFMNEVEILTK-L 163
            LG G FG VY    ++    ++A+K +  +N           K I   ++EV I+ + L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HPN+V+ Y  T  ++  L +V + I    + +H ++ +            +I ++   A
Sbjct: 67  RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 224 LAYLHASD-VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH    ++HRD+  NNI+L  + +V + DFGL++    +    S    GT  Y  P+
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTILYSCPE 183

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP 342
             +     +K+DV++FG +L ++ + L+        +  N+ ++AT KI       L + 
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT-LQPP-----FYSTNMLSLAT-KIVEAVYEPLPEG 236

Query: 343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              + +D  V +++T        C+  D + RP + +V
Sbjct: 237 M--YSED--VTDVIT-------SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 23/204 (11%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILT-KLQHPNLVK 170
           K LG G FG V L  L+  G   AVK L ++       +E  M E  +L    ++P L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI------AIETAGAL 224
           LY CT +    L  V E++  G +  H+ ++           R  +      A E    L
Sbjct: 61  LY-CTFQTKEHLFFVMEFLNGGDLMFHIQDKG----------RFDLYRATFYAAEIVCGL 109

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
            +LH+  +I+RD+K +N++LD +  +K+ADFG+ +         ST   GTP Y+ P+  
Sbjct: 110 QFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEIL 168

Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           Q  K T   D +SFGV+L E++ G
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 41/287 (14%)

Query: 116 KQLGDGGFGAVYLGI-LRDG---RI-VAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLV 169
           K LG G FG VY GI + DG   +I VA+K L EN   K  ++ ++E  ++  +  P + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLH---NRQPNSCLLPWPVRLSIAIETAGALA 225
           +L G C +   +   LV + +P G + D++    +R  +  LL W V++      A  ++
Sbjct: 73  RLLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMS 123

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYF 284
           YL    ++HRD+ + N+L+ +   VK+ DFGL+RL   D T         P  ++  +  
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 285 QCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS 343
              + T +SDV+S+GV + EL++ G +  D    R   +L       ++ G    L  P 
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-------LEKG--ERLPQPP 234

Query: 344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL-EILRETKD 389
                          V  +  +C   D + RP  +E++ E  R  +D
Sbjct: 235 ----------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 111 NFNSSKQLGDGGFGAVYL----GILRDGRIVAVKRLYENNF----KRIEQFMNEVEILTK 162
           NF   + LG G +G V+L    G    G++ A+K L +       K  E    E ++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 163 LQH-PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           ++  P LV L+      ++ L L+ +Y+  G +  HL+ R+         VR+ IA E  
Sbjct: 61  VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREH---FTESEVRVYIA-EIV 115

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            AL +LH   +I+RD+K  NILLD+   V + DFGLS+ F  +    + +  GT  Y+ P
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 282 DYFQCYKL--TDKSDVYSFGVVLIELISG 308
           +  +          D +S GV+  EL++G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 84.4 bits (208), Expect = 3e-18
 Identities = 78/287 (27%), Positives = 140/287 (48%), Gaps = 27/287 (9%)

Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNE 156
           K+ S   + +    +   +++G G  G VY  + +  G+ VA++++      + E  +NE
Sbjct: 8   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           + ++ + ++PN+V  Y  +     EL +V EY+  G++ D +      +C+    +  ++
Sbjct: 68  ILVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIA-AV 121

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
             E   AL +LH++ VIHRD+KS+NILL  +  VK+ DFG       + +  ST   GTP
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTP 180

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
            ++ P+         K D++S G++ IE+I G            + L  +ATN       
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATN-----GT 233

Query: 337 NELVDPSLGFEKDYAV-RNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            EL +P    EK  A+ R+ +        RC+  D + R + KE+L+
Sbjct: 234 PELQNP----EKLSAIFRDFLN-------RCLDMDVEKRGSAKELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 21/214 (9%)

Query: 112 FNSSKQLGDGGFGAVYLGI-LRDG---RI-VAVKRLYENNFKRIEQ-FMNEVEILTKLQH 165
           F   K LG G FG VY G+ + +G   +I VA+K L E    +  +  ++E  ++  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 166 PNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC---LLPWPVRLSIAIETA 221
           P++ +L G C +   +   L+ + +P G + D++   + N     LL W V++      A
Sbjct: 69  PHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------A 119

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   D           P  ++ 
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVD 313
            +       T +SDV+S+GV + EL++ G +  D
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 79/304 (25%), Positives = 140/304 (46%), Gaps = 51/304 (16%)

Query: 116 KQLGDGGFGAVYL----GILR-------------DGRIVAVKRLYENNFKRIEQ-FMNEV 157
           ++LG+G FG V+L    G+ +                +VAVK L E+  K     F+ E+
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 158 EILTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR--- 213
           +I+++L+ PN+++L   C +  S  L ++ EY+ NG +   L   +P        V    
Sbjct: 71  KIMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 214 ----LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHV 268
               + +A + A  + YL + + +HRD+ + N L+  N+ +K+ADFG+SR L+  D   +
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 269 STAPQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
               QG    V P  +  +      K T  SDV++FGV L E+++  +    S+   +  
Sbjct: 189 ----QGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242

Query: 323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           + N        G    L  P+L  +          S+ +L   C +++   RP+ +E+  
Sbjct: 243 IENTGEFFRDQGRQVYLPKPALCPD----------SLYKLMLSCWRRNAKERPSFQEIHA 292

Query: 383 ILRE 386
            L E
Sbjct: 293 TLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 52/308 (16%)

Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDG---RI-VAVK----RLYENNF 147
           A++   +EL +        K LG G FG V+ GI + +G   +I VA+K    R     F
Sbjct: 1   ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53

Query: 148 KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN--- 204
           + I   M     +  L H  +V+L G     S  L LV +  P G++ DH+   + +   
Sbjct: 54  QEITDHMLA---MGSLDHAYIVRLLGICPGAS--LQLVTQLSPLGSLLDHVRQHRDSLDP 108

Query: 205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD 264
             LL W V++      A  + YL    ++HR++ + NILL ++  V++ADFG++ L   D
Sbjct: 109 QRLLNWCVQI------AKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Query: 265 VTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDIN 322
                 +   TP  ++  +     + T +SDV+S+GV + E++S G E        H++ 
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY-AGMRPHEV- 220

Query: 323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL- 381
                 + ++ G    L  P +     Y V  MV        +C   D ++RPT KE+  
Sbjct: 221 -----PDLLEKG--ERLAQPQICTIDVYMV--MV--------KCWMIDENVRPTFKELAN 263

Query: 382 EILRETKD 389
           E  R  +D
Sbjct: 264 EFTRMARD 271

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 58/228 (25%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQF----MNEVEILTK 162
           D +    ++ +G +G VY    RD   G IVA+K+L     K  E F    + E+ IL K
Sbjct: 5   DEYEKLNRIEEGTYGVVYRA--RDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLK 60

Query: 163 LQHPNLVKL----YGCTSRQSRELLLVYEYIPNG--TVADHLHNRQPNS-----CLLPWP 211
           LQHPN+V +     G    +   + +V EY+ +   ++ + +   QP       CL+   
Sbjct: 61  LQHPNIVTVKEVVVGSNLDK---IYMVMEYVEHDLKSLMETMK--QPFLQSEVKCLM--- 112

Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTD----- 264
                 ++    +A+LH + ++HRD+K++N+LL+N   +K+ DFGL+R +  P       
Sbjct: 113 ------LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL 166

Query: 265 -VTHVSTAPQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            VT    AP+   G   Y           +   D++S G +  EL++ 
Sbjct: 167 VVTLWYRAPELLLGAKEY-----------STAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 24/229 (10%)

Query: 93  SYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIV-AVKRLYENNFKRIE 151
           S +       ++L    ++F+  K +G G FG V L   +  + V A+K L  + F+ I+
Sbjct: 26  SRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL--SKFEMIK 83

Query: 152 Q-----FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           +     F  E +I+       +V+L+    +  + L +V EY+P G + + + N      
Sbjct: 84  RSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYD---- 138

Query: 207 LLP--WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPT 263
            +P  W  R   A E   AL  +H+   IHRDVK +N+LLD +  +K+ADFG   ++   
Sbjct: 139 -IPEKW-ARFYTA-EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195

Query: 264 DVTHVSTAPQGTPGYVDPDYFQCYKLTD----KSDVYSFGVVLIELISG 308
            +    TA  GTP Y+ P+  +          + D +S GV L E++ G
Sbjct: 196 GMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 28/205 (13%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNE---VEILTKLQHPNLVK 170
           LG G FG V L   +  G + A+K L + +      +E  M E    E     +HP LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L+ C   +   +  V EY   G +  H+H           P  +  A      L YLH +
Sbjct: 67  LFACFQTEDH-VCFVMEYAAGGDLMMHIHTDV-----FSEPRAVFYAACVVLGLQYLHEN 120

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
            +++RD+K +N+LLD    VK+ADFGL +  +   D T  ST   GTP ++ P+      
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFC-GTPEFLAPEV----- 172

Query: 289 LTDKS-----DVYSFGVVLIELISG 308
           LT+ S     D +  GV++ E++ G
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 23/208 (11%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPN 167
           NF   +++G+G +G VY       G +VA+K  RL           + E+ +L +L HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VKL      +++ L LV+E++ +  +   +     +   +P P+  S   +    LA+ 
Sbjct: 61  IVKLLDVIHTENK-LYLVFEFL-HQDLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFC 116

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV---TH-VST----APQGTPGYV 279
           H+  V+HRD+K  N+L++    +K+ADFGL+R F   V   TH V T    AP+   G  
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 174

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                 C   +   D++S G +  E+++
Sbjct: 175 ------CKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 83.7 bits (207), Expect = 9e-18
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRDG--RIVAVKRLYENNFKR---IEQFMNEVEILTKLQH 165
           +FN    LG G FG V L   R G   + A+K L ++   +   +E  M E  +L     
Sbjct: 1   DFNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59

Query: 166 PN-LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIET 220
           P  L +L+ C     R L  V EY+  G +  H+      ++P++           A E 
Sbjct: 60  PPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--------AAEI 110

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGY 278
           A  L +LH+  +I+RD+K +N++LD    +K+ADFG+ +  +F    T       GTP Y
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDY 167

Query: 279 VDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           + P+    Y+   KS D ++FGV+L E+++G
Sbjct: 168 IAPEII-AYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRI--VAVKRLYENNF---KRIEQFMNEVEILTKLQ 164
           ++FN  + LG G FG V L   ++     VA+KR  ++     K+++   +E +IL  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAG 222
           HP  V LYG    +S  L LV E++  G     L  + R PN     +  ++ +  E   
Sbjct: 90  HPFCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE--- 145

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
              YL + ++++RD+K  N+LLD +  +K+ DFG +++  T    +     GTP Y+ P+
Sbjct: 146 ---YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPE 198

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                     +D ++ G+ + E++ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 43/291 (14%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENN----FKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G+G +G V     ++ G+IVA+K+  E+      K+I   M E+ +L +L+H NLV L 
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MREIRMLKQLRHENLVNLI 66

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
               R+ R L LV+E++ + TV D L    PN   L          +    + + H+ ++
Sbjct: 67  EVFRRKKR-LYLVFEFVDH-TVLDDLEK-YPNG--LDESRVRKYLFQILRGIEFCHSHNI 121

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDV--THVST----APQGTPGYVDPDYF 284
           IHRD+K  NIL+  +  VK+ DFG +R    P +V   +V+T    AP+   G  D  Y 
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYG 179

Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAV----DTSRHRHDI----NLSN-----MATNKI 331
           +        D+++ G ++ E+++G        D  +  H I    NL          N +
Sbjct: 180 RAV------DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             G     V      EK +   + +  V +LA +C++ D D RP+  ++L 
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGL--VLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 40/217 (18%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQ--------FMNEVEILT 161
           ++   +++G+G +G VY G   + G+IVA+K++      R+E          + E+ +L 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI------RLESEEEGVPSTAIREISLLK 54

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           +LQHPN+V L     ++SR L L++E++ +  +  +L +      +    V+ S   +  
Sbjct: 55  ELQHPNIVCLQDVLMQESR-LYLIFEFL-SMDLKKYLDSLPKGQYMDAELVK-SYLYQIL 111

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDV-TH-VST----APQ 273
             + + H+  V+HRD+K  N+L+DN   +K+ADFGL+R F  P  V TH V T    AP+
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE 171

Query: 274 ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
              G+P Y  P            D++S G +  E+ +
Sbjct: 172 VLLGSPRYSTP-----------VDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V +    G+ ++   R+  VAVK L  +   K +   ++E
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73

Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS---CLLPW- 210
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P     C  P  
Sbjct: 74  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131

Query: 211 -PVRL-------SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
            P          S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 188

Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 189 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 26/210 (12%)

Query: 118 LGDGGFGAVYLGILR-DGRIV--AVKRLYE---NNFKRIEQFMNEVEILTKL-QHPNLVK 170
           +G+G FG V   +++ DG  +  A+K L E    N  R   F  E+E+L KL  HPN++ 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR--DFAGELEVLCKLGHHPNIIN 67

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHN------------RQPNSCLLPWPVRLSIA 217
           L G C +R    L +  EY P G + D L                  +  L     L  A
Sbjct: 68  LLGACENRGY--LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  + YL     IHRD+ + N+L+  N   K+ADFGLSR    +V    T  +    
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVR 183

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++  +       T KSDV+SFGV+L E++S
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 16/191 (8%)

Query: 134 GRIVAVKRLYENNFKRIEQ---FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP 190
           G  VA+K L  +  +   Q   F  E  +  +L HPN+V L          L  V+EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNN 247
             T+ + L         LP      + ++   ALA  H   ++HRD+K  NI++      
Sbjct: 63  GRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 248 FRVKVADFGLSRLFP----TDVTHVSTAPQ--GTPGYVDPDYFQCYKLTDKSDVYSFGVV 301
              KV DFG+  L P     DV  ++   +  GTP Y  P+  +   +T  SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 302 LIELISGLEAV 312
            +E ++G   V
Sbjct: 179 FLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 25/168 (14%)

Query: 112 FNSSKQLGDGGFGAVYLGIL---RDGRIVAVKRLYENNFKRIEQF----MNEVEILTKLQ 164
           +     +G G +G VY       +DG+  A+K+ ++ + ++          E+ +L +L+
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60

Query: 165 HPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADH------LHNRQPNSCLLPWPVRLSIA 217
           H N+V L         + + L+++Y      A+H        +RQ     +P  +  S+ 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 218 IETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF 261
            +    + YLH++ V+HRD+K  NIL+         VK+ D GL+RLF
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 34/230 (14%)

Query: 106 EEATDNFNSSKQLGDGGFGAVY----LGILRD----GRIVAVKRLYEN-NFKRIEQFMNE 156
           E + D     K LG+G FG V     LGI +D       VAVK L ++   K +   ++E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR- 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +  
Sbjct: 71  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R   
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--- 185

Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            DV ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 186 -DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 81.3 bits (200), Expect = 5e-17
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 118 LGDGGFGAVYLGILRD-GRIVA---VKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLY 172
           +G G +  V L  L+   RI A   VK+   N+ + I+    E  +  +   HP LV L+
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
            C   +SR L  V EY+  G +  H+  ++     LP       + E + AL YLH   +
Sbjct: 63  SCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGI 117

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
           I+RD+K +N+LLD+   +K+ D+G+ +  L P D T       GTP Y+ P+  +     
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGEDYG 174

Query: 291 DKSDVYSFGVVLIELISGLEAVD 313
              D ++ GV++ E+++G    D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 78/310 (25%)

Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           E E   D       LG G +G VY    L     +A+K + E + + ++    E+ + + 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVRL---SIAI 218
           L+H N+V+  G  S ++    +  E +P G+++  L ++        W P++    +I  
Sbjct: 62  LKHRNIVQYLGSDS-ENGFFKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIIF 112

Query: 219 ETAG---ALAYLHASDVIHRDVKSNNILLDNNFR--VKVADFG----LSRLFPTDVTHVS 269
            T      L YLH + ++HRD+K +N+L+ N +   VK++DFG    L+ + P   T   
Sbjct: 113 YTKQILEGLKYLHDNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTETFTG 171

Query: 270 T----AP----QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
           T    AP    +G  GY  P           +D++S G  ++E                 
Sbjct: 172 TLQYMAPEVIDKGPRGYGAP-----------ADIWSLGCTIVE----------------- 203

Query: 322 NLSNMATNKIQNGALNELVDPS-----LGFEKDYAVRNMVTSVAELA----FRCVQQDRD 372
               MAT K       EL +P      +G  K +    +  S++  A     RC + D D
Sbjct: 204 ----MATGK---PPFIELGEPQAAMFKVGMFKIHP--EIPESLSAEAKNFILRCFEPDPD 254

Query: 373 MRPTMKEVLE 382
            R +  ++L+
Sbjct: 255 KRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 45/227 (19%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF----MNEVEIL 160
           +   D F+   Q+G+G +G VY    +D G +VA+K++  +N K  E F    + E++IL
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 161 TKLQHPNLVKLYGCTS---------RQSRELLLVYEYIPNGTVADH----------LHNR 201
            +L H N+V L    +         +      LV+EY+      DH          +H  
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFS 114

Query: 202 QPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           + +          S   +    L Y H  + +HRD+K +NILL+N  ++K+ADFGL+RL+
Sbjct: 115 EDHIK--------SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166

Query: 262 PTDVTHVSTAPQGTPGYVDPDYF---QCYKLTDKSDVYSFGVVLIEL 305
            ++ +   T    T  Y  P+     + Y      DV+S G +L EL
Sbjct: 167 NSEESRPYTNKVITLWYRPPELLLGEERY--GPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 6/194 (3%)

Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQF---MNEVEILTKLQHPNLVKLYG 173
           LG GGFG V    +R  G++ A K+L +   K+ + +   M E  IL K+    +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
              +   +L LV   +  G +  H++N    +   P P       +    L +LH   +I
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           +RD+K  N+LLDN+  V+++D GL+     D    +    GTPG++ P+  Q  +     
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178

Query: 294 DVYSFGVVLIELIS 307
           D ++ GV L E+I+
Sbjct: 179 DYFALGVTLYEMIA 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 80.2 bits (198), Expect = 7e-17
 Identities = 61/274 (22%), Positives = 115/274 (41%), Gaps = 48/274 (17%)

Query: 126 VYLGILRDGRIVAVKRL--YENNFKR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL 182
           +Y GI  + + V ++    +    K  I+   NE++ L ++   N++K+YG       +L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 183 ---LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-VIHRDVK 238
               L+ EY   G + + L   +     L +  +L +AI+    L  L+      ++++ 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150

Query: 239 SNNILLDNNFRVKVADFGLSRLFPT----DVTHVSTAPQGTPGYVDP----DYFQCYKLT 290
           S + L+  N+++K+   GL ++  +    +V  +         Y       D F   + T
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV--------YFSYKMLNDIFS--EYT 200

Query: 291 DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            K D+YS GVVL E+ +G            I   N+ T +I +  +N+     L  +   
Sbjct: 201 IKDDIYSLGVVLWEIFTG-----------KIPFENLTTKEIYDLIINKNNSLKLPLDCPL 249

Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            ++ +V         C   D   RP +KE+L  L
Sbjct: 250 EIKCIVE-------ACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.7 bits (200), Expect = 8e-17
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 53/222 (23%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEILTKLQHPNL 168
           K +G G +G V   +  R GR VA+K++  N F      KRI   + E+++L  L+H N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKI-SNVFDDLIDAKRI---LREIKLLRHLRHENI 61

Query: 169 VKLYGCTSRQS----RELLLVYEYIPNGTVAD-H--LHNRQPNSCLLPWPVRLSIAIETA 221
           + L       S     ++ +V E +      D H  + + QP   L    ++     +  
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQP---LTDDHIQY-FLYQIL 113

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF------PTDVT-HVST---- 270
             L YLH+++VIHRD+K +NIL+++N  +K+ DFGL+R           +T +V T    
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 271 APQ---GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           AP+    +  Y             K+ D++S G +  EL++ 
Sbjct: 174 APELLLSSSRY------------TKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 46/240 (19%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN---EVEILTKLQH 165
           D+F S K +G G FG V L   +D G I A+K+L ++     EQ  +   E +IL +  +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P +VKLY  + +    L L+ EY+P G +   L  +           R  IA ET  A+ 
Sbjct: 61  PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIA-ETILAID 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF----------------PTDVTHVS 269
            +H    IHRD+K +N+LLD    +K++DFGL                    P++     
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 270 TAPQ---------------------GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P                      GTP Y+ P+ F       + D +S GV++ E++ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 118 LGDGGFGAVYLG-ILRDG-RI-VAVKRLYENNFKRIEQ-FMNEVEILTKL-QHPNLVKLY 172
           +G+G FG V    I +DG R+  A+KR+ E   K   + F  E+E+L KL  HPN++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 173 G-CTSRQSRELLLVYEYIPNGTVADHLHNRQ------------PNSCLLPWPVRLSIAIE 219
           G C  R    L L  EY P+G + D L   +              +  L     L  A +
Sbjct: 75  GACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
            A  + YL     IHRD+ + NIL+  N+  K+ADFGLSR    +V    T  +    ++
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWM 190

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             +       T  SDV+S+GV+L E++S
Sbjct: 191 AIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 79.7 bits (196), Expect = 9e-17
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 22/216 (10%)

Query: 116 KQLGDGGFGAVYLGIL------RDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
           ++LG+  FG VY G L         + VA+K L +       E+F +E  + ++LQHPN+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS------------CLLPWPVRLSI 216
           V L G  +++ + L +++ Y  +  + + L  R P+S              L     + I
Sbjct: 71  VCLLGVVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGT 275
             + A  + +L +  V+H+D+ + N+L+ +   VK++D GL R ++  D   +       
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLE 310
             ++ P+     K +  SD++S+GVVL E+ S GL+
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 34/220 (15%)

Query: 116 KQLGDGGFGAVYL----GILRD----GRIVAVKRLYENNF-KRIEQFMNEVEILTKL-QH 165
           K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++  + +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 166 PNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQP-------NSCLLP-----WPV 212
            N++ L G CT  Q   L ++ EY   G + ++L  R+P       ++C LP     +  
Sbjct: 78  KNIINLLGACT--QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
            +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R    DV ++    
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYK 191

Query: 273 QGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 49/214 (22%)

Query: 117 QLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQ--------FMNEVEILTKLQHPN 167
           ++G+G +G VY       G IVA+K++      R+E          + E+ +L +L HPN
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVAD----HLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +V+L      +++ L LV+E++      D       +  P + L P  ++ S   +    
Sbjct: 60  IVRLLDVVHSENK-LYLVFEFL------DLDLKKYMDSSPLTGLDPPLIK-SYLYQLLQG 111

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV---TH-VST----APQ-- 273
           +AY H+  V+HRD+K  N+L+D    +K+ADFGL+R F   V   TH V T    AP+  
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 274 -GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
            G+  Y  P            D++S G +  E++
Sbjct: 172 LGSRQYSTP-----------VDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 112 FNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQH 165
           F   + LG G FG+V    L+      + VAVK L  + F    IE+F+ E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 166 PNLVKLYGCT--SRQSREL---LLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAI 218
           PN++KL G +  SR    L   +++  ++ +G +   L   +       LP    +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPG 277
           + A  + YL + + IHRD+ + N +L+ N  V VADFGLS+ ++  D        QG   
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR-----QGCAS 175

Query: 278 YVDPDYFQCYKLTD-----KSDVYSFGVVLIELIS 307
            +   +     L D      SDV++FGV + E+++
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 79/288 (27%), Positives = 125/288 (43%), Gaps = 40/288 (13%)

Query: 118 LGDGGFGAVYLGILRD------GRI-VAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           LG G FG VY G   D      G I VAVK L +    +  ++F+ E  +++   HPN+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC---LLPWPVRLSIAIETAGALA 225
           KL G C   + + +++  E +  G +  +L + +       LL     L I ++ A    
Sbjct: 63  KLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 226 YLHASDVIHRDVKSNNILL-----DNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYV 279
           YL     IHRD+ + N L+     D +  VK+ DFGL+R ++ +D             ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT-NKIQNGALNE 338
            P+     K T +SDV+SFGV++ E++       T   +    L+N      +  G    
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEIL-------TLGQQPYPALNNQEVLQHVTAGG--R 231

Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           L  P           N    + +L   C  QD   RPT   + EIL+ 
Sbjct: 232 LQKP----------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 34/226 (15%)

Query: 110 DNFNSSKQLGDGGFGAVY----LGILRDGR----IVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V      GI +        VAVK L +N   K +   ++E+E++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC------------ 206
             + +H N++ L G CT  Q   L ++ EY   G + + L  R+P               
Sbjct: 72  KLIGKHKNIINLLGVCT--QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129

Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
            L +   +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R     V 
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVH 185

Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +    + + G     ++ P+       T +SDV+SFG+++ E+ +
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 26/210 (12%)

Query: 118 LGDGGFGAVYLGILR-DGRIV--AVKRLYE---NNFKRIEQFMNEVEILTKL-QHPNLVK 170
           +G+G FG V    ++ DG  +  A+KR+ E    +  R   F  E+E+L KL  HPN++ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIIN 60

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHN------------RQPNSCLLPWPVRLSIA 217
           L G C  R    L L  EY P+G + D L                  +  L     L  A
Sbjct: 61  LLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  + YL     IHRD+ + NIL+  N+  K+ADFGLSR    +V    T  +    
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 176

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++  +       T  SDV+S+GV+L E++S
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 52/221 (23%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN---------EVEILTKL-Q 164
           ++LG G +G V+  I R    +VA+K++++        F N         E+  L +L  
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFD-------AFRNATDAQRTFREIMFLQELGD 65

Query: 165 HPNLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           HPN+VKL     +   +++ LV+EY+      D LH     + L     R  I  +   A
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYME----TD-LHAVIRANILEDVHKR-YIMYQLLKA 119

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT--------DVT-HVST---- 270
           L Y+H+ +VIHRD+K +NILL+++ RVK+ADFGL+R             +T +V+T    
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 271 APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           AP+   G+  Y           T   D++S G +L E++ G
Sbjct: 180 APEILLGSTRY-----------TKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 20/211 (9%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENNF----KRIEQFMNEVEIL 160
           NF   K LG G +G V+L  +R       G++ A+K L +       K  E    E ++L
Sbjct: 1   NFELLKVLGTGAYGKVFL--VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58

Query: 161 TKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
             + Q P LV L+      ++ L L+ +YI  G +  HL  R+         V++    E
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFK---EQEVQIYSG-E 113

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
              AL +LH   +I+RD+K  NILLD+N  V + DFGLS+ F  D    + +  GT  Y+
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 280 DPDYFQCYKLT-DKS-DVYSFGVVLIELISG 308
            PD  +      DK+ D +S GV++ EL++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR---IEQFMNEVEILT-KLQHPNLVK 170
           K LG G FG V L  L+    + A+K L ++   +   ++  M E  IL    +HP L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L+ C   + R L  V EY+  G   D +   Q +        R   A E   AL +LH  
Sbjct: 61  LHCCFQTKDR-LFFVMEYVNGG---DLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRH 115

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
            VI+RD+K +NILLD     K+ADFG+ +  +     T   T   GTP Y+ P+  Q  +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQELE 172

Query: 289 LTDKSDVYSFGVVLIELISG 308
                D ++ GV++ E+++G
Sbjct: 173 YGPSVDWWALGVLMYEMMAG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 116 KQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNL 168
             LG G FG V+L   +         +V VK L +   + ++  F  E+++  KL H N+
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 169 VKLYG-CTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPV----RLSIAIETAG 222
           V+L G C  R++    ++ EY   G +   L   +  +  L P P+    ++++  + A 
Sbjct: 71  VRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            + +L  +  +HRD+ + N L+ +   VKV+   LS+       +          ++ P+
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
             Q    + KSDV+SFGV++ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 116 KQLGDGGFGAVYLGIL-RDGRI--VAVKRLYENNFKR--IEQFMNEVEILTKLQHPNLVK 170
           K LG+G FG+V  G L +D  I  VAVK +      R  +E F++E   + +  HPN+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 171 LYG-CTSRQSRE----LLLVYEYIPNGTVADHLHNRQPNSC--LLPWPVRLSIAIETAGA 223
           L G C      E     +++  ++ +G +   L   +   C   LP  + +    + A  
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGYVDPD 282
           + YL +   IHRD+ + N +L+ N  V VADFGLS +++  D        +    ++  +
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184

Query: 283 YFQCYKLTDKSDVYSFGVVLIEL 305
                  T KSDV+SFGV + E+
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 18/214 (8%)

Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ-----FMNEVEI 159
           L+   ++++  K +G G FG V L   +  + V   +L  + F+ I++     F  E +I
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL-SKFEMIKRSDSAFFWEERDI 96

Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
           +     P +V+L+ C  +  + L +V EY+P G + + + N       +P         E
Sbjct: 97  MAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAE 150

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGY 278
              AL  +H+  +IHRDVK +N+LLD +  +K+ADFG   ++  T +    TA  GTP Y
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDY 209

Query: 279 VDPDYFQCYK----LTDKSDVYSFGVVLIELISG 308
           + P+  +          + D +S GV L E++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 116 KQLGDGGFGAV---YLGILRDGRIVAVKRLY-ENNFKRI-EQFMNEVEILTKLQHPNLVK 170
            +LG G FG V      + +  + VAVK L  +NN   + ++ + E  ++ +L +P +V+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAY 226
           + G    +S   +LV E    G +   L    H  + N   L   V +         + Y
Sbjct: 61  MIGICEAES--WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKY 110

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT-P-GYVDPDYF 284
           L  ++ +HRD+ + N+LL      K++DFGLS+    D  +      G  P  +  P+  
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 285 QCYKLTDKSDVYSFGVVLIELIS 307
             YK + KSDV+SFGV++ E  S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)

Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE----QFMNEVEILTKLQH 165
           NF   ++LG+G +  VY G  R  G IVA+K   E +    E      + E+ ++ +L+H
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALK---EIHLDAEEGTPSTAIREISLMKELKH 57

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
            N+V+L+     +++ L+LV+EY+ +  +  ++        L P  V+ S   +    +A
Sbjct: 58  ENIVRLHDVIHTENK-LMLVFEYM-DKDLKKYMDTHGVRGALDPNTVK-SFTYQLLKGIA 114

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           + H + V+HRD+K  N+L++    +K+ADFGL+R F   V   S     T  Y  PD   
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173

Query: 286 CYKLTDKS-DVYSFGVVLIELISGL 309
             +    S D++S G ++ E+I+G 
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 10/160 (6%)

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           +P LV L+ C    SR L LV EY+  G +  H+  ++     LP       A E   AL
Sbjct: 55  NPFLVGLHSCFQTTSR-LFLVIEYVNGGDLMFHMQRQRK----LPEEHARFYAAEICIAL 109

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPD 282
            +LH   +I+RD+K +N+LLD +  +K+ D+G+ +  L P D T       GTP Y+ P+
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPE 166

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
             +  +     D ++ GV++ E+++G    D      D+N
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHP 166
           +FN    LG G FG V L   +    + A+K L ++   +   +E  M E  +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 167 N-LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
             L +L+ C     R L  V EY+  G +  H+      ++P +           A E +
Sbjct: 61  PFLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--------AAEIS 111

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             L +LH   +I+RD+K +N++LD+   +K+ADFG+ +    D     T   GTP Y+ P
Sbjct: 112 VGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAP 170

Query: 282 DY--FQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
           +   +Q Y  +   D +++GV+L E+++G    D
Sbjct: 171 EIIAYQPYGKS--VDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRDG--RIVAVKRLYENNFKR---IEQFMNEVEILT-KLQ 164
           +FN    LG G FG V L   R G   + A+K L ++   +   +E  M E  +L    +
Sbjct: 1   DFNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIET 220
            P L +L+ C     R L  V EY+  G +   +      ++P++           A E 
Sbjct: 60  PPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--------AAEI 110

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A  L +LH+  +I+RD+K +N++LD+   +K+ADFG+ +    D     T   GTP Y+ 
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIA 169

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P+           D ++FGV+L E+++G
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 71/293 (24%), Positives = 130/293 (44%), Gaps = 27/293 (9%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
             LG G  G+V     +  G ++A K ++        +Q + E++I+ + + P +V  YG
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH-ASDV 232
               ++  + +  E++  G++        P    +P  +   IA+     L YL+    +
Sbjct: 71  AFLNEN-NICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHRI 125

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           +HRD+K +NIL+++  ++K+ DFG+S      +  ++    GT  Y+ P+  Q  K T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 293 SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD--PSLGFEKDY 350
           SDV+S G+ +IEL  G      S    D     M    +    + E     PS  F +D 
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED- 241

Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVVDIR 403
            +R+ V         C+ +D   RPT +++           +   +A  VD++
Sbjct: 242 -LRDFVD-------ACLLKDPTERPTPQQLCA-----MPPFIQALRASNVDLQ 281

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 118 LGDGGFGAVYLGILRDG-RIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYG 173
           +G G FG V     RD  RI A+K + + +      +   + E  +L ++  P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 174 CTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
             S QS E L LV  +I  G +  HL   Q          R   A E   AL  LH  +V
Sbjct: 60  -FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTA-ELLCALENLHKFNV 114

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           I+RD+K  NILLD    + + DFGL +L   D    +T   GTP Y+ P+    +  T  
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKA 173

Query: 293 SDVYSFGVVLIELISGL 309
            D ++ GV+L E+++GL
Sbjct: 174 VDWWTLGVLLYEMLTGL 190

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 16/204 (7%)

Query: 116 KQLGDGGFGAVYLGILRDGRI---VAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKL 171
           K++G+G FG V LG +  G     V VK L  + + +   +F+ E +    LQH NL++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 172 YG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS-IAIETAGALAYLHA 229
            G CT  +    LLV E+ P G +  +L + +    + P P  L  +A E A  L +LH 
Sbjct: 61  LGQCT--EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQ--- 285
           ++ IH D+   N LL  +  VK+ D+GLS     +  +V+      P  ++ P+      
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 286 ----CYKLTDKSDVYSFGVVLIEL 305
                   T +S+V+S GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHP 166
           ++   +++G G +G VY    L  G + AVK +     ++F  I+Q   E+ ++ + +H 
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHC 66

Query: 167 NLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNS-CLLPWPVRLSIAIETAGAL 224
           N+V  +G  S  SRE L +  EY   G++ D  H   P S   + +  R     ET   L
Sbjct: 67  NIVAYFG--SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGL 119

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           AYLH+   +HRD+K  NILL +N  VK+ADFG++      +    +   GTP ++ P+  
Sbjct: 120 AYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVA 178

Query: 285 QCYK---LTDKSDVYSFGVVLIEL 305
              K        D+++ G+  IEL
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 110 DNFNSSKQLGDGGFGAVY-LGILRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQH-P 166
           D+    ++LG G +G V  +  +  G I+AVKR+    N +  ++ + +++I  +    P
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 167 NLVKLYGCTSRQS-----RELL--LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
             V  YG   R+       E++   + ++        +          +P  +   IA+ 
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKV----YDKGLT-----IPEDILGKIAVS 111

Query: 220 TAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA---PQGT 275
              AL YLH+   VIHRDVK +N+L++ N +VK+ DFG+S      V     A   P   
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171

Query: 276 PGYVDPDY-FQCYKLTDKSDVYSFGVVLIELISG 308
           P  ++P+   + Y +  KSDV+S G+ +IEL +G
Sbjct: 172 PERINPELNQKGYDV--KSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 118 LGDGGFGAVYLGILR---DGRIVAVKRLYENNFKRIEQ-------FMNEVEILTKLQHPN 167
           LG G F  +Y G+LR   D  IV   +      K +         F     ++++L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           LVKLYG   R   E ++V EY+  G +   LH R+ N+  L W  +L +A + A AL YL
Sbjct: 63  LVKLYGVCVRD--ENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYL 117

Query: 228 HASDVIHRDVKSNNILL-------DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
               ++H +V   NIL+            +K++D G+     +    V   P   P  + 
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIR 177

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEA 311
                   LT  +D +SFG  L+E+ S  E 
Sbjct: 178 NGQ---ASLTIAADKWSFGTTLLEICSNGEE 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 16/203 (7%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           ++F   +++G G +G VY    +  G + A+K +     +       E+ ++   +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI---ETAGALA 225
           V  +G   R+ + L +  E+   G++ D  H   P S          IA    ET   L 
Sbjct: 69  VAYFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGPLS-------ESQIAYVSRETLQGLY 120

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+   +HRD+K  NILL +N  VK+ADFG+S      +    +   GTP ++ P+   
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAA 179

Query: 286 CYK---LTDKSDVYSFGVVLIEL 305
             +        D+++ G+  IEL
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 11/202 (5%)

Query: 112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQHPN 167
           F   + LG GGFG V    +R  G++ A K+L +   K+ +     +NE +IL K+    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 168 LVKL-YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           +V L Y   ++ +  L LV   +  G +  H+++             +  A E    L  
Sbjct: 62  VVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLED 117

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           LH   +++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ P+  + 
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 175

Query: 287 YKLTDKSDVYSFGVVLIELISG 308
            + T   D ++ G +L E+I+G
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)

Query: 111 NFNSSKQLGDGGFGAVYL----GILRDGRIVAVKRLYE----NNFKRIEQFMNEVEILTK 162
           NF   K LG G +G V+L         G++ A+K L +       K +E    E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 163 L-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           + Q P LV L+     +++ L L+ +Y+  G +  HL+ R   S      VR     E  
Sbjct: 61  VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSG-EII 115

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            AL +LH   +++RD+K  NILLD+   V + DFGLS+ F ++    + +  GT  Y+ P
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 282 DYFQCYKLTDKS-DVYSFGVVLIELISG 308
           +  +      K+ D +S G+++ EL++G
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 13/210 (6%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-----RIVAVKRLYEN-NFKRIEQFMNEVEILTKL 163
           D    S  L +G FG ++ GIL D        V VK + ++ +  ++   + E  +L  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----LSIAIE 219
            H N++ +            ++Y Y+  G +   L   +      P  +     + +AI+
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTP-G 277
            A  ++YLH   VIH+D+ + N ++D   +VK+ D  LSR LFP D  H     +  P  
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVK 184

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++  +     + +  SDV+SFGV+L EL++
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 19/171 (11%)

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP LV L+ C   +SR L  V E++  G +  H+  RQ     LP       + E + AL
Sbjct: 55  HPFLVGLHSCFQTESR-LFFVIEFVSGGDLMFHMQ-RQRK---LPEEHARFYSAEISLAL 109

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPD 282
            +LH   +I+RD+K +N+LLD    +K+ D+G+ +  + P D T       GTP Y+ P+
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPE 166

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
             +        D ++ GV++ E+++G         R   ++  M+ N  QN
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAG---------RSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE-QFMNEVEILTKLQHPNLVKLYG 173
           ++LG+G +  VY GI R +G++VA+K +     + +    + E  +L  L+H N+V L+ 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 174 CTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
                ++E L  V+EY+ +  +A ++   Q    L P+ VRL    +    LAY+H   +
Sbjct: 71  II--HTKETLTFVFEYM-HTDLAQYM--IQHPGGLHPYNVRL-FMFQLLRGLAYIHGQHI 124

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           +HRD+K  N+L+     +K+ADFGL+R   +  +   ++   T  Y  PD       TD 
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDVL--LGATDY 181

Query: 293 S---DVYSFGVVLIELISG 308
           S   D++  G + IE++ G
Sbjct: 182 SSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 26/205 (12%)

Query: 117 QLGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRIEQFM-----NEVEILTKLQ--- 164
           ++G+G +G V+    RD    GR VA+KR+     +  E+ M      EV +L  L+   
Sbjct: 8   EIGEGAYGKVFKA--RDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 165 HPNLVKLYG-CT-SRQSRE--LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           HPN+V+L+  CT SR  RE  L LV+E++ +  +  +L ++ P   +    ++  +  + 
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK-DMMFQL 119

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L +LH+  V+HRD+K  NIL+ ++ ++K+ADFGL+R++   +    T+   T  Y  
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRA 177

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIEL 305
           P+           D++S G +  E+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 14/199 (7%)

Query: 116 KQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLV 169
           K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   +HP L 
Sbjct: 1   KLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
            L        R L  V EY   G +  HL   +          R   A E   AL YLH+
Sbjct: 59  ALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSALEYLHS 113

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
            DV++RD+K  N++LD +  +K+ DFGL +   +D   + T   GTP Y+ P+  +    
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172

Query: 290 TDKSDVYSFGVVLIELISG 308
               D +  GVV+ E++ G
Sbjct: 173 GRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 14/206 (6%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLY-- 172
           + LG G  G V+  +  D  + VAVK++   + + ++  + E++I+ +L H N+VK+Y  
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 173 -GCTSRQSRELL-----LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            G +     E +     L   YI    +   L N      L     RL    +    L Y
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129

Query: 227 LHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQG--TPGYVDPD- 282
           +H+++V+HRD+K  N+ ++  +  +K+ DFGL+R+     +H     +G  T  Y  P  
Sbjct: 130 IHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL 189

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                  T   D+++ G +  E+++G
Sbjct: 190 LLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 43/237 (18%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN---EVEILTKLQH 165
           D+F S K +G G FG V L   +D G I A+K L + +    EQ  +   E +IL +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             +VK++  + +  R L L+ E++P G +   L  +     L     +  IA ET  A+ 
Sbjct: 61  AWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIA-ETVLAID 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGL--------SRLFPTDVTH---------- 267
            +H    IHRD+K +N+LLD    VK++DFGL           F  ++TH          
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 268 ----------------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                           ++ +  GTP Y+ P+ F         D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 116 KQLGDGGFGAVYLG---ILRD-GRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNL 168
           K LG G FG V+L       D G++ A+K L +   K   R+   M E +IL ++ HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFI 60

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           VKL+     + + L L+ +++  G +   L             V+  +A E A AL +LH
Sbjct: 61  VKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLA-ELALALDHLH 115

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYFQC 286
           +  +I+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P+    
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              T  +D +SFGV++ E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 46/213 (21%)

Query: 117 QLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN--EVEILTKLQ-HPNLVKLY 172
           ++G+G F  V      + G+  A+K + + +FK +EQ  N  E++ L +L  HPN+++L 
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 173 GCT-SRQSRELLLV--------YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
                R++  L LV        YE I           ++P    LP     S   +   +
Sbjct: 65  EVLFDRKTGRLALVFELMDMNLYELIKG--------RKRP----LPEKRVKSYMYQLLKS 112

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVST----APQG-- 274
           L ++H + + HRD+K  NIL+ ++  +K+ADFG  R     P    ++ST    AP+   
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLL 171

Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           T GY  P          K D+++ G V  E++S
Sbjct: 172 TDGYYGP----------KMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 116 KQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLV 169
           K LG G FG V L  +R+   G+  A+K L +        +   + E  +L   +HP L 
Sbjct: 1   KLLGKGTFGKVIL--VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
            L        R L  V EY   G +  HL   +    +           E   AL YLH+
Sbjct: 59  ALKYSFQTHDR-LCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS 113

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP------DY 283
            DV++RD+K  N++LD +  +K+ DFGL +   +D   + T   GTP Y+ P      DY
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172

Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 173 GRAV------DWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKL 163
           E   D+F    +LG G  G V     +   ++  ++L     K     Q + E+++L + 
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
             P +V  YG       E+ +  E++  G++   L   +     +P  +   ++I     
Sbjct: 61  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRG 115

Query: 224 LAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAYL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P+
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPE 172

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
             Q    + +SD++S G+ L+EL  G
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 14/199 (7%)

Query: 116 KQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLV 169
           K LG G FG V L  +R+   G+  A+K L +        +   + E  +L   +HP L 
Sbjct: 1   KLLGKGTFGKVIL--VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
            L      + R L  V EY+  G +  HL   +    +           E   AL YLH+
Sbjct: 59  SLKYSFQTKDR-LCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS 113

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
             +++RD+K  N++LD +  +K+ DFGL +   TD   + T   GTP Y+ P+  +    
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDY 172

Query: 290 TDKSDVYSFGVVLIELISG 308
               D +  GVV+ E++ G
Sbjct: 173 GRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQ------FMNEVEILTKLQ 164
           F   + LG GGFG V    +R  G++ A K+L +   KRI++       +NE +IL K+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVN 58

Query: 165 HPNLVKL-YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
              +V L Y   ++ +  L LV   +  G +  H++N             +  A E    
Sbjct: 59  SRFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCG 114

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L  LH   +++RD+K  NILLD+   ++++D GL+   P   T       GT GY+ P+ 
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEV 172

Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +  + T   D +  G ++ E+I G
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 23/212 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           D++   ++LG+G +  VY G  + +G++VA+K  RL E         + E  +L  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N+V L+     +   L LV+EY+          ++ P   L P  V+L +  +    L+Y
Sbjct: 64  NIVLLHDIIHTK-ETLTLVFEYVHTDLC--QYMDKHPGG-LHPENVKLFL-FQLLRGLSY 118

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD---- 282
           +H   ++HRD+K  N+L+ +   +K+ADFGL+R   +  +H  +    T  Y  PD    
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 283 ---YFQCYKLTDKSDVYSFGVVLIELISGLEA 311
              Y  C       D++  G + +E+I G+ A
Sbjct: 178 STEYSTCL------DMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 32/215 (14%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKR---IEQFMNEVEIL 160
           E T+ +   + +G G FG V     RD   G+ VA+K++    F      ++   E+++L
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSA--RDQLTGQNVAIKKIM-KPFSTPVLAKRTYRELKLL 63

Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
             L+H N++ L         ++  V E +  GT    L   +P   L    ++     + 
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRP---LEKQFIQY-FLYQI 117

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++ V+HRD+K +NIL++ N  +K+ DFGL+R    D       PQ T GYV 
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR--IQD-------PQMT-GYVS 167

Query: 281 PDYFQC-------YKLTDKSDVYSFGVVLIELISG 308
             Y++         K   + D++S G +  E++ G
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 18/156 (11%)

Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQF----MNEVEILTKLQHPNLVKLY 172
           +G G FG V+    +   +IVA+K++   N K  E F    + E++IL  L+H N+V L 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 77

Query: 173 G-CTSRQSRE------LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             C ++ +          LV+E+  +  +A  L N+     L        +       L 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTL---SEIKKVMKMLLNGLY 133

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           Y+H + ++HRD+K+ NIL+  +  +K+ADFGL+R F
Sbjct: 134 YIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 46/221 (20%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQ--------FMNEVE 158
           D +   +++G+G +G VY    RD      +A+K++      R+EQ         + E+ 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKI------RLEQEDEGVPSTAIREIS 53

Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           +L ++QH N+V+L      + R L LV+EY+ +  +  H+ +  P+    P  ++ +   
Sbjct: 54  LLKEMQHGNIVRLQDVVHSEKR-LYLVFEYL-DLDLKKHMDS-SPDFAKNPRLIK-TYLY 109

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV---TH-VST--- 270
           +    +AY H+  V+HRD+K  N+L+D     +K+ADFGL+R F   V   TH V T   
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWY 169

Query: 271 -APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            AP+   G+  Y  P            D++S G +  E+++
Sbjct: 170 RAPEILLGSRHYSTP-----------VDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 13/203 (6%)

Query: 112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQHPN 167
           F   + LG GGFG V    +R  G++ A KRL +   K+ +     +NE +IL K+    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 168 LVKL-YGCTSRQSRELLLVYEYIPNGTVADHLHNR-QPNSCLLPWPVRLSIAIETAGALA 225
           +V L Y   ++ +  L LV   +  G +  H++N   P          L  A E    L 
Sbjct: 62  VVNLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEILCGLE 116

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
            LH  + ++RD+K  NILLD+   ++++D GL+   P           GT GY+ P+   
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPEVLN 174

Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
             + T   D +  G ++ E+I G
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 24/214 (11%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
            +F+    +G G FG V +  +R+   G I A+K + ++     + +  F  E +IL+  
Sbjct: 1   KDFDVKSLVGRGHFGEVQV--VREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 164 QHPNLVKL-YGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIET 220
             P + +L Y    + +  L LV EY P G +   L  +  Q +  +     +  +A E 
Sbjct: 59  NSPWIPQLQYAFQDKDN--LYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLA-EL 111

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
             A+  +H    +HRD+K  N+L+D    +K+ADFG +     +    S  P GTP Y+ 
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171

Query: 281 PDYFQCYKLTDKS------DVYSFGVVLIELISG 308
           P+         K       D +S GV+  E+I G
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query: 103 SELEEATDNFNSSKQLG--DGGFGAVYLGILR---DGRIVAVKRLYENNFKRIEQFMNEV 157
           SEL +   N    K+L   DG FG V +  L+     ++   K +   NF  IE  M  V
Sbjct: 7   SELVQFLKNCEIVKKLKLIDGKFGKVSV--LKHKPTQKLFVQKIIKAKNFNAIE-PM--V 61

Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
             L K  +PN +KLY   +   +  +L+ +YI +G + D L      S      V+  I 
Sbjct: 62  HQLMK-DNPNFIKLYYSVT-TLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE---VKK-II 115

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
            +   AL  LH  ++IH D+K  N+L D    R+ + D+GL +        +     GTP
Sbjct: 116 RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------II-----GTP 163

Query: 277 GYVDP--DYFQCYKLTDKSDVYSF-----GVVLIELISG 308
              D   DYF   K+   +   SF     GV+  EL++G
Sbjct: 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 43/237 (18%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN---EVEILTKLQH 165
           ++F S K +G G FG V L   +D G + A+K L + +    EQ  +   E +IL +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             +VK++  + +    L L+ E++P G +   L  +     L     +  IA ET  A+ 
Sbjct: 61  LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIA-ETVLAID 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGL----------------SRLFPTDVT--- 266
            +H    IHRD+K +N+LLD+   VK++DFGL                +   P+D T   
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 267 ---------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                           ++ +  GTP Y+ P+ F         D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 19/211 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYE-NNFKRIEQ--FMNEVEILTKLQH 165
           ++F   K +G G FG V +  L++  ++ A+K L +    KR E   F  E ++L    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
             +  L+    +    L LV +Y   G   T+     +R P      +   + IAI++  
Sbjct: 61  QWITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            L Y      +HRD+K +NIL+D N  +++ADFG       D T  S+   GTP Y+ P+
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173

Query: 283 YFQCY-----KLTDKSDVYSFGVVLIELISG 308
             Q       K   + D +S GV + E++ G
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 32/276 (11%)

Query: 117 QLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           +LG G +G+VY  + R  G  +A+K  RL E +  +  Q + E++IL K   P +V  YG
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DV 232
               +   + +  EY+  G++ D L+     +  +P  V   I       L +L    ++
Sbjct: 67  AFFIEG-AVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD- 291
           IHRDVK  N+L++ N +VK+ DFG+S      V  ++    G   Y+ P+  +       
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 292 -----KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
                +SDV+S G+ ++E+  G         R+       A    Q  A+ +   P+L  
Sbjct: 182 PTYTVQSDVWSLGLSILEMALG---------RYPYPPETYANIFAQLSAIVDGDPPTLPS 232

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                 ++ V         C+ +  + RPT  ++LE
Sbjct: 233 GYSDDAQDFVAK-------CLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 37/222 (16%)

Query: 118 LGDGGFGAVYLGILRD---GRIVAVKRLYEN--NFKRI-EQFMNEVEILTKLQHPNLVKL 171
           +G GG G VYL    D    R VA+K++ E+      + ++F+ E +I   L HP +V +
Sbjct: 10  IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHN-RQPNSCLLPWPVR--------LSIAIETAG 222
           Y   S     +     YI   T+   L +  Q  S  L   +         LSI  +   
Sbjct: 68  YSICS-DGDPVYYTMPYIEGYTLKSLLKSVWQKES--LSKELAEKTSVGAFLSIFHKICA 124

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL--------------FPTDVTHV 268
            + Y+H+  V+HRD+K +NILL     V + D+G +                        
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 269 STAPQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            T P    GTP Y+ P+       ++ +D+Y+ GV+L ++++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 35/86 (40%), Positives = 57/86 (66%), Gaps = 1/86 (1%)

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDP 281
           A+ ++H+  +IHRD+KS NILL +N  VK+ DFG S+++   V+  V     GTP YV P
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELIS 307
           + ++    + K+D++S GV+L EL++
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 9/156 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENNFKRIEQFMN---EVEILTKLQH 165
           ++F++ K +G G FG V L      G+I A+K L ++   + +Q  +   E ++L +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P +V LY  + + ++ L L+ E++P G +   L      S  +    R  +A E   A+ 
Sbjct: 61  PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMA-ECVLAIE 115

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
            +H    IHRD+K +NIL+D    +K++DFGLS  F
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 117 QLGDGGFGAVYLGILRD-GRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ---HPNLVK 170
           ++G G +G VY       G  VA+K  R+  N        + EV +L +L+   HPN+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 171 LYG--CTSRQSRE--LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           L     TSR  RE  + LV+E++ +  +  +L    P    LP      +  +    L +
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGLDF 123

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP-QGTPGYVDPDYFQ 285
           LHA+ ++HRD+K  NIL+ +  +VK+ADFGL+R++      ++  P   T  Y  P+   
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180

Query: 286 CYKLTDKSDVYSFGVVLIEL 305
                   D++S G +  E+
Sbjct: 181 QSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKL 163
           E   D+F    +LG G  G V+    +   ++  ++L     K     Q + E+++L + 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
             P +V  YG       E+ +  E++  G++   L      +  +P  +   ++I     
Sbjct: 61  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 115

Query: 224 LAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           L YL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P+
Sbjct: 116 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPE 172

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
             Q    + +SD++S G+ L+E+  G
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 8/194 (4%)

Query: 118 LGDGGFGAVYLGILRDGR-IVAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +G+G +G V     ++ + IVA+K+    E N +  E  + E+++L  L+  N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
             R+ + L LV+EY+    +   L    PN  + P  VR S   +   A+ + H +D++H
Sbjct: 69  FRRRGK-LYLVFEYVEKNML--ELLEEMPNG-VPPEKVR-SYIYQLIKAIHWCHKNDIVH 123

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+K  N+L+ +N  +K+ DFG +R          T    T  Y  P+           D
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183

Query: 295 VYSFGVVLIELISG 308
           ++S G +L EL  G
Sbjct: 184 MWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 43/214 (20%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF---------MNEVEILTKLQHPN 167
           +G+G +G V        G  VA+K+        I  F         + E++IL + +H N
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 168 LVKLYGCTSRQS----RELLLVYEYIPNGTVADHLHNRQPNS----CLLPWPVRLSIAIE 219
           ++ +       S     ++ +V E +   T    L   Q  S        +        +
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELME--TDLYKLIKTQHLSNDHIQYFLY--------Q 114

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS----TAPQGT 275
               L Y+H+++V+HRD+K +N+LL+ N  +K+ DFGL+R+   D  H      T    T
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVAT 172

Query: 276 PGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
             Y  P+     K   K+ D++S G +L E++S 
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 16/214 (7%)

Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ-----FMNEVE 158
           +L    +++   K +G G FG V L   +  R V   +L  + F+ I++     F  E +
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERD 95

Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           I+     P +V+L+    +  R L +V EY+P G + + + N       +P         
Sbjct: 96  IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA 149

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E   AL  +H+   IHRDVK +N+LLD +  +K+ADFG       +         GTP Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209

Query: 279 VDPDYFQCYK----LTDKSDVYSFGVVLIELISG 308
           + P+  +          + D +S GV L E++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 14/199 (7%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTK---LQHPNLVK 170
           +G G FG VY    +D  RI A+K L +      K +   + E  IL +    + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L   + +   +L LV +Y+  G +  HL   Q          +  IA E   AL +LH  
Sbjct: 61  L-KFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFSEDRAKFYIA-ELVLALEHLHKY 115

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK-L 289
           D+++RD+K  NILLD    + + DFGLS+   TD    +T   GT  Y+ P+     K  
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVLLDEKGY 174

Query: 290 TDKSDVYSFGVVLIELISG 308
           T   D +S GV++ E+  G
Sbjct: 175 TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 9/201 (4%)

Query: 112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQHPN 167
           F   + LG GGFG V    +R  G++ A K+L +   K+ +     +NE  IL K+    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +V L          L LV   +  G +  H++N             +  A E    L  L
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDL 118

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
               +++RD+K  NILLD+   ++++D GL+   P   T       GT GY+ P+     
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNE 176

Query: 288 KLTDKSDVYSFGVVLIELISG 308
           K T   D +  G ++ E+I G
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 11/196 (5%)

Query: 118 LGDGGFGAV-YLGILRDGRIVAVKRLYENNFKRI---EQFMNEVEILTKLQHPNLVKL-Y 172
           LG GGFG V  + +   G++ A K+L +   K+    +  + E EIL K+  P +V L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
              S+    L LV   +  G +  H++N       +   +  S  I T G L +LH+ D+
Sbjct: 61  AFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI-TCGIL-HLHSMDI 116

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDK 292
           ++RD+K  N+LLD+    +++D GL+       T   T   GT GY+ P+  +    +  
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYP 174

Query: 293 SDVYSFGVVLIELISG 308
            D ++ G  + E+++G
Sbjct: 175 VDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 19/211 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYE-NNFKRIEQ--FMNEVEILTKLQH 165
           D+F   K +G G FG V +  ++   RI A+K L +    KR E   F  E  +L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
             +  L+    +    L LV +Y   G   T+     +R P      +   + +AI +  
Sbjct: 61  QWITTLH-YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS-- 117

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
               +H    +HRD+K +N+LLD N  +++ADFG       D T  S+   GTP Y+ P+
Sbjct: 118 ----IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 283 YFQCY-----KLTDKSDVYSFGVVLIELISG 308
             Q       K   + D +S GV + E++ G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 64/275 (23%), Positives = 123/275 (44%), Gaps = 33/275 (12%)

Query: 118 LGDGGFGAVYLGIL----RDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLY 172
           LG G FG +  G L    +    VA+  L    + K+   F+ E   L +  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 173 GCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           G  +R +  +++V EY+ NG +   L  H  Q  +  L     + +    A  + YL   
Sbjct: 73  GVITRGN-TMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGLASGMKYLSEM 126

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
             +H+ + ++ +L++++   K++ F   +   ++  + + + +    +  P+  Q +  +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 291 DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKD 349
             SDV+SFG+V+ E++S  E       R   ++S     K +++G    L  P       
Sbjct: 187 SASDVWSFGIVMWEVMSYGE-------RPYWDMSGQDVIKAVEDGF--RLPAP------- 230

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
              RN    + +L   C Q++R  RP   ++  IL
Sbjct: 231 ---RNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 47/228 (20%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRL----YENNFKRIEQF----------MNEVEIL 160
             LG+G +G V        G+IVA+K++      N+  +  Q           + E++I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS----- 215
            +++H N++ L          + LV + +    +   +  +          +RL+     
Sbjct: 75  NEIKHENIMGLVDVYVEGDF-INLVMDIM-ASDLKKVVDRK----------IRLTESQVK 122

Query: 216 -IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG 274
            I ++    L  LH    +HRD+   NI +++    K+ADFGL+R +       + +   
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 275 TPG-------------YVDPD-YFQCYKLTDKSDVYSFGVVLIELISG 308
           T               Y  P+      K     D++S G +  EL++G
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 17/152 (11%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVA---VKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKL 171
           +++G+G FG V L  +     VA   VK L  N + K   +F+ + +    LQHPN+++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 172 YG-CTSRQSRELLLVYEYIPNGTVADHL-----HNRQPNSCLLPWPVRLSIAIETAGALA 225
            G C   ++   LLV+EY   G +  +L     H R     LL       +A E A  + 
Sbjct: 61  LGQCV--EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           ++H  + +H D+   N  L ++  VKV D+G+
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 31/219 (14%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKR-LYENNFKRI-EQFMNEVEILTKLQH- 165
           D +   +++G+G +G VY       G++VA+K+   E + + I    + E+ +L  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 166 PNLVKLYGCTSRQSRE----LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
             +V+L      + +     L LV+EY+ +        N +     LP     S   +  
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDV---TH-VST----AP 272
             +A+ H   V+HRD+K  N+L+D    + K+AD GL R F   V   TH + T    AP
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180

Query: 273 Q---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           +   G+  Y  P            D++S G +  E+   
Sbjct: 181 EVLLGSTHYSTP-----------VDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 116 KQLGDGGFGAVYLGILRDG----RIVAVKRLYE----NNFKRIEQFMNEVEILTKLQHPN 167
           K LG GG+G V+      G    +I A+K L +     N K       E  IL  ++HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR----QPNSCLLPWPVRLSIAIETAGA 223
           +V L        + L L+ EY+  G +  HL       +  +C       LS   E + A
Sbjct: 62  IVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFY-----LS---EISLA 112

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDP 281
           L +LH   +I+RD+K  NILLD    VK+ DFGL +  +    VTH      GT  Y+ P
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D +S G ++ ++++G
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.5 bits (159), Expect = 9e-12
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 57/243 (23%)

Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE------QFMNEVEILTKLQHPNLVK 170
           ++G G +G VY    +DG     K   E   K+IE          E+ +L +L+HPN++ 
Sbjct: 8   KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62

Query: 171 LYGC-TSRQSRELLLVYEYIPNGTVADH-------LH-----NRQPNSCLLPWPVRLSIA 217
           L     S   R++ L+++Y      A+H        H     N++P    LP  +  S+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQ--LPRSMVKSLL 114

Query: 218 IETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF-----------P 262
            +    + YLHA+ V+HRD+K  NIL+        RVK+AD G +RLF           P
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
             VT    AP+   G            T   D+++ G +  EL++  E +   R + DI 
Sbjct: 175 VVVTFWYRAPELLLG--------ARHYTKAIDIWAIGCIFAELLTS-EPIFHCR-QEDIK 224

Query: 323 LSN 325
            SN
Sbjct: 225 TSN 227

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 18/180 (10%)

Query: 137 VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTV-- 194
           V  K +  N+ ++     +E+  L    H  +VK +    +   +LLL+ EY   G +  
Sbjct: 96  VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-DFKSDDKLLLIMEYGSGGDLNK 154

Query: 195 ------ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF 248
                  +HL  ++    LL + + L        AL  +H+  ++HRD+KS NI L    
Sbjct: 155 QIKQRLKEHLPFQEYEVGLLFYQIVL--------ALDEVHSRKMMHRDLKSANIFLMPTG 206

Query: 249 RVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +K+ DFG S+ +   V+  V+++  GTP Y+ P+ ++  + + K+D++S GV+L EL++
Sbjct: 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 63/263 (23%), Positives = 116/263 (44%), Gaps = 37/263 (14%)

Query: 69  TTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQ------LGDGG 122
                 S         + + ER  +    +     ++ +   N + +K       +G+G 
Sbjct: 19  KANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGS 78

Query: 123 FGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNLVKLYG-----CT 175
           FG VY  I  D    VA+K++ ++      Q+ N E+ I+  L H N++ L       C 
Sbjct: 79  FGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECF 133

Query: 176 SRQSRELLL--VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
            +  + + L  V E+IP  TV  ++ +   N+  LP  +    + +   ALAY+H+  + 
Sbjct: 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFIC 192

Query: 234 HRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL--- 289
           HRD+K  N+L+D N   +K+ DFG ++           A Q +  Y+   +++  +L   
Sbjct: 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LAGQRSVSYICSRFYRAPELMLG 244

Query: 290 ----TDKSDVYSFGVVLIELISG 308
               T   D++S G ++ E+I G
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 64/250 (25%), Positives = 97/250 (38%), Gaps = 65/250 (26%)

Query: 112 FNSSKQLGDGGFGAVYLGILRDGRIV-AVKRLYENNFKRIEQFMN---EVEILTKLQHPN 167
           F   K +G G FG V L    D   + A+K L + +     Q  +   E +IL +  +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 168 LVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPV------RLSIAIET 220
           +VKLY   S Q ++ L  V +YIP G +          S L+   +      R  IA E 
Sbjct: 63  VVKLY--YSFQDKDNLYFVMDYIPGGDMM---------SLLIRLGIFEEDLARFYIA-EL 110

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL----------------------S 258
             A+  +H    IHRD+K +NIL+D +  +K+ DFGL                      S
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 259 RLFPTDVTHVSTAPQ--------------------GTPGYVDPDYFQCYKLTDKSDVYSF 298
                + + +                         GTP Y+ P+       T   D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 299 GVVLIELISG 308
           GV+L E++ G
Sbjct: 231 GVILYEMLVG 240

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYE-NNFKRIEQ--FMNEVEILTKLQH 165
           D+F   K +G G FG V +  +++ G++ A+K L +    KR E   F  E ++L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
             +  L+    +    L LV +Y   G   T+     +R P      +   + +AI++  
Sbjct: 61  RWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            L Y      +HRD+K +N+LLD N  +++ADFG       D T  S    GTP Y+ P+
Sbjct: 120 QLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 283 YFQCY-----KLTDKSDVYSFGVVLIELISG 308
             Q       +   + D +S GV + E++ G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 41/161 (25%)

Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQ-------FMNEVEILTKLQHPNLV 169
           LG+G +  VY G  +  G++VA+K +      R+E         + E  +L  L+H N+V
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANIV 66

Query: 170 KLYGCTSRQSRELLLVYEYI-----------PNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
            L+       + L LV+EY+             G     +HN           VRL +  
Sbjct: 67  TLHD-IIHTKKTLTLVFEYLDTDLKQYMDDCGGGL---SMHN-----------VRLFLFQ 111

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
              G LAY H   V+HRD+K  N+L+     +K+ADFGL+R
Sbjct: 112 LLRG-LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 11/156 (7%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQH 165
           + F   K +  G FG VYLG  + + ++ AVK + +    N   + Q   E + L   + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 166 PNLVKLYGCTSRQS-RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           P +V LY   S QS   + LV EY+  G V   LH            + +    E A AL
Sbjct: 64  PFIVHLY--YSLQSANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALAL 117

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
            YLH   +IHRD+K +N+L+ N   +K+ DFGLS++
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 61/198 (30%), Positives = 89/198 (44%), Gaps = 11/198 (5%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKL 171
           K LG G FG V L   +  GR  A+K L +        +   + E  +L   +HP L  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS- 230
                   R L  V EY   G +  HL   +  S       R   A E   AL YLH+  
Sbjct: 61  KYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS---EDRARFYGA-EIVSALDYLHSEK 115

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
           +V++RD+K  N++LD +  +K+ DFGL +    D   + T   GTP Y+ P+  +     
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYG 174

Query: 291 DKSDVYSFGVVLIELISG 308
              D +  GVV+ E++ G
Sbjct: 175 RAVDWWGLGVVMYEMMCG 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 39/223 (17%)

Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIE---QFMNEVEIL 160
           + E  D + +   +G G +G V           VA+K+L    F+      +   E+ +L
Sbjct: 10  VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLL 68

Query: 161 TKLQHPNLVKLYGCTSRQS-----RELLLVYEYIPNGTVADHLHN--RQPNSCLLPWPVR 213
             + H N++ L    +  S     +++ LV   +     AD L+N  +           +
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----AD-LNNIVKCQ---------K 114

Query: 214 LS------IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT- 266
           LS      +  +    L Y+H++ +IHRD+K +NI ++ +  +K+ DFGL+R    ++T 
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174

Query: 267 HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISG 308
           +V      T  Y  P+    +       D++S G ++ EL++G
Sbjct: 175 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 57/243 (23%)

Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE------QFMNEVEILTKLQHPNLVK 170
           ++G G +G VY    +DG     K   +   K+IE          E+ +L +L+HPN++ 
Sbjct: 8   KVGRGTYGHVYKAKRKDG-----KDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS 62

Query: 171 LYGC-TSRQSRELLLVYEYIPNGTVADH-------LH-----NRQPNSCLLPWPVRLSIA 217
           L     S   R++ L+++Y      A+H        H     N++P    LP  +  S+ 
Sbjct: 63  LQKVFLSHADRKVWLLFDY------AEHDLWHIIKFHRASKANKKP--VQLPRGMVKSLL 114

Query: 218 IETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF-----------P 262
            +    + YLHA+ V+HRD+K  NIL+        RVK+AD G +RLF           P
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
             VT    AP+   G            T   D+++ G +  EL++  E +   R + DI 
Sbjct: 175 VVVTFWYRAPELLLG--------ARHYTKAIDIWAIGCIFAELLTS-EPIFHCR-QEDIK 224

Query: 323 LSN 325
            SN
Sbjct: 225 TSN 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 15/202 (7%)

Query: 116 KQLGDGGFGAVY-LGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           + +G G FG V+ +   RDG+ VA+K++     N    ++   E+++L   +H N++   
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 173 GCTSRQSRELLLVYE-YIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETAGALAYL 227
                Q   +    E Y+    +   LH      QP   L    V++ +     G L YL
Sbjct: 66  DIL--QPPHIDPFEEIYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQILRG-LKYL 119

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ-C 286
           H++ ++HRD+K  N+L+++N  +K+ DFGL+R+   D +   T    T  Y  P+     
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              T   D++S G +  EL+  
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 20/204 (9%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQHPNLVK--- 170
           +G G +G V   I    G  VA+K++  + F+ +    + + E+++L  L+HP++V+   
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 171 -LYGCTSRQSRELLLVYEYIPNGTVADHLHNR-QPNSCLLPWPVRLSIAIETAGALAYLH 228
            +   + R+ +++ +V+E + +      LH   + N  L P   +  +  +   AL Y+H
Sbjct: 67  IMLPPSRREFKDIYVVFELMES-----DLHQVIKANDDLTPEHHQFFL-YQLLRALKYIH 120

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV--THVSTAPQGTPGYVDPDYFQC 286
            ++V HRD+K  NIL + + ++K+ DFGL+R+   D       T    T  Y  P+    
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 287 Y--KLTDKSDVYSFGVVLIELISG 308
           +  K T   D++S G +  E+++G
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 68/250 (27%), Positives = 102/250 (40%), Gaps = 61/250 (24%)

Query: 112 FNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPN 167
           F   K LG G FG V L    D   + A+K L +    N  ++     E +IL +  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 168 LVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAIETAGAL 224
           +VKLY   S Q ++ L  V +YIP G +   L   +  P      +   L++AIE+    
Sbjct: 63  VVKLY--YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIES---- 116

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---------------------PT 263
             +H    IHRD+K +NIL+D +  +K+ DFGL   F                     P+
Sbjct: 117 --VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174

Query: 264 DV----------THVSTAPQ---------------GTPGYVDPDYFQCYKLTDKSDVYSF 298
           D+            + T  Q               GTP Y+ P+       T   D +S 
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234

Query: 299 GVVLIELISG 308
           GV+L E++ G
Sbjct: 235 GVILFEMLVG 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPN 167
           D+F    +LG G  G V   + R   ++  ++L     K     Q + E+++L +   P 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN--RQPNSCLLPWPVRLSIAIETAGALA 225
           +V  YG       E+ +  E++  G++   L    R P + L     ++SIA+     L 
Sbjct: 61  IVGFYG-AFYSDGEISICMEHMDGGSLDQVLKKAGRIPENIL----GKISIAV--LRGLT 113

Query: 226 YLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPD 282
           YL     ++HRDVK +NIL+++   +K+ DFG+S          S A    GT  Y+ P+
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPE 168

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
             Q    T +SD++S G+ L+E+  G
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 17/157 (10%)

Query: 156 EVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           E  +L  + HP+++++       +   +++  Y  +  +  +L  R       P P+  +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY--SSDLYTYLTKRSR-----PLPIDQA 159

Query: 216 IAIETA--GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           + IE      L YLHA  +IHRDVK+ NI +++  +V + D G ++ FP     V+ A  
Sbjct: 160 LIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV----VAPAFL 214

Query: 274 GTPGYVD---PDYFQCYKLTDKSDVYSFGVVLIELIS 307
           G  G V+   P+     K   K+D++S G+VL E+++
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 64/290 (22%), Positives = 105/290 (36%), Gaps = 63/290 (21%)

Query: 134 GRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN 191
             +VAVK+  L   + + ++    E+    +LQHPN++         S EL +V   +  
Sbjct: 25  NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMAY 83

Query: 192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK 251
           G+  D L    P    LP      I  +   AL Y+H+   IHR VK+++ILL  + +V 
Sbjct: 84  GSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVV 141

Query: 252 VADFGLSR-------------LFPTDVTHVS--TAP----QGTPGYVDPDYFQCYKLTDK 292
           ++    S               FP          +P    Q   GY            +K
Sbjct: 142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-----------NEK 190

Query: 293 SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD-----PSLGFE 347
           SD+YS G+   EL +G           D+  + M   K+  G +  L+D           
Sbjct: 191 SDIYSVGITACELANGHVPF------KDMPATQMLLEKV-RGTVPCLLDKSTYPLYEDSM 243

Query: 348 KDYAVRNMVTSVAE----------------LAFRCVQQDRDMRPTMKEVL 381
                 N   +  +                    C+Q+D + RP+  ++L
Sbjct: 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 43/212 (20%)

Query: 117 QLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQ-------FMNEVEILTKLQHPNL 168
           +LG+G +  VY G  +    +VA+K +      R+E         + EV +L  L+H N+
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 169 VKLYGCTSRQSRELLLVYEYIPN---------GTVADHLHNRQPNSCLLPWPVRLSIAIE 219
           V L+     + + L LV+EY+           G    ++HN           V+L +  +
Sbjct: 67  VTLHDIIHTE-KSLTLVFEYLDKDLKQYLDDCGNSI-NMHN-----------VKLFL-FQ 112

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL--FPTDVTHVSTAPQGTPG 277
               L Y H   V+HRD+K  N+L++    +K+ADFGL+R    PT           T  
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV---TLW 169

Query: 278 YVDPD-YFQCYKLTDKSDVYSFGVVLIELISG 308
           Y  PD        + + D++  G +  E+ +G
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 22/224 (9%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC-- 174
           +G GGFG VY     D G++ A+K L   + KRI+    E   L +    +LV    C  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 175 ------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
                       +L  + + +  G +  HL     +       +R   A E    L ++H
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGVFSEKEMRF-YATEIILGLEHMH 114

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
              V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ P+  Q   
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171

Query: 289 LTDKS-DVYSFGVVLIELISGLEAV--DTSRHRHDINLSNMATN 329
             D S D +S G +L +L+ G        ++ +H+I+   +  N
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 38/221 (17%)

Query: 111 NFNSSKQLGDGGFGAV----YLGILRDGRIVAVKRLYENNF-KRI--EQFMNEVEILTKL 163
            +   K+LG G +G V          +   VA+K++  N F K+I  ++ + E+++L   
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKI-TNVFSKKILAKRALRELKLLRHF 58

Query: 164 Q-HPNLVKLYG---CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA-- 217
           + H N+  LY           EL L YE +    +   + + QP          L+ A  
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQP----------LTDAHF 107

Query: 218 ----IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVST 270
                +    L Y+H+++V+HRD+K  N+L++ +  +K+ DFGL+R F   P +     T
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 271 APQGTPGYVDPDY---FQCYKLTDKSDVYSFGVVLIELISG 308
               T  Y  P+    FQ Y  T   DV+S G +L EL+  
Sbjct: 168 EYVATRWYRAPEIMLSFQSY--TKAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT- 175
           +G GGFG VY     D G++ A+K L   + KRI+    E   L +    +LV    C  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 176 ------SRQSRELLLVYEYIPNGTVAD-HLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
                 +  + + L     + NG   D H H  Q +       +R   A E    L ++H
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQ-HGVFSEAEMRF-YAAEIILGLEHMH 114

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
              V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ P+  Q   
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171

Query: 289 LTDKS-DVYSFGVVLIELISG 308
             D S D +S G +L +L+ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 38/224 (16%)

Query: 118 LGDGGFGAVYLGILRD----GRI----VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           LG G F  ++ GI R+    G +    V +K L +++    E F     ++++L H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             YG       E ++V EY+  G++  +L  +  N   + W  +L +A + A AL +L  
Sbjct: 63  LNYG-VCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQLAWALHFLED 118

Query: 230 SDVIHRDVKSNNILL--------DNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGYVD 280
             + H +V + N+LL         N   +K++D G+S  + P ++  +   P     +V 
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL-LERIP-----WVP 172

Query: 281 PDYFQCYK----LTDKSDVYSFGVVLIELISG----LEAVDTSR 316
           P   +C +    L+  +D +SFG  L E+ SG    L A+D+ +
Sbjct: 173 P---ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 1/95 (1%)

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           +S + + A  + +L +   IHRD+ + NILL  N  VK+ DFGL+R    D  +V     
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 274 GTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             P  ++ P+       T +SDV+SFGV+L E+ S
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL---FPTDVT-----HVSTAPQGT 275
           L Y+H+++VIHRD+K +N+L++ +  +++ DFG++R     PT+       +V+T     
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 276 PG--YVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
           P      P+Y      T   D++S G +  E++
Sbjct: 180 PELLLSLPEY------TTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 7/104 (6%)

Query: 210 WPVR----LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV 265
           WP+     L  + + A  + +L + + IHRDV + N+LL +    K+ DFGL+R    D 
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 266 THVSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
            +V       P  ++ P+  F C   T +SDV+S+G++L E+ S
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 65/252 (25%), Positives = 97/252 (38%), Gaps = 65/252 (25%)

Query: 112 FNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPN 167
           F   K LG G FG V L    D   + A+K L + +     ++     E +IL +  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 168 LVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAIETAGAL 224
           +V+LY   S Q ++ L  V +YIP G +   L      P      +   L+ A+E+    
Sbjct: 63  VVRLY--YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES---- 116

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ----------- 273
             +H    IHRD+K +NIL+D +  +K+ DFGL   F    TH S   Q           
Sbjct: 117 --VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDSKYYQSGDHVRQDSMD 172

Query: 274 -------------------------------------GTPGYVDPDYFQCYKLTDKSDVY 296
                                                GTP Y+ P+       T   D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232

Query: 297 SFGVVLIELISG 308
           S GV+L E++ G
Sbjct: 233 SVGVILYEMLVG 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 3/96 (3%)

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           LS + + A  +++L + + IHRD+ + NILL +    K+ DFGL+R    D  +V     
Sbjct: 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 274 GTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
             P  ++ P+  F C   T +SDV+S+G++L E+ S
Sbjct: 277 RLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 47/169 (27%), Positives = 72/169 (42%), Gaps = 18/169 (10%)

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
           + + A  + +L +   IHRD+ + NILL  N  VK+ DFGL+R    D  +V       P
Sbjct: 180 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 277 -GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA 335
             ++ P+       T +SDV+SFGV+L E+ S             +  S     +I    
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-------------LGASPYPGVQINEEF 286

Query: 336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
              L D +     + A       +  +   C Q D   RPT   ++EIL
Sbjct: 287 CQRLKDGTRMRAPENA----TPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 25/203 (12%)

Query: 117 QLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQ-------FMNEVEILTKLQHPNL 168
           +LG+G +  V+ G  +    +VA+K +      R+E         + EV +L  L+H N+
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEI------RLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V L+     + R L LV+EY+ +  +  +L N      +    + +    +    L+Y H
Sbjct: 66  VTLHDIIHTE-RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCH 120

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRL--FPTDVTHVSTAPQGTPGYVDPD-YFQ 285
              ++HRD+K  N+L++    +K+ADFGL+R    PT           T  Y  PD    
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLG 177

Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
             + +   D++  G +L E+ +G
Sbjct: 178 STEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKL 163
           E  + + S KQ+G G +G+V   I  R G  VA+K+L       I  ++   E+ +L  +
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71

Query: 164 QHPNLVKLYGCTSRQSR-------ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           QH N++ L    +            L++ Y       +  H  +      L+        
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV-------- 123

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
             +    L Y+H++ +IHRD+K  N+ ++ +  +K+ DFGL+R    ++T          
Sbjct: 124 -YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 172

Query: 277 GYVDPDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
           GYV   +++  ++           D++S G ++ E+++G
Sbjct: 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 8/154 (5%)

Query: 156 EVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           E  IL  + HP++++L G  +      L++  Y  +  +  +L  ++     +     L+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRN----IAICDILA 186

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQG 274
           I      A+ YLH + +IHRD+K+ NI +++   V + DFG +  FP D+  +      G
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           T     P+           D++S G+VL E+ + 
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 49/226 (21%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLY-----ENNFKRIEQFMNEVEIL 160
           E  D +   KQ+G G +G V   +  R G  VA+K+LY     E   KR  +   E+ +L
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLL 68

Query: 161 TKLQHPNLVKLYGC-----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
             ++H N++ L        +  +  +  LV  ++  GT    L   +          +LS
Sbjct: 69  KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHE----------KLS 116

Query: 216 ------IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS 269
                 +  +    L Y+HA+ +IHRD+K  N+ ++ +  +K+ DFGL+R   +++T   
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT--- 173

Query: 270 TAPQGTPGYVDPDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
                  GYV   +++  ++       T   D++S G ++ E+++G
Sbjct: 174 -------GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 62/283 (21%)

Query: 58  SGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFG-------------AKVFSCS- 103
           SGA  + ++          +    P +   L+    +                K+F C+ 
Sbjct: 110 SGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICAL 169

Query: 104 ----ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI 159
               E  EA    NS+ Q           G  +  R++A KR+ +   +   Q  NE+  
Sbjct: 170 RASTEEAEARRGVNSTNQ-----------GKPKCERLIA-KRV-KAGSRAAIQLENEILA 216

Query: 160 LTKLQHPNLVKL----------YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
           L +L H N++K+          Y  T +   +L   Y ++ +            +  LL 
Sbjct: 217 LGRLNHENILKIEEILRSEANTYMITQKYDFDL---YSFMYDEAF------DWKDRPLL- 266

Query: 210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-----PTD 264
              R +I  +   A+ Y+H   +IHRD+K  NI L+ + ++ + DFG +  F       D
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325

Query: 265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
              V T    +P  +  D +      + +D++S G++L++++S
Sbjct: 326 YGWVGTVATNSPEILAGDGY-----CEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 43/213 (20%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQ-------FMNEVEILTKLQHPN 167
           ++LG+G +  V+ G  +    +VA+K +      R+E         + EV +L  L+H N
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 168 LVKLYGCTSRQSRELLLVYEYIPN---------GTVADHLHNRQPNSCLLPWPVRLSIAI 218
           +V L+       + L LV+EY+           G +   +HN           V++ +  
Sbjct: 66  IVTLHDIV-HTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHN-----------VKIFL-Y 111

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL--FPTDVTHVSTAPQGTP 276
           +    LAY H   V+HRD+K  N+L++    +K+ADFGL+R    PT           T 
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV---TL 168

Query: 277 GYVDPD-YFQCYKLTDKSDVYSFGVVLIELISG 308
            Y  PD      + + + D++  G +  E+ SG
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 1/92 (1%)

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
           + + A  + +L +   IHRD+ + NILL  N  VK+ DFGL+R    D  +V       P
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 277 -GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             ++ P+       T +SDV+SFGV+L E+ S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 32/233 (13%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENNFKRIE--QFMNEVEILTK 162
           E   + +   K++G+G FG V+L    R       K +     K  E  Q + EV ++ +
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 163 LQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           L+H N+V+      ++ +++L ++ E+   G ++ ++         +     + I  +  
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 222 GALAYLH-------ASDVIHRDVKSNNILLDNNFR-----------------VKVADFGL 257
            ALAY H          V+HRD+K  NI L    R                  K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 258 SRLFPTDVTHVSTAPQGTPGYVDPDYF--QCYKLTDKSDVYSFGVVLIELISG 308
           S+     +  ++ +  GTP Y  P+    +     DKSD+++ G ++ EL SG
Sbjct: 189 SK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Length = 1021

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 72

Query: 163 LQHPNLVKLYGCTS--RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L    +  R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 73  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 129

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 179

Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRL---YEN--NFKRIEQFMNEVEILTKLQHPNLV 169
           K +G G +G V      +    VA+K++   ++N  + KR    + E+++L  L H N++
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT---LREIKLLRHLDHENVI 67

Query: 170 KLYGCTSRQSRE----LLLVYEYIPNGTVADHLH----NRQPNS---C--LLPWPVRLSI 216
            +        RE    + +VYE +        LH    + Q  S   C   L   +R   
Sbjct: 68  AIKDIMPPPHREAFNDVYIVYELMDT-----DLHQIIRSSQTLSDDHCQYFLYQLLR--- 119

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGT 275
                  L Y+H+++V+HRD+K +N+LL+ N  +K+ DFGL+R   T       T    T
Sbjct: 120 ------GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVT 171

Query: 276 PGYVDPD-YFQCYKLTDKSDVYSFGVVLIELI 306
             Y  P+    C + T   DV+S G +  EL+
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.6 bits (124), Expect = 5e-08
 Identities = 37/152 (24%), Positives = 55/152 (36%), Gaps = 20/152 (13%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLV-KLYG 173
           K L  G    VYL  L       V ++  +  K       EV IL  L +    V K+  
Sbjct: 4   KLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGA-DREREVAILQLLARKGLPVPKVLA 60

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-- 231
                    LL  E+I  G   D +   +          +  IA + A  LA LH     
Sbjct: 61  SGESDGWSYLL-MEWIE-GETLDEVSEEE----------KEDIAEQLAELLAKLHQLPLL 108

Query: 232 -VIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
            + H D+   NIL+D+   + + D+  +   P
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 3/100 (3%)

Query: 209 PWPVRLSIAIETA--GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDV 265
           P P+  +I I+     ALAYLH   +IHRDVK+ NI LD      + DFG + +L     
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240

Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIEL 305
           T       GT     P+         K+D++S G+VL E+
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 1/95 (1%)

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           LS   + A  + +L + + +HRD+ + N+LL     VK+ DFGL+R    D  +VS    
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 274 GTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             P  ++ P+       T  SDV+S+G++L E+ S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 34/119 (28%), Positives = 59/119 (49%), Gaps = 4/119 (3%)

Query: 190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR 249
           P  T  D L N  P    L +   +  + + A  + +L + + +HRD+ + N+L+     
Sbjct: 221 PERTRRDTLINESP---ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL 277

Query: 250 VKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           VK+ DFGL+R    D  ++S      P  ++ P+       T  SDV+SFG++L E+ +
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 45/181 (24%), Positives = 87/181 (48%), Gaps = 20/181 (11%)

Query: 137 VAVKRLYE--NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----RELLLVYEYI 189
           VAVK+L     N    ++   E+ +L  + H N++ L    + Q      +++ LV E +
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 190 PNGTVADHLHNRQPNSCLLPWPVRLSIAI-ETAGALAYLHASDVIHRDVKSNNILLDNNF 248
            +  +   +H    +        R+S  + +    + +LH++ +IHRD+K +NI++ ++ 
Sbjct: 109 -DANLCQVIHMELDHE-------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 160

Query: 249 RVKVADFGLSRLFPTDVTHVSTAPQ-GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +K+ DFGL+R   T  T+    P   T  Y  P+        +  D++S G ++ EL+ 
Sbjct: 161 TLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217

Query: 308 G 308
           G
Sbjct: 218 G 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 31/214 (14%)

Query: 116 KQLGDGGFGAVY-----------------LGILRDGRIVAVKRLYENNFK--RIEQFMNE 156
           K +G GGFG VY                 +  L +  IV    +Y N +   +I  + N 
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN- 76

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
              +  + H  + K YGC S +   +   Y +I    + ++              +  +I
Sbjct: 77  ---IHNIDHLGIPKYYGCGSFKRCRMY--YRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--- 273
             +    L Y+H   + H D+K  NI++D N R  + D+G++  F     H+  + +   
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191

Query: 274 ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIE 304
              GT  Y   D      +T + D+ S G  +++
Sbjct: 192 LHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 15/146 (10%)

Query: 166 PNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHN--RQPNSCLLPWPVRLSIAIETAG 222
           PN+V L+    S  S  + LV ++   G +  H+      P  C+  W   + +A++   
Sbjct: 45  PNMVCLHKYIVSEDS--VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA-- 100

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
               LH   ++ RD+  NNILLD+   +++  F        +V            Y  P+
Sbjct: 101 ----LHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS----EVEDSCDGEAVENMYCAPE 152

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                + T+  D +S G +L EL++G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 55/238 (23%)

Query: 100 FSCSELEEAT----DNFNSSKQLGDGGFG---AVYLGILRDGRIVAVKRLYE--NNFKRI 150
           F   E+ ++T      + + K +G G  G   A Y  IL   R VA+K+L     N    
Sbjct: 10  FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67

Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQS-----RELLLVYEYIPNGTVADHLHNRQPNS 205
           ++   E+ ++  + H N++ L    + Q      +++ +V E +              N 
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------------DANL 115

Query: 206 CLLPWPVRLSIAIETAGALAY--------LHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           C +   +++ +  E    L Y        LH++ +IHRD+K +NI++ ++  +K+ DFGL
Sbjct: 116 CQV---IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172

Query: 258 SR-------LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           +R       + P  VT    AP+   G         YK  +  D++S G ++ E+I G
Sbjct: 173 ARTAGTSFMMTPYVVTRYYRAPEVILG-------MGYK--ENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 18/94 (19%)

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R   T           TP YV   
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-------TP-YVVTR 181

Query: 283 YFQC--------YKLTDKSDVYSFGVVLIELISG 308
           Y++         YK  +  D++S G ++ E+I G
Sbjct: 182 YYRAPEVILGMGYK--ENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 39/178 (21%)

Query: 110 DNFNSSKQLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           D+F   K+LG+G FG VY   L      ++G+ V +K+  E  +  +E +MNE     ++
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATE--YGAVEIWMNE-----RV 183

Query: 164 QH--PNLVK--LYG----CTSRQSRELLLVYEYIPNGTVADHLHNRQ-PNSC-------- 206
           +   PN     +YG     +S++  E  LV+ Y    T+AD + +++ P +         
Sbjct: 184 RRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKV 243

Query: 207 --LLPWPVRLSIAIETA-----GALAYLHASDVIHRDVKSNNILLDNNFR-VKVADFG 256
             L     R +  I+T       AL  LH++ ++HRDVK  NI+        K+ D G
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 15/160 (9%)

Query: 153 FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPV 212
           F     ++ ++ H ++V LYG   R   E ++V E++  G +   +H R+ +    PW  
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRD-VENIMVEEFVEFGPLDLFMH-RKSDVLTTPW-- 106

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILL-----DNNFR--VKVADFGLSRLFPTDV 265
           +  +A + A AL+YL   D++H +V + NILL     D      +K++D G+     +  
Sbjct: 107 KFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ 166

Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIEL 305
             V   P   P  V+        L+  +D +SFG  L E+
Sbjct: 167 ECVERIPWIAPECVE----DSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 37/213 (17%)

Query: 112 FNSSKQLGDGGFG---AVYLGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILTKLQHP 166
           + + K +G G  G   A Y  +L   R VA+K+L     N    ++   E+ ++  + H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 167 NLVKLYGCTSRQS-----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           N++ L    + Q      +++ LV E +              N C +   +++ +  E  
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELM------------DANLCQV---IQMELDHERM 121

Query: 222 GALAY--------LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             L Y        LH++ +IHRD+K +NI++ ++  +K+ DFGL+R   T  + + T   
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 179

Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
            T  Y  P+        +  D++S G ++ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.4 bits (112), Expect = 8e-06
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYE--NNFKRIEQFMNEVEILTKL 163
           E  + + +   +G G +G+V      R  + VAVK+L     +     +   E+ +L  +
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71

Query: 164 QHPNLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           +H N++ L    T   S E       + N   AD L+N      L    V+  I     G
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGAD-LNNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            L Y+H++ +IHRD+K +N+ ++ +  +++ DFGL+R    ++T          GYV   
Sbjct: 131 -LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----------GYVATR 179

Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           +++  ++           D++S G ++ EL+ G
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 29/193 (15%)

Query: 134 GRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN 191
           G +V V+   L     + ++   NEV +    +HPN++  +   +  S  L ++  ++  
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW-LWVISPFMAY 83

Query: 192 GTVADHLHNRQP---NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF 248
           G+    L    P   +  L+      +I       L YLH +  IHR++K+++IL+  + 
Sbjct: 84  GSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNGYIHRNIKASHILISGDG 138

Query: 249 RVKVADFGLSRLFPT-----------DVTHVSTA--PQGTPGYVDPDYFQCYKLTDKSDV 295
            V ++  GLS L+             D    ST+  P  +P  +  D    Y    KSD+
Sbjct: 139 LVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDL---YGYNVKSDI 193

Query: 296 YSFGVVLIELISG 308
           YS G+   EL +G
Sbjct: 194 YSVGITACELATG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 39/164 (23%), Positives = 79/164 (48%), Gaps = 23/164 (14%)

Query: 153 FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPV 212
           F     +++++ H +L  ++G   R S E ++V E++ +G + D    ++     + W  
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGS-ENIMVEEFVEHGPL-DVCLRKEKGRVPVAW-- 118

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILL------DNNFR-VKVADFGLSRLFPTDV 265
           ++++A + A AL+YL   +++H +V + NILL      +     +K++D G+S    +  
Sbjct: 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE 178

Query: 266 THVSTAPQGTPGYVDPDYFQCYK----LTDKSDVYSFGVVLIEL 305
             V   P   P        +C      L+  +D +SFG  L+E+
Sbjct: 179 ERVERIPWIAP--------ECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 8e-04
 Identities = 25/93 (26%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG 274
           ++A +   A+ Y+H   +IHRD+K+ N+L++    + + DFG +       +  +    G
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF--ARGSWSTPFHYG 321

Query: 275 TPGYVD---PDYFQCYKLTDKSDVYSFGVVLIE 304
             G VD   P+       T   D++S G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	438
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
smart00090	237	RIO RIO-like kinase.	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
COG4248	637	Uncharacterized protein with protein kinase and he	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.28
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.06
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.97
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.93
PRK09902	216	hypothetical protein; Provisional	98.91
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.64
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.5
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.36
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.27
PLN02876	822	acyl-CoA dehydrogenase	98.26
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.1
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.07
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.02
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.96
PRK05231	319	homoserine kinase; Provisional	97.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.93
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.92
PRK10593	297	hypothetical protein; Provisional	97.91
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.83
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.78
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.51
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.36
PLN02236	344	choline kinase	97.27
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.27
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.18
KOG2270	520	consensus Serine/threonine protein kinase involved	97.06
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	96.93
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.93
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.89
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.88
PLN02756	418	S-methyl-5-thioribose kinase	96.84
PRK12396	409	5-methylribose kinase; Reviewed	96.73
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.71
COG2334	331	Putative homoserine kinase type II (protein kinase	96.56
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.48
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.47
PRK06148	1013	hypothetical protein; Provisional	96.43
PRK11768	325	serine/threonine protein kinase; Provisional	96.42
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.41
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.37
PTZ00384	383	choline kinase; Provisional	96.1

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-55  Score=420.61  Aligned_cols=289  Identities=49%  Similarity=0.803  Sum_probs=250.2

Q ss_pred             CccccChHHHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeee
Q 013686           96 GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT  175 (438)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  175 (438)
                      ..+.|+++++..++++|...+.||+|+||.||+|.+.+|..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999998999999988765433134599999999999999999999988


Q ss_pred             eccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCEEecCCCeEEE
Q 013686          176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       176 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      .+.+.+.+||||||++|+|.++|+.....  .++|..+++||.++|+||+|||..   .|+||||||+|||||+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            87654589999999999999999987643  589999999999999999999986   4999999999999999999999


Q ss_pred             eeeCcccccCC-CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          253 ADFGLSRLFPT-DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       253 ~Dfgla~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      +|||+|+..+. ........ .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+.........+..|....+
T Consensus       219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999977654 32221111 79999999999999999999999999999999999999998776556666889999999


Q ss_pred             hcCcccccccCcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          332 QNGALNELVDPSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       332 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ..+.+.+++|+.+. .....  ......+..++.+|++.+|.+||+|.||+++|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPD--EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCCh--HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999986 22221  1455668899999999999999999999999966544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-53  Score=388.67  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=213.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ++...+.||+|..|+||++.++ +++.+|+|.+... +....+++.+|+++++.++||+||.+||+|..++..+.|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4455789999999999999987 6899999999544 3444578999999999999999999999887775469999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |++|+|.+++...+.    +++....+++.+|++||.|||+ ++||||||||+||||+..|.|||||||.+..+...   
T Consensus       160 MDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             cCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            999999999987654    9999999999999999999996 89999999999999999999999999999876443   


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||...... ...... ....|..+..+.     +   
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~-Ll~~Iv~~ppP~-----l---  302 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFE-LLCAIVDEPPPR-----L---  302 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHH-HHHHHhcCCCCC-----C---
Confidence            456678999999999999999999999999999999999999999865111 111111 112222222211     1   


Q ss_pred             ccHHHH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          348 KDYAVR-NMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       348 ~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                          +. .+++++++++.+||++||.+||+++|++++-.-.+
T Consensus       303 ----P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  303 ----PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             ----CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence                12 37888999999999999999999999999755443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-52  Score=395.85  Aligned_cols=262  Identities=34%  Similarity=0.560  Sum_probs=213.4

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ++.+.+.||+|+||+||+|.+++...||||++.....  ...+.|.+|+.+|.+++|||||+++|++......+++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3445567999999999999997544499999976532  22568999999999999999999999887765468999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCEEecCCC-eEEEeeeCcccccCCCcc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-VIHRDVKSNNILLDNNF-RVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~~~~  266 (438)
                      +++|+|.++++..  ....+++..++.++.||++||.|||+++ ||||||||+||||+.++ ++||+|||+++...... 
T Consensus       122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            9999999999884  1234999999999999999999999999 99999999999999998 99999999998764432 


Q ss_pred             ccccCCCCCCCccCccccc--cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          267 HVSTAPQGTPGYVDPDYFQ--CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.||.....      ...+......+...     .+
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp-----~~  267 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRP-----PI  267 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCC-----CC
Confidence            2233467999999999999  56999999999999999999999999986443      11122222222211     11


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCC
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLG  393 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  393 (438)
                      +       ..+++.+..++.+||+.||++||++.+++..|+.+......
T Consensus       268 p-------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  268 P-------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             C-------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            1       22667789999999999999999999999999988765443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-53  Score=371.83  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=218.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-cCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEee-eeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL-RDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYG-CTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~~~~l  184 (438)
                      ..+|++.++||+|.||+||++.. .+|..||.|.+.-.  +.+..+++..|+.+|++|+|||||++++ .+.++...++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            35678889999999999999995 48999999998643  4456678999999999999999999999 44445545999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA--SD--VIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~--ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      |||||.+|+|...++..+.....+++..+++++.|++.||.++|+  .+  |+||||||.||+|+.+|.|||+||||++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999999888778889999999999999999999999  45  89999999999999999999999999998


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      +..... .....+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+..       ......+|.++..+.+.
T Consensus       178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHHHHHHHcCCCCCCc
Confidence            865533 3456689999999999999999999999999999999999999998652       12234566666554332


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +           ..++..+.+||.-|+..||+.||+.-.++..+.
T Consensus       250 ~-----------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  250 D-----------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             H-----------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            2           467889999999999999999998655555443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-52  Score=398.02  Aligned_cols=260  Identities=34%  Similarity=0.547  Sum_probs=221.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .+.++..+.||+|.||.||.|.+++...||+|.++..... .+.|.+|+++|++|+|+|||+++|++..++ .+||||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~  282 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEY  282 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEe
Confidence            3445567899999999999999987779999999876443 378899999999999999999999887765 79999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      |+.|+|.++|+....  ..+...+.+.++.|||+||+||+++++|||||.++||||+++..+||+|||||+...++....
T Consensus       283 m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            999999999998332  348899999999999999999999999999999999999999999999999999777777766


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....-+..|.|||.+....|+.|||||||||+||||+| |+.||......+       +.+.+..|...         +
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~GyRl---------p  424 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGYRL---------P  424 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccCcC---------C
Confidence            666677889999999999999999999999999999999 888887543321       22333333211         1


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                         .+..||+.+.++|..||..+|++|||++.+...|+++....
T Consensus       425 ---~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  425 ---RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             ---CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence               23468899999999999999999999999999999886544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-51  Score=395.21  Aligned_cols=248  Identities=29%  Similarity=0.490  Sum_probs=212.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE-cCCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGIL-RDGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .+|...+.||+|||+.||.+.. ..|+.||+|++.+.   .....+.+.+|+++.+.|+|||||+++++|++. +++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-NNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-CceEEE
Confidence            4688999999999999999997 67999999998663   334567899999999999999999999977665 589999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      .|+|++++|..+++.++.    +++.+++.+++||+.||.|||+++|+|||||..|+||+++.+|||+|||||.....+.
T Consensus        97 LELC~~~sL~el~Krrk~----ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKP----LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEecCCccHHHHHHhcCC----CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999986654    9999999999999999999999999999999999999999999999999999876553


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .. ..+.+|||.|+|||++....++..+||||+||++|-|++|++||+...-       ......+.....   .-    
T Consensus       173 Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------kety~~Ik~~~Y---~~----  237 (592)
T KOG0575|consen  173 ER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------KETYNKIKLNEY---SM----  237 (592)
T ss_pred             cc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------HHHHHHHHhcCc---cc----
Confidence            33 3456899999999999999999999999999999999999999986432       122233332211   11    


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            +...+.+..+||.++|++||.+|||+++|+.+
T Consensus       238 ------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  238 ------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                  12456778899999999999999999999975

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-52  Score=380.36  Aligned_cols=256  Identities=28%  Similarity=0.428  Sum_probs=213.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH-------hHHHHHHHHHHHHhCCCCCceeEeeeeeccC
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK-------RIEQFMNEVEILTKLQHPNLVKLYGCTSRQS  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  179 (438)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||.+.+....       ......+|+++|++|+|||||++++++... 
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence            4567889999999999999999965 6999999999754221       123467999999999999999999977665 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC---CeEEEeeeC
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN---FRVKVADFG  256 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg  256 (438)
                      +..||||||++||+|.+++-.++.    +.+.....+++|++.|+.|||+.||+||||||+|||+..+   ..+||+|||
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence            478999999999999999988765    7888889999999999999999999999999999999766   779999999


Q ss_pred             cccccCCCccccccCCCCCCCccCccccccCC---CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          257 LSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK---LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       257 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      +|+..+  ....+.+.+|||.|.|||++.+..   +..+.|+||+||+||-+++|.+||........      ....+..
T Consensus       325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~~  396 (475)
T KOG0615|consen  325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQILK  396 (475)
T ss_pred             hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHhc
Confidence            999876  345567889999999999997654   33488999999999999999999985433211      2234444


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      |.+..         .+..|...+++..+||.+||..||++|||+.|+|++-+
T Consensus       397 G~y~f---------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  397 GRYAF---------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             Ccccc---------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence            43321         22356788999999999999999999999999998754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-51  Score=374.61  Aligned_cols=202  Identities=32%  Similarity=0.598  Sum_probs=181.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  ..+..+.+..|+.+|+.++|||||.+++|.+.. +.+|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-DFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-CeEEEE
Confidence            457888899999999999999977 5899999999766  555677889999999999999999999977665 589999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC------CeEEEeeeCccc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN------FRVKVADFGLSR  259 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~------~~~kl~Dfgla~  259 (438)
                      ||||.||+|.++|+.++.    +++.....++.||+.||++||+++||||||||.||||+.+      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999998875    9999999999999999999999999999999999999764      468999999999


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH  317 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~  317 (438)
                      .+...  ....+.+|++.|||||++....|+.|+|+||+|++||+|++|+.||+....
T Consensus       164 ~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  164 FLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            88643  334567899999999999999999999999999999999999999986544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.7e-50  Score=401.06  Aligned_cols=263  Identities=32%  Similarity=0.512  Sum_probs=222.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      ..+....+.||+|.||+||+|...      +...||||.++..... ..++|++|++++..++|||||+|+|+|.++ +.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-DP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-Ce
Confidence            344556789999999999999853      2467999999887655 678999999999999999999999988766 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNS----------CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                      +|+|+|||..|+|.+||..+.+..          ..|+..+.+.||.|||.||+||-++.+|||||..+|+||.++..||
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence            999999999999999998654321          2388899999999999999999999999999999999999999999


Q ss_pred             EeeeCcccc-cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHH
Q 013686          252 VADFGLSRL-FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATN  329 (438)
Q Consensus       252 l~Dfgla~~-~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~  329 (438)
                      |+|||+++. +..+.+.......-+.+|||||.+..++||.+||||||||+|||+++ |+.||.+....+       +..
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe  716 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIE  716 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHH
Confidence            999999994 45566665555567889999999999999999999999999999998 888987655432       345


Q ss_pred             HHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      .++.+.+-.            .++++|.++.+||..||+.+|.+||+++||-..|+..-...
T Consensus       717 ~i~~g~lL~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  717 CIRAGQLLS------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHHcCCccc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            566555421            23578999999999999999999999999999998875433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-49  Score=352.64  Aligned_cols=268  Identities=24%  Similarity=0.378  Sum_probs=208.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-Hh-HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      +.|+.+.++|+|+||+||+++.+ +|+.||||++..... .. .+-.++|+++|++|+|+|+|.++.+|... ..+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-rklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-RKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-ceeEEEe
Confidence            46778889999999999999987 599999999976533 23 34568999999999999999999987665 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |||+. ++.+-|......   ++...+.++++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+... .
T Consensus        81 E~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-g  155 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-G  155 (396)
T ss_pred             eecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC-c
Confidence            99966 666667665543   899999999999999999999999999999999999999999999999999987642 3


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHH--------Hh-cCcc
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK--------IQ-NGAL  336 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~--------~~-~~~~  336 (438)
                      ...+..+.|.+|+|||.+.+ ..|....||||+||++.||++|.+.|.+....+...........        +. ++.+
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            34556678999999999987 68999999999999999999999999876654433222111111        11 1111


Q ss_pred             cccccCcC--CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSL--GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..+.-|..  ..+.+....+.+.-+.+++..||..||.+|++.+|++.+
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            11111111  111111234566678999999999999999999999963

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=362.53  Aligned_cols=262  Identities=30%  Similarity=0.508  Sum_probs=209.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc-eEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR-ELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e  187 (438)
                      .+|...+.||+|+||+||++...+ |+..|||.....+....+.+.+|+.+|.+++|||||+++|....... .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456778999999999999999764 89999999866544446778999999999999999999996333333 6899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCcccccCC--C
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPT--D  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~~~~--~  264 (438)
                      |+++|+|.+++.+.+.   .+++..+..+.+||++||+|||++||+||||||+|||++. ++.+||+|||++.....  .
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            9999999999998764   2999999999999999999999999999999999999999 79999999999987653  2


Q ss_pred             ccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .........||+.|||||++..+ ....++|||||||++.||+||++||...     ................+     .
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P-----~  243 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP-----E  243 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----C
Confidence            22233456799999999999853 3345999999999999999999999753     01111111111111111     1


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                             .+..++....+++.+|+..||++||||.++|++.....+..
T Consensus       244 -------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  244 -------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                   12346778899999999999999999999999876554433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=356.95  Aligned_cols=249  Identities=28%  Similarity=0.419  Sum_probs=206.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.++||+|+||.||.++.+ +++.||+|++++...   .+.+...+|..+|.+++||.||++.-.|.. .+.+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEE
Confidence            467999999999999999999976 599999999976532   346778899999999999999999865544 458999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+||+.||.|..+|++.+.    +++..+.-++.+|+.||.|||++|||||||||+|||||.+|+++|+||||++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999997765    899999999999999999999999999999999999999999999999999965433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      . ....+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||......       .....+..+.....     
T Consensus       179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~~~~~I~~~k~~~~-----  245 (357)
T KOG0598|consen  179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------KMYDKILKGKLPLP-----  245 (357)
T ss_pred             C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------HHHHHHhcCcCCCC-----
Confidence            2 2334578999999999999999999999999999999999999999864321       12233333331110     


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP----TMKEVLE  382 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  382 (438)
                             +.-.+.+.++++.+.|..||++|.    .+.+|-+
T Consensus       246 -------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  246 -------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             -------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence                   112456788999999999999995    5566544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-49  Score=368.07  Aligned_cols=271  Identities=26%  Similarity=0.358  Sum_probs=213.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHH-HHHHHHHHHHhCC-CCCceeEeeeeeccCceEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE-QFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~l  184 (438)
                      ..++|.+.++||.|.||.||+|+.. +|+.||||+++..-....+ .-.+|+..|++|+ |||||++.+++.+....+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3568889999999999999999955 6999999999766444322 2358999999998 99999999988777668999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||| ..+|.++++.+..   .+++..+..|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||+||.....
T Consensus        88 VfE~M-d~NLYqLmK~R~r---~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNR---LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCC---cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            99999 5699999998743   5999999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccCCCCCCCccCcccc-ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc-------
Q 013686          265 VTHVSTAPQGTPGYVDPDYF-QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL-------  336 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  336 (438)
                        ...+..+.|.+|+|||++ +..-|+.+.||||+|||++|+.+-++.|.+....+.+.....+...-....+       
T Consensus       164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence              234566789999999987 5678999999999999999999999999877654443221111100000000       


Q ss_pred             ---cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          337 ---NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       337 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         .-.+..--+........+.+.++.++|.+||++||.+|||+.|++++-
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence               000111111222233445788899999999999999999999999864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=368.21  Aligned_cols=269  Identities=30%  Similarity=0.491  Sum_probs=217.9

Q ss_pred             cChHHHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec
Q 013686          100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR  177 (438)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  177 (438)
                      .+..+++...+++.+...||+|.||+||+|.+.+  .||||++...  .....+.|++|+.++++-+|.||+-++|++..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3446777778888899999999999999999863  4999998754  44567899999999999999999999998876


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      .+  +.||+.+|+|-+|+.+|+.....   +.....+.|++||++||.|||.++|||||||..|||+.++++|||+||||
T Consensus       460 p~--~AIiTqwCeGsSLY~hlHv~etk---fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  460 PP--LAIITQWCEGSSLYTHLHVQETK---FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             Cc--eeeeehhccCchhhhhccchhhh---hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence            54  59999999999999999987643   88999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-CccccccCCCCCCCccCcccccc---CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          258 SRLFPT-DVTHVSTAPQGTPGYVDPDYFQC---YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       258 a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      +..-.. ..........|...|||||++..   .+|++++||||||+++|||+||..||. ....+.+.+      .+..
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIif------mVGr  607 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIF------MVGR  607 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEE------Eecc
Confidence            974321 11112233458899999999854   479999999999999999999999998 333222211      1111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      |.    ..+.+    .....+++.++++|+..||..+|++||.+.+|+..|+.+..+
T Consensus       608 G~----l~pd~----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  608 GY----LMPDL----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cc----cCccc----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            11    11111    112356888999999999999999999999999998887654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-48  Score=365.13  Aligned_cols=271  Identities=25%  Similarity=0.392  Sum_probs=214.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~l  184 (438)
                      .+.|..++.||+|.||.||+++.. +|+.||+|++.....  ....-..+||.+|++|+||||+++.+..... ...+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            456778899999999999999954 799999999876542  2344567899999999999999999966555 568999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+|||+. +|.-++....-.   +++.++..++.||+.||+|||++||+|||||.+|||||++|.+||+|||||+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vk---ft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVK---FTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcc---cChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999965 898888775432   999999999999999999999999999999999999999999999999999998877


Q ss_pred             ccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc------
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN------  337 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  337 (438)
                      .....+..+-|.+|+|||.+.|. .|+.+.|+||.||||.||++|++.|.+....+......-.-....+..+.      
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            77777888899999999999875 79999999999999999999999998876543322111000000001111      


Q ss_pred             -ccccCcCCCCc--cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 -ELVDPSLGFEK--DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 -~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       ..+.+.-.+..  ......++....+|+..+|..||.+|.|+.++|+.
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence             11111111111  11234567788999999999999999999999863

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=362.41  Aligned_cols=267  Identities=27%  Similarity=0.432  Sum_probs=215.8

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      +...+...+.++||+|-||.|.++....+..||||.++..... ...+|..|+++|.+|+||||+.++|+|..++ .+++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-Picm  612 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCM  612 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHH
Confidence            4456677889999999999999999987899999999876544 3478999999999999999999999887764 7999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc-cCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL-FPT  263 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~-~~~  263 (438)
                      |+|||++|+|.+|+..+....  +......+|+.||+.||+||.+.++|||||.++|||++.++++||+|||+++. +..
T Consensus       613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999999999875432  45566788999999999999999999999999999999999999999999994 444


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh--CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS--GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      +........+.+.+|||||.+..++++.++|||+||+++||+++  ...||.....+..+   +........+ -...+-
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~-~~~~~l  766 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQ-GRQVVL  766 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCC-Ccceec
Confidence            55555556677899999999999999999999999999999765  56788754332111   1111111111 111111


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      +        .+.-|+..+.+++.+||..|-++||+++++...|++.
T Consensus       767 ~--------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 S--------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             c--------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1        1235778899999999999999999999999998754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=363.51  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=210.2

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCce
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  181 (438)
                      ...++|..++.||+|+|++|++|..+ .++.||||++.+..   ....+.+..|-.+|.+| .||.|++|+-.|.++ ..
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-~s  148 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-ES  148 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-cc
Confidence            34578999999999999999999965 69999999986653   23345677899999999 799999999766555 57


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +|+|+||+++|+|.++|++.+.    +++...+.++.||+.||+|||++|||||||||+|||||.+|++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999998865    999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCccc----------c--ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHH
Q 013686          262 PTDVTH----------V--STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN  329 (438)
Q Consensus       262 ~~~~~~----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~  329 (438)
                      +.....          .  ....+||..|.+||+|.....+..+|+|+||||||+|+.|.+||........       -+
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-------Fq  297 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-------FQ  297 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-------HH
Confidence            542211          1  1346799999999999999999999999999999999999999986544211       11


Q ss_pred             HHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .|.        .-.+.+     ++++++.+.+|+.+.|..||.+|+|.+||-++.
T Consensus       298 kI~--------~l~y~f-----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  298 KIQ--------ALDYEF-----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHH--------HhcccC-----CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            111        111111     134557789999999999999999999998763

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=368.37  Aligned_cols=251  Identities=27%  Similarity=0.435  Sum_probs=215.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ...|....+||+|+.|.||.+... +++.||||++........+-+.+|+.+|+..+|+|||++++.+... +++|+|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEe
Confidence            356788889999999999999854 6899999999877777778899999999999999999999966655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ||+||+|.+.+....     +++.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       351 ym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             ecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            999999999998764     89999999999999999999999999999999999999999999999999997765543 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+|||.|||||++....|+.+.||||||++++||+-|.+||-...+-       .+...+......++-       
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------rAlyLIa~ng~P~lk-------  490 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNGTPKLK-------  490 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------HHHHHHhhcCCCCcC-------
Confidence            456678999999999999999999999999999999999999999753221       122223322222221       


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         .+..++..+++++.+||+.||++||++.|+|++
T Consensus       491 ---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 ---NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ---CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence               235678899999999999999999999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=347.95  Aligned_cols=262  Identities=26%  Similarity=0.387  Sum_probs=213.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .+.|++.++||.|..++||+|+.. .++.||||++.-+ .....+.+.+|+..|+.++||||++++.+|..+ +.+|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-SELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-ceeEEee
Confidence            467888999999999999999965 5899999999644 333468899999999999999999999877665 5899999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      .||.+|++.+.+....+.+  +++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+.....
T Consensus       104 pfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            9999999999999877665  99999999999999999999999999999999999999999999999998775533221


Q ss_pred             c--cc-cCCCCCCCccCccccc--cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          267 H--VS-TAPQGTPGYVDPDYFQ--CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       267 ~--~~-~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .  .. ....|++.|||||++.  ...|+.|+||||||++..||.+|..||....+      .......+++.. +... 
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~p-p~~~-  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDP-PTLL-  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCC-CCcc-
Confidence            1  11 4567999999999964  34799999999999999999999999975433      122223333221 1111 


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        .+.......+.++..+++++..||..||.+|||+++++++
T Consensus       254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence              1222233446677899999999999999999999999974

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-46  Score=364.34  Aligned_cols=263  Identities=27%  Similarity=0.420  Sum_probs=208.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||+|...      +++.||||++.... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            568999999999999999999742      35689999986543 33456789999999999 89999999997776666


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC--------------------------------------------------------
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN--------------------------------------------------------  204 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  204 (438)
                      .+++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            789999999999999999754210                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc-ccCCCCCCCccCc
Q 013686          205 --SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV-STAPQGTPGYVDP  281 (438)
Q Consensus       205 --~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~g~~~y~aP  281 (438)
                        ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... .....+++.|+||
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence              1247788899999999999999999999999999999999999999999999998653322211 1223466889999


Q ss_pred             cccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHH
Q 013686          282 DYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA  360 (438)
Q Consensus       282 E~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  360 (438)
                      |.+.+..++.++|||||||++|||++ |..||.......      .....+..+....     .       +..++..+.
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~-----~-------~~~~~~~l~  307 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMR-----A-------PENATPEIY  307 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCC-----C-------CCCCCHHHH
Confidence            99998899999999999999999997 999997543211      1112222221111     0       123456789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          361 ELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       361 ~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      +++.+||+.||++|||+.|+++.|+.+..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=373.63  Aligned_cols=258  Identities=27%  Similarity=0.465  Sum_probs=214.7

Q ss_pred             CCCCCCcccccCceEEEEEEEcC----CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ..++.++||.|.||.||+|.++.    ...||||.++... .++..+|+.|+.+|.++.||||++|.|+.... +..+||
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-~PvMIi  708 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-KPVMII  708 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-ceeEEE
Confidence            45678999999999999999862    3579999998764 45567899999999999999999999976554 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      +|||++|+|..||+.+..+   +.+-+...++++|+.||+||-++++|||||.++||||+.+...|++|||+++.+.++.
T Consensus       709 TEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999999987654   8888999999999999999999999999999999999999999999999999886655


Q ss_pred             cccccCCC--CCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          266 THVSTAPQ--GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       266 ~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ....++..  -+.+|.|||.+..++++.++|||||||++||.++ |..||......+       +.+.+.++-       
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~gy-------  851 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQGY-------  851 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhcc-------
Confidence            33333332  3579999999999999999999999999999766 999987543322       122222221       


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      +++     .+.+||..|.+|++.||++|..+||++.||+..|+++....
T Consensus       852 RLP-----pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  852 RLP-----PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             CCC-----CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            111     12368889999999999999999999999999999986544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=330.59  Aligned_cols=237  Identities=31%  Similarity=0.479  Sum_probs=204.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..   .++.+...+|..+|+.+.||+++++++.+.+. ..+||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-~~lym  121 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-SNLYM  121 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-CeEEE
Confidence            457888999999999999999976 68999999997764   35567788999999999999999999866555 58999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||++||.|..++++.+.    +++..++-++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus       122 vmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999999998775    999999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                          .-+.+|||.|+|||++....|+.++|.|||||++|||+.|.+||...+.       ....++|.++.+.       
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~-------  259 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVK-------  259 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCccc-------
Confidence                3456899999999999999999999999999999999999999986544       2234455554432       


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCC
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMR  374 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  374 (438)
                            .+.-++..+++|+...|+.|-.+|
T Consensus       260 ------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 ------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------CCcccCHHHHHHHHHHHhhhhHhh
Confidence                  112356678999999999999999

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=358.71  Aligned_cols=251  Identities=30%  Similarity=0.474  Sum_probs=207.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc----ch-HhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN----NF-KRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  181 (438)
                      ..+|.+.+.||+|.||.|++|... +|+.||+|.+...    .. ...+.+.+|+.+++.++ ||||+++++++.... .
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-~   94 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-K   94 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-e
Confidence            567899999999999999999865 6899999976553    11 23456778999999998 999999999877665 5


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCcccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRL  260 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~  260 (438)
                      +++||||+.||+|.+++.+.+.    +.+..+..+++|++.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999998544    8889999999999999999999999999999999999999 9999999999998


Q ss_pred             cCCCccccccCCCCCCCccCccccccCC-CC-ChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYK-LT-DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      .. .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...      .... ...+..+.+. 
T Consensus       171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l-~~ki~~~~~~-  241 (370)
T KOG0583|consen  171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNL-YRKIRKGEFK-  241 (370)
T ss_pred             cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHH-HHHHhcCCcc-
Confidence            74 2233446678999999999999877 85 78999999999999999999998622      1111 1223332211 


Q ss_pred             cccCcCCCCccHHHHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          339 LVDPSLGFEKDYAVRNM-VTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                             .+     ..+ +.++..|+.+||..||.+|+|+.+++++-+
T Consensus       242 -------~p-----~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w  277 (370)
T KOG0583|consen  242 -------IP-----SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW  277 (370)
T ss_pred             -------CC-----CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence                   11     122 667899999999999999999999995443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=386.66  Aligned_cols=269  Identities=29%  Similarity=0.484  Sum_probs=219.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC--Cc----EEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD--GR----IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .+.+..+.||+|.||.||.|...+  |.    .||||.+.+. +.....+|.+|..+|++++|||||+++|++... ...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-GPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-CCc
Confidence            345567899999999999999763  44    4899998765 455678999999999999999999999988774 578


Q ss_pred             EEEEeccCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      +|++|||++|+|..||++.+..   ...+.....+.++.|||+|+.||+++++|||||.++|+||+....|||+|||+|+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            9999999999999999987332   2358899999999999999999999999999999999999999999999999999


Q ss_pred             c-cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          260 L-FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       260 ~-~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      . +..+.+.......-...|||||.+..+.|+.|+|||||||+|||++| |..||.......      ........+.+.
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~ggRL~  924 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGGRLD  924 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCCccC
Confidence            4 44444433333345679999999999999999999999999999999 889997544321      111222333211


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCCCCccc
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAK  398 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~  398 (438)
                         .          +..|+..+.++|.+||+.+|++||++..|++.+..+....++.....
T Consensus       925 ---~----------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~  972 (1025)
T KOG1095|consen  925 ---P----------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP  972 (1025)
T ss_pred             ---C----------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence               1          24578889999999999999999999999999998876665554433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=360.98  Aligned_cols=263  Identities=27%  Similarity=0.429  Sum_probs=213.5

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++...+....++-||.|+.|.||+|+++ ++.||||+++.-.       ..+|+-|++|+||||+.|.|+|... ..+||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs-PcyCI  189 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS-PCYCI  189 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC-ceeEE
Confidence            4444455556788999999999999996 6899999774332       2478999999999999999988665 48999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||||..|-|..+|+....    +.......|..+||.||.|||.+.|||||||.-||||..+..|||+|||-++.....
T Consensus       190 iMEfCa~GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             eeeccccccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            9999999999999998765    788888999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                        .....+.||..|||||++.+.+.++|.|||||||+||||+||..||..-...           .|.-|.-...+-  +
T Consensus       266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------AIIwGVGsNsL~--L  330 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------AIIWGVGSNSLH--L  330 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----------eeEEeccCCccc--c
Confidence              2334567999999999999999999999999999999999999999743211           111111111110  1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCCCCccccc
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVV  400 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~  400 (438)
                      +     .+..+++.++-|+++||+..|.+||++++++.+|+.....-+......++
T Consensus       331 p-----vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf  381 (904)
T KOG4721|consen  331 P-----VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYF  381 (904)
T ss_pred             c-----CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHH
Confidence            1     12467888999999999999999999999999998876655555554444

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-46  Score=353.02  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=210.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.  ..++.+.+.+|+++++.++|||||.++++|+.. .++|+|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-AHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-ceEEEEe
Confidence            57888999999999999999966 6899999998654  445677899999999999999999999977554 5899999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+.| +|..+|...+.    ++++.+..++.|++.||.|||+.+|.|||+||.|||++.+|.+|+||||+|+.+... .
T Consensus        81 e~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t  154 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T  154 (808)
T ss_pred             hhhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence            99966 99999988765    999999999999999999999999999999999999999999999999999987653 3


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      ...+...|||.|||||.+.+..|+..+|+||+||++|||++|++||-...-      .... ..|..+...         
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv-~~I~~d~v~---------  218 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLV-KSILKDPVK---------  218 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHH-HHHhcCCCC---------
Confidence            445566799999999999999999999999999999999999999964321      1111 122211110         


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          .+...+..+.+++...|.+||.+|.|-.+++.+-
T Consensus       219 ----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  219 ----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             ----CcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence                1125677899999999999999999999998753

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=347.91  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=208.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..|+..+.||+|.||.||+|.+. .++.||+|.+.-. ....++++++|+.+|.+++++||.++|+.+..+ ..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-TKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-ccHHHHHH
Confidence            35667789999999999999965 6899999998654 344578899999999999999999999976655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ||.||++.+.|.....    +.+..+.-++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus        92 y~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999999987653    577778889999999999999999999999999999999999999999999877655444


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      . .+.+||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+.....            .+.+-..|.+   
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L---  231 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRL---  231 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcc---
Confidence            3 67789999999999998899999999999999999999999997554421110            0111111222   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ..+++..+++++..||.+||+.||++.+++++
T Consensus       232 ----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 ----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                12567789999999999999999999999974

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.8e-45  Score=320.79  Aligned_cols=269  Identities=23%  Similarity=0.351  Sum_probs=207.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh--HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .+|...+.||+|.||.||+|++. +|+.||||+++..+.++  .....+|++.|+.++|+||+.+++++... ..+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-SNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-CceEEEE
Confidence            46778899999999999999965 79999999997664432  23567899999999999999999977655 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |||+ .+|...++....   .++...+..++.++++||+|||++.|+||||||.|+|++.+|.+||+|||+++.+.....
T Consensus        81 Efm~-tdLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             Eecc-ccHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9995 599999987643   489999999999999999999999999999999999999999999999999998876543


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc-----
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV-----  340 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  340 (438)
                      . .+..+-|.+|+|||.+.| ..|+...||||.||++.||+-|.+-|.+.++-+.....-.+...-....++++.     
T Consensus       157 ~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 I-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             c-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            3 233378999999998876 479999999999999999999999888765433221111110000111111111     


Q ss_pred             -cCc-CCCC-ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          341 -DPS-LGFE-KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       341 -~~~-~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                       .-. .+.. ........+....+|+..+|..||.+|+|+.|++++-
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence             000 0000 0112234566778999999999999999999999863

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=357.33  Aligned_cols=265  Identities=30%  Similarity=0.486  Sum_probs=214.7

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEcC--C--cE-EEEEEeec---cchHhHHHHHHHHHHHHhCCCCCceeEeee
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILRD--G--RI-VAVKRLYE---NNFKRIEQFMNEVEILTKLQHPNLVKLYGC  174 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  174 (438)
                      ..++...++....++||+|+||.||+|.++.  +  .. ||||..+.   .......+|++|+++|++++|||||+++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3455556777778999999999999999763  2  23 89998874   234567899999999999999999999997


Q ss_pred             eeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       175 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                      +..+ ..+++|||+|.||+|.++|.+.+.   .++..+++.++.+.+.||+|||+++++||||.++|+|++.++.+||+|
T Consensus       230 a~~~-~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  230 AVLE-EPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             EcCC-CccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence            7665 479999999999999999998765   399999999999999999999999999999999999999999999999


Q ss_pred             eCcccccCCCcccccc-CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHH-
Q 013686          255 FGLSRLFPTDVTHVST-APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKI-  331 (438)
Q Consensus       255 fgla~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~-  331 (438)
                      ||+++....  ..... ...-+..|+|||.+....|+.++|||||||++||+++ |..||.+....       .+...+ 
T Consensus       306 FGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~  376 (474)
T KOG0194|consen  306 FGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIV  376 (474)
T ss_pred             cccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHH
Confidence            999886431  11111 2236789999999999999999999999999999999 78898764432       222333 


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                      .++.... ..           ...+..+..++.+||..||++||+|.++.+.++.+.....
T Consensus       377 ~~~~r~~-~~-----------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 KNGYRMP-IP-----------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             hcCccCC-CC-----------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            2222111 11           1356678899999999999999999999999998875443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.5e-45  Score=347.41  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=203.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.++++||+|+||.||+|+-+ +|..+|+|++++...   .+++.++.|-.+|....+|+||+++-.|.+ ...+||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LYL  218 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLYL  218 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeEE
Confidence            478999999999999999999976 599999999987644   345678889999999999999999975554 468999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC-
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT-  263 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~-  263 (438)
                      ||||++||++..+|.+...    |++..+..++.+++.|++.||+.|+|||||||+|+|||..|++||+||||+..+.. 
T Consensus       219 iMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999988765    99999999999999999999999999999999999999999999999999863311 


Q ss_pred             ----------------------Cccc----c-------------------ccCCCCCCCccCccccccCCCCChhhHHHH
Q 013686          264 ----------------------DVTH----V-------------------STAPQGTPGYVDPDYFQCYKLTDKSDVYSF  298 (438)
Q Consensus       264 ----------------------~~~~----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~  298 (438)
                                            +...    .                   ....+|||.|||||++.+..|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  0000    0                   012359999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC---
Q 013686          299 GVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP---  375 (438)
Q Consensus       299 Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---  375 (438)
                      |||+||||.|.+||....+...       ...+..-.      ..+.++..   ..++.+..+||.+||. ||++|.   
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr------~~l~fP~~---~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQET-------YRKIVNWR------ETLKFPEE---VDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHh------hhccCCCc---CcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            9999999999999987654322       22221110      00011111   1244678999999999 999996   


Q ss_pred             CHHHHHHH
Q 013686          376 TMKEVLEI  383 (438)
Q Consensus       376 s~~evl~~  383 (438)
                      .++||-++
T Consensus       438 G~~EIK~H  445 (550)
T KOG0605|consen  438 GAEEIKKH  445 (550)
T ss_pred             cHHHHhcC
Confidence            57777764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-44  Score=338.44  Aligned_cols=247  Identities=22%  Similarity=0.341  Sum_probs=200.4

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeec--c-CceEEEEEec
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSR--Q-SRELLLVYEY  188 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~-~~~~~lv~e~  188 (438)
                      ...||+|++|.||+|.+ +|+.||||.+......   ..+.+.+|+.+|++++||||++++|++..  + ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 6899999998654322   25778899999999999999999997755  2 3468999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      +++|+|.+++.....    +++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++......  
T Consensus       104 ~~~g~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCCC----CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            999999999987543    88999999999999999999985 99999999999999999999999999998653321  


Q ss_pred             cccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          268 VSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                        ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||......      .........+. .    +.++
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~-~----~~~~  244 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNN-S----LKLP  244 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC-C----CCCC
Confidence              23357899999999976  68999999999999999999999999754321      11111111111 1    1111


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                             ..++..+.+++.+||+.||++|||+.|+++.|+..+
T Consensus       245 -------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        245 -------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                   134667999999999999999999999999998765

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-44  Score=340.63  Aligned_cols=269  Identities=21%  Similarity=0.291  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|+||.||++..+ +++.||+|++....  ....+.+.+|+.+++.++||||+++++++... +..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-GKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-CEEEEEE
Confidence            46889999999999999999986 58899999986542  22346788999999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||++++.+..+.....    .+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus        80 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          80 EYVEKNMLELLEEMPN----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             ecCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9998877665543322    388999999999999999999999999999999999999999999999999987644333


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHHH-HhcCccc
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATNK-IQNGALN  337 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~~-~~~~~~~  337 (438)
                      .......+++.|+|||.+.+..++.++|||||||++|||++|++||..............        .... .......
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            223345689999999999988999999999999999999999999976432211000000        0000 0000000


Q ss_pred             ccccCcCCCCc---cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEK---DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ....+......   ......++..+.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000   01122366789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9e-44  Score=339.39  Aligned_cols=264  Identities=24%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-----------------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCcee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-----------------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVK  170 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  170 (438)
                      .++|.+.+.||+|+||.||+|.+++                 +..||+|.+.... ......+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999998532                 3479999887543 334567999999999999999999


Q ss_pred             EeeeeeccCceEEEEEeccCCCCHHHHhhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013686          171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---------------SCLLPWPVRLSIAIETAGALAYLHASDVIHR  235 (438)
Q Consensus       171 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~  235 (438)
                      +++++... +..++||||+++|+|.+++......               ...+++..++.++.||+.||.|||+.||+||
T Consensus        84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          84 LLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEecC-CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99977665 4689999999999999998754211               1237888899999999999999999999999


Q ss_pred             CCCCCCEEecCCCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhC--CCCc
Q 013686          236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG--LEAV  312 (438)
Q Consensus       236 Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG--~~p~  312 (438)
                      ||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+++  ..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999999999986533221 122233467899999999888999999999999999999874  5666


Q ss_pred             ccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          313 DTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .......   .............. ....   .     .+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus       243 ~~~~~~~---~~~~~~~~~~~~~~-~~~~---~-----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         243 GELTDEQ---VIENAGEFFRDQGR-QVYL---F-----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CcCCHHH---HHHHHHHHhhhccc-cccc---c-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            5432211   11111111111100 0000   0     01134567899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=331.68  Aligned_cols=270  Identities=22%  Similarity=0.324  Sum_probs=211.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEee--ccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec----cCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLY--ENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR----QSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  181 (438)
                      ...|...+.||+|+||.|+.+..+ +|+.||||++.  -.+....++..+|+.+|+.++|+||+.+++++..    .-+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            445666799999999999999976 69999999987  3455566788999999999999999999997654    3357


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +|+|+|+| +.+|...++....    ++......++.|+++||.|+|+.+|+||||||.|+|++.+..+||||||+|+..
T Consensus       101 vYiV~elM-etDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence            99999999 6799999987764    899999999999999999999999999999999999999999999999999987


Q ss_pred             CCC-ccccccCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH--------HHHHHH
Q 013686          262 PTD-VTHVSTAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN--------MATNKI  331 (438)
Q Consensus       262 ~~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------~~~~~~  331 (438)
                      ... .....+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++.|.+...-+...+..        .....+
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            542 122335567899999999874 4689999999999999999999999998776544332211        111122


Q ss_pred             hcCccccccc---CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          332 QNGALNELVD---PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       332 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ........+.   ..-..+.....++..+...+|+.+||..||.+|+|++|.|++
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2111111111   011111122234566778999999999999999999999985

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.3e-44  Score=341.98  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=200.3

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      |+..+.||+|+||.||++... +|+.||+|.+.....   .....+.+|+.++++++|+||+++++++... +..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEEE
Confidence            667889999999999999965 689999999865432   2234578899999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-  157 (285)
T ss_pred             ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence            9999999988865432  2389999999999999999999999999999999999999999999999999987543221 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.........   ......+....        ..  
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~~--  223 (285)
T cd05631         158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ--------EE--  223 (285)
T ss_pred             -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc--------cc--
Confidence             23346899999999999999999999999999999999999999854322110   11111111110        00  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                         ....++..+.+|+.+||+.||.+||+     +++++++
T Consensus       224 ---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         224 ---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence               11234567889999999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-45  Score=351.67  Aligned_cols=252  Identities=28%  Similarity=0.454  Sum_probs=213.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-c--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-N--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .-|+.++.||.|+.|.|-+|++. +|+.+|||.+.+. .  ......+.+|+-+|+.+.||||+++|++++.. .++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-QHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-ceEEEE
Confidence            34778999999999999999965 7999999998654 1  12235678899999999999999999976555 589999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      .||+++|-|+++|..++.    +++.++.++++||+.|+.|+|..+|+||||||+|+|||..+++||+|||+|.+-..  
T Consensus        91 lEyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             EEecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            999999999999998876    99999999999999999999999999999999999999999999999999987433  


Q ss_pred             cccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .....+.||+|.|.|||++.|.+| +.++||||-|||||.|+||+.||+..+       ......+++.|.+.-      
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f~M------  231 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVFEM------  231 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcccC------
Confidence            334466789999999999999998 458999999999999999999998322       223344555554321      


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                             +..++.++.+|+.+|+..||++|.|++||+++..-..
T Consensus       232 -------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  232 -------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             -------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence                   1346778999999999999999999999999865544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=352.97  Aligned_cols=243  Identities=28%  Similarity=0.447  Sum_probs=201.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  182 (438)
                      ..++|...++||+|.||+|+++..+ +++.+|||.+++...   .+++..+.|.+++...+ ||.+++++.++... .++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-~~l  444 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-EHL  444 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-CeE
Confidence            3578999999999999999999987 588999999987643   45678889999998885 99999999866554 589


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      |+||||+.||++..+.+...     +++..+.-++..|+.||+|||++|||+||||.+|||||.+|.+||+|||+++..-
T Consensus       445 ~fvmey~~Ggdm~~~~~~~~-----F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHTDV-----FSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEEEeccc-----ccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999999655554332     9999999999999999999999999999999999999999999999999998543


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .. .....+.+|||.|||||++.+..|+.+.|.|||||+||||+.|..||.+...++..       ..|...      ++
T Consensus       520 ~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-------dsI~~d------~~  585 (694)
T KOG0694|consen  520 GQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-------DSIVND------EV  585 (694)
T ss_pred             CC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHhcC------CC
Confidence            22 22456789999999999999999999999999999999999999999875543211       111111      11


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM  377 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  377 (438)
                      .       .+..++.+..++++++|..+|++|.-+
T Consensus       586 ~-------yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 R-------YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             C-------CCCcccHHHHHHHHHHhccCcccccCC
Confidence            1       234567788999999999999999754

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=358.51  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=214.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCC-cEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEee-eeecc-----Cc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYG-CTSRQ-----SR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~~-----~~  180 (438)
                      ..++++.+.|.+|||+.||++....+ ..||+|++...+....+.+.+|+++|++|+ |+|||.+++ .....     .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45667889999999999999998765 999999998888888899999999999996 999999999 32211     24


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      +++|.||||.||.|-++|..+....  |++.++++|+.|+++|+.+||...  |||||||-+||||+.++..||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            6899999999999999999876554  999999999999999999999986  999999999999999999999999998


Q ss_pred             cccCCCc-ccc-------ccCCCCCCCccCcccc---ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH
Q 013686          259 RLFPTDV-THV-------STAPQGTPGYVDPDYF---QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA  327 (438)
Q Consensus       259 ~~~~~~~-~~~-------~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~  327 (438)
                      ...-... ...       .-...-|+.|+|||.+   .+...++|+|||||||+||-|+....||+....          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            7321111 100       0112379999999976   567899999999999999999999999985422          


Q ss_pred             HHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCC
Q 013686          328 TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLG  393 (438)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  393 (438)
                               ..+++..+.++..   ..++..+.+||+.||+.||.+||++-|+++.+.++......
T Consensus       264 ---------laIlng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  264 ---------LAILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             ---------eeEEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                     1222223322221   46788999999999999999999999999999988765543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-45  Score=339.33  Aligned_cols=262  Identities=29%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--------------hHHHHHHHHHHHHhCCCCCcee
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--------------RIEQFMNEVEILTKLQHPNLVK  170 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~  170 (438)
                      ....++|++.+.||+|.||.|-+|... +++.||||++.+....              ..++..+|+.+|++|.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            445688999999999999999999965 6999999998653221              1468899999999999999999


Q ss_pred             Eeeeeec-cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe
Q 013686          171 LYGCTSR-QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR  249 (438)
Q Consensus       171 ~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~  249 (438)
                      |+.+..+ ..+.+|||+|||..|.+...=.    ....+.+.++++++++++.||+|||.+||+||||||+|+||+++|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            9996644 3457999999999888754322    2222899999999999999999999999999999999999999999


Q ss_pred             EEEeeeCcccccCCCcc----ccccCCCCCCCccCccccccCC----CCChhhHHHHHHHHHHHHhCCCCcccCCccccc
Q 013686          250 VKVADFGLSRLFPTDVT----HVSTAPQGTPGYVDPDYFQCYK----LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI  321 (438)
Q Consensus       250 ~kl~Dfgla~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~  321 (438)
                      |||+|||.+..+.....    .......|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-.....   
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---  325 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---  325 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence            99999999987633211    1112357999999999987632    356889999999999999999999753221   


Q ss_pred             chhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                          ....+|.+.        .+.++..   +.+...+++||.++|++||++|.+..+|..+.+....
T Consensus       326 ----~l~~KIvn~--------pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  326 ----ELFDKIVND--------PLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ----HHHHHHhcC--------cccCCCc---ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                111223222        2222211   1345678999999999999999999999999877654

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-45  Score=313.26  Aligned_cols=262  Identities=23%  Similarity=0.390  Sum_probs=215.5

Q ss_pred             hcCCCCCCcccccCceEEEEEE-EcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec----cCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR----QSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~  183 (438)
                      .++|.+.+.||+|||+-||+++ ..+++.||+|++.....++.+..++|++..++++|||+++++++...    ..++.|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            5689999999999999999999 55789999999988877888999999999999999999999885422    345699


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      ++++|...|+|.+.++.....+..+++.+.+.|+.+|++||++||+..  +.||||||.|||+.+++.++|.|||.++..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            999999999999999988777777999999999999999999999998  999999999999999999999999999865


Q ss_pred             CCCcccc--------ccCCCCCCCccCccccccC---CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHH
Q 013686          262 PTDVTHV--------STAPQGTPGYVDPDYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       262 ~~~~~~~--------~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      +-.....        -.....|..|.|||.+.-.   ..++++|||||||+||+|+.|..||+..-.             
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------------  246 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------------  246 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------------
Confidence            4321111        1123478999999998643   568899999999999999999999974211             


Q ss_pred             HhcCc-ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          331 IQNGA-LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       331 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                       +.+. .-.+..+.+.++..   ..+++.+.+++..||+.||.+||++.+++..++.+
T Consensus       247 -~GgSlaLAv~n~q~s~P~~---~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 -QGGSLALAVQNAQISIPNS---SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -cCCeEEEeeeccccccCCC---CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence             1111 11222333333322   12778899999999999999999999999998765

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-44  Score=347.87  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++..++||||+++++++... ...|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-EYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-CEEEEE
Confidence            36888999999999999999976 58999999987542   23346788999999999999999999977654 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        80 ~e~~~g~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EeCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999976543    88999999999999999999999999999999999999999999999999986543  


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                        ......|++.|+|||.+.+..++.++|||||||++|||++|..||........       ...+.... .....+...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~-~~~~~~~~~  223 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYWK-ETLQRPVYD  223 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhcc-ccccCCCCC
Confidence              22345689999999999999999999999999999999999999975432111       11111100 000001100


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..    ...++.++.+++.+||..+|.+||++++++++
T Consensus       224 ~~----~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DP----RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cc----ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00    02356778999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-45  Score=348.13  Aligned_cols=254  Identities=27%  Similarity=0.461  Sum_probs=215.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|..++.+|+|+||.++++..+ ++..|++|.+.-..  ....+...+|+.++++++|||||.+.+.+..++..++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357888999999999999999976 57899999986443  334457889999999999999999999887777569999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |+||+||+|.+.+.+.+.  ..++++.+..|+.|++.|+.|||+++|+|||||+.|||++.++.|||+|||+|+.+..+.
T Consensus        83 m~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999999998763  349999999999999999999999999999999999999999999999999999887664


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      . ......||+.||.||.+.+.+|+.|+|||||||++|||++-+++|......      .. ...+..+.    ..|   
T Consensus       161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~L-i~ki~~~~----~~P---  225 (426)
T KOG0589|consen  161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------EL-ILKINRGL----YSP---  225 (426)
T ss_pred             h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HH-HHHHhhcc----CCC---
Confidence            2 234567999999999999999999999999999999999999999865432      11 12222222    111   


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                           .+..++.++..++..||..+|+.||++.++|.+.
T Consensus       226 -----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  226 -----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             -----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence                 1245778899999999999999999999999863

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=342.53  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+....   ....+.+.+|+.++++++||||+++++++... ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEE
Confidence            46888999999999999999976 68999999986542   23456788999999999999999999866554 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++.....++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          80 MEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             EeCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            999999999999987543    8899999999999999999999999999999999999999999999999998654321


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                          ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+..+...      + 
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~------~-  217 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKILAGKLE------F-  217 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcC------C-
Confidence                2346899999999999989999999999999999999999999754321       111222221110      0 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEIL  384 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  384 (438)
                            +..++..+.+++.+||+.||.+||+     +++++++-
T Consensus       218 ------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         218 ------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             ------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence                  1123556889999999999999995     88888754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=331.02  Aligned_cols=250  Identities=27%  Similarity=0.470  Sum_probs=214.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-cCCcEEEEEEeeccchHh---HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGIL-RDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ...+|.+.+.||+|.||.|-++.. ..|+.||||.+++...+.   .-.+.+|+++|..|+||||+.++.+|+.. +.+.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-dKIv  129 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-DKIV  129 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-ceEE
Confidence            356788899999999999999996 579999999997764443   34578999999999999999999977665 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      |||||..+|.|++|+.+++.    +++.++..+++||..|+.|+|.++++|||||.+|||+|.++++||+|||++..+..
T Consensus       130 ivMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999999998876    99999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ..  ...+++|+|-|.+||++.|.+| .+..|.|||||+||-|+.|..||++...       ......|..|...+.-. 
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaYrEP~~-  275 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAYREPET-  275 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccccCCCC-
Confidence            53  3456789999999999999988 5689999999999999999999986543       23345566665554322 


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                                   +....-||++||..||++|.|+.+|..+-+
T Consensus       276 -------------PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  276 -------------PSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             -------------CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                         233557999999999999999999998753

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.8e-45  Score=326.02  Aligned_cols=270  Identities=21%  Similarity=0.306  Sum_probs=207.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh--HHHHHHHHHHHHhCCCCCceeEeeeee-ccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHPNLVKLYGCTS-RQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~~l  184 (438)
                      .++|+.++.|++|.||.||+|.++ +++.||+|+++....+.  ----.+|+.+|.+++|||||.+-.+.. ..-+.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            456778899999999999999976 69999999997654221  113468999999999999999988443 33457999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||||+. +|..++...+.   .+...++..+..|+++|++|||.+.|+|||||++|+|+++.|.+||+|||+|+.++..
T Consensus       155 VMe~~Eh-DLksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999976 99999988763   3889999999999999999999999999999999999999999999999999988766


Q ss_pred             ccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .. ..+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++.|.+....+..+..-.....-.+..++.+....
T Consensus       231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            33 34556789999999998764 69999999999999999999999998876554433221111110111111111100


Q ss_pred             ----CCC--------CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 ----LGF--------EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ----~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          +.+        .........++.-.+|+..+|..||.+|.|++|.|++
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                000        0000011144677899999999999999999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.8e-43  Score=342.96  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=193.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|+..+.||+|+||.||++... +|+.||||.+..... ...+.+.+|+++++.++|+||+++++++... +.+++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-GEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-CeEEEEEe
Confidence            45667889999999999999976 689999999865432 3346789999999999999999999977554 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++|+|.+..        ...+..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++....... 
T Consensus       153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            99999986532        256777889999999999999999999999999999999999999999999986643321 


Q ss_pred             cccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          268 VSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ......|+..|+|||.+..     ...+.++|||||||++|||++|+.||.......   ..... ..+......     
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~-~~~~~~~~~-----  294 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLM-CAICMSQPP-----  294 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHH-HHHhccCCC-----
Confidence            1233468999999998743     234568999999999999999999997322111   11111 111111000     


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .       ....++.++.+|+.+||+.||++|||+.|++++-
T Consensus       295 ~-------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        295 E-------APATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             C-------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            0       0123456789999999999999999999999863

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-43  Score=332.11  Aligned_cols=256  Identities=22%  Similarity=0.387  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcE
Confidence            456888999999999999999854    35789999987653 33446789999999999999999999977654 5799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999999976432   389999999999999999999999999999999999999999999999998765432


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ..........++..|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+...     
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~-----  227 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRL-----  227 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC-----
Confidence            22111222335678999999999999999999999999999775 999997543211       11122221110     


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..       +..++..+.+++.+||+.+|++||++++|++.|.++
T Consensus       228 ~~-------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 PA-------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC-------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            00       123566789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-43  Score=347.50  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=204.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------cCCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL------RDGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||+|..      .++..||||+++... ....+.+.+|+.++..+ +||||+++++++... .
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-G  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-C
Confidence            55788999999999999999973      235689999986542 33456788999999999 899999999977665 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC---------------------------------------------------------
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQP---------------------------------------------------------  203 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  203 (438)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            78999999999999999975321                                                         


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc-
Q 013686          204 --------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV-  268 (438)
Q Consensus       204 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~-  268 (438)
                                    ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... 
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                          01247888999999999999999999999999999999999999999999999998654332211 


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......      .....+..+....  .+     
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~--~~-----  339 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML--SP-----  339 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC--CC-----
Confidence            122335678999999999999999999999999999998 888886532211      1111222221100  00     


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                           ...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus       340 -----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 -----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                 12345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=348.41  Aligned_cols=264  Identities=28%  Similarity=0.493  Sum_probs=225.5

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          102 CSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      +++++....+..+..+||.|.||.||.|.++. .-.||||.++.+... .++|+.|+.+|+.++|||+|+++|+|..+. 
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~Ep-  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCC-
Confidence            36788888888999999999999999999875 678999999876554 689999999999999999999999888775 


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|||+|||..|+|.+||++.....  ++--..++++.||..||+||..+++|||||.++|+||.++..||++||||+++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            6999999999999999999876544  77778899999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      +..+.+...........|.|||.+.-..++.|+|||+|||+|||+.| |..||.+.      ++.. +...+..+-..  
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSq-VY~LLEkgyRM--  485 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQ-VYGLLEKGYRM--  485 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHH-HHHHHhccccc--
Confidence            98777665555567889999999999999999999999999999998 77888643      2222 12222222211  


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                             +   .+++|++.+.+|+++||+++|.+||++.|+-+.++.+.
T Consensus       486 -------~---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  486 -------D---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -------c---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                   1   13578899999999999999999999999999988764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8e-44  Score=344.78  Aligned_cols=268  Identities=23%  Similarity=0.370  Sum_probs=199.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----RELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  183 (438)
                      +|++.+.||+|+||.||+|... +|+.||||++...  .......+.+|++++++++||||+++++++....    ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999965 6899999988643  2233457889999999999999999999664332    3589


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+ +++|.+++.....    +++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~-~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELM-ESDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecC-CCCHHHHHHhccc----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            999999 5799999876543    89999999999999999999999999999999999999999999999999985432


Q ss_pred             Ccc--ccccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHHHH
Q 013686          264 DVT--HVSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATNKI  331 (438)
Q Consensus       264 ~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~~~  331 (438)
                      ...  .......+++.|+|||.+.+  ..++.++|||||||++|||++|++||............        ......+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            211  11233468999999999876  57899999999999999999999999754321110000        0000011


Q ss_pred             hcCccccc---ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          332 QNGALNEL---VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       332 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ........   +...............+..+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            10000000   00000111111112345678899999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-43  Score=346.59  Aligned_cols=264  Identities=19%  Similarity=0.219  Sum_probs=198.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..+|++.+.||+|+||.||++... +++.||+|...      .+.+.+|++++++++||||+++++++... ...++|||
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEEe
Confidence            367999999999999999999975 68999999643      23467899999999999999999977654 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ++ +++|..++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       164 ~~-~~~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        164 RY-KTDLYCYLAAKRN----IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             cC-CCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            99 5789988876543    889999999999999999999999999999999999999999999999999754332222


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc-ccchhHHHHHHHh-cCcc---------
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH-DINLSNMATNKIQ-NGAL---------  336 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~-~~~~~~~~~~~~~-~~~~---------  336 (438)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||-...... ...........+. .+..         
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            2334569999999999999899999999999999999999997764322111 0000000000000 0000         


Q ss_pred             ---c--------ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          337 ---N--------ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       337 ---~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         .        ..................+.++.+|+.+||+.||++|||++|++++-
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence               0        00000000001111234567899999999999999999999999753

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-43  Score=341.87  Aligned_cols=266  Identities=23%  Similarity=0.383  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||++... +|..||+|.+.... ....+.+.+|++++++++||||+++++++... +..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEe
Confidence            468899999999999999999976 58899999886542 33456799999999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          83 EHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             ecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999999987543    88999999999999999999986 69999999999999999999999999997653322


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc--cccc---
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL--NELV---  340 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---  340 (438)
                         .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......   +..........+..  ....   
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence               223468999999999999899999999999999999999999996432211   00000000000000  0000   


Q ss_pred             -------------cC--cC----------CC-CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          341 -------------DP--SL----------GF-EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       341 -------------~~--~~----------~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                                   +.  ..          .. ........++.++.+|+.+||+.||++|||++|++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                         00  00          00 000001135667999999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-44  Score=344.25  Aligned_cols=246  Identities=28%  Similarity=0.439  Sum_probs=202.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|.+....   ....+.+.+|+.++++++||||+++++++... +..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEE
Confidence            357888999999999999999976 58999999987542   23456788999999999999999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        96 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEcCCCCChHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999999987543    889999999999999999999999999999999999999999999999999866433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .    ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+..+...      +
T Consensus       172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~------~  234 (329)
T PTZ00263        172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRLK------F  234 (329)
T ss_pred             c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCcC------C
Confidence            2    2346899999999999999999999999999999999999999643221       111222222111      0


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                        +     ..++..+.+|+.+||+.||.+||+     +++++.+
T Consensus       235 --p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 --P-----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --C-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              0     123456889999999999999997     6888866

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-43  Score=328.44  Aligned_cols=256  Identities=25%  Similarity=0.498  Sum_probs=207.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++... ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEec
Confidence            457889999999999999999988888999998765433 357889999999999999999999976554 468999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++......  .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          83 MAKGSLLDFLKSDEGG--KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCCcHHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            9999999999765322  38888999999999999999999999999999999999999999999999998765433222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||......       .....+..+...    +.    
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~~----~~----  225 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQRGYRM----PR----  225 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCCCC----CC----
Confidence            223346778999999988889999999999999999998 99998643221       111222221110    00    


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          ...++..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                012456788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.8e-44  Score=337.19  Aligned_cols=269  Identities=22%  Similarity=0.315  Sum_probs=200.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.++++++||||+++++++..+ ...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEE
Confidence            356889999999999999999976 689999999864432 2235677899999999999999999977654 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||++ ++|.+++.....   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          83 EYLD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             eCCC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9996 599999876532   378899999999999999999999999999999999999999999999999976433221


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH--------HHHH-hcCcc
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA--------TNKI-QNGAL  336 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~~  336 (438)
                       ......+++.|+|||.+.+ ..++.++||||+||++|||++|++||...............        +..+ .....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             1233468999999998865 56899999999999999999999999754322111100000        0000 00000


Q ss_pred             cccccCcCCCCc-cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLGFEK-DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .....+...... .......+.++.+|+.+||+.||.+|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000111100000 00112345678899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-44  Score=345.84  Aligned_cols=242  Identities=27%  Similarity=0.378  Sum_probs=196.7

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.||+|+||.||++..+ +|+.||+|.+....   ......+.+|+.++++++||||+++++++... +..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCC
Confidence            46999999999999975 68999999987542   23345678899999999999999999977655 479999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccC
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA  271 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  271 (438)
                      |+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~  154 (323)
T cd05571          80 GELFFHLSRERV----FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT  154 (323)
T ss_pred             CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence            999999976543    8999999999999999999999999999999999999999999999999987532221 11233


Q ss_pred             CCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHH
Q 013686          272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA  351 (438)
Q Consensus       272 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (438)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+..+..      .+       
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~------~~-------  214 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEI------RF-------  214 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCCC------CC-------
Confidence            46899999999999999999999999999999999999999653221       11111211111      11       


Q ss_pred             HHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          352 VRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       352 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      +..++..+.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            123466788999999999999999     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-43  Score=327.75  Aligned_cols=251  Identities=31%  Similarity=0.528  Sum_probs=202.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      ++|++.+.||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++||||+++++++... ...++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEEEcC
Confidence            45778899999999999999988888999998764433 236788999999999999999999977655 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++|+|.+++.....   .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            99999999976432   288999999999999999999999999999999999999999999999999986543322222


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......      .. ...+..+...  ..+      
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~-~~~i~~~~~~--~~~------  223 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EV-VEMISRGFRL--YRP------  223 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHCCCCC--CCC------
Confidence            23345678999999988889999999999999999999 89998654321      11 1122222111  011      


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          ...+..+.+++.+||+.+|.+||++.++++.|
T Consensus       224 ----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 ----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                11345688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-43  Score=336.37  Aligned_cols=266  Identities=22%  Similarity=0.352  Sum_probs=198.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEc--CCcEEEEEEeeccch--HhHHHHHHHHHHHHhC---CCCCceeEeeeeec----c
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR--DGRIVAVKRLYENNF--KRIEQFMNEVEILTKL---QHPNLVKLYGCTSR----Q  178 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----~  178 (438)
                      ++|++.+.||+|+||.||+|...  +|+.||+|.+.....  .....+.+|+.+++.+   +||||+++++++..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  468899998864322  2234566788777766   69999999997642    3


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      ...+++||||++ ++|.+++......  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            346899999995 6999999765432  3899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh---cCc
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ---NGA  335 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~---~~~  335 (438)
                      +.....  .......|++.|+|||.+.+..++.++|||||||++|||++|++||..........  .. .....   ...
T Consensus       158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~--~i-~~~~~~~~~~~  232 (290)
T cd07862         158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KI-LDVIGLPGEED  232 (290)
T ss_pred             EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH--HH-HHHhCCCChhh
Confidence            865433  22234468999999999988899999999999999999999999998654321110  00 00000   000


Q ss_pred             cc-------ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LN-------ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +.       ..+.+............++..+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00       0000000001111123456778899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=311.19  Aligned_cols=252  Identities=29%  Similarity=0.463  Sum_probs=211.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+++.||+|-||.||+|..+ ++-.||+|++.+....   ...++.+|+++-+.|+||||+++|+++.+. ...|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-KRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-ceeEE
Confidence            567899999999999999999966 5789999998765432   235788999999999999999999987766 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ++||.++|+|...|...+..  .+++.....+..|+|.||.|+|.++|+||||||+|+|++..+.+||+|||.+...+  
T Consensus       100 ilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999999965433  38888889999999999999999999999999999999999999999999987654  


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                       .....+.+||..|.+||...+..++...|+|++|++.||++.|.+||+.....       .....+..-.   +..|  
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k~~---~~~p--  242 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRKVD---LKFP--  242 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHHcc---ccCC--
Confidence             23345678999999999999999999999999999999999999999864321       1222332211   1111  


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                              ..++....++|.+|+..+|.+|.+..|++.+-.-
T Consensus       243 --------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  243 --------STISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             --------cccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence                    3466788999999999999999999999987553

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.6e-43  Score=340.69  Aligned_cols=263  Identities=28%  Similarity=0.425  Sum_probs=208.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+..|+.++.++ +|+||+++++++...+.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999742      25789999886442 33456788899999999 79999999997776666


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC--------------------------------------------------------
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN--------------------------------------------------------  204 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  204 (438)
                      .++++|||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            789999999999999998653211                                                        


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc-ccCCCCCCCccCcc
Q 013686          205 -SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV-STAPQGTPGYVDPD  282 (438)
Q Consensus       205 -~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE  282 (438)
                       ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....... .....++..|+|||
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence             1248899999999999999999999999999999999999999999999999998654332221 22234577899999


Q ss_pred             ccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHH
Q 013686          283 YFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAE  361 (438)
Q Consensus       283 ~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  361 (438)
                      .+.+..++.++|||||||++|||++ |..||.......      .....+..+.... .           +...+.++.+
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~-~-----------~~~~~~~~~~  307 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMR-A-----------PEYATPEIYS  307 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCC-C-----------CccCCHHHHH
Confidence            9999999999999999999999998 999997532211      1111222221110 0           1134567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          362 LAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       362 li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ++.+||+.+|++||++.|++++|+++..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-43  Score=345.20  Aligned_cols=262  Identities=26%  Similarity=0.383  Sum_probs=204.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      ...++|++.+.||+|+||.||+|...      ++..||+|++.... ....+.+.+|+++++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34568999999999999999999842      24579999987543 33456788999999999 899999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCC-------------------------------------------------------
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQP-------------------------------------------------------  203 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  203 (438)
                       ...++||||+++|+|.+++.....                                                       
T Consensus       115 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         115 -GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             -CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence             478999999999999999865321                                                       


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc-cccC
Q 013686          204 -----------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTA  271 (438)
Q Consensus       204 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~  271 (438)
                                 ....+++..+++++.||+.||.|||++||+||||||+|||+++++.+||+|||+++........ ....
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                       0124788889999999999999999999999999999999999999999999999865433221 1122


Q ss_pred             CCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       272 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ..++..|+|||.+.+..++.++|||||||++|||++ |+.||.......      .....+..+. .. ..+        
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~-~~-~~~--------  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGY-QM-SRP--------  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHccc-Cc-cCC--------
Confidence            335678999999988899999999999999999997 999997532211      0111111111 00 000        


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                        ...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       338 --~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 --DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              11356788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=358.11  Aligned_cols=253  Identities=22%  Similarity=0.345  Sum_probs=204.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-C-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-D-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .|.+.+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++... +.+|+||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEEC
Confidence            3778899999999999999854 3 678899987665555556788899999999999999999977665 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc-c
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-H  267 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-~  267 (438)
                      +++|+|.+++.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            999999999876433334588999999999999999999999999999999999999999999999999987643322 1


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......      .. ...+..+....     .   
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~-~~~~~~~~~~~-----~---  291 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EI-MQQVLYGKYDP-----F---  291 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHhCCCCC-----C---
Confidence            233456999999999999999999999999999999999999999753221      11 11121111110     0   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          +..++..+.+++.+||+.||++||++.+++..
T Consensus       292 ----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        292 ----PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                12345678999999999999999999999753

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.6e-43  Score=327.53  Aligned_cols=257  Identities=26%  Similarity=0.468  Sum_probs=210.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ...+|++.+.||.|+||.||+|...+++.+++|.+........+.+.+|+.+++.++|+||+++++++... ...++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-EPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-CCeEEEEe
Confidence            35678899999999999999999888999999998877665667899999999999999999999977555 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....  ..+++..+..++.||+.||.|||+.|++||||||+||++++++.+||+|||++.........
T Consensus        83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999986543  23899999999999999999999999999999999999999999999999999876443322


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      . ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......       ....+..+...     ..  
T Consensus       161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~-----~~--  225 (261)
T cd05148         161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQITAGYRM-----PC--  225 (261)
T ss_pred             c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHhCCcC-----CC--
Confidence            2 23346778999999988899999999999999999998 899996543111       11111111100     00  


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                           +..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       226 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         226 -----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                 123456788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-42  Score=339.35  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=196.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||+||++... +++.||+|++....   ....+.+.+|+.++.+++|+||+++++++... ..+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-LNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CeEEEE
Confidence            47888999999999999999876 58999999987542   22345688899999999999999999977655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EcCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999987543    8999999999999999999999999999999999999999999999999987543211


Q ss_pred             c----------------------------------ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCC
Q 013686          266 T----------------------------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA  311 (438)
Q Consensus       266 ~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p  311 (438)
                      .                                  .......||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001234699999999999999999999999999999999999999


Q ss_pred             cccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 013686          312 VDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQ--QDRDMRPTMKEVLEI  383 (438)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~  383 (438)
                      |.......       ....+......-.+.+.         ..++..+.+++.+++.  .++..||+++|++++
T Consensus       236 f~~~~~~~-------~~~~i~~~~~~~~~p~~---------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQE-------TYKKVMNWKETLIFPPE---------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHH-------HHHHHHcCcCcccCCCc---------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            97543211       11122111100001111         1234567788887554  233456899999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-43  Score=341.26  Aligned_cols=242  Identities=28%  Similarity=0.385  Sum_probs=195.9

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.||+|+||.||++... +|+.||+|.+....   ......+.+|+++++.++||||+++++++... +.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCC
Confidence            46999999999999975 68999999987542   23345678899999999999999999977655 479999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccC
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA  271 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  271 (438)
                      |+|..++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  154 (323)
T cd05595          80 GELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT  154 (323)
T ss_pred             CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence            999999876543    89999999999999999999999999999999999999999999999999875322211 1233


Q ss_pred             CCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHH
Q 013686          272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA  351 (438)
Q Consensus       272 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (438)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+..      .+       
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~~------~~-------  214 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------RF-------  214 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC------CC-------
Confidence            468999999999999899999999999999999999999997533211       1111111110      01       


Q ss_pred             HHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          352 VRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       352 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      +..++..+.+++.+||+.||.+||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            123456788999999999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=342.13  Aligned_cols=259  Identities=29%  Similarity=0.495  Sum_probs=218.6

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEcC---Cc--EEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILRD---GR--IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      ...+.....+.||.|-||.||+|.+.+   |+  .||||..+.+ .....+.|+.|..+|++++||||++++|++.++  
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~--  463 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--  463 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc--
Confidence            345556677899999999999999643   33  5889988764 445678999999999999999999999988766  


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..|||||.++.|.|..+|+.++..   ++......++.||+.||.|||+.++|||||..+|||+.....|||+|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence            589999999999999999987654   88999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      +..+.........-+..|||||.+.-.+++.++|||-|||++||++. |..||.+-...+.+       ..+.+|     
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnG-----  608 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENG-----  608 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCC-----
Confidence            87766655555556789999999999999999999999999999776 99999875443221       112222     


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                             +....+++|++.+..|+.+||+.||.+||++.|+...|.++..
T Consensus       609 -------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 -------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             -------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                   1222345789999999999999999999999999999988865

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.1e-43  Score=337.86  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccc----hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCce
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENN----FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  181 (438)
                      +|++.+.||+|+||.||++...    +|+.||+|.+....    ....+.+.+|+.+++.+ +|+||+++++++... +.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE-AK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC-CE
Confidence            4778899999999999998853    57899999986532    22345678899999999 599999999876555 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +++||||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            8999999999999999976543    899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........   ......+...      
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~------  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC------  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC------
Confidence            43333223345699999999999865 4788999999999999999999999754322111   1111111111      


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      ++.++       ..++..+.+++.+||+.||++||     ++++++++
T Consensus       227 ~~~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 DPPFP-------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11111       12456788999999999999999     78888875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-42  Score=324.96  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .+|.+.+.||+|+||.||+|..+ .++.||+|.+.... ...+.+.+|+++++.++|+||+++++++..+ ..++++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEEEe
Confidence            45777899999999999999976 58899999886543 3356789999999999999999999977655 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++......  .+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++..........
T Consensus        84 ~~~~~L~~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          84 MTYGNLLDYLRECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCCcHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9999999999765432  38999999999999999999999999999999999999999999999999998765433222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||......      . ....+..+..     +..   
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~-~~~~~~~~~~-----~~~---  226 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------Q-VYELLEKGYR-----MER---  226 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHCCCC-----CCC---
Confidence            222335678999999998899999999999999999998 88998643221      1 1112221110     000   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          +..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       227 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 ----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                123456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.4e-43  Score=329.44  Aligned_cols=257  Identities=31%  Similarity=0.492  Sum_probs=206.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      ++|++.+.||+|+||.||+|....      ...|++|.+.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-Cce
Confidence            468889999999999999998643      2579999886543 23446789999999999999999999977654 478


Q ss_pred             EEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          183 LLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      +++|||+++++|.+++......            ...+++..++.++.|++.||.|||++|++||||||+||++++++.+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence            9999999999999999764321            1347889999999999999999999999999999999999999999


Q ss_pred             EEeeeCcccccCCCc-cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHH
Q 013686          251 KVADFGLSRLFPTDV-THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       251 kl~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~  328 (438)
                      ||+|||+++...... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||......       ...
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~~~  236 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------EVI  236 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence            999999998653322 122233456789999999988899999999999999999998 99998754321       111


Q ss_pred             HHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                      ..+..+....            .+..++.++.+|+.+||+.||.+||++.||+++|+.
T Consensus       237 ~~i~~~~~~~------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRSRQLLP------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCcCC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            2222222111            113467789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6e-43  Score=352.85  Aligned_cols=272  Identities=21%  Similarity=0.267  Sum_probs=197.4

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC------CCceeEeeeee
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH------PNLVKLYGCTS  176 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~  176 (438)
                      ++....++|++.+.||+|+||+||+|... .++.||||++.... ...+.+..|++++..++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999975 58899999986432 223445667777777654      45888888777


Q ss_pred             ccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCC-------
Q 013686          177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNF-------  248 (438)
Q Consensus       177 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~-------  248 (438)
                      .+...+|+|||++ +++|.+++.....    +++..+..++.||+.||+|||+ .||+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGP----FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence            6666899999998 7899999876543    8999999999999999999998 5999999999999998765       


Q ss_pred             ---------eEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc
Q 013686          249 ---------RVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH  319 (438)
Q Consensus       249 ---------~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~  319 (438)
                               .+||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                     499999998864322    2234568999999999999999999999999999999999999997644321


Q ss_pred             ccchhHHHHH----HHhc----Ccccccc------cCcCC--------CCccHHHHHHHHHHHHHHHHhhccCCCCCCCH
Q 013686          320 DINLSNMATN----KIQN----GALNELV------DPSLG--------FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM  377 (438)
Q Consensus       320 ~~~~~~~~~~----~~~~----~~~~~~~------~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  377 (438)
                      ..........    .+..    ....+++      .+...        .............+.+||.+||+.||++|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            1111000000    0000    0000000      00000        00000000123457899999999999999999


Q ss_pred             HHHHHHHH
Q 013686          378 KEVLEILR  385 (438)
Q Consensus       378 ~evl~~L~  385 (438)
                      +|++++-.
T Consensus       433 ~e~L~Hp~  440 (467)
T PTZ00284        433 RQMTTHPY  440 (467)
T ss_pred             HHHhcCcc
Confidence            99998643

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=358.54  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  179 (438)
                      ..++|.+.+.||+|+||+||++... +|+.||||.+...  .......+.+|+.++..++|+||+++.+.+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3568999999999999999999865 6899999998654  2344567889999999999999999887543221     


Q ss_pred             --ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          180 --RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       180 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                        ..+++||||+++|+|.+++.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence              136899999999999999987654445689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc-cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          258 SRLFPTDV-THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       258 a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      ++.+.... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......      .. ...+..+..
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~-~~~~~~~~~  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EV-MHKTLAGRY  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHhcCCC
Confidence            98654322 12223456999999999999999999999999999999999999999753221      11 112222111


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..            .+..++..+.+++.+||+.||.+||++.+++++
T Consensus       263 ~~------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 DP------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CC------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11            012345678999999999999999999999875

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-43  Score=330.89  Aligned_cols=263  Identities=30%  Similarity=0.450  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-----CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~  183 (438)
                      .+|++.+.||+|+||.||++..+     +++.||+|.+........+.+.+|++++++++||||+++++++.. +...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     478999999877666667789999999999999999999996543 334689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++++|.+++.....   .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999976432   289999999999999999999999999999999999999999999999999987644


Q ss_pred             Cccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccc---------cchhHHHHHHHh
Q 013686          264 DVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD---------INLSNMATNKIQ  332 (438)
Q Consensus       264 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~---------~~~~~~~~~~~~  332 (438)
                      ....  ......++..|+|||.+.+..++.++|||||||++|||++|..++........         ..........+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3221  11122244569999999988999999999999999999998776543221100         000000000111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ...       ...     ....++..+.+++.+||..+|++|||+.|+++.|+.+
T Consensus       241 ~~~-------~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNG-------RLP-----APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCC-------cCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            100       000     0123456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.3e-43  Score=332.26  Aligned_cols=267  Identities=22%  Similarity=0.322  Sum_probs=198.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++... ...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEE
Confidence            467999999999999999999976 689999999865432 2234577899999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||++ ++|.+++.....   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          83 EYVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             ECCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            9994 688888876432   38889999999999999999999999999999999999999999999999987543221 


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Ccc------
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GAL------  336 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------  336 (438)
                      .......+++.|+|||.+.+ ..++.++|||||||++|||++|..||.........  ..........   ..+      
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhhc
Confidence            22234468999999999865 45888999999999999999999999754321100  0000000000   000      


Q ss_pred             cccccCcCC--CCc--cHHH--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLG--FEK--DYAV--RNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~--~~~--~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .........  ...  ....  ...+..+.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000000000  000  0000  1134568899999999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=322.73  Aligned_cols=255  Identities=27%  Similarity=0.477  Sum_probs=205.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++... +..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeeeec
Confidence            456888999999999999999987788999999865432 346788999999999999999999976655 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          83 MKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             ccCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            999999999976542  238999999999999999999999999999999999999999999999999998765332222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+..|+|||.+.+..++.++||||||+++|||++ |+.||......       .....+.... .      ... 
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~-~------~~~-  225 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGY-R------MPC-  225 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC-C------CCC-
Confidence            222233468999999998899999999999999999999 99999753211       1111221111 0      000 


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                          ...++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       226 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 ----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                01345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-43  Score=340.81  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=196.2

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.||+|+||.||++... +|+.||+|.+....   ......+.+|+++++.++||||+++++++... +..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-DRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CEEEEEEeCCCC
Confidence            46999999999999975 68999999987542   23456788899999999999999999876655 479999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccC
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA  271 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  271 (438)
                      |+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus        80 g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  154 (328)
T cd05593          80 GELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT  154 (328)
T ss_pred             CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence            999999876543    89999999999999999999999999999999999999999999999999875432211 1233


Q ss_pred             CCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHH
Q 013686          272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA  351 (438)
Q Consensus       272 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (438)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+..      .+       
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~------~~-------  214 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEDI------KF-------  214 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCCc------cC-------
Confidence            468999999999998899999999999999999999999997532211       1111111110      01       


Q ss_pred             HHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          352 VRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       352 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      +..++..+.+++.+||+.||++||     ++.|++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            123456788999999999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-43  Score=342.19  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=201.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC--CcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD--GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|..++  +..||+|.+....   ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEE
Confidence            4578889999999999999998653  3689999986542   23356788999999999999999999977655 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....    +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999987653    89999999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ..    ....||+.|+|||.+.+..++.++|||||||++|||++|..||......       .....+..+...  ..  
T Consensus       184 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~--~p--  248 (340)
T PTZ00426        184 RT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGIIY--FP--  248 (340)
T ss_pred             Cc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCC--CC--
Confidence            21    2346899999999999888999999999999999999999999754321       112222222110  00  


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                               ...+..+.+++.+||+.||++|+     ++++++++
T Consensus       249 ---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        249 ---------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                     12345678999999999999995     89998876

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-42  Score=322.98  Aligned_cols=261  Identities=26%  Similarity=0.431  Sum_probs=208.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||+|... +++.||||.+...   .......+.+|+++++.++||||+++++++... +..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-NELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-CeEEEE
Confidence            47889999999999999999965 6899999987542   234456788999999999999999999977655 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.........+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            99999999999987544333458899999999999999999999999999999999999999999999999998764432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .. .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||......    .... ...+......     .. 
T Consensus       161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~-~~~~~~~~~~-----~~-  228 (267)
T cd08228         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSL-CQKIEQCDYP-----PL-  228 (267)
T ss_pred             HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHH-HHHHhcCCCC-----CC-
Confidence            21 22345888999999998888999999999999999999999998643211    1111 1112111111     11 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                           ....++..+.+++.+||..+|++||++.++++.++.++
T Consensus       229 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 -----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 11245667899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.1e-42  Score=327.38  Aligned_cols=262  Identities=30%  Similarity=0.483  Sum_probs=209.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++... ..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-Ccc
Confidence            357888999999999999999852      2456899988766555667899999999999999999999977655 478


Q ss_pred             EEEEeccCCCCHHHHhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEe
Q 013686          183 LLVYEYIPNGTVADHLHNRQP---------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVA  253 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~  253 (438)
                      ++||||+++++|.+++.....         ....+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence            999999999999999976532         12248999999999999999999999999999999999999999999999


Q ss_pred             eeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHH
Q 013686          254 DFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       254 Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      |||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~i  235 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECI  235 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence            9999986533221 11223345778999999998899999999999999999998 899986543211       11222


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      ..+.....            ...++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       236 ~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         236 TQGRVLQR------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HcCCcCCC------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            22221110            012445789999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-43  Score=322.24  Aligned_cols=273  Identities=22%  Similarity=0.318  Sum_probs=205.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCC-ceeEeeeeeccCc----
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPN-LVKLYGCTSRQSR----  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~----  180 (438)
                      ...|...++||+|.||+||+|+.+ +|+.||+|++.-....  .-....+|+.+++.|+|+| |+.+++++.....    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            344666778999999999999965 6899999998654331  2245678999999999999 9999997766543    


Q ss_pred             -eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          181 -ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       181 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                       .+++|+||+ .-+|..++.........++...+..+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             789999999 569999999876432347778899999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      .+.-+.. ..+..++|..|+|||++.+. .|+...||||+|||++||+++++.|.+..........-.....-.+..++.
T Consensus       169 a~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  169 AFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            6643322 24556799999999999876 799999999999999999999999987654221110000000000111111


Q ss_pred             cc---cCcCCCCccH----H---HHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          339 LV---DPSLGFEKDY----A---VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       339 ~~---~~~~~~~~~~----~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..   +-...+....    .   .+.......+++.+||+.+|.+|.|++.++.+
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11   1110111110    1   11222478899999999999999999999986

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-42  Score=341.71  Aligned_cols=264  Identities=27%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCC-CCCceeEeeeeec
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSR  177 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  177 (438)
                      ....++|.+.+.||+|+||.||+|...      .+..||||++.... ....+.+.+|+++++++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            334678999999999999999999853      13479999986543 334567999999999996 9999999997765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCC-----------------------------------------------------
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPN-----------------------------------------------------  204 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------  204 (438)
                      . ...|+|||||++|+|.+++......                                                     
T Consensus       113 ~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         113 S-GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             C-CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            5 4799999999999999998753210                                                     


Q ss_pred             ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec
Q 013686          205 ---------------------------------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD  245 (438)
Q Consensus       205 ---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~  245 (438)
                                                             ...+++..+..++.||+.||+|||+.+|+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                   12377888899999999999999999999999999999999


Q ss_pred             CCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccch
Q 013686          246 NNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINL  323 (438)
Q Consensus       246 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~  323 (438)
                      .++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......    
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----  347 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----  347 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence            9999999999999865432221 1222346788999999998899999999999999999997 888886432111    


Q ss_pred             hHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          324 SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                        .....+..+...     .       ....++..+.+++.+||+.||++||++.+|.++|+++.
T Consensus       348 --~~~~~~~~~~~~-----~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 --TFYNKIKSGYRM-----A-------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --HHHHHHhcCCCC-----C-------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              111122221100     0       01235667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.8e-43  Score=327.55  Aligned_cols=252  Identities=29%  Similarity=0.493  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      ++|++.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++... ...++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-RPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CCcEEEEEcC
Confidence            45778899999999999999887777899998875433 346789999999999999999999977655 4689999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      .+|+|.+++.....   .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            99999999976433   389999999999999999999999999999999999999999999999999886544332222


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||......      .. ...+..+....  .+      
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~-~~~~~~~~~~~--~~------  223 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ET-VEKVSQGLRLY--RP------  223 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HH-HHHHhcCCCCC--CC------
Confidence            22345678999999988889999999999999999998 99998643321      11 11222211110  00      


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                          ...+..+.+++.+||+.||.+||++.++++.|+
T Consensus       224 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 ----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                123467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.3e-42  Score=333.70  Aligned_cols=264  Identities=22%  Similarity=0.363  Sum_probs=202.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++... +..++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEE
Confidence            468999999999999999999976 5888999987654 233446789999999999999999999987665 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+++++|.+++.....    +++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          83 EHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             ecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            99999999999976543    88999999999999999999975 79999999999999999999999999987653321


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc------
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL------  339 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  339 (438)
                         .....++..|+|||.+.+..++.++|||||||++|||++|+.||.........   ...... ..+.....      
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~  231 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE---LMFGCP-VEGDPAESETSPRP  231 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH---HHhcCc-ccCCccccccCccc
Confidence               22346899999999999889999999999999999999999999753321100   000000 00000000      


Q ss_pred             ---------ccCcC--------------CCCccH-HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          340 ---------VDPSL--------------GFEKDY-AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       340 ---------~~~~~--------------~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                               ..+..              ...... ....++.++.+|+.+||+.||++|||+.|++.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                     00000              000000 0011346789999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-43  Score=327.66  Aligned_cols=249  Identities=37%  Similarity=0.601  Sum_probs=193.6

Q ss_pred             CCCcccccCceEEEEEEEc-----CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          114 SSKQLGDGGFGAVYLGILR-----DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.. .....+.+.+|++.+++++||||++++|++... ...++|||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-EPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-SSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-cccccccc
Confidence            3578999999999999976     2578999999654 334478899999999999999999999988744 46899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC-cc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD-VT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~-~~  266 (438)
                      |+++|+|.++|......  .+++..+..|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++...... ..
T Consensus        82 ~~~~g~L~~~L~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKE--PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTT--TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999987222  3899999999999999999999999999999999999999999999999999876322 22


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      ...........|+|||.+.+..++.++||||||+++|||++ |+.||.....      ... ...+..+.....      
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~-~~~~~~~~~~~~------  226 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEI-IEKLKQGQRLPI------  226 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHH-HHHHHTTEETTS------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccc-ccccccccccee------
Confidence            22233457789999999998889999999999999999999 6788764321      111 122222222111      


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                            ...++..+.+++.+||+.||++|||+.++++.|
T Consensus       227 ------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 ------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  013456788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-42  Score=327.61  Aligned_cols=257  Identities=31%  Similarity=0.495  Sum_probs=205.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||.||+|...+      ++.||+|.+...... ..+.+.+|+++++.++|+||+++++++... ..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CC
Confidence            3468888999999999999998643      478999998765433 457899999999999999999999977665 57


Q ss_pred             EEEEEeccCCCCHHHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          182 LLLVYEYIPNGTVADHLHNRQP----------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                      .++||||+++++|.+++.....          ....+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence            9999999999999999986532          123478899999999999999999999999999999999999999999


Q ss_pred             EeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHH
Q 013686          252 VADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATN  329 (438)
Q Consensus       252 l~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~  329 (438)
                      |+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......       ...
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~~  235 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VIE  235 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence            999999975433221 11223345788999999999999999999999999999998 999986433211       111


Q ss_pred             HHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .+..+.....            +..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       236 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 CITQGRLLQR------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHcCCcCCC------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            2222221111            1134567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.7e-42  Score=330.09  Aligned_cols=257  Identities=24%  Similarity=0.416  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCc----EEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGR----IVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .+|++.+.||+|+||.||+|.+. +|+    .||+|.+.... ....+.+.+|+.+++.++||||++++|++...  ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence            56889999999999999999864 343    38999886543 34457889999999999999999999977654  468


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +++||+++|+|.+++.....   .+++...+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            99999999999999987543   388999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccccc-cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVTHVS-TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......      . ....+..+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~----  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKGERL----  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCCCCC----
Confidence            332211 22234678999999999999999999999999999998 99998753211      1 11111111100    


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                         +..     ..++..+.+++.+||..||.+||++.+++..+..+...
T Consensus       231 ---~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         231 ---PQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ---CCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence               000     12345688999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-42  Score=327.98  Aligned_cols=267  Identities=30%  Similarity=0.490  Sum_probs=202.3

Q ss_pred             CCCCcccccCceEEEEEEE-----cCCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEEEE
Q 013686          113 NSSKQLGDGGFGAVYLGIL-----RDGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELLLV  185 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv  185 (438)
                      +..+.||+|+||+||++..     .+++.||+|.+..... ...+.+.+|++++++++||||+++++++... ....++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7889999999999988753     2578899999875432 3456788999999999999999999976543 3468999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++....     +++..++.++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++......
T Consensus        87 ~e~~~~~~l~~~~~~~~-----l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            99999999999997642     8999999999999999999999999999999999999999999999999998764432


Q ss_pred             cc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          266 TH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       266 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ..  ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ................+..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcC
Confidence            21  11223456779999999888899999999999999999999999864332100 0000000000000001111111


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      ....   ....++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus       241 ~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 MRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1000   01235678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-43  Score=334.79  Aligned_cols=240  Identities=27%  Similarity=0.377  Sum_probs=193.6

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ||+|+||.||++... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++... ...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCc
Confidence            799999999999976 58899999986532   23456788899999999999999999877654 57999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ  273 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  273 (438)
                      |.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......
T Consensus        80 L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  154 (312)
T cd05585          80 LFHHLQREGR----FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC  154 (312)
T ss_pred             HHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence            9999976543    8999999999999999999999999999999999999999999999999998543222 1223456


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .... ..+..+..      .+       +.
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~-~~~~~~~~------~~-------~~  214 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMY-RKILQEPL------RF-------PD  214 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHH-HHHHcCCC------CC-------CC
Confidence            89999999999999999999999999999999999999975321      1111 11211111      00       12


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRPT---MKEVLEI  383 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  383 (438)
                      .++..+.+++.+||+.||.+||+   +.|++.+
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            34567889999999999999975   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-43  Score=325.19  Aligned_cols=251  Identities=31%  Similarity=0.517  Sum_probs=201.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .+|++.+.||+|+||.||++..+++..+|+|.+..... ..+.+.+|++++++++||||+++++++... ...++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecC
Confidence            35778899999999999999987778899998765432 235688899999999999999999976555 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++.....   .+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999999976543   389999999999999999999999999999999999999999999999999986543322222


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..||.......       ....+..+.     ....    
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~----  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGY-----RLYR----  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCC-----cCCC----
Confidence            22234568999999998899999999999999999999 789987533211       111121111     0000    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         +..++..+.+++.+||..+|++|||+.|+++.|
T Consensus       223 ---~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 ---PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               012466789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.7e-43  Score=329.41  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=196.3

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ||+|+||+||++..+ +|+.||+|.+.....   ...+.+..|+++++.++|+||+++.+++... ...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-CeEEEEEeCCCCCC
Confidence            799999999999976 689999999865432   2335678899999999999999999866555 47999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ  273 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  273 (438)
                      |.+++.........+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++......... .....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~  158 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYA  158 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccccC
Confidence            99888654333345899999999999999999999999999999999999999999999999999865433221 23346


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      |++.|+|||.+.+..++.++|||||||++|||++|+.||.........   ......+..        ....     .+.
T Consensus       159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~--------~~~~-----~~~  222 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILN--------DSVT-----YPD  222 (280)
T ss_pred             CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcc--------cCCC-----Ccc
Confidence            899999999999999999999999999999999999999754321110   000111111        0000     112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      .++..+.+++.+||+.||++||     ++++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            3567789999999999999999     77888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.4e-43  Score=337.93  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +|+.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++... ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEE
Confidence            36888999999999999999976 689999999875432   2345688999999999999999999877654 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....   .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999999987532   38999999999999999999999999999999999999999999999999998765443


Q ss_pred             cccccCCCCCCCccCccccc------cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC-cccc
Q 013686          266 THVSTAPQGTPGYVDPDYFQ------CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG-ALNE  338 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  338 (438)
                      ........||+.|+|||.+.      ...++.++|||||||++|||++|+.||.......      . ...+... ....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~-~~~i~~~~~~~~  229 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------T-YNNIMNFQRFLK  229 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------H-HHHHHcCCCccC
Confidence            33333456899999999986      4567889999999999999999999997543211      1 1111111 1000


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .       +.   ...++..+.+|+..||+ +|.+|||+.+++.+
T Consensus       230 ~-------~~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 F-------PE---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             C-------CC---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0       00   01245678899999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.2e-42  Score=320.30  Aligned_cols=254  Identities=30%  Similarity=0.527  Sum_probs=204.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++..  ...+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEe
Confidence            457889999999999999999988888899998875433 23678999999999999999999997643  357999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||++..........
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          82 MSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            999999999976432  238999999999999999999999999999999999999999999999999998764433222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||......      . ....+..+...     ..   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~-----~~---  224 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------E-VLEQVERGYRM-----PC---  224 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC-----CC---
Confidence            222335678999999988889999999999999999999 88998643211      1 11112111100     00   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                          ....+..+.+++.+||..+|++|||+.++.+.|++
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 ----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                12345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.6e-43  Score=336.61  Aligned_cols=249  Identities=23%  Similarity=0.383  Sum_probs=196.6

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++... +++.||+|.+....   ....+.+.+|..++..+ +||||+++++++... ..+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCC
Confidence            46999999999999976 58899999997542   23345688899999998 699999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 ~g~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (329)
T cd05588          80 GGDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS  154 (329)
T ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence            9999999876543    8999999999999999999999999999999999999999999999999987432211 1123


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc--ccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH--DINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||+......  ......+....+......      +    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~----  224 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I----  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C----
Confidence            3468999999999999999999999999999999999999997433221  111112222222222111      1    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPT------MKEVLEI  383 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  383 (438)
                         +..++..+.+++.+||+.||.+||+      +++++++
T Consensus       225 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         225 ---PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence               0124556889999999999999997      6777754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-42  Score=324.76  Aligned_cols=255  Identities=28%  Similarity=0.484  Sum_probs=204.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+++++.++||||+++++++..  ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEc
Confidence            356889999999999999999987767899999875433 23578899999999999999999986643  357999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++|+|.+++.....  ..+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||+++.........
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999999976432  237899999999999999999999999999999999999999999999999998665433222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||...+..++.++||||||+++|||++ |..||......       .....+..+..     ...   
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~-----~~~---  224 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYR-----MPC---  224 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCCC-----CCC---
Confidence            223346778999999988899999999999999999999 88888643221       11111211110     000   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          ...++..+.+++.+||+.||++||++.++++.|+..
T Consensus       225 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         225 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                123566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=341.71  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=203.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|++++..++||||+++++++... ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-EHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-CeEEEE
Confidence            46888999999999999999976 689999999875432   3346788999999999999999999876554 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDV----FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EcCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999987632    8999999999999999999999999999999999999999999999999998654432


Q ss_pred             ----------------------------cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCc
Q 013686          266 ----------------------------THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH  317 (438)
Q Consensus       266 ----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~  317 (438)
                                                  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122334689999999999999999999999999999999999999975432


Q ss_pred             ccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHH
Q 013686          318 RHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-MKEVLEIL  384 (438)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L  384 (438)
                      .       .....+.... ...   .++..     ..++..+.+++.+||. ||.+||+ +++++++.
T Consensus       236 ~-------~~~~~i~~~~-~~~---~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         236 Q-------ETYNKIINWK-ESL---RFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             H-------HHHHHHhccC-Ccc---cCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            1       1111111100 000   00000     1146678899999997 9999999 99999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-42  Score=322.27  Aligned_cols=254  Identities=27%  Similarity=0.491  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+||+++++++..  ...+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEEEc
Confidence            467889999999999999999988899999999875443 34678899999999999999999986533  368999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          82 MENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence            999999999876443  238899999999999999999999999999999999999999999999999998765332222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......      . ...+..+....     .   
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~~~~-----~---  224 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------V-IQNLERGYRMP-----R---  224 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------H-HHHHHcCCCCC-----C---
Confidence            223346778999999988889999999999999999999 999997533211      1 11111111000     0   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                          ....+.++.+++.+||+.+|++||++++++..|+.
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                11245678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-42  Score=324.45  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++..+ ...++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEe
Confidence            457899999999999999999964 6889999998755444556788999999999999999999977655 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....    +++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          87 YCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            9999999999976543    88999999999999999999999999999999999999999999999999986543221 


Q ss_pred             cccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          268 VSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ......+++.|+|||.+.   ...++.++|||||||++|||++|..||.........       ..+.....   ..+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~---~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSNF---QPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCCC---CCCCC
Confidence            122345888999999884   345788999999999999999999998543221110       00000000   00111


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .     ....++..+.+++.+||+.+|++|||++++++++
T Consensus       232 ~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K-----DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c-----cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0     0123456789999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3e-42  Score=326.79  Aligned_cols=260  Identities=30%  Similarity=0.481  Sum_probs=209.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|++++++++|+||+++++++... ...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-DPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-CceE
Confidence            45778899999999999999843      3457899988776666667899999999999999999999977654 4789


Q ss_pred             EEEeccCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          184 LVYEYIPNGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                      +||||+++++|.+++.....            ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            99999999999999976432            112388999999999999999999999999999999999999999999


Q ss_pred             EeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHH
Q 013686          252 VADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATN  329 (438)
Q Consensus       252 l~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~  329 (438)
                      |+|||++........ .......++..|+|||.+.+..++.++|||||||++|||+| |+.||.......       ...
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~  236 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIE  236 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence            999999976543221 12223446788999999998899999999999999999999 999986543211       112


Q ss_pred             HHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      .+..+.....            ...++..+.+++.+||+.||++||++.++++.|+++..
T Consensus       237 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 CITQGRVLER------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHhCCCCCCC------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            2222222111            01245678899999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.2e-43  Score=345.20  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=197.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .|++++.||+|+||+||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++... ..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEE
Confidence            5788999999999999999865 58899999986543   23456788999999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++|+|.+++.....    +++..+..++.||+.||+|||+.||+||||||+|||++.++++||+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          81 DYIPGGDMMSLLIRMEV----FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             ecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999999999986543    88999999999999999999999999999999999999999999999999764311000


Q ss_pred             ----------------------------------------------ccccCCCCCCCccCccccccCCCCChhhHHHHHH
Q 013686          267 ----------------------------------------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGV  300 (438)
Q Consensus       267 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv  300 (438)
                                                                    .......||+.|+|||.+.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0012246999999999999889999999999999


Q ss_pred             HHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHH--hhccCCCCCCCHH
Q 013686          301 VLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFR--CVQQDRDMRPTMK  378 (438)
Q Consensus       301 ~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~  378 (438)
                      ++|||++|..||.......      .....+....... ..+         ...++.++.+++.+  |+..+|..||++.
T Consensus       237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~-~~~---------~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTE------TQLKVINWENTLH-IPP---------QVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHH------HHHHHHccccccC-CCC---------CCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            9999999999997543211      0111111000000 000         01245678889988  4556666799999


Q ss_pred             HHHHHH
Q 013686          379 EVLEIL  384 (438)
Q Consensus       379 evl~~L  384 (438)
                      |++.+-
T Consensus       301 ~~l~hp  306 (381)
T cd05626         301 DIKAHP  306 (381)
T ss_pred             HHhcCc
Confidence            999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.6e-43  Score=341.28  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=202.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ..++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-KYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CEEE
Confidence            3567999999999999999999976 58899999986532   22335578899999999999999999876554 5799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++....     +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       120 lv~Ey~~gg~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999999987542     78888899999999999999999999999999999999999999999999986644


Q ss_pred             CccccccCCCCCCCccCccccccC----CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCY----KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ..........||+.|+|||.+.+.    .++.++|||||||++|||++|+.||......      . ....+......  
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~~--  265 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHKNS--  265 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCCc--
Confidence            332223345699999999998653    4788999999999999999999999754321      1 11122111100  


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM--RPTMKEVLEIL  384 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  384 (438)
                          +..+.   ...++..+.+++.+||+.+|.+  ||++.|++++-
T Consensus       266 ----~~~~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         266 ----LTFPD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             ----CCCCC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence                00010   0134667889999999999988  99999998864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-43  Score=341.35  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +|+.||||++....   ....+.+.+|++++..++||||+++++++... ..+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-NYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CeEEEE
Confidence            46889999999999999999976 58999999987542   23345678899999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        80 ~E~~~~g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDT----FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             ECCCCCcHHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999999999986543    8999999999999999999999999999999999999999999999999987543211


Q ss_pred             cc-------------------------------------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhC
Q 013686          266 TH-------------------------------------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG  308 (438)
Q Consensus       266 ~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG  308 (438)
                      ..                                     ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01123589999999999998999999999999999999999


Q ss_pred             CCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 013686          309 LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT---MKEVLEI  383 (438)
Q Consensus       309 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  383 (438)
                      ..||.......      . ...+....      ..+..+..   ..++..+.+++.+|+. +|.+|++   +.|++.+
T Consensus       236 ~~Pf~~~~~~~------~-~~~i~~~~------~~~~~~~~---~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         236 YPPFCSDNPQE------T-YRKIINWK------ETLQFPDE---VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCHHH------H-HHHHHcCC------CccCCCCC---CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99997543211      1 11111110      00001100   1245678899999996 9999998   9999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-42  Score=334.28  Aligned_cols=242  Identities=28%  Similarity=0.379  Sum_probs=195.1

Q ss_pred             CcccccCceEEEEEEEc----CCcEEEEEEeeccc----hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          116 KQLGDGGFGAVYLGILR----DGRIVAVKRLYENN----FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +.||+|+||.||++...    +++.||+|.+....    ......+.+|+.+++.++||||+++++++..+ +..|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-CeEEEEEe
Confidence            67999999999999853    57899999987542    22335678899999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          81 YLSGGELFMHLEREGI----FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCCchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            9999999999976543    78888899999999999999999999999999999999999999999999875432221 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+..+...      +   
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~~~~------~---  219 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKGKLN------L---  219 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC------C---
Confidence            223346899999999999888999999999999999999999999754321       111122221110      0   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                          +..++..+.+++.+||+.||++||     ++.+++++
T Consensus       220 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         220 ----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                012355788999999999999999     88998875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-42  Score=319.77  Aligned_cols=255  Identities=27%  Similarity=0.474  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|++.+.||+|+||.||+|.+..    ...||+|.+.... ....+.+.+|+.++++++||||+++++++... +..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceEE
Confidence            568899999999999999999752    4579999886543 33456788999999999999999999976554 47899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....   .+++..+..++.|++.||.|||+++|+||||||+|||+++++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999976543   3899999999999999999999999999999999999999999999999999876422


Q ss_pred             cc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          265 VT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       265 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .. .......++..|+|||.+.+..++.++||||||+++|||++ |..||......      . ....+..+...    +
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~----~  228 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------D-VIKAVEDGYRL----P  228 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------H-HHHHHHcCCCC----C
Confidence            11 11222345678999999998899999999999999999998 99998643211      1 11222211110    0


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      .        ...++..+.+++.+||+.+|++||++.|++++|+++
T Consensus       229 ~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 P--------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0        113456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-42  Score=341.39  Aligned_cols=269  Identities=22%  Similarity=0.320  Sum_probs=200.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----RELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  183 (438)
                      +|++.+.||+|+||.||++... +|+.||+|++...  .....+.+.+|+++++.++|+||+++++++....    ...|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778999999999999999965 6899999988643  2334567889999999999999999999775543    2689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+. ++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQP----LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999995 688888865433    89999999999999999999999999999999999999999999999999986544


Q ss_pred             CccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH----------HHH--HH
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN----------MAT--NK  330 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~----------~~~--~~  330 (438)
                      ..........+++.|+|||.+.+. .++.++|||||||++|||++|+.||.............          +..  ..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            333333344678999999998774 57899999999999999999999997654321110000          000  00


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ...........+.............+..+.+|+.+||+.||++|||+.|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence            000000000000000000000112356788999999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-44  Score=326.69  Aligned_cols=279  Identities=24%  Similarity=0.351  Sum_probs=204.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc----eEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR----ELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~lv  185 (438)
                      .|...+++|.|+||.||+|... +++.||||+...+..    .-.+|+++|+.+.|||||++.-++....+    ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4566789999999999999976 579999998865432    12359999999999999999886644322    34589


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+. +|.++++........++.-.+.-+.+||.+||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+...
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            999965 9999998643333447888888899999999999999999999999999999966 99999999999987655


Q ss_pred             ccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHH-----HHHhcCcc--
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT-----NKIQNGAL--  336 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~--  336 (438)
                      ....+  ...|..|+|||.+.| ..|+.+.||||.||++.||+-|++-|.+....+......-..     ..+..-..  
T Consensus       180 epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  180 EPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             CCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            44422  246889999998876 479999999999999999999999998765433221110000     11111000  


Q ss_pred             cccccCcCCCCc--cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhccCCCCCc
Q 013686          337 NELVDPSLGFEK--DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI--LRETKDSNLGTSK  396 (438)
Q Consensus       337 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~  396 (438)
                      .+..-+.+....  .......+++..+|+.++|..+|.+|.++.|++.+  ...+++.+...+.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~  321 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPN  321 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcC
Confidence            011111111110  01234567789999999999999999999999974  5555555443333

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.6e-42  Score=322.99  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|++.+.||+|+||.||+|...+     +..|++|.+... .....+.+.+|+.++++++|+||+++++++...+...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            5678889999999999999999765     688999988654 3445677889999999999999999999777666678


Q ss_pred             EEEEeccCCCCHHHHhhccCCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNS----CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      ++++||+++++|.+++.......    ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~  164 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS  164 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence            99999999999999997653321    35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          259 RLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       259 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      +.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......      .+ ...+..+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~  237 (280)
T cd05043         165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EM-AAYLKDGYR  237 (280)
T ss_pred             ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HH-HHHHHcCCC
Confidence            865332221 2223346778999999988889999999999999999999 99999753221      11 111111110


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                           ...       ...++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       238 -----~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         238 -----LAQ-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -----CCC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                 000       11245678999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-42  Score=324.11  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=202.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.... .....++.+|+.+++.++||||+++++++... .
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-Q   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence            4577999999999999999999753      25679999886432 33456788999999999999999999977554 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                      ..++||||+++++|.+++......      ...+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            789999999999999999764321      12367888999999999999999999999999999999999999999999


Q ss_pred             eCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHh
Q 013686          255 FGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       255 fgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      ||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......      .. ...+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~-~~~~~  235 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QV-LRFVM  235 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHH
Confidence            9998755332221 1122345778999999998899999999999999999999 68888643321      11 11111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .+.....            ...++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       236 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 EGGLLDK------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCcCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            2111111            0124557899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-41  Score=317.77  Aligned_cols=261  Identities=28%  Similarity=0.486  Sum_probs=210.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++... +..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEE
Confidence            57889999999999999999977 7899999988532   223356789999999999999999999977665 578999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.........+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            99999999999997654444458999999999999999999999999999999999999999999999999988654332


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.....    ..... ...+..+....     . 
T Consensus       161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~~-----~-  228 (267)
T cd08224         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCDYPP-----L-  228 (267)
T ss_pred             cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCCCCC-----C-
Confidence            11 2234578899999999988899999999999999999999999864321    11111 11111111111     0 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                           ....++..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       229 -----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 -----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 01245667899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-42  Score=338.50  Aligned_cols=268  Identities=24%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  179 (438)
                      ..++|++.+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999975 5899999998643  2334567889999999999999999999765432     


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...|+||||++ ++|.+.+...      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhcc------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            35799999995 4677766432      7888899999999999999999999999999999999999999999999997


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccc------------hhHHH
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN------------LSNMA  327 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~------------~~~~~  327 (438)
                      ......  ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||..........            .....
T Consensus       172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            543321  1233468999999999999999999999999999999999999997543211100            00000


Q ss_pred             ----HHHHhc-Ccc-----cccccCcCCCC-ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          328 ----TNKIQN-GAL-----NELVDPSLGFE-KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       328 ----~~~~~~-~~~-----~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                          ...... ...     .+.... .... ........+..+.+|+.+||+.||++|||+.|++++-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPD-WIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccc-cccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence                000000 000     000000 0000 00011123567899999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-42  Score=334.08  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=195.2

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.++.++ +||||+++++++... ...++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCC
Confidence            46999999999999976 5889999998754   223445678899998877 799999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|..++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus        80 ~~~L~~~~~~~~~----l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (329)
T cd05618          80 GGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS  154 (329)
T ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence            9999998876543    89999999999999999999999999999999999999999999999999875322211 123


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccc--cchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD--INLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||........  .....+....+......      +    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~----  224 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------I----  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC------C----
Confidence            34689999999999999999999999999999999999999964322111  11112222222221110      1    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPT------MKEVLEI  383 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  383 (438)
                         +..++..+.+++.+||+.||++||+      +.+++++
T Consensus       225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         225 ---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               1124556889999999999999998      4677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5e-42  Score=332.85  Aligned_cols=263  Identities=27%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------cCCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL------RDGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||+|..      .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999974      247899999987543 33456788999999999 68999999997766666


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC--------------------------------------------------------
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN--------------------------------------------------------  204 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  204 (438)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            789999999999999999753210                                                        


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc-cccCCCCCC
Q 013686          205 -------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP  276 (438)
Q Consensus       205 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~  276 (438)
                             ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......++.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence                   123678888999999999999999999999999999999999999999999999865332221 112233567


Q ss_pred             CccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHH
Q 013686          277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM  355 (438)
Q Consensus       277 ~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (438)
                      .|+|||.+.+..++.++||||||+++|||++ |..||.......      .....+..+.....  +          ...
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~--~----------~~~  307 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA--P----------DYT  307 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC--C----------CCC
Confidence            8999999988899999999999999999997 888986432211      11112222211110  0          113


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       356 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      +..+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            4568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=326.14  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      +|++.+.||+|+||.||++... +++.||+|.+......   ....+.+|+.+++.++||||+++++++... +.+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEE
Confidence            3778899999999999999965 6899999998654322   234577899999999999999999977555 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||++........
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             eccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999998875432  2389999999999999999999999999999999999999999999999999986543222


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                        .....|++.|+|||.+.+..++.++|||||||++|||++|..||.........   ......+....      ..   
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~------~~---  223 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ------EE---  223 (285)
T ss_pred             --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc------cc---
Confidence              22346899999999999889999999999999999999999999754321110   11111111110      00   


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                          .+..++..+.+|+.+||..||.+||     ++++++++
T Consensus       224 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         224 ----YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ----cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                1123566788999999999999999     88888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.7e-42  Score=321.64  Aligned_cols=253  Identities=30%  Similarity=0.496  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      ++|.+.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++..  ...+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEcC
Confidence            45788899999999999999987777899998765432 23678899999999999999999997643  3578999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++.....  ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++...........
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          83 GKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            99999999976432  2378999999999999999999999999999999999999999999999999986643322222


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..||.......       ....+..+...     ..    
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~-----~~----  224 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYRM-----PC----  224 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC-----CC----
Confidence            23346678999999988899999999999999999999 889987532211       11112111100     00    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                         +...+..+.+++.+||+.||++||+++++++.|++
T Consensus       225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 ---PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               12345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.6e-43  Score=335.61  Aligned_cols=245  Identities=26%  Similarity=0.423  Sum_probs=194.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHH---HhCCCCCceeEeeeeeccCceEEE
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEIL---TKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      |++.+.||+|+||.||+|... +|+.||||.+....   ....+.+.+|++++   +.++||||+++++++... +..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-DHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-CEEEE
Confidence            567889999999999999976 58999999987542   22345677776665   456799999999977655 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|..++...     .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus        80 v~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          80 VMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999999888653     2899999999999999999999999999999999999999999999999998753222


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      . .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+...      .
T Consensus       155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~~------~  220 (324)
T cd05589         155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEVR------Y  220 (324)
T ss_pred             C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC------C
Confidence            1 12234568999999999999999999999999999999999999997543211       11112211110      0


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                             +..++..+.+++.+||+.||.+||     ++.+++++
T Consensus       221 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         221 -------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                   112456788999999999999999     57777764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.8e-43  Score=305.88  Aligned_cols=256  Identities=26%  Similarity=0.414  Sum_probs=211.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-------ch-HhHHHHHHHHHHHHhC-CCCCceeEeeeee
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-------NF-KRIEQFMNEVEILTKL-QHPNLVKLYGCTS  176 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  176 (438)
                      ...++|...+.||+|..++|-++..+ +|..+|+|++...       .. .-.+.-.+|+.+|+++ .||+|+.+.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34567888899999999999999876 6889999988432       11 1235567899999998 6999999999776


Q ss_pred             ccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeC
Q 013686          177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG  256 (438)
Q Consensus       177 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  256 (438)
                      .. ..+++|+|.|+.|.|+|+|...-.    ++++...+|++|+.+|+.|||.++||||||||+|||++++.++||+|||
T Consensus        94 s~-sF~FlVFdl~prGELFDyLts~Vt----lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SD-AFVFLVFDLMPRGELFDYLTSKVT----LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             Cc-chhhhhhhhcccchHHHHhhhhee----ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence            55 478999999999999999987654    9999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCCCccCcccccc------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHH
Q 013686          257 LSRLFPTDVTHVSTAPQGTPGYVDPDYFQC------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       257 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      ++..+.....  ....+|||+|+|||.+..      ..|+...|+|+.||++|.|+.|.+||....       .......
T Consensus       169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~  239 (411)
T KOG0599|consen  169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRM  239 (411)
T ss_pred             eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHH
Confidence            9998765433  345689999999999854      357889999999999999999999997421       1223344


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +.+|...        + ....|.+.+...++||.+||+.||.+|.|++|+|.+-.
T Consensus       240 ImeGkyq--------F-~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf  285 (411)
T KOG0599|consen  240 IMEGKYQ--------F-RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF  285 (411)
T ss_pred             HHhcccc--------c-CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence            4444432        1 12346788899999999999999999999999998643

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-41  Score=318.35  Aligned_cols=257  Identities=23%  Similarity=0.373  Sum_probs=200.0

Q ss_pred             CCCCCcccccCceEEEEEEEcC-Cc--EEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-----Cce
Q 013686          112 FNSSKQLGDGGFGAVYLGILRD-GR--IVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-----SRE  181 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  181 (438)
                      |.+.+.||+|+||.||+|...+ +.  .||+|.+...  .....+.+.+|+++++.++|+||+++++++...     ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999764 33  5899987643  334467889999999999999999999965322     124


Q ss_pred             EEEEEeccCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      .+++|||+++|+|.+++....  .....+++.....++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            689999999999999885432  122348999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          260 LFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       260 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      .+...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......       .....+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~  233 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGNRL  233 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCCC
Confidence            76433221 1122346778999999999899999999999999999999 78888643221       111222222211


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..            ...++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       234 ~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 KQ------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10            012455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.6e-42  Score=319.32  Aligned_cols=260  Identities=27%  Similarity=0.456  Sum_probs=207.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +|+.++||.+...   .....+.+.+|+.+++.++|+||+++++++... +..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-CeEEEE
Confidence            46788899999999999999964 7899999987643   223446788999999999999999999977655 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.........+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            99999999999987543333458999999999999999999999999999999999999999999999999988664332


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .. .....++..|+|||.+.+..++.++|+||||+++|||++|..||......    .... ...+....     .+.. 
T Consensus       161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~-----~~~~-  228 (267)
T cd08229         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCD-----YPPL-  228 (267)
T ss_pred             cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHH-hhhhhcCC-----CCCC-
Confidence            21 22345889999999998888999999999999999999999998643221    0011 11111111     1111 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                           ....++..+.+++.+||..||++|||+.+|++.++++
T Consensus       229 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 -----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                 0123566799999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.9e-43  Score=345.01  Aligned_cols=252  Identities=26%  Similarity=0.352  Sum_probs=197.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .+|++.+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+++++.++|+||+++++.+..+ +.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CEEEEE
Confidence            36889999999999999999965 589999999865422   2346688999999999999999999977655 589999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC-
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD-  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~-  264 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+... 
T Consensus        80 ~E~~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGI----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999999977543    888999999999999999999999999999999999999999999999997532100 


Q ss_pred             -----------------------------------------ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHH
Q 013686          265 -----------------------------------------VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLI  303 (438)
Q Consensus       265 -----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~  303 (438)
                                                               .........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000011246899999999999999999999999999999


Q ss_pred             HHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC---CHHHH
Q 013686          304 ELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP---TMKEV  380 (438)
Q Consensus       304 el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev  380 (438)
                      ||++|+.||........       ...+...... ...+.        ...++..+.+++.+|+ .+|.+|+   ++.|+
T Consensus       236 ell~G~~Pf~~~~~~~~-------~~~i~~~~~~-~~~~~--------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         236 EMLVGQPPFLADTPAET-------QLKVINWETT-LHIPS--------QAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             ehhhCCCCCCCCCHHHH-------HHHHhccCcc-ccCCC--------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999975432111       1111111000 00000        0124556788888876 5999999   89999


Q ss_pred             HHH
Q 013686          381 LEI  383 (438)
Q Consensus       381 l~~  383 (438)
                      +++
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.9e-43  Score=338.17  Aligned_cols=242  Identities=26%  Similarity=0.373  Sum_probs=195.1

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.||+|+||.||++... +|+.||+|.+....   ......+.+|++++..++||||+++++++... ...|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCC
Confidence            46999999999999965 68999999987542   23345678899999999999999999876655 479999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      |+|..++.....    +++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... ...
T Consensus        80 ~~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (325)
T cd05594          80 GELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK  154 (325)
T ss_pred             CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence            999999876543    8999999999999999999997 7999999999999999999999999999875432221 123


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+.....      .+      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~~------~~------  215 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI------RF------  215 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCCC------CC------
Confidence            3468999999999999999999999999999999999999997533211       1111111110      01      


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                       +..++..+.+++.+||+.||++|+     ++.+++++
T Consensus       216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             112456788999999999999996     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.8e-42  Score=332.41  Aligned_cols=249  Identities=23%  Similarity=0.377  Sum_probs=196.8

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++.++ +||||+++++++... ..+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCC
Confidence            46999999999999976 57899999997542   23456688999999888 699999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|..++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 ~~~L~~~~~~~~~----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (327)
T cd05617          80 GGDLMFHMQRQRK----LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS  154 (327)
T ss_pred             CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence            9999998876543    8999999999999999999999999999999999999999999999999987532211 1123


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|..||..................+......      +      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~------  222 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------I------  222 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC------C------
Confidence            4568999999999999999999999999999999999999997543332222222223333221111      0      


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTM------KEVLEI  383 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  383 (438)
                       +..++..+.+++.+||+.||.+|+++      ++++++
T Consensus       223 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         223 -PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             11244567899999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-42  Score=338.48  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=200.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      ...++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..+ ..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-KYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEE
Confidence            34578999999999999999999976 58899999986432   22345678899999999999999999977654 579


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      |+||||+++|+|.+++....     +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~-----~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999999997542     7888999999999999999999999999999999999999999999999998764


Q ss_pred             CCccccccCCCCCCCccCccccccCC----CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYK----LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      ...........||+.|+|||.+.+..    ++.++|||||||++|||++|+.||......      . ....+...... 
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~-~~~~i~~~~~~-  265 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------G-TYSKIMDHKNS-  265 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCcc-
Confidence            43322233456999999999987543    788999999999999999999999754321      1 11112111100 


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM--RPTMKEVLEIL  384 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  384 (438)
                           +..+.   ...++..+.+++.+||..++.+  |+++.|++++-
T Consensus       266 -----~~~p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         266 -----LNFPE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             -----cCCCC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence                 00111   0134567889999999865544  89999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=313.99  Aligned_cols=268  Identities=24%  Similarity=0.342  Sum_probs=219.9

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeee
Q 013686          102 CSELEEATDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGC  174 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~  174 (438)
                      ..++....++++...++-+|.||.||.|++++      .+.|-+|.++.. ..-+...+..|.-++..+.|||++++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            35566667889999999999999999998653      345667766543 23345678899999999999999999998


Q ss_pred             eeccCceEEEEEeccCCCCHHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          175 TSRQSRELLLVYEYIPNGTVADHLHNRQPN----SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       175 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      +.++....++++.++.-|+|..||...+..    .+.++..+...++.|++.|++|||++||||.||.++|++||+..+|
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence            888777899999999999999999843321    2357778889999999999999999999999999999999999999


Q ss_pred             EEeeeCccc-ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHH
Q 013686          251 KVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       251 kl~Dfgla~-~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~  328 (438)
                      ||+|-.+++ .++.+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+....+      .++ .
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------fEm-~  508 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------FEM-E  508 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------HHH-H
Confidence            999999999 566777777777788999999999999999999999999999999998 8888864322      222 2


Q ss_pred             HHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      ..+.+|...            ..+-+||+++..++..||+.+|++||+++|++.-|.++.
T Consensus       509 ~ylkdGyRl------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  509 HYLKDGYRL------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HHHhcccee------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            233332211            112468999999999999999999999999999888764

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-41  Score=316.76  Aligned_cols=251  Identities=27%  Similarity=0.474  Sum_probs=203.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ..+|++.+.||+|+||.||++... |..|++|.+....  ..+.+.+|+.++++++|+|++++++++...+...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            357888999999999999999775 7889999886443  3467889999999999999999999766665678999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++......  .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCCcHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999999865432  38899999999999999999999999999999999999999999999999987543321   


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.....      .. ....+..+....     .   
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~~~-----~---  220 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPRVEKGYKMD-----A---  220 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCCCC-----C---
Confidence             22235678999999998899999999999999999998 9999864321      11 111222211111     0   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          ...++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 ----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                123456788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-43  Score=343.29  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=197.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +|+.||||++....   ....+.+.+|++++++++||||+++++++... ...|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-QYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CeeEEE
Confidence            46888999999999999999865 68999999986542   23346788999999999999999999977655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus        80 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDT----FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999999976543    8899999999999999999999999999999999999999999999999996432100


Q ss_pred             c------------c----------------------------------cccCCCCCCCccCccccccCCCCChhhHHHHH
Q 013686          266 T------------H----------------------------------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFG  299 (438)
Q Consensus       266 ~------------~----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G  299 (438)
                      .            .                                  ......||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0            0                                  00123589999999999998999999999999


Q ss_pred             HHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCC---CC
Q 013686          300 VVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR---PT  376 (438)
Q Consensus       300 v~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps  376 (438)
                      |++|||++|..||.......       ....+....      ..+..+.   ...++..+.+++.+||. +|.+|   ++
T Consensus       236 vil~elltG~~Pf~~~~~~~-------~~~~i~~~~------~~~~~p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHE-------TYRKIINWR------ETLYFPD---DIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHH-------HHHHHHccC------CccCCCC---CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            99999999999997543211       111111100      0000000   01245678899999997 67665   69


Q ss_pred             HHHHHHHH
Q 013686          377 MKEVLEIL  384 (438)
Q Consensus       377 ~~evl~~L  384 (438)
                      +.|++.+-
T Consensus       299 ~~~~l~hp  306 (377)
T cd05629         299 AHEIKSHP  306 (377)
T ss_pred             HHHHhcCC
Confidence            99999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=333.05  Aligned_cols=253  Identities=28%  Similarity=0.431  Sum_probs=214.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchH---hHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFK---RIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  183 (438)
                      ...|.+.+.||+|.||.||++..+. |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+++.++... .++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SVY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eEE
Confidence            5678888999999999999999874 999999999765442   3468999999999998 999999999777664 799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC----CCeEEEeeeCccc
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN----NFRVKVADFGLSR  259 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~----~~~~kl~Dfgla~  259 (438)
                      +|||+|.||.|.+.+...   .  +++..+..++.|++.++.|||+.||+||||||+|+|+..    ++.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~---~--~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---H--YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc---c--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999887   1  899999999999999999999999999999999999953    3579999999999


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ....  .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.........       ..+..+.+   
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~---  255 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF---  255 (382)
T ss_pred             EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC---
Confidence            8766  33456678999999999999999999999999999999999999999876543211       13333332   


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                           .+. ...+..++..+.+++..|+..||.+|+|+.++|++.+
T Consensus       256 -----~f~-~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  256 -----DFT-SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             -----CCC-CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                 111 1234567889999999999999999999999999754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=370.34  Aligned_cols=261  Identities=30%  Similarity=0.452  Sum_probs=205.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ...|...+.||+|+||.||+|... +|..||||++......    ...|++.+++++|||||+++|++.... ..++|||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~E  763 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK-GAYLIHE  763 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC-CCEEEEe
Confidence            345778889999999999999974 7899999988644322    124688999999999999999886654 6899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH---ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+++|+|.++++.       ++|..+..++.||++||+|||   +.+|+||||||+||+++.++.+++. ||.......+
T Consensus       764 y~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        764 YIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             CCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            9999999999963       889999999999999999999   6699999999999999999888876 6665433221


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                           ....+++.|+|||++.+..++.++|||||||++|||+||+.||+.... .......|.............+++.+
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence                 123578999999999999999999999999999999999999964322 22334444444333334444555544


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ...... ......++.+++.+||+.||++||||+|+++.|+++..
T Consensus       910 ~~~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        910 RGDVSV-NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cCCCCc-cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            322211 23445678899999999999999999999999998755

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.8e-42  Score=329.76  Aligned_cols=242  Identities=27%  Similarity=0.431  Sum_probs=194.0

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++..+ +++.||+|.+....   ....+.+..|..++..+ +||||+++++++... +.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-DRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999976 58899999987542   23346677888988877 699999999977655 57999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|.+++.....    +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 ~g~L~~~i~~~~~----l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (320)
T cd05590          80 GGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS  154 (320)
T ss_pred             CchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence            9999999976543    8999999999999999999999999999999999999999999999999987542221 1223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||......      . ....+..+...      +      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~-~~~~i~~~~~~------~------  215 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------D-LFEAILNDEVV------Y------  215 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHhcCCCC------C------
Confidence            346899999999999989999999999999999999999999754321      1 11222221110      0      


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTM------KEVLEI  383 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  383 (438)
                       +..++..+.+++.+||+.||++||++      ++++.+
T Consensus       216 -~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         216 -PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence             01245678899999999999999998      666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=315.64  Aligned_cols=252  Identities=29%  Similarity=0.468  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-----hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-----FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ++|.+.+.||+|++|.||++... +++.|++|.+....     ....+.+.+|++++++++||||+++++++..+ ...+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-ETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-CeEE
Confidence            46888999999999999999965 68999999876432     12346788999999999999999999977665 4899


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++++|.+++.....    +++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||+++....
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999999986543    88899999999999999999999999999999999999999999999999976543


Q ss_pred             Cccccc--cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVTHVS--TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ......  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......      ... ........    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~-~~~~~~~~----  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIF-KIATQPTN----  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHH-HHhccCCC----
Confidence            221111  23457889999999999889999999999999999999999986432210      011 11111100    


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +.+       +..++..+.+++.+||..+|++|||+.|++++.
T Consensus       226 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         226 PQL-------PSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             CCC-------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            011       123456788999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-41  Score=320.59  Aligned_cols=257  Identities=28%  Similarity=0.465  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-----CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-----DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ++|++.+.||+|+||.||+|...     ++..|++|.+... .....+.+.+|+++++.++||||+++++++... ...|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CceE
Confidence            46778899999999999999842     4678999998643 334456788999999999999999999976554 4789


Q ss_pred             EEEeccCCCCHHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          184 LVYEYIPNGTVADHLHNRQP-------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      +||||+++++|.+++.....             ....+++...+.++.|++.||.|||++|++||||||+|||++.++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence            99999999999999964321             11247888999999999999999999999999999999999999999


Q ss_pred             EEeeeCcccccCCCc-cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHH
Q 013686          251 KVADFGLSRLFPTDV-THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       251 kl~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~  328 (438)
                      ||+|||+++...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||......       ...
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~~~  236 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVI  236 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence            999999998653322 112223345778999999988889999999999999999998 98898643211       111


Q ss_pred             HHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                      ..+.......     .       +..++..+.+++.+||+.||++||++.+++++|+.
T Consensus       237 ~~~~~~~~~~-----~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVRKRQLLP-----C-------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCcCC-----C-------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            2222211110     0       11345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.4e-42  Score=330.99  Aligned_cols=242  Identities=26%  Similarity=0.390  Sum_probs=194.8

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|... +++.||+|.+....   ....+.+..|.+++..+ +||||+++++++... +.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCC
Confidence            46999999999999976 57899999987542   23345677899999876 799999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|..++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus        80 ~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05591          80 GGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT  154 (321)
T ss_pred             CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence            9999999976543    88999999999999999999999999999999999999999999999999875432221 223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+...   .+        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~~---~p--------  216 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDVL---YP--------  216 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---CC--------
Confidence            4468999999999999899999999999999999999999997543211       11122221110   00        


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRP-------TMKEVLEI  383 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  383 (438)
                        ..++..+.+++.+||+.||++||       ++++++++
T Consensus       217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence              12355788999999999999999       88888865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.3e-42  Score=316.71  Aligned_cols=247  Identities=28%  Similarity=0.447  Sum_probs=195.7

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      +.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++... ...++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCeEEEEeeccCCc
Confidence            46999999999999975 68999999876443 33446789999999999999999999977655 47899999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc-cCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS-TAP  272 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  272 (438)
                      |.+++.....   .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++........... ...
T Consensus        80 L~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          80 FLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9999976432   388999999999999999999999999999999999999999999999999886543211111 111


Q ss_pred             CCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHH
Q 013686          273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA  351 (438)
Q Consensus       273 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (438)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..||......       .....+......     .       .
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~~-----~-------~  217 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVRL-----P-------C  217 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCC-----C-------C
Confidence            23467999999998899999999999999999998 88888643221       111111111000     0       0


Q ss_pred             HHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          352 VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       352 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-42  Score=325.07  Aligned_cols=247  Identities=22%  Similarity=0.352  Sum_probs=193.5

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ||+|+||.||++..+ +|+.||+|.+......   ..+.+..|++++++++||||+++++++... ...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-THLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-CeEEEEEecCCCCC
Confidence            799999999999975 5899999998643221   234456799999999999999999877554 57999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ  273 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  273 (438)
                      |.+++......  .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++........  .....
T Consensus        80 L~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05607          80 LKYHIYNVGER--GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA  155 (277)
T ss_pred             HHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence            99988765432  388999999999999999999999999999999999999999999999999986643322  23346


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      +++.|+|||.+.+..++.++|||||||++|||++|+.||.......  ...... .......        ...    ...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~-~~~~~~~--------~~~----~~~  220 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELK-RRTLEDE--------VKF----EHQ  220 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHH-HHhhccc--------ccc----ccc
Confidence            8999999999998889999999999999999999999997432211  111111 1111111        000    012


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .++.++.+++.+||+.||++||+++|+++.+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            3566789999999999999999998776433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-42  Score=347.00  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-------Cc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-------SR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------~~  180 (438)
                      ..+|++.+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...       ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999975 58999999885432    2234699999999999999998865321       12


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGLSR  259 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~  259 (438)
                      .+++||||++ ++|.+++.........+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            4679999996 588887765433334589999999999999999999999999999999999998664 79999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh------
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ------  332 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~------  332 (438)
                      .+.....  .....+++.|+|||.+.+. .++.++|||||||++|||++|.+||..........  .. ...+.      
T Consensus       220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~i-~~~~~~p~~~~  294 (440)
T PTZ00036        220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--RI-IQVLGTPTEDQ  294 (440)
T ss_pred             hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HH-HHHhCCCCHHH
Confidence            6543322  2234589999999988654 68999999999999999999999997643321110  00 00000      


Q ss_pred             ----cCcccccccCcCCCC--ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          333 ----NGALNELVDPSLGFE--KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       333 ----~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          ........-+.....  ....+...+.++.+|+.+||+.||.+|||+.|++++-
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp  352 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP  352 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence                000000000000000  0001123456899999999999999999999999753

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=311.49  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=207.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .+.|.+.++||+|.|+.||++... +|+.+|+|.+...  .....+++.+|+.+.+.|+||||+++.+...++ +..|||
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-ceeEEE
Confidence            456778899999999999999866 6999999987543  233568899999999999999999999955544 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec---CCCeEEEeeeCcccccC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFP  262 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgla~~~~  262 (438)
                      +|+|.|++|..-+-.+.-    +++..+-...+||+++|.|+|.+||||||+||+|+++-   ...-+||+|||+|....
T Consensus        89 Fe~m~G~dl~~eIV~R~~----ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREF----YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999999877766532    78888889999999999999999999999999999994   34469999999999876


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                        .........|||.|||||++...+|+..+|||+-||+||-|+.|.+||......       ...+.+..+...     
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd-----  230 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYD-----  230 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccC-----
Confidence              333445678999999999999999999999999999999999999999863221       122233333221     


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         ++ ...+...+++.++|+++||..||.+|.|+.|.|++-
T Consensus       231 ---~~-~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  231 ---YP-SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             ---CC-CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence               11 113457788899999999999999999999999754

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-41  Score=315.18  Aligned_cols=246  Identities=26%  Similarity=0.425  Sum_probs=197.5

Q ss_pred             cccccCceEEEEEEEc---CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          117 QLGDGGFGAVYLGILR---DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      .||+|+||.||+|.++   ++..+|+|++....  ....+.+.+|+.+++.+.||||+++++++..  +..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence            5899999999999753   57899999886442  3345788999999999999999999997643  367999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc--c
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--S  269 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~  269 (438)
                      ++|.+++.....    +++..+..++.|++.||+|||++|++||||||.||+++.++.+||+|||+++.........  .
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          80 GPLNKFLQKNKH----VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999976543    8899999999999999999999999999999999999999999999999998664432211  1


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....++..|+|||.+....++.++|||||||++|||++ |..||......       .....+..+....     .    
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~~-----~----  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGERME-----C----  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCC-----C----
Confidence            12234678999999988889999999999999999998 99999753221       1122233222111     1    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                         +..++..+.+++.+||+.||++||++.+|.+.|++.
T Consensus       220 ---~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 ---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               113556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-42  Score=315.73  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .+.|+.++.||.|.-|+||++.+++ +..+|+|++.+....   ...+...|-++|+.+.||.+..+|+.+..+ +..|+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-KYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-ceeEE
Confidence            4567778999999999999999874 689999999776443   345677899999999999999999977554 58999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC-
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT-  263 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~-  263 (438)
                      |||||+||+|...++++...  .+++..++-++.+|+.||+|||..|||.|||||+||||.++|++.|+||.|+..... 
T Consensus       155 ~meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999999877654  499999999999999999999999999999999999999999999999998753210 


Q ss_pred             --------------------------------Ccc----------------------ccccCCCCCCCccCccccccCCC
Q 013686          264 --------------------------------DVT----------------------HVSTAPQGTPGYVDPDYFQCYKL  289 (438)
Q Consensus       264 --------------------------------~~~----------------------~~~~~~~g~~~y~aPE~~~~~~~  289 (438)
                                                      ...                      ......+||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                      00112359999999999999999


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhcc
Q 013686          290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQ  369 (438)
Q Consensus       290 ~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  369 (438)
                      +.+.|.|+|||+||||+.|..||.+.......               ..++...+.++..   ...+..+++||++.|.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEE---PEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCC---CcchhHHHHHHHHHhcc
Confidence            99999999999999999999999876543221               1111122222211   14567899999999999


Q ss_pred             CCCCCCC----HHHHHHH
Q 013686          370 DRDMRPT----MKEVLEI  383 (438)
Q Consensus       370 dP~~RPs----~~evl~~  383 (438)
                      ||.+|.-    +.||-++
T Consensus       375 dP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ChhhhhccccchHHhhcC
Confidence            9999998    7787764

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-41  Score=318.98  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++... +..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEe
Confidence            36778899999999999999864 6889999988654 333456789999999999999999999977665 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|..+.        .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......  
T Consensus        80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            99999997542        17888889999999999999999999999999999999999999999999998654322  


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..................+.....     +.+.  
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--  221 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----PVLP--  221 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----CCCC--
Confidence             22346899999999999889999999999999999999999999753322111111111111111110     1110  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                          ....+..+.+++.+||+.||++||+++|++++..
T Consensus       222 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         222 ----VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             ----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence                0123456889999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-42  Score=339.26  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      +|.+.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++++... ..+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEE
Confidence            5788999999999999999975 58899999987543   23456788999999999999999999977655 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      |||++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        81 E~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          81 DYIPGGDMMSLLIRMGI----FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999976543    8899999999999999999999999999999999999999999999999975331100 


Q ss_pred             ---------------------------------------------cccccCCCCCCCccCccccccCCCCChhhHHHHHH
Q 013686          266 ---------------------------------------------THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGV  300 (438)
Q Consensus       266 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv  300 (438)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00011235899999999999999999999999999


Q ss_pred             HHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC---H
Q 013686          301 VLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT---M  377 (438)
Q Consensus       301 ~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  377 (438)
                      ++|||++|+.||.......       ....+....      ..+..+.   ....++++.+++.+|+ .+|++|++   +
T Consensus       237 il~elltG~~Pf~~~~~~~-------~~~~i~~~~------~~~~~p~---~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLE-------TQMKVINWQ------TSLHIPP---QAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHH-------HHHHHHccC------CCcCCCC---cccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999997543211       111111100      0000000   1234566788888875 59999987   8


Q ss_pred             HHHHHH
Q 013686          378 KEVLEI  383 (438)
Q Consensus       378 ~evl~~  383 (438)
                      .|++++
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-41  Score=319.75  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=201.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCc----EEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGR----IVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ++|++.+.||+|+||+||+|.+. +|+    .+++|.+.... .....++..|+..+++++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccE
Confidence            46888999999999999999964 344    47777775432 2334678889999999999999999997643  3578


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +++||+++|+|.+++.....   .+++..+..++.||+.||.|||+++++||||||+|||+++++.+||+|||+++....
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999986543   389999999999999999999999999999999999999999999999999986543


Q ss_pred             Ccc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+....  .
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~  232 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--Q  232 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--C
Confidence            322 12223446778999999988899999999999999999998 999987543211       111222221111  1


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      +          ..++..+.+++.+||..||++|||+.|+++.|..+.+
T Consensus       233 ~----------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         233 P----------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             C----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1          1133457889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-41  Score=333.89  Aligned_cols=265  Identities=21%  Similarity=0.275  Sum_probs=199.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc---CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR---DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ..+|.+.+.||+|+||.||++...   .++.||+|.+...     ....+|++++++++||||+++++++... ...++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK-STVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC-CEEEEE
Confidence            457999999999999999999754   3578999987543     2345799999999999999999977554 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||++ +++|.+++....    .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       165 ~e~~-~~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        165 MPKY-KCDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             ehhc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9999 478999885443    38999999999999999999999999999999999999999999999999997654332


Q ss_pred             cc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc---------
Q 013686          266 TH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA---------  335 (438)
Q Consensus       266 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  335 (438)
                      .. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................+....         
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            21 22245689999999999999999999999999999999999999976543221111111111110000         


Q ss_pred             --------ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          336 --------LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       336 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                              ......+....+.......++..+.+++.+||..||++|||+.|++.+-
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                    0000011111111001123456788999999999999999999999874

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-42  Score=333.38  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCC-CceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHP-NLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~lv  185 (438)
                      +|++.+.||+|+||.||+|..+ +++.||+|.+....   ....+.+..|.+++..+.|+ +|+++++++... +.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-CEEEEE
Confidence            4778899999999999999976 57899999987542   23456788899999999765 577888766554 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999999976543    8899999999999999999999999999999999999999999999999987432211


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      . ......|++.|+|||.+.+..++.++|||||||++|||+||+.||......       .....+.....      .+ 
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~~------~~-  220 (324)
T cd05587         156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHNV------SY-  220 (324)
T ss_pred             C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCC------CC-
Confidence            1 123346899999999999999999999999999999999999999754321       11112221110      01 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM-----KEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  383 (438)
                            +..++..+.+++.+||+.||.+|++.     ++++++
T Consensus       221 ------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         221 ------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                  11245678899999999999999986     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-41  Score=327.28  Aligned_cols=237  Identities=30%  Similarity=0.433  Sum_probs=185.9

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHH-HHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVE-ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|... +|+.||+|.+.....   .....+..|.. +++.++||||+++++++... +..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999976 588999999865422   22344555554 67889999999999876554 57999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|..++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 ~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (321)
T cd05603          80 GGELFFHLQRERC----FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS  154 (321)
T ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence            9999998876543    8888899999999999999999999999999999999999999999999987532221 1223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|..||.....      .. ....+.....        ...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~i~~~~~--------~~~---  216 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQ-MYDNILHKPL--------QLP---  216 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HH-HHHHHhcCCC--------CCC---
Confidence            44689999999999988999999999999999999999999975421      11 1112211111        000   


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMK  378 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~  378 (438)
                        ...+..+.+++.+||+.||.+||++.
T Consensus       217 --~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 --GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              12345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.4e-42  Score=337.02  Aligned_cols=260  Identities=26%  Similarity=0.374  Sum_probs=203.1

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ  178 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  178 (438)
                      .++....++|++.+.||+|+||.||++..+ +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344455689999999999999999999976 58899999986432   22345678899999999999999999977654


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                       ...++||||+++|+|.+++....     +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       116 -~~~~lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         116 -RYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             -CEEEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence             57999999999999999997542     788889999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCCCccCccccccC----CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCY----KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG  334 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (438)
                      ...............||+.|+|||.+.+.    .++.++|||||||++|||++|..||......      . ....+...
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~  262 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMNH  262 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------H-HHHHHHcC
Confidence            87654332233345699999999998754    3788999999999999999999999754321      1 11122111


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM--RPTMKEVLEIL  384 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  384 (438)
                      ..      .+..+.   ...++..+.+++.+||..++.+  |++++|++++.
T Consensus       263 ~~------~~~~~~---~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 KN------SLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CC------cccCCC---cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            10      000000   1235667889999999844443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-41  Score=314.20  Aligned_cols=250  Identities=28%  Similarity=0.463  Sum_probs=203.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|.+.+.||+|++|.||++... +|+.|++|.+...  .....+.+.+|+++++.++|||++++++++... +..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEE
Confidence            4677889999999999999976 6899999988643  334567889999999999999999999977655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....  ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          80 YAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             eCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999987532  24889999999999999999999999999999999999999999999999998866443221


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||......       .....+..+.....        
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~--------  221 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFPPV--------  221 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCCC--------
Confidence             23345889999999999889999999999999999999999999754311       11112222211111        


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ...++..+.+++.+||+.+|++||++.++++.
T Consensus       222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                11355678999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-42  Score=320.56  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=201.9

Q ss_pred             CCCCCcccccCceEEEEEEEcC----CcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----c
Q 013686          112 FNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----R  180 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  180 (438)
                      |++.+.||+|+||.||+|....    +..||+|.+...  .....+.+.+|++.++.++||||+++++++....     .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998642    367999998643  2344578999999999999999999999665433     2


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      ..+++|||+++|+|..++.....  ....+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            37999999999999999865432  1234899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          259 RLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       259 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      +........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......      .. ...+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~-~~~~~~~~~  233 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EI-YDYLRHGNR  233 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHHcCCC
Confidence            865433221 1122235678999999988899999999999999999999 88888643321      11 111111111


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..     .       +..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       234 ~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 LK-----Q-------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC-----C-------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10     0       123556789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-42  Score=331.27  Aligned_cols=241  Identities=27%  Similarity=0.424  Sum_probs=190.6

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|... +++.||+|.+....   ....+.+..|..++..+ +||||+++++++... ...++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999976 58899999987542   22345566677777654 799999999977654 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 gg~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          80 GGDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            9999999976543    8999999999999999999999999999999999999999999999999997543222 2223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      . ....+....      +.+      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~------~~~------  215 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------E-LFDSILNDR------PHF------  215 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCC------CCC------
Confidence            446899999999999989999999999999999999999999754321      1 111121111      111      


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMK-EVLE  382 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  382 (438)
                       +..++..+.+++.+||+.||.+||++. ++++
T Consensus       216 -~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         216 -PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             112455678999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-42  Score=335.66  Aligned_cols=267  Identities=20%  Similarity=0.279  Sum_probs=199.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  179 (438)
                      ..++|++.+.||+|+||.||++... .++.||+|.+...  .....+.+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4678999999999999999999865 5889999998653  2334567888999999999999999999764332     


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...++||||++ ++|.+.+...      +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            35799999995 4777777532      7888999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh---------------
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS---------------  324 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~---------------  324 (438)
                      ......  ......+++.|+|||.+.+..++.++|||||||++|||++|+.||............               
T Consensus       168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            654322  223346899999999999989999999999999999999999999754321110000               


Q ss_pred             -HHHHHHHhcC-ccc-----ccccCc-CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          325 -NMATNKIQNG-ALN-----ELVDPS-LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       325 -~~~~~~~~~~-~~~-----~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                       ......+... ...     ...... .+.. .......+..+.+|+.+||+.||++|||+.|++++-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPAD-SEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccc-cccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence             0000000000 000     000000 0000 001122346788999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.1e-41  Score=312.44  Aligned_cols=247  Identities=29%  Similarity=0.468  Sum_probs=198.1

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCH
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTV  194 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L  194 (438)
                      +.||+|+||.||+|...+++.+|+|.+..... .....+.+|+++++.++||||+++++++... ...++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-QPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-CccEEEEECCCCCcH
Confidence            36999999999999988889999998865532 3345788999999999999999999977655 478999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCC
Q 013686          195 ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG  274 (438)
Q Consensus       195 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g  274 (438)
                      .+++.....   .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...............+
T Consensus        80 ~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            999876443   37899999999999999999999999999999999999999999999999997654332222222345


Q ss_pred             CCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       275 ~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      +..|+|||.+.+..++.++||||||+++|||++ |..||......       .....+..+...     ..       ..
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~-----~~-------~~  217 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYRM-----SC-------PQ  217 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCCC-----CC-------CC
Confidence            678999999998899999999999999999998 99998643221       111122221111     00       01


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            24567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6e-42  Score=328.85  Aligned_cols=242  Identities=25%  Similarity=0.396  Sum_probs=195.1

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++..+ +++.||+|.+....   ....+.+.+|..++..+ +||||+++++++... +.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999976 57899999987542   23345677899999888 699999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|..++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus        80 ~~~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (318)
T cd05570          80 GGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS  154 (318)
T ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence            9999999876543    89999999999999999999999999999999999999999999999999875322211 122


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+.....      .+      
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~~~------~~------  215 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILEDEV------RY------  215 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCC------CC------
Confidence            345899999999999999999999999999999999999999753321       11112221111      00      


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTM-----KEVLEI  383 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  383 (438)
                       +..++..+.+++.+||+.||.+||++     .+++++
T Consensus       216 -~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 -PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             11345678899999999999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.1e-41  Score=319.64  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=203.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ....+.+.+|+.+++.++||||+++++++... +..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-GPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CCcE
Confidence            4778899999999999999853      23578888876543 34457889999999999999999999977655 4689


Q ss_pred             EEEeccCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 013686          184 LVYEYIPNGTVADHLHNRQP--------------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL  243 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nil  243 (438)
                      ++|||+.+++|.+++.....                    ....+++..++.++.|++.||.|||+.+++||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            99999999999999875321                    1134789999999999999999999999999999999999


Q ss_pred             ecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCccccc
Q 013686          244 LDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDI  321 (438)
Q Consensus       244 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~  321 (438)
                      +++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......  
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--  237 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--  237 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence            999999999999999865332221 1222345678999999988889999999999999999998 999986533211  


Q ss_pred             chhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                           ....+..+.     ....       +..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       238 -----~~~~~~~~~-----~~~~-------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 -----LFNLLKTGY-----RMER-------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -----HHHHHhCCC-----CCCC-------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                 111111111     0000       12345678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=326.40  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.++..++|+||+++++++... ..+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEE
Confidence            46889999999999999999976 58999999986532   22345688999999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999976432   28899999999999999999999999999999999999999999999999987654433


Q ss_pred             cccccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          266 THVSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......      .............. +
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~  229 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ-F  229 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc-C
Confidence            222233468999999999863     45788999999999999999999999753221      11111111110000 0


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRD--MRPTMKEVLEIL  384 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~L  384 (438)
                      .+        ....++..+.+++.+||..+++  .||++++++++-
T Consensus       230 ~~--------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         230 PP--------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             CC--------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence            00        0122566788999998865444  378999999873

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=315.48  Aligned_cols=255  Identities=30%  Similarity=0.519  Sum_probs=206.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|.+.+.||+|+||.||++..++++.||+|.+..... ..+++.+|+.++++++|+||+++++++... ...++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-EPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC-CceEEEEec
Confidence            568899999999999999999988788999998875443 346788999999999999999999976554 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          83 MSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             cCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence            999999999987542  238999999999999999999999999999999999999999999999999998765432222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......       ....+..+. .    ...   
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~-~----~~~---  225 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGY-R----MPR---  225 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-C----CCC---
Confidence            223345678999999998889999999999999999999 999996432211       111111110 0    000   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                          +...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       226 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 ----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                01235578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.3e-42  Score=324.42  Aligned_cols=265  Identities=23%  Similarity=0.328  Sum_probs=196.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhC---CCCCceeEeeeeecc----Cc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKL---QHPNLVKLYGCTSRQ----SR  180 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~----~~  180 (438)
                      +|.+.+.||+|+||+||+|..+ +|+.||+|.+.....  .....+.+|+.+++.+   +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999976 589999998864321  1123455677777665   799999999966432    34


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||++ ++|.+++......  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPP--GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            5899999996 5899988765432  389999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh---cCccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ---NGALN  337 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  337 (438)
                      ......  .....++..|+|||.+.+..++.++|||||||++|||++|++||.........  .. ......   ...+.
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~--~~-~~~~~~~~~~~~~~  232 (288)
T cd07863         158 YSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GK-IFDLIGLPPEDDWP  232 (288)
T ss_pred             ccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH--HH-HHHHhCCCChhhCc
Confidence            643221  22345789999999998889999999999999999999999999654322111  00 000000   00000


Q ss_pred             -------ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 -------ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             ....+............++..+.+++.+||+.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   0001111111111223456778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.9e-42  Score=329.70  Aligned_cols=241  Identities=27%  Similarity=0.446  Sum_probs=191.1

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|... +++.||+|.+....   ....+.+..|..++..+ +||||+++++++... +.+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCC
Confidence            46999999999999976 57899999987642   12345567788888764 899999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|.+++.....    +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus        80 ~g~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (316)
T cd05619          80 GGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC  154 (316)
T ss_pred             CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence            9999999976543    88999999999999999999999999999999999999999999999999875322111 122


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|..||......       .....+....      +.++     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~------~~~~-----  216 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDN------PCYP-----  216 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC------CCCC-----
Confidence            346899999999999989999999999999999999999999753321       1111121111      1110     


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMK-EVLE  382 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  382 (438)
                        ..++..+.+++.+||+.||++||++. +++.
T Consensus       217 --~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 --RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             --ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence              12445688999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-41  Score=333.14  Aligned_cols=264  Identities=24%  Similarity=0.387  Sum_probs=206.0

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCC-CCCceeEeeeeec
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSR  177 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  177 (438)
                      ....++|.+.+.||+|+||.||+|.++      .++.||+|++.... ....+.+.+|++++.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            334567888999999999999999864      24689999997542 233457889999999997 9999999997766


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCC------------------------------------------------------
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQP------------------------------------------------------  203 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  203 (438)
                      . ...++||||+++|+|.++++....                                                      
T Consensus       113 ~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         113 G-GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             C-CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            5 478999999999999999975421                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 013686          204 ----------------------------------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL  243 (438)
Q Consensus       204 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nil  243 (438)
                                                              ....+++...+.++.||+.||+|||+.+++||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                    1124677888999999999999999999999999999999


Q ss_pred             ecCCCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCccccc
Q 013686          244 LDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDI  321 (438)
Q Consensus       244 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~  321 (438)
                      +++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......   
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---  348 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---  348 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence            99999999999999986533221 11122346788999999988889999999999999999998 88888643211   


Q ss_pred             chhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                         ......+..+...     ..       +..++..+.+++.+||+.+|.+||+++||++.|+.+.
T Consensus       349 ---~~~~~~~~~~~~~-----~~-------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 ---EQFYNAIKRGYRM-----AK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ---HHHHHHHHcCCCC-----CC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               1111222222110     00       0124567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.4e-42  Score=328.52  Aligned_cols=269  Identities=22%  Similarity=0.314  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++..+ +..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEe
Confidence            56888999999999999999976 588999999864432 2234677899999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |++ ++|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        85 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          85 YLD-KDLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            996 488888876543   378899999999999999999999999999999999999999999999999976433221 


Q ss_pred             cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHHHHhc-Cccc
Q 013686          268 VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATNKIQN-GALN  337 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~~~~~-~~~~  337 (438)
                      ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||..............        .+..+.. ....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            1223457899999998865 4688999999999999999999999976543221111000        0000000 0000


Q ss_pred             ccccCcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          338 ELVDPSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       338 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ....+... .........++..+.+++.+||+.||.+|||+.|++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence            00000000 000001123567789999999999999999999999843

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-41  Score=319.55  Aligned_cols=262  Identities=26%  Similarity=0.410  Sum_probs=203.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-----CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-----DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  182 (438)
                      ..|++.+.||+|+||.||++...     ++..||+|.+.... ....+.+.+|+++++.++|||++++++++... ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34688999999999999999742     47889999986543 34456899999999999999999999977654 3568


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++++|.+++.....   .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            999999999999999976532   38999999999999999999999999999999999999999999999999998664


Q ss_pred             CCccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcc---------cccchhHHHHHHH
Q 013686          263 TDVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR---------HDINLSNMATNKI  331 (438)
Q Consensus       263 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~---------~~~~~~~~~~~~~  331 (438)
                      .....  ......++..|+|||.+.+..++.++|||||||++|||++++.|.......         ...... .....+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLVRVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHHHHH
Confidence            33221  122345677899999998888999999999999999999987665322110         000000 011111


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..+...       +.     +..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       240 ~~~~~~-------~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKRL-------PR-----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCccC-------CC-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111100       00     123566799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-41  Score=323.29  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            457889999999999999999753        23579999887542 34456788899999999 799999999977665


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                      + ..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus        97 ~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          97 G-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence            4 789999999999999999865321            124889999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......      
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~------  249 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------  249 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH------
Confidence            999999999998765432111 1112234578999999998889999999999999999998 88888643211      


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                       .....+..+...+.            +..++..+.+++.+||..+|++|||+.++++.|+++...
T Consensus       250 -~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         250 -ELFKLLKEGHRMDK------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             -HHHHHHHcCCCCCC------------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence             11112222111110            123456788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-41  Score=326.71  Aligned_cols=237  Identities=32%  Similarity=0.475  Sum_probs=187.5

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHH-HHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVE-ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||+||+|... +|+.||+|.+.....   ...+.+..|.. +++.++||||+++++++... ...++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCC
Confidence            46999999999999976 689999999865422   22344555555 56779999999999877654 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        80 ~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (323)
T cd05575          80 GGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS  154 (323)
T ss_pred             CCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence            9999999976543    8899999999999999999999999999999999999999999999999987532221 1223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|..||......      .. ...+..+...  ..         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~-~~~i~~~~~~--~~---------  216 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EM-YDNILNKPLR--LK---------  216 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HH-HHHHHcCCCC--CC---------
Confidence            446899999999999999999999999999999999999999753211      11 1112111110  00         


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMK  378 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~  378 (438)
                        ...+..+.+++.+||+.||.+||++.
T Consensus       217 --~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 --PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              12356788999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.6e-42  Score=325.02  Aligned_cols=260  Identities=29%  Similarity=0.426  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC-Cc--EEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD-GR--IVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++... ..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-CcceE
Confidence            478889999999999999998753 33  4788887643 334456789999999999 799999999977655 46899


Q ss_pred             EEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEE
Q 013686          185 VYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      ||||+++++|.+++......            ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            99999999999999764311            124889999999999999999999999999999999999999999999


Q ss_pred             eeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHH
Q 013686          253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      +|||++........  ......+..|+|||.+.+..++.++|||||||++|||++ |..||......      .. ...+
T Consensus       161 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~-~~~~  231 (297)
T cd05089         161 ADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------EL-YEKL  231 (297)
T ss_pred             CCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHH
Confidence            99999874322111  111223567999999988889999999999999999997 99999654321      11 1112


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      ..+..     ...       +..++..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       232 ~~~~~-----~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         232 PQGYR-----MEK-------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             hcCCC-----CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11110     000       1234567889999999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.7e-42  Score=332.01  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      +|.+.+.||+|+||.||+|... +++.||+|.+....   ....+.+..|..++..+ +|++|+++++++... +.+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-DRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-CEEEEE
Confidence            4778899999999999999976 57899999987542   22334567788888887 588999999877655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EcCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999999976543    8899999999999999999999999999999999999999999999999997543221


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      . ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+.....      .+ 
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~~~~------~~-  220 (323)
T cd05616         156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNV------AY-  220 (323)
T ss_pred             C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CC-
Confidence            1 123456899999999999999999999999999999999999999754321       11112222111      01 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM-----KEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  383 (438)
                            +..++..+.+++.+||+.||.+|++.     .+++++
T Consensus       221 ------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         221 ------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                  11345678899999999999999984     666543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.2e-42  Score=321.99  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .+|...++||+|+||.||++...      ++..+++|.+........+.+.+|+++++.++|+||+++++++... ...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-RPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-CceE
Confidence            46778899999999999999742      3568999988776666677899999999999999999999977655 4689


Q ss_pred             EEEeccCCCCHHHHhhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEE
Q 013686          184 LVYEYIPNGTVADHLHNRQPN-----------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      ++|||+++++|.+++......           ...+++..++.++.|++.||+|||+.|++||||||+|||+++++.+||
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence            999999999999999865421           124789999999999999999999999999999999999999999999


Q ss_pred             eeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHH
Q 013686          253 ADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       253 ~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      +|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||........       ...
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~  236 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------IEC  236 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------HHH
Confidence            99999975533221 11222335788999999998899999999999999999998 8999864332111       111


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +..+....  .          +..++..+.+++.+||+.||++||++.||++.|+
T Consensus       237 ~~~~~~~~--~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ITQGRELE--R----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcCccCC--C----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11111100  0          0134567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-41  Score=317.28  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=206.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|.+.+.||+|+||.||+|...+    ...|++|...... ....+.+.+|+.++++++||||+++++++...  ..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN--PVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--CcE
Confidence            3467888999999999999998653    2468999876554 44567899999999999999999999976543  578


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999999976543   389999999999999999999999999999999999999999999999999986644


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ..........++..|+|||.+....++.++||||||+++|||++ |..||.......      . ...+..+....    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~-~~~~~~~~~~~----  228 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------V-IGRIENGERLP----  228 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------H-HHHHHcCCcCC----
Confidence            32222223335578999999988889999999999999999986 999997543211      1 11122211110    


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                       .       +..++..+.+++.+||..+|++|||+.+++..|+.+...
T Consensus       229 -~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         229 -M-------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             0       123456789999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=322.82  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=199.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC---------------CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD---------------GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLY  172 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~  172 (438)
                      ..+|++.+.||+|+||.||++...+               ...||+|.+... .....+.+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578899999999999999987542               235899988654 233456799999999999999999999


Q ss_pred             eeeeccCceEEEEEeccCCCCHHHHhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe
Q 013686          173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQP--------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL  244 (438)
Q Consensus       173 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill  244 (438)
                      +++... ...++||||+++++|.+++.....        ....+++..++.++.|++.||.|||++|++||||||+||++
T Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          84 GVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            977655 478999999999999999965421        11237889999999999999999999999999999999999


Q ss_pred             cCCCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh--CCCCcccCCccccc
Q 013686          245 DNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS--GLEAVDTSRHRHDI  321 (438)
Q Consensus       245 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--G~~p~~~~~~~~~~  321 (438)
                      +.++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++  |..||.........
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~  242 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI  242 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence            9999999999999986533221 11222345778999999988899999999999999999998  55677643221110


Q ss_pred             chhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                         .................    .     ...++..+.+++.+||+.||++||++.+|++.|+
T Consensus       243 ---~~~~~~~~~~~~~~~~~----~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         243 ---ENTGEFFRNQGRQIYLS----Q-----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHhhhhccccccCC----C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               00000011000000000    0     0124567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=312.06  Aligned_cols=251  Identities=29%  Similarity=0.493  Sum_probs=205.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||++... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.. ....++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEe
Confidence            357888999999999999999875 78999999876644 45788999999999999999999997765 4578999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++......  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRA--VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             cCCCcHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999999865432  389999999999999999999999999999999999999999999999999986633221  


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                        ....+..|+|||.+.+..++.++||||||+++|||++ |..||......       .....+..+....     .   
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-----~---  220 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRME-----A---  220 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCCC-----C---
Confidence              2235668999999988889999999999999999997 99998643221       1111222111100     0   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          ...++..+.+++.+||..+|++||++.+++++|+.+
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                123456789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.8e-41  Score=321.69  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=205.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      ...++|++.+.||+|+||.||++...+      ...+|+|.+... .......+.+|++++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345678889999999999999998642      367999988654 333456788999999999 799999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQ------------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       ..++++|||+++|+|.+++....            .....+++..++.++.|++.||.|||+++|+||||||+|||++.
T Consensus        89 -~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          89 -GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence             47999999999999999997542            12235889999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......     
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  242 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----  242 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-----
Confidence            999999999999866443221 1122235678999999988899999999999999999998 888886432211     


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                        ....+..+....     .       +..++..+.+|+.+||..||++|||+.|+++.|+.+.
T Consensus       243 --~~~~~~~~~~~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 --LFKLLKEGYRME-----K-------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHcCCcCC-----C-------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              111121111110     0       0123557889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-41  Score=315.35  Aligned_cols=254  Identities=25%  Similarity=0.475  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++++++..  ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEe
Confidence            46788999999999999999998777889999876543 235678899999999999999999997655  468999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++..........
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          82 MAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999999999976432  237888999999999999999999999999999999999999999999999998664332222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.......       ....+..+.....        
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~--------  224 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMPR--------  224 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCCCC--------
Confidence            223345678999999988889999999999999999999 899997532211       1112222111000        


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                          ....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       225 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                12345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.8e-41  Score=312.76  Aligned_cols=247  Identities=25%  Similarity=0.420  Sum_probs=196.3

Q ss_pred             cccccCceEEEEEEEc---CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCC
Q 013686          117 QLGDGGFGAVYLGILR---DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  192 (438)
                      .||+|+||.||+|.++   ++..||+|.+..... ...+.+.+|+.++++++||||+++++++..  ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence            3899999999999864   355799998865533 334678999999999999999999997643  3689999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc--cc
Q 013686          193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--ST  270 (438)
Q Consensus       193 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~  270 (438)
                      +|.+++.....   .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........  ..
T Consensus        80 ~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999975432   38999999999999999999999999999999999999999999999999998654332211  11


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                      ...++..|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+.... .         
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-~---------  219 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLD-C---------  219 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCC-C---------
Confidence            2234578999999988889999999999999999996 999997543211       112222221111 0         


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                        +..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus       220 --~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 --PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              113456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-41  Score=319.96  Aligned_cols=259  Identities=25%  Similarity=0.432  Sum_probs=204.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCc----EEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGR----IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|++.+.||+|+||+||+|.+. +|+    .||+|.+... .....+.+.+|+.+++.++|+||+++++++...  ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--Cc
Confidence            357888999999999999999854 444    4899988654 333456788999999999999999999977543  47


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      +++|||+++|+|.+++.....   .+++..++.++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            899999999999999976432   38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCcccc-ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVTHV-STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+..... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~-  232 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERLPQ-  232 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCCC-
Confidence            332211 112235678999999988899999999999999999998 889986432211       1112222111100 


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                                 ...++..+.+++.+||+.||++||++.++++.|+++....
T Consensus       233 -----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         233 -----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                       1134567889999999999999999999999998775443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.4e-41  Score=312.53  Aligned_cols=251  Identities=28%  Similarity=0.445  Sum_probs=195.5

Q ss_pred             CcccccCceEEEEEEEcC----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|...+    +..||+|.+... .....+.+.+|+.+++.++||||+++++++...+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998542    357999988543 344567888999999999999999999976655556899999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc---
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH---  267 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~---  267 (438)
                      +|+|.+++......   +++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++........   
T Consensus        81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHN---PTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999765432   677888899999999999999999999999999999999999999999999855332111   


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhC-CCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG-LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      ......++..|+|||.+.+..++.++|||||||++|||++| .+||.....      ..... .+..+...     ..  
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~-~~~~~~~~-----~~--  223 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITV-YLLQGRRL-----LQ--  223 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH-HHhcCCCC-----CC--
Confidence            11123457789999999888999999999999999999995 566653221      11111 11111100     00  


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                           ...++..+.+++.+||..+|++||++.|+++.|+++.
T Consensus       224 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 -----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                 0123567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-41  Score=321.22  Aligned_cols=265  Identities=28%  Similarity=0.429  Sum_probs=204.5

Q ss_pred             ChHHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeee--
Q 013686          101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTS--  176 (438)
Q Consensus       101 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~--  176 (438)
                      .++.+....++|++.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+.+++.+ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34455567889999999999999999999975 588999998754322 235678899999999 6999999999663  


Q ss_pred             --ccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          177 --RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       177 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                        ..+..+++||||+++++|.+++.........+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence              233568999999999999998875433334588999999999999999999999999999999999999999999999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHH
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN  329 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~  329 (438)
                      ||+++....... ......|++.|+|||.+..     ..++.++|||||||++|||++|+.||........       ..
T Consensus       168 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~  239 (286)
T cd06638         168 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LF  239 (286)
T ss_pred             CCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hh
Confidence            999986543221 1223458999999998853     4578899999999999999999999875322110       00


Q ss_pred             HHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ............+          ..++..+.+++.+||+.||++|||+.|+++++
T Consensus       240 ~~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KIPRNPPPTLHQP----------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hccccCCCcccCC----------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            1111110111111          12345688999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1e-41  Score=326.87  Aligned_cols=241  Identities=27%  Similarity=0.414  Sum_probs=191.3

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|..+ +|+.||+|.+....   ....+.+..|..++..+ +||||+++++++... +.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCC
Confidence            46999999999999976 58899999987542   12345667788888765 899999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|..++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 ~g~L~~~i~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05620          80 GGDLMFHIQDKGR----FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS  154 (316)
T ss_pred             CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence            9999999976543    8899999999999999999999999999999999999999999999999987432211 1223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+....      +.++     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~------~~~~-----  216 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDT------PHYP-----  216 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC------CCCC-----
Confidence            456899999999999999999999999999999999999999754321       1111111111      1111     


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMK-EVLE  382 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  382 (438)
                        ..++..+.+++.+||+.||++||++. ++++
T Consensus       217 --~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         217 --RWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence              12455688999999999999999984 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-41  Score=323.29  Aligned_cols=265  Identities=24%  Similarity=0.389  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.+.||+|+||.||++... +|..+|+|.+... .....+.+.+|++++++++||||+++++++..+ +.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-GEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CEEEEEee
Confidence            36889999999999999999976 5888999987654 233346788999999999999999999977665 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |+++++|.+++.....    +++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++....... 
T Consensus        80 y~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          80 HMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             ccCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999999987543    8899999999999999999997 599999999999999999999999999987553321 


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc---------
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN---------  337 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------  337 (438)
                        .....+++.|+|||.+.+..++.++|||||||++|||++|+.||.........   .............         
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE---AMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH---HhhcCccccccccCCcccccCC
Confidence              22346889999999998888999999999999999999999998643211100   0000000000000         


Q ss_pred             -----------ccccCcCCCC-ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          338 -----------ELVDPSLGFE-KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       338 -----------~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                                 +..+...... .......++..+.+++.+||..||++|||+.|++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                       0000000000 00000124567899999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.4e-41  Score=319.25  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .+|.+.+.||+|+||.||+|...      +++.||+|++..... ...+.+.+|+.++..++||||+++++++.... ..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-PL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-ce
Confidence            34667889999999999999863      257899999875433 23467889999999999999999999776554 68


Q ss_pred             EEEEeccCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          183 LLVYEYIPNGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      ++++||+.+++|.+++.....            ....+++..+..++.|++.||.|||++||+||||||+|||+++++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence            999999999999999864321            11247888899999999999999999999999999999999999999


Q ss_pred             EEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHH
Q 013686          251 KVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       251 kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~  328 (438)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......      . ..
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~~  236 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D-VI  236 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H-HH
Confidence            9999999886533221 11223346789999999988889999999999999999998 88888643221      1 11


Q ss_pred             HHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                      ..+..+.....            +..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       237 ~~i~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQVLPC------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCCcCCC------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22222221110            12356678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.1e-41  Score=320.65  Aligned_cols=265  Identities=24%  Similarity=0.423  Sum_probs=201.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-----------------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCcee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-----------------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVK  170 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  170 (438)
                      .++|++.+.||+|+||.||++...                 ++..||+|.+.... ....+.+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357889999999999999998532                 23468999887543 334568899999999999999999


Q ss_pred             EeeeeeccCceEEEEEeccCCCCHHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 013686          171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN-------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL  243 (438)
Q Consensus       171 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nil  243 (438)
                      +++++... +..++||||+++++|.+++......       ...+++..+..++.|++.||+|||++|++||||||+|||
T Consensus        84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          84 LLAVCITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEecC-CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99977655 4689999999999999999865422       124778899999999999999999999999999999999


Q ss_pred             ecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh--CCCCcccCCcccc
Q 013686          244 LDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS--GLEAVDTSRHRHD  320 (438)
Q Consensus       244 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--G~~p~~~~~~~~~  320 (438)
                      ++.++.++|+|||+++.+...... ......++..|++||...+..++.++|||||||++|||++  |..||........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            999999999999999865332211 1122334678999999888889999999999999999998  6678864332111


Q ss_pred             cchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          321 INLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                      .   ................ +.        ...++..+.+++.+||+.||++||++.+|++.|++
T Consensus       243 ~---~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 I---ENTGEFFRDQGRQVYL-PK--------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHhhccccccC-CC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   0000111111000000 00        01245678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.8e-41  Score=320.24  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=204.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|.+.+.||+|+||.||++...      .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++... +
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-G  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-C
Confidence            467889999999999999999742      24579999886543 33456789999999999 799999999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+++|+|.++++....  ..+++..+..++.|++.||.|||+++++|+||||+|||++.++.++|+|||++..
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            78999999999999999976432  2389999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          261 FPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       261 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......      .....+..+....
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~  264 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRMA  264 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcCC
Confidence            5433221 1222346788999999998899999999999999999998 999986432211      1111111111000


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                           .       ....+..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus       265 -----~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         265 -----Q-------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----C-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 0       012345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.6e-42  Score=334.00  Aligned_cols=268  Identities=21%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-----C
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-----S  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  179 (438)
                      ..++|++.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...     .
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999965 5889999998653  233456788999999999999999999866432     2


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...|+||||++ ++|.+++...      +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHhc------CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            35799999995 5787777532      7888999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH--------HHHHH-
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN--------MATNK-  330 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------~~~~~-  330 (438)
                      ......  ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.............        ..... 
T Consensus       175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            654322  1233468999999999999999999999999999999999999997543221110000        00000 


Q ss_pred             -------Hhc-Cccccc----ccCcCCCCc-cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          331 -------IQN-GALNEL----VDPSLGFEK-DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       331 -------~~~-~~~~~~----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                             ... ......    ..+...... ..........+.+|+.+||+.||.+|||+.|++++-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence                   000 000000    000000000 000112345688999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.7e-41  Score=320.64  Aligned_cols=262  Identities=25%  Similarity=0.395  Sum_probs=206.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .++|.+.+.||+|+||.||++...        ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            567888999999999999999742        2457999988654 234457789999999999 799999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       ...++||||+++|+|.+++......            ...+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus        94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~  172 (304)
T cd05101          94 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE  172 (304)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence             4789999999999999999865321            124788899999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......      
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------  246 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------  246 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------
Confidence            999999999999866433222 1222345678999999988889999999999999999998 77888643211      


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      . ....+..+.....            ...++..+.+++.+||+.+|.+|||+.|+++.|+++...
T Consensus       247 ~-~~~~~~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 E-LFKLLKEGHRMDK------------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H-HHHHHHcCCcCCC------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1 1112222211100            113456788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.9e-41  Score=311.32  Aligned_cols=251  Identities=25%  Similarity=0.450  Sum_probs=203.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|++|.||++..+ +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+......++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999976 57899999986432  23456788999999999999999999866555556899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....  ..+++..++.++.|++.||.+||+.|++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-  157 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence            9999999999986432  2389999999999999999999999999999999999999999999999999986643322 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ..... .+..+....     .   
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~-~~~~~~~~~-----~---  222 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVY-RIIEGKLPP-----M---  222 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHH-HHHhcCCCC-----C---
Confidence            22344588999999999999999999999999999999999999874321      11111 122222111     1   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          +..++..+.+++.+||+.||++||++.+++++
T Consensus       223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                12355678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.6e-41  Score=320.98  Aligned_cols=264  Identities=28%  Similarity=0.444  Sum_probs=203.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-----------------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCcee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-----------------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVK  170 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  170 (438)
                      ..+|.+.+.||+|+||.||++...+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999988542                 2468999887543 344578899999999999999999


Q ss_pred             EeeeeeccCceEEEEEeccCCCCHHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 013686          171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN-------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL  243 (438)
Q Consensus       171 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nil  243 (438)
                      +++++..+ ...+++|||+++++|.+++......       ...+++..++.++.|++.||.|||++|++||||||+||+
T Consensus        84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99977655 5789999999999999999775421       124899999999999999999999999999999999999


Q ss_pred             ecCCCeEEEeeeCcccccCCCc-cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh--CCCCcccCCcccc
Q 013686          244 LDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS--GLEAVDTSRHRHD  320 (438)
Q Consensus       244 l~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--G~~p~~~~~~~~~  320 (438)
                      ++.++.++|+|||+++...... ........+++.|+|||.+.+..++.++|||||||++|||++  |..||....... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-  241 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence            9999999999999998653322 122233446789999999988889999999999999999998  667775432111 


Q ss_pred             cchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          321 INLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                        ...................         ....++.++.+++.+||+.||++|||+.||++.|+
T Consensus       242 --~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 --VIENAGHFFRDDGRQIYLP---------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHhccccccccccCC---------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              0011111100000000000         01234567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-41  Score=320.09  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      |+..+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+.++++++|+|++++++.+... +..++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEEE
Confidence            667789999999999999976 689999998865422   2234577899999999999999999877655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++......  .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~g~~L~~~l~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEA--GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             ecCCCcHHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999998654332  388999999999999999999999999999999999999999999999999876543222 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.........   .... ..... ...    .    
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~-~~~~~-~~~----~----  223 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVE-RLVKE-VQE----E----  223 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHH-hhhhh-hhh----h----
Confidence             12346899999999999889999999999999999999999999754321100   0000 00000 000    0    


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEIL  384 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  384 (438)
                         ....++..+.+|+.+||+.||++|||     ++|++++-
T Consensus       224 ---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~  262 (285)
T cd05630         224 ---YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP  262 (285)
T ss_pred             ---cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence               01234567889999999999999999     88988753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.3e-41  Score=320.48  Aligned_cols=251  Identities=26%  Similarity=0.433  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..+|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.+.|+||+++++++... ...++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeec
Confidence            357888999999999999999965 6899999998766555567889999999999999999999977654 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++....     +++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........ 
T Consensus        98 ~~~~~~L~~~~~~~~-----~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654          98 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             ccCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            999999999986532     78899999999999999999999999999999999999999999999999876533221 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........     . ......+ .     +.+.  
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~-~~~~~~~-~-----~~~~--  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----L-YLIATNG-T-----PELQ--  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----H-HHHhcCC-C-----CCCC--
Confidence            12234588999999999988899999999999999999999999965432110     0 0011110 0     0000  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         .+..++..+.+++.+||..||++||++.+++++
T Consensus       238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ---CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence               012355678899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-42  Score=333.41  Aligned_cols=238  Identities=26%  Similarity=0.351  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEE----cCCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          116 KQLGDGGFGAVYLGIL----RDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+.+|++++++++||||+++++++... ...|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcCC
Confidence            5799999999999875    2578999999875432  2345677899999999999999999977655 4799999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~  155 (318)
T cd05582          81 RGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA  155 (318)
T ss_pred             CCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence            99999999976543    89999999999999999999999999999999999999999999999999886533321 12


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+.....        ..   
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~~~~--------~~---  217 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILKAKL--------GM---  217 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHcCCC--------CC---
Confidence            3356899999999999888999999999999999999999999754321       11111211111        00   


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKE  379 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  379 (438)
                        +..++..+.+++.+||+.||++||++.+
T Consensus       218 --p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 --PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              0124567889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-41  Score=313.48  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=202.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      +|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++... ..++++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEee
Confidence            4778899999999999999976 6899999988543 334557788999999999999999999977555 579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....  ..+++.....++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ .
T Consensus        80 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          80 CDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            999999999875432  2378999999999999999999999999999999999999999999999999986643221 1


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......      .. ...+..+.....         
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~~---------  220 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NL-ILKVCQGSYKPL---------  220 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HH-HHHHhcCCCCCC---------
Confidence            22345889999999999889999999999999999999999999753211      11 112222221111         


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         +..++..+.+++.+||+.||++||++.+++..
T Consensus       221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               11245568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.9e-41  Score=325.30  Aligned_cols=199  Identities=26%  Similarity=0.418  Sum_probs=162.2

Q ss_pred             CCcccccCceEEEEEEEc---CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceEEEEEeccC
Q 013686          115 SKQLGDGGFGAVYLGILR---DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSRELLLVYEYIP  190 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  190 (438)
                      .++||+|+||+||+|..+   +++.||+|.+.....  ...+.+|+.++++++||||+++++++.. .+...+++|||+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence            568999999999999865   467899998865432  2456789999999999999999996643 345689999999 


Q ss_pred             CCCHHHHhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe----cCCCeEEEeeeCccccc
Q 013686          191 NGTVADHLHNRQP-----NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF  261 (438)
Q Consensus       191 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgla~~~  261 (438)
                      +++|.+++.....     ....+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            4689888764321     11248899999999999999999999999999999999999    45678999999999876


Q ss_pred             CCCccc--cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCC
Q 013686          262 PTDVTH--VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSR  316 (438)
Q Consensus       262 ~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~  316 (438)
                      ......  ......+|+.|+|||.+.+ ..++.++||||+||++|||++|++||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            543221  1234568999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=314.33  Aligned_cols=264  Identities=28%  Similarity=0.425  Sum_probs=197.2

Q ss_pred             CCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHh--CCCCCceeEeeeeecc---CceEEEEE
Q 013686          112 FNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK--LQHPNLVKLYGCTSRQ---SRELLLVY  186 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~---~~~~~lv~  186 (438)
                      .+..++||+|.||.||+|.+. ++.||||++...   ..+.|.+|-++.+.  ++|+||+++++.....   ..+++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            345678999999999999995 699999988544   34668888888876  4799999999844322   23799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS---------DVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      ||.+.|+|.++|..+.     ++|....+|+.-+++||+|||+.         .|+|||||.+||||.+|++..|+||||
T Consensus       288 ~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999998865     89999999999999999999974         599999999999999999999999999


Q ss_pred             ccccCCCccc-cccCCCCCCCccCccccccC-CCC-----ChhhHHHHHHHHHHHHhCCCCccc-CCcccccc-------
Q 013686          258 SRLFPTDVTH-VSTAPQGTPGYVDPDYFQCY-KLT-----DKSDVYSFGVVLIELISGLEAVDT-SRHRHDIN-------  322 (438)
Q Consensus       258 a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~-----~~~Dvws~Gv~l~el~tG~~p~~~-~~~~~~~~-------  322 (438)
                      |..+...... .....+||.+|||||++.+. .+.     .+.||||+|.+||||++....+.. ..+.....       
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9977543322 22346799999999999774 233     268999999999999997655432 11111111       


Q ss_pred             ---hhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          323 ---LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       323 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                         +..+....+.+     ...|.++..  +........+.+.+..||..||+.|.|+.=+.+++..+....
T Consensus       443 hPt~e~mq~~VV~k-----K~RP~~p~~--W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  443 HPTLEEMQELVVRK-----KQRPKIPDA--WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCCHHHHHHHHHhh-----ccCCCChhh--hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence               11111111221     122222111  111134566889999999999999999999988888775433

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-41  Score=328.56  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++..+ +++.||+|.+.+..   ....+.+.+|+.++..++|+||+++++++... ..+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEE
Confidence            46888999999999999999976 47889999986432   22334588899999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.+...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999986432   28999999999999999999999999999999999999999999999999987654333


Q ss_pred             cccccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          266 THVSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......      .. ...+......   
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~-~~~i~~~~~~---  226 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ET-YGKIMNHKER---  226 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HH-HHHHhCCCcc---
Confidence            32233456999999999986     346888999999999999999999999753221      11 1112111100   


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM--RPTMKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  383 (438)
                         ...  +.....++..+.+++.+|+..++.+  |++++|++++
T Consensus       227 ---~~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 ---FQF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---ccC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence               000  0011235677889999988665444  7899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-41  Score=350.53  Aligned_cols=263  Identities=23%  Similarity=0.371  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|.+.++||+|+||.||+|... +|+.||+|++...   .....+++.+|++++++++||||+++++++... +..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEE
Confidence            57889999999999999999976 5899999998653   223346789999999999999999999977654 478999


Q ss_pred             EeccCCCCHHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          186 YEYIPNGTVADHLHNRQPN-------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      |||++||+|.+++......       ...+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999998753111       123567788999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc-----------------ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc
Q 013686          259 RLFPTDVT-----------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI  321 (438)
Q Consensus       259 ~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~  321 (438)
                      +.......                 .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ 
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-
Confidence            86521100                 011124589999999999999999999999999999999999999975322110 


Q ss_pred             chhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhcc
Q 013686          322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-TMKEVLEILRETKDS  390 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~  390 (438)
                           ...    ...   .++.. .   .....++..+.+++.+||+.||++|| +++++++.|+.....
T Consensus       240 -----~~~----~~i---~~P~~-~---~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        240 -----SYR----DVI---LSPIE-V---APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             -----hhh----hhc---cChhh-c---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                 000    000   00000 0   00124567788999999999999995 677888888776543

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-41  Score=311.31  Aligned_cols=248  Identities=28%  Similarity=0.464  Sum_probs=198.0

Q ss_pred             CcccccCceEEEEEEEcC----CcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRD----GRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|.+..    +..+|+|.+..... ...+.+.+|+++++.+.|+||+++++++..  ...++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence            469999999999998542    26899999875543 345678999999999999999999996643  36899999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc-
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS-  269 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-  269 (438)
                      +++|.+++.....    +++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.......... 
T Consensus        79 ~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          79 LGPLLKYLKKRRE----IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CCcHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            9999999987652    89999999999999999999999999999999999999999999999999986643322211 


Q ss_pred             -cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          270 -TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       270 -~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |..||......      . ....+.......         
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~------~-~~~~~~~~~~~~---------  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA------E-VIAMLESGERLP---------  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH------H-HHHHHHcCCcCC---------
Confidence             11224568999999998899999999999999999998 99999653221      1 111222211100         


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                         .+..++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus       219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence               01234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-41  Score=321.80  Aligned_cols=261  Identities=27%  Similarity=0.441  Sum_probs=203.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      ..++|++.+.||+|+||.||+|..++      +..||+|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-Q   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence            45789999999999999999997542      4589999876443 23345688899999999999999999976555 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                      ..++||||+++|+|.+++......      ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            789999999999999999764321      12356778899999999999999999999999999999999999999999


Q ss_pred             eCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHh
Q 013686          255 FGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       255 fgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      ||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......      . ....+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~-~~~~~~  235 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------Q-VLKFVM  235 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHH
Confidence            999985533221 11122235678999999998899999999999999999998 78888643221      1 111111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      .+.....            ...++..+.+++.+||+.||++|||+.++++.|++..
T Consensus       236 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGGYLDQ------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCCCCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111110            0123467899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.6e-42  Score=333.46  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=197.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++..+ +++.||+|.+....   ....+.+.+|+.++..++|+||+++++++... ..+++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-RNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence            46888999999999999999976 58999999986532   23346788899999999999999999977654 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EeCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999999976543    8999999999999999999999999999999999999999999999999987542210


Q ss_pred             c----------------------------------ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCC
Q 013686          266 T----------------------------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA  311 (438)
Q Consensus       266 ~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p  311 (438)
                      .                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  001134689999999999999999999999999999999999999


Q ss_pred             cccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 013686          312 VDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT---MKEVLEI  383 (438)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  383 (438)
                      |.......       ....+........+.+.         ..++..+.+++.+|+ .||.+|++   +.|++++
T Consensus       236 f~~~~~~~-------~~~~i~~~~~~~~~p~~---------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         236 FCSETPQE-------TYRKVMNWKETLVFPPE---------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCHHH-------HHHHHHcCCCceecCCC---------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            97543211       11112111000001110         124556788998876 49999985   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=314.06  Aligned_cols=248  Identities=26%  Similarity=0.452  Sum_probs=207.9

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      |.++++||+|+||.||++.++ .|+.+|||.+...  .+.+++..|+.+|+++..|++|++||.++... .+|+|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-DLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-DLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-ceEeehhhcC
Confidence            556789999999999999987 5999999987544  45678899999999999999999999776654 6999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      .|++.+.++.+..   .+.+.++..+++..++||+|||...-+|||||+.|||++.+|.+||+|||.+..+.+.. ....
T Consensus       112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN  187 (502)
T KOG0574|consen  112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN  187 (502)
T ss_pred             CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence            9999999987765   39999999999999999999999999999999999999999999999999998664332 2344


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      +..|||.|||||++..-.|+.++||||||++..||..|++||....+...+              +.-...|...+..  
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMIPT~PPPTF~K--  251 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMIPTKPPPTFKK--  251 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------EeccCCCCCCCCC--
Confidence            567999999999999999999999999999999999999999754332111              0001122222222  


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       ++..+.++.++++.||-++|++|-|+-+++++
T Consensus       252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence             35677889999999999999999999999986

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.9e-41  Score=313.40  Aligned_cols=255  Identities=27%  Similarity=0.472  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-C---CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-D---GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|++.+.||+|+||.||+|... +   +..+|+|.+.... ....+.+.+|+.++++++||||+++++++... +..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEE
Confidence            56888999999999999999864 2   3379999886543 33456889999999999999999999977654 57899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....   .+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999999976542   3789999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccc--CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          265 VTHVST--APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       265 ~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ......  ...++..|+|||.+.+..++.++|+||||+++||+++ |..||.......       ....+..+..     
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~-----  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYR-----  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCc-----
Confidence            222211  1223568999999998899999999999999999886 999987543211       1111221110     


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ...       ...++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       228 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 LPA-------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCC-------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            000       013456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=334.24  Aligned_cols=244  Identities=23%  Similarity=0.441  Sum_probs=201.6

Q ss_pred             cccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHH
Q 013686          117 QLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVA  195 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~  195 (438)
                      +||+|.||+||-|++.+ ...+|||.+...+....+-+.+|+.+.++|+|.|||+++|++.++ +.+-|.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-Gf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-GFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-CeEEEEeecCCCCcHH
Confidence            79999999999999764 567999999888888888999999999999999999999976555 4788999999999999


Q ss_pred             HHhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec-CCCeEEEeeeCcccccCCCccccccCC
Q 013686          196 DHLHNRQPNSCLL--PWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAP  272 (438)
Q Consensus       196 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~  272 (438)
                      ++|+..-..   +  .+...-.+.+||++||.|||+..|||||||-+||||+ -.|.+||+|||-++.+.. ......+.
T Consensus       661 sLLrskWGP---lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF  736 (1226)
T KOG4279|consen  661 SLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF  736 (1226)
T ss_pred             HHHHhccCC---CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence            999875432   4  6777888999999999999999999999999999996 578999999999886632 33445567


Q ss_pred             CCCCCccCccccccC--CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          273 QGTPGYVDPDYFQCY--KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       273 ~g~~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      .||..|||||++..+  .|..++|||||||++.||.||++||-.......        ..+.-|-+.  +-|.       
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmyK--vHP~-------  799 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMYK--VHPP-------  799 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhccee--cCCC-------
Confidence            799999999999764  589999999999999999999999964332211        111111111  1111       


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  382 (438)
                      .+..++.+.+.+|.+|+.+||.+||+++++|.
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            24678889999999999999999999999987

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.7e-41  Score=312.12  Aligned_cols=250  Identities=28%  Similarity=0.503  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ++|++.+.||+|+||.||+|...+ ++.|++|.+.....  .+.+.+|+++++.++|+||+++++++... ...|+++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEec
Confidence            578889999999999999999874 78999998865533  67899999999999999999999977665 579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....   .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++........ .
T Consensus        80 ~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (256)
T cd06612          80 CGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K  155 (256)
T ss_pred             CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence            999999999976432   389999999999999999999999999999999999999999999999999986643321 1


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........       ..+....     .+.+    
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~-----~~~~----  219 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKP-----PPTL----  219 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCC-----CCCC----
Confidence            22344788999999999889999999999999999999999999753221110       0000000     0000    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       .....++..+.+++.+||+.||++|||+.|++++
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             0123456678999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-41  Score=324.88  Aligned_cols=261  Identities=29%  Similarity=0.439  Sum_probs=202.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCc--EEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGR--IVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|.++ ++.  .+++|.+.... ....+.+.+|++++.++ +|+||+++++++... ..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCce
Confidence            357888999999999999999975 454  45777765432 33456788999999999 899999999977655 4799


Q ss_pred             EEEeccCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          184 LVYEYIPNGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                      +||||+++++|.+++.....            ....+++..++.++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence            99999999999999976532            112478999999999999999999999999999999999999999999


Q ss_pred             EeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHH
Q 013686          252 VADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       252 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      |+|||++.......  ......++..|+|||.+.+..++.++|||||||++|||+| |..||......      .. ...
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~-~~~  235 (303)
T cd05088         165 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL-YEK  235 (303)
T ss_pred             eCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HH-HHH
Confidence            99999986432111  1111234668999999988889999999999999999998 99998643221      11 111


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      +..+.     ....       +..++..+.+++.+||+.+|++||++.+++..|+.+....
T Consensus       236 ~~~~~-----~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         236 LPQGY-----RLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HhcCC-----cCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11110     0000       0124556889999999999999999999999998875544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-41  Score=335.95  Aligned_cols=264  Identities=21%  Similarity=0.252  Sum_probs=196.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ...|.+.+.||+|+||.||++... .++.||||....      ..+.+|++++++++|+||+++++++... +..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEE
Confidence            346899999999999999999976 478999996422      3456799999999999999999976655 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ++ .++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       241 ~~-~~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KY-RSDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             cc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            99 5799998876432   3899999999999999999999999999999999999999999999999999865432211


Q ss_pred             -cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCccc-CCcccccchhHHHHHHHhcCccc--ccc---
Q 013686          268 -VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT-SRHRHDINLSNMATNKIQNGALN--ELV---  340 (438)
Q Consensus       268 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~--~~~---  340 (438)
                       ......||+.|+|||++.+..++.++|||||||+||||++|..|+-. ..............+.+......  +..   
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence             12234699999999999999999999999999999999998765432 22111111111112222211100  000   


Q ss_pred             ----------------cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          341 ----------------DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       341 ----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                                      .+................+.+|+.+||+.||.+|||+.|+|++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                            0000000000111334578899999999999999999999986

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.6e-41  Score=315.54  Aligned_cols=251  Identities=32%  Similarity=0.563  Sum_probs=201.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .+|++.+.||+|+||.||++...+++.+|+|.+...... .+.+.+|++++++++|||++++++++... ...++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEcC
Confidence            467788999999999999999877889999988654332 35788999999999999999999976555 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++.....   .+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999976543   278999999999999999999999999999999999999999999999999886543322222


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..||......      . ....+..+.  ....+.     
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~--~~~~~~-----  224 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------E-VVETINAGF--RLYKPR-----  224 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------H-HHHHHhCCC--CCCCCC-----
Confidence            23335678999999998899999999999999999998 99998743221      1 111111111  011111     


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                           ..+..+.+++.+||+.+|++|||+.++++.|
T Consensus       225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 1346788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.2e-41  Score=316.80  Aligned_cols=252  Identities=27%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|||++++++++... ...++||||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEec
Confidence            3567889999999999999976 4788999988766666678899999999999999999999977655 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|..++.....   .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ ..
T Consensus        85 ~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~  160 (282)
T cd06643          85 AGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  160 (282)
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence            99999998875332   389999999999999999999999999999999999999999999999999876533221 12


Q ss_pred             cCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          270 TAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ....+++.|+|||.+.     +..++.++|||||||++|||++|++||......      ..... +.......     +
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~-----~  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPT-----L  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHH-HhhcCCCC-----C
Confidence            3345889999999884     446788999999999999999999998643211      11111 11111111     0


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ..     +..++..+.+++.+||+.||.+||++.+++++-
T Consensus       229 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         229 AQ-----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            00     123456789999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=315.97  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|++.+.||+|+||.||+|..++      +..||+|.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CC
Confidence            4678899999999999999998652      3689999986543 34456788999999999999999999977655 57


Q ss_pred             EEEEEeccCCCCHHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeee
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPN------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                      .++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+.+++||||||+|||++.++.+||+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence            89999999999999999764321      123788899999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhc
Q 013686          256 GLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       256 gla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~  236 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVID  236 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHhc
Confidence            99886533221 12223346789999999988889999999999999999998 899986433211       1111111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +....     .+       ..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       237 ~~~~~-----~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGHLD-----LP-------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCC-----CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111     11       123567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-40  Score=312.15  Aligned_cols=256  Identities=29%  Similarity=0.500  Sum_probs=202.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CC---cEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DG---RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|+..+.||+|+||.||+|... ++   ..+++|.+... .....+.+.+|++++++++|+|++++++++... ...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-KPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-CCcE
Confidence            346778899999999999999975 33   37999988654 334457789999999999999999999977655 4789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++++|.+++.....   .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          83 IITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999999976432   389999999999999999999999999999999999999999999999999986543


Q ss_pred             Ccccccc--CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          264 DVTHVST--APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       264 ~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      .......  ....+..|+|||.+.+..++.++|||||||++|||++ |+.||......      . ....+..+...   
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~-~~~~i~~~~~~---  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------E-VMKAINDGFRL---  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------H-HHHHHhcCCCC---
Confidence            2221111  1223567999999988889999999999999999998 99999643321      1 11222211100   


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                       +   .     ...++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 -~---~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 -P---A-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -C---C-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0   0     113456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.2e-42  Score=330.54  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|..++..++|+||+++++++... +..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-NYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence            47889999999999999999976 58899999986532   22345688899999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999986432   28899999999999999999999999999999999999999999999999998765443


Q ss_pred             cccccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          266 THVSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ........|++.|+|||.+.+     ..++.++|||||||++|||++|+.||......      . ....+........+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~~~~  229 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------E-TYGKIMNHEERFQF  229 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------H-HHHHHHcCCCcccC
Confidence            332333569999999999875     46788999999999999999999999743221      1 11111111100000


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM--RPTMKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  383 (438)
                      ..        ....++..+.+++.+|+..++.+  |+++++++++
T Consensus       230 p~--------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 PS--------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CC--------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00        11235667889999999876554  4688888875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.5e-41  Score=319.72  Aligned_cols=251  Identities=26%  Similarity=0.441  Sum_probs=204.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..+|++.+.||+|+||.||++... +|+.||+|.+........+.+.+|+.+++.++|+||+++++++... +..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEeec
Confidence            467889999999999999999964 6899999998766555567788999999999999999999977654 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.+..     +++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.........
T Consensus        97 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          97 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             ccCCCCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            999999999986532     788999999999999999999999999999999999999999999999998765433221


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||..........       .+....     .+.+.  
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~~~~~-----~~~~~--  236 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNG-----TPELQ--  236 (297)
T ss_pred             -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------eeccCC-----CCCCC--
Confidence             223458889999999998889999999999999999999999997543211100       000000     00000  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         .+..++..+.+++.+||+.||++||++++++++
T Consensus       237 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         237 ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               112345668899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.9e-41  Score=314.98  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++... +..++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e   86 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICME   86 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEe
Confidence            356778899999999999999865 5889999998766555556788999999999999999999977655 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....    +++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          87 FCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             ccCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            9999999999976543    89999999999999999999999999999999999999999999999999876543221 


Q ss_pred             cccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          268 VSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|..||.........      . .......   ..+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~-~~~~~~~---~~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMTKSNF---QPPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------H-hhhccCC---CCCcc
Confidence            123346899999999874   456888999999999999999999998643221100      0 0111100   00100


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..     ...++..+.+++.+||+.+|++||++++++++
T Consensus       232 ~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KD-----KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc-----cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00     01234568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-40  Score=316.45  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=201.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .+.|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++++..+ ..+++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-GKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-CeEEEEEe
Confidence            467889999999999999999976 4899999998877666678899999999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|..++.+...   .+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++....... .
T Consensus        90 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~  165 (292)
T cd06644          90 FCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q  165 (292)
T ss_pred             cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence            9999999988865432   28999999999999999999999999999999999999999999999999987543221 1


Q ss_pred             cccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          268 VSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ......+++.|+|||.+.     ...++.++|||||||++|||++|..||......      . ....+.......    
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~~----  234 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R-VLLKIAKSEPPT----  234 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------H-HHHHHhcCCCcc----
Confidence            122345788999999884     345788999999999999999999998643211      1 111111111111    


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       ...     ...++..+.+++.+||..||++||++++++++
T Consensus       235 -~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         235 -LSQ-----PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -CCC-----CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             100     12345568899999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.2e-41  Score=314.40  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=199.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc-----Cc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ-----SR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~  180 (438)
                      +.+.|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...     ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999976 58899999886543 2345688899999998 699999999976543     23


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+++++|.+++.....  ..+++..+..++.|++.||.|||+++|+|+||||+||++++++.+||+|||++..
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            68999999999999999986432  2388999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA  335 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (438)
                      ...... ......|++.|+|||.+.     +..++.++|||||||++|||++|..||.......       .........
T Consensus       161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~~~  232 (272)
T cd06637         161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNP  232 (272)
T ss_pred             cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhcCC
Confidence            543221 223446889999999986     3457889999999999999999999996432110       001111111


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .....           ...++..+.+|+.+||..||.+|||+.|++++
T Consensus       233 ~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         233 APRLK-----------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCCCC-----------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            11110           11245678899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3e-41  Score=317.66  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=201.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||.||+|.+.+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.... .
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-P   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-C
Confidence            4678899999999999999999753      5678999876443 233457899999999999999999999766554 6


Q ss_pred             EEEEEeccCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---eEEEeee
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---RVKVADF  255 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---~~kl~Df  255 (438)
                      .++||||+++++|.+++......   ...+++..++.++.||+.||.|||+++++||||||+||+++.++   .+||+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence            89999999999999999765421   12489999999999999999999999999999999999998654   5999999


Q ss_pred             CcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhc
Q 013686          256 GLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       256 gla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||.......      . ...+..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~-~~~~~~  236 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------V-MEFVTG  236 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHHc
Confidence            999865322111 1112234568999999998899999999999999999997 999997543221      1 111111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .....     .       +..++..+.+++.+||+.+|++||++.+|+++|+
T Consensus       237 ~~~~~-----~-------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGRLD-----P-------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCcCC-----C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11000     0       1234567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-41  Score=315.90  Aligned_cols=253  Identities=33%  Similarity=0.563  Sum_probs=198.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhH--HHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      |++.+.||+|+||+||++... +++.||+|.+........  ....+|+.++++++||||+++++++... ...++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-NYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-SEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-ccccccccc
Confidence            456789999999999999977 467899999987654433  2345699999999999999999977664 578999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....    +++..+..++.||++||.+||+.+++|+||||+||++++++.++|+|||.+.... .....
T Consensus        80 ~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~  154 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKP----LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN  154 (260)
T ss_dssp             ETTEBHHHHHHHHSS----BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred             ccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc
Confidence            999999999984433    8999999999999999999999999999999999999999999999999997642 22223


Q ss_pred             ccCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+. +..++.++||||+|+++|+|++|..||..........   ....... ........      
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~-~~~~~~~~------  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE---IIEKILK-RPLPSSSQ------  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH---HHHHHHH-THHHHHTT------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhh---hhhhccc-cccccccc------
Confidence            34456899999999998 8889999999999999999999999998651111110   1111110 00000000      


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         ........+.+++.+||+.||++||++.+++++
T Consensus       225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000113679999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.6e-41  Score=320.32  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .++|.+.+.||+|+||.||++...        .+..+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467889999999999999999742        24579999886542 34456788999999999 699999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       ...+++|||+++|+|.+++.....            ....+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus        91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence             468999999999999999976432            1134889999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......      
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------  243 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE------  243 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH------
Confidence            999999999999865432111 1112234568999999988899999999999999999999 88888643211      


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                       .....+..+.....            +..++..+.+++.+||..||++|||+.|+++.|+++..
T Consensus       244 -~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 -ELFKLLREGHRMDK------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -HHHHHHHcCCCCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence             11122222211110            11345578899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.2e-42  Score=329.35  Aligned_cols=241  Identities=30%  Similarity=0.438  Sum_probs=188.2

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHH-HHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVE-ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++... +++.||+|.+.....   .....+..|.. +++.++||||+++++++... +..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCC
Confidence            46999999999999976 578899999865422   22234444444 56788999999999977655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 ~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~  154 (325)
T cd05602          80 GGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS  154 (325)
T ss_pred             CCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence            9999999976543    7888888999999999999999999999999999999999999999999987542221 1223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|..||......      .. ...+......  ..         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-~~~i~~~~~~--~~---------  216 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EM-YDNILNKPLQ--LK---------  216 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HH-HHHHHhCCcC--CC---------
Confidence            456899999999999999999999999999999999999999753321      11 1111111110  01         


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  382 (438)
                        ..++..+.+++.+||+.||.+||++.+.+.
T Consensus       217 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         217 --PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             --CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence              134567889999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.9e-41  Score=319.14  Aligned_cols=266  Identities=29%  Similarity=0.411  Sum_probs=206.4

Q ss_pred             ccChHHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeee
Q 013686           99 VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTS  176 (438)
Q Consensus        99 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  176 (438)
                      .+.+.++..+.++|.+.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+.+++++ +|||++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            4455666667889999999999999999999975 688999998865422 235677899999999 7999999999765


Q ss_pred             ccC----ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEE
Q 013686          177 RQS----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       177 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      ..+    ...++||||+++++|.++++........+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence            432    3689999999999999998754333334899999999999999999999999999999999999999999999


Q ss_pred             eeeCcccccCCCccccccCCCCCCCccCccccccC-----CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH
Q 013686          253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY-----KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA  327 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~  327 (438)
                      +|||++......... .....++..|+|||.+...     .++.++|||||||++|||++|+.||........       
T Consensus       170 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-------  241 (291)
T cd06639         170 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-------  241 (291)
T ss_pred             eecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-------
Confidence            999998865432211 2234578999999988543     368899999999999999999999974322110       


Q ss_pred             HHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          328 TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...+.........+          ....+..+.+++.+||+.+|++||++.|++++
T Consensus       242 ~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 LFKIPRNPPPTLLH----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHhcCCCCCCCc----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            01111111111111          12244568999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-40  Score=321.73  Aligned_cols=263  Identities=25%  Similarity=0.385  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC--------CcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD--------GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      ..+|++.+.||+|+||.||++....        +..||+|.+... .....+.+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            4578899999999999999997421        236899987643 234457889999999999 799999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       ...+++|||+++|+|.+++.....            ....+++..+..++.|++.||.|||++|++||||||+|||++.
T Consensus        91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence             478999999999999999976432            1234788999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......      
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  243 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------  243 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH------
Confidence            999999999999865432211 1122234568999999999899999999999999999998 88888643211      


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      . ....+..+.....            +..++..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus       244 ~-~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 E-LFKLLKEGHRMDK------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             H-HHHHHHcCCCCCC------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            1 1112222111110            0134557889999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-40  Score=309.22  Aligned_cols=248  Identities=29%  Similarity=0.484  Sum_probs=199.3

Q ss_pred             CcccccCceEEEEEEEcC--C--cEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRD--G--RIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+..  ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999998653  3  3699999877655 556789999999999999999999997765  57899999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc--c
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH--V  268 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~--~  268 (438)
                      +++|.+++.....  ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........  .
T Consensus        79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999999987643  24899999999999999999999999999999999999999999999999999876442211  1


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......      ..........       .... 
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~-------~~~~-  222 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGE-------RLER-  222 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC-------cCCC-
Confidence            122346789999999998899999999999999999999 999986432211      1111111110       0000 


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                          ....+..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 ----PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                1124567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.1e-41  Score=316.10  Aligned_cols=258  Identities=29%  Similarity=0.469  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|++.+.||+|+||.||++...      ++..||+|.+.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG-KP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-Cc
Confidence            467889999999999999999863      46789999886543 33446788999999999999999999977654 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 013686          182 LLLVYEYIPNGTVADHLHNRQP------------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL  243 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nil  243 (438)
                      .++||||+++|+|.+++.....                  ....+++..++.++.|++.||.|||+.+++||||||+||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            8999999999999999975321                  1134788899999999999999999999999999999999


Q ss_pred             ecCCCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCccccc
Q 013686          244 LDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDI  321 (438)
Q Consensus       244 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~  321 (438)
                      ++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......   
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---  239 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---  239 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999875433221 11122235678999999988899999999999999999998 88888643221   


Q ss_pred             chhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                         . ....+..+.....            +..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus       240 ---~-~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ---E-VIYYVRDGNVLSC------------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---H-HHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               1 1122222221100            11345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.6e-41  Score=317.75  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=197.9

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      |+..+.||+|+||+||++... +++.||+|.+.....   ...+.+.+|+++++.++|+||+++.+++..+ +..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEEE
Confidence            566788999999999999975 689999999865432   2234578899999999999999999876655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++......  .+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNP--GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             eccCccHHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            99999999988764322  389999999999999999999999999999999999999999999999999976543221 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....|+..|+|||.+.+..++.++|+|||||++|||++|..||.........   ......+....  ...       
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~--~~~-------  224 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE--EVY-------  224 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc--ccc-------
Confidence             22346899999999999889999999999999999999999999754321110   01111111110  000       


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                          ...++..+.+|+.+||+.||++||+     +.+++.+
T Consensus       225 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 ----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                1234556889999999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=313.19  Aligned_cols=249  Identities=28%  Similarity=0.433  Sum_probs=203.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++... ..+++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEE
Confidence            36788899999999999999976 58999999886543 34456788999999999999999999977655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+.+++||||+|+||++++++.++|+|||+++....... 
T Consensus        80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            99999999999865     389999999999999999999999999999999999999999999999999987654322 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+++.|+|||.+.+..++.++||||||+++|+|+||..||......       .....+..........      
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~------  220 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPKNNPPSLEG------  220 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhhcCCCCCcc------
Confidence            123345788999999999888999999999999999999999999754311       0111111111111110      


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ..++..+.+++.+||..||++|||+++++++
T Consensus       221 -----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         221 -----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                 1145678899999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-40  Score=325.12  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=191.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..+|.+.+.||+|+||.||+|... +++.||+|.....      ....|+.++++++||||+++++++... ...++|||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSG-AITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeC-CeeEEEEE
Confidence            457999999999999999999976 4788999975432      234589999999999999999977655 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+ .++|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus       138 ~~-~~~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HY-SSDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             cc-CCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            99 5689998876433   38999999999999999999999999999999999999999999999999997533221  


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCC-cccCCcccccchhH---HHHHHHhc-Cccccccc-
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA-VDTSRHRHDINLSN---MATNKIQN-GALNELVD-  341 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p-~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~-  341 (438)
                      ......||+.|+|||.+.+..++.++|||||||++|||+++..+ |.............   .....+.. +.....+. 
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            12234589999999999999999999999999999999986544 44322110000000   00000000 00000000 


Q ss_pred             -C---------------cCCCCc--cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 -P---------------SLGFEK--DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 -~---------------~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       +               ..+...  .....+++..+.++|.+||+.||.+|||+.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence             0               000000  00111345567789999999999999999999975

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-40  Score=312.54  Aligned_cols=255  Identities=27%  Similarity=0.490  Sum_probs=200.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC-C---cEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD-G---RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .+|++.+.||+|+||.||+|.... +   ..||+|.+... .....+.|..|+.+++.++||||+++++++... ...++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-CceEE
Confidence            357788999999999999999753 3   36999998654 344457899999999999999999999976554 47899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....   .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          83 ITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999976533   3889999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccc-c-CC--CCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          265 VTHVS-T-AP--QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       265 ~~~~~-~-~~--~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ..... . ..  ..+..|+|||.+.+..++.++|||||||++|||++ |..||......      . ....+.... .  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~-~~~~i~~~~-~--  229 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------D-VINAIEQDY-R--  229 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------H-HHHHHHcCC-c--
Confidence            21111 1 11  12457999999998899999999999999999886 99998643221      1 111121110 0  


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          .+.     +..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus       230 ----~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ----LPP-----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----CCC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                000     123456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-41  Score=312.00  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ++|++.+.||.|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++... ..++++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEEeC
Confidence            57888999999999999999975 5789999998766555678899999999999999999999976554 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....   .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++........ .
T Consensus        82 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  157 (262)
T cd06613          82 CGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K  157 (262)
T ss_pred             CCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence            999999999876522   288999999999999999999999999999999999999999999999999886543221 1


Q ss_pred             ccCCCCCCCccCccccccC---CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          269 STAPQGTPGYVDPDYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .....++..|+|||.+.+.   .++.++||||||+++|||++|+.||........       ...+......   .+.+ 
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~~~~---~~~~-  226 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKSNFP---PPKL-  226 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccCC---Cccc-
Confidence            2334578899999999776   889999999999999999999999975332111       0111111000   0011 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ......+..+.+++.+||..+|.+|||+.+++.+
T Consensus       227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 ----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0123456789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-41  Score=322.85  Aligned_cols=266  Identities=21%  Similarity=0.307  Sum_probs=199.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.+++.++||||+++++++... ...++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEEE
Confidence            357889999999999999999976 588999998864422 2234677899999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||++ ++|.+++.....   .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus        84 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          84 EYLD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             eccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            9996 699998876533   388999999999999999999999999999999999999999999999999976433221


Q ss_pred             ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh---cCccccccc-
Q 013686          267 HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ---NGALNELVD-  341 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-  341 (438)
                       ......+++.|+|||.+.+. .++.++|||||||++|||++|++||..........   .......   ...+..... 
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhcc
Confidence             12233578899999988653 57889999999999999999999997543221110   0000000   000000000 


Q ss_pred             -----CcCCCCc----cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 -----PSLGFEK----DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 -----~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ..++...    ......++..+.+|+.+||+.||.+|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 0000000    00112356678999999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-41  Score=326.54  Aligned_cols=239  Identities=30%  Similarity=0.437  Sum_probs=187.7

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHH-HHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVE-ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++... +|+.||+|++....   ......+..|.. +++.++||||+++++++... +..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCC
Confidence            46999999999999965 68999999986542   223345555655 46778999999999877654 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|..++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        80 ~~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (325)
T cd05604          80 GGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT  154 (325)
T ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence            9999999876543    8999999999999999999999999999999999999999999999999987532221 1223


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|..||......      .. ...+.....  ...         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~-~~~~~~~~~--~~~---------  216 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EM-YDNILHKPL--VLR---------  216 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HH-HHHHHcCCc--cCC---------
Confidence            446899999999999999999999999999999999999999754221      11 111211111  011         


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV  380 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  380 (438)
                        ...+..+.+++.+||+.||.+||++.+.
T Consensus       217 --~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         217 --PGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             --CCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence              1234567899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=308.60  Aligned_cols=250  Identities=33%  Similarity=0.515  Sum_probs=202.2

Q ss_pred             CcccccCceEEEEEEEcC----CcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRD----GRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||++....    +..|++|.+...... ..+.+.+|++++..++|+|++++++++.. ....++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            469999999999999763    789999998765433 36789999999999999999999997765 457999999999


Q ss_pred             CCCHHHHhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          191 NGTVADHLHNRQPN-----SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       191 ~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      +++|.+++......     ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999876321     2348999999999999999999999999999999999999999999999999998765432


Q ss_pred             c-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          266 T-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       266 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      . .......++..|+|||.+....++.++||||||+++|||++ |..||......      . ....+..+....     
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~~-----  227 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------E-VLEYLRKGYRLP-----  227 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCCC-----
Confidence            1 12233457889999999988889999999999999999999 68999754221      1 111222111100     


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                             .+..++..+.+++.+||..||++|||+.|++++|+
T Consensus       228 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 -------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   01234677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-41  Score=327.30  Aligned_cols=268  Identities=20%  Similarity=0.306  Sum_probs=198.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeecc-----
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-----  178 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  178 (438)
                      ...++|++.+.||+|+||.||+|... +++.||||.+.....  ...+.+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999965 688999999865422  2345678899999999999999999866432     


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      ....|+++|++ +++|.+++...     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence            23578999998 78999887643     2899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHH
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATN  329 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~  329 (438)
                      +.....    .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||............        .....
T Consensus       166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865432    223468999999999876 56899999999999999999999999754321110000        00000


Q ss_pred             HHhcCccccccc--CcCCC-CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          330 KIQNGALNELVD--PSLGF-EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       330 ~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .+..........  +.... ..........+.+.+|+.+||+.||.+|||+.|++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp  299 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP  299 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            000000000000  00000 00001112345678999999999999999999999863

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.6e-41  Score=324.11  Aligned_cols=241  Identities=25%  Similarity=0.392  Sum_probs=192.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  185 (438)
                      +|+..+.||+|+||.||++..+ +|+.||+|.+....   ....+.+..|..++..+. |++|+++++++... +.+|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-DRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-CEEEEE
Confidence            3677899999999999999976 68999999987542   233456778999998886 57788888866554 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~Ey~~~g~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999999976543    8999999999999999999999999999999999999999999999999987543221


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      . ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+.....      .+ 
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~~------~~-  220 (323)
T cd05615         156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHNV------SY-  220 (323)
T ss_pred             c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CC-
Confidence            1 123345899999999999989999999999999999999999999754321       11112221111      00 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM  377 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  377 (438)
                            +..++..+.+++.+||+.||.+|++.
T Consensus       221 ------p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 ------PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence                  11245678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4e-41  Score=317.84  Aligned_cols=269  Identities=23%  Similarity=0.324  Sum_probs=198.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|++|.||+|..+ +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..+ ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEe
Confidence            4778899999999999999976 68999999886432  22346688899999999999999999977654 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |++ ++|.+++..... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... .
T Consensus        80 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~  156 (285)
T cd07861          80 FLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R  156 (285)
T ss_pred             cCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence            996 689998876432 2348999999999999999999999999999999999999999999999999997654332 1


Q ss_pred             cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH-----HHHHhc----Cccc
Q 013686          268 VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA-----TNKIQN----GALN  337 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~-----~~~~~~----~~~~  337 (438)
                      ......+++.|+|||.+.+. .++.++|||||||++|||+||++||...............     ...+..    ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            12233578899999988654 5788999999999999999999999754321110000000     000000    0000


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .................++.++.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000000001112356778899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.5e-41  Score=313.69  Aligned_cols=258  Identities=21%  Similarity=0.357  Sum_probs=200.4

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      +.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++... +..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEE
Confidence            344566666789999999999999965 5788999998777666677899999999999999999999977655 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCcccccCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPT  263 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~~~~  263 (438)
                      |+||+++++|.+++...... ...++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999999864321 01278888899999999999999999999999999999976 67999999999876533


Q ss_pred             CccccccCCCCCCCccCccccccC--CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCY--KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ... ......+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.........   .+.. ... ..     .
T Consensus       162 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~-~~~-~~-----~  230 (268)
T cd06624         162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKV-GMF-KI-----H  230 (268)
T ss_pred             CCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhh-hhh-cc-----C
Confidence            221 12233578999999998654  3788999999999999999999998643221100   0000 000 00     0


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +.+       +..++..+.+++.+||+.+|.+|||+.|++.+
T Consensus       231 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         231 PEI-------PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CCC-------CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            111       12345678899999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-40  Score=308.65  Aligned_cols=251  Identities=27%  Similarity=0.482  Sum_probs=200.2

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccc------hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENN------FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      +|++.+.||+|+||.||+|...+|+.+|+|.+....      ....+.+.+|+++++.++|+||+++++++... ...++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEEE
Confidence            478899999999999999998789999999886432      12345688999999999999999999977665 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.+...    +++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          80 FMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999999976543    789999999999999999999999999999999999999999999999998754321


Q ss_pred             c-----cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          265 V-----THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       265 ~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      .     ........++..|+|||.+.+..++.++||||||+++|+|++|..||........       ...+....   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~---~  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-------MFYIGAHR---G  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-------HHHhhhcc---C
Confidence            1     1112234588999999999988999999999999999999999999974322110       01111100   0


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..+..       ...++..+.+++.+||+.+|.+||++.|++.+
T Consensus       226 ~~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         226 LMPRL-------PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCC-------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00111       12345678899999999999999999999863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.8e-41  Score=318.26  Aligned_cols=251  Identities=26%  Similarity=0.437  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .+|++.+.||.|+||.||+|... +|+.|++|.+........+.+.+|+.+++.++|||++++++++... ...++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEEEe
Confidence            46888999999999999999864 6899999998766555567889999999999999999999977654 579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|..++....     +++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......... 
T Consensus        98 ~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655          98 LAGGSLTDVVTETC-----MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             cCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            99999999986532     899999999999999999999999999999999999999999999999998865433221 


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........       ...+.......     +.   
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-------~~~~~~~~~~~-----~~---  236 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGTPE-----LQ---  236 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCcc-----cC---
Confidence            2234588899999999988899999999999999999999999975432111       01111111000     00   


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        .+..++..+.+++.+||..||++||++.+++.+=
T Consensus       237 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~  270 (296)
T cd06655         237 --NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (296)
T ss_pred             --CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence              0123556788999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-41  Score=350.54  Aligned_cols=256  Identities=23%  Similarity=0.385  Sum_probs=200.5

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceE
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSREL  182 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  182 (438)
                      ...++|.+.+.||+|+||+||++... +++.||+|.+...  .....+.+..|+.+++.|+|||||++++++.. ....+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34678999999999999999999976 5788999988643  23345678999999999999999999996643 34578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCCEEecC---------
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-------DVIHRDVKSNNILLDN---------  246 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~ivH~Dlkp~Nill~~---------  246 (438)
                      ||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.       +||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            999999999999999986433333499999999999999999999984       4999999999999964         


Q ss_pred             --------CCeEEEeeeCcccccCCCccccccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCC
Q 013686          247 --------NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSR  316 (438)
Q Consensus       247 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~  316 (438)
                              .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||+||..||....
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    3358999999998654332  1234468999999999854  458899999999999999999999997432


Q ss_pred             cccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..     . .....+...       +.++.      ...+..+.+||.+||+.+|.+||++.|++..
T Consensus       248 ~~-----~-qli~~lk~~-------p~lpi------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 NF-----S-QLISELKRG-------PDLPI------KGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             cH-----H-HHHHHHhcC-------CCCCc------CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            21     1 111111111       11110      1235678899999999999999999999953

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.6e-41  Score=316.02  Aligned_cols=268  Identities=26%  Similarity=0.400  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++.....  ...+.+.+|+.++++++|+|++++++++... ...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEE
Confidence            46888999999999999999976 589999998864422  2235678999999999999999999977654 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|..++.....    +++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus        80 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          80 EYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             eccCccHHHHHHhCCCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99999888887755432    89999999999999999999999999999999999999999999999999987644321


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH--------HHHHhcCc-c
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA--------TNKIQNGA-L  336 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-~  336 (438)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|..||...............        ........ .
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223357889999999876 46789999999999999999999999754322111000000        00000000 0


Q ss_pred             cccccCcCC--CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLG--FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .....+...  ..........+..+.+++.+||+.||++||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            000000000  00111123456789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-41  Score=315.15  Aligned_cols=253  Identities=29%  Similarity=0.424  Sum_probs=204.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||.|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++.+... ...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-CeEEEEee
Confidence            456888999999999999999975 5899999998776666678899999999999999999999977654 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....   .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            9999999999876533   389999999999999999999999999999999999999999999999999875433221 


Q ss_pred             cccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          268 VSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||......      .. ...+..+....    
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~----  227 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RV-LLKILKSEPPT----  227 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HH-HHHHhcCCCCC----
Confidence            122345889999999874     345778999999999999999999999753221      11 11122211111    


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       +.     .+..++..+.+++.+||+.+|.+||++.+++++
T Consensus       228 -~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 -LD-----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -cC-----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             10     012355678899999999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-40  Score=311.22  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=203.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      ++|++.+.||+|+||.||+|..+      +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++... ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-Ccc
Confidence            57888999999999999999964      2467999988654433 457899999999999999999999976554 478


Q ss_pred             EEEEeccCCCCHHHHhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNS-----CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      ++||||+++|+|.+++.......     ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence            99999999999999998655221     1489999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      +...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......      . ....+..+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~-~~~~~~~~~~  236 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------E-VLNRLQAGKL  236 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------H-HHHHHHcCCc
Confidence            87543322222233346778999999988889999999999999999999 77888643211      1 1112221111


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ....           ...++..+.+++.+||+.+|++||++.|++..|.
T Consensus       237 ~~~~-----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 ELPV-----------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCC-----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1100           0134567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-40  Score=307.95  Aligned_cols=251  Identities=30%  Similarity=0.474  Sum_probs=204.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|+..+.||+|+||.||.+... +++.+++|.+...  .....+.+.+|++++++++|+||+++++++... +.++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEE
Confidence            4778899999999999999865 5889999987643  334456788999999999999999999977665 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........ 
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          80 YANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             ecCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999986532  2388999999999999999999999999999999999999999999999999986644332 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|..||......      .. ...+..+.....        
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~-~~~~~~~~~~~~--------  221 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NL-VVKIVQGNYTPV--------  221 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHcCCCCCC--------
Confidence            223446899999999998888999999999999999999999999753221      11 111122211111        


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          ...++..+.+++.+||+.+|.+||++.++++++
T Consensus       222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                123456788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.1e-41  Score=321.99  Aligned_cols=260  Identities=21%  Similarity=0.295  Sum_probs=194.0

Q ss_pred             CCCccccc--CceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          114 SSKQLGDG--GFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       114 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      +.++||+|  +||+||++..+ +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..+ +..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEec
Confidence            46789999  78999999875 68999999986542  23346678899999999999999999977665 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc-
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-  267 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~-  267 (438)
                      +++|+|.+++......  .+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++||+........... 
T Consensus        81 ~~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999999764322  2889999999999999999999999999999999999999999999999875433211110 


Q ss_pred             -----cccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          268 -----VSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       268 -----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                           ......++..|+|||.+.+  ..++.++|||||||++|||++|+.||........      ..... .+......
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~-~~~~~~~~  231 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM------LLEKL-NGTVPCLL  231 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH------HHHHh-cCCccccc
Confidence                 0112346778999999976  4689999999999999999999999974322110      00000 00000000


Q ss_pred             c-------------------CcC--------------CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          341 D-------------------PSL--------------GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       341 ~-------------------~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +                   ..+              ..........++..+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0                   000              000011123456789999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-40  Score=313.06  Aligned_cols=263  Identities=28%  Similarity=0.449  Sum_probs=205.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-----CCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  182 (438)
                      ..|++.+.||+|+||.||++...     +++.||+|.+...... ..+.+.+|+++++.++|+||+++++++.. .....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999854     3689999998765443 46789999999999999999999997654 23468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++++|.+++.....   .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999987543   38999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc--------chhHHHHHHHh
Q 013686          263 TDVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI--------NLSNMATNKIQ  332 (438)
Q Consensus       263 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~--------~~~~~~~~~~~  332 (438)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++|..|+.........        .........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            32211  111233566799999998888999999999999999999999888643221100        00000011111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      .+.       ..  ..   ...++.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus       241 ~~~-------~~--~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGE-------RL--PR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCC-------cC--CC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            110       00  00   123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-41  Score=311.65  Aligned_cols=239  Identities=24%  Similarity=0.407  Sum_probs=187.0

Q ss_pred             CcccccCceEEEEEEEcC-------------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          116 KQLGDGGFGAVYLGILRD-------------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      +.||+|+||.||+|...+             ...|++|.+..........+.+|+.+++.++||||+++++++... ...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-VEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CCC
Confidence            468999999999998532             235888987665555556788999999999999999999977655 468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe-------EEEeee
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR-------VKVADF  255 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~-------~kl~Df  255 (438)
                      ++||||+++|+|..++.....   .+++..++.++.||+.||+|||+++|+||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999998875432   3899999999999999999999999999999999999987664       899999


Q ss_pred             CcccccCCCccccccCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHH-hCCCCcccCCcccccchhHHHHHHHhc
Q 013686          256 GLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELI-SGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       256 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~-tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.......        ......
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~~  223 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KERFYE  223 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HHHHHh
Confidence            998754322     2234788899999886 467899999999999999997 5888876432110        011111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +... ..            ...+..+.+|+.+||+.||++||++.+|++.|
T Consensus       224 ~~~~-~~------------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQCM-LV------------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cCcc-CC------------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1110 00            01235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.3e-40  Score=308.64  Aligned_cols=251  Identities=27%  Similarity=0.465  Sum_probs=197.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-----chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-----NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  182 (438)
                      .+|+..+.||+|+||.||++... ++..|++|.+...     .....+.+.+|+.+++.++||||+++++++... ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999975 5899999987533     123456788999999999999999999976543 4578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      +++|||+++++|.+++.....    +++...+.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            899999999999999976543    7899999999999999999999999999999999999999999999999987653


Q ss_pred             CCcc--ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVT--HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....  .......++..|+|||.+.+..++.++|||||||++|||++|+.||......      ..........     .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~-----~  226 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP-----T  226 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC-----C
Confidence            2111  1112245788999999999888999999999999999999999999743211      1111111111     0


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+.+       +..+...+.+++ +||..+|++||+++|++++
T Consensus       227 ~~~~-------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         227 NPQL-------PSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CCCC-------chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            1111       123445677777 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-40  Score=310.73  Aligned_cols=249  Identities=28%  Similarity=0.509  Sum_probs=199.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.....         ...+.+.+|+.++++++||||+++++++... .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-D   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-C
Confidence            4778899999999999999865 588999998754321         1235688999999999999999999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+++++|.+++.....    +++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            78999999999999999976543    88899999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccc-----cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc
Q 013686          261 FPTDVTH-----VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA  335 (438)
Q Consensus       261 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (438)
                      .......     ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......       ....+... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~-  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------AIFKIGEN-  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------HHHHHhcc-
Confidence            6432111     1112347889999999998889999999999999999999999997532210       00111111 


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ..+.+       +..++..+.+++.+||+.||.+||++.|++++
T Consensus       228 ----~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 ----ASPEI-------PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ----CCCcC-------CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                11111       12345678899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-40  Score=319.63  Aligned_cols=199  Identities=25%  Similarity=0.414  Sum_probs=161.5

Q ss_pred             CCcccccCceEEEEEEEc---CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceEEEEEeccC
Q 013686          115 SKQLGDGGFGAVYLGILR---DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSRELLLVYEYIP  190 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  190 (438)
                      ..+||+|+||.||+|..+   ++..||+|.+.....  ...+.+|++++++++||||+++++++.. .+...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            467999999999999965   357899998865432  2457789999999999999999997643 3457899999995


Q ss_pred             CCCHHHHhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe----cCCCeEEEeeeCccccc
Q 013686          191 NGTVADHLHNRQP-----NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF  261 (438)
Q Consensus       191 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgla~~~  261 (438)
                       ++|.+++.....     ....+++..+..++.||+.||.|||+.+|+||||||+|||+    +.++.+||+|||+++..
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence             588888753221     12348899999999999999999999999999999999999    56679999999999876


Q ss_pred             CCCccc--cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCC
Q 013686          262 PTDVTH--VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSR  316 (438)
Q Consensus       262 ~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~  316 (438)
                      ......  ......+|+.|+|||.+.+ ..++.++|||||||++|||+||++||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            443221  1223458999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=326.08  Aligned_cols=244  Identities=30%  Similarity=0.467  Sum_probs=200.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      |.-++.||.|+||.||.+.+. +.+.||||++.-.   ....++++..|+..|++++|||++.+-||+..+. ..|+|||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-TaWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-TAWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-hHHHHHH
Confidence            555788999999999999954 7899999998543   3455688999999999999999999999887764 7899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      || -|+-.|++.-.+.   ++.+.++..|+.+.+.||.|||+++.||||||+.|||+++.|.|||+|||.|......   
T Consensus       107 YC-lGSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HH-hccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            99 6788888876654   3889999999999999999999999999999999999999999999999999876432   


Q ss_pred             cccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          268 VSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                        ..++|||.|||||++.   .+.|+.++||||||++..||.-.++|+-..      +...... .|....     .|.+
T Consensus       180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALY-HIAQNe-----sPtL  245 (948)
T KOG0577|consen  180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALY-HIAQNE-----SPTL  245 (948)
T ss_pred             --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHH-HHHhcC-----CCCC
Confidence              4567999999999874   468999999999999999999999887532      1111122 222211     1222


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .      ...++..+.+++..||++-|.+|||.++++.+
T Consensus       246 q------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 Q------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             C------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1      23567789999999999999999999999864

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-40  Score=308.72  Aligned_cols=251  Identities=30%  Similarity=0.449  Sum_probs=195.0

Q ss_pred             CcccccCceEEEEEEEcC-Cc--EEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRD-GR--IVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|...+ +.  .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+ ..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeCC
Confidence            368999999999999753 43  46888876432 34456788999999999 7999999999776654 6899999999


Q ss_pred             CCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          191 NGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       191 ~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      +|+|.+++.....            ....+++..+..++.|++.||+|||+.|++||||||+|||+++++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            9999999976431            1124789999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      .......  .......+..|+|||.+.+..++.++|||||||++|||++ |..||......      .. ...+..+...
T Consensus       160 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~-~~~~~~~~~~  230 (270)
T cd05047         160 RGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL-YEKLPQGYRL  230 (270)
T ss_pred             cccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HH-HHHHhCCCCC
Confidence            6432111  1111234567999999988889999999999999999997 99998643211      11 1111111100


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      +     .       ...++..+.+++.+||..||.+|||+.+++..|+++.
T Consensus       231 ~-----~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         231 E-----K-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C-----C-------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0     0       0124456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-40  Score=304.67  Aligned_cols=247  Identities=28%  Similarity=0.499  Sum_probs=197.7

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCH
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTV  194 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L  194 (438)
                      ++||+|+||.||++...+++.|++|.+...... ..+.+.+|++++++++|+||+++++++... ...++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCCcH
Confidence            469999999999999877999999988765433 457899999999999999999999977655 478999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc-cCCC
Q 013686          195 ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS-TAPQ  273 (438)
Q Consensus       195 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~  273 (438)
                      .+++.....   .+++..+..++.+++.||.|||+++++||||||+||+++.++.+||+|||++........... ....
T Consensus        80 ~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999976432   378999999999999999999999999999999999999999999999999986543222111 1223


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAV  352 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (438)
                      .+..|+|||.+.+..++.++|||||||++|||+| |..||.......       ....+....  ..   ..       +
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~--~~---~~-------~  217 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY--RM---PA-------P  217 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC--CC---CC-------C
Confidence            4567999999988899999999999999999999 788886443211       111121110  00   00       1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          353 RNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       353 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-42  Score=332.83  Aligned_cols=250  Identities=28%  Similarity=0.481  Sum_probs=203.9

Q ss_pred             CCCCCcccccCceEEEEEEEc--CCc--EEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          112 FNSSKQLGDGGFGAVYLGILR--DGR--IVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .+..++||+|.||.|++|.|.  +|+  .||||.+...... ...+|.+|+.+|.+|+|+|++++||+....  ...|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q--p~mMV~  189 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ--PAMMVF  189 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc--hhhHHh
Confidence            345689999999999999986  344  5899999876544 678999999999999999999999977653  689999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      |+++.|+|.+.|++..  ...|.......++.||+.||.||..+++|||||..+|+||-..-.|||+||||.+.++... 
T Consensus       190 ELaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hhcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999999833  2347788889999999999999999999999999999999999999999999999775433 


Q ss_pred             -cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          266 -THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       266 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                       +.......-...|+|||.+....|+.++|||+|||+||||+| |..||.+.....       ..+.+..+.       +
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------IL~~iD~~e-------r  333 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------ILKNIDAGE-------R  333 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-------HHHhccccc-------c
Confidence             222333446778999999999999999999999999999999 668887644321       112222111       1


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +.     .++.|++.+.+++++||..+|++|||+..|.+.+
T Consensus       334 Lp-----RPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  334 LP-----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CC-----CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            11     1245889999999999999999999999997543

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=330.27  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=207.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .+.|.++..||.|+||.||++..++ +-..|.|++........++++-|+++|..+.||+||++++.|+.++ .+||..|
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwiliE  109 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWILIE  109 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEEEEe
Confidence            3456778899999999999999774 4556778887777788899999999999999999999999665554 6999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ||.||-+..++-.-..   .|.+.++..+++|++.||.|||+++|||||||+.|||++-+|.++|+|||.+...... ..
T Consensus       110 FC~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q  185 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ  185 (1187)
T ss_pred             ecCCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence            9999999999887654   3999999999999999999999999999999999999999999999999998754322 22


Q ss_pred             cccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          268 VSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ....+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|.....+      . .+.-.+.....+-++. 
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------M-RVllKiaKSePPTLlq-  257 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------M-RVLLKIAKSEPPTLLQ-  257 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------H-HHHHHHhhcCCCcccC-
Confidence            344567999999999874     45899999999999999999999988753221      1 1222333332222222 


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                               +..++..+.+++.+||.+||..||++.+++++-
T Consensus       258 ---------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  258 ---------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             ---------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence                     245677899999999999999999999999753

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-41  Score=313.61  Aligned_cols=238  Identities=23%  Similarity=0.356  Sum_probs=185.4

Q ss_pred             cccccCceEEEEEEEcC-------------------------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeE
Q 013686          117 QLGDGGFGAVYLGILRD-------------------------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL  171 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  171 (438)
                      .||+|+||.||+|....                         ...|++|.+........+.+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13588998866554555678899999999999999999


Q ss_pred             eeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---
Q 013686          172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---  248 (438)
Q Consensus       172 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---  248 (438)
                      ++++.... ..++||||+++|+|..++.....   .+++..+..++.||++||+|||+++|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGS-ENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCC-ceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99876654 68999999999999999875432   388999999999999999999999999999999999997643   


Q ss_pred             ----eEEEeeeCcccccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHH-hCCCCcccCCcccccc
Q 013686          249 ----RVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELI-SGLEAVDTSRHRHDIN  322 (438)
Q Consensus       249 ----~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~-tG~~p~~~~~~~~~~~  322 (438)
                          .+|++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||........  
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence                4899999987643221     12346788999998865 56899999999999999985 68999875432111  


Q ss_pred             hhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                           ........       ..+       ......+.+++.+||+.+|++|||+.++++.|
T Consensus       231 -----~~~~~~~~-------~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 -----ERFYEKKH-------RLP-------EPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             -----HHHHHhcc-------CCC-------CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                 00111000       000       01223578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.7e-40  Score=306.61  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=205.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSRELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~  186 (438)
                      +|++.+.||.|+||.||++... +|+.||+|.+...  .....+.+.+|+++++.++|+||+++++++.. .....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999865 6889999988643  23445678899999999999999999986543 345689999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH-----ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      ||+++++|.+++.........+++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999875433445899999999999999999999     889999999999999999999999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......       .....+..+....   
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~---  229 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGKFRR---  229 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCCCCC---
Confidence            543321 22346899999999999888999999999999999999999999754311       1112222222111   


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        +       ...++..+.+++.+||+.+|++||++.+|+++
T Consensus       230 --~-------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 --I-------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --C-------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              1       12455678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.9e-40  Score=309.56  Aligned_cols=254  Identities=26%  Similarity=0.337  Sum_probs=190.8

Q ss_pred             CcccccCceEEEEEEEcC---CcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          116 KQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.||+|+||.||+|...+   +..+|+|.+..... .....+.+|+.++++++||||+++++++... ...++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCCC
Confidence            369999999999998643   46799998865432 3335788899999999999999999977554 468999999999


Q ss_pred             CCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc-cc
Q 013686          192 GTVADHLHNRQPN-SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VS  269 (438)
Q Consensus       192 g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~  269 (438)
                      |+|.+++...... ....++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......... ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            9999999764321 223677788899999999999999999999999999999999999999999999754332211 12


Q ss_pred             cCCCCCCCccCccccccC-------CCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          270 TAPQGTPGYVDPDYFQCY-------KLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~-------~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ....++..|+|||.+.+.       .++.++||||||+++|||++ |..||........      ....+.. .......
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~-~~~~~~~  232 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV------LTYTVRE-QQLKLPK  232 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHhhc-ccCCCCC
Confidence            234577889999988642       35789999999999999996 9999965332111      0111111 1111112


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +.+.       ...+..+.+++.+|| .+|++|||++||+..|+
T Consensus       233 ~~~~-------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLK-------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccC-------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2111       123456788999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.3e-41  Score=328.57  Aligned_cols=199  Identities=28%  Similarity=0.409  Sum_probs=172.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-C-----CCceeEeeeeeccCceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-H-----PNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~  183 (438)
                      +|.+.+.||+|.||.|.+|.+. +++.||||+++... ....+-..|+.+|..|+ |     -|+|++++++...+ ++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-cee
Confidence            6788999999999999999966 69999999886543 33456677999999997 4     48999999876664 799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC--CeEEEeeeCccccc
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLF  261 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~--~~~kl~Dfgla~~~  261 (438)
                      ||+|.+ .-+|.++|+.++..+  ++...++.++.||+.||.+||+.||||+||||+||||.+-  ..+||+|||.+...
T Consensus       265 iVfELL-~~NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999999 679999999876554  9999999999999999999999999999999999999643  47999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR  318 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~  318 (438)
                      .....    ....+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+....
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            54332    335788999999999999999999999999999999999999876544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=311.52  Aligned_cols=264  Identities=25%  Similarity=0.376  Sum_probs=199.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHh--CCCCCceeEeeeeeccC---ceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK--LQHPNLVKLYGCTSRQS---RELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~---~~~~  183 (438)
                      ..+..+.+.||+|.||.||+|.++ |+.||||++...+.   +...+|.++.+.  |+|+||+.+++......   ..+|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            456677899999999999999997 89999999976543   346678888775  59999999998543332   3689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCEEecCCCeEEEeee
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS--------DVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                      ||++|.+.|||+|||.+..     ++....++++.-+|.||+|||..        .|.|||||+.||||..++...|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            9999999999999998853     88999999999999999999964        5999999999999999999999999


Q ss_pred             CcccccCCCcccc---ccCCCCCCCccCccccccC------CCCChhhHHHHHHHHHHHHhC----------CCCcccCC
Q 013686          256 GLSRLFPTDVTHV---STAPQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELISG----------LEAVDTSR  316 (438)
Q Consensus       256 gla~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tG----------~~p~~~~~  316 (438)
                      |||.....+....   ....+||.+|||||++...      ..-..+||||||.++||+...          +.||..-.
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998766553322   2345799999999999653      122368999999999999753          45554322


Q ss_pred             cccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      +.+..  .......+....+    .|.++  ..+........+.++|+.||..+|..|-|+-.|-+.|.++.+
T Consensus       441 p~DPs--~eeMrkVVCv~~~----RP~ip--nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSDPS--FEEMRKVVCVQKL----RPNIP--NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCC--HHHHhcceeeccc----CCCCC--cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            22111  0111112222222    22222  222234566778899999999999999999999999988764

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4e-40  Score=309.95  Aligned_cols=249  Identities=27%  Similarity=0.437  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..|+..+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++... ...++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-TKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEe
Confidence            35677889999999999999976 58899999886543 34567889999999999999999999977655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++....     +++.....++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~i~~~~-----l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          83 YLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             cCCCCcHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            999999999987532     78889999999999999999999999999999999999999999999999976543221 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......++..|+|||.+.+..++.++|+|||||++|||++|..||........       ...+.....     +     
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~-----~-----  219 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLIPKNNP-----P-----  219 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhhhcCCC-----C-----
Confidence            12233578899999999888899999999999999999999999874322110       001111100     1     


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        .....++..+.+++.+||+.+|++||++.+++.+-
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         220 --TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             --CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence              11234667889999999999999999999998864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-40  Score=310.33  Aligned_cols=265  Identities=26%  Similarity=0.344  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~  186 (438)
                      ++|...+.||.|++|.||++... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++.. ....+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35778899999999999999975 588999998865432 345678999999999999999999997644 344689999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|.+++.........+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            99999999998875433334588999999999999999999999999999999999999999999999999875433221


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                         ....++..|+|||.+.+..++.++|||||||++|+|++|..||........ ...... ..+.........+ ....
T Consensus       161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~-~~~~  234 (287)
T cd06621         161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPELKD-EPGN  234 (287)
T ss_pred             ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhhcc-CCCC
Confidence               233478899999999988999999999999999999999999985532111 111111 1111111111100 0000


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                           ....+..+.+++.+||..+|.+|||+.|++++-.
T Consensus       235 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         235 -----GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             -----CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence                 0124567899999999999999999999998543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.7e-41  Score=310.22  Aligned_cols=250  Identities=26%  Similarity=0.454  Sum_probs=202.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|+||.+|++... +|+.||+|.+...  .....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-GNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-CeEEEEEe
Confidence            4778899999999999999965 6899999998643  233456789999999999999999999977554 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++......  .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          80 YCEGGDLYKKINAQRGV--LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             cCCCCcHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999999764322  3789999999999999999999999999999999999999999999999999865443221


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....+++.|+|||.+.+..++.++|+|||||++++|++|+.||.....      ..... .+..+....         
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~-~~~~~~~~~---------  220 (256)
T cd08218         158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVL-KIIRGSYPP---------  220 (256)
T ss_pred             -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHH-HHhcCCCCC---------
Confidence             2233578899999999988999999999999999999999999864321      11111 111111111         


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         ....++..+.+++.+||+.+|.+||++.+++++
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         221 ---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               012345678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-41  Score=321.02  Aligned_cols=253  Identities=24%  Similarity=0.386  Sum_probs=198.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEee--ccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLY--ENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ...|++++.||+||.+.||++...+.+.||+|++.  ..+....+-|.+|+..|.+|+ |.+||++++|-.. ++.+|||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence            35688999999999999999998888899999864  345566788999999999995 9999999995554 4689999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||= ..+|..+|+.....   ++.-.+..+..|++.++.++|++||||.||||.|+|+-. |.+||+|||+|..+..+.
T Consensus       439 mE~G-d~DL~kiL~k~~~~---~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSI---DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCC---CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            9985 56999999887653   332267788899999999999999999999999999864 589999999999887766


Q ss_pred             cccc-cCCCCCCCccCccccccCC-----------CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          266 THVS-TAPQGTPGYVDPDYFQCYK-----------LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       266 ~~~~-~~~~g~~~y~aPE~~~~~~-----------~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      .... ...+||+.||+||.+....           .+.++||||+|||||+|+.|++||.....         .+.    
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~a----  580 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QIA----  580 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HHH----
Confidence            5543 4567999999999996543           46789999999999999999999973210         011    


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       .+..+.+|.-..+.+..+.+  .++.++++.||..||.+||+..|+|++
T Consensus       581 -Kl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 -KLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             12223333221111111111  128899999999999999999999975

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-40  Score=308.20  Aligned_cols=256  Identities=25%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC-Cc----EEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD-GR----IVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .+|++.+.||+|+||.||+|..++ |+    .+|+|.+.... ....+.+.+|+.++++++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence            567888999999999999998653 33    58999876553 3345678899999999999999999997765  4789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..+..++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999986543   289999999999999999999999999999999999999999999999999987643


Q ss_pred             Cccccc-cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVTHVS-TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...... ....++..|+|||.+....++.++|+||||+++|||++ |+.||......      .. ...+..+...  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~--~~  232 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EI-PDLLEKGERL--PQ  232 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HH-HHHHhCCCCC--CC
Confidence            322211 12224568999999988889999999999999999998 99999754321      11 1122211100  00


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      +          ..++..+.+++.+||..||.+||++.++++.|+++..
T Consensus       233 ~----------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         233 P----------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             C----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            0          1133467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-40  Score=312.91  Aligned_cols=259  Identities=24%  Similarity=0.398  Sum_probs=205.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||+||++... +|+.||+|.+.... ....+.+.+|+++++.++||||+++++++... ..+++||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEE
Confidence            356888899999999999999965 58899999876543 33456789999999999999999999977665 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+++++|.+++...+.    +++.....++.+++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus        83 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          83 EFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             ecCCCCCHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            99999999999876543    8999999999999999999997 699999999999999999999999999987543221


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc-----chhHHHHHHHhcCcccccc
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI-----NLSNMATNKIQNGALNELV  340 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  340 (438)
                         .....++..|+|||.+.+..++.++|||||||++|+|++|..||.......+.     .........+. ..     
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----  229 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP-----  229 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc-----
Confidence               12346899999999998889999999999999999999999999854432111     11111111111 11     


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      .+.+.      ...++..+.+++.+||+.||++|||+.|++++..-+
T Consensus       230 ~~~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         230 PPRLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             CCCCC------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            01110      112556788999999999999999999999875433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.8e-40  Score=308.70  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=189.3

Q ss_pred             CcccccCceEEEEEEEcC---CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          116 KQLGDGGFGAVYLGILRD---GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++|+||+++++.+... ...++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-IPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-CceEEEEEeCCC
Confidence            359999999999997543   3578888775443 23346788999999999999999999977655 478999999999


Q ss_pred             CCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc-ccc
Q 013686          192 GTVADHLHNRQPN-SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVS  269 (438)
Q Consensus       192 g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~  269 (438)
                      |+|.+++...... ....++.....++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ...
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            9999999875432 12356788889999999999999999999999999999999999999999999875432211 112


Q ss_pred             cCCCCCCCccCcccccc-------CCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          270 TAPQGTPGYVDPDYFQC-------YKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ....++..|+|||.+..       ..++.++|||||||++|||++ |..||.......      .....+... ......
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~~~  232 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIKLPK  232 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-CccCCC
Confidence            23346778999998743       356889999999999999999 778886432211      111111111 111111


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +.+       ...++..+.+++..|| .||++|||+++|++.|
T Consensus       233 ~~~-------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         233 PQL-------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             Ccc-------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            111       1234566778888998 5999999999999987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.5e-40  Score=307.19  Aligned_cols=247  Identities=29%  Similarity=0.490  Sum_probs=199.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      ++|++.+.||+|+||.||++.. +++.||+|.+....  ..+.+.+|+.++++++|||++++++++..+  ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEECC
Confidence            4688899999999999999975 57889999886543  236788999999999999999999977543  479999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++......  .+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......    
T Consensus        81 ~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          81 SKGNLVNFLRTRGRA--LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCCHHHHHHhcCcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999999999865432  37899999999999999999999999999999999999999999999999987543221    


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....+..|+|||.+.+..++.++|+|||||++|||++ |+.||......      . ....+..+....   +      
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~---~------  218 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------E-VKECVEKGYRME---P------  218 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------H-HHHHHhCCCCCC---C------
Confidence            12234678999999988899999999999999999998 99998654321      1 111222211110   0      


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                         ...++..+.+++.+||+.+|++||++.++++.|++
T Consensus       219 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               12345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.4e-40  Score=306.66  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=189.1

Q ss_pred             cccccCceEEEEEEEcCC---cEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCC
Q 013686          117 QLGDGGFGAVYLGILRDG---RIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  192 (438)
                      .||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++++... ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-IPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-CccEEEEecCCCC
Confidence            599999999999985443   346677665433 34457899999999999999999999977654 4789999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC-ccccccC
Q 013686          193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD-VTHVSTA  271 (438)
Q Consensus       193 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~-~~~~~~~  271 (438)
                      +|.+++..........++.....++.||+.||+|||+.+++||||||+|||++.++.+||+|||++...... .......
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            999999875433334677788899999999999999999999999999999999999999999998643221 1111223


Q ss_pred             CCCCCCccCcccccc-------CCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          272 PQGTPGYVDPDYFQC-------YKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       272 ~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ..++..|+|||.+..       ..++.++|||||||++|||++ |..||......      ......+ .+......++.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~-~~~~~~~~~~~  233 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVI-KDQQVKLFKPQ  233 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-hhcccccCCCc
Confidence            457889999998753       245789999999999999997 46787543221      1111111 12222223333


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +..       .+...+.+++..|| .+|++||++++|++.|.
T Consensus       234 ~~~-------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LEL-------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCC-------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            221       24456788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6e-40  Score=304.97  Aligned_cols=248  Identities=28%  Similarity=0.497  Sum_probs=199.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-----hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-----FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+||+++++++... ..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEE
Confidence            4677899999999999999976 78999999886543     23456789999999999999999999976554 57899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      +|||+++++|.+++.....    +++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEEecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999999976543    889999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccCCCCCCCccCccccccCC-CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......      ..............     
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~-----  222 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP-----  222 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC-----
Confidence            2  123445889999999987766 899999999999999999999999653311      11111111011110     


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +       +..++..+.+++.+||+.+|.+||++.+++.+
T Consensus       223 ~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         223 I-------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             c-------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            0       12345678899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-40  Score=313.33  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=201.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|+||.||+|... +|+.|++|.+....  ....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEec
Confidence            4778899999999999999975 68999999986543  23346789999999999999999999977654 57899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+ +++|.+++.....   .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~~-~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          80 YM-PSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             cc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            99 9999999876542   3899999999999999999999999999999999999999999999999999876544322


Q ss_pred             cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC------------
Q 013686          268 VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG------------  334 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~------------  334 (438)
                      ......++..|+|||.+.+. .++.++||||+|+++|||++|.+||........   .......+...            
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcc
Confidence            23345689999999998654 468899999999999999999888865432111   00001100000            


Q ss_pred             cccccccC-cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 ALNELVDP-SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .......+ ...........+.+..+.+++.+||+.||++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000 00000001112345788999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=333.40  Aligned_cols=252  Identities=30%  Similarity=0.455  Sum_probs=207.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CC----cEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          113 NSSKQLGDGGFGAVYLGILR-DG----RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      +..++||+|+||+||+|.+- .|    -+||+|++... ..+..+++.+|+-+|.++.|||+++++|++...  .+.||+
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlvt  776 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLVT  776 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHHH
Confidence            34689999999999999964 33    46899988654 344567899999999999999999999987654  488999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      +||++|+|.++++..+..   +..+..+.|..||++||.|||.+++|||||.++||||..-..+||.|||+++....+..
T Consensus       777 q~mP~G~LlDyvr~hr~~---igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDN---IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhcc---ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999987654   88889999999999999999999999999999999999999999999999998766544


Q ss_pred             ccc-cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          267 HVS-TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       267 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ... ....-.+.|||-|.+....|+.++|||||||++||++| |..|++...-.+..       ..++.+..       +
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~geR-------L  919 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGER-------L  919 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhcccc-------C
Confidence            332 22335778999999999999999999999999999998 88998865432211       12222111       1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      +     .++.++.++..++.+||..|++.||+++++...+.++.
T Consensus       920 s-----qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  920 S-----QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             C-----CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            1     22457778999999999999999999999999887763

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-40  Score=308.29  Aligned_cols=237  Identities=28%  Similarity=0.428  Sum_probs=188.0

Q ss_pred             CcccccCceEEEEEEEcCCc-----------EEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          116 KQLGDGGFGAVYLGILRDGR-----------IVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.+++.++||||+++++++..  ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence            46999999999999976422           5778876554333 5788899999999999999999997766  45799


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-------eEEEeeeCc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-------RVKVADFGL  257 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-------~~kl~Dfgl  257 (438)
                      ||||+++|+|.+++.....   .+++..+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999999987553   388999999999999999999999999999999999999887       799999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccC--CCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcC
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCY--KLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNG  334 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (438)
                      +.....     .....++..|+|||.+.+.  .++.++|||||||++|||++ |..||........       .......
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~~~~  222 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQDQ  222 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHHhcC
Confidence            986543     1223467789999999876  78999999999999999999 5677764421110       0011100


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .       .....       ....+.+++.+||..+|.+|||+.++++.|
T Consensus       223 ~-------~~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 H-------RLPMP-------DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             C-------CCCCC-------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0       00000       015688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.8e-40  Score=308.92  Aligned_cols=251  Identities=27%  Similarity=0.439  Sum_probs=198.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-----chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-----NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  182 (438)
                      ++|++.+.||+|+||.||++... +|+.||+|.+...     .....+.+.+|+.++++++||||+++++++... ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999975 5899999987532     123456788999999999999999999976543 3468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      +++|||+++++|.+++.....    +++.....++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            899999999999999976543    7888899999999999999999999999999999999999999999999988653


Q ss_pred             CCcc--ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVT--HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....  .......++..|+|||.+.+..++.++|||||||++|||++|+.||.......      .. .......    .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~----~  226 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AI-FKIATQP----T  226 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HH-HHHhcCC----C
Confidence            2111  11223458889999999988889999999999999999999999996432110      00 1111110    0


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+.       .+...+..+.+++.+||. +|++||+++|++++
T Consensus       227 ~~~-------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 NPV-------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CCC-------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            111       123455678889999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-40  Score=313.19  Aligned_cols=260  Identities=28%  Similarity=0.432  Sum_probs=202.4

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeec--
Q 013686          102 CSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSR--  177 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--  177 (438)
                      ..++......|++.+.||.|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            3444456678999999999999999999975 58899999875543 2345688899999998 69999999997642  


Q ss_pred             ---cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          178 ---QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       178 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                         .....+++|||+++|+|.+++......  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d  164 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGN--ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD  164 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence               235789999999999999999765432  378888999999999999999999999999999999999999999999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHH
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN  329 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~  329 (438)
                      ||++........ ......+++.|+|||.+.     ...++.++|||||||++|||++|..||.........       .
T Consensus       165 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-------~  236 (282)
T cd06636         165 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-------F  236 (282)
T ss_pred             Ccchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-------h
Confidence            999876532211 122345889999999875     346788999999999999999999999643221110       0


Q ss_pred             HHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+....     .+..      ....++..+.+++.+||+.||.+||++.|++++
T Consensus       237 ~~~~~~-----~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 LIPRNP-----PPKL------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hHhhCC-----CCCC------cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            011100     0111      112356679999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.1e-40  Score=307.23  Aligned_cols=254  Identities=24%  Similarity=0.432  Sum_probs=201.1

Q ss_pred             CCCCCCcccccCceEEEEEEEcC--CcEEEEEEeecc----------chHhHHHHHHHHHHHHh-CCCCCceeEeeeeec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRD--GRIVAVKRLYEN----------NFKRIEQFMNEVEILTK-LQHPNLVKLYGCTSR  177 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  177 (438)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999764  688999987532          22234567789998875 699999999997765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeC
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFG  256 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg  256 (438)
                      . +..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||
T Consensus        81 ~-~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          81 N-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             C-CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence            5 57999999999999999986543333348999999999999999999996 689999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          257 LSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       257 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      ++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||......      .. ...+..+..
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~-~~~~~~~~~  230 (269)
T cd08528         160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SL-ATKIVEAVY  230 (269)
T ss_pred             ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HH-HHHHhhccC
Confidence            998654432  223446889999999999888999999999999999999999998643211      11 111111111


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ....           ...++..+.+++.+||+.||++||++.|+.++++
T Consensus       231 ~~~~-----------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EPLP-----------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcCC-----------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1100           0124567889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-40  Score=316.69  Aligned_cols=257  Identities=28%  Similarity=0.468  Sum_probs=201.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCc----EEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGR----IVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|+..+.||+|+||.||+|... +|+    .||+|.+..... .....+.+|+.+++.++||||+++++++...  ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--Cc
Confidence            356788899999999999999864 444    478888765432 3345788999999999999999999977543  46


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++++||+++|+|.+++.....   .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence            799999999999999976543   38899999999999999999999999999999999999999999999999998664


Q ss_pred             CCcccc-ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVTHV-STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+...   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---  230 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERL---  230 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCC---
Confidence            332211 122345778999999998899999999999999999997 889986432111       11112111110   


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                          ...     ..++..+.+++.+||..+|++||++.++++.|+.+..
T Consensus       231 ----~~~-----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 ----PQP-----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ----CCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                000     1234568899999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.7e-40  Score=304.10  Aligned_cols=251  Identities=35%  Similarity=0.566  Sum_probs=201.3

Q ss_pred             CCCCCcccccCceEEEEEEEcC-----CcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          112 FNSSKQLGDGGFGAVYLGILRD-----GRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      |++.+.||+|+||.||++...+     +..||+|.+...... ..+.+.+|+.++..++|+||+++++++... +..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEE
Confidence            3567899999999999999763     388999998765433 567899999999999999999999977665 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.......  +++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EeccCCCCHHHHHHhhhhcc--CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999998654322  8999999999999999999999999999999999999999999999999998765442


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.....      ... ...+..+.....     
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~-~~~~~~~~~~~~-----  225 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEV-LEYLKKGYRLPK-----  225 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHHhcCCCCCC-----
Confidence            222212337789999999988889999999999999999998 7888864221      111 111221111100     


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                             ...++..+.+++.+||..||++|||+.|+++.|
T Consensus       226 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 -------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   112566789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-40  Score=307.87  Aligned_cols=253  Identities=25%  Similarity=0.475  Sum_probs=200.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc------hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN------FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      +|+..+.||+|+||.||++... +++.||+|.+....      ....+.+.+|+.++++++|+||+++++++... +..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-SHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-CeEE
Confidence            4778899999999999999864 68999999886432      12356789999999999999999999977554 4789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCcccccC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGLSRLFP  262 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~  262 (438)
                      +||||+++++|.+++.+...    +++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++....
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGA----FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999976543    88999999999999999999999999999999999998775 69999999998665


Q ss_pred             CCccc---cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          263 TDVTH---VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       263 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      .....   ......++..|+|||.+.+..++.++||||+|+++|+|++|..||........   ..... .+.....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~-~~~~~~~---  228 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIF-KIASATT---  228 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHH-HHhccCC---
Confidence            43211   11234578899999999888899999999999999999999999964332111   11111 1100000   


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       .+.       .+...+..+.+++.+||..+|.+||++.+++++
T Consensus       229 -~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         229 -APS-------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -CCC-------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence             011       113456778899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.6e-41  Score=317.31  Aligned_cols=249  Identities=26%  Similarity=0.443  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+... +..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeCC
Confidence            3444567999999999999865 5889999998766555667889999999999999999999976554 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++...     .+++..+..++.||+.||.|||+++|+||||||+||++++++.++|+|||++......... .
T Consensus       102 ~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~  175 (292)
T cd06658         102 EGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-R  175 (292)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-C
Confidence            999999988543     2789999999999999999999999999999999999999999999999998765432221 2


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||........       ...+... .    .+....   
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~-~----~~~~~~---  240 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIRDN-L----PPRVKD---  240 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-C----CCcccc---
Confidence            234588999999999888899999999999999999999999874322110       0111111 0    111100   


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        ....+..+.+++.+||..||.+|||++|++++
T Consensus       241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              11245568899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.5e-40  Score=304.77  Aligned_cols=252  Identities=28%  Similarity=0.511  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|+||.||+|... +++.|++|.+.....  ...+.+.+|+++++.++|+||+++++++... +..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEe
Confidence            4778899999999999999965 689999999876544  3567899999999999999999999966544 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....    +++..+..++.|++.||.|||+.|++|+||+|+||++++++.+||+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          80 YCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             cCCCCcHHHHHhhcCC----CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999986543    788899999999999999999999999999999999999999999999999876543332


Q ss_pred             ccc---CCCCCCCccCccccccCC---CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          268 VST---APQGTPGYVDPDYFQCYK---LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       268 ~~~---~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...   ...++..|+|||.+.+..   ++.++||||||+++|||++|+.||......     .... ..+..+.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~-~~~~~~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIM-FHVGAGH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHH-HHHhcCC-----C
Confidence            211   345788999999998766   889999999999999999999999743211     0001 1111111     1


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +.++.     ...++..+.+++.+||+.+|++|||+.+++.+
T Consensus       225 ~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         225 PPIPD-----SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCCc-----ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11110     11235668899999999999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-40  Score=312.84  Aligned_cols=266  Identities=23%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|++++++++||||+++++++... ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEe
Confidence            4778899999999999999976 689999999864322  2235677899999999999999999976554 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |++ ++|.+++.....   .+++..++.++.||++||.|||+++++||||||+||+++.++.+||+|||+++........
T Consensus        80 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          80 YCD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             cCC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            996 588888765432   3899999999999999999999999999999999999999999999999999865433221


Q ss_pred             cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH----------HHHHHhc-Cc
Q 013686          268 VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM----------ATNKIQN-GA  335 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~----------~~~~~~~-~~  335 (438)
                       .....+++.|+|||.+.+. .++.++|||||||++|||+||..|+........ .+...          .+..+.. ..
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhccc
Confidence             2234578899999998764 478999999999999999999888643221100 00000          0000000 00


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...................++..+.+++.+||+.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000000000011123456788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-40  Score=333.86  Aligned_cols=275  Identities=17%  Similarity=0.274  Sum_probs=190.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEcC--CcEEEEEEe--------------e---ccchHhHHHHHHHHHHHHhCCCCC
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILRD--GRIVAVKRL--------------Y---ENNFKRIEQFMNEVEILTKLQHPN  167 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~n  167 (438)
                      ...++|++.+.||+|+||+||++..+.  +...+.|.+              .   .........+.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            346789999999999999999987542  222222211              0   011123456889999999999999


Q ss_pred             ceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN-SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       168 iv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                      |+++++++...+ ..|+|+|++ +++|.+++...... ...........++.||+.||.|||++||+||||||+|||++.
T Consensus       225 Iv~l~~~~~~~~-~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        225 ILKIEEILRSEA-NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cCcEeEEEEECC-eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            999999776654 689999998 56888887653321 112345667789999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCC-CcccCCcccccchhH
Q 013686          247 NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLE-AVDTSRHRHDINLSN  325 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~-p~~~~~~~~~~~~~~  325 (438)
                      ++.+||+|||+++.+............|+..|+|||.+.+..++.++|||||||++|||++|.. |+..........+..
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            9999999999998765443333334569999999999999999999999999999999999875 443222111111111


Q ss_pred             HHHHHHh--cCcccc-------ccc-CcC-----CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          326 MATNKIQ--NGALNE-------LVD-PSL-----GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       326 ~~~~~~~--~~~~~~-------~~~-~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ... .+.  ...+.+       .++ ..+     ..........++..+.+++.+||+.||.+|||+.|++.+-
T Consensus       383 ~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        383 IID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            000 000  000000       000 000     0000001112445678889999999999999999999853

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-41  Score=322.37  Aligned_cols=241  Identities=26%  Similarity=0.356  Sum_probs=187.6

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhC---CCCCceeEeeeeeccCceEEEEEeccC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKL---QHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      ||+|+||+||+|... +|+.||+|++.....   .....+..|..++..+   +||||+++++++... ..+|+||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCC
Confidence            799999999999976 589999999865422   2233455677777665   699999999877655 47999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        80 ~g~L~~~l~~~~~----~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~  154 (330)
T cd05586          80 GGELFWHLQKEGR----FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN  154 (330)
T ss_pred             CChHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence            9999999876543    8999999999999999999999999999999999999999999999999987543221 1223


Q ss_pred             CCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          271 APQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                      ...||+.|+|||.+.+. .++.++|||||||++|||++|+.||......       .....+..+...      ++  . 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~------~~--~-  218 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKVR------FP--K-  218 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCCC------CC--C-
Confidence            45689999999998754 4899999999999999999999999753221       111222222111      10  0 


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRP----TMKEVLEI  383 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~  383 (438)
                         ..++..+.+++.+||+.||.+||    ++.+++++
T Consensus       219 ---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         219 ---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence               12456788999999999999998    57777664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=308.10  Aligned_cols=257  Identities=31%  Similarity=0.468  Sum_probs=202.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc-----Cc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ-----SR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~  180 (438)
                      ..++|++.+.||+|+||.||+|..+ +++.+++|.+..... ..+.+.+|+.+++++ .|+||+++++++...     +.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3678999999999999999999976 578999998865543 346789999999999 699999999977543     33


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+++||||+++++|.+++.........+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            58999999999999999876542233489999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA  335 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (438)
                      ...... ......++..|+|||.+..     ..++.++|||||||++|+|++|+.||.......       ....+....
T Consensus       163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~  234 (275)
T cd06608         163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALFKIPRNP  234 (275)
T ss_pred             cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHHHhhccC
Confidence            543222 2233458899999998753     346789999999999999999999996432110       011111111


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..     .+.     ....++..+.+++.+||..||++|||+.+++++
T Consensus       235 ~~-----~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         235 PP-----TLK-----SPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CC-----CCC-----chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11     110     112356788999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-40  Score=312.99  Aligned_cols=248  Identities=28%  Similarity=0.445  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEEc
Confidence            4556788999999999999865 57899999886443 34456789999999999999999999977654 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++...     .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++........ .
T Consensus        84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          84 LGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             cCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            9999999998643     288999999999999999999999999999999999999999999999999986543221 1


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||........       ...+..+.     .+.+    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~-----~~~~----  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKNS-----PPTL----  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcCC-----CCCC----
Confidence            2233578899999999988999999999999999999999999864322110       01111111     1111    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         ...++..+.+++.+||+.+|++||++.+++++-
T Consensus       222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence               113456788999999999999999999999853

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.1e-40  Score=306.68  Aligned_cols=250  Identities=28%  Similarity=0.442  Sum_probs=195.8

Q ss_pred             CcccccCceEEEEEEEcC-------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          116 KQLGDGGFGAVYLGILRD-------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +.||+|+||.||+|...+       ++.+++|.+.... ......+.+|+.+++.++||||+++++++... ...++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-EPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-CCeEEEEe
Confidence            369999999999998642       2579999875443 23456788999999999999999999977655 46899999


Q ss_pred             ccCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-----eEEEeeeCccc
Q 013686          188 YIPNGTVADHLHNRQP---NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-----RVKVADFGLSR  259 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfgla~  259 (438)
                      |+++++|.+++.....   ....+++..++.++.|++.||.|||+.+++|+||||+||+++.++     .++|+|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9999999999976432   123478899999999999999999999999999999999999877     89999999997


Q ss_pred             ccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          260 LFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       260 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......      .. ...+..+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~-~~~~~~~~~~  232 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EV-LQHVTAGGRL  232 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HH-HHHHhcCCcc
Confidence            5533211 11222345788999999999999999999999999999998 99998643221      11 1111111100


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .            ....++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       233 ~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         233 Q------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             C------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0            01235667899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.9e-40  Score=311.48  Aligned_cols=245  Identities=30%  Similarity=0.497  Sum_probs=201.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++++... ..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEE
Confidence            36888999999999999999976 58999999986542   23456788999999999999999999977655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++...... 
T Consensus        80 ~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGR----FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999999987643    899999999999999999999999999999999999999999999999999876443 


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.....       ......+..+..      .+ 
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------~~-  217 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKV------RF-  217 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCc------cC-
Confidence               2234588999999999888899999999999999999999999975431       111112211111      01 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                            +..++..+.+++.+||..||.+|+     +++|++++
T Consensus       218 ------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         218 ------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                  012356788999999999999999     77888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.2e-40  Score=312.44  Aligned_cols=264  Identities=24%  Similarity=0.369  Sum_probs=199.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH-----hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK-----RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      +|++.+.||+|+||.||+|... +|+.|++|.+......     ....+.+|+++++.++|+||+++++++... ...++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-SNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-CEEEE
Confidence            4778899999999999999976 6899999998654322     234577899999999999999999977664 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+ +++|.+++....   ..+++..+..++.||++||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            99999 899999997654   13899999999999999999999999999999999999999999999999999876443


Q ss_pred             ccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---------C
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---------G  334 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---------~  334 (438)
                      ... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.........   .........         .
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhcc
Confidence            221 223346788999998855 46789999999999999999998888654322111   000000000         0


Q ss_pred             ccccccc--CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 ALNELVD--PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 ~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .......  ..............+..+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000  000001111123456788999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=314.14  Aligned_cols=269  Identities=24%  Similarity=0.347  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|+||.||+|..+ +++.|++|.+....  ....+.+.+|++++++++|+||+++++++... +..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-GRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-CEEEEEE
Confidence            36888999999999999999976 58899999886432  23346789999999999999999999977654 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||++++.+..++....    .+++..+..++.||+.||.|||+.+++|+||+|+||++++++.+||+|||++........
T Consensus        80 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          80 EYVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             ecCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            9998877766554432    288999999999999999999999999999999999999999999999999987655433


Q ss_pred             ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHH--------HHHh-cCcc
Q 013686          267 HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT--------NKIQ-NGAL  336 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~--------~~~~-~~~~  336 (438)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|++||................        .... ....
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            233345678899999999887 88999999999999999999999997543211100000000        0000 0000


Q ss_pred             c--ccccCcCCCCc-cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 N--ELVDPSLGFEK-DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~--~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .  +.......... ......++..+.+++.+||..+|++||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0  00000000000 00111236789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-40  Score=311.16  Aligned_cols=255  Identities=24%  Similarity=0.417  Sum_probs=200.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.+.||+|+||.||++... +|+.||+|.+... .....+.+.+|++++++++|+||+++++++... +..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-GAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-CeEEEEEe
Confidence            36788999999999999999976 6899999988654 334457789999999999999999999976654 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |+++++|..++..... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             ecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999999876421 2248999999999999999999996 599999999999999999999999999997653322 


Q ss_pred             ccccCCCCCCCccCccccccC------CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          267 HVSTAPQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                        .....+++.|+|||.+.+.      .++.++|||||||++|||++|+.||.......   ... ....+..+....  
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~-~~~~~~~~~~~~--  229 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFA-QLSAIVDGDPPT--  229 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHH-HHHHHhhcCCCC--
Confidence              2234578899999998554      35889999999999999999999996432111   000 011111111111  


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                                .+..++..+.+++.+||+.+|++||++.+++.+-.
T Consensus       230 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         230 ----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             ----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence                      11235677889999999999999999999998543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-40  Score=314.18  Aligned_cols=268  Identities=23%  Similarity=0.371  Sum_probs=199.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..+ ...++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-KRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-CeEEEEE
Confidence            46888999999999999999976 589999998754322  2345688999999999999999999977654 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|..+......    +++..+..++.||+.||.|||+.+++|+||+|+||++++++.++|+|||++....... 
T Consensus        80 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          80 EFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             ecCCccHHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99999998887765432    8999999999999999999999999999999999999999999999999988654332 


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch--------hHHHHHHHhcCc-c
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL--------SNMATNKIQNGA-L  336 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~--------~~~~~~~~~~~~-~  336 (438)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...........        ............ .
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22233457889999999875 3578899999999999999999999864432110000        000000000000 0


Q ss_pred             cccccCcCCC--CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLGF--EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .....+....  ........++..+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000000  0001122456789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.8e-41  Score=310.81  Aligned_cols=239  Identities=25%  Similarity=0.396  Sum_probs=187.4

Q ss_pred             CcccccCceEEEEEEEcC--------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          116 KQLGDGGFGAVYLGILRD--------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +.||+|+||.||+|..+.        ...|++|.+........+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-DESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-CCcEEEEe
Confidence            469999999999998642        234888887655555567889999999999999999999977654 46899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe--------EEEeeeCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR--------VKVADFGLSR  259 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~--------~kl~Dfgla~  259 (438)
                      |+++|+|.+++.....   .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999986543   3889999999999999999999999999999999999987664        6999999987


Q ss_pred             ccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCC-CCcccCCcccccchhHHHHHHHhcCccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGL-EAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      .....     ....++..|+|||.+.+ ..++.++|||||||++|||++|. .|+.......        ........  
T Consensus       157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~--  221 (258)
T cd05078         157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYEDR--  221 (258)
T ss_pred             ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHHcc--
Confidence            54321     22357889999999976 45799999999999999999995 5554322111        00111100  


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          ..++       ......+.+++.+||+.||++|||++++++.|
T Consensus       222 ----~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 ----HQLP-------APKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ----ccCC-------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                0011       11234688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-40  Score=315.19  Aligned_cols=253  Identities=27%  Similarity=0.403  Sum_probs=200.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+++++.++|+||+++++++... ...++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-TYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-CEEEEE
Confidence            36888899999999999999976 489999999875532   2456788999999999999999999976554 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+.+++|.+++.....  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          80 MDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999999975432  238999999999999999999999999999999999999999999999999987543221


Q ss_pred             cc----------------------------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCc
Q 013686          266 TH----------------------------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH  317 (438)
Q Consensus       266 ~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~  317 (438)
                      ..                            ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            01123578899999999988899999999999999999999999975432


Q ss_pred             ccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 013686          318 RHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT----MKEVLEI  383 (438)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~  383 (438)
                      ...       ...+....        ......   ...+..+.+++.+||+.||++|||    ++|++.+
T Consensus       238 ~~~-------~~~~~~~~--------~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         238 DET-------FSNILKKE--------VTFPGS---PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HHH-------HHHHhcCC--------ccCCCc---cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            110       01111111        000100   125677999999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-39  Score=309.67  Aligned_cols=255  Identities=26%  Similarity=0.422  Sum_probs=199.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||++... .++.|++|.+.....   ...+.+.+|+++++.++||||+++++.+... ...++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-RHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-CEEEEE
Confidence            36888999999999999999976 578999998875532   3346788999999999999999999977654 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus        80 ~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          80 MEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999976543    8999999999999999999999999999999999999999999999999986421110


Q ss_pred             c--------------ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          266 T--------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       266 ~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      .              .......++..|+|||.+.+..++.++|+|||||++|||++|..||......      .. ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~-~~~~  228 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------EL-FGQV  228 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHH
Confidence            0              0111234788999999998888999999999999999999999999643211      11 1111


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                      ..+...   .+..       ...++..+.+++.+||+.||++||++.++.+.|+.
T Consensus       229 ~~~~~~---~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 ISDDIE---WPEG-------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HhcccC---CCCc-------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111110   0100       01355678999999999999999997666555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-39  Score=305.86  Aligned_cols=254  Identities=25%  Similarity=0.448  Sum_probs=198.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch----------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccC
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF----------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS  179 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  179 (438)
                      +|.+.+.||+|+||.||+|... +|+.||+|.+.....          ...+.+.+|+.+++.++|||++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            4678899999999999999865 689999998753211          1235678899999999999999999976554 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...++||||+++++|.+++.....    +++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGR----FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            578999999999999999987633    8899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccc-cccCCCCCCCccCccccccCC--CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          260 LFPTDVTH-VSTAPQGTPGYVDPDYFQCYK--LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       260 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      ........ ......++..|+|||.+....  ++.++|+||||+++|||++|..||......      .... .+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMF-KLGNKRS  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHH-Hhhcccc
Confidence            65432211 122345788999999987654  889999999999999999999998632211      0000 1111111


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...+...       ....++..+.+++.+||..+|.+||++.+++++
T Consensus       230 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPPD-------VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCcc-------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            1111111       112456789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-39  Score=304.20  Aligned_cols=258  Identities=29%  Similarity=0.465  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+... +..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEe
Confidence            46889999999999999999965 58899999986543 23567899999999999999999999966554 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++..... ...+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++.........
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            9999999999976532 123889999999999999999999999999999999999999999999999998866443222


Q ss_pred             ---cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          268 ---VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       268 ---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                         ......++..|+|||.+... .++.++|+|||||++|||++|+.||.......      ........ .     .+.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~-~-----~~~  226 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN-D-----PPS  226 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC-C-----CCC
Confidence               12234588999999998776 78999999999999999999999997443211      11111111 0     011


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +.  .......++..+.+++.+||+.||++||++.+++++
T Consensus       227 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         227 LE--TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cC--CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11  111123466788999999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.9e-40  Score=305.97  Aligned_cols=249  Identities=28%  Similarity=0.491  Sum_probs=199.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|+..+.||+|+||.||++... +++.+|+|.+....  ....+.+.+|++++++++|||++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-KALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-CEEEEEEe
Confidence            4778899999999999999865 68899999986542  33456889999999999999999999966544 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~~~~~~~  266 (438)
                      |+++++|.+++.....  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          80 YAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             cCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999987542  238899999999999999999999999999999999999854 5689999999986643322


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......      .... .+..+.....       
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~-~~~~~~~~~~-------  221 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVL-KIMSGTFAPI-------  221 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHH-HHHhcCCCCC-------
Confidence              22345788999999999888999999999999999999999998754321      1111 1111111111       


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ...++..+.+++.+||+.+|++|||+.|++.+
T Consensus       222 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 -----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                 11245678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.3e-39  Score=303.94  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=199.3

Q ss_pred             CCCCCcccccCceEEEEEEEc----CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----c
Q 013686          112 FNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----R  180 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  180 (438)
                      |++.+.||+|+||.||+|...    +++.||||.+...  .....+++.+|+++++.++||||+++++++....     .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999854    3688999988654  3344677899999999999999999999664322     1


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      ..++++||+.+|+|.+++.....  ....+++.....++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            24789999999999988764321  1224788999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          259 RLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       259 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      +........ ......+++.|++||.+.+..++.++|||||||++|||++ |++||......      .. ...+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------~~-~~~~~~~~~  233 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------EI-YNYLIKGNR  233 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------HH-HHHHHcCCc
Confidence            865432211 1122345678999999988889999999999999999999 88888643221      11 111111110


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      .     ...       ...+..+.+++.+||+.+|++||++.|++..|+.+
T Consensus       234 ~-----~~~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 L-----KQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C-----CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0     000       12445789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=292.09  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=209.5

Q ss_pred             HhcCCCCC-CcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeec---cCce
Q 013686          108 ATDNFNSS-KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSR---QSRE  181 (438)
Q Consensus       108 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---~~~~  181 (438)
                      .+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++...     ....+|+++.-.. .|||||.+++++..   ....
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35666554 68999999999999976 6999999988543     3455788876665 59999999996643   3457


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCcc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLS  258 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla  258 (438)
                      +.+|||.|+||.|++.++.++...  +++.++..|..||+.|+.|||+.+|.||||||+|+|...   |..+||+|||+|
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~a--fTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQA--FTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eEeeeecccchHHHHHHHHccccc--chHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            889999999999999999887544  999999999999999999999999999999999999964   557999999999


Q ss_pred             cccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      +....  .....+.+-||.|.|||++...+|+..+|+||+||++|-|++|.+||-.....   .+.--...+|..+..  
T Consensus       212 K~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy--  284 (400)
T KOG0604|consen  212 KETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY--  284 (400)
T ss_pred             cccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc--
Confidence            87543  23345667899999999999999999999999999999999999999765431   122222334443332  


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                            .+ ....|...++..+++|+.+|..+|.+|.|+.|++.+-+-.
T Consensus       285 ------~F-P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  285 ------EF-PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             ------cC-CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence                  22 2345788999999999999999999999999999875533

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.8e-40  Score=312.03  Aligned_cols=247  Identities=27%  Similarity=0.441  Sum_probs=198.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCC
Q 013686          114 SSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  192 (438)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++... +..++||||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCCCC
Confidence            3457999999999999865 6899999998765545557788999999999999999999976654 4799999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCC
Q 013686          193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP  272 (438)
Q Consensus       193 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  272 (438)
                      +|..++...     .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......... ....
T Consensus       104 ~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~  177 (297)
T cd06659         104 ALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL  177 (297)
T ss_pred             CHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence            999987653     2889999999999999999999999999999999999999999999999998765433221 2234


Q ss_pred             CCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHH
Q 013686          273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAV  352 (438)
Q Consensus       273 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (438)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+.......     ..     ..
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~~-----~~  240 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPPK-----LK-----NA  240 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCCC-----cc-----cc
Confidence            58899999999998899999999999999999999999997432211       011111111000     00     01


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          353 RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       353 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ...+..+.+++.+||+.+|++||++++++++-
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence            23455688999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.8e-40  Score=310.56  Aligned_cols=252  Identities=26%  Similarity=0.437  Sum_probs=203.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++||||+++++++... +..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-DELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-CcEEEEEe
Confidence            367889999999999999999864 6889999998655555567789999999999999999999977654 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.+..     +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ 
T Consensus        97 ~~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          97 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             cCCCCcHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            999999999997542     78899999999999999999999999999999999999999999999999876543322 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........       .+....     .+...  
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~~~~-----~~~~~--  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNG-----TPELQ--  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehhcCC-----CCCCC--
Confidence            1223458889999999988889999999999999999999999997543211110       000000     00000  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         ....++..+.+++.+||+.+|++||++.+++.+-
T Consensus       237 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         237 ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence               1123456788999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=310.94  Aligned_cols=248  Identities=24%  Similarity=0.400  Sum_probs=207.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh--HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .-|...+.||+|.|..|-++++- +|+.||||++.+.....  ...+.+|++.|+.++|||||++|.+...+ ..+|+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-TKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-TKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-ceEEEEE
Confidence            34667788999999999999854 79999999997664433  35688899999999999999999966555 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe-cCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL-DNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill-~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |+=++|+|++||-++...   +.+....+++.||+.|+.|+|+..+|||||||+||.+ ..-|-|||.|||++..+....
T Consensus        97 ELGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999887653   8999999999999999999999999999999999877 567889999999998775543


Q ss_pred             cccccCCCCCCCccCccccccCCCCC-hhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTD-KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .  ..+.+|+..|-|||++.|..|+. +.||||||||||-|++|++||+.....+..               ..++|..+
T Consensus       174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKY  236 (864)
T KOG4717|consen  174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKY  236 (864)
T ss_pred             h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcccc
Confidence            3  35668999999999999998864 789999999999999999999865443221               12233333


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .     .+..++.++++||..||..||.+|.+.+||...
T Consensus       237 t-----vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 T-----VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             c-----CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            2     235678899999999999999999999999864

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-39  Score=304.81  Aligned_cols=254  Identities=30%  Similarity=0.467  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|+..+.||+|+||.||++..+ +++.|++|.+.... ....+.+.+|++++++++||||+++++++... ...++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEE
Confidence            35777889999999999999976 58999999886653 34456788999999999999999999977665 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |+++++|.+++....   ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999999998753   238899999999999999999999 9999999999999999999999999999876533221


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      .   ...++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...... ..+..+..     +.+. 
T Consensus       157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~-----~~~~-  225 (265)
T cd06605         157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELL-QYIVNEPP-----PRLP-  225 (265)
T ss_pred             h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHH-HHHhcCCC-----CCCC-
Confidence            1   25688899999999998999999999999999999999999965422111 111111 11111111     1110 


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ...++..+.++|.+||..||++|||+.+++.+
T Consensus       226 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 -----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                 01256678999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-40  Score=319.73  Aligned_cols=277  Identities=22%  Similarity=0.314  Sum_probs=203.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----RE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  181 (438)
                      .++|.+.+.||+|+||+||++... +|+.||||.+...  .......+.+|+.+++.++|+||+++++++....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999965 6899999988643  2223456778999999999999999998664432    35


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .++||||+. ++|.+++.....    +++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQT----LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            899999995 789998876543    899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHHHHh
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATNKIQ  332 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~~~~  332 (438)
                      .... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||..............        ....+.
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            4332 12233457889999998764 4688999999999999999999999975432111000000        000000


Q ss_pred             cCccccccc--CcC-CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhccC
Q 013686          333 NGALNELVD--PSL-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI--LRETKDSN  391 (438)
Q Consensus       333 ~~~~~~~~~--~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~  391 (438)
                      .........  +.. ..........++..+.+++.+||+.||++|||++|++++  +..+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence            000000000  000 000011123467788999999999999999999999987  65554443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3e-39  Score=301.25  Aligned_cols=252  Identities=28%  Similarity=0.477  Sum_probs=205.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.+.||+|++|.||++... +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++... ...++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEE
Confidence            36888999999999999999977 489999999876543 4457899999999999999999999977655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |+++++|.+++....    .+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          80 YMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             ecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            999999999998753    38999999999999999999999 9999999999999999999999999999986644332


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ..... ..+.......     +  
T Consensus       156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~-~~~~~~~~~~-----~--  223 (264)
T cd06623         156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELM-QAICDGPPPS-----L--  223 (264)
T ss_pred             c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHH-HHHhcCCCCC-----C--
Confidence            2 123357889999999998899999999999999999999999997654211   11111 1111111111     1  


Q ss_pred             CccHHHHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          347 EKDYAVRN-MVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       347 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ... ++..+.+++.+||..+|++||++.|++++
T Consensus       224 -----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 -----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 112 56679999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.2e-40  Score=308.48  Aligned_cols=265  Identities=23%  Similarity=0.378  Sum_probs=196.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|+..+.||.|++|.||+|... +|+.||||.+.....  ...+.+.+|++++++++||||+++++++... +..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEee
Confidence            4778899999999999999976 689999998864322  2235788999999999999999999977554 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+. ++|.+++......  .+++..+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++.........
T Consensus        80 ~~~-~~l~~~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          80 FLH-QDLKKFMDASPLS--GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             ccc-cCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            995 6899998765432  3899999999999999999999999999999999999999999999999998765432211


Q ss_pred             cccCCCCCCCccCccccccCC-CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC------------
Q 013686          268 VSTAPQGTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG------------  334 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~------------  334 (438)
                       .....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||.........  .... ......            
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIF-RTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHH-HHhCCCChhhhhhhhHHH
Confidence             22334688999999887644 688999999999999999999999754321110  0000 000000            


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .....+..............++..+.+++.+||+.||.+|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0000000000000001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=308.38  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++... ...++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEEEE
Confidence            357888999999999999999976 6899999998654322 224567899999999999999999977654 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+. ++|.+++.....   .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          83 EYLD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             ecCC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9997 599999876543   388999999999999999999999999999999999999999999999999875432211


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Ccccc----
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALNE----  338 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~----  338 (438)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ...........   .....    
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhc
Confidence             1122346889999998865 4588999999999999999999999965431100  00000000000   00000    


Q ss_pred             --cccCcCCCC-cc---HHHHHHH--HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          339 --LVDPSLGFE-KD---YAVRNMV--TSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       339 --~~~~~~~~~-~~---~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        ......... ..   .......  ..+.+++.+||+.+|++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence              000000000 00   0001122  567899999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-39  Score=306.46  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=194.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHH-HHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEI-LTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|+||.||++... +|+.||+|++..... .....+..|+.. ++.++||||+++++++... ...+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-GDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-CcEEEEh
Confidence            46888999999999999999976 699999999865422 223445556665 5667899999999977655 4699999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||++ |+|.+++.........+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9995 789888876443334589999999999999999999997 99999999999999999999999999998654322


Q ss_pred             cccccCCCCCCCccCcccccc----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          266 THVSTAPQGTPGYVDPDYFQC----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .  .....++..|+|||.+.+    ..++.++|+|||||++|||++|+.||......    . ....... .+..     
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~-~~~~-----  225 (283)
T cd06617         159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVV-EEPS-----  225 (283)
T ss_pred             c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHH-hcCC-----
Confidence            1  122457889999998865    45688999999999999999999998642211    0 0011111 1111     


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +.+.      ...++..+.+++.+||..+|++||++.+++++
T Consensus       226 ~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 PQLP------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CCCC------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1110      11356678999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2e-39  Score=307.41  Aligned_cols=267  Identities=22%  Similarity=0.275  Sum_probs=195.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++|+||+++++++... ...++||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEEEE
Confidence            467889999999999999999865 6899999998654322 224577899999999999999999977654 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+. ++|.+++.....   .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 688777755432   277888889999999999999999999999999999999999999999999875433211


Q ss_pred             ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh------------c
Q 013686          267 HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ------------N  333 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~------------~  333 (438)
                       ......+++.|+|||.+.+. .++.++|||||||++|||++|..||..........  ......+.            .
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL--EKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH--HHHHHHcCCCChhhhhhhhhc
Confidence             12233578999999998754 57889999999999999999999997543211100  00000000            0


Q ss_pred             Ccc-cccccCcCCCCccHHH--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GAL-NELVDPSLGFEKDYAV--RNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~~-~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ... ...............+  ...+..+.+++.+|+..||.+|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000 0000000000000000  0124568899999999999999999998763

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.3e-39  Score=305.03  Aligned_cols=249  Identities=28%  Similarity=0.468  Sum_probs=200.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++... +..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-DELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-CeEEEEEecc
Confidence            3445679999999999999965 6889999998765555567788999999999999999999976554 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++...     .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++......... .
T Consensus        99 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~  172 (285)
T cd06648          99 EGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-R  172 (285)
T ss_pred             CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-c
Confidence            999999999762     2889999999999999999999999999999999999999999999999998765433221 2


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                      ....+++.|+|||.+.+..++.++|||||||++|||++|+.||......      . ....+.....     +.+..   
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~-~~~~~~~~~~-----~~~~~---  237 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------Q-AMKRIRDNLP-----PKLKN---  237 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------H-HHHHHHhcCC-----CCCcc---
Confidence            2345889999999998888999999999999999999999998643221      1 1111221111     11100   


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        ...++..+.+++.+||+.+|++||++.+++++
T Consensus       238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             --cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence              01245678999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-39  Score=309.50  Aligned_cols=269  Identities=21%  Similarity=0.290  Sum_probs=198.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv  185 (438)
                      ++|++.+.||+|+||.||+|..+ +++.+++|.++.....  ....+.+|+.++++++||||+++++++... ....++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999976 5889999998654322  234567899999999999999999966544 2579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||++ ++|.+++.....   .+++..+..++.||+.||+|||+.+++|+||||+||+++.++.+||+|||++.......
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99996 599999876543   38999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH--------HHHHHHhc---
Q 013686          266 THVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN--------MATNKIQN---  333 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------~~~~~~~~---  333 (438)
                      . ......+++.|+|||.+.+. .++.++|+||||+++|||++|.+||.............        ..+..+..   
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            1 12234578899999998764 46889999999999999999999997543211110000        00000000   


Q ss_pred             CcccccccCcCCCCccHHHHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRN-MVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..................... ++..+.+++.+||+.||++|||+.|++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000000000000000011 36678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-40  Score=316.99  Aligned_cols=293  Identities=22%  Similarity=0.316  Sum_probs=213.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----RELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  183 (438)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++|+||+++++++....    ...|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999976 48999999886543  334567889999999999999999999765543    3689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||++ ++|.+++....    .+++..+..++.||+.||.|||+.||+||||||.|||++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999996 58999987654    389999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc--ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH---------
Q 013686          264 DVT--HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI---------  331 (438)
Q Consensus       264 ~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~---------  331 (438)
                      ...  .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||..........   ......         
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~  232 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHhh
Confidence            321  112334578899999999887 78999999999999999999999997654221100   000000         


Q ss_pred             --hcCcccccc---cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhccCCCCCccccccccc
Q 013686          332 --QNGALNELV---DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI--LRETKDSNLGTSKAKVVDIRI  404 (438)
Q Consensus       332 --~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~~~~~~~~  404 (438)
                        ........+   ...............+..+.+++.+||+.+|++||++.+++.+  ++...+...+...........
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~  312 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDF  312 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccc
Confidence              000000000   0000000011112356778999999999999999999999985  565555443333333333322


Q ss_pred             cchhhhh
Q 013686          405 ADDAALL  411 (438)
Q Consensus       405 ~~~~~~~  411 (438)
                      .++....
T Consensus       313 ~~~~~~~  319 (330)
T cd07834         313 FDDDELT  319 (330)
T ss_pred             cchhhcC
Confidence            3333333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=318.41  Aligned_cols=274  Identities=22%  Similarity=0.318  Sum_probs=200.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----REL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  182 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.++++++|+||+++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 6899999998643 2234467888999999999999999998654332    357


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++|+||+. ++|.+++...     .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999995 5888887653     28999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccc--cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHHHH
Q 013686          263 TDVTH--VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATNKI  331 (438)
Q Consensus       263 ~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~~~  331 (438)
                      .....  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||............        ......+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32221  1123457899999998654 56899999999999999999999999653321100000        0000000


Q ss_pred             hcCcccccc---cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 013686          332 QNGALNELV---DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI--LRETK  388 (438)
Q Consensus       332 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  388 (438)
                      .........   ...............+..+.+++.+||+.||++|||+.|++++  ++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            000000000   0000000011112346778999999999999999999999987  44443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-39  Score=310.28  Aligned_cols=269  Identities=25%  Similarity=0.358  Sum_probs=200.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----  179 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  179 (438)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.+.....  .....+.+|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34678999999999999999999976 589999999865432  22356778999999999999999999665432    


Q ss_pred             -----ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          180 -----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       180 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                           ..+++|+||+++ +|.+.+.....   .+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV---HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                 368999999965 77777765432   389999999999999999999999999999999999999999999999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      ||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||.........   ..... ...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~---~~~~~-~~~  235 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL---ELISR-LCG  235 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHH-HhC
Confidence            99998765443222233346788999998865 35788999999999999999999999754321110   00000 000


Q ss_pred             Cc----cccccc--------CcCC--CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GA----LNELVD--------PSLG--FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~----~~~~~~--------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +.    .+.+..        ..-.  .........++..+.+++.+||+.||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00    000000        0000  00001112356789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=303.91  Aligned_cols=248  Identities=27%  Similarity=0.441  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCC---CCCceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQ---HPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++   |||++++++++... ...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEEEE
Confidence            4677889999999999999964 6899999988654 2344567889999999996   99999999977654 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++...     .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          81 MEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            9999999999998654     28999999999999999999999999999999999999999999999999998765433


Q ss_pred             cccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.........       ..+...     ..+.+
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~  222 (277)
T cd06917         156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKS-----KPPRL  222 (277)
T ss_pred             cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccC-----CCCCC
Confidence            21 233458899999998865 45788999999999999999999999754321110       011110     01111


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..      ...+..+.+++.+||+.||++||++.+++.+
T Consensus       223 ~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         223 ED------NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             Cc------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            11      1245678899999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.2e-39  Score=303.48  Aligned_cols=264  Identities=22%  Similarity=0.296  Sum_probs=194.3

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCC-CCCceeEeeeeecc-CceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQ-SRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv~e  187 (438)
                      |++.+.||+|+||.||+|... +++.||+|.+.... ........+|+.++.++. |+|++++++++... .+.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999965 68999999886532 122234457899999885 99999999977654 247899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |++ ++|.+++.....   .+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++.........
T Consensus        81 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 588888876432   3899999999999999999999999999999999999999 99999999999865433221


Q ss_pred             cccCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch---------hHHHHHHHhcCccc
Q 013686          268 VSTAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL---------SNMATNKIQNGALN  337 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~  337 (438)
                        ....++..|+|||.+. +..++.++|||||||++|||++|..||...........         ..+ ..........
T Consensus       156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (282)
T cd07831         156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHM  232 (282)
T ss_pred             --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccc
Confidence              2235788999999764 45678899999999999999999999975432211000         000 0011100000


Q ss_pred             cc-ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 EL-VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .. ...............++..+.+++.+||+.+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00 00000001111223567889999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=306.87  Aligned_cols=265  Identities=23%  Similarity=0.364  Sum_probs=199.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e  187 (438)
                      |++.+.||+|+||.||+|... +|+.+|+|.+....  ....+.+.+|++++++++|+|++++++++... .+..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999976 48999999987653  33346788999999999999999999977655 257999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |++ ++|.+++.....   .+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~-~~l~~~~~~~~~---~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMD-HDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             ccc-ccHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            996 589988876532   3899999999999999999999999999999999999999999999999999876544322


Q ss_pred             cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh---cCccccc----
Q 013686          268 VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ---NGALNEL----  339 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----  339 (438)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........   .......   ...+...    
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccccch
Confidence            2233457889999998765 467899999999999999999999997544221110   0000000   0000000    


Q ss_pred             ----ccCcCCCC--ccHHHHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 ----VDPSLGFE--KDYAVRN-MVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ----~~~~~~~~--~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ..+.....  ....... ++..+.+++.+||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                00000000  0001112 36788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.1e-39  Score=295.68  Aligned_cols=250  Identities=30%  Similarity=0.493  Sum_probs=203.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++... ...++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence            4677899999999999999976 6889999998776555667899999999999999999999977655 5789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++....   ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||.+........  .
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            9999999998753   2389999999999999999999999999999999999999999999999999987654432  2


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......      .. .............        
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~~~--------  219 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------AL-FKIATNGPPGLRN--------  219 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HH-HHHHhcCCCCcCc--------
Confidence            34458899999999988889999999999999999999999987532111      00 0111111111111        


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        ...++..+.+++.+||+.||++|||+.|++++
T Consensus       220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             --ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              01135678999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-39  Score=311.21  Aligned_cols=268  Identities=24%  Similarity=0.341  Sum_probs=199.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCCceeEeeeeeccC-ceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-RELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+......  ....+.+|+.++++++|+||+++++++.... +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999976 5899999998644322  1234667999999999999999999765442 46899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+. ++|.+++.....   .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        86 v~e~~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999995 589888876432   3899999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccc---
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALN---  337 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---  337 (438)
                      ... .....+++.|+|||.+.+ ..++.++|||||||++|||++|++||.........   .........   ..+.   
T Consensus       162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChhhchhhh
Confidence            211 222345788999999865 46789999999999999999999999754322111   000000000   0000   


Q ss_pred             -----cccc-CcCCCC-ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          338 -----ELVD-PSLGFE-KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       338 -----~~~~-~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                           .... +..... ........+..+.+++.+||+.||++|||++|++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                 0000 000000 0001122467788999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.7e-39  Score=301.65  Aligned_cols=247  Identities=28%  Similarity=0.451  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      -|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEe
Confidence            4667889999999999999865 68899999876433 33456788999999999999999999977655 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++...     .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          84 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            9999999998653     288999999999999999999999999999999999999999999999999876543221 1


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......       .....+......     .+    
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-----~~----  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKNNPP-----TL----  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHHhcCCCC-----CC----
Confidence            22345788999999998888999999999999999999999998643211       011111111111     01    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         ...++..+.+++.+||+.+|.+||++.+++++
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               12345678899999999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.8e-39  Score=308.15  Aligned_cols=269  Identities=21%  Similarity=0.314  Sum_probs=197.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCc----e
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSR----E  181 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----~  181 (438)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|+.+++.+. ||||+++++++.....    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999976 689999998754322  22356888999999995 6999999997655432    3


Q ss_pred             EEEEEeccCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPN-SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLSR  259 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~  259 (438)
                      .|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7999999975 899888764432 345899999999999999999999999999999999999998 8899999999988


Q ss_pred             ccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC---c
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG---A  335 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---~  335 (438)
                      ........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.........  ... ...+...   .
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~-~~~~~~~~~~~  235 (295)
T cd07837         160 AFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHI-FKLLGTPTEQV  235 (295)
T ss_pred             ecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH-HHHhCCCChhh
Confidence            65332211 122346889999998865 45789999999999999999999999754321110  000 0000000   0


Q ss_pred             cccccc-------CcC-CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LNELVD-------PSL-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~~~~~-------~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ......       +.. ..........++..+.++|.+||..||.+||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000       000 000001112456779999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=303.82  Aligned_cols=265  Identities=23%  Similarity=0.348  Sum_probs=197.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      |++.+.||.|++|.||+|... +|..||+|++.....  ...+.+.+|+++++.++|||++++++++... ...+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence            567889999999999999975 699999998864432  2235688899999999999999999977655 579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      + +++|.+++.....  ..+++..+..++.|+++||+|||+++++||||+|+||+++.++.++|+|||++......... 
T Consensus        80 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          80 L-DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             c-CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            9 4699999876552  23899999999999999999999999999999999999999999999999999765432211 


Q ss_pred             ccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHH----------HHh-cCcc
Q 013686          269 STAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN----------KIQ-NGAL  336 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~----------~~~-~~~~  336 (438)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........  .......          .+. ....
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhh
Confidence            1223468899999988654 578899999999999999999999975432111  0000000          000 0000


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...+..............++..+.+++.+||+.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000000011123355678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.5e-39  Score=299.03  Aligned_cols=250  Identities=26%  Similarity=0.451  Sum_probs=199.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|+||.||++..+ +|..+|+|.+....  ....+.+.+|+++++.++|+||+++++++... ...++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-GRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-CeEEEEEe
Confidence            4778899999999999999976 58899999986542  23346788999999999999999999976554 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~~~~  266 (438)
                      |+++++|.+++......  .+++..+..++.|++.||.|||+.+++|+||||+||++++++ .+||+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGV--LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             cCCCCcHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999999765432  378999999999999999999999999999999999999885 579999999986644322


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      . .....|++.|+|||.+.+..++.++|+||||+++|||++|..||.....      ...... +..+..... .     
T Consensus       158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~-~-----  223 (257)
T cd08225         158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLK-ICQGYFAPI-S-----  223 (257)
T ss_pred             c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HhcccCCCC-C-----
Confidence            2 2234588999999999888899999999999999999999999864321      111111 111111111 0     


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            ...+..+.+++.+||..+|++|||+.|++++
T Consensus       224 ------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         224 ------PNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  1234568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5e-39  Score=303.92  Aligned_cols=254  Identities=27%  Similarity=0.448  Sum_probs=205.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ..+.|...+.||+|+||.||++... +++.|++|.+..... ..+.+.+|+++++.++|+|++++++++... ...++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEE
Confidence            4567888899999999999999976 688999999876544 456788999999999999999999977665 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999999998765   1389999999999999999999999999999999999999999999999999875543221


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......      . ...+.........      
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~------  237 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------A-LFLITTKGIPPLK------  237 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhcCCCCCc------
Confidence             1223347889999999988889999999999999999999999986432211      0 1111111111100      


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          ....++..+.+++.+||+.+|.+||++.+++++.
T Consensus       238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         238 ----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             ----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence                1123567789999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.7e-39  Score=311.39  Aligned_cols=270  Identities=26%  Similarity=0.402  Sum_probs=200.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc-CceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~  182 (438)
                      ..++|++.+.||+|+||.||+|... +|+.+|+|++...  .......+.+|+.+++++ +||||+++++++... ...+
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567889999999999999999976 5889999988542  233445677899999999 999999999976543 3468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||++ ++|.+++...     .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 5999988764     28899999999999999999999999999999999999999999999999998654


Q ss_pred             CCccc----cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHH
Q 013686          263 TDVTH----VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATN  329 (438)
Q Consensus       263 ~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~  329 (438)
                      .....    ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............        ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            33221    1223457889999998754 4578899999999999999999999965432211000000        000


Q ss_pred             HHhcCccccccc---CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          330 KIQNGALNELVD---PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       330 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+........++   ..-..........++..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000000000   000000011112356789999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-38  Score=304.11  Aligned_cols=249  Identities=29%  Similarity=0.440  Sum_probs=197.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ...|...+.||+|+||.||+|... +|+.||+|.+...   .....+.+.+|+++++.++||||+++++++... +..++
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-~~~~l   92 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-HTAWL   92 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-CeEEE
Confidence            345888899999999999999975 6899999988643   223446788999999999999999999977655 47899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+. |+|.+++.....   .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus        93 v~e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          93 VMEYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EHHhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            999996 688777764432   3899999999999999999999999999999999999999999999999998765332


Q ss_pred             ccccccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                           ....++..|+|||.+.   ...++.++||||||+++|||++|..||.......      . ...+.....     
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~-~~~~~~~~~-----  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A-LYHIAQNDS-----  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------H-HHHHhcCCC-----
Confidence                 2235788999999874   3568889999999999999999999986432211      0 011111110     


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +.+      ....++..+.+++.+||+.||++||++.+++.+..
T Consensus       232 ~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         232 PTL------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             CCC------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            111      01235667899999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.7e-39  Score=314.08  Aligned_cols=268  Identities=21%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  179 (438)
                      ..++|++.+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+.++++++|+||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999975 6899999988643  2334466788999999999999999999765332     


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...|+||||+. ++|.+.+...      +++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999995 5888887643      7888899999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch---------hHH----
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL---------SNM----  326 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~---------~~~----  326 (438)
                      .......  .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........         ..+    
T Consensus       167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            6543322  2234578899999999999999999999999999999999999975432111000         000    


Q ss_pred             ---HHHHHhcCc------ccccccCcC-CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          327 ---ATNKIQNGA------LNELVDPSL-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       327 ---~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         .........      +.+...... ...........+..+.+++.+||+.||++|||+.|++.+-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence               000000000      000000000 0000000123466788999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.4e-40  Score=338.13  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=193.5

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeee---------
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGC---------  174 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~---------  174 (438)
                      .+...+|...+.||+||||.||+++.+ ||+.||||++.-. .......+.+|+.+|++|+|||||+++..         
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345678888999999999999999987 8999999998654 33345678899999999999999998742         


Q ss_pred             -------------------------------------------------e--e------c--------------------
Q 013686          175 -------------------------------------------------T--S------R--------------------  177 (438)
Q Consensus       175 -------------------------------------------------~--~------~--------------------  177 (438)
                                                                       .  .      .                    
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0  0      0                    


Q ss_pred             --------------------------------cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 013686          178 --------------------------------QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA  225 (438)
Q Consensus       178 --------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  225 (438)
                                                      ....+||-||||+..+|.++++.+...   -.....++++++|++||.
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence                                            002378999999998888888776532   146678999999999999


Q ss_pred             HHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC----------C-------CccccccCCCCCCCccCccccccCC
Q 013686          226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP----------T-------DVTHVSTAPQGTPGYVDPDYFQCYK  288 (438)
Q Consensus       226 ~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~----------~-------~~~~~~~~~~g~~~y~aPE~~~~~~  288 (438)
                      |+|++|||||||||.||++++++.|||+|||+|+...          .       ......+...||.-|+|||++.+..
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999999999999999998721          0       0111234557999999999997654


Q ss_pred             ---CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHH
Q 013686          289 ---LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFR  365 (438)
Q Consensus       289 ---~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  365 (438)
                         |+.|+|+||+||+|+||+.   ||...-.      .......++.+.++..        .+. ..+....-..+|++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~iL~~LR~g~iP~~--------~~f-~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASILTNLRKGSIPEP--------ADF-FDPEHPEEASLIRW  853 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHH------HHHHHHhcccCCCCCC--------ccc-ccccchHHHHHHHH
Confidence               9999999999999999985   4543211      1112223333333332        111 11122234579999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 013686          366 CVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       366 cl~~dP~~RPs~~evl~  382 (438)
                      +++.||.+|||+.|+|.
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999986

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=321.02  Aligned_cols=271  Identities=27%  Similarity=0.423  Sum_probs=205.4

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----ceEEE
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----RELLL  184 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~~l  184 (438)
                      |...+.||+|+||.||+|+.+ .|+.||||.+... .....+...+|+++|++|+|+|||+++++-....     ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345678999999999999965 6999999998654 3345678889999999999999999998543332     35789


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec--CCCe--EEEeeeCcccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD--NNFR--VKVADFGLSRL  260 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~--~~~~--~kl~Dfgla~~  260 (438)
                      |||||.||+|...|++-. +...|++.+.+.++.++..||.|||++||+||||||.||++-  .+|+  -||+|||.|+.
T Consensus        95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999998643 345699999999999999999999999999999999999993  3343  69999999998


Q ss_pred             cCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC--ccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG--ALN  337 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~  337 (438)
                      ++++.  ......||+.|++||.+.. ..|+..+|.|||||++|+..||..||..........  ...+..+...  ...
T Consensus       174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~--~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK--EIMWHIITKKPSGVA  249 (732)
T ss_pred             CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc--hhhhhhhccCCCcee
Confidence            86654  4566789999999999984 789999999999999999999999998655433211  1122221110  000


Q ss_pred             c----------cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhh
Q 013686          338 E----------LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP--TMKEVLEILRETK  388 (438)
Q Consensus       338 ~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~  388 (438)
                      -          .....++.+ ..........+...+..+|..+|++|.  .+.+....+..+.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p-~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQP-NHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             EeeecccCCceeeeccCCCc-ccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            0          011112221 112234445566778889999999999  7666666666554

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=286.90  Aligned_cols=252  Identities=25%  Similarity=0.443  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++.+.+..||.|..|.|+++..+ .|...|||.+.+. +..+.+++...++++...+ .|.||+.+|+|..+. ..++.|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~IcM  170 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFICM  170 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHHHH
Confidence            44556778999999999999977 5899999999765 5556678888888887775 899999999887765 689999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |.| ...+..++...+.   ++++..+-++..-++.||.||.++ +|+|||+||+|||+|+.|++|+||||++..+-+..
T Consensus       171 elM-s~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  171 ELM-STCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHH-HHHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            999 4566666665443   389988889999999999999875 89999999999999999999999999998765544


Q ss_pred             cccccCCCCCCCccCcccccc---CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          266 THVSTAPQGTPGYVDPDYFQC---YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .+  +...|.+.|||||.+.-   ..|+-++||||||++|+||.||+.||.......+      ....+.+.. +    |
T Consensus       247 Ah--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~e-P----P  313 (391)
T KOG0983|consen  247 AH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNEE-P----P  313 (391)
T ss_pred             cc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhcC-C----C
Confidence            43  33459999999999964   3688899999999999999999999986432211      112222211 1    2


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .+...     .++++.+.+++..||++|+.+||...+++++-
T Consensus       314 ~L~~~-----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  314 LLPGH-----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             CCCcc-----cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            22221     23677899999999999999999999999864

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.5e-39  Score=296.84  Aligned_cols=250  Identities=27%  Similarity=0.449  Sum_probs=204.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|+||.||++... +++.+++|.+....  ......+.+|+++++.++|+||+++++++... ...++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence            4778899999999999999865 68899999986542  33456788899999999999999999976655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.........+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            99999999999774433345899999999999999999999999999999999999999999999999999876544   


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||......      . ....+..+.....        
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~--------  221 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------D-LRYKVQRGKYPPI--------  221 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCCCCCC--------
Confidence            222345788999999999989999999999999999999999999754321      1 1111222111111        


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ...++.++.+++.+||+.+|++||++.+++++
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                12456779999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-39  Score=314.14  Aligned_cols=273  Identities=20%  Similarity=0.331  Sum_probs=202.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeec---cCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSR---QSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~  182 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..   .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367889999999999999999965 58999999986542  2334677889999999999999999886543   23468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+. ++|.+++.....    +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 699999876543    8999999999999999999999999999999999999999999999999997653


Q ss_pred             CCccc---cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHHH
Q 013686          263 TDVTH---VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATNK  330 (438)
Q Consensus       263 ~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~~  330 (438)
                      .....   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............        ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211   1123468899999998865 4688999999999999999999999975432111100000        0000


Q ss_pred             HhcCccccc---ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          331 IQNGALNEL---VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       331 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                      .......+.   ................+..+.+++.+||+.+|++||++.+++.+..-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence            000000000   00001111111123457789999999999999999999999986543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=305.71  Aligned_cols=272  Identities=20%  Similarity=0.293  Sum_probs=198.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc---CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR---DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~  183 (438)
                      +|.+.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++... ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778889999999999999975   37899999987632   23346678899999999999999999977654 25799


Q ss_pred             EEEeccCCCCHHHHhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC----CCeEEEeeeCcc
Q 013686          184 LVYEYIPNGTVADHLHNRQPNS-CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN----NFRVKVADFGLS  258 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~----~~~~kl~Dfgla  258 (438)
                      +||||++ ++|.+++....... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999996 57777776443322 25889999999999999999999999999999999999999    999999999999


Q ss_pred             cccCCCcc--ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch--hHHHH----H
Q 013686          259 RLFPTDVT--HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL--SNMAT----N  329 (438)
Q Consensus       259 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~--~~~~~----~  329 (438)
                      ........  .......+++.|+|||.+.+. .++.++|||||||++|||++|++||...........  .....    .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86643322  112234578899999988664 578999999999999999999999976543321000  00000    0


Q ss_pred             HHhc------------Ccccc----cccCcCCCC--ccHHHH--HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          330 KIQN------------GALNE----LVDPSLGFE--KDYAVR--NMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       330 ~~~~------------~~~~~----~~~~~~~~~--~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+..            .....    .........  ......  ..+..+.+++.+||+.||++|||+.|++++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000            00000    000000000  000111  345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.7e-38  Score=294.78  Aligned_cols=251  Identities=29%  Similarity=0.512  Sum_probs=204.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-ceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-RELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~  186 (438)
                      +|+..+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|++++++++|+||+++++++.... ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999977 689999999865542  45678999999999999999999999765541 5789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765    389999999999999999999999999999999999999999999999999987654432


Q ss_pred             c-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc-CcccccccCcC
Q 013686          267 H-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN-GALNELVDPSL  344 (438)
Q Consensus       267 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  344 (438)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....     ...... .+.. .....      
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~~~~~------  224 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY-KIGSSGEPPE------  224 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH-hccccCCCcC------
Confidence            1 12334688999999999888899999999999999999999999975431     111111 1111 01100      


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            .+...+..+.+++.+||+.||++||++.+++.+
T Consensus       225 ------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         225 ------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                  112336779999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.3e-39  Score=301.55  Aligned_cols=266  Identities=24%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      +|++.+.||.|++|.||+|... +|+.||+|.+..... ...+.+.+|+.++++++|+||+++++++... +..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEec
Confidence            4778899999999999999976 589999999865432 2345677899999999999999999977665 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      ++ ++|.+++..... ...+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++........ .
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  156 (284)
T cd07836          80 MD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T  156 (284)
T ss_pred             CC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence            97 489998876542 22489999999999999999999999999999999999999999999999999986543322 1


Q ss_pred             ccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH--------HHHHHHhcCccccc
Q 013686          269 STAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN--------MATNKIQNGALNEL  339 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  339 (438)
                      .....++..|++||.+.+. .++.++|||||||++|+|++|+.||.............        .....+.  .... 
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-  233 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLPE-  233 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCch-
Confidence            2234578899999988654 57889999999999999999999997544321110000        0000000  0000 


Q ss_pred             ccCcCCCCc----cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 VDPSLGFEK----DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .........    .......+..+.+++.+||+.||.+||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            001111000    11122456778999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.6e-39  Score=303.50  Aligned_cols=245  Identities=25%  Similarity=0.376  Sum_probs=192.9

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ||+|+||+||++... +|+.||+|.+.....   ...+.+.+|+++++.++||||+++++++... +..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCc
Confidence            699999999999865 689999998865422   2234667899999999999999999877655 47899999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ  273 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  273 (438)
                      |.+++.....  ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||++.......  ......
T Consensus        80 L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          80 LKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            9999986553  238999999999999999999999999999999999999999999999999987654321  122345


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      ++..|+|||.+.+..++.++|||||||++|+|++|+.||.........       ..+.......  ...       .+.
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~--~~~-------~~~  219 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------EELKRRTLEM--AVE-------YPD  219 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------HHHHhccccc--ccc-------CCc
Confidence            788999999998888999999999999999999999999754331110       0111111000  000       112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      .+++.+.+++.+||+.||.+||     ++.+++.+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            3466788999999999999999     66667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.1e-40  Score=304.11  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=200.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      +|++.+.||.|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.. +...++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence            4778899999999999999976 58999999987543   2345788999999999999999999986654 45799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+.+++|.+++....    .+++..+..++.|+++||.|||+.+++|+||+|+||++++++.++|+|||++....... 
T Consensus        80 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          80 DLLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             eCCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            9999999999997753    38899999999999999999999999999999999999999999999999988654432 


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......    ..........  ....       
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~~~-------  220 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--ADVL-------  220 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--cccc-------
Confidence             1233458889999999988889999999999999999999999998654321    1111111111  0000       


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTM--KEVLE  382 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~  382 (438)
                          .+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         221 ----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ----CcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                112345778899999999999999999  66653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=296.55  Aligned_cols=251  Identities=27%  Similarity=0.430  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-----chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-----NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  182 (438)
                      .+|.+.+.||+|+||.||++... +++.||+|.+...     .....+.+.+|++++++++|+||+++++++... ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999965 5899999987432     223456788999999999999999999976543 3468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      +++|||+++++|.+++.....    +++.....++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            899999999999999976543    7888999999999999999999999999999999999999999999999998653


Q ss_pred             CCcc--ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVT--HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....  .......++..|+|||.+.+..++.++|+|||||++|||++|+.||......      .... .+......   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~---  227 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIF-KIATQPTK---  227 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHH-HHHcCCCC---
Confidence            2111  1112345889999999999888999999999999999999999999743211      1111 11111111   


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       +.+       +..++..+.+++.+||. +|..||++.+++.+
T Consensus       228 -~~~-------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         228 -PML-------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -CCC-------CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence             111       13456778999999999 57999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-39  Score=303.15  Aligned_cols=263  Identities=24%  Similarity=0.365  Sum_probs=201.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      |++.+.||+|++|.||++... +|+.+++|.+......  ....+.+|++++++++|+||+++++++... ...++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence            566789999999999999975 6899999998654322  346788899999999999999999976555 579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++ +|.+++.....   .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||.+....... ..
T Consensus        80 ~~~-~l~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          80 MDT-DLYKLIKDRQR---GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             cCC-CHHHHHHhhcc---cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            964 88888876532   38999999999999999999999999999999999999999999999999998765443 12


Q ss_pred             ccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccccccc---
Q 013686          269 STAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALNELVD---  341 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---  341 (438)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..........   .....+..   ..+.....   
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCchHhcccchhhhh
Confidence            2234578899999998776 78999999999999999999999997544321110   00000000   00000000   


Q ss_pred             -------CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 -------PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 -------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             .............++..+.+++.+||+.||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                   000011112234577889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-38  Score=295.64  Aligned_cols=252  Identities=31%  Similarity=0.523  Sum_probs=205.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|.+.+.||+|+||.||++... +++.|++|++.....  ...+.+.+|+++++.++|+|++++++.+... ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence            4778899999999999999976 589999999865432  4556788999999999999999999977655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.........+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~  158 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D  158 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence            999999999998764333459999999999999999999999999999999999999999999999999998765443 1


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......      ...... .......     ++  
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~-----~~--  224 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKI-LKGQYPP-----IP--  224 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHH-hcCCCCC-----CC--
Confidence            223346888999999998888999999999999999999999998654311      111111 1111111     11  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ..++..+.+++.+||..+|++|||+.+++++
T Consensus       225 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         225 -----SQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 1345678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.6e-39  Score=308.20  Aligned_cols=271  Identities=21%  Similarity=0.300  Sum_probs=195.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCCceeEeeeeeccC------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPNLVKLYGCTSRQS------  179 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  179 (438)
                      .++|++.+.||+|+||.||++... +++.||||.+......  ....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999976 6899999988643221  2235678999999999999999999764432      


Q ss_pred             -ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          180 -RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       180 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                       ...++||||+. ++|.+++.....   .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNV---KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence             34699999995 588888865432   3899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc---cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC
Q 013686          259 RLFPTDVTH---VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG  334 (438)
Q Consensus       259 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (438)
                      .........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..................+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            865432211   11233578899999988664 47889999999999999999999997543221111000000000000


Q ss_pred             ccccc-----ccC-cCCCCcc-HHH-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 ALNEL-----VDP-SLGFEKD-YAV-----RNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 ~~~~~-----~~~-~~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .....     .+. .++.... ...     ......+.+++.+||+.||.+|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000     000 0000000 000     0123457799999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-38  Score=296.81  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=193.6

Q ss_pred             HHHHHHhcCCCCCCcc--cccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          103 SELEEATDNFNSSKQL--GDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .+.....++|.+.+.+  |+|+||.||++..+ +++.+|+|.+........     |+.....+ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444455677777777  99999999999965 688999998865432221     22222222 699999999977665


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGL  257 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl  257 (438)
                      + ..++||||+++++|.+++....    .+++..+..++.|+++||.|||+.|++||||||+||+++.++ .++|+|||+
T Consensus        82 ~-~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         82 K-GHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             C-eeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            4 7999999999999999998764    389999999999999999999999999999999999999998 999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      +......     ....++..|+|||.+.+..++.++||||||+++|||++|..||...... ......+....  ..   
T Consensus       157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~---  225 (267)
T PHA03390        157 CKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QK---  225 (267)
T ss_pred             ceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cc---
Confidence            8865432     1235889999999999889999999999999999999999999743221 11111111111  00   


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-MKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  383 (438)
                           ..     .....++..+.+++.+||+.||.+||+ ++|++++
T Consensus       226 -----~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 -----KL-----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -----cC-----CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                 00     011246677899999999999999996 6998863

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.9e-38  Score=301.65  Aligned_cols=253  Identities=28%  Similarity=0.427  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .|...+.||+|+||.||++... +|..||+|.+...   .....+.+.+|++++++++|||++++++++... ...++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-HTAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CeEEEEE
Confidence            3677889999999999999965 6889999988643   223446788999999999999999999977655 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+. |+|.+.+.....   .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++......  
T Consensus       105 e~~~-g~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         105 EYCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             eCCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            9996 588887765432   3899999999999999999999999999999999999999999999999998754322  


Q ss_pred             ccccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          267 HVSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                         ....+++.|+|||.+.   ...++.++|||||||++|||++|..||......      .. ...+..+......   
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~-~~~~~~~~~~~~~---  245 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-LYHIAQNESPTLQ---  245 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HH-HHHHHhccCCCCC---
Confidence               2335788999999873   456889999999999999999999998643211      11 1111111110000   


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                              ...++..+.+++.+||+.+|.+||++.++++++.......
T Consensus       246 --------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         246 --------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             --------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                    1134567899999999999999999999999877654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.5e-39  Score=300.96  Aligned_cols=243  Identities=25%  Similarity=0.331  Sum_probs=186.5

Q ss_pred             cccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHH---hCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          117 QLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILT---KLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..+++   ..+||||+.+++++..+ +..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecC
Confidence            4899999999999975 589999998865321   11223344544443   34799999999877655 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++.....    +++..+..++.|++.||.|||+.+|+||||||+|||+++++.++|+|||++.......   .
T Consensus        80 ~~~~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~  152 (279)
T cd05633          80 NGGDLHYHLSQHGV----FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (279)
T ss_pred             CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence            99999999876543    8999999999999999999999999999999999999999999999999987553322   1


Q ss_pred             cCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....|++.|+|||.+. +..++.++|||||||++|||++|..||.........    ........      ....+    
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~~~----  218 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNVEL----  218 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCcCC----
Confidence            2345899999999886 456899999999999999999999999754322111    01111000      01111    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEIL  384 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  384 (438)
                         +..++..+.+++.+||..||.+||     +++|++++.
T Consensus       219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence               123567789999999999999999     599998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.5e-39  Score=303.91  Aligned_cols=265  Identities=22%  Similarity=0.346  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|++|.||+|... +|+.||+|.+.....  ...+.+.+|+++++.++||||+++++++... ...++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEE
Confidence            46888999999999999999976 689999998854322  2335688899999999999999999977655 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||++ ++|.+++......  .+++.....++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++.......
T Consensus        81 e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDF--AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             eccc-ccHHHHHHhCCCC--CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9995 5888887654332  2678888899999999999999999999999999999985 5679999999997654332


Q ss_pred             cccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc---
Q 013686          266 THVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD---  341 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  341 (438)
                      . ......+++.|+|||.+.+ ..++.++|||||||++|+|+||++||..........  . ....... ......+   
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~-~~~~~~~-~~~~~~~~~~  232 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--K-IFRILGT-PNEETWPGVT  232 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhCC-CChhhccccc
Confidence            1 1223457889999998866 457899999999999999999999997543221110  0 0000000 0000000   


Q ss_pred             ---------CcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 ---------PSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ---------~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                               +... ..........+..+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0000 00000112345678899999999999999999999974

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=292.25  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=210.5

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEE-EcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccC
Q 013686          102 CSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQS  179 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  179 (438)
                      +.++...+     .+.||+|+|+.|--+. ..+|..||||++.+...-...++.+|++++.+++ |+||++++++|+++ 
T Consensus        75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-  148 (463)
T KOG0607|consen   75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-  148 (463)
T ss_pred             HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-
Confidence            45555555     3679999999999988 5589999999998775555678899999999995 99999999977665 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe---EEEeeeC
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFG  256 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg  256 (438)
                      ..+|+|||-|.||+|..+|++++.    +++.++.++.++|+.||+|||.+||.||||||+|||-.....   ||||||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccc
Confidence            579999999999999999998876    899999999999999999999999999999999999965543   8999999


Q ss_pred             cccccCC--Cccc----cccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc----cc
Q 013686          257 LSRLFPT--DVTH----VSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH----DI  321 (438)
Q Consensus       257 la~~~~~--~~~~----~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~----~~  321 (438)
                      +..-...  +...    ...+.+|+..|||||+..     ...|+.++|.|||||+||-|++|.+||.+....+    ..
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            8764322  2111    122457899999999763     2368999999999999999999999998765432    22


Q ss_pred             chh----HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          322 NLS----NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       322 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ...    ...-..|++|...        + ++..|..++.+..+++...|-.|+.+|.++.+++.+-
T Consensus       305 e~Cr~CQ~~LFesIQEGkYe--------F-PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKYE--------F-PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             CccHHHHHHHHHHHhccCCc--------C-ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            221    1222344444332        1 2445778999999999999999999999999999843

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.5e-39  Score=310.12  Aligned_cols=268  Identities=23%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      ....++|++.+.||+|+||.||++... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++.......
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            345788999999999999999999866 68999999875432  223467788999999999999999999876655678


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      +++|||+ +++|.+++....     +++.....++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++....
T Consensus        86 ~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSRP-----LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEeehh-ccCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            9999999 679998886432     7888888999999999999999999999999999999999999999999987543


Q ss_pred             CCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHHHHhc
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATNKIQN  333 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~~~~~  333 (438)
                      ...    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............        ......+..
T Consensus       160 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         160 PQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            221    22356889999998765 56899999999999999999999999754321110000        000000000


Q ss_pred             Cccccccc---CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GALNELVD---PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +...+...   .....+.......++..+.+++.+||+.+|++|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000   000001111112356789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-38  Score=295.31  Aligned_cols=243  Identities=27%  Similarity=0.396  Sum_probs=194.7

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ||.|+||.||++... +++.|++|.+.....   ...+.+.+|+.+++.++||||+++++++... ...+++|||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCc
Confidence            699999999999976 489999999865422   3346789999999999999999999976554 57999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ  273 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  273 (438)
                      |.+++.....    +++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        80 L~~~l~~~~~----l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          80 LWTILRDRGL----FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            9999987543    8899999999999999999999999999999999999999999999999998764432  122345


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      +++.|++||.+.+..++.++|+||||+++|+|++|..||......    ...... .+..+..      ....     +.
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~------~~~~-----~~  217 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYN-DILKGNG------KLEF-----PN  217 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHH-HHhccCC------CCCC-----Cc
Confidence            788999999998888999999999999999999999999754321    111111 1111000      0000     11


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                      ..+..+.+++.+||+.+|++||+     ++|++++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            23567899999999999999999     7888774

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=307.43  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=202.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh---HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .+.|..-++||+|+||.||-++.+ +|+.||.|++.+...+.   ....++|-.+|.+++.+.||.+-- ..+..+.+|+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY-AfeTkd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY-AFETKDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee-eecCCCceEE
Confidence            366888899999999999999976 69999999986554332   235678999999999999998754 4444568999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+..|+||+|.-+|.+.+..  .+++..++-++.+|+.||++||+.+||.|||||+|||+|+.|+++|+|+|||..+...
T Consensus       263 VLtlMNGGDLkfHiyn~g~~--gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNP--GFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEeecCCceeEEeeccCCC--CCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999999887653  3999999999999999999999999999999999999999999999999999988665


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ...  ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||.......   ......+.+.            
T Consensus       341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k~eEvdrr~~------------  403 (591)
T KOG0986|consen  341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---KREEVDRRTL------------  403 (591)
T ss_pred             Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---hHHHHHHHHh------------
Confidence            443  34479999999999999999999999999999999999999997532211   0001111111            


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM  377 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  377 (438)
                       ......+..++++.++|....|++||++|.-.
T Consensus       404 -~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  404 -EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             -cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence             11122335678899999999999999999643

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=302.33  Aligned_cols=257  Identities=18%  Similarity=0.266  Sum_probs=185.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeeccchHh-H----------HHHHHHHHHHHhCCCCCceeEee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYENNFKR-I----------EQFMNEVEILTKLQHPNLVKLYG  173 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~niv~~~~  173 (438)
                      ..+|++.+.||+|+||.||+|...+    +..+|+|......... .          .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3578999999999999999999764    3456666533221110 0          11223344555678999999998


Q ss_pred             eeeccCc---eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          174 CTSRQSR---ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       174 ~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      +......   ..++++|++ ..++.+.+.....    .++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC----KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhhcc----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            6543322   346788887 4477777665432    5788889999999999999999999999999999999999999


Q ss_pred             EEeeeCcccccCCCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc-ch
Q 013686          251 KVADFGLSRLFPTDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI-NL  323 (438)
Q Consensus       251 kl~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~-~~  323 (438)
                      +|+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|..||......... ..
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999865332111      112245999999999999999999999999999999999999999865322111 00


Q ss_pred             hH-HHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          324 SN-MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       324 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .. .....+..+..              ...+++..+.+++..|+..+|++||++.++++.+
T Consensus       246 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRLHEGKI--------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHhhhhhh--------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00 00111111110              1123456789999999999999999999999876

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.6e-39  Score=302.20  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=192.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|...+.||+|+||.||++... +|+.||+|.+.... ......+.+|+.++.++. |+||+++++++... ...+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-GDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-CcEEEEEe
Confidence            4556788999999999999976 58999999986542 234567889999999996 99999999977654 46899999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNR-QPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |+. ++|.++.... ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            985 4665543221 01112489999999999999999999975 99999999999999999999999999997654322


Q ss_pred             cccccCCCCCCCccCccccccC---CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ..  ....++..|+|||.+.+.   .++.++|||||||++|||++|+.||.....     ...... .+..+..     +
T Consensus       163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~-~~~~~~~-----~  229 (288)
T cd06616         163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLT-QVVKGDP-----P  229 (288)
T ss_pred             cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHh-hhcCCCC-----C
Confidence            21  223578899999999766   689999999999999999999999964320     001111 1111111     1


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+...   ....++..+.+|+.+||+.||++|||+++++++
T Consensus       230 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ILSNS---EEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCc---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111   012356779999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-38  Score=291.75  Aligned_cols=247  Identities=29%  Similarity=0.528  Sum_probs=201.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++++++|+|++++++++... ...+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence            4778899999999999999876 578999999876543  4567899999999999999999999976654 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....    +++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~~~----l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          80 YAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             cCCCCcHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999999987633    899999999999999999999999999999999999999999999999999876543322


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       .....++..|+|||.+.+..++.++|||+||+++|+|++|..||......     .. ... .......     .+   
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~-~~~-~~~~~~~-----~~---  219 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AA-LFR-IVQDDHP-----PL---  219 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HH-HHH-HhccCCC-----CC---
Confidence             23345788999999998888899999999999999999999998743211     00 011 1111111     01   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  382 (438)
                          +...+..+.+++.+||..+|++|||+.+++.
T Consensus       220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                1234567889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-39  Score=315.03  Aligned_cols=244  Identities=24%  Similarity=0.439  Sum_probs=196.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCcEEEEEEeec----cchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEEEEEe
Q 013686          114 SSKQLGDGGFGAVYLGILR-DGRIVAVKRLYE----NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELLLVYE  187 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e  187 (438)
                      ....||+|+|-+||+|.+. +|-.||=-.++.    ......++|..|+.+|+.|+||||+++|.++.+. .+.+-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4578999999999999975 466665433321    2334568899999999999999999999965443 446889999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCEEec-CCCeEEEeeeCcccccCCC
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS--DVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~~  264 (438)
                      .+..|+|..|+.+.+.    +..+....|++||++||.|||++  .|+|||||.+||||+ ..|.|||+|+|||+.....
T Consensus       124 L~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999998876    88899999999999999999998  699999999999997 5689999999999987544


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ..   ....|||.|||||.+. ..|++..||||||++++||+|+..||..-..      ......++..|.-+..+..  
T Consensus       200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~k--  267 (632)
T KOG0584|consen  200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSK--  267 (632)
T ss_pred             cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhc--
Confidence            32   2357999999999997 7999999999999999999999999963222      2223344444443332221  


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                               ---++++++|.+||.. ..+|||+.|+|+.
T Consensus       268 ---------V~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  268 ---------VKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ---------cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                     1124688999999999 9999999999974

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-39  Score=307.99  Aligned_cols=268  Identities=24%  Similarity=0.334  Sum_probs=195.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCCceeEeeeeeccC------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPNLVKLYGCTSRQS------  179 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  179 (438)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|++......  ....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            568999999999999999999976 5899999988644322  2245678999999999999999998654332      


Q ss_pred             -ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          180 -RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       180 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                       ..+++||||+. ++|...+.....   .+++..+..++.|+++||.|||++|++||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~---~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSV---KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             24799999995 578777765432   3899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccc----------ccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH
Q 013686          259 RLFPTDVTHV----------STAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA  327 (438)
Q Consensus       259 ~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~  327 (438)
                      +.........          .....+++.|+|||.+.+. .++.++|||||||++|||++|++||...........   .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~---~  239 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL---I  239 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H
Confidence            8654322111          1223467889999987654 588999999999999999999999975433211100   0


Q ss_pred             HHHHhc---------Ccccc----cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          328 TNKIQN---------GALNE----LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       328 ~~~~~~---------~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ......         .....    ....................+.+++.+||+.||++|||+.|++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000000         00000    000001000111112344678899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=299.38  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=196.6

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhC---CCCCceeEeeeeeccCc----e
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKL---QHPNLVKLYGCTSRQSR----E  181 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----~  181 (438)
                      |++.+.||+|+||.||+|..+ +++.||+|++.....  .....+.+|+.+++++   +|+|++++++++.....    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999987 489999999864322  2234566788877766   59999999997765432    3


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .+++|||+. ++|.+++......  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKP--GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            899999996 5899988765432  3899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc-C--cc--
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN-G--AL--  336 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-~--~~--  336 (438)
                      ......  ....++..|+|||.+.+..++.++|||||||++|||++|++||.........  ... ...... .  ..  
T Consensus       158 ~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~  232 (287)
T cd07838         158 SFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKI-FDVIGLPSEEEWPR  232 (287)
T ss_pred             cCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHH-HHHcCCCChHhcCC
Confidence            433221  2234788999999999889999999999999999999999998754322110  000 000000 0  00  


Q ss_pred             -----cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 -----NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ...................+..+.+++.+||+.||.+||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 00000000111112223556788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-39  Score=311.39  Aligned_cols=250  Identities=27%  Similarity=0.433  Sum_probs=208.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ...|.+.+.||+|.|+.|.++.+. +|..||||.+.+.  +....+.+.+|+++|..|+|||||+++.+...+ ..+|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-ATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-ceeEEE
Confidence            567889999999999999999976 6999999998765  334456689999999999999999999977655 489999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+.+|.+++++.+...    +.+..+..++.|+..|++|||+++|||||||++||||+.+.++||+|||++..+..  
T Consensus       134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--
Confidence            999999999999998775    66688899999999999999999999999999999999999999999999998863  


Q ss_pred             cccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .....+.+|++.|.|||++.+..| .+++|+||+|++||-|++|..||++..-..-       ......+.+.      +
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~gk~r------I  274 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRGKYR------I  274 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheeeeec------c
Confidence            344567789999999999999876 5799999999999999999999986432110       0111111110      0


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                             +.-++.++.++++++|-.+|.+|++++++.+.-+
T Consensus       275 -------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  275 -------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             -------cceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence                   1124566889999999999999999999987543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=343.08  Aligned_cols=254  Identities=26%  Similarity=0.437  Sum_probs=204.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ..+-+|+....||.|.||.||-|... +|+..|+|.++-.  ..+......+|..++..|+|||+|+++|+-... +..+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-ekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-EKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-HHHH
Confidence            34567888999999999999999954 6999999987543  334456778899999999999999999955444 5789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      |.||||++|+|.+.+...+.    .++.....+..|++.|+.|||++|||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1311 IFMEyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999999987653    66666777889999999999999999999999999999999999999999997755


Q ss_pred             Cccccc---cCCCCCCCccCccccccC---CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          264 DVTHVS---TAPQGTPGYVDPDYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       264 ~~~~~~---~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ......   ....||+.|||||++.+.   ....+.||||+||++.||+||+.||.......      ...-.+..|..+
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~------aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW------AIMYHVAAGHKP 1460 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh------HHHhHHhccCCC
Confidence            432211   234699999999999764   35668999999999999999999997533221      111233333322


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .            .+..++.+-++++.+||..||+.|+++.|++++
T Consensus      1461 q------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 Q------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2            234578888999999999999999999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.8e-39  Score=303.51  Aligned_cols=245  Identities=28%  Similarity=0.462  Sum_probs=196.3

Q ss_pred             CCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          115 SKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ..+||+|+||.||++... +|+.||+|++........+.+.+|+.+++.++|+|++++++++... +..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCCc
Confidence            367999999999999875 6899999988655545567789999999999999999999977654 57999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ  273 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  273 (438)
                      |.+++....     +++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........ ......
T Consensus       104 L~~~~~~~~-----~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  177 (292)
T cd06657         104 LTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV  177 (292)
T ss_pred             HHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence            999875432     78999999999999999999999999999999999999999999999999876543321 122345


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      +++.|+|||.+.+..++.++|+||||+++|||++|..||........       ...+.... .    +.+.     ...
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~-~----~~~~-----~~~  240 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNL-P----PKLK-----NLH  240 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhC-C----cccC-----Ccc
Confidence            78999999999888899999999999999999999999874322110       11111110 0    0000     011


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .++..+.+++.+||+.||.+||++.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            245568899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=327.15  Aligned_cols=264  Identities=28%  Similarity=0.434  Sum_probs=211.8

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEcC--------CcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeee
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILRD--------GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGC  174 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~  174 (438)
                      ++...++..+.+.||+|.||.|++|....        ...||||.++.. ...+.+.+..|+++|+.+ .|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            44455666777899999999999998541        357999998755 335668899999999999 59999999998


Q ss_pred             eeccCceEEEEEeccCCCCHHHHhhccC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 013686          175 TSRQSRELLLVYEYIPNGTVADHLHNRQ---PN-------S--CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNI  242 (438)
Q Consensus       175 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Ni  242 (438)
                      +.. ...+++|+||+..|+|.++|+..+   .-       .  ..+.....+.++.||+.|++||++.++|||||.++||
T Consensus       371 ~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  371 CTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             ecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence            877 457999999999999999999877   00       0  1388899999999999999999999999999999999


Q ss_pred             EecCCCeEEEeeeCcccccCCCccccccCCC--CCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCccc
Q 013686          243 LLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRH  319 (438)
Q Consensus       243 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~  319 (438)
                      |+.++..+||+|||+++..............  -...|||||.+....|+.++|||||||+||||+| |..||.+-..  
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--  527 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--  527 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence            9999999999999999965443333222222  3557999999999999999999999999999999 7788864211  


Q ss_pred             ccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                         .... ...+..|...+            .+..++.++.++++.||+.+|++||++.++.+.+...
T Consensus       528 ---~~~l-~~~l~~G~r~~------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 ---TEEL-LEFLKEGNRME------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ---HHHH-HHHHhcCCCCC------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence               1112 23444443322            1235678899999999999999999999999999885

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3e-38  Score=302.60  Aligned_cols=261  Identities=22%  Similarity=0.279  Sum_probs=192.4

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.+.+|.|+++.||++.. +++.||+|++...  .....+.+.+|+++++.++|+||+++++++... +..+++|||+++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~   83 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAY   83 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCC
Confidence            344455555555555544 6899999998654  344567899999999999999999999977655 478999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc-----
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-----  266 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-----  266 (438)
                      |+|.+++......  .+++.....++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........     
T Consensus        84 ~~l~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          84 GSCEDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CCHHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999999865432  388999999999999999999999999999999999999999999999998875432111     


Q ss_pred             -ccccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc-----
Q 013686          267 -HVSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE-----  338 (438)
Q Consensus       267 -~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  338 (438)
                       .......++..|+|||.+.+  ..++.++|||||||++|||++|..||........      ....+. +....     
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~------~~~~~~-~~~~~~~~~~  234 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM------LLEKVR-GTVPCLLDKS  234 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-ccCccccccC
Confidence             11122347788999999866  3588999999999999999999999975432110      001110 00000     


Q ss_pred             ---------------cccCcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          339 ---------------LVDPSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       339 ---------------~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                                     ..++... .........++..+.+++.+||+.||++|||++|++++-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence                           0000000 0011122345678999999999999999999999998543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.9e-38  Score=301.65  Aligned_cols=257  Identities=19%  Similarity=0.317  Sum_probs=192.5

Q ss_pred             Cccccc--CceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDG--GFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      ..||+|  +||+||++... +|+.||+|.+...  .....+.+.+|+.+++.++||||+++++++... ...++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-CceEEEEeccc
Confidence            356666  89999999975 6999999998643  334457889999999999999999999987665 47899999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc--
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--  268 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~--  268 (438)
                      +++|.+++......  .+++..+..++.|++.||+|||+.|++||||||+|||++.++.++++||+.+..........  
T Consensus        83 ~~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999999875432  38899999999999999999999999999999999999999999999998654322111100  


Q ss_pred             ----ccCCCCCCCccCccccccC--CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc-------
Q 013686          269 ----STAPQGTPGYVDPDYFQCY--KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA-------  335 (438)
Q Consensus       269 ----~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  335 (438)
                          .....++..|+|||.+.+.  .++.++|||||||++|||++|..||........      ....+....       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~  234 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDIT  234 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCcccc
Confidence                0112346679999999763  478999999999999999999999975422110      000000000       


Q ss_pred             -----------------------------ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          336 -----------------------------LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       336 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                                                   ........+   .......++..+.+|+.+||+.||++|||+.|++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL---RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccc---cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                                         000000000   1112345778899999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=298.72  Aligned_cols=266  Identities=26%  Similarity=0.360  Sum_probs=196.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEec
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      |++.+.||+|++|+||+|... +++.|++|++..... .......+|+..+++++ |+|++++++++.. +...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            567889999999999999986 478999998865422 22234557999999998 9999999997766 4579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      + +|+|.+++.....  ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........  
T Consensus        80 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          80 M-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             C-CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence            9 8899999877642  2389999999999999999999999999999999999999999999999999986543222  


Q ss_pred             ccCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh----------HHHHHHHhcCccc
Q 013686          269 STAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS----------NMATNKIQNGALN  337 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~~  337 (438)
                      .....++..|+|||.+. +..++.++|+||||+++|||++|++||............          .+...........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            12345788999999874 456789999999999999999999999655332111000          0000000000010


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..+...............+..+.+++.+||+.||++|||++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000001111224678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.7e-38  Score=299.50  Aligned_cols=252  Identities=28%  Similarity=0.403  Sum_probs=195.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccch----HhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCce
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENNF----KRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  181 (438)
                      +|++.+.||+|+||.||++...    +|+.||+|++.....    ...+.+.+|++++.++ +|+||+++++++..+ ..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-TK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-Ce
Confidence            4778899999999999999863    688999999865322    2346678899999999 599999999876554 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .++||||+++++|.+++.....    +++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            8999999999999999986543    889999999999999999999999999999999999999999999999999865


Q ss_pred             CCCccccccCCCCCCCccCccccccC--CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCY--KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ............++..|+|||.+.+.  .++.++||||||+++|+|++|..||.......  ............      
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~------  227 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS------  227 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc------
Confidence            44322222334588999999998653  46789999999999999999999996432211  111111111110      


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                       .+.+       +..++..+.+++.+||+.||++||     ++++++.+
T Consensus       228 -~~~~-------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 -EPPY-------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -CCCC-------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence             0001       122456788999999999999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.4e-39  Score=311.51  Aligned_cols=268  Identities=21%  Similarity=0.327  Sum_probs=196.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC--------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS--------  179 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  179 (438)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|.+........+.+.+|+++++.++||||+++++++....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            357889999999999999999975 58999999987666566677889999999999999999998554332        


Q ss_pred             -----ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec-CCCeEEEe
Q 013686          180 -----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVA  253 (438)
Q Consensus       180 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~-~~~~~kl~  253 (438)
                           ...++||||++ ++|.+++...     .+++..+..++.||+.||.|||+.|++||||||+||+++ .++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 25789999996 5998888643     288999999999999999999999999999999999997 45678999


Q ss_pred             eeCcccccCCCcccc--ccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH----
Q 013686          254 DFGLSRLFPTDVTHV--STAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM----  326 (438)
Q Consensus       254 Dfgla~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~----  326 (438)
                      |||++..........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............    
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999998654322111  122357889999997654 5688899999999999999999999975432111000000    


Q ss_pred             ----HHHHHhcCccccccc--C-cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          327 ----ATNKIQNGALNELVD--P-SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       327 ----~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ........ ......  . ............++..+.+++.+||+.||++|||+.|++.+
T Consensus       238 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         238 VREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                00000000 000000  0 00000001112355678899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=294.97  Aligned_cols=242  Identities=27%  Similarity=0.368  Sum_probs=187.2

Q ss_pred             CcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHH-HhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEIL-TKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|... +|+.||+|.+.....   .....+..|..++ ...+|+|++++++++... ..+++||||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-DYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-CeEEEEEeccC
Confidence            56999999999999975 589999999865432   2223445555544 345899999999977654 57999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      +++|.+++.....    +++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....     ..
T Consensus        81 ~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~  151 (260)
T cd05611          81 GGDCASLIKTLGG----LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK  151 (260)
T ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence            9999999976543    88999999999999999999999999999999999999999999999999875432     12


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccH
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY  350 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (438)
                      ...+++.|+|||.+.+..++.++||||||+++|||++|..||......      . ....+..+....  ..       .
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~--~~-------~  215 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------A-VFDNILSRRINW--PE-------E  215 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhcccCC--CC-------c
Confidence            335788999999998888999999999999999999999999753221      1 111111111110  00       0


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       351 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ....++..+.+++.+||+.||++||++.++.+.
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            112356778999999999999999977544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.8e-38  Score=299.05  Aligned_cols=256  Identities=26%  Similarity=0.377  Sum_probs=198.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccc----hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCce
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENN----FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  181 (438)
                      +|++.+.||+|+||.||++...    +++.||||.+....    ....+.+.+|++++.++ +||||+++++++... ..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD-TK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-CE
Confidence            3677899999999999999843    47889999986532    22345688999999999 599999999866554 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .++||||+++++|.+++.....    +++..+..++.|+++||.|||+.+++||||+|+||+++.++.++|+|||+++..
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREH----FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCC----cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            8999999999999999876432    889999999999999999999999999999999999999999999999998865


Q ss_pred             CCCccccccCCCCCCCccCccccccCC--CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYK--LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ............++..|+|||.+.+..  ++.++||||||+++|||++|..||.......  ....... .+....    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~-~~~~~~----  228 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISR-RILKSK----  228 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHH-HHHccC----
Confidence            443222222345889999999987655  7889999999999999999999996432211  1111111 111110    


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                        +..       +..++..+.+++.+||+.||++|||+.++.+.|+..
T Consensus       229 --~~~-------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         229 --PPF-------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             --CCC-------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence              000       122456688999999999999999988887776553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.2e-38  Score=293.42  Aligned_cols=244  Identities=30%  Similarity=0.495  Sum_probs=193.5

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ||.|+||.||++... +|+.|++|.+.....   ...+.+.+|++++++++||||+++++++... ...|++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-KNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-cEEEEEEecCCCCc
Confidence            689999999999987 489999999865433   3456788999999999999999999866544 57999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc-------
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-------  266 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-------  266 (438)
                      |.+++....    .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++........       
T Consensus        80 L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          80 LASLLENVG----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999998754    289999999999999999999999999999999999999999999999999875433211       


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      .......++..|+|||.+.+..++.++||||||+++|||++|..||......      .. ...+..+...        .
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~--------~  220 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EI-FQNILNGKIE--------W  220 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhcCCcC--------C
Confidence            1222345788999999998888999999999999999999999999754321      11 1111111111        0


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ...   ...+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus       221 ~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         221 PED---VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             Ccc---ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            000   11366789999999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-38  Score=308.13  Aligned_cols=273  Identities=20%  Similarity=0.316  Sum_probs=201.0

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc
Q 013686          102 CSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ  178 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  178 (438)
                      ..++....++|.+.+.||+|+||.||++... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3456667899999999999999999999864 68999999986542  22346788899999999999999999866432


Q ss_pred             -----CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEe
Q 013686          179 -----SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVA  253 (438)
Q Consensus       179 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~  253 (438)
                           ....+++++++ +++|.+++....     +++..+..++.|+++||+|||+.||+||||||+||++++++.+||+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEe
Confidence                 23478888887 789998886532     8899999999999999999999999999999999999999999999


Q ss_pred             eeCcccccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH-------
Q 013686          254 DFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN-------  325 (438)
Q Consensus       254 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~-------  325 (438)
                      |||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............       
T Consensus       163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998864322    223457889999998866 468889999999999999999999996533211100000       


Q ss_pred             -HHHHHHhcCccccc---ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          326 -MATNKIQNGALNEL---VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       326 -~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                       .....+........   ................+..+.+++.+||+.||.+||++.+++.+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence             00000000000000   000000000000112456788999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-40  Score=292.00  Aligned_cols=248  Identities=26%  Similarity=0.391  Sum_probs=201.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|..+++||+|.||.|.+++-+ .|+.||+|.+++...   .+...-..|-++|+..+||.+..+--.+ ...+.+|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-Qt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-QTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-ccCceEEE
Confidence            467888999999999999999966 699999999877633   2334456788999999999988875434 44568999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||..||.|.-+|.+.+.    +++...+.+..+|+.||.|||+++||.||||.+|.|+|.+|++||+|||+++.--..
T Consensus       246 VMeyanGGeLf~HLsrer~----FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERV----FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEccCceEeeehhhhhc----ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999999999887554    888888999999999999999999999999999999999999999999999854332


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                       .....+.+|||.|+|||++....|..+.|.|.+||++|||++|+.||....+..-..+       |.-+        .+
T Consensus       322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL-------Il~e--------d~  385 (516)
T KOG0690|consen  322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL-------ILME--------DL  385 (516)
T ss_pred             -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH-------HHhh--------hc
Confidence             2345678999999999999999999999999999999999999999976543321111       1100        01


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLE  382 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  382 (438)
                      .     .+..++++.+.|+...|.+||.+|.     .+.||.+
T Consensus       386 k-----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  386 K-----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             c-----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            1     1245667888999999999999995     3556554

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-38  Score=299.37  Aligned_cols=249  Identities=28%  Similarity=0.439  Sum_probs=200.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|.+.+.||+|+||.||++..+ +|+.|++|.+...   .....+.+.+|++++++++ |+||+++++++... ...++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-ENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-ceEEE
Confidence            46888999999999999999976 6899999988653   2233467889999999998 99999999966554 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~----l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999999987643    999999999999999999999999999999999999999999999999998865433


Q ss_pred             cc-------------------ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH
Q 013686          265 VT-------------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN  325 (438)
Q Consensus       265 ~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~  325 (438)
                      ..                   .......++..|+|||.+.+..++.++||||||++++++++|..||.......      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------  229 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------  229 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------
Confidence            21                   11223357889999999988889999999999999999999999998543210      


Q ss_pred             HHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 013686          326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM----KEVLEI  383 (438)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~  383 (438)
                       ....+.....      .++       ..++..+.+++.+||+.+|.+||++    ++++++
T Consensus       230 -~~~~~~~~~~------~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 -TFQKILKLEY------SFP-------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -HHHHHHhcCC------CCC-------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence             0111111000      000       1235668899999999999999999    777753

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-38  Score=305.31  Aligned_cols=270  Identities=22%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----c
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----R  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  180 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.+++.++||||+++++++....     .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999965 68999999986532  222356788999999999999999999765432     3


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++|+||+. .+|..++..      .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            5799999995 477776531      288999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHHHH
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATNKI  331 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~~~  331 (438)
                      ....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............        ....+
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            4322    123357889999999876 4688999999999999999999999975432111000000        00000


Q ss_pred             hcCccccccc--CcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 013686          332 QNGALNELVD--PSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI--LRETKD  389 (438)
Q Consensus       332 ~~~~~~~~~~--~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~  389 (438)
                      ..........  +... ..........+..+.+++.+||+.||++||++.|++.+  ++..++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000000000  0000 00001112345678899999999999999999999965  555543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.8e-38  Score=304.74  Aligned_cols=266  Identities=20%  Similarity=0.249  Sum_probs=195.6

Q ss_pred             cCCC-CCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh--------------HHHHHHHHHHHHhCCCCCceeEee
Q 013686          110 DNFN-SSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--------------IEQFMNEVEILTKLQHPNLVKLYG  173 (438)
Q Consensus       110 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~  173 (438)
                      ++|. +.+.||+|+||+||+|... +++.||+|.+.......              ...+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999966 68999999886442211              124678999999999999999999


Q ss_pred             eeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEe
Q 013686          174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVA  253 (438)
Q Consensus       174 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~  253 (438)
                      ++... ...++||||+. |+|.+++.....    +++.....++.|++.||.|||+.|++||||+|+||+++.++.+||+
T Consensus        88 ~~~~~-~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEG-DFINLVMDIMA-SDLKKVVDRKIR----LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecC-CcEEEEEeccc-cCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            77655 47899999996 699999876443    8999999999999999999999999999999999999999999999


Q ss_pred             eeCcccccCCCc-------------cccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCccc
Q 013686          254 DFGLSRLFPTDV-------------THVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRH  319 (438)
Q Consensus       254 Dfgla~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~  319 (438)
                      |||++.......             ........+++.|+|||.+.+. .++.++|||||||++|||++|.+||.......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998654111             1111223467889999998764 46889999999999999999999997554321


Q ss_pred             ccchhHHHHHHHhcC---cccccc--------cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          320 DINLSNMATNKIQNG---ALNELV--------DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       320 ~~~~~~~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .   ...........   .+....        ...............+..+.+++.+||+.+|++|||++|++.+-
T Consensus       242 ~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        242 Q---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             H---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            1   00000100000   000000        00000000111123467788999999999999999999999754

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-38  Score=303.33  Aligned_cols=267  Identities=23%  Similarity=0.365  Sum_probs=198.6

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----  179 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  179 (438)
                      ...++|++.+.||+|+||.||++... +|+.||||++....  ....+.+.+|+++++.++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34678999999999999999999865 68999999985432  223456889999999999999999999765443    


Q ss_pred             -ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          180 -RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       180 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                       ...++||||+ +++|.+++...     .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence             2468999999 78999888643     2899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch--------hHHHHH
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL--------SNMATN  329 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~--------~~~~~~  329 (438)
                      .......    ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........        ......
T Consensus       166 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         166 RQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8654321    23357889999998876 4588999999999999999999999975432110000        000000


Q ss_pred             HHhcCccccccc--CcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          330 KIQNGALNELVD--PSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       330 ~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+..........  +... .........++..+.+++.+||+.||++|||+.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000  0000 00011123456678999999999999999999999963

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9e-38  Score=294.15  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=185.7

Q ss_pred             cccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHH---HHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          117 QLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVE---ILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .||+|+||.||++... +++.||+|.+......   ....+..|..   .++...||||+.+++++... +..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecC
Confidence            4899999999999865 5889999988654221   1122333433   44456799999999877655 4799999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++....    .+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.......   .
T Consensus        80 ~g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~  152 (278)
T cd05606          80 NGGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (278)
T ss_pred             CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence            9999999987543    38999999999999999999999999999999999999999999999999987553322   1


Q ss_pred             cCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....|+..|+|||.+.+. .++.++||||+||++|||++|+.||..........    .......      ....+    
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~----  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVEL----  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCC----
Confidence            234689999999998754 68999999999999999999999997543221110    0011100      01111    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                         +..++..+.+++.+||..+|.+||     ++.+++++
T Consensus       219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence               112456788999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.9e-37  Score=294.83  Aligned_cols=244  Identities=29%  Similarity=0.434  Sum_probs=192.8

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      |...+.||+|+||.||+|... +|+.|++|.+...   .....+.+.+|+++++.++|||++++++++... ...|+|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEe
Confidence            566788999999999999965 6899999998643   223446788999999999999999999977665 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+. |+|.+++.....   .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++.....    
T Consensus       102 ~~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         102 YCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             cCC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            995 688888765432   389999999999999999999999999999999999999999999999999864322    


Q ss_pred             cccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          268 VSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                       .....++..|+|||.+.   ...++.++|||||||++|||++|..||.......      ... .+.........    
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~-~~~~~~~~~~~----  241 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNDSPTLQ----  241 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHHhcCCCCCC----
Confidence             12345888999999984   4568889999999999999999999986532211      111 11111111111    


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             ...++..+.+++.+||+.+|.+||++.+++.+
T Consensus       242 -------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 -------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   11234568899999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.5e-38  Score=303.27  Aligned_cols=268  Identities=23%  Similarity=0.312  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-C--CcEEEEEEeecc--chHhHHHHHHHHHHHHhC-CCCCceeEeeeeec---cCce
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-D--GRIVAVKRLYEN--NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSR---QSRE  181 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---~~~~  181 (438)
                      +|++.+.||+|+||.||++... .  +..||+|.+...  .....+.+.+|+++++++ +||||++++++...   ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999975 3  779999988643  222345678899999999 59999999985322   2245


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .++++||+. ++|.+++.....    +++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQP----LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 699999875443    899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCccc---cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHH
Q 013686          262 PTDVTH---VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATN  329 (438)
Q Consensus       262 ~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~  329 (438)
                      ......   ......|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||............        .....
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            432211   1123458899999998765 46899999999999999999999999754321100000        00000


Q ss_pred             HHhcCccccc---ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          330 KIQNGALNEL---VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       330 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+........   ................+..+.+++.+||+.||++|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000   00000000000112235678899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-37  Score=296.84  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=197.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      +.|+..+.||+|+||.||+|... +++.+++|.+...   .....+++.+|+++++.++|+|++++++++... ...++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEE
Confidence            34667789999999999999975 5889999988532   223456788999999999999999999977665 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+. |+|.+++.....   .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++...... 
T Consensus        94 ~e~~~-~~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            99995 688887765432   3789999999999999999999999999999999999999999999999998765432 


Q ss_pred             cccccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          266 THVSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                          ....+++.|+|||.+.   ...++.++|||||||++|||++|..||......      .. ...+..+......  
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~-~~~~~~~~~~~~~--  235 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-LYHIAQNESPALQ--  235 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HH-HHHHhhcCCCCcC--
Confidence                2235788999999874   346788999999999999999999998643211      01 1111111111100  


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                               ...++..+.+++.+||+.+|++||++.+++++......
T Consensus       236 ---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         236 ---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ---------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                     12345678899999999999999999999988665544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-37  Score=295.29  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=195.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|..++ ++.||||.+.... ......+..|+.++.++. |+||+++++++... ...++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v   92 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFIC   92 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEEE
Confidence            4678889999999999999999874 8999999987543 233456677887777775 99999999977655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||+ +++|.+++.....   .+++..+..++.|++.||.|||+ .||+||||+|+||++++++.+||+|||++..+...
T Consensus        93 ~e~~-~~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELM-STCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eecc-CcCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9998 4578777765332   38999999999999999999997 59999999999999999999999999998765432


Q ss_pred             ccccccCCCCCCCccCccccccCC----CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYK----LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ...  ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......     ..... .+.......  
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~-~~~~~~~~~--  238 (296)
T cd06618         169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLT-KILQEEPPS--  238 (296)
T ss_pred             Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHH-HHhcCCCCC--
Confidence            221  2234788999999987654    788999999999999999999999642211     01111 111111110  


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                         ....     ..++.++.+++.+||+.||++||++.+++.+..
T Consensus       239 ---~~~~-----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         239 ---LPPN-----EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             ---CCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence               1000     124567899999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-37  Score=289.88  Aligned_cols=251  Identities=26%  Similarity=0.393  Sum_probs=194.6

Q ss_pred             CCCCCCcccccCceEEEEEEEcC-CcEEEEEEeecc-----chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYEN-----NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     .......+.+|+.++++++||||+++++++... ...++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEE
Confidence            47888999999999999998653 455556655431     112234567899999999999999999976555 46899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.+||+|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            99999999999999764433445899999999999999999999999999999999999975 56999999998865432


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ... ...+..+....     .
T Consensus       159 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~-~~~~~~~~~~~-----~  225 (260)
T cd08222         159 CD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSV-VLRIVEGPTPS-----L  225 (260)
T ss_pred             cc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHH-HHHHHcCCCCC-----C
Confidence            21 12234578899999999888899999999999999999999999864321      111 11111111111     1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             ...++..+.+++.+||..||++||++.|++++
T Consensus       226 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         226 -------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                   13456678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=292.27  Aligned_cols=266  Identities=25%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      |+..+.||+|+||.||+|... +++.|++|.+....  ....+.+.+|+.+++.++|+|++++++++... ...++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence            456788999999999999976 48999999987643  23346778899999999999999999977655 579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      ++ ++|.+++.....   .+++..+..++.|++.||.|||+.||+||||+|+||++++++.+||+|||++........ .
T Consensus        80 ~~-~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          80 CD-MDLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             cC-cCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            96 599999987632   389999999999999999999999999999999999999999999999999986644322 1


Q ss_pred             ccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHHHHhcCc-ccc
Q 013686          269 STAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATNKIQNGA-LNE  338 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~  338 (438)
                      .....++..|+|||.+.+. .++.++|||||||++|||++|.+||............        ...+..+..-. ...
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2233467789999998766 7899999999999999999999999754321110000        00000000000 000


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .................+..+.+++.+||..||++||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000001111122346679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-38  Score=304.76  Aligned_cols=266  Identities=21%  Similarity=0.333  Sum_probs=197.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  179 (438)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++|+|++++++++....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567899999999999999999976 5889999988643  2233466788999999999999999988654432     


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...++|+||+ +++|.+++...     .+++..+..++.|+++||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence            2489999999 67999998753     28999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHHH
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATNK  330 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~~  330 (438)
                      .....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............        ......
T Consensus       167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            65433    223357889999998865 36788999999999999999999999754321110000        000000


Q ss_pred             HhcCcccccccCcC---CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          331 IQNGALNELVDPSL---GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       331 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +.............   ..........++..+.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000000000000   000001112346789999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=284.08  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=194.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEecc
Q 013686          113 NSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      +-+..||.|+||+|+|-.++ .|+..|||++..... ++.+++..|.+...+- +.||||++||..+.++ ..||.||+|
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-dcWiCMELM  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-DCWICMELM  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-ceeeeHHHH
Confidence            34568999999999999977 599999999976644 5667888999877665 6999999999777776 589999999


Q ss_pred             CCCCHHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          190 PNGTVADHLHNRQ-PNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       190 ~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                       ..+|..+...-. -....+++...-.|..-...||.||... +|+|||+||+|||++..|.+||||||++..+......
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk  224 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK  224 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh
Confidence             457665543210 0112388888888888899999999865 8999999999999999999999999999765443322


Q ss_pred             cccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          268 VSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                        +...|...|||||.+..  ..|+-+|||||||++|||+.||+.|+.....      .-.....+-.+..+.+..+.  
T Consensus       225 --T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp~l~~~~--  294 (361)
T KOG1006|consen  225 --TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPPILLFDK--  294 (361)
T ss_pred             --hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCCeecCcc--
Confidence              33468999999999964  3588999999999999999999999974321      01111222333333332211  


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           ...+++..+..+|.-||.+|-..||++.+++++
T Consensus       295 -----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 -----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                 123467789999999999999999999999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=325.06  Aligned_cols=260  Identities=27%  Similarity=0.366  Sum_probs=209.3

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ  178 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  178 (438)
                      .++....++|.++++||+|+||.|.+++.+ +++.||+|++.+-.   .....-|..|-++|..-+.+=|+++.-.|. +
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-D  146 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-D  146 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-C
Confidence            345556789999999999999999999986 58999999987632   233467889999999888888998875454 4


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      ..++|+|||||+||+|..+|.+...    +++..+..++..|..||..||+.|+|||||||+|||||..|++||+|||.+
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~~----~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFDR----LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcCC----ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence            5689999999999999999998763    999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCCCccCccccc----c-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQ----C-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      -.+..+..-.+...+|||.|++||++.    + +.|+..+|.||+||++|||+.|..||-...-.       ....+|-.
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------eTY~KIm~  295 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------ETYGKIMN  295 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------HHHHHHhc
Confidence            988877776677789999999999994    2 57999999999999999999999999643211       11112211


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT---MKEVLEIL  384 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L  384 (438)
                      .      ...+.++.   ...++...++||.+.+. +|+.|..   ++++-.+.
T Consensus       296 h------k~~l~FP~---~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  296 H------KESLSFPD---ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             h------hhhcCCCc---ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            1      11222221   12377888999988775 5677766   88887754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=301.99  Aligned_cols=243  Identities=24%  Similarity=0.352  Sum_probs=200.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++.|.....+|.|+|+.|-.+... +++..++|++.+..    .+..+|+.++... +||||+++.+.+.+. .+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~-~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDG-KEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCC-ceeeeee
Confidence            667888888999999999999966 68899999986651    2233577777666 699999999977655 5899999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe-cCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL-DNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill-~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |++.|+-|.+.+...+.    . ...+..|+.+|+.|+.|||++|+|||||||+|||+ ++.++++|+|||.++....+ 
T Consensus       396 e~l~g~ell~ri~~~~~----~-~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE----F-CSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcch----h-HHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999988888876653    2 36777899999999999999999999999999999 69999999999999877554 


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                         ....+-|..|.|||++....|++++|+||||++||+|++|+.||......      ......+..+...        
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s--------  532 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS--------  532 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc--------
Confidence               33446789999999999999999999999999999999999999875543      1223333333222        


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                             ..++...++|+.+||+.||.+||++.++..+-..
T Consensus       533 -------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 -------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                   3567889999999999999999999999987655

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-38  Score=282.79  Aligned_cols=277  Identities=22%  Similarity=0.343  Sum_probs=203.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcC-----CcEEEEEEeeccch-Hh-HHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRD-----GRIVAVKRLYENNF-KR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      ....|+....||+|.||.||++.-++     ...+|+|+++.... .. .....+|+.+++.++|||++.+..++...+.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            35678899999999999999996432     34799999865421 11 2456789999999999999999998877677


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC----CeEEEeee
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN-SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN----FRVKVADF  255 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~----~~~kl~Df  255 (438)
                      .+++++||.+. +|.+.++-.... ...++...+..|+.||+.|+.|||++=|+||||||.||||..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999976 899998754332 2468999999999999999999999999999999999999876    89999999


Q ss_pred             CcccccCCCcccc--ccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch--hHHHHHH
Q 013686          256 GLSRLFPTDVTHV--STAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL--SNMATNK  330 (438)
Q Consensus       256 gla~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~--~~~~~~~  330 (438)
                      |+++.+.......  ....+-|.+|+|||.+.|. .|+.+.||||.|||+.||+|-.+.|.+.........  .......
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999887654433  2334579999999998775 699999999999999999999998876543221110  0000011


Q ss_pred             Hh-------cCccccccc-CcCC-----CC----cc-----H--HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          331 IQ-------NGALNELVD-PSLG-----FE----KD-----Y--AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       331 ~~-------~~~~~~~~~-~~~~-----~~----~~-----~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      |-       ...++.+.. |...     +.    ..     +  ....-++...+|+.++|+.||-+|.|+++.+++.-
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            10       001111000 0000     00    00     0  01112234678999999999999999999998653

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=280.89  Aligned_cols=239  Identities=30%  Similarity=0.459  Sum_probs=192.4

Q ss_pred             ccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       118 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ||+|+||.||++... +++.+++|.+.....   ...+.+.+|++++++++|+||+++++.+... ...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-EKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-CeeEEEEecCCCCc
Confidence            699999999999976 589999999865433   2456788999999999999999999866544 57999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ  273 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  273 (438)
                      |.+++.....    +++.....++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus        80 L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (250)
T cd05123          80 LFSHLSKEGR----FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC  154 (250)
T ss_pred             HHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCc
Confidence            9999987643    89999999999999999999999999999999999999999999999999986543321 123345


Q ss_pred             CCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       274 g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      ++..|+|||.+.+...+.++|+||||+++|+|++|..||.....      ... ...+.....      .+  +     .
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~-~~~~~~~~~------~~--~-----~  214 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEI-YEKILKDPL------RF--P-----E  214 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHH-HHHHhcCCC------CC--C-----C
Confidence            78899999999888899999999999999999999999965432      111 111111110      01  0     1


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCH---HHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRPTM---KEVLE  382 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RPs~---~evl~  382 (438)
                      ..+..+.+++.+||..||++||++   +++++
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            225678899999999999999999   55544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.7e-37  Score=318.86  Aligned_cols=146  Identities=33%  Similarity=0.512  Sum_probs=129.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||+|... +++.||||++....   ....+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-NNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-CEEEE
Confidence            357889999999999999999976 68999999986542   23346788999999999999999999866554 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ||||+.+++|.+++.....    +++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~----l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999976543    8889999999999999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=303.39  Aligned_cols=259  Identities=28%  Similarity=0.439  Sum_probs=209.4

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeec----
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSR----  177 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----  177 (438)
                      .+...++.|.+.+.||.|.+|.||++..+ +|+..|+|++...... -+++..|.++++.+ .|||++.++|++..    
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            33445677889999999999999999954 6899999977654333 36677899999988 59999999996643    


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      .++.+|||||||.+|+..|+++...  +..+.|..+..|++.++.|+.|||...++|||||-.|||++.++.|||+|||+
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence            3468999999999999999998876  44599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccC-----CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCY-----KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      +..+..... ...+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+....+...         .+ 
T Consensus       170 SaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---------LF-  238 (953)
T KOG0587|consen  170 SAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LF-  238 (953)
T ss_pred             eeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---------hc-
Confidence            987654332 24456799999999999653     477799999999999999999999874332110         00 


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             .-++-+.+.-..+...+.++.++|..||.+|-++||++.+++++
T Consensus       239 -------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  239 -------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                   01111112222356788999999999999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-36  Score=278.07  Aligned_cols=219  Identities=21%  Similarity=0.235  Sum_probs=175.0

Q ss_pred             cCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhh
Q 013686          121 GGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH  199 (438)
Q Consensus       121 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  199 (438)
                      |.+|.||++... +|+.||+|.+....     .+.+|...+....||||+++++++... ...++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHH
Confidence            899999999975 68999999986543     233455555566799999999976654 57999999999999999997


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCcc
Q 013686          200 NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV  279 (438)
Q Consensus       200 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~  279 (438)
                      ....    +++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||++......    .....++..|+
T Consensus        78 ~~~~----l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~  149 (237)
T cd05576          78 KFLN----IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC  149 (237)
T ss_pred             HhcC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence            6543    899999999999999999999999999999999999999999999999988755432    12234577899


Q ss_pred             CccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHH
Q 013686          280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSV  359 (438)
Q Consensus       280 aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  359 (438)
                      |||.+.+..++.++||||+|+++|||++|..|+......            +..     .....+       +..++..+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~-----~~~~~~-------~~~~~~~~  205 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INT-----HTTLNI-------PEWVSEEA  205 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccc-----ccccCC-------cccCCHHH
Confidence            999998888999999999999999999999887532110            000     000000       12245678


Q ss_pred             HHHHHHhhccCCCCCCCH
Q 013686          360 AELAFRCVQQDRDMRPTM  377 (438)
Q Consensus       360 ~~li~~cl~~dP~~RPs~  377 (438)
                      .+++.+||+.||++||++
T Consensus       206 ~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         206 RSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHccCCHHHhcCC
Confidence            899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=250.92  Aligned_cols=267  Identities=21%  Similarity=0.324  Sum_probs=198.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +|...++||+|.||+||+++.+ +++.||+|++.-.+.  .--....+|+-+++.++|.|||+++++...+ +.+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-kkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-ceeEEeHH
Confidence            4556788999999999999966 589999999864422  2235678899999999999999999966554 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      || .-+|..+.......   ++.+....++.|+++||.++|++++.|||+||.|.||+.+|++|++|||+++.++-...+
T Consensus        82 ~c-dqdlkkyfdslng~---~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             Hh-hHHHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            99 55898888776543   889999999999999999999999999999999999999999999999999988765443


Q ss_pred             cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc---ccC
Q 013686          268 VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL---VDP  342 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  342 (438)
                       ....+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+..-.+.....-+......+..++.+   .|-
T Consensus       158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence             3445689999999998775 48889999999999999986 66777654322211111111111111111111   110


Q ss_pred             -cC-CCCccHHH----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          343 -SL-GFEKDYAV----RNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       343 -~~-~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       .+ .++....+    +.+...-++++.+.|.-+|.+|.++++.+++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence             00 11111122    3334445788999999999999999988764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=282.03  Aligned_cols=267  Identities=23%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC--C----CceeEeeeeeccCc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH--P----NLVKLYGCTSRQSR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~  180 (438)
                      ..++|.+...+|+|.||.|-.+.++ .+..||||+++.- .+..+..+-|+++|.++.+  |    -+|.+.+++.-. +
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-g  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-G  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-C
Confidence            3789999999999999999999976 4789999977543 2344677789999999942  2    367777766555 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC--------------
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN--------------  246 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~--------------  246 (438)
                      +.|||+|.+ |-++.++|..+..  .+++...++.++.|++++++|||+.+++|-||||+|||+.+              
T Consensus       165 hiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            799999999 7799999987654  34899999999999999999999999999999999999821              


Q ss_pred             ------CCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccc
Q 013686          247 ------NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD  320 (438)
Q Consensus       247 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~  320 (438)
                            +..+||+|||.|+.-....    ...+.|..|.|||++.+..++..+||||+||||+|++||...|+.....+.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                  3458999999998754432    345689999999999999999999999999999999999999987653322


Q ss_pred             cchhHHHHH-----HH---------hcCccc-----------ccccCcCCCCc-cHHHHHHHHHHHHHHHHhhccCCCCC
Q 013686          321 INLSNMATN-----KI---------QNGALN-----------ELVDPSLGFEK-DYAVRNMVTSVAELAFRCVQQDRDMR  374 (438)
Q Consensus       321 ~~~~~~~~~-----~~---------~~~~~~-----------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~R  374 (438)
                      .........     .+         ..+.+.           ...++-.+... -.........|.+|+.+||..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            111110000     00         000000           00000000000 00012234569999999999999999


Q ss_pred             CCHHHHHHH
Q 013686          375 PTMKEVLEI  383 (438)
Q Consensus       375 Ps~~evl~~  383 (438)
                      +|+.|++.+
T Consensus       398 iTl~EAL~H  406 (415)
T KOG0671|consen  398 ITLREALSH  406 (415)
T ss_pred             ccHHHHhcC
Confidence            999999875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=290.93  Aligned_cols=247  Identities=28%  Similarity=0.427  Sum_probs=201.3

Q ss_pred             CCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          115 SKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      .++||.|.||+||-|+++ +|+.||||++.+...  +..+.+.+|+.+|.++.||.||.+...++. .+..++|||.+ +
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhh-c
Confidence            478999999999999976 699999999965432  334678999999999999999999865544 45799999999 5


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC---CeEEEeeeCcccccCCCcccc
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN---FRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      |+..+.+-.....  .+++.....+..||+.||.|||.++|+|+||||+|||+...   -.+||||||+|+++++...  
T Consensus       647 GDMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  647 GDMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             chHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            5666665544332  38999889999999999999999999999999999999643   3699999999999876543  


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....+|||.|+|||++.+..|...-|+||.|||+|--++|..||.....         ....|++-.+.-         .
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------IndQIQNAaFMy---------P  784 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------INDQIQNAAFMY---------P  784 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---------hhHHhhcccccc---------C
Confidence            4567899999999999999999999999999999999999999974332         122344332221         1


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ...|.+++....+||...|+..-++|-|....+.+.+
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence            2236778889999999999999999999998887643

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=285.25  Aligned_cols=241  Identities=26%  Similarity=0.407  Sum_probs=195.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  183 (438)
                      ..+|..+.+||+|+||.|-++.-+ +.+.||||++++...   .+.+--+.|-++|+.. +-|.++++..|+... +.+|
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-DRLy  426 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-DRLY  426 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-hhee
Confidence            356888999999999999999876 478899999876532   3344456788888776 468888888866554 5799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+.||+|--.+++-+.    +.+..+.-+|.+|+-||-+||++||+.||||.+|||++.+|++||+|||+++..-.
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999999999988765    78888899999999999999999999999999999999999999999999985322


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      + .....+.+|||.|+|||++...+|+...|.|||||+||||+.|++||++....+.       -+.|-+..        
T Consensus       503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~ehn--------  566 (683)
T KOG0696|consen  503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIMEHN--------  566 (683)
T ss_pred             C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHHcc--------
Confidence            2 2234567899999999999999999999999999999999999999997543211       11221111        


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCC
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP  375 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  375 (438)
                      ..     .++.++.+...++...|.+.|.+|.
T Consensus       567 vs-----yPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 VS-----YPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             Cc-----CcccccHHHHHHHHHHhhcCCcccc
Confidence            11     1245677888999999999999995

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-38  Score=272.37  Aligned_cols=274  Identities=22%  Similarity=0.321  Sum_probs=201.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCCceeEeeeeec-------cCc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPNLVKLYGCTSR-------QSR  180 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------~~~  180 (438)
                      .|....+||+|.||.||++..+ +|+.||+|++...+.+  .-....+|+++|..|+|+|++.++..|..       ...
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3455678999999999999976 4788999876443222  12346689999999999999999885432       123


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|+||.+|+. +|.-.|.+...   .++..++.+++.++..||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            58999999965 89888877643   388999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCc---cccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          261 FPTDV---THVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       261 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      +....   ....+..+-|..|++||.+.|. .|+++.|||+.||++.||.||.+-+++........+....-..+..+.+
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            64322   2224455679999999988764 7999999999999999999999999876654433332222222222222


Q ss_pred             cccccC---------cCCCCccHHHHHHH------HHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          337 NELVDP---------SLGFEKDYAVRNMV------TSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       337 ~~~~~~---------~~~~~~~~~~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      +....-         .++.......++..      +...+|+.+++..||.+|+++.+++.+-.-.+
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            221110         01100000111111      25678999999999999999999998754443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.5e-36  Score=308.14  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=172.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-C----CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeee----e-ec
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-D----GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC----T-SR  177 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~----~-~~  177 (438)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++......  +...+|  .+....+.++..++..    . ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4678999999999999999999976 4    689999987643322  111111  1122222222222211    1 13


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPN----------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNN  241 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~N  241 (438)
                      .....++||||+++++|.+++......                ........+..++.||+.||.|||+++|+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            445789999999999999999754311                0011234456799999999999999999999999999


Q ss_pred             EEecC-CCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccC----------------------CCCChhhHHHH
Q 013686          242 ILLDN-NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY----------------------KLTDKSDVYSF  298 (438)
Q Consensus       242 ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Dvws~  298 (438)
                      ||++. ++.+||+|||+++.+............+++.|+|||.+...                      .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            99985 67999999999986654443444456789999999966322                      24456799999


Q ss_pred             HHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC-----cccccccCcCCCCcc---HHHHHHHHHHHHHHHHhhccC
Q 013686          299 GVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG-----ALNELVDPSLGFEKD---YAVRNMVTSVAELAFRCVQQD  370 (438)
Q Consensus       299 Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~d  370 (438)
                      ||+||||+++..+++....       .. ...+...     .+.....+....+..   ...........+|+.+||+.|
T Consensus       366 GviL~el~~~~~~~~~~~~-------~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSNLI-------QF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHhCcCCCchHHH-------HH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999997665432100       00 0000000     000001111000000   000111223568999999999


Q ss_pred             CCCCCCHHHHHHHH
Q 013686          371 RDMRPTMKEVLEIL  384 (438)
Q Consensus       371 P~~RPs~~evl~~L  384 (438)
                      |++|||++|++++-
T Consensus       438 P~kR~ta~e~L~Hp  451 (566)
T PLN03225        438 GRQRISAKAALAHP  451 (566)
T ss_pred             cccCCCHHHHhCCc
Confidence            99999999999863

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-35  Score=293.71  Aligned_cols=269  Identities=20%  Similarity=0.271  Sum_probs=184.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-----------------cCCcEEEEEEeeccchHhHHH--------------HHHH
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGIL-----------------RDGRIVAVKRLYENNFKRIEQ--------------FMNE  156 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  156 (438)
                      ..++|.+.++||+|+||+||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                 235689999986543322223              3347


Q ss_pred             HHHHHhCCCCCc-----eeEeeeeec-------cCceEEEEEeccCCCCHHHHhhccCCC--------------------
Q 013686          157 VEILTKLQHPNL-----VKLYGCTSR-------QSRELLLVYEYIPNGTVADHLHNRQPN--------------------  204 (438)
Q Consensus       157 ~~~l~~l~h~ni-----v~~~~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------  204 (438)
                      +.++.+++|.++     +++++++..       .....++||||+++++|.++++.....                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876554     566665532       124689999999999999999753211                    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCcccc
Q 013686          205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF  284 (438)
Q Consensus       205 ~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~  284 (438)
                      ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++...............+++.|+|||.+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            11246778899999999999999999999999999999999999999999999976543322222223358899999987


Q ss_pred             ccCC----------------------CCChhhHHHHHHHHHHHHhCCC-CcccCCcccc-cchhHHHHHHHhcCcccccc
Q 013686          285 QCYK----------------------LTDKSDVYSFGVVLIELISGLE-AVDTSRHRHD-INLSNMATNKIQNGALNELV  340 (438)
Q Consensus       285 ~~~~----------------------~~~~~Dvws~Gv~l~el~tG~~-p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....                      ...+.||||+||++++|++|.. ||........ ..........+.     ...
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-----~~~  457 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-----MYK  457 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----hhc
Confidence            5322                      1234799999999999999874 6653211100 000000000000     000


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDR---DMRPTMKEVLEIL  384 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~L  384 (438)
                      ...+.+.   .+...+....+|+.++|..+|   .+|+|++|+|++-
T Consensus       458 ~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        458 GQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             ccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            0011111   123356778899999999876   6899999999864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=289.40  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=206.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCc-EEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ..+++++..||-|+||.|=++..+... .+|+|.+++.   +.++.+.+..|-.+|..++.|.||++|-.+ .+++.+|+
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-rd~kyvYm  497 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-RDSKYVYM  497 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-ccchhhhh
Confidence            356777889999999999999976433 4899988765   334556788899999999999999999855 44568999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      .||-|-||.|+..|+.++.    ++......++..+++|++|||++|||.|||||+|++++.+|-+||.|||+|+.+...
T Consensus       498 LmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  498 LMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999999998876    888888899999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ..  .-+.+|||.|.|||++.+...+.++|.||||+++|||++|.+||.+..+..       ..+.|..|.-.-      
T Consensus       574 ~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-------tYn~ILkGid~i------  638 (732)
T KOG0614|consen  574 RK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-------TYNLILKGIDKI------  638 (732)
T ss_pred             Cc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-------HHHHHHhhhhhh------
Confidence            33  356789999999999999999999999999999999999999998765432       223333322111      


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEILR  385 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~  385 (438)
                           ..+..+.....+||++.+..+|.+|.-     ..+|-++-+
T Consensus       639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  639 -----EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             -----hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence                 112345566779999999999999975     566766543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=266.46  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=199.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  182 (438)
                      ..++|..+++||+|+|..|.++.++ +.+.||+|++++.   ..+.++=.+.|-.++.+- +||.+|-+..|+..+. .+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes-rl  326 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES-RL  326 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-eE
Confidence            3578999999999999999999966 5889999998764   233445566788888776 6999999998776664 79


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++|.||++||+|.-++++++.    ++++.+..+..+|+.||.|||++||+.||||.+|||+|..|.+||+|+|+++.--
T Consensus       327 ffvieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999999888877665    9999999999999999999999999999999999999999999999999998543


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcc-cccchhHHHHHHHhcCccccccc
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR-HDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .+. ....+.+|||.|+|||++.+..|....|.|++||+++||+.|+.||+.-... .+.+...+..+.+.+..++    
T Consensus       403 ~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----  477 (593)
T KOG0695|consen  403 GPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----  477 (593)
T ss_pred             CCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----
Confidence            322 2345678999999999999999999999999999999999999999854322 2222233333333332211    


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP  375 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  375 (438)
                          .     ++.++.....+++.-|++||.+|.
T Consensus       478 ----i-----prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 ----I-----PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ----c-----cceeehhhHHHHHHhhcCCcHHhc
Confidence                0     122344556788899999999985

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=252.03  Aligned_cols=203  Identities=27%  Similarity=0.453  Sum_probs=169.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++...+..||+|+||.|-+.++. +|...|+|++... +.+..+++.+|+++..+. .+|.+|.+||....++ ..++.
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-dvwIc  123 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-DVWIC  123 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-cEEEe
Confidence            344555778999999999998865 7999999999654 344556788899988776 6999999999776665 69999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||.| .-+|..+-.+--..+..+++...-+|+.-|..||.|||++ .++|||+||+|||++.+|+|||||||.+..+.+.
T Consensus       124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            9999 5688887766544555699999999999999999999987 8999999999999999999999999999876544


Q ss_pred             ccccccCCCCCCCccCcccccc----CCCCChhhHHHHHHHHHHHHhCCCCcccC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC----YKLTDKSDVYSFGVVLIELISGLEAVDTS  315 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~  315 (438)
                      ....  ...|...|||||.+..    ..|+-++||||||+++.||.+++.||+..
T Consensus       203 iAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  203 IAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             hHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            3322  2358899999998854    36889999999999999999999999753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=278.45  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=200.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-ch------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NF------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      .++|-++.+||+|||+.||++.+- ..+.||||+-.-+ ++      ...+...+|.++.+.|.||.||++|+++.-+.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            356777889999999999999854 5788999975322 11      123456789999999999999999999888888


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCEEec---CCCeEEEeee
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS--DVIHRDVKSNNILLD---NNFRVKVADF  255 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~ivH~Dlkp~Nill~---~~~~~kl~Df  255 (438)
                      .+|-|+|||+|.+|.-+|+..+.    +++.++..|..||+.||.||...  .|+|-||||.|||+-   .-|.+||+||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence            99999999999999999987764    99999999999999999999986  699999999999994   4578999999


Q ss_pred             CcccccCCCccc------cccCCCCCCCccCccccccC----CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH
Q 013686          256 GLSRLFPTDVTH------VSTAPQGTPGYVDPDYFQCY----KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN  325 (438)
Q Consensus       256 gla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~  325 (438)
                      ||++.+..+...      ......||.+|++||.+.-+    ..+.+.||||+|||+|..+.|+.||.......+     
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-----  692 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-----  692 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-----
Confidence            999998765443      12234699999999988432    568899999999999999999999985432211     


Q ss_pred             HHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 013686          326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  382 (438)
                          .+....+.....-  .++..   +.++.+...+|++||+..-++|....++..
T Consensus       693 ----ILqeNTIlkAtEV--qFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  693 ----ILQENTILKATEV--QFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ----HHhhhchhcceec--cCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                1111111111111  11111   235667889999999999999998888764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.6e-34  Score=263.66  Aligned_cols=238  Identities=33%  Similarity=0.490  Sum_probs=192.3

Q ss_pred             CceEEEEEEEc-CCcEEEEEEeeccchHh-HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhh
Q 013686          122 GFGAVYLGILR-DGRIVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH  199 (438)
Q Consensus       122 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  199 (438)
                      +||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+|++++++++... ...++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHH
Confidence            58999999987 48999999987654443 67899999999999999999999977654 47899999999999999997


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCcc
Q 013686          200 NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV  279 (438)
Q Consensus       200 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~  279 (438)
                      ....    +++..+..++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+.......  ......++..|+
T Consensus        80 ~~~~----~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       80 KRGR----LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             hccC----CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            6543    7899999999999999999999999999999999999999999999999998765432  223445888999


Q ss_pred             CccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHH
Q 013686          280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSV  359 (438)
Q Consensus       280 aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  359 (438)
                      +||.+.+..++.++|||+||+++++|++|..||......      .........+......          ....++..+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~----------~~~~~~~~~  217 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFPP----------PEWKISPEA  217 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCcc----------ccccCCHHH
Confidence            999998888999999999999999999999998653111      1111111111111000          001145678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 013686          360 AELAFRCVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       360 ~~li~~cl~~dP~~RPs~~evl~  382 (438)
                      .+++.+||..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=264.98  Aligned_cols=132  Identities=23%  Similarity=0.423  Sum_probs=112.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-----C---CCceeEeeeeec--
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-----H---PNLVKLYGCTSR--  177 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~--  177 (438)
                      ..+|.+.++||.|.|++||++.+. +.+.||+|+.+... ...+..+.||++|++++     |   .+||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            368999999999999999999865 57899999876543 23467788999999983     2   379999996643  


Q ss_pred             -cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEe
Q 013686          178 -QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILL  244 (438)
Q Consensus       178 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill  244 (438)
                       ++.++|||+|++ |.+|..+|......+  ++...+.+|++||+.||.|||.+ ||||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence             456899999999 889999998876555  99999999999999999999986 99999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=287.80  Aligned_cols=247  Identities=28%  Similarity=0.477  Sum_probs=185.6

Q ss_pred             CCCCCcccccCce-EEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEecc
Q 013686          112 FNSSKQLGDGGFG-AVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       112 ~~~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      |...+.+|.|+.| .||+|.. +|+.||||++.....   +-..+|+..|+.- .|||||++++ .+.+....||+.|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc-~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYC-SEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEe-eccCCceEEEEehHh
Confidence            3345678999886 5789988 489999999865533   3456799999998 5999999997 555566899999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---C--CeEEEeeeCcccccCCC
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---N--FRVKVADFGLSRLFPTD  264 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~--~~~kl~Dfgla~~~~~~  264 (438)
                       ..+|.+++...............+.+..|++.||+|||+.+||||||||.||||+.   +  .+++|+|||+++.+..+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence             56999999885211111111344778899999999999999999999999999975   3  57999999999988665


Q ss_pred             ccccc--cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhC-CCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          265 VTHVS--TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG-LEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       265 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .....  ....||-+|+|||.+....-+.++||||+||++|+.++| .+||...-...        .+.+........+.
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L~  736 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHLE  736 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeeec
Confidence            44333  345699999999999988888899999999999998886 89997532211        11111111000011


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +      .   .++  +..+||.+|+++||..||++.+|+.+
T Consensus       737 ~------~---~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  737 P------L---PDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             c------C---chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0      0   111  67899999999999999999999963

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=263.99  Aligned_cols=270  Identities=21%  Similarity=0.331  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeec--cchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ceEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYE--NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----RELL  183 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  183 (438)
                      +.+..+.||-|+||.||.+.+. +|+.||+|++..  .+....+.+.+|+++|.-++|.|++..+++.....    .++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3455789999999999999864 799999998743  23344578889999999999999999887543321    2578


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +++|.| ..+|...+..-..    ++.+.+.-+.+||++||+|||+.+|.||||||.|.|++.|..+||||||+++....
T Consensus       134 V~TELm-QSDLHKIIVSPQ~----Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSPQA----LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHH-HhhhhheeccCCC----CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence            999999 5588888766443    88888888999999999999999999999999999999999999999999998776


Q ss_pred             CccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH--------HHHHHHhcC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN--------MATNKIQNG  334 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------~~~~~~~~~  334 (438)
                      +....++..+-|..|.|||++.|. .|+.+.||||.||++.||+..+-.|+...+....++..        .....-.+|
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            666666666789999999999875 69999999999999999999988887665443332211        111111222


Q ss_pred             cccccccC-----cCCCCcc-HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          335 ALNELVDP-----SLGFEKD-YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       335 ~~~~~~~~-----~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .-..++..     .++.-.. ..+..--.+...+..+++..||++|.+..+.+..+.
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            22222111     1100000 000112234557788999999999999999987653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-34  Score=276.68  Aligned_cols=203  Identities=28%  Similarity=0.413  Sum_probs=170.8

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      |..++.||-|+||.|.++... +...||+|.+.+.+.-   ....++.|-++|..-..+-||+||-.|.+ .+++|+||+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdnLYFVMd  709 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMD  709 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCceEEEEe
Confidence            667789999999999999844 4678999998765432   33457789999999999999999965554 458999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC---
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD---  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~---  264 (438)
                      |++||++-.+|-+.+-    +++..++.++.++..|+++.|..|+|||||||+|||||.+|++||+||||++-+.-.   
T Consensus       710 YIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            9999999999987664    888888889999999999999999999999999999999999999999999754210   


Q ss_pred             -----ccc---------------------------------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHH
Q 013686          265 -----VTH---------------------------------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI  306 (438)
Q Consensus       265 -----~~~---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~  306 (438)
                           ..+                                 .....+||+.|+|||++....|+..+|.||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                 000                                 011235999999999999999999999999999999999


Q ss_pred             hCCCCcccCCccc
Q 013686          307 SGLEAVDTSRHRH  319 (438)
Q Consensus       307 tG~~p~~~~~~~~  319 (438)
                      .|++||-...+.+
T Consensus       866 ~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  866 VGQPPFLADTPGE  878 (1034)
T ss_pred             hCCCCccCCCCCc
Confidence            9999998765543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.7e-34  Score=246.90  Aligned_cols=260  Identities=22%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-cCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeec-cCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL-RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSR-QSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~~~~~lv  185 (438)
                      .++|++.+++|+|-|+.||.|.. .+++.++||.+++-.   .+.+.+|+.+|..|. ||||++++++..+ .+..+.+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            57889999999999999999994 468899999987653   356788999999996 9999999996544 34567899


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~~~~~  264 (438)
                      +||+++.+...+...       ++...+..++.+++.||.|+|++||+|||+||.|++||.. -.++|+|+|+|.++...
T Consensus       114 FE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999988777665543       6777888999999999999999999999999999999865 46999999999987554


Q ss_pred             ccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHH--------HHHhcCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT--------NKIQNGA  335 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  335 (438)
                      ..  ..-.+.+..|.-||.+... .|+..-|+|||||+|.+|+..+.||-......+ ++...+.        ..+..  
T Consensus       187 ~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~K--  261 (338)
T KOG0668|consen  187 KE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNK--  261 (338)
T ss_pred             ce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHH--
Confidence            32  2234567788999998765 578889999999999999999999864433211 1111111        00000  


Q ss_pred             ccccccCcCC----CCc---------cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LNELVDPSLG----FEK---------DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~~~~~~~~~----~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..-.++|.+.    ...         .....-.+++..+++.+.|..|-.+|+|++|.+.+
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            0001122110    000         00011134778899999999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-33  Score=244.45  Aligned_cols=253  Identities=19%  Similarity=0.327  Sum_probs=192.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .+.|.+.+.||+|.||.+-++.++. ...+++|.+.... ....+|.+|..---.| .|.||+.-|++.....+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4678899999999999999999884 6788999775543 3457899998876666 49999999987666667889999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec--CCCeEEEeeeCcccccCCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD--NNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~--~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||++.|+|..-+...+     +.+.....++.|++.|+.|+|++++||||||.+||||-  +..+|||||||+.+..+..
T Consensus       102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999998887643     78888899999999999999999999999999999993  3348999999998865433


Q ss_pred             ccccccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ..    ...-+..|.+||....     ....+.+|||.||+++|.++||+.||+... .+  +..-|.+..+..+.....
T Consensus       177 V~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~--d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  177 VK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IM--DKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             eh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-cc--CchHHHHHHHhcccCccC
Confidence            22    1234667899997642     245778999999999999999999998332 22  223333444444433322


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+         ..+.+++.+..+.++-|.++|++|=...++.++
T Consensus       250 P~---------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  250 PK---------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             ch---------hhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            11         123456677889999999999999555554443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3e-31  Score=237.48  Aligned_cols=210  Identities=41%  Similarity=0.703  Sum_probs=181.4

Q ss_pred             ccccCceEEEEEEEcC-CcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHH
Q 013686          118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVA  195 (438)
Q Consensus       118 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~  195 (438)
                      ||+|.+|.||++...+ |+.+++|.+...... ..+.+.+|++.++.+.|++++++++++... ...+++|||+++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence            6899999999999864 899999998765432 346788999999999999999999977654 5789999999999999


Q ss_pred             HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCcccccCCCccccccCCCC
Q 013686          196 DHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPTDVTHVSTAPQG  274 (438)
Q Consensus       196 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g  274 (438)
                      +++....   ..+++..+..++.++++++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            9998753   12889999999999999999999999999999999999999 89999999999987644321 1223457


Q ss_pred             CCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHH
Q 013686          275 TPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR  353 (438)
Q Consensus       275 ~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (438)
                      ...|++||.+... .++.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8899999999877 888999999999999998                                                


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          354 NMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       354 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         ..+.+++.+|++.||++||++.++++.
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence               246789999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=8.5e-33  Score=247.50  Aligned_cols=263  Identities=23%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----ce
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----RE  181 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~  181 (438)
                      .+|.-++.+|.|.- .|.-+.+. .++.||+|++...  +....++..+|..++..++|+||++++.++....     .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35556778888887 55555543 5899999987543  2334567788999999999999999999775442     36


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .|+|||+| ..+|...+...      ++-.....++.|++.|++|||+.||+||||||+||++..+..+||.|||+++..
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence            89999999 67999998843      677888999999999999999999999999999999999999999999999865


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccc----------------hhH
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN----------------LSN  325 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~----------------~~~  325 (438)
                      +.+  -..+....+..|.|||++-+..|.+.+||||+||++.||++|+..|.+...-+...                +..
T Consensus       169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            443  34455678999999999999899999999999999999999999887543221110                000


Q ss_pred             HHHHHHhc------CcccccccC-cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          326 MATNKIQN------GALNELVDP-SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       326 ~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+......      -...+.+.. .+..... ..+--...+++++.+||-.||++|.+++++|.+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e-~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLE-GSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCccccccccc-CCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            01111100      001111100 0000000 001223457899999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=8.6e-33  Score=264.09  Aligned_cols=197  Identities=22%  Similarity=0.378  Sum_probs=168.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhH-----HHHHHHHHHHHhCC---CCCceeEeeeee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRI-----EQFMNEVEILTKLQ---HPNLVKLYGCTS  176 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~-----~~~~~E~~~l~~l~---h~niv~~~~~~~  176 (438)
                      ..+|...+.||.|+||.|++|.++ +...|+||.+.+...   .++     -.+-.|+++|..|+   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356899999999999999999987 577899999876532   111     13456999999997   999999999776


Q ss_pred             ccCceEEEEEecc-CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeee
Q 013686          177 RQSRELLLVYEYI-PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       177 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                      ++ +.+||+||-. ++.+|++++..+..    +++.++..|++||+.|+++||+.||||||||-+||.++.+|-+||+||
T Consensus       640 dd-d~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  640 DD-DYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             cC-CeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence            65 5899999986 45699999988765    999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcc
Q 013686          256 GLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVD  313 (438)
Q Consensus       256 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~  313 (438)
                      |.+.......   .....||..|.|||++.|.+| ...-|||++|++||.++....||-
T Consensus       715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9998765432   344679999999999999887 456799999999999998888774

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=9.3e-33  Score=260.83  Aligned_cols=277  Identities=22%  Similarity=0.254  Sum_probs=205.7

Q ss_pred             ChHHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC------CCceeEee
Q 013686          101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH------PNLVKLYG  173 (438)
Q Consensus       101 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~  173 (438)
                      .+.-.+....+|.+....|+|-|++|..|... .|..||||++..+..- .+.=+.|+++|++|+.      -|+++++-
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            33334556678999999999999999999965 4889999988655322 2344569999999952      47888887


Q ss_pred             eeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEE
Q 013686          174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKV  252 (438)
Q Consensus       174 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl  252 (438)
                      .|... +++|||+|-+ ..+|.++|...+.+ ..|....+..++.|+..||..|...||+|.||||+||||++. ..+||
T Consensus       502 ~F~hk-nHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  502 HFKHK-NHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             Hhhhc-ceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence            66555 4899999998 67999999987653 358889999999999999999999999999999999999865 46899


Q ss_pred             eeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH-----H
Q 013686          253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM-----A  327 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~-----~  327 (438)
                      ||||.|.......-.   ...-+..|.|||++.|.+|+...|+||.||+||||.||+..|.+.+...-..+...     .
T Consensus       579 CDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  579 CDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP  655 (752)
T ss_pred             ccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence            999999876543221   22346689999999999999999999999999999999999987654322111110     1


Q ss_pred             HHHHhcCccc-ccccCcCCC----------------------------------CccHHHHHHHHHHHHHHHHhhccCCC
Q 013686          328 TNKIQNGALN-ELVDPSLGF----------------------------------EKDYAVRNMVTSVAELAFRCVQQDRD  372 (438)
Q Consensus       328 ~~~~~~~~~~-~~~~~~~~~----------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~  372 (438)
                      ...+..+.+. ..+|..+.+                                  ............|.+|+.+||..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence            1112111111 111111100                                  00111234667899999999999999


Q ss_pred             CCCCHHHHHHHH
Q 013686          373 MRPTMKEVLEIL  384 (438)
Q Consensus       373 ~RPs~~evl~~L  384 (438)
                      +|.|..|.|.+-
T Consensus       736 KRit~nqAL~Hp  747 (752)
T KOG0670|consen  736 KRITVNQALKHP  747 (752)
T ss_pred             hcCCHHHHhcCC
Confidence            999999998753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-33  Score=269.69  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|.....+|.|.||.|||+++. .++..|+|.++-.......-++.|+-+++.++||||+.++|.+.... .+|++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEEEE
Confidence            567888999999999999999965 69999999998766666677788999999999999999999665554 6999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ||.+|+|.+.-+-.+.    +++.++..++++.++||+|||+.|-+|||||-.|||+++.|.+|++|||.+..+..... 
T Consensus        93 ycgggslQdiy~~Tgp----lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-  167 (829)
T ss_pred             ecCCCcccceeeeccc----chhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence            9999999998877654    99999999999999999999999999999999999999999999999999876644332 


Q ss_pred             cccCCCCCCCccCcccc---ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          268 VSTAPQGTPGYVDPDYF---QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ......||+.|||||+.   ..+.|...+|||+.|++..|+---++|.....+..       +.......   ..-.+.+
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS---~~qpp~l  237 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKS---GFQPPTL  237 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhcc---CCCCCcc
Confidence            23456799999999976   35679999999999999999987776653221110       00000000   0011111


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  382 (438)
                      ..     ....++.+.++++.|+.++|.+||+++.++.
T Consensus       238 kD-----k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KD-----KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cC-----CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11     1245677899999999999999999988775

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.2e-30  Score=235.11  Aligned_cols=199  Identities=38%  Similarity=0.608  Sum_probs=171.4

Q ss_pred             CCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          112 FNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      |.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++... ...++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEecc
Confidence            4567889999999999999875 899999998766544 567899999999999999999999976554 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++++|.+++......   +++.....++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||++...........
T Consensus        80 ~~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       80 EGGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            999999999875432   78899999999999999999999999999999999999999999999999987654421122


Q ss_pred             cCCCCCCCccCcccc-ccCCCCChhhHHHHHHHHHHHHhCCCCccc
Q 013686          270 TAPQGTPGYVDPDYF-QCYKLTDKSDVYSFGVVLIELISGLEAVDT  314 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~  314 (438)
                      ....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334578899999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=3e-30  Score=239.40  Aligned_cols=269  Identities=23%  Similarity=0.368  Sum_probs=195.0

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccC
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQS  179 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  179 (438)
                      +....+.|...++||+|.|++||++.+.    .++.||+|.+......  ..+.+|+++|..+. +.||+++.+++..+ 
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnn-  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNN-  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccC-
Confidence            4445677999999999999999999854    3678999998765433  45888999999995 99999999966544 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCcc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLS  258 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla  258 (438)
                      +..++|+||++..+..++...       ++...+..+++.++.||.++|.+|||||||||.|+|.+. .++-.|+|||+|
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence            579999999999999888865       778889999999999999999999999999999999974 567899999999


Q ss_pred             cccCCCc---------------------------------cc----------cccCCCCCCCccCcccccc-CCCCChhh
Q 013686          259 RLFPTDV---------------------------------TH----------VSTAPQGTPGYVDPDYFQC-YKLTDKSD  294 (438)
Q Consensus       259 ~~~~~~~---------------------------------~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~~D  294 (438)
                      .......                                 ..          ......||++|.|||++.. ...+.+.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7211000                                 00          0012349999999999864 46788999


Q ss_pred             HHHHHHHHHHHHhCCCCcccCCcccccch-----hHH-HHHH--HhcCc--ccc--------------------cccC-c
Q 013686          295 VYSFGVVLIELISGLEAVDTSRHRHDINL-----SNM-ATNK--IQNGA--LNE--------------------LVDP-S  343 (438)
Q Consensus       295 vws~Gv~l~el~tG~~p~~~~~~~~~~~~-----~~~-~~~~--~~~~~--~~~--------------------~~~~-~  343 (438)
                      |||.|||++.+++++.||-.....-+...     ..+ ...+  ...|.  +.+                    .+.+ .
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999999954433221110     000 0000  00111  000                    0000 0


Q ss_pred             C-CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 L-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      . ...........+..+.+++.+|+..||.+|.|+++.|++
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0 001111112344578999999999999999999999985

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=7.1e-30  Score=273.08  Aligned_cols=198  Identities=16%  Similarity=0.205  Sum_probs=138.1

Q ss_pred             hCCC-CCceeEeeeeec------cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013686          162 KLQH-PNLVKLYGCTSR------QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH  234 (438)
Q Consensus       162 ~l~h-~niv~~~~~~~~------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH  234 (438)
                      .++| +||+++++++..      ....+++++||+ +++|.++|....   ..+++..++.++.||++||.|||++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            3445 577777775411      123577889988 679999997532   23899999999999999999999999999


Q ss_pred             cCCCCCCEEecCCC-------------------eEEEeeeCcccccCCCc---------------cccccCCCCCCCccC
Q 013686          235 RDVKSNNILLDNNF-------------------RVKVADFGLSRLFPTDV---------------THVSTAPQGTPGYVD  280 (438)
Q Consensus       235 ~Dlkp~Nill~~~~-------------------~~kl~Dfgla~~~~~~~---------------~~~~~~~~g~~~y~a  280 (438)
                      |||||+||||+..+                   .+||+|||+++......               ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996544                   45555666654321100               000011347889999


Q ss_pred             ccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHH
Q 013686          281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA  360 (438)
Q Consensus       281 PE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  360 (438)
                      ||.+.+..++.++|||||||+||||++|.+|+.....         ....+....    ..+..        ........
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~~~----~~~~~--------~~~~~~~~  242 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRHRV----LPPQI--------LLNWPKEA  242 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHHhh----cChhh--------hhcCHHHH
Confidence            9999999999999999999999999999888653110         001111110    11100        01123356


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHH
Q 013686          361 ELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       361 ~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +++.+||++||.+||++.|++++.
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhch
Confidence            788999999999999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=3.5e-28  Score=212.79  Aligned_cols=168  Identities=23%  Similarity=0.276  Sum_probs=128.3

Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccC
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA  271 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  271 (438)
                      |+|.+++..++.   .+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||++.......      
T Consensus         1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            689999986433   3999999999999999999999998      999999999999999  99998654322      


Q ss_pred             CCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHH
Q 013686          272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA  351 (438)
Q Consensus       272 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (438)
                      ..|++.|||||.+.+..++.++|||||||++|||+||+.||.......     .... .+.......  .+.    ....
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~-~~~~~~~~~--~~~----~~~~  131 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILE-ILLNGMPAD--DPR----DRSN  131 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHH-HHHHHhccC--Ccc----cccc
Confidence            258899999999999999999999999999999999999996432211     1111 111110000  000    0001


Q ss_pred             HHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          352 VRNMVT--SVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       352 ~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      ......  .+.+++.+||..||.+||++.|+++++..+.
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            123333  6899999999999999999999999987764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.4e-27  Score=225.99  Aligned_cols=175  Identities=19%  Similarity=0.154  Sum_probs=133.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc--CCcEEEEEEeecc-----chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR--DGRIVAVKRLYEN-----NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS  179 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  179 (438)
                      ...++|.+.+.||+|+||+||+|.++  +++.||||++...     .....+.+.+|+++|++++|+|+++.+...    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34577999999999999999999865  5778899986532     122346789999999999999998533212    


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCEEecCCCeEEEeeeCcc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDV-KSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dl-kp~Nill~~~~~~kl~Dfgla  258 (438)
                      ...++||||++|++|... .   .    ..   ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||++
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~---~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-R---P----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-C---c----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            247999999999999632 1   1    11   1467889999999999999999999 999999999999999999999


Q ss_pred             cccCCCccccc-------cCCCCCCCccCccccccCC------CCChhhHH
Q 013686          259 RLFPTDVTHVS-------TAPQGTPGYVDPDYFQCYK------LTDKSDVY  296 (438)
Q Consensus       259 ~~~~~~~~~~~-------~~~~g~~~y~aPE~~~~~~------~~~~~Dvw  296 (438)
                      +.+........       ....+++.|+|||.+...+      .+..+|-|
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            97654321111       2345788899999986542      23346665

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-26  Score=218.67  Aligned_cols=263  Identities=22%  Similarity=0.274  Sum_probs=196.0

Q ss_pred             CCCCCCcccccCceEEEEEEEcCC--cEEEEEEeeccchHhHHHHHHHHHHHHhCCC----CCceeEeeeeeccCceEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDG--RIVAVKRLYENNFKRIEQFMNEVEILTKLQH----PNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~l  184 (438)
                      +|++.+.||+|+||.||++.....  ..+|+|............+..|..++..+..    +++..+++.........++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  5789987655432222267789999998863    5888888755334457899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-----CeEEEeeeCccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-----FRVKVADFGLSR  259 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-----~~~kl~Dfgla~  259 (438)
                      ||+.+ |.+|.++.....  ...++......|+.|++.+|++||+.|++||||||.|+++...     ..+.|.|||+++
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            99998 889999887665  2349999999999999999999999999999999999999754     469999999998


Q ss_pred             --ccCCCccc----c---ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHH
Q 013686          260 --LFPTDVTH----V---STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       260 --~~~~~~~~----~---~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                        .+......    .   .....||..|.++....+...+.+.|+||++.++.|++.|..||.............  ...
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--~~~  253 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--KDP  253 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH--HHh
Confidence              33222111    1   123459999999999999999999999999999999999999986544322211111  000


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                           ....... .       ....+..+.++...+-..+...+|....+...++......
T Consensus       254 -----~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  254 -----RKLLTDR-F-------GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -----hhhcccc-c-------cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                 0000000 0       1123445666777777789999999999999988775543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-25  Score=202.66  Aligned_cols=262  Identities=18%  Similarity=0.275  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCceEEEEEE-EcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      -.|+++++||+|.||..+.|. +-+++.||||.-...  .+.-++..|.+..+.|. .++|-.++ +|..++..-.||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vY-YFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVY-YFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCcee-eeccccchhhhhhh
Confidence            368899999999999999998 447999999953222  22345777999999885 68888877 45566667789999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-----CCeEEEeeeCcccccC
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-----NFRVKVADFGLSRLFP  262 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfgla~~~~  262 (438)
                      ++ |.+|.|++.-++..   ++.+.+..+|.|++.-++|+|++.+|.|||||+|+||..     ...+.|+|||+|+.+.
T Consensus       105 LL-GPSLEDLFD~CgR~---FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRR---FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCc---ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99 88999999877654   999999999999999999999999999999999999964     3468999999999875


Q ss_pred             CCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          263 TDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       263 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      +....      ......||.+||+-....|.+.+.+.|+=|+|-+++.++-|..||++.......    ...++|.+   
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK----~kYeKIGe---  253 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK----EKYEKIGE---  253 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH----HHHHHhcc---
Confidence            54332      123456999999999999999999999999999999999999999875433221    11222221   


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                           ..-..+......++|.++..-+.-.-..+-.+-|..+-+...+..+.+.
T Consensus       254 -----~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  254 -----TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             -----ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence                 1112233445567888888888888888999999999888877776543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=7.3e-24  Score=202.65  Aligned_cols=261  Identities=31%  Similarity=0.515  Sum_probs=196.9

Q ss_pred             CCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCC-CceeEeeeeeccCceEEEEEe
Q 013686          112 FNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHP-NLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~e  187 (438)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ..+.+.+|+.+++.+.|+ +++++++++... ...+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-GSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-CEEEEEEe
Confidence            566788999999999999986  78899988655332   367899999999999988 799999977443 35799999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~~~~  266 (438)
                      ++.++++.+++...... ..+.......+..|++.++.|+|+.+++|||+||+||+++..+ .++++|||++........
T Consensus        79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            99999999777765421 2388899999999999999999999999999999999999988 799999999986544332


Q ss_pred             c-----cccCCCCCCCccCcccccc---CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          267 H-----VSTAPQGTPGYVDPDYFQC---YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       267 ~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      .     ......++..|++||.+.+   ..++...|+|++|++++++++|..||......   .........+...... 
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-  233 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-  233 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence            2     2355679999999999987   57888999999999999999999997654321   0011111222211111 


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...........   ......+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000000   2223567889999999999999999887764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4.3e-26  Score=232.36  Aligned_cols=254  Identities=20%  Similarity=0.291  Sum_probs=190.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCcEEEEEEee----cc-chHh-HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          113 NSSKQLGDGGFGAVYLGILR-DGRIVAVKRLY----EN-NFKR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .....+|.|++|.|+..... ..+.++.|...    .. .... ...+..|+-+-..+.|+|++..+....+... ..-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence            35678999999988877644 34444444332    11 1111 1226667777888899999887775544433 3344


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||||++ +|..++.....    +....+..++.|++.|++|||+.||.|||+|++|+++..+|.+||+|||.+..+..+.
T Consensus       400 mE~~~~-Dlf~~~~~~~~----~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGK----LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhcccH-HHHHHHhcccc----cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            999999 99999987633    7888889999999999999999999999999999999999999999999998775543


Q ss_pred             c---ccccCCCCCCCccCccccccCCCCC-hhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          266 T---HVSTAPQGTPGYVDPDYFQCYKLTD-KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       266 ~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .   .......|+..|+|||.+.+..|++ ..||||.|++++.|.+|+.||......++...     .....+.      
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~~~~~------  543 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNNYSDQ------  543 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhccccc------
Confidence            3   4455678999999999999999977 57999999999999999999986554433210     0000000      


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..........+..++...+.++.++|+.||.+|.|+++|++.
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            011112233456788889999999999999999999999873

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.2e-26  Score=199.18  Aligned_cols=245  Identities=19%  Similarity=0.354  Sum_probs=185.4

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCC
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      ...+|.+...|..|+|++.. .-+++|++.....  ...++|..|.-.|+-+.||||++++|.|.... ++.++..||+.
T Consensus       194 l~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~isq~mp~  271 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVIISQYMPF  271 (448)
T ss_pred             hhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEeeeeccc
Confidence            45678899999999999974 4456677654322  22367999999999999999999999887664 78999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cc-ccCCCCCCEEecCCCeEEEe--eeCcccccCCCccc
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-VI-HRDVKSNNILLDNNFRVKVA--DFGLSRLFPTDVTH  267 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-iv-H~Dlkp~Nill~~~~~~kl~--Dfgla~~~~~~~~~  267 (438)
                      |+|+++|++...  ...+..++.+++.+|++|++|||+.. ++ .-.|....|++|++.+++|.  |--++-        
T Consensus       272 gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--------  341 (448)
T KOG0195|consen  272 GSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------  341 (448)
T ss_pred             hHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--------
Confidence            999999998653  23677888999999999999999973 33 44699999999999988774  322211        


Q ss_pred             cccCCCCCCCccCccccccCCC---CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKL---TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~---~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ......-.|.||+||.+...+-   -.++|+|||+++||||.|...||....+.+.       ..++.-+.++-.+.   
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------gmkialeglrv~ip---  411 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------GMKIALEGLRVHIP---  411 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------hhhhhhccccccCC---
Confidence            1112235789999999976543   3478999999999999999999985543221       12232222222222   


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                              ++.+..+..|+.-|++.||.+||.+..|+-.|++..
T Consensus       412 --------pgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  412 --------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                    345667889999999999999999999999998764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=4.5e-25  Score=190.68  Aligned_cols=261  Identities=19%  Similarity=0.285  Sum_probs=199.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-cCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC-CCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL-RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH-PNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ..+|.++++||.|+||.+|+|.. .+|+.||||.-....  ....+..|..+.+.|++ ..|..+..+. .+...-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~-~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG-TEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc-cccccceeee
Confidence            46789999999999999999994 579999999653321  12346678999998875 4555555433 3445678999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCcccccCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~~~~~  263 (438)
                      +.+ |.+|.+++.-....   ++...++-++-|++.-++|+|.++++||||||+|+|..-   ...+.++|||+++.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999 88999998876543   899999999999999999999999999999999999963   45789999999997644


Q ss_pred             Cccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          264 DVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       264 ~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ....      ......||.+|.+-..+.+...+.+.|+-|+|.+|..+..|..||++.......+.    ..+|.     
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK----yEkI~-----  237 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK----YEKIS-----  237 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH----HHHHH-----
Confidence            2221      22344699999999888888889999999999999999999999987544322211    11222     


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                         ...++........++|.++.-.+.-|-..--++-|....+.+.+..+.
T Consensus       238 ---EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  238 ---EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             ---HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence               222333344455677888888999999998899999888777666553

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=5.4e-25  Score=224.71  Aligned_cols=242  Identities=24%  Similarity=0.308  Sum_probs=179.9

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccc-hHhHHHH---HHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENN-FKRIEQF---MNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      +|...+.||.+.|=.|.+++++.|. |+||++.+.. .-..+.|   ..|++ ...++|||++++.-+ ....+-.|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHHH
Confidence            5677899999999999999998887 8899886553 2233333   34444 555689999998764 33345678999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc--cCCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL--FPTD  264 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~--~~~~  264 (438)
                      +|.. -+|.|.+..+.-    +..-+...|+.|++.||.-+|..||+|||||.+||||+.-+-+.|+||...+.  ++.+
T Consensus       101 qyvk-hnLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHh-hhhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            9994 599999988764    88888899999999999999999999999999999999999999999987752  2333


Q ss_pred             cccc----ccCCCCCCCccCccccccC----------C-CCChhhHHHHHHHHHHHHh-CCCCcccCCcc----cccchh
Q 013686          265 VTHV----STAPQGTPGYVDPDYFQCY----------K-LTDKSDVYSFGVVLIELIS-GLEAVDTSRHR----HDINLS  324 (438)
Q Consensus       265 ~~~~----~~~~~g~~~y~aPE~~~~~----------~-~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~----~~~~~~  324 (438)
                      ....    ..+...-.+|+|||.+...          . .+++.||||+||+++||++ |++||...+--    ......
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP  255 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence            2221    1233355689999988441          2 6778999999999999988 78999743210    000001


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ......+                       ....+++++..|++.||++|.++++.|+.
T Consensus       256 e~~Le~I-----------------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKI-----------------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhC-----------------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111111                       11247889999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.7e-24  Score=193.21  Aligned_cols=172  Identities=13%  Similarity=0.122  Sum_probs=133.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHh---HHH------HHHHHHHHHhCCCCCceeEeeeeecc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR---IEQ------FMNEVEILTKLQHPNLVKLYGCTSRQ  178 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~~~~~~~~~  178 (438)
                      ...+|+..+.||.|+||.||+... ++..+|+|.+.+.....   .+.      +.+|++.+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999755 57789999986543222   222      67899999999999999998864432


Q ss_pred             -------CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          179 -------SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       179 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                             ....++||||++|.+|.++..        ++.    ....+++.+|..||+.|++|||++|+||+++.++ ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence                   235789999999999988732        332    2456999999999999999999999999999988 99


Q ss_pred             EeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHH
Q 013686          252 VADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI  306 (438)
Q Consensus       252 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~  306 (438)
                      |+|||.......+....             ..+....|..++|+|+||+++.-+.
T Consensus       175 liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            99999887553221110             1333445667999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=7.4e-24  Score=186.87  Aligned_cols=139  Identities=16%  Similarity=0.133  Sum_probs=107.6

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchH--h-------H-----------------HHHHHHHHHHHhCCCCCc
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK--R-------I-----------------EQFMNEVEILTKLQHPNL  168 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  168 (438)
                      ...||+|+||.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998654211  0       0                 122359999999987776


Q ss_pred             eeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCEEecCC
Q 013686          169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL-HASDVIHRDVKSNNILLDNN  247 (438)
Q Consensus       169 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~ivH~Dlkp~Nill~~~  247 (438)
                      .....+. ..  ..+|||||++++++...+....    .++......++.|++.+|.++ |+.||+||||||+|||++ +
T Consensus        82 ~~p~~~~-~~--~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPIL-LK--SHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEE-ec--CCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C
Confidence            4332222 12  2389999998877765533222    288899999999999999999 799999999999999998 4


Q ss_pred             CeEEEeeeCccccc
Q 013686          248 FRVKVADFGLSRLF  261 (438)
Q Consensus       248 ~~~kl~Dfgla~~~  261 (438)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.91  E-value=5.1e-25  Score=214.69  Aligned_cols=264  Identities=24%  Similarity=0.403  Sum_probs=203.3

Q ss_pred             HHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCC
Q 013686          160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV-IHRDVK  238 (438)
Q Consensus       160 l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-vH~Dlk  238 (438)
                      |+.+.|.|+.+++|.+... ...++|.+||..|+|.+.+.....   .+++.....+.++|+.||.|||...| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~---~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDI---KLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcccc---CccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            3568899999999977766 579999999999999999988433   38899999999999999999999866 999999


Q ss_pred             CCCEEecCCCeEEEeeeCcccccCCC-ccccccCCCCCCCccCccccccCC-------CCChhhHHHHHHHHHHHHhCCC
Q 013686          239 SNNILLDNNFRVKVADFGLSRLFPTD-VTHVSTAPQGTPGYVDPDYFQCYK-------LTDKSDVYSFGVVLIELISGLE  310 (438)
Q Consensus       239 p~Nill~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dvws~Gv~l~el~tG~~  310 (438)
                      +.|++++..+.+||+|||+....... .........-...|.|||.+.+..       .+.+.||||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998876421 111111122456799999997641       4667999999999999999999


Q ss_pred             CcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          311 AVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       311 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      ||.........   ......+.. .....+.|.+..     .....+.+..++.+||..+|++||+++++-..++.+...
T Consensus       157 ~~~~~~~~~~~---~eii~~~~~-~~~~~~rP~i~~-----~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  157 PFDLRNLVEDP---DEIILRVKK-GGSNPFRPSIEL-----LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccccCCh---HHHHHHHHh-cCCCCcCcchhh-----hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99865433322   111112222 112222222211     113445788999999999999999999999999888653


Q ss_pred             -----CCCCCccccccccccchhhhhccCCCCCCCCCcccccccCCCCCCC
Q 013686          391 -----NLGTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKWVSSSNPSS  436 (438)
Q Consensus       391 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (438)
                           ++.+....+.+.+.+..+...++.+..+..+...++..+..+.|++
T Consensus       228 ~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~  278 (484)
T KOG1023|consen  228 GSSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKS  278 (484)
T ss_pred             ccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHH
Confidence                 4556667778889999999999988899999999999999998864

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.2e-22  Score=179.82  Aligned_cols=140  Identities=17%  Similarity=0.163  Sum_probs=110.1

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchH------------------------h--HHHHHHHHHHHHhCCCCCc
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK------------------------R--IEQFMNEVEILTKLQHPNL  168 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------------~--~~~~~~E~~~l~~l~h~ni  168 (438)
                      .+.||+|+||.||+|...+|+.||||++......                        .  ...+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999999878999999998654210                        0  1234679999999999887


Q ss_pred             eeEeeeeeccCceEEEEEeccCCCCHHHH-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecC
Q 013686          169 VKLYGCTSRQSRELLLVYEYIPNGTVADH-LHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDN  246 (438)
Q Consensus       169 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~  246 (438)
                      .....+...   ..++||||++|+++... +.. .    .++......++.|++.++.+||+ .||+||||||+|||++ 
T Consensus        82 ~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~-~----~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK---KNVLVMEFIGDDGSPAPRLKD-V----PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec---CCEEEEEEecCCCchhhhhhh-c----cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence            543332222   24899999988755433 332 2    27788889999999999999999 9999999999999999 


Q ss_pred             CCeEEEeeeCcccccCC
Q 013686          247 NFRVKVADFGLSRLFPT  263 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~  263 (438)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=2.8e-23  Score=190.90  Aligned_cols=234  Identities=23%  Similarity=0.292  Sum_probs=152.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCC-----------CC-----ceeE
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH-----------PN-----LVKL  171 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-----------~n-----iv~~  171 (438)
                      +...+.||.|+++.||.+.+. +|+.+|||......   ....+++++|.-....+.+           .-     ++++
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345688999999999999987 58999999874332   2345677777655555432           11     1121


Q ss_pred             ee---eeeccC--c-----eEEEEEeccCCCCHHHHhhc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013686          172 YG---CTSRQS--R-----ELLLVYEYIPNGTVADHLHN---RQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVK  238 (438)
Q Consensus       172 ~~---~~~~~~--~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlk  238 (438)
                      -+   ++....  .     +.+++|+-+ -++|.+++..   .......+....++.+..|+++.+++||+.|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            11   111110  1     346788887 5688888653   22211124455567788999999999999999999999


Q ss_pred             CCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCcccccc--------CCCCChhhHHHHHHHHHHHHhCCC
Q 013686          239 SNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC--------YKLTDKSDVYSFGVVLIELISGLE  310 (438)
Q Consensus       239 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dvws~Gv~l~el~tG~~  310 (438)
                      |+|++++.+|.++|+||+.....+.....    ...+..|.+||....        -.++.+.|.|++|+++|.|.+|..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999988765443222    234578999997743        257889999999999999999999


Q ss_pred             CcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCC
Q 013686          311 AVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR  374 (438)
Q Consensus       311 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  374 (438)
                      ||...........                       ....+. ++++.++.||..+|+.||++|
T Consensus       249 Pf~~~~~~~~~~~-----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW-----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG-----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc-----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9986543322211                       011122 678889999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=2.3e-22  Score=175.75  Aligned_cols=186  Identities=16%  Similarity=0.115  Sum_probs=139.5

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccchH----hHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEec
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK----RIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      +...|++|+||+||.+.. ++..++.+.+.....-    ....+.+|+++|++|. |+++.+++++     ...+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEee
Confidence            467899999999997765 6788887777654331    1235789999999995 5889999874     236899999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDV-KSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dl-kp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      +.|.+|...+..          . ...++.|++.+|.++|++||+|||| ||.|||++.++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321          1 1357789999999999999999999 799999999999999999999865433210


Q ss_pred             ----c--------ccCCCCCCCccCccccccC-CCC-ChhhHHHHHHHHHHHHhCCCCcccCC
Q 013686          268 ----V--------STAPQGTPGYVDPDYFQCY-KLT-DKSDVYSFGVVLIELISGLEAVDTSR  316 (438)
Q Consensus       268 ----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~Dvws~Gv~l~el~tG~~p~~~~~  316 (438)
                          .        ..-...++.|+.|+...-. ..+ ...+.++-|..+|.++|+..++....
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0        0011267788888754322 233 46788899999999999998876543

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.6e-21  Score=173.62  Aligned_cols=136  Identities=15%  Similarity=0.212  Sum_probs=105.5

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhC-----CCCCceeEeeeeeccC--ce-EEEE
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-----QHPNLVKLYGCTSRQS--RE-LLLV  185 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~--~~-~~lv  185 (438)
                      -.+.||+|+||.||.  +......+||++........+.+.+|+.+++.+     .||||++++|++..+.  +. +.+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            457899999999996  433333479988765444557799999999999     5799999999776653  23 3478


Q ss_pred             Eec--cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCEEecC----CCeEEEeeeCcc
Q 013686          186 YEY--IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL-AYLHASDVIHRDVKSNNILLDN----NFRVKVADFGLS  258 (438)
Q Consensus       186 ~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~ivH~Dlkp~Nill~~----~~~~kl~Dfgla  258 (438)
                      +||  +.+++|.+++.+..     +++.  ..++.|++.++ +|||+++|+||||||+|||++.    ++.++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  55799999996632     5554  35677888777 9999999999999999999974    347999995544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.6e-23  Score=201.08  Aligned_cols=225  Identities=26%  Similarity=0.309  Sum_probs=176.9

Q ss_pred             cccccCceEEEEEEE----cCCcEEEEEEeeccchHh--HHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEecc
Q 013686          117 QLGDGGFGAVYLGIL----RDGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .+|+|.||.|+++..    ..|..+|+|.+++.....  ......|-.++..++ ||.+|++.-++..+ ...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-GKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-cchhHhhhhc
Confidence            379999999998762    247889999886543221  124556888888886 99999988655544 4789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      .+|.|...+.....    +.+.....+...++-+++++|+.+++|||+|++||+++.+|++++.|||+++..-.....  
T Consensus        80 rgg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             ccchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99999998877654    666677777888999999999999999999999999999999999999999865433221  


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                         +||..|||||++.  ....+.|.||||++++||+||..||..           .....|...        .+     
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~--------~~-----  204 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA--------EL-----  204 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh--------cc-----
Confidence               7999999999998  567789999999999999999999975           111122110        11     


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCCCH
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRPTM  377 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RPs~  377 (438)
                      ..+..++....+++.+++..+|.+|--.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            1124567778899999999999999754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.5e-20  Score=195.66  Aligned_cols=197  Identities=23%  Similarity=0.321  Sum_probs=151.9

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC---CCCceeEeeeeeccCce
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ---HPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~  181 (438)
                      .+...+.|.+.+.||+|+||.||+|...+|+.||+|.=+....-+   |.-=.+++.+|+   -+.|..+..++.-.+ .
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~-~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN-A  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC-c
Confidence            444567788999999999999999998889999999866543321   111123333443   234444444332232 4


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec-------CCCeEEEee
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-------NNFRVKVAD  254 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~-------~~~~~kl~D  254 (438)
                      -++|+||.+.|+|.++++..+    .++|.....+..|++..+++||..+||||||||+|+||.       .+.-++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            589999999999999998544    389999999999999999999999999999999999993       234589999


Q ss_pred             eCcccccCCC-ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCC
Q 013686          255 FGLSRLFPTD-VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL  309 (438)
Q Consensus       255 fgla~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~  309 (438)
                      ||.+-.+.-- ........++|-.+-.+|...|..++.+.|.|.|+-+++-|+.|+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            9998644211 112334567889999999999999999999999999999999995

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=4.7e-20  Score=170.30  Aligned_cols=198  Identities=22%  Similarity=0.301  Sum_probs=141.6

Q ss_pred             CCCCceeEeeeeec--------------------------cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHH
Q 013686          164 QHPNLVKLYGCTSR--------------------------QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA  217 (438)
Q Consensus       164 ~h~niv~~~~~~~~--------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~  217 (438)
                      +|||||++.++|.+                          ++..+|+||...+ -+|..++..+.     .+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence            59999999875422                          2346899999884 59999998765     4566677788


Q ss_pred             HHHHHHHHHHHhCCccccCCCCCCEEec--CCC--eEEEeeeCcccccCC-----CccccccCCCCCCCccCccccccCC
Q 013686          218 IETAGALAYLHASDVIHRDVKSNNILLD--NNF--RVKVADFGLSRLFPT-----DVTHVSTAPQGTPGYVDPDYFQCYK  288 (438)
Q Consensus       218 ~~i~~~l~~LH~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfgla~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~  288 (438)
                      .|+++|+.|||++||.|||+|.+||||.  +++  .+.|+|||++-.-..     +.........|....||||+....+
T Consensus       348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999999999999999999993  443  578999998753221     1111122334788899999986532


Q ss_pred             ------CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHH
Q 013686          289 ------LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAEL  362 (438)
Q Consensus       289 ------~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  362 (438)
                            --.|+|.|+.|.+.||+++...||-.... ...+..     ..++..++.     +       +..+++.++++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r-----~Yqe~qLPa-----l-------p~~vpp~~rql  489 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTR-----TYQESQLPA-----L-------PSRVPPVARQL  489 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechh-----hhhhhhCCC-----C-------cccCChHHHHH
Confidence                  13489999999999999999999975221 111111     122222221     1       23466778999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHH
Q 013686          363 AFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       363 i~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +...|+.||.+|++..=....|.
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            99999999999999776665554

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.5e-20  Score=170.04  Aligned_cols=142  Identities=17%  Similarity=0.113  Sum_probs=110.7

Q ss_pred             cCCCCCCcccccCceEEEEEE--EcCCcEEEEEEeeccchH------------------------hHHHHHHHHHHHHhC
Q 013686          110 DNFNSSKQLGDGGFGAVYLGI--LRDGRIVAVKRLYENNFK------------------------RIEQFMNEVEILTKL  163 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  163 (438)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||+|.+......                        ....+.+|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357889999999999999998  457999999988643210                        012356899999999


Q ss_pred             CCC--CceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCC
Q 013686          164 QHP--NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-VIHRDVKSN  240 (438)
Q Consensus       164 ~h~--niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~Dlkp~  240 (438)
                      .+.  .+.+++++   .  ..++||||+++++|...+....    .+.......++.|++.++.+||+.| ++||||||+
T Consensus       108 ~~~~i~~p~~~~~---~--~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW---R--RNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe---c--CceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence            753  33444432   2  3489999999988876653322    1555667889999999999999999 999999999


Q ss_pred             CEEecCCCeEEEeeeCccccc
Q 013686          241 NILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       241 Nill~~~~~~kl~Dfgla~~~  261 (438)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=3.7e-21  Score=184.42  Aligned_cols=173  Identities=24%  Similarity=0.374  Sum_probs=132.1

Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+||.|++|...+|.+||..+.. ....++...+.++.|++.|++|   ++.+|+|+||.||+...+..+||.|||+...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            57899999999999999986543 3347788889999999999999   9999999999999999999999999999987


Q ss_pred             cCCCc-----cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhC-CCCcccCCcccccchhHHHHHHHhcC
Q 013686          261 FPTDV-----THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG-LEAVDTSRHRHDINLSNMATNKIQNG  334 (438)
Q Consensus       261 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (438)
                      .....     ....+...||..||+||.+.+..|+.++||||||++|+||++- ..+++.          .-+...++.+
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r~g  475 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIRDG  475 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhhcC
Confidence            65544     2233455699999999999999999999999999999999872 222221          1112233333


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE  379 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  379 (438)
                      .++..+           ..+++. -..|+.+++.+.|.+||++.+
T Consensus       476 ~ip~~~-----------~~d~p~-e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  476 IIPPEF-----------LQDYPE-EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             CCChHH-----------hhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence            333111           112222 247899999999999994443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.4e-19  Score=159.89  Aligned_cols=144  Identities=20%  Similarity=0.140  Sum_probs=111.7

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch--H--------------------hHHHHHHHHHHHH
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--K--------------------RIEQFMNEVEILT  161 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~--------------------~~~~~~~E~~~l~  161 (438)
                      ++......|.+.+.||+|+||.||++...+|+.||||++.....  .                    ....+.+|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            33444445788899999999999999988899999998654320  0                    0123677899999


Q ss_pred             hCCCCC--ceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013686          162 KLQHPN--LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKS  239 (438)
Q Consensus       162 ~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp  239 (438)
                      .+.|++  +...++.     ...++||||++|++|......          .....++.+++.++.++|+.|++||||||
T Consensus        89 ~l~~~~i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p  153 (198)
T cd05144          89 ALYEEGFPVPKPIDW-----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHGIIHGDLSE  153 (198)
T ss_pred             HHHHcCCCCCceeec-----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCc
Confidence            998774  4444431     245899999999998765421          22457889999999999999999999999


Q ss_pred             CCEEecCCCeEEEeeeCcccccC
Q 013686          240 NNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       240 ~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      +||++++++.++|+|||++....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.7e-19  Score=161.28  Aligned_cols=134  Identities=22%  Similarity=0.372  Sum_probs=109.7

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccch--------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      +.||+|++|.||+|.. +|..+++|.......        .....+.+|++++..+.|+++.....++... ...+++||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEEEE
Confidence            5799999999999987 678899997653321        1124678899999999998876655544333 35789999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      |++|++|.+++....       + .+..++.+++.+|.+||+.+++|||++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999986531       2 7788999999999999999999999999999999 78899999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=3.7e-19  Score=158.86  Aligned_cols=131  Identities=21%  Similarity=0.345  Sum_probs=103.6

Q ss_pred             cccccCceEEEEEEEcCCcEEEEEEeeccch--------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNF--------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .||+|+||.||+|.. +|..+++|.......        ...+.+.+|++++..+.|+++.....++... ...++||||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEEE
Confidence            489999999999986 578899998643211        1235678899999999887644333222222 356899999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      ++|++|.+++....     .      .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999999875431     1      7889999999999999999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.80  E-value=6.5e-20  Score=187.71  Aligned_cols=207  Identities=27%  Similarity=0.438  Sum_probs=145.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..+|..++.|..|+||.||++.++. .+.+|+| +.+++.           ++     +||+.+-+       +.+.|  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----------il-----Rnilt~a~-------npfvv--  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----------IL-----RNILTFAG-------NPFVV--  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----------hh-----hccccccC-------Cccee--
Confidence            3578889999999999999999873 6778884 433321           11     12333322       22333  


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc-
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-  266 (438)
                          |+-...+...+.    ++.        +++.+++|||+.||+|||+||+|.+|+.-|++|++|||+.+..-.... 
T Consensus       136 ----gDc~tllk~~g~----lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGP----LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcccCCC----Ccc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                444444444332    332        227889999999999999999999999999999999999874321110 


Q ss_pred             -------------ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          267 -------------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       267 -------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                                   -.....+||+.|+|||++....|....|.|++|+|+||.+.|+.||.+..+++-.      ...+..
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISD  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhh
Confidence                         0123357999999999999999999999999999999999999999876554221      111111


Q ss_pred             -CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC
Q 013686          334 -GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP  375 (438)
Q Consensus       334 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  375 (438)
                       ..+.+- |           ...+.+.++++.+.|+.+|..|-
T Consensus       274 ~i~wpE~-d-----------ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 DIEWPEE-D-----------EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hcccccc-C-----------cCCCHHHHHHHHHHHHhChHhhc
Confidence             111111 1           23456788999999999999994

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.2e-18  Score=178.29  Aligned_cols=137  Identities=19%  Similarity=0.270  Sum_probs=108.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--ch------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NF------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      ...|...+.||+|+||+||+|.+.+. .+++|+....  ..      ...+.+.+|+++++.++|++++....+.... .
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-E  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-C
Confidence            34456789999999999999987543 4444432211  11      1235688999999999999988766544443 3


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+++++|.+++.            ....++.+++++|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            5789999999999999885            235789999999999999999999999999999 677899999999975

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=1.7e-17  Score=151.74  Aligned_cols=136  Identities=18%  Similarity=0.232  Sum_probs=105.2

Q ss_pred             CCccc-ccCceEEEEEEEcCCcEEEEEEeeccch-------------HhHHHHHHHHHHHHhCCCCCc--eeEeeeeecc
Q 013686          115 SKQLG-DGGFGAVYLGILRDGRIVAVKRLYENNF-------------KRIEQFMNEVEILTKLQHPNL--VKLYGCTSRQ  178 (438)
Q Consensus       115 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~  178 (438)
                      ...|| .|+.|+||++... +..++||.+.....             .....+.+|++++.+|.|+++  ...+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8999999999874 77899998754211             123467889999999988774  5666643333


Q ss_pred             Cce---EEEEEeccCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          179 SRE---LLLVYEYIPN-GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       179 ~~~---~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                      ...   .++|||+++| .+|.+++....     ++..    .+.+|+.+|.+||+.||+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            222   3599999997 69999886532     4443    357899999999999999999999999999999999999


Q ss_pred             eCcccc
Q 013686          255 FGLSRL  260 (438)
Q Consensus       255 fgla~~  260 (438)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=1.8e-17  Score=146.41  Aligned_cols=135  Identities=22%  Similarity=0.255  Sum_probs=97.8

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchH--hHHH----------------------HHHHHHHHHhCCCC--Cc
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK--RIEQ----------------------FMNEVEILTKLQHP--NL  168 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni  168 (438)
                      .+.||+|+||.||+|...+|+.||||++......  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5689999999999999878999999987653211  1111                      13566666666433  24


Q ss_pred             eeEeeeeeccCceEEEEEeccCCCCHHHH-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecC
Q 013686          169 VKLYGCTSRQSRELLLVYEYIPNGTVADH-LHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDN  246 (438)
Q Consensus       169 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~  246 (438)
                      .+.+++     ...++||||++++++... +....     .. .....++.+++.++.++|. .+|+||||||+||+++ 
T Consensus        82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec-----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence            444432     135899999998543321 11111     11 4567899999999999999 9999999999999999 


Q ss_pred             CCeEEEeeeCccccc
Q 013686          247 NFRVKVADFGLSRLF  261 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~  261 (438)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=2.9e-16  Score=133.03  Aligned_cols=132  Identities=25%  Similarity=0.202  Sum_probs=109.1

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC--CCceeEeeeeeccCceEEEEEeccCC
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH--PNLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  .++.+++++.... +..+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecCC
Confidence            45789999999999999854 7899998765433  4578889999999976  5888888755444 468999999988


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      +.+..+           +......++.++++++.+||..   +++|+|++|+||++++++.++++|||.+..
T Consensus        78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777654           3445567889999999999985   699999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=2.3e-18  Score=175.95  Aligned_cols=255  Identities=23%  Similarity=0.325  Sum_probs=188.5

Q ss_pred             CCCCCCcccccCceEEEEEEEcC--CcEEEEEEeeccc--hHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRD--GRIVAVKRLYENN--FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .|.+.+.||+|+|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++.+++... .....+++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-~~~~~~~~   99 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-SPRSYLLS   99 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-CCcccccc
Confidence            35556779999999999887643  4556677664432  223344556888888886 999999999554 44578999


Q ss_pred             EeccCCCCHHHHhh-ccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCEEecCCC-eEEEeeeCcccccC
Q 013686          186 YEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLH-ASDVIHRDVKSNNILLDNNF-RVKVADFGLSRLFP  262 (438)
Q Consensus       186 ~e~~~~g~L~~~l~-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~  262 (438)
                      ++|..++++.+.+. ....   ..+......++.|+..++.|+| ..++.|+||||+|.+++.++ ..+++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999883 3221   2566667788999999999999 99999999999999999999 99999999999765


Q ss_pred             C--CccccccCCCC-CCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          263 T--DVTHVSTAPQG-TPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       263 ~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      .  .........+| ++.|+|||.+.+. -..+..|+||.|+++.-+++|..|++........ ...|....   +.   
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~---  249 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GR---  249 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---cc---
Confidence            5  33344445668 9999999999885 4466789999999999999999998865443311 11111111   00   


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                              .....+........+++.+++..+|..|.+.+++...-
T Consensus       250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~  287 (601)
T KOG0590|consen  250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN  287 (601)
T ss_pred             --------cccCccccCChhhhhcccccccCCchhccccccccccc
Confidence                    00112234555677889999999999999998886543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.65  E-value=1.3e-15  Score=151.02  Aligned_cols=146  Identities=23%  Similarity=0.254  Sum_probs=105.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHH--------------------------------------
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE--------------------------------------  151 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--------------------------------------  151 (438)
                      ..|. .+.||.|++|.||+|++++|+.||||+.++......+                                      
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3344 3689999999999999999999999998654211100                                      


Q ss_pred             --HHHHHHHHHHhC----CCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH-HH
Q 013686          152 --QFMNEVEILTKL----QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG-AL  224 (438)
Q Consensus       152 --~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l  224 (438)
                        +|.+|++.+.++    +|.+-+.+-.++..-....++||||++|++|.++.......   ..   ...++.+++. .+
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---LD---RKALAENLARSFL  270 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---CC---HHHHHHHHHHHHH
Confidence              244566655554    34344444444433334579999999999999887543211   22   3456666666 47


Q ss_pred             HHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       225 ~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ..+|..|++|+|++|.||+++.+++++++|||++..+.
T Consensus       271 ~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            88999999999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=2e-15  Score=147.89  Aligned_cols=249  Identities=22%  Similarity=0.247  Sum_probs=183.2

Q ss_pred             hcCCCCCCcccc--cCceEEEEEEE--c-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGD--GGFGAVYLGIL--R-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  180 (438)
                      ...|.+.+.+|.  |.+|.||.+..  + ++..+|+|+-+....  .....-.+|+...++++ |+|.++.+..+. ..+
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e-~~~  191 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE-GSG  191 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc-cCC
Confidence            345677889999  99999999987  3 588899997433211  22223345777777774 999999777454 445


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCCEEecCC-CeEEEeee
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNN-FRVKVADF  255 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Df  255 (438)
                      ..++-+|+| +.+|..+.+.....   ++....+..+.+..+    ||.++|..+++|-|+||.||+...+ ...+++||
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~~~---~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPCNF---LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cceeeeccc-cchhHHhhhccccc---CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            789999999 67998888876542   777888888888888    9999999999999999999999999 78999999


Q ss_pred             CcccccCCCccc----cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          256 GLSRLFPTDVTH----VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       256 gla~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      |+...+......    ......+...|++||.+++ -++...|+|++|.++.+..+|..+....-.      ..|  ..+
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W--~~~  338 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSW--SQL  338 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCc--ccc
Confidence            999877654321    1122357889999999865 678899999999999999998765543210      000  111


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE  382 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  382 (438)
                      ....           .........+.++...+..+++.+|..|++.+.+..
T Consensus       339 r~~~-----------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 RQGY-----------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccc-----------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1110           111122334455666899999999999999988876

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.59  E-value=1.2e-13  Score=138.76  Aligned_cols=148  Identities=22%  Similarity=0.245  Sum_probs=98.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHh----------------------------------HH
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR----------------------------------IE  151 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~  151 (438)
                      .....|.. +.||.|++|.||+|.+++ |+.||||++.+.-...                                  .+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34456776 899999999999999987 9999999987542110                                  01


Q ss_pred             ------HHHHHHHHHHhC----CCCCceeEeeeeeccCceEEEEEeccCCCCHHHHh--hccCCCCCCCCHHHHHHHHHH
Q 013686          152 ------QFMNEVEILTKL----QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIE  219 (438)
Q Consensus       152 ------~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~~  219 (438)
                            ++.+|+.-+.++    .+.+.+.+-.++.+-....+|||||++|+.+.++-  ...+.+...+.......++  
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~--  273 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF--  273 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH--
Confidence                  134455444444    24444554444444344678999999999998753  2222110012222222233  


Q ss_pred             HHHHHHHHHhCCccccCCCCCCEEecCCC----eEEEeeeCcccccC
Q 013686          220 TAGALAYLHASDVIHRDVKSNNILLDNNF----RVKVADFGLSRLFP  262 (438)
Q Consensus       220 i~~~l~~LH~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgla~~~~  262 (438)
                           .-+...|++|+|+||.||+++.++    +++++|||++..++
T Consensus       274 -----~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 -----TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 334568999999999999999888    99999999987653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=2.7e-14  Score=129.61  Aligned_cols=204  Identities=21%  Similarity=0.347  Sum_probs=140.6

Q ss_pred             HHHHhCCCCCceeEeeeeecc----CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 013686          158 EILTKLQHPNLVKLYGCTSRQ----SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS--D  231 (438)
Q Consensus       158 ~~l~~l~h~niv~~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~  231 (438)
                      .-|-.+.|.|||++..++.+.    .....++.|||..|+|..+|++.+.....+......+|+.||+.||.|||+.  -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            344456799999998865432    2357899999999999999998877777788888999999999999999987  6


Q ss_pred             ccccCCCCCCEEecCCCeEEEeeeCcccccC---CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhC
Q 013686          232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFP---TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG  308 (438)
Q Consensus       232 ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG  308 (438)
                      |+|+++..+-|++..+|-+||+--.....-.   ...........+-++|.+||.=.....+.++|||+||.+..||..|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999988875221111100   0000011123467899999987666778899999999999999887


Q ss_pred             CCC-cccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          309 LEA-VDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       309 ~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ..- -.......       ....+..-    ++    +.+.+        .=+.++.+|++..|..||+|++++.+.
T Consensus       279 Eiq~tnseS~~~-------~ee~ia~~----i~----~len~--------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSESKVE-------VEENIANV----II----GLENG--------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcceee-------hhhhhhhh----ee----eccCc--------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            532 22111100       00001000    00    00000        012468899999999999999998654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=1.3e-12  Score=129.55  Aligned_cols=163  Identities=20%  Similarity=0.232  Sum_probs=123.9

Q ss_pred             CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHH
Q 013686          133 DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPV  212 (438)
Q Consensus       133 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~  212 (438)
                      ++.+|.|...+.......+...+-++.|+.++||||+++++.+..++ .+|||+|-+  ..|..++.+.       ....
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV--~Pl~~~lk~l-------~~~~  105 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERV--RPLETVLKEL-------GKEE  105 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeecc--ccHHHHHHHh-------HHHH
Confidence            68888888887665555566778899999999999999999666554 799999998  3777787763       3455


Q ss_pred             HHHHHHHHHHHHHHHH-hCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCC
Q 013686          213 RLSIAIETAGALAYLH-ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD  291 (438)
Q Consensus       213 ~~~i~~~i~~~l~~LH-~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  291 (438)
                      ...-+.||+.||.||| +.+++|++|.-..|+|+..|..||++|.++........ .......--.|..|+.+....  -
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence            5667789999999998 56899999999999999999999999998864322111 111111223456666554322  3


Q ss_pred             hhhHHHHHHHHHHHHhC
Q 013686          292 KSDVYSFGVVLIELISG  308 (438)
Q Consensus       292 ~~Dvws~Gv~l~el~tG  308 (438)
                      ..|.|-|||+++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            46999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.7e-13  Score=118.88  Aligned_cols=128  Identities=20%  Similarity=0.185  Sum_probs=95.5

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCce-eEeeeeeccCceEEEEEeccCCCC
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV-KLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      .+.|+.|.++.||++... ++.|++|....... ....+..|+.+++.+.+.+++ +++.+. ..  ..++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~--~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-PE--TGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-CC--CCeEEEEecCCCc
Confidence            457899999999999875 78899998754432 123457799999988655544 344432 22  3479999999988


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV-----IHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-----vH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      +.+.    .     ..   ...++.+++++|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~----~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE----D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc----c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            7643    0     11   12456789999999999885     9999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.44  E-value=9.7e-12  Score=116.92  Aligned_cols=270  Identities=17%  Similarity=0.189  Sum_probs=170.8

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEee------eeeccCceEEEEE
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYG------CTSRQSRELLLVY  186 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~------~~~~~~~~~~lv~  186 (438)
                      .++.||+|+-+.+|-.-.- +.. +.|+..........+   .+..|... .||-+-.-+.      +....+....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4678999999999965321 222 346554443322222   23344444 4554332111      1112233467888


Q ss_pred             eccCCC-CHHHHhhc--cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          187 EYIPNG-TVADHLHN--RQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g-~L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      ..+.+. ....++.-  ++.......|...++.++.++.+.+.||..|.+-||++++|+|+.+++.|.|.|-......  
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~--  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN--  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec--
Confidence            888764 22233221  1122234789999999999999999999999999999999999999999999986554433  


Q ss_pred             CccccccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhC-CCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISG-LEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      .........+|...|.+||.-.     +..-+...|.|.|||++++++.| ++||.+.....+..-.  ....|..+.+.
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p--~E~~Ia~g~f~  245 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP--LETDIAHGRFA  245 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc--chhhhhcceee
Confidence            2233345567999999999654     34556789999999999998876 8999865432221110  01122222222


Q ss_pred             ccccC---cCCCCccHHHHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHhhhccCC
Q 013686          338 ELVDP---SLGFEKDYAVRNMVTSVAELAFRCVQQD--RDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       338 ~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~~~  392 (438)
                      ...+.   ..+.+....+.-+++.+.-|..+|+...  +.-|||++.++..|..+.++-.
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            11111   1112223334567788889999999874  5689999999998877765443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=2.2e-12  Score=112.91  Aligned_cols=136  Identities=15%  Similarity=0.106  Sum_probs=96.6

Q ss_pred             CCcccccCceEEEEEEEcC-------CcEEEEEEeeccc------h----------------HhHHHHH----HHHHHHH
Q 013686          115 SKQLGDGGFGAVYLGILRD-------GRIVAVKRLYENN------F----------------KRIEQFM----NEVEILT  161 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------~----------------~~~~~~~----~E~~~l~  161 (438)
                      ...||.|--+.||.|...+       +..+|||..+...      .                ...+.+.    +|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998553       4799999753210      0                0112233    7999999


Q ss_pred             hCCC--CCceeEeeeeeccCceEEEEEeccCCCCHHH-HhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCC
Q 013686          162 KLQH--PNLVKLYGCTSRQSRELLLVYEYIPNGTVAD-HLHNRQPNSCLLPWPVRLSIAIETAGALAYL-HASDVIHRDV  237 (438)
Q Consensus       162 ~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~ivH~Dl  237 (438)
                      ++..  -++-..+++     ...+|||||+.+..+.. .+...     .++......+..+++.+|..| |+.|+|||||
T Consensus        82 rl~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECNLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            8842  455555542     23589999996643322 22221     145556677889999999999 8999999999


Q ss_pred             CCCCEEecCCCeEEEeeeCccccc
Q 013686          238 KSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       238 kp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      ++.|||+++ +.+.|+|||.+...
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeC
Confidence            999999974 67999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=2.4e-13  Score=133.40  Aligned_cols=250  Identities=23%  Similarity=0.274  Sum_probs=177.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc--CCcEEEEEEeeccchHhHHH--HHHHHHHHHhC-CCCCceeEeeeeeccCceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR--DGRIVAVKRLYENNFKRIEQ--FMNEVEILTKL-QHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  182 (438)
                      ...+|..+..||.|.|+.|++...+  ++..|++|.+........++  -..|+.+...+ .|.+++.++..+... +..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-RQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-ccc
Confidence            4567889999999999999998754  57899999886654333222  24577777766 488888877644433 356


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCccccc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRLF  261 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~~  261 (438)
                      |+-.|||+++++...+....    .+.+..++.+..|++.++.++|++.++|+|+||+||++..+ +.-++.|||+...+
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~----~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQ----MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhhHHHH----hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence            79999999998887763322    27777889999999999999999999999999999999886 78899999998642


Q ss_pred             CCCccccccCCCCCCCc-cCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          262 PTDVTHVSTAPQGTPGY-VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      .-..   ......+..| .+++......+..+.|+|+||..+.|.++|...-+....          +..+..+...   
T Consensus       418 ~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p---  481 (524)
T KOG0601|consen  418 AFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTP---  481 (524)
T ss_pred             ceec---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeeccccc---
Confidence            1111   1111233334 356666777889999999999999999998643322111          1111122111   


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                        ..        .+....+..+...+..+++..||.+.++..+.+...
T Consensus       482 --~~--------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  482 --NL--------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             --CC--------CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence              11        122245677888999999999999998887665443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2e-11  Score=103.40  Aligned_cols=129  Identities=25%  Similarity=0.377  Sum_probs=95.6

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeecc--chH------hHHHHHHHHHHHHhCCC--CCceeEeeeeeccCceEEEE
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFK------RIEQFMNEVEILTKLQH--PNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~------~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~lv  185 (438)
                      ..+++|+-+.+|.+.+. |..+++|.=.++  ...      ..+.-.+|+.++.+++-  -+...++++.   .....|+
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD---~~~~~I~   77 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD---PDNGLIV   77 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc---CCCCEEE
Confidence            46889999999999775 455777743221  111      12456789999998853  2333344422   2346799


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      |||++|..|.+.+....           ..++..|-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus        78 me~I~G~~lkd~l~~~~-----------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          78 MEYIEGELLKDALEEAR-----------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEeCChhHHHHHHhcc-----------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999998987651           35677777888899999999999999999998775 99999999975

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.32  E-value=1.1e-10  Score=112.61  Aligned_cols=219  Identities=20%  Similarity=0.279  Sum_probs=152.7

Q ss_pred             CceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeee---ccCceEEEEEeccCC-CCHHH
Q 013686          122 GFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS---RQSRELLLVYEYIPN-GTVAD  196 (438)
Q Consensus       122 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---~~~~~~~lv~e~~~~-g~L~~  196 (438)
                      ...+.|++... ||..|++|++.............-++.++++.|+|+|++.+++.   -.+..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            45688999854 89999999995443333333445688999999999999988553   234579999999876 57777


Q ss_pred             HhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          197 HLHNRQP-----------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       197 ~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      .--....           .....++...|.++.|+..||.++|+.|+.-+-|.+.+|+++.+.+++|..-|.......+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            6543222           12347789999999999999999999999999999999999999999998888776654432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .               |.+.   --.+-|.=.||.+++.|.||..--......     .....                 
T Consensus       448 ~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-----~~s~~-----------------  487 (655)
T KOG3741|consen  448 T---------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDST-----QSSHL-----------------  487 (655)
T ss_pred             C---------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccch-----HHHHH-----------------
Confidence            0               1111   123678999999999999995321110000     00000                 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         ......++.++++++.-....++++ -+..+++.++
T Consensus       488 ---~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  488 ---TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ---HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence               0112456677777888888777776 5666666543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=1.5e-11  Score=111.34  Aligned_cols=140  Identities=24%  Similarity=0.295  Sum_probs=104.2

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCC--CceeEeeeeeccC--ceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHP--NLVKLYGCTSRQS--RELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~--~~~~lv~e~~~  190 (438)
                      +.|+.|.++.||++...+|+.+++|....... .....+.+|+++++.+.+.  ++.+++.+.....  +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987678999998754332 1345688899999999753  4566666443321  25689999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-----------------------------------------  229 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----------------------------------------  229 (438)
                      |.++.+.+.. .    .++......++.+++++|.+||+                                         
T Consensus        84 G~~l~~~~~~-~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-P----ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-C----CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776532 1    15666666777777777777773                                         


Q ss_pred             ---------------CCccccCCCCCCEEecC--CCeEEEeeeCcccc
Q 013686          230 ---------------SDVIHRDVKSNNILLDN--NFRVKVADFGLSRL  260 (438)
Q Consensus       230 ---------------~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~  260 (438)
                                     ..++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           23689999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.31  E-value=3e-11  Score=101.77  Aligned_cols=141  Identities=22%  Similarity=0.277  Sum_probs=101.5

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccc--hH------hHHHHHHHHHHHHhCCCCCc--eeEeeeeeccCceEE
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENN--FK------RIEQFMNEVEILTKLQHPNL--VKLYGCTSRQSRELL  183 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~------~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~  183 (438)
                      ....|-+|+-+.|+++.+. |+...||.=....  ..      ...+..+|+++|.++.--.|  ..++  +.+. ..-.
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~--~~D~-~~~~   86 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI--FIDT-YGGQ   86 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE--EEec-CCCe
Confidence            4678999999999999884 7887888532221  11      13567889999998853222  2233  2222 2347


Q ss_pred             EEEeccCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---eEEEeeeCccc
Q 013686          184 LVYEYIPN-GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---RVKVADFGLSR  259 (438)
Q Consensus       184 lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---~~kl~Dfgla~  259 (438)
                      |+|||++| .++.+++.......  ........++.+|-+.+.-||..+|+||||..+||++..++   .+.++|||++.
T Consensus        87 i~ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   87 IYMEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEEEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            99999976 48888887765432  23333368889999999999999999999999999996554   46899999986


Q ss_pred             c
Q 013686          260 L  260 (438)
Q Consensus       260 ~  260 (438)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.28  E-value=2.5e-12  Score=132.89  Aligned_cols=247  Identities=22%  Similarity=0.268  Sum_probs=164.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      +.|.+.+.+-+|.++.++.+.-. .|...+.|.......   .+.+....+-.++-...+|-++...-- .......+++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-FPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-CCCCCCcchh
Confidence            45556677888999998887643 344445554322111   111222222223222344555544332 1234568999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC--
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT--  263 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~--  263 (438)
                      ++|..+++|...|+....    .+.+........+..+++|||...+.|+|++|.|.+...++..++.|||.....+.  
T Consensus       883 ~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            999999999999988763    44444455667788999999999999999999999999999999999984332110  


Q ss_pred             ---Cc-------------------------cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccC
Q 013686          264 ---DV-------------------------THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS  315 (438)
Q Consensus       264 ---~~-------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~  315 (438)
                         +.                         ........+|+.|.+||.+.+......+|.|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence               00                         00112345899999999999999999999999999999999999999866


Q ss_pred             CcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHH
Q 013686          316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMK  378 (438)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  378 (438)
                      .+....       ..+..+.....          .-....+....+++.+.+..+|.+|-.+.
T Consensus      1039 tpq~~f-------~ni~~~~~~~p----------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF-------ENILNRDIPWP----------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhh-------hccccCCCCCC----------CCccccChhhhhhhhhhhccCchhccCcc
Confidence            543211       11111111110          11123455678899999999999997765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.23  E-value=3.6e-10  Score=104.54  Aligned_cols=142  Identities=14%  Similarity=0.124  Sum_probs=98.9

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccchHh-H----------HHHHHHHHHHHhCCCC--CceeEeeeeecc----
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR-I----------EQFMNEVEILTKLQHP--NLVKLYGCTSRQ----  178 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~--niv~~~~~~~~~----  178 (438)
                      +.+-......|+++.. +|+.|.||+........ .          ..+.+|...+.+|..-  .....+++....    
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444455777766 57899999775443221 1          1377899988887322  222333322221    


Q ss_pred             CceEEEEEeccCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-------CCeE
Q 013686          179 SRELLLVYEYIPNG-TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-------NFRV  250 (438)
Q Consensus       179 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-------~~~~  250 (438)
                      ...-++|||++++. +|.+++......  ..+...+..++.+++..+.-||..||+|+|+++.|||++.       ++.+
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~--~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATN--PPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceE
Confidence            23468999999876 899998643211  2456677889999999999999999999999999999975       4689


Q ss_pred             EEeeeCcccc
Q 013686          251 KVADFGLSRL  260 (438)
Q Consensus       251 kl~Dfgla~~  260 (438)
                      .++||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=2.7e-10  Score=99.43  Aligned_cols=125  Identities=28%  Similarity=0.317  Sum_probs=81.9

Q ss_pred             EEEEEEEcCCcEEEEEEeeccc--hH------------------------hHHHHHHHHHHHHhCCCC--CceeEeeeee
Q 013686          125 AVYLGILRDGRIVAVKRLYENN--FK------------------------RIEQFMNEVEILTKLQHP--NLVKLYGCTS  176 (438)
Q Consensus       125 ~V~~~~~~~~~~vavK~~~~~~--~~------------------------~~~~~~~E~~~l~~l~h~--niv~~~~~~~  176 (438)
                      .||.|...+|..+|||..+...  .+                        ......+|.+.|.++..-  ++-+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999764210  00                        013467899999999755  455555422 


Q ss_pred             ccCceEEEEEeccC--CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCCEEecCCCeEEEe
Q 013686          177 RQSRELLLVYEYIP--NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY-LHASDVIHRDVKSNNILLDNNFRVKVA  253 (438)
Q Consensus       177 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~ivH~Dlkp~Nill~~~~~~kl~  253 (438)
                          ..+|||||++  |..+..+....      ++......++.+++..+.. +|..||+||||.+.|||++++ .+.|+
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence                2379999998  55554433322      1123345677888886555 579999999999999999988 89999


Q ss_pred             eeCccccc
Q 013686          254 DFGLSRLF  261 (438)
Q Consensus       254 Dfgla~~~  261 (438)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.06  E-value=1.3e-09  Score=97.96  Aligned_cols=134  Identities=21%  Similarity=0.133  Sum_probs=98.8

Q ss_pred             CCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch----------------------HhHHHHHHHHHHHHhCCCC--C
Q 013686          112 FNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF----------------------KRIEQFMNEVEILTKLQHP--N  167 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n  167 (438)
                      ..++..||-|--+.||.|...+|.++|||.-.....                      -......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456789999999999999999999999995432110                      0123457899999998643  5


Q ss_pred             ceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC
Q 013686          168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN  247 (438)
Q Consensus       168 iv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~  247 (438)
                      +-+.++     .+...+||||++|-.|...--         .....-.++..|++-+..+-..||||+|+.+-||+++++
T Consensus       173 VP~P~~-----~nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIA-----WNRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCccc-----cccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC
Confidence            555554     124589999998866654321         122334566667777776668999999999999999999


Q ss_pred             CeEEEeeeCccc
Q 013686          248 FRVKVADFGLSR  259 (438)
Q Consensus       248 ~~~kl~Dfgla~  259 (438)
                      |.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999997654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=6.2e-09  Score=93.16  Aligned_cols=124  Identities=24%  Similarity=0.269  Sum_probs=87.8

Q ss_pred             CcEEEEEEeeccch-------HhHHHHHHHHHHHHhCCC--CCceeEeeeeecc---CceEEEEEeccCCC-CHHHHhhc
Q 013686          134 GRIVAVKRLYENNF-------KRIEQFMNEVEILTKLQH--PNLVKLYGCTSRQ---SRELLLVYEYIPNG-TVADHLHN  200 (438)
Q Consensus       134 ~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~~lv~e~~~~g-~L~~~l~~  200 (438)
                      ++.+.+|.......       -......+|...+..|..  =.+.+.+++....   ....++|+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            56666765432111       122457778888777732  2223333333221   13458999999874 89999987


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---eEEEeeeCccccc
Q 013686          201 RQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---RVKVADFGLSRLF  261 (438)
Q Consensus       201 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---~~kl~Dfgla~~~  261 (438)
                      ...    .+......++.+++..+.-||+.||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       112 ~~~----~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  112 WEQ----LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hcc----cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            433    45566788999999999999999999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=1.1e-10  Score=116.38  Aligned_cols=149  Identities=22%  Similarity=0.292  Sum_probs=105.9

Q ss_pred             HHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc--------cccCCCCCCCccCccccccCC
Q 013686          218 IETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH--------VSTAPQGTPGYVDPDYFQCYK  288 (438)
Q Consensus       218 ~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~  288 (438)
                      .+++.|+.|+|+. ++||++|.|++|.++.++.+||+.|+++.........        ..........|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            4455999999976 9999999999999999999999999998754331110        111123567899999999988


Q ss_pred             CCChhhHHHHHHHHHHHH-hCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhh
Q 013686          289 LTDKSDVYSFGVVLIELI-SGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCV  367 (438)
Q Consensus       289 ~~~~~Dvws~Gv~l~el~-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  367 (438)
                      .+.++|+||+||++|.+. .|+.-+............   ...   .....          .....+++.++++=+.+++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---~~~---~~~~~----------~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---RNL---LNAGA----------FGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---hcc---ccccc----------ccccccCcHHHHHHHHHHh
Confidence            899999999999999999 566655543322111100   000   00000          0011457788999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 013686          368 QQDRDMRPTMKEVLE  382 (438)
Q Consensus       368 ~~dP~~RPs~~evl~  382 (438)
                      ..++..||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.93  E-value=4.6e-09  Score=105.18  Aligned_cols=150  Identities=20%  Similarity=0.243  Sum_probs=100.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhH------------------------------H-----
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI------------------------------E-----  151 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~-----  151 (438)
                      .....|. .+.|+.++-|.||+|++++|+.||||+.++.-...+                              +     
T Consensus       123 e~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~  201 (517)
T COG0661         123 ELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR  201 (517)
T ss_pred             HHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence            3344454 378999999999999999999999998765422110                              1     


Q ss_pred             -----HHHHHHHHHHhC----CCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH
Q 013686          152 -----QFMNEVEILTKL----QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG  222 (438)
Q Consensus       152 -----~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~  222 (438)
                           ++.+|..-+.++    ++..-+.+-.++++-...-.|+|||++|-.+.+........   ++.   ..++..+++
T Consensus       202 l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~---k~ia~~~~~  275 (517)
T COG0661         202 LREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDR---KELAELLVR  275 (517)
T ss_pred             HHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCH---HHHHHHHHH
Confidence                 133455545444    22223333334444334568999999999998884332211   442   234444444


Q ss_pred             H-HHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          223 A-LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       223 ~-l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      + +..+-..|++|.|..|.||+++.+|++.+.|||+...++.
T Consensus       276 ~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         276 AFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            3 3444458999999999999999999999999999876654

>PRK09902 hypothetical protein; Provisional

Probab=98.91  E-value=4.9e-08  Score=85.84  Aligned_cols=139  Identities=19%  Similarity=0.162  Sum_probs=101.1

Q ss_pred             ccccCceEEEEEEEcCCcEEEEEEeecc---c---hHhHHHHHHHHHHHHhCCC--CCceeEeeeeec----cCceEEEE
Q 013686          118 LGDGGFGAVYLGILRDGRIVAVKRLYEN---N---FKRIEQFMNEVEILTKLQH--PNLVKLYGCTSR----QSRELLLV  185 (438)
Q Consensus       118 lg~G~~g~V~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~----~~~~~~lv  185 (438)
                      -|+||.+-|+..... |+.+-+|+-...   .   ......|.+|+..+.+|..  -.+.+.+ ++..    ..-.-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            477899999998774 567888875311   0   1234679999999998853  2233333 2211    11236799


Q ss_pred             EeccCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe--EEEeeeCcccc
Q 013686          186 YEYIPN-GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR--VKVADFGLSRL  260 (438)
Q Consensus       186 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfgla~~  260 (438)
                      +|-++| -+|.+++.+....  ..+...+..+..+|+..+.-||+.|+.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998754 5899988664322  2567778899999999999999999999999999999986666  99999986653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=1.3e-07  Score=83.45  Aligned_cols=138  Identities=21%  Similarity=0.253  Sum_probs=91.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHH---------HHHHHHHHHhCC---CCCceeEeeee
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ---------FMNEVEILTKLQ---HPNLVKLYGCT  175 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~~~~~~  175 (438)
                      ...+|...+.+-......|.+... +|+.+++|..........+.         ..+++..+.++.   -.....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346777778888877777777766 57899999886553322222         223444444442   22222322211


Q ss_pred             e----ccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          176 S----RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       176 ~----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                      .    .-....+++|||++|..|.++..        ++.    .++..+.+++.-||+.|++|+|..|.|+++++++ ++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EE
Confidence            1    11235678999999988876642        222    3456678889999999999999999999999665 99


Q ss_pred             EeeeCccc
Q 013686          252 VADFGLSR  259 (438)
Q Consensus       252 l~Dfgla~  259 (438)
                      ++||+..+
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.64  E-value=4.2e-07  Score=82.44  Aligned_cols=136  Identities=19%  Similarity=0.194  Sum_probs=79.6

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC--ceeEeeeeeccCceEEEEEeccCCCC
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN--LVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-+  +.+.+++... ++...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCcc
Confidence            57899999999984   25567788765432  2345678999998875332  3444553333 345788999998863


Q ss_pred             -HHHH---------------------hhccCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHh----CCccccC
Q 013686          194 -VADH---------------------LHNRQPNSCLLPWPVRLSIAI----------ETAG-ALAYLHA----SDVIHRD  236 (438)
Q Consensus       194 -L~~~---------------------l~~~~~~~~~l~~~~~~~i~~----------~i~~-~l~~LH~----~~ivH~D  236 (438)
                       +...                     ++........++... ..+-.          .+.. ...+|..    ..++|+|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence             2111                     111111111111100 00100          0111 1222221    2478999


Q ss_pred             CCCCCEEecCCCeEEEeeeCccc
Q 013686          237 VKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       237 lkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      +.|.||++++++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.57  E-value=1e-06  Score=78.78  Aligned_cols=149  Identities=20%  Similarity=0.202  Sum_probs=96.9

Q ss_pred             hHHHHHHhcCCCCCCc---ccccCceEEEEEEEcCCcEEEEEEeeccchH--hH-----------------HH-----HH
Q 013686          102 CSELEEATDNFNSSKQ---LGDGGFGAVYLGILRDGRIVAVKRLYENNFK--RI-----------------EQ-----FM  154 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~-----------------~~-----~~  154 (438)
                      ...+....++..+...   |..|--+.||+|...++..+|||+.+.....  .+                 .+     ..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            3445555555555544   5567778999998888999999987543211  10                 00     23


Q ss_pred             HHHHHHHhCC--CCCceeEeeeeeccCceEEEEEeccCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 013686          155 NEVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNG-TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-S  230 (438)
Q Consensus       155 ~E~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~  230 (438)
                      .|+.-|.++.  +-.+-+-+++.     ...|||||+... .-.-.|..     ..+...+...+..++++.+.-|-. .
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~-----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR-----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec-----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            4666676663  32333333311     247999999542 11111111     123333567788899999988877 8


Q ss_pred             CccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       231 ~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      ++||+||..-|||+. ++.+.|+|||-+...
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECcccccc
Confidence            999999999999999 889999999988654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=9e-07  Score=80.56  Aligned_cols=143  Identities=24%  Similarity=0.248  Sum_probs=83.3

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCC--CceeEeeeeec--cCceEEEEEeccC
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP--NLVKLYGCTSR--QSRELLLVYEYIP  190 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~--~~~~~~lv~e~~~  190 (438)
                      ++.|+.|..+.||++...+ +.+++|.....  .....+.+|..+++.+...  .+.+++.+...  .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999999876 68999986554  3446777899998888532  24455542211  2234789999999


Q ss_pred             CCCHHH----------------Hh---hccCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 013686          191 NGTVAD----------------HL---HNRQPNSCLLPWPVR---------LSI------------AIETAG-ALAYLHA  229 (438)
Q Consensus       191 ~g~L~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~i~~-~l~~LH~  229 (438)
                      |..+..                .+   +..............         ...            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111111111111110         000            111222 2333332


Q ss_pred             -------CCccccCCCCCCEEec-CCCeEEEeeeCcccc
Q 013686          230 -------SDVIHRDVKSNNILLD-NNFRVKVADFGLSRL  260 (438)
Q Consensus       230 -------~~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~  260 (438)
                             ..++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                   3589999999999999 667778999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.50  E-value=1.6e-06  Score=73.34  Aligned_cols=130  Identities=20%  Similarity=0.189  Sum_probs=92.4

Q ss_pred             CCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCC
Q 013686          113 NSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  192 (438)
                      ...+.||+|.+|.||+|.+. |..+|+|+-..+..  ...+..|+++|..+.-.++.+=+-.+ ..   -.+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y-g~---~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY-GE---DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe-ch---hhhhhhhhcCc
Confidence            34578999999999999996 56889997655432  36788899999998866665433112 12   24669999888


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCCEEecCCCeEEEeeeCcccc
Q 013686          193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVK-SNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       193 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlk-p~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .|.++-...       +    .+-...+++.---|-..||-|+.|. |...+|-+++.+.|+||.-|+.
T Consensus        98 ~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG-------D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc-------c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887765432       1    2334556666666778899999997 5555555555999999998874

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=4e-06  Score=84.02  Aligned_cols=143  Identities=18%  Similarity=0.193  Sum_probs=92.0

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHh---------------------------H----H------HHHHHH
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR---------------------------I----E------QFMNEV  157 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------------------------~----~------~~~~E~  157 (438)
                      .+.||.-+.|.||+|++++|+.||||+-++.-...                           .    +      +|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46899999999999999999999999865432111                           0    0      133444


Q ss_pred             HHHHh----CCCCC---ceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHh
Q 013686          158 EILTK----LQHPN---LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL-AYLHA  229 (438)
Q Consensus       158 ~~l~~----l~h~n---iv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~  229 (438)
                      +-..+    +.|-+   -|.+-.++++-.....|+||||+|..+.|.-.-....   ++..   .++..+.++. .-|-.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~---~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPH---DILNKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHH---HHHHHHHHHHHHHHHh
Confidence            43332    34544   1223333444444678999999998776653322211   4443   3444444442 22335


Q ss_pred             CCccccCCCCCCEEecC----CCeEEEeeeCcccccCC
Q 013686          230 SDVIHRDVKSNNILLDN----NFRVKVADFGLSRLFPT  263 (438)
Q Consensus       230 ~~ivH~Dlkp~Nill~~----~~~~kl~Dfgla~~~~~  263 (438)
                      .|++|+|=.|.||++..    ++.+.+-|||+......
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            68999999999999983    67899999999876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.36  E-value=1e-07  Score=94.74  Aligned_cols=184  Identities=20%  Similarity=0.204  Sum_probs=129.3

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC-ceeEeeeeeccCceEEEEEeccCCC-
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN-LVKLYGCTSRQSRELLLVYEYIPNG-  192 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv~e~~~~g-  192 (438)
                      .+-+++|+++.++|.+....+....+.+...     ....-++++|.+++||| .+..++-+. .+...+++++++.++ 
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~-~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYD-GEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCC-cccccchhhhhhcCCc
Confidence            3457899999999987543344445544322     34456899999999999 666665333 334688999999776 


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCC
Q 013686          193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP  272 (438)
Q Consensus       193 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  272 (438)
                      +...-+..   ....+..-+...+.+.-++++++||+.-=+|+|    ||+..+ +..|..||+....+....  .....
T Consensus       321 s~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~  390 (829)
T KOG0576|consen  321 SSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA  390 (829)
T ss_pred             cccccCCh---hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence            22221111   111133344456667778899999998778998    777665 578999999987665443  23455


Q ss_pred             CCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCccc
Q 013686          273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT  314 (438)
Q Consensus       273 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~  314 (438)
                      .+++.|+|||......+....|+|++|+--.+|--|.+|-..
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            699999999999999999999999999977777777666543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=1e-05  Score=74.45  Aligned_cols=138  Identities=20%  Similarity=0.124  Sum_probs=81.4

Q ss_pred             cccccCc-eEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEeccCCCCH
Q 013686          117 QLGDGGF-GAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTV  194 (438)
Q Consensus       117 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g~L  194 (438)
                      .|-.|.+ ..||+.... +..+.+|......   ...+.+|+++++.+. +--+.+++++.... +..++|||+++|.+|
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCccH
Confidence            3455555 788998764 4778888765433   234667999988884 33344566644433 457899999999877


Q ss_pred             HHHh-------------------hccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 013686          195 ADHL-------------------HNRQPNSCLLPWP--VRLSIAI--------------------ETAGALAYLH-----  228 (438)
Q Consensus       195 ~~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~~LH-----  228 (438)
                      ....                   +........+...  .......                    .+...+..|-     
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6442                   1111111111100  0000000                    0111122221     


Q ss_pred             --hCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          229 --ASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       229 --~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                        ...++|+|+.|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              1248999999999999998888999999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.27  E-value=3e-05  Score=68.41  Aligned_cols=131  Identities=23%  Similarity=0.319  Sum_probs=90.3

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccc----------------hHhHHHHHHHHHHHHhCC------CCCceeEe
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENN----------------FKRIEQFMNEVEILTKLQ------HPNLVKLY  172 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~  172 (438)
                      ...||+|+.-.||.  +.++....||+.....                .....+..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999999997  3445667888876554                112345666777666655      78899999


Q ss_pred             eeeeccCceEEEEEeccCC------CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          173 GCTSRQSRELLLVYEYIPN------GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       173 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                      |+...+. -+.+|+|.+.+      .+|.+++....     ++.    .+...+-+-..||-+.+|+.+|++|.||++..
T Consensus        84 G~veT~~-G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVETNL-GLGLVVELIRDADGNISPTLEDYLKEGG-----LTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEecCC-ceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence            9665554 57888888643      37888885443     444    23334445567889999999999999999953


Q ss_pred             C---C-eEEEee-eCc
Q 013686          247 N---F-RVKVAD-FGL  257 (438)
Q Consensus       247 ~---~-~~kl~D-fgl  257 (438)
                      +   . .+.|+| ||.
T Consensus       154 ~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cCCCceEEEEEeCCCC
Confidence            2   2 567776 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=8.6e-06  Score=87.94  Aligned_cols=80  Identities=18%  Similarity=0.327  Sum_probs=55.4

Q ss_pred             CCcccccCceEEEEEEEcCC---cEEEEEEeeccc-hHhHHHHHHHHHHHHhCC-CCCc--eeEeeeeeccC--ceEEEE
Q 013686          115 SKQLGDGGFGAVYLGILRDG---RIVAVKRLYENN-FKRIEQFMNEVEILTKLQ-HPNL--VKLYGCTSRQS--RELLLV  185 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~--~~~~lv  185 (438)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.++.+..  +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999887653   467777754322 122356889999999995 6654  66666554321  357899


Q ss_pred             EeccCCCCH
Q 013686          186 YEYIPNGTV  194 (438)
Q Consensus       186 ~e~~~~g~L  194 (438)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.17  E-value=1.9e-05  Score=69.09  Aligned_cols=126  Identities=28%  Similarity=0.359  Sum_probs=89.5

Q ss_pred             cCCCCCCcccccCc-eEEEEEEEcCCcEEEEEEeec---c-------ch-----------HhHHHHHHHHHHHHhCC---
Q 013686          110 DNFNSSKQLGDGGF-GAVYLGILRDGRIVAVKRLYE---N-------NF-----------KRIEQFMNEVEILTKLQ---  164 (438)
Q Consensus       110 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~-------~~-----------~~~~~~~~E~~~l~~l~---  164 (438)
                      .+++.++.||.|.- |.||++.. +|+.||+|.+..   .       ..           ...+.|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67788999999999 99999998 478999998321   0       00           11245788999888884   


Q ss_pred             CCCc--eeEeeeeeccC-----------------ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 013686          165 HPNL--VKLYGCTSRQS-----------------RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA  225 (438)
Q Consensus       165 h~ni--v~~~~~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  225 (438)
                      +.++  |+++|+..-..                 ....||.||++...             .+..    +-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence            4466  88888652220                 12356777765433             0222    33457778889


Q ss_pred             HHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       226 ~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      .+|..||+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999999977     3489999854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.7e-05  Score=72.55  Aligned_cols=75  Identities=17%  Similarity=0.152  Sum_probs=45.0

Q ss_pred             CCcccccCce-EEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCC---CceeEeeeeecc--CceEEEEEec
Q 013686          115 SKQLGDGGFG-AVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP---NLVKLYGCTSRQ--SRELLLVYEY  188 (438)
Q Consensus       115 ~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~--~~~~~lv~e~  188 (438)
                      ++.|+.|+.. .||+.    +..+++|......  ....+.+|.+++..+...   .+-.+++.....  ....+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567777766 58876    3457778654322  235788899999887531   223333322111  1234789999


Q ss_pred             cCCCCHH
Q 013686          189 IPNGTVA  195 (438)
Q Consensus       189 ~~~g~L~  195 (438)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=9.4e-06  Score=71.20  Aligned_cols=99  Identities=26%  Similarity=0.294  Sum_probs=78.8

Q ss_pred             HHHHHHHHhCCC-CCceeEeeeeeccCceEEEEEeccCCCCHHHH---hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013686          154 MNEVEILTKLQH-PNLVKLYGCTSRQSRELLLVYEYIPNGTVADH---LHNRQPNSCLLPWPVRLSIAIETAGALAYLHA  229 (438)
Q Consensus       154 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  229 (438)
                      ..|.-+++.+++ +++.+++|+|.     .++|.||...+++...   +....    .-+|..+.+||.++++.+.+|+.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~~~----~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQFL----QSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCcccccccccccccc----ccCHHHHHHHHHHHHHHHHHHhc
Confidence            358888999976 69999999772     2578899987766432   11111    26899999999999999999998


Q ss_pred             ---CCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          230 ---SDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       230 ---~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                         ..+...|++++|+-+++++++|++|...+...
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence               35778999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.10  E-value=1.4e-05  Score=84.97  Aligned_cols=200  Identities=18%  Similarity=0.207  Sum_probs=138.2

Q ss_pred             HHHHHHHHHHHhCCCCCceeEeeeeeccCc---eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 013686          151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSR---ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL  227 (438)
Q Consensus       151 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  227 (438)
                      ....-|+..+.+..|+|++.++++......   ...+..|+|...++...+..-..    ++....+.+..++.+||.|+
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~----i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS----IPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc----cCHHHHHHHHHHHhhhHHHH
Confidence            334457777888899999999886544321   12345678888888888877654    78888889999999999999


Q ss_pred             HhCCccccCCCCC---CEEecCCCeEEEe--eeCcccccCCCccccccCCCCCCCccCccccccCCCCC--hhhHHHHHH
Q 013686          228 HASDVIHRDVKSN---NILLDNNFRVKVA--DFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD--KSDVYSFGV  300 (438)
Q Consensus       228 H~~~ivH~Dlkp~---Nill~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dvws~Gv  300 (438)
                      |+....|.-+..+   +...+..+.+.++  ||+....++.....  .....+..|.++|......++.  ..|+|.+|.
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            9997766665555   4455666777777  99888766543322  2223566788888876655544  479999999


Q ss_pred             HHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 013686          301 VLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV  380 (438)
Q Consensus       301 ~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  380 (438)
                      ++..+..|..+-.....                  ...+.+           ........+...+|+..++++|+++.++
T Consensus       381 l~~~~~~~~~i~~~~~~------------------~~~~l~-----------~~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV------------------PVSLLD-----------VLSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHhhhhhcCcccccccc------------------hhhhhc-----------cccchhhhhhhhhhcchhhhhccchhhh
Confidence            99999988544321100                  000000           0111145677889999999999999999


Q ss_pred             HHHHH
Q 013686          381 LEILR  385 (438)
Q Consensus       381 l~~L~  385 (438)
                      +.+.-
T Consensus       432 l~~~f  436 (1351)
T KOG1035|consen  432 LTHPF  436 (1351)
T ss_pred             hhchh
Confidence            98754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.07  E-value=5.9e-06  Score=76.47  Aligned_cols=134  Identities=17%  Similarity=0.162  Sum_probs=95.7

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--ch----------------Hh----HHHHHHHHHHHHhCC-CCC
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NF----------------KR----IEQFMNEVEILTKLQ-HPN  167 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~----------------~~----~~~~~~E~~~l~~l~-h~n  167 (438)
                      -+.+++.||-|--+.+|.+...+|++.++|.-.-.  ..                .+    .-...+|...|+.|. |-.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            46788999999999999999999999999943211  00                00    112456888888874 433


Q ss_pred             cee-EeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          168 LVK-LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       168 iv~-~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                      -|+ .++     .+..++|||++.+-.|...-+-..       .   -.+...+..-+.-|-.+|+||+|.+-=||++++
T Consensus       173 pVPkpiD-----~~RH~Vvmelv~g~Pl~~v~~v~d-------~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPID-----HNRHCVVMELVDGYPLRQVRHVED-------P---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCccc-----ccceeeHHHhhcccceeeeeecCC-------h---HHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            332 222     235689999999888876543221       1   244555666677888999999999999999999


Q ss_pred             CCeEEEeeeCccc
Q 013686          247 NFRVKVADFGLSR  259 (438)
Q Consensus       247 ~~~~kl~Dfgla~  259 (438)
                      ++.++++||--+.
T Consensus       238 d~~i~vIDFPQmv  250 (465)
T KOG2268|consen  238 DDKIVVIDFPQMV  250 (465)
T ss_pred             CCCEEEeechHhh
Confidence            9999999997554

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.02  E-value=4.6e-05  Score=69.61  Aligned_cols=74  Identities=24%  Similarity=0.246  Sum_probs=47.9

Q ss_pred             CCcccccCceEEEEEEEcC--CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCc-eeEeeeeeccCceEEEEEeccCC
Q 013686          115 SKQLGDGGFGAVYLGILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL-VKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      .+.|..|-...+|+....+  ++.|++|........ .-...+|+.+++.+...++ .++++.. . +   .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~---~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF-Q-N---GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe-C-C---cEEEEeeCC
Confidence            3567888899999998764  678889966443221 1233468888888853333 3444322 2 2   479999998


Q ss_pred             CCH
Q 013686          192 GTV  194 (438)
Q Consensus       192 g~L  194 (438)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.96  E-value=0.00012  Score=69.41  Aligned_cols=141  Identities=19%  Similarity=0.180  Sum_probs=83.8

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC--ceeEeee-----eeccCceEEEEEe
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN--LVKLYGC-----TSRQSRELLLVYE  187 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~~lv~e  187 (438)
                      .+.|..|....+|+.... +..+++|.....   ..+.+..|++++..+.+.+  +.+++..     .....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            567888888999998764 456888876542   2345667888888774322  3444331     1111235689999


Q ss_pred             ccCCCCHHH----H----------hhccCCC-------CCCCCHHHHH----------HHHHHHHHHHHHHHh-------
Q 013686          188 YIPNGTVAD----H----------LHNRQPN-------SCLLPWPVRL----------SIAIETAGALAYLHA-------  229 (438)
Q Consensus       188 ~~~~g~L~~----~----------l~~~~~~-------~~~l~~~~~~----------~i~~~i~~~l~~LH~-------  229 (438)
                      |++|..+..    .          ++.....       .....|....          .....+..++.++.+       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998876532    0          1111000       0111221110          011123344445443       


Q ss_pred             CCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          230 SDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       230 ~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            379999999999999998778999999775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.94  E-value=0.00035  Score=66.97  Aligned_cols=153  Identities=16%  Similarity=0.183  Sum_probs=81.3

Q ss_pred             HHHHHHhcCCCC-----CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-----CCCceeEe
Q 013686          103 SELEEATDNFNS-----SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-----HPNLVKLY  172 (438)
Q Consensus       103 ~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~  172 (438)
                      +++......|.+     .+.|+.|....+|+....+| .+++|+.....   .+.+..|+.++..|.     .|.++.-.
T Consensus        10 ~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~   85 (319)
T PRK05231         10 DELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARR   85 (319)
T ss_pred             HHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCC
Confidence            444444444543     35677788889999887655 68889765222   233444556655552     33333211


Q ss_pred             e--eeeccCceEEEEEeccCCCCHH-----------HH---hhccCCC-------CCCCCH-HHHHH------------H
Q 013686          173 G--CTSRQSRELLLVYEYIPNGTVA-----------DH---LHNRQPN-------SCLLPW-PVRLS------------I  216 (438)
Q Consensus       173 ~--~~~~~~~~~~lv~e~~~~g~L~-----------~~---l~~~~~~-------~~~l~~-~~~~~------------i  216 (438)
                      +  .+..-.+..++++||++|..+.           ..   ++.....       ...+.| .....            .
T Consensus        86 ~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (319)
T PRK05231         86 DGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAAL  165 (319)
T ss_pred             CCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHH
Confidence            1  1111134578999999886431           11   1111100       001112 11111            1


Q ss_pred             HHH-HHHHHHHHH-------hCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          217 AIE-TAGALAYLH-------ASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       217 ~~~-i~~~l~~LH-------~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ..+ +...++.+.       ..++||+|+.|.||+++.+...-|+||+.+.
T Consensus       166 l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        166 LEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            111 111223332       2379999999999999977666899999875

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.93  E-value=0.00012  Score=67.80  Aligned_cols=137  Identities=15%  Similarity=0.077  Sum_probs=77.6

Q ss_pred             cccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCce-eEeeeeeccCceEEEEEeccCCCCHH
Q 013686          117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV-KLYGCTSRQSRELLLVYEYIPNGTVA  195 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~g~L~  195 (438)
                      .+..|-.+.+|+... +++.+++|..........-...+|.++++.+...+++ +++...  .   -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~---~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E---HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C---CEEEEEeccCcccc
Confidence            356788889999874 5778888875433211101346788999888643333 233322  2   26899999886654


Q ss_pred             HH-----------------hhccCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHh--------CCccccCCCCC
Q 013686          196 DH-----------------LHNRQPNSCLLPWPV-RLSIAIET---------AGALAYLHA--------SDVIHRDVKSN  240 (438)
Q Consensus       196 ~~-----------------l~~~~~~~~~l~~~~-~~~i~~~i---------~~~l~~LH~--------~~ivH~Dlkp~  240 (438)
                      ..                 ++........++... ...+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 122211111122211 11111111         111222221        14899999999


Q ss_pred             CEEecCCCeEEEeeeCcccc
Q 013686          241 NILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       241 Nill~~~~~~kl~Dfgla~~  260 (438)
                      ||++++++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.92  E-value=0.00029  Score=67.16  Aligned_cols=142  Identities=20%  Similarity=0.237  Sum_probs=81.5

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC--ceeEeee-----eeccCceEEEEEe
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN--LVKLYGC-----TSRQSRELLLVYE  187 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~~lv~e  187 (438)
                      .+.++.|....+|+....+| .+++|......  ..+.+..|.+++..|...+  +.+++..     .....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            56778888889999876544 57788764421  1234556777777763222  3333321     1112345789999


Q ss_pred             ccCCCCHHH--------------HhhccCCC---C-----CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 013686          188 YIPNGTVAD--------------HLHNRQPN---S-----CLLPWPVRL------------SIAIETAGALAYLHA----  229 (438)
Q Consensus       188 ~~~~g~L~~--------------~l~~~~~~---~-----~~l~~~~~~------------~i~~~i~~~l~~LH~----  229 (438)
                      |++|..+..              .++.....   .     ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998854321              01111100   0     001111100            011223345555542    


Q ss_pred             ---CCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          230 ---SDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       230 ---~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                         .+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               589999999999999998877899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10593 hypothetical protein; Provisional

Probab=97.91  E-value=0.00018  Score=68.14  Aligned_cols=79  Identities=13%  Similarity=0.092  Sum_probs=54.9

Q ss_pred             CCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC---CCceeEeeeeecc--CceEEEEEe
Q 013686          113 NSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH---PNLVKLYGCTSRQ--SRELLLVYE  187 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~--~~~~~lv~e  187 (438)
                      ...+.||.|..+.||.....++ .+++|..+..  .....+..|.+.|+.|..   -.+.++++++...  .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456899999999999876555 4666764321  122568889999998852   3566777654322  345799999


Q ss_pred             ccCCCCH
Q 013686          188 YIPNGTV  194 (438)
Q Consensus       188 ~~~~g~L  194 (438)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.83  E-value=3.2e-06  Score=91.63  Aligned_cols=161  Identities=15%  Similarity=0.032  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHhCCCCCceeEee-eeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013686          152 QFMNEVEILTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS  230 (438)
Q Consensus       152 ~~~~E~~~l~~l~h~niv~~~~-~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  230 (438)
                      ....|.+.++...|+++...+. .-...+.+.+.+++|+.+|.+.+.+-+.-.....+...-+...-.+......-+|+.
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            3445666666778998887665 223344567899999999999999987665555555555554444546666666654


Q ss_pred             -C----ccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHH
Q 013686          231 -D----VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIEL  305 (438)
Q Consensus       231 -~----ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el  305 (438)
                       +    .+|+++|+.|.+|..+..+|++++|+.+..... ........+++.|+.|++...-.++.++|+|..|+.+|+.
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence             2    689999999999999999999999999943332 2223445688899999999888999999999999999999


Q ss_pred             HhCCCCcc
Q 013686          306 ISGLEAVD  313 (438)
Q Consensus       306 ~tG~~p~~  313 (438)
                      .-|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            98877763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.79  E-value=0.00013  Score=69.34  Aligned_cols=75  Identities=27%  Similarity=0.329  Sum_probs=48.2

Q ss_pred             CcccccCceEEEEEEEcC-------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCce-eEeeeeeccCceEEEEEe
Q 013686          116 KQLGDGGFGAVYLGILRD-------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV-KLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e  187 (438)
                      +.|..|-...+|+....+       ++.+++|...... .......+|.+++..+...++. ++++++ .+    .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~~----~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF-PN----GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe-CC----Cchhh
Confidence            456677788999988654       4789999865432 2223456788888888533333 344433 22    36899


Q ss_pred             ccCCCCHHH
Q 013686          188 YIPNGTVAD  196 (438)
Q Consensus       188 ~~~~g~L~~  196 (438)
                      |++|.++..
T Consensus        78 ~i~G~~l~~   86 (302)
T cd05156          78 FIPSRTLTT   86 (302)
T ss_pred             eeCCCcCCH
Confidence            998876643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.78  E-value=0.00055  Score=66.98  Aligned_cols=76  Identities=20%  Similarity=0.246  Sum_probs=53.3

Q ss_pred             CCcccccCceEEEEEEEcCC-cEEEEEEeecc------c-hHhHHHHHHHHHHHHhCC---CCCceeEeeeeeccCceEE
Q 013686          115 SKQLGDGGFGAVYLGILRDG-RIVAVKRLYEN------N-FKRIEQFMNEVEILTKLQ---HPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~  183 (438)
                      .+.||.|.+..||++...+| +.|+||.-.+.      . .-..+++..|.+.|..+.   ..++.+++.+. .  ...+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-~--~~~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-E--ELAV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-C--CCCE
Confidence            36799999999999998776 58999974311      1 123466778888888763   24566677632 2  3468


Q ss_pred             EEEeccCCCC
Q 013686          184 LVYEYIPNGT  193 (438)
Q Consensus       184 lv~e~~~~g~  193 (438)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.51  E-value=0.0012  Score=61.79  Aligned_cols=30  Identities=23%  Similarity=0.523  Sum_probs=25.3

Q ss_pred             CccccCCCCCCEEecCCCe-EEEeeeCcccc
Q 013686          231 DVIHRDVKSNNILLDNNFR-VKVADFGLSRL  260 (438)
Q Consensus       231 ~ivH~Dlkp~Nill~~~~~-~kl~Dfgla~~  260 (438)
                      .++|+|+.+.|||++++++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.36  E-value=0.0025  Score=60.23  Aligned_cols=147  Identities=15%  Similarity=0.195  Sum_probs=82.0

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEee-ccchHhHHHHHHHHHHHHhCCC--CCceeEeeeeeccC-ceEEEEEecc
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQH--PNLVKLYGCTSRQS-RELLLVYEYI  189 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~-~~~~lv~e~~  189 (438)
                      +.+.+-.|..-.+|..... ++.+++.+.. ...........+|+.+++.+.-  --+-..++++..+. ...+.||+|+
T Consensus        29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            3444444444455555443 7788888321 2233445677789999988742  22233455555544 4679999999


Q ss_pred             CCCCHHHHhhccC---------------------CC-------------CCCCCHHHHHHHHH--------HHHHHHHHH
Q 013686          190 PNGTVADHLHNRQ---------------------PN-------------SCLLPWPVRLSIAI--------ETAGALAYL  227 (438)
Q Consensus       190 ~~g~L~~~l~~~~---------------------~~-------------~~~l~~~~~~~i~~--------~i~~~l~~L  227 (438)
                      +|..+.+.+....                     ..             ...-.|......+.        ....-..+|
T Consensus       108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl  187 (321)
T COG3173         108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL  187 (321)
T ss_pred             cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence            8833222111100                     00             00001111111000        122224455


Q ss_pred             HhC--------CccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          228 HAS--------DVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       228 H~~--------~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +.+        .++|||+.+.|++++.+.-+=+.||+++..-
T Consensus       188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            443        3899999999999999988999999998764

>PLN02236 choline kinase

Probab=97.27  E-value=0.0019  Score=62.52  Aligned_cols=139  Identities=18%  Similarity=0.205  Sum_probs=79.3

Q ss_pred             CcccccCceEEEEEEEcC-----CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCce-eEeeeeeccCceEEEEEecc
Q 013686          116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV-KLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~  189 (438)
                      ..|-.|-.-.+|++...+     ++.|++|.........++ ..+|..+++.+..-++. ++++.+ ..+    .|+||+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~-~~g----~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRF-PNG----RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEE-CCc----eEEEee
Confidence            456568888999987532     367888876554322222 35688888888543333 344433 222    579999


Q ss_pred             CCCCHHHH-----------------hhccCCCC--CCCCHHHHHHHHHHH-----------------HHHHHHH----H-
Q 013686          190 PNGTVADH-----------------LHNRQPNS--CLLPWPVRLSIAIET-----------------AGALAYL----H-  228 (438)
Q Consensus       190 ~~g~L~~~-----------------l~~~~~~~--~~l~~~~~~~i~~~i-----------------~~~l~~L----H-  228 (438)
                      ++.+|...                 +|......  ....+.....+..++                 ...+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87666421                 12211111  012233333332211                 1112222    1 


Q ss_pred             ---hCCccccCCCCCCEEecC-CCeEEEeeeCcccc
Q 013686          229 ---ASDVIHRDVKSNNILLDN-NFRVKVADFGLSRL  260 (438)
Q Consensus       229 ---~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~  260 (438)
                         ...++|+|+++.|||+++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               125899999999999986 46899999988753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.27  E-value=0.0029  Score=60.68  Aligned_cols=79  Identities=18%  Similarity=0.236  Sum_probs=50.6

Q ss_pred             cccccCceEEEEEEEcCC-cEEEEEEeec-------cchHhHHHHHHHHHHHHhCC--CC-CceeEeeeeeccCceEEEE
Q 013686          117 QLGDGGFGAVYLGILRDG-RIVAVKRLYE-------NNFKRIEQFMNEVEILTKLQ--HP-NLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~lv  185 (438)
                      .||.|....||++...+| +.|+||.-.+       ...-..++..-|.+.|+...  -| .+.+++. +..  ....+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~--e~~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDT--EMAVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-Ecc--ccceeh
Confidence            589999999999997654 6899996421       11223455667888887763  34 4445654 322  245799


Q ss_pred             EeccCCC-CHHHHh
Q 013686          186 YEYIPNG-TVADHL  198 (438)
Q Consensus       186 ~e~~~~g-~L~~~l  198 (438)
                      ||+++.. .|.+.|
T Consensus        79 MEdL~~~~ilR~~L   92 (370)
T TIGR01767        79 MEDLSHHKIARKGL   92 (370)
T ss_pred             HhhCccchHHHHHH
Confidence            9999543 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.18  E-value=0.0077  Score=57.41  Aligned_cols=29  Identities=34%  Similarity=0.464  Sum_probs=25.3

Q ss_pred             CCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          230 SDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       230 ~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      .+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999988 568999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.06  E-value=0.0046  Score=58.77  Aligned_cols=138  Identities=17%  Similarity=0.172  Sum_probs=87.6

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeecc------chHh----------------HH--H--HHHHHHHHHhCCCCC
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN------NFKR----------------IE--Q--FMNEVEILTKLQHPN  167 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~----------------~~--~--~~~E~~~l~~l~h~n  167 (438)
                      +-..|..|--+.||.+...+|..+|||+.+..      ....                .+  .  ...|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34567788889999999889999999976421      1000                00  0  224666677765433


Q ss_pred             ceeEeeeeeccCceEEEEEeccCCCC-HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEec
Q 013686          168 LVKLYGCTSRQSRELLLVYEYIPNGT-VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLD  245 (438)
Q Consensus       168 iv~~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~  245 (438)
                      |. +-.-..-  ....|||+|+.... -.-.|..     ..++...+..+-.|++.-|.-|-+ .++||.||.--|+|+.
T Consensus       228 IP-~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  228 IP-CPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH  299 (520)
T ss_pred             CC-CCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence            21 1110001  13479999994211 1111211     236666777777888888887754 5999999999999986


Q ss_pred             CCCeEEEeeeCcccc
Q 013686          246 NNFRVKVADFGLSRL  260 (438)
Q Consensus       246 ~~~~~kl~Dfgla~~  260 (438)
                      + |.+.|+|-+-+..
T Consensus       300 d-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 D-GKLYIIDVSQSVE  313 (520)
T ss_pred             C-CEEEEEEcccccc
Confidence            5 5789999887653

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=96.93  E-value=0.00094  Score=53.20  Aligned_cols=23  Identities=43%  Similarity=0.378  Sum_probs=18.1

Q ss_pred             CCCcccccchhHHHHHHHHHHHH
Q 013686            6 KNGFSTGAGIGIALGSAAAVILG   28 (438)
Q Consensus         6 ~~~~~~~~~i~i~~g~~~~~~~~   28 (438)
                      ..+|+.+++++|++|+.+++++.
T Consensus        58 ~h~fs~~~i~~Ii~gv~aGvIg~   80 (122)
T PF01102_consen   58 VHRFSEPAIIGIIFGVMAGVIGI   80 (122)
T ss_dssp             SSSSS-TCHHHHHHHHHHHHHHH
T ss_pred             ccCccccceeehhHHHHHHHHHH
Confidence            46899999999999999876543

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.93  E-value=0.0024  Score=63.06  Aligned_cols=51  Identities=22%  Similarity=0.333  Sum_probs=41.6

Q ss_pred             HHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccC
Q 013686          151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ  202 (438)
Q Consensus       151 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  202 (438)
                      .++.-..++++.+.|+|...++++.........+|||++ +.+|.+.+..+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            345667788999999999999987665555688999999 779999987764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.89  E-value=0.013  Score=55.95  Aligned_cols=30  Identities=13%  Similarity=0.217  Sum_probs=27.5

Q ss_pred             CccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          231 DVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       231 ~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ++||+|+.++|||+++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999988763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.88  E-value=0.0058  Score=58.82  Aligned_cols=139  Identities=16%  Similarity=0.215  Sum_probs=77.4

Q ss_pred             CcccccCceEEEEEEEcC----CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCce-eEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV-KLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.|..|-...+|+....+    +..|++|........ .-.-.+|..+++.+..-++- ++++++ .. +   +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~~-G---~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-GN-G---MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-CC-c---Eeehhhc
Confidence            456667788899887543    237888876543221 12235688888888644443 344433 22 2   5899997


Q ss_pred             CCCHHH-----------------HhhccCCCCC--CCCHHHHHHHHHHH----------------------HHHHHHHH-
Q 013686          191 NGTVAD-----------------HLHNRQPNSC--LLPWPVRLSIAIET----------------------AGALAYLH-  228 (438)
Q Consensus       191 ~g~L~~-----------------~l~~~~~~~~--~l~~~~~~~i~~~i----------------------~~~l~~LH-  228 (438)
                      +.+|..                 .+|.......  .-.|.....+..++                      ..-+..+. 
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            765521                 0122111110  11233332222221                      11122221 


Q ss_pred             ---hCC----ccccCCCCCCEEecC-CCeEEEeeeCcccc
Q 013686          229 ---ASD----VIHRDVKSNNILLDN-NFRVKVADFGLSRL  260 (438)
Q Consensus       229 ---~~~----ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~  260 (438)
                         ..+    ++|+|+.+.|||+++ ++.++++||..|..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               112    699999999999975 57899999998753

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.84  E-value=0.017  Score=56.57  Aligned_cols=80  Identities=18%  Similarity=0.214  Sum_probs=51.5

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeecc----ch---HhHHHHHHHHHHHHhCC---CCCceeEeeeeeccCceEEE
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYEN----NF---KRIEQFMNEVEILTKLQ---HPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~l  184 (438)
                      .+.||.|....||+.... ++.|+||.-...    ..   -..++-..|.+.|+.+.   ..++.+++.++.+   ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded---~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT---MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---CCEE
Confidence            567899999999998874 567999975411    10   12344455677776653   2467777775542   3578


Q ss_pred             EEeccCC--CCHHHHh
Q 013686          185 VYEYIPN--GTVADHL  198 (438)
Q Consensus       185 v~e~~~~--g~L~~~l  198 (438)
                      +|||+++  ..+.+.+
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            9999976  3454443

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.73  E-value=0.011  Score=57.63  Aligned_cols=81  Identities=20%  Similarity=0.171  Sum_probs=52.7

Q ss_pred             CCcccccCceEEEEEEEcC-CcEEEEEEeec------cchHhHHHHHHHHHHHHhCC--CC-CceeEeeeeeccCceEEE
Q 013686          115 SKQLGDGGFGAVYLGILRD-GRIVAVKRLYE------NNFKRIEQFMNEVEILTKLQ--HP-NLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~l  184 (438)
                      .+.||.|.-.-||++...+ ++.|+||.-.+      .-.-..++..-|.+.|+...  -| ++.+++. +..  ....+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~D~--e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-FDS--VMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-ECc--HHhhH
Confidence            4679999999999999753 57899996421      11223566777888888763  34 4555664 322  24579


Q ss_pred             EEeccCCC-CHHHHh
Q 013686          185 VYEYIPNG-TVADHL  198 (438)
Q Consensus       185 v~e~~~~g-~L~~~l  198 (438)
                      |||+++.. .|.+.|
T Consensus       111 vMEdL~~~~ilR~~L  125 (409)
T PRK12396        111 VMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHhCcccHHHHHHH
Confidence            99999542 344443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.71  E-value=0.0051  Score=55.13  Aligned_cols=30  Identities=30%  Similarity=0.491  Sum_probs=21.3

Q ss_pred             CccccCCCCCCEEe-cCCCeEEEeeeCcccc
Q 013686          231 DVIHRDVKSNNILL-DNNFRVKVADFGLSRL  260 (438)
Q Consensus       231 ~ivH~Dlkp~Nill-~~~~~~kl~Dfgla~~  260 (438)
                      -++|+|+.+.|||+ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47899999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.56  E-value=0.031  Score=53.49  Aligned_cols=138  Identities=22%  Similarity=0.287  Sum_probs=82.0

Q ss_pred             cccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC---CCCcee---Eee----eeeccCceEEEEE
Q 013686          117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ---HPNLVK---LYG----CTSRQSRELLLVY  186 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~---~~~----~~~~~~~~~~lv~  186 (438)
                      .|.+ .-..+|+....+|+. ++|.....  ....++..|+..|..|.   .+=.++   +-|    ..... ...+-++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeEEEE
Confidence            4444 557899998877766 78866554  33456677888888773   222222   212    11111 3678899


Q ss_pred             eccCCCCHHH-H--------------hhc----c----CCCCCCCCHHH----H---------HHHHHHHHHHHHHHHhC
Q 013686          187 EYIPNGTVAD-H--------------LHN----R----QPNSCLLPWPV----R---------LSIAIETAGALAYLHAS  230 (438)
Q Consensus       187 e~~~~g~L~~-~--------------l~~----~----~~~~~~l~~~~----~---------~~i~~~i~~~l~~LH~~  230 (438)
                      +|++|..+.. .              |+.    .    ........|..    .         .....++...++.+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999877762 1              111    1    01111233431    0         11233444555555442


Q ss_pred             --------C--ccccCCCCCCEEecCCCe-EEEeeeCccc
Q 013686          231 --------D--VIHRDVKSNNILLDNNFR-VKVADFGLSR  259 (438)
Q Consensus       231 --------~--ivH~Dlkp~Nill~~~~~-~kl~Dfgla~  259 (438)
                              +  +||+|+.|.||+++.+.. +.++||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                    4  999999999999998875 8999999775

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.48  E-value=0.033  Score=52.26  Aligned_cols=74  Identities=23%  Similarity=0.255  Sum_probs=44.4

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC---CCCceeEeeeeeccCceEEEEEeccC
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ---HPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      ..+.++.|....+|+.. .+++.+.||.-...   ....|..|.+-|+.|.   --.+.+++++....+ ..+|||||++
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-~~fLlle~l~   95 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-DAFLLLEFLE   95 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-CCEEEEE---
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-CceEEEEeec
Confidence            35678999999999987 56788999976522   2245777888888873   334556676554443 4589999997


Q ss_pred             CC
Q 013686          191 NG  192 (438)
Q Consensus       191 ~g  192 (438)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.47  E-value=0.0098  Score=56.52  Aligned_cols=73  Identities=26%  Similarity=0.271  Sum_probs=56.2

Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeC
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFG  256 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg  256 (438)
                      +....|++|++- |+++.-. ..       ..+++...++++.+..+.-+..+ ..-|||+...||||+ +|.|.|+||-
T Consensus       297 e~~y~yl~~kdh-gt~is~i-k~-------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII-KA-------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             CceEEEEEEecC-Cceeeee-ec-------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEee
Confidence            344567777775 5555322 11       56788899999988777777655 788999999999999 9999999999


Q ss_pred             cccc
Q 013686          257 LSRL  260 (438)
Q Consensus       257 la~~  260 (438)
                      +++.
T Consensus       367 lsRl  370 (488)
T COG5072         367 LSRL  370 (488)
T ss_pred             eeec
Confidence            9994

>PRK06148 hypothetical protein; Provisional

Probab=96.43  E-value=0.052  Score=60.14  Aligned_cols=142  Identities=20%  Similarity=0.243  Sum_probs=79.6

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhC-------CCCCceeEee-----eeec-cC-ce
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-------QHPNLVKLYG-----CTSR-QS-RE  181 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~-----~~~~-~~-~~  181 (438)
                      +.|+ |..-.+|+....+|+.+++|+......  ......|.++|..|       .-|.+++-.+     .... .+ ..
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 456788998887888999998875422  22333455555544       2344444322     0111 11 14


Q ss_pred             EEEEEeccCCCCHHHHh-----------------hc----cCC--CCCCCCHHH-----------------HHHHHHHHH
Q 013686          182 LLLVYEYIPNGTVADHL-----------------HN----RQP--NSCLLPWPV-----------------RLSIAIETA  221 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l-----------------~~----~~~--~~~~l~~~~-----------------~~~i~~~i~  221 (438)
                      .+.+++|++|..|.+..                 +.    ...  ....+.|..                 ...++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            67789999998776511                 10    000  011122321                 122233333


Q ss_pred             HHHH-----HHH--hCCccccCCCCCCEEecCCC--eEE-EeeeCcccc
Q 013686          222 GALA-----YLH--ASDVIHRDVKSNNILLDNNF--RVK-VADFGLSRL  260 (438)
Q Consensus       222 ~~l~-----~LH--~~~ivH~Dlkp~Nill~~~~--~~k-l~Dfgla~~  260 (438)
                      +.+.     .+.  ..++||+|+.+.|||++.++  ++. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3322     121  24799999999999999875  555 999997753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.42  E-value=0.095  Score=50.36  Aligned_cols=73  Identities=16%  Similarity=0.070  Sum_probs=43.6

Q ss_pred             ccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCC--CceeEe---e-eeeccCceEEEEEeccCCCC
Q 013686          120 DGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP--NLVKLY---G-CTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       120 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~---~-~~~~~~~~~~lv~e~~~~g~  193 (438)
                      .+.-..||+....+|..+++|...... .....+..|++.+..|...  .++...   | ....-++..+.++++++|..
T Consensus        35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         35 NSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            345578999988778889999765332 2335566788887776321  122211   1 11111235778999998754

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.41  E-value=0.013  Score=56.62  Aligned_cols=60  Identities=22%  Similarity=0.306  Sum_probs=46.1

Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCEEec
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH-ASDVIHRDVKSNNILLD  245 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~Dlkp~Nill~  245 (438)
                      ...++-+|+.|-++..++....     .+++...+++.-.++|+.-+- -.+++|.|+.|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            3567888999999999998754     556667777776667655443 45899999999999995

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.37  E-value=0.016  Score=51.39  Aligned_cols=149  Identities=15%  Similarity=0.182  Sum_probs=87.5

Q ss_pred             cCceEEEEEEEcCCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhh
Q 013686          121 GGFGAVYLGILRDGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH  199 (438)
Q Consensus       121 G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  199 (438)
                      |+.++.-.+..+-| ...+|++..-.-. ...-|.++.++++++.  .|+++..   +.+..+.++.|+|.....     
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i-----  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI-----  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc-----
Confidence            34444444443323 3455655433222 2345678899998875  5777763   345567899999842110     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCC
Q 013686          200 NRQPNSCLLPWPVRLSIAIETAGALAYLHAS--DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG  277 (438)
Q Consensus       200 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~  277 (438)
                              ...    .+..-=+.+|.-.|+.  +.+|||..|+|||-|..|.+||.|=+.--.             .+.-
T Consensus       142 --------~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~  196 (308)
T PF07387_consen  142 --------NFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVN  196 (308)
T ss_pred             --------chh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh-------------heee
Confidence                    111    1111114567777853  799999999999999999999999775321             1122


Q ss_pred             ccCccccccCCCCChhhHHHHHHHHHHHHhC
Q 013686          278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG  308 (438)
Q Consensus       278 y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG  308 (438)
                      |.--|   -...+.++.+=+|=.-++++...
T Consensus       197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  197 MVNIE---YESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             EEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence            22211   12346677777776666666653

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=96.10  E-value=0.041  Score=53.97  Aligned_cols=75  Identities=20%  Similarity=0.221  Sum_probs=43.9

Q ss_pred             CCcccccCceEEEEEEEcCC--cE-----EEEEEeeccchHhHHHHHHHHHHHHhCCCCCcee-EeeeeeccCceEEEEE
Q 013686          115 SKQLGDGGFGAVYLGILRDG--RI-----VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK-LYGCTSRQSRELLLVY  186 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~lv~  186 (438)
                      .+.|..|-...+|++...++  ..     |.++.. .......-+-.+|+++++.+...++-+ +++.+ .    -++++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-~----~g~l~  128 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-G----DFTIQ  128 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEec-C----CEEEE
Confidence            34666788899999976432  22     333321 111111112356899999997555544 44433 2    25899


Q ss_pred             eccCCCCHH
Q 013686          187 EYIPNGTVA  195 (438)
Q Consensus       187 e~~~~g~L~  195 (438)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	438
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-51
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-50
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-50
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-36
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-29
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-29
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-29
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-29
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-28
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-28
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-28
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-27
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-27
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-27
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-26
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-26
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-26
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-26
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-26
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-26
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-26
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-26
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-26
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-26
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-26
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-26
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-26
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-26
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-26
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-26
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-26
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-26
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-26
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-26
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-26
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-26
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-26
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-26
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-26
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-26
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-26
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-26
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-26
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-26
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-26
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-26
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-26
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-26
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-26
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-26
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-25
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-25
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-25
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-25
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-25
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-25
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-25
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-25
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-24
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-24
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-24
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-24
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-24
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-24
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-24
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-24
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-24
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-24
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-23
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-23
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-23
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-23
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-23
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-23
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-23
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-23
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-23
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-22
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-22
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-22
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-22
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-22
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-22
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-22
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-22
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-22
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-22
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-22
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-22
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-22
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-21
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-21
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-21
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-21
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-21
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-21
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-21
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-21
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-21
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-21
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-21
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-21
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-21
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-21
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-21
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-21
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-21
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-21
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-21
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-21
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-21
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-21
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-21
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-21
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-21
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-21
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-21
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-20
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-20
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-20
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-20
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-20
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-20
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-20
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-20
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-19
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-19
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-19
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-19
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-19
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-19
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-19
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-19
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-17
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-17
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-17
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-17
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-17
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-17
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-17
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-17
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-17
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-16
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-16
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-16
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-16
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-16
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-16
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-16
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-16
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-16
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-16
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-16
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-16
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-16
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-16
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-16
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-16
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-16
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-15
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-15
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-11
3soa_A	444	Full-Length Human Camkii Length = 444		4e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-07
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-07
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-07
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-07
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-07
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-07
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-07
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-07
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-07
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-07
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-07
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-07
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-07
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-07
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  199 bits (505), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 124/295 (42%), Positives = 169/295 (57%), Gaps = 14/295 (4%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE-QFMNE 156
           K FS  EL+ A+DNF++   LG GGFG VY G L DG +VAVKRL E   +  E QF  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 157 VEILTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           VE+++   H NL++L G C +   R  LLVY Y+ NG+VA  L  R  +   L WP R  
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 216 IAIETAGALAYLHA---SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
           IA+ +A  LAYLH      +IHRDVK+ NILLD  F   V DFGL++L      HV  A 
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR--HRHDINLSNMATNK 330
           +GT G++ P+Y    K ++K+DV+ +GV+L+ELI+G  A D +R  +  D+ L +     
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 331 IQNGALNELVDPSL-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           ++   L  LVD  L G  KD  V  ++    ++A  C Q     RP M EV+ +L
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEVVRML 314

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  198 bits (503), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 119/280 (42%), Positives = 166/280 (59%), Gaps = 7/280 (2%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           +LEEAT+NF+    +G G FG VY G+LRDG  VA+KR    + + IE+F  E+E L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 164 QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           +HP+LV L G C  R   E++L+Y+Y+ NG +  HL+     +  + W  RL I I  A 
Sbjct: 93  RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL-FPTDVTHVSTAPQGTPGYVDP 281
            L YLH   +IHRDVKS NILLD NF  K+ DFG+S+     D TH+    +GT GY+DP
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD 341
           +YF   +LT+KSDVYSFGVVL E++    A+  S  R  +NL+  A     NG L ++VD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           P+L    D      +    + A +C+    + RP+M +VL
Sbjct: 271 PNLA---DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 123/295 (41%), Positives = 167/295 (56%), Gaps = 14/295 (4%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE-QFMNE 156
           K FS  EL+ A+DNF +   LG GGFG VY G L DG +VAVKRL E   +  E QF  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 157 VEILTKLQHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           VE+++   H NL++L G C +   R  LLVY Y+ NG+VA  L  R  +   L WP R  
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 216 IAIETAGALAYLHA---SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
           IA+ +A  LAYLH      +IHRDVK+ NILLD  F   V DFGL++L      HV  A 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR--HRHDINLSNMATNK 330
           +G  G++ P+Y    K ++K+DV+ +GV+L+ELI+G  A D +R  +  D+ L +     
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 331 IQNGALNELVDPSL-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           ++   L  LVD  L G  KD  V  ++    ++A  C Q     RP M EV+ +L
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 119/281 (42%), Positives = 168/281 (59%), Gaps = 9/281 (3%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           +LEEAT+NF+    +G G FG VY G+LRDG  VA+KR    + + IE+F  E+E L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 164 QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           +HP+LV L G C  R   E++L+Y+Y+ NG +  HL+     +  + W  RL I I  A 
Sbjct: 93  RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV--THVSTAPQGTPGYVD 280
            L YLH   +IHRDVKS NILLD NF  K+ DFG+S+   T++  TH+    +GT GY+D
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLGYID 209
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
           P+YF   +LT+KSDVYSFGVVL E++    A+  S  R  +NL+  A     NG L ++V
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           DP+L    D      +    + A +C+    + RP+M +VL
Sbjct: 270 DPNLA---DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 167/309 (54%), Gaps = 34/309 (11%)
Query: 100 FSCSELEEATDNFNS------SKQLGDGGFGAVYLGILRDGRIVAVKRLYE----NNFKR 149
           FS  EL+  T+NF+         ++G+GGFG VY G + +   VAVK+L         + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-- 207
            +QF  E++++ K QH NLV+L G +S    +L LVY Y+PNG++ D L      SCL  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRL------SCLDG 126
Query: 208 ---LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL---F 261
              L W +R  IA   A  + +LH +  IHRD+KS NILLD  F  K++DFGL+R    F
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
              V        GT  Y+ P+  +  ++T KSD+YSFGVVL+E+I+GL AVD  R    +
Sbjct: 187 AQTVMXXRIV--GTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-L 242
Query: 322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            L      + +   + + +D  +      +V  M +    +A +C+ + ++ RP +K+V 
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYS----VASQCLHEKKNKRPDIKKVQ 298
Query: 382 EILRETKDS 390
           ++L+E   S
Sbjct: 299 QLLQEMTAS 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 169/309 (54%), Gaps = 34/309 (11%)
Query: 100 FSCSELEEATDNFNS------SKQLGDGGFGAVYLGILRDGRIVAVKRLYE----NNFKR 149
           FS  EL+  T+NF+         ++G+GGFG VY G + +   VAVK+L         + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-- 207
            +QF  E++++ K QH NLV+L G +S    +L LVY Y+PNG++ D L      SCL  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRL------SCLDG 126
Query: 208 ---LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL---F 261
              L W +R  IA   A  + +LH +  IHRD+KS NILLD  F  K++DFGL+R    F
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
              V  + +   GT  Y+ P+  +  ++T KSD+YSFGVVL+E+I+GL AVD  R    +
Sbjct: 187 AQTV--MXSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-L 242
Query: 322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            L      + +   + + +D  +      +V  M +    +A +C+ + ++ RP +K+V 
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYS----VASQCLHEKKNKRPDIKKVQ 298
Query: 382 EILRETKDS 390
           ++L+E   S
Sbjct: 299 QLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 167/309 (54%), Gaps = 34/309 (11%)
Query: 100 FSCSELEEATDNFN------SSKQLGDGGFGAVYLGILRDGRIVAVKRLYE----NNFKR 149
           FS  EL+  T+NF+         ++G+GGFG VY G + +   VAVK+L         + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-- 207
            +QF  E++++ K QH NLV+L G +S    +L LVY Y+PNG++ D L      SCL  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRL------SCLDG 120
Query: 208 ---LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL---F 261
              L W +R  IA   A  + +LH +  IHRD+KS NILLD  F  K++DFGL+R    F
Sbjct: 121 TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
              V        GT  Y+ P+  +  ++T KSD+YSFGVVL+E+I+GL AVD  R    +
Sbjct: 181 AQXVMXXRIV--GTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-L 236
Query: 322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            L      + +   + + +D  +      +V  M +    +A +C+ + ++ RP +K+V 
Sbjct: 237 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYS----VASQCLHEKKNKRPDIKKVQ 292
Query: 382 EILRETKDS 390
           ++L+E   S
Sbjct: 293 QLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 108/307 (35%), Positives = 162/307 (52%), Gaps = 30/307 (9%)
Query: 100 FSCSELEEATDNFN------SSKQLGDGGFGAVYLGILRDGRIVAVKRLYE----NNFKR 149
           FS  EL+  T+NF+         + G+GGFG VY G + +   VAVK+L         + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-- 207
            +QF  E+++  K QH NLV+L G +S    +L LVY Y PNG++ D L      SCL  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSS-DGDDLCLVYVYXPNGSLLDRL------SCLDG 117
Query: 208 ---LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD 264
              L W  R  IA   A  + +LH +  IHRD+KS NILLD  F  K++DFGL+R     
Sbjct: 118 TPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 265 VTHVSTAP-QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL 323
              V  +   GT  Y  P+  +  ++T KSD+YSFGVVL+E+I+GL AVD  R    + L
Sbjct: 178 AQXVXXSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 235
Query: 324 SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI 383
                 + +   + + +D     + + A    V +   +A +C+ + ++ RP +K+V ++
Sbjct: 236 DIKEEIEDEEKTIEDYIDK----KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQL 291
Query: 384 LRETKDS 390
           L+E   S
Sbjct: 292 LQEXTAS 298

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 23/277 (8%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG V+LG   +   VA+K + E      E F+ E E++ KL HP LV+LYG  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             Q+  + LV+E++ +G ++D+L  ++    L      L + ++    +AYL  + VIHR
Sbjct: 75  LEQA-PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N L+  N  +KV+DFG++R    D    ST  +    +  P+ F   + + KSDV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM 355
           +SFGV++ E+ S             I   N + +++       + D S GF + Y  R  
Sbjct: 191 WSFGVLMWEVFS----------EGKIPYENRSNSEV-------VEDISTGF-RLYKPRLA 232
Query: 356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            T V ++   C ++  + RP    +L  L E  +S L
Sbjct: 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 23/277 (8%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG V+LG   +   VA+K + E      E F+ E E++ KL HP LV+LYG  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             Q+  + LV+E++ +G ++D+L  ++    L      L + ++    +AYL  + VIHR
Sbjct: 72  LEQA-PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N L+  N  +KV+DFG++R    D    ST  +    +  P+ F   + + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM 355
           +SFGV++ E+ S             I   N + +++       + D S GF + Y  R  
Sbjct: 188 WSFGVLMWEVFS----------EGKIPYENRSNSEV-------VEDISTGF-RLYKPRLA 229
Query: 356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            T V ++   C ++  + RP    +L  L E  +S L
Sbjct: 230 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 23/277 (8%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG V+LG   +   VA+K + E      E F+ E E++ KL HP LV+LYG  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             Q+  + LV+E++ +G ++D+L  ++    L      L + ++    +AYL  + VIHR
Sbjct: 70  LEQA-PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N L+  N  +KV+DFG++R    D    ST  +    +  P+ F   + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM 355
           +SFGV++ E+ S             I   N + +++       + D S GF + Y  R  
Sbjct: 186 WSFGVLMWEVFS----------EGKIPYENRSNSEV-------VEDISTGF-RLYKPRLA 227
Query: 356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            T V ++   C ++  + RP    +L  L E  +S L
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 140/277 (50%), Gaps = 23/277 (8%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG V+LG   +   VA+K + E +    + F+ E E++ KL HP LV+LYG  
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             Q+  + LV+E++ +G ++D+L  ++    L      L + ++    +AYL  + VIHR
Sbjct: 92  LEQA-PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N L+  N  +KV+DFG++R    D    ST  +    +  P+ F   + + KSDV
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM 355
           +SFGV++ E+ S             I   N + +++       + D S GF + Y  R  
Sbjct: 208 WSFGVLMWEVFS----------EGKIPYENRSNSEV-------VEDISTGF-RLYKPRLA 249
Query: 356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            T V ++   C ++  + RP    +L  L E  +S L
Sbjct: 250 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 138/277 (49%), Gaps = 23/277 (8%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG V+LG   +   VA+K + E      E F+ E E++ KL HP LV+LYG  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             Q+  + LV E++ +G ++D+L  ++    L      L + ++    +AYL  + VIHR
Sbjct: 73  LEQA-PICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N L+  N  +KV+DFG++R    D    ST  +    +  P+ F   + + KSDV
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM 355
           +SFGV++ E+ S             I   N + +++       + D S GF + Y  R  
Sbjct: 189 WSFGVLMWEVFS----------EGKIPYENRSNSEV-------VEDISTGF-RLYKPRLA 230
Query: 356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            T V ++   C ++  + RP    +L  L E  +S L
Sbjct: 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/282 (33%), Positives = 143/282 (50%), Gaps = 32/282 (11%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNL 168
           + N  +++G G FG V+      G  VAVK L E +F  +R+ +F+ EV I+ +L+HPN+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V   G  + Q   L +V EY+  G++   LH       L     RLS+A + A  + YLH
Sbjct: 97  VLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE-RRRLSMAYDVAKGMNYLH 154
Query: 229 ASD--VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
             +  ++HRD+KS N+L+D  + VKV DFGLSRL  +       A  GTP ++ P+  + 
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA-AGTPEWMAPEVLRD 213
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL-VDPSLG 345
               +KSDVYSFGV+L EL                     AT +   G LN   V  ++G
Sbjct: 214 EPSNEKSDVYSFGVILWEL---------------------ATLQQPWGNLNPAQVVAAVG 252
Query: 346 F--EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
           F  ++    RN+   VA +   C   +   RP+   ++++LR
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 23/277 (8%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG V+LG   +   VA+K + E      E F+ E E++ KL HP LV+LYG  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             Q+  + LV+E++ +G ++D+L  ++    L      L + ++    +AYL  + VIHR
Sbjct: 72  LEQA-PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N L+  N  +KV+DFG++R    D    ST  +    +  P+ F   + + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM 355
           +SFGV++ E+ S             I   N + +++       + D S GF + Y  R  
Sbjct: 188 WSFGVLMWEVFS----------EGKIPYENRSNSEV-------VEDISTGF-RLYKPRLA 229
Query: 356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            T V ++   C ++  + RP    +L  L     S L
Sbjct: 230 STHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 144/282 (51%), Gaps = 32/282 (11%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNL 168
           + N  +++G G FG V+      G  VAVK L E +F  +R+ +F+ EV I+ +L+HPN+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V   G  + Q   L +V EY+  G++   LH       L     RLS+A + A  + YLH
Sbjct: 97  VLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE-RRRLSMAYDVAKGMNYLH 154
Query: 229 ASD--VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
             +  ++HR++KS N+L+D  + VKV DFGLSRL  +      +A  GTP ++ P+  + 
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVLRD 213
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL-VDPSLG 345
               +KSDVYSFGV+L EL                     AT +   G LN   V  ++G
Sbjct: 214 EPSNEKSDVYSFGVILWEL---------------------ATLQQPWGNLNPAQVVAAVG 252
Query: 346 F--EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
           F  ++    RN+   VA +   C   +   RP+   ++++LR
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 142/275 (51%), Gaps = 28/275 (10%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V LG  +    VAVK + E +    ++F  E + + KL HP LVK YG  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           S++   + +V EYI NG + ++L  R     L P  + L +  +    +A+L +   IHR
Sbjct: 73  SKE-YPIYIVTEYISNGCLLNYL--RSHGKGLEPSQL-LEMCYDVCEGMAFLESHQFIHR 128
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSD 294
           D+ + N L+D +  VKV+DFG++R +  D  +VS+     P  +  P+ F  +K + KSD
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 295 VYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRN 354
           V++FG+++ E+ S        +  +D+  ++    K+  G  + L  P L  +       
Sbjct: 188 VWAFGILMWEVFS------LGKMPYDLYTNSEVVLKVSQG--HRLYRPHLASD------- 232
Query: 355 MVTSVAELAFRCVQQDRDMRPTMKEVL---EILRE 386
              ++ ++ + C  +  + RPT +++L   E LRE
Sbjct: 233 ---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G FG VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  S +    V L +A + + A+ YL   + I
Sbjct: 77  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV----VLLYMATQISSAMEYLEKKNFI 131
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQ-------------------VYELL------EKD 226
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 227 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEI 159
           S  + E    +     +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  +
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 60
Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIA 217
           + +++HPNLV+L G  +R+     ++ E++  G + D+L   NRQ  S +    V L +A
Sbjct: 61  MKEIKHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV----VLLYMA 115
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + + A+ YL   + IHRD+ + N L+  N  VKVADFGLSRL   D        +    
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQN 333
           +  P+     K + KSDV++FGV+L E+    +S    +D S+                 
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------------- 218
Query: 334 GALNELVDPSLGFEKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
             + EL+      EKDY +         V EL   C Q +   RP+  E+
Sbjct: 219 --VYELL------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  S +    V L +A + + A+ YL   + I
Sbjct: 79  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV----VLLYMATQISSAMEYLEKKNFI 133
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 228
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 139/291 (47%), Gaps = 41/291 (14%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVE 158
            S  + E    +     +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAA 59
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSI 216
           ++ +++HPNLV+L G  +R+     ++ E++  G + D+L   NRQ  S +    V L +
Sbjct: 60  VMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV----VLLYM 114
Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
           A + + A+ YL   + IHRD+ + N L+  N  VKVADFGLSRL   D        +   
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQ 332
            +  P+     K + KSDV++FGV+L E+    +S    +D S+                
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ---------------- 218
Query: 333 NGALNELVDPSLGFEKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              + EL+      EKDY +         V EL   C Q +   RP+  E+
Sbjct: 219 ---VYELL------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  S +    V L +A + + A+ YL   + I
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV----VLLYMATQISSAMEYLEKKNFI 138
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 233
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  S +    V L +A + + A+ YL   + I
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV----VLLYMATQISSAMEYLEKKNFI 133
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 228
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  S +    V L +A + + A+ YL   + I
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV----VLLYMATQISSAMEYLEKKNFI 133
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 228
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  S +    V L +A + + A+ YL   + I
Sbjct: 79  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV----VLLYMATQISSAMEYLEKKNFI 133
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 228
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 138/277 (49%), Gaps = 47/277 (16%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 80  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 134
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPDYFQCYKLT 290
           HRD+ + N L+  N  VKVADFGLSRL   D     TAP G      +  P+     K +
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPIKWTAPESLAYNKFS 191
Query: 291 DKSDVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            KSDV++FGV+L E+    +S    +D S+                   + EL+      
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------ 226
Query: 347 EKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           EKDY +         V EL   C Q +   RP+  E+
Sbjct: 227 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 138/277 (49%), Gaps = 47/277 (16%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 81  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 135
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP---GYVDPDYFQCYKLT 290
           HRD+ + N L+  N  VKVADFGLSRL   D     TAP G      +  P+     K +
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPIKWTAPESLAYNKFS 192
Query: 291 DKSDVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            KSDV++FGV+L E+    +S    +D S+                   + EL+      
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------ 227
Query: 347 EKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           EKDY +         V EL   C Q +   RP+  E+
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 80  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 134
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 195 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 229
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 230 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 133
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIE 218

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 138
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 233
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 137
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 198 ESKFSVASDVWSFGVVLYELFTYIE 222

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 161
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIE 246

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 135
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 196 ESKFSVASDVWSFGVVLYELFTYIE 220

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 136
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 197 ESKFSVASDVWSFGVVLYELFTYIE 221

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIE 215

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 81  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 135
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 230
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIE 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 129
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 190 ESKFSVASDVWSFGVVLYELFTYIE 214

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 134
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 195 ESKFSVASDVWSFGVVLYELFTYIE 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIE 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 81  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 135
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 230
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 128
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 189 ESKFSVASDVWSFGVVLYELFTYIE 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 148
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIE 233

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 148
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIE 233

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 138
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 233
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 84  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 138
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 233
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 92  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 146
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 207 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 241
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 242 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 83  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 137
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 198 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 232
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  S +    V L +A + + A+ YL   + I
Sbjct: 286 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV----VLLYMATQISSAMEYLEKKNFI 340
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HR++ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 435
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             G C S   R L L+ EY+P G++ D+L   Q ++  +     L    +    + YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQCY 287
              IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+     
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 288 KLTDKSDVYSFGVVLIELISGLE 310
           K +  SDV+SFGVVL EL + +E
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIE 218

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 138
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 233
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 119/223 (53%), Gaps = 13/223 (5%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEI 159
           S  + E    +     +LG G +G VY+G+ +   + VAVK L E+  + +E+F+ E  +
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 81
Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIA 217
           + +++HPNLV+L G  + +     +V EY+P G + D+L   NR+  + +    V L +A
Sbjct: 82  MKEIKHPNLVQLLGVCTLEP-PFYIVTEYMPYGNLLDYLRECNREEVTAV----VLLYMA 136
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + + A+ YL   + IHRD+ + N L+  N  VKVADFGLSRL   D        +    
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIEL----ISGLEAVDTSR 316
           +  P+       + KSDV++FGV+L E+    +S    +D S+
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 239

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 133
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 228
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 133
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 228
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 110/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ EY+P G++ D+L  H  + +   L     L    +    + YL
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 131
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHR++ + NIL++N  RVK+ DFGL+++ P D  +      G     +  P+   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 192 ESKFSVASDVWSFGVVLYELFTYIE 216

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LG G +G VY G+ +   + VAVK L E+  + +E+F+ E  ++ +++HPNLV+L G  
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 176 SRQSRELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           +R+     ++ E++  G + D+L   NRQ  + +    V L +A + + A+ YL   + I
Sbjct: 325 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAMEYLEKKNFI 379
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           HR++ + N L+  N  VKVADFGLSRL   D        +    +  P+     K + KS
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 294 DVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           DV++FGV+L E+    +S    +D S+                   + EL+      EKD
Sbjct: 440 DVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELL------EKD 474
Query: 350 YAV---RNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           Y +         V EL   C Q +   RP+  E+
Sbjct: 475 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 116 KQLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +     L+D  G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             G C S   R L L+ E++P G++ ++L  H  + +   L     L    +    + YL
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEYL 133
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                IHRD+ + NIL++N  RVK+ DFGL+++ P D         G     +  P+   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
             K +  SDV+SFGVVL EL + +E
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIE 218

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 45/288 (15%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 176 SRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           ++Q R + ++ EY+ NG + ++L    H  Q    L        +  +   A+ YL +  
Sbjct: 74  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLL-------EMCKDVCEAMEYLESKQ 125
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
            +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K + 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE-------LVDPSL 344
           KSD+++FGV++ E+ S               L  M   +  N    E       L  P L
Sbjct: 186 KSDIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHL 230
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
             EK Y +           + C  +  D RPT K +L  + +  D NL
Sbjct: 231 ASEKVYTI----------MYSCWHEKADERPTFKILLSNILDVMDENL 268

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 29/274 (10%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG+G FG V++G       VA+K L        E F+ E +I+ KL+H  LV+LY   
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           S +   + +V EY+  G++ D L + +  +  LP    + +A + A  +AY+   + IHR
Sbjct: 74  SEEP--IYIVTEYMNKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYIERMNYIHR 129
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D++S NIL+ N    K+ADFGL+RL   +        +    +  P+     + T KSDV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAV--- 352
           +SFG++L EL++          +  +    M   ++               E+ Y +   
Sbjct: 190 WSFGILLTELVT----------KGRVPYPGMNNREVLEQV-----------ERGYRMPCP 228
Query: 353 RNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           ++   S+ EL   C ++D + RPT + +   L +
Sbjct: 229 QDCPISLHELMIHCWKKDPEERPTFEYLQSFLED 262

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 113/210 (53%), Gaps = 21/210 (10%)
Query: 117 QLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +LG+G FG V+L         +D  +VAVK L E +    + F  E E+LT LQH ++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL-------PWPVRL----SIAI 218
            +G CT  + R LL+V+EY+ +G +   L +  P++ LL       P P+ L    ++A 
Sbjct: 108 FFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPG 277
           + A  + YL     +HRD+ + N L+     VK+ DFG+SR ++ TD   V         
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++ P+     K T +SDV+SFGVVL E+ +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 113/210 (53%), Gaps = 21/210 (10%)
Query: 117 QLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +LG+G FG V+L         +D  +VAVK L E +    + F  E E+LT LQH ++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL-------PWPVRL----SIAI 218
            +G CT  + R LL+V+EY+ +G +   L +  P++ LL       P P+ L    ++A 
Sbjct: 79  FFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPG 277
           + A  + YL     +HRD+ + N L+     VK+ DFG+SR ++ TD   V         
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++ P+     K T +SDV+SFGVVL E+ +
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 113/210 (53%), Gaps = 21/210 (10%)
Query: 117 QLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +LG+G FG V+L         +D  +VAVK L E +    + F  E E+LT LQH ++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL-------PWPV----RLSIAI 218
            +G CT  + R LL+V+EY+ +G +   L +  P++ LL       P P+     L++A 
Sbjct: 85  FFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPG 277
           + A  + YL     +HRD+ + N L+     VK+ DFG+SR ++ TD   V         
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++ P+     K T +SDV+SFGVVL E+ +
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 176 SRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           ++Q R + ++ EY+ NG + ++L    H  Q    L        +  +   A+ YL +  
Sbjct: 89  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLL-------EMCKDVCEAMEYLESKQ 140
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
            +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K + 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           KSD+++FGV++ E+ S               L  M   +  N    E +   L   + + 
Sbjct: 201 KSDIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHL 245
Query: 352 VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD 389
               V ++    + C  +  D RPT K +L  + +  D
Sbjct: 246 ASEKVYTI---MYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 176 SRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           ++Q R + ++ EY+ NG + ++L    H  Q    L        +  +   A+ YL +  
Sbjct: 89  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLL-------EMCKDVCEAMEYLESKQ 140
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
            +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K + 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           KSD+++FGV++ E+ S               L  M   +  N    E +   L   + + 
Sbjct: 201 KSDIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHL 245
Query: 352 VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD 389
               V ++    + C  +  D RPT K +L  + +  D
Sbjct: 246 ASEKVYTI---MYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 176 SRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           ++Q R + ++ EY+ NG + ++L    H  Q    L        +  +   A+ YL +  
Sbjct: 73  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLL-------EMCKDVCEAMEYLESKQ 124
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
            +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K + 
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE-------LVDPSL 344
           KSD+++FGV++ E+ S               L  M   +  N    E       L  P L
Sbjct: 185 KSDIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHL 229
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN 391
             EK Y +           + C  +  D RPT K +L  + +  D  
Sbjct: 230 ASEKVYTI----------MYSCWHEKADERPTFKILLSNILDVMDEE 266

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 176 SRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           ++Q R + ++ EY+ NG + ++L    H  Q    L        +  +   A+ YL +  
Sbjct: 80  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLL-------EMCKDVCEAMEYLESKQ 131
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
            +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K + 
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE-------LVDPSL 344
           KSD+++FGV++ E+ S               L  M   +  N    E       L  P L
Sbjct: 192 KSDIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHL 236
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN 391
             EK Y +           + C  +  D RPT K +L  + +  D  
Sbjct: 237 ASEKVYTI----------MYSCWHEKADERPTFKILLSNILDVMDEE 273

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 176 SRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           ++Q R + ++ EY+ NG + ++L    H  Q    L        +  +   A+ YL +  
Sbjct: 69  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLL-------EMCKDVCEAMEYLESKQ 120
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
            +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE-------LVDPSL 344
           KSD+++FGV++ E+ S               L  M   +  N    E       L  P L
Sbjct: 181 KSDIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN 391
             EK Y +           + C  +  D RPT K +L  + +  D  
Sbjct: 226 ASEKVYTI----------MYSCWHEKADERPTFKILLSNILDVMDEE 262

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 45/285 (15%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 176 SRQSRELLLVYEYIPNGTVADHL----HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           ++Q R + ++ EY+ NG + ++L    H  Q    L        +  +   A+ YL +  
Sbjct: 74  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLL-------EMCKDVCEAMEYLESKQ 125
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
            +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K + 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE-------LVDPSL 344
           KSD+++FGV++ E+ S               L  M   +  N    E       L  P L
Sbjct: 186 KSDIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHL 230
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD 389
             EK Y +           + C  +  D RPT K +L  + +  D
Sbjct: 231 ASEKVYTI----------MYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 38/285 (13%)
Query: 118 LGDGGFG-AVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           LG G FG A+ +     G ++ +K L   + +    F+ EV+++  L+HPN++K  G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
           +  R L  + EYI  GT+   + +        PW  R+S A + A  +AYLH+ ++IHRD
Sbjct: 78  KDKR-LNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS-----TAPQ--------GTPGYVDPDY 283
           + S+N L+  N  V VADFGL+RL   + T          P         G P ++ P+ 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS 343
                  +K DV+SFG+VL E+I              +N       +  +  LN      
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIG------------RVNADPDYLPRTMDFGLN-----V 236
Query: 344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT---MKEVLEILR 385
            GF   Y   N   S   +  RC   D + RP+   ++  LE LR
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 141/309 (45%), Gaps = 42/309 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ 164
           N    ++LG+G FG V+L         +D  +VAVK L + +    + F  E E+LT LQ
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL----PWPVRLS----- 215
           H ++VK YG    +   L++V+EY+ +G +   L    P++ L+    P P  L+     
Sbjct: 74  HEHIVKFYG-VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP-PTELTQSQML 131
Query: 216 -IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQ 273
            IA + A  + YL +   +HRD+ + N L+  N  VK+ DFG+SR ++ TD   V     
Sbjct: 132 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
               ++ P+     K T +SDV+S GVVL E+ +                      ++ N
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT---------------YGKQPWYQLSN 236
Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLG 393
             + E +      ++    R     V EL   C Q++  MR  +K +  +L+     NL 
Sbjct: 237 NEVIECITQGRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ-----NLA 288
Query: 394 TSKAKVVDI 402
            +    +DI
Sbjct: 289 KASPVYLDI 297

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 38/288 (13%)
Query: 116 KQLGDGGFGAVYLG------ILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++LG+G FG V+L         +D  +VAVK L +      + F  E E+LT LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL----PWPVR--------LSIA 217
           K YG        L++V+EY+ +G +   L    P++ +L    P   +        L IA
Sbjct: 81  KFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTP 276
            + A  + YL +   +HRD+ + N L+  N  VK+ DFG+SR ++ TD   V        
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
            ++ P+     K T +SDV+SFGV+L E+ +                      ++ N  +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQLSNTEV 244
Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            E +      E+    R     V ++   C Q++   R  +KE+ +IL
Sbjct: 245 IECITQGRVLERP---RVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 106/194 (54%), Gaps = 8/194 (4%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V++G   +   VAVK L       ++ F+ E  ++  LQH  LV+LY   
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +R+   + ++ EY+  G++ D L + +    LLP  +  S  I  A  +AY+   + IHR
Sbjct: 78  TREE-PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIERKNYIHR 134
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY--FQCYKLTDKS 293
           D+++ N+L+  +   K+ADFGL+R+   +        +    +  P+   F C+  T KS
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF--TIKS 192
Query: 294 DVYSFGVVLIELIS 307
           DV+SFG++L E+++
Sbjct: 193 DVWSFGILLYEIVT 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 114/220 (51%), Gaps = 22/220 (10%)
Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVE 158
           S+ +   ++F+  + LG G FG VYL   R  + I+A+K L++   ++     Q   EVE
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVR 213
           I + L+HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +     
Sbjct: 65  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTATYI----- 118
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
                E A AL+Y H+  VIHRD+K  N+LL +N  +K+ADFG S   P+      T   
Sbjct: 119 ----TELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS---RRTTLC 171
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
           GT  Y+ P+  +     +K D++S GV+  E + G+   +
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHP 166
           +F   + LG G FG V+L   R +GR  A+K L +      K++E   +E  +L+ + HP
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            +++++G T + ++++ ++ +YI  G +   L   Q      P PV    A E   AL Y
Sbjct: 67  FIIRMWG-TFQDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEY 121
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           LH+ D+I+RD+K  NILLD N  +K+ DFG ++  P DVT+      GTP Y+ P+    
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYXLC---GTPDYIAPEVVST 177
Query: 287 YKLTDKSDVYSFGVVLIELISG 308
                  D +SFG+++ E+++G
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAG 199

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L   N    E F+ E +++ KL+H  LV+LY   S
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 251 EEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 306
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL RL   +        +    +  P+     + T KSDV+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 367 SFGILLTELTT 377

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 18/279 (6%)
Query: 116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G +VAVK L  +   +    +  E++IL  L H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 170 KLYGCTSRQS-RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  GC   Q  + L LV EY+P G++ D+L         L     L  A +    +AYLH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 134
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQC 286
           A   IHR++ + N+LLDN+  VK+ DFGL++  P    +      G     +  P+  + 
Sbjct: 135 AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
           YK    SDV+SFGV L EL++  ++  +   +  + L  +A  ++    L EL++     
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLERG--- 250
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
           E+          V  L   C + +   RPT + ++ IL+
Sbjct: 251 ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 133/283 (46%), Gaps = 18/283 (6%)
Query: 116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G +VAVK L E    ++   +  E+EIL  L H ++V
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 170 KLYGCTSRQS-RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  GC   Q  + + LV EY+P G++ D+L    P  C+      L  A +    +AYLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCV-GLAQLLLFAQQICEGMAYLH 129
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQC 286
           A   IHR + + N+LLDN+  VK+ DFGL++  P    +      G     +  P+  + 
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K    SDV+SFGV L EL++  ++ + S H     L      ++    L EL++     
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLRLTELLERG--- 245
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD 389
           E+          +  L   C + +   RPT + ++ IL+  ++
Sbjct: 246 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 288

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 133/283 (46%), Gaps = 18/283 (6%)
Query: 116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G +VAVK L E    ++   +  E+EIL  L H ++V
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 170 KLYGCTSRQS-RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  GC   Q  + + LV EY+P G++ D+L    P  C+      L  A +    +AYLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCV-GLAQLLLFAQQICEGMAYLH 128
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQC 286
           A   IHR + + N+LLDN+  VK+ DFGL++  P    +      G     +  P+  + 
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K    SDV+SFGV L EL++  ++ + S H     L      ++    L EL++     
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLRLTELLERG--- 244
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD 389
           E+          +  L   C + +   RPT + ++ IL+  ++
Sbjct: 245 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 287

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 113/220 (51%), Gaps = 22/220 (10%)
Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVE 158
           S+ +   ++F+  + LG G FG VYL   R  + I+A+K L++   ++     Q   EVE
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVR 213
           I + L+HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +     
Sbjct: 65  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTATYI----- 118
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
                E A AL+Y H+  VIHRD+K  N+LL +N  +K+ADFG S   P+          
Sbjct: 119 ----TELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC--- 171
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
           GT  Y+ P+  +     +K D++S GV+  E + G+   +
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   ++ + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDSTR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+       A  GT  Y
Sbjct: 116 ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRAALCGTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N   +  +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQDTYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 59
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 115
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 2   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 60
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 61  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 116
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 117 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 176
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 116
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS---RRTTLSGTLDY 173
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 223
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 224 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 257

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 136/289 (47%), Gaps = 42/289 (14%)
Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVE 158
           S+ + A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVE
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 64
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVR 213
           I + L+HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +     
Sbjct: 65  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI----- 118
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
                E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   
Sbjct: 119 ----TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLC 171
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
           GT  Y+ P+  +     +K D++S GV+  E + G    +          +N      + 
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKR 221
Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            +  E   P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 222 ISRVEFTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 260

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 3   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 61
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 62  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 117
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 118 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 177
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 59
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 115
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 9   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 67
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 68  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 123
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 124 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 183
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 184 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 7   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 121
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 122 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 181
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 250 EEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 305
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 366 SFGILLTELTT 376

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 10  KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 68
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 69  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 124
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 125 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 184
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 6   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 64
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 65  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 121 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 180
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 333 EEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 388
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 449 SFGILLTELTT 459

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 120
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 177
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 227
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 228 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPXLREVLE 261

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 59
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 115
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 250 EEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 305
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 366 SFGILLTELTT 376

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 7   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 121
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 122 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 181
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 108/204 (52%), Gaps = 5/204 (2%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           E E   +     ++LG G FG V++G       VAVK L + +    + F+ E  ++ +L
Sbjct: 2   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 60
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           QH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A + A  
Sbjct: 61  QHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    +  P+ 
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
                 T KSDV+SFG++L E+++
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVT 200

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 74  EEP--IXIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 129
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 190 SFGILLTELTT 200

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 18/279 (6%)
Query: 116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G +VAVK L  +   +    +  E++IL  L H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 170 KLYGCTSRQS-RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  GC   Q  + L LV EY+P G++ D+L         L     L  A +    +AYLH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 134
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQC 286
           +   IHR++ + N+LLDN+  VK+ DFGL++  P    +      G     +  P+  + 
Sbjct: 135 SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
           YK    SDV+SFGV L EL++  ++  +   +  + L  +A  ++    L EL++     
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLERG--- 250
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
           E+          V  L   C + +   RPT + ++ IL+
Sbjct: 251 ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 118
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 175
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 225
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 226 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 120
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 177
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 227
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 228 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 118
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 175
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 225
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 226 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 259

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V +S  I  A  +AY+   + +HRD
Sbjct: 81  EEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERMNYVHRD 136
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 197 SFGILLTELTT 207

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+       A  GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRAALCGTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEV 157
           K +   E E   +     ++LG G FG V++G       VAVK L + +    + F+ E 
Sbjct: 11  KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 69
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            ++ +LQH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A
Sbjct: 70  NLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMA 125
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            + A  +A++   + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    
Sbjct: 126 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 185
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +  P+       T KSDV+SFG++L E+++
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 65  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 114
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 115 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 171
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 221
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 222 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 255

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 18/291 (6%)
Query: 116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G +VAVK L  +   +    +  E++IL  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 170 KLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  GC     +  L LV EY+P G++ D+L         L     L  A +    +AYLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQC 286
           A   IHRD+ + N+LLDN+  VK+ DFGL++  P           G     +  P+  + 
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
           YK    SDV+SFGV L EL++  ++  +   +  + L  +A  ++    L EL++     
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLERG--- 267
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKA 397
           E+          V  L   C + +   RPT + ++ IL+   +   G + +
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 83  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 132
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 133 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 189
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 239
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 240 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 273

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 250 EEP--IYIVGEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 305
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 366 SFGILLTELTT 376

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTXLCGTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 73  EEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 128
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 189 SFGILLTELTT 199

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 75  EEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 130
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 191 SFGILLTELTT 201

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V +S  I  A  +AY+   + +HRD
Sbjct: 81  EEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERMNYVHRD 136
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 197 SFGILLTELTT 207

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 77  EEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 132
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 193 SFGILLTELTT 203

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P G V   L      + Q  +  +          
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTATYI---------T 120
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 177
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 227
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 228 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 261

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 118
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+       A  GT  Y
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRAALCGTLDY 175
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 225
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 226 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 259

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 141
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 198
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 248
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 249 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 282

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTELCGTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G + D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G + D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 120
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDY 177
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 227
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 228 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 116
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDY 173
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 223
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 224 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ K++H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           +++ NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 63  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 112
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+      T   GT  Y
Sbjct: 113 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDY 169
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 219
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 220 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 253

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/322 (28%), Positives = 153/322 (47%), Gaps = 49/322 (15%)
Query: 93  SYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE- 144
           S+  A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEA 60
Query: 145 -NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP 203
            +  +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P
Sbjct: 61  ASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRP 118
Query: 204 ---NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG 256
              N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG
Sbjct: 119 EMENNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 257 LSRLFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA 311
           ++R    D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       
Sbjct: 178 MTR----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE------- 226
Query: 312 VDTSRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD 370
           + T   +    LSN    + +  G L +  D            N    + EL   C Q +
Sbjct: 227 IATLAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYN 274
Query: 371 RDMRPTMKEVLEILRETKDSNL 392
             MRP+  E++  ++E  +   
Sbjct: 275 PKMRPSFLEIISSIKEEMEPGF 296

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 5/191 (2%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            +   + +V EY+  G++ D L         LP  V   +A + A  +AY+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRD 139
Query: 237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVY 296
           + + NIL+  N   KVADFGL+RL   +        +    +  P+     + T KSDV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 297 SFGVVLIELIS 307
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 106/194 (54%), Gaps = 8/194 (4%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V++G   +   VAVK L       ++ F+ E  ++  LQH  LV+LY   
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +++   + ++ E++  G++ D L + +    LLP  +  S  I  A  +AY+   + IHR
Sbjct: 77  TKE-EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIERKNYIHR 133
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY--FQCYKLTDKS 293
           D+++ N+L+  +   K+ADFGL+R+   +        +    +  P+   F C+  T KS
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF--TIKS 191
Query: 294 DVYSFGVVLIELIS 307
           +V+SFG++L E+++
Sbjct: 192 NVWSFGILLYEIVT 205

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 141/294 (47%), Gaps = 31/294 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 15  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    +      + IA +T
Sbjct: 75  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQT 129
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GT 275
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+    T+ +  S + Q     G+
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGS 185
Query: 276 PGYVDPDYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
             ++ P+  +       + +SDVY+FG+VL EL++G           +IN  +     + 
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVG 239
Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
            G+L+    P L   +    + M   +AE    C+++ RD RP+   +L  + E
Sbjct: 240 RGSLS----PDLSKVRSNCPKRMKRLMAE----CLKKKRDERPSFPRILAEIEE 285

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 117
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+          GT  Y
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDY 174
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 224
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 225 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 116
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+          GT  Y
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC---GTLDY 173
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 223
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 224 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 115
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+          GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 222
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 223 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 118
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+          GT  Y
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDY 175
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 225
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 226 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 259

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P G V   L      + Q  +  +          
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTATYI---------T 120
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+          GT  Y
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRXXLXGTLDY 177
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 227
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 228 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 117
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+A+FG S   P+      T   GT  Y
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS---RRTTLCGTLDY 174
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 224
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 225 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 258

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 118/232 (50%), Gaps = 28/232 (12%)
Query: 95  FGAKVFSCSELEEATDN-FNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENN------ 146
            G   F  S L    DN     KQ+G GGFG V+ G +++D  +VA+K L   +      
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 147 -FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
             ++ ++F  EV I++ L HPN+VKLYG      R   +V E++P G   D  H     +
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR---MVMEFVPCG---DLYHRLLDKA 116
Query: 206 CLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNIL---LDNNFRV--KVADFGLS 258
             + W V+L + ++ A  + Y+   +  ++HRD++S NI    LD N  V  KVADFGLS
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCYK--LTDKSDVYSFGVVLIELISG 308
           +       H  +   G   ++ P+     +   T+K+D YSF ++L  +++G
Sbjct: 177 Q----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 5/204 (2%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           E E   +     ++LG G FG V++G       VAVK L + +    + F+ E  ++ +L
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           QH  LV+LY   +++   + ++ EY+ NG++ D L  + P+   L     L +A + A  
Sbjct: 62  QHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           +A++   + IHR++++ NIL+ +    K+ADFGL+RL   +        +    +  P+ 
Sbjct: 118 MAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 177
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
                 T KSDV+SFG++L E+++
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVT 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 42/284 (14%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 118
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E A AL+Y H+  VIHRD+K  N+LL +   +K+A+FG S   P+      T   GT  Y
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS---RRTTLCGTLDY 175
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           + P+  +     +K D++S GV+  E + G    +          +N      +  +  E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVE 225
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
              P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 226 FTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 259

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 116 KQLGDGGFGAVYLGILRDGR-----IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           K +G G FG VY G+L+         VA+K L      K+   F+ E  I+ +  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +L G  S+  + ++++ EY+ NG +   L  +     +L     + +    A  + YL  
Sbjct: 110 RLEGVISKY-KPMMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAGMKYLAN 165
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD--VTHVSTAPQGTPGYVDPDYFQCY 287
            + +HRD+ + NIL+++N   KV+DFGLSR+   D   T+ ++  +    +  P+     
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE 347
           K T  SDV+SFG+V+ E++       T   R    LSN    K    A+N+      GF 
Sbjct: 226 KFTSASDVWSFGIVMWEVM-------TYGERPYWELSNHEVMK----AIND------GFR 268
Query: 348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
               + +  +++ +L  +C QQ+R  RP   +++ IL
Sbjct: 269 LPTPM-DCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 138/290 (47%), Gaps = 23/290 (7%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 3   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 62
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    +      + IA +T
Sbjct: 63  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQT 117
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYV 279
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++
Sbjct: 118 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 177
Query: 280 DPDYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
            P+  +       + +SDVY+FG+VL EL++G           +IN  +     +  G+L
Sbjct: 178 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGSL 231
Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +    P L   +    + M   +AE    C+++ RD RP+   +L  + E
Sbjct: 232 S----PDLSKVRSNCPKRMKRLMAE----CLKKKRDERPSFPRILAEIEE 273

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 138/279 (49%), Gaps = 31/279 (11%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG VY G       V +  +     ++++ F NEV +L K +H N++   G +
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +  + +L +V ++    ++  HLH  +    +      + IA +TA  + YLHA  +IHR
Sbjct: 90  T--APQLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQTARGMDYLHAKSIIHR 144
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDYFQCY--- 287
           D+KSNNI L  +  VK+ DFGL+    T+ +  S + Q     G+  ++ P+  +     
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE 347
             + +SDVY+FG+VL EL++G           +IN  +     +  G+L+    P L   
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGSLS----PDLSKV 250
Query: 348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +    + M   +AE    C+++ RD RP+   +L  + E
Sbjct: 251 RSNCPKRMKRLMAE----CLKKKRDERPSFPRILAEIEE 285

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 140/292 (47%), Gaps = 37/292 (12%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 78
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    ++     + IA +T
Sbjct: 79  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQT 133
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GT 275
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+    T+ +  S + Q     G+
Sbjct: 134 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGS 189
Query: 276 PGYVDPDYFQCYKLTDK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN 329
             ++ P+     ++ DK      SDVY+FG+VL EL++G           +IN  +    
Sbjct: 190 ILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIF 240
Query: 330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            +  G L+    P L   +    + M   +AE    C+++ RD RP   ++L
Sbjct: 241 MVGRGYLS----PDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 91/322 (28%), Positives = 153/322 (47%), Gaps = 49/322 (15%)
Query: 93  SYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE- 144
           S+  A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEA 60
Query: 145 -NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP 203
            +  +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P
Sbjct: 61  ASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRP 118
Query: 204 ---NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG 256
              N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG
Sbjct: 119 EMENNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 257 LSRLFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA 311
           ++R    D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       
Sbjct: 178 MTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE------- 226
Query: 312 VDTSRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD 370
           + T   +    LSN    + +  G L +  D            N    + EL   C Q +
Sbjct: 227 IATLAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYN 274
Query: 371 RDMRPTMKEVLEILRETKDSNL 392
             MRP+  E++  ++E  +   
Sbjct: 275 PKMRPSFLEIISSIKEEMEPGF 296

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 140/292 (47%), Gaps = 37/292 (12%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 86
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    ++     + IA +T
Sbjct: 87  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQT 141
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GT 275
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+    T+ +  S + Q     G+
Sbjct: 142 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGS 197
Query: 276 PGYVDPDYFQCYKLTDK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN 329
             ++ P+     ++ DK      SDVY+FG+VL EL++G           +IN  +    
Sbjct: 198 ILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIF 248
Query: 330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            +  G L+    P L   +    + M   +AE    C+++ RD RP   ++L
Sbjct: 249 MVGRGYLS----PDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 292

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 91/312 (29%), Positives = 148/312 (47%), Gaps = 45/312 (14%)
Query: 95  FGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF- 147
           F + VF   E E + +     ++LG G FG VY G  RD   G     VAVK + E+   
Sbjct: 2   FPSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 148 -KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   
Sbjct: 62  RERIE-FLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 204 NSCLLPWPV---RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           N+   P P     + +A E A  +AYL+A   +HRD+ + N ++ ++F VK+ DFG++R 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR- 178
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+       +G  G     ++ P+  +    T  SD++SFGVVL E+ S  E     
Sbjct: 179 ---DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ- 234
Query: 316 RHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
                  LSN    K + +G   +  D            N    V +L   C Q +  MR
Sbjct: 235 ------GLSNEQVLKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPKMR 276
Query: 375 PTMKEVLEILRE 386
           PT  E++ +L++
Sbjct: 277 PTFLEIVNLLKD 288

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 50/288 (17%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 118
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ----G 274
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S        H  ++ +    G
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCG 171
Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
           T  Y+ P+  +     +K D++S GV+  E + G    +          +N      +  
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRI 221
Query: 335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +  E   P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 222 SRVEFTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 134/288 (46%), Gaps = 50/288 (17%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKRI---EQFMNEVEILTKL 163
           A ++F   + LG G FG VYL   +  + I+A+K L++   ++     Q   EVEI + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-----NRQPNSCLLPWPVRLSIAI 218
           +HPN+++LYG     +R + L+ EY P GTV   L      + Q  +  +          
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------T 141
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT----DVTHVSTAPQG 274
           E A AL+Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+    D+        G
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-------G 194
Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
           T  Y+ P+  +     +K D++S GV+  E + G    +          +N      +  
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRI 244
Query: 335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +  E   P    E     R++++       R ++ +   RP ++EVLE
Sbjct: 245 SRVEFTFPDFVTE---GARDLIS-------RLLKHNPSQRPMLREVLE 282

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/319 (28%), Positives = 151/319 (47%), Gaps = 49/319 (15%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE--NN 146
            A VF   E E A +    S++LG G FG VY G+ + G +       VA+K + E  + 
Sbjct: 2   AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 60
Query: 147 FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P   
Sbjct: 61  RERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEME 118
Query: 204 NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
           N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R
Sbjct: 119 NNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 260 LFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT 314
               D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       + T
Sbjct: 178 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IAT 226
Query: 315 SRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM 373
              +    LSN    + +  G L +  D            N    + EL   C Q +  M
Sbjct: 227 LAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYNPKM 274
Query: 374 RPTMKEVLEILRETKDSNL 392
           RP+  E++  ++E  +   
Sbjct: 275 RPSFLEIISSIKEEMEPGF 293

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 131/271 (48%), Gaps = 23/271 (8%)
Query: 115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           S ++G G FG VY G       V + ++ +   ++ + F NEV +L K +H N++   G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
            ++ +  L +V ++    ++  HLH ++    +      + IA +TA  + YLHA ++IH
Sbjct: 101 MTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDYLHAKNIIH 155
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPDYFQCY---KLT 290
           RD+KSNNI L     VK+ DFGL+ +      +     P G+  ++ P+  +       +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 291 DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            +SDVYS+G+VL EL++G        +R  I    M      +  L++L           
Sbjct: 216 FQSDVYSYGIVLYELMTGELPYSHINNRDQIIF--MVGRGYASPDLSKL----------- 262
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
             +N   ++  L   CV++ ++ RP   ++L
Sbjct: 263 -YKNCPKAMKRLVADCVKKVKEERPLFPQIL 292

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 137/288 (47%), Gaps = 29/288 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 86
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    ++     + IA +T
Sbjct: 87  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQT 141
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYV 279
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++
Sbjct: 142 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 201
Query: 280 DPDYFQCYKLTDK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
            P+     ++ DK      SDVY+FG+VL EL++G           +IN  +     +  
Sbjct: 202 APEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGR 252
Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           G L+    P L   +    + M   +AE    C+++ RD RP   ++L
Sbjct: 253 GYLS----PDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 292

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 137/288 (47%), Gaps = 29/288 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    ++     + IA +T
Sbjct: 61  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQT 115
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYV 279
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++
Sbjct: 116 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 280 DPDYFQCYKLTDK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
            P+     ++ DK      SDVY+FG+VL EL++G           +IN  +     +  
Sbjct: 176 APEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGR 226
Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           G L+    P L   +    + M   +AE    C+++ RD RP   ++L
Sbjct: 227 GYLS----PDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 266

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 137/288 (47%), Gaps = 29/288 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 26  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 85
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    ++     + IA +T
Sbjct: 86  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQT 140
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYV 279
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++
Sbjct: 141 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 280 DPDYFQCYKLTDK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
            P+     ++ DK      SDVY+FG+VL EL++G           +IN  +     +  
Sbjct: 201 APEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGR 251
Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           G L+    P L   +    + M   +AE    C+++ RD RP   ++L
Sbjct: 252 GYLS----PDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 291

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 137/288 (47%), Gaps = 29/288 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    ++     + IA +T
Sbjct: 64  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQT 118
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYV 279
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 280 DPDYFQCYKLTDK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
            P+     ++ DK      SDVY+FG+VL EL++G           +IN  +     +  
Sbjct: 179 APEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGR 229
Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           G L+    P L   +    + M   +AE    C+++ RD RP   ++L
Sbjct: 230 GYLS----PDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 269

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 137/288 (47%), Gaps = 29/288 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL 160
           S  + E         +++G G FG VY G       V +  +     ++++ F NEV +L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
            K +H N++   G +++   +L +V ++    ++  HLH  +    ++     + IA +T
Sbjct: 64  RKTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQT 118
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYV 279
           A  + YLHA  +IHRD+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 280 DPDYFQCYKLTDK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
            P+     ++ DK      SDVY+FG+VL EL++G           +IN  +     +  
Sbjct: 179 APEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGR 229
Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           G L+    P L   +    + M   +AE    C+++ RD RP   ++L
Sbjct: 230 GYLS----PDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 269

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/219 (33%), Positives = 109/219 (49%), Gaps = 15/219 (6%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQ 152
           G  + SC++ +    N+   K +G G F  V L   +  GR VA+K + +   N   +++
Sbjct: 1   GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK 60
Query: 153 FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPW 210
              EV I+  L HPN+VKL+     + + L L+ EY   G V D+L  H R         
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETE-KTLYLIMEYASGGEVFDYLVAHGRMKEK----- 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST 270
             R S   +   A+ Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F   V     
Sbjct: 115 EAR-SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLD 171
Query: 271 APQGTPGYVDPDYFQCYKLTD-KSDVYSFGVVLIELISG 308
           A  G P Y  P+ FQ  K    + DV+S GV+L  L+SG
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 149/312 (47%), Gaps = 45/312 (14%)
Query: 95  FGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF- 147
           F + V+   E E + +     ++LG G FG VY G  RD   G     VAVK + E+   
Sbjct: 2   FPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 148 -KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   
Sbjct: 62  RERIE-FLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 204 NSCLLPWPV---RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           N+   P P     + +A E A  +AYL+A   +HRD+ + N ++ ++F VK+ DFG++R 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR- 178
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+       +G  G     ++ P+  +    T  SD++SFGVVL E+ S  E     
Sbjct: 179 ---DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 235
Query: 316 RHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
                  LSN    K + +G   +  D            N    V +L   C Q + +MR
Sbjct: 236 -------LSNEQVLKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPNMR 276
Query: 375 PTMKEVLEILRE 386
           PT  E++ +L++
Sbjct: 277 PTFLEIVNLLKD 288

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 91/312 (29%), Positives = 149/312 (47%), Gaps = 45/312 (14%)
Query: 95  FGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF- 147
           F + VF   E E + +     ++LG G FG VY G  RD   G     VAVK + E+   
Sbjct: 2   FPSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 148 -KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   
Sbjct: 62  RERIE-FLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 204 NSCLLPWPV---RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           N+   P P     + +A E A  +AYL+A   +HRD+ + N ++ ++F VK+ DFG++R 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR- 178
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   +   +G  G     ++ P+  +    T  SD++SFGVVL E+ S  E     
Sbjct: 179 ---DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ- 234
Query: 316 RHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
                  LSN    K + +G   +  D            N    V +L   C Q +  MR
Sbjct: 235 ------GLSNEQVLKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPKMR 276
Query: 375 PTMKEVLEILRE 386
           PT  E++ +L++
Sbjct: 277 PTFLEIVNLLKD 288

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 137/277 (49%), Gaps = 37/277 (13%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG VY G       V +  +     ++++ F NEV +L K +H N++   G +
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           ++   +L +V ++    ++  HLH  +    ++     + IA +TA  + YLHA  +IHR
Sbjct: 74  TKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKSIIHR 128
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDYFQCYKLT 290
           D+KSNNI L  +  VK+ DFGL+    T+ +  S + Q     G+  ++ P+     ++ 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 181
Query: 291 DK------SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
           DK      SDVY+FG+VL EL++G           +IN  +     +  G L+    P L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLS----PDL 231
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
              +    + M   +AE    C+++ RD RP   ++L
Sbjct: 232 SKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQIL 264

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/322 (28%), Positives = 153/322 (47%), Gaps = 50/322 (15%)
Query: 94  YF-GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE- 144
           YF  A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E 
Sbjct: 8   YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEA 66
Query: 145 -NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP 203
            +  +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P
Sbjct: 67  ASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRP 124
Query: 204 ---NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG 256
              N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG
Sbjct: 125 AMANNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183
Query: 257 LSRLFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA 311
           ++R    D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       
Sbjct: 184 MTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE------- 232
Query: 312 VDTSRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD 370
           + T   +    LSN    + +  G L +  D            N    + EL   C Q +
Sbjct: 233 IATLAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYN 280
Query: 371 RDMRPTMKEVLEILRETKDSNL 392
             MRP+  E++  ++E  +   
Sbjct: 281 PKMRPSFLEIISSIKEEMEPGF 302

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 142/310 (45%), Gaps = 44/310 (14%)
Query: 95  FGAKVFSCSELEEATDN-FNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENN------ 146
            G   F  S L    DN     KQ+G GGFG V+ G +++D  +VA+K L   +      
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 147 -FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
             ++ ++F  EV I++ L HPN+VKLYG      R   +V E++P G   D  H     +
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR---MVMEFVPCG---DLYHRLLDKA 116
Query: 206 CLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNIL---LDNNFRV--KVADFGLS 258
             + W V+L + ++ A  + Y+   +  ++HRD++S NI    LD N  V  KVADFG S
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS 176
Query: 259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCYK--LTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +       H  +   G   ++ P+     +   T+K+D YSF ++L  +++G    D   
Sbjct: 177 Q----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
           +   I   NM   +     + E   P L        RN++    EL   C   D   RP 
Sbjct: 233 Y-GKIKFINMIREEGLRPTIPEDCPPRL--------RNVI----EL---CWSGDPKKRPH 276
Query: 377 MKEVLEILRE 386
              +++ L E
Sbjct: 277 FSYIVKELSE 286

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 92/322 (28%), Positives = 153/322 (47%), Gaps = 50/322 (15%)
Query: 94  YF-GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE- 144
           YF  A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E 
Sbjct: 8   YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEA 66
Query: 145 -NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP 203
            +  +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P
Sbjct: 67  ASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRP 124
Query: 204 ---NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG 256
              N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG
Sbjct: 125 EMENNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183
Query: 257 LSRLFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA 311
           ++R    D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       
Sbjct: 184 MTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE------- 232
Query: 312 VDTSRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD 370
           + T   +    LSN    + +  G L +  D            N    + EL   C Q +
Sbjct: 233 IATLAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYN 280
Query: 371 RDMRPTMKEVLEILRETKDSNL 392
             MRP+  E++  ++E  +   
Sbjct: 281 PKMRPSFLEIISSIKEEMEPGF 302

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 151/319 (47%), Gaps = 49/319 (15%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE--NN 146
            A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E  + 
Sbjct: 1   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 59
Query: 147 FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P   
Sbjct: 60  RERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMA 117
Query: 204 NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
           N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R
Sbjct: 118 NNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 176
Query: 260 LFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT 314
               D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       + T
Sbjct: 177 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IAT 225
Query: 315 SRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM 373
              +    LSN    + +  G L +  D            N    + EL   C Q +  M
Sbjct: 226 LAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYNPKM 273
Query: 374 RPTMKEVLEILRETKDSNL 392
           RP+  E++  ++E  +   
Sbjct: 274 RPSFLEIISSIKEEMEPGF 292

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 153
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 214 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 265
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 266 Y----------EVMLKCWHPKAEMRPSFSELV 287

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + +L +   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKF 213
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    ++  +  Q  K 
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 274 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 325
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 326 Y----------EVMLKCWHPKAEMRPSFSELV 347

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 29/273 (10%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG VY G       V +  +     ++++ F NEV +L K +H N++   G +
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           ++   +L +V ++    ++  HLH  +    ++     + IA +TA  + YLHA  +IHR
Sbjct: 74  TKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKSIIHR 128
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPDYFQCYKLTDK-- 292
           D+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++ P+     ++ DK  
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNP 185
Query: 293 ----SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK 348
               SDVY+FG+VL EL++G           +IN  +     +  G L+    P L   +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLS----PDLSKVR 235
Query: 349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
               + M   +AE    C+++ RD RP   ++L
Sbjct: 236 SNCPKAMKRLMAE----CLKKKRDERPLFPQIL 264

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 146
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 206
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 207 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 258
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 259 Y----------EVMLKCWHPKAEMRPSFSELV 280

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/312 (29%), Positives = 148/312 (47%), Gaps = 45/312 (14%)
Query: 95  FGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF- 147
           F + VF   E E + +     ++LG G FG VY G  RD   G     VAVK + E+   
Sbjct: 2   FPSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 148 -KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   
Sbjct: 62  RERIE-FLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 204 NSCLLPWPV---RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           N+   P P     + +A E A  +AYL+A   +HRD+ + N ++ ++F VK+ DFG++R 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR- 178
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+       +G  G     ++ P+  +    T  SD++SFGVVL E+ S  E     
Sbjct: 179 ---DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ- 234
Query: 316 RHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
                  LSN    K + +G   +  D            N    V +L   C Q +  MR
Sbjct: 235 ------GLSNEQVLKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPKMR 276
Query: 375 PTMKEVLEILRE 386
           PT  E++ +L++
Sbjct: 277 PTFLEIVNLLKD 288

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 117/232 (50%), Gaps = 28/232 (12%)
Query: 95  FGAKVFSCSELEEATDN-FNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENN------ 146
            G   F  S L    DN     KQ+G GGFG V+ G +++D  +VA+K L   +      
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 147 -FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
             ++ ++F  EV I++ L HPN+VKLYG      R   +V E++P G   D  H     +
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR---MVMEFVPCG---DLYHRLLDKA 116
Query: 206 CLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNIL---LDNNFRV--KVADFGLS 258
             + W V+L + ++ A  + Y+   +  ++HRD++S NI    LD N  V  KVADF LS
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS 176
Query: 259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCYK--LTDKSDVYSFGVVLIELISG 308
           +       H  +   G   ++ P+     +   T+K+D YSF ++L  +++G
Sbjct: 177 Q----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 147/310 (47%), Gaps = 45/310 (14%)
Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF--K 148
           + VF   E E + +     ++LG G FG VY G  RD   G     VAVK + E+    +
Sbjct: 1   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 60
Query: 149 RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP---NS 205
           RIE F+NE  ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   N+
Sbjct: 61  RIE-FLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENN 118
Query: 206 CLLPWPV---RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
              P P     + +A E A  +AYL+A   +HRD+ + N ++ ++F VK+ DFG++R   
Sbjct: 119 PGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--- 175
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH 317
            D+       +G  G     ++ P+  +    T  SD++SFGVVL E+ S  E       
Sbjct: 176 -DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ--- 231
Query: 318 RHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                LSN    K + +G   +  D            N    V +L   C Q +  MRPT
Sbjct: 232 ----GLSNEQVLKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPKMRPT 275
Query: 377 MKEVLEILRE 386
             E++ +L++
Sbjct: 276 FLEIVNLLKD 285

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + +L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKF 155
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    ++  +  Q  K 
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 216 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 267
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 268 Y----------EVMLKCWHPKAEMRPSFSELV 289

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + +L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKF 155
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    ++  +  Q  K 
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 216 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 267
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 268 Y----------EVMLKCWHPKAEMRPSFSELV 289

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 151/319 (47%), Gaps = 49/319 (15%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE--NN 146
            A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E  + 
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 62
Query: 147 FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P   
Sbjct: 63  RERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 204 NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
           N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R
Sbjct: 121 NNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 260 LFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT 314
               D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       + T
Sbjct: 180 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IAT 228
Query: 315 SRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM 373
              +    LSN    + +  G L +  D            N    + EL   C Q +  M
Sbjct: 229 LAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYNPKM 276
Query: 374 RPTMKEVLEILRETKDSNL 392
           RP+  E++  ++E  +   
Sbjct: 277 RPSFLEIISSIKEEMEPGF 295

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 92/322 (28%), Positives = 153/322 (47%), Gaps = 50/322 (15%)
Query: 94  YF-GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE- 144
           YF  A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E 
Sbjct: 30  YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEA 88
Query: 145 -NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP 203
            +  +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P
Sbjct: 89  ASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRP 146
Query: 204 ---NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG 256
              N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG
Sbjct: 147 EMENNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 205
Query: 257 LSRLFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA 311
           ++R    D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       
Sbjct: 206 MTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE------- 254
Query: 312 VDTSRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD 370
           + T   +    LSN    + +  G L +  D            N    + EL   C Q +
Sbjct: 255 IATLAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYN 302
Query: 371 RDMRPTMKEVLEILRETKDSNL 392
             MRP+  E++  ++E  +   
Sbjct: 303 PKMRPSFLEIISSIKEEMEPGF 324

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 152
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 213 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 264
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 265 Y----------EVMLKCWHPKAEMRPSFSELV 286

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 154
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 215 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 266
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 267 Y----------EVMLKCWHPKAEMRPSFSELV 288

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 151
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 212 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 263
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 264 Y----------EVMLKCWHPKAEMRPSFSELV 285

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 172
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 232
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 233 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 284
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 285 Y----------EVMLKCWHPKAEMRPSFSELV 306

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + +L +   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKF 159
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    ++  +  Q  K 
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 219
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 220 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 271
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 272 Y----------EVMLKCWHPKAEMRPSFSELV 293

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 151/319 (47%), Gaps = 49/319 (15%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE--NN 146
            A V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E  + 
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 62
Query: 147 FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P   
Sbjct: 63  RERIE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 204 NSCLLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
           N+ +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R
Sbjct: 121 NNPVLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 260 LFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT 314
               D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       + T
Sbjct: 180 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IAT 228
Query: 315 SRHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM 373
              +    LSN    + +  G L +  D            N    + EL   C Q +  M
Sbjct: 229 LAEQPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYNPKM 276
Query: 374 RPTMKEVLEILRETKDSNL 392
           RP+  E++  ++E  +   
Sbjct: 277 RPSFLEIISSIKEEMEPGF 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + +L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKF 154
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    ++  +  Q  K 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 215 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 266
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 267 Y----------EVMLKCWHPKAEMRPSFSELV 288

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + +L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKF 154
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    ++  +  Q  K 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 215 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 266
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 267 Y----------EVMLKCWHPKAEMRPSFSELV 288

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + +L +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKF 152
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    ++  +  Q  K 
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 213 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 264
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 265 Y----------EVMLKCWHPKAEMRPSFSELV 286

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 173
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 233
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 234 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 285
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 286 Y----------EVMLKCWHPKAEMRPSFSELV 307

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 149
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 210 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 261
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 262 Y----------EVMLKCWHPKAEMRPSFSELV 283

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 29/273 (10%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +++G G FG VY G       V +  +     ++++ F NEV +L K +H N++   G +
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +  + +L +V ++    ++  HLH  +    ++     + IA +TA  + YLHA  +IHR
Sbjct: 74  T--APQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKSIIHR 128
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPDYFQCYKLTDK-- 292
           D+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++ P+     ++ DK  
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNP 185
Query: 293 ----SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK 348
               SDVY+FG+VL EL++G           +IN  +     +  G L+    P L   +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLS----PDLSKVR 235
Query: 349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
               + M   +AE    C+++ RD RP   ++L
Sbjct: 236 SNCPKAMKRLMAE----CLKKKRDERPLFPQIL 264

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 154
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 215 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 266
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 267 Y----------EVMLKCWHPKAEMRPSFSELV 288

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 118 LGDGGFGAVYLGIL--RDGRIV--AVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLY 172
           +G G FG VY G L   DG+ +  AVK L    +   + QF+ E  I+    HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G   R     L+V  Y+ +G + + + N   N  +      +   ++ A  + YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKF 153
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDV--THVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+ + N +LD  F VKVADFGL+R ++  +    H  T  +    ++  +  Q  K 
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFGV+L EL++       +    D+N  ++    +Q      L+ P    +  
Sbjct: 214 TTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPL 265
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           Y          E+  +C     +MRP+  E++
Sbjct: 266 Y----------EVMLKCWHPKAEMRPSFSELV 287

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 147/305 (48%), Gaps = 49/305 (16%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE--NNFKRIEQFM 154
           E E A +    S++LG G FG VY G+ + G +       VA+K + E  +  +RIE F+
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASMRERIE-FL 61
Query: 155 NEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP---NSCLLPWP 211
           NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P   N+ +L  P
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA-P 119
Query: 212 VRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R    D+  
Sbjct: 120 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXE 175
Query: 268 VSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
                +G  G     ++ P+  +    T  SDV+SFGVVL E       + T   +    
Sbjct: 176 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IATLAEQPYQG 228
Query: 323 LSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           LSN    + +  G L +  D            N    + EL   C Q +  MRP+  E++
Sbjct: 229 LSNEQVLRFVMEGGLLDKPD------------NCPDMLLELMRMCWQYNPKMRPSFLEII 276
Query: 382 EILRE 386
             ++E
Sbjct: 277 SSIKE 281

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 103/192 (53%), Gaps = 5/192 (2%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           ++LG G  G V++G       VAVK L + +    + F+ E  ++ +LQH  LV+LY   
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +++   + ++ EY+ NG++ D L  + P+   L     L +A + A  +A++   + IHR
Sbjct: 78  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+++ NIL+ +    K+ADFGL+RL            +    +  P+       T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 296 YSFGVVLIELIS 307
           +SFG++L E+++
Sbjct: 194 WSFGILLTEIVT 205

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 137/274 (50%), Gaps = 38/274 (13%)
Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR 177
           +G G FG V     R  + VA+K++ E+  +R + F+ E+  L+++ HPN+VKLYG    
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQI-ESESER-KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR---LSIAIETAGALAYLHASD--- 231
               + LV EY   G++ + LH  +P    LP+      +S  ++ +  +AYLH+     
Sbjct: 74  P---VCLVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 232 VIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
           +IHRD+K  N+LL     V K+ DFG +     D+    T  +G+  ++ P+ F+    +
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYS 182
Query: 291 DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
           +K DV+S+G++L E+I+  +  D          +      + NG    L           
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIG-----GPAFRIMWAVHNGTRPPL----------- 226
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            ++N+   +  L  RC  +D   RP+M+E+++I+
Sbjct: 227 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 137/274 (50%), Gaps = 38/274 (13%)
Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR 177
           +G G FG V     R  + VA+K++ E+  +R + F+ E+  L+++ HPN+VKLYG    
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQI-ESESER-KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR---LSIAIETAGALAYLHASD--- 231
               + LV EY   G++ + LH  +P    LP+      +S  ++ +  +AYLH+     
Sbjct: 73  P---VCLVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 232 VIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
           +IHRD+K  N+LL     V K+ DFG +     D+    T  +G+  ++ P+ F+    +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 291 DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
           +K DV+S+G++L E+I+  +  D          +      + NG    L           
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIG-----GPAFRIMWAVHNGTRPPL----------- 225
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            ++N+   +  L  RC  +D   RP+M+E+++I+
Sbjct: 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 108/219 (49%), Gaps = 15/219 (6%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQ 152
           G  + S ++ +    N+   K +G G F  V L   +  GR VAVK + +   N   +++
Sbjct: 1   GNSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQK 60
Query: 153 FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPW 210
              EV I+  L HPN+VKL+     + + L LV EY   G V D+L  H R         
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEK----- 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST 270
             R     +   A+ Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F   V +   
Sbjct: 115 EARAKFR-QIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF--TVGNKLD 171
Query: 271 APQGTPGYVDPDYFQCYKLTD-KSDVYSFGVVLIELISG 308
              G+P Y  P+ FQ  K    + DV+S GV+L  L+SG
Sbjct: 172 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 105/198 (53%), Gaps = 5/198 (2%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++    K+LG G FG V++        VAVK +   +   +E F+ E  ++  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 73
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           KL+   +++   + ++ E++  G++ D L + + +    P P  +  + + A  +A++  
Sbjct: 74  KLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQ 129
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
            + IHRD+++ NIL+  +   K+ADFGL+R+   +        +    +  P+       
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 290 TDKSDVYSFGVVLIELIS 307
           T KSDV+SFG++L+E+++
Sbjct: 190 TIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 105/198 (53%), Gaps = 5/198 (2%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++    K+LG G FG V++        VAVK +   +   +E F+ E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           KL+   +++   + ++ E++  G++ D L + + +    P P  +  + + A  +A++  
Sbjct: 247 KLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQ 302
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
            + IHRD+++ NIL+  +   K+ADFGL+R+   +        +    +  P+       
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 290 TDKSDVYSFGVVLIELIS 307
           T KSDV+SFG++L+E+++
Sbjct: 363 TIKSDVWSFGILLMEIVT 380

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 149/312 (47%), Gaps = 45/312 (14%)
Query: 95  FGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF- 147
           F + V+   E E + +     ++LG G FG VY G  RD   G     VAVK + E+   
Sbjct: 3   FPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 62
Query: 148 -KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   
Sbjct: 63  RERIE-FLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAE 120
Query: 204 NSCLLPWPV---RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           N+   P P     + +A E A  +AYL+A   +HR++ + N ++ ++F VK+ DFG++R 
Sbjct: 121 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR- 179
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+       +G  G     ++ P+  +    T  SD++SFGVVL E+ S  E     
Sbjct: 180 ---DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 236
Query: 316 RHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
                  LSN    K + +G   +  D            N    V +L   C Q + +MR
Sbjct: 237 -------LSNEQVLKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPNMR 277
Query: 375 PTMKEVLEILRE 386
           PT  E++ +L++
Sbjct: 278 PTFLEIVNLLKD 289

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 149/316 (47%), Gaps = 49/316 (15%)
Query: 99  VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE--NNFKR 149
           V+   E E A +    S++LG G FG VY G+ + G +       VA+K + E  +  +R
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASMRER 59
Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP---NSC 206
           IE F+NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P   N+ 
Sbjct: 60  IE-FLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 117
Query: 207 LLPWPVRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
           +L  P  LS  I+ AG     +AYL+A+  +HRD+ + N  +  +F VK+ DFG++R   
Sbjct: 118 VLA-PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTR--- 173
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH 317
            D+       +G  G     ++ P+  +    T  SDV+SFGVVL E       + T   
Sbjct: 174 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IATLAE 225
Query: 318 RHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
           +    LSN    + +  G L +  D            N    + EL   C Q +  MRP+
Sbjct: 226 QPYQGLSNEQVLRFVMEGGLLDKPD------------NCPDMLLELMRMCWQYNPKMRPS 273
Query: 377 MKEVLEILRETKDSNL 392
             E++  ++E  +   
Sbjct: 274 FLEIISSIKEEMEPGF 289

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 149/312 (47%), Gaps = 45/312 (14%)
Query: 95  FGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF- 147
           F + V+   E E + +     ++LG G FG VY G  RD   G     VAVK + E+   
Sbjct: 2   FPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 148 -KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
            +RIE F+NE  ++      ++V+L G  S+  +  L+V E + +G +  +L + +P   
Sbjct: 62  RERIE-FLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 204 NSCLLPWPV---RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           N+   P P     + +A E A  +AYL+A   +HR++ + N ++ ++F VK+ DFG++R 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR- 178
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+       +G  G     ++ P+  +    T  SD++SFGVVL E+ S  E     
Sbjct: 179 ---DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 235
Query: 316 RHRHDINLSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
                  LSN    K + +G   +  D            N    V +L   C Q + +MR
Sbjct: 236 -------LSNEQVLKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPNMR 276
Query: 375 PTMKEVLEILRE 386
           PT  E++ +L++
Sbjct: 277 PTFLEIVNLLKD 288

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 88/311 (28%), Positives = 148/311 (47%), Gaps = 49/311 (15%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRI-------VAVKRLYE--NNFKRIEQFM 154
           E E A +    S++LG G FG VY G+ + G +       VA+K + E  +  +RIE F+
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASMRERIE-FL 63
Query: 155 NEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP---NSCLLPWP 211
           NE  ++ +    ++V+L G  S Q +  L++ E +  G +  +L + +P   N+ +L  P
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA-P 121
Query: 212 VRLSIAIETAG----ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             LS  I+ AG     +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R    D+  
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYE 177
Query: 268 VSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
                +G  G     ++ P+  +    T  SDV+SFGVVL E       + T   +    
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IATLAEQPYQG 230
Query: 323 LSNMATNK-IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
           LSN    + +  G L +  D            N    + EL   C Q +  MRP+  E++
Sbjct: 231 LSNEQVLRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYNPKMRPSFLEII 278
Query: 382 EILRETKDSNL 392
             ++E  +   
Sbjct: 279 SSIKEEMEPGF 289

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           DNF    ++G+G  G V +  +R  G++VAVK++     +R E   NEV I+   QH N+
Sbjct: 34  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V++Y  +     EL +V E++  G + D + + + N   +      ++ +    AL+ LH
Sbjct: 91  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 144
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           A  VIHRD+KS++ILL ++ RVK++DFG       +V        GTP ++ P+      
Sbjct: 145 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 203
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D++S G+++IE++ G
Sbjct: 204 YGPEVDIWSLGIMVIEMVDG 223

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           DNF    ++G+G  G V +  +R  G++VAVK++     +R E   NEV I+   QH N+
Sbjct: 32  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V++Y  +     EL +V E++  G + D + + + N   +      ++ +    AL+ LH
Sbjct: 89  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 142
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           A  VIHRD+KS++ILL ++ RVK++DFG       +V        GTP ++ P+      
Sbjct: 143 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 201
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D++S G+++IE++ G
Sbjct: 202 YGPEVDIWSLGIMVIEMVDG 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           DNF    ++G+G  G V +  +R  G++VAVK++     +R E   NEV I+   QH N+
Sbjct: 154 DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V++Y  +     EL +V E++  G + D + + + N   +      ++ +    AL+ LH
Sbjct: 211 VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 264
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           A  VIHRD+KS++ILL ++ RVK++DFG       +V        GTP ++ P+      
Sbjct: 265 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 323
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D++S G+++IE++ G
Sbjct: 324 YGPEVDIWSLGIMVIEMVDG 343

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 91
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 92  DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 145
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 146 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 253
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 254 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 74
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L   +R       A
Sbjct: 75  DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIA 128
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 129 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 236
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 237 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           DNF    ++G+G  G V +  +R  G++VAVK++     +R E   NEV I+   QH N+
Sbjct: 23  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V++Y  +     EL +V E++  G + D + + + N   +      ++ +    AL+ LH
Sbjct: 80  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 133
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           A  VIHRD+KS++ILL ++ RVK++DFG       +V        GTP ++ P+      
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 192
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D++S G+++IE++ G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 141/289 (48%), Gaps = 46/289 (15%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHPN 167
           F+  +++G G FGAVY    +R+  +VA+K++    + + ++ +  + EV  L KL+HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGAL-- 224
            ++  GC  R+     LV EY   G+ +D L  +++P          + IA  T GAL  
Sbjct: 116 TIQYRGCYLRE-HTAWLVMEYC-LGSASDLLEVHKKPLQ-------EVEIAAVTHGALQG 166
Query: 225 -AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
            AYLH+ ++IHRDVK+ NILL     VK+ DFG + +       V     GTP ++ P+ 
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 221
Query: 284 FQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
                  +   K DV+S G+  IEL          R     N++ M+   + + A NE  
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSA--LYHIAQNESP 271
Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRE 386
               G   +Y  RN V S       C+Q+    RPT + +L+   +LRE
Sbjct: 272 ALQSGHWSEY-FRNFVDS-------CLQKIPQDRPTSEVLLKHRFVLRE 312

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           DNF    ++G+G  G V +  +R  G++VAVK++     +R E   NEV I+   QH N+
Sbjct: 27  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V++Y  +     EL +V E++  G + D + + + N   +      ++ +    AL+ LH
Sbjct: 84  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 137
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           A  VIHRD+KS++ILL ++ RVK++DFG       +V        GTP ++ P+      
Sbjct: 138 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 196
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D++S G+++IE++ G
Sbjct: 197 YGPEVDIWSLGIMVIEMVDG 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 144/291 (49%), Gaps = 50/291 (17%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHPN 167
           F+  +++G G FGAVY    +R+  +VA+K++    + + ++ +  + EV  L KL+HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGAL-- 224
            ++  GC  R+     LV EY   G+ +D L  +++P          + IA  T GAL  
Sbjct: 77  TIQYRGCYLRE-HTAWLVMEYC-LGSASDLLEVHKKPLQ-------EVEIAAVTHGALQG 127
Query: 225 -AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
            AYLH+ ++IHRDVK+ NILL     VK+ DFG + +       V     GTP ++ P+ 
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 284 FQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
                  +   K DV+S G+  IEL          R     N++ M+   + + A NE  
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSA--LYHIAQNE-- 230
Query: 341 DPSL--GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRE 386
            P+L  G   +Y  RN V S       C+Q+    RPT + +L+   +LRE
Sbjct: 231 SPALQSGHWSEY-FRNFVDS-------CLQKIPQDRPTSEVLLKHRFVLRE 273

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V LG  R G  VAVK +   N    + F+ E  ++T+L+H NLV+L G  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             +   L +V EY+  G++ D+L +R     +L     L  +++   A+ YL  ++ +HR
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 141
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N+L+  +   KV+DFGL++    + +      +    +  P+  +  K + KSDV
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 296 YSFGVVLIELIS 307
           +SFG++L E+ S
Sbjct: 198 WSFGILLWEIYS 209

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 101
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 102 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 155
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 156 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 263
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 264 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           DNF    ++G+G  G V +  +R  G++VAVK++     +R E   NEV I+   QH N+
Sbjct: 77  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V++Y  +     EL +V E++  G + D + + + N   +      ++ +    AL+ LH
Sbjct: 134 VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 187
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           A  VIHRD+KS++ILL ++ RVK++DFG       +V        GTP ++ P+      
Sbjct: 188 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 246
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D++S G+++IE++ G
Sbjct: 247 YGPEVDIWSLGIMVIEMVDG 266

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V LG  R G  VAVK +   N    + F+ E  ++T+L+H NLV+L G  
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             +   L +V EY+  G++ D+L +R     +L     L  +++   A+ YL  ++ +HR
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 126
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N+L+  +   KV+DFGL++    + +      +    +  P+  +  K + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 296 YSFGVVLIELIS 307
           +SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 21/201 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++    K+LG G FG V++        VAVK +   +   +E F+ E  ++  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 240
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           KL+   +++   + ++ E++  G++ D L + + +    P P  +  + + A  +A++  
Sbjct: 241 KLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQ 296
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRL---FPTDVTHVSTAPQGTPGYVDPDYFQC 286
            + IHRD+++ NIL+  +   K+ADFGL+R+   FP   T              P+    
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTA-------------PEAINF 343
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              T KSDV+SFG++L+E+++
Sbjct: 344 GSFTIKSDVWSFGILLMEIVT 364

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V LG  R G  VAVK +   N    + F+ E  ++T+L+H NLV+L G  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             +   L +V EY+  G++ D+L +R     +L     L  +++   A+ YL  ++ +HR
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N+L+  +   KV+DFGL++    + +      +    +  P+  +  K + KSDV
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 296 YSFGVVLIELIS 307
           +SFG++L E+ S
Sbjct: 370 WSFGILLWEIYS 381

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 26/285 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRL-YENNFKRIEQFMNEVEILTKLQHPN 167
           D++   + +G G    V        +  VA+KR+  E     +++ + E++ +++  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVAD---HLHNR-QPNSCLLPWPVRLSIAIETAGA 223
           +V  Y     +  EL LV + +  G+V D   H+  + +  S +L      +I  E    
Sbjct: 75  IVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT--DVTH--VSTAPQGTPGYV 279
           L YLH +  IHRDVK+ NILL  +  V++ADFG+S    T  D+T   V     GTP ++
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 280 DPDYFQCYKLTD-KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
            P+  +  +  D K+D++SFG+  IEL +G        H++      M T  +QN     
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGA----APYHKYPPMKVLMLT--LQNDP--- 244
Query: 339 LVDPSL--GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
              PSL  G +    ++    S  ++   C+Q+D + RPT  E+L
Sbjct: 245 ---PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 26/285 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRL-YENNFKRIEQFMNEVEILTKLQHPN 167
           D++   + +G G    V        +  VA+KR+  E     +++ + E++ +++  HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVAD---HLHNR-QPNSCLLPWPVRLSIAIETAGA 223
           +V  Y     +  EL LV + +  G+V D   H+  + +  S +L      +I  E    
Sbjct: 70  IVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT--DVTH--VSTAPQGTPGYV 279
           L YLH +  IHRDVK+ NILL  +  V++ADFG+S    T  D+T   V     GTP ++
Sbjct: 129 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 280 DPDYFQCYKLTD-KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
            P+  +  +  D K+D++SFG+  IEL +G        H++      M T  +QN     
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATGA----APYHKYPPMKVLMLT--LQNDP--- 239
Query: 339 LVDPSL--GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
              PSL  G +    ++    S  ++   C+Q+D + RPT  E+L
Sbjct: 240 ---PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGL+R+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 136/285 (47%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V EY+ NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGL R+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 10/199 (5%)
Query: 112 FNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F+  ++LG+G +G+VY  I ++ G+IVA+K++  E++ + I   + E+ I+ +   P++V
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI---IKEISIMQQCDSPHVV 87
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           K YG   + + +L +V EY   G+V+D +  R  N  L    +  +I   T   L YLH 
Sbjct: 88  KYYGSYFKNT-DLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIA-TILQSTLKGLEYLHF 143
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
              IHRD+K+ NILL+     K+ADFG++    TD         GTP ++ P+  Q    
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 290 TDKSDVYSFGVVLIELISG 308
              +D++S G+  IE+  G
Sbjct: 203 NCVADIWSLGITAIEMAEG 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 12/212 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKR--IE-QFMNEVEILTKLQH 165
           D+F   + LG G FG VYL   +    IVA+K L+++  ++  +E Q   E+EI   L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+++LY       R + L+ EY P G +   L      SC        +I  E A AL 
Sbjct: 83  PNILRLYNYFY-DRRRIYLILEYAPRGELYKELQK----SCTFDEQRTATIMEELADALM 137
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   VIHRD+K  N+LL     +K+ADFG S   P+          GT  Y+ P+  +
Sbjct: 138 YCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC---GTLDYLPPEMIE 194
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRH 317
                +K D++  GV+  EL+ G    +++ H
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFESASH 226

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 140/291 (48%), Gaps = 45/291 (15%)
Query: 116 KQLGDGGFGAVYLGILRD---GRI---VAVKRLYENNF--KRIEQFMNEVEILTKLQHPN 167
           ++LG G FG VY G  RD   G     VAVK + E+    +RIE F+NE  ++      +
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHH 80
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP---NSCLLPWPV---RLSIAIETA 221
           +V+L G  S+  +  L+V E + +G +  +L + +P   N+   P P     + +A E A
Sbjct: 81  VVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG---- 277
             +AYL+A   +HRD+ + N ++ ++F VK+ DFG++R    D+       +G  G    
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 195
Query: 278 -YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK-IQNGA 335
            ++ P+  +    T  SD++SFGVVL E+ S  E            LSN    K + +G 
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-------LSNEQVLKFVMDGG 248
Query: 336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
             +  D            N    V +L   C Q +  MRPT  E++ +L++
Sbjct: 249 YLDQPD------------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 287

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V LG  R G  VAVK +   N    + F+ E  ++T+L+H NLV+L G  
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             +   L +V EY+  G++ D+L +R     +L     L  +++   A+ YL  ++ +HR
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 132
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDV 295
           D+ + N+L+  +   KV+DFGL++    + +      +    +  P+  +    + KSDV
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 296 YSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNM 355
           +SFG++L E+ S    V   R    I L ++   +++            G++ D A    
Sbjct: 189 WSFGILLWEIYS-FGRVPYPR----IPLKDVVP-RVEK-----------GYKMD-APDGC 230
Query: 356 VTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
             +V E+   C   D  MRP+  ++ E L   K   L
Sbjct: 231 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 267

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 118/224 (52%), Gaps = 20/224 (8%)
Query: 97  AKVFSCSE---LEEATDNFNSSKQLGDGGFGAVYLG---ILRD--GRIVAVKRLYENNFK 148
           A++++C +    EE    + S  QLG G FG+V L     L D  G +VAVK+L  +   
Sbjct: 9   AQLYACQDPTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66
Query: 149 RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHL--HNRQPNS 205
           +   F  E++IL  L    +VK  G +    R+ L LV EY+P+G + D L  H  + ++
Sbjct: 67  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 126
Query: 206 CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV 265
             L     L  + +    + YL +   +HRD+ + NIL+++   VK+ADFGL++L P D 
Sbjct: 127 SRL-----LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
Query: 266 T-HVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             +V   P  +P  +  P+       + +SDV+SFGVVL EL +
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIV----AVKRLYENNFKRIE-QFMNEVEILTKLQHPNLV 169
           K LG G FG VY GI + +G  V    A+K L E    +   +FM+E  I+  + HP+LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAY 226
           +L G     S  + LV + +P+G + +++H  + N     LL W       ++ A  + Y
Sbjct: 81  RLLGVCL--SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMY 132
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQ 285
           L    ++HRD+ + N+L+ +   VK+ DFGL+RL   D    +      P  ++  +   
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             K T +SDV+S+GV + EL++
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  GR VA+K + +   N   +++   EV I+  L HPN
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALA 225
           +VKL+     + + L L+ EY   G V D+L  H R           R S   +   A+ 
Sbjct: 73  IVKLFEVIETE-KTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR-SKFRQIVSAVQ 125
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F       +    G+P Y  P+ FQ
Sbjct: 126 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC--GSPPYAAPELFQ 183
Query: 286 CYKLTD-KSDVYSFGVVLIELISG 308
             K    + DV+S GV+L  L+SG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 136/285 (47%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V E + NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIV----AVKRLYENNFKRIE-QFMNEVEILTKLQHPNLV 169
           K LG G FG VY GI + +G  V    A+K L E    +   +FM+E  I+  + HP+LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAY 226
           +L G     S  + LV + +P+G + +++H  + N     LL W       ++ A  + Y
Sbjct: 104 RLLGVCL--SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMY 155
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQ 285
           L    ++HRD+ + N+L+ +   VK+ DFGL+RL   D    +      P  ++  +   
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             K T +SDV+S+GV + EL++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMT 237

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 136/285 (47%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 74
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V E + NG++   L  H+ Q     L   +R       A
Sbjct: 75  DHPNIIRLEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIA 128
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 129 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 236
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 237 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKR--IE-QFMNEVEILTKLQH 165
           D+F+  + LG G FG VYL   +  + I+A+K L+++  ++  +E Q   E+EI + L+H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNR---QPNSCLLPWPVRLSIAIET 220
           PN++++Y     + R + L+ E+ P G +   L  H R   Q ++  +          E 
Sbjct: 75  PNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRSATFME---------EL 124
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A AL Y H   VIHRD+K  N+L+     +K+ADFG S   P+          GT  Y+ 
Sbjct: 125 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLP 181
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH 317
           P+  +     +K D++  GV+  E + G+   D+  H
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 218

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 117 QLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           QLG G FG+V L     L D  G +VAVK+L  +   +   F  E++IL  L    +VK 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 172 YGCTSRQSR-ELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
            G +    R EL LV EY+P+G + D L  H  + ++  L     L  + +    + YL 
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLG 128
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTP-GYVDPDYFQC 286
           +   +HRD+ + NIL+++   VK+ADFGL++L P D    V   P  +P  +  P+    
Sbjct: 129 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              + +SDV+SFGVVL EL +
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  G+ VAVK + +   N   +++   EV I+  L HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALA 225
           +VKL+     + + L LV EY   G V D+L  H R           R     +   A+ 
Sbjct: 75  IVKLFEVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAKFR-QIVSAVQ 127
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F     +   A  G P Y  P+ FQ
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQ 185
Query: 286 CYKLTD-KSDVYSFGVVLIELISG 308
             K    + DV+S GV+L  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  G+ VAVK + +   N   +++   EV I+  L HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALA 225
           +VKL+     + + L LV EY   G V D+L  H R           R     +   A+ 
Sbjct: 75  IVKLFEVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAKFR-QIVSAVQ 127
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F T    + T   G+P Y  P+ FQ
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFC-GSPPYAAPELFQ 185
Query: 286 CYKLTD-KSDVYSFGVVLIELISG 308
             K    + DV+S GV+L  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 145/286 (50%), Gaps = 40/286 (13%)
Query: 107 EATDNFNSSKQLGDGGFG-AVYLGILRDGRIVAVKRLYENNFKRI-----EQFMNEVEIL 160
           ++ + +   +++G+G FG A+ +    DGR   +K   E N  R+     E+   EV +L
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK---EINISRMSSKEREESRREVAVL 77
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ----PNSCLLPWPVRLSI 216
             ++HPN+V+ Y  +  ++  L +V +Y   G +   ++ ++        +L W V++ +
Sbjct: 78  ANMKHPNIVQ-YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
           A      L ++H   ++HRD+KS NI L  +  V++ DFG++R+  + V  ++ A  GTP
Sbjct: 137 A------LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTP 189
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
            Y+ P+  +     +KSD+++ G VL EL +   A +        ++ N+   KI +G+ 
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVL-KIISGSF 242
Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                P +     Y +R++V+ + +      +  RD RP++  +LE
Sbjct: 243 -----PPVSLHYSYDLRSLVSQLFK------RNPRD-RPSVNSILE 276

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 136/285 (47%), Gaps = 37/285 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRL---YENNFKRIEQFMNEVEILTKL 163
           N +  K +G G FG V  G L+        VA+K L   Y    +R   F+ E  I+ + 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQF 103
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETA 221
            HPN+++L G  ++ S+ +++V E + NG++   L  H+ Q     L     + +    A
Sbjct: 104 DHPNIIRLEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 157
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YV 279
             + YL     +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     + 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+     K T  SDV+S+G+VL E++S  E       R    +SN    K    A++E 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RPYWEMSNQDVIK----AVDE- 265
Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                G+     + +   ++ +L   C Q+DR+ RP  ++++ IL
Sbjct: 266 -----GYRLPPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  G+ VAVK + +   N   +++   EV I+  L HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALA 225
           +VKL+     + + L LV EY   G V D+L  H R           R     +   A+ 
Sbjct: 75  IVKLFEVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAKFR-QIVSAVQ 127
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F T    + T   G+P Y  P+ FQ
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFC-GSPPYAAPELFQ 185
Query: 286 CYKLTD-KSDVYSFGVVLIELISG 308
             K    + DV+S GV+L  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYENNFKR--IE-QFMNEVEILTKLQH 165
           D+F+  + LG G FG VYL   +  + I+A+K L+++  ++  +E Q   E+EI + L+H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNR---QPNSCLLPWPVRLSIAIET 220
           PN++++Y     + R + L+ E+ P G +   L  H R   Q ++  +          E 
Sbjct: 74  PNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRSATFME---------EL 123
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A AL Y H   VIHRD+K  N+L+     +K+ADFG S   P+          GT  Y+ 
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLP 180
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH 317
           P+  +     +K D++  GV+  E + G+   D+  H
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 117 QLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           QLG G FG+V L     L D  G +VAVK+L  +   +   F  E++IL  L    +VK 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 172 YGCTSRQSRE-LLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
            G +    R+ L LV EY+P+G + D L  H  + ++  L     L  + +    + YL 
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLG 131
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTP-GYVDPDYFQC 286
           +   +HRD+ + NIL+++   VK+ADFGL++L P D   +V   P  +P  +  P+    
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              + +SDV+SFGVVL EL +
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT 212

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 139/296 (46%), Gaps = 46/296 (15%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGR---IVAVKRLYEN-NFKRIEQFMN 155
           SC ++E+          +G G FG V  G L+  G+    VA+K L      K+   F++
Sbjct: 33  SCVKIEQV---------IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 83
Query: 156 EVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           E  I+ +  HPN++ L G  ++ S  ++++ E++ NG++   L        ++     + 
Sbjct: 84  EASIMGQFDHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVG 139
Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP---TDVTHVSTAP 272
           +    A  + YL   + +HRD+ + NIL+++N   KV+DFGLSR      +D T+ S   
Sbjct: 140 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199
Query: 273 QGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI 331
              P  +  P+  Q  K T  SDV+S+G+V+ E++S  E     R   D     M    +
Sbjct: 200 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWD-----MTNQDV 249
Query: 332 QNGALNELVDPSLGFEKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            N             E+DY +    +  +++ +L   C Q+DR+ RP   +++  L
Sbjct: 250 IN-----------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 117 QLGDGGFGAVYL---GILRD--GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           QLG G FG+V L     L D  G +VAVK+L  +   +   F  E++IL  L    +VK 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 172 YGCTSRQSRE-LLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
            G +    R+ L LV EY+P+G + D L  H  + ++  L     L  + +    + YL 
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLG 132
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTP-GYVDPDYFQC 286
           +   +HRD+ + NIL+++   VK+ADFGL++L P D   +V   P  +P  +  P+    
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              + +SDV+SFGVVL EL +
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 8/198 (4%)
Query: 112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
            +S  ++G+G  G V L   +  GR VAVK +     +R E   NEV I+   QH N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           +Y  +     EL ++ E++  G + D +   + N   +      ++      ALAYLHA 
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-----TVCEAVLQALAYLHAQ 160
Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
            VIHRD+KS++ILL  + RVK++DFG       DV        GTP ++ P+        
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXL-VGTPYWMAPEVISRSLYA 219
Query: 291 DKSDVYSFGVVLIELISG 308
            + D++S G+++IE++ G
Sbjct: 220 TEVDIWSLGIMVIEMVDG 237

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LGDG FG VY    ++  ++A  ++ +  + + +E +M E++IL    HPN+VKL    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 176 SRQSRELLLVYEYIPNGTV-ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
             ++  L ++ E+   G V A  L   +P   L    +++ +  +T  AL YLH + +IH
Sbjct: 104 YYENN-LWILIEFCAGGAVDAVMLELERP---LTESQIQV-VCKQTLDALNYLHDNKIIH 158
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD--- 291
           RD+K+ NIL   +  +K+ADFG+S    T       +  GTP ++ P+   C    D   
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 292 --KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             K+DV+S G+ LIE+       +     H++N   +   KI       L  PS      
Sbjct: 218 DYKADVWSLGITLIEM------AEIEPPHHELNPMRVLL-KIAKSEPPTLAQPS------ 264
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN------LGTSKAKVVD 401
                  ++  +   +C++++ D R T  ++L+    T DSN      +  +KA+V +
Sbjct: 265 ----RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 30/279 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPN 167
           D F   ++LG G FG V+L   R   +  V +    +  ++  EQ   E+E+L  L HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           ++K++         + +V E    G + + + + Q     L       +  +   ALAY 
Sbjct: 82  IIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 228 HASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           H+  V+H+D+K  NIL  +   +  +K+ DFGL+ LF +D    ST   GT  Y+ P+ F
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVF 198
Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
           +   +T K D++S GVV+  L++G            +  +  +  ++Q  A  +      
Sbjct: 199 K-RDVTFKCDIWSAGVVMYFLLTGC-----------LPFTGTSLEEVQQKATYK------ 240
Query: 345 GFEKDYAV--RNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
             E +YAV  R +     +L  + + +D + RP+  +VL
Sbjct: 241 --EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 134/281 (47%), Gaps = 41/281 (14%)
Query: 118 LGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +G G FG V  G L+  G+    VA+K L   Y    +R  +F++E  I+ + +HPN+++
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMGQFEHPNIIR 79
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L G  +  S  ++++ E++ NG +   L        ++     + +    A  + YL   
Sbjct: 80  LEGVVT-NSMPVMILTEFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYLAEM 135
Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTP-GYVDPDYFQC 286
             +HRD+ + NIL+++N   KV+DFGLSR      +D T+ S+     P  +  P+    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K T  SD +S+G+V+ E++S  E       R   ++SN               D     
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGE-------RPYWDMSNQ--------------DVINAI 234
Query: 347 EKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           E+DY +    +  TS+ +L   C Q+DR+ RP   +V+  L
Sbjct: 235 EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  G+ VAV+ + +   N   +++   EV I+  L HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALA 225
           +VKL+     + + L LV EY   G V D+L  H R           R     +   A+ 
Sbjct: 75  IVKLFEVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAKFR-QIVSAVQ 127
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F T    + T   G+P Y  P+ FQ
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFC-GSPPYAAPELFQ 185
Query: 286 CYKLTD-KSDVYSFGVVLIELISG 308
             K    + DV+S GV+L  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LGDG FG VY    ++  ++A  ++ +  + + +E +M E++IL    HPN+VKL    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 176 SRQSRELLLVYEYIPNGTV-ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
             ++  L ++ E+   G V A  L   +P   L    +++ +  +T  AL YLH + +IH
Sbjct: 104 YYENN-LWILIEFCAGGAVDAVMLELERP---LTESQIQV-VCKQTLDALNYLHDNKIIH 158
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD--- 291
           RD+K+ NIL   +  +K+ADFG+S    T       +  GTP ++ P+   C    D   
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 292 --KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             K+DV+S G+ LIE+       +     H++N   +   KI       L  PS      
Sbjct: 218 DYKADVWSLGITLIEM------AEIEPPHHELNPMRVLL-KIAKSEPPTLAQPS------ 264
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN------LGTSKAKVVD 401
                  ++  +   +C++++ D R T  ++L+    T DSN      +  +KA+V +
Sbjct: 265 ----RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  G+ VAVK + +   N   +++   EV I+  L HPN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VKL+     + + L LV EY   G V D+L     +  +     R     +   A+ Y 
Sbjct: 68  IVKLFEVIETE-KTLYLVMEYASGGEVFDYL---VAHGWMKEKEARAKFR-QIVSAVQYC 122
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H   ++HRD+K+ N+LLD +  +K+ADFG S  F T    + T   G+P Y  P+ FQ  
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFC-GSPPYAAPELFQGK 180
Query: 288 KLTD-KSDVYSFGVVLIELISG 308
           K    + DV+S GV+L  L+SG
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSG 202

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 142/298 (47%), Gaps = 36/298 (12%)
Query: 117 QLGDGGFGAVYLGILRDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LGDG FG VY    ++  ++A  ++ +  + + +E +M E++IL    HPN+VKL    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 176 SRQSRELLLVYEYIPNGTV-ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
             ++  L ++ E+   G V A  L   +P   L    +++ +  +T  AL YLH + +IH
Sbjct: 104 YYENN-LWILIEFCAGGAVDAVMLELERP---LTESQIQV-VCKQTLDALNYLHDNKIIH 158
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD--- 291
           RD+K+ NIL   +  +K+ADFG+S    T          GTP ++ P+   C    D   
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPY 217
Query: 292 --KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             K+DV+S G+ LIE+       +     H++N   +   KI       L  PS      
Sbjct: 218 DYKADVWSLGITLIEM------AEIEPPHHELNPMRVLL-KIAKSEPPTLAQPS------ 264
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN------LGTSKAKVVD 401
                  ++  +   +C++++ D R T  ++L+    T DSN      +  +KA+V +
Sbjct: 265 ----RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 131/281 (46%), Gaps = 43/281 (15%)
Query: 118 LGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +G G FG V  G L+  G+    VA+K L   Y    +R   F+ E  I+ +  HPN+V 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRR--DFLCEASIMGQFDHPNVVH 108
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           L G  +R  + +++V E++ NG +   L  H+ Q     L     + +    A  + YL 
Sbjct: 109 LEGVVTR-GKPVMIVIEFMENGALDAFLRKHDGQFTVIQL-----VGMLRGIAAGMRYLA 162
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQC 286
               +HRD+ + NIL+++N   KV+DFGLSR+   D   V T   G     +  P+  Q 
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K T  SDV+S+G+V+ E++S  E       R   ++SN    K                
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGE-------RPYWDMSNQDVIK--------------AI 261
Query: 347 EKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           E+ Y   A  +    + +L   C Q++R  RP  ++++ IL
Sbjct: 262 EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 41/281 (14%)
Query: 118 LGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +G G FG V  G L+  G+    VA+K L   Y    +R  +F++E  I+ + +HPN+++
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMGQFEHPNIIR 81
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L G  +  S  ++++ E++ NG +   L        ++     + +    A  + YL   
Sbjct: 82  LEGVVT-NSMPVMILTEFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYLAEM 137
Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTP-GYVDPDYFQC 286
             +HRD+ + NIL+++N   KV+DFGLSR      +D T  S+     P  +  P+    
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K T  SD +S+G+V+ E++S  E       R   ++SN               D     
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSFGE-------RPYWDMSNQ--------------DVINAI 236
Query: 347 EKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           E+DY +    +  TS+ +L   C Q+DR+ RP   +V+  L
Sbjct: 237 EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  G+ VAV+ + +   N   +++   EV I+  L HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALA 225
           +VKL+     + + L LV EY   G V D+L  H R           R     +   A+ 
Sbjct: 75  IVKLFEVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAKFR-QIVSAVQ 127
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDY 283
           Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F    T  +   +  G+P Y  P+ 
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDEFCGSPPYAAPEL 183
Query: 284 FQCYKLTD-KSDVYSFGVVLIELISG 308
           FQ  K    + DV+S GV+L  L+SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPN 167
           N+   K +G G F  V L   +  G+ VAVK + +   N   +++   EV I   L HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALA 225
           +VKL+     + + L LV EY   G V D+L  H R           R     +   A+ 
Sbjct: 75  IVKLFEVIETE-KTLYLVXEYASGGEVFDYLVAHGRXKEK-----EARAKFR-QIVSAVQ 127
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F     +   A  G P Y  P+ FQ
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQ 185
Query: 286 CYKLTDKS-DVYSFGVVLIELISG 308
             K      DV+S GV+L  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 138/297 (46%), Gaps = 46/297 (15%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGR---IVAVKRLYEN-NFKRIEQFM 154
            SC ++E+          +G G FG V  G L+  G+    VA+K L      K+   F+
Sbjct: 6   ISCVKIEQV---------IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL 56
Query: 155 NEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           +E  I+ +  HPN++ L G  ++ S  ++++ E++ NG++   L        ++     +
Sbjct: 57  SEASIMGQFDHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LV 112
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP---TDVTHVSTA 271
            +    A  + YL   + +HR + + NIL+++N   KV+DFGLSR      +D T+ S  
Sbjct: 113 GMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 172
Query: 272 PQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK 330
               P  +  P+  Q  K T  SDV+S+G+V+ E++S  E     R   D     M    
Sbjct: 173 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWD-----MTNQD 222
Query: 331 IQNGALNELVDPSLGFEKDYAV---RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           + N             E+DY +    +  +++ +L   C Q+DR+ RP   +++  L
Sbjct: 223 VIN-----------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 133/289 (46%), Gaps = 39/289 (13%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++   P + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----LSIAIETAGALA 225
           K YG   + ++ L ++ EY+  G+  D L          P P+      +I  E    L 
Sbjct: 89  KYYGSYLKDTK-LWIIMEYLGGGSALDLLE---------PGPLDETQIATILREILKGLD 138
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+   IHRD+K+ N+LL  +  VK+ADFG++    TD         GTP ++ P+  +
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIK 197
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                 K+D++S G+  IEL  G E   +  H   +       N            P+L 
Sbjct: 198 QSAYDSKADIWSLGITAIELARG-EPPHSELHPMKVLFLIPKNNP-----------PTL- 244
Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSN 391
            E +Y+       + E    C+ ++   RPT KE+L+   ILR  K ++
Sbjct: 245 -EGNYS-----KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++   P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           K YG   + ++ L ++ EY+  G+  D L     +   +      +I  E    L YLH+
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 122
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
              IHRD+K+ N+LL  +  VK+ADFG++    TD         GTP ++ P+  +    
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             K+D++S G+  IEL  G E   +  H   +       N            P+L  E +
Sbjct: 182 DSKADIWSLGITAIELARG-EPPHSELHPMKVLFLIPKNN-----------PPTL--EGN 227
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSN 391
           Y+       + E    C+ ++   RPT KE+L+   ILR  K ++
Sbjct: 228 YS-----KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 267

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++   P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           K YG   + ++ L ++ EY+  G+  D L     +   +      +I  E    L YLH+
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 122
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
              IHRD+K+ N+LL  +  VK+ADFG++    TD         GTP ++ P+  +    
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             K+D++S G+  IEL  G E   +  H   +       N            P+L  E +
Sbjct: 182 DSKADIWSLGITAIELARG-EPPHSELHPMKVLFLIPKNN-----------PPTL--EGN 227
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSN 391
           Y+       + E    C+ ++   RPT KE+L+   ILR  K ++
Sbjct: 228 YS-----KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 267

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 133/289 (46%), Gaps = 39/289 (13%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++   P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----LSIAIETAGALA 225
           K YG   + ++ L ++ EY+  G+  D          L P P+      +I  E    L 
Sbjct: 84  KYYGSYLKDTK-LWIIMEYLGGGSALD---------LLEPGPLDETQIATILREILKGLD 133
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+   IHRD+K+ N+LL  +  VK+ADFG++    TD         GTP ++ P+  +
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIK 192
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                 K+D++S G+  IEL  G E   +  H   +       N            P+L 
Sbjct: 193 QSAYDSKADIWSLGITAIELARG-EPPHSELHPMKVLFLIPKNNP-----------PTL- 239
Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSN 391
            E +Y+       + E    C+ ++   RPT KE+L+   ILR  K ++
Sbjct: 240 -EGNYS-----KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 22/279 (7%)
Query: 111 NFNSSKQLGDGGFGAVY-LGILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHP 166
           NF   K++G G F  VY    L DG  VA+K++   +    K     + E+++L +L HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N++K Y  +  +  EL +V E    G ++  + + +    L+P        ++   AL +
Sbjct: 93  NVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           +H+  V+HRD+K  N+ +     VK+ D GL R F +  T   +   GTP Y+ P+    
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHE 210
Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
                KSD++S G +L E    + A+ +  +   +NL ++   KI+      L  PS  +
Sbjct: 211 NGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLYSLC-KKIEQCDYPPL--PSDHY 263
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR 385
            ++  +R +V         C+  D + RP +  V ++ +
Sbjct: 264 SEE--LRQLVNM-------CINPDPEKRPDVTYVYDVAK 293

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNFKRIEQFMNEVEILT 161
           S L +    F   + +G+G +G VY G  ++ G++ A+K + +      E+   E+ +L 
Sbjct: 17  SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLK 75
Query: 162 KL-QHPNLVKLYGCTSRQSR-----ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           K   H N+   YG   +++      +L LV E+   G+V D + N + N+    W     
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--Y 133
Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           I  E    L++LH   VIHRD+K  N+LL  N  VK+ DFG+S      V   +T   GT
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGT 192
Query: 276 PGYVDPDYFQCYKLTD-----KSDVYSFGVVLIELISG 308
           P ++ P+   C +  D     KSD++S G+  IE+  G
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 116 KQLGDGGFGAVYLGILRDGR----IVAVKR------LYENNFKRIEQF----MNEVEILT 161
           ++LG G +G V L   ++G     I  +K+       Y ++ K IE+F     NE+ +L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP-NSCLLPWPVRLSIAIET 220
            L HPN++KL+       +   LV E+   G + + + NR   + C        +I  + 
Sbjct: 102 SLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-----NIMKQI 155
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNN---FRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
              + YLH  +++HRD+K  NILL+N      +K+ DFGLS  F  D  +      GT  
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAY 213
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           Y+ P+  +  K  +K DV+S GV++  L+ G
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 116 KQLGDGGFGAVYLGILR-DGR---IVAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNLVK 170
           K +G G  G V  G LR  G+    VA+K L     +R  + F++E  I+ +  HPN+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA-LAYLHA 229
           L G  +R  R  ++V EY+ NG++   L        ++    +L   +   GA + YL  
Sbjct: 115 LEGVVTR-GRLAMIVTEYMENGSLDTFLRTHDGQFTIM----QLVGMLRGVGAGMRYLSD 169
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP--TDVTHVSTAPQGTPGYVDPDYFQCY 287
              +HRD+ + N+L+D+N   KV+DFGLSR+     D  + +T  +    +  P+     
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM-ATNKIQNGALNELVDPSLGF 346
             +  SDV+SFGVV+ E+++  E       R   N++N    + ++ G            
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGE-------RPYWNMTNRDVISSVEEGY----------- 271
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            +  A      ++ +L   C  +DR  RP   +++ +L
Sbjct: 272 -RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 21/200 (10%)
Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LGDG FG VY    ++ G + A K +   + + +E ++ E+EIL    HP +VKL G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
               + L ++ E+ P G V   +         L  P    +  +   AL +LH+  +IHR
Sbjct: 86  YHDGK-LWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSKRIIHR 141
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDYFQCYKLT 290
           D+K+ N+L+     +++ADFG+S        ++ T  +     GTP ++ P+   C  + 
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 291 D-----KSDVYSFGVVLIEL 305
           D     K+D++S G+ LIE+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 21/200 (10%)
Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           +LGDG FG VY    ++ G + A K +   + + +E ++ E+EIL    HP +VKL G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
               + L ++ E+ P G V   +         L  P    +  +   AL +LH+  +IHR
Sbjct: 78  YHDGK-LWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSKRIIHR 133
Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDYFQCYKLT 290
           D+K+ N+L+     +++ADFG+S        ++ T  +     GTP ++ P+   C  + 
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 291 D-----KSDVYSFGVVLIEL 305
           D     K+D++S G+ LIE+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 116 KQLGDGGFGAVYLGILR-DGR---IVAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNLVK 170
           K +G G  G V  G LR  G+    VA+K L     +R  + F++E  I+ +  HPN+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA-LAYLHA 229
           L G  +R  R  ++V EY+ NG++   L        ++    +L   +   GA + YL  
Sbjct: 115 LEGVVTR-GRLAMIVTEYMENGSLDTFLRTHDGQFTIM----QLVGMLRGVGAGMRYLSD 169
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQCY 287
              +HRD+ + N+L+D+N   KV+DFGLSR+   D     T   G     +  P+     
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM-ATNKIQNGALNELVDPSLGF 346
             +  SDV+SFGVV+ E+++  E       R   N++N    + ++ G            
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGE-------RPYWNMTNRDVISSVEEGY----------- 271
Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            +  A      ++ +L   C  +DR  RP   +++ +L
Sbjct: 272 -RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 11/211 (5%)
Query: 99  VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEV 157
           V S  +  E   NF    ++G+G  G V +   +  G+ VAVK++     +R E   NEV
Sbjct: 37  VVSPGDPREYLANF---IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 93
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            I+    H N+V +Y  +     EL +V E++  G + D + + + N   +      ++ 
Sbjct: 94  VIMRDYHHDNVVDMYS-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVC 147
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG 277
           +    AL+YLH   VIHRD+KS++ILL ++ R+K++DFG       +V        GTP 
Sbjct: 148 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL-VGTPY 206
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           ++ P+         + D++S G+++IE+I G
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 33/276 (11%)
Query: 118 LGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +G G FG V  G L+  G+    VA+K L   Y    +R   F+ E  I+ +  HPN++ 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIH 87
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L G  ++ S+ +++V EY+ NG++   L        ++     + +    +  + YL   
Sbjct: 88  LEGVVTK-SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ---LVGMLRGISAGMKYLSDM 143
Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQCYK 288
             +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G     +  P+     K
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 289 LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK 348
            T  SDV+S+G+V+ E++S  E         D+         ++ G    L  P      
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV------IKAVEEGY--RLPSPM----- 250
Query: 349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                +   ++ +L   C Q++R+ RP   E++ +L
Sbjct: 251 -----DCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G G  G VY  + +  G+ VA++++      + E  +NE+ ++ + ++PN+V  Y  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN-YLD 84
Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +     EL +V EY+  G++ D +      +C+    +  ++  E   AL +LH++ VIH
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALEFLHSNQVIH 139
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+KS+NILL  +  VK+ DFG       + +  ST   GTP ++ P+         K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVD 198
Query: 295 VYSFGVVLIELISG 308
           ++S G++ IE+I G
Sbjct: 199 IWSLGIMAIEMIEG 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 116 KQLGDGGFGAVYLGIL-----RDGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G  VAVK L  E+    I     E+EIL  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  G CT      + L+ E++P+G++ ++L     N   +    +L  A++    + YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLG 143
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA-PQGTP-GYVDPDYFQC 286
           +   +HRD+ + N+L+++  +VK+ DFGL++   TD    +    + +P  +  P+    
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
            K    SDV+SFGV L EL++
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 116 KQLGDGGFGAVYLGIL-----RDGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G  VAVK L  E+    I     E+EIL  L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  G CT      + L+ E++P+G++ ++L     N   +    +L  A++    + YL 
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLG 131
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA-PQGTP-GYVDPDYFQC 286
           +   +HRD+ + N+L+++  +VK+ DFGL++   TD    +    + +P  +  P+    
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
            K    SDV+SFGV L EL++
Sbjct: 192 SKFYIASDVWSFGVTLHELLT 212

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 123/273 (45%), Gaps = 28/273 (10%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           K YG   + S+ L ++ EY+  G+  D L     +   +      ++  E    L YLH+
Sbjct: 85  KYYGSYLKGSK-LWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 138
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
              IHRD+K+ N+LL     VK+ADFG++    TD         GTP ++ P+  Q    
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             K+D++S G+  IEL  G E  ++  H   +       N            P+L     
Sbjct: 198 DSKADIWSLGITAIELAKG-EPPNSDMHPMRVLFLIPKNNP-----------PTL----- 240
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             V +   S  E    C+ +D   RPT KE+L+
Sbjct: 241 --VGDFTKSFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 117/245 (47%), Gaps = 30/245 (12%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GIL--RDGRIVAVKRLYENNFKRIEQ-FMNEVE 158
           E   +N    + +G+G FG V+     G+L      +VAVK L E     ++  F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-CLL--------- 208
           ++ +  +PN+VKL G  +   + + L++EY+  G + + L +  P++ C L         
Sbjct: 103 LMAEFDNPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 209 ------PWPV----RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS 258
                 P P+    +L IA + A  +AYL     +HRD+ + N L+  N  VK+ADFGLS
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 259 R-LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSR 316
           R ++  D             ++ P+     + T +SDV+++GVVL E+ S GL+      
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 317 HRHDI 321
           H   I
Sbjct: 282 HEEVI 286

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN----FKRIEQFMNEVEILTKLQ 164
           + +    ++G+G +G V+    RD G+IVA+K+  E+      K+I   + E+ +L +L+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLK 60
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HPNLV L     R+ R L LV+EY  + TV   L   Q     +P  +  SI  +T  A+
Sbjct: 61  HPNLVNLLE-VFRRKRRLHLVFEYC-DHTVLHELDRYQRG---VPEHLVKSITWQTLQAV 115
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDVTHVSTAPQGTPGYVDPD 282
            + H  + IHRDVK  NIL+  +  +K+ DFG +RL   P+D      A   T  Y  P+
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---TRWYRSPE 172
Query: 283 YFQC-YKLTDKSDVYSFGVVLIELISGL 309
                 +     DV++ G V  EL+SG+
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE-QFMNEVEILTKLQHPNLVKLYG 173
           +Q+G G FG V+ G LR D  +VAVK   E     ++ +F+ E  IL +  HPN+V+L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
            CT +Q   + +V E +  G   D L   +     L     L +  + A  + YL +   
Sbjct: 180 VCTQKQP--IYIVMELVQGG---DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           IHRD+ + N L+     +K++DFG+SR     V   S   +  P  +  P+     + + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 292 KSDVYSFGVVLIELIS 307
           +SDV+SFG++L E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G G  G VY  + +  G+ VA++++      + E  +NE+ ++ + ++PN+V  Y  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN-YLD 85
Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +     EL +V EY+  G++ D +      +C+    +  ++  E   AL +LH++ VIH
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALEFLHSNQVIH 140
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           R++KS+NILL  +  VK+ DFG       + +  ST   GTP ++ P+         K D
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVD 199
Query: 295 VYSFGVVLIELISG 308
           ++S G++ IE+I G
Sbjct: 200 IWSLGIMAIEMIEG 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 134/269 (49%), Gaps = 27/269 (10%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G G  G VY  + +  G+ VA++++      + E  +NE+ ++ + ++PN+V  Y  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN-YLD 84
Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +     EL +V EY+  G++ D +      +C+    +  ++  E   AL +LH++ VIH
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALEFLHSNQVIH 139
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+KS+NILL  +  VK+ DFG       + +  S    GTP ++ P+         K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVTRKAYGPKVD 198
Query: 295 VYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAV-R 353
           ++S G++ IE+I G            + L  +ATN        EL +P    EK  A+ R
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYL--IATN-----GTPELQNP----EKLSAIFR 247
Query: 354 NMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           + +        RC++ D + R + KE+L+
Sbjct: 248 DFLN-------RCLEMDVEKRGSAKELLQ 269

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 37/280 (13%)
Query: 116 KQLGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNL 168
           K +G G FG V  G L+  G+    VA+K L   Y +  +R   F++E  I+ +  HPN+
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNI 92
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA-LAYL 227
           + L G  ++  + ++++ EY+ NG++   L        +    ++L   +   G+ + YL
Sbjct: 93  IHLEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTV----IQLVGMLRGIGSGMKYL 147
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                +HRD+ + NIL+++N   KV+DFG+SR+   D     T   G     +  P+   
Sbjct: 148 SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK-IQNGALNELVDPSL 344
             K T  SDV+S+G+V+ E++S  E       R   ++SN    K I+ G     + P +
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGE-------RPYWDMSNQDVIKAIEEGY---RLPPPM 257
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                    +   ++ +L   C Q++R  RP   +++ +L
Sbjct: 258 ---------DCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 104/194 (53%), Gaps = 8/194 (4%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G G  G VY  + +  G+ VA++++      + E  +NE+ ++ + ++PN+V  Y  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN-YLD 85
Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +     EL +V EY+  G++ D +      +C+    +  ++  E   AL +LH++ VIH
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALEFLHSNQVIH 140
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+KS+NILL  +  VK+ DFG       + +  S    GTP ++ P+         K D
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVTRKAYGPKVD 199
Query: 295 VYSFGVVLIELISG 308
           ++S G++ IE+I G
Sbjct: 200 IWSLGIMAIEMIEG 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 104/194 (53%), Gaps = 8/194 (4%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G G  G VY  + +  G+ VA++++      + E  +NE+ ++ + ++PN+V  Y  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN-YLD 84
Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +     EL +V EY+  G++ D +      +C+    +  ++  E   AL +LH++ VIH
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALEFLHSNQVIH 139
Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD 294
           RD+KS+NILL  +  VK+ DFG       + +  S    GTP ++ P+         K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM-VGTPYWMAPEVVTRKAYGPKVD 198
Query: 295 VYSFGVVLIELISG 308
           ++S G++ IE+I G
Sbjct: 199 IWSLGIMAIEMIEG 212

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE-QFMNEVEILTKLQHPNLVKLYG 173
           +Q+G G FG V+ G LR D  +VAVK   E     ++ +F+ E  IL +  HPN+V+L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
            CT +Q   + +V E +  G   D L   +     L     L +  + A  + YL +   
Sbjct: 180 VCTQKQP--IYIVMELVQGG---DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           IHRD+ + N L+     +K++DFG+SR     V   S   +  P  +  P+     + + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 292 KSDVYSFGVVLIELIS 307
           +SDV+SFG++L E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 20/223 (8%)
Query: 90  RGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYEN 145
           RGS  +G           A ++   ++ LG+G FG VY G+  + +     VAVK   ++
Sbjct: 14  RGSPQYGI----------AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD 63
Query: 146 -NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN 204
                 E+FM+E  I+  L HP++VKL G    +   +++  E  P G +  +L  R  N
Sbjct: 64  CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM--ELYPYGELGHYLE-RNKN 120
Query: 205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD 264
           S  +   V  S+ I    A+AYL + + +HRD+   NIL+ +   VK+ DFGLSR    +
Sbjct: 121 SLKVLTLVLYSLQI--CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 178
Query: 265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             + ++  +    ++ P+     + T  SDV+ F V + E++S
Sbjct: 179 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 37/280 (13%)
Query: 116 KQLGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNL 168
           K +G G FG V  G L+  G+    VA+K L   Y +  +R   F++E  I+ +  HPN+
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNI 77
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA-LAYL 227
           + L G  ++  + ++++ EY+ NG++   L        +    ++L   +   G+ + YL
Sbjct: 78  IHLEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTV----IQLVGMLRGIGSGMKYL 132
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                +HRD+ + NIL+++N   KV+DFG+SR+   D     T   G     +  P+   
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK-IQNGALNELVDPSL 344
             K T  SDV+S+G+V+ E++S  E       R   ++SN    K I+ G     + P +
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGE-------RPYWDMSNQDVIKAIEEGY---RLPPPM 242
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                    +   ++ +L   C Q++R  RP   +++ +L
Sbjct: 243 ---------DCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 37/280 (13%)
Query: 116 KQLGDGGFGAVYLGILR-DGR---IVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNL 168
           K +G G FG V  G L+  G+    VA+K L   Y +  +R   F++E  I+ +  HPN+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNI 71
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA-LAYL 227
           + L G  ++  + ++++ EY+ NG++   L        +    ++L   +   G+ + YL
Sbjct: 72  IHLEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTV----IQLVGMLRGIGSGMKYL 126
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPG--YVDPDYFQ 285
                +HRD+ + NIL+++N   KV+DFG+SR+   D     T   G     +  P+   
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK-IQNGALNELVDPSL 344
             K T  SDV+S+G+V+ E++S  E       R   ++SN    K I+ G     + P +
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGE-------RPYWDMSNQDVIKAIEEGY---RLPPPM 236
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                    +   ++ +L   C Q++R  RP   +++ +L
Sbjct: 237 ---------DCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 145/302 (48%), Gaps = 40/302 (13%)
Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK---RLYENNFKR--I 150
           A++F  +EL +        K LG G FG V+ G+ + +G  + +    ++ E+   R   
Sbjct: 25  ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 77
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           +   + +  +  L H ++V+L G     S  L LV +Y+P G++ DH+  RQ    L P 
Sbjct: 78  QAVTDHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHV--RQHRGALGP- 132
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST 270
            + L+  ++ A  + YL    ++HR++ + N+LL +  +V+VADFG++ L P D   +  
Sbjct: 133 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 192
Query: 271 APQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT 328
           +   TP  ++  +     K T +SDV+S+GV + EL++ G E     R     +L     
Sbjct: 193 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL----- 247
Query: 329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL-EILRET 387
             ++ G    L  P +     Y V  MV        +C   D ++RPT KE+  E  R  
Sbjct: 248 --LEKG--ERLAQPQICTIDVYMV--MV--------KCWMIDENIRPTFKELANEFTRMA 293
Query: 388 KD 389
           +D
Sbjct: 294 RD 295

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 145/302 (48%), Gaps = 40/302 (13%)
Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK---RLYENNFKR--I 150
           A++F  +EL +        K LG G FG V+ G+ + +G  + +    ++ E+   R   
Sbjct: 7   ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           +   + +  +  L H ++V+L G     S  L LV +Y+P G++ DH+  RQ    L P 
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHV--RQHRGALGP- 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST 270
            + L+  ++ A  + YL    ++HR++ + N+LL +  +V+VADFG++ L P D   +  
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 271 APQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT 328
           +   TP  ++  +     K T +SDV+S+GV + EL++ G E     R     +L     
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL----- 229
Query: 329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL-EILRET 387
             ++ G    L  P +     Y V  MV        +C   D ++RPT KE+  E  R  
Sbjct: 230 --LEKG--ERLAQPQICTIDVYMV--MV--------KCWMIDENIRPTFKELANEFTRMA 275
Query: 388 KD 389
           +D
Sbjct: 276 RD 277

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQ 164
           +D +   + LG GG   V+L   LRD R VAVK L  +  +      +F  E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 165 HPNLVKLYGCTSRQSRELLLVY---EYIPNGTVADHLHNRQPNSCLLPWPVR-LSIAIET 220
           HP +V +Y     ++    L Y   EY+   T+ D +H   P +     P R + +  + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT-----PKRAIEVIADA 125
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--STAPQGTPGY 278
             AL + H + +IHRDVK  NIL+     VKV DFG++R        V  + A  GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  +   +  +SDVYS G VL E+++G
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 113/226 (50%), Gaps = 32/226 (14%)
Query: 109 TDNFNSSKQLGDGGFGAV------YLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           +DN++  ++LG G F  V        G+    +I+  K+L   +F+++E+   E  I  K
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 84
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ------PNSCLLPWPVRLSI 216
           LQHPN+V+L+     +S   L V++ +  G + + +  R+       + C+         
Sbjct: 85  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 135
Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQ 273
             +   ++AY H++ ++HR++K  N+LL +  +   VK+ADFGL+     + +       
Sbjct: 136 --QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFA 191
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           GTPGY+ P+  +    +   D+++ GV+L  L+ G     D  +HR
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYEN-NFKRIEQFMNEVEILTK 162
           A ++   ++ LG+G FG VY G+  + +     VAVK   ++      E+FM+E  I+  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HP++VKL G    +   +++  E  P G +  +L  R  NS  +   V  S+ I    
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIM--ELYPYGELGHYLE-RNKNSLKVLTLVLYSLQI--CK 120
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           A+AYL + + +HRD+   NIL+ +   VK+ DFGLSR    +  + ++  +    ++ P+
Sbjct: 121 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 180
Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
                + T  SDV+ F V + E++S
Sbjct: 181 SINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGRI----VAVKRLYEN-NFKRIEQFMNEVEILTK 162
           A ++   ++ LG+G FG VY G+  + +     VAVK   ++      E+FM+E  I+  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HP++VKL G    +   +++  E  P G +  +L  R  NS  +   V  S+ I    
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIM--ELYPYGELGHYLE-RNKNSLKVLTLVLYSLQI--CK 124
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           A+AYL + + +HRD+   NIL+ +   VK+ DFGLSR    +  + ++  +    ++ P+
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
                + T  SDV+ F V + E++S
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILS 209

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K +G G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 113/221 (51%), Gaps = 22/221 (9%)
Query: 109 TDNFNSSKQLGDGGFGAV------YLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           +DN++  ++LG G F  V        G+    +I+  K+L   +F+++E+   E  I  K
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 61
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA- 221
           LQHPN+V+L+     +S   L V++ +  G + + +  R+  S         S  I+   
Sbjct: 62  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYS-----EADASHCIQQIL 115
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            ++AY H++ ++HR++K  N+LL +  +   VK+ADFGL+     + +       GTPGY
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 173
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           + P+  +    +   D+++ GV+L  L+ G     D  +HR
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 113/221 (51%), Gaps = 22/221 (9%)
Query: 109 TDNFNSSKQLGDGGFGAV------YLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           +DN++  ++LG G F  V        G+    +I+  K+L   +F+++E+   E  I  K
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 61
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA- 221
           LQHPN+V+L+     +S   L V++ +  G + + +  R+  S         S  I+   
Sbjct: 62  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYS-----EADASHCIQQIL 115
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            ++AY H++ ++HR++K  N+LL +  +   VK+ADFGL+     + +       GTPGY
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 173
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           + P+  +    +   D+++ GV+L  L+ G     D  +HR
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 29/289 (10%)
Query: 113 NSSKQLGDGGFGAVYLGILRD---GRI-VAVKRLYE-NNFKRIEQFMNEVEILTKLQHPN 167
           +S + +G G FG VY G   D    RI  A+K L      +++E F+ E  ++  L HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           ++ L G          ++  Y+ +G +   + + Q N  +      +S  ++ A  + YL
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYL 140
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQG--TPGYVDPDYF 284
                +HRD+ + N +LD +F VKVADFGL+R +   +   V           +   +  
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
           Q Y+ T KSDV+SFGV+L EL++        RH    +L++             L  P  
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT--RGAPPYRHIDPFDLTHFLAQG------RRLPQPEY 252
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLG 393
             +  Y V            +C + D  +RPT + ++  + +   + LG
Sbjct: 253 CPDSLYQVMQ----------QCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 113/221 (51%), Gaps = 22/221 (9%)
Query: 109 TDNFNSSKQLGDGGFGAV------YLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           +DN++  ++LG G F  V        G+    +I+  K+L   +F+++E+   E  I  K
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 60
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA- 221
           LQHPN+V+L+     +S   L V++ +  G + + +  R+  S         S  I+   
Sbjct: 61  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYS-----EADASHCIQQIL 114
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            ++AY H++ ++HR++K  N+LL +  +   VK+ADFGL+     + +       GTPGY
Sbjct: 115 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           + P+  +    +   D+++ GV+L  L+ G     D  +HR
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 213

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE--- 151
           G+ + + S L   +D +   + LG GG   V+L   LRD R VAVK L  +  +      
Sbjct: 1   GSHMTTPSHL---SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL 57
Query: 152 QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY---EYIPNGTVADHLHNRQPNSCLL 208
           +F  E +    L HP +V +Y     ++    L Y   EY+   T+ D +H   P +   
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--- 114
Query: 209 PWPVR-LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             P R + +  +   AL + H + +IHRDVK  NI++     VKV DFG++R        
Sbjct: 115 --PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 268 V--STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V  + A  GT  Y+ P+  +   +  +SDVYS G VL E+++G
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 142
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      + A  GT  YV P+
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE--- 151
           G+ + + S L   +D +   + LG GG   V+L   LRD R VAVK L  +  +      
Sbjct: 1   GSHMTTPSHL---SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL 57
Query: 152 QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY---EYIPNGTVADHLHNRQPNSCLL 208
           +F  E +    L HP +V +Y     ++    L Y   EY+   T+ D +H   P +   
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--- 114
Query: 209 PWPVR-LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             P R + +  +   AL + H + +IHRDVK  NI++     VKV DFG++R        
Sbjct: 115 --PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 268 V--STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V  + A  GT  Y+ P+  +   +  +SDVYS G VL E+++G
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDGRIV-AVKRLYENNF---KRIEQFMNEVEILTK-LQH 165
           +F+  K +G G FG V L   +   +  AVK L +      K  +  M+E  +L K ++H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P LV L+  + + + +L  V +YI  G +  HL   Q   C L    R   A E A AL 
Sbjct: 99  PFLVGLH-FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARF-YAAEIASALG 153
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDY 283
           YLH+ ++++RD+K  NILLD+   + + DFGL +    ++ H ST     GTP Y+ P+ 
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEV 210
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGL 309
                     D +  G VL E++ GL
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 118 LGDGGFGAVYLGILR--DGRIVAVKRLYENNFKRIEQFM--NEVEILTKLQHPNLVKLYG 173
           +G G +G     I R  DG+I+  K L   +    E+ M  +EV +L +L+HPN+V+ Y 
Sbjct: 14  IGTGSYGRCQ-KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH---- 228
               R +  L +V EY   G +A  +         L     L +  +   AL   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 229 -ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
               V+HRD+K  N+ LD    VK+ DFGL+R+   D T  + A  GTP Y+ P+     
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRM 191
Query: 288 KLTDKSDVYSFGVVLIELIS 307
              +KSD++S G +L EL +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY C  +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 97  PFFVKLYFCF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 149
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 150 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGL 236

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K +G G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 39/292 (13%)
Query: 112 FNSSKQLGDGGFGAVYLGILRDGR-IVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           F    ++G G FG VY GI    + +VA+K +  E     IE    E+ +L++   P + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----LSIAIETAGALA 225
           + +G +  +S +L ++ EY+  G+  D          L P P+      +I  E    L 
Sbjct: 81  RYFG-SYLKSTKLWIIMEYLGGGSALD---------LLKPGPLEETYIATILREILKGLD 130
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+   IHRD+K+ N+LL     VK+ADFG++    TD         GTP ++ P+  +
Sbjct: 131 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIK 189
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                 K+D++S G+  IEL  G E  ++  H   + L  +  N            P+L 
Sbjct: 190 QSAYDFKADIWSLGITAIELAKG-EPPNSDLHPMRV-LFLIPKNS----------PPTLE 237
Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSNLGT 394
            +     +  V +       C+ +D   RPT KE+L+   I R TK ++  T
Sbjct: 238 GQHSKPFKEFVEA-------CLNKDPRFRPTAKELLKHKFITRYTKKTSFLT 282

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K +G G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 20/227 (8%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILT-KLQ 164
           ++F   K LG G FG V+L   +   +  A+K L ++       +E  M E  +L+   +
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI-AIETAGA 223
           HP L  ++ CT +    L  V EY+  G +  H+      SC      R +  A E    
Sbjct: 78  HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILG 131
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDP 281
           L +LH+  +++RD+K +NILLD +  +K+ADFG+ +    ++   +   +  GTP Y+ P
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFCGTPDYIAP 188
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDINLSN 325
           +     K     D +SFGV+L E++ G       D     H I + N
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 235

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC-----TRFYTA-EIVSA 144
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      + +  GT  YV P+
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                  +  SD+++ G ++ +L++GL
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAGL 231

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 118 LGDGGFGAVYLGILR--DGRIVAVKRLYENNFKRIEQFM--NEVEILTKLQHPNLVKLYG 173
           +G G +G     I R  DG+I+  K L   +    E+ M  +EV +L +L+HPN+V+ Y 
Sbjct: 14  IGTGSYGRCQ-KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH---- 228
               R +  L +V EY   G +A  +         L     L +  +   AL   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 229 -ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
               V+HRD+K  N+ LD    VK+ DFGL+R+   D +   T   GTP Y+ P+     
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNRM 191
Query: 288 KLTDKSDVYSFGVVLIELIS 307
              +KSD++S G +L EL +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 112 FNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           +   ++LG GGFG V   I +D G  VA+K+   E + K  E++  E++I+ KL HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 170 KLY----GCTSRQSREL-LLVYEYIPNGTVADHLHNRQPNSC-LLPWPVRLSIAIETAGA 223
                  G       +L LL  EY   G +  +L N+  N C L   P+R ++  + + A
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR-TLLSDISSA 133
Query: 224 LAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           L YLH + +IHRD+K  NI+L         K+ D G ++    D   + T   GT  Y+ 
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLA 191
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           P+  +  K T   D +SFG +  E I+G 
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGF 220

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 112 FNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLV 169
           +   ++LG GGFG V   I +D G  VA+K+   E + K  E++  E++I+ KL HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 170 KLY----GCTSRQSREL-LLVYEYIPNGTVADHLHNRQPNSC-LLPWPVRLSIAIETAGA 223
                  G       +L LL  EY   G +  +L N+  N C L   P+R ++  + + A
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR-TLLSDISSA 134
Query: 224 LAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           L YLH + +IHRD+K  NI+L         K+ D G ++    D   + T   GT  Y+ 
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLA 192
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           P+  +  K T   D +SFG +  E I+G 
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGF 221

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 13/222 (5%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNFKR---IEQFMNEVEILTK 162
           E  ++F     LG G F  VY    +  G  VA+K + +    +   +++  NEV+I  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR-QPNSCLLPWPVRLSIAIETA 221
           L+HP++++LY      S  + LV E   NG +  +L NR +P S       R  +     
Sbjct: 68  LKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFMHQIIT 123
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL-SRLFPTDVTHVSTAPQGTPGYVD 280
           G L YLH+  ++HRD+  +N+LL  N  +K+ADFGL ++L      H +    GTP Y+ 
Sbjct: 124 GML-YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYIS 180
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
           P+         +SDV+S G +   L+ G    DT   ++ +N
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVY--LGILRDGR----IVAVKRLYEN-NFKRI 150
           K+    + E    N    K LG+G FG V         GR     VAVK L EN +   +
Sbjct: 11  KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ-------- 202
              ++E  +L ++ HP+++KLYG  S Q   LLL+ EY   G++   L   +        
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACS-QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 203 ------------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV 250
                       P+   L     +S A + +  + YL    ++HRD+ + NIL+    ++
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKM 189
Query: 251 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD-----KSDVYSFGVVLIEL 305
           K++DFGLSR    DV    +  + + G +   +     L D     +SDV+SFGV+L E+
Sbjct: 190 KISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 306 IS 307
           ++
Sbjct: 246 VT 247

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           +F   + +G GGFG V+    R DG+   +KR+  NN    E+   EV+ L KL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 170 KLYGC--------------TSR-QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
              GC              +SR +++ L +  E+   GT+   +  R+     L   + L
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLAL 125
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG 274
            +  +    + Y+H+  +I+RD+K +NI L +  +VK+ DFGL      D     +  +G
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KG 183
Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLE-AVDTSRHRHDI 321
           T  Y+ P+         + D+Y+ G++L EL+   + A +TS+   D+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVY--LGILRDGR----IVAVKRLYEN-NFKRI 150
           K+    + E    N    K LG+G FG V         GR     VAVK L EN +   +
Sbjct: 11  KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ-------- 202
              ++E  +L ++ HP+++KLYG  S Q   LLL+ EY   G++   L   +        
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACS-QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 203 ------------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV 250
                       P+   L     +S A + +  + YL    ++HRD+ + NIL+    ++
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189
Query: 251 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD-----KSDVYSFGVVLIEL 305
           K++DFGLSR    DV    +  + + G +   +     L D     +SDV+SFGV+L E+
Sbjct: 190 KISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 306 IS 307
           ++
Sbjct: 246 VT 247

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 15/208 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR---IEQFMNEVEILTKL 163
             DNF   + LG G FG V L  +++ G + AVK L ++   +   +E  M E  IL+  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 164 Q-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETA 221
           + HP L +L+ C     R L  V E++  G +  H+  +R+ +     +      A E  
Sbjct: 81  RNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARF-----YAAEII 134
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP-QGTPGYVD 280
            AL +LH   +I+RD+K +N+LLD+    K+ADFG+ +        V+TA   GTP Y+ 
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIA 192
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P+  Q        D ++ GV+L E++ G
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 145
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      + +  GT  YV P+
Sbjct: 146 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 131/309 (42%), Gaps = 34/309 (11%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D  N  K LG G FG V      GI +    R VAVK L E         
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ----PNSCL 207
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++    P   L
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 208 ----LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT 263
               L     +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK 196
Query: 264 DVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
           D  +V       P  ++ P+       T +SDV+SFGV+L E+ S             + 
Sbjct: 197 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LG 243
Query: 323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            S     KI       L + +     DY    M  ++ +    C   +   RPT  E++E
Sbjct: 244 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVE 299
Query: 383 ILRETKDSN 391
            L     +N
Sbjct: 300 HLGNLLQAN 308

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    +KV DFGL++     V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 20/227 (8%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILT-KLQ 164
           ++F   K LG G FG V+L   +   +  A+K L ++       +E  M E  +L+   +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI-AIETAGA 223
           HP L  ++ CT +    L  V EY+  G +  H+      SC      R +  A E    
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILG 130
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDP 281
           L +LH+  +++RD+K +NILLD +  +K+ADFG+ +  +     T+      GTP Y+ P
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC---GTPDYIAP 187
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDINLSN 325
           +     K     D +SFGV+L E++ G       D     H I + N
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 131/309 (42%), Gaps = 34/309 (11%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D  N  K LG G FG V      GI +    R VAVK L E         
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ----PNSCL 207
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++    P   L
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 208 ----LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT 263
               L     +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK 196
Query: 264 DVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
           D  +V       P  ++ P+       T +SDV+SFGV+L E+ S             + 
Sbjct: 197 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LG 243
Query: 323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            S     KI       L + +     DY    M  ++ +    C   +   RPT  E++E
Sbjct: 244 ASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVE 299
Query: 383 ILRETKDSN 391
            L     +N
Sbjct: 300 HLGNLLQAN 308

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 87  PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 137
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG ++     V   +    GTP Y+ P
Sbjct: 138 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAP 193
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 117 QLGDGGFGAVYLGI--LRDGRI-VAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLY 172
           +LG G FG+V  G+  +R  +I VA+K L +   K   E+ M E +I+ +L +P +V+L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G    Q+  L+LV E    G +   L  ++     +P      +  + +  + YL   + 
Sbjct: 77  GVC--QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYFQCYKLT 290
           +HRD+ + N+LL N    K++DFGLS+    D ++ +  +A +    +  P+     K +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 291 DKSDVYSFGVVLIELIS 307
            +SDV+S+GV + E +S
Sbjct: 192 SRSDVWSYGVTMWEALS 208

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 144
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGL 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 141
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      + +  GT  YV P+
Sbjct: 142 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGL 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 144
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 142
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLY----ENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           +G GGFG VY      G  VAVK       E+  + IE    E ++   L+HPN++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHN-RQPNSCLLPWPVRLSIAIETAGALAYLHAS-- 230
              ++   L LV E+   G +   L   R P   L+ W      A++ A  + YLH    
Sbjct: 74  VCLKEPN-LCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAI 126
Query: 231 -DVIHRDVKSNNILLD--------NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             +IHRD+KS+NIL+         +N  +K+ DFGL+R +    T +S A  G   ++ P
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAA--GAYAWMAP 183
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +  +    +  SDV+S+GV+L EL++G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVY--LGILRDGR----IVAVKRLYEN-NFKRI 150
           K+    + E    N    K LG+G FG V         GR     VAVK L EN +   +
Sbjct: 11  KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ-------- 202
              ++E  +L ++ HP+++KLYG  S Q   LLL+ EY   G++   L   +        
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACS-QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 203 ------------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV 250
                       P+   L     +S A + +  + YL    ++HRD+ + NIL+    ++
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189
Query: 251 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD-----KSDVYSFGVVLIEL 305
           K++DFGLSR    DV    +  + + G +   +     L D     +SDV+SFGV+L E+
Sbjct: 190 KISDFGLSR----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 306 IS 307
           ++
Sbjct: 246 VT 247

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 144
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 144
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 145
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 146 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 122 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 172
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 228
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 142
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV P+
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 144
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 119
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV P+
Sbjct: 120 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGL 206

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 94  PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--------AAQIV 144
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 200
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 147
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV P+
Sbjct: 148 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGL 234

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 126/305 (41%), Gaps = 37/305 (12%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D  N  K LG G FG V      GI +    R VAVK L E         
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++        P
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 212 VRL-----------SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
             L             + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 261 FPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH 319
              D   V       P  ++ P+       T +SDV+SFGV+L E+ S            
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------------ 245
Query: 320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
            +  S     KI       L + +     DY    M  ++ +    C   +   RPT  E
Sbjct: 246 -LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSE 300
Query: 380 VLEIL 384
           ++E L
Sbjct: 301 LVEHL 305

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+P G +  HL       +P++           A +  
Sbjct: 94  PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 144
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 200
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 126
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV P+
Sbjct: 127 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGL 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 116 KQLGDGGFGAVYLGIL--RDGRIV--AVKRLYENNFKRIE---QFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G      G+ V  AVK L  +   + E    F+ EV  +  L H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++LYG     +  + +V E  P G++ D L   Q +  L         A++ A  + YL 
Sbjct: 78  IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLE 132
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP-GYVDPDYFQC 286
           +   IHRD+ + N+LL     VK+ DFGL R  P +  H V    +  P  +  P+  + 
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              +  SD + FGV L E+ +
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 120
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV P+
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGL 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 141
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV P+
Sbjct: 142 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGL 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 121
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 122 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGL 208

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 131/315 (41%), Gaps = 42/315 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYK 125
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D  +V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 186 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 236
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 237 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 288
Query: 377 MKEVLEILRETKDSN 391
             E++E L     +N
Sbjct: 289 FSELVEHLGNLLQAN 303

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 122
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV P+
Sbjct: 123 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGL 209

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVA---VKRLYENNFKRIEQFMNEVEILTKL-QH 165
           +F+  + +G G +  V L  L+   RI A   VK+   N+ + I+    E  +  +   H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P LV L+ C   +SR L  V EY+  G +  H+  ++     LP       + E + AL 
Sbjct: 113 PFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALN 167
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDY 283
           YLH   +I+RD+K +N+LLD+   +K+ D+G+ +  L P D T       GTP Y+ P+ 
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEI 224
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
            +        D ++ GV++ E+++G    D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVA---VKRLYENNFKRIEQFMNEVEILTKL-QH 165
           +F+  + +G G +  V L  L+   RI A   VK+   N+ + I+    E  +  +   H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P LV L+ C   +SR L  V EY+  G +  H+  ++     LP       + E + AL 
Sbjct: 81  PFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALN 135
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDY 283
           YLH   +I+RD+K +N+LLD+   +K+ D+G+ +  L P D T       GTP Y+ P+ 
Sbjct: 136 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEI 192
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
            +        D ++ GV++ E+++G    D
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 116 KQLGDGGFGAVYLGIL--RDGRIV--AVKRLYENNFKRIE---QFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G      G+ V  AVK L  +   + E    F+ EV  +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++LYG     +  + +V E  P G++ D L   Q +  L         A++ A  + YL 
Sbjct: 84  IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLE 138
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP-GYVDPDYFQC 286
           +   IHRD+ + N+LL     VK+ DFGL R  P +  H V    +  P  +  P+  + 
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              +  SD + FGV L E+ +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 108/241 (44%), Gaps = 38/241 (15%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           +F   + +G GGFG V+    R DG+   ++R+  NN    E+   EV+ L KL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 170 KLYGC---------TSRQSRE-------------------LLLVYEYIPNGTVADHLHNR 201
              GC         TS  S E                   L +  E+   GT+   +  R
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 202 QPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           +     L   + L +  +    + Y+H+  +IHRD+K +NI L +  +VK+ DFGL    
Sbjct: 129 RGEK--LDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLE-AVDTSRHRHD 320
             D     T  +GT  Y+ P+         + D+Y+ G++L EL+   + A +TS+   D
Sbjct: 187 KNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 244
Query: 321 I 321
           +
Sbjct: 245 L 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 131/315 (41%), Gaps = 42/315 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYK 125
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D  +V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 186 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 236
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 237 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 288
Query: 377 MKEVLEILRETKDSN 391
             E++E L     +N
Sbjct: 289 FSELVEHLGNLLQAN 303

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 116 KQLGDGGFGAVYLGIL--RDGRIV--AVKRLYENNFKRIE---QFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G      G+ V  AVK L  +   + E    F+ EV  +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++LYG     +  + +V E  P G++ D L   Q +  L         A++ A  + YL 
Sbjct: 84  IRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLE 138
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP-GYVDPDYFQC 286
           +   IHRD+ + N+LL     VK+ DFGL R  P +  H V    +  P  +  P+  + 
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              +  SD + FGV L E+ +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 116 KQLGDGGFGAVYLGIL--RDGRIV--AVKRLYENNFKRIE---QFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G      G+ V  AVK L  +   + E    F+ EV  +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++LYG     +  + +V E  P G++ D L   Q +  L         A++ A  + YL 
Sbjct: 74  IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLE 128
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP-GYVDPDYFQC 286
           +   IHRD+ + N+LL     VK+ DFGL R  P +  H V    +  P  +  P+  + 
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              +  SD + FGV L E+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 116 KQLGDGGFGAVYLGIL--RDGRIV--AVKRLYENNFKRIE---QFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G      G+ V  AVK L  +   + E    F+ EV  +  L H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++LYG     +  + +V E  P G++ D L   Q +  L         A++ A  + YL 
Sbjct: 78  IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLE 132
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP-GYVDPDYFQC 286
           +   IHRD+ + N+LL     VK+ DFGL R  P +  H V    +  P  +  P+  + 
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              +  SD + FGV L E+ +
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 131/315 (41%), Gaps = 42/315 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYK 171
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 231
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D  +V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 232 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 282
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 283 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 334
Query: 377 MKEVLEILRETKDSN 391
             E++E L     +N
Sbjct: 335 FSELVEHLGNLLQAN 349

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 131/315 (41%), Gaps = 42/315 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYK 134
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D  +V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 245
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 246 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 297
Query: 377 MKEVLEILRETKDSN 391
             E++E L     +N
Sbjct: 298 FSELVEHLGNLLQAN 312

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 130/315 (41%), Gaps = 42/315 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYK 125
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D   V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 186 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 236
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 237 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 288
Query: 377 MKEVLEILRETKDSN 391
             E++E L     +N
Sbjct: 289 FSELVEHLGNLLQAN 303

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 128/308 (41%), Gaps = 42/308 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYK 125
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D   V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 186 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 236
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 237 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 288
Query: 377 MKEVLEIL 384
             E++E L
Sbjct: 289 FSELVEHL 296

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 116 KQLGDGGFGAVYLGIL--RDGRIV--AVKRLYENNFKRIE---QFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G      G+ V  AVK L  +   + E    F+ EV  +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++LYG     +  + +V E  P G++ D L   Q +  L         A++ A  + YL 
Sbjct: 74  IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLE 128
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP-GYVDPDYFQC 286
           +   IHRD+ + N+LL     VK+ DFGL R  P +  H V    +  P  +  P+  + 
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              +  SD + FGV L E+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQ 164
           +D +   + LG GG   V+L   LR  R VAVK L  +  +      +F  E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 165 HPNLVKLYGCTSRQSRELLLVY---EYIPNGTVADHLHNRQPNSCLLPWPVR-LSIAIET 220
           HP +V +Y     ++    L Y   EY+   T+ D +H   P +     P R + +  + 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT-----PKRAIEVIADA 125
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--STAPQGTPGY 278
             AL + H + +IHRDVK  NI++     VKV DFG++R        V  + A  GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  +   +  +SDVYS G VL E+++G
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    ++V DFGL++     V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 116 KQLGDGGFGAVYLGIL--RDGRIV--AVKRLYENNFKRIE---QFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G      G+ V  AVK L  +   + E    F+ EV  +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           ++LYG     +  + +V E  P G++ D L   Q +  L         A++ A  + YL 
Sbjct: 74  IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLE 128
Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTP-GYVDPDYFQC 286
           +   IHRD+ + N+LL     VK+ DFGL R  P +  H V    +  P  +  P+  + 
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              +  SD + FGV L E+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVA---VKRLYENNFKRIEQFMNEVEILTKL-QH 165
           +F+  + +G G +  V L  L+   RI A   VK+   N+ + I+    E  +  +   H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P LV L+ C   +SR L  V EY+  G +  H+  ++     LP       + E + AL 
Sbjct: 66  PFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALN 120
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDY 283
           YLH   +I+RD+K +N+LLD+   +K+ D+G+ +  L P D T       GTP Y+ P+ 
Sbjct: 121 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEI 177
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
            +        D ++ GV++ E+++G    D
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ-----FMNEVEI 159
           L+   ++++  K +G G FG V L   +  + V   +L  + F+ I++     F  E +I
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLL-SKFEMIKRSDSAFFWEERDI 128
Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
           +     P +V+L+ C  +  + L +V EY+P G + + + N       +P         E
Sbjct: 129 MAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAE 182
Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGY 278
              AL  +H+  +IHRDVK +N+LLD +  +K+ADFG   ++  T + H  TA  GTP Y
Sbjct: 183 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VGTPDY 241
Query: 279 VDPDYFQCYK----LTDKSDVYSFGVVLIELISG 308
           + P+  +          + D +S GV L E++ G
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 130/315 (41%), Gaps = 42/315 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYK 134
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D   V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 245
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 246 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 297
Query: 377 MKEVLEILRETKDSN 391
             E++E L     +N
Sbjct: 298 FSELVEHLGNLLQAN 312

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLG-ILRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F    L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGA 223
           P  VKLY  T +   +L     Y  NG +  ++        +C      R   A E   A
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSA 142
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPD 282
           L YLH   +IHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV P+
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGL 309
                     SD+++ G ++ +L++GL
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVA---VKRLYENNFKRIEQFMNEVEILTKL-QH 165
           +F+  + +G G +  V L  L+   RI A   VK+   N+ + I+    E  +  +   H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P LV L+ C   +SR L  V EY+  G +  H+  ++     LP       + E + AL 
Sbjct: 70  PFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALN 124
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPDY 283
           YLH   +I+RD+K +N+LLD+   +K+ D+G+ +  L P D T       GTP Y+ P+ 
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEI 181
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
            +        D ++ GV++ E+++G    D
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 116 KQLGDGGFGAVYLGI-LRDGR----IVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLV 169
           K LG G FG VY GI + DG      VA+K L EN   +  ++ ++E  ++  +  P + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLH---NRQPNSCLLPWPVRLSIAIETAGALAY 226
           +L G     + +L  V + +P G + DH+     R  +  LL W       ++ A  ++Y
Sbjct: 83  RLLGICLTSTVQL--VTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSY 134
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQ 285
           L    ++HRD+ + N+L+ +   VK+ DFGL+RL   D T         P  ++  +   
Sbjct: 135 LEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             + T +SDV+S+GV + EL++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 122 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 172
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGATWTLCGTPEYLAP 228
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLXGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLAGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 130/315 (41%), Gaps = 42/315 (13%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++     +P+ 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYK 134
Query: 212 VR--------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL 257
           V               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 258 SRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           +R    D   V       P  ++ P+       T +SDV+SFGV+L E+ S         
Sbjct: 195 ARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 245
Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
               +  S     KI       L + +     DY    M  ++ +    C   +   RPT
Sbjct: 246 ----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPT 297
Query: 377 MKEVLEILRETKDSN 391
             E++E L     +N
Sbjct: 298 FSELVEHLGNLLQAN 312

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKL 163
           E  +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETA 221
            HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +  
Sbjct: 67  NHPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAP 179
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQ 164
           +D +   + LG GG   V+L   LR  R VAVK L  +  +      +F  E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 165 HPNLVKLYGCTSRQSRELLLVY---EYIPNGTVADHLHNRQPNSCLLPWPVR-LSIAIET 220
           HP +V +Y     ++    L Y   EY+   T+ D +H   P +     P R + +  + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT-----PKRAIEVIADA 125
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--STAPQGTPGY 278
             AL + H + +IHRDVK  NI++     VKV DFG++R        V  + A  GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  +   +  +SDVYS G VL E+++G
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P L KL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 102 PFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P L KL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 102 PFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   + LG G FG V L   ++ G   A+K L +      K+IE  +NE  I   +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQ 164
           +D +   + LG GG   V+L   LR  R VAVK L  +  +      +F  E +    L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 165 HPNLVKLYGCTSRQSRELLLVY---EYIPNGTVADHLHNRQPNSCLLPWPVR-LSIAIET 220
           HP +V +Y     ++    L Y   EY+   T+ D +H   P +     P R + +  + 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT-----PKRAIEVIADA 142
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--STAPQGTPGY 278
             AL + H + +IHRDVK  NI++     VKV DFG++R        V  + A  GT  Y
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  +   +  +SDVYS G VL E+++G
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P L KL   + + +  L +V EY P G +  HL       +P++           A +  
Sbjct: 102 PFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + P  
Sbjct: 84  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSH 141
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 198
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 199 -DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E+     V   L      S L  +P P+  S   +    L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEH-----VHQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 118 LGDGGFGAVYLGILR--DGRIVAVKRLYENNFKRIEQFM--NEVEILTKLQHPNLVKLYG 173
           +G G +G     I R  DG+I+  K L   +    E+ M  +EV +L +L+HPN+V+ Y 
Sbjct: 14  IGTGSYGRCQ-KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH---- 228
               R +  L +V EY   G +A  +         L     L +  +   AL   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 229 -ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
               V+HRD+K  N+ LD    VK+ DFGL+R+   D    +    GTP Y+ P+     
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-EDFAKEFVGTPYYMSPEQMNRM 191
Query: 288 KLTDKSDVYSFGVVLIELIS 307
              +KSD++S G +L EL +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 126/304 (41%), Gaps = 36/304 (11%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR-------QPN 204
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L ++       +P 
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 205 SC---LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
                 L     +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R  
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 262 PTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD 320
             D   V       P  ++ P+       T +SDV+SFGV+L E+ S             
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------------- 245
Query: 321 INLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           +  S     KI       L + +     DY    M  ++ +    C   +   RPT  E+
Sbjct: 246 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 301
Query: 381 LEIL 384
           +E L
Sbjct: 302 VEHL 305

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPE 174
Query: 283 -YFQCYKLTDKSDVYSFGVVLIELIS 307
               C   +   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENNF----KRIEQFMNEVEI 159
           +NF   K LG G +G V+L  +R       G++ A+K L +       K  E    E ++
Sbjct: 54  ENFELLKVLGTGAYGKVFL--VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 160 LTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           L  + Q P LV L+     +++ L L+ +YI  G +  HL  R+  +      V++ +  
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFT---EHEVQIYVG- 166
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E   AL +LH   +I+RD+K  NILLD+N  V + DFGLS+ F  D T  +    GT  Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 279 VDPDYFQCYKLT-DKS-DVYSFGVVLIELISG 308
           + PD  +      DK+ D +S GV++ EL++G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS---CLLPW- 210
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P     C  P  
Sbjct: 69  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 126
Query: 211 -PVR-------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
            P         +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 183
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 184 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 129/313 (41%), Gaps = 38/313 (12%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVY----LGILRDG--RIVAVKRLYEN-NFKRIEQ 152
           +  S+ E   D     K LG G FG V      GI +    R VAVK L E         
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 153 FMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ--------- 202
            M+E++IL  +  H N+V L G  ++    L+++ E+   G ++ +L +++         
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 203 PNSC---LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
           P       L     +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 260 LFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR 318
               D  +V       P  ++ P+       T +SDV+SFGV+L E+ S           
Sbjct: 199 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----------- 247
Query: 319 HDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMK 378
             +  S     KI       L + +     DY    M  ++ +    C   +   RPT  
Sbjct: 248 --LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFS 301
Query: 379 EVLEILRETKDSN 391
           E++E L     +N
Sbjct: 302 ELVEHLGNLLQAN 314

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 67  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 179
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS---CLLPW- 210
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P     C  P  
Sbjct: 84  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 141
Query: 211 -PVR-------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
            P         +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 198
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 199 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 208
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 122 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--------AAQIV 172
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 228
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQ-----FMNEVEILTKL 163
           D+F   + +G G FG V +    D  ++ A+K  Y N  K +E+        E++I+  L
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMK--YMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP LV L+  + +   ++ +V + +  G +  HL   Q N       V+L I  E   A
Sbjct: 73  EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFIC-ELVMA 127
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YL    +IHRD+K +NILLD +  V + DF ++ + P + T ++T   GT  Y+ P+ 
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTM-AGTKPYMAPEM 185
Query: 284 FQCYKLTDKS---DVYSFGVVLIELISG 308
           F   K    S   D +S GV   EL+ G
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 96  PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--------AAQIV 146
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 202
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYL-GILRDGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F   K LG G FG V L   +  G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 88  PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 138
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 194
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 99  VFSCSELEEATDNFNSSKQLGDGGFGAVYL---GILRDGRIVAVKRLYENNFKRIEQFMN 155
           +F  S+    ++ +   K+LG G +G V L    +    R + + R    +     + + 
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 156 EVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           EV +L  L HPN++KLY     + R   LV E    G + D + +R   +      V  +
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDK-RNYYLVMECYKGGELFDEIIHRMKFN-----EVDAA 139
Query: 216 IAI-ETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTA 271
           + I +    + YLH  +++HRD+K  N+LL++  +   +K+ DFGLS +F          
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             GT  Y+ P+  +  K  +K DV+S GV+L  L++G
Sbjct: 200 --GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + P  
Sbjct: 84  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH 141
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 198
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 199 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 118 LGDGGFGAVYLG-ILRDG-RI-VAVKRLYENNFKRIEQ-FMNEVEILTKL-QHPNLVKLY 172
           +G+G FG V    I +DG R+  A+KR+ E   K   + F  E+E+L KL  HPN++ L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQ------------PNSCLLPWPVRLSIAIET 220
           G    +   L L  EY P+G + D L   +              +  L     L  A + 
Sbjct: 93  GACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A  + YL     IHRD+ + NIL+  N+  K+ADFGLSR    +V    T  +    ++ 
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 209
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T  SDV+S+GV+L E++S
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIITLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIIHLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 118 LGDGGFGAVYLG-ILRDG-RI-VAVKRLYENNFKRIEQ-FMNEVEILTKL-QHPNLVKLY 172
           +G+G FG V    I +DG R+  A+KR+ E   K   + F  E+E+L KL  HPN++ L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQ------------PNSCLLPWPVRLSIAIET 220
           G    +   L L  EY P+G + D L   +              +  L     L  A + 
Sbjct: 83  GACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A  + YL     IHRD+ + NIL+  N+  K+ADFGLSR    +V    T  +    ++ 
Sbjct: 142 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 199
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T  SDV+S+GV+L E++S
Sbjct: 200 IESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYL------GILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           +D +   K+LG G +G V L      G  R  +I+  K+            ++EV +L +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKII--KKSSVTTTSNSGALLDEVAVLKQ 60
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI-ETA 221
           L HPN++KLY     + R   LV E    G + D +  RQ  S      V  ++ + +  
Sbjct: 61  LDHPNIMKLYEFFEDK-RNYYLVMEVYRGGELFDEIILRQKFS-----EVDAAVIMKQVL 114
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
               YLH  +++HRD+K  N+LL++  R   +K+ DFGLS  F  +V        GT  Y
Sbjct: 115 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  +  K  +K DV+S GV+L  L+ G
Sbjct: 173 IAPEVLR-KKYDEKCDVWSCGVILYILLCG 201

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 33/295 (11%)
Query: 94  YF-GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYENNFK 148
           YF GA   S  + E   +     + +G+G FG V+ GI          VA+K        
Sbjct: 21  YFQGAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD 80
Query: 149 RI-EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL 207
            + E+F+ E   + +  HP++VKL G  +     + ++ E    G +   L  R+ +   
Sbjct: 81  SVREKFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYS--- 135
Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
           L     +  A + + ALAYL +   +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+
Sbjct: 136 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 194
Query: 268 VSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSN 325
              +    P  ++ P+     + T  SDV+ FGV + E L+ G++     ++       N
Sbjct: 195 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------N 247
Query: 326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
               +I+NG            E+     N   ++  L  +C   D   RP   E+
Sbjct: 248 DVIGRIENG------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 116 KQLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNL 168
           ++LG+  FG VY G L         + VA+K L +     + E+F +E  +  +LQHPN+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-------------CLLPWPVRLS 215
           V L G  ++  + L +++ Y  +G + + L  R P+S              L P P  + 
Sbjct: 75  VCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP-PDFVH 132
Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQG 274
           +  + A  + YL +  V+H+D+ + N+L+ +   VK++D GL R ++  D   +      
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLE 310
              ++ P+     K +  SD++S+GVVL E+ S GL+
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 116 KQLGDGGFGAVYLGIL------RDGRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNL 168
           ++LG+  FG VY G L         + VA+K L +     + E+F +E  +  +LQHPN+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-------------CLLPWPVRLS 215
           V L G  ++  + L +++ Y  +G + + L  R P+S              L P P  + 
Sbjct: 92  VCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP-PDFVH 149
Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQG 274
           +  + A  + YL +  V+H+D+ + N+L+ +   VK++D GL R ++  D   +      
Sbjct: 150 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLE 310
              ++ P+     K +  SD++S+GVVL E+ S GL+
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 246

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 117 QLGDGGFGAVYLGI--LRDGRI-VAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLY 172
           +LG G FG+V  G+  +R  +I VA+K L +   K   E+ M E +I+ +L +P +V+L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G    Q+  L+LV E    G +   L  ++     +P      +  + +  + YL   + 
Sbjct: 403 GVC--QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYFQCYKLT 290
           +HR++ + N+LL N    K++DFGLS+    D ++ +  +A +    +  P+     K +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 291 DKSDVYSFGVVLIELIS 307
            +SDV+S+GV + E +S
Sbjct: 518 SRSDVWSYGVTMWEALS 534

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 13  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 72
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + P  
Sbjct: 73  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 130
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 187
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 188 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYL------GILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           +D +   K+LG G +G V L      G  R  +I+  K+            ++EV +L +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKII--KKSSVTTTSNSGALLDEVAVLKQ 77
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI-ETA 221
           L HPN++KLY     + R   LV E    G + D +  RQ  S      V  ++ + +  
Sbjct: 78  LDHPNIMKLYEFFEDK-RNYYLVMEVYRGGELFDEIILRQKFS-----EVDAAVIMKQVL 131
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
               YLH  +++HRD+K  N+LL++  R   +K+ DFGLS  F  +V        GT  Y
Sbjct: 132 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYY 189
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  +  K  +K DV+S GV+L  L+ G
Sbjct: 190 IAPEVLR-KKYDEKCDVWSCGVILYILLCG 218

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKL 163
           E  +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETA 221
            HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +  
Sbjct: 67  NHPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAP 179
Query: 282 DYFQCYKLTDKS-DVYSFGVVLIELIS 307
           +     K    + D++S G +  E+++
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 16  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 75
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + P  
Sbjct: 76  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 133
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 190
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 191 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + P  
Sbjct: 84  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 141
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 198
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 199 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 32/292 (10%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYENNFKRI- 150
           GA   S  + E   +     + +G+G FG V+ GI          VA+K         + 
Sbjct: 1   GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 60
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           E+F+ E   + +  HP++VKL G  +     + ++ E    G +   L  R+ +   L  
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYS---LDL 115
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST 270
              +  A + + ALAYL +   +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+   
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKA 174
Query: 271 APQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMAT 328
           +    P  ++ P+     + T  SDV+ FGV + E L+ G++     ++       N   
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVI 227
Query: 329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
            +I+NG            E+     N   ++  L  +C   D   RP   E+
Sbjct: 228 GRIENG------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 17  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 76
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + P  
Sbjct: 77  MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 134
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 191
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 192 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++      T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM-NEVEILT 161
           + E+  D ++    LG G F  V L    R  ++VA+K + +   +  E  M NE+ +L 
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL-----HNRQPNSCLLPWPVRLSI 216
           K++HPN+V L          L L+ + +  G + D +     +  +  S L+        
Sbjct: 72  KIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-------- 122
Query: 217 AIETAGALAYLHASDVIHRDVKSNNIL---LDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             +   A+ YLH   ++HRD+K  N+L   LD + ++ ++DFGLS++   D   V +   
Sbjct: 123 -FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC 179
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTPGYV P+       +   D +S GV+   L+ G
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 87  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 144
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 145 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 200
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           ++ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 117 SFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM-NEVEILT 161
           + E+  D ++    LG G F  V L    R  ++VA+K + +   +  E  M NE+ +L 
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL-----HNRQPNSCLLPWPVRLSI 216
           K++HPN+V L          L L+ + +  G + D +     +  +  S L+        
Sbjct: 72  KIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-------- 122
Query: 217 AIETAGALAYLHASDVIHRDVKSNNIL---LDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             +   A+ YLH   ++HRD+K  N+L   LD + ++ ++DFGLS++   D   V +   
Sbjct: 123 -FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC 179
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTPGYV P+       +   D +S GV+   L+ G
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           +D +   + LG G FG V L   +D   G+  AVK + +   K+    E  + EV++L +
Sbjct: 49  SDRYKGQRVLGKGSFGEVIL--CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 106
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HPN++KLY     +     LV E    G + D + +R+  S +        I  +   
Sbjct: 107 LDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDA----ARIIRQVLS 161
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
            + Y+H + ++HRD+K  N+LL++  +   +++ DFGLS  F  + +       GT  Y+
Sbjct: 162 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYI 219
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+        +K DV+S GV+L  L+SG
Sbjct: 220 APEVLHG-TYDEKCDVWSTGVILYILLSG 247

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++     +  L +    S L  +P P+  S   +   
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFL-----SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 174
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           +D +   + LG G FG V L   +D   G+  AVK + +   K+    E  + EV++L +
Sbjct: 48  SDRYKGQRVLGKGSFGEVIL--CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 105
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HPN++KLY     +     LV E    G + D + +R+  S +        I  +   
Sbjct: 106 LDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDA----ARIIRQVLS 160
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
            + Y+H + ++HRD+K  N+LL++  +   +++ DFGLS  F  + +       GT  Y+
Sbjct: 161 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYI 218
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+        +K DV+S GV+L  L+SG
Sbjct: 219 APEVLHG-TYDEKCDVWSTGVILYILLSG 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 84  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 141
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 142 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 197
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++     +  L +    S L  +P P+  S   +   
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFL-----SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 175
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L +    S L  +P P+  S   +   
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 172
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDG----RIVAVKRLYENNFKRIEQFMNEVE--ILTKLQ 164
            F   K LG G FG V+L     G    ++ A+K L +   K  ++   ++E  IL ++ 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP +VKL+     + + L L+ +++  G +   L             V+  +A E A AL
Sbjct: 86  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLA-ELALAL 140
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPD 282
            +LH+  +I+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P+
Sbjct: 141 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 197
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                  T  +D +SFGV++ E+++G
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYENNFKR-IEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++  +  +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 141 KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 254
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDG----RIVAVKRLYENNFKRIEQFMNEVE--ILTKLQ 164
            F   K LG G FG V+L     G    ++ A+K L +   K  ++   ++E  IL ++ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP +VKL+     + + L L+ +++  G +   L             V+  +A E A AL
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLA-ELALAL 139
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPD 282
            +LH+  +I+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P+
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 196
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                  T  +D +SFGV++ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           +D +   + LG G FG V L   +D   G+  AVK + +   K+    E  + EV++L +
Sbjct: 25  SDRYKGQRVLGKGSFGEVIL--CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HPN++KLY     +     LV E    G + D + +R+  S +        I  +   
Sbjct: 83  LDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDA----ARIIRQVLS 137
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
            + Y+H + ++HRD+K  N+LL++  +   +++ DFGLS  F  + +       GT  Y+
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYI 195
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+        +K DV+S GV+L  L+SG
Sbjct: 196 APEVLHG-TYDEKCDVWSTGVILYILLSG 223

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +++ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM-NEVEILTKL 163
           E+  D ++    LG G F  V L    R  ++VA+K + +   +  E  M NE+ +L K+
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL-----HNRQPNSCLLPWPVRLSIAI 218
           +HPN+V L          L L+ + +  G + D +     +  +  S L+          
Sbjct: 74  KHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI---------F 123
Query: 219 ETAGALAYLHASDVIHRDVKSNNIL---LDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +   A+ YLH   ++HRD+K  N+L   LD + ++ ++DFGLS++   D   V +   GT
Sbjct: 124 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGT 181
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           PGYV P+       +   D +S GV+   L+ G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+++D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDG----RIVAVKRLYENNFKRIEQFMNEVE--ILTKLQ 164
            F   K LG G FG V+L     G    ++ A+K L +   K  ++   ++E  IL ++ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP +VKL+     + + L L+ +++  G +   L             V+  +A E A AL
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLA-ELALAL 139
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPD 282
            +LH+  +I+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P+
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 196
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                  T  +D +SFGV++ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM-NEVEILT 161
           + E+  D ++    LG G F  V L    R  ++VA+K + +   +  E  M NE+ +L 
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 71
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL-----HNRQPNSCLLPWPVRLSI 216
           K++HPN+V L          L L+ + +  G + D +     +  +  S L+        
Sbjct: 72  KIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-------- 122
Query: 217 AIETAGALAYLHASDVIHRDVKSNNIL---LDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             +   A+ YLH   ++HRD+K  N+L   LD + ++ ++DFGLS++   D   V +   
Sbjct: 123 -FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC 179
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTPGYV P+       +   D +S GV+   L+ G
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +      
Sbjct: 82  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 139
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 140 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR----DIN 195
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 172
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 172
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
                       D ++ GV++ E+ +G
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 172
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 46/309 (14%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK--LQHPNLVKLYG 173
           KQ+G G +G V++G  R G  VAVK  +         +  E EI     ++H N++    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 174 CTSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
              + +    +L L+ +Y  NG++ D+L      S  L     L +A  +   L +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 231 --------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYV 279
                    + HRD+KS NIL+  N    +AD GL+  F +D   V   P    GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 280 DPD---------YFQCYKLTDKSDVYSFGVVLIEL----ISGLEAVDTSRHRHDINLSNM 326
            P+         +FQ Y +   +D+YSFG++L E+    +SG    +     HD+  S+ 
Sbjct: 214 PPEVLDESLNRNHFQSYIM---ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT---MKEVLEI 383
           +   ++     + + PS  F   ++    +  + +L   C   +   R T   +K+ L  
Sbjct: 271 SYEDMREIVCIKKLRPS--FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 384 LRETKDSNL 392
           + E++D  L
Sbjct: 329 MSESQDIKL 337

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 139/307 (45%), Gaps = 45/307 (14%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRDGRI--VAVKRLYEN-NFKRIEQFMNE 156
           + E   +N    K LG G FG    A   G+ ++  +  VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           ++I++ L QH N+V L G CT      +L++ EY   G + + L  ++P      + P  
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      L  + + A  +A+L + + IHRDV + N+LL N    K+ DFGL+R   
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 263 TDVTHVSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRH 319
            D  ++       P  ++ P+  F C   T +SDV+S+G++L E+ S GL          
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYP------ 270
Query: 320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
            I +++     +++G   ++  P+   +  Y++             C   +   RPT ++
Sbjct: 271 GILVNSKFYKLVKDGY--QMAQPAFAPKNIYSIMQA----------CWALEPTHRPTFQQ 318
Query: 380 VLEILRE 386
           +   L+E
Sbjct: 319 ICSFLQE 325

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E+     V   L      S L  +P P+  S   +   
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEH-----VDQDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 175
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYL----GILRD--GRI--VAVKRLYEN-NFKRIEQFMNE 156
           E   D     K LG+G FG V L    G+ +D   R+  VAVK L  +   K +   ++E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR 213
           +E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+P      + P  
Sbjct: 125 MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 214 -----------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R   
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--- 239
Query: 263 TDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            D+ H+    + T G     ++ P+       T +SDV+SFGV+L E+ +
Sbjct: 240 -DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K    + D++S G +  E+++
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           +D +   + LG G FG V L   +D   G+  AVK + +   K+    E  + EV++L +
Sbjct: 31  SDRYKGQRVLGKGSFGEVIL--CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 88
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HPN++KLY     +     LV E    G + D + +R+  S +        I  +   
Sbjct: 89  LDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDA----ARIIRQVLS 143
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
            + Y+H + ++HRD+K  N+LL++  +   +++ DFGLS  F  + +       GT  Y+
Sbjct: 144 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYI 201
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+        +K DV+S GV+L  L+SG
Sbjct: 202 APEVLHG-TYDEKCDVWSTGVILYILLSG 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 172
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 173
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 174
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKTFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 175
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 38/273 (13%)
Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQHPNLVKLYG 173
           LG G FG V +G  +  G  VAVK L     + ++   +   E++ L   +HP+++KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 174 CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
             S  + +  +V EY+  G + D++  H R           RL   I +A  + Y H   
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSA--VDYCHRHM 131
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF--QCYKL 289
           V+HRD+K  N+LLD +   K+ADFGLS +  +D   + T+  G+P Y  P+    + Y  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS-CGSPNYAAPEVISGRLYA- 188
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             + D++S GV+L  L+ G    D      D ++  +   KI+ G               
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD------DEHVPTL-FKKIRGGVF------------- 228
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           Y    +  SVA L    +Q D   R T+K++ E
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 78  GVITENP--VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKRF 132
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 232
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 233 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 173
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 175
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 117 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 174
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRDGR----IVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 80  GVITENP--VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKRF 134
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 194 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 234
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 235 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 65  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 176
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 41/302 (13%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRDGRI--VAVKRLYEN-NFKRIEQFMNE 156
           + E   +N    K LG G FG    A   G+ ++  +  VAVK L    +    E  M+E
Sbjct: 32  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 91
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-----LP 209
           ++I++ L QH N+V L G CT      +L++ EY   G + + L  R+  + L      P
Sbjct: 92  LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLR-RKAEADLDKEDGRP 148
Query: 210 WPVR--LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             +R  L  + + A  +A+L + + IHRDV + N+LL N    K+ DFGL+R    D  +
Sbjct: 149 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 208
Query: 268 VSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS 324
           +       P  ++ P+  F C   T +SDV+S+G++L E+ S GL           I ++
Sbjct: 209 IVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYP------GILVN 261
Query: 325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           +     +++G   ++  P+   +  Y++             C   +   RPT +++   L
Sbjct: 262 SKFYKLVKDGY--QMAQPAFAPKNIYSIMQA----------CWALEPTHRPTFQQICSFL 309
Query: 385 RE 386
           +E
Sbjct: 310 QE 311

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 175
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++     +  L      S L  +P P+  S   +   
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFL-----SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 173
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++        L      S L  +P P+  S   +   
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 174
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRDGR----IVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 81  GVITENP--VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKRF 135
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 235
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 236 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQ 164
           + +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAG 222
           HPN+VKL      +++ L LV+E++     +  L      S L  +P P+  S   +   
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFL-----SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDP 281
            LA+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P
Sbjct: 118 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAP 175
Query: 282 D-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +    C   +   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDPD- 282
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P+ 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 173
Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
              C   +   D++S G +  E+++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDPD- 282
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P+ 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 173
Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
              C   +   D++S G +  E+++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K  RL           + E+ +L +L HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 64  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-THVSTAPQGTPGYVDPD- 282
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  P+ 
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 175
Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
              C   +   D++S G +  E+++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 22/222 (9%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRDGRI--VAVKRLYEN-NFKRIEQFMNE 156
           + E   +N    K LG G FG    A   G+ ++  +  VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-----LP 209
           ++I++ L QH N+V L G CT      +L++ EY   G + + L  R+  + L      P
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLR-RKAEADLDKEDGRP 156
Query: 210 WPVR--LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             +R  L  + + A  +A+L + + IHRDV + N+LL N    K+ DFGL+R    D  +
Sbjct: 157 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 216
Query: 268 VSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
           +       P  ++ P+  F C   T +SDV+S+G++L E+ S
Sbjct: 217 IVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRDGR----IVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 78  GVITENP--VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKRF 132
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 232
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 233 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+   RL           + E+ +L +L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+   RL           + E+ +L +L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGAL 224
           N+VKL      +++ L LV+E++        L      S L  +P P+  S   +    L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD-Y 283
           A+ H+  V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+  
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
             C   +   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRDGR----IVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 75  GVITENP--VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKRF 129
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 229
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 458 GVITENP--VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF 512
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+ +N  VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 612
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 118 LGDGGFGAVYLG-ILRDG-RI-VAVKRLYENNFKRIEQ-FMNEVEILTKL-QHPNLVKLY 172
           +G+G FG V    I +DG R+  A+KR+ E   K   + F  E+E+L KL  HPN++ L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQ------------PNSCLLPWPVRLSIAIET 220
           G    +   L L  EY P+G + D L   +              +  L     L  A + 
Sbjct: 90  GACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A  + YL     IHR++ + NIL+  N+  K+ADFGLSR    +V    T  +    ++ 
Sbjct: 149 ARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 206
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T  SDV+S+GV+L E++S
Sbjct: 207 IESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 27/203 (13%)
Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN---EVEILTKLQHPNLVKLYG 173
           LG+G FG V L    +  + VA+K +     K+ +  M    E+  L  L+HP+++KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETAGALAYL 227
             +  + ++++V EY   G + D++  ++          R++         +   A+ Y 
Sbjct: 77  VITTPT-DIVMVIEY-AGGELFDYIVEKK----------RMTEDEGRRFFQQIICAIEYC 124
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF--Q 285
           H   ++HRD+K  N+LLD+N  VK+ADFGLS +  TD   + T+  G+P Y  P+    +
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPEVINGK 182
Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
            Y    + DV+S G+VL  ++ G
Sbjct: 183 LYA-GPEVDVWSCGIVLYVMLVG 204

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++  Y   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIINLLGACT--QDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 78  GVITENP--VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF 132
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+ +N  VK+ DFGLSR +  D T    +    P  ++ P+     + T 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 232
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 233 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 139/306 (45%), Gaps = 45/306 (14%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRDGRI--VAVKRLYEN-NFKRIEQFMNE 156
           + E   +N    K LG G FG    A   G+ ++  +  VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQ-----------P 203
           ++I++ L QH N+V L G CT      +L++ EY   G + + L  +             
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT 263
           NS L    + L  + + A  +A+L + + IHRDV + N+LL N    K+ DFGL+R    
Sbjct: 158 NSTLSTRDL-LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 264 DVTHVSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHD 320
           D  ++       P  ++ P+  F C   T +SDV+S+G++L E+ S GL           
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYP------G 269
Query: 321 INLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
           I +++     +++G   ++  P+   +  Y++             C   +   RPT +++
Sbjct: 270 ILVNSKFYKLVKDGY--QMAQPAFAPKNIYSIMQA----------CWALEPTHRPTFQQI 317
Query: 381 LEILRE 386
              L+E
Sbjct: 318 CSFLQE 323

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           LG G F  V+L   R  G++ A+K + ++   R     NE+ +L K++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED-IY 75
Query: 177 RQSRELLLVYEYIPNGTVADHLHNR----QPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
             +    LV + +  G + D +  R    + ++ L        +  +   A+ YLH + +
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--------VIQQVLSAVKYLHENGI 127
Query: 233 IHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           +HRD+K  N+L    + N ++ + DFGLS++    +  +STA  GTPGYV P+       
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLAQKPY 184
Query: 290 TDKSDVYSFGVVLIELISG 308
           +   D +S GV+   L+ G
Sbjct: 185 SKAVDCWSIGVITYILLCG 203

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 34/226 (15%)
Query: 110 DNFNSSKQLGDGGFGAVYL----GILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEIL 160
           D     K LG+G FG V +    GI +D       VAVK L ++   K +   ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 161 TKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----- 213
             + +H N++ L G CT  Q   L ++  Y   G + ++L  R+P      + +      
Sbjct: 95  KMIGKHKNIINLLGACT--QDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 214 -------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
                  +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DIN 208
Query: 267 HVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           ++    + T G     ++ P+       T +SDV+SFGV++ E+ +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           +D +   + LG G FG V L   +D   G+  AVK + +   K+    E  + EV++L +
Sbjct: 25  SDRYKGQRVLGKGSFGEVIL--CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L HPN+ KLY     +     LV E    G + D + +R+  S +        I  +   
Sbjct: 83  LDHPNIXKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDA----ARIIRQVLS 137
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
            + Y H + ++HRD+K  N+LL++  +   +++ DFGLS  F  + +       GT  Y+
Sbjct: 138 GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYI 195
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+        +K DV+S GV+L  L+SG
Sbjct: 196 APEVLHG-TYDEKCDVWSTGVILYILLSG 223

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 45/302 (14%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN----FKRIEQFMNEVEILT 161
           ++ + + +   +G+G +G V     +D GRIVA+K+  E++     K+I   M E+++L 
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLK 79
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           +L+H NLV L     ++ R   LV+E++ + T+ D L    PN   L + V      +  
Sbjct: 80  QLRHENLVNLLEVCKKKKR-WYLVFEFV-DHTILDDL-ELFPNG--LDYQVVQKYLFQII 134
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDV------THVSTAPQ 273
             + + H+ ++IHRD+K  NIL+  +  VK+ DFG +R    P +V      T    AP+
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIE------LISGLEAVDTSRHRHDINLSNMA 327
              G V        K     DV++ G ++ E      L  G   +D   H   + L N+ 
Sbjct: 195 LLVGDV--------KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM-MCLGNLI 245
Query: 328 --------TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
                    N +  G     +      E+ Y    +   V +LA +C+  D D RP   E
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYP--KLSEVVIDLAKKCLHIDPDKRPFCAE 303
Query: 380 VL 381
           +L
Sbjct: 304 LL 305

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFK------RIEQFMNEVEILTKL 163
           N+   K LG+G FG V L      G+ VA+K + +          RIE+   E+  L  L
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLL 71
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP+++KLY    +   E+++V EY  N  + D++  R   S       R     +   A
Sbjct: 72  RHPHIIKLYDVI-KSKDEIIMVIEYAGN-ELFDYIVQRDKMS---EQEARRFFQ-QIISA 125
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           + Y H   ++HRD+K  N+LLD +  VK+ADFGLS +  TD   + T+  G+P Y  P+ 
Sbjct: 126 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPEV 183
Query: 284 F--QCYKLTDKSDVYSFGVVL 302
              + Y    + DV+S GV+L
Sbjct: 184 ISGKLYA-GPEVDVWSCGVIL 203

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 139/307 (45%), Gaps = 47/307 (15%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRDGRI--VAVKRLYEN-NFKRIEQFMNE 156
           + E   +N    K LG G FG    A   G+ ++  +  VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPV-- 212
           ++I++ L QH N+V L G CT      +L++ EY   G + + L  R+ +  L   P   
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFA 155
Query: 213 ----------RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
                      L  + + A  +A+L + + IHRDV + N+LL N    K+ DFGL+R   
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 263 TDVTHVSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRH 319
            D  ++       P  ++ P+  F C   T +SDV+S+G++L E+ S GL          
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYP------ 268
Query: 320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
            I +++     +++G   ++  P+   +  Y++             C   +   RPT ++
Sbjct: 269 GILVNSKFYKLVKDGY--QMAQPAFAPKNIYSIMQA----------CWALEPTHRPTFQQ 316
Query: 380 VLEILRE 386
           +   L+E
Sbjct: 317 ICSFLQE 323

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETA 221
           P LVKL   + + +  L +V EY+  G +  HL       +P++           A +  
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--------AAQIV 151
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
               YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP  + P
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEALAP 207
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +           D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFK------RIEQFMNEVEILTKL 163
           N+   K LG+G FG V L      G+ VA+K + +          RIE+   E+  L  L
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLL 70
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP+++KLY    +   E+++V EY  N  + D++  R   S       R     +   A
Sbjct: 71  RHPHIIKLYDVI-KSKDEIIMVIEYAGN-ELFDYIVQRDKMS---EQEARRFFQ-QIISA 124
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           + Y H   ++HRD+K  N+LLD +  VK+ADFGLS +  TD   + T+  G+P Y  P+ 
Sbjct: 125 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPEV 182
Query: 284 F--QCYKLTDKSDVYSFGVVL 302
              + Y    + DV+S GV+L
Sbjct: 183 ISGKLYA-GPEVDVWSCGVIL 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
           ++F+  K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   
Sbjct: 8   NDFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP L  L        R L  V EY   G +  HL   +          R   A E   A
Sbjct: 66  RHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSA 120
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   + T   GTP Y+ P+ 
Sbjct: 121 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEV 179
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCG 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFK------RIEQFMNEVEILTKL 163
           N+   K LG+G FG V L      G+ VA+K + +          RIE+   E+  L  L
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLL 65
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP+++KLY    +   E+++V EY  N  + D++  R   S       R     +   A
Sbjct: 66  RHPHIIKLYDVI-KSKDEIIMVIEYAGN-ELFDYIVQRDKMS---EQEARRFFQ-QIISA 119
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           + Y H   ++HRD+K  N+LLD +  VK+ADFGLS +  TD   + T+  G+P Y  P+ 
Sbjct: 120 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPEV 177
Query: 284 F--QCYKLTDKSDVYSFGVVL 302
              + Y    + DV+S GV+L
Sbjct: 178 ISGKLYA-GPEVDVWSCGVIL 197

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFK------RIEQFMNEVEILTKL 163
           N+   K LG+G FG V L      G+ VA+K + +          RIE+   E+  L  L
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLL 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP+++KLY     +  E+++V EY  N  + D++  R   S       R     +   A
Sbjct: 62  RHPHIIKLYDVIKSKD-EIIMVIEYAGN-ELFDYIVQRDKMS---EQEARRFFQ-QIISA 115
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           + Y H   ++HRD+K  N+LLD +  VK+ADFGLS +  TD   + T+  G+P Y  P+ 
Sbjct: 116 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPEV 173
Query: 284 F--QCYKLTDKSDVYSFGVVL 302
              + Y    + DV+S GV+L
Sbjct: 174 ISGKLYA-GPEVDVWSCGVIL 193

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
           ++F+  K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP L  L        R L  V EY   G +  HL   +          R   A E   A
Sbjct: 63  RHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSA 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   + T   GTP Y+ P+ 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEV 176
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 111/247 (44%), Gaps = 27/247 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNL 168
           +F   + LG GGFG V+    + D    A+KR+   N +   E+ M EV+ L KL+HP +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 169 VKLYGC------TSRQSRELLLVYEYIPNGTV-ADHLHNRQPNSCLLPWPVR---LSIAI 218
           V+ +        T +       VY YI       ++L +     C +    R   L I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL-----------SRLFPTDVTH 267
           + A A+ +LH+  ++HRD+K +NI    +  VKV DFGL           + L P     
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI----SGLEAVDTSRHRHDINL 323
             T   GT  Y+ P+       + K D++S G++L EL+    + +E V T     ++  
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKF 245
Query: 324 SNMATNK 330
             + T K
Sbjct: 246 PPLFTQK 252

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
           ++F+  K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP L  L        R L  V EY   G +  HL   +          R   A E   A
Sbjct: 63  RHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSA 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   + T   GTP Y+ P+ 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEV 176
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 117 QLGDGGFGAVYLG---ILRDGRIVAVKRLY------ENNFKRIEQFMNEVEILTKLQHPN 167
           +LG GG   VYL    IL     VA+K ++      E   KR E+   EV   ++L H N
Sbjct: 18  KLGGGGMSTVYLAEDTILNIK--VAIKAIFIPPREKEETLKRFER---EVHNSSQLSHQN 72
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +V +      +     LV EYI   T+++++ +  P    L     ++   +    + + 
Sbjct: 73  IVSMIDV-DEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHA 127
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           H   ++HRD+K  NIL+D+N  +K+ DFG+++ L  T +T  +    GT  Y  P+  + 
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPEQAKG 186
Query: 287 YKLTDKSDVYSFGVVLIELISG 308
               + +D+YS G+VL E++ G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVG 208

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 162
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 214
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDG--RIVAVKRLYENNFKR---IEQFMNEVEILTKLQH 165
           +FN    LG G FG V L   R G   + A+K L ++   +   +E  M E  +L  L  
Sbjct: 20  DFNFLMVLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 166 PN-LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIET 220
           P  L +L+ C     R L  V EY+  G +  H+      ++P +           A E 
Sbjct: 79  PPFLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--------AAEI 129
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD-VTHVSTAPQGTPGYV 279
           +  L +LH   +I+RD+K +N++LD+   +K+ADFG+ +    D VT       GTP Y+
Sbjct: 130 SIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC--GTPDYI 187
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVD 313
            P+           D +++GV+L E+++G    D
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 38/273 (13%)
Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQHPNLVKLYG 173
           LG G FG V +G  +  G  VAVK L     + ++   +   E++ L   +HP+++KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 174 CTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
             S  + +  +V EY+  G + D++  H R           RL   I +A  + Y H   
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSA--VDYCHRHM 131
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF--QCYKL 289
           V+HRD+K  N+LLD +   K+ADFGLS +  +D   +  +  G+P Y  P+    + Y  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDS-CGSPNYAAPEVISGRLYA- 188
Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             + D++S GV+L  L+ G    D      D ++  +   KI+ G               
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD------DEHVPTL-FKKIRGGVF------------- 228
Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           Y    +  SVA L    +Q D   R T+K++ E
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 168
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 220
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPN 167
           + ++  +++G+G +G VY      G   A+K  RL + +       + E+ IL +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGALA 225
           +VKLY     + R L+LV+E++      D    +  + C   L      S  ++    +A
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PD   
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWYRAPDVLM 173
Query: 286 -CYKLTDKSDVYSFGVVLIELISG 308
              K +   D++S G +  E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPN 167
           + ++  +++G+G +G VY      G   A+K  RL + +       + E+ IL +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGALA 225
           +VKLY     + R L+LV+E++      D    +  + C   L      S  ++    +A
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PD   
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWYRAPDVLM 173
Query: 286 -CYKLTDKSDVYSFGVVLIELISG 308
              K +   D++S G +  E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 172
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 224
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 170
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 222
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 213
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 265
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 266 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPN 167
           + ++  +++G+G +G VY      G   A+K  RL + +       + E+ IL +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL--LPWPVRLSIAIETAGALA 225
           +VKLY     + R L+LV+E++      D    +  + C   L      S  ++    +A
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   V+HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PD   
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDVLM 173
Query: 286 -CYKLTDKSDVYSFGVVLIELISG 308
              K +   D++S G +  E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 128/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 15  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 74
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++KL H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 75  EQDELDFLMEALIISKLNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 133
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 134 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 192
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 193 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 241
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 242 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 291
Query: 376 TMKEVLE 382
               +LE
Sbjct: 292 NFAIILE 298

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 139
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 191
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 192 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 124/274 (45%), Gaps = 34/274 (12%)
Query: 117 QLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQ--FMNEVEILTKLQHPNLVKLYG 173
           ++G G F  VY G+  +  + VA   L +    + E+  F  E E L  LQHPN+V+ Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 174 ---CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH-- 228
               T +  + ++LV E   +GT+  +L   +    +    V  S   +    L +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFK----VXKIKVLRSWCRQILKGLQFLHTR 148
Query: 229 ASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
              +IHRD+K +NI +      VK+ D GL+ L        + A  GTP +  P+ ++  
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXYE-E 204
Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE 347
           K  +  DVY+FG   +E  +       S  ++   +    T+ ++  + +++  P     
Sbjct: 205 KYDESVDVYAFGXCXLEXATS--EYPYSECQNAAQIYRRVTSGVKPASFDKVAIP----- 257
Query: 348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
                      V E+   C++Q++D R ++K++L
Sbjct: 258 ----------EVKEIIEGCIRQNKDERYSIKDLL 281

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 31/227 (13%)
Query: 110 DNFNSSKQLGDGGFGAVY----LGILRDGRI--VAVKRLYEN-NFKRIEQFMNEVEILTK 162
           +N    K LG G FG V      GI + G    VAVK L E  +    E  M+E++++T+
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 163 L-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNR------------------- 201
           L  H N+V L G CT   S  + L++EY   G + ++L ++                   
Sbjct: 105 LGSHENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 202 QPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           + +  +L +   L  A + A  + +L     +HRD+ + N+L+ +   VK+ DFGL+R  
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 262 PTDVTHVSTAPQGTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +D  +V       P  ++ P+       T KSDV+S+G++L E+ S
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 36/240 (15%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           L  A+D F     LG G FG V       D R  A+K++     +++   ++EV +L  L
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASL 59
Query: 164 QHPNLVKLYGC------------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            H  +V+ Y                ++   L +  EY  NGT+ D +H+   N     + 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-------LFPTD 264
                 +E   AL+Y+H+  +IHRD+K  NI +D +  VK+ DFGL++       +   D
Sbjct: 120 RLFRQILE---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 265 VTHVS------TAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELI----SGLEAVD 313
             ++       T+  GT  YV  +         +K D+YS G++  E+I    +G+E V+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 128/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 29  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 88
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++KL H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 89  EQDELDFLMEALIISKLNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 147
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 148 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 206
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 207 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 255
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 256 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 305
Query: 376 TMKEVLE 382
               +LE
Sbjct: 306 NFAIILE 312

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 78  GVITENP--VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF 132
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+     VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 232
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 233 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYE--NNFKRIEQFMNEVEILTKLQ-HPNLVKL 171
           K+LG G +G V+  I  R G +VAVK++++   N    ++   E+ ILT+L  H N+V L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 172 YGCT-SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
                +   R++ LV++Y+        LH     + L P   +  +  +    + YLH+ 
Sbjct: 75  LNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVH-KQYVVYQLIKVIKYLHSG 128
Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLF----------PTDVTH----------VST 270
            ++HRD+K +NILL+    VKVADFGLSR F          P  +            + T
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 271 APQGTPGYVDPD-YFQCYKLTDKSDVYSFGVVLIELISG 308
               T  Y  P+      K T   D++S G +L E++ G
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 147
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 199
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 118 LGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRI-EQFMNEVEILTKLQHPNLVKLY 172
           +G+G FG V+ GI          VA+K         + E+F+ E   + +  HP++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
           G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL +   
Sbjct: 458 GVITENP--VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF 512
Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVDPDYFQCYKLTD 291
           +HRD+ + N+L+     VK+ DFGLSR +  D T+   +    P  ++ P+     + T 
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 292 KSDVYSFGVVLIE-LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY 350
            SDV+ FGV + E L+ G++     ++       N    +I+NG            E+  
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENG------------ERLP 612
Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEV 380
              N   ++  L  +C   D   RP   E+
Sbjct: 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/315 (26%), Positives = 141/315 (44%), Gaps = 54/315 (17%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRDGRI--VAVKRLYEN-NFKRIEQFMNE 156
           + E   +N    K LG G FG    A   G+ ++  +  VAVK L    +    E  M+E
Sbjct: 25  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 84
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW---- 210
           ++I++ L QH N+V L G CT      +L++ EY   G + + L  R+  + L P     
Sbjct: 85  LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLR-RKAEAMLGPSLAPG 141
Query: 211 ------------PVRL----SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD 254
                       P+ L      + + A  +A+L + + IHRDV + N+LL N    K+ D
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 201
Query: 255 FGLSRLFPTDVTHVSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS-GLEA 311
           FGL+R    D  ++       P  ++ P+  F C   T +SDV+S+G++L E+ S GL  
Sbjct: 202 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP 260
Query: 312 VDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDR 371
                    I +++     +++G   ++  P+   +  Y++             C   + 
Sbjct: 261 YP------GILVNSKFYKLVKDGY--QMAQPAFAPKNIYSIMQA----------CWALEP 302
Query: 372 DMRPTMKEVLEILRE 386
             RPT +++   L+E
Sbjct: 303 THRPTFQQICSFLQE 317

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 111 NFNSSKQLGDGGFGAVYL--GILR--DGRIVAVKRLYENNFKRIEQFMNEVE--ILTKLQ 164
           +F   K LG G FG V+L   + R   G + A+K L +   K  ++   ++E  IL  + 
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP +VKL+     + + L L+ +++  G +   L             V+  +A E A  L
Sbjct: 89  HPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLA-ELALGL 143
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPD 282
            +LH+  +I+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P+
Sbjct: 144 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPE 200
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                  +  +D +S+GV++ E+++G
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 130/312 (41%), Gaps = 43/312 (13%)
Query: 91  GSSY-FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRL 142
           G +Y F  K  S S+L+E    N    + LG G FG VY G +           VAVK L
Sbjct: 1   GPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 60
Query: 143 YENNFKRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR 201
            E   ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   
Sbjct: 61  PEVCSEQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRET 119
Query: 202 QP---NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADF 255
           +P       L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DF
Sbjct: 120 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 179
Query: 256 GLSRLFPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLE 310
           G++R    D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S   
Sbjct: 180 GMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--- 232
Query: 311 AVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQD 370
                       L  M      N  + E V  + G   D   +N    V  +  +C Q  
Sbjct: 233 ------------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQ 277
Query: 371 RDMRPTMKEVLE 382
            + RP    +LE
Sbjct: 278 PEDRPNFAIILE 289

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 186
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINAML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 168
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS     +  Y  P+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPE 226
Query: 283 Y-FQCYKLTDKSDVYSFGVVLIELISG 308
             F     T   DV+S G VL EL+ G
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 60
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 61  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 115
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDG--RIVAVKRLYENNFKR---IEQFMNEVEILT-KLQ 164
           +FN    LG G FG V L   R G   + AVK L ++   +   +E  M E  +L    +
Sbjct: 21  DFNFLMVLGKGSFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIET 220
            P L +L+ C     R L  V EY+  G +  H+      ++P++           A E 
Sbjct: 80  PPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--------AAEI 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A  L +L +  +I+RD+K +N++LD+   +K+ADFG+ +    D    +    GTP Y+ 
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIA 189
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDINLSNMATNK 330
           P+           D ++FGV+L E+++G    E  D       I   N+A  K
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 242

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+   +P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPD-IGMPEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+   +P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPD-IGMPEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 110/208 (52%), Gaps = 12/208 (5%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL-YENNFKRIEQFMNEVEILTKLQH 165
           ++  F   ++LG+G +  VY G+ +  G  VA+K +  ++        + E+ ++ +L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA----IETA 221
            N+V+LY     +++ L LV+E++ N  +  ++ +R   +   P  + L++      +  
Sbjct: 63  ENIVRLYDVIHTENK-LTLVFEFMDN-DLKKYMDSRTVGNT--PRGLELNLVKYFQWQLL 118
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             LA+ H + ++HRD+K  N+L++   ++K+ DFGL+R F   V   S+    T  Y  P
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-VVTLWYRAP 177
Query: 282 DYFQCYKLTDKS-DVYSFGVVLIELISG 308
           D     +    S D++S G +L E+I+G
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
           ++F+  K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP L  L        R L  V EY   G +  HL   +          R   A E   A
Sbjct: 63  RHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSA 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   +     GTP Y+ P+ 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-GTPEYLAPEV 176
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
           ++F+  K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   
Sbjct: 10  NDFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP L  L        R L  V EY   G +  HL   +          R   A E   A
Sbjct: 68  RHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSA 122
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   +     GTP Y+ P+ 
Sbjct: 123 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-GTPEYLAPEV 181
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 146
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS     +  Y  P+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPE 204
Query: 283 Y-FQCYKLTDKSDVYSFGVVLIELISG 308
             F     T   DV+S G VL EL+ G
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G +G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 63  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 153
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS     +  Y  P+
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPE 211
Query: 283 Y-FQCYKLTDKSDVYSFGVVLIELISG 308
             F     T   DV+S G VL EL+ G
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 146
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVST-------APQGT 275
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        AP+  
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 206
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G  D         T   DV+S G VL EL+ G
Sbjct: 207 FGATD--------YTSSIDVWSAGCVLAELLLG 231

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 143/324 (44%), Gaps = 62/324 (19%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYENNF-----KRIEQFMN---EVEIL 160
           D +  SK LG G  G V L   R   + VA+K + +  F     +  +  +N   E+EIL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAI 218
            KL HP ++K+       + +  +V E +  G + D +  + R   +    +  ++ +A+
Sbjct: 70  KKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 219 ETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +      YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T +     GT
Sbjct: 128 Q------YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 179
Query: 276 PGYVDPDYFQCYKLTDKS---DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN--- 329
           P Y+ P+          +   D +S GV+L   +SG      S HR  ++L +  T+   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKY 237
Query: 330 --------KIQNGALN-----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                   ++   AL+      +VDP   F  + A+R+              QD DM+  
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----------QDEDMKRK 286
Query: 377 MKEVLEILRETKDSNLGTSKAKVV 400
            +++L       + N  T+K +V+
Sbjct: 287 FQDLL------SEENESTAKPQVL 304

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 15  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 74
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 133
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 134 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 192
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 193 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 241
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 242 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 291
Query: 376 TMKEVLE 382
               +LE
Sbjct: 292 NFAIILE 298

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 29  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 88
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 89  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILMELMAGGDLKSFLRETRPRPS 147
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 148 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 206
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 207 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 255
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 256 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 305
Query: 376 TMKEVLE 382
               +LE
Sbjct: 306 NFAIILE 312

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
           ++F+  K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP L  L        R L  V EY   G +  HL   +          R   A E   A
Sbjct: 63  RHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSA 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   +     GTP Y+ P+ 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYLAPEV 176
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 142
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS     +  Y  P+
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPE 200
Query: 283 Y-FQCYKLTDKSDVYSFGVVLIELISG 308
             F     T   DV+S G VL EL+ G
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDG--RIVAVKRLYENNFKR---IEQFMNEVEILT-KLQ 164
           +FN    LG G FG V L   R G   + AVK L ++   +   +E  M E  +L    +
Sbjct: 342 DFNFLMVLGKGSFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIET 220
            P L +L+ C     R L  V EY+  G +  H+      ++P++           A E 
Sbjct: 401 PPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--------AAEI 451
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           A  L +L +  +I+RD+K +N++LD+   +K+ADFG+ +    D    +    GTP Y+ 
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIA 510
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDINLSNMATNK 330
           P+           D ++FGV+L E+++G    E  D       I   N+A  K
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 563

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 118 LGDGGFGAVY-LGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           LG G FG V+       G  +A K +     K  E+  NE+ ++ +L H NL++LY    
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD 236
            ++ +++LV EY+  G + D + +   N   L   + +    E    + ++H   ++H D
Sbjct: 157 SKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQMYILHLD 212
Query: 237 VKSNNILLDNN--FRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           +K  NIL  N    ++K+ DFGL+R + P +   V+    GTP ++ P+      ++  +
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSFPT 269
Query: 294 DVYSFGVVLIELISGL 309
           D++S GV+   L+SGL
Sbjct: 270 DMWSVGVIAYMLLSGL 285

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 169 VKL--YGCTSRQSRELL---LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L  +  +S + ++++   LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVST-------APQGT 275
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        AP+  
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 194
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G  D         T   DV+S G VL EL+ G
Sbjct: 195 FGATD--------YTSSIDVWSAGCVLAELLLG 219

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 77  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 128
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNF---KRIEQFMNEVEILTKL 163
           ++F+  K LG G FG V L  +R+   GR  A+K L +        +   + E  +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP L  L        R L  V EY   G +  HL   +          R   A E   A
Sbjct: 63  RHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSA 117
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   +     GTP Y+ P+ 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYLAPEV 176
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 76  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 80  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 21  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 80
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 81  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 139
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 140 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 198
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 199 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 247
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 248 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 297
Query: 376 TMKEVLE 382
               +LE
Sbjct: 298 NFAIILE 304

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 14  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 73
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 191
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 192 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 240
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 241 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 290
Query: 376 TMKEVLE 382
               +LE
Sbjct: 291 NFAIILE 297

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 29  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYS 88
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 89  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 147
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 148 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 206
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 207 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 255
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 256 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 305
Query: 376 TMKEVLE 382
               +LE
Sbjct: 306 NFAIILE 312

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 78  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 77  NPHVCRLLGICLTSTVQLIM--QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIA 128
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 118 LGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQHPNLVKLYG 173
           LG G FG V +G     G  VAVK L     + ++   +   E++ L   +HP+++KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
             S  S ++ +V EY+  G + D++     N  L     R  +  +    + Y H   V+
Sbjct: 84  VISTPS-DIFMVMEYVSGGELFDYICK---NGRLDEKESR-RLFQQILSGVDYCHRHMVV 138
Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF--QCYKLTD 291
           HRD+K  N+LLD +   K+ADFGLS +  +D   +  +  G+P Y  P+    + Y    
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXS-CGSPNYAAPEVISGRLYA-GP 195
Query: 292 KSDVYSFGVVLIELISGLEAVD 313
           + D++S GV+L  L+ G    D
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 79  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 116 KQLGDGGFGAVYLGILR--DGRI--VAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLV 169
           K LG+G FG+V  G L+  DG    VAVK +  +N   + IE+F++E   +    HPN++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 170 KLYG-CTSRQSREL---LLVYEYIPNGTVADHL-HNR-QPNSCLLPWPVRLSIAIETAGA 223
           +L G C    S+ +   +++  ++  G +  +L ++R +     +P    L   ++ A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGYVDPD 282
           + YL   + +HRD+ + N +L ++  V VADFGLS +++  D        +    ++  +
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219
Query: 283 YFQCYKLTDKSDVYSFGVVLIEL 305
                  T KSDV++FGV + E+
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEI 242

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVST-------APQGT 275
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        AP+  
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 194
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G  D         T   DV+S G VL EL+ G
Sbjct: 195 FGATD--------YTSSIDVWSAGCVLAELLLG 219

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 31  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 90
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 91  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 149
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 150 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 208
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 209 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 257
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 258 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 307
Query: 376 TMKEVLE 382
               +LE
Sbjct: 308 NFAIILE 314

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 135
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVST-------APQGT 275
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        AP+  
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 195
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G  D         T   DV+S G VL EL+ G
Sbjct: 196 FGATD--------YTSSIDVWSAGCVLAELLLG 220

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 14  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 73
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 132
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 191
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 192 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 240
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 241 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 290
Query: 376 TMKEVLE 382
               +LE
Sbjct: 291 NFAIILE 297

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 41  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 100
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 101 EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 159
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 160 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 218
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 219 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 267
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 268 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 317
Query: 376 TMKEVLE 382
               +LE
Sbjct: 318 NFAIILE 324

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVST-------APQGT 275
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        AP+  
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 194
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G  D         T   DV+S G VL EL+ G
Sbjct: 195 FGATD--------YTSSIDVWSAGCVLAELLLG 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 138
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVST-------APQGT 275
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        AP+  
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 198
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G  D         T   DV+S G VL EL+ G
Sbjct: 199 FGATD--------YTSSIDVWSAGCVLAELLLG 223

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 110 DNFNSSKQLGDGGFGAVYLG---ILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP 166
           + +N    LG G FG V      I +    V V        K     + EVE+L KL HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIET 220
           N++KL+      S    +V E    G + D +  R+          R S      I  + 
Sbjct: 82  NIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQV 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPG 277
              + Y+H  +++HRD+K  NILL++  +   +K+ DFGLS  F  +         GT  
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAY 188
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           Y+ P+  +     +K DV+S GV+L  L+SG
Sbjct: 189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 110 DNFNSSKQLGDGGFGAVYLG---ILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP 166
           + +N    LG G FG V      I +    V V        K     + EVE+L KL HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIET 220
           N++KL+      S    +V E    G + D +  R+          R S      I  + 
Sbjct: 82  NIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQV 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPG 277
              + Y+H  +++HRD+K  NILL++  +   +K+ DFGLS  F  +         GT  
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAY 188
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           Y+ P+  +     +K DV+S GV+L  L+SG
Sbjct: 189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 110 DNFNSSKQLGDGGFGAVYLG---ILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP 166
           + +N    LG G FG V      I +    V V        K     + EVE+L KL HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIET 220
           N++KL+      S    +V E    G + D +  R+          R S      I  + 
Sbjct: 82  NIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQV 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPG 277
              + Y+H  +++HRD+K  NILL++  +   +K+ DFGLS  F  +         GT  
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAY 188
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           Y+ P+  +     +K DV+S GV+L  L+SG
Sbjct: 189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ +      + F N E++I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 186
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ +      + F N E++I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 186
Query: 283 YFQCYKL-------TDKSDVYSFGVVLIELISG 308
           Y++  +L       T   DV+S G VL EL+ G
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 112 FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFM-NEVEILTKLQHPNLV 169
           F   + LG G F  V L   +  G++ AVK + +   K  E  + NE+ +L K++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHL-----HNRQPNSCLLPWPVRLSIAIETAGAL 224
            L       +  L LV + +  G + D +     +  +  S L+          +   A+
Sbjct: 84  ALEDIYESPNH-LYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR---------QVLDAV 133
Query: 225 AYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            YLH   ++HRD+K  N+L    D   ++ ++DFGLS++       V +   GTPGYV P
Sbjct: 134 YYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAP 191
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +       +   D +S GV+   L+ G
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPN 167
           + +   +++G+G +G VY      GRIVA+KR  L   +       + E+ +L +L HPN
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 168 LVKLYGCTSRQSRELLLVYEYIPN--GTVADHLHNRQPNSCLLPWPVRLSIAI-ETAGAL 224
           +V L      + R L LV+E++      V D       +S       ++ I + +    +
Sbjct: 81  IVSLIDVIHSE-RCLTLVFEFMEKDLKKVLDENKTGLQDS-------QIKIYLYQLLRGV 132
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           A+ H   ++HRD+K  N+L++++  +K+ADFGL+R F   V    T    T  Y  PD  
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVVTLWYRAPDVL 191
Query: 285 QCYKLTDKS-DVYSFGVVLIELISG 308
              K    S D++S G +  E+I+G
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPN 167
           + +   +++G+G +G VY      GRIVA+KR  L   +       + E+ +L +L HPN
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 168 LVKLYGCTSRQSRELLLVYEYIPN--GTVADHLHNRQPNSCLLPWPVRLSIAI-ETAGAL 224
           +V L      + R L LV+E++      V D       +S       ++ I + +    +
Sbjct: 81  IVSLIDVIHSE-RCLTLVFEFMEKDLKKVLDENKTGLQDS-------QIKIYLYQLLRGV 132
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           A+ H   ++HRD+K  N+L++++  +K+ADFGL+R F   V    T    T  Y  PD  
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVVTLWYRAPDVL 191
Query: 285 QCYKLTDKS-DVYSFGVVLIELISG 308
              K    S D++S G +  E+I+G
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 111 NFNSSKQLGDGGFGAVYLGILR--DGRIV--AVKRLYENNFKR--IEQFMNEVEILTKLQ 164
            F   + LG G FG+V    L+  DG  V  AVK L  +      IE+F+ E   + +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 165 HPNLVKLYGCT--SRQSREL---LLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIA 217
           HP++ KL G +  SR    L   +++  ++ +G +   L   +   N   LP    +   
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTP 276
           ++ A  + YL + + IHRD+ + N +L  +  V VADFGLSR ++  D      A +   
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
            ++  +       T  SDV++FGV + E+++          R     + +   +I N  +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMT----------RGQTPYAGIENAEIYNYLI 253
Query: 337 --NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
             N L  P    E+ Y          +L ++C   D   RP+
Sbjct: 254 GGNRLKQPPECMEEVY----------DLMYQCWSADPKQRPS 285

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 76  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 118/259 (45%), Gaps = 41/259 (15%)
Query: 137 VAVKRLYENNFKRI-EQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTV 194
           V  +RL     + + E    E  IL ++  HP+++ L   +   S  + LV++ +  G +
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID-SYESSSFMFLVFDLMRKGEL 187
Query: 195 ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD 254
            D+L  +      L      SI      A+++LHA++++HRD+K  NILLD+N +++++D
Sbjct: 188 FDYLTEK----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243
Query: 255 FGLSRLFPTDVTHVSTAPQ-----GTPGYVDPDYFQCYK------LTDKSDVYSFGVVLI 303
           FG S        H+    +     GTPGY+ P+  +C           + D+++ GV+L 
Sbjct: 244 FGFS-------CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 304 ELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELA 363
            L++G        HR  I +  M        +  E  D S             ++V +L 
Sbjct: 297 TLLAGSPPF---WHRRQILMLRMIMEGQYQFSSPEWDDRS-------------STVKDLI 340
Query: 364 FRCVQQDRDMRPTMKEVLE 382
            R +Q D + R T ++ L+
Sbjct: 341 SRLLQVDPEARLTAEQALQ 359

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 56/305 (18%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYENNF-----KRIEQFMN---EVEIL 160
           D +  SK LG G  G V L   R   + VA+K + +  F     +  +  +N   E+EIL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAI 218
            KL HP ++K+       + +  +V E +  G + D +  + R   +    +  ++ +A+
Sbjct: 70  KKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 219 ETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +      YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T +     GT
Sbjct: 128 Q------YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 179
Query: 276 PGYVDPDYFQCYKLTDKS---DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN--- 329
           P Y+ P+          +   D +S GV+L   +SG      S HR  ++L +  T+   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKY 237
Query: 330 --------KIQNGALN-----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                   ++   AL+      +VDP   F  + A+R+              QD DM+  
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----------QDEDMKRK 286
Query: 377 MKEVL 381
            +++L
Sbjct: 287 FQDLL 291

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 86  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 137
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 138 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 83  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 56/305 (18%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYENNF-----KRIEQFMN---EVEIL 160
           D +  SK LG G  G V L   R   + VA+K + +  F     +  +  +N   E+EIL
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAI 218
            KL HP ++K+       + +  +V E +  G + D +  + R   +    +  ++ +A+
Sbjct: 69  KKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 126
Query: 219 ETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +      YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T +     GT
Sbjct: 127 Q------YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 178
Query: 276 PGYVDPDYFQCYKLTDKS---DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN--- 329
           P Y+ P+          +   D +S GV+L   +SG      S HR  ++L +  T+   
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKY 236
Query: 330 --------KIQNGALN-----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                   ++   AL+      +VDP   F  + A+R+              QD DM+  
Sbjct: 237 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----------QDEDMKRK 285
Query: 377 MKEVL 381
            +++L
Sbjct: 286 FQDLL 290

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 79  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 56/305 (18%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYENNF-----KRIEQFMN---EVEIL 160
           D +  SK LG G  G V L   R   + VA+K + +  F     +  +  +N   E+EIL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAI 218
            KL HP ++K+       + +  +V E +  G + D +  + R   +    +  ++ +A+
Sbjct: 70  KKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 219 ETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +      YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T +     GT
Sbjct: 128 Q------YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 179
Query: 276 PGYVDPDYFQCYKLTDKS---DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN--- 329
           P Y+ P+          +   D +S GV+L   +SG      S HR  ++L +  T+   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKY 237
Query: 330 --------KIQNGALN-----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                   ++   AL+      +VDP   F  + A+R+              QD DM+  
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----------QDEDMKRK 286
Query: 377 MKEVL 381
            +++L
Sbjct: 287 FQDLL 291

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 70  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 121
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 78  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 82  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 133
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 134 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 79  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG------RIVAVKRLYENNFKRIEQFMN---EVEIL 160
           D +  SK LG G  G V L   R        RI++ ++    + +  +  +N   E+EIL
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAI 218
            KL HP ++K+       + +  +V E +  G + D +  + R   +    +  ++ +A+
Sbjct: 209 KKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 266
Query: 219 ETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +      YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T +     GT
Sbjct: 267 Q------YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 318
Query: 276 PGYVDPDYFQCYKLTDKS---DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN--- 329
           P Y+ P+          +   D +S GV+L   +SG      S HR  ++L +  T+   
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKY 376
Query: 330 --------KIQNGALN-----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                   ++   AL+      +VDP   F  + A+R+              QD DM+  
Sbjct: 377 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----------QDEDMKRK 425
Query: 377 MKEVL 381
            +++L
Sbjct: 426 FQDLL 430

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 79  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 56/305 (18%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYENNF-----KRIEQFMN---EVEIL 160
           D +  SK LG G  G V L   R   + VA+K + +  F     +  +  +N   E+EIL
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAI 218
            KL HP ++K+       + +  +V E +  G + D +  + R   +    +  ++ +A+
Sbjct: 76  KKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 133
Query: 219 ETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +      YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T +     GT
Sbjct: 134 Q------YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 185
Query: 276 PGYVDPDYFQCYKLTDKS---DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN--- 329
           P Y+ P+          +   D +S GV+L   +SG      S HR  ++L +  T+   
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKY 243
Query: 330 --------KIQNGALN-----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                   ++   AL+      +VDP   F  + A+R+              QD DM+  
Sbjct: 244 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----------QDEDMKRK 292
Query: 377 MKEVL 381
            +++L
Sbjct: 293 FQDLL 297

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 76  NPHVCRLLGICLTSTVQL--ITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 73  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 124
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 83  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 135
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G     +  P+    Y
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 71  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 123
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G     +  P+    Y
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI----EQFMNEVEILTKL 163
            ++++  + LG+G  G V L + R     VAVK +   + KR     E    E+ I   L
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+VK YG   R+     L  EY   G + D +   +P+  + P P       +    
Sbjct: 62  NHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDIGM-PEPDAQRFFHQLMAG 116
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP-TDVTHVSTAPQGTPGYVDPD 282
           + YLH   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 283 YFQCYKL-TDKSDVYSFGVVLIELISG 308
             +  +   +  DV+S G+VL  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 76  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 101 NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 152
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 153 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG------RIVAVKRLYENNFKRIEQFMN---EVEIL 160
           D +  SK LG G  G V L   R        RI++ ++    + +  +  +N   E+EIL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL--HNRQPNSCLLPWPVRLSIAI 218
            KL HP ++K+       + +  +V E +  G + D +  + R   +    +  ++ +A+
Sbjct: 195 KKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 219 ETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +      YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T +     GT
Sbjct: 253 Q------YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 304
Query: 276 PGYVDPDYFQCYKLTDKS---DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN--- 329
           P Y+ P+          +   D +S GV+L   +SG      S HR  ++L +  T+   
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKY 362
Query: 330 --------KIQNGALN-----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT 376
                   ++   AL+      +VDP   F  + A+R+              QD DM+  
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----------QDEDMKRK 411
Query: 377 MKEVL 381
            +++L
Sbjct: 412 FQDLL 416

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ-----FMNEVE 158
           +L    +++   K +G G FG V L   +  R V   +L  + F+ I++     F  E +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERD 121
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           I+     P +V+L+    +  R L +V EY+P G + + + N       +P         
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA 175
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPG 277
           E   AL  +H+   IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP 
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPD 234
Query: 278 YVDPDYFQCYK----LTDKSDVYSFGVVLIELISG 308
           Y+ P+  +          + D +S GV L E++ G
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ-----FMNEVE 158
           +L    +++   K +G G FG V L   +  R V   +L  + F+ I++     F  E +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERD 126
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           I+     P +V+L+    +  R L +V EY+P G + + + N       +P         
Sbjct: 127 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA 180
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPG 277
           E   AL  +H+   IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP 
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPD 239
Query: 278 YVDPDYFQCYK----LTDKSDVYSFGVVLIELISG 308
           Y+ P+  +          + D +S GV L E++ G
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 126/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 32  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 91
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 92  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 150
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 151 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 209
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+       +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 210 ---DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 258
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 259 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 308
Query: 376 TMKEVLE 382
               +LE
Sbjct: 309 NFAIILE 315

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ-----FMNEVE 158
           +L    +++   K +G G FG V L   +  R V   +L  + F+ I++     F  E +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERD 126
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           I+     P +V+L+    +  R L +V EY+P G + + + N       +P         
Sbjct: 127 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA 180
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPG 277
           E   AL  +H+   IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP 
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPD 239
Query: 278 YVDPDYFQCYK----LTDKSDVYSFGVVLIELISG 308
           Y+ P+  +          + D +S GV L E++ G
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 93  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 145
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G     +  P+    Y
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 93  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 145
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G     +  P+    Y
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 127/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 15  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 74
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 133
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG+++ 
Sbjct: 134 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ- 192
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+   S   +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 193 ---DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 241
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 242 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 291
Query: 376 TMKEVLE 382
               +LE
Sbjct: 292 NFAIILE 298

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 73  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 125
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G     +  P+    Y
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 77  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 129
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G     +  P+    Y
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 91  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 143
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G     +  P+    Y
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 126/307 (41%), Gaps = 42/307 (13%)
Query: 95  FGAKVFSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF 147
           F  K  S S+L+E    N    + LG G FG VY G +           VAVK L E   
Sbjct: 55  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114
Query: 148 KRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--- 203
           ++ E  F+ E  I++K  H N+V+  G  S QS    ++ E +  G +   L   +P   
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPS 173
Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRV-KVADFGLSRL 260
               L     L +A + A    YL  +  IHRD+ + N LL      RV K+ DFG++R 
Sbjct: 174 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 232
Query: 261 FPTDVTHVSTAPQGTPG-----YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
              D+       +G        ++ P+ F     T K+D +SFGV+L E+ S        
Sbjct: 233 ---DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 281
Query: 316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
                  L  M      N  + E V  + G   D   +N    V  +  +C Q   + RP
Sbjct: 282 -------LGYMPYPSKSNQEVLEFV--TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRP 331
Query: 376 TMKEVLE 382
               +LE
Sbjct: 332 NFAIILE 338

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 435 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 487
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT-P-GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G  P  +  P+    Y
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 548 KFSSKSDVWSFGVLMWEAFS 567

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNL 168
           ++  +K +G+G FG VY   L D G +VA+K++ +      + F N E++I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 169 VKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L    Y    ++    L LV +Y+P        H  +    L    V+L +  +   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVST-------APQGT 275
           LAY+H+  + HRD+K  N+LLD +  V K+ DFG ++       +VS        AP+  
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 194
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G  D         T   DV+S G VL EL+ G
Sbjct: 195 FGATD--------YTSSIDVWSAGCVLAELLLG 219

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 436 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 488
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT-P-GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G  P  +  P+    Y
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 549 KFSSKSDVWSFGVLMWEAFS 568

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLG--ILRDGRIVAVKRLYENNFKRIEQF--MNEVEILTKL 163
           A   +    ++G+G +G V+    +   GR VA+KR+     +       + EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 164 Q---HPNLVKLYG-CT-SRQSRE--LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           +   HPN+V+L+  CT SR  RE  L LV+E++            +P    +P      +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDM 125
Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
             +    L +LH+  V+HRD+K  NIL+ ++ ++K+ADFGL+R++   +   S     T 
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTL 183
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
            Y  P+           D++S G +  E+ 
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 36/240 (15%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           L  A+D F     LG G FG V       D R  A+K++     +++   ++EV +L  L
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASL 59
Query: 164 QHPNLVKLYGC------------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            H  +V+ Y                ++   L +  EY  N T+ D +H+   N     + 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-------LFPTD 264
                 +E   AL+Y+H+  +IHRD+K  NI +D +  VK+ DFGL++       +   D
Sbjct: 120 RLFRQILE---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 265 VTHVS------TAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELI----SGLEAVD 313
             ++       T+  GT  YV  +         +K D+YS G++  E+I    +G+E V+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLG--ILRDGRIVAVKRLYENNFKRIEQF--MNEVEILTKL 163
           A   +    ++G+G +G V+    +   GR VA+KR+     +       + EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 164 Q---HPNLVKLYG-CT-SRQSRE--LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           +   HPN+V+L+  CT SR  RE  L LV+E++            +P    +P      +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDM 125
Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
             +    L +LH+  V+HRD+K  NIL+ ++ ++K+ADFGL+R++   +   S     T 
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTL 183
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
            Y  P+           D++S G +  E+ 
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 141/310 (45%), Gaps = 29/310 (9%)
Query: 105 LEEATDNFNSSKQLGDGGFGAV-YLGILRDGRIVAVKRLYEN-NFKRIEQFMNEVEI-LT 161
           +E   D+     +LG G +G V  +  +  G+I+AVKR+    N +  ++ + +++I + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC-LLPWPVRLSIAIET 220
            +  P  V  YG   R+  ++ +  E +   T  D  + +  +    +P  +   IA+  
Sbjct: 62  TVDCPFTVTFYGALFREG-DVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 221 AGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH---VSTAPQGTP 276
             AL +LH+   VIHRDVK +N+L++   +VK+ DFG+S     DV         P   P
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
             ++P+  Q    + KSD++S G+ +IEL          R  +D    +  T   Q   +
Sbjct: 179 ERINPELNQ-KGYSVKSDIWSLGITMIELA-------ILRFPYD----SWGTPFQQLKQV 226
Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSK 396
            E   P L  +K  A         +   +C++++   RPT  E+++    T   + GT  
Sbjct: 227 VEEPSPQLPADKFSA------EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280
Query: 397 AKVVDIRIAD 406
           A  V + + D
Sbjct: 281 ASFVKLILGD 290

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLG--ILRDGRIVAVKRLYENNFKRIEQF--MNEVEIL 160
           L  A   +    ++G+G +G V+    +   GR VA+KR+     +       + EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 161 TKLQ---HPNLVKLYG-CT-SRQSRE--LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
             L+   HPN+V+L+  CT SR  RE  L LV+E++            +P    +P    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETI 122
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             +  +    L +LH+  V+HRD+K  NIL+ ++ ++K+ADFGL+R++   +   S    
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 180
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
            T  Y  P+           D++S G +  E+ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
           +D F    +LG G    VY    +   +  A+K L +   K+I +   E+ +L +L HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPN 109
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI-ETAGALAY 226
           ++KL       + E+ LV E +  G + D +  +   S         + A+ +   A+AY
Sbjct: 110 IIKLKEIFETPT-EISLVLELVTGGELFDRIVEKGYYS-----ERDAADAVKQILEAVAY 163
Query: 227 LHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           LH + ++HRD+K  N+L      +  +K+ADFGLS++    V   +    GTPGY  P+ 
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEI 221
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLE 310
            +      + D++S G++   L+ G E
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFE 248

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K L  G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 83  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 78  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFG ++L   +           P  ++ 
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 78  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFG ++L   +           P  ++ 
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L++  + +P G + D++   + N     LL W       ++ A
Sbjct: 80  NPHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFG ++L   +           P  ++ 
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 112 FNSSKQLGDGGFGAVYLGILRDG-RIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNL 168
           +   +++G+G +G V+    R+   IVA+KR  L +++       + E+ +L +L+H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC---LLPWPVRLSIAIETAGALA 225
           V+L+       ++L LV+E+       D    +  +SC   L P  V+ S   +    L 
Sbjct: 64  VRLHD-VLHSDKKLTLVFEF------CDQDLKKYFDSCNGDLDPEIVK-SFLFQLLKGLG 115
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           + H+ +V+HRD+K  N+L++ N  +K+ADFGL+R F   V    +A   T  Y  PD   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLF 174
Query: 286 CYKLTDKS-DVYSFGVVLIEL 305
             KL   S D++S G +  EL
Sbjct: 175 GAKLYSTSIDMWSAGCIFAEL 195

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +         V + +   N+    ++ + E  ++ +L +P +V+
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLH-NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G    +S   +LV E    G +  +L  NR      +     + +  + +  + YL  
Sbjct: 77  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 129
Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP--GYVDPDYFQCY 287
           S+ +HRD+ + N+LL      K++DFGLS+    D         G     +  P+    Y
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 288 KLTDKSDVYSFGVVLIELIS 307
           K + KSDV+SFGV++ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 111/237 (46%), Gaps = 12/237 (5%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTK 162
           +E   D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
              P +V  YG       E+ +  E++  G++   L      +  +P  +   ++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115
Query: 223 ALAYL-HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            L YL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           +  Q    + +SD++S G+ L+E+  G   +     + D +   MA  ++ +  +NE
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKED-SRPPMAIFELLDYIVNE 228

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI--LTKLQHPN 167
           DN    + +G G +GAVY G L D R VAVK     +F   + F+NE  I  +  ++H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDN 68
Query: 168 LVKLY----GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           + +        T+    E LLV EY PNG++  +L     +     W     +A      
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVTRG 123
Query: 224 LAYLHAS---------DVIHRDVKSNNILLDNNFRVKVADFGLS------RLF-PTDVTH 267
           LAYLH            + HRD+ S N+L+ N+    ++DFGLS      RL  P +  +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 268 VSTAPQGTPGYVDPDYFQ-CYKLTD------KSDVYSFGVVLIELI 306
            + +  GT  Y+ P+  +    L D      + D+Y+ G++  E+ 
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTK 162
           +E   D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
              P +V  YG       E+ +  E++  G++   L      +  +P  +   ++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115
Query: 223 ALAYL-HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            L YL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +  Q    + +SD++S G+ L+E+  G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTK 162
           +E   D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
              P +V  YG       E+ +  E++  G++   L      +  +P  +   ++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115
Query: 223 ALAYL-HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            L YL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +  Q    + +SD++S G+ L+E+  G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTK 162
           +E   D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
              P +V  YG       E+ +  E++  G++   L      +  +P  +   ++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115
Query: 223 ALAYL-HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            L YL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +  Q    + +SD++S G+ L+E+  G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTK 162
           +E   D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
              P +V  YG       E+ +  E++  G++   L      +  +P  +   ++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115
Query: 223 ALAYL-HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            L YL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +  Q    + +SD++S G+ L+E+  G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPN 167
           D+F    +LG G  G V     R   ++  ++L     K     Q + E+++L +   P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +V  YG       E+ +  E++  G++   L   +     +P  +   ++I     LAYL
Sbjct: 76  IVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYL 130
Query: 228 HAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
                ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P+  Q 
Sbjct: 131 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMAPERLQG 187
Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              + +SD++S G+ L+EL  G
Sbjct: 188 THYSVQSDIWSMGLSLVELAVG 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPN 167
           D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +   P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +V  YG       E+ +  E++  G++   L      +  +P  +   ++I     L YL
Sbjct: 128 IVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYL 182
Query: 228 HAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
                ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P+  Q 
Sbjct: 183 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 239
Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              + +SD++S G+ L+E+  G
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVG 261

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+  L E  + K  ++ ++E  ++  + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 110 NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 161
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 162 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPN 167
           D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +   P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +V  YG       E+ +  E++  G++   L      +  +P  +   ++I     L YL
Sbjct: 93  IVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYL 147
Query: 228 HAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
                ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P+  Q 
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 204
Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              + +SD++S G+ L+E+  G
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVG 226

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           TD++   ++LG G F  V   + +        +I+  K+L   + +++E+   E  I   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER---EARICRL 86
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI-ETA 221
           L+HPN+V+L+   S +    L V++ +  G + + +  R+  S         S  I +  
Sbjct: 87  LKHPNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYS-----EADASHCIHQIL 140
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            ++ ++H  D++HRD+K  N+LL +  +   VK+ADFGL+     +         GTPGY
Sbjct: 141 ESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE-QQAWFGFAGTPGY 199
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           + P+  +        D+++ GV+L  L+ G     D  +H+
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHK 240

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKL 163
           E   D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L + 
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
             P +V  YG       E+ +  E++  G++   L      +  +P  +   ++I     
Sbjct: 81  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 135
Query: 224 LAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           L YL     ++HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P+
Sbjct: 136 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPE 192
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
             Q    + +SD++S G+ L+E+  G
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 104/258 (40%), Gaps = 50/258 (19%)
Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGR-IVAVKRLYEN-----NFKRIEQF 153
           F    L E    ++    +G G +G V + I    R I A+K + +N     N K +E+ 
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 154 MNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH---NRQPNSC---- 206
             EV ++ KL HPN+ +LY       + + LV E    G + D L+   +     C    
Sbjct: 76  KTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 207 ----LLPWP-------------------------VRLSIAIETAGALAYLHASDVIHRDV 237
               + P P                         +  +I  +   AL YLH   + HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 238 KSNNILLDNN--FRVKVADFGLSRLF---PTDVTHVSTAPQGTPGYVDPDYFQCYKLT-- 290
           K  N L   N  F +K+ DFGLS+ F        +  T   GTP +V P+       +  
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 291 DKSDVYSFGVVLIELISG 308
            K D +S GV+L  L+ G
Sbjct: 255 PKCDAWSAGVLLHLLLMG 272

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K L  G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 83  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 83  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFG ++L   +           P  ++ 
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 78  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFG ++L   +           P  ++ 
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K LG G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 76  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFG ++L   +           P  ++ 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGR----IVAVKRLYE-NNFKRIEQFMNEVEILTKLQ 164
            F   K L  G FG VY G+ + +G      VA+K L E  + K  ++ ++E  ++  + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETA 221
           +P++ +L G     + +L  + + +P G + D++   + N     LL W       ++ A
Sbjct: 76  NPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP-GYVD 280
             + YL    ++HRD+ + N+L+     VK+ DFGL++L   +           P  ++ 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELIS 307
            +       T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPN 167
           D+F    +LG G  G V+    +   +V  ++L     K     Q + E+++L +   P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +V  YG       E+ +  E++  G++   L      +  +P  +   ++I     L YL
Sbjct: 69  IVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYL 123
Query: 228 -HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
                ++HRDVK +NIL+++   +K+ DFG+S      +  ++    GT  Y+ P+  Q 
Sbjct: 124 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTRSYMSPERLQG 180
Query: 287 YKLTDKSDVYSFGVVLIELISG 308
              + +SD++S G+ L+E+  G
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVG 202

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 140/310 (45%), Gaps = 29/310 (9%)
Query: 105 LEEATDNFNSSKQLGDGGFGAV-YLGILRDGRIVAVKRLYEN-NFKRIEQFMNEVEI-LT 161
            E   D+     +LG G +G V  +  +  G+I+AVKR+    N +  ++ + +++I + 
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 105
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC-LLPWPVRLSIAIET 220
            +  P  V  YG   R+  ++ +  E +   T  D  + +  +    +P  +   IA+  
Sbjct: 106 TVDCPFTVTFYGALFREG-DVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 221 AGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA---PQGTP 276
             AL +LH+   VIHRDVK +N+L++   +VK+ DFG+S      V     A   P   P
Sbjct: 163 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAP 222
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
             ++P+  Q    + KSD++S G+ +IEL          R  +D    +  T   Q   +
Sbjct: 223 ERINPELNQ-KGYSVKSDIWSLGITMIELA-------ILRFPYD----SWGTPFQQLKQV 270
Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSK 396
            E   P L  +K  A         +   +C++++   RPT  E+++    T   + GT  
Sbjct: 271 VEEPSPQLPADKFSA------EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 324
Query: 397 AKVVDIRIAD 406
           A  V + + D
Sbjct: 325 ASFVKLILGD 334

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 43/216 (19%)
Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ-FMNEVEILTK--LQHPNLVKLYGC 174
           +G G +G V+ G L  G  VAVK        R EQ +  E EI     L+H N++     
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS----SRDEQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 175 --TSRQSR-ELLLVYEYIPNGTVADHLHNR--QPNSCLLPWPVRLSIAIETAGALAYLHA 229
             TSR S  +L L+  Y  +G++ D L  +  +P+       + L +A+  A  LA+LH 
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPH-------LALRLAVSAACGLAHLHV 123
Query: 230 S--------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFP--TDVTHVSTAPQ-GTPGY 278
                     + HRD KS N+L+ +N +  +AD GL+ +    +D   +   P+ GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 183
Query: 279 VDP---------DYFQCYKLTDKSDVYSFGVVLIEL 305
           + P         D F+ YK T   D+++FG+VL E+
Sbjct: 184 MAPEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 112 FNSSKQLGDGGFGAVYLGILRDG-RIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNL 168
           +   +++G+G +G V+    R+   IVA+KR  L +++       + E+ +L +L+H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC---LLPWPVRLSIAIETAGALA 225
           V+L+       ++L LV+E+       D    +  +SC   L P  V+ S   +    L 
Sbjct: 64  VRLHDVL-HSDKKLTLVFEF------CDQDLKKYFDSCNGDLDPEIVK-SFLFQLLKGLG 115
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           + H+ +V+HRD+K  N+L++ N  +K+A+FGL+R F   V    +A   T  Y  PD   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLF 174
Query: 286 CYKLTDKS-DVYSFGVVLIEL 305
             KL   S D++S G +  EL
Sbjct: 175 GAKLYSTSIDMWSAGCIFAEL 195

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYE-NNFKRIEQ--FMNEVEILTKLQH 165
           ++F   K +G G FG V +  L++  ++ A+K L +    KR E   F  E ++L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
             +  L+    +    L LV +Y   G   T+     +R P      +   + IAI++  
Sbjct: 134 KWITTLHY-AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            L Y      +HRD+K +NIL+D N  +++ADFG       D T  S+   GTP Y+ P+
Sbjct: 193 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 283 YFQCY-----KLTDKSDVYSFGVVLIELISG 308
             Q       +   + D +S GV + E++ G
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMN-EVEILTKLQ 164
           E+    + + K +G+G FG V+   L +   VA+K++ ++     ++F N E++I+  ++
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVK 90
Query: 165 HPNLVKL----YGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
           HPN+V L    Y    ++    L LV EY+P        H  +    +    ++L +  +
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM-YQ 149
Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGY 278
              +LAY+H+  + HRD+K  N+LLD    V K+ DFG +++      +VS     +  Y
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI--CSRYY 207
Query: 279 VDPDY-FQCYKLTDKSDVYSFGVVLIELISG 308
             P+  F     T   D++S G V+ EL+ G
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 22/200 (11%)
Query: 118 LGDGGFGAVYLGILRDGRIV-AVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +G G +G V + + +  RI  A K++ +   + +++F  E+EI+  L HPN+++LY  T 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-TF 75
Query: 177 RQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
             + ++ LV E    G + + + +    R+ ++          I  +   A+AY H  +V
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHKLNV 127
Query: 233 IHRDVKSNNILL---DNNFRVKVADFGL-SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
            HRD+K  N L      +  +K+ DFGL +R  P  +        GTP YV P   +   
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVLEGL- 183
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D +S GV++  L+ G
Sbjct: 184 YGPECDEWSAGVMMYVLLCG 203

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 121 GGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR 180
           G FG V+   L +   VAVK ++    K+  Q   EV  L  ++H N+++  G   R + 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVK-IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 181 ---ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS------- 230
              +L L+  +   G+++D L      + ++ W     IA   A  LAYLH         
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 231 ---DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTPGYVDPDYFQC 286
               + HRD+KS N+LL NN    +ADFGL+  F    +   T  Q GT  Y+ P+  + 
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 287 YKLTDKS-----DVYSFGVVLIELISGLEAVD 313
                +      D+Y+ G+VL EL S   A D
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 22/200 (11%)
Query: 118 LGDGGFGAVYLGILRDGRIV-AVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           +G G +G V + + +  RI  A K++ +   + +++F  E+EI+  L HPN+++LY  T 
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-TF 92
Query: 177 RQSRELLLVYEYIPNGTVADHLHN----RQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
             + ++ LV E    G + + + +    R+ ++          I  +   A+AY H  +V
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHKLNV 144
Query: 233 IHRDVKSNNILL---DNNFRVKVADFGL-SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
            HRD+K  N L      +  +K+ DFGL +R  P  +        GTP YV P   +   
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVLEGL- 200
Query: 289 LTDKSDVYSFGVVLIELISG 308
              + D +S GV++  L+ G
Sbjct: 201 YGPECDEWSAGVMMYVLLCG 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 93/185 (50%), Gaps = 24/185 (12%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQF--MNEVEILTK 162
           AT  +    ++G G +G VY    RD   G  VA+K +   N +       + EV +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 163 LQ---HPNLVKLYG--CTSRQSREL--LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           L+   HPN+V+L     TSR  RE+   LV+E++ +  +  +L    P    LP      
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG--LPAETIKD 116
Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-------LFPTDVTHV 268
           +  +    L +LHA+ ++HRD+K  NIL+ +   VK+ADFGL+R       LFP  VT  
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLW 176
Query: 269 STAPQ 273
             AP+
Sbjct: 177 YRAPE 181

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 116 KQLGDGGFG----AVYLGILRD--GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG    A   G+++      VAVK L  + +    E  M+E+++L+ L  H N
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-CLLPWPVRL----------- 214
           +V L G CT       L++ EY   G + + L  ++ +  C    P  +           
Sbjct: 105 IVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 215 --SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
             S + + A  +A+L + + IHRD+ + NILL +    K+ DFGL+R    D  +V    
Sbjct: 163 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 273 QGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
              P  ++ P+  F C   T +SDV+S+G+ L EL S
Sbjct: 223 ARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 64
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 65  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 119
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 177
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRD--GRIVAVKRLYEN-NFKRIEQFMNE 156
           + E   +  +  K LG G FG    A   G+++      VAVK L  + +    E  M+E
Sbjct: 40  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 99
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-CLLPWPVR 213
           +++L+ L  H N+V L G CT       L++ EY   G + + L  ++ +  C    P  
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 214 L-------------SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           +             S + + A  +A+L + + IHRD+ + NILL +    K+ DFGL+R 
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARH 217
Query: 261 FPTDVTHVSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
              D  +V       P  ++ P+  F C   T +SDV+S+G+ L EL S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 64
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 65  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 119
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 177
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 116 KQLGDGGFG----AVYLGILRD--GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG    A   G+++      VAVK L  + +    E  M+E+++L+ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-CLLPWPVRL----------- 214
           +V L G CT       L++ EY   G + + L  ++ +  C    P  +           
Sbjct: 89  IVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 215 --SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
             S + + A  +A+L + + IHRD+ + NILL +    K+ DFGL+R    D  +V    
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 273 QGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
              P  ++ P+  F C   T +SDV+S+G+ L EL S
Sbjct: 207 ARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQF---MNEVEILTKLQH 165
           D F   + LG GGFG V+   ++  G++ A K+L +   K+ + +   M E +IL K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             +V L      ++ +L LV   +  G +  H++N   ++     P  +    +    L 
Sbjct: 245 RFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           +LH  ++I+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ P+   
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             +     D ++ GV L E+I+
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIA 384

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 116 KQLGDGGFG----AVYLGILRD--GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG    A   G+++      VAVK L  + +    E  M+E+++L+ L  H N
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-CLLPWPVRL----------- 214
           +V L G CT       L++ EY   G + + L  ++ +  C    P  +           
Sbjct: 107 IVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 215 --SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
             S + + A  +A+L + + IHRD+ + NILL +    K+ DFGL+R    D  +V    
Sbjct: 165 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 273 QGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
              P  ++ P+  F C   T +SDV+S+G+ L EL S
Sbjct: 225 ARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQF---MNEVEILTKLQH 165
           D F   + LG GGFG V+   ++  G++ A K+L +   K+ + +   M E +IL K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             +V L      ++ +L LV   +  G +  H++N   ++     P  +    +    L 
Sbjct: 245 RFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           +LH  ++I+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ P+   
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             +     D ++ GV L E+I+
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIA 384

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQF---MNEVEILTKLQH 165
           D F   + LG GGFG V+   ++  G++ A K+L +   K+ + +   M E +IL K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             +V L      ++ +L LV   +  G +  H++N   ++     P  +    +    L 
Sbjct: 245 RFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           +LH  ++I+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ P+   
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             +     D ++ GV L E+I+
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIA 384

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQF---MNEVEILTKLQH 165
           D F   + LG GGFG V+   ++  G++ A K+L +   K+ + +   M E +IL K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             +V L      ++ +L LV   +  G +  H++N   ++     P  +    +    L 
Sbjct: 245 RFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           +LH  ++I+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ P+   
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             +     D ++ GV L E+I+
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIA 384

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 44/281 (15%)
Query: 117 QLGDGGFGAVY-LGILRDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQH-PNLVKLYG 173
           ++G G  G V+ +   + G ++AVK++  + N +  ++ + +++++ K    P +V+ +G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL--SIAIETAGALAYL-HAS 230
            T   + ++ +  E +  GT A+ L  R       P P R+   + +    AL YL    
Sbjct: 92  -TFITNTDVFIAMELM--GTCAEKLKKRMQG----PIPERILGKMTVAIVKALYYLKEKH 144
Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
            VIHRDVK +NILLD   ++K+ DFG+S     D     +A  G   Y+ P+       T
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPT 202
Query: 291 D-----KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATN-KIQNGALNE---LVD 341
                 ++DV+S G+ L+EL +G                N  T+ ++    L E   L+ 
Sbjct: 203 KPDYDIRADVWSLGISLVELATG-----------QFPYKNCKTDFEVLTKVLQEEPPLLP 251
Query: 342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             +GF  D+               C+ +D   RP   ++LE
Sbjct: 252 GHMGFSGDF---------QSFVKDCLTKDHRKRPKYNKLLE 283

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 21/221 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           TD +   ++LG G F  V        G     +I+  K+L   + +++E+   E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA- 221
           L+HPN+V+L+   S +    L V++ +  G + + +  R+  S         S  I+   
Sbjct: 60  LKHPNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYS-----EADASHCIQQIL 113
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            ++ + H + ++HRD+K  N+LL +  +   VK+ADFGL+     D         GTPGY
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           + P+  +        D+++ GV+L  L+ G     D  +HR
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHR 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 104 ELEEATDNFNSSKQLGDGGFG----AVYLGILRD--GRIVAVKRLYEN-NFKRIEQFMNE 156
           + E   +  +  K LG G FG    A   G+++      VAVK L  + +    E  M+E
Sbjct: 40  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 99
Query: 157 VEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNS-CLLPWPVR 213
           +++L+ L  H N+V L G CT       L++ EY   G + + L  ++ +  C    P  
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 214 L-------------SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
           +             S + + A  +A+L + + IHRD+ + NILL +    K+ DFGL+R 
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 217
Query: 261 FPTDVTHVSTAPQGTP-GYVDPD-YFQCYKLTDKSDVYSFGVVLIELIS 307
              D  +V       P  ++ P+  F C   T +SDV+S+G+ L EL S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 97  AKVFS--CSELEEATDNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYE-NNFKRIEQ 152
           AK F+    E++   ++F   K +G G FG V +  +++  RI A+K L +    KR E 
Sbjct: 59  AKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 118
Query: 153 --FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCL 207
             F  E ++L       +  L+     ++  L LV +Y   G   T+     ++ P    
Sbjct: 119 ACFREERDVLVNGDCQWITALHYAFQDENH-LYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177
Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             +   + +AI++   L Y      +HRD+K +N+LLD N  +++ADFG       D T 
Sbjct: 178 RFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 231
Query: 268 VSTAPQGTPGYVDPDYFQCY-----KLTDKSDVYSFGVVLIELISG 308
            S+   GTP Y+ P+  Q       K   + D +S GV + E++ G
Sbjct: 232 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQF--MNEVEILTK 162
           AT  +    ++G G +G VY    RD   G  VA+K +   N +       + EV +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 163 LQ---HPNLVKLYG--CTSRQSREL--LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           L+   HPN+V+L     TSR  RE+   LV+E++ +  +  +L    P    LP      
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG--LPAETIKD 116
Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP-QG 274
           +  +    L +LHA+ ++HRD+K  NIL+ +   VK+ADFGL+R++      ++ AP   
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVV 173
Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
           T  Y  P+           D++S G +  E+ 
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 97  AKVFS--CSELEEATDNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLYE-NNFKRIEQ 152
           AK F+    E++   ++F   K +G G FG V +  +++  RI A+K L +    KR E 
Sbjct: 75  AKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 134
Query: 153 --FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCL 207
             F  E ++L       +  L+     ++  L LV +Y   G   T+     ++ P    
Sbjct: 135 ACFREERDVLVNGDCQWITALHYAFQDENH-LYLVMDYYVGGDLLTLLSKFEDKLPEDMA 193
Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
             +   + +AI++   L Y      +HRD+K +N+LLD N  +++ADFG       D T 
Sbjct: 194 RFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 247
Query: 268 VSTAPQGTPGYVDPDYFQCY-----KLTDKSDVYSFGVVLIELISG 308
            S+   GTP Y+ P+  Q       K   + D +S GV + E++ G
Sbjct: 248 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 21/221 (9%)
Query: 109 TDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           TD +   ++LG G F  V        G     +I+  K+L   + +++E+   E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA- 221
           L+HPN+V+L+   S +    L V++ +  G + + +  R+  S         S  I+   
Sbjct: 60  LKHPNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYS-----EADASHCIQQIL 113
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            ++ + H + ++HRD+K  N+LL +  +   VK+ADFGL+     D         GTPGY
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           + P+  +        D+++ GV+L  L+ G     D  +HR
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHR 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 106 EEATDNFNSSKQLGDGGFGAVY------LGILRDGRIVAVKRLYENNFKRI--EQFMNEV 157
           E   D +++ ++LG G F  V        G+    + +  KR  +++ + +  E    EV
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREV 65
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL ++QHPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 66  SILKEIQHPNVITLHEVYENKT-DVILIGELVAGGELFDFLAEKES----LTEEEATEFL 120
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFGL+     D  +      
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYE-------------NNFK-- 148
           E ++  +++   + L  G F  + L   +D +  A+K+ YE             NN K  
Sbjct: 25  EKDKYINDYRIIRTLNQGKFNKIIL-CEKDNKFYALKK-YEKSLLEKKRDFTKSNNDKIS 82
Query: 149 ---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVA---DHLHNRQ 202
              + + F NE++I+T +++   +   G  +    E+ ++YEY+ N ++    ++     
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLD 141
Query: 203 PN-SCLLPWPVRLSIAIETAGALAYLH-ASDVIHRDVKSNNILLDNNFRVKVADFGLSRL 260
            N +C +P  V   I      + +Y+H   ++ HRDVK +NIL+D N RVK++DFG S  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD--KSDVYSFGVVL 302
               V       +GT  ++ P++F      +  K D++S G+ L
Sbjct: 202 M---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQFM-----NEVEI 159
           AT  +    ++G G +G VY    RD   G  VA+K +   N       +      EV +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 160 LTKLQ---HPNLVKLYG--CTSRQSREL--LLVYEYIPNGTVADHLHNRQPNSCLLPWPV 212
           L +L+   HPN+V+L     TSR  RE+   LV+E++ +  +  +L    P    LP   
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG--LPAET 121
Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
              +  +    L +LHA+ ++HRD+K  NIL+ +   VK+ADFGL+R++   +       
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV- 180
Query: 273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIEL 305
             T  Y  P+           D++S G +  E+
Sbjct: 181 -VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL--TKLQHPNLVKLYG 173
           + +G G FG V+ G  R G  VAVK ++ +  +R   +  E EI     L+H N++    
Sbjct: 15  ESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREER--SWFREAEIYQTVMLRHENILGFIA 70
Query: 174 CTSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
             ++ +    +L LV +Y  +G++ D+L     N   +     + +A+ TA  LA+LH  
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 125
Query: 231 --------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYV 279
                    + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y+
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 280 DPD---------YFQCYKLTDKSDVYSFGVVLIEL 305
            P+         +F+ +K   ++D+Y+ G+V  E+
Sbjct: 186 APEVLDDSINMKHFESFK---RADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL--TKLQHPNLVKLYG 173
           + +G G FG V+ G  R G  VAVK ++ +  +R   +  E EI     L+H N++    
Sbjct: 12  ESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREER--SWFREAEIYQTVMLRHENILGFIA 67
Query: 174 CTSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
             ++ +    +L LV +Y  +G++ D+L     N   +     + +A+ TA  LA+LH  
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 231 --------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYV 279
                    + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y+
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 280 DPD---------YFQCYKLTDKSDVYSFGVVLIEL 305
            P+         +F+ +K   ++D+Y+ G+V  E+
Sbjct: 183 APEVLDDSINMKHFESFK---RADIYAMGLVFWEI 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 37/216 (17%)
Query: 115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL--TKLQHPNLVKLY 172
            + +G G FG V+ G  R G  VAVK ++ +  +R   +  E EI     L+H N++   
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREER--SWFREAEIYQTVMLRHENILGFI 63
Query: 173 GCTSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
              ++ +    +L LV +Y  +G++ D+L     N   +     + +A+ TA  LA+LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 230 S--------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGY 278
                     + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 279 VDPD---------YFQCYKLTDKSDVYSFGVVLIEL 305
           + P+         +F+ +K   ++D+Y+ G+V  E+
Sbjct: 179 MAPEVLDDSINMKHFESFK---RADIYAMGLVFWEI 211

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL--TKLQHPNLVKLYG 173
           + +G G FG V+ G  R G  VAVK ++ +  +R   +  E EI     L+H N++    
Sbjct: 10  ESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREER--SWFREAEIYQTVMLRHENILGFIA 65
Query: 174 CTSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
             ++ +    +L LV +Y  +G++ D+L     N   +     + +A+ TA  LA+LH  
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 231 --------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYV 279
                    + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y+
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 280 DPD---------YFQCYKLTDKSDVYSFGVVLIEL 305
            P+         +F+ +K   ++D+Y+ G+V  E+
Sbjct: 181 APEVLDDSINMKHFESFK---RADIYAMGLVFWEI 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL--TKLQHPNLVKLYG 173
           + +G G FG V+ G  R G  VAVK ++ +  +R   +  E EI     L+H N++    
Sbjct: 35  ESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREER--SWFREAEIYQTVMLRHENILGFIA 90
Query: 174 CTSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
             ++ +    +L LV +Y  +G++ D+L     N   +     + +A+ TA  LA+LH  
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 231 --------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYV 279
                    + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y+
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 280 DPD---------YFQCYKLTDKSDVYSFGVVLIEL 305
            P+         +F+ +K   ++D+Y+ G+V  E+
Sbjct: 206 APEVLDDSINMKHFESFK---RADIYAMGLVFWEI 237

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 36/240 (15%)
Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           L  A+D F     LG G FG V       D R  A+K++     +++   ++EV +L  L
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVXLLASL 59
Query: 164 QHPNLVKLYGC------------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
            H  +V+ Y                ++   L +  EY  N T+ D +H+   N     + 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-------LFPTD 264
                 +E   AL+Y+H+  +IHR++K  NI +D +  VK+ DFGL++       +   D
Sbjct: 120 RLFRQILE---ALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 265 VTHVS------TAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELI----SGLEAVD 313
             ++       T+  GT  YV  +         +K D YS G++  E I    +G E V+
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVN 236

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEIL--TKLQHPNLVKLYG 173
           + +G G FG V+ G  R G  VAVK ++ +  +R   +  E EI     L+H N++    
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREER--SWFREAEIYQTVMLRHENILGFIA 103
Query: 174 CTSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
             ++ +    +L LV +Y  +G++ D+L     N   +     + +A+ TA  LA+LH  
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 231 --------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYV 279
                    + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 280 DPD---------YFQCYKLTDKSDVYSFGVVLIEL 305
            P+         +F+ +K   ++D+Y+ G+V  E+
Sbjct: 219 APEVLDDSINMKHFESFK---RADIYAMGLVFWEI 250

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF---KRI---------EQF 153
           E+  D++   ++LG G F      I+R  R     + Y   F   +R+         E+ 
Sbjct: 8   EDVEDHYEMGEELGSGQFA-----IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 62
Query: 154 MNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
             EV IL +++HPN++ L+     ++ +++L+ E +  G + D L  ++     L     
Sbjct: 63  EREVNILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKES----LTEDEA 117
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVS 269
                +    + YLH+  + H D+K  NI LLD N    R+K+ DFG++     +  +  
Sbjct: 118 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEF 175
Query: 270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
               GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFM--NEVEILTKLQHP 166
           D ++  ++LG G FG V+  + +  GR+   K +  N    ++++   NE+ I+ +L HP
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHP 108
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            L+ L+     +  E++L+ E++  G + D +         +     ++   +    L +
Sbjct: 109 KLINLHDAFEDKY-EMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKH 164
Query: 227 LHASDVIHRDVKSNNILLDNN--FRVKVADFGL-SRLFPTDVTHVSTAPQGTPGYVDPDY 283
           +H   ++H D+K  NI+ +      VK+ DFGL ++L P ++  V+TA   T  +  P+ 
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAEFAAPEI 221
Query: 284 FQCYKLTDKSDVYSFGVVLIELISGL 309
                +   +D+++ GV+   L+SGL
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGL 247

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 82/163 (50%), Gaps = 10/163 (6%)
Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLL 208
           IEQ   E+ IL KL HPN+VKL       + + L +V+E +  G V + +   +P   L 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKP---LS 135
Query: 209 PWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV 268
               R        G + YLH   +IHRD+K +N+L+  +  +K+ADFG+S  F      +
Sbjct: 136 EDQARFYFQDLIKG-IEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
Query: 269 STAPQGTPGYVDPDYFQCYK--LTDKS-DVYSFGVVLIELISG 308
           S    GTP ++ P+     +   + K+ DV++ GV L   + G
Sbjct: 195 SNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLYGCT 175
           LG G    V+ G  +  G + A+K     +F R ++  M E E+L KL H N+VKL+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 176 SR-QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
               +R  +L+ E+ P G++   L     N+  LP    L +  +  G + +L  + ++H
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 235 RDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ----- 285
           R++K  NI+     D     K+ DFG +R    D   VS    GT  Y+ PD ++     
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYERAVLR 193
Query: 286 ---CYKLTDKSDVYSFGVVLIELISG 308
                K     D++S GV      +G
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 17/166 (10%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQF--MNEVEILTK 162
           AT  +    ++G G +G VY    RD   G  VA+K +   N +       + EV +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 163 LQ---HPNLVKLYG--CTSRQSREL--LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           L+   HPN+V+L     TSR  RE+   LV+E++ +  +  +L    P    LP      
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG--LPAETIKD 116
Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           +  +    L +LHA+ ++HRD+K  NIL+ +   VK+ADFGL+R++
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG------RIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           D +   + +G G F  V   I R+       +IV V +   +     E    E  I   L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP++V+L    S     L +V+E++    +   +  R     +    V      +   A
Sbjct: 84  KHPHIVELLETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 224 LAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           L Y H +++IHRDVK  N+LL   +N+  VK+ DFG++     +   V+    GTP ++ 
Sbjct: 143 LRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTPHFMA 201
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P+  +        DV+  GV+L  L+SG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 39/216 (18%)
Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCT 175
           L +GGF  VY    +  GR  A+KRL  N  ++    + EV  + KL  HPN+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 176 S-------RQSRELLLVYEYIPNGTVA--DHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           S           E LL+ E      V     + +R P SC       L I  +T  A+ +
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC----DTVLKIFYQTCRAVQH 151
Query: 227 LH--ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH---VSTAPQ-------- 273
           +H     +IHRD+K  N+LL N   +K+ DFG +    T ++H    S + Q        
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA----TTISHYPDYSWSAQRRALVEEE 207
Query: 274 ----GTPGYVDP---DYFQCYKLTDKSDVYSFGVVL 302
                TP Y  P   D +  + + +K D+++ G +L
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 134/307 (43%), Gaps = 49/307 (15%)
Query: 117 QLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQH-PNLVKLYG 173
           ++G G +G+V   + +  G+I+AVKR+    + K  +Q + +++++ +    P +V+ YG
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 174 ----------CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
                     C    S      Y+Y+   +V D +         +P  +   I + T  A
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYV--YSVLDDV---------IPEEILGKITLATVKA 137
Query: 224 LAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA---PQGTPGYV 279
           L +L  +  +IHRD+K +NILLD +  +K+ DFG+S      +     A   P   P  +
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 197
Query: 280 DPDYF-QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           DP    Q Y +  +SDV+S G+ L EL +G         R      N   +++      +
Sbjct: 198 DPSASRQGYDV--RSDVWSLGITLYELATG---------RFPYPKWNSVFDQLTQVVKGD 246
Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE----ILRETKDSNLGT 394
              P L   ++   R    S       C+ +D   RP  KE+L+    ++ E +   +  
Sbjct: 247 --PPQLSNSEE---REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301
Query: 395 SKAKVVD 401
              K++D
Sbjct: 302 YVCKILD 308

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 116 KQLGDGGFGAV------YLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++LG G F  V        G     +I+  K+L   + +++E+   E  I   L+HPN+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIV 84
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA-GALAYLH 228
           +L+   S +    L +++ +  G + + +  R+  S         S  I+    A+ + H
Sbjct: 85  RLHDSISEEGHHYL-IFDLVTGGELFEDIVAREYYS-----EADASHCIQQILEAVLHCH 138
Query: 229 ASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
              V+HRD+K  N+LL +  +   VK+ADFGL+     +         GTPGY+ P+  +
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLR 197
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
                   D+++ GV+L  L+ G     D  +HR
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 231

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           + F   K LG G FG V L   +  GR  A+K L +        +   + E  +L   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI-AIETAGAL 224
           P L  L        R L  V EY   G +  HL   +  S       R      E   AL
Sbjct: 208 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 261
Query: 225 AYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
            YLH+  +V++RD+K  N++LD +  +K+ DFGL +    D   + T   GTP Y+ P+ 
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320
Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
            +        D +  GVV+ E++ G
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCG 345

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           + F   K LG G FG V L   +  GR  A+K L +        +   + E  +L   +H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P L  L        R L  V EY   G +  HL   +  S       R   A E   AL 
Sbjct: 211 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFSEDR---ARFYGA-EIVSALD 265
Query: 226 YLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           YLH+  +V++RD+K  N++LD +  +K+ DFGL +    D   + T   GTP Y+ P+  
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVL 324
Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           +        D +  GVV+ E++ G
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCG 348

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 135/313 (43%), Gaps = 47/313 (15%)
Query: 97  AKVFSCSELEEATDNFN-SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMN 155
           +++ +    E++  N   S K LG G  G V       GR VAVKR+  + F  I   + 
Sbjct: 1   SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIA--LM 57
Query: 156 EVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ---PNSCLLPWP 211
           E+++LT+   HPN+++ Y C+    R L +  E + N  + D + ++     N  L    
Sbjct: 58  EIKLLTESDDHPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-------------NFRVKVADFGLS 258
             +S+  + A  +A+LH+  +IHRD+K  NIL+               N R+ ++DFGL 
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 259 RLFPTDVTHVST---APQGTPGYVDPDYFQ-------CYKLTDKSDVYSFGVVLIELISG 308
           +   +  +   T    P GT G+  P+  +         +LT   D++S G V   ++  
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL-- 233
Query: 309 LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQ 368
                 S+ +H         + I  G        SL   K    R+++    +L  + + 
Sbjct: 234 ------SKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSLIAEATDLISQMID 281
Query: 369 QDRDMRPTMKEVL 381
            D   RPT  +VL
Sbjct: 282 HDPLKRPTAMKVL 294

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF---KRI---------EQFMNEV 157
           D++   ++LG G F      I+R  R     + Y   F   +R+         E+   EV
Sbjct: 5   DHYEMGEELGSGQFA-----IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL +++HPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 60  NILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKES----LTEDEATQFL 114
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFG++     +  +      
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 172
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 21/221 (9%)
Query: 109 TDNFNSSKQLGDGGFGAV------YLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           T+ +   ++LG G F  V        G      I+  K+L   + +++E+   E  I   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRL 66
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA- 221
           L+HPN+V+L+   S +    L +++ +  G + + +  R+  S         S  I+   
Sbjct: 67  LKHPNIVRLHDSISEEGHHYL-IFDLVTGGELFEDIVAREYYS-----EADASHCIQQIL 120
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            A+ + H   V+HR++K  N+LL +  +   VK+ADFGL+     +         GTPGY
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGY 179
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV-DTSRHR 318
           + P+  +        D+++ GV+L  L+ G     D  +HR
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 112 FNSSKQLGDGGFGAVY----LGILRDGRIVAVKRLYE----NNFKRIEQFMNEVEILTKL 163
           F   + LG GG+G V+    +     G+I A+K L +     N K       E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR----QPNSCLLPWPVRLSIAIE 219
           +HP +V L     +   +L L+ EY+  G +   L       +  +C            E
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAE 129
Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPG 277
            + AL +LH   +I+RD+K  NI+L++   VK+ DFGL +  +    VTH      GT  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIE 186
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           Y+ P+           D +S G ++ ++++G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF---------MNEVE 158
           + +F     LG+G +G V     +  G IVA+K+        IE F         + E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           IL   +H N++ ++      S E      YI    +   LH       L    ++  I  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEV-YIIQELMQTDLHRVISTQMLSDDHIQYFI-Y 119
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---------PTDVTHVS 269
           +T  A+  LH S+VIHRD+K +N+L+++N  +KV DFGL+R+          PT      
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 270 TAPQGTPGYVDPD-YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL 323
           T    T  Y  P+      K +   DV+S G +L EL           +RH + L
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF---KRI---------EQFMNEV 157
           D++   ++LG G F      I+R  R     + Y   F   +R+         E+   EV
Sbjct: 26  DHYEMGEELGSGQFA-----IVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREV 80
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL +++HPN++ L+     ++ +++L+ E +  G + D L  ++     L         
Sbjct: 81  NILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKES----LTEDEATQFL 135
Query: 218 IETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVTHVSTAPQ 273
            +    + YLH+  + H D+K  NI LLD N    R+K+ DFG++     +  +      
Sbjct: 136 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 193
Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           D+++  ++LG G FG V+    R  G   A K +   +    E    E++ ++ L+HP L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 169 VKLYGCTSRQSRELLLVYEYIPNG----TVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           V L+        E++++YE++  G     VAD  HN+      + +        +    L
Sbjct: 111 VNLHDAFE-DDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEY------MRQVCKGL 162
Query: 225 AYLHASDVIHRDVKSNNILL--DNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGYVDP 281
            ++H ++ +H D+K  NI+     +  +K+ DFGL+  L P     V+T   GT  +  P
Sbjct: 163 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP 219
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGL 309
           +  +   +   +D++S GV+   L+SGL
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSGL 247

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 112 FNSSKQLGDGGFGAVY----LGILRDGRIVAVKRLYE----NNFKRIEQFMNEVEILTKL 163
           F   + LG GG+G V+    +     G+I A+K L +     N K       E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNR----QPNSCLLPWPVRLSIAIE 219
           +HP +V L     +   +L L+ EY+  G +   L       +  +C            E
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAE 129
Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPG 277
            + AL +LH   +I+RD+K  NI+L++   VK+ DFGL +  +    VTH      GT  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC---GTIE 186
Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           Y+ P+           D +S G ++ ++++G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 113/271 (41%), Gaps = 36/271 (13%)
Query: 118 LGDGGFGAVYLGILRD------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           LG GGF   Y     D      G++V    L + + K  E+   E+ I   L +P++V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHVVGF 107
Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           +G    +  + + V   I        LH R+     +  P       +T   + YLH + 
Sbjct: 108 HGFF--EDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 162
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           VIHRD+K  N+ L+++  VK+ DFGL+     D     T   GTP Y+ P+       + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-CGTPNYIAPEVLCKKGHSF 221
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           + D++S G +L  L+ G    +TS       L        +N               +Y+
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS------CLKETYIRIKKN---------------EYS 260
Query: 352 VRNMVTSVAE-LAFRCVQQDRDMRPTMKEVL 381
           V   +  VA  L  R +  D  +RP++ E+L
Sbjct: 261 VPRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 118 LGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLYGCT 175
           LG G    V+ G  +  G + A+K     +F R ++  M E E+L KL H N+VKL+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 176 SR-QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
               +R  +L+ E+ P G++   L     N+  LP    L +  +  G + +L  + ++H
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 235 RDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ----- 285
           R++K  NI+     D     K+ DFG +R    D   V     GT  Y+ PD ++     
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL--YGTEEYLHPDMYERAVLR 193
Query: 286 ---CYKLTDKSDVYSFGVVLIELISG 308
                K     D++S GV      +G
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 18/167 (10%)
Query: 151 EQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
           E  + EV+IL K+  HPN+++L   T   +    LV++ +  G + D+L  +      L 
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK----VTLS 109
Query: 210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHV 268
                 I       +  LH  +++HRD+K  NILLD++  +K+ DFG S +L P +    
Sbjct: 110 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 169
Query: 269 STAPQGTPGYVDPDYFQCYKLTD-------KSDVYSFGVVLIELISG 308
                GTP Y+ P+  +C  + D       + D++S GV++  L++G
Sbjct: 170 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           D+++  ++LG G FG V+    R  G   A K +   +    E    E++ ++ L+HP L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 169 VKLYGCTSRQSRELLLVYEYIPNG----TVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           V L+        E++++YE++  G     VAD  HN+      + +        +    L
Sbjct: 217 VNLHDAFE-DDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEY------MRQVCKGL 268
Query: 225 AYLHASDVIHRDVKSNNILL--DNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGYVDP 281
            ++H ++ +H D+K  NI+     +  +K+ DFGL+  L P     V+T   GT  +  P
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP 325
Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGL 309
           +  +   +   +D++S GV+   L+SGL
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGL 353

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 43/309 (13%)
Query: 97  AKVFSCSELEEATDNFN-SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMN 155
           +++ +    E++  N   S K LG G  G V       GR VAVKR+   +F  I   + 
Sbjct: 19  SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-IDFCDIA--LM 75
Query: 156 EVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ---PNSCLLPWP 211
           E+++LT+   HPN+++ Y C+    R L +  E + N  + D + ++     N  L    
Sbjct: 76  EIKLLTESDDHPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-------------NFRVKVADFGLS 258
             +S+  + A  +A+LH+  +IHRD+K  NIL+               N R+ ++DFGL 
Sbjct: 134 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 193
Query: 259 RLFPTDVTHVS---TAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAV 312
           +   +           P GT G+  P+  +     +LT   D++S G V   ++      
Sbjct: 194 KKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL------ 247
Query: 313 DTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRD 372
             S+ +H         + I  G        SL   K    R+++    +L  + +  D  
Sbjct: 248 --SKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSLIAEATDLISQMIDHDPL 299
Query: 373 MRPTMKEVL 381
            RPT  +VL
Sbjct: 300 KRPTAMKVL 308

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 18/167 (10%)
Query: 151 EQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
           E  + EV+IL K+  HPN+++L   T   +    LV++ +  G + D+L  +      L 
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK----VTLS 122
Query: 210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHV 268
                 I       +  LH  +++HRD+K  NILLD++  +K+ DFG S +L P +    
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS 182
Query: 269 STAPQGTPGYVDPDYFQCYKLTD-------KSDVYSFGVVLIELISG 308
                GTP Y+ P+  +C  + D       + D++S GV++  L++G
Sbjct: 183 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 109 TDNFNSSKQLGDGGFGAV------YLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           TD +   + +G G F  V        G     +I+  K+L   + +++E+   E  I   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA- 221
           L+H N+V+L+   S +    L V++ +  G + + +  R+  S         S  I+   
Sbjct: 60  LKHSNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYS-----EADASHCIQQIL 113
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            A+ + H   V+HRD+K  N+LL +  +   VK+ADFGL+     D         GTPGY
Sbjct: 114 EAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGY 172
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           + P+  +        D+++ GV+L  L+ G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQH 165
           + F   + LG GGFG V    +R  G++ A K+L +   K+ +     +NE +IL K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 166 PNLVKL-YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
             +V L Y   ++ +  L LV   +  G +  H+++        P    +  A E    L
Sbjct: 244 RFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGL 299
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
             LH   +++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ P+  
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVV 357
Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           +  + T   D ++ G +L E+I+G
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAG 381

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIE---QFMNEVEILTKLQH 165
           + F   + LG GGFG V    +R  G++ A K+L +   K+ +     +NE +IL K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 166 PNLVKL-YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
             +V L Y   ++ +  L LV   +  G +  H+++        P    +  A E    L
Sbjct: 244 RFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGL 299
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
             LH   +++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ P+  
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVV 357
Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           +  + T   D ++ G +L E+I+G
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAG 381

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 18/167 (10%)
Query: 151 EQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
           E  + EV+IL K+  HPN+++L   T   +    LV++ +  G + D+L  +      L 
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK----VTLS 122
Query: 210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHV 268
                 I       +  LH  +++HRD+K  NILLD++  +K+ DFG S +L P +    
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 269 STAPQGTPGYVDPDYFQCYKLTD-------KSDVYSFGVVLIELISG 308
                GTP Y+ P+  +C  + D       + D++S GV++  L++G
Sbjct: 183 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 43/309 (13%)
Query: 97  AKVFSCSELEEATDNFN-SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMN 155
           +++ +    E++  N   S K LG G  G V       GR VAVKR+   +F  I   + 
Sbjct: 19  SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-IDFCDIA--LM 75
Query: 156 EVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ---PNSCLLPWP 211
           E+++LT+   HPN+++ Y C+    R L +  E + N  + D + ++     N  L    
Sbjct: 76  EIKLLTESDDHPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-------------NFRVKVADFGLS 258
             +S+  + A  +A+LH+  +IHRD+K  NIL+               N R+ ++DFGL 
Sbjct: 134 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 193
Query: 259 RLFPTDVTHVS---TAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAV 312
           +   +           P GT G+  P+  +     +LT   D++S G V   ++      
Sbjct: 194 KKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL------ 247
Query: 313 DTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRD 372
             S+ +H         + I  G        SL   K    R+++    +L  + +  D  
Sbjct: 248 --SKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSLIAEATDLISQMIDHDPL 299
Query: 373 MRPTMKEVL 381
            RPT  +VL
Sbjct: 300 KRPTAMKVL 308

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF---------MNEVE 158
           + +F     LG+G +G V     +  G IVA+K+        IE F         + E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           IL   +H N++ ++      S E      YI    +   LH       L    ++  I  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEV-YIIQELMQTDLHRVISTQMLSDDHIQYFI-Y 119
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---------PTDVTHVS 269
           +T  A+  LH S+VIHRD+K +N+L+++N  +KV DFGL+R+          PT      
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 270 TAPQGTPGYVDPD-YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL 323
           T    T  Y  P+      K +   DV+S G +L EL           +RH + L
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 81/155 (52%), Gaps = 21/155 (13%)
Query: 118 LGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQFMN-----EVEILTKLQHPNLV 169
           LG+G F  VY    RD    +IVA+K++   +    +  +N     E+++L +L HPN++
Sbjct: 18  LGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 170 KLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            L      +S  + LV++++       + D       NS +L      +  + T   L Y
Sbjct: 76  GLLDAFGHKS-NISLVFDFMETDLEVIIKD-------NSLVLTPSHIKAYMLMTLQGLEY 127
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           LH   ++HRD+K NN+LLD N  +K+ADFGL++ F
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 29/309 (9%)
Query: 105 LEEATDNFNSSKQLGDGGFGAV-YLGILRDGRIVAVKRLYEN-NFKRIEQFMNEVEILTK 162
            E   D+     +LG G +G V     +  G+I AVKR+    N +  ++ + +++I  +
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXR 88
Query: 163 -LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC-LLPWPVRLSIAIET 220
            +  P  V  YG   R+  ++ +  E     T  D  + +  +    +P  +   IA+  
Sbjct: 89  TVDCPFTVTFYGALFREG-DVWICXEL--XDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 145
Query: 221 AGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH---VSTAPQGTP 276
             AL +LH+   VIHRDVK +N+L++   +VK  DFG+S     DV         P   P
Sbjct: 146 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAP 205
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
             ++P+  Q    + KSD++S G+  IEL          R  +D    +  T   Q   +
Sbjct: 206 ERINPELNQ-KGYSVKSDIWSLGITXIELA-------ILRFPYD----SWGTPFQQLKQV 253
Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSK 396
            E   P L  +K            +   +C++++   RPT  E+ +    T   + GT  
Sbjct: 254 VEEPSPQLPADK------FSAEFVDFTSQCLKKNSKERPTYPELXQHPFFTLHESKGTDV 307
Query: 397 AKVVDIRIA 405
           A  V + +A
Sbjct: 308 ASFVKLILA 316

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 33/208 (15%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           LG G +G VY G     ++ +A+K + E + +  +    E+ +   L+H N+V+  G  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR---LSIAIETAG---ALAYLHA 229
                + +  E +P G+++  L ++        W P++    +I   T      L YLH 
Sbjct: 90  ENGF-IKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 230 SDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           + ++HRD+K +N+L++    V K++DFG S+     +   +    GT  Y+ P+      
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPE------ 193
Query: 289 LTDK--------SDVYSFGVVLIELISG 308
           + DK        +D++S G  +IE+ +G
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 49/268 (18%)
Query: 112 FNSSKQLGDGGFGAVYLGILRD----GRI----VAVKRLYENNFKRIEQFMNEVEILTKL 163
           FN S  LG G F  ++ G+ R+    G++    V +K L + +    E F     +++KL
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 164 QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
            H +LV  YG C      E +LV E++  G++  +L  +  N   + W  +L +A + A 
Sbjct: 70  SHKHLVLNYGVCVC--GDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAA 124
Query: 223 ALAYLHASDVIHRDVKSNNILL--------DNNFRVKVADFGLS-RLFPTDVTHVSTAPQ 273
           A+ +L  + +IH +V + NILL         N   +K++D G+S  + P D+       Q
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL------Q 178
Query: 274 GTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISG----LEAVDTSRH------RHDIN 322
               +V P+  +  K L   +D +SFG  L E+ SG    L A+D+ R       RH + 
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238
Query: 323 LSNMATNKIQNGALNELVDPSLGFEKDY 350
               A        L  L++  + +E D+
Sbjct: 239 APKAA-------ELANLINNCMDYEPDH 259

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           E+   EV IL ++ HPN++ L+     ++ +++L+ E +  G + D L  ++     L  
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRT-DVVLILELVSGGELFDFLAQKES----LSE 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVT 266
               S   +    + YLH   + H D+K  NI LLD N     +K+ DFGL+      V 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             +    GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 175 FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           K LG GG G V+  +  D  + VA+K++   + + ++  + E++I+ +L H N+VK++  
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 175 TSRQSRELL--------LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
                 +L         L   YI    +   L N      LL    RL    +    L Y
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKY 135
Query: 227 LHASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPTDVTHVSTAPQG--TPGYVDPD- 282
           +H+++V+HRD+K  N+ ++  +  +K+ DFGL+R+     +H     +G  T  Y  P  
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                  T   D+++ G +  E+++G
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ----HPNLVK 170
           K LG+G F      +  +  +  AVK +     KR+E   N  + +T L+    HPN+VK
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIIS----KRME--ANTQKEITALKLCEGHPNIVK 70
Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS-IAIETAGALAYLHA 229
           L+     Q     LV E +  G + + +  ++  S         S I  +   A++++H 
Sbjct: 71  LHEVFHDQ-LHTFLVMELLNGGELFERIKKKKHFS-----ETEASYIMRKLVSAVSHMHD 124
Query: 230 SDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
             V+HRD+K  N+L    ++N  +K+ DFG +RL P D   + T P  T  Y  P+    
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQ 183
Query: 287 YKLTDKSDVYSFGVVLIELISG 308
               +  D++S GV+L  ++SG
Sbjct: 184 NGYDESCDLWSLGVILYTMLSG 205

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +G G +G V+ G  + G  VAVK      E ++ R  +  N V     L+H N++     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 175 --TSRQSR-ELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             TSR S  +L L+  Y   G++ D+L        SCL        I +  A  LA+LH 
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASGLAHLHI 123
Query: 230 S--------DVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDVTHVSTAPQ-GTPGY 278
                     + HRD+KS NIL+  N +  +AD GL+ +    T+   V   P+ GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 279 VDPDYF------QCYKLTDKSDVYSFGVVLIEL 305
           + P+         C+    + D+++FG+VL E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +G G +G V+ G  + G  VAVK      E ++ R  +  N V     L+H N++     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 175 --TSRQSR-ELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             TSR S  +L L+  Y   G++ D+L        SCL        I +  A  LA+LH 
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASGLAHLHI 123
Query: 230 S--------DVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDVTHVSTAPQ-GTPGY 278
                     + HRD+KS NIL+  N +  +AD GL+ +    T+   V   P+ GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 279 VDPDYF------QCYKLTDKSDVYSFGVVLIEL 305
           + P+         C+    + D+++FG+VL E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 118 LGDGGFGAVYLGILRDGRIVAVKRLY---ENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +G G +G V+ G  + G  VAVK      E ++ R  +  N V     L+H N++     
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 99
Query: 175 --TSRQSR-ELLLVYEYIPNGTVADHLH--NRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             TSR S  +L L+  Y   G++ D+L        SCL        I +  A  LA+LH 
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASGLAHLHI 152
Query: 230 S--------DVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDVTHVSTAPQ-GTPGY 278
                     + HRD+KS NIL+  N +  +AD GL+ +    T+   V   P+ GT  Y
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 279 VDPDYF------QCYKLTDKSDVYSFGVVLIEL 305
           + P+         C+    + D+++FG+VL E+
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRDGR---IVAVKRLYENNFKRIEQFMNEVEILTKLQH 165
           +D +   K +G G FG   L  +RD +   +VAVK + E   K  E    E+     L+H
Sbjct: 18  SDRYELVKDIGAGNFGVARL--MRDKQANELVAVKYI-ERGEKIDENVKREIINHRSLRH 74
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+V+        +  L +V EY   G     L  R  N+             +    ++
Sbjct: 75  PNIVRFKEVILTPTH-LAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 226 YLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVD 280
           Y HA  V HRD+K  N LLD +   R+K+ADFG S+     V H  + P+   GTP Y+ 
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLH--SQPKSAVGTPAYIA 184
Query: 281 PDYFQCYKLTDK-SDVYSFGVVLIELISG 308
           P+     +   K +DV+S GV L  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 11/204 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           + F   K LG G FG V L   +  GR  A+K L +        +   + E  +L   +H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P L  L        R L  V EY   G +  HL   +    +           E   AL 
Sbjct: 69  PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALD 123
Query: 226 YLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           YLH+  +V++RD+K  N++LD +  +K+ DFGL +    D   +     GTP Y+ P+  
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYLAPEVL 182
Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           +        D +  GVV+ E++ G
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 31/218 (14%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYEN-NFKRIE-QFMNEVEILTKLQHP 166
           D F   +  G G FG V LG  +  G  VA+K++ ++  F+  E Q M ++ +L    HP
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL---HHP 79
Query: 167 NLVKL----YGCTSRQSRELLL--VYEYIPNGT--VADHLHNRQPNSCLLPWPVRLSI-- 216
           N+V+L    Y    R  R++ L  V EY+P+       + + RQ    + P P+ + +  
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ----VAPPPILIKVFL 135
Query: 217 --AIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLS-RLFPTD--VTHVST 270
              I + G L +L + +V HRD+K +N+L++  +  +K+ DFG + +L P++  V ++ +
Sbjct: 136 FQLIRSIGCL-HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                P  +    F     T   D++S G +  E++ G
Sbjct: 195 RYYRAPELI----FGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 11/204 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           + F   K LG G FG V L   +  GR  A+K L +        +   + E  +L   +H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P L  L        R L  V EY   G +  HL   +    +           E   AL 
Sbjct: 68  PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALD 122
Query: 226 YLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           YLH+  +V++RD+K  N++LD +  +K+ DFGL +    D   +     GTP Y+ P+  
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-CGTPEYLAPEVL 181
Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           +        D +  GVV+ E++ G
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCG 205

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 11/204 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           + F   K LG G FG V L   +  GR  A+K L +        +   + E  +L   +H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P L  L        R L  V EY   G +  HL   +    +           E   AL 
Sbjct: 70  PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALD 124
Query: 226 YLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           YLH+  +V++RD+K  N++LD +  +K+ DFGL +    D   +     GTP Y+ P+  
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-CGTPEYLAPEVL 183
Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
           +        D +  GVV+ E++ G
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCG 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 33/208 (15%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTS 176
           LG G +G VY G     ++ +A+K + E + +  +    E+ +   L+H N+V+  G  S
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW-PVR---LSIAIETAG---ALAYLHA 229
                + +  E +P G+++  L ++        W P++    +I   T      L YLH 
Sbjct: 76  ENGF-IKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 230 SDVIHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           + ++HRD+K +N+L++    V K++DFG S+     +   +    GT  Y+ P+      
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPE------ 179
Query: 289 LTDK--------SDVYSFGVVLIELISG 308
           + DK        +D++S G  +IE+ +G
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATG 207

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 36/271 (13%)
Query: 118 LGDGGFGAVYLGILRD------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           LG GGF   Y     D      G++V    L + + K  E+   E+ I   L +P++V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHVVGF 107
Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           +G    +  + + V   I        LH R+     +  P       +T   + YLH + 
Sbjct: 108 HGFF--EDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 162
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           VIHRD+K  N+ L+++  VK+ DFGL+     D         GTP Y+ P+       + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-CGTPNYIAPEVLCKKGHSF 221
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           + D++S G +L  L+ G    +TS       L        +N               +Y+
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS------CLKETYIRIKKN---------------EYS 260
Query: 352 VRNMVTSVAE-LAFRCVQQDRDMRPTMKEVL 381
           V   +  VA  L  R +  D  +RP++ E+L
Sbjct: 261 VPRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRDGR---IVAVKRLYENNFKRIEQFMNEVEILTKLQH 165
           +D +   K +G G FG   L  +RD +   +VAVK + E   K  E    E+     L+H
Sbjct: 17  SDRYELVKDIGSGNFGVARL--MRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRH 73
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+V+        +  L +V EY   G     L  R  N+             +    ++
Sbjct: 74  PNIVRFKEVILTPTH-LAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 226 YLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVD 280
           Y HA  V HRD+K  N LLD +   R+K+ DFG S+   + V H  + P+   GTP Y+ 
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH--SQPKSTVGTPAYIA 183
Query: 281 PDYFQCYKLTDK-SDVYSFGVVLIELISG 308
           P+     +   K +DV+S GV L  ++ G
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 34/227 (14%)
Query: 112 FNSSKQLGDGGFGAVYLGILRD----GRI----VAVKRLYENNFKRIEQFMNEVEILTKL 163
           FN S  LG G F  ++ G+ R+    G++    V +K L + +    E F     +++KL
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H +LV  YG       E +LV E++  G++  +L  +  N   + W  +L +A + A A
Sbjct: 70  SHKHLVLNYG-VCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAWA 125
Query: 224 LAYLHASDVIHRDVKSNNILL--------DNNFRVKVADFGLS-RLFPTDVTHVSTAPQG 274
           + +L  + +IH +V + NILL         N   +K++D G+S  + P D+       Q 
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL------QE 179
Query: 275 TPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISG----LEAVDTSR 316
              +V P+  +  K L   +D +SFG  L E+ SG    L A+D+ R
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 36/271 (13%)
Query: 118 LGDGGFGAVYLGILRD------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           LG GGF   Y     D      G++V    L + + K  E+   E+ I   L +P++V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHVVGF 107
Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           +G    +  + + V   I        LH R+     +  P       +T   + YLH + 
Sbjct: 108 HGFF--EDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 162
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           VIHRD+K  N+ L+++  VK+ DFGL+     D         GTP Y+ P+       + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVLCKKGHSF 221
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           + D++S G +L  L+ G    +TS       L        +N               +Y+
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS------CLKETYIRIKKN---------------EYS 260
Query: 352 VRNMVTSVAE-LAFRCVQQDRDMRPTMKEVL 381
           V   +  VA  L  R +  D  +RP++ E+L
Sbjct: 261 VPRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 36/271 (13%)
Query: 118 LGDGGFGAVYLGILRD------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKL 171
           LG GGF   Y     D      G++V    L + + K  E+   E+ I   L +P++V  
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHVVGF 91
Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           +G    +  + + V   I        LH R+     +  P       +T   + YLH + 
Sbjct: 92  HGFF--EDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 146
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           VIHRD+K  N+ L+++  VK+ DFGL+     D         GTP Y+ P+       + 
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVLCKKGHSF 205
Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           + D++S G +L  L+ G    +TS       L        +N               +Y+
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFETS------CLKETYIRIKKN---------------EYS 244
Query: 352 VRNMVTSVAE-LAFRCVQQDRDMRPTMKEVL 381
           V   +  VA  L  R +  D  +RP++ E+L
Sbjct: 245 VPRHINPVASALIRRMLHADPTLRPSVAELL 275

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 133/313 (42%), Gaps = 47/313 (15%)
Query: 97  AKVFSCSELEEATDNFN-SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMN 155
           +++ +    E++  N   S K LG G  G V       GR VAVKR+  + F  I   + 
Sbjct: 1   SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIA--LM 57
Query: 156 EVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ---PNSCLLPWP 211
           E+++LT+   HPN+++ Y C+    R L +  E + N  + D + ++     N  L    
Sbjct: 58  EIKLLTESDDHPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-------------NFRVKVADFGLS 258
             +S+  + A  +A+LH+  +IHRD+K  NIL+               N R+ ++DFGL 
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 259 RLFPTDVTHVS---TAPQGTPGYVDPDYFQ-------CYKLTDKSDVYSFGVVLIELISG 308
           +   +           P GT G+  P+  +         +LT   D++S G V   ++  
Sbjct: 176 KKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL-- 233
Query: 309 LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQ 368
                 S+ +H         + I  G        SL   K    R+++    +L  + + 
Sbjct: 234 ------SKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSLIAEATDLISQMID 281
Query: 369 QDRDMRPTMKEVL 381
            D   RPT  +VL
Sbjct: 282 HDPLKRPTAMKVL 294

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 30/235 (12%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF---------MNEVE 158
           + +F     LG+G +G V     +  G IVA+K+        IE F         + E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           IL   +H N++ ++      S E      YI    +   LH       L    ++  I  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEV-YIIQELMQTDLHRVISTQMLSDDHIQYFI-Y 119
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGT 275
           +T  A+  LH S+VIHRD+K +N+L+++N  +KV DFGL+R+      D +  +    G 
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 276 PGYVDPDYFQC-------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL 323
             +V   +++         K +   DV+S G +L EL           +RH + L
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 61/282 (21%)
Query: 121 GGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR 180
           G FG V+   L +   VAVK ++    K+  Q   E+     ++H NL++      R S 
Sbjct: 26  GRFGCVWKAQLMND-FVAVK-IFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 181 ---ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH--------- 228
              EL L+  +   G++ D+L        ++ W     +A   +  L+YLH         
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 229 --ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF----PTDVTHVSTAPQGTPGYVDPD 282
                + HRD KS N+LL ++    +ADFGL+  F    P   TH      GT  Y+ P+
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYMAPE 195
Query: 283 YFQCYKLTDKS-----DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN 337
             +      +      D+Y+ G+VL EL+S  +A D                    G ++
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD--------------------GPVD 235
Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
           E + P   FE++      +  + E+        + MRPT+K+
Sbjct: 236 EYMLP---FEEEIGQHPSLEELQEVVVH-----KKMRPTIKD 269

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI---EQFMNEVEILTKLQH 165
           D +   + +G+G +G V     R  G+ VA+K++  N F  +   ++ + E++IL   +H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKH 113
Query: 166 PNLVKL---------YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
            N++ +         YG    + + + +V + +    +   +H+ QP +      VR  +
Sbjct: 114 DNIIAIKDILRPTVPYG----EFKSVYVVLDLM-ESDLHQIIHSSQPLTLEH---VRYFL 165
Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQ 273
             +    L Y+H++ VIHRD+K +N+L++ N  +K+ DFG++R     P +  +  T   
Sbjct: 166 -YQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 274 GTPGYVDPD-YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
            T  Y  P+     ++ T   D++S G +  E+++  +      + H + L  M
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 278

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRI---EQFMNEVEILTKLQH 165
           D +   + +G+G +G V     R  G+ VA+K++  N F  +   ++ + E++IL   +H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKH 112
Query: 166 PNLVKL---------YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
            N++ +         YG    + + + +V + +    +   +H+ QP   L    VR  +
Sbjct: 113 DNIIAIKDILRPTVPYG----EFKSVYVVLDLM-ESDLHQIIHSSQP---LTLEHVRYFL 164
Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQ 273
             +    L Y+H++ VIHRD+K +N+L++ N  +K+ DFG++R     P +  +  T   
Sbjct: 165 -YQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 223
Query: 274 GTPGYVDPD-YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
            T  Y  P+     ++ T   D++S G +  E+++  +      + H + L  M
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCT 175
           LG+G    V   I L   +  AVK + +       +   EVE+L + Q H N+++L    
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE-TAGALAYLHASDVIH 234
             + R   LV+E +  G++  H+H R+  + L       S+ ++  A AL +LH   + H
Sbjct: 81  EEEDR-FYLVFEKMRGGSILSHIHKRRHFNEL-----EASVVVQDVASALDFLHNKGIAH 134
Query: 235 RDVKSNNILLDNNFR---VKVADFGLSRLFPT--DVTHVST----APQGTPGYVDPDYFQ 285
           RD+K  NIL ++  +   VK+ DFGL        D + +ST     P G+  Y+ P+  +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 286 CY----KLTDK-SDVYSFGVVLIELISG 308
            +     + DK  D++S GV+L  L+SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLV 169
           +F     LG G  G +    + D R VAVKR+    F   ++   EV++L +  +HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ-PNSCLLPWPVRLSIAIETAGALAYLH 228
           + Y CT +  R+   +   +   T+ +++  +   +  L P    +++  +T   LA+LH
Sbjct: 82  R-YFCTEK-DRQFQYIAIELCAATLQEYVEQKDFAHLGLEP----ITLLQQTTSGLAHLH 135
Query: 229 ASDVIHRDVKSNNILLD-----NNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDP 281
           + +++HRD+K +NIL+         +  ++DFGL +         S  +   GT G++ P
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 282 DYFQ--CYK-LTDKSDVYSFGVVLIELIS 307
           +     C +  T   D++S G V   +IS
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRDGR---IVAVKRLYENNFKRIEQFMNEVEILTKLQH 165
           +D +   K +G G FG   L  +RD +   +VAVK + E   K       E+     L+H
Sbjct: 18  SDRYELVKDIGSGNFGVARL--MRDKQSNELVAVKYI-ERGEKIAANVKREIINHRSLRH 74
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+V+        +  L +V EY   G     L  R  N+             +    ++
Sbjct: 75  PNIVRFKEVILTPTH-LAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 226 YLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVD 280
           Y HA  V HRD+K  N LLD +   R+K+ DFG S+   + V H  + P+   GTP Y+ 
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH--SQPKSTVGTPAYIA 184
Query: 281 PDYFQCYKLTDK-SDVYSFGVVLIELISG 308
           P+     +   K +DV+S GV L  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRDG---RIVAVKRLYENNFKRIEQFMNEVEILTKLQH 165
           +D ++  K +G G FG   L  +RD     +VAVK + E      E    E+     L+H
Sbjct: 19  SDRYDFVKDIGSGNFGVARL--MRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRH 75
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+V+        +  L ++ EY   G     L+ R  N+             +    ++
Sbjct: 76  PNIVRFKEVILTPTH-LAIIMEYASGG----ELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 226 YLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVD 280
           Y H+  + HRD+K  N LLD +   R+K+ DFG S+   + V H  + P+   GTP Y+ 
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH--SQPKSTVGTPAYIA 185
Query: 281 PDYFQCYKLTDK-SDVYSFGVVLIELISG 308
           P+     +   K +DV+S GV L  ++ G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 110 DNFNSSKQLGDGGFGAVY--LGILRDGRIVA--VKRLYENNFKRIEQFMNEVEILTKLQH 165
           D++   ++LG G +  V+  + I  + ++V   +K + +N  KR      E++IL  L+ 
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR------EIKILENLRG 90
Query: 166 -PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   A
Sbjct: 91  GPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKA 143
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDP 281
           L Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---P 200
Query: 282 DYFQCYKLTDKS-DVYSFGVVLIELI 306
           +    Y++ D S D++S G +L  +I
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           ++F+  + +G GGFG VY     D G++ A+K L   + KRI+    E   L +    +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 169 VKLYGC--------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           V    C              +L  + + +  G +  HL     +       +R   A E 
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRF-YAAEI 301
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L ++H   V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISGLEAV--DTSRHRHDIN 322
           P+  Q     D S D +S G +L +L+ G        ++ +H+I+
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           ++F+  + +G GGFG VY     D G++ A+K L   + KRI+    E   L +    +L
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 244
Query: 169 VKLYGC--------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           V    C              +L  + + +  G +  HL     +       +R   A E 
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRF-YAAEI 300
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L ++H   V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 357
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISGLEAV--DTSRHRHDIN 322
           P+  Q     D S D +S G +L +L+ G        ++ +H+I+
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 402

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 110 DNFNSSKQLGDGGFGAVY-LGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILTKL-QH 165
            +F    +LG G +G V+ +    DGR+ AVKR        K   + + EV    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P  V+L    + +   +L +   +   ++  H    +     LP         +T  ALA
Sbjct: 117 PCCVRLE--QAWEEGGILYLQTELCGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALA 171
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           +LH+  ++H DVK  NI L    R K+ DFGL  L            +G P Y+ P+  Q
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 286 CYKLTDKSDVYSFGVVLIELISGLE 310
               T  +DV+S G+ ++E+   +E
Sbjct: 230 GSYGT-AADVFSLGLTILEVACNME 253

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG------RIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           D +   + +G G F  V   I R+       +IV V +   +     E    E  I   L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP++V+L    S     L +V+E++    +   +  R     +    V      +   A
Sbjct: 86  KHPHIVELLETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 224 LAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           L Y H +++IHRDVK + +LL   +N+  VK+  FG++     +   V+    GTP ++ 
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMA 203
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P+  +        DV+  GV+L  L+SG
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 114 SSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKL 171
           +S+ LG+G +  V   + L++G+  AVK + +       +   EVE L + Q + N+++L
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQP-NSCLLPWPVRLSIAIETAGALAYLHAS 230
                  +R   LV+E +  G++  H+  ++  N       VR     + A AL +LH  
Sbjct: 77  IEFFEDDTR-FYLVFEKLQGGSILAHIQKQKHFNEREASRVVR-----DVAAALDFLHTK 130
Query: 231 DVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTD------VTHVSTAPQGTPGYVDP 281
            + HRD+K  NIL ++  +   VK+ DF L      +       T   T P G+  Y+ P
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 282 DYFQCYKLTDKS-------DVYSFGVVLIELISG 308
           +  + +  TD++       D++S GVVL  ++SG
Sbjct: 191 EVVEVF--TDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           ++F+  + +G GGFG VY     D G++ A+K L   + KRI+    E   L +    +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 169 VKLYGC--------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           V    C              +L  + + +  G +  HL     +       +R   A E 
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRF-YAAEI 301
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L ++H   V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISGLEAV--DTSRHRHDIN 322
           P+  Q     D S D +S G +L +L+ G        ++ +H+I+
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           ++F+  + +G GGFG VY     D G++ A+K L   + KRI+    E   L +    +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 169 VKLYGC--------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           V    C              +L  + + +  G +  HL     +       +R   A E 
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRF-YAAEI 301
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L ++H   V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISGLEAV--DTSRHRHDIN 322
           P+  Q     D S D +S G +L +L+ G        ++ +H+I+
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH + VIHRD+K  N+ L+ +  VK+ DFGL+     D     T   GTP Y+ P+   
Sbjct: 132 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLS 190
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
               + + DV+S G ++  L+ G    +TS                       L +  L 
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------------LKETYLR 228
Query: 346 FEK-DYAVRNMVTSV-AELAFRCVQQDRDMRPTMKEVL 381
            +K +Y++   +  V A L  + +Q D   RPT+ E+L
Sbjct: 229 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH + VIHRD+K  N+ L+ +  VK+ DFGL+     D     T   GTP Y+ P+   
Sbjct: 132 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLS 190
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
               + + DV+S G ++  L+ G    +TS                       L +  L 
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------------LKETYLR 228
Query: 346 FEK-DYAVRNMVTSV-AELAFRCVQQDRDMRPTMKEVL 381
            +K +Y++   +  V A L  + +Q D   RPT+ E+L
Sbjct: 229 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH + VIHRD+K  N+ L+ +  VK+ DFGL+     D     T   GTP Y+ P+   
Sbjct: 136 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLS 194
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
               + + DV+S G ++  L+ G    +TS                       L +  L 
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------------LKETYLR 232
Query: 346 FEK-DYAVRNMVTSV-AELAFRCVQQDRDMRPTMKEVL 381
            +K +Y++   +  V A L  + +Q D   RPT+ E+L
Sbjct: 233 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG------RIVAVKRLYENNFKRIEQFMNEVEILTKL 163
           D +   + +G G F  V   I R+       +IV V +   +     E    E  I   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +HP++V+L    S     L +V+E++    +   +  R     +    V      +   A
Sbjct: 84  KHPHIVELLETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 224 LAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
           L Y H +++IHRDVK + +LL   +N+  VK+  FG++     +   V+    GTP ++ 
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMA 201
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P+  +        DV+  GV+L  L+SG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRDGR---IVAVKRLYENNFKRIEQFMNEVEILTKLQH 165
           +D +   K +G G FG   L  +RD +   +VAVK + E   K  E    E+     L+H
Sbjct: 18  SDRYELVKDIGSGNFGVARL--MRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRH 74
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+V+        +  L +V EY   G     L  R  N+             +    ++
Sbjct: 75  PNIVRFKEVILTPTH-LAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 226 YLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVD 280
           Y HA  V HRD+K  N LLD +   R+K+  FG S+   + V H  + P+   GTP Y+ 
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLH--SQPKSTVGTPAYIA 184
Query: 281 PDYFQCYKLTDK-SDVYSFGVVLIELISG 308
           P+     +   K +DV+S GV L  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           E+   EV IL ++ H N++ L+     ++ +++L+ E +  G + D L  ++     L  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFLAQKES----LSE 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVT 266
               S   +    + YLH   + H D+K  NI LLD N     +K+ DFGL+      V 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             +    GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 175 FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 109 TDNFNSSKQLGDGGFGAVYLGILRDGR---IVAVKRLYENNFKRIEQFMNEVEILTKLQH 165
           +D +   K +G G FG   L  +RD +   +VAVK + E   K  E    E+     L+H
Sbjct: 18  SDRYELVKDIGSGNFGVARL--MRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRH 74
Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+V+        +  L +V EY   G     L  R  N+             +    ++
Sbjct: 75  PNIVRFKEVILTPTH-LAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 226 YLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVD 280
           Y HA  V HRD+K  N LLD +   R+K+  FG S+   + V H  + P+   GTP Y+ 
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLH--SQPKDTVGTPAYIA 184
Query: 281 PDYFQCYKLTDK-SDVYSFGVVLIELISG 308
           P+     +   K +DV+S GV L  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           E+   EV IL ++ H N++ L+     ++ +++L+ E +  G + D L  ++     L  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFLAQKES----LSE 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVT 266
               S   +    + YLH   + H D+K  NI LLD N     +K+ DFGL+      V 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             +    GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 175 FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           E+   EV IL ++ H N++ L+     ++ +++L+ E +  G + D L  ++     L  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFLAQKES----LSE 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVT 266
               S   +    + YLH   + H D+K  NI LLD N     +K+ DFGL+      V 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             +    GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 175 FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           E+   EV IL ++ H N++ L+     ++ +++L+ E +  G + D L  ++     L  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFLAQKES----LSE 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVT 266
               S   +    + YLH   + H D+K  NI LLD N     +K+ DFGL+      V 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             +    GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 175 FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------E 156
           E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N      E
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 157 VEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           V +L K+      +++L     R    +L++    P   + D +  R      L   +  
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA----LQEELAR 117
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   
Sbjct: 118 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFD 174
Query: 274 GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 151 EQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPW 210
           E+   EV IL ++ H N++ L+     ++ +++L+ E +  G + D L  ++     L  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFLAQKES----LSE 114
Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNI-LLDNNF---RVKVADFGLSRLFPTDVT 266
               S   +    + YLH   + H D+K  NI LLD N     +K+ DFGL+      V 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             +    GTP +V P+      L  ++D++S GV+   L+SG
Sbjct: 175 FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 137
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 138 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 198 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 9   ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 68
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 69  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 124
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 125 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 184
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 185 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 9   ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 68
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 69  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 124
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 125 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 184
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 185 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 10  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 69
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 70  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 125
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 126 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 185
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 186 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 138
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 139 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 198
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 199 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 137
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 138 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 198 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 138
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 139 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 198
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 199 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 10  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 69
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 70  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 125
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 126 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 185
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 186 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 37  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 96
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 97  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 152
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 153 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 212
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 213 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 10  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 69
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 70  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 125
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 126 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 185
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 186 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 138
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 139 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 198
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 199 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 137
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 138 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 198 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 114/264 (43%), Gaps = 54/264 (20%)
Query: 95  FGAKVFSCSELEEATDNFN-SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE-- 151
           +  KV   SE E   D F     ++G G +G VY    +DG+      L     K+IE  
Sbjct: 5   YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL-----KQIEGT 59
Query: 152 ----QFMNEVEILTKLQHPNLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLH------- 199
                   E+ +L +L+HPN++ L     S   R++ L+++Y  +    D  H       
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH----DLWHIIKFHRA 115
Query: 200 ---NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKV 252
              N++P    LP  +  S+  +    + YLHA+ V+HRD+K  NIL+        RVK+
Sbjct: 116 SKANKKP--VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173
Query: 253 ADFGLSRLF-----------PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVV 301
           AD G +RLF           P  VT    AP+   G            T   D+++ G +
Sbjct: 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG--------ARHYTKAIDIWAIGCI 225
Query: 302 LIELISGLEAVDTSRHRHDINLSN 325
             EL++  E +   R + DI  SN
Sbjct: 226 FAELLTS-EPIFHCR-QEDIKTSN 247

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 138
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 139 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 198
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 199 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 37  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 96
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 97  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 152
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 153 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 212
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 213 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 137
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 138 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 198 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN 155
            K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N
Sbjct: 30  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89
Query: 156 ------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL 207
                 EV +L K+      +++L     R    +L++    P   + D +  R      
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----A 145
Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVT 266
           L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V 
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205
Query: 267 HVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
              T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 206 ---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGILRDG------RIVAVKRLYENNF---KRIEQFMNEV 157
           E +  +++   LG G FG V+  + ++       + +  +++ E+ +    ++ +   E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 158 EILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
            IL++++H N++K+      Q     LV E   +G       +R P    L  P+   I 
Sbjct: 81  AILSRVEHANIIKVLDIFENQGF-FQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIF 136
Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG 256
            +   A+ YL   D+IHRD+K  NI++  +F +K+ DFG
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFM 154
             K+    E E     +     LG GGFG+VY GI + D   VA+K + ++      +  
Sbjct: 42  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 101
Query: 155 N------EVEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
           N      EV +L K+      +++L     R    +L++    P   + D +  R     
Sbjct: 102 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---- 157
Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
            L   +  S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V
Sbjct: 158 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 217
Query: 266 THVSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
               T   GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 218 Y---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------E 156
           E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N      E
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 157 VEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           V +L K+      +++L     R    +L++    P   + D +  R      L   +  
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELAR 118
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFD 175
Query: 274 GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------E 156
           E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N      E
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 157 VEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           V +L K+      +++L     R    +L++    P   + D +  R      L   +  
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELAR 117
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   
Sbjct: 118 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFD 174
Query: 274 GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------E 156
           E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N      E
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 157 VEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           V +L K+      +++L     R    +L++    P   + D +  R      L   +  
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELAR 118
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFD 175
Query: 274 GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------E 156
           E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N      E
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 157 VEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           V +L K+      +++L     R    +L++    P   + D +  R      L   +  
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELAR 118
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFD 175
Query: 274 GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------E 156
           E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N      E
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 60
Query: 157 VEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           V +L K+      +++L     R    +L++    P   + D +  R      L   +  
Sbjct: 61  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELAR 116
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   
Sbjct: 117 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFD 173
Query: 274 GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCT 175
           LG+G    V   I L   +  AVK + +       +   EVE+L + Q H N+++L    
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE-TAGALAYLHASDVIH 234
             + R   LV+E +  G++  H+H R+  +      +  S+ ++  A AL +LH   + H
Sbjct: 81  EEEDR-FYLVFEKMRGGSILSHIHKRRHFN-----ELEASVVVQDVASALDFLHNKGIAH 134
Query: 235 RDVKSNNILLDNNFR---VKVADFGLSRLFPT--DVTHVST----APQGTPGYVDPDYFQ 285
           RD+K  NIL ++  +   VK+ DF L        D + +ST     P G+  Y+ P+  +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 286 CY----KLTDK-SDVYSFGVVLIELISG 308
            +     + DK  D++S GV+L  L+SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 139
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 25/158 (15%)
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH + VIHRD+K  N+ L+ +  VK+ DFGL+     D         GTP Y+ P+   
Sbjct: 154 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLS 212
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
               + + DV+S G ++  L+ G    +TS                       L +  L 
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------------LKETYLR 250
Query: 346 FEK-DYAVRNMVTSV-AELAFRCVQQDRDMRPTMKEVL 381
            +K +Y++   +  V A L  + +Q D   RPT+ E+L
Sbjct: 251 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 25/158 (15%)
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH + VIHRD+K  N+ L+ +  VK+ DFGL+     D         GTP Y+ P+   
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLS 214
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
               + + DV+S G ++  L+ G    +TS                       L +  L 
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------------LKETYLR 252
Query: 346 FEK-DYAVRNMVTSV-AELAFRCVQQDRDMRPTMKEVL 381
            +K +Y++   +  V A L  + +Q D   RPT+ E+L
Sbjct: 253 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 139
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNLVKL---- 171
           +G+G +G V        ++ VA+K++     +   Q  + E++IL + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 172 YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
              T  Q +++ +V + +           HL N   + C   +        +    L Y+
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKYI 144
Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYFQ 285
           H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+   
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 286 CYKLTDKS-DVYSFGVVLIELIS 307
             K   KS D++S G +L E++S
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------E 156
           E E     +     LG GGFG+VY GI + D   VA+K + ++      +  N      E
Sbjct: 25  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 84
Query: 157 VEILTKLQ--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           V +L K+      +++L     R    +L++    P   + D +  R      L   +  
Sbjct: 85  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELAR 140
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           S   +   A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   
Sbjct: 141 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFD 197
Query: 274 GTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           GT  Y  P++ + ++   +S  V+S G++L +++ G
Sbjct: 198 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 25/158 (15%)
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH + VIHRD+K  N+ L+ +  VK+ DFGL+     D         GTP Y+ P+   
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLS 188
Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
               + + DV+S G ++  L+ G    +TS                       L +  L 
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------------LKETYLR 226
Query: 346 FEK-DYAVRNMVTSV-AELAFRCVQQDRDMRPTMKEVL 381
            +K +Y++   +  V A L  + +Q D   RPT+ E+L
Sbjct: 227 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 139
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 91
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 141
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 143
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSND--HICYFLY--------QILRGLKY 143
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 97
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 147
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 148 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 139
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 87
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 137
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 116 KQLGDGGFGAVYL-GILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           ++LG+GGF  V L   L DG   A+KR+  +  +  E+   E ++     HPN+++L   
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 175 TSRQ---SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
             R+     E  L+  +   GT+ + +   +     L     L + +     L  +HA  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG-----------TPGYVD 280
             HRD+K  NILL +  +  + D G          HV  + Q            T  Y  
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMN---QACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 281 PDYF--QCYKLTD-KSDVYSFGVVLIELISG 308
           P+ F  Q + + D ++DV+S G VL  ++ G
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 109
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 159
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 94
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 144
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 95
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 145
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 146 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 86
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 136
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 137 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 143
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 87
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 137
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 139
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 18/172 (10%)
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    D  +V     
Sbjct: 194 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 274 GTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
             P  ++ P+       T +SDV+SFGV+L E+ S             +  S     KI 
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKID 300
Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                 L + +     DY    M  ++ +    C   +   RPT  E++E L
Sbjct: 301 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 348

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N    + L    V+  I  + 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCAKLTDDHVQFLI-YQI 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 180
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 18/172 (10%)
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    D  +V     
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 274 GTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
             P  ++ P+       T +SDV+SFGV+L E+ S             +  S     KI 
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKID 302
Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                 L + +     DY    M  ++ +    C   +   RPT  E++E L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 18/172 (10%)
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    D  +V     
Sbjct: 201 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 274 GTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
             P  ++ P+       T +SDV+SFGV+L E+ S             +  S     KI 
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKID 307
Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                 L + +     DY    M  ++ +    C   +   RPT  E++E L
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 18/172 (10%)
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    D  +V     
Sbjct: 203 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 274 GTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
             P  ++ P+       T +SDV+SFGV+L E+ S             +  S     KI 
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKID 309
Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                 L + +     DY    M  ++ +    C   +   RPT  E++E L
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 357

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 143
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H     +   T  Y  P+  
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 94
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 144
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H     +   T  Y  P+  
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 84
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 141
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R          TA + T GYV 
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTADEMT-GYVA 191
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 109
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ LV   +           HL N   + C   +        +    L Y
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND--HICYFLY--------QILRGLKY 159
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 21/224 (9%)
Query: 99  VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYE-NNFKR--IEQFM 154
           V    E+    D+F   K +G G F  V +  ++  G++ A+K + + +  KR  +  F 
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 155 NEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG---TVADHLHNRQPNSCLLPWP 211
            E ++L       + +L+    +    L LV EY   G   T+      R P      + 
Sbjct: 110 EERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA 271
             + +AI++   L Y      +HRD+K +NILLD    +++ADFG       D T  S  
Sbjct: 169 AEIVMAIDSVHRLGY------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
Query: 272 PQGTPGYVDPDYFQC-------YKLTDKSDVYSFGVVLIELISG 308
             GTP Y+ P+  Q             + D ++ GV   E+  G
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL-----------SRL 260
           V L I I+ A A+ +LH+  ++HRD+K +NI    +  VKV DFGL           + L
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
            P           GT  Y+ P+       + K D++S G++L EL+
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKXQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 97
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 154
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 204
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 84
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 141
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R          TA + T GYV 
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTADEMT-GYVA 191
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 96
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 153
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 203
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 84
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 141
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R          TA + T GYV 
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTADEMT-GYVA 191
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 83
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 140
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 190
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------EVEILTKL 163
            +     LG GGFG+VY GI + D   VA+K + ++      +  N      EV +L K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 164 Q--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
                 +++L     R    +L++    P   + D +  R      L   +  S   +  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVL 120
Query: 222 GALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
            A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   GT  Y  
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSP 177
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           P++ + ++   +S  V+S G++L +++ G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------EVEILTKL 163
            +     LG GGFG+VY GI + D   VA+K + ++      +  N      EV +L K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 164 Q--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
                 +++L     R    +L++    P   + D +  R      L   +  S   +  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVL 120
Query: 222 GALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
            A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   GT  Y  
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSP 177
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           P++ + ++   +S  V+S G++L +++ G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 31/206 (15%)
Query: 117 QLGDGGFGAVYLGILR-DGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +LG+G +  VY G  +    +VA+K +  E+        + EV +L  L+H N+V L+  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 175 TSRQSRELLLVYEYIPN---------GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
              + + L LV+EY+           G + + +HN           V+L +  +    LA
Sbjct: 69  IHTE-KSLTLVFEYLDKDLKQYLDDCGNIIN-MHN-----------VKLFL-FQLLRGLA 114
Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL--FPTDVTHVSTAPQGTPGYVDPD- 282
           Y H   V+HRD+K  N+L++    +K+ADFGL+R    PT           T  Y  PD 
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---TLWYRPPDI 171
Query: 283 YFQCYKLTDKSDVYSFGVVLIELISG 308
                  + + D++  G +  E+ +G
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL   +H N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLAFRHENIIGINDI 91
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 141
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 87
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 88  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 144
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 145 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 194
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 195 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 180
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKXQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 112 FNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKLQHPNL 168
           +   + +G G +GAV   +  R G  VA+K+LY      +  ++   E+ +L  ++H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 169 VKLYGC-----TSRQSRELLLVYEYIPN--GTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           + L        T     +  LV  ++    G +  H    +     L          +  
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL--------VYQML 138
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD-----VTHVSTAPQGTP 276
             L Y+HA+ +IHRD+K  N+ ++ +  +K+ DFGL+R   ++     VT    AP+   
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVIL 198
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH 317
            ++        + T   D++S G ++ E+I+G      S H
Sbjct: 199 NWM--------RYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 82
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 139
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVA 189
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------EVEILTKL 163
            +     LG GGFG+VY GI + D   VA+K + ++      +  N      EV +L K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 164 Q--HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
                 +++L     R    +L++    P   + D +  R      L   +  S   +  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVL 120
Query: 222 GALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
            A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   GT  Y  
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSP 177
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           P++ + ++   +S  V+S G++L +++ G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA++++  +E+     ++ + E++IL + +H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 143
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SKPFQSIIHAKRTYRELRLLKH 89
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 146
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 196
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 88
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 145
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVA 195
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 107 EATDNFN-----SSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR--IEQFMNEVE 158
           ++ +NFN     +SK+LG G F  V   I +  G+  A K L +    +    + ++E+ 
Sbjct: 21  QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 159 ILTKLQH-PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL--- 214
           +L   +  P ++ L+      S E++L+ EY   G +          S  LP    +   
Sbjct: 81  VLELAKSCPRVINLHEVYENTS-EIILILEYAAGGEIF---------SLCLPELAEMVSE 130
Query: 215 ----SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTH 267
                +  +    + YLH ++++H D+K  NILL + +    +K+ DFG+SR     + H
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGH 186
Query: 268 VSTAPQ--GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                +  GTP Y+ P+      +T  +D+++ G++   L++
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 118 LGDGGFGAVYLGILRDGRI-VAVKRL--YENNFKRIEQFMNEVEILTKLQHPNLVKL--- 171
           +G+G +G V        ++ VA+K++  +E+     ++ + E++IL   +H N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLAFRHENIIGINDI 91
Query: 172 -YGCTSRQSRELLLVYEYIPNGTV----ADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
               T  Q +++ +V + +           HL N   + C   +        +    L Y
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLY--------QILRGLKY 141
Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDPDYF 284
           +H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H    T    T  Y  P+  
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 285 QCYKLTDKS-DVYSFGVVLIELIS 307
              K   KS D++S G +L E++S
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 89
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 146
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 196
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 89
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 146
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 196
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++    T    T  Y  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGXVATRWYRA 190
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           P+    +   +++ D++S G ++ EL++G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 88
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 145
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 195
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 82
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 139
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVA 189
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 79
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 136
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 186
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N   +  L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKSQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 100
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 157
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 207
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V     ++ G  +AVK+L    F+ I   ++   E+ +L  
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKL-SRPFQSIIHAKRTYRELRLLKH 106
Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           ++H N++ L    +  +        Y+    +   L+N      L    V+  I  +   
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILR 165
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV   
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATR 215
Query: 283 YFQC---------YKLTDKSDVYSFGVVLIELISG 308
           +++          Y +T   D++S G ++ EL++G
Sbjct: 216 WYRAPEIMLNWMHYNMT--VDIWSVGCIMAELLTG 248

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 97
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 154
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 204
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 96
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 153
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 203
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 83
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 140
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 190
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 79
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 136
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 186
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 84
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 141
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 191
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYV 279
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T +V+T     P  +
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                         D++S G ++ EL++G
Sbjct: 195 ----LNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 112 FNSSKQLGDGGFGAVYLGI--LRDGRIVAVKRL--YENNFKRIEQFMNEVEILTKLQHPN 167
           +   + +G+G +G V      +R  R VA+K++  +E+     ++ + E++IL + +H N
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTR-VAIKKISPFEHQ-TYCQRTLREIQILLRFRHEN 102
Query: 168 LVK----LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           ++     L   T    R++ +V + +    +   L ++Q ++  + +        +    
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICY-----FLYQILRG 156
Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS--TAPQGTPGYVDP 281
           L Y+H+++V+HRD+K +N+L++    +K+ DFGL+R+   +  H    T    T  Y  P
Sbjct: 157 LKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 282 DYFQCYKLTDKS-DVYSFGVVLIELIS 307
           +     K   KS D++S G +L E++S
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 82
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 139
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 189
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 76
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 77  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 133
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 134 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 183
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 83
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 140
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 190
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 75
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 132
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 133 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 182
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 83
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 140
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT----------GYVA 190
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 79
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 136
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT----------GYVA 186
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 79
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 136
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 186
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 180
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 74
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 131
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 181
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 82
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 139
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 189
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 74
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 131
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T          GYV 
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 181
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 1/95 (1%)
Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           +S + + A  + +L +   IHRD+ + NILL  N  VK+ DFGL+R    +  +V     
Sbjct: 202 ISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 274 GTP-GYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             P  ++ P+       + KSDV+S+GV+L E+ S
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 97
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 154
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG---TPG 277
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R       H      G   T  
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRW 207
Query: 278 YVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           Y  P+    +   +++ D++S G ++ EL++G
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG---TPG 277
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R       H      G   T  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRW 187
Query: 278 YVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           Y  P+    +   +++ D++S G ++ EL++G
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG---TPG 277
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R       H      G   T  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRW 187
Query: 278 YVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           Y  P+    +   +++ D++S G ++ EL++G
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 130
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG---TPG 277
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R       H      G   T  
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRW 183
Query: 278 YVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           Y  P+    +   +++ D++S G ++ EL++G
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 46/277 (16%)
Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN------EVEILTKLQ----HP 166
           LG GGFG V+ G  L D   VA+K +  N         +      EV +L K+     HP
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            +++L      Q   +L++   +P   + D++  + P   L   P R     +   A+ +
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFG-QVVAAIQH 154
Query: 227 LHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
            H+  V+HRD+K  NIL+D      K+ DFG   L   +     T   GT  Y  P++  
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---TDFDGTRVYSPPEWIS 211
Query: 286 CYKLTD-KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
            ++     + V+S G++L +++ G           DI                E+++  L
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCG-----------DIPFERD----------QEILEAEL 250
Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            F       ++      L  RC+      RP+++E+L
Sbjct: 251 HFPA-----HVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 14/182 (7%)
Query: 88  LERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YEN 145
           LE  +   G+   S +    + D +    +LG+G +G VY  I       VA+KR+  E+
Sbjct: 12  LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 146 NFKRIE-QFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN 204
             + +    + EV +L +LQH N+++L        R L L++EY  N        ++ P+
Sbjct: 72  EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-LHLIFEYAENDL--KKYMDKNPD 128
Query: 205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL-----DNNFRVKVADFGLSR 259
             +    V  S   +    + + H+   +HRD+K  N+LL          +K+ DFGL+R
Sbjct: 129 VSMR---VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
Query: 260 LF 261
            F
Sbjct: 186 AF 187

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 100
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 157
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG---TPG 277
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R       H      G   T  
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRW 210
Query: 278 YVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           Y  P+    +   +++ D++S G ++ EL++G
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 155 NEVEILTKLQHPNLVKLYGCT-SRQSRELLLVYEYIPNGT--VADHLHNRQPNSCLLPWP 211
            E+++L +L+H N+++L     + + +++ +V EY   G   + D +  ++   C     
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC----- 109
Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVST 270
                  +    L YLH+  ++H+D+K  N+LL     +K++  G++  L P        
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 271 APQGTPGYVDP------DYFQCYKLTDKSDVYSFGVVLIELISGL---EAVDTSRHRHDI 321
             QG+P +  P      D F  +K+    D++S GV L  + +GL   E  +  +   +I
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
Query: 322 NLSNMATNKIQNGALNELVDPSLGFE--KDYAVRNM 355
              + A        L++L+   L +E  K +++R +
Sbjct: 226 GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ D+GL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKL 163
           E    + S   +G G +G+V   I  R G  VA+K+L       I  ++   E+ +L  +
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 98
Query: 164 QHPNLVKLYGCTSRQS--RELLLVYEYIP-NGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           QH N++ L    +  S  R     Y  +P   T    +   + +   + +     +  + 
Sbjct: 99  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQM 153
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++ V+HRD+K  N+ ++ +  +K+ DFGL+R    ++T        T  Y  
Sbjct: 154 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRA 209
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           P+    +   +++ D++S G ++ E+++G
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 191
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+     K     D++S GV++  L+ G     ++   H + +S     +I+ G   E
Sbjct: 192 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKTRIRMGQY-E 247
Query: 339 LVDP---SLGFEKDYAVRNMVTS 358
             +P    +  E    +RN++ +
Sbjct: 248 FPNPEWSEVSEEVKMLIRNLLKT 270

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 190
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+     K     D++S GV++  L+ G     ++   H + +S     +I+ G   E
Sbjct: 191 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKTRIRMGQY-E 246
Query: 339 LVDP---SLGFEKDYAVRNMVTS 358
             +P    +  E    +RN++ +
Sbjct: 247 FPNPEWSEVSEEVKMLIRNLLKT 269

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 189
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+     K     D++S GV++  L+ G     ++   H + +S     +I+ G   E
Sbjct: 190 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKTRIRMGQY-E 245
Query: 339 LVDP---SLGFEKDYAVRNMVTS 358
             +P    +  E    +RN++ +
Sbjct: 246 FPNPEWSEVSEEVKMLIRNLLKT 268

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 229
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V P+     K     D++S GV++  L+ G
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 10/116 (8%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 199
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
           V P+     K     D++S GV++  L+ G     ++   H + +S     +I+ G
Sbjct: 200 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKTRIRMG 252

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 183
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V P+     K     D++S GV++  L+ G
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 184
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+     K     D++S GV++  L+ G     ++   H + +S     +I+ G   E
Sbjct: 185 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKTRIRMGQY-E 240
Query: 339 LVDP---SLGFEKDYAVRNMVTS 358
             +P    +  E    +RN++ +
Sbjct: 241 FPNPEWSEVSEEVKMLIRNLLKT 263

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 185
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+     K     D++S GV++  L+ G     ++   H + +S     +I+ G   E
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKTRIRMGQY-E 241
Query: 339 LVDP---SLGFEKDYAVRNMVTS 358
             +P    +  E    +RN++ +
Sbjct: 242 FPNPEWSEVSEEVKMLIRNLLKT 264

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 235
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V P+     K     D++S GV++  L+ G
Sbjct: 236 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 185
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V P+     K     D++S GV++  L+ G
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLY------------ENNF--K 148
           +EL      +   + +  G +GAV  G+  +G  VA+KR++             ++F  K
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 149 RIEQFMNEVEILTKLQHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHNRQPN 204
           R+   + E+ +L    HPN++ L             +L LV E +    +A  +H+++  
Sbjct: 75  RV---LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR-- 128
Query: 205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD 264
             + P  ++  +     G L  LH + V+HRD+   NILL +N  + + DF L+R    D
Sbjct: 129 IVISPQHIQYFMYHILLG-LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 265 V--THVSTAPQGTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
              TH  T       Y  P+    +K  T   D++S G V+ E+ +       S   + +
Sbjct: 188 ANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 322 N--LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCV 367
           N  +  + T KI++  +     PS    +DY +RN +++V   A+  V
Sbjct: 244 NKIVEVVGTPKIEDVVM--FSSPS---ARDY-LRNSLSNVPARAWTAV 285

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLY------------ENNF--K 148
           +EL      +   + +  G +GAV  G+  +G  VA+KR++             ++F  K
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 149 RIEQFMNEVEILTKLQHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHNRQPN 204
           R+   + E+ +L    HPN++ L             +L LV E +    +A  +H+++  
Sbjct: 75  RV---LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR-- 128
Query: 205 SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD 264
             + P  ++  +     G L  LH + V+HRD+   NILL +N  + + DF L+R    D
Sbjct: 129 IVISPQHIQYFMYHILLG-LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 265 V--THVSTAPQGTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
              TH  T       Y  P+    +K  T   D++S G V+ E+ +       S   + +
Sbjct: 188 ANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 322 N--LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCV 367
           N  +  + T KI++  +     PS    +DY +RN +++V   A+  V
Sbjct: 244 NKIVEVVGTPKIEDVVM--FSSPS---ARDY-LRNSLSNVPARAWTAV 285

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYY 183
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V P+     K     D++S GV++  L+ G
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 156 EVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           E+EIL +  QHPN++ L        + + LV E +  G + D +  ++  S         
Sbjct: 70  EIEILLRYGQHPNIITLKDVYD-DGKHVYLVTELMRGGELLDKILRQKFFS-----EREA 123
Query: 215 SIAIETAG-ALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVS 269
           S  + T G  + YLH+  V+HRD+K +NIL      N   +++ DFG ++    +   + 
Sbjct: 124 SFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLM 183
Query: 270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           T P  T  +V P+  +     +  D++S G++L  +++G
Sbjct: 184 T-PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 109 TDNFNSSKQ-LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE-----QFMNEVEILT 161
           TD++  SKQ LG G  G V      R G+  A+K LY++   R E     Q      I+ 
Sbjct: 8   TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC 67
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI--E 219
                 ++ +Y       R LL++ E +  G +   +  R   +    +  R +  I  +
Sbjct: 68  ------ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRD 117
Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTP 276
              A+ +LH+ ++ HRDVK  N+L  +  +   +K+ DFG ++       +    P  TP
Sbjct: 118 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTP 174
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
            YV P+     K     D++S GV++  L+ G 
Sbjct: 175 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 207

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 109 TDNFNSSKQ-LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIE-----QFMNEVEILT 161
           TD++  SKQ LG G  G V      R G+  A+K LY++   R E     Q      I+ 
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC 86
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI--E 219
                 ++ +Y       R LL++ E +  G +   +  R   +    +  R +  I  +
Sbjct: 87  ------ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRD 136
Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFPTDVTHVSTAPQGTP 276
              A+ +LH+ ++ HRDVK  N+L  +  +   +K+ DFG ++       +    P  TP
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTP 193
Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
            YV P+     K     D++S GV++  L+ G 
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 156 EVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           E+EIL +  QHPN++ L        + + LV E +  G + D +  ++  S         
Sbjct: 70  EIEILLRYGQHPNIITLKDVYD-DGKHVYLVTELMRGGELLDKILRQKFFS-----EREA 123
Query: 215 SIAIETAG-ALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVS 269
           S  + T G  + YLH+  V+HRD+K +NIL      N   +++ DFG ++    +   + 
Sbjct: 124 SFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLM 183
Query: 270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           T P  T  +V P+  +     +  D++S G++L  +++G
Sbjct: 184 T-PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI--EQFMNEVEILTKL 163
           E    + S   +G G +G+V   I  R G  VA+K+L       I  ++   E+ +L  +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 164 QHPNLVKLYGCTSRQS--RELLLVYEYIP-NGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           QH N++ L    +  S  R     Y  +P   T    +   + +   + +     +  + 
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQM 135
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++ V+HRD+K  N+ ++ +  +K+ DFGL+R    ++T        T  Y  
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRA 191
Query: 281 PDYFQCYKLTDKS-DVYSFGVVLIELISG 308
           P+    +   +++ D++S G ++ E+++G
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ DF L+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+  FGL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKLT-------DKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 156 EVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           E+EIL +  QHPN++ L        + + +V E +  G + D +  ++  S      V  
Sbjct: 65  EIEILLRYGQHPNIITLKDVYD-DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF 123
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVST 270
           +I       + YLHA  V+HRD+K +NIL      N   +++ DFG ++    +   + T
Sbjct: 124 TIT----KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P  T  +V P+  +        D++S GV+L  +++G
Sbjct: 180 -PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 107 EATDNFNSSKQLGDGGFGAV---YLGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILT 161
           E        + +G G +G+V   Y   LR    VAVK+L     +     +   E+ +L 
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
            L+H N++ L    +  +        Y+    +   L+N   +  L    V+  +  +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLL 141
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             L Y+H++ +IHRD+K +N+ ++ +  +++ DFGL+R    ++T          GYV  
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT----------GYVAT 191
Query: 282 DYFQCYKLT-------DKSDVYSFGVVLIELISG 308
            +++  ++           D++S G ++ EL+ G
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF----MN 155
            C   +E +  +    ++G G FG V+    R  G+ VA+K++   N K  E F    + 
Sbjct: 10  ECPFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALR 66
Query: 156 EVEILTKLQHPNLVKLYG-CTSRQS------RELLLVYEYIPNGTVADHLHNRQPNSCLL 208
           E++IL  L+H N+V L   C ++ S        + LV+++  +  +A  L N      L 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 209 PWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
                + + +     L Y+H + ++HRD+K+ N+L+  +  +K+ADFGL+R F
Sbjct: 126 EIKRVMQMLL---NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 175

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ D GL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 18/157 (11%)
Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF----MNEVEILTKLQHPNLVKL 171
           ++G G FG V+    R  G+ VA+K++   N K  E F    + E++IL  L+H N+V L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 82
Query: 172 YG-CTSRQSR------ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
              C ++ S        + LV+++  +  +A  L N      L      + + +     L
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLL---NGL 138
Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
            Y+H + ++HRD+K+ N+L+  +  +K+ADFGL+R F
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 175

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF----MN 155
            C   +E +  +    ++G G FG V+    R  G+ VA+K++   N K  E F    + 
Sbjct: 10  ECPFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALR 66
Query: 156 EVEILTKLQHPNLVKLYG-CTSRQSR------ELLLVYEYIPNGTVADHLHNRQPNSCLL 208
           E++IL  L+H N+V L   C ++ S        + LV+++  +  +A  L N      L 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 209 PWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
                + + +     L Y+H + ++HRD+K+ N+L+  +  +K+ADFGL+R F
Sbjct: 126 EIKRVMQMLL---NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 175

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF----MN 155
            C   +E +  +    ++G G FG V+    R  G+ VA+K++   N K  E F    + 
Sbjct: 9   ECPFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALR 65
Query: 156 EVEILTKLQHPNLVKLYG-CTSRQSR------ELLLVYEYIPNGTVADHLHNRQPNSCLL 208
           E++IL  L+H N+V L   C ++ S        + LV+++  +  +A  L N      L 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 209 PWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
                + + +     L Y+H + ++HRD+K+ N+L+  +  +K+ADFGL+R F
Sbjct: 125 EIKRVMQMLL---NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 30/174 (17%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYEN--NFKRIEQFMNEVEIL 160
           +  DN+     +G G +G VYL   ++      I  V R++E+  + KRI   + E+ IL
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRI---LREITIL 81
Query: 161 TKLQHPNLVKLYGCTSRQS----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS- 215
            +L+   +++L+     +      EL +V E      +AD    +     L   P+ L+ 
Sbjct: 82  NRLKSDYIIRLHDLIIPEDLLKFDELYIVLE------IADSDLKK-----LFKTPIFLTE 130
Query: 216 -----IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD 264
                I         ++H S +IHRD+K  N LL+ +  VK+ DFGL+R   +D
Sbjct: 131 QHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSD 184

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ D GL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI---EQFMNEVEILTK 162
           E  + + +   +G G +G+V      + G  VAVK+L    F+ I   ++   E+ +L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 77
Query: 163 LQHPNLVKLYGC--TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           ++H N++ L      +R   E   VY  +    +   L+N      L    V+  I  + 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQI 134
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              L Y+H++D+IHRD+K +N+ ++ +  +K+ D GL+R    ++T          GYV 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT----------GYVA 184
Query: 281 PDYFQCYKL-------TDKSDVYSFGVVLIELISG 308
             +++  ++           D++S G ++ EL++G
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 14/143 (9%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVS-TAPQGTPGY 278
           A+ YLH+ ++ HRDVK  N+L  +   N  +K+ DFG ++      +H S T P  TP Y
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 229
Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+     K     D +S GV+   L+ G     ++   H + +S     +I+ G   E
Sbjct: 230 VAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSN---HGLAISPGXKTRIRXGQY-E 285
Query: 339 LVDP---SLGFEKDYAVRNMVTS 358
             +P    +  E    +RN++ +
Sbjct: 286 FPNPEWSEVSEEVKXLIRNLLKT 308

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 107 EATDNFNSSKQLGDGGFGAV---YLGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILT 161
           E        + +G G +G+V   Y   LR    VAVK+L     +     +   E+ +L 
Sbjct: 17  EVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLK 74
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
            L+H N++ L    +  +        Y+    +   L+N      L    V+  +  +  
Sbjct: 75  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLL 133
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             L Y+H++ +IHRD+K +N+ ++ +  +++ DFGL+R    ++T          GYV  
Sbjct: 134 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT----------GYVAT 183
Query: 282 DYFQCYKLT-------DKSDVYSFGVVLIELISG 308
            +++  ++           D++S G ++ EL+ G
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+L+D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRI---EQFM--NEVEIL 160
           +E  + +  ++ LG G FG V+  +         K+ Y   F ++   +Q +   E+ IL
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSS-----KKTYMAKFVKVKGTDQVLVKKEISIL 55
Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR--LSIAI 218
              +H N++ L+  +     EL++++E+I    + + +     N+       R  +S   
Sbjct: 56  NIARHRNILHLHE-SFESMEELVMIFEFISGLDIFERI-----NTSAFELNEREIVSYVH 109
Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSR-LFPTD-VTHVSTAPQG 274
           +   AL +LH+ ++ H D++  NI+     +  +K+ +FG +R L P D    + TAP+ 
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE- 168
Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
              Y  P+  Q   ++  +D++S G ++  L+SG+
Sbjct: 169 ---YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 107 EATDNFNSSKQLGDGGFGAV---YLGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILT 161
           E        + +G G +G+V   Y   LR    VAVK+L     +     +   E+ +L 
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
            L+H N++ L    +  +        Y+    +   L+N      L    V+  +  +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLL 141
Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             L Y+H++ +IHRD+K +N+ ++ +  +++ DFGL+R    ++T          GYV  
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT----------GYVAT 191
Query: 282 DYFQCYKLT-------DKSDVYSFGVVLIELISG 308
            +++  ++           D++S G ++ EL+ G
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLRQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 112/247 (45%), Gaps = 57/247 (23%)
Query: 107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVK---RLYEN--NFKRIEQFMNEVEIL 160
           +  D +     +G G +G V     + + R+VA+K   R++E+  + KRI   + E+ IL
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAIL 106
Query: 161 TKLQHPNLVKLYGCT----SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS- 215
            +L H ++VK+          +  EL +V E      +AD    +     L   PV L+ 
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLE------IADSDFKK-----LFRTPVYLTE 155
Query: 216 IAIETA-----GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL--FPTD---- 264
           + I+T        + Y+H++ ++HRD+K  N L++ +  VKV DFGL+R   +P +    
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 265 --------------VTHVSTAPQGTPGYVDPDYFQCYKL-------TDKSDVYSFGVVLI 303
                           H     +   G+V   +++  +L       T+  DV+S G +  
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 304 ELISGLE 310
           EL++ ++
Sbjct: 276 ELLNMIK 282

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 112 FNSSKQLGDGGFG---AVYLGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILTKLQHP 166
           +   K +G G  G   A +  +L  G  VAVK+L     N    ++   E+ +L  + H 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 167 NLVKLYGCTSRQS-----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI-ET 220
           N++ L    + Q      +++ LV E + +  +   +H    +        R+S  + + 
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHE-------RMSYLLYQM 133
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R   T+   + T    T  Y  
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF--MMTPYVVTRYYRA 191
Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P+        +  D++S G ++ EL+ G
Sbjct: 192 PEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 156 EVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           E+EIL +  QHPN++ L        + + +V E    G + D +  ++  S      V  
Sbjct: 65  EIEILLRYGQHPNIITLKDVYD-DGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLF 123
Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVST 270
           +I       + YLHA  V+HRD+K +NIL      N   +++ DFG ++    +   + T
Sbjct: 124 TIT----KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P  T  +V P+  +        D++S GV+L   ++G
Sbjct: 180 -PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 143
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 200
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 118 LGDGGFGAVYLGILRD--GRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +  GG G +YL + R+  GR V +K L +  + +     M E + L ++ HP++V+++  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 175 TSRQSREL----LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
                R       +V EY+   ++      ++     LP    ++  +E   AL+YLH+ 
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 231 DVIHRDVKSNNILLDNNFRVKVADFG-LSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
            +++ D+K  NI+L    ++K+ D G +SR+      +      GTPG+  P+  +    
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY------GTPGFQAPEIVRTGP- 253
Query: 290 TDKSDVYSFGVVLIEL 305
           T  +D+Y+ G  L  L
Sbjct: 254 TVATDIYTVGRTLAAL 269

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 16/93 (17%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-------LFPTDVTHVSTAPQGT 275
            + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP+  
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G         YK  +  D++S GV++ E+I G
Sbjct: 198 LG-------MGYK--ENVDIWSVGVIMGEMIKG 221

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 143
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 200
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 149
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 150 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 206
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 207 LLVDYQMYDYSLDMWSLGCMLASMI 231

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 16/93 (17%)
Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-------LFPTDVTHVSTAPQGT 275
            + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP+  
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            G         YK  +  D++S GV++ E+I G
Sbjct: 198 LG-------MGYK--ENVDIWSVGVIMGEMIKG 221

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 142
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 199
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMI 224

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 112 FNSSKQLGDGGFG---AVYLGILRDGRIVAVKRLYE--NNFKRIEQFMNEVEILTKLQHP 166
           +   K +G G  G   A +  +L  G  VAVK+L     N    ++   E+ +L  + H 
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 167 NLVKLYGCTSRQS-----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI-ET 220
           N++ L    + Q      +++ LV E + +  +   +H    +        R+S  + + 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHE-------RMSYLLYQM 135
Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTPGYV 279
              + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R   T  T+    P   T  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 192
Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+           D++S G ++ EL+ G
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 166 PNLVKLYGCTSRQ-SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           PN++ L        SR   LV+E++ N         +Q    L  + +R  +  E   AL
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKAL 144
Query: 225 AYLHASDVIHRDVKSNNILLDNNFR-VKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
            Y H+  ++HRDVK +N+++D+  R +++ D+GL+  + P    +V  A +   G   P+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PE 201
Query: 283 YFQCYKLTDKS-DVYSFGVVLIELI 306
               Y++ D S D++S G +L  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 30/168 (17%)
Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYEN--NFKRIEQFMNEVEILT 161
             DN+     +G G +G VYL   ++      I  V R++E+  + KRI   + E+ IL 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILN 80
Query: 162 KLQHPNLVKLYGCTSR----QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS-- 215
           +L+   +++LY         +  EL +V E      +AD    +     L   P+ L+  
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLE------IADSDLKK-----LFKTPIFLTEE 129
Query: 216 ----IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
               I         ++H S +IHRD+K  N LL+ +  VKV DFGL+R
Sbjct: 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	438
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-138
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-126
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-118
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-85
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-72
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-71
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-69
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-68
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-68
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-67
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-67
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-67
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-65
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-64
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-61
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-61
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-60
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-57
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-50
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-50
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-49
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-49
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-48
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-48
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-47
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-47
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-46
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-46
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-45
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-45
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-45
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-45
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-45
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-45
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-44
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-44
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-44
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-44
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-43
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-43
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-43
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-42
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-42
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-42
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-41
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-41
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-41
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-41
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-40
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-39
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-39
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-38
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-38
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-38
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-38
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-38
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-37
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-37
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-36
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-35
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-35
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-35
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-34
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-34
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-33
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-33
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-32
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-32
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-32
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-32
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-32
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-32
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-31
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-31
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-31
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-31
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-31
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-31
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-30
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-30
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-30
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-29
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-29
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-29
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-29
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-29
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-29
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-28
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-28
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-28
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-27
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-27
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-27
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-26
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-25
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-24
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-23
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-22
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  398 bits (1024), Expect = e-138
 Identities = 122/312 (39%), Positives = 174/312 (55%), Gaps = 5/312 (1%)

Query: 74  SSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD 133
           S  S  +   +          F +      +LEEAT+NF+    +G G FG VY G+LRD
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 134 GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT 193
           G  VA+KR    + + IE+F  E+E L+  +HP+LV L G    +  E++L+Y+Y+ NG 
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF-CDERNEMILIYKYMENGN 121

Query: 194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVA 253
           +  HL+     +  + W  RL I I  A  L YLH   +IHRDVKS NILLD NF  K+ 
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKIT 181

Query: 254 DFGLSRLFPT-DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAV 312
           DFG+S+     D TH+ST  +GT GY+DP+YF   +LT+KSDVYSFGVVL E++    A+
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

Query: 313 DTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRD 372
             S  R  +NL+  A     NG L ++VDP+L         ++     + A +C+    +
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRK-FGDTAVKCLALSSE 298

Query: 373 MRPTMKEVLEIL 384
            RP+M +VL  L
Sbjct: 299 DRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  367 bits (944), Expect = e-126
 Identities = 123/294 (41%), Positives = 169/294 (57%), Gaps = 10/294 (3%)

Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE-QFMN 155
            K FS  EL+ A+DNF++   LG GGFG VY G L DG +VAVKRL E   +  E QF  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 156 EVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           EVE+++   H NL++L G       E LLVY Y+ NG+VA  L  R  +   L WP R  
Sbjct: 77  EVEMISMAVHRNLLRLRGF-CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 216 IAIETAGALAYLH-ASD--VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
           IA+ +A  LAYLH   D  +IHRDVK+ NILLD  F   V DFGL++L     THV+TA 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR--HDINLSNMATNK 330
           +GT G++ P+Y    K ++K+DV+ +GV+L+ELI+G  A D +R     D+ L +     
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           ++   L  LVD  L  + +Y    +   + ++A  C Q     RP M EV+ +L
Sbjct: 256 LKEKKLEALVDVDL--QGNYKDEEVE-QLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  348 bits (894), Expect = e-118
 Identities = 103/310 (33%), Positives = 162/310 (52%), Gaps = 22/310 (7%)

Query: 87  DLERGSSYFGAKVFSCSELEEATDNFNSSKQ------LGDGGFGAVYLGILRDGRIVAVK 140
           +     S      FS  EL+  T+NF+          +G+GGFG VY G + +   VAVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 141 RLYENNFKRIEQ----FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVAD 196
           +L        E+    F  E++++ K QH NLV+L G  S    +L LVY Y+PNG++ D
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF-SSDGDDLCLVYVYMPNGSLLD 119

Query: 197 HLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG 256
            L      +  L W +R  IA   A  + +LH +  IHRD+KS NILLD  F  K++DFG
Sbjct: 120 RLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG 178

Query: 257 LSRLFPT-DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTS 315
           L+R       T +++   GT  Y+ P+  +  ++T KSD+YSFGVVL+E+I+GL AVD  
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237

Query: 316 RHRHDINLSNMATNKIQN-GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
           R      L ++          + + +D  +    D    ++   +  +A +C+ + ++ R
Sbjct: 238 REPQ--LLLDIKEEIEDEEKTIEDYIDKKMN---DADSTSVEA-MYSVASQCLHEKKNKR 291

Query: 375 PTMKEVLEIL 384
           P +K+V ++L
Sbjct: 292 PDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  262 bits (672), Expect = 3e-85
 Identities = 73/311 (23%), Positives = 118/311 (37%), Gaps = 33/311 (10%)

Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI 159
                L   +      +    G FG V+   L     VAVK     + K+  Q   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYS 71

Query: 160 LTKLQHPNLVKLYGC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           L  ++H N+++  G     +    +L L+  +   G+++D L         + W     I
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHI 126

Query: 217 AIETAGALAYLHASD----------VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT 266
           A   A  LAYLH             + HRD+KS N+LL NN    +ADFGL+  F    +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 267 HVSTAPQ-GTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD 320
              T  Q GT  Y+ P+  +           + D+Y+ G+VL EL S   A D     + 
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 321 INLSNM-----ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP 375
           +          +   +Q   +++   P L     +     +  + E    C   D + R 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVL--RDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 376 TMKEVLEILRE 386
           +   V E + +
Sbjct: 305 SAGCVGERITQ 315

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  227 bits (582), Expect = 7e-72
 Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 37/286 (12%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG- 173
           + LG G FG       R+ G ++ +K L   + +    F+ EV+++  L+HPN++K  G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
               + + L  + EYI  GT+   + +        PW  R+S A + A  +AYLH+ ++I
Sbjct: 76  LY--KDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSMNII 130

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-------------VSTAPQGTPGYVD 280
           HRD+ S+N L+  N  V VADFGL+RL   + T                    G P ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
           P+        +K DV+SFG+VL E+I  + A        D     M       G L +  
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------DPDYLPRTMDFGLNVRGFL-DRY 243

Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
            P           N   S   +  RC   D + RP+  ++   L  
Sbjct: 244 CPP----------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  226 bits (577), Expect = 4e-71
 Identities = 85/281 (30%), Positives = 138/281 (49%), Gaps = 26/281 (9%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYG 173
           +++G G FG V+      G  VAVK L E +F  +R+ +F+ EV I+ +L+HPN+V   G
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-- 231
             ++    L +V EY+  G++   LH        L    RLS+A + A  + YLH  +  
Sbjct: 102 AVTQPPN-LSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNRNPP 159

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           ++HR++KS N+L+D  + VKV DFGLSRL  +     S +  GTP ++ P+  +     +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           KSDVYSFGV+L EL +                 N+   ++      +     +       
Sbjct: 219 KSDVYSFGVILWELATL-----------QQPWGNLNPAQVVAAVGFKCKRLEIP------ 261

Query: 352 VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            RN+   VA +   C   +   RP+   ++++LR    S +
Sbjct: 262 -RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  220 bits (563), Expect = 9e-69
 Identities = 77/323 (23%), Positives = 123/323 (38%), Gaps = 46/323 (14%)

Query: 100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI 159
            + SE     DN    + +G G +GAVY G L   R VAVK     N +    F+NE  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58

Query: 160 --LTKLQHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
             +  ++H N+ +        T+    E LLV EY PNG++  +L           W   
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113

Query: 214 LSIAIETAGALAYLHASD---------VIHRDVKSNNILLDNNFRVKVADFGLSRLF--- 261
             +A      LAYLH            + HRD+ S N+L+ N+    ++DFGLS      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 262 ----PTDVTHVSTAPQGTPGYVDPDYFQ-------CYKLTDKSDVYSFGVVLIELISGLE 310
               P +  + + +  GT  Y+ P+  +             + D+Y+ G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 311 AVDTSRHRHDINL-------SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELA 363
            +       +  +       ++     +Q     E   P    E        V S+ E  
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP-EAWKENSLAVRSLKETI 292

Query: 364 FRCVQQDRDMRPTMKEVLEILRE 386
             C  QD + R T +   E + E
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAE 315

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  219 bits (559), Expect = 1e-68
 Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 27/277 (9%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYG 173
           +++G G FG VY G       VAVK L       ++++ F NEV +L K +H N++   G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
            ++    +L +V ++    ++  HLH  +           + IA +TA  + YLHA  +I
Sbjct: 88  YSTAP--QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSII 142

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDP---DYFQCYKL 289
           HRD+KSNNI L  +  VK+ DFGL+        +H      G+  ++ P           
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           + +SDVY+FG+VL EL++G           +IN  +     +  G+L+  +         
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGSLSPDLSK------- 249

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
               N    +  L   C+++ RD RP+   +L  + E
Sbjct: 250 -VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  217 bits (556), Expect = 4e-68
 Identities = 73/286 (25%), Positives = 135/286 (47%), Gaps = 34/286 (11%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V     R  + VA+K++   + +  + F+ E+  L+++ HPN+VKLYG  
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD---V 232
                 + LV EY   G++ + LH  +P          +S  ++ +  +AYLH+     +
Sbjct: 71  LN---PVCLVMEYAEGGSLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 233 IHRDVKSNNILLDNNFRV-KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           IHRD+K  N+LL     V K+ DFG +     D+    T  +G+  ++ P+ F+    ++
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182

Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ-NGALNELVDPSLGFEKDY 350
           K DV+S+G++L E+I+                  +     +   A++    P L      
Sbjct: 183 KCDVFSWGIILWEVITR-----------RKPFDEIGGPAFRIMWAVHNGTRPPL------ 225

Query: 351 AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSK 396
            ++N+   +  L  RC  +D   RP+M+E+++I+        G  +
Sbjct: 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  215 bits (549), Expect = 2e-67
 Identities = 57/282 (20%), Positives = 116/282 (41%), Gaps = 35/282 (12%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYG 173
            +L +   G ++ G  + G  + VK L   ++  ++   F  E   L    HPN++ + G
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD- 231
            C S  +    L+  ++P G++ + LH        +     +  A++ A  +A+LH  + 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHTLEP 132

Query: 232 -VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ---CY 287
            +    + S ++++D +   +++   +   F       S      P +V P+  Q     
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPED 186

Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE 347
                +D++SF V+L EL++              +LSNM    I      E + P++   
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFA--------DLSNME---IGMKVALEGLRPTIP-- 233

Query: 348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD 389
                  +   V++L   C+ +D   RP    ++ IL + +D
Sbjct: 234 -----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  215 bits (549), Expect = 8e-67
 Identities = 59/297 (19%), Positives = 110/297 (37%), Gaps = 44/297 (14%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYG 173
           + +G G FG VY G       VA++ +        +++ F  EV    + +H N+V   G
Sbjct: 39  ELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
            C S     L ++       T+   + + +     L       IA E    + YLHA  +
Sbjct: 97  ACMSPP--HLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRL----FPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           +H+D+KS N+  DN  +V + DFGL  +                 G   ++ P+  +   
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 289 L---------TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT-NKIQNGALNE 338
                     +  SDV++ G +  EL +                   A   ++  G    
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK--------TQPAEAIIWQMGTGMKPN 262

Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTS 395
           L    +G             ++++   C   +++ RPT  +++++L +    N   S
Sbjct: 263 LSQIGMG-----------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  210 bits (537), Expect = 2e-65
 Identities = 74/289 (25%), Positives = 131/289 (45%), Gaps = 45/289 (15%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-------KRIEQFMNEVEILTKLQHPN 167
           KQ+G GGFG V+ G L  D  +VA+K L   +        ++ ++F  EV I++ L HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           +VKLYG           +V E++P G +   L ++   +  + W V+L + ++ A  + Y
Sbjct: 85  IVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEY 137

Query: 227 LHASD--VIHRDVKSNNILLDN-----NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
           +   +  ++HRD++S NI L +         KVADFGLS+       H  +   G   ++
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWM 193

Query: 280 DPDYFQCYKL--TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN 337
            P+     +   T+K+D YSF ++L  +++G    D      + +   +      N    
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGKIK---FINMIRE 244

Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           E + P++         +    +  +   C   D   RP    +++ L E
Sbjct: 245 EGLRPTIP-------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  205 bits (524), Expect = 9e-64
 Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 45/287 (15%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNF----KRIEQFMNEVEILTKLQHPNLVKL 171
           + +G GGFG VY      G  VAVK    +      + IE    E ++   L+HPN++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 172 YG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
            G C    +  L LV E+   G +   L  ++     +P  + ++ A++ A  + YLH  
Sbjct: 72  RGVCLKEPN--LCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDE 124

Query: 231 ---DVIHRDVKSNNILLDN--------NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
               +IHRD+KS+NIL+          N  +K+ DFGL+R +         +  G   ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWM 181

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+  +    +  SDV+S+GV+L EL++G           ++    +    +  G     
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTG-----------EVPFRGIDGLAVAYGVAMNK 230

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +   +               A+L   C   D   RP+   +L+ L  
Sbjct: 231 LALPIP-------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  202 bits (515), Expect = 1e-61
 Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 43/300 (14%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI--LTKLQHPNLVKLYG 173
           KQ+G G +G V++G  R G  VAVK  +         +  E EI     ++H N++    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98

Query: 174 -CT--SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
                +    +L L+ +Y  NG++ D+L +       L     L +A  +   L +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153

Query: 231 D--------VIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGY- 278
                    + HRD+KS NIL+  N    +AD GL+  F     +V        GT  Y 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 279 --------VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR----HDINLSNM 326
                   ++ ++FQ Y     +D+YSFG++L E+     +           HD+  S+ 
Sbjct: 214 PPEVLDESLNRNHFQSYI---MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +   ++     + + PS  F   ++    +  + +L   C   +   R T   V + L +
Sbjct: 271 SYEDMREIVCIKKLRPS--FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  199 bits (508), Expect = 5e-61
 Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 43/300 (14%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI--LTKLQHPNLVKLYG 173
           + +G G +G V+ G  + G  VAVK     + K    +  E E+     L+H N++    
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69

Query: 174 CTSR---QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
                   S +L L+  Y   G++ D+L         L     L I +  A  LA+LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIE 124

Query: 231 D--------VIHRDVKSNNILLDNNFRVKVADFGLSRLF---PTDVTHVSTAPQGTPGY- 278
                    + HRD+KS NIL+  N +  +AD GL+ +       +   +    GT  Y 
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 279 --------VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR----HDINLSNM 326
                   +  D F  YK   + D+++FG+VL E+   + +           +D+  ++ 
Sbjct: 185 APEVLDETIQVDCFDSYK---RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +   ++     +   P++     +     +TS+A+L   C  Q+   R T   + + L +
Sbjct: 242 SFEDMRKVVCVDQQRPNI--PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  191 bits (488), Expect = 1e-57
 Identities = 65/300 (21%), Positives = 125/300 (41%), Gaps = 43/300 (14%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI--LTKLQHPNLVKLYG 173
           + +G G FG V+ G  R G  VAVK       +    +  E EI     L+H N++    
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103

Query: 174 CTSRQSR---ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
             ++ +    +L LV +Y  +G++ D+L+        +     + +A+ TA  LA+LH  
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHME 158

Query: 231 --------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP---QGTPGY- 278
                    + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y 
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 279 --------VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR----HDINLSNM 326
                   ++  +F+ +K   ++D+Y+ G+V  E+                 +D+  S+ 
Sbjct: 219 APEVLDDSINMKHFESFK---RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275

Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +  +++     + + P+      +     +  +A++   C   +   R T   + + L +
Sbjct: 276 SVEEMRKVVCEQKLRPN--IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  177 bits (452), Expect = 1e-52
 Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 26/280 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYEN-NFKRIEQFMNEVEILTKLQH 165
            NF   K++G G F  VY    L DG  VA+K  ++++  + K     + E+++L +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN++K Y     +  EL +V E    G ++  + + +    L+P        ++   AL 
Sbjct: 92  PNVIKYYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           ++H+  V+HRD+K  N+ +     VK+ D GL R F +  T   +   GTP Y+ P+   
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIH 209

Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT--NKIQNGALNELVDPS 343
                 KSD++S G +L E+ +        +     +  N+ +   KI+      L  PS
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAAL-------QSPFYGDKMNLYSLCKKIEQCDYPPL--PS 260

Query: 344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI 383
             + ++  +R +V         C+  D + RP +  V ++
Sbjct: 261 DHYSEE--LRQLVNM-------CINPDPEKRPDVTYVYDV 291

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  174 bits (444), Expect = 1e-50
 Identities = 73/291 (25%), Positives = 112/291 (38%), Gaps = 59/291 (20%)

Query: 116 KQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLYG 173
           +Q+G G FG V+ G LR     VAVK   E        +F+ E  IL +  HPN+V+L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 174 -CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDV 232
            CT  Q + + +V E +  G     L         L     L +  + A  + YL +   
Sbjct: 180 VCT--QKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS----------TAPQGTPGYVDPD 282
           IHRD+ + N L+     +K++DFG+SR     V   S          TAP+         
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA-------- 286

Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKIQNGA 335
                + + +SDV+SFG++L E  S        L    T                ++ G 
Sbjct: 287 -LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-------------FVEKG- 331

Query: 336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
              L  P               +V  L  +C   +   RP+   + + L+ 
Sbjct: 332 -GRLPCP----------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  171 bits (436), Expect = 1e-50
 Identities = 61/289 (21%), Positives = 119/289 (41%), Gaps = 48/289 (16%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
            +F   + +G GGFG V+      DG+   +KR+    +   E+   EV+ L KL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNN-EKAEREVKALAKLDHVNI 66

Query: 169 VKLYGC---------------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
           V   GC               +  +++ L +  E+   GT+   +  R+     L   + 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLA 124

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           L +  +    + Y+H+  +I+RD+K +NI L +  +VK+ DFGL      D     +   
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182

Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN 333
           GT  Y+ P+         + D+Y+ G++L EL+             +    +     +++
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC------DTAFET---SKFFTDLRD 233

Query: 334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           G ++++ D           + ++          + +  + RP   E+L 
Sbjct: 234 GIISDIFDKKE--------KTLLQK-------LLSKKPEDRPNTSEILR 267

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  170 bits (433), Expect = 1e-49
 Identities = 62/303 (20%), Positives = 110/303 (36%), Gaps = 38/303 (12%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           ++LG+GGF  V L   L DG   A+KR+  +  +  E+   E ++     HPN+++L   
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 175 TSRQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
             R+     E  L+  +   GT+ + +   +     L     L + +     L  +HA  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--------GTPGYVDPDY 283
             HRD+K  NILL +  +  + D G        V     A           T  Y  P+ 
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

Query: 284 FQCYK---LTDKSDVYSFGVVLIELISGLEAVDTSRHRH---DINLSNMATNKIQNGALN 337
           F       + +++DV+S G VL  ++ G               +     +        L+
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFG---------EGPYDMVFQKGDSVALAVQNQLS 265

Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKA 397
               P        A+  ++ S        +  D   RP +  +L  L   +    G    
Sbjct: 266 IPQSPRHS----SALWQLLNS-------MMTVDPHQRPHIPLLLSQLEALQPPAPGQHTT 314

Query: 398 KVV 400
           +++
Sbjct: 315 QIL 317

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  167 bits (426), Expect = 7e-49
 Identities = 68/297 (22%), Positives = 109/297 (36%), Gaps = 46/297 (15%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPN 167
            +F   + LG GGFG V+      D    A+KR+   N     E+ M EV+ L KL+HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 168 LVKLYGC-----------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           +V+ +              S     L +  +      + D ++ R          V L I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVCLHI 123

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--- 273
            ++ A A+ +LH+  ++HRD+K +NI    +  VKV DFGL      D    +       
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 274 --------GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN 325
                   GT  Y+ P+       + K D++S G++L EL+                   
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQ---------MERV 234

Query: 326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                ++N        P L  +K      MV          +      RP    ++E
Sbjct: 235 RTLTDVRNLKF-----PPLFTQKYPCEYVMVQD-------MLSPSPMERPEAINIIE 279

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  166 bits (422), Expect = 1e-48
 Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 37/286 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           +++     +G G +G         DG+I+  K            +  ++EV +L +L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 167 NLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           N+V+ Y     R +  L +V EY   G +A  +         L     L +  +   AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 226 YLH-----ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
             H        V+HRD+K  N+ LD    VK+ DFGL+R+   D +   T   GTP Y+ 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMS 184

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT--NKIQNGALNE 338
           P+        +KSD++S G +L EL +                 +      KI+ G    
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCAL---------MPPFTAFSQKELAGKIREGKFRR 235

Query: 339 LVDPSLGFEKDY--AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +  P       Y   +  ++T         +      RP+++E+LE
Sbjct: 236 I--PY-----RYSDELNEIITR-------MLNLKDYHRPSVEEILE 267

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  169 bits (431), Expect = 7e-48
 Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 49/283 (17%)

Query: 116 KQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG- 173
            +LG G +G VY G+ +   + VAVK L E+  +  E+F+ E  ++ +++HPNLV+L G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           CT  +     ++ E++  G + D+L         +   V L +A + + A+ YL   + I
Sbjct: 285 CT--REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKKNFI 340

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYF 284
           HR++ + N L+  N  VKVADFGLSRL   D              TAP+           
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES---------L 391

Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
              K + KSDV++FGV+L E+ +                       I    + EL+    
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPYPGIDLSQVYELL---- 432

Query: 345 GFEKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
             EKDY           V EL   C Q +   RP+  E+ +  
Sbjct: 433 --EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  166 bits (422), Expect = 7e-48
 Identities = 66/280 (23%), Positives = 127/280 (45%), Gaps = 34/280 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP 166
           + +   +++G+G FG   L     DGR   +K   +   + K  E+   EV +L  ++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N+V+       ++  L +V +Y   G +   ++ ++    L      L   ++   AL +
Sbjct: 84  NIVQYRES-FEENGSLYIVMDYCEGGDLFKRINAQKGV--LFQEDQILDWFVQICLALKH 140

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
           +H   ++HRD+KS NI L  +  V++ DFG++R+  + V        GTP Y+ P+  + 
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICEN 199

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT--NKIQNGALNELVDPSL 344
               +KSD+++ G VL EL +          +H     +M     KI +G+   +     
Sbjct: 200 KPYNNKSDIWALGCVLYELCTL---------KHAFEAGSMKNLVLKIISGSFPPV--SL- 247

Query: 345 GFEKDY--AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                Y   +R++V+          +++   RP++  +LE
Sbjct: 248 ----HYSYDLRSLVSQ-------LFKRNPRDRPSVNSILE 276

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  163 bits (414), Expect = 3e-47
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 30/291 (10%)

Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +          G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             G C S   R L L+ EY+P G++ D+L   +     +     L    +    + YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT 132

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG-------TPGYVDPD 282
              IHRD+ + NIL++N  RVK+ DFGL+++ P D        +              P+
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKEPGESPIFWYA----PE 187

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP 342
                K +  SDV+SFGVVL EL + +E   +        + N    ++    L EL+  
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-- 245

Query: 343 SLGFEKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS 390
               + +            +  +   C   + + RP+ +++   + + +D+
Sbjct: 246 ----KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  162 bits (413), Expect = 4e-47
 Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 46/282 (16%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHPNLVKLY 172
            ++G G F  VY G+       VA    +  +      ++F  E E+L  LQHPN+V+ Y
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 173 GC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
                T +  + ++LV E + +GT+  +L   +     +   V  S   +    L +LH 
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT 147

Query: 230 SD--VIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
               +IHRD+K +NI +      VK+ D GL+ L          A  GTP ++ P+ ++ 
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA------TNKIQNGALNELV 340
            K  +  DVY+FG+ ++E+ +                 N A      T+ ++  + +++ 
Sbjct: 205 -KYDESVDVYAFGMCMLEMATS--------EYPYSECQNAAQIYRRVTSGVKPASFDKVA 255

Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            P         V+ ++         C++Q++D R ++K++L 
Sbjct: 256 IP--------EVKEIIE-------GCIRQNKDERYSIKDLLN 282

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  163 bits (415), Expect = 5e-47
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 28/293 (9%)

Query: 116 KQLGDGGFGAVYLGIL-----RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
           +QLG G FG+V +          G +VAVK+L  +  + +  F  E+EIL  LQH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             G C S   R L L+ EY+P G++ D+L   +     +     L    +    + YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT 163

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPDY 283
              IHRD+ + NIL++N  RVK+ DFGL+++ P D  +      G            P+ 
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA----PES 219

Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS 343
               K +  SDV+SFGVVL EL + +E   +        + N    ++    L EL+   
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL--- 276

Query: 344 LGFEKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLG 393
              + +            +  +   C   + + RP+ +++   + + +D   G
Sbjct: 277 ---KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  162 bits (411), Expect = 9e-47
 Identities = 65/303 (21%), Positives = 117/303 (38%), Gaps = 53/303 (17%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
             +F     LG G FG V       D R  A+K++     +++   ++EV +L  L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQY 63

Query: 168 LVKLYGC------------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           +V+ Y                ++   L +  EY  NGT+ D +H+               
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWR 120

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-- 273
           +  +   AL+Y+H+  +IHRD+K  NI +D +  VK+ DFGL++     +  +    Q  
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 274 -----------GTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH 319
                      GT  YV  +       Y   +K D+YS G++  E+I             
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKIDMYSLGIIFFEMIYPFS--------T 230

Query: 320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
            +   N+   K+++ ++     P     K    + ++          +  D + RP  + 
Sbjct: 231 GMERVNIL-KKLRSVSIEF--PPDFDDNKMKVEKKIIR-------LLIDHDPNKRPGART 280

Query: 380 VLE 382
           +L 
Sbjct: 281 LLN 283

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  159 bits (404), Expect = 5e-46
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 25/202 (12%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG-C 174
           K+LG G FG V LG  +    VAVK + E +    ++F  E + + KL HP LVK YG C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           +  +   + +V EYI NG + ++L +       L     L +  +    +A+L +   IH
Sbjct: 73  S--KEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESHQFIH 127

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQ 285
           RD+ + N L+D +  VKV+DFG++R    D    S         +AP+          F 
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV---------FH 178

Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
            +K + KSDV++FG+++ E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  159 bits (404), Expect = 9e-46
 Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 25/203 (12%)

Query: 116 KQLGDGGFGAVYLGILRDGRI-VAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG- 173
            +LG G +G VY G+ +   + VAVK L E+  +  E+F+ E  ++ +++HPNLV+L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           CT  +     ++ E++  G + D+L  R+ N   +   V L +A + + A+ YL   + I
Sbjct: 78  CT--REPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133

Query: 234 HRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYF 284
           HRD+ + N L+  N  VKVADFGLSRL   D              TAP+           
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES---------L 184

Query: 285 QCYKLTDKSDVYSFGVVLIELIS 307
              K + KSDV++FGV+L E+ +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  159 bits (404), Expect = 1e-45
 Identities = 62/290 (21%), Positives = 115/290 (39%), Gaps = 54/290 (18%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNL--VKL 171
           KQ+G GG   V+  +    +I A+K   L E + + ++ + NE+  L KLQ  +   ++L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           Y       + + +V E   N  +   L  ++     +    R S       A+  +H   
Sbjct: 94  YDY-EITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQHG 147

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTPGYVDP--------- 281
           ++H D+K  N L+ +   +K+ DFG++     D T V    Q GT  Y+ P         
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 282 --DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR---HDINLSNMATNKIQNGAL 336
             +     K++ KSDV+S G +L  +  G         +     I       + I +   
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYG---------KTPFQQIINQISKLHAIIDPNH 257

Query: 337 N----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                ++ +  L   +D            +   C+++D   R ++ E+L 
Sbjct: 258 EIEFPDIPEKDL---QD------------VLKCCLKRDPKQRISIPELLA 292

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  158 bits (402), Expect = 2e-45
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 25/202 (12%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG-C 174
           K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV+LYG C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
           T  + R + ++ EY+ NG + ++L   +           L +  +   A+ YL +   +H
Sbjct: 89  T--KQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQFLH 143

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQ 285
           RD+ + N L+++   VKV+DFGLSR    D    S         + P+            
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV---------LM 194

Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             K + KSD+++FGV++ E+ S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  158 bits (401), Expect = 2e-45
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           ++LG G FG V++G       VAVK L + +    + F+ E  ++ +LQH  LV+LY   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +++   + ++ EY+ NG++ D L         L     L +A + A  +A++   + IHR
Sbjct: 78  TQEP--IYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERNYIHR 133

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQC 286
           D+++ NIL+ +    K+ADFGL+RL   +              TAP+             
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA---------INY 184

Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              T KSDV+SFG++L E+++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  162 bits (412), Expect = 2e-45
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 65/288 (22%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V LG  R G  VAVK +  +     + F+ E  ++T+L+H NLV+L G  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             +   L +V EY+  G++ D+L +R  +   L     L  +++   A+ YL  ++ +HR
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNNFVHR 313

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQC 286
           D+ + N+L+  +   KV+DFGL++    + +            TAP+           + 
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA---------LRE 360

Query: 287 YKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            K + KSDV+SFG++L E+ S                              I    +   
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPR----------------------IPLKDVVPR 398

Query: 340 VDPSLGFEKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           V      EK Y   A      +V ++   C   D   RPT  ++ E L
Sbjct: 399 V------EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  162 bits (411), Expect = 3e-45
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 47/281 (16%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
            +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           S +   + +V EY+  G++ D L         L  P  + +A + A  +AY+   + +HR
Sbjct: 249 SEEP--IYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMNYVHR 304

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQC 286
           D+++ NIL+  N   KVADFGL+RL   +              TAP+             
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA---------ALY 355

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            + T KSDV+SFG++L EL +                  +    + N  + + V      
Sbjct: 356 GRFTIKSDVWSFGILLTELTT---------------KGRVPYPGMVNREVLDQV------ 394

Query: 347 EKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           E+ Y          S+ +L  +C +++ + RPT + +   L
Sbjct: 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  159 bits (404), Expect = 3e-45
 Identities = 62/290 (21%), Positives = 115/290 (39%), Gaps = 54/290 (18%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNL--VKL 171
           KQ+G GG   V+  +    +I A+K   L E + + ++ + NE+  L KLQ  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           Y       + + +V E   N  +   L  ++     +    R S       A+  +H   
Sbjct: 75  YDY-EITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQHG 128

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTPGYVDP--------- 281
           ++H D+K  N L+ +   +K+ DFG++     D T V    Q GT  Y+ P         
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 282 --DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR---HDINLSNMATNKIQNG-- 334
             +     K++ KSDV+S G +L  +  G         +     I       + I +   
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYG---------KTPFQQIINQISKLHAIIDPNH 238

Query: 335 --ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                ++ +  L   +D            +   C+++D   R ++ E+L 
Sbjct: 239 EIEFPDIPEKDL---QD------------VLKCCLKRDPKQRISIPELLA 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  157 bits (399), Expect = 7e-45
 Identities = 64/298 (21%), Positives = 116/298 (38%), Gaps = 29/298 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR-IEQFMNEVEILTKLQHPN 167
             +  S  LG G    V+ G  +  G + A+K     +F R ++  M E E+L KL H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 168 LVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           +VKL+       +R  +L+ E+ P G++   L     N+  LP    L +  +  G + +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNH 127

Query: 227 LHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           L  + ++HR++K  NI+     D     K+ DFG +R    D   VS    GT  Y+ PD
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185

Query: 283 YFQCYKLTD--------KSDVYSFGVVLIELISGL---EAVDTSRHRHDINLSNMATNKI 331
            ++   L            D++S GV      +G       +  R   ++ +  + T K 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV-MYKIITGKP 244

Query: 332 QNGALNELVDPSLGFEKDYAV-------RNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                      +   +    +       R +   +  +    ++ D++      +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  156 bits (396), Expect = 8e-45
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 27/201 (13%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V LG  R G  VAVK +  +     + F+ E  ++T+L+H NLV+L G  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
             +   L +V EY+  G++ D+L +R  +   L     L  +++   A+ YL  ++ +HR
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNNFVHR 141

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQC 286
           D+ + N+L+  +   KV+DFGL++    + +            TAP+           + 
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA---------LRE 188

Query: 287 YKLTDKSDVYSFGVVLIELIS 307
            K + KSDV+SFG++L E+ S
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  155 bits (395), Expect = 9e-45
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 25/202 (12%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG-C 174
           +++G G FG V+LG   +   VA+K + E      E F+ E E++ KL HP LV+LYG C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
              +   + LV E++ +G ++D+L  ++    L      L + ++    +AYL  + VIH
Sbjct: 73  L--EQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH 127

Query: 235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQ 285
           RD+ + N L+  N  +KV+DFG++R    D    S          +P+          F 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV---------FS 178

Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             + + KSDV+SFGV++ E+ S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  159 bits (403), Expect = 1e-44
 Identities = 66/354 (18%), Positives = 123/354 (34%), Gaps = 62/354 (17%)

Query: 52  TPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDN 111
                    +     A           P       D    S+     V            
Sbjct: 6   HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISV--------KGRI 57

Query: 112 FNSSKQLGDGGFGAVYLGILRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNL- 168
           ++  KQ+G GG   V+  +    +I A+K   L E + + ++ + NE+  L KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117

Query: 169 -VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
            ++LY       + + +V E   N  +   L  ++     +    R S       A+  +
Sbjct: 118 IIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTI 171

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTPGYVDP----- 281
           H   ++H D+K  N L+ +   +K+ DFG++     D T V    Q G   Y+ P     
Sbjct: 172 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 282 ------DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR---HDINLSNMATNKIQ 332
                 +     K++ KSDV+S G +L  +  G         +     I       + I 
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYG---------KTPFQQIINQISKLHAII 281

Query: 333 NGALN----ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +        ++ +  L   +D            +   C+++D   R ++ E+L 
Sbjct: 282 DPNHEIEFPDIPEKDL---QD------------VLKCCLKRDPKQRISIPELLA 320

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  161 bits (408), Expect = 3e-44
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 47/281 (16%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
            +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV+LY   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           S +   + +V EY+  G++ D L         L  P  + +A + A  +AY+   + +HR
Sbjct: 332 SEEP--IYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMNYVHR 387

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQC 286
           D+++ NIL+  N   KVADFGL+RL   +              TAP+             
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA---------ALY 438

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            + T KSDV+SFG++L EL +                  +    + N  + + V      
Sbjct: 439 GRFTIKSDVWSFGILLTELTT---------------KGRVPYPGMVNREVLDQV------ 477

Query: 347 EKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           E+ Y          S+ +L  +C +++ + RPT + +   L
Sbjct: 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  155 bits (393), Expect = 3e-44
 Identities = 73/304 (24%), Positives = 114/304 (37%), Gaps = 67/304 (22%)

Query: 116 KQLGDGGFGAVYLGILRDGRI----VAVKRL---YENNFKRIEQFMNEVEILTKLQHPNL 168
           ++LGDG FG V  G           VAVK L     +  + ++ F+ EV  +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 169 VKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           ++LYG   +     + +V E  P G++ D L   Q +            A++ A  + YL
Sbjct: 84  IRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL 137

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDP 281
            +   IHRD+ + N+LL     VK+ DFGL R  P +  H                   P
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----P 193

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG-------------LEAVDTSRHRHDINLSNMAT 328
           +  +    +  SD + FGV L E+ +              L  +D    R          
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---------- 243

Query: 329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK 388
                     L  P    +  Y V  MV        +C     + RPT   + + L E +
Sbjct: 244 ----------LPRPEDCPQDIYNV--MV--------QCWAHKPEDRPTFVALRDFLLEAQ 283

Query: 389 DSNL 392
            +++
Sbjct: 284 PTDM 287

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  157 bits (398), Expect = 5e-44
 Identities = 66/328 (20%), Positives = 121/328 (36%), Gaps = 36/328 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR-IEQFMNEVEILTKLQHPN 167
             +  S  LG G    V+ G  +  G + A+K     +F R ++  M E E+L KL H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 168 LVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           +VKL+       +R  +L+ E+ P G++   L     N+  LP    L +  +  G + +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNH 127

Query: 227 LHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           L  + ++HR++K  NI+     D     K+ DFG +R    D   VS    GT  Y+ PD
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185

Query: 283 YFQCYKLTD--------KSDVYSFGVVLIELISGL---EAVDTSRHRHDINLSNMATNKI 331
            ++   L            D++S GV      +G       +  R   ++ +  + T K 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV-MYKIITGKP 244

Query: 332 QNGALNELVDPSLGFEKDYAV-------RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
                      +   +    +       R +   +  +    ++ D++      +     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

Query: 385 RETKDSNLGTSKAKVVDIRIADDAALLK 412
            +            V+ +         K
Sbjct: 305 SDILHR-------MVIHVFSLQQMTAHK 325

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  158 bits (401), Expect = 8e-44
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           K+LG G FG V++        VAVK +   +    E F+ E  ++  LQH  LVKL+   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHR 235
           +++   + ++ E++  G++ D L + + +    P P  +  + + A  +A++   + IHR
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQRNYIHR 308

Query: 236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQC 286
           D+++ NIL+  +   K+ADFGL+R+   +              TAP+             
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA---------INF 359

Query: 287 YKLTDKSDVYSFGVVLIELIS 307
              T KSDV+SFG++L+E+++
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  153 bits (389), Expect = 2e-43
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 116 KQLGDGGFGAVYLGIL-----RDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G  VAVK L        I     E+EIL  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  G CT      + L+ E++P+G++ ++L   +     +    +L  A++    + YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPD 282
           +   +HRD+ + N+L+++  +VK+ DFGL++   TD  + +                 P+
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA----PE 199

Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
                K    SDV+SFGV L EL++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  153 bits (389), Expect = 3e-43
 Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 15/202 (7%)

Query: 116 KQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK 170
            QLG G FG+V L          G +VAVK+L  +   +   F  E++IL  L    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
             G       + L LV EY+P+G + D L   +     L     L  + +    + YL +
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGS 145

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVD---PDYFQ 285
              +HRD+ + NIL+++   VK+ADFGL++L P D  + V   P  +P  +    P+   
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IFWYAPESLS 203

Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
               + +SDV+SFGVVL EL +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  151 bits (384), Expect = 6e-43
 Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 12/203 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQH 165
           ++F   + LG G FG VYL    +   I+A+K L++   ++     Q   EVEI + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+++LYG     +R + L+ EY P GTV   L                +   E A AL+
Sbjct: 69  PNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALS 123

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+          GT  Y+ P+  +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIE 180

Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
                +K D++S GV+  E + G
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVG 203

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  152 bits (387), Expect = 6e-43
 Identities = 63/295 (21%), Positives = 121/295 (41%), Gaps = 64/295 (21%)

Query: 116 KQLGDGGFGAVYLGILRDGR-----IVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLV 169
           K LG G FG VY G+           VA+K L E    +  ++ ++E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           +L G C +     + L+ + +P G + D++   + N   +     L+  ++ A  + YL 
Sbjct: 81  RLLGICLTST---VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE 134

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS----------TAPQGTPGY 278
              ++HRD+ + N+L+     VK+ DFGL++L   +                A +     
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES---- 190

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKI 331
                      T +SDV+S+GV + EL++       G+ A +              ++ +
Sbjct: 191 -----ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------ISSIL 232

Query: 332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           + G    L  P +     Y +  M         +C   D D RP  +E++    +
Sbjct: 233 EKG--ERLPQPPICTIDVYMI--MR--------KCWMIDADSRPKFRELIIEFSK 275

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  151 bits (384), Expect = 1e-42
 Identities = 66/279 (23%), Positives = 103/279 (36%), Gaps = 37/279 (13%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKL-QH 165
            +F    +LG G +G V+      DGR+ AVK         K   + + EV    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P  V+L      +   L L  E     ++  H          LP         +T  ALA
Sbjct: 117 PCCVRLEQAW-EEGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALA 171

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPDYF 284
           +LH+  ++H DVK  NI L    R K+ DFGL   L       V     G P Y+ P+  
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELL 228

Query: 285 Q-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS 343
           Q  Y     +DV+S G+ ++E+   +E          +                  +   
Sbjct: 229 QGSY--GTAADVFSLGLTILEVACNMELPHGGEGWQQLR------QGYLPPEFTAGLSSE 280

Query: 344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           L        R+++          ++ D  +R T + +L 
Sbjct: 281 L--------RSVLVM-------MLEPDPKLRATAEALLA 304

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  152 bits (385), Expect = 1e-42
 Identities = 57/259 (22%), Positives = 100/259 (38%), Gaps = 16/259 (6%)

Query: 56  SASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSS 115
           S S   A + A+   T +S  +        T+   G            E  E        
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ 63

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
            ++G G FG V+     + G   AVK++    F+     + E+     L  P +V LYG 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
             R+   + +  E +  G++   +         LP    L    +    L YLH   ++H
Sbjct: 119 -VREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 235 RDVKSNNILLDNN-FRVKVADFGLSRLFPTDVTHVSTAP----QGTPGYVDPDYFQCYKL 289
            DVK++N+LL ++  R  + DFG +     D    S        GT  ++ P+       
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233

Query: 290 TDKSDVYSFGVVLIELISG 308
             K D++S   +++ +++G
Sbjct: 234 DAKVDIWSSCCMMLHMLNG 252

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  151 bits (384), Expect = 1e-42
 Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 32/210 (15%)

Query: 116 KQLGDGGFGAVYLGILRD-----GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLV 169
           + LG+G FG V L          G +VAVK L  +   +    +  E++IL  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           K  G C    +  L LV EY+P G++ D+L         L     L  A +    +AYLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT--DVTHVS---------TAPQGTPG 277
           A   IHRD+ + N+LLDN+  VK+ DFGL++  P   +   V           AP+    
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--- 208

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                  + YK    SDV+SFGV L EL++
Sbjct: 209 ------LKEYKFYYASDVWSFGVTLYELLT 232

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  151 bits (383), Expect = 2e-42
 Identities = 72/331 (21%), Positives = 131/331 (39%), Gaps = 67/331 (20%)

Query: 116 KQLGDGGFGAVYLGILRDGR-----IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLV 169
           K LG G FG V+ G+           V +K + +    +  +   + +  +  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +L G     S  L LV +Y+P G++ DH+   +     L   + L+  ++ A  + YL  
Sbjct: 79  RLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEE 133

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS----------TAPQGTPGYV 279
             ++HR++ + N+LL +  +V+VADFG++ L P D   +            A +      
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES----- 188

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKIQ 332
                   K T +SDV+S+GV + EL++       GL   +               + ++
Sbjct: 189 ----IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------------VPDLLE 231

Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            G    L  P +     Y V  MV        +C   D ++RPT KE+         + +
Sbjct: 232 KG--ERLAQPQICTIDVYMV--MV--------KCWMIDENIRPTFKELANEF-----TRM 274

Query: 393 GTSKAKVVDIRIADDAALLKKDSPSLSPDDS 423
                + + I+      +     P    +  
Sbjct: 275 ARDPPRYLVIKRESGPGIAPGPEPHGLTNKK 305

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  157 bits (397), Expect = 4e-42
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 13/213 (6%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLY-ENNFKRIEQFMNEVEILTKL 163
            +    +   ++LG GGFG V   I +D G  VA+K+   E + K  E++  E++I+ KL
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 164 QHPNLVKLY-----GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
            HPN+V              +   LL  EY   G +  +L+  + N C L      ++  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLS 128

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           + + AL YLH + +IHRD+K  NI+L         K+ D G ++        + T   GT
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGT 186

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             Y+ P+  +  K T   D +SFG +  E I+G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  149 bits (379), Expect = 4e-42
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR---IEQFMNEVEILTKLQH 165
           D+F+  + LG G FG VYL   +    I+A+K L+++  ++     Q   E+EI + L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN++++Y     + R + L+ E+ P G +   L                +   E A AL 
Sbjct: 74  PNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALH 128

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H   VIHRD+K  N+L+     +K+ADFG S   P+          GT  Y+ P+  +
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIE 185

Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
                +K D++  GV+  E + G
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVG 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  148 bits (377), Expect = 7e-42
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)

Query: 116 KQLGDGGFGAVYLGILRDGRI---VAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +  ++   VAVK L          ++ + E  ++ +L +P +V+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + G C +      +LV E    G +  +L   +     +     + +  + +  + YL  
Sbjct: 83  MIGICEAES---WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE 135

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPDY 283
           S+ +HRD+ + N+LL      K++DFGLS+    D  +      G            P+ 
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PEC 191

Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
              YK + KSDV+SFGV++ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  148 bits (376), Expect = 1e-41
 Identities = 63/310 (20%), Positives = 119/310 (38%), Gaps = 68/310 (21%)

Query: 116 KQLGDGGFGAVYLGILRDGRI--------VAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
           + LG G F  ++ G+ R+           V +K L + +    E F     +++KL H +
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           LV  YG C      E +LV E++  G++  +L   +     +    +L +A + A A+ +
Sbjct: 74  LVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHF 128

Query: 227 LHASDVIHRDVKSNNILLD--------NNFRVKVADFGLSR-LFPTDVTHVS---TAPQG 274
           L  + +IH +V + NILL         N   +K++D G+S  + P D+         P+ 
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188

Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMA 327
                  +  +       +D +SFG  L E+ S        L++                
Sbjct: 189 I------ENPKNL--NLATDKWSFGTTLWEICSGGDKPLSALDSQR-------------K 227

Query: 328 TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET 387
               ++   ++L  P                +A L   C+  + D RP+ + ++  L   
Sbjct: 228 LQFYEDR--HQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

Query: 388 KDSNLGTSKA 397
              +L    +
Sbjct: 274 FTPDLVPRGS 283

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  147 bits (374), Expect = 2e-41
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 60/292 (20%)

Query: 116 KQLGDGGFGAVYLGILRDGRI----VAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVK 170
           + LG+G FG VY G+  + +     VAVK   ++      E+FM+E  I+  L HP++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L G    +     ++ E  P G +  +L   + +   L     +  +++   A+AYL + 
Sbjct: 78  LIGIIEEEP--TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESI 132

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDP 281
           + +HRD+   NIL+ +   VK+ DFGLSR    +  + +          +P+        
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES------- 185

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKIQNG 334
                 + T  SDV+ F V + E++S        LE  D                 ++ G
Sbjct: 186 --INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------------VIGVLEKG 230

Query: 335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
             + L  P                +  L  RC   D   RP   E++  L +
Sbjct: 231 --DRLPKP----------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  148 bits (377), Expect = 2e-41
 Identities = 68/335 (20%), Positives = 119/335 (35%), Gaps = 50/335 (14%)

Query: 53  PPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNF 112
           P  +  G       A      ++      P  + D      Y                  
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRY---------VRG------ 46

Query: 113 NSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNL 168
              + LG GGF   +         + A K + ++   +    E+   E+ I   L H ++
Sbjct: 47  ---RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V  +G        + +V E     ++ +    R+    L     R     +      YLH
Sbjct: 104 VGFHGFFEDNDF-VFVVLELCRRRSLLELHKRRKA---LTEPEAR-YYLRQIVLGCQYLH 158

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
            + VIHRD+K  N+ L+ +  VK+ DFGL+     D         GTP Y+ P+      
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKG 217

Query: 289 LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK 348
            + + DV+S G ++  L+ G    +TS       L      +I+                
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETS------CLKET-YLRIKKN-------------- 256

Query: 349 DYAV-RNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +Y++ +++    A L  + +Q D   RPT+ E+L 
Sbjct: 257 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (379), Expect = 2e-41
 Identities = 82/373 (21%), Positives = 140/373 (37%), Gaps = 56/373 (15%)

Query: 36  RRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYF 95
             RR+ +  A    L    S       +    +T+    + S   Y      +    S  
Sbjct: 14  HGRRRASVAAGI--LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71

Query: 96  GAKVFSCS---ELEEATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYEN-NF 147
             ++        +  ++   + ++ +G G FG VY G L D        AVK L    + 
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131

Query: 148 KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL 207
             + QF+ E  I+    HPN++ L G   R     L+V  Y+ +G + + + N   N   
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--- 188

Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVT 266
                 +   ++ A  + +L +   +HRD+ + N +LD  F VKVADFGL+R ++  +  
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248

Query: 267 HVSTAPQG------TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVD 313
            V                   +  Q  K T KSDV+SFGV+L EL++        +   D
Sbjct: 249 SVHNKTGAKLPVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

Query: 314 TSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM 373
                         T  +  G    L+ P                + E+  +C     +M
Sbjct: 305 -------------ITVYLLQG--RRLLQP----------EYCPDPLYEVMLKCWHPKAEM 339

Query: 374 RPTMKEVLEILRE 386
           RP+  E++  +  
Sbjct: 340 RPSFSELVSRISA 352

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  147 bits (372), Expect = 3e-41
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 117 QLGDGGFGAVYLGILR--DGRI-VAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLY 172
           +LG G FG+V  G+ R    +I VA+K L +   K   E+ M E +I+ +L +P +V+L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 173 G-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           G C +     L+LV E    G +   L  ++     +P      +  + +  + YL   +
Sbjct: 77  GVCQAEA---LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN 130

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPDYFQ 285
            +HRD+ + N+LL N    K++DFGLS+    D ++ +    G            P+   
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186

Query: 286 CYKLTDKSDVYSFGVVLIELIS 307
             K + +SDV+S+GV + E +S
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS 208

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  146 bits (371), Expect = 5e-41
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 116 KQLGDGGFGAVYLGILRDGR----IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVK 170
           + +G G FG VY G   D        A+K L      +++E F+ E  ++  L HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L G          ++  Y+ +G +   + + Q N         +S  ++ A  + YL   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLAEQ 143

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQG------TPGYVDPDY 283
             +HRD+ + N +LD +F VKVADFGL+R +   +   V            T      + 
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----LES 199

Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
            Q Y+ T KSDV+SFGV+L EL++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  146 bits (370), Expect = 6e-41
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 28/206 (13%)

Query: 116 KQLGDGGFGAVYLGILRDGR----IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVK 170
           + +G+G FG V+ GI          VA+K      +    E+F+ E   + +  HP++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           L G  +     + ++ E    G +   L  R+ +   L     +  A + + ALAYL + 
Sbjct: 81  LIGVITENP--VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESK 135

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS---------TAPQGTPGYVDP 281
             +HRD+ + N+L+ +N  VK+ DFGLSR       + +          AP+        
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES------- 188

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELIS 307
                 + T  SDV+ FGV + E++ 
Sbjct: 189 --INFRRFTSASDVWMFGVCMWEILM 212

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  149 bits (377), Expect = 1e-40
 Identities = 63/283 (22%), Positives = 119/283 (42%), Gaps = 35/283 (12%)

Query: 111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLV 169
           +F     LG G  G +    + D R VAVKR+    F   ++   EV++L +  +HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           + + CT +  +   +  E     T+ +++  +            +++  +T   LA+LH+
Sbjct: 82  RYF-CTEKDRQFQYIAIELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHS 136

Query: 230 SDVIHRDVKSNNILLDN-----NFRVKVADFGLSRLFPTDV--THVSTAPQGTPGYVDPD 282
            +++HRD+K +NIL+         +  ++DFGL +            +   GT G++ P+
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 283 YFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
                     T   D++S G V   +IS         H    +L   A   +   +L+ L
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISE------GSHPFGKSLQRQANILLGACSLDCL 250

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                   +D   R ++        + +  D   RP+ K VL+
Sbjct: 251 HPEK---HEDVIARELIE-------KMIAMDPQKRPSAKHVLK 283

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  146 bits (371), Expect = 1e-40
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 116 KQLGDGGFGAVYLGILRDGRI-----VAVKRLYENNFKRIEQ-FMNEVEILTKLQHPNLV 169
           K +G G FG VY G+L+         VA+K L     ++    F+ E  I+ +  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           +L G  +  + + ++++ EY+ NG +   L  +            + +    A  + YL 
Sbjct: 110 RLEGVIS--KYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLA 164

Query: 229 ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPD 282
             + +HRD+ + NIL+++N   KV+DFGLSR+   D     T   G      T     P+
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PE 220

Query: 283 YFQCYKLTDKSDVYSFGVVLIELIS 307
                K T  SDV+SFG+V+ E+++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  146 bits (370), Expect = 2e-40
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 116 KQLGDGGFGAVYLGILRDGR----IVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVK 170
           K +G G  G V  G LR        VA+K L     +R    F++E  I+ +  HPN+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           L G  T  + R  ++V EY+ NG++   L               + +       + YL  
Sbjct: 115 LEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSD 169

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPDY 283
              +HRD+ + N+L+D+N   KV+DFGLSR+   D     T   G      T     P+ 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEA 225

Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
                 +  SDV+SFGVV+ E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (367), Expect = 2e-40
 Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 51/300 (17%)

Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGR----IVAVKRLYEN-NFKRIEQFMNEVE 158
            +  ++   + ++ +G G FG VY G L D        AVK L    +   + QF+ E  
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           I+    HPN++ L G   R     L+V  Y+ +G + + + N   N         +   +
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGL 135

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQG--- 274
           + A  + YL +   +HRD+ + N +LD  F VKVADFGL+R ++  +   V         
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195

Query: 275 ---TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLS 324
                     +  Q  K T KSDV+SFGV+L EL++        +   D           
Sbjct: 196 VKWMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------- 240

Query: 325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
              T  +  G    L+ P                + E+  +C     +MRP+  E++  +
Sbjct: 241 --ITVYLLQG--RRLLQP----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  145 bits (369), Expect = 3e-40
 Identities = 66/343 (19%), Positives = 131/343 (38%), Gaps = 67/343 (19%)

Query: 116 KQLGDGGFGAVYLGILRDGR-----IVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLV 169
           K LG G FG VY G+           VA+K L E    +  ++ ++E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +L G     +  + L+ + +P G + D++   + N   +     L+  ++ A  + YL  
Sbjct: 81  RLLGICLTST--VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS----------TAPQGTPGYV 279
             ++HRD+ + N+L+     VK+ DFGL++L   +                A +      
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES----- 190

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNKIQ 332
                     T +SDV+S+GV + EL++       G+ A +              ++ ++
Sbjct: 191 ----ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------ISSILE 233

Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
            G    L  P +     Y +  MV        +C   D D RP  +E++        S +
Sbjct: 234 KG--ERLPQPPICTIDVYMI--MV--------KCWMIDADSRPKFRELIIEF-----SKM 276

Query: 393 GTSKAKVVDIRIADDAALLKKDSPSLSPDDSGTDKWVSSSNPS 435
                + + I+  +   L      +        +      +  
Sbjct: 277 ARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 319

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  144 bits (366), Expect = 7e-40
 Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 47/300 (15%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYG 173
           + L +GGF  VY    +  GR  A+KRL  N  ++    + EV  + KL  HPN+V+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 174 CTSRQSREL------LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
             S    E        L+   +  G + + L   +     L     L I  +T  A+ ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG-PLSCDTVLKIFYQTCRAVQHM 152

Query: 228 HASD--VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----------G 274
           H     +IHRD+K  N+LL N   +K+ DFG +        +  +A +            
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 275 TPGYVDP---DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI 331
           TP Y  P   D +  + + +K D+++ G +L  L       +             A  +I
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG-----------AKLRI 261

Query: 332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN 391
            NG  +     +             T    L    +Q + + R ++ EV+  L+E   + 
Sbjct: 262 VNGKYSIPPHDT-----------QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  145 bits (368), Expect = 8e-40
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 21/204 (10%)

Query: 116 KQLGDGGFGAVYLGIL----RDGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVK 170
           K +G G FG V  G L    +    VA+K L      K+   F+ E  I+ +  HPN+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           L G  T  +S+ +++V EY+ NG++   L               + +    A  + YL  
Sbjct: 111 LEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSD 165

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPDY 283
              +HRD+ + NIL+++N   KV+DFGL R+   D     T   G      T     P+ 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEA 221

Query: 284 FQCYKLTDKSDVYSFGVVLIELIS 307
               K T  SDV+S+G+VL E++S
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMS 245

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  144 bits (364), Expect = 1e-39
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 22/210 (10%)

Query: 116 KQLGDGGFGAVYLGILRDG----RIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLV 169
           + LG G FG+V    L+        VAVK L  +      IE+F+ E   + +  HP++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 170 KLYG-CTSRQSRE----LLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAG 222
           KL G     +++      +++  ++ +G +   L   +   N   LP    +   ++ A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV--- 279
            + YL + + IHRD+ + N +L  +  V VADFGLSR     +       QG    +   
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASKLPVK 204

Query: 280 --DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
               +       T  SDV++FGV + E+++
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  144 bits (364), Expect = 2e-39
 Identities = 60/303 (19%), Positives = 125/303 (41%), Gaps = 41/303 (13%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR-----------------IEQ 152
           +++   + L  G F  + L   +D +  A+K+  ++  ++                  + 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 153 FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP----NSCLL 208
           F NE++I+T +++   +   G       E+ ++YEY+ N ++              +C +
Sbjct: 90  FKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 209 PWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
           P  V   I      + +Y+H   ++ HRDVK +NIL+D N RVK++DFG S         
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

Query: 268 VSTAPQGTPGYVDPDYFQCYKLTD--KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN 325
            S   +GT  ++ P++F      +  K D++S G+ L  +   +           I+L  
Sbjct: 209 GS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVE 260

Query: 326 MATNKIQNGAL------NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
           +  N I+   +      N  + P    +   +   +     +     ++++   R T ++
Sbjct: 261 LF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319

Query: 380 VLE 382
            L+
Sbjct: 320 ALK 322

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  142 bits (360), Expect = 3e-39
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 40/221 (18%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++LG+G FG V+L    +        +VAVK L +      + F  E E+LT LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR------------LSI 216
           K YG C       L++V+EY+ +G +   L    P++ +L                 L I
Sbjct: 81  KFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS------ 269
           A + A  + YL +   +HRD+ + N L+  N  VK+ DFG+SR ++ TD   V       
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 270 ---TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                P+              K T +SDV+SFGV+L E+ +
Sbjct: 199 IRWMPPES---------IMYRKFTTESDVWSFGVILWEIFT 230

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  142 bits (359), Expect = 5e-39
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 31/214 (14%)

Query: 116 KQLGDGGFGAVYLGILRDGR----IVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLV 169
           K LG+G FG+V  G L+        VAVK +  +N   + IE+F++E   +    HPN++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 170 KLYG-CTSRQSRE---LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR--LSIAIETAGA 223
           +L G C    S+     +++  ++  G +  +L   +  +     P++  L   ++ A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS---------TAPQ 273
           + YL   + +HRD+ + N +L ++  V VADFGLS+ ++  D               A +
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219

Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                           T KSDV++FGV + E+ +
Sbjct: 220 S---------LADRVYTSKSDVWAFGVTMWEIAT 244

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  140 bits (356), Expect = 8e-39
 Identities = 52/248 (20%), Positives = 100/248 (40%), Gaps = 31/248 (12%)

Query: 65  SAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFG 124
           S  +T   +    +  Y Y   +                              LG G +G
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDR------------------------VVLGKGTYG 36

Query: 125 AVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL 183
            VY G  L +   +A+K + E + +  +    E+ +   L+H N+V+  G  S     + 
Sbjct: 37  IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF-IK 95

Query: 184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL 243
           +  E +P G+++  L ++          +      +    L YLH + ++HRD+K +N+L
Sbjct: 96  IFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQIVHRDIKGDNVL 154

Query: 244 LDN-NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL--TDKSDVYSFGV 300
           ++  +  +K++DFG S+          T   GT  Y+ P+            +D++S G 
Sbjct: 155 INTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213

Query: 301 VLIELISG 308
            +IE+ +G
Sbjct: 214 TIIEMATG 221

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  144 bits (364), Expect = 8e-39
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 46/300 (15%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNL 168
           +   S K LG G  G V       GR VAVKR+        +  + E+++LT+   HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI---ETAGALA 225
           ++ Y C+    R L +  E   N  + D + ++  +   L      +      + A  +A
Sbjct: 72  IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 226 YLHASDVIHRDVKSNNILLDN-------------NFRVKVADFGLSRLFPTDVTHVSTA- 271
           +LH+  +IHRD+K  NIL+               N R+ ++DFGL +   +  +   T  
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 272 --PQGTPGYVDP-------DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN 322
             P GT G+  P       +     +LT   D++S G V   ++S        +H     
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------GKHPFGDK 243

Query: 323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            S  +   I  G  +      L   K    R+++    +L  + +  D   RPT  +VL 
Sbjct: 244 YSRES--NIIRGIFS------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  146 bits (370), Expect = 1e-38
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 116 KQLGDGGFGAVYLGILR--DGRI-VAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKL 171
            +LG G FG+V  G+ R    +I VA+K L +   K   E+ M E +I+ +L +P +V+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 172 YG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
            G C +     L+LV E    G +   L  ++     +P      +  + +  + YL   
Sbjct: 402 IGVCQAEA---LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK 455

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG------TPGYVDPDYF 284
           + +HR++ + N+LL N    K++DFGLS+    D ++ +    G            P+  
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECI 511

Query: 285 QCYKLTDKSDVYSFGVVLIELIS 307
              K + +SDV+S+GV + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  139 bits (354), Expect = 1e-38
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 9/203 (4%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQH 165
           ++F     LG G F  VY    +  G  VA+K + +    +   +++  NEV+I  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P++++LY      +  + LV E   NG +  +L NR           R  +  +    + 
Sbjct: 71  PSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMH-QIITGML 126

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+  ++HRD+  +N+LL  N  +K+ADFGL+           T   GTP Y+ P+   
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIAT 185

Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
                 +SDV+S G +   L+ G
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIG 208

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  140 bits (354), Expect = 2e-38
 Identities = 50/299 (16%), Positives = 103/299 (34%), Gaps = 54/299 (18%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKL-Q 164
           T  F+  +++G G FG+V+  +   DG I A+KR           +  + EV     L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           H ++V+ +   +     +L+  EY   G++AD +                 + ++    L
Sbjct: 70  HSHVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 225 AYLHASDVIHRDVKSNNILLDNN-------------------FRVKVADFGLSRLFPTDV 265
            Y+H+  ++H D+K +NI +                         K+ D G      +  
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188

Query: 266 THVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS 324
                   G   ++  +  Q  Y    K+D+++  + ++               H     
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----- 238

Query: 325 NMATNKIQNGALNELVDP-SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                +I+ G L  +    S  F        ++          +  D + RP+   +++
Sbjct: 239 -----EIRQGRLPRIPQVLSQEF------TELLKV-------MIHPDPERRPSAMALVK 279

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  142 bits (358), Expect = 2e-38
 Identities = 41/227 (18%), Positives = 79/227 (34%), Gaps = 24/227 (10%)

Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENNFKRIEQFMNE 156
           +E +  +        LG+G F  VY     D       +   +K     N          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHL-HNRQPNSCLLPWPVRLS 215
           +E L        +K Y     Q+   +LV E    GT+ + +   +     ++P  + +S
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILL-----------DNNFRVKVADFGLS---RLF 261
            A+     +  +H  ++IH D+K +N +L           D +  + + D G S   +LF
Sbjct: 177 FAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           P      +     T G+   +         + D +     +  ++ G
Sbjct: 237 PKGTIFTAKC--ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  139 bits (353), Expect = 2e-38
 Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 32/272 (11%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNLVKL 171
           + LG GGF   +         + A K + ++   +    E+   E+ I   L H ++V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           +G        + +V E     ++ +    R+    L     R     +      YLH + 
Sbjct: 81  HGFFEDNDF-VFVVLELCRRRSLLELHKRRK---ALTEPEAR-YYLRQIVLGCQYLHRNR 135

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           VIHRD+K  N+ L+ +  VK+ DFGL+     D         GTP Y+ P+       + 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSF 194

Query: 292 KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA 351
           + DV+S G ++  L+ G    +TS       L      +I+                +Y+
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETS------CLKET-YLRIKKN--------------EYS 233

Query: 352 V-RNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           + +++    A L  + +Q D   RPT+ E+L 
Sbjct: 234 IPKHINPVAASLIQKMLQTDPTARPTINELLN 265

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  140 bits (355), Expect = 2e-38
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 33/215 (15%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
           ++LG G FG VY G+ +          VA+K + E  + +   +F+NE  ++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETAG 222
           V+L G  S Q +  L++ E +  G +  +L + +P     P     S      +A E A 
Sbjct: 91  VRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS---------TAP 272
            +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R ++ TD               +P
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           +           +    T  SDV+SFGVVL E+ +
Sbjct: 210 ES---------LKDGVFTTYSDVWSFGVVLWEIAT 235

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  139 bits (352), Expect = 4e-38
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 19/200 (9%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYEN-----NFKRIEQFMNEVEILTKLQHPNLVKL 171
           +G GG G VY        RIVA+K + E       F    +   E     +LQ P++V +
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF--RTRMQREARTAGRLQEPHVVPI 99

Query: 172 Y--GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +  G    Q   L +    I    +A  L  + P    L  P  ++I  +   AL   HA
Sbjct: 100 HDFGEIDGQ---LYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHA 152

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPDYFQCYK 288
           +   HRDVK  NIL+  +    + DFG++       +T +     GT  Y+ P+ F    
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211

Query: 289 LTDKSDVYSFGVVLIELISG 308
            T ++D+Y+   VL E ++G
Sbjct: 212 ATYRADIYALTCVLYECLTG 231

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  140 bits (354), Expect = 4e-38
 Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 39/220 (17%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
            +LG+G FG V+L    +        +VAVK L E +    + F  E E+LT LQH ++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 170 KLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR-----------LSIA 217
           + +G CT  + R LL+V+EY+ +G +   L +  P++ LL                L++A
Sbjct: 107 RFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS------- 269
            + A  + YL     +HRD+ + N L+     VK+ DFG+SR ++ TD   V        
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224

Query: 270 --TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
               P+              K T +SDV+SFGVVL E+ +
Sbjct: 225 RWMPPES---------ILYRKFTTESDVWSFGVVLWEIFT 255

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  138 bits (351), Expect = 4e-38
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 41/222 (18%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
           ++LG+  FG VY G L           VA+K L +       E+F +E  +  +LQHPN+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 169 VKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR------------LS 215
           V L G  T  + + L +++ Y  +G + + L  R P+S +                  + 
Sbjct: 75  VCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS----- 269
           +  + A  + YL +  V+H+D+ + N+L+ +   VK++D GL R ++  D   +      
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192

Query: 270 ----TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                AP+              K +  SD++S+GVVL E+ S
Sbjct: 193 PIRWMAPEA---------IMYGKFSIDSDIWSYGVVLWEVFS 225

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  139 bits (352), Expect = 5e-38
 Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 13/200 (6%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVKLY- 172
           LG GG   V+L   LRD R VAVK L      +     +F  E +    L HP +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 173 -GCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
            G     +  L  +V EY+   T+ D +H   P    +     + +  +   AL + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQN 135

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYFQCYK 288
            +IHRDVK  NI++     VKV DFG++R        V+      GT  Y+ P+  +   
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195

Query: 289 LTDKSDVYSFGVVLIELISG 308
           +  +SDVYS G VL E+++G
Sbjct: 196 VDARSDVYSLGCVLYEVLTG 215

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  138 bits (351), Expect = 5e-38
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 11/198 (5%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVKL 171
            +LG GG   VYL         VA+K +        + +++F  EV   ++L H N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
                 +     LV EYI   T+++++ +  P    L     ++   +    + + H   
Sbjct: 77  ID-VDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDMR 131

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT 290
           ++HRD+K  NIL+D+N  +K+ DFG+++ L  T +T  +    GT  Y  P+  +     
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPEQAKGEATD 190

Query: 291 DKSDVYSFGVVLIELISG 308
           + +D+YS G+VL E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVG 208

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (365), Expect = 8e-38
 Identities = 76/388 (19%), Positives = 134/388 (34%), Gaps = 63/388 (16%)

Query: 20  GSAAAVILGLIFFCIIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIP 79
               A  +  +     R           R  K    +        +       + + S+ 
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362

Query: 80  SYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGR---- 135
                   ++   +Y         + E   +     + +G+G FG V+ GI         
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTR---DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAM 419

Query: 136 IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTV 194
            VA+K      +    E+F+ E   + +  HP++VKL G  +     + ++ E    G +
Sbjct: 420 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGEL 477

Query: 195 ADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD 254
              L  R+ +   L     +  A + + ALAYL +   +HRD+ + N+L+ +N  VK+ D
Sbjct: 478 RSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 534

Query: 255 FGLSRLFPTDVTHVS---------TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIEL 305
           FGLSR       + +          AP+              + T  SDV+ FGV + E+
Sbjct: 535 FGLSRYMEDSTYYKASKGKLPIKWMAPES---------INFRRFTSASDVWMFGVCMWEI 585

Query: 306 IS-------GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTS 358
           +        G++  D                +I+NG    L  P           N   +
Sbjct: 586 LMHGVKPFQGVKNND-------------VIGRIENG--ERLPMP----------PNCPPT 620

Query: 359 VAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +  L  +C   D   RP   E+   L  
Sbjct: 621 LYSLMTKCWAYDPSRRPRFTELKAQLST 648

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  137 bits (346), Expect = 3e-37
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 116 KQLGDGGFGAVYLGILRD------GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG V              R VAVK L E          M+E++IL  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR------------LS 215
           +V L G  ++    L+++ E+   G ++ +L +++                       + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
            + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    D+       +  
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKG 208

Query: 276 PGYV-----DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
              +      P+       T +SDV+SFGV+L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  143 bits (361), Expect = 3e-37
 Identities = 46/199 (23%), Positives = 90/199 (45%), Gaps = 22/199 (11%)

Query: 118 LGDGGFGAVYLGI-LR-DGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPNLVKLY-- 172
           +  GG G +YL +    +GR V +K L +  + +     M E + L ++ HP++V+++  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 173 GCTSRQSRELL--LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
              + +  + +  +V EY+   ++      +      LP    ++  +E   AL+YLH+ 
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLHSI 201

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKL 289
            +++ D+K  NI+L    ++K+ D G        +        GTPG+  P+        
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPE--IVRTGP 253

Query: 290 TDKSDVYSFGVVLIELISG 308
           T  +D+Y+ G  L  L   
Sbjct: 254 TVATDIYTVGRTLAALTLD 272

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  138 bits (348), Expect = 4e-37
 Identities = 40/321 (12%), Positives = 78/321 (24%), Gaps = 48/321 (14%)

Query: 95  FGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLY---ENNFKRI 150
             A+    S L +        + L  G    V+L    +     A+K      EN+   +
Sbjct: 47  QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106

Query: 151 EQFMNEVEILTKLQHPNLVKLY-------------------------GCTSRQSRELLLV 185
           E+         +L   +  +                           G         LL+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 186 YEYIP--NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL 243
                     +   L                 +  +     A L +  ++H     +N+ 
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226

Query: 244 LDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVV 301
           +  + R+ + D        T       A      Y   ++        T   + +  G+ 
Sbjct: 227 IMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282

Query: 302 LIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAE 361
           +  +                  +       +  +L      SL F        +   V  
Sbjct: 283 IYRVWCLFLPFGLV--------TPGIKGSWKRPSLRVPGTDSLAFGSC---TPLPDFVKT 331

Query: 362 LAFRCVQQDRDMRPTMKEVLE 382
           L  R +  DR  R    E +E
Sbjct: 332 LIGRFLNFDRRRRLLPLEAME 352

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  135 bits (342), Expect = 9e-37
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 31/216 (14%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
            + +    +LGDG FG VY       G + A K +   + + +E ++ E+EIL    HP 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS---IAI---ETA 221
           +VKL G       +L ++ E+ P G V   +               L+   I +   +  
Sbjct: 78  IVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLEL---------DRGLTEPQIQVVCRQML 127

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDV---THVSTAPQGTPG 277
            AL +LH+  +IHRD+K+ N+L+     +++ADFG+S +   T     + +     GTP 
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182

Query: 278 YVDPDYFQCYKLTD-----KSDVYSFGVVLIELISG 308
           ++ P+   C  + D     K+D++S G+ LIE+   
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  135 bits (341), Expect = 1e-36
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
              +   +++G G  G VY  + +  G+ VA++++      + E  +NE+ ++ + ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS---IAI---ETA 221
           +V           EL +V EY+  G++ D +               +    IA    E  
Sbjct: 79  IVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECL 126

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG----LSRLFPTDVTHVSTAPQGTPG 277
            AL +LH++ VIHRD+KS+NILL  +  VK+ DFG    ++       T V     GTP 
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPY 181

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           ++ P+         K D++S G++ IE+I G
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  135 bits (341), Expect = 1e-36
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 14/211 (6%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPN 167
           D++   + +G G    V           VA+KR+  E     +++ + E++ +++  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR-LSIAI---ETAGA 223
           +V  Y     +  EL LV + +  G+V D + +           +   +IA    E    
Sbjct: 75  IVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-----GTPGY 278
           L YLH +  IHRDVK+ NILL  +  V++ADFG+S  F      ++         GTP +
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCW 192

Query: 279 VDPDYFQCYKLTD-KSDVYSFGVVLIELISG 308
           + P+  +  +  D K+D++SFG+  IEL +G
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (341), Expect = 2e-36
 Identities = 73/295 (24%), Positives = 113/295 (38%), Gaps = 57/295 (19%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
           + LG G FG VY G +           VAVK L E  + +    F+ E  I++K  H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC---LLPWPVRLSIAIETAGALA 225
           V+  G +  QS    ++ E +  G +   L   +P       L     L +A + A    
Sbjct: 96  VRCIGVSL-QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 226 YLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV--- 279
           YL  +  IHRD+ + N LL         K+ DFG++R    D+   S   +G    +   
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210

Query: 280 --DPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNM-ATN 329
              P+ F     T K+D +SFGV+L E+ S                       SN     
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS--------------KSNQEVLE 256

Query: 330 KIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
            + +G    +  P          +N    V  +  +C Q   + RP    +LE +
Sbjct: 257 FVTSG--GRMDPP----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  134 bits (340), Expect = 3e-36
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 40/219 (18%)

Query: 116 KQLGDGGFGAVYLGILRDG---RIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVK 170
             +G+G FG V    ++        A+KR+ E  +      F  E+E+L KL  HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 171 LYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR------------LSIA 217
           L G C       L L  EY P+G + D L   +       + +             L  A
Sbjct: 91  LLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS-------- 269
            + A  + YL     IHRD+ + NIL+  N+  K+ADFGLSR    +V            
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 206

Query: 270 -TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             A +                T  SDV+S+GV+L E++S
Sbjct: 207 WMAIES---------LNYSVYTTNSDVWSYGVLLWEIVS 236

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  134 bits (340), Expect = 4e-36
 Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 54/228 (23%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG V                VAVK L    +    E  M+E++I++ L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----------LSI 216
           +V L G CT      +L++ EY   G + + L  +       P              L  
Sbjct: 112 IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
           + + A  +A+L + + IHRDV + N+LL N    K+ DFGL+R    D+           
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DI----------- 214

Query: 277 GYVDPDY-----------------FQCYKLTDKSDVYSFGVVLIELIS 307
              D +Y                       T +SDV+S+G++L E+ S
Sbjct: 215 -MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  135 bits (342), Expect = 4e-36
 Identities = 35/249 (14%), Positives = 65/249 (26%), Gaps = 48/249 (19%)

Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLY------------------ 143
           SEL E          LG     A         G    V   Y                  
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 144 ----------ENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNG- 192
                     +   K   +F+   +++   Q   ++++                      
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185

Query: 193 --TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV 250
             T  + L +       L    RL + ++    LA LH   ++H  ++  +I+LD    V
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 245

Query: 251 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL-----------TDKSDVYSFG 299
            +  F         V         + G+  P+                  T   D ++ G
Sbjct: 246 FLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300

Query: 300 VVLIELISG 308
           +V+  +   
Sbjct: 301 LVIYWIWCA 309

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  132 bits (335), Expect = 8e-36
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 11/203 (5%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHP 166
            + F   +++G G FG V+ GI  R  ++VA+K +  E     IE    E+ +L++   P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            + K YG   + + +L ++ EY+  G+  D L         L      +I  E    L Y
Sbjct: 81  YVTKYYGSYLKDT-KLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDY 134

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           LH+   IHRD+K+ N+LL  +  VK+ADFG++ +L  T +   +    GTP ++ P+  +
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIK 192

Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
                 K+D++S G+  IEL  G
Sbjct: 193 QSAYDSKADIWSLGITAIELARG 215

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  134 bits (339), Expect = 9e-36
 Identities = 70/294 (23%), Positives = 111/294 (37%), Gaps = 55/294 (18%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
           + LG G FG VY G +           VAVK L E  + +    F+ E  I++K  H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC---LLPWPVRLSIAIETAGALA 225
           V+  G +  QS    ++ E +  G +   L   +P       L     L +A + A    
Sbjct: 137 VRCIGVSL-QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 226 YLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV--- 279
           YL  +  IHRD+ + N LL         K+ DFG++R    D+       +G    +   
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 251

Query: 280 --DPDYFQCYKLTDKSDVYSFGVVLIELIS-------GLEAVDTSRHRHDINLSNMATNK 330
              P+ F     T K+D +SFGV+L E+ S            +                 
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF------------- 298

Query: 331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL 384
           + +G    +  P          +N    V  +  +C Q   + RP    +LE +
Sbjct: 299 VTSG--GRMDPP----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  133 bits (336), Expect = 1e-35
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 28/211 (13%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
               +S  ++G+G  G V L      GR VAVK +     +R E   NEV I+   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS---IAI---ETA 221
           +V++Y        EL ++ E++  G + D +              RL+   IA       
Sbjct: 104 VVEMYKSYLVGE-ELWVLMEFLQGGALTDIVSQV-----------RLNEEQIATVCEAVL 151

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG----LSRLFPTDVTHVSTAPQGTPG 277
            ALAYLHA  VIHRD+KS++ILL  + RVK++DFG    +S+  P   + V     GTP 
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPY 206

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           ++ P+         + D++S G+++IE++ G
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (336), Expect = 1e-35
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 39/225 (17%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
           K LG+G FG V        +       VAVK L EN +   +   ++E  +L ++ HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 169 VKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR-------------- 213
           +KLYG C+  Q   LLL+ EY   G++   L   +                         
Sbjct: 89  IKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 214 ------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
                 +S A + +  + YL    ++HRD+ + NIL+    ++K++DFGLSR    DV  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYE 202

Query: 268 VSTAPQGTPGYV-----DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             +  + + G +       +    +  T +SDV+SFGV+L E+++
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  132 bits (334), Expect = 2e-35
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)

Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEI 159
           S L +    F   + +G+G +G VY G  ++ G++ A+K   +  +  + I+Q   E+ +
Sbjct: 17  SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINM 73

Query: 160 LTKL-QHPNLVKLYGC-----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
           L K   H N+   YG            +L LV E+   G+V D + N + N+    W   
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--- 130

Query: 214 LSIAI---ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS 269
             IA    E    L++LH   VIHRD+K  N+LL  N  VK+ DFG+S  L  T     +
Sbjct: 131 --IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188

Query: 270 TAPQGTPGYVDPDYFQCYKLTD-----KSDVYSFGVVLIELISG 308
               GTP ++ P+   C +  D     KSD++S G+  IE+  G
Sbjct: 189 FI--GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  133 bits (335), Expect = 5e-35
 Identities = 42/204 (20%), Positives = 75/204 (36%), Gaps = 20/204 (9%)

Query: 119 GDGGFGAVYLGI-LRDGRIVAVKR--LYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           G      V L      G  V V+R  L   + + +     E+ +     HPN+V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI---ETAGALAYLHASDV 232
              + EL +V  ++  G+  D +     +   +       IA        AL Y+H    
Sbjct: 96  IADN-ELWVVTSFMAYGSAKDLICTHFMDG--MNELA---IAYILQGVLKALDYIHHMGY 149

Query: 233 IHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ------GTPGYVDPDYFQC 286
           +HR VK+++IL+  + +V ++    +    +                    ++ P+  Q 
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 287 YKL--TDKSDVYSFGVVLIELISG 308
                  KSD+YS G+   EL +G
Sbjct: 210 NLQGYDAKSDIYSVGITACELANG 233

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (332), Expect = 6e-35
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 39/225 (17%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNL 168
           + +G+G FG V+              +VAVK L E  +      F  E  ++ +  +PN+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 169 VKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR-------------- 213
           VKL G C     + + L++EY+  G + + L +  P++                      
Sbjct: 113 VKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 214 ------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
                 L IA + A  +AYL     +HRD+ + N L+  N  VK+ADFGLSR    ++  
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIYS 226

Query: 268 VSTAPQGTPGYV-----DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                      +      P+     + T +SDV+++GVVL E+ S
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  131 bits (331), Expect = 6e-35
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 41/296 (13%)

Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK-----RLYENNFKR 149
           G  + SC++ +    N+   K +G G F  V L   +  GR VA+K     +L   + ++
Sbjct: 1   GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK 60

Query: 150 IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLP 209
           + +   EV I+  L HPN+VKL+     +   L L+ EY   G V D+L         + 
Sbjct: 61  LFR---EVRIMKILNHPNIVKLFEVIETEKT-LYLIMEYASGGEVFDYLVAHGR----MK 112

Query: 210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS 269
                S   +   A+ Y H   ++HRD+K+ N+LLD +  +K+ADFG S  F T    + 
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLD 171

Query: 270 TAPQGTPGYVDPDYFQCYKLTD--KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA 327
               G P Y  P+ FQ  K  D  + DV+S GV+L  L+SG    D        NL  + 
Sbjct: 172 AFC-GAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELR 223

Query: 328 TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAE-LAFRCVQQDRDMRPTMKEVLE 382
             ++  G               Y +   +++  E L  R +  +   R T++++++
Sbjct: 224 E-RVLRG--------------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  130 bits (329), Expect = 8e-35
 Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 42/224 (18%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG V                VAVK L  + +    E  M+E+++L+ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR-------------- 213
           +V L G  +      L++ EY   G + + L  ++ +                       
Sbjct: 89  IVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHVS--- 269
           LS + + A  +A+L + + IHRD+ + NILL +    K+ DFGL+R +       V    
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 270 ------TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
                  AP+                T +SDV+S+G+ L EL S
Sbjct: 208 RLPVKWMAPES---------IFNCVYTFESDVWSYGIFLWELFS 242

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  130 bits (328), Expect = 1e-34
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 28/211 (13%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
            + F+  ++LG+G +G+VY  I    G+IVA+K++       +++ + E+ I+ +   P+
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS---IAI---ETA 221
           +VK YG   + + +L +V EY   G+V+D +  R            L+   IA     T 
Sbjct: 86  VVKYYGSYFKNT-DLWIVMEYCGAGSVSDIIRLR---------NKTLTEDEIATILQSTL 135

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDV---THVSTAPQGTPG 277
             L YLH    IHRD+K+ NILL+     K+ADFG++ +L  T     T +     GTP 
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPF 190

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           ++ P+  Q       +D++S G+  IE+  G
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  131 bits (331), Expect = 1e-34
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 116 KQLGDGGFGAVYLGILRD--------GRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QH 165
           K LG+G FG V L                VAVK L  +   K +   ++E+E++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL------------LPWPVR 213
            N++ L G  + Q   L ++ EY   G + ++L  R+P                L     
Sbjct: 135 KNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 214 LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
           +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R    D+ H+    +
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 249

Query: 274 GTPGYV-----DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            T G +      P+       T +SDV+SFGV+L E+ +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  131 bits (331), Expect = 2e-34
 Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 53/302 (17%)

Query: 34  IIRRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSS 93
           I  RR+ T +   S  +    S+      TT  ++T  T     +  Y            
Sbjct: 24  IPLRRQVTVSAESSSSM---NSNTPLVRITTRLSSTADTPMLAGVSEYELPEDP------ 74

Query: 94  YFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGR--------IVAVKRLYEN 145
                     + E   D     K LG+G FG V +                VAVK L ++
Sbjct: 75  ----------KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 124

Query: 146 -NFKRIEQFMNEVEILTKL-QHPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQ 202
              K +   ++E+E++  + +H N++ L G CT  Q   L ++ EY   G + ++L  R+
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARR 182

Query: 203 PNSCLLPWPVR------------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV 250
           P      + +             +S   + A  + YL +   IHRD+ + N+L+  N  +
Sbjct: 183 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 242

Query: 251 KVADFGLSRLFPTDVTHVSTAPQGTPGYV-----DPDYFQCYKLTDKSDVYSFGVVLIEL 305
           K+ADFGL+R    D+ ++    + T G +      P+       T +SDV+SFGV++ E+
Sbjct: 243 KIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

Query: 306 IS 307
            +
Sbjct: 299 FT 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  130 bits (328), Expect = 2e-34
 Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 34/220 (15%)

Query: 116 KQLGDGGFGAVYLGILRDGR--------IVAVKRLYEN-NFKRIEQFMNEVEILTKL-QH 165
           K LG+G FG V +                VAVK L ++   K +   ++E+E++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 166 PNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR----------- 213
            N++ L G CT  Q   L ++ EY   G + ++L  R+P      + +            
Sbjct: 101 KNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 214 -LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
            +S   + A  + YL +   IHRD+ + N+L+  N  +K+ADFGL+R    D+ ++    
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK 214

Query: 273 QGTPGYV-----DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
           + T G +      P+       T +SDV+SFGV++ E+ +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  131 bits (331), Expect = 2e-34
 Identities = 31/230 (13%), Positives = 59/230 (25%), Gaps = 37/230 (16%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLY----------------------------ENN 146
             LG     A         G    V   Y                            +  
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 147 FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ---SRELLLVYEYIPNGTVADHLHNRQP 203
            K   +F+   +++   Q   ++++          SR  L         T  + L +   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 204 NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT 263
               L    RL + ++    LA LH   ++H  ++  +I+LD    V +  F        
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 264 DVTHVSTAPQGTPGYVDP-----DYFQCYKLTDKSDVYSFGVVLIELISG 308
                       P                 +T   D ++ G+ +  +   
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (328), Expect = 2e-34
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 39/225 (17%)

Query: 116 KQLGDGGFGAVYLGILRDGR------IVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG V                VAVK L E  +    E  M+E++++T+L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR------------- 213
           +V L G CT   S  + L++EY   G + ++L +++                        
Sbjct: 111 IVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 214 ------LSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
                 L  A + A  + +L     +HRD+ + N+L+ +   VK+ DFGL+R    D+  
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMS 224

Query: 268 VSTAPQGTPGYV-----DPDYFQCYKLTDKSDVYSFGVVLIELIS 307
            S         +      P+       T KSDV+S+G++L E+ S
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  132 bits (334), Expect = 4e-34
 Identities = 73/307 (23%), Positives = 129/307 (42%), Gaps = 46/307 (14%)

Query: 90  RGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK 148
           +G       +F  S+    ++ +   K+LG G +G V L   +      A+K + + +  
Sbjct: 17  QGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS 76

Query: 149 R--IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
                + + EV +L  L HPN++KLY       R   LV E    G + D + +R     
Sbjct: 77  TSSNSKLLEEVAVLKLLDHPNIMKLYD-FFEDKRNYYLVMECYKGGELFDEIIHRM---- 131

Query: 207 LLPWPVRLS------IAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGL 257
                 + +      I  +    + YLH  +++HRD+K  N+LL++   +  +K+ DFGL
Sbjct: 132 ------KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185

Query: 258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSR 316
           S +F            GT  Y+ P+  +  Y   +K DV+S GV+L  L++G       +
Sbjct: 186 SAVFENQKKMKERL--GTAYYIAPEVLRKKY--DEKCDVWSIGVILFILLAGYPPFG-GQ 240

Query: 317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRP 375
              +I        K++ G           F+        V+  A +L  + +Q D   R 
Sbjct: 241 TDQEI------LRKVEKGKYT--------FDSPEW--KNVSEGAKDLIKQMLQFDSQRRI 284

Query: 376 TMKEVLE 382
           + ++ LE
Sbjct: 285 SAQQALE 291

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  128 bits (323), Expect = 6e-34
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L       R  A+K L + +     ++     E +++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 166 PNLVKLYGCTSRQSRELL-LVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAIETAG 222
           P  VKLY     Q  E L     Y  NG +  ++        +C      R   A E   
Sbjct: 90  PFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVS 141

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ-GTPGYVDP 281
           AL YLH   +IHRD+K  NILL+ +  +++ DFG +++   +          GT  YV P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 282 DYFQCYKLTDKS-DVYSFGVVLIELISGL 309
           +     K   KS D+++ G ++ +L++GL
Sbjct: 202 ELLT-EKSACKSSDLWALGCIIYQLVAGL 229

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (320), Expect = 4e-33
 Identities = 66/322 (20%), Positives = 122/322 (37%), Gaps = 44/322 (13%)

Query: 90  RGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLY-ENNF 147
                   KV    +     D+F    +LG G  G V+    +  G ++A K ++ E   
Sbjct: 18  EAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP 72

Query: 148 KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL 207
               Q + E+++L +   P +V  YG       E+ +  E++  G++   L         
Sbjct: 73  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGR---- 127

Query: 208 LPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLS-RLFPTDV 265
           +P  +   ++I     L YL     ++HRDVK +NIL+++   +K+ DFG+S +L  +  
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187

Query: 266 -THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDI 321
            + V     GT  Y+ P+  Q    + +SD++S G+ L+E+  G   +   D        
Sbjct: 188 NSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

Query: 322 NLSNMATNKIQNGALNELVDPSLGFEKD------------YAVRNMVTSVAELAF----- 364
                               P   F  D            Y V      +    F     
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302

Query: 365 ----RCVQQDRDMRPTMKEVLE 382
               +C+ ++   R  +K+++ 
Sbjct: 303 DFVNKCLIKNPAERADLKQLMV 324

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  129 bits (326), Expect = 4e-33
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 47/289 (16%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQ 164
           +D +   + LG G FG V L   +  G+  AVK + +   K+    E  + EV++L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAI 218
           HPN++KLY           LV E    G + D + +R+          R S      I  
Sbjct: 85  HPNIMKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRK----------RFSEVDAARIIR 133

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +    + Y+H + ++HRD+K  N+LL++   +  +++ DFGLS  F            GT
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GT 191

Query: 276 PGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
             Y+ P+     Y   +K DV+S GV+L  L+SG          +  N  ++   K++ G
Sbjct: 192 AYYIAPEVLHGTY--DEKCDVWSTGVILYILLSGCPPF------NGANEYDIL-KKVEKG 242

Query: 335 ALNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRPTMKEVLE 382
                      FE        V+  A +L  + +     MR + ++ L+
Sbjct: 243 KYT--------FELPQW--KKVSESAKDLIRKMLTYVPSMRISARDALD 281

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  126 bits (319), Expect = 2e-32
 Identities = 70/299 (23%), Positives = 117/299 (39%), Gaps = 52/299 (17%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL--------YENNFKRIEQFMNE 156
           +   D +  SK LG G  G V L   R   + VA++ +                     E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS- 215
           +EIL KL HP ++K+       + +  +V E +  G + D +   +          RL  
Sbjct: 191 IEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNK----------RLKE 238

Query: 216 -----IAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTH 267
                   +   A+ YLH + +IHRD+K  N+LL   + +  +K+ DFG S++   + + 
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 297

Query: 268 VSTAPQGTPGYVDP---DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS 324
           + T   GTP Y+ P               D +S GV+L   +SG       R +  +   
Sbjct: 298 MRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--- 353

Query: 325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRPTMKEVLE 382
               ++I +G  N        F  +      V+  A +L  + +  D   R T +E L 
Sbjct: 354 ---KDQITSGKYN--------FIPEVW--AEVSEKALDLVKKLLVVDPKARFTTEEALR 399

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  124 bits (313), Expect = 3e-32
 Identities = 71/264 (26%), Positives = 110/264 (41%), Gaps = 29/264 (10%)

Query: 58  SGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQ 117
           S             T  +         +    R  S     V      ++    F+  ++
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           +G G FGAVY    +R+  +VA+K++    + + ++ +  + EV  L KL+HPN ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS---IAI---ETAGALAYL 227
           C  R+     LV EY   G+ +D L               L    IA         LAYL
Sbjct: 122 CYLREH-TAWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYL 170

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H+ ++IHRDVK+ NILL     VK+ DFG + +     + V     GTP ++ P+     
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225

Query: 288 KLTD---KSDVYSFGVVLIELISG 308
                  K DV+S G+  IEL   
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAER 249

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  123 bits (310), Expect = 3e-32
 Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 41/239 (17%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRI----EQFMNEVEILTKLQHPNLVK 170
             LG+G +G V   +        AVK L +   +RI         E+++L +L+H N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 171 LYGCTSRQSR-ELLLVYEYIPNGTVA--DHLHNRQPNSCLLPWPVRLSIAIETA------ 221
           L      + + ++ +V EY   G     D +  +           R  +    A      
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPV--CQAHGYFCQ 117

Query: 222 --GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP--TDVTHVSTAPQGTPG 277
               L YLH+  ++H+D+K  N+LL     +K++  G++             T+ QG+P 
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPA 176

Query: 278 YVDPDYFQCYKLTD--KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG 334
           +  P+           K D++S GV L  + +GL   +        N+  +    I  G
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKL-FENIGKG 228

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  124 bits (312), Expect = 3e-32
 Identities = 62/252 (24%), Positives = 96/252 (38%), Gaps = 50/252 (19%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVK-----RLYENNFKRIEQFMNEVEI 159
            E    ++    +G G +G V + I      I A+K     ++ + N K +E+   EV +
Sbjct: 22  LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81

Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
           + KL HPN+ +LY       + + LV E    G + D L+    +S        +   I 
Sbjct: 82  MKKLHHPNIARLYEVYE-DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 220 TAG------------------------------------ALAYLHASDVIHRDVKSNNIL 243
                                                  AL YLH   + HRD+K  N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200

Query: 244 L--DNNFRVKVADFGLSRLFP---TDVTHVSTAPQGTPGYVDPD--YFQCYKLTDKSDVY 296
              + +F +K+ DFGLS+ F        +  T   GTP +V P+           K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 297 SFGVVLIELISG 308
           S GV+L  L+ G
Sbjct: 261 SAGVLLHLLLMG 272

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  122 bits (308), Expect = 4e-32
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 9/205 (4%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHP 166
            D F   ++LG G FG V+L   R  G    +K + ++  +  +EQ   E+E+L  L HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N++K++         + +V E    G + + + + Q     L       +  +   ALAY
Sbjct: 81  NIIKIFE-VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 227 LHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
            H+  V+H+D+K  NIL  +   +  +K+ DFGL+ LF +D    + A  GT  Y+ P+ 
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEV 197

Query: 284 FQCYKLTDKSDVYSFGVVLIELISG 308
           F+   +T K D++S GVV+  L++G
Sbjct: 198 FK-RDVTFKCDIWSAGVVMYFLLTG 221

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  126 bits (318), Expect = 5e-32
 Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 46/288 (15%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQH 165
            + +N    LG G FG V     R   +  AVK + + + K       + EVE+L KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIE 219
           PN++KL+      S    +V E    G + D +  R+          R S      I  +
Sbjct: 81  PNIMKLFE-ILEDSSSFYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQ 129

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
               + Y+H  +++HRD+K  NILL++   +  +K+ DFGLS  F  +         GT 
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTA 187

Query: 277 GYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA 335
            Y+ P+  +  Y   +K DV+S GV+L  L+SG      +   +  N  ++   +++ G 
Sbjct: 188 YYIAPEVLRGTY--DEKCDVWSAGVILYILLSG------TPPFYGKNEYDIL-KRVETGK 238

Query: 336 LNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRPTMKEVLE 382
                     F+        ++  A +L  + +     +R T  + LE
Sbjct: 239 YA--------FDLPQWRT--ISDDAKDLIRKMLTFHPSLRITATQCLE 276

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  122 bits (309), Expect = 5e-32
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
              F   + LG G F  V+L   R  G++ A+K + ++   R     NE+ +L K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETA 221
           +V L       +    LV + +  G + D +  R             +      +  +  
Sbjct: 68  IVTLED-IYESTTHYYLVMQLVSGGELFDRILERG----------VYTEKDASLVIQQVL 116

Query: 222 GALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            A+ YLH + ++HRD+K  N+L    + N ++ + DFGLS++    +    +   GTPGY
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGY 173

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           V P+       +   D +S GV+   L+ G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  122 bits (308), Expect = 7e-32
 Identities = 69/311 (22%), Positives = 129/311 (41%), Gaps = 47/311 (15%)

Query: 91  GSSYFGAKVFSCSELEEATDNFNSS-----KQLGDGGFGAVYLGI-LRDGRIVAVKRL-Y 143
           GSS    K      +         +      ++G G  G V+     + G ++AVK++  
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 144 ENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ 202
             N +  ++ + +++++ K    P +V+ +G     + ++ +  E +  GT A+ L  R 
Sbjct: 61  SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-DVFIAMELM--GTCAEKLKKRM 117

Query: 203 PNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
                +P  +   + +    AL YL     VIHRDVK +NILLD   ++K+ DFG+S   
Sbjct: 118 QGP--IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175

Query: 262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTD-----KSDVYSFGVVLIELISGLEAVDTSR 316
             D     +A  G   Y+ P+       T      ++DV+S G+ L+EL +G       +
Sbjct: 176 VDDKAKDRSA--GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG-------Q 226

Query: 317 HRHDINLSNMATNKIQNGALNELVD---PSLGFEKDY--AVRNMVTSVAELAFRCVQQDR 371
             +    ++          L +++    P L     +    ++ V         C+ +D 
Sbjct: 227 FPYKNCKTDFE-------VLTKVLQEEPPLLPGHMGFSGDFQSFVKD-------CLTKDH 272

Query: 372 DMRPTMKEVLE 382
             RP   ++LE
Sbjct: 273 RKRPKYNKLLE 283

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  125 bits (317), Expect = 8e-32
 Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 61/301 (20%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRL-------------YENNFKRIEQFM 154
            +++   ++LG G +G V L   +      A+K +              +N  K  E+  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 155 NEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           NE+ +L  L HPN++KL+       +   LV E+   G + + + NR           + 
Sbjct: 95  NEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIINRH----------KF 143

Query: 215 S------IAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDV 265
                  I  +    + YLH  +++HRD+K  NILL+N      +K+ DFGLS  F  D 
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 266 THVSTAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR--HDIN 322
                   GT  Y+ P+  +  Y   +K DV+S GV++  L+ G        +      N
Sbjct: 204 KLRDRL--GTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCG--------YPPFGGQN 251

Query: 323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRPTMKEVL 381
             ++   K++ G           F+ +      ++  A EL    +  D + R T +E L
Sbjct: 252 DQDII-KKVEKGKYY--------FDFNDWKN--ISDEAKELIKLMLTYDYNKRCTAEEAL 300

Query: 382 E 382
            
Sbjct: 301 N 301

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  121 bits (305), Expect = 1e-31
 Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 36/274 (13%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNLVKL 171
             LG G FG V +G     G  VAVK L     +    + +   E++ L   +HP+++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           Y   S  + +  +V EY+  G + D++         +       +  +   A+ Y H   
Sbjct: 77  YQVISTPT-DFFMVMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHRHM 131

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           V+HRD+K  N+LLD +   K+ADFGLS +       + T+  G+P Y  P+     +L  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVISG-RLYA 188

Query: 292 --KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             + D++S GV+L  L+ G    D      D ++  +   KI+ G               
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD------DEHVPTL-FKKIRGG--------------V 227

Query: 350 YAV-RNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           + +   +  SVA L    +Q D   R T+K++ E
Sbjct: 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  120 bits (302), Expect = 2e-31
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
              +     +G G +G V + + +      A K++ +   + +++F  E+EI+  L HPN
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETA 221
           +++LY  T   + ++ LV E    G + + + +++                   I  +  
Sbjct: 68  IIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKR----------VFRESDAARIMKDVL 116

Query: 222 GALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            A+AY H  +V HRD+K  N L      +  +K+ DFGL+  F       +    GTP Y
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYY 174

Query: 279 VDPDYFQ-CYKLTDKSDVYSFGVVLIELISG 308
           V P   +  Y    + D +S GV++  L+ G
Sbjct: 175 VSPQVLEGLY--GPECDEWSAGVMMYVLLCG 203

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  121 bits (306), Expect = 3e-31
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 11/209 (5%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVK-----RLYENNFKRIEQFMNEVEILTK 162
            D +   + +G G F  V   I R+ G+  AVK     +   +     E    E  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L+HP++V+L    S     L +V+E++    +   +  R     +    V      +   
Sbjct: 83  LKHPHIVELLETYS-SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 223 ALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
           AL Y H +++IHRDVK + +LL   +N+  VK+  FG++               GTP ++
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFM 200

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+  +        DV+  GV+L  L+SG
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  120 bits (304), Expect = 3e-31
 Identities = 59/270 (21%), Positives = 100/270 (37%), Gaps = 42/270 (15%)

Query: 55  SSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNS 114
            S+      +S      ++ +     +   +   +                      +  
Sbjct: 2   GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES--------------QYQV 47

Query: 115 SKQLGDGGFGAVYLGI-LRDGRIVAVK---------RLYENNFKRIEQFMNEVEILTKLQ 164
              LG GGFG+VY GI + D   VA+K              N  R+     EV +L K+ 
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM---EVVLLKKVS 104

Query: 165 H--PNLVKLYGCTSRQSRELLLVYEYI-PNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
                +++L     R     +L+ E   P   + D +  R      L   +  S   +  
Sbjct: 105 SGFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVL 159

Query: 222 GALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
            A+ + H   V+HRD+K  NIL+D N   +K+ DFG   L    V        GT  Y  
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSP 216

Query: 281 PDYFQCYKLTD--KSDVYSFGVVLIELISG 308
           P++ + Y       + V+S G++L +++ G
Sbjct: 217 PEWIR-YHRYHGRSAAVWSLGILLYDMVCG 245

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  119 bits (302), Expect = 3e-31
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF--KRIEQFMNEVEILTKLQH 165
           +DN++  ++LG G F  V   + +  G   A K +       +  ++   E  I  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIE 219
           PN+V+L+  + ++     LV++ +  G + + +  R+            S         +
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVARE----------FYSEADASHCIQQ 113

Query: 220 TAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
              ++AY H++ ++HR++K  N+LL        VK+ADFGL+            A  GTP
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTP 171

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GY+ P+  +    +   D+++ GV+L  L+ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  119 bits (301), Expect = 5e-31
 Identities = 58/232 (25%), Positives = 89/232 (38%), Gaps = 53/232 (22%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVK--------------------------RLYENNFK 148
            ++G G +G V L     D    A+K                                  
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 149 RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR-ELLLVYEYIPNGTVADHLHNRQPNSCL 207
            IEQ   E+ IL KL HPN+VKL       +   L +V+E +  G V +    +      
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------ 132

Query: 208 LPWPVRLSIAIETA--------GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
                 LS   + A          + YLH   +IHRD+K +N+L+  +  +K+ADFG+S 
Sbjct: 133 -----PLSE--DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT---DKSDVYSFGVVLIELISG 308
            F      +S    GTP ++ P+     +        DV++ GV L   + G
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  121 bits (305), Expect = 6e-31
 Identities = 65/295 (22%), Positives = 123/295 (41%), Gaps = 35/295 (11%)

Query: 36  RRRRKTAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYF 95
           RR R+   +  + + +   +         S +      + +   + P    +L   S   
Sbjct: 20  RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79

Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL--------YENN 146
             ++   +  +E    ++    +G G    V   + R  G   AVK +         E  
Sbjct: 80  EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139

Query: 147 FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
            +  E    E  IL ++  HP+++ L   +   S  + LV++ +  G + D+L  +    
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLID-SYESSSFMFLVFDLMRKGELFDYLTEK---- 194

Query: 206 CLLPWPVRLS------IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
                 V LS      I      A+++LHA++++HRD+K  NILLD+N +++++DFG S 
Sbjct: 195 ------VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248

Query: 260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD------KSDVYSFGVVLIELISG 308
                         GTPGY+ P+  +C           + D+++ GV+L  L++G
Sbjct: 249 HLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  120 bits (302), Expect = 8e-31
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNFKRIEQFMNEVEILTKL-QHP 166
           ++     ++G G +G+V   +    G+I+AVKR+    + K  +Q + +++++ +    P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            +V+ YG   R+  +  +  E +       + +       ++P  +   I + T  AL +
Sbjct: 82  YIVQFYGALFREG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 227 LHASD-VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           L  +  +IHRD+K +NILLD +  +K+ DFG+S      +     A  G   Y+ P+   
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERID 198

Query: 286 CYKLTD----KSDVYSFGVVLIELISG 308
                     +SDV+S G+ L EL +G
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATG 225

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  119 bits (301), Expect = 8e-31
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 35/224 (15%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL--------YENNFKRIEQFMNE 156
           +   D +  SK LG G  G V L   R   + VA+K +                     E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 157 VEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS- 215
           +EIL KL HP ++K+       + +  +V E +  G + D +   +          RL  
Sbjct: 66  IEILKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVGNK----------RLKE 113

Query: 216 -----IAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTH 267
                   +   A+ YLH + +IHRD+K  N+LL   + +  +K+ DFG S++     T 
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETS 171

Query: 268 VSTAPQGTPGYVDP---DYFQCYKLTDKSDVYSFGVVLIELISG 308
           +     GTP Y+ P               D +S GV+L   +SG
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (299), Expect = 9e-31
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 28/213 (13%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR--IEQFMNEVEILTKLQH 165
            + +N    LG G FG V     R   +  AVK + + + K       + EVE+L KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIE 219
           PN++KL+      S    +V E    G + D +  R+          R S      I  +
Sbjct: 81  PNIMKLFE-ILEDSSSFYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQ 129

Query: 220 TAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
               + Y+H  +++HRD+K  NILL   + +  +K+ DFGLS  F  +         GT 
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTA 187

Query: 277 GYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISG 308
            Y+ P+  +  Y   +K DV+S GV+L  L+SG
Sbjct: 188 YYIAPEVLRGTY--DEKCDVWSAGVILYILLSG 218

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  120 bits (303), Expect = 2e-30
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 16/208 (7%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           D+F   + +G G FG V +    D  ++ A+K + +        +     E++I+  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 166 PNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           P LV L+   S Q  E + +V + +  G +  HL   Q N       V+L I  E   AL
Sbjct: 75  PFLVNLWY--SFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFIC-ELVMAL 128

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
            YL    +IHRD+K +NILLD +  V + DF ++ + P +    + A  GT  Y+ P+ F
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMF 186

Query: 285 QCYKLT--DKS-DVYSFGVVLIELISGL 309
              K      + D +S GV   EL+ G 
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  120 bits (302), Expect = 3e-30
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 17/212 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           D+F   K +G G F  V +  ++  G++ A+K + + +      +  F  E ++L     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 166 PNLVKLYGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
             + +L+     Q    L LV EY   G +   L   +    +     R  +A E   A+
Sbjct: 121 RWITQLHFAF--QDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYLA-EIVMAI 175

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
             +H    +HRD+K +NILLD    +++ADFG       D T  S    GTP Y+ P+  
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235

Query: 285 QCYKLTDKSDVY-------SFGVVLIELISGL 309
           Q       +  Y       + GV   E+  G 
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  117 bits (295), Expect = 3e-30
 Identities = 67/287 (23%), Positives = 125/287 (43%), Gaps = 31/287 (10%)

Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRL-YENNFKRIEQFMNEVEILTK 162
           +E   D+     +LG G +G V        G+I+AVKR+    N +  ++ + +++I  +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 163 L-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
               P  V  YG   R+  ++ +  E + + ++             +P  +   IA+   
Sbjct: 62  TVDCPFTVTFYGALFREG-DVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 222 GALAYLHASD-VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
            AL +LH+   VIHRDVK +N+L++   +VK+ DFG+S     DV     A  G   Y+ 
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMA 177

Query: 281 PDYFQCYKLTD----KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT-NKIQNGA 335
           P+             KSD++S G+ +IEL          R  +D   +      ++    
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAIL-------RFPYDSWGTPFQQLKQVVEEP 230

Query: 336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             +L  P+  F  ++   +  +        C++++   RPT  E+++
Sbjct: 231 SPQL--PADKFSAEF--VDFTSQ-------CLKKNSKERPTYPELMQ 266

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  116 bits (293), Expect = 5e-30
 Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 29/207 (14%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           + LG+G +G V L +       VAVK +  +      E    E+ I   L H N+VK YG
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA--------GALA 225
               +     L  EY   G + D +               +      A          + 
Sbjct: 73  HRR-EGNIQYLFLEYCSGGELFDRIEPDI----------GMPE--PDAQRFFHQLMAGVV 119

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP--TDVTHVSTAPQGTPGYVDPDY 283
           YLH   + HRD+K  N+LLD    +K++DFGL+ +F        ++    GT  YV P+ 
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 284 FQCYKLTD--KSDVYSFGVVLIELISG 308
            +  +       DV+S G+VL  +++G
Sbjct: 179 LKR-REFHAEPVDVWSCGIVLTAMLAG 204

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (293), Expect = 7e-30
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 36/223 (16%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRI---------EQFMNEVE 158
            +N+   + LG G    V   I +   +  AVK +                 E  + EV+
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 159 ILTKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS-- 215
           IL K+  HPN+++L   T   +    LV++ +  G + D+L  +            LS  
Sbjct: 76  ILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEKV----------TLSEK 124

Query: 216 ----IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA 271
               I       +  LH  +++HRD+K  NILLD++  +K+ DFG S             
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184

Query: 272 PQGTPGYVDPDYFQCYKLTDKS------DVYSFGVVLIELISG 308
             GTP Y+ P+  +C    +        D++S GV++  L++G
Sbjct: 185 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  118 bits (298), Expect = 8e-30
 Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
            D ++  ++LG G FG V+  + +  GR+   K +            NE+ I+ +L HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS--IAIETA---- 221
           L+ L+        E++L+ E++  G + D +              ++S    I       
Sbjct: 110 LINLHD-AFEDKYEMVLILEFLSGGELFDRIAAED---------YKMSEAEVINYMRQAC 159

Query: 222 GALAYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
             L ++H   ++H D+K  NI+ +      VK+ DFGL+     D     T    T  + 
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFA 217

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
            P+      +   +D+++ GV+   L+SGL
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGL 247

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  116 bits (293), Expect = 1e-29
 Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 30/213 (14%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN--EVEILTKLQHP 166
           + +    ++G+G +G V+    RD G+IVA+K+  E+    + + +   E+ +L +L+HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           NLV L     R+ R L LV+EY  + TV   L        +    V+ SI  +T  A+ +
Sbjct: 63  NLVNLLEVF-RRKRRLHLVFEYCDH-TVLHELDRY--QRGVPEHLVK-SITWQTLQAVNF 117

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDV-TH-VST----APQ---GT 275
            H  + IHRDVK  NIL+  +  +K+ DFG +RL   P+D     V+T    +P+   G 
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             Y  P            DV++ G V  EL+SG
Sbjct: 178 TQYGPP-----------VDVWAIGCVFAELLSG 199

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  116 bits (293), Expect = 2e-29
 Identities = 73/330 (22%), Positives = 124/330 (37%), Gaps = 43/330 (13%)

Query: 64  TSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGF 123
           +S     T N      S   +       S      +   S  +  +D F    +LG G  
Sbjct: 8   SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDG-SNRDALSDFFEVESELGRGAT 66

Query: 124 GAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL 182
             VY    +   +  A+K L        +    E+ +L +L HPN++KL         E+
Sbjct: 67  SIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKE-IFETPTEI 123

Query: 183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETAGALAYLHASDVIHRD 236
            LV E +  G + D +  +             S         +   A+AYLH + ++HRD
Sbjct: 124 SLVLELVTGGELFDRIVEKG----------YYSERDAADAVKQILEAVAYLHENGIVHRD 173

Query: 237 VKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKS 293
           +K  N+L      +  +K+ADFGLS++    V   +    GTPGY  P+  +      + 
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGCAYGPEV 231

Query: 294 DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVR 353
           D++S G++   L+ G E     R    +        +I N            F   +   
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEYY--------FISPWW-- 275

Query: 354 NMVTSVA-ELAFRCVQQDRDMRPTMKEVLE 382
           + V+  A +L  + +  D   R T  + L+
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  118 bits (297), Expect = 2e-29
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 15/210 (7%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K +G G FG V +  L++  ++ A+K L +           F  E ++L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 166 PNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
             +  L+     Q    L LV +Y   G +   L   +    L     R  +A E   A+
Sbjct: 134 KWITTLHYAF--QDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLA-EMVIAI 188

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
             +H    +HRD+K +NIL+D N  +++ADFG       D T  S+   GTP Y+ P+  
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 285 QCYKLTDKS-----DVYSFGVVLIELISGL 309
           Q  +          D +S GV + E++ G 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  115 bits (291), Expect = 2e-29
 Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 35/232 (15%)

Query: 96  GAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVK------RLYENNFK 148
           G + F   ++E   D ++  ++LG G F  V     +  G   A K              
Sbjct: 1   GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57

Query: 149 RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL 208
             E+   EV IL ++ H N++ L+        +++L+ E +  G + D L  ++      
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKE------ 110

Query: 209 PWPVRLS------IAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLS 258
                LS         +    + YLH   + H D+K  NI+L         +K+ DFGL+
Sbjct: 111 ----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

Query: 259 RLF-PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
                           GTP +V P+      L  ++D++S GV+   L+SG 
Sbjct: 167 HEIEDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  115 bits (291), Expect = 2e-29
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 35/210 (16%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLY-ENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           + LG+G +G V L +       VAVK +  +      E    E+ I   L H N+VK YG
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS-----------IAIETAG 222
               +     L  EY   G + D +               +            +A     
Sbjct: 73  HRR-EGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMA----- 116

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP--TDVTHVSTAPQGTPGYVD 280
            + YLH   + HRD+K  N+LLD    +K++DFGL+ +F        ++    GT  YV 
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175

Query: 281 PDYFQCYKLTD--KSDVYSFGVVLIELISG 308
           P+  +  +       DV+S G+VL  +++G
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVLTAMLAG 204

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  116 bits (293), Expect = 3e-29
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR--IEQFMNEVEILTKLQH 165
           +DN++  ++LG G F  V   + +  G   A K +          ++   E  I  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIE 219
           PN+V+L+  + ++     LV++ +  G + + +  R+            S         +
Sbjct: 88  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVARE----------FYSEADASHCIQQ 136

Query: 220 TAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
              ++AY H++ ++HR++K  N+LL        VK+ADFGL+            A  GTP
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTP 194

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GY+ P+  +    +   D+++ GV+L  L+ G
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  115 bits (290), Expect = 3e-29
 Identities = 70/330 (21%), Positives = 121/330 (36%), Gaps = 64/330 (19%)

Query: 108 ATDNFNSS---------KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEV 157
           +TD+F+             LG+G    V   I     +  AVK + +       +   EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 158 EILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS- 215
           E+L + Q H N+++L      + R   LV+E +  G++  H+H R+            + 
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRR----------HFNE 110

Query: 216 -----IAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTH 267
                +  + A AL +LH   + HRD+K  NIL    +    VK+ DF L      +   
Sbjct: 111 LEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170

Query: 268 VSTAPQ------GTPGYVDPDYFQCYKLTDKS-----DVYSFGVVLIELISG-------- 308
              +        G+  Y+ P+  + +           D++S GV+L  L+SG        
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230

Query: 309 LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCV 367
                  R        NM    IQ G           F         ++  A +L  + +
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYE--------FPDKDW--AHISCAAKDLISKLL 280

Query: 368 QQDRDMRPTMKEVLE---ILRETKDSNLGT 394
            +D   R +  +VL+   +     ++ L T
Sbjct: 281 VRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  118 bits (298), Expect = 4e-29
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 12/226 (5%)

Query: 92  SSYFGAKV-FSCSELEEAT-DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFK 148
           S YF   + +   E +    D F   + LG GGFG V+   ++  G++ A K+L +   K
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224

Query: 149 R---IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPN 204
           +    +  M E +IL K+    +V L      +++  L LV   +  G +  H++N   +
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDED 282

Query: 205 SCLLPWP-VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT 263
           +     P      A +    L +LH  ++I+RD+K  N+LLD++  V+++D GL+     
Sbjct: 283 NPGFQEPRAIFYTA-QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341

Query: 264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
             T       GTPG++ P+     +     D ++ GV L E+I+  
Sbjct: 342 GQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  114 bits (288), Expect = 5e-29
 Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 30/211 (14%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVK---------RLYENNFKRIEQFMNEVEILTKL-- 163
             LG GGFG V+ G  L D   VA+K             ++         EV +L K+  
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGA 93

Query: 164 --QHPNLVKLYGCTSRQSRELLLVYEY-IPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
              HP +++L      Q    +LV E  +P   + D++  + P    L          + 
Sbjct: 94  GGGHPGVIRLLDWFETQEG-FMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQV 148

Query: 221 AGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
             A+ + H+  V+HRD+K  NIL+D      K+ DFG   L   +         GT  Y 
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYS 205

Query: 280 DPDYFQCYKLTD--KSDVYSFGVVLIELISG 308
            P++           + V+S G++L +++ G
Sbjct: 206 PPEWIS-RHQYHALPATVWSLGILLYDMVCG 235

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  115 bits (291), Expect = 6e-29
 Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 32/285 (11%)

Query: 41  TAAYAKSRDLKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVF 100
              Y +S        S SG        +         + S   S   ++  +       F
Sbjct: 17  ENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP---PAPF 73

Query: 101 SCSELEEATDNFNS------SKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQF 153
               +       NS      ++ LG G FG V+       G  +A K +     K  E+ 
Sbjct: 74  DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV 133

Query: 154 MNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR 213
            NE+ ++ +L H NL++LY        +++LV EY+  G + D + +             
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFE-SKNDIVLVMEYVDGGELFDRIIDES---------YN 183

Query: 214 LS------IAIETAGALAYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSRLF-PTD 264
           L+         +    + ++H   ++H D+K  NIL  N    ++K+ DFGL+R + P +
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243

Query: 265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
              V+    GTP ++ P+      ++  +D++S GV+   L+SGL
Sbjct: 244 KLKVNF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  118 bits (296), Expect = 6e-29
 Identities = 55/271 (20%), Positives = 108/271 (39%), Gaps = 25/271 (9%)

Query: 49  DLKTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEA 108
                P                     +   S  Y     +    Y+   V    + +  
Sbjct: 98  APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEI--KHDHV 155

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
            D+++  ++LG G FG V+    R  G   A K +   +    E    E++ ++ L+HP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETA 221
           LV L+        E++++YE++  G + + + +            ++S         +  
Sbjct: 216 LVNLHD-AFEDDNEMVMIYEFMSGGELFEKVADEH---------NKMSEDEAVEYMRQVC 265

Query: 222 GALAYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGY 278
             L ++H ++ +H D+K  NI+     +  +K+ DFGL+    P     V+T   GT  +
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEF 322

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
             P+  +   +   +D++S GV+   L+SGL
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (287), Expect = 9e-29
 Identities = 53/249 (21%), Positives = 88/249 (35%), Gaps = 36/249 (14%)

Query: 146 NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
           +   ++    ++  +      N V      S     L +  +      + D ++ R    
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVG-QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159

Query: 206 CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR------ 259
                 V L I I+ A A+ +LH+  ++HRD+K +NI    +  VKV DFGL        
Sbjct: 160 -DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 260 -----LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT 314
                L P       T   GT  Y+ P+       + K D++S G++L EL+       T
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS---T 275

Query: 315 SRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDY-AVRNMVTSVAELAFRCVQQDRDM 373
              R  I         ++N     L      F + Y     MV          +      
Sbjct: 276 QMERVRII------TDVRNLKFPLL------FTQKYPQEHMMVQD-------MLSPSPTE 316

Query: 374 RPTMKEVLE 382
           RP   +++E
Sbjct: 317 RPEATDIIE 325

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  114 bits (287), Expect = 1e-28
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 20/210 (9%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVK-----RLYEN---NFKRIEQFMNEVEILT 161
            +++   LG G FG V+  +     + V VK     ++ E+      ++ +   E+ IL+
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYE-YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           +++H N++K+      Q     LV E +     +   +         L  P+   I  + 
Sbjct: 85  RVEHANIIKVLDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQL 139

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
             A+ YL   D+IHRD+K  NI++  +F +K+ DFG +           T   GT  Y  
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFC-GTIEYCA 197

Query: 281 PDYFQCYKLTD--KSDVYSFGVVLIELISG 308
           P+           + +++S GV L  L+  
Sbjct: 198 PEVLMG-NPYRGPELEMWSLGVTLYTLVFE 226

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  113 bits (285), Expect = 1e-28
 Identities = 63/281 (22%), Positives = 111/281 (39%), Gaps = 37/281 (13%)

Query: 114 SSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKL 171
             K LG+G F      + +   +  AVK + +   +       E+  L   + HPN+VKL
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKL 71

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETAGALA 225
           +           LV E +  G + + +  ++            S      I  +   A++
Sbjct: 72  HE-VFHDQLHTFLVMELLNGGELFERIKKKK----------HFSETEASYIMRKLVSAVS 120

Query: 226 YLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           ++H   V+HRD+K  N+L    ++N  +K+ DFG +RL P D   + T P  T  Y  P+
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE 179

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP 342
                   +  D++S GV+L  ++SG     +         +     KI+ G  +     
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS----- 234

Query: 343 SLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRPTMKEVLE 382
              FE +      V+  A +L    +  D + R  M  +  
Sbjct: 235 ---FEGEAW--KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  113 bits (286), Expect = 2e-28
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 30/209 (14%)

Query: 114 SSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKL 171
           S + LG G  G V     R  G+  A+K L         +   EV+   +    P++V +
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCI 87

Query: 172 YGC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETAG 222
                      R LL++ E +  G +   +  R             +      I  +   
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ--------AFTEREAAEIMRDIGT 139

Query: 223 ALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
           A+ +LH+ ++ HRDVK  N+L    + +  +K+ DFG ++    +   + T P  TP YV
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYV 196

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P+     K     D++S GV++  L+ G
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  115 bits (291), Expect = 2e-28
 Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 24/212 (11%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR--IEQFMNEVEILTKLQH 165
           T+ +   ++LG G F  V   +    G+  A   +          ++   E  I   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIE 219
           PN+V+L+   S +     L+++ +  G + + +  R+            S         +
Sbjct: 70  PNIVRLHDSIS-EEGHHYLIFDLVTGGELFEDIVARE----------YYSEADASHCIQQ 118

Query: 220 TAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
              A+ + H   V+HR++K  N+LL        VK+ADFGL+     +         GTP
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTP 177

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           GY+ P+  +        D+++ GV+L  L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  113 bits (285), Expect = 2e-28
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNLVKL 171
           + LG+G FG V L    +  + VA+K +     K+     +   E+  L  L+HP+++KL
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD 231
           Y   +  + ++++V EY   G + D++  ++     +          +   A+ Y H   
Sbjct: 75  YDVITTPT-DIVMVIEYA-GGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCHRHK 128

Query: 232 VIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTD 291
           ++HRD+K  N+LLD+N  VK+ADFGLS +       + T+  G+P Y  P+     KL  
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSC-GSPNYAAPEVING-KLYA 185

Query: 292 --KSDVYSFGVVLIELISG 308
             + DV+S G+VL  ++ G
Sbjct: 186 GPEVDVWSCGIVLYVMLVG 204

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  115 bits (290), Expect = 2e-28
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQHPNLVKL 171
             LG G FG V +G     G  VAVK L     +    + +   E++ L   +HP+++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA--------GA 223
           Y   S  S ++ +V EY+  G + D++              RL    + +          
Sbjct: 82  YQVISTPS-DIFMVMEYVSGGELFDYICKNG----------RLDE--KESRRLFQQILSG 128

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           + Y H   V+HRD+K  N+LLD +   K+ADFGLS +       + T+  G+P Y  P+ 
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEV 186

Query: 284 FQCYKLTD--KSDVYSFGVVLIELISG 308
               +L    + D++S GV+L  L+ G
Sbjct: 187 ISG-RLYAGPEVDIWSSGVILYALLCG 212

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  113 bits (285), Expect = 3e-28
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 32/222 (14%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVK------RLYENNFKRIEQFMNEVE 158
           ++  D ++  ++LG G F  V     +  G   A K                E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS--- 215
           IL ++ HPN++ L+        +++L+ E +  G + D L  ++           LS   
Sbjct: 68  ILRQVLHPNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKE----------SLSEEE 116

Query: 216 ---IAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF-PTDVTH 267
                 +    + YLH   + H D+K  NI+L         +K+ DFGL+          
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176

Query: 268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
                 GTP +V P+      L  ++D++S GV+   L+SG 
Sbjct: 177 NIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  113 bits (286), Expect = 3e-28
 Identities = 62/255 (24%), Positives = 112/255 (43%), Gaps = 36/255 (14%)

Query: 72  TNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGIL 131
           + +  + P     +  L+  +             E+    + + K +G+G FG V+   L
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61

Query: 132 RDGRIVAVKR-LYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGC-----TSRQSRELLL 184
            +   VA+K+ L +  FK R      E++I+  ++HPN+V L          +    L L
Sbjct: 62  VESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115

Query: 185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL 244
           V EY+P  TV     +       +P  +      +   +LAY+H+  + HRD+K  N+LL
Sbjct: 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

Query: 245 D-NNFRVKVADFGLSRLF---PTDVTHVST----APQ---GTPGYVDPDYFQCYKLTDKS 293
           D  +  +K+ DFG +++      +V+++ +    AP+   G   Y           T   
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNY-----------TTNI 223

Query: 294 DVYSFGVVLIELISG 308
           D++S G V+ EL+ G
Sbjct: 224 DIWSTGCVMAELMQG 238

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  111 bits (280), Expect = 4e-28
 Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 32/219 (14%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVK------RLYENNFKRIEQFMNEVEILT 161
            D++   ++LG G F  V     +  G+  A K                E+   EV IL 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------ 215
           +++HPN++ L+        +++L+ E +  G + D L  ++           L+      
Sbjct: 64  EIRHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKE----------SLTEDEATQ 112

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDN----NFRVKVADFGLSRLF-PTDVTHVST 270
              +    + YLH+  + H D+K  NI+L +    N R+K+ DFG++      +      
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172

Query: 271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
              GTP +V P+      L  ++D++S GV+   L+SG 
Sbjct: 173 ---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  115 bits (289), Expect = 7e-28
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 12/219 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR---IEQFMNEVEILTKLQH 165
           + F   + LG GGFG V    +R  G++ A K+L +   K+       +NE +IL K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             +V L      +   L LV   +  G +  H+++                A E    L 
Sbjct: 244 RFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAA-EICCGLE 300

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
            LH   +++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ P+  +
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVK 358

Query: 286 CYKLTDKSDVYSFGVVLIELISGL---EAVDTSRHRHDI 321
             + T   D ++ G +L E+I+G    +       R ++
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  111 bits (281), Expect = 7e-28
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHP 166
           TD +   + +G G +      I +      AVK +     K       E+EIL +  QHP
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHP 76

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIET 220
           N++ L        + + +V E +  G + D +  ++            S      +    
Sbjct: 77  NIITLKD-VYDDGKYVYVVTELMKGGELLDKILRQK----------FFSEREASAVLFTI 125

Query: 221 AGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
              + YLHA  V+HRD+K +NIL      N   +++ DFG ++    +   + T P  T 
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTA 184

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            +V P+  +        D++S GV+L  +++G
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  113 bits (284), Expect = 8e-28
 Identities = 73/270 (27%), Positives = 119/270 (44%), Gaps = 37/270 (13%)

Query: 58  SGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSC-SELEEATDNFNSSK 116
           SG   TTS A +       S       ++  + GS                   ++  +K
Sbjct: 2   SGRPRTTSFAESCKPVQQPS-AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60

Query: 117 QLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTKLQHPNLVKLYGC 174
            +G+G FG VY   L D G +VA+K++ ++     ++F N E++I+ KL H N+V+L   
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 175 ---TSRQSRE--LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
              +  +  E  L LV +Y+P  TV     +       LP         +   +LAY+H+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174

Query: 230 SDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTD---VTHVST----APQ---GTPGY 278
             + HRD+K  N+LLD +   +K+ DFG ++        V+++ +    AP+   G   Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 234

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                      T   DV+S G VL EL+ G
Sbjct: 235 -----------TSSIDVWSAGCVLAELLLG 253

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  111 bits (280), Expect = 9e-28
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 32/214 (14%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN--EVEILTKLQHP 166
           + + +   +G+G +G V     +D GRIVA+K+  E++  ++ + +   E+++L +L+H 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           NLV L     ++ R   LV+E++ + T+ D L      + L    V+     +    + +
Sbjct: 85  NLVNLLEVCKKKKR-WYLVFEFVDH-TILDDLELF--PNGLDYQVVQ-KYLFQIINGIGF 139

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDV-TH-VST----APQ---GT 275
            H+ ++IHRD+K  NIL+  +  VK+ DFG +R    P +V    V+T    AP+   G 
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199

Query: 276 PGYVDPDYFQCYKLTDKS-DVYSFGVVLIELISG 308
             Y             K+ DV++ G ++ E+  G
Sbjct: 200 VKY------------GKAVDVWAIGCLVTEMFMG 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  112 bits (283), Expect = 9e-28
 Identities = 59/272 (21%), Positives = 101/272 (37%), Gaps = 34/272 (12%)

Query: 51  KTPPSSASGATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATD 110
           ++PP             T    +     P  P          S    K  +  +     D
Sbjct: 8   QSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID-----D 62

Query: 111 NFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNL 168
              +S+ LG G  G V     +      A+K L     +   +   EVE+  +    P++
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHI 117

Query: 169 VKLYGC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIE 219
           V++           + LL+V E +  G +   + +R   +         +      I   
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--------FTEREASEIMKS 169

Query: 220 TAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
              A+ YLH+ ++ HRDVK  N+L      N  +K+ DFG ++   +   +  T P  TP
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTP 227

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            YV P+     K     D++S GV++  L+ G
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  111 bits (279), Expect = 1e-27
 Identities = 44/215 (20%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQ 164
           +E  + +  ++ LG G FG V+  +     +    K +             E+ IL   +
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIAR 59

Query: 165 HPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IA 217
           H N++ L+    S +  EL++++E+I    + + ++              L+        
Sbjct: 60  HRNILHLHESFESME--ELVMIFEFISGLDIFERINTSA---------FELNEREIVSYV 108

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSRLF-PTDVTHVSTAPQG 274
            +   AL +LH+ ++ H D++  NI+     +  +K+ +FG +R   P D   +      
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---T 165

Query: 275 TPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
            P Y  P+  Q   ++  +D++S G ++  L+SG+
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  114 bits (287), Expect = 1e-27
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR---IEQFMNEVEILTKL-- 163
           ++F+  + +G GGFG VY     D G++ A+K L +   K        +NE  +L+ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 164 -QHPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
              P +V +       + + L  + + +  G +  HL             +R   A E  
Sbjct: 249 GDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAA-EII 302

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             L ++H   V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ P
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 359

Query: 282 DYFQCYKLTDKS-DVYSFGVVLIELISGL 309
           +  Q     D S D +S G +L +L+ G 
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  112 bits (282), Expect = 2e-27
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           +++   K +G G FG V L   +   ++ A+K L +           F  E +I+     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 166 PNLVKLYGCTSRQSRELL-LVYEYIPNGTVADHLHNRQPNSCLLPWPV-RLSIAIETAGA 223
           P +V+L+   + Q    L +V EY+P G + + + N       +P    R   A E   A
Sbjct: 129 PWVVQLFY--AFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA-EVVLA 180

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP-- 281
           L  +H+   IHRDVK +N+LLD +  +K+ADFG       +         GTP Y+ P  
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 282 ----DYFQCYKLTDKS-DVYSFGVVLIELISGL 309
                    Y    +  D +S GV L E++ G 
Sbjct: 241 LKSQGGDGYY---GRECDWWSVGVFLYEMLVGD 270

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 2e-27
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 30/221 (13%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRL------YENNFKRIEQFMNEVE 158
           E   D +++ ++LG G F  V     +  G   A K +              E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS--- 215
           IL ++QHPN++ L+        +++L+ E +  G + D L  ++           L+   
Sbjct: 67  ILKEIQHPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKE----------SLTEEE 115

Query: 216 ---IAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLFPTDVTHV 268
                 +    + YLH+  + H D+K  NI+L        R+K+ DFGL+          
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175

Query: 269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           +    GTP +V P+      L  ++D++S GV+   L+SG 
Sbjct: 176 NIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  110 bits (277), Expect = 2e-27
 Identities = 50/233 (21%), Positives = 96/233 (41%), Gaps = 27/233 (11%)

Query: 92  SSYFGAKVFSCSELEEATDNFN-SSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR 149
               G +      +E   + +  +SK+LG G F  V   I +  G+  A K L +    +
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69

Query: 150 --IEQFMNEVEILTKLQH-PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC 206
               + ++E+ +L   +  P ++ L+      + E++L+ EY   G +            
Sbjct: 70  DCRAEILHEIAVLELAKSCPRVINLHE-VYENTSEIILILEYAAGGEIFSLCLPELAEM- 127

Query: 207 LLPWPVRLS--IAIETA----GALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGL 257
                  +S    I         + YLH ++++H D+K  NILL +      +K+ DFG+
Sbjct: 128 -------VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180

Query: 258 SRLF-PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           SR               GTP Y+ P+      +T  +D+++ G++   L++  
Sbjct: 181 SRKIGHACELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT 230

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  110 bits (277), Expect = 4e-27
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 15/205 (7%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQH 165
           D F+  K LG G FG V L   ++ G   A+K L +      K+IE  +NE  IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P LVKL       S  L +V EY+  G +  HL            P     A +      
Sbjct: 101 PFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+ D+I+RD+K  N+L+D    ++V DFG ++      T       GTP  + P+   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWTLC---GTPEALAPEIIL 211

Query: 286 CYKLTDKS-DVYSFGVVLIELISGL 309
             K  +K+ D ++ GV++ E+ +G 
Sbjct: 212 -SKGYNKAVDWWALGVLIYEMAAGY 235

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  109 bits (275), Expect = 6e-27
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 42/212 (19%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVK-----RLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           K +G G FG   L        +VAVK        + N +R      E+     L+HPN+V
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR------EIINHRSLRHPNIV 79

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG------- 222
           +        +  L ++ EY   G + + + N            R S   E          
Sbjct: 80  RFKEVILTPT-HLAIIMEYASGGELYERICNAG----------RFS---EDEARFFFQQL 125

Query: 223 --ALAYLHASDVIHRDVKSNNILLDNNF--RVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
              ++Y H+  + HRD+K  N LLD +   R+K+ DFG S+         ST   GTP Y
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAY 183

Query: 279 VDPDYFQCYKLTD--KSDVYSFGVVLIELISG 308
           + P+     +  D   +DV+S GV L  ++ G
Sbjct: 184 IAPEVLLR-QEYDGKIADVWSCGVTLYVMLVG 214

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  106 bits (267), Expect = 2e-26
 Identities = 39/282 (13%), Positives = 85/282 (30%), Gaps = 60/282 (21%)

Query: 117 QLGDGGFGAVYLGILRD---GRIVAVKRL---YENNFKRIEQFMNEVEILTKLQHPNLVK 170
             G       +     D    R VA+  +          +++ ++    L+++  P + +
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR-LSIAIETAGALAYLHA 229
           +      ++   L+V E+I  G++ +            P PV  +      A A    H 
Sbjct: 96  VLDVVHTRAG-GLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR 147

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           + V       + + +  +  V +A                T P   P             
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA-------------TMPDANP------------- 181

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
             + D+   G  L  L+         R               +     + ++P+      
Sbjct: 182 --QDDIRGIGASLYALLVN-------RWPLPEAGVRSGLAPAERDTAGQPIEPAD----- 227

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRP--TMKEVLEILRETKD 389
              R++   ++ +A R VQ D  +R   T+  +++      D
Sbjct: 228 -IDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVAD 268

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  106 bits (266), Expect = 6e-26
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 47/221 (21%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQF--------MNEVEILT 161
           + +   +++G+G +G VY      GRIVA+KR+      R++          + E+ +L 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLK 74

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADH-LHN--RQPNSCLLPWPVRLSIAI 218
           +L HPN+V L      +   L LV+E++      +  L     +  + L    ++     
Sbjct: 75  ELHHPNIVSLIDVIHSERC-LTLVFEFM------EKDLKKVLDENKTGLQDSQIK-IYLY 126

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV---TH-VST---- 270
           +    +A+ H   ++HRD+K  N+L++++  +K+ADFGL+R F   V   TH V T    
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186

Query: 271 APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           AP    G+  Y           +   D++S G +  E+I+G
Sbjct: 187 APDVLMGSKKY-----------STSVDIWSIGCIFAEMITG 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  105 bits (264), Expect = 7e-26
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 47/221 (21%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQF--------MNEVEILT 161
           + ++  +++G+G +G VY      G   A+K++      R+E+         + E+ IL 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI------RLEKEDEGIPSTTIREISILK 55

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADH-LHN--RQPNSCLLPWPVRLSIAI 218
           +L+H N+VKLY     + R L+LV+E++      D  L          L     + S  +
Sbjct: 56  ELKHSNIVKLYDVIHTKKR-LVLVFEHL------DQDLKKLLDVCEGGLESVTAK-SFLL 107

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV---TH-VST---- 270
           +    +AY H   V+HRD+K  N+L++    +K+ADFGL+R F   V   TH + T    
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 271 APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           AP    G+  Y           +   D++S G +  E+++G
Sbjct: 168 APDVLMGSKKY-----------STTIDIWSVGCIFAEMVNG 197

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  105 bits (265), Expect = 1e-25
 Identities = 68/207 (32%), Positives = 110/207 (53%), Gaps = 19/207 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
            +F   + LG G FG V+L   R  GR  A+K L +      K++E   +E  +L+ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAIETAGA 223
           P +++++G      + + ++ +YI  G +   L   Q  PN        +   A E   A
Sbjct: 66  PFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAA-EVCLA 118

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L YLH+ D+I+RD+K  NILLD N  +K+ DFG ++  P DVT+      GTP Y+ P+ 
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLC---GTPDYIAPEV 174

Query: 284 FQCYKLTDKS-DVYSFGVVLIELISGL 309
               K  +KS D +SFG+++ E+++G 
Sbjct: 175 VS-TKPYNKSIDWWSFGILIYEMLAGY 200

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  106 bits (266), Expect = 3e-25
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 13/206 (6%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           + F   K LG G FG V L   +  GR  A+K L +        +   + E  +L   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 166 PNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           P L  L      Q+ + L  V EY   G +  HL   +          R   A E   AL
Sbjct: 208 PFLTALKYSF--QTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGA-EIVSAL 261

Query: 225 AYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
            YLH+  +V++RD+K  N++LD +  +K+ DFGL +    D   + T   GTP Y+ P+ 
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320

Query: 284 FQCYKLTDKSDVYSFGVVLIELISGL 309
            +        D +  GVV+ E++ G 
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  104 bits (262), Expect = 3e-25
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F+  K LG G FG V L   +  GR  A+K L +        +   + E  +L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 166 PNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           P L  L      Q+ + L  V EY   G +  HL   +          R   A E   AL
Sbjct: 65  PFLTALKYAF--QTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGA-EIVSAL 118

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
            YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D   + T   GTP Y+ P+  
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177

Query: 285 QCYKLTDKSDVYSFGVVLIELISGL 309
           +        D +  GVV+ E++ G 
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  103 bits (259), Expect = 5e-25
 Identities = 42/164 (25%), Positives = 82/164 (50%), Gaps = 18/164 (10%)

Query: 108 ATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQ-------FMNEVEI 159
           ++  F   ++LG+G +  VY G+    G  VA+K +      +++         + E+ +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISL 56

Query: 160 LTKLQHPNLVKLYGCTSRQSRELLLVYEYIPN--GTVADHLHNRQPNSCLLPWPVRLSIA 217
           + +L+H N+V+LY     +++ L LV+E++ N      D          L    V+    
Sbjct: 57  MKELKHENIVRLYDVIHTENK-LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQ 114

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
            +    LA+ H + ++HRD+K  N+L++   ++K+ DFGL+R F
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 1e-24
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 15/160 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN-----EVEILTKL 163
             +     LG+G F  VY        +IVA+K++   +    +  +N     E+++L +L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPN--GTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
            HPN++ L      +S  + LV++++      +         +  L P  ++ +  + T 
Sbjct: 70  SHPNIIGLLDAFGHKSN-ISLVFDFMETDLEVIIKD-----NSLVLTPSHIK-AYMLMTL 122

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
             L YLH   ++HRD+K NN+LLD N  +K+ADFGL++ F
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (255), Expect = 1e-24
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 48/221 (21%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF--------MNEVEIL 160
             +   +++G+G +G V+         IVA+KR+      R++          + E+ +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLL 55

Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADH-LHN--RQPNSCLLPWPVRLSIA 217
            +L+H N+V+L+       + L LV+E+       D  L       N  L P  V+ S  
Sbjct: 56  KELKHKNIVRLHDVLHSDKK-LTLVFEFC------DQDLKKYFDSCNGDLDPEIVK-SFL 107

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV---TH-VST--- 270
            +    L + H+ +V+HRD+K  N+L++ N  +K+A+FGL+R F   V   +  V T   
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167

Query: 271 -APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
             P    G   Y           +   D++S G +  EL +
Sbjct: 168 RPPDVLFGAKLY-----------STSIDMWSAGCIFAELAN 197

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  102 bits (256), Expect = 2e-24
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 47/221 (21%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQ-------FMNEVEILT 161
           + +    +LG+G +  VY G  +    +VA+K +      R+E         + EV +L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLK 55

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADH-LHN--RQPNSCLLPWPVRLSIAI 218
            L+H N+V L+     +   L LV+EY+      D  L        + +    V+     
Sbjct: 56  DLKHANIVTLHDIIHTEKS-LTLVFEYL------DKDLKQYLDDCGNIINMHNVK-LFLF 107

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDV-TH-VST---- 270
           +    LAY H   V+HRD+K  N+L++    +K+ADFGL+R    PT    + V T    
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR 167

Query: 271 APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            P    G+  Y           + + D++  G +  E+ +G
Sbjct: 168 PPDILLGSTDY-----------STQIDMWGVGCIFYEMATG 197

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  102 bits (257), Expect = 2e-24
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 28/169 (16%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF----MNEVEILTKLQ 164
             +    ++G G FG V+     + G+ VA+K++   N K  E F    + E++IL  L+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74

Query: 165 HPNLVKLYG-CTSRQSRE------LLLVYEYIPNGTVADH-----LHNRQPNSCLLPWPV 212
           H N+V L   C ++ S        + LV+++       +H     L N           +
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSN--VLVKFTLSEI 126

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF 261
           +  +       L Y+H + ++HRD+K+ N+L+  +  +K+ADFGL+R F
Sbjct: 127 K-RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  101 bits (253), Expect = 4e-24
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYL---GILRD-GRIVAVKRLYE----NNFKRIEQFMNEVEILT 161
           + F   + LG GG+G V+        + G+I A+K L +     N K       E  IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 162 KLQHPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWP-VRLSIAIE 219
           +++HP +V L      Q+   L L+ EY+  G +   L        +         +A E
Sbjct: 77  EVKHPFIVDLIYAF--QTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLA-E 129

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPG 277
            + AL +LH   +I+RD+K  NI+L++   VK+ DFGL +  +    VTH      GT  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIE 186

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           Y+ P+           D +S G ++ ++++G 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  100 bits (252), Expect = 6e-24
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 18/209 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYL----GILRDGRIVAVKRLYENNFKRIEQF--MNEVEILTKL 163
             F   K LG G FG V+L          ++ A+K L +   K  ++     E +IL ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 164 QHPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
            HP +VKL+     Q+   L L+ +++  G +   L             V+  +A E A 
Sbjct: 84  NHPFIVKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLA-ELAL 137

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVD 280
           AL +LH+  +I+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ 
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCGTVEYMA 194

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           P+       T  +D +SFGV++ E+++G 
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (255), Expect = 6e-24
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 14/157 (8%)

Query: 117 QLGDGGFGAVYLGILRD---GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYG 173
           ++G G +G VY    +D    +  A+K++             E+ +L +L+HPN++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM--SACREIALLRELKHPNVISLQK 85

Query: 174 -CTSRQSRELLLVYEYIPN--GTVADHLHNRQPNSCLLPWPVRL--SIAIETAGALAYLH 228
              S   R++ L+++Y  +    +       + N   +  P  +  S+  +    + YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 229 ASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF 261
           A+ V+HRD+K  NIL+        RVK+AD G +RLF
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  101 bits (253), Expect = 6e-24
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQ 164
            +F+  + +G G +  V L  L+   RI A+K + +      + I+    E  +  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP LV L+ C   +SR L  V EY+  G +  H+  ++    L     R   A E + AL
Sbjct: 69  HPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSA-EISLAL 123

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPD 282
            YLH   +I+RD+K +N+LLD+   +K+ D+G+ +  L P D T       GTP Y+ P+
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPE 180

Query: 283 YFQCYKLTDKS-DVYSFGVVLIELISGL 309
             +  +    S D ++ GV++ E+++G 
Sbjct: 181 ILR-GEDYGFSVDWWALGVLMFEMMAGR 207

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  100 bits (251), Expect = 7e-24
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 26/179 (14%)

Query: 108 ATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN-----EVEILT 161
           AT  +    ++G G +G VY       G  VA+K +   N       +      EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 162 KLQ---HPNLVKLY----GCTSRQSRELLLVYEYIPNGTVADH----LHNRQPNSCLLPW 210
           +L+   HPN+V+L        + +  ++ LV+E++      D       ++ P   L   
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQDLRTYLDKAPPPGLPAE 120

Query: 211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTDVTH 267
            ++  +  +    L +LHA+ ++HRD+K  NIL+ +   VK+ADFGL+R++     +T 
Sbjct: 121 TIK-DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  100 bits (251), Expect = 1e-23
 Identities = 69/213 (32%), Positives = 104/213 (48%), Gaps = 20/213 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYL----GILRDGRIVAVKRL----YENNFKRIEQFMNEVEILT 161
           +NF   K LG G +G V+L         G++ A+K L         K  E    E ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 162 KLQH-PNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWP-VRLSIAI 218
            ++  P LV L+     Q+   L L+ +YI  G +  HL  R+          V++ +  
Sbjct: 114 HIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVG- 166

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           E   AL +LH   +I+RD+K  NILLD+N  V + DFGLS+ F  D T  +    GT  Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226

Query: 279 VDPDYFQCYKL-TDKS-DVYSFGVVLIELISGL 309
           + PD  +      DK+ D +S GV++ EL++G 
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =   99 bits (250), Expect = 1e-23
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 17/208 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQ 164
           ++F   K LG G FG V+L   +   +  A+K L ++       +E  M E  +L+   +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 165 HPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           HP L  ++     Q++E L  V EY+  G +  H+ +                A E    
Sbjct: 77  HPFLTHMFCTF--QTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILG 130

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDP 281
           L +LH+  +++RD+K +NILLD +  +K+ADFG+ +  +     T+      GTP Y+ P
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---GTPDYIAP 187

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGL 309
           +     K     D +SFGV+L E++ G 
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  100 bits (251), Expect = 1e-23
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQ 164
            +F+  K +G G FG V L   +      AVK L +      K  +  M+E  +L K ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 165 HPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           HP LV L+     Q+ + L  V +YI  G +  HL   +   C L    R   A E A A
Sbjct: 98  HPFLVGLHFSF--QTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAA-EIASA 151

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDP 281
           L YLH+ ++++RD+K  NILLD+   + + DFGL +    ++ H ST     GTP Y+ P
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCGTPEYLAP 208

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGL 309
           +           D +  G VL E++ GL
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  102 bits (254), Expect = 2e-23
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEIL-TKLQ 164
            +FN    LG G FG V L   +    + AVK L ++       +E  M E  +L    +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 165 HPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            P L +L+ C   Q+ + L  V EY+  G +  H+            P  +  A E A  
Sbjct: 401 PPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIG 454

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L +L +  +I+RD+K +N++LD+   +K+ADFG+ +    D     T   GTP Y+ P+ 
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI 513

Query: 284 FQCYKLTDKSDVYSFGVVLIELISGL 309
                     D ++FGV+L E+++G 
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  100 bits (250), Expect = 2e-23
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 31/222 (13%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENN-FK-RIEQFMNEVEILTK 162
            +  D F   +  G G FG V LG  +  G  VA+K++ ++  F+ R  Q M   + L  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIM---QDLAV 75

Query: 163 LQHPNLVKLYGC----TSRQSRE--LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
           L HPN+V+L         R  R+  L +V EY+P+ T+     N        P  +    
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134

Query: 217 AIETAGALAYLHAS--DVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQ 273
             +   ++  LH    +V HRD+K +N+L++  +  +K+ DFG ++       +V+    
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---- 190

Query: 274 GTPGYVDPDY-------FQCYKLTDKSDVYSFGVVLIELISG 308
               Y+   Y       F     T   D++S G +  E++ G
Sbjct: 191 ----YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 15/207 (7%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQ 164
           DNF   + LG G FG V L  +++ G + AVK L ++       +E  M E  IL+    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 165 HPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           HP L +L+ C   Q+ + L  V E++  G +  H+   +          R   A E   A
Sbjct: 83  HPFLTQLFCCF--QTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAA-EIISA 136

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY 283
           L +LH   +I+RD+K +N+LLD+    K+ADFG+ +    +    +T   GTP Y+ P+ 
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEI 195

Query: 284 FQCYKLTDKS-DVYSFGVVLIELISGL 309
            Q   L   + D ++ GV+L E++ G 
Sbjct: 196 LQ-EMLYGPAVDWWAMGVLLYEMLCGH 221

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 48/184 (26%), Positives = 90/184 (48%), Gaps = 40/184 (21%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRIEQFMN--------EV 157
             +    ++G+G +G V+    RD    GR VA+KR+      R++            EV
Sbjct: 11  QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRV------RVQTGEEGMPLSTIREV 62

Query: 158 EILTKLQ---HPNLVKLY----GCTSRQSRELLLVYEYIPNGTVADH----LHNRQPNSC 206
            +L  L+   HPN+V+L+       + +  +L LV+E++      D       ++ P   
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPG 116

Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF--PTD 264
           +    ++  +  +    L +LH+  V+HRD+K  NIL+ ++ ++K+ADFGL+R++     
Sbjct: 117 VPTETIK-DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 265 VTHV 268
           +T V
Sbjct: 176 LTSV 179

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  100 bits (250), Expect = 3e-23
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQ 164
            +F+  + +G G +  V L  L+   RI A++ + +      + I+    E  +  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP LV L+ C   +SR L  V EY+  G +  H+  ++    L     R   A E + AL
Sbjct: 112 HPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSA-EISLAL 166

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVDPD 282
            YLH   +I+RD+K +N+LLD+   +K+ D+G+ +  L P D T       GTP Y+ P+
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPE 223

Query: 283 YFQCYKLTDKS-DVYSFGVVLIELISGL 309
             +  +    S D ++ GV++ E+++G 
Sbjct: 224 ILR-GEDYGFSVDWWALGVLMFEMMAGR 250

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 19/209 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQ 164
            +FN    LG G FG V L   +    + AVK L ++       +E  M E  +L    +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 165 HPNLVKLYGCTSRQSRE-LLLVYEYIPNGTVADHLHNRQPNSCLLPWP-VRLSIAIETAG 222
            P L +L+ C   Q+ + L  V EY+  G +  H+            P      A E A 
Sbjct: 80  PPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAA-EIAI 132

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR--LFPTDVTHVSTAPQGTPGYVD 280
            L +L +  +I+RD+K +N++LD+   +K+ADFG+ +  ++    T       GTP Y+ 
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIA 189

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           P+           D ++FGV+L E+++G 
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 58/229 (25%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQF--------MNEVEIL 160
           D +    +LG+G +G VY  I       VA+KR+      R+E          + EV +L
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLL 87

Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADH-----LHNRQPNSCLLPWPVRLS 215
            +LQH N+++L        R L L++EY       ++     +        +    ++ S
Sbjct: 88  KELQHRNIIELKSVIHHNHR-LHLIFEYA------ENDLKKYMDKNPD---VSMRVIK-S 136

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNF-----RVKVADFGLSRLF--PTDV-TH 267
              +    + + H+   +HRD+K  N+LL  +       +K+ DFGL+R F  P    TH
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196

Query: 268 -VST----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            + T     P+   G+  Y           +   D++S   +  E++  
Sbjct: 197 EIITLWYRPPEILLGSRHY-----------STSVDIWSIACIWAEMLMK 234

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 46/224 (20%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
           E    + S   +G G +G+V   I  R G  VA+K+L    F      KR      E+ +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRA---YRELLL 76

Query: 160 LTKLQHPNLVKLY-----GCTSRQSRELLLVYEYIPNGTVADHLHN--RQPNSCLLPWPV 212
           L  +QH N++ L        + R   +  LV  ++      D L               +
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLK---FSEEKI 128

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH-VST- 270
           +  +  +    L Y+H++ V+HRD+K  N+ ++ +  +K+ DFGL+R    ++T  V T 
Sbjct: 129 Q-YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187

Query: 271 ---APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
              AP+       Y               D++S G ++ E+++G
Sbjct: 188 WYRAPEVILSWMHY-----------NQTVDIWSVGCIMAEMLTG 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 92.3 bits (230), Expect = 5e-21
 Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 27/244 (11%)

Query: 75  SQSIPSYP--YSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-L 131
           S  +PS    Y+  +  R   Y+  +           D++   ++LG G +  V+  I +
Sbjct: 1   SGPVPSRARVYTDVNTHRPREYWDYESHVVEW--GNQDDYQLVRKLGRGKYSEVFEAINI 58

Query: 132 RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGC-TSRQSRELLLVYEYI 189
            +   V VK L     K+I++   E++IL  L+  PN++ L        SR   LV+E++
Sbjct: 59  TNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115

Query: 190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNF 248
            N    D          L  + +R     E   AL Y H+  ++HRDVK +N+++D  + 
Sbjct: 116 NN---TD-FKQLYQT--LTDYDIR-FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 168

Query: 249 RVKVADFGLSRLF--PTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKS-DVYSFGVVLIE 304
           ++++ D+GL+  +    +    V++       +  P+    Y++ D S D++S G +L  
Sbjct: 169 KLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLAS 223

Query: 305 LISG 308
           +I  
Sbjct: 224 MIFR 227

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.4 bits (230), Expect = 8e-21
 Identities = 48/217 (22%), Positives = 94/217 (43%), Gaps = 31/217 (14%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
                + + K +G G  G V         R VA+K+L    F      KR      E+ +
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRA---YRELVL 77

Query: 160 LTKLQHPNLVKLY-----GCTSRQSRELLLVYEYIPNGTVADHLHN--RQPNSCLLPWPV 212
           +  + H N++ L        +  + +++ +V E +     A+ L    +           
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQVIQMELD-----HE 127

Query: 213 RLS-IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA 271
           R+S +  +    + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R      + + T 
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTP 185

Query: 272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
              T  Y  P+        +  D++S G ++ E+I G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 50/229 (21%), Positives = 85/229 (37%), Gaps = 44/229 (19%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQ--FMN--------- 155
                +   + +  G +GAV  G+  +G  VA+KR++             +         
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 156 EVEILTKLQHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHN--RQPNSCLLP 209
           E+ +L    HPN++ L             +L LV E +      D L          + P
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TD-LAQVIHDQRIVISP 133

Query: 210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT--- 266
             ++          L  LH + V+HRD+   NILL +N  + + DF L+R    D     
Sbjct: 134 QHIQ-YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192

Query: 267 HVST----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           +V+     AP+      G+           T   D++S G V+ E+ + 
Sbjct: 193 YVTHRWYRAPELVMQFKGF-----------TKLVDMWSAGCVMAEMFNR 230

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 33/242 (13%)

Query: 59  GATATTSAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELE-EATDNFNSSKQ 117
           G++   +AA    + +  ++          ++  S            + +  D +     
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEILTKLQHPNLVK 170
           +G G +G V       + R+VA+K++    F      KRI   + E+ IL +L H ++VK
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRI---LREIAILNRLNHDHVVK 116

Query: 171 LY----GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIET 220
           +          +  EL +V E       +D          L   PV L+      +    
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIAD----SD-FKK------LFRTPVYLTELHIKTLLYNL 165

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
              + Y+H++ ++HRD+K  N L++ +  VKV DFGL+R         S  P        
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 281 PD 282
             
Sbjct: 226 NL 227

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 89.8 bits (223), Expect = 7e-20
 Identities = 45/250 (18%), Positives = 91/250 (36%), Gaps = 59/250 (23%)

Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMN-EVEILTK 162
           LE ++  ++  K LG G FG V      + G+  A+K++      +  ++ N E++I+  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKV 56

Query: 163 LQHPNLVKLYGC-TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR-------- 213
           L H N++KL     +    E         +  +    +    +   +             
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 214 -------LSIAIETAG--------------------ALAYLHASDVIHRDVKSNNILLD- 245
                  L   +++                      A+ ++H+  + HRD+K  N+L++ 
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 246 NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDY-------FQCYKLTDKSDVYSF 298
            +  +K+ DFG ++        V+        Y+   +           + T   D++S 
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVA--------YICSRFYRAPELMLGATEYTPSIDLWSI 228

Query: 299 GVVLIELISG 308
           G V  ELI G
Sbjct: 229 GCVFGELILG 238

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 46/207 (22%), Positives = 78/207 (37%), Gaps = 50/207 (24%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYG 173
           + LG G  G V     +      A+K L     +   +   EVE+  +  Q P++V++  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVD 78

Query: 174 C---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS------IAIETAGAL 224
                    + LL+V E +  G +   + +R   +         +      I      A+
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--------FTEREASEIMKSIGEAI 130

Query: 225 AYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            YLH+ ++ HRDVK  N+L      N  +K+ DFG              A + T    D 
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------AKETTGEKYDK 177

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG 308
                       D++S GV++  L+ G
Sbjct: 178 ----------SCDMWSLGVIMYILLCG 194

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 54/244 (22%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
              DN+     +G G +G VYL       + VA+K++    F      KRI   + E+ I
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRI---LREITI 78

Query: 160 LTKLQHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           L +L+   +++LY         +  EL +V E       +D L        L   P+ L+
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LKK------LFKTPIFLT 127

Query: 216 ------IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR-LFPTDVTHV 268
                 I         ++H S +IHRD+K  N LL+ +  VKV DFGL+R +     T++
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 269 STAPQGTPGYVDPDYFQCYKLTD--------------------KS-DVYSFGVVLIELIS 307
               +        +     +LT                     KS D++S G +  EL++
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 308 GLEA 311
            L++
Sbjct: 248 MLQS 251

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 47/222 (21%), Positives = 90/222 (40%), Gaps = 41/222 (18%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
                + + K +G G  G V         R VA+K+L    F      KR      E+ +
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRA---YRELVL 114

Query: 160 LTKLQHPNLVKLY-----GCTSRQSRELLLVYEYIPNGTVADHLHN--RQPNSCLLPWPV 212
           +  + H N++ L        T  + +++ LV E +     A+ L    +     L    +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQVIQME---LDHERM 166

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
              +  +    + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R   T         
Sbjct: 167 S-YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------- 217

Query: 273 QGTPGYVD------PDYFQCYKLTDKSDVYSFGVVLIELISG 308
                YV       P+        +  D++S G ++ E++  
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 41/222 (18%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
           E    +   + +G G +GAV   +  R G  VA+K+LY   F      KR      E+ +
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRA---YRELRL 77

Query: 160 LTKLQHPNLVKLY-----GCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRL 214
           L  ++H N++ L        T     +  LV  ++      D L     +  L    ++ 
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LGKLMKHEKLGEDRIQ- 131

Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVST--- 270
            +  +    L Y+HA+ +IHRD+K  N+ ++ +  +K+ DFGL+R   +++T +V T   
Sbjct: 132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWY 191

Query: 271 -APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            AP+       Y           T   D++S G ++ E+I+G
Sbjct: 192 RAPEVILNWMRY-----------TQTVDIWSVGCIMAEMITG 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 42/228 (18%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
             + +F     LG+G +G V        G IVA+K++    F       R    + E++I
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRT---LREIKI 62

Query: 160 LTKLQHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHN---RQPNSCLLPWPV 212
           L   +H N++ ++      +     E+ ++ E +      D LH     Q    L    +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TD-LHRVISTQM---LSDDHI 114

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
           +     +T  A+  LH S+VIHRD+K +N+L+++N  +KV DFGL+R+        S   
Sbjct: 115 Q-YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 273 QGTP---GYVDPDY---------FQCYKLTDKSDVYSFGVVLIELISG 308
                   +V   +            Y  +   DV+S G +L EL   
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLR 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 53/230 (23%), Positives = 103/230 (44%), Gaps = 53/230 (23%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
           +    + +   +G+G +G V       +   VA+K++  + F      +R    + E++I
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRT---LREIKI 78

Query: 160 LTKLQHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHN---RQPNSCLLPWPV 212
           L + +H N++ +       T  Q +++ +V + +      D L+     Q    L    +
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQH---LSNDHI 130

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH----- 267
                 +    L Y+H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H     
Sbjct: 131 C-YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 268 --VST----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             V+T    AP+    + GY           T   D++S G +L E++S 
Sbjct: 190 EYVATRWYRAPEIMLNSKGY-----------TKSIDIWSVGCILAEMLSN 228

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 47/225 (20%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
           E  + + +   +G G +G+V      + G  VAVK+L    F      KR      E+ +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRT---YRELRL 81

Query: 160 LTKLQHPNLVKLY-----GCTSRQSRELLLVYEYIPNGTVADHLHN---RQPNSCLLPWP 211
           L  ++H N++ L        +  +  ++ LV   +     AD L+N    Q    L    
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNNIVKCQK---LTDDH 133

Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HVST 270
           V+  +  +    L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T +V+T
Sbjct: 134 VQ-FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192

Query: 271 ----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
               AP+       Y               D++S G ++ EL++G
Sbjct: 193 RWYRAPEIMLNWMHY-----------NQTVDIWSVGCIMAELLTG 226

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 53/237 (22%), Positives = 102/237 (43%), Gaps = 58/237 (24%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL-YENNF--KRIEQFMNEVEILTK 162
           +    +   K LG GG G V+  +     + VA+K++   +    K     + E++I+ +
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRR 64

Query: 163 LQHPNLVKLY-------------GCTSRQSRELLLVYEYIPNGTVADHLHN---RQPNSC 206
           L H N+VK++               +  +   + +V EY+      D L N   + P   
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LANVLEQGP--- 116

Query: 207 LLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDV 265
           LL    RL    +    L Y+H+++V+HRD+K  N+ ++  +  +K+ DFGL+R+     
Sbjct: 117 LLEEHARL-FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 266 TH-------VST----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
           +H       + T    +P+       Y           T   D+++ G +  E+++G
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNY-----------TKAIDMWAAGCIFAEMLTG 221

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 46/235 (19%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF------KRIEQFMNEVEI 159
                +   K+LG G +G V+  I  R G +VAVK+++ + F      +R      E+ I
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRT---FREIMI 61

Query: 160 LTKLQ-HPNLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHN---RQPNSCLLPWPVRL 214
           LT+L  H N+V L     +   R++ LV++Y+      D LH          L P   + 
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TD-LHAVIRANI---LEPVHKQ- 112

Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQG 274
            +  +    + YLH+  ++HRD+K +NILL+    VKVADFGLSR F       +  P  
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 275 TPGYVDPDYFQCYKLTD---------------------KSDVYSFGVVLIELISG 308
                +        LTD                       D++S G +L E++ G
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 18/204 (8%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH-PNLVKLYG 173
           +++G G FG +YLG  +  G  VA+K   E    +  Q   E +I   +Q    +  +  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 72

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
           C   +    ++V E +  G   + L N             L +A +    + Y+H+ + I
Sbjct: 73  C-GAEGDYNVMVMELL--GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFI 127

Query: 234 HRDVKSNNILL---DNNFRVKVADFGLSRLF--PTDVTHV----STAPQGTPGYVDPDYF 284
           HRDVK +N L+        V + DFGL++ +       H+    +    GT  Y   +  
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187

Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
              + + + D+ S G VL+    G
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLG 211

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.8 bits (188), Expect = 1e-15
 Identities = 35/201 (17%), Positives = 62/201 (30%), Gaps = 53/201 (26%)

Query: 108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLY--------ENNFKRIEQFMNEVEI 159
            T+     +++G+G FG V+  I  D   VA+K +          ++ K  E+ + E+ I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 160 LTKLQ---------HPNLVKLYG---CTSRQSRELL------------------------ 183
             +L              + L             LL                        
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 184 --LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSN 240
             +V E+   G   + +  +  +          SI  +   +LA   AS    HRD+   
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSS-----LATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 241 NILLDNNFRVKVADFGLSRLF 261
           N+LL      K+      +  
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSS 212

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 1/169 (0%)

Query: 140 KRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLH 199
           +  +     +  +F    + +  +      +L   TS QS       E      V +   
Sbjct: 122 RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

Query: 200 NRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
                   L     +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R
Sbjct: 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 260 LFPTDVTHVSTAPQGTPG-YVDPDYFQCYKLTDKSDVYSFGVVLIELIS 307
               D  +V       P  ++ P+       T +SDV+SFGV+L E+ S
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.4 bits (167), Expect = 7e-13
 Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 8/97 (8%)

Query: 116 KQLGDGGFGAVYLGIL------RDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPN 167
           K LG G FG V              R VAVK L E          M+E++IL  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN 204
           +V L G  ++    L+++ E+   G ++ +L +++  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 124

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 40/222 (18%), Positives = 76/222 (34%), Gaps = 34/222 (15%)

Query: 116 KQLGDGGFGAVYLGI---------LRDGRIVAVK-------RLYENNFKRIEQFMNEVEI 159
                   G +Y                +  ++K          E NF +      +V  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 160 LTKLQHPNLV---KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR--L 214
             KL    L+      G    Q +   LV   +  G       +  P   L     R  L
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVL---SERSVL 162

Query: 215 SIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRVKVADFGLSRLFPTDVTHVSTAP 272
            +A     AL +LH ++ +H +V + NI +  ++  +V +A +G +  +     HV+   
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 273 Q------GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                  G   ++  D  +    + +SD+ S G  +++ + G
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 37/227 (16%), Positives = 78/227 (34%), Gaps = 44/227 (19%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIE--QFMNEVEILTKLQHPNLV---- 169
             +G GGFG +YL  +     V          +  +      E++   +   P  +    
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 170 -----------KLYGCTSRQSREL---LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
                      K +G             ++ +    G+    ++             R S
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK--------RFS 150

Query: 216 ------IAIETAGALAYLHASDVIHRDVKSNNILLD--NNFRVKVADFGLSRLFPTDVTH 267
                 +++     L Y+H  + +H D+K++N+LL+  N  +V + D+GL+  +  +  H
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

Query: 268 V------STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
                       GT  +   D       + + D+   G  +I+ ++G
Sbjct: 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 39/212 (18%), Positives = 84/212 (39%), Gaps = 20/212 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH-PN 167
            ++   +++G+G FG ++ G  L + + VA+K  +E       Q  +E      L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTG 67

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +  +Y    ++    +LV + +  G   + L +                A +    +  +
Sbjct: 68  IPNVYYF-GQEGLHNVLVIDLL--GPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSI 122

Query: 228 HASDVIHRDVKSNNILL-----DNNFRVKVADFGLSRLF--PTDVTHV----STAPQGTP 276
           H   +++RD+K +N L+      N   + V DFG+ + +  P    H+         GT 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            Y+  +     + + + D+ + G V +  + G
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 47/204 (23%), Positives = 89/204 (43%), Gaps = 18/204 (8%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYG 173
           +++G G FG +YLG  ++    VA+K   EN   +  Q + E +I   LQ    +  +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVI 233
               +    +LV + +  G   + L N       L     L +A +    + ++H+   +
Sbjct: 71  F-GVEGDYNVLVMDLL--GPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125

Query: 234 HRDVKSNNILL---DNNFRVKVADFGLSRLF--PTDVTHV----STAPQGTPGYVDPDYF 284
           HRD+K +N L+       +V + DFGL++ +   +   H+    +    GT  Y   +  
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185

Query: 285 QCYKLTDKSDVYSFGVVLIELISG 308
              + + + D+ S G VL+  + G
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFLRG 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 68.2 bits (167), Expect = 9e-13
 Identities = 44/219 (20%), Positives = 81/219 (36%), Gaps = 31/219 (14%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKR-----------LYENNFKRIEQFMNEVEILTKL 163
           K++G GGFG +YL          A                E  F +     + ++   + 
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 164 QHPNLV---KLYGCTSRQSREL---LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIA 217
           +  + +     YG    + +      +V E +  G     +  +            L + 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT---FKKSTVLQLG 157

Query: 218 IETAGALAYLHASDVIHRDVKSNNILLD--NNFRVKVADFGLSRLFPTDVTHV------S 269
           I     L Y+H ++ +H D+K+ N+LL   N  +V +AD+GLS  +  +  H        
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217

Query: 270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
               GT  +   D  +   L+ +SDV   G  ++  + G
Sbjct: 218 KGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 14/164 (8%)

Query: 111 NFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH-PNL 168
           NF   K++G G FG + LG  L     VA+K   E    R  Q   E     +L     +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGI 67

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
            ++Y       +   +V E +  G   + L +    +        L IAI+    + Y+H
Sbjct: 68  PQVYYF-GPCGKYNAMVLELL--GPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVH 122

Query: 229 ASDVIHRDVKSNNILL-----DNNFRVKVADFGLSRLFPTDVTH 267
           + ++I+RDVK  N L+          + + DF L++ +    T 
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 34/212 (16%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP------NL 168
             +G G FG V       +   VA+K + +N    + Q   EV +L  +          +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 169 VKLYGC-TSRQ----SRELLLV--YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           V L      R       E+L    Y+ + N        N +  S  L    R   A +  
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRN-------TNFRGVSLNL---TR-KFAQQMC 167

Query: 222 GALAYLHASD--VIHRDVKSNNILLDNNFR--VKVADFGLSRLFPTDVTHVSTAPQGTPG 277
            AL +L   +  +IH D+K  NILL N  R  +K+ DFG S         +    Q +  
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQ--RIYQYIQ-SRF 223

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           Y  P+           D++S G +L+E+ +G 
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 43/221 (19%), Positives = 85/221 (38%), Gaps = 42/221 (19%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           ++LG G F  V+L   + +   VA+K +   +    E   +E+++L ++   +  K    
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL------------------PWPVRL-- 214
            +    +LL  + +   G    H+        ++                    P+    
Sbjct: 84  GANHILKLLDHFNHK--GPNGVHV-------VMVFEVLGENLLALIKKYEHRGIPLIYVK 134

Query: 215 SIAIETAGALAYLHAS-DVIHRDVKSNNILLD------NNFRVKVADFGLSRLFPTDVTH 267
            I+ +    L Y+H    +IH D+K  N+L++      N  ++K+AD G +         
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190

Query: 268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             T    T  Y  P+          +D++S   ++ ELI+G
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 60/216 (27%), Positives = 86/216 (39%), Gaps = 48/216 (22%)

Query: 118 LGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH------PNLVK 170
           +G G FG V      +  + VA+K +  N  +   Q   E+ IL  L+        N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 171 LYGC-TSRQ----SRELLL--VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           +    T R     + ELL   +YE I            Q  S  L   VR   A      
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKN-------KFQGFSLPL---VR-KFAHSILQC 212

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFR--VKVADFGLSRLFPTDV-THVST----APQ--- 273
           L  LH + +IH D+K  NILL    R  +KV DFG S      V T++ +    AP+   
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVIL 272

Query: 274 GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL 309
           G   Y               D++S G +L EL++G 
Sbjct: 273 GAR-Y-----------GMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 54/273 (19%), Positives = 89/273 (32%), Gaps = 90/273 (32%)

Query: 110 DNFNS----SKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ 164
           D FN      ++LG G F  V+L   ++  + VA+K + ++     E  ++E+ +L  ++
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVR 91

Query: 165 -----HPNLVKLYGCTSRQSRELLLVYEYI-PNGTVADHL--------HN-----RQPNS 205
                 PN   +         +LL  ++    NGT   H+        H+      + N 
Sbjct: 92  NSDPNDPNREMV--------VQLLDDFKISGVNGT---HICMVFEVLGHHLLKWIIKSNY 140

Query: 206 CLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILL-------------------- 244
             LP P    I  +    L YLH    +IH D+K  NILL                    
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 245 -----------------------------DNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
                                            +VK+AD G +       T        T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----T 256

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
             Y   +          +D++S   +  EL +G
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 62/242 (25%), Positives = 92/242 (38%), Gaps = 76/242 (31%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQH-----PN 167
           +++GDG FG V L   + + +  AVK  R   N  K       E +IL K+Q+      N
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNN 97

Query: 168 LVKLYGCTSRQSR-----ELLL--VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
           +VK +G            E L   +YE I         +N           ++    IE 
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGPSLYEIITR-------NNYNGFHIED---IK-LYCIEI 146

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNF-------------------------RVKVADF 255
             AL YL    + H D+K  NILLD+ +                          +K+ DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 256 GLSRLFPTDV--THVST----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELI 306
           G    F +D   + ++T    AP+       +   D          SD++SFG VL EL 
Sbjct: 207 G-CATFKSDYHGSIINTRQYRAPEVILNLG-W---DV--------SSDMWSFGCVLAELY 253

Query: 307 SG 308
           +G
Sbjct: 254 TG 255

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 54/238 (22%), Positives = 85/238 (35%), Gaps = 72/238 (30%)

Query: 116 KQLGDGGFGAVY--LGILRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP----- 166
             LG+G FG V   +     GR VAVK  +   N  +  E   +E+++L  L        
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 167 -NLVKLYGCTSRQSR-----ELLL--VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
              V++              ELL    Y++I         +   P        +R  +A 
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE-------NGFLPFRLDH---IR-KMAY 125

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNN-------------------FRVKVADFGLSR 259
           +   ++ +LH++ + H D+K  NIL   +                     +KV DFG S 
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SA 184

Query: 260 LFPTDV--THVST----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            +  +   T VST    AP+       +               DV+S G +LIE   G
Sbjct: 185 TYDDEHHSTLVSTRHYRAPEVILALG-W---SQ--------PCDVWSIGCILIEYYLG 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 59/238 (24%), Positives = 86/238 (36%), Gaps = 72/238 (30%)

Query: 116 KQLGDGGFGAVY--LGILRDGRIVAVK--RLYENNFKRIEQFMNEVEILTKLQHP----- 166
             LG+G FG V   L   R    VA+K  R   N  K  E    E+ +L K++       
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENK 81

Query: 167 -NLVKLYGCTSRQSR-----ELLL--VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
              V +    +         ELL    +E++         +N QP        VR  +A 
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE-------NNFQPYPLPH---VR-HMAY 130

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNF-------------------RVKVADFGLSR 259
           +   AL +LH + + H D+K  NIL  N+                     ++VADFG S 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SA 189

Query: 260 LFPTDV--THVST----APQ---GTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG 308
            F  +   T V+T     P+       +  P            DV+S G +L E   G
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELG-WAQP-----------CDVWSIGCILFEYYRG 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 4e-07
 Identities = 53/396 (13%), Positives = 102/396 (25%), Gaps = 144/396 (36%)

Query: 98  KVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDG-RIVAVKRLY----ENNFKRIEQ 152
             F C ++++   +  S +++           I+     +    RL+        + +++
Sbjct: 31  DNFDCKDVQDMPKSILSKEEIDH---------IIMSKDAVSGTLRLFWTLLSKQEEMVQK 81

Query: 153 FMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPV 212
           F+ EV    ++ +  L+       RQ   +  +Y         D L+N   N     + V
Sbjct: 82  FVEEVL---RINYKFLMSPIKTEQRQPSMMTRMYIE-----QRDRLYND--NQVFAKYNV 131

Query: 213 -RLSIAIETAGALAYLHASD--VIH---------------RDVKSNNILLDNNFRVKVAD 254
            RL   ++   AL  L  +   +I                   K   +    +F++   +
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK---VQCKMDFKIFWLN 188

Query: 255 FG--------------LSRLFPTDVTHVSTAPQGTPGYVD------------PDYFQCYK 288
                           L      + T  S         +               Y  C  
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 289 LTDKSDVYSFGVVLIELISGLEAVD-------TSRHRHDIN-LSNMATNKIQNGALNELV 340
           +    +V +             A +       T+R +   + LS   T  I       L 
Sbjct: 249 VLL--NVQNAKAW--------NAFNLSCKILLTTRFKQVTDFLSAATTTHI------SLD 292

Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTSKAKVV 400
             S+    D                             EV  +L             K +
Sbjct: 293 HHSMTLTPD-----------------------------EVKSLL------------LKYL 311

Query: 401 DIRIADDAALLKKDSP--------SLSPDDSGTDKW 428
           D R  D    +   +P        S+    +  D W
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	438
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.21
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.17
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.96
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.82
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.63
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.58
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.45
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.31
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.82
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.81
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.71
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.56
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.56
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	97.56
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.4
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.1
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.02
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.81
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.76
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	96.72
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.7
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.4
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.25
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	94.71
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.39
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	91.38
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.57
2llm_A	43	Amyloid beta A4 protein; alzheimer'S disease, prot	86.07
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.58

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-59  Score=442.99  Aligned_cols=261  Identities=30%  Similarity=0.483  Sum_probs=207.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .+++++.+.||+|+||+||+|.+++  .||||+++..  .....+.|.+|+++|++++|||||+++|++..  +.++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEE
Confidence            4678889999999999999998753  5999998643  34556789999999999999999999997754  3589999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      |||++|+|.++|+....   .+++..+..|+.||+.||+|||+++||||||||+||||++++.+||+|||+|+...... 
T Consensus       111 Ey~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999986543   39999999999999999999999999999999999999999999999999998764322 


Q ss_pred             cccccCCCCCCCccCcccccc---CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          266 THVSTAPQGTPGYVDPDYFQC---YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ........||+.|||||++.+   ..|+.++|||||||+||||+||+.||......      ......+..+..    .+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~----~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA----SP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----CC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----CC
Confidence            223345679999999999864   36899999999999999999999999754321      112222222211    11


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      .+..    .+.+++..+.+|+.+||+.||++|||+.||++.|+.++.+
T Consensus       258 ~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          258 DLSK----LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CSTT----SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             Cccc----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            1110    1124667899999999999999999999999999988654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-60  Score=447.40  Aligned_cols=262  Identities=30%  Similarity=0.463  Sum_probs=215.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|.+.+.||+|+||+||+|.+.      ++..||||+++.......++|.+|+++|++++|||||+++|++... +.+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEE
Confidence            356788899999999999999864      3788999999877767778899999999999999999999988665 479


Q ss_pred             EEEEeccCCCCHHHHhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEe
Q 013686          183 LLVYEYIPNGTVADHLHNRQ---------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVA  253 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~  253 (438)
                      +||||||++|+|.++|+...         .....++|..++.++.||+.||.|||+++|+||||||+||||++++.+||+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence            99999999999999998643         123459999999999999999999999999999999999999999999999


Q ss_pred             eeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHH
Q 013686          254 DFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       254 Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      |||+++....... .......||+.|||||.+.+..|+.++|||||||+||||+| |+.||......       .....+
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~~~i  243 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIECI  243 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH
Confidence            9999986544322 22233458999999999999999999999999999999999 89999754321       122233


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      ..+.....            +..+++++.+|+.+||+.||++|||++||++.|+++...
T Consensus       244 ~~~~~~~~------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 TQGRVLQR------------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCC------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            33322111            124567899999999999999999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.9e-59  Score=448.06  Aligned_cols=261  Identities=30%  Similarity=0.455  Sum_probs=210.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ++|.+.++||+|+||+||+|.++      +++.||||+++.......++|.+|+++|++++|||||+++|++... +.+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-RPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEE
Confidence            46777889999999999999864      4789999999877777778999999999999999999999988665 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEE
Q 013686          184 LVYEYIPNGTVADHLHNRQPN-----------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      ||||||++|+|.++++.....           ...++|..++.|+.||+.||.|||+++|+||||||+||||++++.+||
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki  199 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI  199 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence            999999999999999875432           235899999999999999999999999999999999999999999999


Q ss_pred             eeeCcccccCCCc-cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHH
Q 013686          253 ADFGLSRLFPTDV-THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       253 ~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      +|||+++...... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||......       .....
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~~~  272 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------EAIDC  272 (329)
T ss_dssp             CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-------HHHHH
T ss_pred             cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence            9999998664332 223344579999999999999999999999999999999999 89999754321       11223


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      +..+....     .       +..+++++.+|+.+||+.||++|||++||+++|+.+.+.
T Consensus       273 i~~g~~~~-----~-------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 ITQGRELE-----R-------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHTCCCC-----C-------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHcCCCCC-----C-------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            33322111     1       124567899999999999999999999999999988654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.2e-59  Score=442.37  Aligned_cols=259  Identities=26%  Similarity=0.413  Sum_probs=211.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++++.+.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|++... +.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-QPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-CEE
Confidence            34566789999999999999863      46889999996543 33457899999999999999999999988665 478


Q ss_pred             EEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          183 LLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      +||||||++|+|.++|..+...            ...++|..++.|+.||++||+|||+++||||||||+||||++++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence            9999999999999999764321            1358999999999999999999999999999999999999999999


Q ss_pred             EEeeeCcccccCCC-ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHH
Q 013686          251 KVADFGLSRLFPTD-VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       251 kl~Dfgla~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~  328 (438)
                      ||+|||+++..... .........||+.|||||++.+..|+.++|||||||+||||+| |..||......       ...
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-------~~~  257 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DVV  257 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-------HHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-------HHH
Confidence            99999999865432 2233345679999999999999999999999999999999998 89999754321       122


Q ss_pred             HHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      ..+..+.....            +..++..+.+|+.+||+.||++||||.||+++|+...
T Consensus       258 ~~i~~~~~~~~------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          258 EMIRNRQVLPC------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHcCCCCCC------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            23333322111            1246678999999999999999999999999998653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-59  Score=446.02  Aligned_cols=252  Identities=26%  Similarity=0.441  Sum_probs=204.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++++.||+|+||+||+|..+ +|+.||||++...  .....+.+.+|+++|++|+|||||++++++..+ +.+|||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiV  101 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIV  101 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEE
Confidence            368999999999999999999976 6999999999754  334567899999999999999999999987665 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||||+||+|.++|...+..  .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus       102 mEy~~gg~L~~~i~~~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGV--LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             EeCCCCCcHHHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999999765432  37899999999999999999999999999999999999999999999999998764322


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                       ......+||+.|||||++.+..|+.++|||||||+||||+||+.||......      . ....+..+.....      
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~-~~~~i~~~~~~~~------  245 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------N-LVLKIISGSFPPV------  245 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCCCC------
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------H-HHHHHHcCCCCCC------
Confidence             1223456999999999999999999999999999999999999999754321      1 1222333322111      


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            +..++.++.+||.+||+.||++|||++|++++
T Consensus       246 ------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          246 ------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  12356779999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.1e-59  Score=443.81  Aligned_cols=251  Identities=28%  Similarity=0.457  Sum_probs=211.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      +.|++.+.||+|+||+||+|..+ +|+.||||++........+.+.+|+++|++++|||||++++++..+ +.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeC
Confidence            56899999999999999999986 6999999999766555556788999999999999999999987665 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      |+||+|.+++....     +++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus       153 ~~gg~L~~~l~~~~-----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  226 (346)
T 4fih_A          153 LEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  226 (346)
T ss_dssp             CTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred             CCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence            99999999997642     89999999999999999999999999999999999999999999999999997654432 2


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|++||.......       ....+..+..     +.+.   
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~-----~~~~---  291 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLP-----PRLK---  291 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSSC-----CCCS---
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCC-----CCCC---
Confidence            345689999999999999999999999999999999999999997543211       1122222211     1111   


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        .+..+++++.+||.+||+.||++|||++|++++-
T Consensus       292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp  325 (346)
T 4fih_A          292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  325 (346)
T ss_dssp             --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence              1134667899999999999999999999998863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-58  Score=444.72  Aligned_cols=273  Identities=26%  Similarity=0.380  Sum_probs=222.4

Q ss_pred             ChHHHHHHhcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCC-CCceeEe
Q 013686          101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENN-FKRIEQFMNEVEILTKLQH-PNLVKLY  172 (438)
Q Consensus       101 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~~~  172 (438)
                      ..++++...++|++.+.||+|+||+||+|.+..      ++.||||++.... ....+.|.+|+++|.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345566667899999999999999999998653      3689999997653 3445789999999999965 8999999


Q ss_pred             eeeeccCceEEEEEeccCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013686          173 GCTSRQSRELLLVYEYIPNGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSN  240 (438)
Q Consensus       173 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~  240 (438)
                      |++...+..++||||||++|+|.++|+....            ....+++..++.++.||++||+|||+++||||||||+
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~  214 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  214 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence            9887666678999999999999999986432            1234899999999999999999999999999999999


Q ss_pred             CEEecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcc
Q 013686          241 NILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHR  318 (438)
Q Consensus       241 Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~  318 (438)
                      |||+++++.+||+|||+|+....+... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||......
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999976543322 2334568999999999999999999999999999999998 99999754322


Q ss_pred             cccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          319 HDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                            ......+..+.....            +..+++++.+++.+||+.||++|||+.||+++|+.+.+++
T Consensus       295 ------~~~~~~i~~g~~~~~------------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          295 ------EEFCRRLKEGTRMRA------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             ------HHHHHHHHHTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ------HHHHHHHHcCCCCCC------------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence                  122233333322111            1235667899999999999999999999999999886544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-57  Score=423.86  Aligned_cols=246  Identities=27%  Similarity=0.464  Sum_probs=201.2

Q ss_pred             CCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec---cCceEEEEE
Q 013686          113 NSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR---QSRELLLVY  186 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~  186 (438)
                      ++.++||+|+||+||+|.++ +++.||+|++...  .....+.|.+|+++|++|+|||||++++++..   ....+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999976 5899999998654  33445789999999999999999999997654   234689999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEec-CCCeEEEeeeCcccccCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLD-NNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~  263 (438)
                      |||+||+|.+++.+...    +++..+..++.||+.||+|||++|  |+||||||+||||+ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999987654    999999999999999999999998  99999999999997 479999999999986543


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .   .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||......      ......+..+..+...+  
T Consensus       185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~~--  252 (290)
T 3fpq_A          185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD--  252 (290)
T ss_dssp             T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG--
T ss_pred             C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCCC--
Confidence            2   2334579999999999875 6999999999999999999999999643221      11223333322211111  


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                               ..+++++.+|+.+||+.||++|||++|++++
T Consensus       253 ---------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          253 ---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     2244578999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-58  Score=434.45  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=209.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++.+..   ....+.+.+|+++|++++|||||++++++..+ +.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            56899999999999999999976 69999999997543   23457899999999999999999999987665 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||||+||+|.+++.+.+.    +++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus       111 mEy~~gG~L~~~i~~~~~----l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            999999999999987654    9999999999999999999999999999999999999999999999999999775432


Q ss_pred             -cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 -THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                       .......+||+.|||||++.+..|+.++||||+||++|||+||+.||......       .....+..+...      +
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~~~------~  253 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFAKIIKLEYD------F  253 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC------C
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC------C
Confidence             23345568999999999999999999999999999999999999999754321       112233322211      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        +     ..+++++.+||.+||+.||++|||++|++..
T Consensus       254 --p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          254 --P-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             --C-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             --C-----cccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence              1     1345678999999999999999999997654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-57  Score=444.75  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=211.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .+.|++.+.||+|+||.||+|..+ +|+.||||++........+.+.+|+.+|+.++|||||++++++... +.+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmE  228 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVME  228 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEe
Confidence            356999999999999999999986 6999999999766555557789999999999999999999987765 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ||+||+|.+++....     +++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+..... 
T Consensus       229 y~~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          229 FLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             CCTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            999999999997643     89999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......       .....+..+...     .+.. 
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~~~-----~~~~-  369 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPP-----RLKN-  369 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCC-----CCSC-
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCCCC-----CCcc-
Confidence            234567999999999999999999999999999999999999999754321       112223222111     1110 


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          +..++..+.+||.+||+.||++|||+.|++++-
T Consensus       370 ----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp  402 (423)
T 4fie_A          370 ----LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  402 (423)
T ss_dssp             ----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence                123567899999999999999999999998863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9e-58  Score=434.93  Aligned_cols=254  Identities=20%  Similarity=0.243  Sum_probs=206.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .+.|.+.++||+|+||+||+|.++ +|+.||||++.....     ..+|+.+++.++|||||++++++..+ +.+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG-PWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEe
Confidence            345778889999999999999976 699999999975432     23699999999999999999977665 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCcccccCCCcc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+||+|.++|+..+.    +++..+..++.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.+..+..
T Consensus       131 y~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             ccCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999999987654    99999999999999999999999999999999999999987 699999999997654321


Q ss_pred             c----cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          267 H----VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       267 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .    .....+||+.|||||++.+..|+.++|||||||++|||+||+.||........       ...+..+....    
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~~~----  275 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------CLKIASEPPPI----  275 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------HHHHHHSCCGG----
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHcCCCCc----
Confidence            1    12335799999999999999999999999999999999999999976433221       11222211110    


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                            ...+..+++.+.+++.+||+.||++|||+.|++++|.....
T Consensus       276 ------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          276 ------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             ------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                  00112456789999999999999999999999999887654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.6e-57  Score=418.29  Aligned_cols=247  Identities=27%  Similarity=0.434  Sum_probs=193.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++.+..   ....+.+.+|+++|++++|||||++++++..+ +.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-DEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEE
Confidence            68999999999999999999975 69999999997543   23356789999999999999999999977665 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||| +|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        92 mEy~-~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            9999 7899999987654    9999999999999999999999999999999999999999999999999998754332


Q ss_pred             cccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                        .....+||+.|||||++.+..| +.++||||+||++|||+||+.||......       .....+..+...      +
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------~~~~~i~~~~~~------~  231 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------VLFKNISNGVYT------L  231 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC------C
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC------C
Confidence              2344679999999999998876 57999999999999999999999754221       112233332211      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        +     ..+++++.+|+.+||+.||++|||++|++++-
T Consensus       232 --p-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  264 (275)
T 3hyh_A          232 --P-----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD  264 (275)
T ss_dssp             --C-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred             --C-----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence              1     13466789999999999999999999999854

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.4e-57  Score=428.28  Aligned_cols=267  Identities=21%  Similarity=0.311  Sum_probs=202.8

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC---ceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS---RELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~e  187 (438)
                      +|.+.+.||+|+||+||+|.+ +|+.||||++....... ..+..|+..+.+++|||||+++|++...+   ..+|||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            466788999999999999998 58999999987553322 23345666667889999999999876543   25899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS--------DVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ||++|+|.++|+...     ++|..+.+++.|++.||+|||++        +|+||||||+||||+.++++||+|||+++
T Consensus        82 y~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           82 YHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             CCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999998653     89999999999999999999987        99999999999999999999999999998


Q ss_pred             ccCCCccc---cccCCCCCCCccCccccccC------CCCChhhHHHHHHHHHHHHhCCCCcccCCcccc----cc----
Q 013686          260 LFPTDVTH---VSTAPQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD----IN----  322 (438)
Q Consensus       260 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~----~~----  322 (438)
                      ........   ......||+.|||||++.+.      .++.++|||||||+||||+||.+||........    ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543322   12235699999999999764      467799999999999999999988764332111    00    


Q ss_pred             hhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      ........+..+    ..+|.++.  ......++..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       237 ~~~~~~~~~~~~----~~rp~~p~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEEMRKVVCEQ----KLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTS----CCCCCCCG--GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhcc----cCCCCCCc--cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            011111222222    12222221  111234667889999999999999999999999999988653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.7e-57  Score=424.96  Aligned_cols=248  Identities=25%  Similarity=0.330  Sum_probs=197.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ++|++.+.||+|+||+||+|...    +++.||||++.....  .....+.+|+++|++++|||||++++++..+ +.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEE
Confidence            56899999999999999999863    478999999865422  2234678899999999999999999987665 5799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      ||||||+||+|.+++.+.+.    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus       103 ivmEy~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEcCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999987654    99999999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......       .....+..+...      
T Consensus       179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~~~------  244 (304)
T 3ubd_A          179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-------ETMTMILKAKLG------  244 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------
T ss_pred             CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------HHHHHHHcCCCC------
Confidence            32 2234567999999999999999999999999999999999999999754321       112223222211      


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM-----KEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  383 (438)
                        .     +..+++++.+|+.+||+.||++|||+     +|++++
T Consensus       245 --~-----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          245 --M-----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             --C-----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             --C-----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence              1     12356778999999999999999984     677654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.4e-55  Score=412.86  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=192.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc-------
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR-------  180 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  180 (438)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++.... ....+.+.+|+++|++|+|||||++++++...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46889999999999999999976 68999999986543 3445789999999999999999999997754332       


Q ss_pred             ----eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeC
Q 013686          181 ----ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG  256 (438)
Q Consensus       181 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  256 (438)
                          .+|+|||||++|+|.+++...... ...++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                479999999999999999875431 225667788999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc-----------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH
Q 013686          257 LSRLFPTDVTH-----------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN  325 (438)
Q Consensus       257 la~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~  325 (438)
                      +|+........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||.....     . .
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~-~  234 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----R-V  234 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----H-H
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----H-H
Confidence            99876543211           1233569999999999999999999999999999999996   6643110     0 0


Q ss_pred             HHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .....+....            .+......++.+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          235 RTLTDVRNLK------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHHTTC------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhcCC------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111122211            122334556677899999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-54  Score=421.30  Aligned_cols=267  Identities=20%  Similarity=0.331  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec-----cCce
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-----QSRE  181 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~  181 (438)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++...  .....+.+.+|+++|+.++|||||++++++..     ..+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999976 6999999999653  33445678899999999999999999997643     2357


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +|||||||+ |+|.+++...+.    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~----l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQP----LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999995 789999987553    999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCc---cccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc-
Q 013686          262 PTDV---THVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL-  336 (438)
Q Consensus       262 ~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  336 (438)
                      ....   .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+........   ........... 
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~---~I~~~~g~p~~~  285 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ---LIMMVLGTPSPA  285 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH---HHHHHHCCCCGG
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhcCCCChH
Confidence            4321   2233456899999999998875 56999999999999999999999998654322111   00000000000 


Q ss_pred             ----------c---ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          337 ----------N---ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       337 ----------~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                                .   ..+.+............++.++.+|+.+||..||++|||+.|++++-
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  346 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP  346 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence                      0   00001111111111223567889999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-52  Score=403.63  Aligned_cols=266  Identities=21%  Similarity=0.335  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCce
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  181 (438)
                      ...++|++.+.||+|+||+||+|..+    +++.||+|++.....  ...+.+|+++|+.+ +||||+++++++... +.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKN-DH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEET-TE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEEC-CE
Confidence            34678999999999999999999864    468899999865532  35678899999998 699999999977655 57


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCcccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRL  260 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~  260 (438)
                      +|+|||||++|+|.+++..       +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        95 ~~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999999842       8999999999999999999999999999999999999876 7999999999986


Q ss_pred             cCCCcc---------------------------ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCc
Q 013686          261 FPTDVT---------------------------HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAV  312 (438)
Q Consensus       261 ~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~  312 (438)
                      ......                           ......+||+.|||||++.+. .|+.++||||+||++|||+||+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            543211                           112234699999999999775 5899999999999999999999999


Q ss_pred             ccCCcccccchhHHHH-----------HHHhcCcc----------c---------ccccCcCC------CCccHHHHHHH
Q 013686          313 DTSRHRHDINLSNMAT-----------NKIQNGAL----------N---------ELVDPSLG------FEKDYAVRNMV  356 (438)
Q Consensus       313 ~~~~~~~~~~~~~~~~-----------~~~~~~~~----------~---------~~~~~~~~------~~~~~~~~~~~  356 (438)
                      .......+. +.....           ........          .         ....+...      ......+..++
T Consensus       248 ~~~~~~~~~-l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          248 YKASDDLTA-LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCHHHH-HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            644321110 000000           00000000          0         00000000      00000112356


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          357 TSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       357 ~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +++.+|+.+||+.||++|||++|++++
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            778999999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.6e-51  Score=391.28  Aligned_cols=282  Identities=42%  Similarity=0.665  Sum_probs=237.6

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ++....++|++.+.||+|+||.||+|.+++|+.||||++........+.+.+|+.+++.++||||+++++++... +..+
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~  111 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-NEMI  111 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-TCCE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEE
Confidence            344457899999999999999999999888999999998776656678899999999999999999999977654 4789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999999987654444699999999999999999999999999999999999999999999999999986543


Q ss_pred             Cc-cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          264 DV-THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       264 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.............+.......+.+...+++
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            22 22223345899999999999889999999999999999999999999876665555555555555555666666665


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      .+....   ...++..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       272 ~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          272 NLADKI---RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SCTTCS---CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcccc---CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            543322   24677889999999999999999999999999998764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.1e-51  Score=418.90  Aligned_cols=254  Identities=21%  Similarity=0.365  Sum_probs=212.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|.+........+.+.+|+++|+.|+|||||++++++... ..+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEe
Confidence            468999999999999999999986 6999999999877766778899999999999999999999977665 58999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC--CeEEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~--~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+||+|.++|.....   .+++..+..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+++.+....
T Consensus       235 ~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          235 FMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             ecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999999999975432   38999999999999999999999999999999999999854  899999999999875432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......       .....+.......       
T Consensus       312 ~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~~~~-------  375 (573)
T 3uto_A          312 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNM-------  375 (573)
T ss_dssp             E--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCCCC-------
T ss_pred             c--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCCCCC-------
Confidence            2  23457999999999999999999999999999999999999999754321       1112222221110       


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        ....+..++..+.+||.+||+.||.+|||+.|++++-
T Consensus       376 --~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp  412 (573)
T 3uto_A          376 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP  412 (573)
T ss_dssp             --CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence              0111234567889999999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.6e-51  Score=417.56  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=201.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHH---HHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFM---NEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||+||+|..+ +|+.||||++.+....   ....+.   .++.+++.++|||||++++++... +.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-CE
Confidence            367999999999999999999976 6999999999654221   122333   346666778999999999977665 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +|||||||+||+|.++|.+.+.    +++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~----l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999999987654    999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....   ....+||+.|||||++. +..|+.++|||||||+||||++|++||........   ... ...+.....    
T Consensus       343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i-~~~i~~~~~----  411 (689)
T 3v5w_A          343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEI-DRMTLTMAV----  411 (689)
T ss_dssp             SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHH-HHHHHHCCC----
T ss_pred             CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHhhcCCCC----
Confidence            5432   23468999999999996 45799999999999999999999999975432211   111 112211111    


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                        .+       +..++.++.+||.+||+.||.+|++     ++||+++
T Consensus       412 --~~-------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          412 --EL-------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --CC-------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --CC-------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence              01       1235677899999999999999998     7888875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4e-50  Score=385.48  Aligned_cols=287  Identities=42%  Similarity=0.653  Sum_probs=236.1

Q ss_pred             ccccChHHHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchH-hHHHHHHHHHHHHhCCCCCceeEeeee
Q 013686           97 AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFK-RIEQFMNEVEILTKLQHPNLVKLYGCT  175 (438)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~  175 (438)
                      .+.++..++....++|.+.+.||+|+||.||+|...+|+.||||++...... ....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            3467889999999999999999999999999999878999999998754322 223688999999999999999999977


Q ss_pred             eccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCEEecCCCeEEE
Q 013686          176 SRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS---DVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       176 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      ... ...++||||+++|+|.+++.........+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||
T Consensus        97 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           97 MTP-TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             CCS-SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             ecC-CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            655 468999999999999999998766666799999999999999999999999   9999999999999999999999


Q ss_pred             eeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcc--cccchhHHHHHH
Q 013686          253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR--HDINLSNMATNK  330 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~--~~~~~~~~~~~~  330 (438)
                      +|||++...............||+.|+|||.+.+..++.++|||||||++|||++|+.||......  .......+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999999977655444455566999999999998889999999999999999999999999743221  222233333333


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..........+..+....   ....+..+.+++.+||+.||.+|||+.||+++|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSC---CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhchhhhhhcChhhcccc---CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            334444444444443222   245678899999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=371.78  Aligned_cols=261  Identities=29%  Similarity=0.482  Sum_probs=212.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++... ...++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEE
Confidence            357888999999999999999976 5899999998777777778899999999999999999999977665 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++|+|.+++.....   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999987543   3899999999999999999999999999999999999999999999999999876433221


Q ss_pred             c-------------ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC
Q 013686          268 V-------------STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG  334 (438)
Q Consensus       268 ~-------------~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (438)
                      .             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+............. ....... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~-  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFLDR-  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHHHH-
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccccc-
Confidence            1             114569999999999999999999999999999999999999987543321111000 0001100 


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                          ...           ..++..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus       243 ----~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          243 ----YCP-----------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ----TCC-----------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cCC-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                000           12345688999999999999999999999999988643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.4e-48  Score=365.90  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=209.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++... +..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-CEEEEEEE
Confidence            568999999999999999999964 6899999998766555567889999999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++|+|.+++....     +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        98 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           98 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            999999999998653     89999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      ........+. ...     .. 
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~-~~~-----~~-  238 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PEL-----QN-  238 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS-CCC-----SC-
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-CCC-----CC-
Confidence            2334579999999999999999999999999999999999999997543211      1111111111 100     00 


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          +..++..+.+++.+||+.||++|||+.|++++-
T Consensus       239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence                124566789999999999999999999999853

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.4e-48  Score=370.25  Aligned_cols=249  Identities=30%  Similarity=0.464  Sum_probs=208.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+++++.++||||+++++++... +..++|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEE
Confidence            567999999999999999999974 7999999998654  334567889999999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999999987654    8999999999999999999999999999999999999999999999999998664432


Q ss_pred             cccccCCCCCCCccCccccccCCCC-ChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLT-DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                        ......||+.|+|||.+.+..++ .++|||||||++|||++|+.||......       .....+..+...      +
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~------~  233 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRERVLRGKYR------I  233 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------C
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC------C
Confidence              23455799999999999888775 7899999999999999999999754321       112222222211      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +       ..++..+.+|+.+||+.||.+|||++|++++-
T Consensus       234 p-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          234 P-------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             C-------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred             C-------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence            1       12456788999999999999999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.3e-48  Score=377.16  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=212.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467889999999999999999863        3567999999755 334567899999999999 899999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       +.+|+||||+++|+|.+++......            ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          160 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             -CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence             4799999999999999999875421            234889999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......     
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-----  313 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-----  313 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence            99999999999986644322 22233457889999999999999999999999999999999 999997543211     


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                        ....+..+....     .       +..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       314 --~~~~~~~~~~~~-----~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 --LFKLLKEGHRMD-----K-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             --HHHHHHTTCCCC-----C-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHhcCCCCC-----C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              112222221111     1       12355678999999999999999999999999998864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-48  Score=366.06  Aligned_cols=263  Identities=24%  Similarity=0.418  Sum_probs=208.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.++++++||||+++++++... +..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-DCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-SEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-CeEEE
Confidence            467899999999999999999976 6899999998543   334457899999999999999999999977654 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        89 v~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EEeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999999987654    899999999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ......+.. ......    
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~~~~~~----  233 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-SVPNVT----  233 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-CCCCHH----
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-cCCCcc----
Confidence            333334456999999999999999999999999999999999999999754321      111112211 111100    


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhccC
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-TMKEVLEILRETKDSN  391 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  391 (438)
                          ......++..+.+++.+||+.||.+|| +++++.+.|+.+....
T Consensus       234 ----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          234 ----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             ----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             ----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence                001123567799999999999999998 9999999998875443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.3e-48  Score=372.75  Aligned_cols=269  Identities=26%  Similarity=0.354  Sum_probs=210.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC---ceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS---RELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|... ++.||||++...... ...+.+|+.++++++||||+++++++....   ..+++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467889999999999999999875 799999998655433 345667999999999999999999776542   347999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCCEEecCCCeEEEeee
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS----------DVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                      |||+++|+|.+++....     +++..++.++.||+.||.|||+.          ||+||||||+|||++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999997643     89999999999999999999999          9999999999999999999999999


Q ss_pred             CcccccCCCccc-cccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH----
Q 013686          256 GLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN----  325 (438)
Q Consensus       256 gla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~----  325 (438)
                      |+++........ ......||+.|+|||.+.+     ..++.++|||||||++|||+||+.||.............    
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            999866543222 2233569999999999986     355668899999999999999999998654332221111    


Q ss_pred             -----HHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          326 -----MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       326 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                           .....+.....    .+.+.  ........+..+.+|+.+||+.||++|||+.|+++.|+++.+.
T Consensus       256 ~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKK----RPVLR--DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCC----CCCCC--GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccC----CCCcc--ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                 01111111111    11111  1111224567799999999999999999999999999988653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.1e-48  Score=359.27  Aligned_cols=259  Identities=31%  Similarity=0.522  Sum_probs=213.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++... ...++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecC-CceEEEEEe
Confidence            3578889999999999999999988899999998765433 36789999999999999999999977655 468999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....   .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        87 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            999999999976543   38999999999999999999999999999999999999999999999999998765544333


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       .....+..+...  ..+     
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~~~~~~~~~~~~--~~~-----  229 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRL--YKP-----  229 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCC--CCC-----
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhcCccC--CCC-----
Confidence            444557889999999998999999999999999999999 99999754321       111222221110  011     


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                           ..++..+.+++.+||+.||++|||+.|++++|+++.++.
T Consensus       230 -----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g  268 (269)
T 4hcu_A          230 -----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  268 (269)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             -----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence                 123567889999999999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.7e-48  Score=365.19  Aligned_cols=267  Identities=28%  Similarity=0.447  Sum_probs=209.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-----CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-----DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  182 (438)
                      .++|++.+.||+|+||.||+|.+.     +++.||||++........+.+.+|++++++++||||+++++++... ...+
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            467889999999999999999842     5889999999877777778899999999999999999999976543 3458


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999987543   28999999999999999999999999999999999999999999999999998764


Q ss_pred             CCcc--ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc--------cc-chhHHHHHHH
Q 013686          263 TDVT--HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH--------DI-NLSNMATNKI  331 (438)
Q Consensus       263 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~--------~~-~~~~~~~~~~  331 (438)
                      ....  .......++..|+|||.+.+..++.++||||||+++|||+||..|+.......        .. .........+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            4322  12223346778999999999999999999999999999999999886432110        00 0000111111


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      ..+...       ..     +..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       246 ~~~~~~-------~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          246 KNNGRL-------PR-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HTTCCC-------CC-----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hccCcC-------CC-----CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            111110       00     124567799999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7e-48  Score=367.16  Aligned_cols=262  Identities=32%  Similarity=0.522  Sum_probs=203.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ..++|++.+.||+|+||+||+|.. +|+.||||++....  ....+.+.+|++++++++||||+++++++... ...++|
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv  112 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-PNLSIV  112 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TCCEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CceEEE
Confidence            356888999999999999999987 58899999986543  34457899999999999999999999977655 468999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      |||+++|+|.+++..... ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999999986432 113889999999999999999999999  99999999999999999999999999986543


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      .. ..+......    ..
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~-~~~~~~~~~----~~  259 (309)
T 3p86_A          192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VV-AAVGFKCKR----LE  259 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HH-HHHHHSCCC----CC
T ss_pred             cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCCC----CC
Confidence            32 12234569999999999999999999999999999999999999997543211      11 111111000    00


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      +       +..++..+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus       260 ~-------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          260 I-------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             C-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             C-------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            1       1234567899999999999999999999999999887654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-47  Score=356.98  Aligned_cols=259  Identities=29%  Similarity=0.507  Sum_probs=213.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|..+++..||+|.+...... .+.+.+|++++++++||||+++++++... ...++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKE-YPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccC-CceEEEEEc
Confidence            4678899999999999999999988889999998765433 36789999999999999999999977554 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....   .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            999999999987543   28999999999999999999999999999999999999999999999999998765554444


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......       ....+..+...  ..+     
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~-----  227 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHRL--YRP-----  227 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCC--CCC-----
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCCC--CCC-----
Confidence            444557788999999998899999999999999999999 999997543211       11122221110  011     


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                           ..++..+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus       228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          228 -----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             -----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             -----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence                 123457889999999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.2e-47  Score=364.60  Aligned_cols=267  Identities=28%  Similarity=0.417  Sum_probs=215.5

Q ss_pred             CCccccChHHHHHHhcC----------CCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC
Q 013686           95 FGAKVFSCSELEEATDN----------FNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL  163 (438)
Q Consensus        95 ~~~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l  163 (438)
                      +....++.+++..+++.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++++
T Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l   99 (321)
T 2c30_A           20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY   99 (321)
T ss_dssp             -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred             ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence            33455777777777654          666779999999999999987 6999999999766555667899999999999


Q ss_pred             CCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 013686          164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL  243 (438)
Q Consensus       164 ~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nil  243 (438)
                      +||||+++++++... ...++||||+++++|.+++...     .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       100 ~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl  173 (321)
T 2c30_A          100 QHFNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL  173 (321)
T ss_dssp             CCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCCcceEEEEEEEC-CEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            999999999977665 4799999999999999998753     2899999999999999999999999999999999999


Q ss_pred             ecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch
Q 013686          244 LDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL  323 (438)
Q Consensus       244 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~  323 (438)
                      ++.++.+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......     
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-----  247 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-----  247 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred             ECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence            999999999999999876543222 23457999999999999999999999999999999999999999754321     


Q ss_pred             hHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          324 SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                        .....+......     .+..     ...++..+.+++.+||+.||++|||+.|++++..
T Consensus       248 --~~~~~~~~~~~~-----~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          248 --QAMKRLRDSPPP-----KLKN-----SHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             --HHHHHHHHSSCC-----CCTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             --HHHHHHhcCCCC-----CcCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence              111222221111     1110     1235567899999999999999999999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=366.35  Aligned_cols=260  Identities=26%  Similarity=0.455  Sum_probs=209.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|.+.    .+..||||.+... .....+.+.+|+.++++++||||+++++++... +..+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~  126 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-RLAM  126 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-GCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CccE
Confidence            457888999999999999999975    3456999999764 344557899999999999999999999977554 5789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       127 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EEeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999999976533   389999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          264 DVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       264 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....  ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+....  
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~~--  274 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYRLP--  274 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCCC--
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCCCC--
Confidence            3222  2223346778999999998899999999999999999999 999997543211       112222221110  


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                         .       +..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       275 ---~-------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          275 ---A-------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ---C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ---C-------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence               0       1235667899999999999999999999999999987654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.5e-46  Score=354.87  Aligned_cols=282  Identities=36%  Similarity=0.624  Sum_probs=224.2

Q ss_pred             cccChHHHHHHhcCCCCC------CcccccCceEEEEEEEcCCcEEEEEEeecc----chHhHHHHHHHHHHHHhCCCCC
Q 013686           98 KVFSCSELEEATDNFNSS------KQLGDGGFGAVYLGILRDGRIVAVKRLYEN----NFKRIEQFMNEVEILTKLQHPN  167 (438)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~n  167 (438)
                      ..|++.++..++++|...      +.||+|+||.||+|.. +++.||+|++...    .....+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457889999999998877      8999999999999987 5889999998643    2234578999999999999999


Q ss_pred             ceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC
Q 013686          168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN  247 (438)
Q Consensus       168 iv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~  247 (438)
                      |+++++++... +..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        92 i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~  169 (307)
T 2nru_A           92 LVELLGFSSDG-DDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA  169 (307)
T ss_dssp             BCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred             eEEEEEEEecC-CceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC
Confidence            99999977655 478999999999999999975432 2348999999999999999999999999999999999999999


Q ss_pred             CeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH
Q 013686          248 FRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM  326 (438)
Q Consensus       248 ~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~  326 (438)
                      +.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|||++|..||.........  ..+
T Consensus       170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~  246 (307)
T 2nru_A          170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDI  246 (307)
T ss_dssp             CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--THH
T ss_pred             CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--HHH
Confidence            99999999999866443222 2234568999999999875 5889999999999999999999999865433221  111


Q ss_pred             HHHHHh-cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          327 ATNKIQ-NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       327 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ...... ...+...+++.+...    ...++..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKMNDA----DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSCSCC----CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHhhhhhhhhhhhcccccccc----chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            111111 112223333333211    24567889999999999999999999999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.2e-48  Score=375.69  Aligned_cols=273  Identities=26%  Similarity=0.387  Sum_probs=219.0

Q ss_pred             cChHHHHHHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeE
Q 013686          100 FSCSELEEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKL  171 (438)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~  171 (438)
                      +...+++...++|++.+.||+|+||.||+|.+.      +++.||||++... .....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            344556666789999999999999999999842      4689999999764 334457899999999999 79999999


Q ss_pred             eeeeeccCceEEEEEeccCCCCHHHHhhccCCC-----------------------------------------------
Q 013686          172 YGCTSRQSRELLLVYEYIPNGTVADHLHNRQPN-----------------------------------------------  204 (438)
Q Consensus       172 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------  204 (438)
                      ++++...+...++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            998877666799999999999999999875431                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc-cc
Q 013686          205 ---------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-HV  268 (438)
Q Consensus       205 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-~~  268 (438)
                                     ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence                           11288999999999999999999999999999999999999999999999999986543322 22


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+|+.|+|||.+.+..++.++|||||||++|||++ |..||.......      .....+..+.....     +  
T Consensus       252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~-----~--  318 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-----P--  318 (359)
T ss_dssp             C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC-----C--
T ss_pred             ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC-----C--
Confidence            334568899999999999999999999999999999998 999997543221      11222222211111     0  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                           ..++..+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus       319 -----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          319 -----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                 12456788999999999999999999999999988653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-47  Score=372.42  Aligned_cols=259  Identities=27%  Similarity=0.475  Sum_probs=199.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|.+.+.||+|+||.||+|...    ++..||||.+... .....+.+.+|+.++++++||||+++++++... ...+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-KPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CceE
Confidence            457899999999999999999865    4778999998754 344557899999999999999999999977655 4789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       123 lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999986543   389999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccccc--ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          264 DVTHV--STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       264 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      .....  .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......      . ....+..+....  
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~-~~~~i~~~~~~~--  270 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------D-VIKAVDEGYRLP--  270 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------H-HHHHHHTTEECC--
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC--
Confidence            32221  112235778999999999999999999999999999998 99999754321      1 112222221100  


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                         .       ...++..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus       271 ---~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          271 ---P-------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ---C-------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---C-------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence               0       013456789999999999999999999999999998653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.5e-47  Score=369.53  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=208.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH------hHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK------RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|.+......      ..+.+.+|+.++++++||||+++++++... ..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~   89 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-TD   89 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-CE
Confidence            567899999999999999999976 5899999998754322      246789999999999999999999977655 57


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC----eEEEeeeCc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF----RVKVADFGL  257 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgl  257 (438)
                      +++||||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCSC----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999976543    99999999999999999999999999999999999998777    799999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......       ....+..+.. 
T Consensus       166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~-  235 (361)
T 2yab_A          166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITAVSY-  235 (361)
T ss_dssp             CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC-
T ss_pred             ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCC-
Confidence            98765432  2234569999999999999999999999999999999999999997543211       1122222111 


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             .+ ....+..++..+.+|+.+||..||++|||+.|++++
T Consensus       236 -------~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 -------DF-DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             -------CC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------CC-CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   11 112334567789999999999999999999999974

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.3e-47  Score=357.72  Aligned_cols=257  Identities=28%  Similarity=0.479  Sum_probs=209.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||++.+.++..||+|++...... .+.+.+|++++++++||||+++++++... ...++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecC-CCeEEEEec
Confidence            4678889999999999999999988889999998765433 36788999999999999999999977654 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....   .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       101 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          101 MANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             cCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            999999999987433   28999999999999999999999999999999999999999999999999998765543333


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       .....+..+...  ..+     
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~~--~~~-----  243 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGLRL--YRP-----  243 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCCC--CCC-----
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhcccCC--CCC-----
Confidence            344557889999999998899999999999999999998 99999754321       111222222110  000     


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                           ..++..+.+++.+||+.||.+|||+.|++++|+++.+
T Consensus       244 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          244 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                 1234578899999999999999999999999998764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.1e-47  Score=362.28  Aligned_cols=266  Identities=22%  Similarity=0.337  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||+||+|...+|+.||+|++.....  ...+.+.+|++++++++||||+++++++... ...++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEEE
Confidence            567899999999999999999998899999999865422  2346788999999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||++ ++|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        99 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           99 EFME-KDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             ECCS-EEHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             cCCC-CCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            9996 588888876543   389999999999999999999999999999999999999999999999999987643322


Q ss_pred             ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc---ccccc--
Q 013686          267 HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA---LNELV--  340 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--  340 (438)
                       ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........   ..........   +....  
T Consensus       175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGTTS
T ss_pred             -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhhcc
Confidence             2234568999999999876 568999999999999999999999997654332211   1111111000   00000  


Q ss_pred             ----cCcC----CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          341 ----DPSL----GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       341 ----~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ....    ..........++.++.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                0000    000111123356678999999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.6e-47  Score=382.36  Aligned_cols=262  Identities=24%  Similarity=0.455  Sum_probs=215.0

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++...++|++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.+|++++||||+++++++.  ....++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~l  259 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYI  259 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEE
Confidence            334467788999999999999999999888999999997654 34578999999999999999999999775  346899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++......  .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus       260 v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGS--KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHH--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEeecCCCcHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999999999864321  2889999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .........+++.|+|||.+....++.++|||||||++|||+| |+.||......      . ....+..+....     
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~~-----  405 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------E-VIRALERGYRMP-----  405 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHHHHHHTCCCC-----
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC-----
Confidence            3333334457789999999998899999999999999999999 99999754321      1 112222221100     


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                        .     +..++..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus       406 --~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          406 --R-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             --C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             --C-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence              0     123567799999999999999999999999999988654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.5e-47  Score=363.19  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=206.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++..+ +|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEE
Confidence            357889999999999999999976 68999999997542   23456788999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 v~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999999999987654    899999999999999999999999999999999999999999999999999864332


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      . ....+..+...      +
T Consensus       159 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~------~  224 (337)
T 1o6l_A          159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------R-LFELILMEEIR------F  224 (337)
T ss_dssp             TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC------C
T ss_pred             CC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC------C
Confidence            22 234457999999999999999999999999999999999999999753321      1 11222221111      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      +       ..++..+.+++.+||+.||++||     +++|++++
T Consensus       225 p-------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          225 P-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C-------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            1       13456789999999999999999     89999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.6e-47  Score=378.39  Aligned_cols=255  Identities=27%  Similarity=0.472  Sum_probs=211.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|.+. |+.||||.++...  ..+.|.+|+.+|++++||||+++++++.......++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888999999999999999885 7899999997654  4477999999999999999999999877665579999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++|+|.+++......  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus       269 ~~~g~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             CTTCBHHHHHHHHCTT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence            9999999999876432  37899999999999999999999999999999999999999999999999998543221   


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||.......       ....+..+....     .   
T Consensus       344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~-----~---  407 (450)
T 1k9a_A          344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMD-----A---  407 (450)
T ss_dssp             ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTCCCC-----C---
T ss_pred             -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----C---
Confidence             22357889999999999999999999999999999998 999997543321       112222221111     0   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                          +..++..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       408 ----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          408 ----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence                1245678999999999999999999999999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.5e-47  Score=367.47  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=208.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH-----hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK-----RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++......     ..+.+.+|+.+++.++||||+++++++... +.+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~  101 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GML  101 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEE
Confidence            457899999999999999999976 6899999998643221     357799999999999999999999977665 579


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe---EEEeeeCccc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSR  259 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfgla~  259 (438)
                      |+||||+++++|.+++.........+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999999988765433345899999999999999999999999999999999999986554   9999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        .....+..+...  
T Consensus       182 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~~--  250 (351)
T 3c0i_A          182 QLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKYK--  250 (351)
T ss_dssp             ECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCCC--
T ss_pred             EecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCCC--
Confidence            7654322 23345799999999999999999999999999999999999999975321        111122221111  


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                            . ....+..++..+.+|+.+||+.||++|||+.|++++-
T Consensus       251 ------~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          251 ------M-NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             ------C-CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ------C-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence                  0 1112335677899999999999999999999999753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.2e-47  Score=358.00  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=203.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHh--CCCCCceeEeeeeec---cCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK--LQHPNLVKLYGCTSR---QSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~---~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|.. +|+.||||++....   .+.+.+|.+++..  ++||||+++++++..   .....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999988 68999999986543   3456667777777  789999999996533   234689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCCEEecCCCeEEEeee
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH--------ASDVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                      +||||+++|+|.++++..     .+++..++.++.||+.||.|||        +++|+||||||+|||++.++.+||+||
T Consensus        83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            999999999999999653     2899999999999999999999        999999999999999999999999999


Q ss_pred             CcccccCCCcccc---ccCCCCCCCccCccccccC------CCCChhhHHHHHHHHHHHHhC----------CCCcccCC
Q 013686          256 GLSRLFPTDVTHV---STAPQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELISG----------LEAVDTSR  316 (438)
Q Consensus       256 gla~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tG----------~~p~~~~~  316 (438)
                      |+++.........   .....||+.|+|||.+.+.      .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998654433221   2234699999999999876      455799999999999999999          77775433


Q ss_pred             cccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..... ... .........    ..+.+  ........++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       238 ~~~~~-~~~-~~~~~~~~~----~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPS-FED-MRKVVCVDQ----QRPNI--PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCC-HHH-HHHHHTTSC----CCCCC--CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcc-hhh-hhHHHhccC----CCCCC--ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22211 111 111111111    11111  11112245678899999999999999999999999999876

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=358.22  Aligned_cols=274  Identities=21%  Similarity=0.331  Sum_probs=213.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-ceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-RELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv  185 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            457889999999999999999987 48999999987543 334577889999999999999999999775543 368999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe----cCCCeEEEeeeCccccc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF  261 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgla~~~  261 (438)
                      |||+++++|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++..
T Consensus        88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            9999999999999875432 238999999999999999999999999999999999999    78889999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccc--------cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQ--------CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      .....  .....||+.|+|||.+.        +..++.++|||||||++|||++|+.||.........  .......+..
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~  242 (319)
T 4euu_A          167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG  242 (319)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHH
T ss_pred             CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcC
Confidence            54432  23456999999999886        467899999999999999999999999754332221  1111111111


Q ss_pred             C---ccccc---------ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          334 G---ALNEL---------VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       334 ~---~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      .   .....         ....+... ......++..+.+++.+||+.||++|||++|++++..+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVS-CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTT-CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcc-cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1   00000         00011111 1123567888999999999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-47  Score=374.91  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEE
Confidence            3567888999999999999999987 68999999987543 33446788999999999999999999977655 468999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....   .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       191 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            999999999999986543   28999999999999999999999999999999999999999999999999998654332


Q ss_pred             cccc-cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          266 THVS-TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       266 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||......       .....+..+....     
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-----  335 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLP-----  335 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCC-----
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-----
Confidence            2211 12235678999999998899999999999999999998 99999754321       1112222221110     


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                        .     +..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       336 --~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          336 --C-----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             --C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence              0     12355678999999999999999999999999998864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=364.08  Aligned_cols=254  Identities=20%  Similarity=0.329  Sum_probs=208.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEE
Confidence            467899999999999999999976 58899999886543 3346788999999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC--CCeEEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~~~~~~  265 (438)
                      |+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.......
T Consensus        82 ~~~g~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            9999999999976532   3899999999999999999999999999999999999987  7899999999998765432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .  .....||+.|+|||.+.+..++.++|||||||++|||++|..||......      . ....+..+...        
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~i~~~~~~--------  221 (321)
T 1tki_A          159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------Q-IIENIMNAEYT--------  221 (321)
T ss_dssp             E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCCC--------
T ss_pred             c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------H-HHHHHHcCCCC--------
Confidence            2  22345899999999999888999999999999999999999999754321      1 11122221111        


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      . ....+..++..+.+++.+||..||.+|||+.|++++-.
T Consensus       222 ~-~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          222 F-DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             C-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             C-ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            1 11223456778999999999999999999999999654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.9e-47  Score=355.75  Aligned_cols=257  Identities=25%  Similarity=0.420  Sum_probs=198.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|....    +..||+|.+... .....+.+.+|+.++++++||||+++++++..  +..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--CccE
Confidence            4678899999999999999999753    457999988654 33445789999999999999999999997643  3689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++++|.+++.....   .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999986543   389999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |..||.......       ....+..+....    
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~i~~~~~~~----  237 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLP----  237 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCC----
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHHHHcCCCCC----
Confidence            43333334457789999999998899999999999999999997 999997543321       112222221111    


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                       +       +..++..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       238 -~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          238 -M-------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             0       12356678999999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-46  Score=354.49  Aligned_cols=263  Identities=16%  Similarity=0.221  Sum_probs=210.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....  .+.+.+|+.+++.+ +|+|++++++++... ...++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCC-ceeEEEE
Confidence            457889999999999999999964 689999998865432  24577899999999 799999999976544 5789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe-----EEEeeeCccccc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR-----VKVADFGLSRLF  261 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfgla~~~  261 (438)
                      ||+ +++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++..
T Consensus        86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 9999999987543   3899999999999999999999999999999999999987766     999999999876


Q ss_pred             CCCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc
Q 013686          262 PTDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA  335 (438)
Q Consensus       262 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (438)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            543221      12345699999999999999999999999999999999999999986543222111111111111111


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      .            ......++..+.+++.+||+.||++|||+++|++.|+++...
T Consensus       242 ~------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          242 L------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             H------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             H------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            0            111124567899999999999999999999999999998654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=361.83  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=207.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH------hHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK------RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+......      ..+.+.+|+.+++.++||||+++++++... ..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~   88 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TD   88 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CE
Confidence            456889999999999999999976 5899999998654321      357799999999999999999999977655 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC----eEEEeeeCc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF----RVKVADFGL  257 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgl  257 (438)
                      .++||||+++++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSC----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCCHHHHHHhcCC----cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999976543    89999999999999999999999999999999999999887    899999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ++.......  .....||+.|+|||.+.+..++.++|||||||++|||++|..||.......       ....+..... 
T Consensus       165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~-  234 (326)
T 2y0a_A          165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY-  234 (326)
T ss_dssp             CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHTCC-
T ss_pred             CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHhcCC-
Confidence            987643322  234569999999999999999999999999999999999999997543211       1111111110 


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                             .. .......++..+.+|+.+||+.||++|||+.|++++-
T Consensus       235 -------~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          235 -------EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             -------CC-CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             -------Cc-CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence                   00 1122335667889999999999999999999999853

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-46  Score=368.00  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++.....   ...+.+.+|..++.++ +||||+++++++... ..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-CEEE
Confidence            467889999999999999999977 588999999976432   2334678899999887 899999999977655 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|..++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       130 lV~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999987654    99999999999999999999999999999999999999999999999999985332


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccc--cchhHHHHHHHhcCccccccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD--INLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..........+......    
T Consensus       206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----  280 (396)
T 4dc2_A          206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----  280 (396)
T ss_dssp             TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC----
T ss_pred             CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC----
Confidence            22 223456799999999999999999999999999999999999999975432211  11112222223222111    


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM------KEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  383 (438)
                        +  +     ..++..+.+|+.+||+.||.+||++      .|++++
T Consensus       281 --~--p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          281 --I--P-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             --C--C-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             --C--C-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence              1  1     1345678899999999999999995      677764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=371.58  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=207.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....  ....+.+.+|+.+++.++||||+++++++... +..++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-GHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-SEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-CEEEE
Confidence            4577999999999999999999975 68999999987543  23456789999999999999999999977655 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec---CCCeEEEeeeCccccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLF  261 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgla~~~  261 (438)
                      ||||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        88 v~E~~~gg~L~~~i~~~~~----~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999987654    89999999999999999999999999999999999998   5678999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||......       .....+..+.... ..
T Consensus       164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~-~~  234 (444)
T 3soa_A          164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAYDF-PS  234 (444)
T ss_dssp             CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCC-CT
T ss_pred             cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCCCC-Cc
Confidence            54322 223457999999999999989999999999999999999999999754321       1122232222111 01


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +        .+..+++.+.+|+.+||+.||++|||+.|++++-
T Consensus       235 ~--------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          235 P--------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             T--------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             c--------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            1        1124567789999999999999999999999853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.1e-46  Score=364.71  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=208.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ..++|.+.+.||+|+||.||+|..+ +|+.||+|.+...  .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~l  105 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYL  105 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEE
Confidence            3567999999999999999999976 5899999998654  334557889999999999999999999977655 47899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC---CeEEEeeeCccccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN---FRVKVADFGLSRLF  261 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfgla~~~  261 (438)
                      ||||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++...
T Consensus       106 v~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999999976543    8999999999999999999999999999999999999865   45999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|..||......       .....+..+....   
T Consensus       182 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~~---  249 (362)
T 2bdw_A          182 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDY---  249 (362)
T ss_dssp             TTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC---
T ss_pred             cCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCC---
Confidence            53322  23456999999999999989999999999999999999999999754321       1122222222110   


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                           . ...+..++..+.+|+.+||+.||++|||+.|++++-
T Consensus       250 -----~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          250 -----P-SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             -----C-TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             -----C-cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence                 0 001234567899999999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-46  Score=350.28  Aligned_cols=259  Identities=31%  Similarity=0.517  Sum_probs=212.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||++...+++.||+|.+...... .+.+.+|++++++++||||+++++++... ...++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCeEEEEeC
Confidence            3578889999999999999999988899999998765433 36789999999999999999999977655 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++.....   .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            999999999987543   38999999999999999999999999999999999999999999999999998765433333


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......      . ....+..+...  ..+     
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~i~~~~~~--~~~-----  227 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTGFRL--YKP-----  227 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCCC--CCC-----
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------H-HHHHHhcCCcC--CCC-----
Confidence            334457889999999998899999999999999999999 89999754321      1 11222222110  000     


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                           ..++..+.+++.+||+.||++|||+.|++++|+.+.++.
T Consensus       228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (267)
T 3t9t_A          228 -----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  266 (267)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             -----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                 123567889999999999999999999999999987643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=362.88  Aligned_cols=264  Identities=27%  Similarity=0.433  Sum_probs=212.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      ..++|++.+.||+|+||.||+|...      +++.||||.+.... ....+.+.+|+.++++++||||+++++++... +
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-K  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-S
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-C
Confidence            4678999999999999999999975      24889999987653 34457899999999999999999999977654 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN--------------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSN  240 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~  240 (438)
                      ..++||||+++|+|.+++......                    ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            789999999999999999875321                    135899999999999999999999999999999999


Q ss_pred             CEEecCCCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcc
Q 013686          241 NILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHR  318 (438)
Q Consensus       241 Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~  318 (438)
                      |||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  283 (343)
T 1luf_A          204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  283 (343)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence            99999999999999999986543221 22234457899999999998899999999999999999999 99999754321


Q ss_pred             cccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          319 HDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                             .....+..+.....            +..++..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       284 -------~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          284 -------EVIYYVRDGNILAC------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             -------HHHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             -------HHHHHHhCCCcCCC------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence                   11222222222111            0234567899999999999999999999999999986543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-46  Score=362.07  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=205.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||++..+ +|+.||+|++...   .....+.+.+|..++.++ +||||+++++++... ..+|
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~   86 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLF   86 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-CEEE
Confidence            357888999999999999999986 5899999999754   334456788999999988 899999999977655 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....    +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        87 lv~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999999987653    89999999999999999999999999999999999999999999999999986432


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc--chhHHHHHHHhcCccccccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI--NLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  .........+......    
T Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----  237 (345)
T 3a8x_A          163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----  237 (345)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----
T ss_pred             CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----
Confidence            22 2234457999999999999999999999999999999999999999753221111  1111222222222111    


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM------KEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  383 (438)
                        +  +     ..++..+.+++.+||+.||.+||++      .|++++
T Consensus       238 --~--p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          238 --I--P-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             --C--C-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             --C--C-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence              1  1     1345678899999999999999995      677764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-46  Score=361.04  Aligned_cols=262  Identities=19%  Similarity=0.235  Sum_probs=208.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||.+.....  .+.+.+|+++++++ +||||+++++++... ...++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-KYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-TEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-CccEEEE
Confidence            357889999999999999999964 689999999865432  24578899999999 899999999977654 5789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe-----EEEeeeCccccc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR-----VKVADFGLSRLF  261 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfgla~~~  261 (438)
                      ||+ +++|.+++.....   .+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 9999999987532   3999999999999999999999999999999999999998887     999999999876


Q ss_pred             CCCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc
Q 013686          262 PTDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA  335 (438)
Q Consensus       262 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (438)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............    ..+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~  236 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY----QKIGDTK  236 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH----HHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH----HHHHhhh
Confidence            443221      123456999999999999999999999999999999999999999865432211111    1111100


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      ...        ........++ .+.+++.+||+.||.+||++.+|++.|+++...
T Consensus       237 ~~~--------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          237 RAT--------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHS--------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccC--------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            000        0000111244 799999999999999999999999999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=364.78  Aligned_cols=249  Identities=27%  Similarity=0.417  Sum_probs=201.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++....   ....+.+.+|..++..+ +||||+++++++... ..+|
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~  100 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLF  100 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEE
Confidence            578999999999999999999976 58999999997542   23456788999999998 699999999977655 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            99999999999999987654    99999999999999999999999999999999999999999999999999985432


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      . ....+..+...      
T Consensus       177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~------  242 (353)
T 3txo_A          177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------D-LFEAILNDEVV------  242 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC------
T ss_pred             CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCC------
Confidence            22 2234457999999999999989999999999999999999999999754321      1 11222222111      


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM------KEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  383 (438)
                        .+     ..++..+.+++.+||+.||.+||++      +|++++
T Consensus       243 --~p-----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          243 --YP-----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             --CC-----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             --CC-----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence              11     1245678899999999999999998      788764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.4e-47  Score=382.34  Aligned_cols=259  Identities=28%  Similarity=0.475  Sum_probs=214.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ..++|++.+.||+|+||.||+|.++. +..||||.+..... ..+.|.+|+.+|++++||||+++++++... ..+++||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~  295 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIIT  295 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecC-CcEEEEE
Confidence            35678889999999999999999874 88999999876543 357899999999999999999999987655 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++|+|.+++......  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       296 E~~~~g~L~~~l~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTT--TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             EccCCCCHHHHHHhcCcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            999999999999875432  389999999999999999999999999999999999999999999999999997655443


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .......+++.|+|||.+.+..++.++|||||||++|||+| |..||.......       ....+..+....     . 
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~-  440 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRME-----R-  440 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCC-----C-
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----C-
Confidence            33344456789999999998899999999999999999999 999997543221       112222211110     0 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                            +..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       441 ------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          441 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                  12356778999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.4e-47  Score=377.95  Aligned_cols=260  Identities=28%  Similarity=0.475  Sum_probs=207.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..++|++.+.||+|+||.||+|.++++..||||.+..... ..+.|.+|+++|++++||||+++++++..  +..++|||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEeh
Confidence            3567888999999999999999998888899999876543 34679999999999999999999997754  46899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++|+|.+++.....  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       259 ~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            9999999999975422  13899999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......       .....+..+....     .  
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~~~~-----~--  402 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMP-----C--  402 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-----C--
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-----C--
Confidence            3334457889999999998899999999999999999999 99999754321       1112222221110     0  


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                           +..++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       403 -----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          403 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                 1235677899999999999999999999999999886543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=365.38  Aligned_cols=264  Identities=26%  Similarity=0.378  Sum_probs=213.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .++|.+.+.||+|+||.||+|...        .+..||||++... .....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467889999999999999999863        2357999998754 344557899999999999 899999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       +..++||||+++|+|.+++......            ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       148 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  226 (382)
T 3tt0_A          148 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  226 (382)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred             -CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence             4689999999999999999876521            134899999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......      
T Consensus       227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~------  300 (382)
T 3tt0_A          227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------  300 (382)
T ss_dssp             TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred             CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence            99999999999986644322 22233457889999999999999999999999999999999 99999754321      


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                       .....+..+.....     .       ..++..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       301 -~~~~~~~~~~~~~~-----~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 -ELFKLLKEGHRMDK-----P-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             -HHHHHHHTTCCCCC-----C-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             -HHHHHHHcCCCCCC-----C-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence             11222222221111     0       1345678999999999999999999999999999875443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.3e-46  Score=358.14  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=185.6

Q ss_pred             CCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEeccCCC
Q 013686          115 SKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g  192 (438)
                      .+.||+|+||.||+|..+ +|+.||||++....   ...+.+|+.+++.+. ||||+++++++... ...++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQ-LHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-CEEEEEEEccCCC
Confidence            478999999999999986 58999999986542   356778999999997 99999999977655 4789999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---eEEEeeeCcccccCCCccccc
Q 013686          193 TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---RVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       193 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      +|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....... ..
T Consensus        92 ~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~  166 (325)
T 3kn6_A           92 ELFERIKKKKH----FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL  166 (325)
T ss_dssp             BHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             cHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence            99999987643    99999999999999999999999999999999999997765   899999999986644322 22


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCcc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD  349 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (438)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||..................+..+...         ...
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---------~~~  237 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---------FEG  237 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---------CCS
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---------CCc
Confidence            34568999999999999999999999999999999999999998654332222222222333332211         112


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       350 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ..+..++..+.+|+.+||+.||++|||++|++++-
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~  272 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE  272 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence            23456788899999999999999999999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.6e-46  Score=367.78  Aligned_cols=258  Identities=23%  Similarity=0.315  Sum_probs=196.7

Q ss_pred             hcCCCCC-CcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHh-CCCCCceeEeeeeec---cCceE
Q 013686          109 TDNFNSS-KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTK-LQHPNLVKLYGCTSR---QSREL  182 (438)
Q Consensus       109 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~---~~~~~  182 (438)
                      .++|.+. +.||+|+||+||++... +|+.||||++...     ..+.+|+.++.+ .+||||+++++++..   +...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3556665 68999999999999976 5899999998643     346678888754 589999999997643   24578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCccc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSR  259 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~  259 (438)
                      |+|||||++|+|.+++.....  ..+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            999999999999999987543  23899999999999999999999999999999999999987   7899999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .....+..+.... 
T Consensus       213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~~~-  286 (400)
T 1nxk_A          213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYEF-  286 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCCCC-
T ss_pred             ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCcccC-
Confidence            654322  2234568999999999999999999999999999999999999997654322111   0112222221110 


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..+        .+..++..+.+|+.+||+.||++|||+.|++++..-.
T Consensus       287 ~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          287 PNP--------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             CTT--------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            000        1123567789999999999999999999999975543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.8e-46  Score=353.32  Aligned_cols=265  Identities=20%  Similarity=0.264  Sum_probs=208.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ..++|++.+.||+|+||.||+|... +++.||||.+.....  .+.+.+|+.+++.++|++++..+..+.......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            3578999999999999999999974 689999998654432  2357789999999999888888876666667899999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe---cCCCeEEEeeeCcccccCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgla~~~~~  263 (438)
                      ||+ +++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 9999999985433   28999999999999999999999999999999999999   7889999999999987654


Q ss_pred             Cccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          264 DVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       264 ~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ....      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence            3221      22345699999999999999999999999999999999999999986544333222211111111100  


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                                .......++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       239 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          239 ----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence                      0111123467899999999999999999999999999988653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.9e-46  Score=351.25  Aligned_cols=265  Identities=20%  Similarity=0.268  Sum_probs=212.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++......  +.+.+|+.+++.++|++++..+..+.......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            467899999999999999999974 7999999988654322  4588899999999998888777766666678899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe---cCCCeEEEeeeCcccccCCC
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+ +++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 9999999985433   38999999999999999999999999999999999999   48889999999999876543


Q ss_pred             ccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          265 VTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       265 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      ...      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  238 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---  238 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence            321      12345699999999999999999999999999999999999999986543332222211111111100   


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                               .......++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       239 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          239 ---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             ---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence                     01111235677999999999999999999999999999886543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=362.14  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR------  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  180 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467889999999999999999987 79999999987543 3345789999999999999999999997644321      


Q ss_pred             --------------------------------------------------eEEEEEeccCCCCHHHHhhccCCCCCCCCH
Q 013686          181 --------------------------------------------------ELLLVYEYIPNGTVADHLHNRQPNSCLLPW  210 (438)
Q Consensus       181 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~  210 (438)
                                                                        ..++||||+++++|.+++...... ...++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-EDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cchhh
Confidence                                                              379999999999999999876432 23567


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc-----------ccccCCCCCCCcc
Q 013686          211 PVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT-----------HVSTAPQGTPGYV  279 (438)
Q Consensus       211 ~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~g~~~y~  279 (438)
                      ..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......           .......||+.|+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            77899999999999999999999999999999999999999999999987654321           1223456999999


Q ss_pred             CccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHH
Q 013686          280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSV  359 (438)
Q Consensus       280 aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  359 (438)
                      |||.+.+..++.++|||||||++|||++|..|+....         ..........            ........++.+
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~~~------------~~~~~~~~~~~~  302 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRNLK------------FPLLFTQKYPQE  302 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHTTC------------CCHHHHHHCHHH
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhccC------------CCcccccCChhH
Confidence            9999999999999999999999999999977653110         0111111111            122345566778


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 013686          360 AELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       360 ~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+++.+||+.||++|||+.|++++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhc
Confidence            999999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-47  Score=375.63  Aligned_cols=259  Identities=25%  Similarity=0.361  Sum_probs=208.5

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      +....++|.+.+.||+|+||.||+|..+ +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++... .
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~  142 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-R  142 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-S
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-C
Confidence            3445678999999999999999999987 589999999865322   1224578899999999999999999977655 5


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|+||||++||+|.+++....     +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            7999999999999999997642     89999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCCCccCccccccCC----CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYK----LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      ............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.......       ....+..+..
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~  290 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHKN  290 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHHH
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-------HHHHHHhccc
Confidence            7554433444667999999999997665    7899999999999999999999997543211       1111211100


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM--RPTMKEVLEILR  385 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~  385 (438)
                      . .   ..+.     ...++..+.+||.+||+.+|.+  ||+++||+++-.
T Consensus       291 ~-~---~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          291 S-L---TFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             H-C---CCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             c-c---cCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence            0 0   0000     0124567899999999999988  999999998743

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=352.99  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=198.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--------------------------hHHHHHHHHHHHH
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--------------------------RIEQFMNEVEILT  161 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~  161 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++......                          ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467889999999999999999976 6899999998654311                          1356889999999


Q ss_pred             hCCCCCceeEeeeeec-cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013686          162 KLQHPNLVKLYGCTSR-QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSN  240 (438)
Q Consensus       162 ~l~h~niv~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~  240 (438)
                      +++||||+++++++.. .....++||||+++++|.+++...     .+++..+..++.||+.||.|||++||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            9999999999997765 345789999999999998875432     3899999999999999999999999999999999


Q ss_pred             CEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCC---CCChhhHHHHHHHHHHHHhCCCCcccCCc
Q 013686          241 NILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYK---LTDKSDVYSFGVVLIELISGLEAVDTSRH  317 (438)
Q Consensus       241 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tG~~p~~~~~~  317 (438)
                      |||++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999987654322 223457999999999997765   37789999999999999999999975321


Q ss_pred             ccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          318 RHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .      . ....+..........           ..++..+.+++.+||+.||++|||+.|++++
T Consensus       246 ~------~-~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          246 M------C-LHSKIKSQALEFPDQ-----------PDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             H------H-HHHHHHHCCCCCCSS-----------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             H------H-HHHHHhcccCCCCCc-----------cccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            1      1 112222221110000           1245678999999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=367.28  Aligned_cols=262  Identities=26%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence            467889999999999999999953      4678999998654 334456788999999999999999999977655 46


Q ss_pred             EEEEEeccCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---eEEEeee
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---RVKVADF  255 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---~~kl~Df  255 (438)
                      .++||||+++|+|.+++......   ...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence            89999999999999999876421   23489999999999999999999999999999999999999554   5999999


Q ss_pred             CcccccCCC-ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhc
Q 013686          256 GLSRLFPTD-VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       256 gla~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |+++..... .........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......       .....+..
T Consensus       229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~~~i~~  301 (367)
T 3l9p_A          229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTS  301 (367)
T ss_dssp             HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHT
T ss_pred             ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHc
Confidence            999754221 1122223457899999999999999999999999999999998 99999754321       11122222


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      +.....            ...++..+.+|+.+||+.||++|||+.||+++|+.+...
T Consensus       302 ~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          302 GGRMDP------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             TCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCC------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            211110            023456788999999999999999999999999988653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-46  Score=360.85  Aligned_cols=268  Identities=28%  Similarity=0.396  Sum_probs=213.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-----cCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL-----RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  182 (438)
                      .++|++.+.||+|+||.||++.+     .+++.||||++........+.+.+|++++++++||||+++++++.. .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35788899999999999999984     3588999999987777777889999999999999999999997653 44578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999987433   28999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc--------ccchhHHHHHHHh
Q 013686          263 TDVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH--------DINLSNMATNKIQ  332 (438)
Q Consensus       263 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~--------~~~~~~~~~~~~~  332 (438)
                      .....  ......+++.|+|||.+.+..++.++||||||+++|||++|..||.......        ...........+.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            43322  2233458888999999998889999999999999999999999986432210        0000011111111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      .+....     .       ...++..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       259 ~~~~~~-----~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          259 EGQRLP-----A-------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             TTCCCC-----C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cccCCC-----C-------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            111100     0       1235677999999999999999999999999999886544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-47  Score=377.76  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=209.5

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeecc
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQ  178 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  178 (438)
                      .++....++|++.++||+|+||+||+|..+ +++.||+|++......   ..+.+.+|..++..++||||+++++++...
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344455688999999999999999999987 4889999998753221   223488899999999999999999977665


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                       ..+|+|||||++|+|.+++.....   .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus       147 -~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          147 -NNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             -SEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             -CEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence             479999999999999999987432   3999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      +..............||+.|+|||++.     ...++.++|||||||++|||++|+.||.......      . ...+..
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~-~~~i~~  295 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T-YGKIMN  295 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHT
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------H-HHhhhh
Confidence            876555444445567999999999987     4578999999999999999999999997543211      1 111111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDM--RPTMKEVLEIL  384 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  384 (438)
                      .... ..-+..       ...++..+.+||.+||..+|++  ||+++|++++-
T Consensus       296 ~~~~-~~~p~~-------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          296 HKER-FQFPTQ-------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             HHHH-CCCCSS-------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             cccc-ccCCcc-------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            0000 000000       0124567889999999888888  99999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.4e-47  Score=354.20  Aligned_cols=259  Identities=26%  Similarity=0.460  Sum_probs=212.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|++++++++||||+++++++..  +..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEe
Confidence            3567889999999999999999988888999999865432 34678999999999999999999997653  35899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        88 ~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             cCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            9999999999976431  12899999999999999999999999999999999999999999999999999877554433


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......      . ....+..+...     ..  
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~-----~~--  231 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------E-VIQNLERGYRM-----VR--  231 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCC-----CC--
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------H-HHHHHhcccCC-----CC--
Confidence            3344557889999999988889999999999999999999 89999754321      1 11122221110     00  


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                           ...++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       232 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          232 -----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                 013456789999999999999999999999999988654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-46  Score=354.60  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.+.||+|+||.||+|...+|+.||+|++.....  ...+.+.+|++++++++||||+++++++... +..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEEE
Confidence            57888999999999999999998899999999865432  2246788999999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++ +|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CCSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ecCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            9965 99999976533   389999999999999999999999999999999999999999999999999986643322 


Q ss_pred             cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC---cccc-----
Q 013686          268 VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG---ALNE-----  338 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----  338 (438)
                      ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.........   ..........   .+..     
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGST
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhccc
Confidence            12334689999999999764 5899999999999999999999999754322110   0011111000   0000     


Q ss_pred             cccCcCC----CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          339 LVDPSLG----FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       339 ~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..++...    .........++..+.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0011110    00011112356778999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.7e-46  Score=356.57  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=212.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||.||+|...      +++.||+|.+... .....+.+.+|++++++++||||+++++++... +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-GP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-Cc
Confidence            567888999999999999999862      3588999998754 344567899999999999999999999977655 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 013686          182 LLLVYEYIPNGTVADHLHNRQP--------------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNN  241 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~N  241 (438)
                      .++||||+++++|.+++.....                    ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N  180 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN  180 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence            8999999999999999987543                    11248899999999999999999999999999999999


Q ss_pred             EEecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCccc
Q 013686          242 ILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRH  319 (438)
Q Consensus       242 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~  319 (438)
                      ||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  260 (314)
T 2ivs_A          181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER  260 (314)
T ss_dssp             EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999866443222 2233457889999999998889999999999999999999 999997543321


Q ss_pred             ccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                             ....+..+.....            +..++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       261 -------~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          261 -------LFNLLKTGHRMER------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             -------HHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHhhcCCcCCC------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                   1122222211110            02355678999999999999999999999999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.5e-46  Score=351.99  Aligned_cols=260  Identities=29%  Similarity=0.484  Sum_probs=198.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|...  ..||+|.+...  .....+.+.+|+.++++++||||++++++...  ...++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEEEE
Confidence            457889999999999999999864  35999998643  34456789999999999999999999995533  3589999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      ||+++++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999976543   38999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          266 THVSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||......      ......+..+........
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCTTS
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcchhh
Confidence            22223446899999999986   567888999999999999999999999754322      112222222222111110


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                              ....++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus       250 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          250 --------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             --------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                    012356779999999999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.8e-47  Score=362.19  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=203.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++.++||||+++++++... ...++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEE
Confidence            468999999999999999999977 689999999865432 2346788999999999999999999977655 5789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      ||+++|+|.+++.....    +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        85 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             ECCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999999976543    8999999999999999999999999999999999999999999999999998653222 


Q ss_pred             cccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........      ....+.....  ...   
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~~--~~~---  229 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKT--YLN---  229 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHHTTCT--TST---
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHhcccc--cCC---
Confidence            222334579999999999987765 7789999999999999999999975433211      0111111100  000   


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                            ....++..+.+|+.+||+.||++|||+.|++++-.
T Consensus       230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence                  01235667889999999999999999999998643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.9e-46  Score=354.53  Aligned_cols=264  Identities=26%  Similarity=0.409  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----cCCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-ceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGIL-----RDGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-REL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~  182 (438)
                      .+|++.+.||+|+||.||+|.+     .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578899999999999999984     358999999987543 334578899999999999999999999776542 468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++++|.+++.....   .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            999999999999999976543   28999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcc--ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCc--------ccccchhHHHHHHHh
Q 013686          263 TDVT--HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRH--------RHDINLSNMATNKIQ  332 (438)
Q Consensus       263 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~--------~~~~~~~~~~~~~~~  332 (438)
                      ....  .......+|..|+|||.+.+..++.++||||||+++|||++|..|+.....        .............+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            4432  223345688889999999998999999999999999999999998753211        000001111111111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      .+....     .       +..++..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus       258 ~~~~~~-----~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EGKRLP-----C-------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTCCCC-----C-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCCC-----C-------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111110     0       1235667999999999999999999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.7e-47  Score=362.85  Aligned_cols=249  Identities=25%  Similarity=0.383  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++......   ..+.+.+|+.+++.++||||+++++++... ...++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~l   86 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVM   86 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEE
Confidence            467889999999999999999975 6899999998654222   235788999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+ +|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        87 v~E~~-~g~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEECC-CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            99999 7899999987654    999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .  ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||..........               .+....
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~~~  224 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNSCV  224 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCSSC
T ss_pred             c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHcCC
Confidence            2  2244579999999999988776 689999999999999999999997543221110               000000


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ...     +..++..+.+|+.+||+.||.+|||++|++++-.
T Consensus       225 ~~~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          225 YVM-----PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             CCC-----CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             CCC-----cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence            000     1234567889999999999999999999998654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-46  Score=359.11  Aligned_cols=257  Identities=23%  Similarity=0.414  Sum_probs=201.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcE----EEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRI----VAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|++.+.||+|+||.||+|.+. +|+.    ||+|.+.... ....+.+.+|+.++++++||||+++++++...  ..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~   91 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--Ce
Confidence            456888999999999999999965 3443    5888775432 34457899999999999999999999987654  47


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++|+||+.+|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            899999999999999987543   38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ..... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.......       ....+..+....  
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~--  239 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLP--  239 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCC--
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCCCCC--
Confidence            43322 2223446889999999999999999999999999999999 999997543321       112222211110  


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                         .       +..++..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       240 ---~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          240 ---Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---C-------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ---C-------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               0       01245678899999999999999999999999988754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=365.70  Aligned_cols=250  Identities=23%  Similarity=0.394  Sum_probs=203.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++... +|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~l   92 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFM   92 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEE
Confidence            467889999999999999999976 58899999986543   23356788999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+.+|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        93 v~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EECCCTTEEHHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999987543    899999999999999999999999999999999999999999999999999876443


Q ss_pred             ccccccCCCCCCCccCcccccc---CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC---YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .  ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.........    .....+......    
T Consensus       169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~----~~~~~~~~~~~~----  238 (384)
T 4fr4_A          169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK----EIVHTFETTVVT----  238 (384)
T ss_dssp             C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH----HHHHHHHHCCCC----
T ss_pred             C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH----HHHHHHhhcccC----
Confidence            2  2345579999999999964   45899999999999999999999999754332211    111111111110    


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-MKEVLE  382 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  382 (438)
                        +       +..++..+.+|+.+||+.||.+||+ ++++++
T Consensus       239 --~-------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 --Y-------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --C-------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --C-------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              0       0134567899999999999999998 777765

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-46  Score=354.86  Aligned_cols=246  Identities=30%  Similarity=0.503  Sum_probs=205.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++..+ +|+.||+|++.....   ...+.+.+|..+++.++||||+++++++... ..+|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEE
Confidence            357889999999999999999976 689999999975432   3456788999999999999999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        84 v~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EEeCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999999987543    899999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                          .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      . ....+..+...      +
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~~------~  222 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------K-TYEKILNAELR------F  222 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHCCCC------C
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCC------C
Confidence                23457999999999999999999999999999999999999999754321      1 11222222111      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                        +     ..++..+.+++.+||+.||++||     +++|++++
T Consensus       223 --p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          223 --P-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --C-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --C-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              1     12456788999999999999999     89999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.4e-46  Score=373.73  Aligned_cols=267  Identities=20%  Similarity=0.273  Sum_probs=200.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----c
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----R  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  180 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            568999999999999999999976 5899999999754  3445678899999999999999999999775432     4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|+||||+++ +|.+.+...      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~~------l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            68999999965 577776532      88999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh----------------
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS----------------  324 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~----------------  324 (438)
                      .....  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||............                
T Consensus       214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            64432  234457999999999999999999999999999999999999999765422111000                


Q ss_pred             HHHHHHHhcC------cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          325 NMATNKIQNG------ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       325 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ......+...      .+...+...+...........+..+.+|+.+||..||++|||++|++++-
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence            0000000000      00000000000111122334577899999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4e-46  Score=350.01  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=206.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|.+.+.||+|+||.||+|...+    +..||+|.+... .....+.+.+|+.++++++||||+++++++...  ..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCE
Confidence            4678889999999999999998653    346999998765 344567899999999999999999999976543  568


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++++|.+++.....   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999999999999987543   389999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........       ...+..+....    
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-------~~~~~~~~~~~----  234 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------IGVLEKGDRLP----  234 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-------HHHHHHTCCCC----
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-------HHHHhcCCCCC----
Confidence            43333344457889999999998899999999999999999998 9999975432211       11222111110    


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                       ..       ..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       235 -~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          235 -KP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence             00       1245678899999999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-46  Score=354.36  Aligned_cols=259  Identities=29%  Similarity=0.478  Sum_probs=214.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCEEEEE
Confidence            46778899999999999999999874 88999999875443 457889999999999999999999977655 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|.+++......  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        89 e~~~~~~L~~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTT--TSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             EcCCCCcHHHHHHhcccC--CccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999999999999875432  389999999999999999999999999999999999999999999999999987765544


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......       ....+.......     . 
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~-  233 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRME-----R-  233 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCC-----C-
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhccCCCC-----C-
Confidence            44444557889999999998999999999999999999999 999997543221       111222111100     0 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                            +..++..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus       234 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          234 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                  02345678999999999999999999999999988754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=368.95  Aligned_cols=254  Identities=21%  Similarity=0.355  Sum_probs=208.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.+++.++||||+++++++... ...++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-CEEEEEEE
Confidence            467999999999999999999976 6899999999876655667899999999999999999999977655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC--CCeEEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~~~~~~  265 (438)
                      |+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++......
T Consensus       129 ~~~gg~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999999999976532   3899999999999999999999999999999999999974  5789999999998765432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      ..  ....||+.|+|||++.+..++.++|||||||++|||++|..||......      . ....+......  .++.  
T Consensus       206 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~-~~~~i~~~~~~--~~~~--  272 (387)
T 1kob_A          206 IV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------E-TLQNVKRCDWE--FDED--  272 (387)
T ss_dssp             CE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------H-HHHHHHHCCCC--CCSS--
T ss_pred             ce--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCC--CCcc--
Confidence            22  2336899999999999999999999999999999999999999754321      1 11122211111  0110  


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                           ....++..+.+++.+||+.||++|||+.|++++-
T Consensus       273 -----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          273 -----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             -----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence                 1123566789999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=373.82  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=209.1

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeec
Q 013686          102 CSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSR  177 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  177 (438)
                      +.+.....++|++.+.||+|+||.||++..+ +|+.||+|++.+...   ...+.+.+|..++..++||||+++++++..
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455688999999999999999999986 699999999975422   223458889999999999999999997765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      . +.+|+||||+++|+|.+++.....   .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       133 ~-~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 E-NYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             S-SEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             C-CEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence            5 479999999999999999987542   289999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccc-------cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHH
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQ-------CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      ++.............+||+.|+|||++.       +..++.++|||||||++|||++|+.||.......      . ...
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~-~~~  281 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------T-YGK  281 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------H-HHH
Confidence            9877554443344567999999999997       3578999999999999999999999997543211      1 111


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHH
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR---PTMKEVLEIL  384 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L  384 (438)
                      +..... ...-+       .....++..+.+||.+||. +|.+|   |+++|++++-
T Consensus       282 i~~~~~-~~~~p-------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          282 IVHYKE-HLSLP-------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HHTHHH-HCCCC-----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             HHhccc-CcCCC-------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            111000 00000       0112456789999999999 99998   6999998763

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.3e-46  Score=363.89  Aligned_cols=270  Identities=17%  Similarity=0.261  Sum_probs=205.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC------CcEEEEEEeeccchHhH-----------HHHHHHHHHHHhCCCCCceeE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYENNFKRI-----------EQFMNEVEILTKLQHPNLVKL  171 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~  171 (438)
                      .++|++.+.||+|+||.||+|.++.      ++.||||++........           ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578899999999999999999764      47899999876542211           224456667778899999999


Q ss_pred             eeeeecc---CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec--C
Q 013686          172 YGCTSRQ---SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD--N  246 (438)
Q Consensus       172 ~~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~--~  246 (438)
                      ++++...   ....++||||+ +++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            9976543   24589999999 9999999987532   399999999999999999999999999999999999999  8


Q ss_pred             CCeEEEeeeCcccccCCCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccc
Q 013686          247 NFRVKVADFGLSRLFPTDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD  320 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~  320 (438)
                      ++.+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            899999999999876433221      11234599999999999999999999999999999999999999985332211


Q ss_pred             cchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          321 INLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                        .......... .....+.++.+..      ..++..+.+++..||+.||++||++.+|++.|+.+....
T Consensus       270 --~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          270 --YVRDSKIRYR-ENIASLMDKCFPA------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             --HHHHHHHHHH-HCHHHHHHHHSCT------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             --HHHHHHHHhh-hhHHHHHHHhccc------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence              1111111111 1111111111100      134677999999999999999999999999999886543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-46  Score=374.88  Aligned_cols=271  Identities=21%  Similarity=0.287  Sum_probs=189.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc----Cce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ----SRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~  181 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+|++++||||+++++++...    ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999976 6899999998653  344567899999999999999999999977433    246


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +|+||||+ +++|.+++.....    +++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPVY----LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSCC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCCC----CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 6799999976543    999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCcc--------------------------ccccCCCCCCCccCcccc-ccCCCCChhhHHHHHHHHHHHHh-------
Q 013686          262 PTDVT--------------------------HVSTAPQGTPGYVDPDYF-QCYKLTDKSDVYSFGVVLIELIS-------  307 (438)
Q Consensus       262 ~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~t-------  307 (438)
                      .....                          .......||+.|+|||++ .+..++.++|||||||++|||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            43211                          112344689999999976 56679999999999999999999       


Q ss_pred             ----CCCCcccCCcccc-----------------cchhHHHHHHHhcCc--------------ccccccCcCCCCccHHH
Q 013686          308 ----GLEAVDTSRHRHD-----------------INLSNMATNKIQNGA--------------LNELVDPSLGFEKDYAV  352 (438)
Q Consensus       308 ----G~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~  352 (438)
                          |+++|.+......                 .+........+....              ....+............
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                5566644321000                 000000000000000              00000000001111111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          353 RNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       353 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ...+..+.+|+.+||..||++|||++|++++-
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp  398 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHP  398 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence            23467789999999999999999999999963

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.7e-46  Score=364.51  Aligned_cols=270  Identities=19%  Similarity=0.268  Sum_probs=204.5

Q ss_pred             hcCCCCCCccccc--CceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDG--GFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|  +||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++... +..+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEEE
Confidence            5678899999999  99999999987 69999999987543  34457788999999999999999999977665 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++......  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999999876332  389999999999999999999999999999999999999999999999999865422


Q ss_pred             Cc------cccccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh---
Q 013686          264 DV------THVSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ---  332 (438)
Q Consensus       264 ~~------~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~---  332 (438)
                      ..      ........||+.|+|||.+.+  ..++.++|||||||++|||++|+.||..........  ........   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~  258 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCLL  258 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC---------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCccc
Confidence            11      111223468999999999987  679999999999999999999999997543321110  00000000   


Q ss_pred             -------------------cCcccccccCc------CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          333 -------------------NGALNELVDPS------LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       333 -------------------~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                                         ...........      ...........++..+.+|+.+||+.||++|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                               00000000000      0000111234567789999999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-46  Score=364.76  Aligned_cols=263  Identities=28%  Similarity=0.450  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc--CC--cEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR--DG--RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .|++.+.||+|+||.||+|...  ++  ..||+|.+... .....+.+.+|+.++++++||||+++++++....+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4666789999999999999864  22  46899988653 3345678999999999999999999999776655678999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            999999999999976543   38899999999999999999999999999999999999999999999999998654322


Q ss_pred             cc---cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          266 TH---VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       266 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ..   ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||........       ...+..+...  ..
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-------~~~~~~~~~~--~~  317 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYLLQGRRL--LQ  317 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-------HHHHHTTCCC--CC
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-------HHHHHcCCCC--CC
Confidence            11   1223457789999999999999999999999999999999 6788865432211       1112222111  01


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCCCC
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTS  395 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  395 (438)
                      +          ..++..+.+++.+||+.||++|||+.|+++.|+.+.....+..
T Consensus       318 p----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~  361 (373)
T 3c1x_A          318 P----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  361 (373)
T ss_dssp             C----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             C----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence            1          1345678999999999999999999999999999876655443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.8e-46  Score=345.64  Aligned_cols=254  Identities=19%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|.++ |+.||||++...  .....+.+.+|+.++++++||||+++++++... ....++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            457889999999999999999985 889999998754  334457899999999999999999999977654 3578999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||.|||++|  ++||||||+|||++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999999987543  24899999999999999999999999  99999999999999999999999998764322


Q ss_pred             CccccccCCCCCCCccCccccccCCCCC---hhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTD---KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                            ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......      .........+...   
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~---  230 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRP---  230 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCCC---
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCCC---
Confidence                  2345899999999998765544   899999999999999999999753321      1111222221111   


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                        .++       ..++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       231 --~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 --TIP-------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              111       2345678999999999999999999999999998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.3e-46  Score=350.44  Aligned_cols=263  Identities=28%  Similarity=0.454  Sum_probs=208.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ..+|++.+.||+|+||.||+|...+    ...||+|.+... .....+.+.+|+.++++++||||+++++++....+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3467888999999999999998643    236899988653 34456789999999999999999999997666666789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999976443   389999999999999999999999999999999999999999999999999986644


Q ss_pred             Ccc---ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          264 DVT---HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       264 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ...   .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.......      .. ..+..+...  
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~-~~~~~~~~~--  251 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------IT-VYLLQGRRL--  251 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HH-HHHHTTCCC--
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HH-HHHhcCCCC--
Confidence            322   11233457889999999999999999999999999999999 556665433221      11 111111110  


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCC
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLG  393 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  393 (438)
                      ..+          ..++..+.+++.+||+.||++|||+.|+++.|+.+.....+
T Consensus       252 ~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          252 LQP----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             CCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             CCC----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            000          12456789999999999999999999999999998765443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.3e-46  Score=346.21  Aligned_cols=251  Identities=28%  Similarity=0.466  Sum_probs=194.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch----HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF----KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|.+. |+.||||.+.....    ...+.+.+|+++++.++||||+++++++... +..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-PNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-CceEE
Confidence            457888999999999999999975 89999999865422    2356789999999999999999999977655 47899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCEEecC--------CCeEEEe
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD---VIHRDVKSNNILLDN--------NFRVKVA  253 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~Dlkp~Nill~~--------~~~~kl~  253 (438)
                      ||||+++++|.+++...     .+++..++.++.|++.||.|||++|   |+||||||+|||++.        ++.+||+
T Consensus        84 v~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EEECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            99999999999999643     2899999999999999999999999   899999999999986        7789999


Q ss_pred             eeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          254 DFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       254 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |||++........   ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......      ... .....
T Consensus       159 Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~  228 (271)
T 3dtc_A          159 DFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVA-YGVAM  228 (271)
T ss_dssp             CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHH-HHHHT
T ss_pred             cCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-Hhhhc
Confidence            9999986543322   2346899999999999989999999999999999999999999754321      111 11111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ......    .       ...++..+.+++.+||+.||.+|||+.|++++|+++
T Consensus       229 ~~~~~~----~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          229 NKLALP----I-------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             SCCCCC----C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCCC----C-------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111111    1       023456789999999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.8e-46  Score=361.05  Aligned_cols=256  Identities=23%  Similarity=0.331  Sum_probs=195.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|.+.+.||+|+||.||++... +|+.||||++...... .+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEEE
Confidence            457889999999999999999987 6899999998754332 35688999999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe--EEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR--VKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfgla~~~~~~~  265 (438)
                      |+++|+|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        97 ~~~~~~L~~~l~~~~~----~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           97 YASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999999999987654    899999999999999999999999999999999999987765  9999999997432221


Q ss_pred             cccccCCCCCCCccCccccccCCCCCh-hhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDK-SDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                        ......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||.........  .... ..+......       
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~-~~~~~~~~~-------  240 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTI-QRILSVKYS-------  240 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHH-HHHHTTCCC-------
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHH-HHHhcCCCC-------
Confidence              2233469999999999988887665 89999999999999999999764432221  1111 111111110       


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                       .+.   ...++..+.+|+.+||+.||++|||+.|++++-.-
T Consensus       241 -~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  278 (361)
T 3uc3_A          241 -IPD---DIRISPECCHLISRIFVADPATRISIPEIKTHSWF  278 (361)
T ss_dssp             -CCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred             -CCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence             000   01245678899999999999999999999987543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=355.31  Aligned_cols=268  Identities=24%  Similarity=0.322  Sum_probs=201.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-----HhHHHHHHHHHHHHhC---CCCCceeEeeeeecc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-----KRIEQFMNEVEILTKL---QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~  178 (438)
                      ..++|++.+.||+|+||+||+|... +|+.||||++.....     .....+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3678999999999999999999964 689999999864321     1124566777777766   499999999977554


Q ss_pred             Cc----eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          179 SR----ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       179 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                      ..    ..++||||+. ++|.+++......  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            32    5799999996 6999999876543  389999999999999999999999999999999999999999999999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc-
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN-  333 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-  333 (438)
                      ||+++.......  .....||+.|+|||.+.+..++.++|||||||++|||++|++||.........   ......... 
T Consensus       164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~  238 (308)
T 3g33_A          164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLP  238 (308)
T ss_dssp             CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred             CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC
Confidence            999987643322  23346899999999999999999999999999999999999999764432111   111111100 


Q ss_pred             --Ccccc-------cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 --GALNE-------LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 --~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        ..+..       .+.+............++..+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence              00000       000000111111223456788999999999999999999999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=356.62  Aligned_cols=267  Identities=23%  Similarity=0.326  Sum_probs=210.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec---cCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR---QSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++... +|+.||||++........+.+.+|+++++.++||||+++++++..   .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            467899999999999999999974 689999999977766677889999999999999999999997752   3347899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            99999999999999875433445999999999999999999999999999999999999999999999999998765321


Q ss_pred             cccc--------ccCCCCCCCccCccccccCC---CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          265 VTHV--------STAPQGTPGYVDPDYFQCYK---LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       265 ~~~~--------~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      ....        .....|++.|+|||.+.+..   ++.++||||||+++|||++|+.||.........     ....+..
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~  262 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAVQN  262 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-----HHHHHHC
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-----hhHHhhc
Confidence            1110        01224799999999987554   689999999999999999999999642111110     0111111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                      . ..      .+.     ...++..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       263 ~-~~------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          263 Q-LS------IPQ-----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             C---------CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             c-CC------CCc-----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            0 00      000     01345678999999999999999999999999998865443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-46  Score=356.83  Aligned_cols=271  Identities=26%  Similarity=0.385  Sum_probs=217.0

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEEE------cCCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEee
Q 013686          102 CSELEEATDNFNSSKQLGDGGFGAVYLGIL------RDGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYG  173 (438)
Q Consensus       102 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~  173 (438)
                      ...+....++|++.+.||+|+||.||+|..      .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            344445578899999999999999999984      246899999987643 34456899999999999 6999999999


Q ss_pred             eeeccCceEEEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 013686          174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNN  241 (438)
Q Consensus       174 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~N  241 (438)
                      ++...+...++||||+++|+|.+++......            ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            8777666799999999999999999876432            1237899999999999999999999999999999999


Q ss_pred             EEecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCccc
Q 013686          242 ILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRH  319 (438)
Q Consensus       242 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~  319 (438)
                      ||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99999999999999999866443222 2223457889999999999999999999999999999998 999997543221


Q ss_pred             ccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                            .....+..+.....     .       ..++..+.+++.+||+.||.+|||+.|++++|+.+.+.
T Consensus       259 ------~~~~~~~~~~~~~~-----~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          259 ------EFCRRLKEGTRMRA-----P-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             ------HHHHHHHHTCCCCC-----C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHhccCccCCC-----C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence                  11122222211110     0       12456788999999999999999999999999988653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.4e-46  Score=349.65  Aligned_cols=253  Identities=29%  Similarity=0.507  Sum_probs=202.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH-------hHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK-------RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||+|... +++.||+|++......       ..+.+.+|++++++++||||+++++++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            357888999999999999999975 6899999998543221       126789999999999999999999977543  


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEecCCCe-----EEEe
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLDNNFR-----VKVA  253 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~~~~~-----~kl~  253 (438)
                       .++||||+++|+|.+++.....   .+++..++.++.|++.||.|||++|  |+||||||+|||++.++.     +||+
T Consensus        96 -~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           96 -PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -TEEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -CeEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             2799999999999999876543   3899999999999999999999999  999999999999987776     9999


Q ss_pred             eeCcccccCCCccccccCCCCCCCccCccccc--cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          254 DFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ--CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       254 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      |||+++.....    .....|++.|+|||.+.  ...++.++|||||||++|||++|+.||........    .. ...+
T Consensus       172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~-~~~~  242 (287)
T 4f0f_A          172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KF-INMI  242 (287)
T ss_dssp             CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HH-HHHH
T ss_pred             CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HH-HHHH
Confidence            99999854332    23456899999999984  45678899999999999999999999975432211    11 1111


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      ..........           ..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       243 ~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLRPTIP-----------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCCCCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCCCCCC-----------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111111111           23456789999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=358.59  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=191.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....  ..+.+.+|++++++++||||+++++++... ...++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEE
Confidence            3567999999999999999999987 58899999987543  335688899999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCcccccCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~~~~~  263 (438)
                      ||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++....
T Consensus       128 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCCSCBHHHHHTTCSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EeCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999999986543    899999999999999999999999999999999999975   88999999999986543


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|||++|..||......      ......+...... ...+ 
T Consensus       204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~~~-  273 (349)
T 2w4o_A          204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FISP-  273 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CCTT-
T ss_pred             cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cCCc-
Confidence            22  223456899999999999999999999999999999999999999653321      1112222222111 0011 


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                             .+..++..+.+|+.+||+.||++|||+.|++++-
T Consensus       274 -------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          274 -------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             -------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             -------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                   1123566789999999999999999999999853

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-45  Score=353.55  Aligned_cols=261  Identities=30%  Similarity=0.491  Sum_probs=207.8

Q ss_pred             CCCCCcccccCceEEEEEEEc-----CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceEEE
Q 013686          112 FNSSKQLGDGGFGAVYLGILR-----DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SRELLL  184 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~l  184 (438)
                      |++.+.||+|+||.||++.++     +|+.||||++.... ....+.+.+|++++++++||||+++++++... ...+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999998753     58899999997653 34467899999999999999999999977654 357899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++....     +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997653     899999999999999999999999999999999999999999999999999876543


Q ss_pred             cc--ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccc----cchh----HHHHHHHhcC
Q 013686          265 VT--HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHD----INLS----NMATNKIQNG  334 (438)
Q Consensus       265 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~----~~~~----~~~~~~~~~~  334 (438)
                      ..  .......+++.|+|||.+.+..++.++||||||+++|||++|..||........    ....    ......+..+
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            32  122344578889999999988999999999999999999999999875321100    0000    0011111111


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ...     ..       ...++..+.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus       268 ~~~-----~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          268 ERL-----PR-------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             CCC-----CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC-----CC-------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            110     00       12356679999999999999999999999999998864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.1e-47  Score=364.37  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=204.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  182 (438)
                      ..++|.+.+.||+|+||.||+|..+ +|+.||+|++....   ....+.+..|..++..+ +||||+++++++... ..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~~   93 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENL   93 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CEE
Confidence            4578999999999999999999986 58999999997643   23356788899999876 899999999977655 479


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      |+||||+++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            999999999999999987654    8999999999999999999999999999999999999999999999999998643


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......       .....+..+..      
T Consensus       170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~------  235 (345)
T 1xjd_A          170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNP------  235 (345)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------
T ss_pred             cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCCC------
Confidence            2221 234557999999999999999999999999999999999999999754321       11122222211      


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMK-EVLEI  383 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  383 (438)
                      .++       ..++..+.+++.+||+.||++||++. +++++
T Consensus       236 ~~p-------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          236 FYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             CCC-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CCC-------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            111       12456788999999999999999997 77653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-45  Score=351.87  Aligned_cols=263  Identities=27%  Similarity=0.390  Sum_probs=212.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------cCCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL------RDGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|.+.+.||+|+||.||+|..      .+++.||+|.+.... ....+.+.+|+.+++++ +||||+++++++... +
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-G  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-C
Confidence            56788999999999999999985      246899999987543 34557899999999999 899999999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN--------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                      ..++||||+++|+|.+++......              ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence            789999999999999999875421              124899999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......     
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----  255 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-----  255 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-----
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-----
Confidence            999999999999876544322 2233457889999999998899999999999999999999 999997543221     


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                       .....+..+.. ....           ..++..+.+++.+||+.||.+|||+.|++++|+++...
T Consensus       256 -~~~~~~~~~~~-~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          256 -KFYKMIKEGFR-MLSP-----------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             -HHHHHHHHTCC-CCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHhccCCC-CCCc-----------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence             11112221111 0000           13456789999999999999999999999999987653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.9e-46  Score=358.09  Aligned_cols=247  Identities=27%  Similarity=0.393  Sum_probs=206.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++..+ +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~l  118 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEE
Confidence            367889999999999999999976 689999999865432   3456788999999999999999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       119 v~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999999987654    899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                          .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+..+...      +
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~------~  257 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKVR------F  257 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------C
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcCCCC------C
Confidence                23456899999999999999999999999999999999999999754321       112223222211      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  384 (438)
                      +       ..++..+.+++.+||+.||.+||+     ++|++++-
T Consensus       258 p-------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          258 P-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             C-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             C-------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            1       134567899999999999999998     89988753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-46  Score=356.80  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=199.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC---ce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS---RE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~  181 (438)
                      .++|++.+.||+|+||.||++... +++.||||++...   .....+.+.+|+.++++++||||+++++++....   ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            467889999999999999999974 6899999998754   2334567899999999999999999999765443   23


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .|+||||+++++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            5999999999999999987654    899999999999999999999999999999999999999999999999999866


Q ss_pred             CCCccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          262 PTDVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       262 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......      .............  
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~--  238 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP--  238 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC--
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC--
Confidence            443221  222345899999999999999999999999999999999999999754321      1112222211111  


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHH-HHHhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE-ILRET  387 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~~  387 (438)
                              .......++..+.+++.+||+.||++||++.+++. .+...
T Consensus       239 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          239 --------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             --------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                    11111235678999999999999999997766665 44433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3e-46  Score=381.69  Aligned_cols=259  Identities=28%  Similarity=0.476  Sum_probs=211.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|.++++..||||++..... ..+.|.+|+++|++++||||+++++++..  +..++||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeeh
Confidence            456777889999999999999998888899999976543 34679999999999999999999997754  468999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++|+|.+++.....  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.........
T Consensus       343 ~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          343 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             CTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred             hcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence            999999999975422  138999999999999999999999999999999999999999999999999998765433222


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....++..|+|||.+.+..++.++|||||||+||||++ |+.||......       .....+..+....     .   
T Consensus       421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~~~~-----~---  485 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMP-----C---  485 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-------HHHHHHHTTCCCC-----C---
T ss_pred             ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-----C---
Confidence            334457789999999998899999999999999999999 99999753321       1112222221110     0   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                          +..++..+.+||.+||+.||++|||+++|++.|+.+....
T Consensus       486 ----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          486 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                1235667899999999999999999999999999886543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-46  Score=355.08  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=201.7

Q ss_pred             hcCCCCC-CcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSS-KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .+.|.+. +.||+|+||.||+|... +|+.||||++........+.+.+|++++.++ +||||+++++++... +..++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEE
Confidence            3567774 78999999999999965 6899999999766555567899999999995 799999999977655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe---EEEeeeCcccccC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFP  262 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfgla~~~~  262 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEcCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999999987653    899999999999999999999999999999999999988776   9999999998653


Q ss_pred             CCcc------ccccCCCCCCCccCcccccc-----CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch--------
Q 013686          263 TDVT------HVSTAPQGTPGYVDPDYFQC-----YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL--------  323 (438)
Q Consensus       263 ~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~--------  323 (438)
                      ....      .......||+.|+|||.+.+     ..++.++|||||||++|||++|+.||...........        
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211      11123458999999999875     5688999999999999999999999976543211000        


Q ss_pred             hHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          324 SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .......+..+..        .. .......++..+.+|+.+||+.||.+|||+.|++++-
T Consensus       246 ~~~~~~~i~~~~~--------~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          246 QNMLFESIQEGKY--------EF-PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             HHHHHHHHHHCCC--------CC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             HHHHHHHHhccCc--------cc-CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            0111122222211        11 1112234667899999999999999999999999853

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-46  Score=359.09  Aligned_cols=265  Identities=26%  Similarity=0.364  Sum_probs=208.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccC
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQS  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  179 (438)
                      ..++|.+.+.||+|+||.||+|...      ++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++... 
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence            3578899999999999999999962      35689999987542 23457899999999999 899999999977655 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPN-------------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSN  240 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~  240 (438)
                      +..++||||+++|+|.+++......                   ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            4789999999999999999875431                   123789999999999999999999999999999999


Q ss_pred             CEEecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcc
Q 013686          241 NILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHR  318 (438)
Q Consensus       241 Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~  318 (438)
                      |||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||......
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            999999999999999999865433221 2233457889999999998899999999999999999998 99999764322


Q ss_pred             cccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          319 HDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      .      .....+..+...     ..+       ..++..+.+++.+||+.||.+|||+.|++++|+.+....
T Consensus       282 ~------~~~~~~~~~~~~-----~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          282 A------NFYKLIQNGFKM-----DQP-------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             H------HHHHHHHTTCCC-----CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             H------HHHHHHhcCCCC-----CCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            1      111222222111     000       124567899999999999999999999999999886544

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-45  Score=349.65  Aligned_cols=261  Identities=21%  Similarity=0.278  Sum_probs=200.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++... +..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEEE
Confidence            578999999999999999999976 68999999986542   23347789999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999987653    899999999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .........+++.|+|||.+.+..++.++||||||+++|||++|+.||......       .....+.... ...     
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~~~-----  254 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-PRP-----  254 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-CCG-----
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-CCc-----
Confidence            333333456899999999999999999999999999999999999999753221       1111222111 100     


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhccC
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-TMKEVLEILRETKDSN  391 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  391 (438)
                          ......++..+.+++.+||+.||++|| +++++++.|+......
T Consensus       255 ----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          255 ----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                001123456788999999999999999 9999999999876544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-46  Score=368.28  Aligned_cols=267  Identities=26%  Similarity=0.396  Sum_probs=194.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCC-CCCceeEeeeeecc-CceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~  182 (438)
                      ..++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.+. ||||+++++++... ...+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4678999999999999999999976 6899999998543  3445677889999999997 99999999977543 3468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      |+|||||+ ++|.+++....     +++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRANI-----LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHTC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999996 69999997642     8999999999999999999999999999999999999999999999999998653


Q ss_pred             CC--------------------ccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc
Q 013686          263 TD--------------------VTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI  321 (438)
Q Consensus       263 ~~--------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~  321 (438)
                      ..                    .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            21                    1112233569999999999976 67899999999999999999999999765432111


Q ss_pred             chhHHHHHHHhcCcccc---cccC----------------cCCCCcc-HHH----------HHHHHHHHHHHHHhhccCC
Q 013686          322 NLSNMATNKIQNGALNE---LVDP----------------SLGFEKD-YAV----------RNMVTSVAELAFRCVQQDR  371 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~---~~~~----------------~~~~~~~-~~~----------~~~~~~l~~li~~cl~~dP  371 (438)
                      ..   ....+.......   ...+                ....... ..+          ..++..+.+|+.+||+.||
T Consensus       241 ~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          241 ER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            00   000000000000   0000                0000000 000          0345678999999999999


Q ss_pred             CCCCCHHHHHHH
Q 013686          372 DMRPTMKEVLEI  383 (438)
Q Consensus       372 ~~RPs~~evl~~  383 (438)
                      ++|||++|++++
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-45  Score=353.07  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=195.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE----cCCcEEEEEEeeccc----hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL----RDGRIVAVKRLYENN----FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||++..    .+|+.||+|++....    ....+.+.+|+.+++.++||||+++++++... +
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-G   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-S
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-C
Confidence            45788999999999999999997    368999999987542    23345688899999999999999999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|+||||+++++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            79999999999999999987654    89999999999999999999999999999999999999999999999999985


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......      . ....+......   
T Consensus       171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~i~~~~~~---  239 (327)
T 3a62_A          171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------K-TIDKILKCKLN---  239 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCC---
T ss_pred             cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCCC---
Confidence            433221 223456999999999999999999999999999999999999999754321      1 11122221110   


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEIL  384 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  384 (438)
                         +  +     ..++..+.+++.+||+.||++||     ++.|++++-
T Consensus       240 ---~--p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          240 ---L--P-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             ---C--C-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             ---C--C-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence               1  0     12456788999999999999999     788888753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8e-46  Score=354.28  Aligned_cols=269  Identities=22%  Similarity=0.396  Sum_probs=190.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|.+..... ...+.+.+|++++++++||||+++++++... +..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE-NKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-TEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-CeEEEEE
Confidence            467899999999999999999975 589999999865432 2346788999999999999999999977655 5799999


Q ss_pred             eccCCCCHHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          187 EYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||++ |+|.+++.....  ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            9997 699999876432  1234899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccccc-
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALNEL-  339 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  339 (438)
                      .. ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........   .........   ..+... 
T Consensus       162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGGGG
T ss_pred             cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhhhh
Confidence            22 2234468999999999976 46899999999999999999999999764432111   001111000   000000 


Q ss_pred             ----ccCcCC----CCccHH-----HHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 ----VDPSLG----FEKDYA-----VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ----~~~~~~----~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ..+.+.    ......     ...++..+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                000000    000000     01345679999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-45  Score=353.06  Aligned_cols=269  Identities=25%  Similarity=0.407  Sum_probs=204.4

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhC--CCCCceeEeeeeeccC---c
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL--QHPNLVKLYGCTSRQS---R  180 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~---~  180 (438)
                      ....++|++.+.||+|+||.||+|... |+.||||++.....   ..+.+|.+++..+  +||||+++++++....   .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            344678999999999999999999885 89999999865432   3345566666554  8999999999765542   4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCEEecCCCeEEE
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS--------DVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      ..++||||+++|+|.+++....     +++..++.++.|++.||.|||++        ||+||||||+|||++.++.+||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEeccCCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            7899999999999999997653     89999999999999999999998        9999999999999999999999


Q ss_pred             eeeCcccccCCCcccc---ccCCCCCCCccCccccccCCCCCh------hhHHHHHHHHHHHHhC----------CCCcc
Q 013686          253 ADFGLSRLFPTDVTHV---STAPQGTPGYVDPDYFQCYKLTDK------SDVYSFGVVLIELISG----------LEAVD  313 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~Dvws~Gv~l~el~tG----------~~p~~  313 (438)
                      +|||++..........   .....||+.|+|||.+.+..++..      +|||||||++|||+||          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999998664432221   124469999999999987766665      9999999999999999          45554


Q ss_pred             cCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          314 TSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      ........  .......+.....    .+.+  ........++..+.+++.+||+.||++|||+.|++++|+.+.++.
T Consensus       264 ~~~~~~~~--~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          264 DLVPSDPS--YEDMREIVCIKKL----RPSF--PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTSCSSCC--HHHHHHHHTTSCC----CCCC--CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhcCCCCc--hhhhHHHHhhhcc----Cccc--cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            32221111  1111111111111    1111  111122367888999999999999999999999999999987654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6e-46  Score=355.90  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=197.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-Cc---EEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc--
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GR---IVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR--  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  180 (438)
                      .++|++.+.||+|+||.||+|.... ++   .||||.+...  .....+.+.+|++++++++||||+++++++.....  
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            5689999999999999999999653 32   7999998654  33456789999999999999999999997765432  


Q ss_pred             ---eEEEEEeccCCCCHHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeee
Q 013686          181 ---ELLLVYEYIPNGTVADHLHNRQP--NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       181 ---~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                         ..++||||+++|+|.+++.....  ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence               13899999999999999976432  1224899999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhc
Q 013686          256 GLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       256 gla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......      . ...+..
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~-~~~~~~  254 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------I-YNYLIG  254 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------H-HHHHHT
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------H-HHHHhc
Confidence            99986543322 12223446789999999999999999999999999999999 899997543321      1 112221


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      +.....            ...++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       255 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          255 GNRLKQ------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             TCCCCC------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCCC------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            111100            0134567899999999999999999999999999986543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=347.58  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=210.1

Q ss_pred             cCCCCCC-cccccCceEEEEEEEc---CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSK-QLGDGGFGAVYLGILR---DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|.+... .....+.+.+|++++++++||||+++++++..  +..++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CCcEE
Confidence            4555666 8999999999999864   5788999999764 33456789999999999999999999997733  36899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCc---cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999975432   3899999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          265 VTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       265 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ....+..+....   
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~~---  233 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME---  233 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCC---
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcCC---
Confidence            322  1223346889999999988889999999999999999998 999997543211       112222221111   


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                        .       +..++..+.+++.+||+.||++||++.+++++|+.+..+..
T Consensus       234 --~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          234 --C-------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             --C-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --C-------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence              1       12356679999999999999999999999999999876543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.6e-46  Score=347.72  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=207.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++... ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-TDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeEEEEEe
Confidence            567889999999999999999976 4789999999776555678899999999999999999999977655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe---cCCCeEEEeeeCcccccCCC
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+++++|.+++.....    +++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999999987654    8999999999999999999999999999999999999   78899999999999876543


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ..  .....+|+.|+|||.+.+. ++.++||||||+++|||++|+.||......       .....+..+...       
T Consensus       163 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-------  225 (277)
T 3f3z_A          163 KM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGTFT-------  225 (277)
T ss_dssp             SC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC-------
T ss_pred             cc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCC-------
Confidence            22  2345699999999998764 899999999999999999999999754321       111222222111       


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        ........++..+.+++.+||+.||++|||+.|++++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          226 --FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0111223466789999999999999999999999974

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=361.03  Aligned_cols=266  Identities=15%  Similarity=0.217  Sum_probs=206.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC---------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCcee---------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD---------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVK---------  170 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  170 (438)
                      .++|.+.+.||+|+||.||+|....         ++.||+|.+...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3578899999999999999999763         789999998654     35778999999999999988         


Q ss_pred             ------EeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe
Q 013686          171 ------LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL  244 (438)
Q Consensus       171 ------~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill  244 (438)
                            +++++...+...++||||+ +++|.+++.....  ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                  5665555556899999999 9999999987521  239999999999999999999999999999999999999


Q ss_pred             cCCC--eEEEeeeCcccccCCCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCC
Q 013686          245 DNNF--RVKVADFGLSRLFPTDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR  316 (438)
Q Consensus       245 ~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~  316 (438)
                      +.++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  8999999999876433221      1133469999999999999999999999999999999999999998643


Q ss_pred             cccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          317 HRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      .... ..... ...+.. ...........      +..++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       273 ~~~~-~~~~~-~~~~~~-~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          273 PNTE-DIMKQ-KQKFVD-KPGPFVGPCGH------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             TCHH-HHHHH-HHHHHH-SCCCEECTTSC------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCHH-HHHHH-HHhccC-Chhhhhhhccc------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            2111 01111 111111 11111111100      0123567899999999999999999999999999886543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.6e-45  Score=349.39  Aligned_cols=266  Identities=26%  Similarity=0.429  Sum_probs=202.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...   .....+.+.+|+.++++++||||+++++++... +..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEE
Confidence            457889999999999999999975 6899999998642   344567889999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.........+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            99999999999999764333345899999999999999999999999999999999999999999999999999865433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. ......+++.|+|||.+.+..++.++||||||+++|||++|..||......    ... ....+..........   
T Consensus       190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~~~---  260 (310)
T 2wqm_A          190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEQCDYPPLPS---  260 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHH-HHHHHHTTCSCCCCT---
T ss_pred             Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHH-HHHHhhcccCCCCcc---
Confidence            22 122346899999999999999999999999999999999999999643211    111 112222222211110   


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                              ..++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       261 --------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          261 --------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence                    1345678999999999999999999999999999875443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-45  Score=356.83  Aligned_cols=249  Identities=25%  Similarity=0.382  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-CcEEEEEEeeccch---HhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNF---KRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|..+. |+.||+|++.....   ...+.+.+|..++..+ +||||+++++++... +.+|
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~   97 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLY   97 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-SEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-CEEE
Confidence            5689999999999999999999874 88999999876422   3456788999999988 799999999977655 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||++||+|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999987654    89999999999999999999999999999999999999999999999999986432


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      . ....+..+...      
T Consensus       174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~------  239 (353)
T 2i0e_A          174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------E-LFQSIMEHNVA------  239 (353)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC------
T ss_pred             CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhCCCC------
Confidence            22 2234557999999999999999999999999999999999999999754321      1 11222222111      


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                      +  +     ..++..+.+|+.+||+.||.+||+     +++++++
T Consensus       240 ~--p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          240 Y--P-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             C--C-----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             C--C-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1  1     135667899999999999999995     5888765

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.6e-46  Score=350.15  Aligned_cols=266  Identities=22%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++... ...++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEE
Confidence            57889999999999999999986 58999999986543  23346788999999999999999999977655 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++ +|.+.+.....   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             ecCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            99965 66666655432   399999999999999999999999999999999999999999999999999987643322


Q ss_pred             ccccCCCCCCCccCccccccCC-CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccccccc-
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALNELVD-  341 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-  341 (438)
                       ......+|+.|+|||.+.+.. ++.++|||||||++|||++|..||........  ...........   ..+..... 
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccc
Confidence             233456899999999997765 89999999999999999998877543221110  00111111100   00000000 


Q ss_pred             ------CcC--CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 ------PSL--GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ------~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            +..  ..........++..+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                  000  000001112356778999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=351.39  Aligned_cols=269  Identities=26%  Similarity=0.406  Sum_probs=201.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++... +..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEE
Confidence            367889999999999999999986 58999999885543  23356788999999999999999999977655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~----~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRG----VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EECCSEEHHHHHHHTSSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEeCCCchHHHHHhhhcC----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999998876543    8999999999999999999999999999999999999999999999999998765332


Q ss_pred             cccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH--------HHHHhcCc-
Q 013686          266 THVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA--------TNKIQNGA-  335 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-  335 (438)
                      . ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...............        ........ 
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            2 2234468999999999876 57899999999999999999999999765432211110000        00000000 


Q ss_pred             ccc--cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LNE--LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...  ..++...........+++..+.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000  001100011111123466778999999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.6e-46  Score=357.20  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=202.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcE----EEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRI----VAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++..  ...
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Ccc
Confidence            357888999999999999999975 4554    7777764432 2223567789999999999999999997753  468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999999986532   38899999999999999999999999999999999999999999999999999765


Q ss_pred             CCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......       ....+..+..... 
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLAQ-  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBCCC-
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCCC-
Confidence            43322 2234457889999999998999999999999999999999 999997643221       1112222111100 


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                       +          ..++..+.+++.+||+.||.+|||+.|++++|+.+..
T Consensus       239 -~----------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          239 -P----------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -C----------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -C----------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             0          1133457789999999999999999999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=363.71  Aligned_cols=275  Identities=21%  Similarity=0.327  Sum_probs=214.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-ceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-RELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv  185 (438)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ...++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            457889999999999999999987 48999999987543 234577889999999999999999999776543 368999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe----cCCCeEEEeeeCccccc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADFGLSRLF  261 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgla~~~  261 (438)
                      |||+++|+|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++..
T Consensus        88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            9999999999999865432 238999999999999999999999999999999999999    78888999999999876


Q ss_pred             CCCccccccCCCCCCCccCcccccc--------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQC--------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      .....  .....||+.|+|||.+.+        ..++.++|||||||++|||++|+.||.........  .......+. 
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~-  241 (396)
T 4eut_A          167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT-  241 (396)
T ss_dssp             CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHH-
T ss_pred             cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhc-
Confidence            54322  234569999999999865        56788999999999999999999999754332211  111111221 


Q ss_pred             Cccccc-------------ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          334 GALNEL-------------VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       334 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      +.....             ....+.... .....++..+.+++.+||+.||++||++.|+++.++.+.+.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTC-SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCCcccchhheeccCCCcccCccCCccc-ccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111000             000111111 12256778899999999999999999999999999988654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.3e-46  Score=351.13  Aligned_cols=255  Identities=28%  Similarity=0.476  Sum_probs=202.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||++... |+.||||.+....  ..+.+.+|++++++++||||+++++++....+..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467889999999999999999874 8999999987543  3467899999999999999999999766665678999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++++|.+++......  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......   
T Consensus        97 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccc--cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence            9999999999865321  27889999999999999999999999999999999999999999999999998654321   


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                       ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ....+..+...     ..   
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~-----~~---  235 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKM-----DA---  235 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCC-----CC---
T ss_pred             -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCC-----CC---
Confidence             22357889999999998899999999999999999998 999997543211       11222222111     11   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                          ...++..+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus       236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          236 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence                1234567899999999999999999999999999987543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=364.18  Aligned_cols=247  Identities=24%  Similarity=0.394  Sum_probs=198.6

Q ss_pred             CCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          115 SKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      .+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++... +..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCCCc
Confidence            568999999999999975 6899999999877666678899999999999999999999977665 47999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe--cCCCeEEEeeeCcccccCCCccccccC
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL--DNNFRVKVADFGLSRLFPTDVTHVSTA  271 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~~~  271 (438)
                      |.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++.......  ...
T Consensus       173 L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~  247 (373)
T 2x4f_A          173 LFDRIIDESY---NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV  247 (373)
T ss_dssp             EHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred             HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence            9999876432   28999999999999999999999999999999999999  5678999999999987654322  233


Q ss_pred             CCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHH
Q 013686          272 PQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYA  351 (438)
Q Consensus       272 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (438)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      .. ..+...... .       . ...
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~-~~i~~~~~~-~-------~-~~~  311 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TL-NNILACRWD-L-------E-DEE  311 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHHTCCC-S-------C-SGG
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhccCC-C-------C-hhh
Confidence            469999999999998899999999999999999999999997543211      11 112111111 0       0 001


Q ss_pred             HHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          352 VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       352 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...++..+.+|+.+||+.||.+|||+.|++++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            12456789999999999999999999999984

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=354.29  Aligned_cols=266  Identities=28%  Similarity=0.449  Sum_probs=211.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-----cCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-CceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL-----RDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-SREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  182 (438)
                      .++|++.+.||+|+||.||++..     .+|+.||||++........+.+.+|++++++++||||+++++++... ....
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45688899999999999999984     25899999999876666678899999999999999999999976544 3468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999987643   38999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc--------ccch-hHHHHHHH
Q 013686          263 TDVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH--------DINL-SNMATNKI  331 (438)
Q Consensus       263 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~--------~~~~-~~~~~~~~  331 (438)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||+||..|+.......        .... .......+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            44321  1223457778999999998889999999999999999999999886431100        0000 00011111


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ..+...       ..     +..++..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       277 ~~~~~~-------~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          277 KNNGRL-------PR-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HTTCCC-------CC-----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCCC-------CC-----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111100       00     12356779999999999999999999999999998865

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=349.33  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=196.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.++||+|+||+||+|... +|+.||||++...  .......+..|+..+.++ +||||+++++++... +..++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~l  134 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYL  134 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEE
Confidence            467999999999999999999987 6999999987543  223334555666666555 899999999977655 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+ +++|.+++.....   .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++......
T Consensus       135 v~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999 7799999887643   3999999999999999999999999999999999999999999999999999876443


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ..  .....||+.|+|||.+.+ .++.++|||||||++|||++|..|+....          ....+..+..        
T Consensus       211 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~--------  269 (311)
T 3p1a_A          211 GA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYL--------  269 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCC--------
T ss_pred             CC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCC--------
Confidence            22  234469999999999876 79999999999999999999976654321          1112222111        


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         .......++..+.+++.+||+.||++|||+.|++++
T Consensus       270 ---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          270 ---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence               112234466789999999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=353.72  Aligned_cols=269  Identities=26%  Similarity=0.369  Sum_probs=199.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHH--HHhCCCCCceeEeeee----eccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEI--LTKLQHPNLVKLYGCT----SRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~----~~~~~~~  182 (438)
                      .++|++.+.||+|+||.||+|.. +++.||||++.....   +.+..|.++  +..++||||+++++++    ......+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46788999999999999999977 689999999865432   334444444  4458999999999733    2233467


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCCEEecCCCeEEEe
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS---------DVIHRDVKSNNILLDNNFRVKVA  253 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~ivH~Dlkp~Nill~~~~~~kl~  253 (438)
                      ++||||+++|+|.+++....     .++..+..++.||+.||.|||+.         ||+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997654     68899999999999999999999         99999999999999999999999


Q ss_pred             eeCcccccCCCc-------cccccCCCCCCCccCcccccc-------CCCCChhhHHHHHHHHHHHHhCCCCcccCCccc
Q 013686          254 DFGLSRLFPTDV-------THVSTAPQGTPGYVDPDYFQC-------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH  319 (438)
Q Consensus       254 Dfgla~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~  319 (438)
                      |||+++.+....       ........||+.|+|||.+.+       ..++.++|||||||++|||++|..||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998764321       111223469999999999986       456778999999999999999977664332221


Q ss_pred             ccchh-----------HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          320 DINLS-----------NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       320 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      .....           ......+........+......     ...++..+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-----NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-----CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-----ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            11100           0011111111111111111110     1246678999999999999999999999999999987


Q ss_pred             ccC
Q 013686          389 DSN  391 (438)
Q Consensus       389 ~~~  391 (438)
                      ...
T Consensus       318 ~~~  320 (336)
T 3g2f_A          318 MIW  320 (336)
T ss_dssp             HCC
T ss_pred             HHH
Confidence            544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=347.75  Aligned_cols=256  Identities=28%  Similarity=0.500  Sum_probs=200.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||++... ++.||+|.+....  ..+.+.+|++++++++||||+++++++..   ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEc
Confidence            356888999999999999999885 7899999986543  34678999999999999999999997652   47999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCCEEecCCCe-EEEeeeCcccccCCC
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA---SDVIHRDVKSNNILLDNNFR-VKVADFGLSRLFPTD  264 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~Dlkp~Nill~~~~~-~kl~Dfgla~~~~~~  264 (438)
                      +++|+|.+++..... ...+++..++.++.|+++||.|||+   +||+||||||+|||++.++. +||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            999999999986542 1237889999999999999999999   89999999999999998876 799999999765432


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                          .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    ..... ....+.....     
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~-~~~~~~~~~~-----  225 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMW-AVHNGTRPPL-----  225 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHH-HHHTTCCCCC-----
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHH-HHhcCCCCCc-----
Confidence                123358999999999999999999999999999999999999997533211    11111 1111111111     


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                             ...++..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       226 -------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          226 -------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             -------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             -------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence                   02345678899999999999999999999999999876443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-45  Score=345.61  Aligned_cols=262  Identities=26%  Similarity=0.392  Sum_probs=207.4

Q ss_pred             CCCCCCcccccCceEEEEEEEcC-C---cEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRD-G---RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .|...+.||+|+||.||+|.+.+ +   ..||+|.+... .....+.+.+|+.+++.++||||+++++++.......++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45567899999999999998642 2   37999998654 3345678999999999999999999999887666556999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+.+|+|.+++.....   .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999987433   38999999999999999999999999999999999999999999999999998654332


Q ss_pred             c---ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCC-cccCCcccccchhHHHHHHHhcCccccccc
Q 013686          266 T---HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA-VDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       266 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .   .......+++.|+|||.+.+..++.++||||||+++|||++|..| |.......       ....+..+.....  
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~~~--  249 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQGRRLPQ--  249 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTTCCCCC--
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcCCCCCC--
Confidence            1   122234578899999999999999999999999999999996544 44322111       1112222111100  


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCCC
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGT  394 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  394 (438)
                                ...++..+.+++.+||+.||.+|||+.++++.|+++.....+.
T Consensus       250 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          250 ----------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             ----------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence                      0124567899999999999999999999999999987655433

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-45  Score=346.26  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=202.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-C-------cEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-G-------RIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  180 (438)
                      .++|.+.+.||+|+||.||+|.... +       ..||+|.+........+.+.+|+.++++++||||+++++++... +
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-D   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-T
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-C
Confidence            4678889999999999999998653 3       47999999776666678899999999999999999999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe--------EEE
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR--------VKV  252 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~--------~kl  252 (438)
                      ..++||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            68999999999999999987543   2899999999999999999999999999999999999998877        999


Q ss_pred             eeeCcccccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCC-CCcccCCcccccchhHHHHHH
Q 013686          253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGL-EAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~-~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      +|||++.......     ...+++.|+|||.+.+ ..++.++|||||||++|||++|. +|+......      . ....
T Consensus       163 ~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~-~~~~  230 (289)
T 4fvq_A          163 SDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------R-KLQF  230 (289)
T ss_dssp             CCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHH
T ss_pred             ccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------H-HHHH
Confidence            9999997553321     1237889999999987 67999999999999999999965 454432211      0 1111


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      .....   ....           ..+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       231 ~~~~~---~~~~-----------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          231 YEDRH---QLPA-----------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHTTC---CCCC-----------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             hhccC---CCCC-----------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            11100   0000           11335779999999999999999999999999887644

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.4e-45  Score=341.76  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=207.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...  .....+.+.+|+.++++++||||+++++++... ...++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-CEEEEE
Confidence            568899999999999999999976 5899999998654  334457788999999999999999999977655 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe---EEEeeeCcccccC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLSRLFP  262 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfgla~~~~  262 (438)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||++....
T Consensus        84 ~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999999999987654    899999999999999999999999999999999999976655   9999999998765


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ....  .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......       .....+..+.... ..+
T Consensus       160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~-~~~  229 (284)
T 3kk8_A          160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDY-PSP  229 (284)
T ss_dssp             SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC-CTT
T ss_pred             cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhccccC-Cch
Confidence            4322  23456899999999999999999999999999999999999999754321       1112222221111 000


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                              ....++..+.+++.+||+.||++|||+.|++++-.
T Consensus       230 --------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (284)
T 3kk8_A          230 --------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  264 (284)
T ss_dssp             --------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred             --------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence                    01234567899999999999999999999998643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.8e-45  Score=352.12  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=210.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .++|.+.+.||+|+||.||+|...        ++..||+|++... .....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467889999999999999999863        4678999998754 334567899999999999 899999999977655


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       +..++||||+++|+|.+++......            ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       114 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          114 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             -SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             -CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence             4789999999999999999875431            123889999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......      
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------  266 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------  266 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH------
Confidence            99999999999987654322 12233457889999999988889999999999999999999 99999754321      


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      . ....+..+....     ..       ..++..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus       267 ~-~~~~~~~~~~~~-----~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          267 E-LFKLLKEGHRMD-----KP-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             H-HHHHHHHTCCCC-----CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-HHHHHhcCCCCC-----CC-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1 112222221111     10       13456789999999999999999999999999998653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=355.44  Aligned_cols=257  Identities=23%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcE----EEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRI----VAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++...  ..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--SE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--Cc
Confidence            467889999999999999999965 4554    577766433 233457899999999999999999999977654  47


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++|+||+.+|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             eEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            899999999999999987543   38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          263 TDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       263 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ..... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+..... 
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-  240 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQ-  240 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCCC-
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC-
Confidence            33221 2223346789999999999999999999999999999999 999997643321       1112222111100 


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                                 +..++..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus       241 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          241 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                       01245678899999999999999999999999998864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-45  Score=356.79  Aligned_cols=264  Identities=26%  Similarity=0.371  Sum_probs=203.9

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-----hHhHHHHHHHHHHHHhCCCCCceeEeeeeec
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-----FKRIEQFMNEVEILTKLQHPNLVKLYGCTSR  177 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  177 (438)
                      ++....++|++.+.||+|+||.||+|... +++.||+|++....     ....+.+.+|++++++++||||+++++++..
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            35566788999999999999999999975 68899999986542     2345789999999999999999999998765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCC------------------------------------CCCCCHHHHHHHHHHHH
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPN------------------------------------SCLLPWPVRLSIAIETA  221 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~  221 (438)
                      . ...++||||+++|+|.+++......                                    ...+++..++.++.||+
T Consensus       100 ~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A          100 E-QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             S-SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             C-CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            5 5799999999999999999632110                                    11135677889999999


Q ss_pred             HHHHHHHhCCccccCCCCCCEEecCCC--eEEEeeeCcccccCCCc---cccccCCCCCCCccCcccccc--CCCCChhh
Q 013686          222 GALAYLHASDVIHRDVKSNNILLDNNF--RVKVADFGLSRLFPTDV---THVSTAPQGTPGYVDPDYFQC--YKLTDKSD  294 (438)
Q Consensus       222 ~~l~~LH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~g~~~y~aPE~~~~--~~~~~~~D  294 (438)
                      .||.|||++||+||||||+|||++.++  .+||+|||++..+....   ........||+.|+|||.+.+  ..++.++|
T Consensus       179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999999999998776  89999999998653211   112234569999999999975  67899999


Q ss_pred             HHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCC
Q 013686          295 VYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR  374 (438)
Q Consensus       295 vws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  374 (438)
                      ||||||++|||++|+.||.......      ....... ....        .. ......++..+.+|+.+||+.||.+|
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~------~~~~~~~-~~~~--------~~-~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLN-KKLC--------FE-NPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCCC--------TT-SGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHh-cccc--------cC-CcccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999997543221      1111111 1110        00 00112356778999999999999999


Q ss_pred             CCHHHHHHHH
Q 013686          375 PTMKEVLEIL  384 (438)
Q Consensus       375 Ps~~evl~~L  384 (438)
                      ||+.|++++-
T Consensus       323 ps~~~~l~hp  332 (345)
T 3hko_A          323 FDAMRALQHP  332 (345)
T ss_dssp             CCHHHHHHSH
T ss_pred             CCHHHHhcCh
Confidence            9999999853

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-45  Score=352.77  Aligned_cols=267  Identities=26%  Similarity=0.433  Sum_probs=213.1

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeee
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCT  175 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  175 (438)
                      ++++...++|++.+.||+|+||.||+|...      +++.||+|.+... .......+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344445678999999999999999999864      3688999998754 334456789999999999999999999977


Q ss_pred             eccCceEEEEEeccCCCCHHHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe
Q 013686          176 SRQSRELLLVYEYIPNGTVADHLHNRQP------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR  249 (438)
Q Consensus       176 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~  249 (438)
                      ... ...++||||+++|+|.+++.....      ....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        98 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           98 SQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             CSS-SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             ccC-CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence            654 478999999999999999976321      1123789999999999999999999999999999999999999999


Q ss_pred             EEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHH
Q 013686          250 VKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMA  327 (438)
Q Consensus       250 ~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~  327 (438)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......      . .
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~  249 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-V  249 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-H
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------H-H
Confidence            99999999986543221 12233457889999999998899999999999999999999 88998754321      1 1


Q ss_pred             HHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          328 TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ...+..+.....            ...++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus       250 ~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 LRFVMEGGLLDK------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHcCCcCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            122222221111            02345678999999999999999999999999988754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-45  Score=352.14  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH------hHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK------RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+......      ..+.+.+|+.++++++||||+++++++... ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   89 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-TD   89 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CE
Confidence            467889999999999999999976 5899999998654321      357799999999999999999999977655 57


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC----eEEEeeeCc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF----RVKVADFGL  257 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgl  257 (438)
                      .++||||+++++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSC----EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999986543    89999999999999999999999999999999999999888    799999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      +........  .....||+.|+|||.+.+..++.++||||||+++|||++|..||.......       ....+..... 
T Consensus       166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~-  235 (321)
T 2a2a_A          166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSVSY-  235 (321)
T ss_dssp             CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC-
T ss_pred             ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc-
Confidence            987654322  234468999999999999999999999999999999999999997543211       1111211110 


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             . ........++..+.+++.+||+.||++|||+.|++++
T Consensus       236 -------~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 -------D-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             -------C-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             -------c-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0 0111223456779999999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.8e-45  Score=342.78  Aligned_cols=252  Identities=27%  Similarity=0.461  Sum_probs=206.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec---------
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR---------  177 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  177 (438)
                      ...+|++.+.||+|+||.||+|... +|+.||+|.+....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3567889999999999999999986 69999999987654    346689999999999999999997643         


Q ss_pred             ------cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          178 ------QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       178 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                            .....++||||+++++|.+++......  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                  234589999999999999999765322  389999999999999999999999999999999999999999999


Q ss_pred             EeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          252 VADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       252 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      |+|||++........  .....+++.|+|||.+.+..++.++||||||+++|||++|..|+....         .....+
T Consensus       163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~  231 (284)
T 2a19_B          163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFTDL  231 (284)
T ss_dssp             ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHHHH
T ss_pred             ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHHHh
Confidence            999999987654322  234468999999999999999999999999999999999998875211         111122


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      ..+...               ..++..+.+++.+||+.||.+|||+.|++++|+.++.+.
T Consensus       232 ~~~~~~---------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          232 RDGIIS---------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HTTCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             hccccc---------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            222111               123456889999999999999999999999999887544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=354.13  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=197.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCC--CCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQH--PNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++... ...++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-CEEEE
Confidence            4568899999999999999999888999999998644  33445789999999999976  9999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||+ .+++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus        87 v~e~-~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EECC-CSEEHHHHHHHSCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEeC-CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9995 58899999987653    89999999999999999999999999999999999997 578999999999876543


Q ss_pred             ccc-cccCCCCCCCccCcccccc-----------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh
Q 013686          265 VTH-VSTAPQGTPGYVDPDYFQC-----------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       265 ~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      ... ......||+.|+|||.+.+           ..++.++|||||||++|||++|+.||......     .......+.
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~  235 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIID  235 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhc
Confidence            322 2234569999999999865           67889999999999999999999999743211     111111111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                      . ....    ..+       ...+..+.+|+.+||+.||.+|||+.|++++..-.
T Consensus       236 ~-~~~~----~~~-------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          236 P-NHEI----EFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             T-TSCC----CCC-------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             C-Cccc----CCc-------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            1 1100    000       11234688999999999999999999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-45  Score=344.01  Aligned_cols=254  Identities=29%  Similarity=0.462  Sum_probs=198.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|.+.+.||+|+||.||++... +|..||+|.+.... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-HNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-CeEEEEE
Confidence            467888999999999999999976 58999999986543 23457889999999999999999999977654 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe---cCCCeEEEeeeCcccccCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgla~~~~~  263 (438)
                      ||+++|+|.+++.........+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            9999999999997643222349999999999999999999999999999999999999   4567899999999986644


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ...  .....+++.|+|||.+. ..++.++||||||+++|||++|+.||......      .. ..........      
T Consensus       180 ~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~-~~~~~~~~~~------  243 (285)
T 3is5_A          180 DEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EV-QQKATYKEPN------  243 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCCC------
T ss_pred             ccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HH-HhhhccCCcc------
Confidence            322  23456899999999986 47899999999999999999999999754321      11 1111111110      


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ....    ...+++.+.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          244 YAVE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cccc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000    01235678899999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-45  Score=356.96  Aligned_cols=245  Identities=29%  Similarity=0.433  Sum_probs=192.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHH-HHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEI-LTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||++..+ +++.||+|++.....   ...+.+.+|..+ ++.++||||+++++++... +.+|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEE
Confidence            457889999999999999999987 588999999976532   233456677776 4678999999999977665 4799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....    +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       116 lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999999987654    88999999999999999999999999999999999999999999999999986432


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|..||......      . ....+......      
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~------  257 (373)
T 2r5t_A          192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------E-MYDNILNKPLQ------  257 (373)
T ss_dssp             CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------H-HHHHHHHSCCC------
T ss_pred             CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhcccC------
Confidence            22 1234457999999999999999999999999999999999999999754321      1 11222222111      


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE  379 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  379 (438)
                        ..     ..++..+.+|+.+||+.||.+||++.+
T Consensus       258 --~~-----~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 --LK-----PNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --CC-----SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --CC-----CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence              11     124567889999999999999999853

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.1e-45  Score=353.01  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=203.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .+.|...+.||+|+||.||+|... +|+.||||++...   .....+.+.+|++++++++||||+++++++... ...++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~l  131 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWL  131 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEE
Confidence            345888999999999999999974 6899999998643   233456789999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+. |+|.+++.....   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       132 v~e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EEecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            999996 688888865433   3899999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                           ....||+.|+|||.+.   +..++.++|||||||++|||++|+.||......      .... .+..+.......
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~-~~~~~~~~~~~~  275 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY-HIAQNESPALQS  275 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCCCCCC
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HHHhcCCCCCCC
Confidence                 2346899999999984   567899999999999999999999999754321      1111 121111111111


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                                 ..++..+.+++.+||+.||++|||+++++++..-..
T Consensus       276 -----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          276 -----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             -----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             -----------CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence                       124567889999999999999999999998765443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=358.39  Aligned_cols=266  Identities=20%  Similarity=0.276  Sum_probs=199.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccchH-----------hHHHHHHHHHHHHhCCCCCceeEee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENNFK-----------RIEQFMNEVEILTKLQHPNLVKLYG  173 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~  173 (438)
                      .++|.+.+.||+|+||.||+|...    ++..||+|.+......           ..+.+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357889999999999999999975    5788999998654321           1134678899999999999999999


Q ss_pred             eeecc---CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC--
Q 013686          174 CTSRQ---SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF--  248 (438)
Q Consensus       174 ~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~--  248 (438)
                      ++...   ....++||||+ +++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT----FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGB----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            76552   45799999999 9999999987653    99999999999999999999999999999999999999887  


Q ss_pred             eEEEeeeCcccccCCCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccc
Q 013686          249 RVKVADFGLSRLFPTDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN  322 (438)
Q Consensus       249 ~~kl~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~  322 (438)
                      .+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... 
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA-  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence            9999999999876432211      113456999999999999989999999999999999999999999643211110 


Q ss_pred             hhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                       .......... ...........      ...++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       270 -~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          270 -VQTAKTNLLD-ELPQSVLKWAP------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             -HHHHHHHHHH-TTTHHHHHHSC------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             -HHHHHHhhcc-cccHHHHhhcc------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence             0111111111 00000000000      0135668999999999999999999999999998764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.1e-45  Score=364.69  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=197.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--------HhHHHHHHHHHHHHhCCCCCceeEeeeeec
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--------KRIEQFMNEVEILTKLQHPNLVKLYGCTSR  177 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  177 (438)
                      ...++|.+.+.||+|+||.||+|... +++.||||++.....        .....+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45688999999999999999999976 589999999865421        112357899999999999999999997643


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---eEEEee
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---RVKVAD  254 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---~~kl~D  254 (438)
                        ...++||||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence              358999999999999999876543    89999999999999999999999999999999999997544   599999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCcccccc---CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC---YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      ||+++......  ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........      ....+
T Consensus       286 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~i  357 (419)
T 3i6u_A          286 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQI  357 (419)
T ss_dssp             SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHHH
T ss_pred             cccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHHH
Confidence            99998764432  2234569999999999853   5688899999999999999999999975432211      11122


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ..+...         .....+..++..+.+|+.+||+.||++|||+.|++++-
T Consensus       358 ~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          358 TSGKYN---------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HTTCCC---------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             hcCCCC---------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            222111         01122345677899999999999999999999999853

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.1e-45  Score=350.03  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=206.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ..+|.+.+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++... +..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEE
Confidence            467888999999999999999986 4889999998654   234557889999999999999999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       119 v~e~~~~~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCCCHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999999987643    899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......      .. ...+......      +
T Consensus       195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~~------~  260 (335)
T 2owb_A          195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ET-YLRIKKNEYS------I  260 (335)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHHTCCC------C
T ss_pred             cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HH-HHHHhcCCCC------C
Confidence            22 223456899999999999889999999999999999999999999754321      11 1112111110      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .       ..++..+.+++.+||+.||++|||+.|++++-
T Consensus       261 ~-------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          261 P-------KHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             C-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            0       12345688999999999999999999999854

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-45  Score=346.26  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=208.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeee-ccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTS-RQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+.++++++||||+++++++. ......++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467889999999999999999976 6899999998654  3345578999999999999999999999664 34457999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-----VIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||+.+     |+||||||+|||++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999875444445899999999999999999999999     9999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||......       .....+..+.....
T Consensus       165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~~~~  236 (279)
T 2w5a_A          165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRI  236 (279)
T ss_dssp             HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCC
T ss_pred             eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHHHHhhcccccC
Confidence            76443221 12235899999999999889999999999999999999999999754321       11222333322111


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                           +       ..++..+.+++.+||+.||++|||+.|+++++...
T Consensus       237 -----~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          237 -----P-------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             -----C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             -----C-------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                 1       13456789999999999999999999999876544

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-45  Score=349.64  Aligned_cols=258  Identities=27%  Similarity=0.471  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC-----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD-----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .+|.+.+.||+|+||.||+|....     +..||||.+... .....+.+.+|+.++++++||||+++++++... +..+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-CCcE
Confidence            467778999999999999998653     236999998754 334456789999999999999999999977654 5799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999999999986533   389999999999999999999999999999999999999999999999999987644


Q ss_pred             Cccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          264 DVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       264 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....  ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......       .....+..+....  
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~~~--  270 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRLP--  270 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCCC--
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCCcCC--
Confidence            3221  1122346788999999998899999999999999999999 99999653321       1112222221110  


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                         .       ...++..+.+++.+||+.||++||++.++++.|+++...
T Consensus       271 ---~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          271 ---T-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             ---C-------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---C-------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               0       013456789999999999999999999999999988653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=381.41  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=202.8

Q ss_pred             CCCCC-cccccCceEEEEEEEc---CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          112 FNSSK-QLGDGGFGAVYLGILR---DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       112 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      +.+.+ .||+|+||.||+|.++   ++..||||+++... ....+.+.+|+++|++++||||+++++++..  +.+++||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~  414 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVM  414 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEE
Confidence            33344 7999999999999875   46689999997643 3356789999999999999999999998765  3589999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++|+|.+++.....   .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus       415 E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999999976433   389999999999999999999999999999999999999999999999999987644322


Q ss_pred             c--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          267 H--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       267 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......       ....+..+.....    
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~----  560 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC----  560 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCCC----
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC----
Confidence            1  1122346789999999998999999999999999999998 999997543321       1223333221110    


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                              +..++..+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus       561 --------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          561 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             --------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                    12356789999999999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-45  Score=366.40  Aligned_cols=248  Identities=28%  Similarity=0.456  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....   ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~l   93 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFM   93 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEE
Confidence            457889999999999999999976 699999999975432   2356789999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++|+|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        94 v~E~~~gg~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEECCSSEEHHHHTTSSSS----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999999976543    899999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .  ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......       .....+..+...   .+ 
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~---~p-  236 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKICDGIFY---TP-  236 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHHHTTCCC---CC-
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCCcC---CC-
Confidence            2  2234579999999999988765 67999999999999999999999754321       112223222211   00 


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                               ..++..+.+|+.+||+.||++|||+.|++++
T Consensus       237 ---------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          237 ---------QYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                     1245678899999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.3e-46  Score=372.80  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=196.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++...   .....+.+.+|+.+++.++||||+++++++... +.+++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEE
Confidence            467889999999999999999976 6899999998754   223346678899999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      ||||+++|+|.+++.....    +++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++....
T Consensus       226 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999999987654    8999999999999999999998 9999999999999999999999999999986433


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      . ....+......      
T Consensus       302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~------  367 (446)
T 4ejn_A          302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------K-LFELILMEEIR------  367 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC------
T ss_pred             CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHHhCCCC------
Confidence            322 234467999999999999999999999999999999999999999754321      1 11122111110      


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEIL  384 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  384 (438)
                      ++       ..++..+.+|+.+||+.||.+||     +++|++++-
T Consensus       368 ~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          368 FP-------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             CC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             CC-------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence            10       12456789999999999999999     999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.3e-45  Score=372.48  Aligned_cols=254  Identities=25%  Similarity=0.369  Sum_probs=207.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|++.....   ...+.+.+|+++|+.++||||+++++++... ..+|+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEEE
Confidence            467899999999999999999986 699999999965432   2346688999999999999999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||++||+|.+++......  .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEcCCCCcHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999875432  3899999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ......+.....      .+
T Consensus       340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~~------~~  408 (576)
T 2acx_A          340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPE------EY  408 (576)
T ss_dssp             CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCCC------CC
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcccc------cC
Confidence            22  23457999999999999989999999999999999999999999864332111   111122221110      11


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                      +       ..++..+.+|+.+||+.||.+||     +++|++++
T Consensus       409 p-------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          409 S-------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             C-------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             C-------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0       23456789999999999999999     78999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.6e-46  Score=360.69  Aligned_cols=272  Identities=24%  Similarity=0.274  Sum_probs=205.4

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-----CCCceeEeeeee
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-----HPNLVKLYGCTS  176 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~  176 (438)
                      .+.....++|.+.+.||+|+||.||+|... +++.||||++... ....+.+..|+.+++.+.     ||||+++++++.
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            333444678999999999999999999975 6899999998643 233466788999999996     999999999776


Q ss_pred             ccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC----------
Q 013686          177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN----------  246 (438)
Q Consensus       177 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~----------  246 (438)
                      .. +..++||||+ +++|.+++......  .+++..+..++.||+.||+|||++||+||||||+|||++.          
T Consensus       107 ~~-~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          107 YY-DHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             ET-TEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             EC-CeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            65 4799999999 99999999876543  3899999999999999999999999999999999999975          


Q ss_pred             ---------------CCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCC
Q 013686          247 ---------------NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA  311 (438)
Q Consensus       247 ---------------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p  311 (438)
                                     ++.+||+|||++......    .....||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence                           789999999999865432    2345689999999999999999999999999999999999999


Q ss_pred             cccCCcccccchhH--------HHHHHHhcCcccccccC-----cCCCCc-------------cHHHHHHHHHHHHHHHH
Q 013686          312 VDTSRHRHDINLSN--------MATNKIQNGALNELVDP-----SLGFEK-------------DYAVRNMVTSVAELAFR  365 (438)
Q Consensus       312 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-----~~~~~~-------------~~~~~~~~~~l~~li~~  365 (438)
                      |.............        ..............++.     ..+...             ..........+.+|+.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            97644321110000        00000000000000000     000000             00111122668899999


Q ss_pred             hhccCCCCCCCHHHHHHH
Q 013686          366 CVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       366 cl~~dP~~RPs~~evl~~  383 (438)
                      ||+.||++|||+.|++++
T Consensus       339 ~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             HhcCChhhCCCHHHHhcC
Confidence            999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.1e-45  Score=364.71  Aligned_cols=263  Identities=20%  Similarity=0.279  Sum_probs=207.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......  +.+.+|+++++.++|++.+..+.++.......++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            468999999999999999999975 6899999987654322  3577899999999875555544445455568899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe---cCCCeEEEeeeCcccccCCC
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+ +++|.+++.....   .+++..++.|+.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 9999999986433   39999999999999999999999999999999999999   68899999999999876543


Q ss_pred             ccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          265 VTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       265 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      ...      ......||+.|+|||.+.+..++.++|||||||+||||++|+.||.......................   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~---  236 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS---  236 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC---
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc---
Confidence            321      12245699999999999999999999999999999999999999986543322211111111111111   


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                               .......++.++.+++.+||+.||++||++.+|++.|+.+..
T Consensus       237 ---------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          237 ---------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             ---------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                     111223456789999999999999999999999999998854

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-45  Score=356.19  Aligned_cols=255  Identities=21%  Similarity=0.346  Sum_probs=203.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||||.+.....    ...+|++++.++ +||||+++++++... ...|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDG-KYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcC-CEEEEEE
Confidence            567999999999999999999986 589999999875532    234688888887 799999999977655 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC----CeEEEeeeCcccccC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN----FRVKVADFGLSRLFP  262 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~----~~~kl~Dfgla~~~~  262 (438)
                      ||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||++....
T Consensus        96 E~~~gg~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKF----FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999999987543    8999999999999999999999999999999999998433    359999999998764


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||++|..||.......    .......+..+.....  .
T Consensus       172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~~~--~  244 (342)
T 2qr7_A          172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGKFSLS--G  244 (342)
T ss_dssp             CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCCCCCC--S
T ss_pred             CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCCcccC--c
Confidence            4322 2334578999999999988889999999999999999999999997532211    1112223333222110  0


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE  386 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  386 (438)
                             ..+..++..+.+|+.+||..||++|||+.|++++-.-
T Consensus       245 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          245 -------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             -------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             -------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence                   0112456778999999999999999999999986543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.7e-45  Score=349.82  Aligned_cols=262  Identities=28%  Similarity=0.424  Sum_probs=206.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEE--EEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIV--AVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|... +|..+  |+|.+... .....+.+.+|+++++++ +||||+++++++... +..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~  102 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLY  102 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceE
Confidence            357888999999999999999965 56644  99988653 223446788999999999 899999999977655 4799


Q ss_pred             EEEeccCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEE
Q 013686          184 LVYEYIPNGTVADHLHNRQ------------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVK  251 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~k  251 (438)
                      +||||+++++|.+++....            .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence            9999999999999998754            1223489999999999999999999999999999999999999999999


Q ss_pred             EeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHH
Q 013686          252 VADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNK  330 (438)
Q Consensus       252 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~  330 (438)
                      |+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       .....
T Consensus       183 L~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~  253 (327)
T 1fvr_A          183 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEK  253 (327)
T ss_dssp             ECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHH
T ss_pred             EcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHHHH
Confidence            9999999743221  11223357889999999988889999999999999999998 99999754321       11122


Q ss_pred             HhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          331 IQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                      +..+...     ...       ..++..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus       254 ~~~~~~~-----~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          254 LPQGYRL-----EKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             GGGTCCC-----CCC-------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             hhcCCCC-----CCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            2222110     011       1345678999999999999999999999999999876543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.3e-45  Score=344.21  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             hcCCCCCC-cccccCceEEEEEEEc---CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          109 TDNFNSSK-QLGDGGFGAVYLGILR---DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       109 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      .++|.+.+ .||+|+||.||+|.+.   +++.||||.+....  ....+.+.+|+++++.++||||+++++++.  .+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCc
Confidence            45677777 9999999999999653   46889999986543  233578999999999999999999999773  3468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCcC----CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999999987543    8999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccc--ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          263 TDVTHV--STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       263 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       .....+..+.... 
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-  240 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG-  240 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCC-
Confidence            433221  222346788999999988889999999999999999999 99999754321       1122222222111 


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                          .       +..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       241 ----~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          241 ----C-------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             ----C-------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                1       123566789999999999999999999999999988543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.5e-45  Score=369.35  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|.+.+.||+|+||.||+|..+ +|+.||+|++.....   ...+.+.+|+.++++++||||+++++++... ..+|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEEE
Confidence            67888999999999999999986 699999999975432   2346788999999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||++||+|.+++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~  343 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ  343 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence            99999999999998765434459999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ... ....+......      + 
T Consensus       344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~-~~~~i~~~~~~------~-  412 (543)
T 3c4z_A          344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRVLEQAVT------Y-  412 (543)
T ss_dssp             CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHH-HHHHHHHCCCC------C-
T ss_pred             cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHH-HHHHHhhcccC------C-
Confidence            22 2345799999999999999999999999999999999999999976432211  111 11222221110      1 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM-----KEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  383 (438)
                       +     ..++..+.+|+.+||+.||++||++     ++++++
T Consensus       413 -p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          413 -P-----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             -C-----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             -C-----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence             1     2346678999999999999999965     677653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.6e-45  Score=356.51  Aligned_cols=252  Identities=22%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCC--CCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQ--HPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .+|.+.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++++++  ||||+++++++... ..+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEEEE
Confidence            458899999999999999999888999999998654  3445678999999999996  59999999977665 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      || +.+++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus       135 ~E-~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSS----CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 558899999987653    88999999999999999999999999999999999995 5789999999998765433


Q ss_pred             cc-cccCCCCCCCccCcccccc-----------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          266 TH-VSTAPQGTPGYVDPDYFQC-----------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       266 ~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     .... ..+..
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~-~~~~~  282 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL-HAIID  282 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHH-HHHHC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHH-HHHhC
Confidence            22 2334569999999999865           36889999999999999999999999743211     1111 11111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .....    ..+       ...+..+.+|+.+||+.||.+|||+.|++++..
T Consensus       283 ~~~~~----~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          283 PNHEI----EFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             TTSCC----CCC-------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ccccC----CCC-------ccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence            11110    000       012456889999999999999999999998654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-45  Score=344.74  Aligned_cols=249  Identities=31%  Similarity=0.497  Sum_probs=202.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +++.||+|++......   ..+.+.+|+.++++++||||+++++++... ...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEE
Confidence            567889999999999999999976 5789999998654322   246788999999999999999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999999987654    899999999999999999999999999999999999999999999999998654332


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......       ....+......      +
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~  226 (279)
T 3fdn_A          163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFT------F  226 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC------C
T ss_pred             c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCCCC------C
Confidence            2   233468999999999999999999999999999999999999997543211       11122211110      0


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +       ..++..+.+|+.+||+.||.+|||++|++++-.
T Consensus       227 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          227 P-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             C-------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             C-------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            0       124567889999999999999999999998754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.9e-45  Score=364.18  Aligned_cols=271  Identities=22%  Similarity=0.303  Sum_probs=199.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----RE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  181 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467899999999999999999976 5889999999653  3345578899999999999999999999775543    46


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .|+||||++ ++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~----l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIF----LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999995 699999986543    899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccc---------------------cccCCCCCCCccCcccc-ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccc
Q 013686          262 PTDVTH---------------------VSTAPQGTPGYVDPDYF-QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRH  319 (438)
Q Consensus       262 ~~~~~~---------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~  319 (438)
                      ......                     ......||+.|+|||++ .+..++.++|||||||++|||++|..||.......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            443211                     12455799999999986 56679999999999999999998655554221000


Q ss_pred             cc-------------------------chhHHHHHHHhcCc-----------cc---ccccCcCCCCccHHHHHHHHHHH
Q 013686          320 DI-------------------------NLSNMATNKIQNGA-----------LN---ELVDPSLGFEKDYAVRNMVTSVA  360 (438)
Q Consensus       320 ~~-------------------------~~~~~~~~~~~~~~-----------~~---~~~~~~~~~~~~~~~~~~~~~l~  360 (438)
                      ..                         +........+....           ..   .................++..+.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence            00                         00000000000000           00   00000001111111234677899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHH
Q 013686          361 ELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       361 ~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +|+.+||+.||++|||++|++++-
T Consensus       340 dLl~~mL~~dP~~R~ta~e~L~Hp  363 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITIDQALDHP  363 (432)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTCG
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCh
Confidence            999999999999999999999853

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6e-45  Score=347.42  Aligned_cols=264  Identities=24%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc-
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR-  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  180 (438)
                      ..++|.+.+.||+|+||.||+|...    +++.||+|.+...  .....+.+.+|+.++++++||||+++++++..... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3567889999999999999999864    2458999998654  34456789999999999999999999997765432 


Q ss_pred             ---eEEEEEeccCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeee
Q 013686          181 ---ELLLVYEYIPNGTVADHLHNRQ--PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       181 ---~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                         ..++||||+++|+|.+++....  .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df  191 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF  191 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence               3599999999999999995432  22235999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhc
Q 013686          256 GLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       256 gla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......      . ...+..
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~-~~~~~~  264 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------M-YDYLLH  264 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------H-HHHHHT
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------H-HHHHHc
Confidence            99986543321 12233457889999999999999999999999999999999 889997543221      1 112222


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      +.....            +..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       265 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          265 GHRLKQ------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             TCCCCC------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCC------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111110            023456789999999999999999999999999988653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=358.28  Aligned_cols=256  Identities=30%  Similarity=0.406  Sum_probs=203.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE----cCCcEEEEEEeeccc----hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccC
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL----RDGRIVAVKRLYENN----FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQS  179 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  179 (438)
                      .++|++.+.||+|+||.||++..    .+|+.||||++....    ....+.+.+|+++++++ +||||+++++++... 
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            46789999999999999999997    368999999986432    12335577899999999 699999999977655 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...++||||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            479999999999999999987653    8999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ..............||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.........  ..... .+....  
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~-~~~~~~--  282 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISR-RILKSE--  282 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHH-HHHHCC--
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHH-HHhccC--
Confidence            765443333344569999999999985  35789999999999999999999999754332211  11111 111110  


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEILR  385 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~  385 (438)
                          +.++       ..++..+.+|+.+||+.||++||     +++|++++..
T Consensus       283 ----~~~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          283 ----PPYP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             ----CCCC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             ----CCCC-------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                1111       13456788999999999999999     9999998654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=353.59  Aligned_cols=245  Identities=22%  Similarity=0.356  Sum_probs=202.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--------HhHHHHHHHHHHHHhCCCCCceeEeeeeecc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ  178 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  178 (438)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+.....        ...+.+.+|+.++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999965 689999999875421        1234577899999999999999999977655


Q ss_pred             CceEEEEEeccCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          179 SRELLLVYEYIPNG-TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       179 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                       +..++||||+.+| +|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       102 -~~~~lv~e~~~~g~~l~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 -GFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             -SEEEEEEECCTTSCBHHHHHHTCCC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             -CEEEEEEEeCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence             4799999999776 99999987654    89999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      +........  .....||+.|+|||.+.+..+ +.++|||||||++|||++|..||......            .     
T Consensus       177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~-----  237 (335)
T 3dls_A          177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V-----  237 (335)
T ss_dssp             CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T-----
T ss_pred             ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H-----
Confidence            987654322  223468999999999988776 78999999999999999999999642110            0     


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .....+.         ..++..+.+|+.+||+.||++|||+.|++++-.
T Consensus       238 ~~~~~~~---------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          238 EAAIHPP---------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             TTCCCCS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             hhccCCC---------cccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            0000000         114567889999999999999999999998643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.4e-44  Score=346.31  Aligned_cols=270  Identities=22%  Similarity=0.351  Sum_probs=210.6

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHh--CCCCCceeEeeeeeccC--
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTK--LQHPNLVKLYGCTSRQS--  179 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~--  179 (438)
                      ......++|.+.+.||+|+||.||+|.. +|+.||||.+....   .+.+.+|.+++..  ++||||+++++++....  
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            3445567899999999999999999988 58999999986543   3567789999988  68999999999776654  


Q ss_pred             -ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCCEEecCCCeE
Q 013686          180 -RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH--------ASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       180 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                       ...++||||+++|+|.+++....     +++..++.++.|++.||.|||        +.||+||||||+|||++.++.+
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             cceeEEEEeecCCCcHHHHHhccC-----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence             26899999999999999997642     899999999999999999999        8999999999999999999999


Q ss_pred             EEeeeCcccccCCCccc---cccCCCCCCCccCccccccC------CCCChhhHHHHHHHHHHHHhC----------CCC
Q 013686          251 KVADFGLSRLFPTDVTH---VSTAPQGTPGYVDPDYFQCY------KLTDKSDVYSFGVVLIELISG----------LEA  311 (438)
Q Consensus       251 kl~Dfgla~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tG----------~~p  311 (438)
                      ||+|||++.........   ......||+.|+|||.+.+.      .++.++|||||||++|||+||          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999866443322   22345699999999999765      234689999999999999999          667


Q ss_pred             cccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          312 VDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      |........ .. ......+.....    .+.++  .......++..+.+|+.+||+.||++|||+.|++++|+.+.+.
T Consensus       267 ~~~~~~~~~-~~-~~~~~~~~~~~~----~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          267 YYDLVPSDP-SV-EEMRKVVCEQKL----RPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTTSCSSC-CH-HHHHHHHTTSCC----CCCCC--GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccCcCcc-cH-HHHHHHHHHHHh----CCCCc--ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            754322111 11 111122222111    11111  1111235677899999999999999999999999999998654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=341.42  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=183.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.....   ...+.+.+|+.++++++||||+++++++... ...++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-NYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-SEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-CeEEE
Confidence            467889999999999999999975 689999999865432   2246789999999999999999999977655 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....   .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999986532   3899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.........       ..+.        ....
T Consensus       166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~--------~~~~  229 (278)
T 3cok_A          166 HEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVV--------LADY  229 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC--------SSCC
T ss_pred             CCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHh--------hccc
Confidence            221 22346899999999999889999999999999999999999999754322110       0000        0001


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..+     ..++..+.+++.+||+.||++|||+++++++
T Consensus       230 ~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          230 EMP-----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCc-----cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            000     1245678899999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=357.71  Aligned_cols=265  Identities=21%  Similarity=0.331  Sum_probs=197.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----c
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----R  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  180 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+++++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467889999999999999999975 6999999998543  3334567899999999999999999999775542     3


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|+||||+ +++|.+++....     +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            569999999 889999998632     89999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHHHH
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATNKI  331 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~~~  331 (438)
                      ....    .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..............        ....+
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            5432    234568999999999877 6799999999999999999999999986543211100000        00000


Q ss_pred             hcCcccc---cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          332 QNGALNE---LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       332 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .......   .+...............+..+.+|+.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000000   000000000001112346678999999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.4e-44  Score=337.70  Aligned_cols=248  Identities=27%  Similarity=0.459  Sum_probs=200.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec---cCceEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR---QSRELLL  184 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~l  184 (438)
                      .|.+.+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.++++++||||+++++++..   ....+++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4667789999999999999976 5889999998654  34456789999999999999999999997644   2456899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEec-CCCeEEEeeeCccccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLD-NNFRVKVADFGLSRLF  261 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~  261 (438)
                      ||||+++++|.+++.....    +++..++.++.||+.||.|||+.+  |+||||||+|||++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHccC----CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            9999999999999987643    899999999999999999999999  99999999999997 7899999999999765


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ....   .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||......      ......+..+......+
T Consensus       183 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          183 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG
T ss_pred             cccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccccC
Confidence            4332   223468999999998874 5999999999999999999999999753321      11112222221111111


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                                 ...++.+.+++.+||+.||.+|||+.|++++
T Consensus       253 -----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          253 -----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                       1234568899999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=353.89  Aligned_cols=269  Identities=21%  Similarity=0.321  Sum_probs=199.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh-----HHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR-----IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      ..++|++.+.||+|+||.||+|... +|+.||||++.......     .+.+.+|+++++.++||||+++++++... ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-Cc
Confidence            4578999999999999999999976 58999999986532211     24678999999999999999999977654 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .++||||+++ +|.+++.....   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            8999999975 89998876542   3888999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALN  337 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  337 (438)
                      ..... ......+|+.|+|||.+.+. .++.++|||||||++|||++|.+||.........   .........   ..+.
T Consensus       163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSS
T ss_pred             cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCChhhhh
Confidence            43322 23345689999999999764 5889999999999999999999999764322110   001111100   0000


Q ss_pred             cccc--C-----cC-CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          338 ELVD--P-----SL-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       338 ~~~~--~-----~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ....  .     .. ..........++..+.+|+.+||+.||++|||+.|++++-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence            0000  0     00 00011112345678999999999999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=350.61  Aligned_cols=260  Identities=26%  Similarity=0.378  Sum_probs=192.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeee-------ccC
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTS-------RQS  179 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-------~~~  179 (438)
                      ..+|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.++. ||||+++++++.       ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457889999999999999999975 68999999997777667788999999999996 999999999763       334


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      ..+++||||+. |+|.+++..... ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            56899999995 799999876322 123899999999999999999999999  99999999999999999999999999


Q ss_pred             ccccCCCcccc-----------ccCCCCCCCccCcccc---ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch
Q 013686          258 SRLFPTDVTHV-----------STAPQGTPGYVDPDYF---QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL  323 (438)
Q Consensus       258 a~~~~~~~~~~-----------~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~  323 (438)
                      +..........           .....+|+.|+|||.+   .+..++.++|||||||++|||++|+.||.......    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence            98764432211           1134589999999998   56678999999999999999999999997432211    


Q ss_pred             hHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCC
Q 013686          324 SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL  392 (438)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  392 (438)
                             +..+.......           ...+..+.+|+.+||+.||.+|||+.|++++|+.+.....
T Consensus       261 -------~~~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 -------IVNGKYSIPPH-----------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ------------CCCCTT-----------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -------hhcCcccCCcc-----------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                   00111100000           1123347789999999999999999999999999876443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.6e-45  Score=347.54  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|.+.+.||+|+||.||++... +|+.||+|.+........+.+.+|+.++++++||||+++++++... ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-THYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-CEEEEEEE
Confidence            467889999999999999999976 6899999999766544556788999999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe---cCCCeEEEeeeCcccccCCC
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |+++++|.+++.....    +++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILERGV----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999999999987653    8999999999999999999999999999999999999   78899999999999765432


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .   .....|++.|+|||.+.+..++.++||||||+++|||++|..||......       .....+..+....  ... 
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~--~~~-  229 (304)
T 2jam_A          163 I---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYYEF--ESP-  229 (304)
T ss_dssp             T---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCCCC--CTT-
T ss_pred             c---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCC--Ccc-
Confidence            1   12235899999999999999999999999999999999999999754321       1112222221110  000 


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                            ....++..+.+++.+||+.||++|||+.|++++-.
T Consensus       230 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          230 ------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             ------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence                  11235667899999999999999999999998644

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-44  Score=376.43  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=200.7

Q ss_pred             CcccccCceEEEEEEEc---CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILR---DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+.+.+|+++|++++||||+++++++..  +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence            47999999999999754   46789999987543  2345789999999999999999999997754  35899999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc--cc
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT--HV  268 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~--~~  268 (438)
                      +|+|.+++.....    +++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....  ..
T Consensus       453 ~g~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          453 LGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCCHHHHHhhCCC----CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9999999986543    89999999999999999999999999999999999999999999999999987654322  12


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......       .....+..+.....        
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~--------  593 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGC--------  593 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCC--------
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC--------
Confidence            223346789999999999999999999999999999998 99999754321       12223332221111        


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                          +..++..+.+|+.+||+.||++||++.+|++.|+++..
T Consensus       594 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          594 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                12356789999999999999999999999999988743

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-44  Score=353.95  Aligned_cols=268  Identities=21%  Similarity=0.284  Sum_probs=197.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----c
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----R  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  180 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999976 6899999998653  3344577889999999999999999999775543     3


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||++ ++|.+++...      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCC-CCHHHHHhhc------cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            6899999996 5888888632      88999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh----------------
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS----------------  324 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~----------------  324 (438)
                      .....  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............                
T Consensus       177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            54322  223456899999999999999999999999999999999999999764321110000                


Q ss_pred             HHHHHHHhcC-c-----ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          325 NMATNKIQNG-A-----LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       325 ~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .......... .     +...................+..+.+|+.+||+.||++|||++|++++-.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence            0000000000 0     00000000000111223455788999999999999999999999998653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.1e-45  Score=353.27  Aligned_cols=265  Identities=21%  Similarity=0.302  Sum_probs=194.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH--hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK--RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||+||+|... +|+.||||++......  ..+.+.+|+.++++++||||+++++++... ...++|
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv  111 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHLI  111 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEEE
Confidence            567999999999999999999966 6899999998654332  245678999999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe-----cCCCeEEEeeeCcccc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL-----DNNFRVKVADFGLSRL  260 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill-----~~~~~~kl~Dfgla~~  260 (438)
                      |||++ |+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||+     +.++.+||+|||+++.
T Consensus       112 ~e~~~-~~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCS-EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCC-CCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99996 599999987654    8999999999999999999999999999999999999     4556699999999987


Q ss_pred             cCCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Ccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GAL  336 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  336 (438)
                      ....... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.........   .........   ..+
T Consensus       187 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          187 FGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL---FKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTS
T ss_pred             cCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH---HHHHHHhCCCchhhh
Confidence            6433222 2334689999999999874 5899999999999999999999999764332111   000011000   000


Q ss_pred             cc------ccc--CcCCCC--ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NE------LVD--PSLGFE--KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~------~~~--~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..      ...  +.....  .......++..+.+|+.+||+.||++|||++|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00      000  000000  001112256788999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-45  Score=351.96  Aligned_cols=262  Identities=27%  Similarity=0.396  Sum_probs=208.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-C-----cEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-G-----RIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|.+.+.||+|+||.||+|.... +     ..||+|.+... .....+.+.+|+.+++.+ +||||+++++++... +
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-G  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-C
Confidence            5678899999999999999999753 2     47999998754 334557899999999999 899999999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQP----------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      ..++||||+++|+|.+++.....          ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence            78999999999999999976421          01247999999999999999999999999999999999999999999


Q ss_pred             EEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHH
Q 013686          251 KVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       251 kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~  328 (438)
                      ||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||+| |..||.......      ...
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~  277 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFY  277 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------HHH
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------HHH
Confidence            9999999986543322 22233457889999999998899999999999999999998 999997543221      111


Q ss_pred             HHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      ..+..+...     ..+       ..++..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus       278 ~~~~~~~~~-----~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          278 KLVKDGYQM-----AQP-------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HHHHHTCCC-----CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCCC-----CCC-------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            122211110     000       1234578899999999999999999999999988753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-46  Score=354.73  Aligned_cols=266  Identities=21%  Similarity=0.319  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh-HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.++++++||||+++++++... ...++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEec
Confidence            57889999999999999999986 68999999986543221 12455799999999999999999977655 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |++ |+|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             CCS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             ccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence            996 699999887543   389999999999999999999999999999999999999999999999999986543322 


Q ss_pred             cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccccccc--
Q 013686          268 VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALNELVD--  341 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--  341 (438)
                      ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........   .........   ..+.....  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcch
Confidence            2234468999999999876 56899999999999999999999999765432111   111111100   00000000  


Q ss_pred             -------CcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          342 -------PSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       342 -------~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                             +... .........++..+.+|+.+||+.||++|||++|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence                   0000 000111224567789999999999999999999999854

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.6e-45  Score=350.04  Aligned_cols=270  Identities=23%  Similarity=0.370  Sum_probs=202.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++... ...++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEE
Confidence            467889999999999999999986 48999999986543  23346688999999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+++++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       103 ~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EECCSEEHHHHHHHSTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EecCCcchHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999999888765443    8999999999999999999999999999999999999999999999999998654332


Q ss_pred             cccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH--------HHHHHHhc-Cc
Q 013686          266 THVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN--------MATNKIQN-GA  335 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~  335 (438)
                      . ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.............        ........ ..
T Consensus       179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            2 22345689999999999875 78999999999999999999999997654321110000        00000000 00


Q ss_pred             ccccccCcCCC--CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          336 LNELVDPSLGF--EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       336 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ......+.+..  ........++..+.+|+.+||+.||++|||+.|++++-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            11111111111  11112234677899999999999999999999999853

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.6e-45  Score=342.40  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=206.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH------hHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK------RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|.+.+.||+|+||.||++... +|+.||+|.+......      ..+.+.+|+.++++++||||+++++++... ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   82 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TD   82 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-Ce
Confidence            356889999999999999999987 6899999998654321      357899999999999999999999977655 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC----eEEEeeeCc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF----RVKVADFGL  257 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgl  257 (438)
                      .++||||+++++|.+++.....    +++..+..++.||+.||.|||++|++||||||+||+++.++    .+||+|||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999999987543    89999999999999999999999999999999999998877    899999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      +........  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......       ....+......
T Consensus       159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~  229 (283)
T 3bhy_A          159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNYD  229 (283)
T ss_dssp             CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCC
T ss_pred             ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhcccC
Confidence            987644322  233468999999999999999999999999999999999999997543211       11111111100


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI--LRETK  388 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  388 (438)
                               ........++..+.+++.+||+.||++|||+.|++++  ++.+.
T Consensus       230 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          230 ---------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             ---------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             ---------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                     0111223456778999999999999999999999984  44443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-44  Score=365.66  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=205.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|.+.+.||+|+||+||+|..+ +|+.||||++....  ....+.+.+|++++++++||||+++++++... ..+++|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-CEEEEE
Confidence            567999999999999999999976 68999999986432  23457789999999999999999999977655 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec---CCCeEEEeeeCcccccC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFP  262 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgla~~~~  262 (438)
                      |||+++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       100 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999987654    89999999999999999999999999999999999995   55679999999998764


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ...  ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.......       ....+..+.....   
T Consensus       176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~---  242 (486)
T 3mwu_A          176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFD---  242 (486)
T ss_dssp             CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSC---
T ss_pred             CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCC---
Confidence            432  2234569999999999976 59999999999999999999999997543211       1122222221110   


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                            ...+..++..+.+|+.+||+.||.+|||+.|++++-.
T Consensus       243 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~  279 (486)
T 3mwu_A          243 ------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (486)
T ss_dssp             ------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred             ------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence                  0112346678999999999999999999999998644

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9e-45  Score=353.16  Aligned_cols=258  Identities=22%  Similarity=0.381  Sum_probs=204.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|.+.+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++... +..++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEE
Confidence            467889999999999999999986 6899999998765 334457899999999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...... 
T Consensus       111 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             ECCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999987654    89999999999999999999996 9999999999999999999999999998754221 


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH--------------------
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN--------------------  325 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------------------  325 (438)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............                    
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              1233468999999999999999999999999999999999999997543211000000                    


Q ss_pred             ---------------HHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          326 ---------------MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       326 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                                     .....+..+..     +..      ....++..+.+|+.+||+.||++|||++|++++-.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPP-----PKL------PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCC-----CCC------CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ccccccCCCCcccchhhhhHHhccCC-----CCC------CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                           00000000000     000      00124567899999999999999999999998644

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.4e-45  Score=341.92  Aligned_cols=248  Identities=20%  Similarity=0.354  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+..+..+ +||||+++++++... +..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEE
Confidence            567899999999999999999986 6999999998754  233456788999999999 899999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-----------------
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-----------------  247 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-----------------  247 (438)
                      ||||+++++|.+++.........+++..++.++.||+.||.|||++||+||||||+|||++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            999999999999998753322348999999999999999999999999999999999999844                 


Q ss_pred             --CeEEEeeeCcccccCCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh
Q 013686          248 --FRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS  324 (438)
Q Consensus       248 --~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~  324 (438)
                        ..+||+|||++.......     ...|++.|+|||.+.+. .++.++|||||||++|||++|.+++....        
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------  235 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------  235 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------
T ss_pred             CceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------
Confidence              479999999998765432     23589999999999765 56689999999999999999988764321        


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        ....+..+......            ..++..+.+++.+||+.||++|||+.|++++-
T Consensus       236 --~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          236 --QWHEIRQGRLPRIP------------QVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             --HHHHHHTTCCCCCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             --HHHHHHcCCCCCCC------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence              11222222221111            12456789999999999999999999998753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.4e-46  Score=366.63  Aligned_cols=245  Identities=15%  Similarity=0.147  Sum_probs=190.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHH---HHHhCCCCCceeEe-------ee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVE---ILTKLQHPNLVKLY-------GC  174 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~  174 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...   .....+.+.+|+.   .+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999999964 6999999998743   3345678999994   55556899999998       44


Q ss_pred             eeccCc----------------eEEEEEeccCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013686          175 TSRQSR----------------ELLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAYLHASDVIHR  235 (438)
Q Consensus       175 ~~~~~~----------------~~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~  235 (438)
                      +...+.                ..|+||||+ +|+|.+++.....-   ...+++..++.++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            333221                378999999 68999999865321   1123458888999999999999999999999


Q ss_pred             CCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccC-----------CCCChhhHHHHHHHHHH
Q 013686          236 DVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY-----------KLTDKSDVYSFGVVLIE  304 (438)
Q Consensus       236 Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dvws~Gv~l~e  304 (438)
                      ||||+|||++.++.+||+|||+++....    ......| +.|+|||.+.+.           .++.++|||||||++||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            9999999999999999999999986433    2234457 999999999887           89999999999999999


Q ss_pred             HHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          305 LISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       305 l~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      |++|+.||..........               ..... .        ..++..+.+|+.+||+.||++|||+.|++++
T Consensus       306 lltg~~Pf~~~~~~~~~~---------------~~~~~-~--------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          306 IWCADLPITKDAALGGSE---------------WIFRS-C--------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHSSCCC------CCSG---------------GGGSS-C--------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHCCCCCcccccccchh---------------hhhhh-c--------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999997543221110               01110 0        1245678899999999999999999999973

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.6e-45  Score=354.23  Aligned_cols=267  Identities=19%  Similarity=0.286  Sum_probs=204.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC----ceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS----REL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  182 (438)
                      .++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++....    ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457899999999999999999976 6889999998753 3344578899999999999999999999775432    468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||++ |+|.+++....     +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999996 69999997643     8999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccc--ccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc---
Q 013686          263 TDVTHV--STAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL---  336 (438)
Q Consensus       263 ~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  336 (438)
                      ......  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........   ..........   
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~  256 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDL  256 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCSCCHHHH
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCCCCHHHH
Confidence            432221  234579999999998654 4589999999999999999999999976543322111   0000000000   


Q ss_pred             -----------cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          337 -----------NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       337 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                                 ..................++..+.+|+.+||+.||++|||+.|++++-
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                       000000000111111234567789999999999999999999999854

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-44  Score=364.60  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=205.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-------------HhHHHHHHHHHHHHhCCCCCceeEeee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-------------KRIEQFMNEVEILTKLQHPNLVKLYGC  174 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~  174 (438)
                      .++|.+.+.||+|+||+||+|..+ +++.||+|++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            578999999999999999999976 588999999865431             224678999999999999999999998


Q ss_pred             eeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC---eEE
Q 013686          175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF---RVK  251 (438)
Q Consensus       175 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~---~~k  251 (438)
                      +... ..+++|||||++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++   .+|
T Consensus       115 ~~~~-~~~~lv~e~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          115 FEDK-KYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EECS-SEEEEEEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEcC-CEEEEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            7655 579999999999999999987654    99999999999999999999999999999999999998776   699


Q ss_pred             EeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          252 VADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       252 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      |+|||++........  .....||+.|+|||.+.+ .++.++|||||||++|+|++|..||......       .....+
T Consensus       190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i  259 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-------DIIKKV  259 (504)
T ss_dssp             ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH
T ss_pred             EEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH
Confidence            999999987654322  234569999999999874 6999999999999999999999999754321       112222


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ..+...        . ....+..++..+.+|+.+||+.||.+|||++|++++-.
T Consensus       260 ~~~~~~--------~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~  304 (504)
T 3q5i_A          260 EKGKYY--------F-DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW  304 (504)
T ss_dssp             HHCCCC--------C-CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HcCCCC--------C-CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence            222211        0 11223456788999999999999999999999998644

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-44  Score=350.33  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=207.3

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--------HhHHHHHHHHHHHHhC-CCCCceeEee
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--------KRIEQFMNEVEILTKL-QHPNLVKLYG  173 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~  173 (438)
                      ......++|.+.+.||+|+||.||+|.+. +|+.||||++.....        ...+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999986 699999999865421        1245688999999999 7999999999


Q ss_pred             eeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEe
Q 013686          174 CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVA  253 (438)
Q Consensus       174 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~  253 (438)
                      ++... ...++||||+++++|.+++.....    +++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus       168 ~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          168 SYESS-SFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEBS-SEEEEEECCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEeeC-CEEEEEEEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEE
Confidence            77654 579999999999999999987543    8999999999999999999999999999999999999999999999


Q ss_pred             eeCcccccCCCccccccCCCCCCCccCcccccc------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH
Q 013686          254 DFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA  327 (438)
Q Consensus       254 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~  327 (438)
                      |||++........  .....||+.|+|||.+.+      ..++.++|||||||++|||++|..||......       ..
T Consensus       243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~  313 (365)
T 2y7j_A          243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------LM  313 (365)
T ss_dssp             CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH
T ss_pred             ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------HH
Confidence            9999987654322  234569999999999863      35888999999999999999999999753221       11


Q ss_pred             HHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          328 TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...+..+...        . ....+..++..+.+++.+||+.||++|||+.|++++
T Consensus       314 ~~~i~~~~~~--------~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRMIMEGQYQ--------F-SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHHHTCCC--------C-CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhCCCC--------C-CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1122222111        0 111223456779999999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.7e-45  Score=352.40  Aligned_cols=273  Identities=21%  Similarity=0.290  Sum_probs=202.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeecc-------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-------  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  178 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....  .....+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            467899999999999999999985 689999999855432  2235678999999999999999999977553       


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      .+..++||||++ ++|.+.+.....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            346899999996 588888876543   2899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc---cccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC
Q 013686          259 RLFPTDV---THVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG  334 (438)
Q Consensus       259 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (438)
                      +......   ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||......................
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            8664321   122234568999999999876 468999999999999999999999998644321111000000000000


Q ss_pred             ccccc--------ccCcCCCCccH----HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          335 ALNEL--------VDPSLGFEKDY----AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       335 ~~~~~--------~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .....        ...........    .....++.+.+|+.+||+.||++|||++|++++-.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence            00000        00000000000    01112466889999999999999999999998643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.9e-45  Score=353.78  Aligned_cols=275  Identities=20%  Similarity=0.288  Sum_probs=203.3

Q ss_pred             ChHHHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccc-----------hHhHHHHHHHHHHHHhCCCCCce
Q 013686          101 SCSELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENN-----------FKRIEQFMNEVEILTKLQHPNLV  169 (438)
Q Consensus       101 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv  169 (438)
                      ...++....++|.+.+.||+|+||.||+|...+|+.||||++....           ....+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3567788889999999999999999999998889999999985432           12247889999999999999999


Q ss_pred             eEeeeeec----cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec
Q 013686          170 KLYGCTSR----QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD  245 (438)
Q Consensus       170 ~~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~  245 (438)
                      ++++++..    .....++||||++ |+|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI---VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc
Confidence            99997643    2336899999996 689888876532   389999999999999999999999999999999999999


Q ss_pred             CCCeEEEeeeCcccccCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh
Q 013686          246 NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS  324 (438)
Q Consensus       246 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~  324 (438)
                      .++.+||+|||++........  .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..........  
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--  244 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN--  244 (362)
T ss_dssp             TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--
T ss_pred             CCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence            999999999999985433322  233468999999999877 678999999999999999999999997644221110  


Q ss_pred             HHHHHHHhcCc-----------ccccc----cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          325 NMATNKIQNGA-----------LNELV----DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       325 ~~~~~~~~~~~-----------~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                       ..........           .....    ..............++..+.+|+.+||+.||++|||+.|++++-
T Consensus       245 -~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          245 -KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             -HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence             0000000000           00000    00000111112234467789999999999999999999999853

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.6e-44  Score=337.61  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=206.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++... +..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-CEEEE
Confidence            467888999999999999999987 5889999998654   234457889999999999999999999977655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999999987653    899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+.....      .+
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~------~~  234 (294)
T 2rku_A          169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY------SI  234 (294)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC------CC
T ss_pred             cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccC------CC
Confidence            22 2234568999999999999899999999999999999999999997543211       1111221111      01


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      +       ..++..+.+++.+||+.||++|||++|++++-.
T Consensus       235 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          235 P-------KHINPVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             C-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             c-------cccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            0       124456889999999999999999999998643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.4e-44  Score=343.93  Aligned_cols=262  Identities=22%  Similarity=0.331  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeecc-CceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQ-SRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|... +++.||||.+....   .+.+.+|+.++++++ ||||+++++++... ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            467899999999999999999975 68999999987543   356889999999997 99999999977653 4568999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~~  264 (438)
                      |||+++++|.+++..       +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999853       88999999999999999999999999999999999999776 8999999999876443


Q ss_pred             ccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHH--------HHHhcCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT--------NKIQNGA  335 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  335 (438)
                      ..  .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......... +.....        ..+....
T Consensus       185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTT
T ss_pred             Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhc
Confidence            22  234568999999999877 67899999999999999999999999543221110 000000        0000000


Q ss_pred             c------cccccCcCC-----CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 L------NELVDPSLG-----FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~------~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .      .........     .........++..+.+|+.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0      000000000     00000112356789999999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.8e-44  Score=340.25  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=207.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .+.|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence            456888999999999999999975 68999999986543 34467899999999999999999999977655 4799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|.+++...     .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus       100 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          100 EYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             ECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999999999753     289999999999999999999999999999999999999999999999999987644322


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                       ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+......     .+. 
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-----~~~-  240 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNPP-----TLE-  240 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCC-----CCC-
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCCC-----CCc-
Confidence             2234568999999999999999999999999999999999999997533211       11112111111     111 


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                            ..++..+.+++.+||+.||++|||+.|++++..-..
T Consensus       241 ------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          241 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             ------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             ------cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence                  124556889999999999999999999998765443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.1e-45  Score=367.39  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=207.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.++++++||||+++++++... ...++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-GYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEE
Confidence            467889999999999999999986 68999999986542   23457899999999999999999999977665 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe---cCCCeEEEeeeCccccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLF  261 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgla~~~  261 (438)
                      ||||+.+|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       104 v~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSC----CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            9999999999999987653    8999999999999999999999999999999999999   56789999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.......       ....+..+.....  
T Consensus       180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~--  247 (484)
T 3nyv_A          180 EASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFE--  247 (484)
T ss_dssp             CCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCC--
T ss_pred             ccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCC--
Confidence            54322  223458999999999976 79999999999999999999999997543211       1122222221110  


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                             ...+..++..+.+|+.+||+.||.+|||+.|++++-.
T Consensus       248 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          248 -------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             -------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence                   0112346678999999999999999999999998644

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.2e-44  Score=335.87  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=204.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++... +..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEEE
Confidence            467889999999999999999976 68999999986543 33457889999999999999999999977654 5789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... 
T Consensus        85 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999999999976433    8999999999999999999999999999999999999999999999999998653322 


Q ss_pred             cccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........      ....+......  ..   
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--~~---  229 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--LN---  229 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTCTT--ST---
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcccc--cC---
Confidence            122334568999999999987665 7799999999999999999999976433211      01111111100  00   


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            ....++..+.+++.+||+.||++|||+.|++++
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                  012356678899999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.5e-44  Score=345.42  Aligned_cols=261  Identities=26%  Similarity=0.380  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------cCCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL------RDGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|++.+.||+|+||.||+|..      .+++.||||.+... .......+.+|+.++++++||||+++++++... ..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-CC
Confidence            46788999999999999999983      24778999998644 334456789999999999999999999977655 46


Q ss_pred             EEEEEeccCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeee
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPN---SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADF  255 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Df  255 (438)
                      .++||||+++++|.+++......   ...+++..++.++.||+.||.|||++||+||||||+|||++.   +..+||+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence            89999999999999999876432   134889999999999999999999999999999999999984   456999999


Q ss_pred             CcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhc
Q 013686          256 GLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       256 gla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      |++........ .......+++.|+|||.+.+..++.++||||||+++|||+| |..||......       .....+..
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~  260 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTS  260 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHT
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHHHhc
Confidence            99975432221 12223457889999999998899999999999999999998 99999754321       11122222


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      +.....            ...++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       261 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          261 GGRMDP------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             TCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCC------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            211110            01345678899999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.4e-44  Score=364.73  Aligned_cols=251  Identities=27%  Similarity=0.450  Sum_probs=201.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|..+ ++..||+|++....  ....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-RNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            457889999999999999999986 68999999987543  22346788999999999999999999987655 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCcccccC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRLFP  262 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~~~~  262 (438)
                      ||||++|+|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus       115 ~e~~~~g~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999999987654    899999999999999999999999999999999999976   4559999999998765


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ...  ......||+.|+|||++. ..++.++|||||||++|+|++|..||......       .....+..+....    
T Consensus       191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~----  256 (494)
T 3lij_A          191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYTF----  256 (494)
T ss_dssp             TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC----
T ss_pred             CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCC----
Confidence            432  233456999999999986 46999999999999999999999999754321       1122222222110    


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          . ...+..++..+.+|+.+||+.||.+|||+.|++++
T Consensus       257 ----~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 ----D-SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ----C-SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----C-chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                0 01123456779999999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-44  Score=343.09  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+........+.+.+|+++++.++||||+++++++... +..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEEEEEE
Confidence            568899999999999999999986 5899999998776666678899999999999999999999977665 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++++|.+++.....   .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....... .
T Consensus        97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred             eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence            9999999999876433   28999999999999999999999999999999999999999999999999976432111 1


Q ss_pred             cccCCCCCCCccCcccc-----ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          268 VSTAPQGTPGYVDPDYF-----QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ......|++.|+|||.+     .+..++.++||||||+++|||++|..||......      .... .+.......... 
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~~~-  244 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLL-KIAKSDPPTLLT-  244 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCCCCSS-
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHH-HHhccCCcccCC-
Confidence            12234689999999998     4667899999999999999999999999754321      1111 111111111110 


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                               ...++..+.+++.+||+.||++|||+.|++++
T Consensus       245 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          245 ---------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ---------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ---------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                     12345678999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-44  Score=341.42  Aligned_cols=260  Identities=27%  Similarity=0.444  Sum_probs=198.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--CCc--EEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--DGR--IVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|++.+.||+|+||.||+|.+.  +++  .||+|.+...   .....+.+.+|++++++++||||+++++++...  .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--C
Confidence            457888999999999999999864  233  6899988654   224467899999999999999999999977654  4


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .++||||+++++|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             ceeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            7999999999999999987532   2899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccc
Q 013686          262 PTDVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNE  338 (438)
Q Consensus       262 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (438)
                      ......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......      ... ..+.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~~~  244 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QIL-HKIDKEGERL  244 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHTSCCCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHH-HHHHccCCCC
Confidence            543322  1223457888999999998889999999999999999999 99999754321      111 1221111110


Q ss_pred             cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                            ..     ...++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       245 ------~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          245 ------PR-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ------CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ------CC-----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                  00     0235667899999999999999999999999999886543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-44  Score=346.69  Aligned_cols=253  Identities=27%  Similarity=0.407  Sum_probs=199.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--------HhHHHHHHHHHHHHhCCCCCceeEeeeeecc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ  178 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  178 (438)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+.....        .....+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3567999999999999999999976 589999999865321        1234588999999999999999999977544


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe---EEEeee
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADF  255 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~---~kl~Df  255 (438)
                        ..++||||+++++|.+++.....    +++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+||
T Consensus        88 --~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 --DYYIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             --SEEEEEECCTTEETHHHHSTTCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             --ceEEEEecCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence              48999999999999999976543    899999999999999999999999999999999999987654   999999


Q ss_pred             CcccccCCCccccccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh
Q 013686          256 GLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       256 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      |++........  .....|++.|+|||.+.   ...++.++|||||||++|||++|..||........  .    ...+.
T Consensus       162 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~~~  233 (322)
T 2ycf_A          162 GHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQIT  233 (322)
T ss_dssp             TTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H----HHHHH
T ss_pred             ccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H----HHHHH
Confidence            99987644321  12335899999999974   46789999999999999999999999975433211  1    11222


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+....         ....+..++..+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          234 SGKYNF---------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HTCCCC---------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hCcccc---------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            221110         111223466789999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.3e-44  Score=336.08  Aligned_cols=248  Identities=28%  Similarity=0.470  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+++++.++||||+++++++... +..++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   91 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-KRIYL   91 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-CEEEE
Confidence            357889999999999999999976 578999999865432   2246788999999999999999999977655 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        92 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999999987653    899999999999999999999999999999999999999999999999999765432


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .   .....|++.|+|||.+.+..++.++||||||+++|||++|..||.......       ....+.....      .+
T Consensus       168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~------~~  231 (284)
T 2vgo_A          168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVDL------KF  231 (284)
T ss_dssp             C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC------CC
T ss_pred             c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhcccc------CC
Confidence            2   234568999999999999999999999999999999999999997543211       1112221111      11


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +       ..++..+.+++.+||+.||.+|||+.|++++-
T Consensus       232 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          232 P-------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             C-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             C-------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence            0       12456788999999999999999999999853

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.6e-45  Score=349.02  Aligned_cols=261  Identities=20%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             HHHHHHhcCCCCC-CcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCC-CCCceeEeeeeec
Q 013686          103 SELEEATDNFNSS-KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQ-HPNLVKLYGCTSR  177 (438)
Q Consensus       103 ~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  177 (438)
                      ...+...++|.+. +.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+.++..+. ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3445566777777 89999999999999976 589999999865432  33577899999999995 7999999997765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEee
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVAD  254 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~D  254 (438)
                      . ...++||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|
T Consensus       101 ~-~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 T-SEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             S-SEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             C-CeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            5 579999999999999999865432  23899999999999999999999999999999999999987   78999999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG  334 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (438)
                      ||+++.......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+...
T Consensus       178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~  248 (327)
T 3lm5_A          178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------TYLNISQV  248 (327)
T ss_dssp             GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHT
T ss_pred             CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHHHhc
Confidence            999987644322  233469999999999999999999999999999999999999997543211       11111111


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .... ..+        ....++..+.+++.+||+.||++|||++|++++-
T Consensus       249 ~~~~-~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          249 NVDY-SEE--------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             CCCC-CTT--------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             cccc-Cch--------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence            1100 000        1123566788999999999999999999998753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-45  Score=359.03  Aligned_cols=255  Identities=14%  Similarity=0.101  Sum_probs=183.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhC--CCCCceeEee-------eee
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKL--QHPNLVKLYG-------CTS  176 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~-------~~~  176 (438)
                      .+|++.+.||+|+||.||+|.+. +|+.||||++.....   ...+.+.+|+.+++.|  +||||++++.       ++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45788999999999999999976 689999999976532   3456778886555544  6999888553       222


Q ss_pred             ccC----------------ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCccc
Q 013686          177 RQS----------------RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVR------LSIAIETAGALAYLHASDVIH  234 (438)
Q Consensus       177 ~~~----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~ivH  234 (438)
                      ..+                ..+|+||||++ |+|.+++......   +++..+      ..++.||+.||+|||++||+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV---YVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc---cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            111                34899999998 8999999875321   455555      788899999999999999999


Q ss_pred             cCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCc
Q 013686          235 RDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAV  312 (438)
Q Consensus       235 ~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~  312 (438)
                      |||||+|||++.++.+||+|||+++.......    ...+|+.|+|||.+.+  ..++.++|||||||++|||++|+.||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEEE----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCcc----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987643221    2346799999999987  78999999999999999999999999


Q ss_pred             ccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          313 DTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...........        ............+....   ...++..+.+|+.+||+.||++|||+.|++++
T Consensus       294 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGIKGSW--------KRPSLRVPGTDSLAFGS---CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTCTTCC--------CBCCTTSCCCCSCCCTT---SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCcccccch--------hhhhhhhccccccchhh---ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            86533211100        00000000011111110   12456789999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.2e-45  Score=355.44  Aligned_cols=263  Identities=19%  Similarity=0.325  Sum_probs=186.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-----Cc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-----SR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  180 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999965 6899999998653  334557788999999999999999999976543     24


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+ +++|.+++...     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            689999999 78999998753     289999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcC-----
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNG-----  334 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-----  334 (438)
                      ....    .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........   .....+...     
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~p~~~~~  254 (367)
T 2fst_X          182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELL  254 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHH
T ss_pred             cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHH
Confidence            5432    234468999999999877 678999999999999999999999997654321110   000000000     


Q ss_pred             ------ccccc---ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          335 ------ALNEL---VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       335 ------~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                            .....   +...............+..+.+|+.+||+.||++|||+.|++++-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence                  00000   000000011111123457789999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=353.34  Aligned_cols=256  Identities=17%  Similarity=0.218  Sum_probs=204.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEE------EcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC---CCCceeEeeeeecc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGI------LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ---HPNLVKLYGCTSRQ  178 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~  178 (438)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||||++....   ..++.+|++++..++   |+||+.+++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35678899999999999999994      3468999999987654   345777888888886   99999999977665


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-----------
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQP-NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-----------  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-----------  246 (438)
                      + ..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+||||+.           
T Consensus       140 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          140 N-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             S-CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             C-CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence            4 68999999999999999986322 1234999999999999999999999999999999999999998           


Q ss_pred             CCeEEEeeeCcccccCC-CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH
Q 013686          247 NFRVKVADFGLSRLFPT-DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN  325 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~  325 (438)
                      ++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||........     
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----  293 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----  293 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence            89999999999975432 122233456799999999999999999999999999999999999999964322110     


Q ss_pred             HHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhhhccC
Q 013686          326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR-PTMKEVLEILRETKDSN  391 (438)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~~  391 (438)
                               .....+. ..         ...+.+.+++..||+.+|.+| |+++++.+.|+......
T Consensus       294 ---------~~~~~~~-~~---------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 ---------KPEGLFR-RL---------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ---------EECSCCT-TC---------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------eechhcc-cc---------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                     0000000 00         124457789999999999998 68888998888876543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8e-44  Score=333.26  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=197.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+.....   ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEE
Confidence            467889999999999999999986 689999999865432   2356788999999999999999999977655 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++.....    +++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999999987653    899999999999999999999999999999999999999999999999999876443


Q ss_pred             ccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ..  .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......       .....+..+...      
T Consensus       165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------  229 (276)
T 2h6d_A          165 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVFY------  229 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------
T ss_pred             cc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCccc------
Confidence            22  233468999999999987765 68999999999999999999999753221       111222222110      


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ++       ..++..+.+++.+||+.||++|||+.|++++-
T Consensus       230 ~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~  263 (276)
T 2h6d_A          230 IP-------EYLNRSVATLLMHMLQVDPLKRATIKDIREHE  263 (276)
T ss_dssp             CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             Cc-------hhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence            00       12345688999999999999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-44  Score=355.72  Aligned_cols=267  Identities=21%  Similarity=0.310  Sum_probs=198.0

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-------
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-------  178 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  178 (438)
                      ...++|++.+.||+|+||.||+|... +|+.||||++.....    ...+|+++++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            34678999999999999999999975 689999999865422    223699999999999999999976432       


Q ss_pred             ------------------------------CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 013686          179 ------------------------------SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH  228 (438)
Q Consensus       179 ------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  228 (438)
                                                    ...+++||||++ |+|.+.+.........+++..+..++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          234889999997 5888887753323334999999999999999999999


Q ss_pred             hCCccccCCCCCCEEec-CCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHH
Q 013686          229 ASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELI  306 (438)
Q Consensus       229 ~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~  306 (438)
                      ++||+||||||+|||++ .++.+||+|||+++.......  .....+|+.|+|||.+.+. .++.++|||||||++|||+
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            99999999999999998 689999999999987644332  2344689999999998765 5899999999999999999


Q ss_pred             hCCCCcccCCcccccchhHHHHHHHh----------cCcccccccCcCCCCc--cHHHHHHHHHHHHHHHHhhccCCCCC
Q 013686          307 SGLEAVDTSRHRHDINLSNMATNKIQ----------NGALNELVDPSLGFEK--DYAVRNMVTSVAELAFRCVQQDRDMR  374 (438)
Q Consensus       307 tG~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~R  374 (438)
                      +|+.||..........  .. .....          .....+..-+.+....  ...+..++..+.+|+.+||+.||++|
T Consensus       237 ~g~~pf~~~~~~~~~~--~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLV--RI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HSSCSSCCSSHHHHHH--HH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             hCCCCCCCCChHHHHH--HH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999998644321110  00 00000          0000110001110000  00112356679999999999999999


Q ss_pred             CCHHHHHHH
Q 013686          375 PTMKEVLEI  383 (438)
Q Consensus       375 Ps~~evl~~  383 (438)
                      ||+.|++++
T Consensus       314 ~t~~e~l~h  322 (383)
T 3eb0_A          314 INPYEAMAH  322 (383)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhcC
Confidence            999999974

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=334.67  Aligned_cols=254  Identities=19%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch----HhHHHHHHHHHHHHhCCCCCceeEeeeee-ccCceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF----KRIEQFMNEVEILTKLQHPNLVKLYGCTS-RQSREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~  182 (438)
                      .++|.+.+.||+|+||.||++... +++.||+|.+.....    ...+.+.+|++++++++||||+++++++. ......
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999975 689999999865432    33577999999999999999999999764 334578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||++++ |.+++......  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEK--RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCccc--ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            9999999765 77877765432  38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCc-cccccCCCCCCCccCccccccCC--CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          263 TDV-THVSTAPQGTPGYVDPDYFQCYK--LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       263 ~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ... ........|++.|+|||.+.+..  ++.++||||||+++|||++|+.||......      . ....+..+...  
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~i~~~~~~--  231 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------K-LFENIGKGSYA--  231 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHCCCC--
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------H-HHHHHhcCCCC--
Confidence            321 22233456899999999997654  377999999999999999999999753321      1 11222222111  


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                          +.       ..++..+.+++.+||+.||.+|||+.|++++-.
T Consensus       232 ----~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  266 (305)
T 2wtk_C          232 ----IP-------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW  266 (305)
T ss_dssp             ----CC-------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred             ----CC-------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence                10       124567889999999999999999999998643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=344.85  Aligned_cols=255  Identities=26%  Similarity=0.400  Sum_probs=197.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc-----Cc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ-----SR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~  180 (438)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+..... ..+.+.+|+.+++++ +||||+++++++...     ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            4678899999999999999999975 689999999865432 346788999999999 799999999977553     35


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+++++|.+++.....  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  178 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  178 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred             eEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence            78999999999999999987532  2389999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA  335 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (438)
                      ...... ......|++.|+|||.+.     +..++.++|||||||++|||++|..||.......      . ...+....
T Consensus       179 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~  250 (326)
T 2x7f_A          179 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------A-LFLIPRNP  250 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------H-HHHHHHSC
T ss_pred             cCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------H-HHHhhcCc
Confidence            543221 123346899999999987     5678999999999999999999999996433211      1 11111111


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ......           ..++..+.+++.+||..||.+|||+.|++++-
T Consensus       251 ~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          251 APRLKS-----------KKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             CCCCSC-----------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             cccCCc-----------cccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence            111111           12456788999999999999999999999853

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=334.34  Aligned_cols=254  Identities=22%  Similarity=0.364  Sum_probs=199.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ++|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++... +..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEe
Confidence            34555679999999999999975 6889999999776656667899999999999999999999977655 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCcccccCCCccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      +++++|.+++..... ...+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........ 
T Consensus       101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            999999999987532 223678889999999999999999999999999999999987 89999999999987643221 


Q ss_pred             cccCCCCCCCccCccccccCC--CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYK--LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      ......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||........    ....... ..     ..+.+.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~-~~-----~~~~~~  248 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGM-FK-----VHPEIP  248 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHH-HC-----CCCCCC
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhcc-cc-----cccccc
Confidence            223456899999999997643  88999999999999999999999974322110    0000000 00     011111


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             ..++..+.+++.+||+.||++|||+.|++++
T Consensus       249 -------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          249 -------ESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             -------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             -------ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   2345678899999999999999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.7e-45  Score=352.21  Aligned_cols=262  Identities=22%  Similarity=0.394  Sum_probs=205.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHh-----------------HHHHHHHHHHHHhCCCCCceeE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR-----------------IEQFMNEVEILTKLQHPNLVKL  171 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~~  171 (438)
                      .++|.+.+.||+|+||.||+|.. +|+.||||.+.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999986543221                 1789999999999999999999


Q ss_pred             eeeeeccCceEEEEEeccCCCCHHHH------hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEe
Q 013686          172 YGCTSRQSRELLLVYEYIPNGTVADH------LHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILL  244 (438)
Q Consensus       172 ~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill  244 (438)
                      ++++... +..++||||+++++|.++      +....  ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus       109 ~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             EEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9977665 479999999999999999      54421  2349999999999999999999999 999999999999999


Q ss_pred             cCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccC-CCCC-hhhHHHHHHHHHHHHhCCCCcccCCcccccc
Q 013686          245 DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTD-KSDVYSFGVVLIELISGLEAVDTSRHRHDIN  322 (438)
Q Consensus       245 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~  322 (438)
                      +.++.+||+|||++......   ......+++.|+|||.+.+. .++. ++||||||+++|||++|..||.......   
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---  259 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---  259 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence            99999999999999876443   23345689999999999877 6666 9999999999999999999998543311   


Q ss_pred             hhHHHHHHHhcCcccccc------cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          323 LSNMATNKIQNGALNELV------DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                         .....+..+......      .+............++..+.+|+.+||+.||.+|||+.|++++
T Consensus       260 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 ---ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             ---HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               112222222111100      0000000111123466789999999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4e-44  Score=337.66  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=187.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hH-hHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FK-RIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||++... +|+.||+|++.... .. ..+.+.++...++.++||||+++++++... +..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-GDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-CCEEEE
Confidence            467889999999999999999975 68999999986542 22 233445555567788999999999977655 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||++ |+|.+++.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            99996 599888875332333499999999999999999999998 9999999999999999999999999999876443


Q ss_pred             ccccccCCCCCCCccCcccc----ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          265 VTHVSTAPQGTPGYVDPDYF----QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ..  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||......     .......+... .....
T Consensus       164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~  235 (290)
T 3fme_A          164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEP-SPQLP  235 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSC-CCCCC
T ss_pred             cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccC-CCCcc
Confidence            22  2234689999999996    5567899999999999999999999999743221     11111111111 11111


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .           ..++..+.+++.+||+.||++|||+.|++++-
T Consensus       236 ~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          236 A-----------DKFSAEFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             T-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             c-----------ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence            0           13456789999999999999999999999854

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=345.79  Aligned_cols=269  Identities=19%  Similarity=0.328  Sum_probs=197.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec----------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR----------  177 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------  177 (438)
                      .++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467889999999999999999987 489999999987776777889999999999999999999987632          


Q ss_pred             ---cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec-CCCeEEEe
Q 013686          178 ---QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVA  253 (438)
Q Consensus       178 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~-~~~~~kl~  253 (438)
                         .....++||||++ |+|.+++...     .+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               2357899999997 6999999653     289999999999999999999999999999999999997 56799999


Q ss_pred             eeCcccccCCCccc--cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH-----
Q 013686          254 DFGLSRLFPTDVTH--VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN-----  325 (438)
Q Consensus       254 Dfgla~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~-----  325 (438)
                      |||+++........  ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.............     
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999876432211  1223347899999998865 678999999999999999999999998654321100000     


Q ss_pred             ---HHHHHHhcCcccccccCcC---CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          326 ---MATNKIQNGALNELVDPSL---GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       326 ---~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                         .....+.. ..........   ..........++..+.+++.+||+.||++|||+.|++++-
T Consensus       244 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (320)
T 2i6l_A          244 VHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP  307 (320)
T ss_dssp             CCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred             Cchhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence               00000000 0000000000   0000111234577899999999999999999999999853

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=337.54  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=200.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|.+....  ..+.+.+|+.+++.++||||+++++++... ...++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEe
Confidence            3567899999999999999999976 58999999987543  346788999999999999999999977655 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+++++|.+++.....   .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus       104 e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             ECCTTEEHHHHHHHHTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             ecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999999999975432   389999999999999999999999999999999999999999999999999987644322


Q ss_pred             ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                       ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.......      .. ..+.......     .. 
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~-----~~-  246 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AI-FMIPTNPPPT-----FR-  246 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-HHHHHSCCCC-----CS-
T ss_pred             -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HH-HHHhcCCCcc-----cC-
Confidence             2234468999999999999899999999999999999999999997533211      11 1111111110     00 


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          ....++..+.+++.+||+.||.+|||+.+++++-
T Consensus       247 ----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          247 ----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             ----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ----CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence                0123456789999999999999999999999854

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.9e-44  Score=356.55  Aligned_cols=266  Identities=25%  Similarity=0.316  Sum_probs=196.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-----CceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-----SRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~  183 (438)
                      .+|++.+.||+|+||.||+|.+. +|+.||||++.....    ...+|+++++.++||||+++++++...     ...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999986 589999999865421    234699999999999999999976432     22467


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCcccccC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRLFP  262 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~~~  262 (438)
                      +||||+++ +|.+.+.........+++..+..++.||++||.|||++||+||||||+||||+.+ +.+||+|||+++...
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99999965 7777765432222349999999999999999999999999999999999999955 678999999998764


Q ss_pred             CCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHH-------HHHh--
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT-------NKIQ--  332 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~-------~~~~--  332 (438)
                      ....  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.........  .....       ..+.  
T Consensus       209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHHHHHH
T ss_pred             cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHHHhh
Confidence            4322  2334689999999998764 7999999999999999999999999865432111  11100       0000  


Q ss_pred             cCcccccccCcCCCCccH--HHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          333 NGALNELVDPSLGFEKDY--AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .....+..-+.+......  .....+..+.+|+.+||+.||.+|||+.|++++-
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            011111111111100000  0123467899999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-43  Score=334.60  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=204.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---------hHhHHHHHHHHHHHHhCC-CCCceeEeeeeec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---------FKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSR  177 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  177 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||||.+....         ....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            568889999999999999999986 58999999986542         123467889999999995 9999999997765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      . ...++||||+++++|.+++.....    +++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus        96 ~-~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           96 N-TFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             S-SEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             C-CeEEEEEeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            4 579999999999999999987643    89999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccc------cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQ------CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      +........  .....+++.|+|||.+.      ...++.++||||||+++|||++|..||......       .....+
T Consensus       171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~  241 (298)
T 1phk_A          171 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMI  241 (298)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH
T ss_pred             hhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------HHHHHH
Confidence            987644322  23456899999999885      456889999999999999999999999753321       111222


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..+..... .+        ....++..+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~-~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          242 MSGNYQFG-SP--------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHTCCCCC-TT--------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hcCCcccC-cc--------cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            22211100 00        112456779999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.3e-44  Score=371.09  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|.+... .....+.+.+|+.++++++||||+++++++..  +..
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cce
Confidence            35678899999999999999999752    467999988654 33445789999999999999999999997743  358


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999999986543   38999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...........+++.|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+..+....   
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~---  612 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLP---  612 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHTCCCC---
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCCCC---
Confidence            443333334457789999999998899999999999999999997 999997543211       112222221111   


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                        +       +..++..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       613 --~-------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          613 --M-------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             --C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              1       12355678999999999999999999999999998753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-43  Score=353.20  Aligned_cols=199  Identities=23%  Similarity=0.313  Sum_probs=171.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC------CCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL------QHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~  181 (438)
                      ..+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.+      +|+||+++++++... ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-Ce
Confidence            457899999999999999999876 58999999986543 3345677888888877      577999999977655 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe--EEEeeeCccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR--VKVADFGLSR  259 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfgla~  259 (438)
                      .++||||+. ++|.+++......  .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            999999995 6999999876543  3899999999999999999999999999999999999999887  9999999997


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCC
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR  316 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~  316 (438)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|.+||....
T Consensus       251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            65432    223468999999999999999999999999999999999999997654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.8e-44  Score=371.66  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=205.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceE
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  182 (438)
                      ..++|++.+.||+|+||.||+|..+ +++.||||++....   ....+.+..|..++..+ +||||+++++++... +.+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-SEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-CEE
Confidence            3567999999999999999999976 58899999997542   23346788899999988 699999999977554 579


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      |+||||+++|+|.+++.....    +++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEeCcCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999999987654    9999999999999999999999999999999999999999999999999998643


Q ss_pred             CCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||......       .....+..+..      
T Consensus       494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~------  559 (674)
T 3pfq_A          494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNV------  559 (674)
T ss_dssp             CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHSSCC------
T ss_pred             cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhCCC------
Confidence            3222 234567999999999999999999999999999999999999999754321       11222222211      


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTM-----KEVLEI  383 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  383 (438)
                        .++     ..++.++.+||.+||+.||++||++     +||+++
T Consensus       560 --~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          560 --AYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --CCC-----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --CCC-----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence              111     2356678999999999999999997     777764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.5e-44  Score=342.53  Aligned_cols=268  Identities=22%  Similarity=0.348  Sum_probs=202.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc--CCcEEEEEEeeccchH--hHHHHHHHHHHHHhC---CCCCceeEeeeee----
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR--DGRIVAVKRLYENNFK--RIEQFMNEVEILTKL---QHPNLVKLYGCTS----  176 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~~~~~~~----  176 (438)
                      ..++|++.+.||+|+||.||+|...  +|+.||+|++......  ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3578999999999999999999973  5889999998643221  123466777777666   8999999999765    


Q ss_pred             ccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeC
Q 013686          177 RQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFG  256 (438)
Q Consensus       177 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  256 (438)
                      ......++||||++ |+|.+++......  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence            23457899999997 6999999876433  38999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---
Q 013686          257 LSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---  333 (438)
Q Consensus       257 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---  333 (438)
                      ++.......  ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.........   .........   
T Consensus       166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~  240 (326)
T 1blx_A          166 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE  240 (326)
T ss_dssp             SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCG
T ss_pred             ccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCc
Confidence            998654322  233456899999999999999999999999999999999999999764332111   001111100   


Q ss_pred             Ccccc-------cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GALNE-------LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..+..       .+..............++..+.+|+.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000       000000000111123456778999999999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=353.23  Aligned_cols=274  Identities=20%  Similarity=0.277  Sum_probs=185.6

Q ss_pred             cCCCC-CCcccccCceEEEEEEEc---CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceEEE
Q 013686          110 DNFNS-SKQLGDGGFGAVYLGILR---DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSRELLL  184 (438)
Q Consensus       110 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~l  184 (438)
                      +.|.+ .++||+|+||.||+|..+   +++.||||++.....  .+.+.+|+.+|++++||||+++++++.. .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44555 568999999999999975   478999999865432  2467889999999999999999997743 4557999


Q ss_pred             EEeccCCCCHHHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe----cCCCeEEEeee
Q 013686          185 VYEYIPNGTVADHLHNRQ-----PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL----DNNFRVKVADF  255 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill----~~~~~~kl~Df  255 (438)
                      ||||++ ++|.+++....     .....+++..++.++.||+.||.|||++||+||||||+||||    +.++.+||+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            999995 58888886432     112248999999999999999999999999999999999999    67889999999


Q ss_pred             CcccccCCCcc--ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCccccc---chhHHHHH
Q 013686          256 GLSRLFPTDVT--HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI---NLSNMATN  329 (438)
Q Consensus       256 gla~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~---~~~~~~~~  329 (438)
                      |+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|++||.........   ........
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~  256 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  256 (405)
T ss_dssp             TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred             CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence            99987654321  222345689999999999874 5899999999999999999999999754432100   00000000


Q ss_pred             H---HhcC---cccccc-------------cCcCCCCccH-HH----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          330 K---IQNG---ALNELV-------------DPSLGFEKDY-AV----RNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       330 ~---~~~~---~~~~~~-------------~~~~~~~~~~-~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .   +...   .+....             .......... ..    ...+..+.+|+.+||+.||.+|||++|++++-.
T Consensus       257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            0   0000   000000             0000000000 00    001456889999999999999999999999754


Q ss_pred             h
Q 013686          386 E  386 (438)
Q Consensus       386 ~  386 (438)
                      -
T Consensus       337 f  337 (405)
T 3rgf_A          337 F  337 (405)
T ss_dssp             G
T ss_pred             h
Confidence            3

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-43  Score=348.27  Aligned_cols=267  Identities=20%  Similarity=0.259  Sum_probs=202.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC--------CCCceeEeeeeec--
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ--------HPNLVKLYGCTSR--  177 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~--  177 (438)
                      .++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++        |+||+++++++..  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467999999999999999999975 5899999998654 234567889999999985        7889999997652  


Q ss_pred             -cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCC-------
Q 013686          178 -QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNF-------  248 (438)
Q Consensus       178 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~-------  248 (438)
                       .....++||||+ +++|.+++......  .+++..++.++.||+.||.|||++ ||+||||||+|||++.++       
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQ--GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence             345799999999 66777777655322  389999999999999999999998 999999999999999775       


Q ss_pred             ------------------------------------------eEEEeeeCcccccCCCccccccCCCCCCCccCcccccc
Q 013686          249 ------------------------------------------RVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC  286 (438)
Q Consensus       249 ------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~  286 (438)
                                                                .+||+|||++......    .....||+.|+|||++.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      7999999999876432    234468999999999999


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH-----------hcCccc-ccccCc-----C----C
Q 013686          287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI-----------QNGALN-ELVDPS-----L----G  345 (438)
Q Consensus       287 ~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-~~~~~~-----~----~  345 (438)
                      ..++.++|||||||++|||++|+.||...................           ..+... ..+...     +    .
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            999999999999999999999999998654332211111111000           000000 000000     0    0


Q ss_pred             CCc-------cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEK-------DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ...       .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            000       00124567789999999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-43  Score=343.91  Aligned_cols=276  Identities=21%  Similarity=0.274  Sum_probs=191.8

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC--
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS--  179 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  179 (438)
                      .......++|++.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345566789999999999999999999986 689999998865432 2245667888899999999999999775432  


Q ss_pred             ----ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCEEecC-CCeEEE
Q 013686          180 ----RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH--ASDVIHRDVKSNNILLDN-NFRVKV  252 (438)
Q Consensus       180 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~Dlkp~Nill~~-~~~~kl  252 (438)
                          ...++||||+++ +|.+.+.........+++..+..++.|++.||.|||  ++||+||||||+|||++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                137899999965 666555543223334899999999999999999999  999999999999999996 899999


Q ss_pred             eeeCcccccCCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH------
Q 013686          253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN------  325 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~------  325 (438)
                      +|||+++.......  .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.............      
T Consensus       174 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  251 (360)
T 3e3p_A          174 CDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP  251 (360)
T ss_dssp             CCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence            99999987654332  2344689999999998665 48999999999999999999999998654321110000      


Q ss_pred             --HHHHHHhcCcc-cccccCcCCCCccHH----HHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          326 --MATNKIQNGAL-NELVDPSLGFEKDYA----VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       326 --~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        .....+..... ....+. ........    ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNS-KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCC-CCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CHHHHHhcccchhhcccccc-ccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              00000000000 000000 00000000    01246789999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.6e-44  Score=345.91  Aligned_cols=267  Identities=24%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc----CceE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ----SREL  182 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~  182 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+... .......+.+|+.++++++||||+++++++...    ....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467889999999999999999976 6899999998654 334456788999999999999999999976543    2578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+. ++|.+++....     +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQM-----LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 69999997642     8999999999999999999999999999999999999999999999999998764


Q ss_pred             CCccc---------cccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh
Q 013686          263 TDVTH---------VSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       263 ~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      .....         ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........   ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~  240 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIG  240 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhC
Confidence            32211         1123468999999998754 67899999999999999999999999865422110   00000000


Q ss_pred             cCccc------------cccc--CcCC-CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          333 NGALN------------ELVD--PSLG-FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       333 ~~~~~------------~~~~--~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      .....            +...  +... .........++..+.+|+.+||+.||++|||+.|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            00000            0000  0000 001111234667889999999999999999999999853

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.1e-44  Score=338.15  Aligned_cols=253  Identities=25%  Similarity=0.426  Sum_probs=193.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc---------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ---------  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------  178 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||.+... ....+.+.+|+.++++++||||+++++++...         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            567889999999999999999975 6899999998653 34457889999999999999999999966432         


Q ss_pred             ---CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeee
Q 013686          179 ---SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADF  255 (438)
Q Consensus       179 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Df  255 (438)
                         ....++||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENL---NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCG---GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcccc---ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               3578999999999999999986542   3788999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCc-------------cccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCccccc
Q 013686          256 GLSRLFPTDV-------------THVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI  321 (438)
Q Consensus       256 gla~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~  321 (438)
                      |++.......             ........|++.|+|||.+.+. .++.++|||||||++|||++   ||.....    
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~----  233 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME----  233 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh----
Confidence            9998654321             1112334589999999999764 68999999999999999998   4432110    


Q ss_pred             chhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       . ......+.....  ...+.+       ....+..+.+++.+||+.||.+|||+.|++++
T Consensus       234 -~-~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 -R-VNILKKLRSVSI--EFPPDF-------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             -H-HHHHHHHHSTTC--CCCTTC-------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -H-HHHHHhcccccc--ccCccc-------cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence             0 011112221110  011111       12345568899999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6e-44  Score=351.43  Aligned_cols=267  Identities=22%  Similarity=0.286  Sum_probs=194.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----ceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----RELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~~  183 (438)
                      ..+|.+.+.||+|+||.||+|....+..||+|++......    ..+|+++++.++||||+++++++...+     ..++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4568899999999999999999887777999988654221    236999999999999999999774432     2378


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec-CCCeEEEeeeCcccccC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFP  262 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~  262 (438)
                      +||||+++ ++.+.+.........+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus       115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            99999976 44444432211123489999999999999999999999999999999999999 79999999999998764


Q ss_pred             CCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH--------HHHHHhc
Q 013686          263 TDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM--------ATNKIQN  333 (438)
Q Consensus       263 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~--------~~~~~~~  333 (438)
                      ....  .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..............        .......
T Consensus       194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            4332  2344689999999998764 589999999999999999999999986543211100000        0000000


Q ss_pred             CcccccccCcCCCCc-c-HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GALNELVDPSLGFEK-D-YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       ...+..-+...... . .....++..+.+|+.+||+.||.+|||+.|++++
T Consensus       272 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          272 -NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             -GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             00000000000000 0 0012356789999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.7e-45  Score=343.94  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=186.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~   92 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWLVM   92 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-CEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEEEe
Confidence            578999999999999999999864 68999999886543 234567889999999999999999999776654 689999


Q ss_pred             eccCCCCHHHHhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          187 EYIPNGTVADHLHNRQ----PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ||+++++|.+++....    .....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            9999999999997521    112348999999999999999999999999999999999999999999999999998654


Q ss_pred             CCcc----ccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          263 TDVT----HVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       263 ~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ....    .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........      ....... ...
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~-~~~  245 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQN-DPP  245 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHTS-SCC
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhcc-CCC
Confidence            3211    11233468999999999876 5689999999999999999999999976433211      1111111 111


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .... ..  ........++..+.+++.+||+.||.+|||+.|++++
T Consensus       246 ~~~~-~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          246 SLET-GV--QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccc-cc--ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0000 00  0000012345678899999999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-43  Score=346.91  Aligned_cols=261  Identities=20%  Similarity=0.302  Sum_probs=198.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc-----
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR-----  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  180 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999976 6899999998754  33345788899999999999999999997765542     


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+. ++|.+++...      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGME------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            2499999996 6898887432      89999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc-
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE-  338 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  338 (438)
                      ....    .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........   ....... ....+ 
T Consensus       194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~-~~~~~~  265 (371)
T 4exu_A          194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTG-VPGTEF  265 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHC-CCCHHH
T ss_pred             cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhC-CCcHHH
Confidence            5432    234468999999999887 689999999999999999999999997643221110   0000000 00000 


Q ss_pred             --------------cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          339 --------------LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       339 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                                    ................++..+.+|+.+||+.||++|||+.|++++-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence                          0000000011111224567899999999999999999999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=341.08  Aligned_cols=258  Identities=22%  Similarity=0.354  Sum_probs=198.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||.||+|...+  .||+|.+....  ....+.+.+|+.++++++||||+++++++.... ..++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-HLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-CEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-ceEEEe
Confidence            5788999999999999999998853  49999886432  223356778999999999999999999776654 699999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      ||+++++|.+++.....   .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... 
T Consensus       109 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCC---CCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            99999999999976542   389999999999999999999999999999999999998 6799999999987543211 


Q ss_pred             ---cccccCCCCCCCccCcccccc---------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          266 ---THVSTAPQGTPGYVDPDYFQC---------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       266 ---~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                         ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||......       .....+..
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~  257 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AIIWQMGT  257 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHHHHHHT
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHhcc
Confidence               112233458999999999874         35788999999999999999999999754321       11122222


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      +........           .++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       258 ~~~~~~~~~-----------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          258 GMKPNLSQI-----------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             TCCCCCCCS-----------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCCCCCCcC-----------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            221111111           23446889999999999999999999999999886543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.7e-43  Score=337.40  Aligned_cols=266  Identities=21%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-c-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCC------CceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGIL-R-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP------NLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||+|.. . +|+.||||++.... ...+.+.+|+++++.++|+      +++++++++... +
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-G   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-T
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-C
Confidence            46899999999999999999987 3 58899999986542 3456788999999988655      499999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC--------------
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN--------------  246 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~--------------  246 (438)
                      ..++||||+ +++|.+++......  .+++..+..++.||+.||+|||++||+||||||+|||++.              
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFL--PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCC--CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            799999999 89999999876532  3889999999999999999999999999999999999987              


Q ss_pred             -----CCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc
Q 013686          247 -----NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI  321 (438)
Q Consensus       247 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~  321 (438)
                           ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|..||.........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 668999999999865432    23346899999999999999999999999999999999999999764332111


Q ss_pred             chhHHHH-----HHHhcCcccccc-cCcCCCCc------------------cHHHHHHHHHHHHHHHHhhccCCCCCCCH
Q 013686          322 NLSNMAT-----NKIQNGALNELV-DPSLGFEK------------------DYAVRNMVTSVAELAFRCVQQDRDMRPTM  377 (438)
Q Consensus       322 ~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~  377 (438)
                      .......     ..+......... ........                  .......+..+.+|+.+||+.||.+|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            0000000     000000000000 00000000                  00012356789999999999999999999


Q ss_pred             HHHHHH
Q 013686          378 KEVLEI  383 (438)
Q Consensus       378 ~evl~~  383 (438)
                      .|++++
T Consensus       324 ~ell~h  329 (339)
T 1z57_A          324 REALKH  329 (339)
T ss_dssp             HHHTTS
T ss_pred             HHHhcC
Confidence            999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.5e-43  Score=328.42  Aligned_cols=253  Identities=26%  Similarity=0.421  Sum_probs=204.0

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++... ...+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-CeEE
Confidence            34578999999999999999999986 68999999986542  23457889999999999999999999977655 5799


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC---CeEEEeeeCcccc
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN---FRVKVADFGLSRL  260 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfgla~~  260 (438)
                      +||||+++++|.+++.....    +++..++.++.||+.||.|||++|++||||||+||+++.+   +.+||+|||++..
T Consensus        98 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEccCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999999977653    8999999999999999999999999999999999999754   4799999999986


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      .......  ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||......      . ....+..+......
T Consensus       174 ~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~  243 (287)
T 2wei_A          174 FQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAFDL  243 (287)
T ss_dssp             BCCCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCS
T ss_pred             ecCCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCCCc
Confidence            6443221  22347889999999876 4899999999999999999999999754321      1 11222222211100


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                               .....++..+.+++.+||+.||++|||+.|++++
T Consensus       244 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          244 ---------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             ---------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                     0112356678999999999999999999999984

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.4e-43  Score=338.82  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=175.2

Q ss_pred             hcCCCCCC-cccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeec---cCceEE
Q 013686          109 TDNFNSSK-QLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR---QSRELL  183 (438)
Q Consensus       109 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~  183 (438)
                      .++|.+.+ .||+|+||.||+|..+ +|+.||||++.....    ...+....++.++||||+++++++..   ....++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            56787754 6999999999999987 689999999865421    12223334567799999999997654   234589


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCcccc
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSRL  260 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~~  260 (438)
                      +||||+++|+|.+++.....  ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus       103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            99999999999999987643  24999999999999999999999999999999999999976   45599999999986


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      .....   .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||..........   .....+..+... ..
T Consensus       181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~-~~  253 (336)
T 3fhr_A          181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQYG-FP  253 (336)
T ss_dssp             C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C-CC
T ss_pred             ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccccc-cC
Confidence            54322   233468999999999988889999999999999999999999997543221100   000111111000 00


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      .+        .+..++..+.+|+.+||+.||++|||+.|++++-.
T Consensus       254 ~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          254 NP--------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             TT--------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             ch--------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            00        11235677899999999999999999999998654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-42  Score=331.80  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=195.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCC--CCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQ--HPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||++...+++.||||.+...  .....+.+.+|+.++.+++  ||||+++++++... ...++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-SEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-CEEEE
Confidence            5678899999999999999999888999999998643  3445678999999999997  59999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||+ .+++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......
T Consensus       106 v~e~-~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          106 VMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EECC-CSEEHHHHHHHCSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             EEec-CCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            9994 58899999987653    899999999999999999999999999999999999975 89999999999876443


Q ss_pred             ccc-cccCCCCCCCccCcccccc-----------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh
Q 013686          265 VTH-VSTAPQGTPGYVDPDYFQC-----------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       265 ~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      ... ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||......     .......+ 
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~-  253 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII-  253 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH-
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHH-
Confidence            222 1233468999999999875           46888999999999999999999999743221     11111111 


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ......    ...       ...+..+.+++.+||+.||.+|||+.|++++..
T Consensus       254 ~~~~~~----~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          254 DPNHEI----EFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             CTTSCC----CCC-------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             hccccc----CCc-------ccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence            111110    010       112456889999999999999999999998654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.2e-43  Score=340.34  Aligned_cols=268  Identities=18%  Similarity=0.288  Sum_probs=199.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-----------CCCceeEeeeee
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-----------HPNLVKLYGCTS  176 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~  176 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357889999999999999999975 68999999986543 33467888999999886           899999999765


Q ss_pred             ccC---ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEec------C
Q 013686          177 RQS---RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLD------N  246 (438)
Q Consensus       177 ~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~------~  246 (438)
                      ..+   ...++||||+ +++|.+++......  .+++..+..++.||+.||.|||++ ||+||||||+|||++      .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            432   3689999999 89999999875433  389999999999999999999998 999999999999994      4


Q ss_pred             CCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHH
Q 013686          247 NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM  326 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~  326 (438)
                      .+.+||+|||++......    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..............
T Consensus       174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            458999999999876432    2334689999999999999999999999999999999999999986543211111111


Q ss_pred             HHHHHh-cCcccc-----------cccC-----cC---CC-Cc-------cHHHHHHHHHHHHHHHHhhccCCCCCCCHH
Q 013686          327 ATNKIQ-NGALNE-----------LVDP-----SL---GF-EK-------DYAVRNMVTSVAELAFRCVQQDRDMRPTMK  378 (438)
Q Consensus       327 ~~~~~~-~~~~~~-----------~~~~-----~~---~~-~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  378 (438)
                      ....+. .+..+.           .+..     .+   .. ..       ......++..+.+|+.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            111000 000000           0000     00   00 00       001245778899999999999999999999


Q ss_pred             HHHHHH
Q 013686          379 EVLEIL  384 (438)
Q Consensus       379 evl~~L  384 (438)
                      |++++-
T Consensus       330 ell~hp  335 (373)
T 1q8y_A          330 GLVNHP  335 (373)
T ss_dssp             HHHTCG
T ss_pred             HHhhCh
Confidence            999854

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.5e-43  Score=335.97  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=178.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHH-HHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVE-ILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++... +..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEE
Confidence            467889999999999999999986 68999999987643 333455666666 66677999999999977665 478999


Q ss_pred             EeccCCCCHHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          186 YEYIPNGTVADHLHNRQ-PNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      |||++ ++|.+++.... .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            99996 48888876411 1122489999999999999999999999 999999999999999999999999999986644


Q ss_pred             CccccccCCCCCCCccCcccc----ccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYF----QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ...  .....|++.|+|||.+    .+..++.++||||||+++|||++|+.||.........      ...+..+..   
T Consensus       179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~---  247 (327)
T 3aln_A          179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKGDP---  247 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC---
T ss_pred             ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcCCC---
Confidence            322  2233689999999998    4567899999999999999999999999753221000      000001111   


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        +.+...   ....++..+.+|+.+||+.||++|||+.|++++-
T Consensus       248 --~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          248 --PQLSNS---EEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             --CCCCCC---SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             --CCCCCc---ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence              111100   0113456789999999999999999999999853

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=342.47  Aligned_cols=258  Identities=20%  Similarity=0.316  Sum_probs=197.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCc-----
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR-----  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  180 (438)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357888999999999999999976 6899999998653  23345678999999999999999999997765432     


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      ..++||||+. ++|.+++..      .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            3599999996 688888743      289999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc------
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN------  333 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~------  333 (438)
                      ....    .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........   .........      
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTEFV  248 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH---HHHHHHHCBCCHHHH
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence            5432    233468999999999877 67899999999999999999999999864422110   000000000      


Q ss_pred             ------------CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          334 ------------GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       334 ------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                                  ..+.....+.+    ......++..+.+|+.+||+.||++|||+.|++++-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDF----TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCT----TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHhhHHHHHHHHhCcCCCCccH----HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence                        00000000000    001124567899999999999999999999999753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.3e-43  Score=347.51  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=185.9

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEecc
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++++ +||||+++++++... ...++|||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD-RFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC-CeEEEEEecC
Confidence            344568899999999987766689999999986543   34577899999876 899999999976554 5799999999


Q ss_pred             CCCCHHHHhhccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-------------CeEEEe
Q 013686          190 PNGTVADHLHNRQPNSCL---LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-------------FRVKVA  253 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-------------~~~kl~  253 (438)
                      + |+|.+++.........   .++..++.++.||+.||+|||++||+||||||+|||++.+             +.+||+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            5 6999999876432211   1233457899999999999999999999999999999754             489999


Q ss_pred             eeCcccccCCCccc---cccCCCCCCCccCcccccc-------CCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccc
Q 013686          254 DFGLSRLFPTDVTH---VSTAPQGTPGYVDPDYFQC-------YKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDIN  322 (438)
Q Consensus       254 Dfgla~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~  322 (438)
                      |||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |..||.......   
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---  247 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---  247 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence            99999876543322   1223569999999999975       578999999999999999999 999996432210   


Q ss_pred             hhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          323 LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           . .+..+....   +.....   ....++..+.+++.+||+.||.+|||+.|++++
T Consensus       248 -----~-~i~~~~~~~---~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -----S-NIIRGIFSL---DEMKCL---HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -----H-HHHHTCCCC---CCCTTC---CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----H-HHhcCCCCc---cccccc---ccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                 1 111111100   000000   123567889999999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-42  Score=332.89  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=198.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CC-cEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC------ceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DG-RIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN------LVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||.||+|... ++ +.||+|++.... ...+.+.+|+.+++.++|++      ++.+++++... .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-G   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-T
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-C
Confidence            468999999999999999999975 34 789999986542 34567888999999987655      88888866655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe----------------
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL----------------  244 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill----------------  244 (438)
                      ..++||||+ +++|.+++......  .+++..++.++.||+.||.|||++||+||||||+|||+                
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQ--PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             eEEEEEecc-CCChHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            799999999 77888888765422  38999999999999999999999999999999999999                


Q ss_pred             ---cCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCccccc
Q 013686          245 ---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI  321 (438)
Q Consensus       245 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~  321 (438)
                         +.++.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence               66789999999999865432    23346899999999999999999999999999999999999999864432111


Q ss_pred             chhHHHHHHHhc--------Cccc-ccccCcCCCCcc------------------HHHHHHHHHHHHHHHHhhccCCCCC
Q 013686          322 NLSNMATNKIQN--------GALN-ELVDPSLGFEKD------------------YAVRNMVTSVAELAFRCVQQDRDMR  374 (438)
Q Consensus       322 ~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~R  374 (438)
                      ..   .......        .... ............                  ......+..+.+|+.+||+.||++|
T Consensus       249 ~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          249 VM---MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HH---HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HH---HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            00   0000000        0000 000000000000                  0001345678999999999999999


Q ss_pred             CCHHHHHHH
Q 013686          375 PTMKEVLEI  383 (438)
Q Consensus       375 Ps~~evl~~  383 (438)
                      ||+.|++++
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=333.05  Aligned_cols=244  Identities=26%  Similarity=0.405  Sum_probs=193.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH------hHHHHHHHHHHHHhC----CCCCceeEeeee
Q 013686          107 EATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK------RIEQFMNEVEILTKL----QHPNLVKLYGCT  175 (438)
Q Consensus       107 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~~~  175 (438)
                      ...++|++.+.||+|+||.||+|... +|+.||||.+......      ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34678999999999999999999865 6899999998654321      223466799999998    899999999977


Q ss_pred             eccCceEEEEEec-cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec-CCCeEEEe
Q 013686          176 SRQSRELLLVYEY-IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVA  253 (438)
Q Consensus       176 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~-~~~~~kl~  253 (438)
                      ... +..++|||| +.+++|.+++.....    +++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus       108 ~~~-~~~~~v~e~~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          108 ETQ-EGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             ecC-CeEEEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence            655 468999999 789999999987654    89999999999999999999999999999999999999 89999999


Q ss_pred             eeCcccccCCCccccccCCCCCCCccCccccccCCCC-ChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh
Q 013686          254 DFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLT-DKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ  332 (438)
Q Consensus       254 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  332 (438)
                      |||++.......   .....|++.|+|||.+.+..+. .++||||||+++|||++|+.||....             .+.
T Consensus       183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~~~  246 (312)
T 2iwi_A          183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------EIL  246 (312)
T ss_dssp             CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHH
T ss_pred             EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------HHh
Confidence            999998765432   2344689999999999876664 48999999999999999999996421             111


Q ss_pred             cCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      ....      .+  .     ..++..+.+++.+||+.||++|||+.|++++-
T Consensus       247 ~~~~------~~--~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          247 EAEL------HF--P-----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             HTCC------CC--C-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             hhcc------CC--c-----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            1110      00  0     12456788999999999999999999999853

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.4e-42  Score=334.91  Aligned_cols=200  Identities=25%  Similarity=0.319  Sum_probs=170.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CC-----CceeEeeeeeccCc
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HP-----NLVKLYGCTSRQSR  180 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~  180 (438)
                      ..++|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++ |+     +|+++++++... .
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-N  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-T
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-C
Confidence            3678999999999999999999976 68899999987542 33467788999988885 55     499999977655 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCEEec--CCCeEEEeeeC
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH--ASDVIHRDVKSNNILLD--NNFRVKVADFG  256 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg  256 (438)
                      ..++||||++ ++|.+++......  .+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            7999999995 5999999876432  3899999999999999999999  46999999999999994  57889999999


Q ss_pred             cccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCC
Q 013686          257 LSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSR  316 (438)
Q Consensus       257 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~  316 (438)
                      +++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99876433    233468999999999999999999999999999999999999998654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.9e-43  Score=334.83  Aligned_cols=244  Identities=26%  Similarity=0.426  Sum_probs=199.0

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH------hHHHHHHHHHHHHhCC--CCCceeEeeeee
Q 013686          106 EEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK------RIEQFMNEVEILTKLQ--HPNLVKLYGCTS  176 (438)
Q Consensus       106 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~  176 (438)
                      ....++|++.+.||+|+||.||+|... +|+.||||.+......      ..+.+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            344678999999999999999999965 6899999998654321      2245677999999996  599999999776


Q ss_pred             ccCceEEEEEeccCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec-CCCeEEEee
Q 013686          177 RQSRELLLVYEYIPN-GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD-NNFRVKVAD  254 (438)
Q Consensus       177 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~-~~~~~kl~D  254 (438)
                      .. +..++|||++.+ ++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++ +++.+||+|
T Consensus       119 ~~-~~~~lv~e~~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          119 RP-DSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             CS-SEEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cC-CcEEEEEEcCCCCccHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            55 478999999976 899999987653    89999999999999999999999999999999999999 789999999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN  333 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  333 (438)
                      ||++.......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....             .+..
T Consensus       194 fg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~  257 (320)
T 3a99_A          194 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIR  257 (320)
T ss_dssp             CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHH
T ss_pred             Ccccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhc
Confidence            99998765432   234468999999999987665 678999999999999999999996421             1111


Q ss_pred             CcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          334 GALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +..  ...           ..++..+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~--~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 GQV--FFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CCC--CCS-----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccc--ccc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            110  011           1245678899999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.7e-42  Score=325.66  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=180.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-Hh-HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++..... .. .+.+.++..+++.++||||+++++++... ...++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEE
Confidence            567888999999999999999986 689999999875432 22 23445555678888999999999977665 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||+ ++.+..+......   .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 5566666554322   389999999999999999999995 9999999999999999999999999999765433


Q ss_pred             ccccccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ..  .....+++.|+|||.+.     +..++.++||||||+++|||++|+.||......     ..... .+..+.... 
T Consensus       179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~-~~~~~~~~~-  249 (318)
T 2dyl_A          179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLT-KVLQEEPPL-  249 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH-HHHHSCCCC-
T ss_pred             cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHH-HHhccCCCC-
Confidence            22  23346899999999984     457889999999999999999999999753221     11111 111111111 


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                          +...     ..++..+.+++.+||+.||.+|||+.|++++-
T Consensus       250 ----~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          250 ----LPGH-----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             ----CCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ----CCcc-----CCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence                1100     12456788999999999999999999999853

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=341.36  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=185.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .+|.+.+.||+|+||+||.....+|+.||||++......   .+.+|+++++.+ +||||+++++++... ...|+||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR-QFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC-CEEEEEEEC
Confidence            457788999999999976655667999999998654332   255799999999 799999999976554 578999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-----CCeEEEeeeCcccccCC
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-----NFRVKVADFGLSRLFPT  263 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfgla~~~~~  263 (438)
                      |+ |+|.+++......   +.+..++.++.||+.||.|||++||+||||||+|||++.     ...+||+|||+++....
T Consensus       100 ~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            95 6999999876532   444556789999999999999999999999999999953     33688999999987653


Q ss_pred             Ccc--ccccCCCCCCCccCccccc---cCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          264 DVT--HVSTAPQGTPGYVDPDYFQ---CYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       264 ~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      ...  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||......       . ..........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~-~~~~~~~~~~  247 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------Q-ANILLGACSL  247 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------H-HHHHTTCCCC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------H-HHHHhccCCc
Confidence            321  2233456999999999997   4577889999999999999999 89998643211       1 1111111111


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ....+         ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus       248 ~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          248 DCLHP---------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TTSCT---------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCc---------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            11110         12345568899999999999999999999953

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6e-42  Score=352.08  Aligned_cols=279  Identities=23%  Similarity=0.317  Sum_probs=204.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeec-----cCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-----QSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~  181 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++..     .++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            468999999999999999999975 6899999988654 34456789999999999999999999996543     2456


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCe---EEEeeeCcc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFR---VKVADFGLS  258 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfgla  258 (438)
                      .++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.   +||+|||++
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            8999999999999999987543 234889999999999999999999999999999999999997664   999999999


Q ss_pred             cccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch--hHHHHH-HHhcCc
Q 013686          259 RLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL--SNMATN-KIQNGA  335 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~--~~~~~~-~~~~~~  335 (438)
                      ........  .....|++.|+|||.+.+..++.++|||||||++|||++|..||...........  ...... ......
T Consensus       172 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          172 KELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            87654322  2345799999999999999999999999999999999999999975321110000  000000 000000


Q ss_pred             cccc--ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHhhhccC
Q 013686          336 LNEL--VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE-----VLEILRETKDSN  391 (438)
Q Consensus       336 ~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~~~  391 (438)
                      ....  +...++. .......++..+.+++.+||..||++|||+.|     +.+.++.+....
T Consensus       250 l~g~~~~~~~lp~-p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          250 LTGAVKFSSVLPT-PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CSSSCCCCSSSCC-SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hccccccccccCC-chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            0000  0001110 01112346788999999999999999999988     456666665433

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.4e-41  Score=317.32  Aligned_cols=234  Identities=13%  Similarity=0.125  Sum_probs=185.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||.+....   ....+.+.+|+.++.+++||||+++++++... +..|+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l  108 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLV  108 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEE
Confidence            357889999999999999999986 48999999987542   34457899999999999999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||++|++|.+++...      .....+..++.||+.||+|||++||+||||||+|||++.++.+||+++|        
T Consensus       109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999999542      3455678899999999999999999999999999999999999998443        


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                                   |++       .++.++|||||||++|||+||+.||............            ........
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~~  222 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQP  222 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSCB
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccCC
Confidence                         333       3688999999999999999999999865433211000            00000000


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                       .........++..+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus       223 -~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          223 -IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             -CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             -CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence             00011123466789999999999999999 9999999999886544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-40  Score=315.29  Aligned_cols=235  Identities=22%  Similarity=0.293  Sum_probs=182.6

Q ss_pred             hcCCCCC-CcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHH-HhCCCCCceeEeeeeec---cCceE
Q 013686          109 TDNFNSS-KQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEIL-TKLQHPNLVKLYGCTSR---QSREL  182 (438)
Q Consensus       109 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~---~~~~~  182 (438)
                      .++|.+. +.||+|+||.||++... +|+.||+|++...     ..+.+|+.++ +.++||||+++++++..   .....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3566666 78999999999999975 6899999998643     3466788888 55689999999997654   24578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCccc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSR  259 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~  259 (438)
                      ++||||+++|+|.+++......  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQ--AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999999876432  3899999999999999999999999999999999999998   7899999999986


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ...                       +..++.++|||||||++|||++|+.||........           ........
T Consensus       169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~  214 (299)
T 3m2w_A          169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRI  214 (299)
T ss_dssp             ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSS
T ss_pred             ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHH
Confidence            532                       23567799999999999999999999975432110           00000111


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                      ...... ........++..+.+++.+||+.||++|||+.|++++..
T Consensus       215 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          215 RMGQYE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             CTTCCS-SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             hhcccc-CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence            111111 111223456788999999999999999999999998644

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.8e-41  Score=353.84  Aligned_cols=240  Identities=25%  Similarity=0.389  Sum_probs=193.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc--CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce----
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR--DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE----  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----  181 (438)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||.+... .....+.+.+|++++++++||||+++++++...+..    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999976  5899999998654 334556789999999999999999999977654421    


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .|+||||+++++|.+++..      .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999988754      28999999999999999999999999999999999999986 8999999999876


Q ss_pred             CCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...     ....||+.|+|||++.+. ++.++|||||||++|||++|.+||.......                      
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------------  283 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------------  283 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------------
T ss_pred             ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------------------
Confidence            443     344699999999998764 4889999999999999999998886421100                      


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHhh
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-MKEVLEILRET  387 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~  387 (438)
                        +.  ........+..+.+++.+||+.||++||+ ++++...|..+
T Consensus       284 --~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 --LP--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             --CC--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --cc--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence              00  00112345567899999999999999995 56666666554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-41  Score=334.76  Aligned_cols=244  Identities=16%  Similarity=0.144  Sum_probs=182.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCC-CCceeEe------------
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQH-PNLVKLY------------  172 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~~~------------  172 (438)
                      ..|...+.||+|+||+||+|.+. +|+.||||++....   ....+.+.+|+.+++.++| +|...+.            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            44677889999999999999965 69999999987332   2235789999999999987 3221110            


Q ss_pred             ---------eeeecc----CceEEEEEeccCCCCHHHHhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013686          173 ---------GCTSRQ----SRELLLVYEYIPNGTVADHLHNR---QPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRD  236 (438)
Q Consensus       173 ---------~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~D  236 (438)
                               .+....    ....+++|+++ +++|.+++...   ......+++..++.++.||+.||+|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                     101110    12467788876 78999998522   11223478889999999999999999999999999


Q ss_pred             CCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCcccc----------ccCCCCChhhHHHHHHHHHHHH
Q 013686          237 VKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF----------QCYKLTDKSDVYSFGVVLIELI  306 (438)
Q Consensus       237 lkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dvws~Gv~l~el~  306 (438)
                      |||+||||+.++.+||+|||+++.....    .....| +.|+|||.+          .+..++.++|||||||++|||+
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999999999865433    334467 999999999          5566888999999999999999


Q ss_pred             hCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          307 SGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       307 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      +|+.||..........               ..+...         ..++..+.+|+.+||+.||++||++.|++++
T Consensus       312 tg~~Pf~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          312 CADLPNTDDAALGGSE---------------WIFRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HSSCCCCTTGGGSCSG---------------GGGSSC---------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HCCCCCCCcchhhhHH---------------HHHhhc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999997543221110               111100         1234678999999999999999999888753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.8e-41  Score=321.91  Aligned_cols=244  Identities=20%  Similarity=0.254  Sum_probs=187.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccc--------hHhHHHHHHHHHHHHhCC---------CCCceeE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENN--------FKRIEQFMNEVEILTKLQ---------HPNLVKL  171 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~  171 (438)
                      .++|++.+.||+|+||+||+|.. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999998 68999999987542        223477889999998885         7777776


Q ss_pred             eeee-----------------ec------------cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH
Q 013686          172 YGCT-----------------SR------------QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG  222 (438)
Q Consensus       172 ~~~~-----------------~~------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~  222 (438)
                      .+++                 ..            ....+|+||||+++|++.+.+.+.     .+++..++.++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHH
Confidence            6642                 21            145799999999999877777442     2899999999999999


Q ss_pred             HHHHHH-hCCccccCCCCCCEEecCCC--------------------eEEEeeeCcccccCCCccccccCCCCCCCccCc
Q 013686          223 ALAYLH-ASDVIHRDVKSNNILLDNNF--------------------RVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP  281 (438)
Q Consensus       223 ~l~~LH-~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aP  281 (438)
                      ||.||| ++||+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+||
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            999999 99999999999999999887                    9999999999876432      22589999999


Q ss_pred             cccccCCCCChhhHHHHHHH-HHHHHhCCCCcccCCcccccchhHHHHHHHh-cCcccccccCcCCCCccHHHHHHHHHH
Q 013686          282 DYFQCYKLTDKSDVYSFGVV-LIELISGLEAVDTSRHRHDINLSNMATNKIQ-NGALNELVDPSLGFEKDYAVRNMVTSV  359 (438)
Q Consensus       282 E~~~~~~~~~~~Dvws~Gv~-l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l  359 (438)
                      |++.+.. +.++||||||++ .+++++|..||.....      .......+. .....       .......+..+++.+
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW------LHYLTDKMLKQMTFK-------TKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH------HHHHHHHHHHTCCCS-------SCCCSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh------hhHHHHhhhhhhccC-------cccchhhhhhcCHHH
Confidence            9998766 889999998777 7788999999853100      000111111 10110       011223456789999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHH-HH
Q 013686          360 AELAFRCVQQDRDMRPTMKEVL-EI  383 (438)
Q Consensus       360 ~~li~~cl~~dP~~RPs~~evl-~~  383 (438)
                      .+|+.+||+.|     |++|++ ++
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999977     999998 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.5e-33  Score=288.82  Aligned_cols=185  Identities=19%  Similarity=0.100  Sum_probs=128.7

Q ss_pred             cccccCceEEEEEEE-cCCcEEEEEEeeccc----------hHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEE
Q 013686          117 QLGDGGFGAVYLGIL-RDGRIVAVKRLYENN----------FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       117 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ..+.|++|.+..+.. -.|+.|++|.+....          ....++|.+|+++|+++ .|+||++++++++++ +.+||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-QSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-SEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-CEEEE
Confidence            456666666665542 248999999986431          22346799999999999 699999999977655 58999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||++|++|.++|.....    ++..   +|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....+
T Consensus       320 VMEyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999999987654    6553   58899999999999999999999999999999999999999999876544


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEA  311 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p  311 (438)
                      ... ....+||+.|||||++.+ .+..++|+|++|+++++|.+|..+
T Consensus       393 ~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Ccc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            322 233469999999999976 467789999999999988776443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1e-29  Score=258.82  Aligned_cols=185  Identities=17%  Similarity=0.206  Sum_probs=142.4

Q ss_pred             CCCCcccccCceEEEEEEEcCCcEEEEEEeeccch--------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          113 NSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ...+.||+|+||.||++.. .++.+++|+......        ...+.+.+|++++++++||||+++..++... ...|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-DNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-TTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-CccEE
Confidence            3467899999999999954 578899998643221        1235689999999999999999443333333 35699


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      ||||+++++|.+++..            +..++.|+++||.|||++||+||||||+|||++.  .+||+|||+++.....
T Consensus       417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999999876            3589999999999999999999999999999999  9999999999987553


Q ss_pred             cccc------ccCCCCCCCccCcccccc--CCCCChhhHHHHHHHHHHHHhCCCCcc
Q 013686          265 VTHV------STAPQGTPGYVDPDYFQC--YKLTDKSDVYSFGVVLIELISGLEAVD  313 (438)
Q Consensus       265 ~~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tG~~p~~  313 (438)
                      ....      .....||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2211      123468999999999987  568888999999999999888776653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=9.6e-27  Score=217.83  Aligned_cols=152  Identities=16%  Similarity=0.077  Sum_probs=121.7

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch------------------HhHHHHHHHHHHHHhCC
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF------------------KRIEQFMNEVEILTKLQ  164 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  164 (438)
                      ..+......|.+.+.||+|+||.||+|...+|+.||+|.+.....                  .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344445566778899999999999999997799999999864321                  13467899999999999


Q ss_pred             CCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEe
Q 013686          165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILL  244 (438)
Q Consensus       165 h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill  244 (438)
                        | +++.+++..  +..++||||++|++|.+ +..        .  ....++.||+.||.|||++||+||||||+|||+
T Consensus       163 --~-~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~~--------~--~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl  226 (282)
T 1zar_A          163 --G-LAVPKVYAW--EGNAVLMELIDAKELYR-VRV--------E--NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             --T-SSSCCEEEE--ETTEEEEECCCCEEGGG-CCC--------S--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred             --C-CCcCeEEec--cceEEEEEecCCCcHHH-cch--------h--hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence              4 566654433  35699999999999998 422        1  134799999999999999999999999999999


Q ss_pred             cCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccc
Q 013686          245 DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ  285 (438)
Q Consensus       245 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~  285 (438)
                      + ++.+||+|||+++.              +..++|||.+.
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9 99999999999863              34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=4.8e-22  Score=183.58  Aligned_cols=136  Identities=18%  Similarity=0.169  Sum_probs=106.1

Q ss_pred             CCCCCcccccCceEEEEEEE-cCCcE--EEEEEeeccchH------------------------hHHHHHHHHHHHHhCC
Q 013686          112 FNSSKQLGDGGFGAVYLGIL-RDGRI--VAVKRLYENNFK------------------------RIEQFMNEVEILTKLQ  164 (438)
Q Consensus       112 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  164 (438)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+..|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999998 67889  999986433111                        1136788999999998


Q ss_pred             CCCc--eeEeeeeeccCceEEEEEeccCC-C----CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccC
Q 013686          165 HPNL--VKLYGCTSRQSRELLLVYEYIPN-G----TVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH-ASDVIHRD  236 (438)
Q Consensus       165 h~ni--v~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~D  236 (438)
                      |+++  ..++++     ...++||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.||+|||
T Consensus       129 ~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred             hCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            8754  333431     246899999942 4    77776543       224456789999999999999 99999999


Q ss_pred             CCCCCEEecCCCeEEEeeeCccccc
Q 013686          237 VKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       237 lkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      |||+|||++.  .++|+|||++...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=7.7e-20  Score=175.76  Aligned_cols=136  Identities=13%  Similarity=0.147  Sum_probs=99.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch--------------HhHH--------HHHHHHHHHHhCCCCC
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--------------KRIE--------QFMNEVEILTKLQHPN  167 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~n  167 (438)
                      .-|.+.+.||.|+||.||+|...+|+.||||+++....              ....        ....|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            44889999999999999999988999999998643210              0001        1234666666664433


Q ss_pred             ce--eEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec
Q 013686          168 LV--KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD  245 (438)
Q Consensus       168 iv--~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~  245 (438)
                      +.  ..++   ..  ..+|||||++|++|..+...        +  ....++.||+.+|.|||+.|||||||||.|||++
T Consensus       175 v~vp~p~~---~~--~~~LVME~i~G~~L~~l~~~--------~--~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          175 FPVPEPIA---QS--RHTIVMSLVDALPMRQVSSV--------P--DPASLYADLIALILRLAKHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             CSCCCEEE---EE--TTEEEEECCSCEEGGGCCCC--------S--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             CCCCeeee---cc--CceEEEEecCCccHhhhccc--------H--HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence            22  2222   11  23799999999888665321        1  2356789999999999999999999999999998


Q ss_pred             CCC----------eEEEeeeCcccc
Q 013686          246 NNF----------RVKVADFGLSRL  260 (438)
Q Consensus       246 ~~~----------~~kl~Dfgla~~  260 (438)
                      +++          .+.|+||+-+..
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCcccccccccceEEEEeCCccc
Confidence            776          489999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=2.2e-13  Score=125.58  Aligned_cols=144  Identities=13%  Similarity=0.070  Sum_probs=111.0

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEE
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  183 (438)
                      +......|.+...++.|+.+.||++... |+.+++|............+.+|+.+++.+. +.++.+++++.... +..|
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-CceE
Confidence            3445567888888999999999999754 6899999886532222345888999999985 66777888766544 5789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA----------------------------------  229 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------  229 (438)
                      +||||++|.+|.+.+..         ......++.+++++|..||+                                  
T Consensus        87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999999999876321         11234678899999999998                                  


Q ss_pred             -------------------------CCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          230 -------------------------SDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       230 -------------------------~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                                               ..++|||++|.|||++++..+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     348999999999999876667899999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=9.3e-13  Score=120.94  Aligned_cols=126  Identities=18%  Similarity=0.155  Sum_probs=93.4

Q ss_pred             cccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC--ceeEeeeeeccCceEEEEEeccCCCCHHH
Q 013686          119 GDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN--LVKLYGCTSRQSRELLLVYEYIPNGTVAD  196 (438)
Q Consensus       119 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~g~L~~  196 (438)
                      +.|..+.||++...+|+.+++|.....   ....+.+|+.+++.+.+.+  +.+++++.... +..++||||++|.+|. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEEEecCCcccC-
Confidence            456669999998767888999987544   2245778999999886444  44577755444 4689999999998884 


Q ss_pred             HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 013686          197 HLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD---------------------------------------------  231 (438)
Q Consensus       197 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  231 (438)
                       ...       ..   ...++.++++.|..||+..                                             
T Consensus       104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence             211       11   1256677888888888643                                             


Q ss_pred             -------------ccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          232 -------------VIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       232 -------------ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                                   ++|||++|.|||+++++.+.|+|||.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                         99999999999998876678999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.21  E-value=2.5e-11  Score=117.06  Aligned_cols=140  Identities=17%  Similarity=0.270  Sum_probs=103.1

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEee--ccc-hHhHHHHHHHHHHHHhCC--CCCceeEeeeeeccC--ceEEEEE
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLY--ENN-FKRIEQFMNEVEILTKLQ--HPNLVKLYGCTSRQS--RELLLVY  186 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~--~~~~lv~  186 (438)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.++++++....  +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4567999999999998875 4678888765  322 122356788999999996  445777777554431  3478999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-------------------------------------  229 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------  229 (438)
                      ||++|..+.+...      ..++...+..++.++++.|..||+                                     
T Consensus       121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999877754211      126788888999999999999997                                     


Q ss_pred             ---------------------CCccccCCCCCCEEecCCCe--EEEeeeCcccc
Q 013686          230 ---------------------SDVIHRDVKSNNILLDNNFR--VKVADFGLSRL  260 (438)
Q Consensus       230 ---------------------~~ivH~Dlkp~Nill~~~~~--~kl~Dfgla~~  260 (438)
                                           ..++|||+++.|||++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 35899999999999997653  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.17  E-value=3.3e-11  Score=113.50  Aligned_cols=185  Identities=21%  Similarity=0.208  Sum_probs=120.5

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCC--ceeEeeeeeccC--ceEEEEEecc
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPN--LVKLYGCTSRQS--RELLLVYEYI  189 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~--~~~~lv~e~~  189 (438)
                      .+.++.|.+..||+.    ++.+++|.....  .....+.+|.++++.+. +..  +..++.......  ...|+|||++
T Consensus        25 i~~~~~G~~n~v~~v----~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI----NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEES----TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEE----CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            467899999999986    356889976433  33467889999998883 322  233443222221  1347899999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA----------------------------------------  229 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------------  229 (438)
                      +|.+|.+.....      ++..++..++.++++.|..||+                                        
T Consensus        99 ~G~~l~~~~~~~------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLLNN------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHHHT------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccccc------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            998887543321      6777777888888888888885                                        


Q ss_pred             ------------------CCccccCCCCCCEEecC--CCeEEEeeeCcccccCCCccccccCCCCCCCccCccccc----
Q 013686          230 ------------------SDVIHRDVKSNNILLDN--NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ----  285 (438)
Q Consensus       230 ------------------~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~----  285 (438)
                                        ..++|+|++|.||++++  +..+.|+||+.+......... ....... .-..|+...    
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~-~~~~~~~~~~~l~  250 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDD-EEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTT-TSCCHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhc-cccCHHHHHHHHH
Confidence                              13699999999999998  556889999998754321110 0000000 002232211    


Q ss_pred             cCCC----------CChhhHHHHHHHHHHHHhCCCCcc
Q 013686          286 CYKL----------TDKSDVYSFGVVLIELISGLEAVD  313 (438)
Q Consensus       286 ~~~~----------~~~~Dvws~Gv~l~el~tG~~p~~  313 (438)
                      ....          ....+.|++|.++|.+.+|..+|.
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1111          113689999999999999987764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.82  E-value=3.9e-08  Score=92.47  Aligned_cols=134  Identities=17%  Similarity=0.189  Sum_probs=91.0

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCC---CceeEeeeeeccCceEEEEEeccCC
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP---NLVKLYGCTSRQSRELLLVYEYIPN  191 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~  191 (438)
                      .+.++.|....||+.    |+.+++|....  ......+.+|.++|+.+.+.   .+.+++.+.....+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888999999998    57788887532  23346788999999999642   2344555443334457899999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-----------------------------------------  230 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------  230 (438)
                      .+|.+.....      ++......++.++++.|..||+.                                         
T Consensus        98 ~~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGMAV------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhhhh------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            8887632111      34444444555555555555432                                         


Q ss_pred             -------------------CccccCCCCCCEEecC---CCe-EEEeeeCcccc
Q 013686          231 -------------------DVIHRDVKSNNILLDN---NFR-VKVADFGLSRL  260 (438)
Q Consensus       231 -------------------~ivH~Dlkp~Nill~~---~~~-~kl~Dfgla~~  260 (438)
                                         .++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   455 58999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=4.4e-07  Score=83.42  Aligned_cols=132  Identities=19%  Similarity=0.149  Sum_probs=89.5

Q ss_pred             cccccCce-EEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          117 QLGDGGFG-AVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       117 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+-++++++... +..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCcc
Confidence            45556655 68988765 4678899976433   2356788999998884 32344566655444 46899999999988


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 013686          194 VADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-------------------------------------------  230 (438)
Q Consensus       194 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  230 (438)
                      +.+......        .....++.+++..|..||+.                                           
T Consensus       107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            877654321        11223445555555555531                                           


Q ss_pred             ---------------CccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          231 ---------------DVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       231 ---------------~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                                     .++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                           168999999999999887778999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.45  E-value=1.6e-07  Score=90.21  Aligned_cols=81  Identities=5%  Similarity=0.023  Sum_probs=53.0

Q ss_pred             CCcc-cccCceEEEEEEEc-------CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCC-C--CCceeEeeeeeccC-
Q 013686          115 SKQL-GDGGFGAVYLGILR-------DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQ-H--PNLVKLYGCTSRQS-  179 (438)
Q Consensus       115 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~-  179 (438)
                      .+.| +.|....+|+....       +++.+++|......   ......+.+|+.+++.+. +  -.+.+++++..... 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88999999998764       26788899764332   101245677888888774 2  24556666443331 


Q ss_pred             -ceEEEEEeccCCCCHH
Q 013686          180 -RELLLVYEYIPNGTVA  195 (438)
Q Consensus       180 -~~~~lv~e~~~~g~L~  195 (438)
                       +..++||||++|.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999887654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.31  E-value=4.5e-06  Score=79.20  Aligned_cols=139  Identities=19%  Similarity=0.245  Sum_probs=77.7

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-----CCCceeEe-e-eeeccCceEEEEEec
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-----HPNLVKLY-G-CTSRQSRELLLVYEY  188 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~-~-~~~~~~~~~~lv~e~  188 (438)
                      +.|+.|..+.||++...+| .+++|+.... .   +.+..|..+++.|.     .|.++... | .+....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987654 5899987652 1   23334555555442     34444311 1 111123467899999


Q ss_pred             cCCCCHH--------------HHhhccCC----C-C-----CCCCHHHH-------------------------------
Q 013686          189 IPNGTVA--------------DHLHNRQP----N-S-----CLLPWPVR-------------------------------  213 (438)
Q Consensus       189 ~~~g~L~--------------~~l~~~~~----~-~-----~~l~~~~~-------------------------------  213 (438)
                      ++|.++.              ..++....    . .     ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11221110    0 0     01123211                               


Q ss_pred             HHHHHHHHHHHHHHHh-------------CCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          214 LSIAIETAGALAYLHA-------------SDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       214 ~~i~~~i~~~l~~LH~-------------~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ..+..++..++.+|+.             ..++|||+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111123345666652             579999999999999888899999999775

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=1.9e-06  Score=83.93  Aligned_cols=75  Identities=19%  Similarity=0.264  Sum_probs=48.4

Q ss_pred             CCcccccCceEEEEEEEc-CCcEEEEEEeeccch-------HhHHHHHHHHHHHHhCCC--CCce-eEeeeeeccCceEE
Q 013686          115 SKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-------KRIEQFMNEVEILTKLQH--PNLV-KLYGCTSRQSRELL  183 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~~~~~~~~~~~~~~  183 (438)
                      .+.||.|.++.||++... +++.++||.......       ...+.+..|.++++.+..  +..+ +++.+ ..+  ..+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~--~~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTE--MAV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETT--TTE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCC--ccE
Confidence            467999999999999754 468899997643211       123456779999887742  3333 45543 222  358


Q ss_pred             EEEeccCCC
Q 013686          184 LVYEYIPNG  192 (438)
Q Consensus       184 lv~e~~~~g  192 (438)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.03  E-value=1.9e-05  Score=73.22  Aligned_cols=79  Identities=19%  Similarity=0.144  Sum_probs=55.8

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCC---CceeEeeeeeccCceEEEEEe
Q 013686          111 NFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP---NLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .....+.+|.|..+.||+....+|+.|++|+...........|..|+..|+.|...   -+.+++++   .  .-++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~--~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---D--DRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---E--TTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---c--CceEEEE
Confidence            34456789999999999999999999999986544333334578899999988421   23344442   1  2378999


Q ss_pred             ccCCCCH
Q 013686          188 YIPNGTV  194 (438)
Q Consensus       188 ~~~~g~L  194 (438)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.89  E-value=3e-05  Score=76.03  Aligned_cols=80  Identities=14%  Similarity=0.076  Sum_probs=47.6

Q ss_pred             HhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccC---CCCChhhHHHHHHHHHH
Q 013686          228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY---KLTDKSDVYSFGVVLIE  304 (438)
Q Consensus       228 H~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~e  304 (438)
                      +...++|||+++.|||++.++ ++|+||+.+........-......-...|++|+.....   .-....++......+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456799999999999998876 99999998875321110000000011235555544311   11123456677888888


Q ss_pred             HHhC
Q 013686          305 LISG  308 (438)
Q Consensus       305 l~tG  308 (438)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.82  E-value=0.00015  Score=67.78  Aligned_cols=137  Identities=18%  Similarity=0.200  Sum_probs=87.3

Q ss_pred             CCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC---CCCceeEeeeeeccCceEEEEEeccC
Q 013686          114 SSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ---HPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       114 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      ..+.|+.|.+..+|+... +++.+++|.....   ....+..|...|+.|.   ...+.+++++.... +..++||||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEecc
Confidence            346789999999999876 4678889976543   2456888999888873   24566777655443 46899999999


Q ss_pred             CCCHH-----------HHhhccCC-CC-----------------CCCCHHHHH---HHH----------------HHHHH
Q 013686          191 NGTVA-----------DHLHNRQP-NS-----------------CLLPWPVRL---SIA----------------IETAG  222 (438)
Q Consensus       191 ~g~L~-----------~~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~~i~~  222 (438)
                      +..+.           ..|+.... ..                 -.-+|....   ++.                ..++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87642           12333221 00                 011344321   111                11222


Q ss_pred             HH-HHHH----hCCccccCCCCCCEEecCCCeEEEeeeC
Q 013686          223 AL-AYLH----ASDVIHRDVKSNNILLDNNFRVKVADFG  256 (438)
Q Consensus       223 ~l-~~LH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  256 (438)
                      .+ ..|.    ...++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22 2342    23689999999999999887 8899974

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.81  E-value=0.00015  Score=68.07  Aligned_cols=156  Identities=14%  Similarity=0.147  Sum_probs=84.8

Q ss_pred             ChHHHHHHhcCCCC-----CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC--ceeEee
Q 013686          101 SCSELEEATDNFNS-----SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN--LVKLYG  173 (438)
Q Consensus       101 ~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~  173 (438)
                      +.+++......|.+     .+.|+.|....+|+....+| .+++|......  ..+.+..|+.++..|...+  +.+++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            34555555555654     24567788899999987655 68889876521  1234556777777663212  222221


Q ss_pred             e-----eeccCceEEEEEeccCCCCHHH--------------HhhccCCC---C--CCC---CHHHHHH-----------
Q 013686          174 C-----TSRQSRELLLVYEYIPNGTVAD--------------HLHNRQPN---S--CLL---PWPVRLS-----------  215 (438)
Q Consensus       174 ~-----~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~---~--~~l---~~~~~~~-----------  215 (438)
                      .     +....+..+++|+|++|..+..              .++.....   .  ...   .|.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1     0011235789999998865321              12221110   0  001   1222100           


Q ss_pred             -HHHHHHHHHHHHHh-------CCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          216 -IAIETAGALAYLHA-------SDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       216 -i~~~i~~~l~~LH~-------~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                       +...+...+++++.       .+++|+|+.+.|||++++..+.|+||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             00113444555552       368999999999999987666899999775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.71  E-value=5.7e-05  Score=70.42  Aligned_cols=136  Identities=15%  Similarity=0.100  Sum_probs=73.5

Q ss_pred             CCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCc-eeEeeeeeccCceEEEEEecc-CCC
Q 013686          115 SKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL-VKLYGCTSRQSRELLLVYEYI-PNG  192 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~-~~g  192 (438)
                      .+.|+.|....+|+.     +.+++|........ .-...+|+.+++.+...++ .+++++. .+  .-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-~~--~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-PA--TGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-TT--TCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-CC--CCEEEEeecCCCc
Confidence            678999999999998     55888876543211 1123458877777642222 3445432 22  247899999 665


Q ss_pred             CHHH------------------HhhccCCCC-CCCC-HHHHHHHHH--------------HHHHHHH----HHHh----C
Q 013686          193 TVAD------------------HLHNRQPNS-CLLP-WPVRLSIAI--------------ETAGALA----YLHA----S  230 (438)
Q Consensus       193 ~L~~------------------~l~~~~~~~-~~l~-~~~~~~i~~--------------~i~~~l~----~LH~----~  230 (438)
                      +|..                  .+|...... .... +.....+..              .+...+.    .+..    .
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            4431                  111111100 0011 111111111              1111111    1111    2


Q ss_pred             CccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          231 DVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       231 ~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4799999999999 5667789999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.64  E-value=0.00031  Score=66.35  Aligned_cols=140  Identities=16%  Similarity=0.094  Sum_probs=71.9

Q ss_pred             CcccccCceE-EEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-C-CCceeEeeeeeccCceEEEEEeccCCC
Q 013686          116 KQLGDGGFGA-VYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-H-PNLVKLYGCTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       116 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~~lv~e~~~~g  192 (438)
                      +.|+.|.... +|+....+|+.+++|.......   +.+..|+.+++.+. + -.+.+++.+. ...+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d-~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEE-HARG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEE-TTTT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeec-CCCC--EEEEeeCCCc
Confidence            4566665554 6676654467787875433211   23445677776663 2 2244455532 2222  6899999777


Q ss_pred             CHHHHhhccC---------------------CCC-CCCCHHHHH-------HH-------------HHHHHHHHHHH---
Q 013686          193 TVADHLHNRQ---------------------PNS-CLLPWPVRL-------SI-------------AIETAGALAYL---  227 (438)
Q Consensus       193 ~L~~~l~~~~---------------------~~~-~~l~~~~~~-------~i-------------~~~i~~~l~~L---  227 (438)
                      ++.+++....                     ... ..+......       .+             ...+...++.+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            7765443211                     000 011111100       00             01112222333   


Q ss_pred             ---HhCCccccCCCCCCEEecCC----CeEEEeeeCccccc
Q 013686          228 ---HASDVIHRDVKSNNILLDNN----FRVKVADFGLSRLF  261 (438)
Q Consensus       228 ---H~~~ivH~Dlkp~Nill~~~----~~~kl~Dfgla~~~  261 (438)
                         +...++|||+.+.|||++.+    +.+.|+||+.+..-
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence               22468999999999999874    67999999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.56  E-value=0.00037  Score=65.52  Aligned_cols=141  Identities=16%  Similarity=0.111  Sum_probs=79.4

Q ss_pred             CcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCC--CceeEeee----eeccCceEEEEEecc
Q 013686          116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHP--NLVKLYGC----TSRQSRELLLVYEYI  189 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~----~~~~~~~~~lv~e~~  189 (438)
                      ..|+ |....||+....+|+.+++|....... ..+.+..|..+++.+...  .+.+++..    .....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 888899998776777899998764321 234566788888777421  23333332    001123567899999


Q ss_pred             CCCCHH-----HH---------hhccCC-----CCCCCCHHHH----------------------HHHHHHHHHHHHHH-
Q 013686          190 PNGTVA-----DH---------LHNRQP-----NSCLLPWPVR----------------------LSIAIETAGALAYL-  227 (438)
Q Consensus       190 ~~g~L~-----~~---------l~~~~~-----~~~~l~~~~~----------------------~~i~~~i~~~l~~L-  227 (438)
                      +|.++.     .+         ++....     ....+.+...                      ...+.+++..+.-+ 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     11         111100     0011222111                      11111222222222 


Q ss_pred             ---HhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          228 ---HASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       228 ---H~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                         ....++|||+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               223589999999999999 4 899999987764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.56  E-value=0.00014  Score=71.32  Aligned_cols=73  Identities=25%  Similarity=0.333  Sum_probs=48.5

Q ss_pred             CCcccccCceEEEEEEEcC--------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCc-eeEeeeeeccCceEEEE
Q 013686          115 SKQLGDGGFGAVYLGILRD--------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL-VKLYGCTSRQSRELLLV  185 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv  185 (438)
                      .+.|+.|....+|++...+        ++.+++|+......  .+.+.+|..+++.|...++ .++++.+. +    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~-~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS-G----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET-T----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC-C----CEE
Confidence            4578889999999998753        47888997743211  1445579999888853333 45665432 2    389


Q ss_pred             EeccCCCCH
Q 013686          186 YEYIPNGTV  194 (438)
Q Consensus       186 ~e~~~~g~L  194 (438)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=97.56  E-value=7e-05  Score=45.46  Aligned_cols=27  Identities=19%  Similarity=0.217  Sum_probs=21.3

Q ss_pred             cCCCCcccccchhHHHHHHHHHHHHHH
Q 013686            4 AGKNGFSTGAGIGIALGSAAAVILGLI   30 (438)
Q Consensus         4 ~~~~~~~~~~~i~i~~g~~~~~~~~~~   30 (438)
                      +++++++.++++||++|+++.+++++.
T Consensus         3 ~~~~~ls~GaIAGiVvG~v~gv~li~~   29 (38)
T 2k1k_A            3 PVSRGLTGGEIVAVIFGLLLGAALLLG   29 (38)
T ss_dssp             SSSTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCceeeeehHHHHHHHHHHH
Confidence            567889999999999999876554433

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.54  E-value=0.0014  Score=57.08  Aligned_cols=98  Identities=13%  Similarity=0.117  Sum_probs=65.5

Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccccc
Q 013686          192 GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVST  270 (438)
Q Consensus       192 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  270 (438)
                      -+|.+.|.....   +++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            389999988765   49999999999999999877622 1212233457999999999988763 1110           


Q ss_pred             CCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh
Q 013686          271 APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS  307 (438)
Q Consensus       271 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t  307 (438)
                        .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              1223456888763 345678899999999998774

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.40  E-value=0.00037  Score=67.00  Aligned_cols=140  Identities=16%  Similarity=0.199  Sum_probs=81.2

Q ss_pred             CCcccccCceEEEEEEEc--------CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCceEEEE
Q 013686          115 SKQLGDGGFGAVYLGILR--------DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  185 (438)
                      .+.|..|-...+|++...        +++.|++|+... .......+.+|..+++.|. +.-..++++++. +    .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-~----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP-E----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-T----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-C----ccE
Confidence            456778888999999864        247899997532 2223456678999998884 322344555432 2    289


Q ss_pred             EeccCCCCHHHH-----------------hhccCCC-CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 013686          186 YEYIPNGTVADH-----------------LHNRQPN-SCLL--PWPVRLSIAIETAG-------------------ALAY  226 (438)
Q Consensus       186 ~e~~~~g~L~~~-----------------l~~~~~~-~~~l--~~~~~~~i~~~i~~-------------------~l~~  226 (438)
                      |||++|.+|..-                 |+..... ....  -+..+.++..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999988655311                 1111110 1111  24455555544322                   2333


Q ss_pred             HH----hC----CccccCCCCCCEEecCC----CeEEEeeeCcccc
Q 013686          227 LH----AS----DVIHRDVKSNNILLDNN----FRVKVADFGLSRL  260 (438)
Q Consensus       227 LH----~~----~ivH~Dlkp~Nill~~~----~~~kl~Dfgla~~  260 (438)
                      |.    ..    .++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            32    22    58999999999999876    7899999998753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.40  E-value=0.00019  Score=68.84  Aligned_cols=74  Identities=12%  Similarity=0.109  Sum_probs=43.4

Q ss_pred             CCcccccCceEEEEEEEcC---------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCc-eeEeeeeeccCceEEE
Q 013686          115 SKQLGDGGFGAVYLGILRD---------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL-VKLYGCTSRQSRELLL  184 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~l  184 (438)
                      .+.|+.|....+|++...+         ++.+++|...... ........|..+++.+...++ .++++..  .   -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N---GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C---CcE
Confidence            4567888889999998753         2678888764432 111123568888887753333 3555432  2   268


Q ss_pred             EEeccCCCCH
Q 013686          185 VYEYIPNGTV  194 (438)
Q Consensus       185 v~e~~~~g~L  194 (438)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.10  E-value=0.002  Score=60.89  Aligned_cols=30  Identities=23%  Similarity=0.429  Sum_probs=27.2

Q ss_pred             CccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          231 DVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       231 ~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            689999999999999888899999987764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.02  E-value=0.0021  Score=63.40  Aligned_cols=74  Identities=12%  Similarity=-0.008  Sum_probs=46.6

Q ss_pred             CCcccccCceEEEEEEEcC-CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCc-eeEeeeeeccCceEEEEEeccCCC
Q 013686          115 SKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL-VKLYGCTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~g  192 (438)
                      .+.|+.|-...+|++...+ +..+++|+....... .-...+|..+++.|...++ .++++++ . +   .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEeeCCc
Confidence            3568888899999998764 478888876432211 1112479999998865444 4566644 2 2   2599999875


Q ss_pred             CH
Q 013686          193 TV  194 (438)
Q Consensus       193 ~L  194 (438)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.81  E-value=0.00095  Score=41.61  Aligned_cols=34  Identities=26%  Similarity=0.255  Sum_probs=18.0

Q ss_pred             CcccccchhHHHH-HHHHHHHHHHHHHHhhhccch
Q 013686            8 GFSTGAGIGIALG-SAAAVILGLIFFCIIRRRRKT   41 (438)
Q Consensus         8 ~~~~~~~i~i~~g-~~~~~~~~~~~~~~~~~~~~~   41 (438)
                      +..+++|++.++| +++++++++++++++|||+++
T Consensus         6 ~s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            6 HARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             SCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             CCCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            3445555555554 555555555555555555544

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=96.72  E-value=0.00098  Score=41.44  Aligned_cols=30  Identities=30%  Similarity=0.536  Sum_probs=20.2

Q ss_pred             ccchhHHHHHHHHHHHHHHHHHHhhhccch
Q 013686           12 GAGIGIALGSAAAVILGLIFFCIIRRRRKT   41 (438)
Q Consensus        12 ~~~i~i~~g~~~~~~~~~~~~~~~~~~~~~   41 (438)
                      ..++++++|+++++++++++++++|||+.+
T Consensus        12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           12 TSIISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             cchHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            456777888776667776666666666554

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.70  E-value=0.0019  Score=40.40  Aligned_cols=32  Identities=13%  Similarity=0.014  Sum_probs=16.8

Q ss_pred             ccccchhHHH-HHHHHHHHHHHHHHHhhhccch
Q 013686           10 STGAGIGIAL-GSAAAVILGLIFFCIIRRRRKT   41 (438)
Q Consensus        10 ~~~~~i~i~~-g~~~~~~~~~~~~~~~~~~~~~   41 (438)
                      .+++|++.++ |+++++++++++++++|||+.+
T Consensus         9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B            9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            3445554444 4555555555555555555543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.40  E-value=0.0043  Score=60.45  Aligned_cols=74  Identities=11%  Similarity=0.069  Sum_probs=46.9

Q ss_pred             CCcccccCceEEEEEEEcC--------CcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCC-ceeEeeeeeccCceEEEE
Q 013686          115 SKQLGDGGFGAVYLGILRD--------GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN-LVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv  185 (438)
                      .+.|..|-...+|+....+        ++.|++|+..... ...-+..+|..+++.+...+ ..++++.+  .   -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~---~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P---EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C---CCEE
Confidence            4567788899999998753        5789998764332 11112356888888774222 33444422  2   2689


Q ss_pred             EeccCCCCH
Q 013686          186 YEYIPNGTV  194 (438)
Q Consensus       186 ~e~~~~g~L  194 (438)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.25  E-value=0.056  Score=52.21  Aligned_cols=29  Identities=31%  Similarity=0.512  Sum_probs=24.7

Q ss_pred             ccccCCCCCCEEe------cCCCeEEEeeeCcccc
Q 013686          232 VIHRDVKSNNILL------DNNFRVKVADFGLSRL  260 (438)
Q Consensus       232 ivH~Dlkp~Nill------~~~~~~kl~Dfgla~~  260 (438)
                      ++|+|+.+.|||+      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3456799999998764

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=94.71  E-value=0.029  Score=32.64  Aligned_cols=29  Identities=21%  Similarity=0.282  Sum_probs=21.2

Q ss_pred             CcccccchhHHHHHHHHHHHHHHHHHHhh
Q 013686            8 GFSTGAGIGIALGSAAAVILGLIFFCIIR   36 (438)
Q Consensus         8 ~~~~~~~i~i~~g~~~~~~~~~~~~~~~~   36 (438)
                      +++.++++||++|.+++.+++++.+++++
T Consensus         3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~   31 (33)
T 2l34_A            3 TVSPGVLAGIVVGDLVLTVLIALAVYFLG   31 (33)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             ccCcceEEeEeHHHHHHHHHHHHHHhhee
Confidence            46789999999999987765555554443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.39  E-value=0.68  Score=40.03  Aligned_cols=116  Identities=11%  Similarity=0.153  Sum_probs=76.2

Q ss_pred             CCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 013686          164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNIL  243 (438)
Q Consensus       164 ~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nil  243 (438)
                      .||+.++. .+...+ +.+.+.++.-+.+.=+..+..       ++...+++++.+|+....+++.  -+|--|.|+|++
T Consensus        43 ~~~~Fl~~-~I~e~e-D~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELR-DSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECS-SEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcc-cEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEE
Confidence            68888866 233333 456666665432222222332       7788999999999887755543  366779999999


Q ss_pred             ecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcc
Q 013686          244 LDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVD  313 (438)
Q Consensus       244 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~  313 (438)
                      ++.++.+++.-.|+-..+                  +|.     ..+...=.-.+=+++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999877764322                  222     12222234468888999999988886

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=91.38  E-value=0.053  Score=31.76  Aligned_cols=25  Identities=32%  Similarity=0.474  Sum_probs=13.2

Q ss_pred             hhHHHHHHHHHHHHHHHHHHhhhcc
Q 013686           15 IGIALGSAAAVILGLIFFCIIRRRR   39 (438)
Q Consensus        15 i~i~~g~~~~~~~~~~~~~~~~~~~   39 (438)
                      +..++|+++++++++.+.+++|||+
T Consensus        11 aagVvglll~vii~l~~~~~iRRr~   35 (35)
T 1iij_A           11 IATVVGVLLFLILVVVVGILIKRRR   35 (35)
T ss_dssp             HHHHHHHHHHHHHTTTTTHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhheEEeecC
Confidence            3444455555555555555565553

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.57  E-value=1.4  Score=38.23  Aligned_cols=114  Identities=12%  Similarity=0.112  Sum_probs=74.7

Q ss_pred             CCCCceeEeeeeeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCCE
Q 013686          164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA-YLHASDVIHRDVKSNNI  242 (438)
Q Consensus       164 ~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~ivH~Dlkp~Ni  242 (438)
                      .||+. ..- +. ...+.+.+.++.-+++.=+..++.       ++...+++++.+|+.... +++  .-+|--|.|+|+
T Consensus        48 ~~~~f-~~~-I~-~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI-VRD-ID-VSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS-EEE-EE-ECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGE
T ss_pred             cCCCC-CeE-EE-EeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceE
Confidence            57887 332 22 334466666666544433334432       778899999998887655 443  346777999999


Q ss_pred             EecCCCeEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhh-HHHHHHHHHHHHhCCCCcc
Q 013686          243 LLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSD-VYSFGVVLIELISGLEAVD  313 (438)
Q Consensus       243 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D-vws~Gv~l~el~tG~~p~~  313 (438)
                      +++.++.++|.-.|+-..                  ++|..+     + ..| .-.+=+++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKES------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTT------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCccc------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999987775432                  333321     1 233 3367888889999888776

>2llm_A Amyloid beta A4 protein; alzheimer'S disease, protein fibril; NMR {Homo sapiens} PDB: 2loh_A

Probab=86.07  E-value=0.15  Score=31.12  Aligned_cols=30  Identities=23%  Similarity=0.482  Sum_probs=19.1

Q ss_pred             CcccccchhHHHHHHHHHHHHHHHHHHhhh
Q 013686            8 GFSTGAGIGIALGSAAAVILGLIFFCIIRR   37 (438)
Q Consensus         8 ~~~~~~~i~i~~g~~~~~~~~~~~~~~~~~   37 (438)
                      +.+.++++|++++++++..++++-.++.||
T Consensus        13 ~~srga~iGL~v~gVai~~vIVvsl~mlRr   42 (43)
T 2llm_A           13 GSNKGAIIGLMVGGVVIATVIVITLVMLKK   42 (43)
Confidence            346788899998777665555444444444

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.58  E-value=0.091  Score=51.72  Aligned_cols=60  Identities=12%  Similarity=0.122  Sum_probs=17.4

Q ss_pred             CCCCcccccCceEEEEEEEcC-CcEEEE------EEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeee
Q 013686          113 NSSKQLGDGGFGAVYLGILRD-GRIVAV------KRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCT  175 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~  175 (438)
                      .+.+.||   ||.||+|.+.. ..+||+      |.......  .....+.+|..+++.++|||+++.+++.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            3456777   99999999864 367888      76654322  2345688899999999999999987743

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	438
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-77
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-76
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-74
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-73
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-73
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-72
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-71
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-70
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-69
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-69
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-69
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-68
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-68
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-67
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-66
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-66
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-65
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-65
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-65
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-64
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-64
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-63
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-63
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-63
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-62
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-60
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-59
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-58
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-56
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-55
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-55
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-54
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-53
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-52
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-51
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-50
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-48
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-47
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-47
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-45
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-44
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-42
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-39
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-38
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-32
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-24

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 4e-77
 Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 23/277 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           +     ++LG G FG V++G       VAVK L + +    + F+ E  ++ +LQH  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +LY   +++   + ++ EY+ NG++ D L         L     L +A + A  +A++  
Sbjct: 72  RLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE 127

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
            + IHRD+++ NIL+ +    K+ADFGL+RL   +        +    +  P+       
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFG++L E+++            ++         ++ G    +V P       
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERG--YRMVRPD------ 233

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
               N    + +L   C ++  + RPT   +  +L +
Sbjct: 234 ----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (606), Expect = 2e-76
 Identities = 73/281 (25%), Positives = 130/281 (46%), Gaps = 23/281 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
                 +++G G FG VY G       V +  +     ++++ F NEV +L K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
              G ++  + +L +V ++    ++  HLH  +           + IA +TA  + YLHA
Sbjct: 68  LFMGYST--APQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHA 122

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT-DVTHVSTAPQGTPGYVDPDYFQCYK 288
             +IHRD+KSNNI L  +  VK+ DFGL+ +      +H      G+  ++ P+  +   
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 289 ---LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
               + +SDVY+FG+VL EL++G           +IN  +     +  G     + P L 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDLS 232

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
             +     N   ++  L   C+++ RD RP   ++L  +  
Sbjct: 233 KVRS----NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 2e-74
 Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 23/281 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
                 +++G G FG V+LG   +   VA+K + E      E F+ E E++ KL HP LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +LYG    +   + LV+E++ +G ++D+L  ++    L      L + ++    +AYL  
Sbjct: 64  QLYGV-CLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE 119

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           + VIHRD+ + N L+  N  +KV+DFG++R    D    ST  +    +  P+ F   + 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           + KSDV+SFGV++ E+ S  +    +R   ++         I  G    L  P       
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKP------- 224

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS 390
              R   T V ++   C ++  + RP    +L  L E  +S
Sbjct: 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 1e-73
 Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 23/277 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
           ++     +LG G FG V++G       VA+K L        E F+ E +++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +LY   S +   + +V EY+  G++ D L            P  + +A + A  +AY+  
Sbjct: 76  QLYAVVSEE--PIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVER 131

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
            + +HRD+++ NIL+  N   KVADFGL+RL   +        +    +  P+     + 
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           T KSDV+SFG++L EL +            ++       ++++ G               
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPP-------- 237

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                   S+ +L  +C +++ + RPT + +   L +
Sbjct: 238 ----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 3e-73
 Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 27/283 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
                 + +G G FG V LG  R G  VAVK +   N    + F+ E  ++T+L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +L G    +   L +V EY+  G++ D+L +R  +  +L     L  +++   A+ YL  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEG 121

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
           ++ +HRD+ + N+L+  +   KV+DFGL++   +         +    +  P+  +  K 
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKF 177

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           + KSDV+SFG++L E+ S            D+        +++ G   +  D        
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPD-------- 223

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNL 392
                   +V E+   C   D  MRP+  ++ E L   K   L
Sbjct: 224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 1e-72
 Identities = 73/277 (26%), Positives = 123/277 (44%), Gaps = 23/277 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLV 169
            +    K+LG G FG V  G  R    VA+K + E +    ++F+ E +++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
           +LYG    + R + ++ EY+ NG + ++L   +           L +  +   A+ YL +
Sbjct: 63  QLYGV-CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES 118

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
              +HRD+ + N L+++   VKV+DFGLSR    D    S   +    +  P+     K 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 290 TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEKD 349
           + KSD+++FGV++ E+ S  +         +          I  G    L  P L  EK 
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASEK- 229

Query: 350 YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                    V  + + C  +  D RPT K +L  + +
Sbjct: 230 ---------VYTIMYSCWHEKADERPTFKILLSNILD 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  225 bits (574), Expect = 2e-71
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 47/312 (15%)

Query: 103 SELEEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNFKRIE-QFMN 155
             LE   +N    + +G+G FG V+              +VAVK L E     ++  F  
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 156 EVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL-------- 207
           E  ++ +  +PN+VKL G      + + L++EY+  G + + L +  P++          
Sbjct: 66  EAALMAEFDNPNIVKLLGVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 208 ------------LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADF 255
                       L    +L IA + A  +AYL     +HRD+ + N L+  N  VK+ADF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184

Query: 256 GLSR-LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDT 314
           GLSR ++  D             ++ P+     + T +SDV+++GVVL E+ S       
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244

Query: 315 SRHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMR 374
                ++         +++G +    +            N    +  L   C  +    R
Sbjct: 245 GMAHEEV------IYYVRDGNILACPE------------NCPLELYNLMRLCWSKLPADR 286

Query: 375 PTMKEVLEILRE 386
           P+   +  IL+ 
Sbjct: 287 PSFCSIHRILQR 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 9e-70
 Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 30/290 (10%)

Query: 104 ELEEATDNFN-SSKQLGDGGFGAVYLGILR---DGRIVAVKRLYENNFKR-IEQFMNEVE 158
           +L    DN   +  +LG G FG+V  G+ R       VA+K L +   K   E+ M E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 159 ILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           I+ +L +P +V+L G    Q+  L+LV E    G +   L  ++     +P      +  
Sbjct: 62  IMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH--VSTAPQGTP 276
           + +  + YL   + +HRD+ + N+LL N    K++DFGLS+    D ++    +A +   
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL 336
            +  P+     K + +SDV+S+GV + E +S  +         ++         I+ G  
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGKR 230

Query: 337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
            E                    +  L   C     + RP    V + +R 
Sbjct: 231 MECPP------------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 1e-69
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 29/282 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHP 166
           +++     +G G +G       + DG+I+  K L   +      +  ++EV +L +L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 167 NLVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           N+V+ Y     R +  L +V EY   G +A  +         L     L +  +   AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 226 YLH-----ASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVD 280
             H        V+HRD+K  N+ LD    VK+ DFGL+R+   D T  + A  GTP Y+ 
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
           P+        +KSD++S G +L EL + +        +           KI+ G    + 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------GKIREGKFRRIP 235

Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                             + E+  R +      RP+++E+LE
Sbjct: 236 Y------------RYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  219 bits (558), Expect = 3e-69
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 23/284 (8%)

Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTK 162
           + E    +     +LG G +G VY G+ +     VAVK L E+  +  E+F+ E  ++ +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKE 69

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           ++HPNLV+L G    +     ++ E++  G + D+L         +   V L +A + + 
Sbjct: 70  IKHPNLVQLLGV-CTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISS 126

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           A+ YL   + IHRD+ + N L+  N  VKVADFGLSRL   D        +    +  P+
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP 342
                K + KSDV++FGV+L E+ +   +         +                EL++ 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELLEK 231

Query: 343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
               E+          V EL   C Q +   RP+  E+ +    
Sbjct: 232 DYRMERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 6e-69
 Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 31/278 (11%)

Query: 116 KQLGDGGFGAVYLGILRD---GRIVAVKRLYE--NNFKRIEQFMNEVEILTKLQHPNLVK 170
           K+LG G FG V  G  +     + VAVK L    N+    ++ + E  ++ +L +P +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 171 LYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS 230
           + G    +S   +LV E    G +  +L   +     +     + +  + +  + YL  S
Sbjct: 73  MIGICEAES--WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 126

Query: 231 DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYVDPDYFQCYK 288
           + +HRD+ + N+LL      K++DFGLS+    D  +            +  P+    YK
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 289 LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK 348
            + KSDV+SFGV++ E  S  +         ++      T  ++ G              
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPA------- 233

Query: 349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                     + +L   C   D + RP    V   LR 
Sbjct: 234 -----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 9e-69
 Identities = 64/295 (21%), Positives = 125/295 (42%), Gaps = 33/295 (11%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCT 175
           + +G G FG V+ G  R G  VAVK    +  +R      E+     L+H N++      
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 176 SRQSR---ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-- 230
           ++ +    +L LV +Y  +G++ D+L+        +     + +A+ TA  LA+LH    
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 231 ------DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ---GTPGYVDP 281
                  + HRD+KS NIL+  N    +AD GL+    +    +  AP    GT  Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 282 DYFQ------CYKLTDKSDVYSFGVVLIELISGL----EAVDTSRHRHDINLSNMATNKI 331
           +          ++   ++D+Y+ G+V  E+           D     +D+  S+ +  ++
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
           +     + + P++     +     +  +A++   C   +   R T   + + L +
Sbjct: 242 RKVVCEQKLRPNI--PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 3e-68
 Identities = 59/305 (19%), Positives = 117/305 (38%), Gaps = 35/305 (11%)

Query: 105 LEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLY-ENNFKRIEQFMNEVEILTK 162
           +E   D+F    +LG G  G V+    +  G ++A K ++ E       Q + E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
              P +V  YG       E+ +  E++  G++   L         +P  +   ++I    
Sbjct: 61  CNSPYIVGFYGA-FYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIK 115

Query: 223 ALAYLHAS-DVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            L YL     ++HRDVK +NIL+++   +K+ DFG+S      +     +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD 341
           +  Q    + +SD++S G+ L+E+  G   +     +    +                  
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 342 PSLGFEKDYAVRNMVTSVAELAF------------------------RCVQQDRDMRPTM 377
           P               ++ EL                          +C+ ++   R  +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 378 KEVLE 382
           K+++ 
Sbjct: 293 KQLMV 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (551), Expect = 6e-68
 Identities = 70/305 (22%), Positives = 128/305 (41%), Gaps = 40/305 (13%)

Query: 100 FSCSELEEATDNFNSS---------KQLGDGGFGAVYLGILR----DGRIVAVKRLYENN 146
           F+  +  EA   F            + +G G FG V  G L+        VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 147 FKR-IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNS 205
            ++    F++E  I+ +  HPN++ L      +S  ++++ E++ NG++   L       
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLE-GVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 206 CLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV 265
                   + +    A  + YL   + +HRD+ + NIL+++N   KV+DFGLSR    D 
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 266 THV----STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
           +      +   +    +  P+  Q  K T  SDV+S+G+V+ E++S  E         D+
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
                  N I+                     +  +++ +L   C Q+DR+ RP   +++
Sbjct: 243 ------INAIEQDYRLPPPM------------DCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 382 EILRE 386
             L +
Sbjct: 285 NTLDK 289

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 4e-67
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 31/296 (10%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRL-YENNFKRIEQFMNEVEIL 160
                +FN  + +G G FG VY G L D        AVK L    +   + QF+ E  I+
Sbjct: 25  SSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 161 TKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIET 220
               HPN++ L G   R     L+V  Y+ +G + + + N   N         +   ++ 
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQV 139

Query: 221 AGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP---TDVTHVSTAPQGTPG 277
           A  + +L +   +HRD+ + N +LD  F VKVADFGL+R       D  H  T  +    
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 278 YVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN 337
           ++  +  Q  K T KSDV+SFGV+L EL++         +  DI      T  +  G   
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQG--R 251

Query: 338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLG 393
            L+ P                + E+  +C     +MRP+  E++  +     + +G
Sbjct: 252 RLLQPE----------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 2e-66
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 28/280 (10%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPN 167
            D +    +LGDG FG VY    ++   + A K +   + + +E +M E++IL    HPN
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VKL          L ++ E+   G V   +   +     L       +  +T  AL YL
Sbjct: 71  IVKLLDA-FYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 126

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H + +IHRD+K+ NIL   +  +K+ADFG+S      +    +   GTP ++ P+   C 
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCE 185

Query: 288 KLTD-----KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP 342
              D     K+DV+S G+ LIE+             H++N   +   KI       L  P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEI------EPPHHELNPMRVL-LKIAKSEPPTLAQP 238

Query: 343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           S             ++  +   +C++++ D R T  ++L+
Sbjct: 239 S----------RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  211 bits (538), Expect = 7e-66
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 38/297 (12%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL---YENNFKRIEQFMNEVEILT 161
           ++    F+  +++G G FGAVY    +R+  +VA+K++    + + ++ +  + EV  L 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           KL+HPN ++  GC  R+     LV EY           +++P    L      ++     
Sbjct: 71  KLRHPNTIQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGAL 125

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             LAYLH+ ++IHRDVK+ NILL     VK+ DFG + +     + V     GTP ++ P
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAP 180

Query: 282 DYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           +        +   K DV+S G+  IEL              ++N  +   +  QN     
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAER------KPPLFNMNAMSALYHIAQNE---- 230

Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE---ILRETKDSNL 392
              P+L         +           C+Q+    RPT + +L+   +LRE   + +
Sbjct: 231 --SPALQSG------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 1e-65
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 34/276 (12%)

Query: 116 KQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHPNLVKLY 172
            ++G G F  VY G+  +    VA   L +    +   ++F  E E+L  LQHPN+V+ Y
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 173 GC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
                T +  + ++LV E + +GT+  +L   +     +   V  S   +    L +LH 
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT 130

Query: 230 --SDVIHRDVKSNNILL-DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
               +IHRD+K +NI +      VK+ D GL+ L          A  GTP ++ P+ ++ 
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEE 187

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K  +  DVY+FG+ ++E+ +        ++   I        ++ +G      D     
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPASFDK---- 236

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                    +  V E+   C++Q++D R ++K++L 
Sbjct: 237 -------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 26/277 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRL-YENNFKRIEQFMNEVEILTKLQHPN 167
           ++++  + LG+G +G V L + R     VAVK +  +      E    E+ I   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VK YG   R+     L  EY   G + D +         +P P       +    + YL
Sbjct: 65  VVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYL 119

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPDYFQC 286
           H   + HRD+K  N+LLD    +K++DFGL+ +F   +   +     GT  YV P+  + 
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 287 YKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
            +   +  DV+S G+VL  +++G           D    +             L      
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAG-------ELPWDQPSDSCQEYSDWKEKKTYLNPW--- 229

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                  + + ++   L  + + ++   R T+ ++ +
Sbjct: 230 -------KKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 3e-65
 Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 31/288 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENNFKR---IEQFMNEVEILTK 162
            +    ++LGDG FG V  G           VAVK L  +   +   ++ F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           L H NL++LYG     +  + +V E  P G++ D L   Q +            A++ A 
Sbjct: 68  LDHRNLIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAE 122

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH--VSTAPQGTPGYVD 280
            + YL +   IHRD+ + N+LL     VK+ DFGL R  P +  H  +    +    +  
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 281 PDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV 340
           P+  +    +  SD + FGV L E+ +  +      +   I              L+++ 
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKID 228

Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK 388
                  +     +    +  +  +C     + RPT   + + L E +
Sbjct: 229 KEGERLPRP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 1e-64
 Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 32/277 (11%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR---IEQFMNEVEILTKLQH 165
           ++F   + LG G FG VYL   +    I+A+K L++   ++     Q   EVEI + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           PN+++LYG     +  + L+ EY P GTV   L                +   E A AL+
Sbjct: 66  PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALS 120

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           Y H+  VIHRD+K  N+LL +   +K+ADFG S   P+          GT  Y+ P+  +
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIE 177

Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                +K D++S GV+  E + G       +   + N       +I      E   P   
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRV---EFTFPD-- 225

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                    +     +L  R ++ +   RP ++EVLE
Sbjct: 226 --------FVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-64
 Identities = 68/285 (23%), Positives = 128/285 (44%), Gaps = 30/285 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG-----RIVAVKRLYENNF-KRIEQFMNEVEILTKL 163
                 K +G G FG VY G+L+         VA+K L      K+   F+ E  I+ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            H N+++L G    + + ++++ EY+ NG +   L  +            + +    A  
Sbjct: 67  SHHNIIRLEGVI-SKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAG 122

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD--VTHVSTAPQGTPGYVDP 281
           + YL   + +HRD+ + NIL+++N   KV+DFGLSR+   D   T+ ++  +    +  P
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD 341
           +     K T  SDV+SFG+V+ E+++  E        H++                + ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAIN 227

Query: 342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                       +  +++ +L  +C QQ+R  RP   +++ IL +
Sbjct: 228 DGFRLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-63
 Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 41/300 (13%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLY-ENNFKRIEQFMNEVEILTK 162
           +  +  K LG G FG V                VAVK L    +    E  M+E+++L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 163 L-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP--------------NSCL 207
           L  H N+V L G         L++ EY   G + + L  ++               +   
Sbjct: 83  LGNHMNIVNLLGA-CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
           L     LS + + A  +A+L + + IHRD+ + NILL +    K+ DFGL+R    D  +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 268 -VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
            V    +    ++ P+       T +SDV+S+G+ L EL S   +               
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256

Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                      +++             +    + ++   C   D   RPT K++++++ +
Sbjct: 257 ---------FYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 2e-63
 Identities = 66/303 (21%), Positives = 120/303 (39%), Gaps = 46/303 (15%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD------GRIVAVKRLYEN-NFKRIEQFMNEVEILTK 162
           +N    K LG G FG V                VAVK L E  +    E  M+E++++T+
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 163 L-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP------------------ 203
           L  H N+V L G     S  + L++EY   G + ++L +++                   
Sbjct: 97  LGSHENIVNLLGA-CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 204 -NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP 262
            +  +L +   L  A + A  + +L     +HRD+ + N+L+ +   VK+ DFGL+R   
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 263 TDVTHVS-TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDI 321
           +D  +V     +    ++ P+       T KSDV+S+G++L E+        +       
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF-------SLGVNPYP 268

Query: 322 NLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
            +   A          +L+      ++ +        +  +   C   D   RP+   + 
Sbjct: 269 GIPVDAN-------FYKLIQNGFKMDQPF---YATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 382 EIL 384
             L
Sbjct: 319 SFL 321

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 8e-63
 Identities = 70/287 (24%), Positives = 126/287 (43%), Gaps = 25/287 (8%)

Query: 97  AKVFSCSELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMN 155
            K+ S   + +    +   +++G G  G VY  + +  G+ VA++++      + E  +N
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 156 EVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLS 215
           E+ ++ + ++PN+V           EL +V EY+  G++ D +                +
Sbjct: 67  EILVMRENKNPNIVNYLDS-YLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAA 120

Query: 216 IAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGT 275
           +  E   AL +LH++ VIHRD+KS+NILL  +  VK+ DFG       + +  ST   GT
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGT 179

Query: 276 PGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA 335
           P ++ P+         K D++S G++ IE+I G          +       A   I    
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EPPYLNENPLRALYLIATNG 232

Query: 336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             EL +P            +     +   RC+  D + R + KE+L+
Sbjct: 233 TPELQNPE----------KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 9e-63
 Identities = 73/294 (24%), Positives = 115/294 (39%), Gaps = 38/294 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDG---RIVAVKRLYENNFKR-IEQFMNEVEILTKL-Q 164
           ++      +G+G FG V    ++        A+KR+ E   K     F  E+E+L KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQP------------NSCLLPWPV 212
           HPN++ L G    +   L L  EY P+G + D L   +              +  L    
Sbjct: 70  HPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 213 RLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAP 272
            L  A + A  + YL     IHRD+ + NIL+  N+  K+ADFGLSR     V       
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 187

Query: 273 QGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
                ++  +       T  SDV+S+GV+L E++S            ++        K+ 
Sbjct: 188 -LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLP 240

Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
            G   E               N    V +L  +C ++    RP+  ++L  L  
Sbjct: 241 QGYRLEKPL------------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-62
 Identities = 65/282 (23%), Positives = 117/282 (41%), Gaps = 28/282 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYENNFKRI-EQFMNEVEILTKLQ 164
           +     + +G+G FG V+ GI          VA+K         + E+F+ E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP++VKL G  +     + ++ E    G +   L  R+ +   L     +  A + + AL
Sbjct: 67  HPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTAL 121

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
           AYL +   +HRD+ + N+L+ +N  VK+ DFGLSR       + ++  +    ++ P+  
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
              + T  SDV+ FGV + E++            +D+        +I+NG    +     
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPP--- 232

Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                    N   ++  L  +C   D   RP   E+   L  
Sbjct: 233 ---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-62
 Identities = 78/314 (24%), Positives = 136/314 (43%), Gaps = 34/314 (10%)

Query: 94  YFGAK-VFSCSELEEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN- 145
           YF A  V+   E E A +    S++LG G FG VY G+ +          VA+K + E  
Sbjct: 3   YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62

Query: 146 NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQ--- 202
           + +   +F+NE  ++ +    ++V+L G  S+     L++ E +  G +  +L + +   
Sbjct: 63  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAM 121

Query: 203 ---PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
              P          + +A E A  +AYL+A+  +HRD+ + N ++  +F VK+ DFG++R
Sbjct: 122 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181

Query: 260 LFP-TDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHR 318
               TD             ++ P+  +    T  SDV+SFGVVL E+ +  E        
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241

Query: 319 HDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMK 378
             +         +  G L +  D            N    + EL   C Q +  MRP+  
Sbjct: 242 EQV------LRFVMEGGLLDKPD------------NCPDMLFELMRMCWQYNPKMRPSFL 283

Query: 379 EVLEILRETKDSNL 392
           E++  ++E  +   
Sbjct: 284 EIISSIKEEMEPGF 297

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 2e-60
 Identities = 61/284 (21%), Positives = 121/284 (42%), Gaps = 30/284 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-----GRIVAVKRLYE-NNFKRIEQFMNEVEILTKL 163
             F   K LG G FG VY G+           VA+K L E  + K  ++ ++E  ++  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 164 QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
            +P++ +L G     +  + L+ + +P G + D++   + N         L+  ++ A  
Sbjct: 69  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKG 123

Query: 224 LAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPD 282
           + YL    ++HRD+ + N+L+     VK+ DFGL++L    +  + +   +    ++  +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP 342
                  T +SDV+S+GV + EL++            +I      ++ ++ G    L  P
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKG--ERLPQP 235

Query: 343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                           V  +  +C   D D RP  +E++    +
Sbjct: 236 P----------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 5e-59
 Identities = 70/303 (23%), Positives = 117/303 (38%), Gaps = 38/303 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENNF-KRIEQFMNEVEILTK 162
           D     K LG G FG V              R VAVK L E          M+E++IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 163 -LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSC------------LLP 209
              H N+V L G  ++    L+++ E+   G ++ +L +++                 L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 210 WPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV- 268
               +  + + A  + +L +   IHRD+ + NILL     VK+ DFGL+R    D  +V 
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT 328
               +    ++ P+       T +SDV+SFGV+L E+ S       +     + +     
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDEEFC 247

Query: 329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK 388
            +++ G      D                 + +    C   +   RPT  E++E L    
Sbjct: 248 RRLKEGTRMRAPD------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

Query: 389 DSN 391
            +N
Sbjct: 296 QAN 298

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  194 bits (493), Expect = 1e-58
 Identities = 54/276 (19%), Positives = 113/276 (40%), Gaps = 25/276 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           D+++  ++LG G FG V+       G   A K +   +    E    E++ ++ L+HP L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           V L+        E++++YE++  G + + + +       +     +    +    L ++H
Sbjct: 86  VNLHDA-FEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMH 141

Query: 229 ASDVIHRDVKSNNILL--DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
            ++ +H D+K  NI+     +  +K+ DFGL+       +   T   GT  +  P+  + 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 199

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
             +   +D++S GV+   L+SGL           +         +++   N       G 
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWNMDDSAFSGI 252

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            +D           +   + +  D + R T+ + LE
Sbjct: 253 SED---------GKDFIRKLLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 2e-56
 Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 34/279 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F   K LG+G F  V L   L   R  A+K L + +     ++     E +++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P  VKLY    +   +L     Y  NG +  ++                    E   AL 
Sbjct: 68  PFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALE 122

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF-PTDVTHVSTAPQGTPGYVDPDYF 284
           YLH   +IHRD+K  NILL+ +  +++ DFG +++  P      + +  GT  YV P+  
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN--ELVDP 342
                   SD+++ G ++ +L++G                 +   KI     +  E   P
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAG-------LPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235

Query: 343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL 381
                             +L  + +  D   R   +E+ 
Sbjct: 236 KA---------------RDLVEKLLVLDATKRLGCEEME 259

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 7e-56
 Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 42/300 (14%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR--------DGRIVAVKRLYENNFKR-IEQFMNEVEIL 160
           D     K LG+G FG V L                VAVK L  +  ++ +   ++E+E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 161 TKL-QHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCL------------ 207
             + +H N++ L G  + Q   L ++ EY   G + ++L  R+P                
Sbjct: 73  KMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 208 LPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH 267
           L     +S A + A  + YL +   IHRD+ + N+L+  +  +K+ADFGL+R       +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 268 VST-APQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNM 326
             T   +    ++ P+       T +SDV+SFGV+L E+ +   +        ++     
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL----- 246

Query: 327 ATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
               ++ G  + +  PS          N    +  +   C       RPT K+++E L  
Sbjct: 247 -FKLLKEG--HRMDKPS----------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  182 bits (464), Expect = 3e-55
 Identities = 64/290 (22%), Positives = 108/290 (37%), Gaps = 40/290 (13%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL---------YENNFKRIEQFMNEVEI 159
           +N+   + LG G    V   I     +  AVK +          E   +  E  + EV+I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 160 LTKLQ-HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           L K+  HPN+++L       +    LV++ +  G + D+L  +      L       I  
Sbjct: 63  LRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMR 117

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
                +  LH  +++HRD+K  NILLD++  +K+ DFG S               GTP Y
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSY 175

Query: 279 VDPDYFQCY------KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ 332
           + P+  +C           + D++S GV++  L++G                 +    I 
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-------SPPFWHRKQMLMLRMIM 228

Query: 333 NGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +G           +            V +L  R +      R T +E L 
Sbjct: 229 SGNYQFGSPEWDDYSDT---------VKDLVSRFLVVQPQKRYTAEEALA 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  184 bits (469), Expect = 3e-55
 Identities = 53/276 (19%), Positives = 105/276 (38%), Gaps = 25/276 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           D ++  ++LG G FG V+  +    GR+   K +            NE+ I+ +L HP L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           + L+        E++L+ E++  G + D +         +     ++   +    L ++H
Sbjct: 89  INLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH 144

Query: 229 ASDVIHRDVKSNNILLD--NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
              ++H D+K  NI+ +      VK+ DFGL+     D     T    T  +  P+    
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR 202

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
             +   +D+++ GV+   L+SGL           +         ++        D     
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWEFDEDAFSSV 255

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             +           +     +Q++   R T+ + LE
Sbjct: 256 SPE---------AKDFIKNLLQKEPRKRLTVHDALE 282

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-54
 Identities = 51/280 (18%), Positives = 108/280 (38%), Gaps = 26/280 (9%)

Query: 106 EEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ 164
           +E  + +  ++ LG G FG V+  +     +    K +      +      E+ IL   +
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIAR 59

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           H N++ L+        EL++++E+I    + + ++        L     +S   +   AL
Sbjct: 60  HRNILHLHES-FESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEAL 115

Query: 225 AYLHASDVIHRDVKSNNILLDN--NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            +LH+ ++ H D++  NI+     +  +K+ +FG +R                P Y  P+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPE 173

Query: 283 YFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP 342
             Q   ++  +D++S G ++  L+SG        +      +      I N         
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSG-------INPFLAETNQQIIENIMNAEYT----- 221

Query: 343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                 + A + +     +   R + ++R  R T  E L+
Sbjct: 222 ----FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (462), Expect = 1e-54
 Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 28/284 (9%)

Query: 104 ELEEATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF-KRIEQFMNEVEILT 161
           + E+  D ++    LG G F  V L    R  ++VA+K + +     +     NE+ +L 
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           K++HPN+V L          L L+ + +  G + D +  +              +  +  
Sbjct: 63  KIKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117

Query: 222 GALAYLHASDVIHRDVKSNNILL---DNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            A+ YLH   ++HRD+K  N+L    D + ++ ++DFGLS++   D   V +   GTPGY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGY 175

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+       +   D +S GV+   L+ G          +D N + +   +I       
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG------YPPFYDENDAKLF-EQILKA---- 224

Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             +            ++  S  +     +++D + R T ++ L+
Sbjct: 225 --EYEFDSPYW---DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 30/287 (10%)

Query: 109 TDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQ 164
           +D +   + LG GG   V+L   LR  R VAVK L      +     +F  E +    L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 165 HPNLVKLYGC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           HP +V +Y      +       +V EY+   T+ D +H   P    +     + +  +  
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV--STAPQGTPGYV 279
            AL + H + +IHRDVK  NI++     VKV DFG++R        V  + A  GT  Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
            P+  +   +  +SDVYS G VL E+++G E   T      +   ++  + I   A +E 
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTG-EPPFTGDSPVSVAYQHVREDPIPPSARHEG 240

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-TMKEVLEILR 385
           +   L                 +  + + ++ + R  T  E+   L 
Sbjct: 241 LSADL---------------DAVVLKALAKNPENRYQTAAEMRADLV 272

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (451), Expect = 3e-53
 Identities = 54/287 (18%), Positives = 99/287 (34%), Gaps = 28/287 (9%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
           + +   +++G G FG +YLG  +  G  VA+K        +  Q   E +I   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64

Query: 169 VKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLH 228
           +        +    ++V E +            +           L +A +    + Y+H
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIH 120

Query: 229 ASDVIHRDVKSNNIL---LDNNFRVKVADFGLSRLFPTDVTHV------STAPQGTPGYV 279
           + + IHRDVK +N L         V + DFGL++ +    TH       +    GT  Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 280 DPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
             +     + + + D+ S G VL+    G               +     K +  +  ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLG-------SLPWQGLKAATKRQKYERISEKKM 233

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
             P     K Y      +  A     C     D +P    + ++ R 
Sbjct: 234 STPIEVLCKGYP-----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-52
 Identities = 62/293 (21%), Positives = 117/293 (39%), Gaps = 23/293 (7%)

Query: 108 ATDNFNSSKQLGDGGFGAVYLGILR--DGRIVAVKRLYENNFKR--IEQFMNEVEILTKL 163
           A   +    ++G+G +G V+        GR VA+KR+     +       + EV +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 164 ---QHPNLVKLYGCTSRQSRE----LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSI 216
              +HPN+V+L+   +    +    L LV+E++            +P    +P      +
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDM 121

Query: 217 AIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
             +    L +LH+  V+HRD+K  NIL+ ++ ++K+ADFGL+R++   +   S     T 
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTL 179

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG------LEAVDTSRHRHDINLSNMATNK 330
            Y  P+           D++S G +  E+            VD      D+       + 
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 331 IQNGALNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRPTMKEVLE 382
            ++ AL      S   +        +  +  +L  +C+  +   R +    L 
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  172 bits (437), Expect = 3e-51
 Identities = 60/284 (21%), Positives = 113/284 (39%), Gaps = 16/284 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHPN 167
           + ++  +++G+G +G VY      G   A+K++             + E+ IL +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 168 LVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYL 227
           +VKLY     + + L+LV+E++                  L      S  ++    +AY 
Sbjct: 62  IVKLYDVIHTK-KRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYC 116

Query: 228 HASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCY 287
           H   V+HRD+K  N+L++    +K+ADFGL+R F   V   +                  
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 288 KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN-----LSNMATNKIQNGALNELVDP 342
           K +   D++S G +  E+++G            +      L    +    N       DP
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 343 SLGFEKDYAVRNMVTSVAELAF----RCVQQDRDMRPTMKEVLE 382
           +    +     + +  + E       + ++ D + R T K+ LE
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 7e-51
 Identities = 60/276 (21%), Positives = 106/276 (38%), Gaps = 29/276 (10%)

Query: 115 SKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLY 172
           S+ LG G  G V      R     A+K L     +   +   EVE+  +  Q P++V++ 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71

Query: 173 GC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
                     + LL+V E +  G +   + +R   +          I      A+ YLH+
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHS 129

Query: 230 SDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
            ++ HRDVK  N+L      N  +K+ DFG ++   +  +  +     TP YV P+    
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGP 187

Query: 287 YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF 346
            K     D++S GV++  L+ G          H + +S     +I+ G            
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            ++         V  L    ++ +   R T+ E + 
Sbjct: 245 SEE---------VKMLIRNLLKTEPTQRMTITEFMN 271

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 7e-50
 Identities = 54/297 (18%), Positives = 123/297 (41%), Gaps = 28/297 (9%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR-IEQFMNEVEILTKLQ 164
           +    + +   +G+G +G V       +   VA+K++     +   ++ + E++IL + +
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 165 HPNLVKLYGC---TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           H N++ +       + +  + + +  ++    +   L  +      L          +  
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQIL 119

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQ--GTPGYV 279
             L Y+H+++V+HRD+K +N+LL+    +K+ DFGL+R+   D  H     +   T  Y 
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 280 DPDYFQCYKLTDKS-DVYSFGVVLIELISGLEAVDTSRHRHDIN-------------LSN 325
            P+     K   KS D++S G +L E++S         +   +N             L+ 
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 326 MATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +   K +N  L+      + + + +   N  +   +L  + +  +   R  +++ L 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLF--PNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 9e-50
 Identities = 59/282 (20%), Positives = 109/282 (38%), Gaps = 21/282 (7%)

Query: 116 KQLGDGGFGAVYLGILR-DGRIVAVKRL-----YENNFKRIEQFMNEVEILTKLQHPNLV 169
             LG+G F  VY    +   +IVA+K++      E         + E+++L +L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 170 KLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA 229
            L      +S  + LV++++          N       L      +  + T   L YLH 
Sbjct: 64  GLLDAFGHKS-NISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQ 118

Query: 230 SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL 289
             ++HRD+K NN+LLD N  +K+ADFGL++ F +      T    T  Y  P+     ++
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGARM 177

Query: 290 TD-KSDVYSFGVVLIELISGLEAVDTSRHRHDINL--------SNMATNKIQNGALNELV 340
                D+++ G +L EL+  +  +        +          +      + +       
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
               G    +        + +L       +   R T  + L+
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-49
 Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 16/285 (5%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHP 166
           +NF   +++G+G +G VY    +  G +VA+K++  +          + E+ +L +L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N+VKL      +++ L LV+E++                  +P P+  S   +    LA+
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
            H+  V+HRD+K  N+L++    +K+ADFGL+R F   V   +                C
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 287 YKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS 343
              +   D++S G +  E+++                I  +    +++    +  + D  
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 344 LGFEKDY------AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
             F K         V  +      L  + +  D + R + K  L 
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-49
 Identities = 73/340 (21%), Positives = 132/340 (38%), Gaps = 37/340 (10%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTK-LQ 164
           ++F   K LG G FG V+L   +   +  A+K L ++       +E  M E  +L+   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 165 HPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGAL 224
           HP L  ++    +    L  V EY+  G +  H+ +                A E    L
Sbjct: 62  HPFLTHMFCT-FQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGL 116

Query: 225 AYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYF 284
            +LH+  +++RD+K +NILLD +  +K+ADFG+ +         +T   GTP Y+ P+  
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEIL 175

Query: 285 QCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
              K     D +SFGV+L E++ G             +   M           E  D   
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD--- 232

Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMK-EVLE--ILRETKDSNLGTSKAK--- 398
                            L  +   ++ + R  ++ ++ +  + RE     L   +     
Sbjct: 233 -----------------LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPF 275

Query: 399 VVDIRIADDAALLKKDSPSLSPDDSGTDKWVSSSNPSSSF 438
              ++   D +   K+  +  P  S  D+ + +S   + F
Sbjct: 276 RPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (423), Expect = 6e-49
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 38/282 (13%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRL---YENNFKRIEQFMNEVEILTKLQH 165
            +F   + LG G FG V+L   R +GR  A+K L        K++E   +E  +L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P +++++G   + ++++ ++ +YI        L +    S   P PV    A E   AL 
Sbjct: 64  PFIIRMWGT-FQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALE 118

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+ D+I+RD+K  NILLD N  +K+ DFG ++  P     +     GTP Y+ P+   
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVS 174

Query: 286 CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG 345
                   D +SFG+++ E+++G          +D N       KI N    EL  P   
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAG------YTPFYDSNTMKTY-EKILNA---ELRFPP-- 222

Query: 346 FEKDYAVRNMVTSVAELAFRCVQQDRDMR-----PTMKEVLE 382
                        V +L  R + +D   R        ++V  
Sbjct: 223 --------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  168 bits (426), Expect = 7e-49
 Identities = 62/286 (21%), Positives = 107/286 (37%), Gaps = 35/286 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFK------RIEQFMNEVEILTK 162
           ++F+  + +G GGFG VY     D G++ A+K L +   K              + +++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
              P +V +         +L  + + +  G +  HL                  A E   
Sbjct: 64  GDCPFIVCMSYA-FHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIIL 118

Query: 223 ALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
            L ++H   V++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ P+
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPE 175

Query: 283 YFQCYKLTD-KSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD 341
             Q     D  +D +S G +L +L+ G       + +    +  M         L +   
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFS 233

Query: 342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVL--EILR 385
           P L                 L    +Q+D + R         E+  
Sbjct: 234 PEL---------------RSLLEGLLQRDVNRRLGCLGRGAQEVKE 264

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  164 bits (417), Expect = 2e-48
 Identities = 41/283 (14%), Positives = 87/283 (30%), Gaps = 30/283 (10%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           +++G+G FG ++ G  L + + VA+K           Q  +E      L     +     
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIH 234
             ++    +LV + +                           A +    +  +H   +++
Sbjct: 69  FGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 235 RDVKSNNILLDNNF-----RVKVADFGLSRLFPTDVTHVSTAPQ------GTPGYVDPDY 283
           RD+K +N L+          + V DFG+ + +   VT      +      GT  Y+  + 
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 284 FQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS 343
               + + + D+ + G V +  + G       +   +         K Q+  L EL    
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA-- 242

Query: 344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRE 386
                            +          D  P    +  +  +
Sbjct: 243 ----------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-47
 Identities = 59/307 (19%), Positives = 114/307 (37%), Gaps = 34/307 (11%)

Query: 102 CSELEEATDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVE 158
           C E+      +    ++G G FG V+    R  G+ VA+K++   N K       + E++
Sbjct: 6   CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61

Query: 159 ILTKLQHPNLVKLYGC-------TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWP 211
           IL  L+H N+V L           +R    + LV+++  +       +            
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS 117

Query: 212 VRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTA 271
               +       L Y+H + ++HRD+K+ N+L+  +  +K+ADFGL+R F          
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 272 PQ---GTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL---- 323
                 T  Y  P+     +      D++  G ++ E+ +    +  +  +H + L    
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 324 ----SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAF----RCVQQDRDMRP 375
               +      + N  L E ++   G ++    R         A     + +  D   R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 376 TMKEVLE 382
              + L 
Sbjct: 298 DSDDALN 304

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 3e-47
 Identities = 63/284 (22%), Positives = 111/284 (39%), Gaps = 34/284 (11%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL------YENNFKRIEQFMNEVEILTK 162
           D +++ ++LG G F  V        G   A K +              E    EV IL +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 163 LQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAG 222
           +QHPN++ L+        +++L+ E +  G + D L  ++     L          +   
Sbjct: 70  IQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILN 124

Query: 223 ALAYLHASDVIHRDVKSNNILLDNN----FRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
            + YLH+  + H D+K  NI+L +      R+K+ DFGL+     D  +      GTP +
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEF 182

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE 338
           V P+      L  ++D++S GV+   L+SG             +        +       
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSG-------ASPFLGDTKQETLANVSAVNYE- 234

Query: 339 LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
                  FE +Y   N      +   R + +D   R T+++ L+
Sbjct: 235 -------FEDEY-FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 9e-47
 Identities = 71/290 (24%), Positives = 112/290 (38%), Gaps = 24/290 (8%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILRD-GRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL 168
            ++  +K +G+G FG VY   L D G +VA+K++     +       E++I+ KL H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNI 75

Query: 169 VKLYGC-----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGA 223
           V+L          +    L LV +Y+P        H  +    L P         +   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-PVIYVKLYMYQLFRS 134

Query: 224 LAYLHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPD 282
           LAY+H+  + HRD+K  N+LLD +   +K+ DFG ++       +VS        Y  P+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--RYYRAPE 192

Query: 283 Y-FQCYKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDI----NLSNMATNKIQNG 334
             F     T   DV+S G VL EL+ G              +I            +  N 
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 335 ALNELVDPSLGFEKDYAVRNMVTSVAELAF--RCVQQDRDMRPTMKEVLE 382
              E   P +       V    T    +A   R ++     R T  E   
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 6e-46
 Identities = 61/278 (21%), Positives = 105/278 (37%), Gaps = 44/278 (15%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLY------ENNFKRIEQFMNEVEILTKLQ--HP 166
             LG GGFG+VY GI + D   VA+K +               +   EV +L K+     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
            +++L     R     +L+ E              +     L   +  S   +   A+ +
Sbjct: 70  GVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 125

Query: 227 LHASDVIHRDVKSNNILLD-NNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
            H   V+HRD+K  NIL+D N   +K+ DFG   L    V    T   GT  Y  P++ +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIR 182

Query: 286 CYKLTDKS-DVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL 344
            ++   +S  V+S G++L +++ G    +                        E++   +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------------------EEIIRGQV 221

Query: 345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            F +  +     +    L   C+      RPT +E+  
Sbjct: 222 FFRQRVS-----SECQHLIRWCLALRPSDRPTFEEIQN 254

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (396), Expect = 3e-45
 Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 18/286 (6%)

Query: 110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR--IEQFMNEVEILTKLQHP 166
             +   +++G+G +G V+    R    IVA+KR+  ++         + E+ +L +L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 167 NLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           N+V+L+       ++L LV+E+                       +  S   +    L +
Sbjct: 62  NIVRLHDVL-HSDKKLTLVFEFCDQDLKKYFDSCNGDL----DPEIVKSFLFQLLKGLGF 116

Query: 227 LHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQC 286
            H+ +V+HRD+K  N+L++ N  +K+A+FGL+R F   V   S              F  
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 287 YKLTDKSDVYSFGVVLIELISG----LEAVDTSRHRHDINLSNMATNKIQNGALNELVD- 341
              +   D++S G +  EL +         D       I        + Q  ++ +L D 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 342 -PSLGFEKDYAVRNMVTSVAELAF----RCVQQDRDMRPTMKEVLE 382
            P   +    ++ N+V  +           ++ +   R + +E L+
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  157 bits (397), Expect = 9e-45
 Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 19/248 (7%)

Query: 65  SAATTTTTNSSQSIPSYPYSITDLERGSSYFGAKVFSCSELEEATDNFNSSKQLGDGGFG 124
           +AA     +  +S+  +      L +    F  K  + S+     D F+  K LG G FG
Sbjct: 2   NAAAAKKGSEQESVKEF------LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFG 55

Query: 125 AVYLGI-LRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSR 180
            V L      G   A+K L +      K+IE  +NE  IL  +  P LVKL     + + 
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNS 114

Query: 181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSN 240
            L +V EY+  G +  HL            P     A +      YLH+ D+I+RD+K  
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 241 NILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGV 300
           N+L+D    ++V DFG ++        +     GTP  + P+           D ++ GV
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYNKAVDWWALGV 226

Query: 301 VLIELISG 308
           ++ E+ +G
Sbjct: 227 LIYEMAAG 234

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 10/203 (4%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQH 165
           ++F+  K LG G FG V L      GR  A+K L +        +   + E  +L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
           P L  L     +    L  V EY   G +  HL        +           E   AL 
Sbjct: 65  PFLTALKYAF-QTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 119

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
           YLH+ DV++RD+K  N++LD +  +K+ DFGL +   +D         GTP Y+ P+  +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLE 178

Query: 286 CYKLTDKSDVYSFGVVLIELISG 308
                   D +  GVV+ E++ G
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCG 201

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  151 bits (381), Expect = 1e-42
 Identities = 59/296 (19%), Positives = 119/296 (40%), Gaps = 35/296 (11%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPN 167
           D++   ++LG G +  V+  I + +   V VK L      + ++   E++IL  L+  PN
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91

Query: 168 LVKLYG-CTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAY 226
           ++ L        SR   LV+E++ N                L          E   AL Y
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDY 144

Query: 227 LHASDVIHRDVKSNNILLDN-NFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQ 285
            H+  ++HRDVK +N+++D+ + ++++ D+GL+  +     +       +  +  P+   
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLV 202

Query: 286 CYKLTD-KSDVYSFGVVLIELISG-----------------LEAVDTSRHRHDINLSNMA 327
            Y++ D   D++S G +L  +I                    + + T      I+  N+ 
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262

Query: 328 TNKIQNGALNELVDPSLGFEKDYAVRNMVTSVA-ELAFRCVQQDRDMRPTMKEVLE 382
            +   N  L                +++V+  A +   + ++ D   R T +E +E
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-42
 Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 28/295 (9%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKR--IEQFMNEVEILTKL 163
           E    +   + +G G +GAV   +  R G  VA+K+LY         ++   E+ +L  +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 164 QHPNLVKLYGC-----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAI 218
           +H N++ L        T     +  LV  ++  GT    L   +     L       +  
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK----LGEDRIQFLVY 128

Query: 219 ETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGY 278
           +    L Y+HA+ +IHRD+K  N+ ++ +  +K+ DFGL+R   +++T            
Sbjct: 129 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRA-- 186

Query: 279 VDPDYFQCYKLTDKSDVYSFGVVLIELISG--------LEAVDTSRHRHDINLSNMATNK 330
                    + T   D++S G ++ E+I+G                 +           +
Sbjct: 187 -PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 331 IQNGALNELVDPSLGFEKDY---AVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
           +Q+      +      EK      + N       L  + +  D + R T  E L 
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 5e-40
 Identities = 55/303 (18%), Positives = 112/303 (36%), Gaps = 39/303 (12%)

Query: 110 DNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRLY--ENNFKRIEQFMNEVEILTKLQHP 166
             + + K +G G  G V         R VA+K+L     N    ++   E+ ++  + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 167 NLVKLYGC-----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
           N++ L        T  + +++ LV E +                          +  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQML 129

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
             + +LH++ +IHRD+K +NI++ ++  +K+ DFGL+R   T    + T    T  Y  P
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAP 187

Query: 282 DYFQCYKLTDKSDVYSFGVVLIELISG----------------LEAVDTSRHRHDINLSN 325
           +        +  D++S G ++ E++                  +E + T        L  
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 326 MATNKIQNG------ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE 379
              N ++N          +L   SL        +   +   +L  + +  D   R ++ +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 380 VLE 382
            L+
Sbjct: 308 ALQ 310

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-39
 Identities = 69/288 (23%), Positives = 108/288 (37%), Gaps = 32/288 (11%)

Query: 110 DNFNSSKQLGDGGFGAVYLGIL----RDGRIVAVKRL----YENNFKRIEQFMNEVEILT 161
           +NF   K LG G +G V+L         G++ A+K L         K  E    E ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 162 KLQHPNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETA 221
            ++    +       +   +L L+ +YI  G +  HL  R+                E  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 222 GALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDP 281
            AL +LH   +I+RD+K  NILLD+N  V + DFGLS+ F  D T  +    GT  Y+ P
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 282 DYFQC--YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL 339
           D  +          D +S GV++ EL++G            ++    +  +I    L   
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTG-------ASPFTVDGEKNSQAEISRRILKSE 252

Query: 340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKE--VLEILR 385
                                +L  R + +D   R         EI  
Sbjct: 253 PPYPQEMSAL---------AKDLIQRLLMKDPKKRLGCGPRDADEIKE 291

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 2e-38
 Identities = 55/297 (18%), Positives = 120/297 (40%), Gaps = 32/297 (10%)

Query: 107 EATDNFNSSKQLGDGGFGAVYLGI-LRDGRIVAVKRL--YENNFKRIEQFMNEVEILTKL 163
           E  + + +   +G G +G+V      + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 164 QHPNLVKLYGC----TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIE 219
           +H N++ L        S +    + +  ++    + + +  ++     L       +  +
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQ 129

Query: 220 TAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVSTAPQGTPGYV 279
               L Y+H++D+IHRD+K +N+ ++ +  +K+ DFGL+R    ++T        T  Y 
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----YVATRWYR 185

Query: 280 DPDYFQCYKLTD-KSDVYSFGVVLIELISG------------LEAVDTSRHRHDINLSNM 326
            P+    +   +   D++S G ++ EL++G            L+ +          L   
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 327 ATNKIQNGALNELVD-PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLE 382
            +++     +  L   P + F   +          +L  + +  D D R T  + L 
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (312), Expect = 1e-32
 Identities = 53/314 (16%), Positives = 112/314 (35%), Gaps = 52/314 (16%)

Query: 116 KQLGDGGFGAVYLGI-LRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGC 174
           ++LG G F  V+L   + +   VA+K +   +    E   +E+++L ++   +  K    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLL-----------PWPVRLSIAIETAGA 223
            +    +LL  + +     V   +        LL           P      I+ +    
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 224 LAYLHASD-VIHRDVKSNNILLDNN------FRVKVADFGLSRLFPTDVTHVSTAPQGTP 276
           L Y+H    +IH D+K  N+L++         ++K+AD G +  +    T+       T 
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQTR 193

Query: 277 GYVDPDYFQCYKLTDKSDVYSFGVVLIELISG---LEAVDTSRHRHDIN--------LSN 325
            Y  P+          +D++S   ++ ELI+G    E  +   +  D +        L  
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 326 MATNKIQNGALNELVDPSLGFEKDYA-----------------VRNMVTSVAELAFRCVQ 368
           + +  ++NG        S G  ++ +                  ++    +++     +Q
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 369 QDRDMRPTMKEVLE 382
            D   R     ++ 
Sbjct: 314 LDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 97.9 bits (243), Expect = 1e-24
 Identities = 26/154 (16%), Positives = 54/154 (35%), Gaps = 19/154 (12%)

Query: 116 KQLGDGGFGAVYLGILRDGRIVAVK--RLYENNFKRI--------EQFMNEVEILTKLQH 165
           K +G+G   AV+           VK  ++   +FK++          F        + + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 166 PNLVKLYGCTSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALA 225
             L KL G    +      VY +  N  + + +  ++     +  P    +       +A
Sbjct: 66  RALQKLQGLAVPK------VYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117

Query: 226 YLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR 259
             +   ++H D+   N+L+     + + DF  S 
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	438
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.74
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.26
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.89
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.63
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=427.71  Aligned_cols=261  Identities=29%  Similarity=0.463  Sum_probs=206.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||+||+|.++  ..||||+++..  .....+.|.+|+++|++++|||||++++++..  ..+++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEE
Confidence            568999999999999999999864  35999998643  34456789999999999999999999997643  3589999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |||++|+|.+++.....   .+++..+..++.||++||+|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus        83 Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999999976543   389999999999999999999999999999999999999999999999999987644322


Q ss_pred             -ccccCCCCCCCccCccccccC---CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          267 -HVSTAPQGTPGYVDPDYFQCY---KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       267 -~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                       .......||+.|||||++.+.   .|+.++|||||||++|||+||+.||.......      .....+..+....... 
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~~-  232 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDLS-  232 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCCGG-
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCcch-
Confidence             233455799999999998643   58999999999999999999999997543221      1222222222111110 


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                             ....++++.+.+|+.+||+.||++|||++||+++|+.+.++
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         233 -------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                   01124567899999999999999999999999999988653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=421.01  Aligned_cols=257  Identities=31%  Similarity=0.523  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      ++|++.+.||+|+||+||+|.+++++.||||++..... ..++|.+|++++++++|||||+++|++..+ +..++|||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccC-CceEEEEEec
Confidence            46788899999999999999998889999999876443 346799999999999999999999987665 4689999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++|+|.+++.....   .+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++..........
T Consensus        83 ~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          83 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            99999999876543   389999999999999999999999999999999999999999999999999987765544444


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhC-CCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISG-LEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....||+.|+|||++.+..|+.++|||||||++|||+|| .+||.....      .. ....+..+...  ..+      
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~-~~~~i~~~~~~--~~p------  224 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SE-VVEDISTGFRL--YKP------  224 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HH-HHHHHHHTCCC--CCC------
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HH-HHHHHHhcCCC--CCc------
Confidence            456789999999999999999999999999999999995 555553221      11 11222222111  111      


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                          ..++.++.+|+.+||+.||++|||++||+++|+++.++
T Consensus       225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                13456789999999999999999999999999988654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=418.98  Aligned_cols=250  Identities=26%  Similarity=0.422  Sum_probs=209.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++........+.+.+|++++++++|||||++++++... +.+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-CEEEEEEEe
Confidence            57999999999999999999975 6999999999766555667899999999999999999999977665 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      |++|+|.+++....     +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... .
T Consensus        99 ~~gg~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~  172 (293)
T d1yhwa1          99 LAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (293)
T ss_dssp             CTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             cCCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence            99999999887642     89999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....||+.|+|||++.+..|+.++|||||||++|||+||+.||......      .........+.. .     +.   
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~-----~~---  237 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-E-----LQ---  237 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-C-----CS---
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-C-----CC---
Confidence            34557999999999999999999999999999999999999999754321      111122222111 1     10   


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        .+..++..+.+|+.+||+.||++|||+.|++++
T Consensus       238 --~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 --NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              013456789999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=422.54  Aligned_cols=258  Identities=26%  Similarity=0.445  Sum_probs=212.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ..++|++.+.||+|+||+||+|.+++++.||||++..... ..+.|.+|++++++++|||||+++|++..  +.+++|||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~E   87 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITE   87 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEE
Confidence            3567888999999999999999998889999999875433 34679999999999999999999997654  35799999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+++|+|.+++......  .+++..++.++.||++||.|||+++|+||||||+||||++++.+||+|||+++........
T Consensus        88 y~~~g~L~~~~~~~~~~--~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CCTTCBHHHHTTSHHHH--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             eCCCCcHHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999999988665422  3899999999999999999999999999999999999999999999999999987655544


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCC-CcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLE-AVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                      ......||+.|||||.+.+..++.++|||||||++|||+||.. |+.....       ......+..+...     ..  
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~~-----~~--  231 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRM-----VR--  231 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCC-----CC--
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCC-----CC--
Confidence            4555679999999999998899999999999999999999654 4443221       1112223222111     11  


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                           +..++..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus       232 -----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         232 -----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                 12356678999999999999999999999999988653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-57  Score=424.51  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=213.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++..... ..++|.+|+++|++++|||||++++++... +..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeC-CeeEEEee
Confidence            567888999999999999999987 588999999875433 457899999999999999999999977655 47899999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      ||++|+|.+++......  .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....+...
T Consensus        94 ~~~~g~l~~~l~~~~~~--~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             CCTTCBHHHHHHHSCTT--TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             cccCcchHHHhhhcccc--chHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            99999999999865433  4899999999999999999999999999999999999999999999999999987665544


Q ss_pred             cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          268 VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      ......|++.|+|||.+.+..|+.++|||||||++|||++|..|+......      ......+..+...     ..   
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~~-----~~---  237 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRM-----ER---  237 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCC-----CC---
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcCCCC-----CC---
Confidence            444556899999999999999999999999999999999977665432211      1112222222111     11   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                          +..++..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus       238 ----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         238 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                12356779999999999999999999999999988754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=410.49  Aligned_cols=254  Identities=28%  Similarity=0.484  Sum_probs=214.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      ++|++.++||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++||||++++|++..+ +.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEcc
Confidence            578899999999999999999988889999999765433 46799999999999999999999977655 4799999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccccc
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHVS  269 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  269 (438)
                      ++|+|.+++......   +++..+.+++.||++||+|||++||+||||||+|||+++++.+||+|||+++..........
T Consensus        82 ~~g~l~~~~~~~~~~---~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          82 ANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TTEEHHHHHHSGGGC---CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCCcHHHhhhccccC---CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            999999998765442   89999999999999999999999999999999999999999999999999987765544444


Q ss_pred             cCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          270 TAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       270 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      ....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......       .....+..+...  ..+      
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~~~~i~~~~~~--~~p------  223 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGLRL--YRP------  223 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTTCCC--CCC------
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HHHHHHHhCCCC--CCc------
Confidence            55679999999999999999999999999999999998 89999754322       112233332211  111      


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          ..++..+.+|+.+||+.||++|||++|++++|.++
T Consensus       224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                23456789999999999999999999999998653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-57  Score=419.06  Aligned_cols=255  Identities=27%  Similarity=0.448  Sum_probs=199.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec-cCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR-QSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~l  184 (438)
                      .++|++.+.||+|+||+||+|..+ +|+.||||.+...  .....+.+.+|++++++++|||||++++++.+ .+..+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999976 6899999998654  33445779999999999999999999997754 3456899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD-----VIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      |||||++|+|.+++.........+++..++.++.||+.||.|||+++     |+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999999764333345999999999999999999999876     9999999999999999999999999999


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ....+.. ......||+.|||||++.+..|+.++|||||||++|||+||+.||......       .....+..+.....
T Consensus       163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~~~~~~~~  234 (269)
T d2java1         163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRI  234 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCCC
T ss_pred             ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence            7654332 234457999999999999999999999999999999999999999754321       12223333332211


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           +       ..+++++.+|+.+||+.||++|||+.|++++
T Consensus       235 -----~-------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         235 -----P-------YRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -----C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----C-------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 1       2356679999999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-57  Score=419.78  Aligned_cols=253  Identities=24%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||+||+|..+ +|+.||||++..... ...+.+.+|+++|++++|||||++++++..+ +..|+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEE
Confidence            357889999999999999999986 689999999865533 2346789999999999999999999977665 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc-
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV-  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~-  265 (438)
                      |||++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        83 Ey~~gg~L~~~l~~~~~----l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          83 EYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             ECCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             eccCCCcHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999999976543    9999999999999999999999999999999999999999999999999998764332 


Q ss_pred             cccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      ........||+.|||||++.+..+ +.++|||||||++|||+||+.||........      ....+......  ..   
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~~~~~~~~~--~~---  227 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--LN---  227 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------HHHHHHTTCTT--ST---
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCCC--CC---
Confidence            223345679999999999988776 5789999999999999999999975433211      01111111100  00   


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            .+..++.++.+|+.+||+.||++|||++|++++
T Consensus       228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  112456778899999999999999999999774

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=412.72  Aligned_cols=247  Identities=31%  Similarity=0.501  Sum_probs=207.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++.....   ...+.+.+|++++++++|||||++++++..+ +.+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-CEEEEE
Confidence            56889999999999999999986 689999999865432   2356788999999999999999999987765 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||||++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        85 mEy~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EeecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            999999999999987654    9999999999999999999999999999999999999999999999999998664432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||......       .....+......      + 
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~------~-  223 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVEFT------F-  223 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCCC------C-
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC------C-
Confidence               23456999999999999999999999999999999999999999754321       112222222111      1 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                       +     ..+++++.+|+.+||+.||++|||++|++++-
T Consensus       224 -p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp  256 (263)
T d2j4za1         224 -P-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHP  256 (263)
T ss_dssp             -C-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred             -C-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence             0     13566789999999999999999999999853

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=418.60  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=208.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      +.|++.+.||+|+||+||+|..+ +|+.||||++........+.+.+|+++|++++|||||++++++... +.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEec
Confidence            56888999999999999999976 6899999999876666677899999999999999999999977665 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      |++|+|.+++.+...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~  166 (288)
T d2jfla1          91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  166 (288)
T ss_dssp             CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence            999999999876543   39999999999999999999999999999999999999999999999999997653321 12


Q ss_pred             ccCCCCCCCccCccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          269 STAPQGTPGYVDPDYFQ-----CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      .....||+.|||||++.     +..|+.++|||||||++|||+||+.||.......      . ...+..+......   
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~-~~~i~~~~~~~~~---  236 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------V-LLKIAKSEPPTLA---  236 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------H-HHHHHHSCCCCCS---
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------H-HHHHHcCCCCCCC---
Confidence            33457999999999984     4568999999999999999999999997543321      1 1122222111110   


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                             .+..++.++.+|+.+||+.||++|||++|++++
T Consensus       237 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         237 -------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   113456789999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-56  Score=416.96  Aligned_cols=257  Identities=26%  Similarity=0.464  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC-C---cEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD-G---RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|++.+.||+|+||+||+|.++. |   ..||||.+... .....+.|.+|+++|++++|||||+++|++... +.+++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~i  104 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-TPVMI  104 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEEEE
Confidence            456677899999999999999752 3   36899988654 444567899999999999999999999987655 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||||++|+|.+++.....   .+++..++.++.||++||.|||+++|+||||||+||||+.++++||+|||+++.....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9999999999999886543   3899999999999999999999999999999999999999999999999999876543


Q ss_pred             cccc----ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          265 VTHV----STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       265 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      ....    .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......      . ....+..+.... 
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~~~-  253 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------D-VINAIEQDYRLP-  253 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCCCC-
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC-
Confidence            2221    122357899999999999999999999999999999998 89999754321      1 122232221110 


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                          .       +.+++..+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       254 ----~-------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         254 ----P-------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ----C-------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----C-------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                0       12356778999999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=410.68  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=208.7

Q ss_pred             cCCCCCC-cccccCceEEEEEEEc---CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSK-QLGDGGFGAVYLGILR---DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|.+.+ +||+|+||+||+|.++   ++..||||+++.. .....+.|.+|+++|++++|||||+++|++..+  .+|+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--eEEE
Confidence            4555666 4999999999999865   3557999999754 344567899999999999999999999987543  5899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||||++|+|.+++.....   .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus        86 vmE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999999865443   3899999999999999999999999999999999999999999999999999976543


Q ss_pred             ccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          265 VTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       265 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ...  ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......       .....+..+...+.  
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~--  233 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRMEC--  233 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCCCCC--
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC--
Confidence            322  2234468999999999999999999999999999999998 89999754321       11223333322111  


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                                +..+++++.+|+.+||+.||++|||+.+|++.|+...
T Consensus       234 ----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         234 ----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             ----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                      1245678999999999999999999999999998764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=403.16  Aligned_cols=246  Identities=26%  Similarity=0.454  Sum_probs=200.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeec---cCceEEEEE
Q 013686          113 NSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSR---QSRELLLVY  186 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~  186 (438)
                      +..+.||+|+||+||+|.+. +++.||+|.+...  .....+.+.+|+++|++++|||||++++++..   ....+|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999976 5889999998654  33456789999999999999999999997643   245689999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEec-CCCeEEEeeeCcccccCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASD--VIHRDVKSNNILLD-NNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~  263 (438)
                      |||++|+|.+++.+...    +++..+..++.||+.||+|||+++  |+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhcccc----ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999987654    899999999999999999999998  99999999999996 578999999999986543


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ..   .....||+.|||||++.+ .++.++|||||||++|||++|+.||......      ......+..+.....+   
T Consensus       168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~---  234 (270)
T d1t4ha_         168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASF---  234 (270)
T ss_dssp             TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGG---
T ss_pred             Cc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCccc---
Confidence            32   234579999999999875 6999999999999999999999999743221      1122233332221111   


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                              ....++++.+|+.+||+.||++|||++|++++
T Consensus       235 --------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         235 --------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                    12345678899999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=406.30  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=201.1

Q ss_pred             CcccccCceEEEEEEEcC---CcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEeccC
Q 013686          116 KQLGDGGFGAVYLGILRD---GRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYIP  190 (438)
Q Consensus       116 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  190 (438)
                      ++||+|+||+||+|.+++   ++.||||++....  ....+.|.+|+++|++++|||||+++|++..+  ..++|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS--SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC--CEEEEEEcCC
Confidence            479999999999998653   5689999986532  23457899999999999999999999987543  5799999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc--c
Q 013686          191 NGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH--V  268 (438)
Q Consensus       191 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~--~  268 (438)
                      +|+|.+++.....    +++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........  .
T Consensus        91 ~g~L~~~l~~~~~----l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          91 LGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCcHHHHHhhccC----CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9999999987654    999999999999999999999999999999999999999999999999999876543322  2


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......       .....+..+....     .   
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~~-----~---  231 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG-----C---  231 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-----C---
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCCCCC-----C---
Confidence            234568999999999999999999999999999999998 89999754321       1122333322111     1   


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          +..++.++.+|+.+||+.||++|||+++|++.|+..
T Consensus       232 ----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         232 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                123567899999999999999999999999988765

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-56  Score=420.84  Aligned_cols=267  Identities=21%  Similarity=0.355  Sum_probs=204.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||+||+|..+ +|+.||+|++.... ....+.+.+|+.+|++++|||||++++++..+. .+|+||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence            568999999999999999999976 68999999987543 333567899999999999999999999887654 799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||++|+|.+++.+...    +++..+..++.||+.||.|||+ +||+||||||+||||+.++++||+|||+|+..... 
T Consensus        84 Ey~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999987654    9999999999999999999997 49999999999999999999999999999865332 


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHH-HHHHhc--------C-c
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMA-TNKIQN--------G-A  335 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~-~~~~~~--------~-~  335 (438)
                        ......||+.|||||++.+..|+.++||||+||++|||++|+.||............... ......        . .
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              223457999999999999999999999999999999999999999764322110000000 000000        0 0


Q ss_pred             cc-ccccCcCCCCccHH-------------HHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          336 LN-ELVDPSLGFEKDYA-------------VRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       336 ~~-~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .. ...+..........             ...++.++.+|+.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00 00000000000000             01235678999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=412.01  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=206.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++....   ....+.+.+|+++|++++||||+++++++..+ +.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEE
Confidence            56899999999999999999986 68999999987543   23456799999999999999999999977665 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||||++|+|.+++...+.    +++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+.+....
T Consensus        87 mEy~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEccCCCCHHHhhhccCC----CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999999987764    9999999999999999999999999999999999999999999999999999765432


Q ss_pred             c-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          266 T-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       266 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      . .......||+.|||||++.+..++.++|||||||++|||++|+.||......       .....+..+...      +
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~~------~  229 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKIIKLEYD------F  229 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCCC------C
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHHHcCCCC------C
Confidence            2 2234457999999999999999999999999999999999999999754321       112223222211      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                      +       ..+++.+.+||.+||+.||++|||++|++...
T Consensus       230 p-------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         230 P-------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             C-------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             C-------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence            1       13456789999999999999999999987653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=403.87  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=201.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCC-----cEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDG-----RIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      +.|++.++||+|+||+||+|.++++     ..||||++... .....++|.+|++++++++|||||+++|++... ...+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-CceE
Confidence            3567789999999999999997642     47999998654 334456799999999999999999999977655 4689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +|||||.+++|.+++.....   .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999998876543   399999999999999999999999999999999999999999999999999987644


Q ss_pred             Cccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      ....  ......||+.|||||.+.+..++.++|||||||++|||++|..|+......      ......+..+...    
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~~----  232 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFRL----  232 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCC----
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhccCCC----
Confidence            3222  223346899999999999999999999999999999999976554432211      1112223322211    


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                       ..+       .+++..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       233 -~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         233 -PTP-------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -CCC-------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -CCc-------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence             111       23566789999999999999999999999999987653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-55  Score=405.77  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=204.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|.+++++.||||++..... ..+.|.+|+.++++++|||||+++|++..  +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEe
Confidence            467899999999999999999998888999999865543 34779999999999999999999997743  357999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++|+|.+++......  .++|..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.........
T Consensus        93 ~~~g~l~~~~~~~~~~--~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          93 MSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             CTTCBHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCchhhhhhhcccc--cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            9999999998765322  38999999999999999999999999999999999999999999999999998775544444


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCCc
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFEK  348 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (438)
                      .....||+.|+|||.+.+..++.++|||||||++|||+||..|+......      ......+..+....     .    
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~~~~~-----~----  235 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYRMP-----C----  235 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCC-----C----
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCCC-----C----
Confidence            44567999999999999999999999999999999999976555432211      11112222221111     1    


Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          349 DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       349 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                         +..++.++.+++.+||+.||++|||+++|+++|+....+
T Consensus       236 ---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         236 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence               123566799999999999999999999999999886543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.3e-55  Score=418.56  Aligned_cols=253  Identities=21%  Similarity=0.374  Sum_probs=210.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++........+.+.+|+.+|++++|||||++++++..+ +.+|+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEE
Confidence            468999999999999999999976 6999999999877766778899999999999999999999977665 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec--CCCeEEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD--NNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~--~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+||+|.+++.....   .+++..+..++.||+.||.|||++||+||||||+|||++  .++.+||+|||+++.+....
T Consensus       104 ~~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         104 FMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             cCCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999999965432   399999999999999999999999999999999999995  46789999999998765443


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .  .....||+.|||||++.+..++.++|||||||++|||++|+.||......      . ....+.......       
T Consensus       181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~~~-------  244 (350)
T d1koaa2         181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------E-TLRNVKSCDWNM-------  244 (350)
T ss_dssp             C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCS-------
T ss_pred             c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCCC-------
Confidence            2  23456999999999999999999999999999999999999999754321      1 112222221110       


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        .......++..+.+|+.+||+.||++|||++|++++
T Consensus       245 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              001123456789999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-54  Score=408.48  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=192.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch-HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF-KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .+.|++.+.||+|+||+||+|..+ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++..+ +.+|+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-GHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEE
Confidence            567999999999999999999976 689999999875533 2345688999999999999999999977665 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec---CCCeEEEeeeCcccccCC
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgla~~~~~  263 (438)
                      |||+||+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+++....
T Consensus        87 E~~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCCSCBHHHHHHTCSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             eccCCCcHHHhhhcccC----CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999987543    99999999999999999999999999999999999994   578999999999986643


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCc
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPS  343 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (438)
                      ..  ......||+.|||||++.+..|+.++|||||||++|||++|+.||......       .....+..+....  .. 
T Consensus       163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~~~--~~-  230 (307)
T d1a06a_         163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAEYEF--DS-  230 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHTTCCCC--CT-
T ss_pred             CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCCCC--CC-
Confidence            32  223457999999999999999999999999999999999999999753321       1122222222110  00 


Q ss_pred             CCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          344 LGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       344 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            ....++++.+.+|+.+||+.||++|||++|++++
T Consensus       231 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         231 ------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                  0112456789999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-54  Score=409.27  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ..|+..+.||+|+||+||+|... +|+.||||++....   ....+.+.+|+++|++++|||||++++++... +.+|+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEE
Confidence            35888999999999999999975 68999999986543   23456789999999999999999999987665 479999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||||++|+|..++.....    +++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... 
T Consensus        94 ~E~~~~g~l~~~~~~~~~----l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             EECCSEEHHHHHHHHTSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEecCCCchHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999999877765543    999999999999999999999999999999999999999999999999999865432 


Q ss_pred             cccccCCCCCCCccCcccccc---CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          266 THVSTAPQGTPGYVDPDYFQC---YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                          ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||......      .. ...+..+....... 
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~-~~~i~~~~~~~~~~-  236 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-LYHIAQNESPALQS-  236 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH-HHHHHHSCCCCCSC-
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHhCCCCCCCC-
Confidence                34569999999999864   45899999999999999999999999753321      11 11222222211111 


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                                ..+++.+.+|+.+||+.||++|||++|++++-
T Consensus       237 ----------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp  268 (309)
T d1u5ra_         237 ----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (309)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ----------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence                      13456789999999999999999999999853

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=403.67  Aligned_cols=257  Identities=25%  Similarity=0.420  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC----CcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD----GRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      .++|++.+.||+|+||.||+|.+..    +..||||.+... .....+.+.+|++++++++|||||+++|++.+  +.++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence            4678899999999999999998753    356899988644 33445789999999999999999999997753  4689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +||||+++|+|.+++.....   .+++..++.++.||++||.|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus        84 iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999998876543   389999999999999999999999999999999999999999999999999987655


Q ss_pred             CccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDP  342 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (438)
                      ..........||+.|+|||.+.+..++.++|||||||++|||+| |.+||.......       ....+..+.....   
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~~~---  230 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM---  230 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCCC---
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCC---
Confidence            44444445568999999999999999999999999999999998 899997654321       1122333221111   


Q ss_pred             cCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          343 SLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       343 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                               +.++++.+.+||.+||+.||++|||+.||++.|+.+.+
T Consensus       231 ---------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         231 ---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     12456789999999999999999999999999988753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=411.58  Aligned_cols=258  Identities=27%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC-C-----cEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD-G-----RIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  180 (438)
                      .++|++.+.||+|+||+||+|.+.. +     ..||+|.+... .....+.+.+|+.+|.++ +|||||++++++... +
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-G  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-C
Confidence            4678899999999999999999753 2     36999988654 333446789999999998 899999999977665 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPN-------------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNN  241 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~N  241 (438)
                      .+++|||||++|+|.++|+.....                   ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            799999999999999999865421                   1348999999999999999999999999999999999


Q ss_pred             EEecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCccc
Q 013686          242 ILLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRH  319 (438)
Q Consensus       242 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~  319 (438)
                      ||++.++.+||+|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999865443322 2234458999999999999999999999999999999998 899997543321


Q ss_pred             ccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 013686          320 DINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILR  385 (438)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  385 (438)
                            .....+..+...     ..       +..+++.+.+||.+||+.||++|||++||+++|.
T Consensus       275 ------~~~~~~~~~~~~-----~~-------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 ------NFYKLIQNGFKM-----DQ-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ------HHHHHHHTTCCC-----CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHHhcCCCC-----CC-------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                  112222222111     11       1235678999999999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=407.85  Aligned_cols=271  Identities=26%  Similarity=0.367  Sum_probs=208.3

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeee
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGC  174 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~  174 (438)
                      +.++...++|++.+.||+|+||.||+|.+.      +++.||||++... .....+.+.+|...+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344444578999999999999999999864      2468999998654 334456788888888877 68999999998


Q ss_pred             eeccCceEEEEEeccCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 013686          175 TSRQSRELLLVYEYIPNGTVADHLHNRQP------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNI  242 (438)
Q Consensus       175 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Ni  242 (438)
                      +...+..+++|||||++|+|.++++....            ....+++..++.++.||++||.|||+++|+||||||+||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI  165 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  165 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence            77776779999999999999999976432            123488999999999999999999999999999999999


Q ss_pred             EecCCCeEEEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCC-CCcccCCcccc
Q 013686          243 LLDNNFRVKVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL-EAVDTSRHRHD  320 (438)
Q Consensus       243 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~-~p~~~~~~~~~  320 (438)
                      ||++++.+||+|||+++........ ......||+.|||||.+.+..++.++|||||||++|||+||. +||......  
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--  243 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--  243 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--
Confidence            9999999999999999865443322 234457999999999999999999999999999999999975 677643321  


Q ss_pred             cchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          321 INLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                          ......+..+......            ..+++++.+++.+||+.||++|||++|++++|+++.+++
T Consensus       244 ----~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         244 ----EEFCRRLKEGTRMRAP------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             ----HHHHHHHHHTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHhcCCCCCCC------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence                1122233333222111            134567899999999999999999999999999886543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.7e-54  Score=412.20  Aligned_cols=253  Identities=21%  Similarity=0.355  Sum_probs=210.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++........+.+.+|+.+|++++|||||++++++..+ ..+|+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEE
Confidence            457999999999999999999975 6999999999877666667889999999999999999999987655 57999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec--CCCeEEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD--NNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~--~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+||+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+||||+  .++.+||+|||+++......
T Consensus       107 ~~~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         107 FLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCChHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999999998876543   389999999999999999999999999999999999997  67899999999999875543


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .  .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......       ....+..+....  ...  
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~~--~~~--  250 (352)
T d1koba_         184 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEF--DED--  250 (352)
T ss_dssp             C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCCC--CSS--
T ss_pred             c--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC--Ccc--
Confidence            2  233468999999999999999999999999999999999999997543211       112222222110  000  


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                           .+..++.++.+|+.+||+.||.+|||+.|++++
T Consensus       251 -----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         251 -----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 112456778999999999999999999999885

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=401.29  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=209.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch------HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF------KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|++.+.||+|+||+||+|..+ +|+.||||++.....      ...+.+.+|+.+|++++|||||++++++... ..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~   87 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TD   87 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CE
Confidence            467999999999999999999985 699999999865422      2357899999999999999999999987665 57


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC----eEEEeeeCc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF----RVKVADFGL  257 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgl  257 (438)
                      +|+|||||++|+|.+++.....    +++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~----l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCccccchhccccc----cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999999987654    99999999999999999999999999999999999998776    599999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      +........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ....+......
T Consensus       164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~  234 (293)
T d1jksa_         164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYE  234 (293)
T ss_dssp             CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCC
T ss_pred             hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCCC
Confidence            987654322  334568999999999999999999999999999999999999997543211       11222222111


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                               .....+.+++..+.+|+.+||+.||++|||++|++++
T Consensus       235 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         235 ---------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ---------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     0112234567789999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=399.01  Aligned_cols=253  Identities=28%  Similarity=0.484  Sum_probs=202.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      .++|++.+.||+|+||.||+|.++ |+.||||+++...  ..+.+.+|++++++++||||++++|++.+..+.+++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            356788899999999999999985 7899999996543  3467999999999999999999999876655578999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +++|+|.+++......  .+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus        83 ~~~g~L~~~l~~~~~~--~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999999999765322  2899999999999999999999999999999999999999999999999999865432    


Q ss_pred             ccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCCC
Q 013686          269 STAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGFE  347 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (438)
                      .....+++.|+|||.+.+..++.++|||||||++|||+| |++||.......       ....+..+...+.     +  
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------~~~~i~~~~~~~~-----~--  222 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDA-----P--  222 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCCCC-----C--
T ss_pred             CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC-----C--
Confidence            223357899999999999999999999999999999998 688876543221       1223333322211     1  


Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          348 KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       348 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                           ..+++++.+|+.+||+.||.+|||+.+++++|++++.
T Consensus       223 -----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         223 -----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                 2345678999999999999999999999999998864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=405.12  Aligned_cols=249  Identities=27%  Similarity=0.383  Sum_probs=208.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      .++|++++.||+|+||.||+|..+ +|+.||||++.+..   ....+.+.+|+.+|++++||||+++++++... +.+|+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~i   82 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-ccccc
Confidence            357899999999999999999975 69999999997542   23457789999999999999999999977665 57999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||||++|+|.+++.....    +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus        83 v~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          83 VMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             ceeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999999988764    899999999999999999999999999999999999999999999999999865433


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. .....+||+.|+|||++.+..|+.++|||||||++|||++|++||......       .....+..+...      +
T Consensus       159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~i~~~~~~------~  224 (337)
T d1o6la_         159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIR------F  224 (337)
T ss_dssp             TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------C
T ss_pred             Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HHHHHHhcCCCC------C
Confidence            22 234567999999999999999999999999999999999999999864421       112222222211      1


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                             +..+++++.+||.+||+.||.+||+     ++|++++
T Consensus       225 -------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         225 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                   1235667899999999999999994     8888875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-54  Score=403.45  Aligned_cols=264  Identities=27%  Similarity=0.415  Sum_probs=213.3

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeeccc-hHhHHHHHHHHHHHHhCCCCCceeEeeeeec
Q 013686          105 LEEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYENN-FKRIEQFMNEVEILTKLQHPNLVKLYGCTSR  177 (438)
Q Consensus       105 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  177 (438)
                      ++...++|++.+.||+|+||+||+|..+      +++.||||++.... ....++|.+|+++|++++||||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3445678999999999999999999864      35789999987543 3345789999999999999999999997765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQP--------------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDV  237 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dl  237 (438)
                      . ...++||||+++|+|.+++.....                    ....+++..++.++.||+.||+|||+++|+||||
T Consensus        88 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          88 G-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             C-CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence            5 478999999999999999975432                    1234889999999999999999999999999999


Q ss_pred             CCCCEEecCCCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCC-CCcccC
Q 013686          238 KSNNILLDNNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL-EAVDTS  315 (438)
Q Consensus       238 kp~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~-~p~~~~  315 (438)
                      ||+||||+.++.+||+|||+++....... .......+++.|+|||.+.+..|+.++|||||||++|||++|. +||...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            99999999999999999999986543322 2233456899999999999999999999999999999999995 677654


Q ss_pred             CcccccchhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          316 RHRHDINLSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                      ....       ....+..+.....            +..++.++.+|+.+||+.||++||||.||+++|+++.
T Consensus       247 ~~~e-------~~~~v~~~~~~~~------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         247 AHEE-------VIYYVRDGNILAC------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CHHH-------HHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CHHH-------HHHHHHcCCCCCC------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            3211       1223333332211            1235567899999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=401.66  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCc----EEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGR----IVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  183 (438)
                      ++|++++.||+|+||+||+|.+. +|+    .||+|++... .....+.|.+|++++++++|||||+++|++..+  ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cee
Confidence            46889999999999999999975 344    5889988654 334467899999999999999999999988654  478


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      +++||+.+|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999999887643   389999999999999999999999999999999999999999999999999997654


Q ss_pred             Cccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccccc
Q 013686          264 DVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNELVD  341 (438)
Q Consensus       264 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (438)
                      .... ......||+.|||||.+.+..++.++|||||||++|||+| |.+||.......       ....+..+....   
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~~---  233 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLP---  233 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTCCCC---
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCC---
Confidence            3332 2233468999999999999999999999999999999998 789987543221       122232222111   


Q ss_pred             CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          342 PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       342 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                        .       +..++..+.+|+.+||+.||++|||+.||+++|+.+.
T Consensus       234 --~-------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         234 --Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             --C-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --C-------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence              0       1235667899999999999999999999999998774

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.1e-53  Score=392.91  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC---ce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS---RE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~  181 (438)
                      .++|++.+.||+|+||+||+|... +|+.||||++....   ....+.+.+|+++++.++||||+++++++....   ..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999975 69999999996542   334567999999999999999999999775543   34


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +|+|||||+|++|.+++...+.    +++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~----l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccCC----CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            8999999999999999987754    999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcc--ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          262 PTDVT--HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       262 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      .....  .......||+.|||||++.+..++.++|||||||++|||+||++||......      ......+........
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPS  235 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCGG
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCCc
Confidence            33222  2233456999999999999999999999999999999999999999754321      122222322211110


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-TMKEVLEILRETK  388 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  388 (438)
                                ....++++.+.+++.+||+.||++|| |++++++.|.++.
T Consensus       236 ----------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         236 ----------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ----------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                      01123567899999999999999999 8999999988775

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=396.52  Aligned_cols=260  Identities=28%  Similarity=0.467  Sum_probs=209.1

Q ss_pred             CCcccccCceEEEEEEEcCC----cEEEEEEeec-cchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEecc
Q 013686          115 SKQLGDGGFGAVYLGILRDG----RIVAVKRLYE-NNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEYI  189 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  189 (438)
                      .++||+|+||+||+|.+.++    ..||||++.. ......++|.+|+++|++++||||++++|++...+...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997532    3689999864 355566889999999999999999999998766656899999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc--
Q 013686          190 PNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH--  267 (438)
Q Consensus       190 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~--  267 (438)
                      ++|+|.+++......   +++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~---~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCC---CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhcccccc---chHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999876543   788899999999999999999999999999999999999999999999999876443222  


Q ss_pred             -cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCCC
Q 013686          268 -VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLGF  346 (438)
Q Consensus       268 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (438)
                       ......||+.|+|||.+.+..++.++||||||+++|||+||..||.......+     . ...+..+...  ..+    
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-----~-~~~i~~g~~~--~~p----  256 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----I-TVYLLQGRRL--LQP----  256 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------C-HHHHHTTCCC--CCC----
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-----H-HHHHHcCCCC--CCc----
Confidence             22234689999999999999999999999999999999998877764322111     1 1122222211  111    


Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccCCCCC
Q 013686          347 EKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSNLGTS  395 (438)
Q Consensus       347 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  395 (438)
                            ..+++.+.+|+.+||+.||++|||+.||+++|+.+..+...+.
T Consensus       257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~  299 (311)
T d1r0pa_         257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  299 (311)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence                  2345678999999999999999999999999999987655544

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-53  Score=398.10  Aligned_cols=245  Identities=30%  Similarity=0.504  Sum_probs=206.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++....   ....+.+.+|+.++++++|||||++++++... +.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-CeeeeE
Confidence            56889999999999999999976 69999999997542   23457889999999999999999999977665 579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      ||||+||+|..++.....    +++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... 
T Consensus        83 mE~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eeecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            999999999999987665    889999999999999999999999999999999999999999999999999876543 


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                         .....||+.|||||++.+..|+.++|||||||++|||+||+.||......       .....+..+...  ..    
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~~--~p----  221 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAELR--FP----  221 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCCCC--CC----
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHHHHcCCCC--CC----
Confidence               23457999999999999999999999999999999999999999754321       112223222211  00    


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                             ..++.++.+++.+||+.||.+|+     |++|++++
T Consensus       222 -------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         222 -------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                   13456788999999999999996     89999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=394.24  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=198.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEcC--C--cEEEEEEeecc---chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRD--G--RIVAVKRLYEN---NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSREL  182 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  182 (438)
                      ++|++.+.||+|+||.||+|.++.  +  ..||||++...   .....+.|.+|+.+|++++|||||+++|++...  ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence            568889999999999999998642  2  37899988654   233457899999999999999999999988543  57


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccC
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFP  262 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  262 (438)
                      ++||||+++|+|.+++.....   .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            899999999999998876543   28999999999999999999999999999999999999999999999999999775


Q ss_pred             CCccc--cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          263 TDVTH--VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       263 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      .....  ......++..|+|||.+.+..++.++|||||||++|||+| |+.||......      .........+.... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~-  235 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP-  235 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC-
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCC-
Confidence            44332  2233457889999999999999999999999999999998 89999754321      11122222211111 


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRET  387 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  387 (438)
                          .       +.+++..+.+|+.+||+.||++|||+.||++.|++.
T Consensus       236 ----~-------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 ----R-------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C-------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                0       124566799999999999999999999999999865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.8e-52  Score=387.65  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch---------HhHHHHHHHHHHHHhCC-CCCceeEeeeeec
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF---------KRIEQFMNEVEILTKLQ-HPNLVKLYGCTSR  177 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  177 (438)
                      .++|++.+.||+|+||+||+|... +|+.||||++.....         ...+.+.+|+.++++++ ||||+++++++..
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368899999999999999999975 689999999865421         12346889999999997 9999999998765


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      + +.+|||||||++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        82 ~-~~~~ivmE~~~~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 N-TFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             S-SEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             C-cceEEEEEcCCCchHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence            5 589999999999999999987654    99999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCcccccc------CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHH
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQC------YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      ++.......  .....||+.|+|||.+.+      ..++.++||||+||++|||++|+.||......       .....+
T Consensus       157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i  227 (277)
T d1phka_         157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMI  227 (277)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH
T ss_pred             eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHH
Confidence            997754332  344579999999998853      34688999999999999999999999864321       122223


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..+.... ..+        ...++++++.+|+.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~-~~~--------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQF-GSP--------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCCC-CTT--------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCCC-CCc--------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            3222110 000        123567789999999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=393.72  Aligned_cols=252  Identities=20%  Similarity=0.329  Sum_probs=208.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      .++|.+.+.||+|+||+||+|..+ +|+.||||.+...... .+.+.+|+++|+.++|||||++++++..+ +.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESM-EELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEe
Confidence            578999999999999999999976 6899999999765443 35688999999999999999999977665 47999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC--CeEEEeeeCcccccCCCc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN--FRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~--~~~kl~Dfgla~~~~~~~  265 (438)
                      ||+||+|.+++.....   .+++..+..++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++......
T Consensus        82 ~~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          82 FISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999999999976542   38999999999999999999999999999999999999854  589999999998764432


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                      .  .....+++.|+|||.+.+..++.++|||||||++|||++|..||......       .....+..+..        .
T Consensus       159 ~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~~~~i~~~~~--------~  221 (321)
T d1tkia_         159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEY--------T  221 (321)
T ss_dssp             E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC--------C
T ss_pred             c--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC--------C
Confidence            2  23346899999999999999999999999999999999999999764321       11122222211        1


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      . ....+..++.++.+|+.+||..||++|||++|++++
T Consensus       222 ~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 F-DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             C-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C-ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1 112234567789999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=397.43  Aligned_cols=254  Identities=23%  Similarity=0.316  Sum_probs=202.6

Q ss_pred             hcCCCCCC-cccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhC-CCCCceeEeeeeec---cCceE
Q 013686          109 TDNFNSSK-QLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSR---QSREL  182 (438)
Q Consensus       109 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---~~~~~  182 (438)
                      .++|.+.+ .||+|+||+||+|... +|+.||||++...     +.+.+|+.++.++ +|||||++++++..   ....+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788765 6999999999999975 6899999998643     4566799987654 89999999997653   24578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC---CCeEEEeeeCccc
Q 013686          183 LLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN---NFRVKVADFGLSR  259 (438)
Q Consensus       183 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~  259 (438)
                      |+|||||+||+|.++|..+..  ..+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence            999999999999999986543  23999999999999999999999999999999999999975   5679999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      .......  .....||+.|||||++.+..|+.++|||||||++|||+||+.||..........   .....+        
T Consensus       163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i--------  229 (335)
T d2ozaa1         163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRI--------  229 (335)
T ss_dssp             ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC--------
T ss_pred             eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHH--------
Confidence            7654332  344579999999999999999999999999999999999999997654321110   000011        


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .......+ ......+++++.+|+.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         230 RMGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CSCSSSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11111111 12345678899999999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-52  Score=399.66  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLV  185 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv  185 (438)
                      ++|++++.||+|+||.||+|.++ +|+.||||++....   ....+.+.+|+++|+.++|||||++++++... ...++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-cccccc
Confidence            57999999999999999999986 69999999986542   23457789999999999999999999977665 478999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCc
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  265 (438)
                      |||+.+|+|.+++...+.    +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus       120 ~e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cccccccchhhhHhhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            999999999999987754    999999999999999999999999999999999999999999999999999876433 


Q ss_pred             cccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcCC
Q 013686          266 THVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSLG  345 (438)
Q Consensus       266 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (438)
                         .....||+.|||||++.+..++.++|||||||++|||+||+.||......       .....+..+...      . 
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~~------~-  257 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKVR------F-  257 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------C-
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-------HHHHHHhcCCCC------C-
Confidence               23456999999999999999999999999999999999999999754321       122223222211      0 


Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          346 FEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       346 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                            +..+++.+.+|+.+||+.||.+|+     |++|++++
T Consensus       258 ------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         258 ------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                  023566789999999999999994     89999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.3e-52  Score=401.92  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=200.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchH---hHHHHHH---HHHHHHhCCCCCceeEeeeeeccCce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFK---RIEQFMN---EVEILTKLQHPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~  181 (438)
                      .++|++.+.||+|+||.||+|... +|+.||||++......   ....+.+   |+.+++.++|||||++++++... +.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~   81 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DK   81 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CE
Confidence            367899999999999999999976 6999999998654221   1223334   46677777899999999977665 47


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      +|+|||||++|+|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHHHhccc----ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999999987654    899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccc
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELV  340 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (438)
                      ....   .....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.........   . .........     
T Consensus       158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~-~~~~~~~~~-----  225 (364)
T d1omwa3         158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLTMA-----  225 (364)
T ss_dssp             SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---H-HHHHSSSCC-----
T ss_pred             CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---H-HHHhcccCC-----
Confidence            5432   234579999999999864 56899999999999999999999999764332111   1 111111100     


Q ss_pred             cCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 013686          341 DPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPT-----MKEVLEI  383 (438)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  383 (438)
                         ...     +..+++++.+||.+||+.||++|||     ++|++++
T Consensus       226 ---~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         226 ---VEL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ---CCC-----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ---CCC-----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence               000     1135667899999999999999999     7899875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=392.34  Aligned_cols=259  Identities=29%  Similarity=0.430  Sum_probs=205.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCc--EEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGR--IVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|++.+.||+|+||+||+|.++ +|.  .||||++... .....+.|.+|+++|+++ +|||||+++|++..+ +.+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEE
Confidence            67888999999999999999976 344  4788887543 333456899999999999 799999999987765 47999


Q ss_pred             EEeccCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEE
Q 013686          185 VYEYIPNGTVADHLHNRQ------------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKV  252 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl  252 (438)
                      ||||+++|+|.++|+...            .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence            999999999999997642            12235999999999999999999999999999999999999999999999


Q ss_pred             eeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCC-CCcccCCcccccchhHHHHHHH
Q 013686          253 ADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL-EAVDTSRHRHDINLSNMATNKI  331 (438)
Q Consensus       253 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~-~p~~~~~~~~~~~~~~~~~~~~  331 (438)
                      +|||+++.......  .....||..|+|||.+.+..++.++|||||||++|||++|. +||......      . ....+
T Consensus       169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------~-~~~~i  239 (309)
T d1fvra_         169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKL  239 (309)
T ss_dssp             CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHG
T ss_pred             cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------H-HHHHH
Confidence            99999986543222  22345899999999999999999999999999999999976 566543211      1 12223


Q ss_pred             hcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcc
Q 013686          332 QNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDS  390 (438)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  390 (438)
                      ..+...     ..       +..+++++.+||.+||+.||++|||++||++.|+++.+.
T Consensus       240 ~~~~~~-----~~-------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         240 PQGYRL-----EK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             GGTCCC-----CC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhcCCC-----CC-------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            322111     11       123567899999999999999999999999999988653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=393.14  Aligned_cols=267  Identities=21%  Similarity=0.304  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC---ceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS---RELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~  186 (438)
                      .+|.+.+.||+|+||.||+|++ +|+.||||++...... ......|+..+.+++|||||++++++..++   ..+|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            3566778999999999999987 5899999998654322 122334555556789999999999776543   3689999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA--------SDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      |||++|+|.+++++..     ++|..++.++.|++.||.|||+        +||+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999998753     8999999999999999999996        59999999999999999999999999999


Q ss_pred             cccCCCccc---cccCCCCCCCccCccccccCC------CCChhhHHHHHHHHHHHHhCCCCcccCCcccccc-------
Q 013686          259 RLFPTDVTH---VSTAPQGTPGYVDPDYFQCYK------LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDIN-------  322 (438)
Q Consensus       259 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~-------  322 (438)
                      +........   ......||+.|+|||++.+..      ++.++|||||||+||||+||..||..........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            876443322   223457999999999987643      5678999999999999999998886433221110       


Q ss_pred             -hhHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          323 -LSNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       323 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                       ...........+    ..+|.++  ........+..+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       236 ~~~~~~~~~~~~~----~~~p~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         236 PSVEEMRKVVCEQ----KLRPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCC--GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----ccCCCCC--cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence             011111122211    1222221  111123456779999999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=392.44  Aligned_cols=263  Identities=26%  Similarity=0.380  Sum_probs=211.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhC-CCCCceeEeeeeeccC
Q 013686          108 ATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQS  179 (438)
Q Consensus       108 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  179 (438)
                      ..++|++.+.||+|+||.||+|.++      +++.||||+++.. .......+.+|+.+++++ +|||||++++++... 
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence            3578888999999999999999863      3578999999754 344556899999999999 699999999987655 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQP--------------NSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD  245 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~  245 (438)
                      +..++|||||++|+|.++++....              ....+++..+..++.||+.||+|||+++++||||||+|||++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            468999999999999999986542              123589999999999999999999999999999999999999


Q ss_pred             CCCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccch
Q 013686          246 NNFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINL  323 (438)
Q Consensus       246 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~  323 (438)
                      .++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||.......    
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~----  255 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----  255 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH----
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999997654332 33344578999999999999999999999999999999999 556665433211    


Q ss_pred             hHHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          324 SNMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                        .....+..+....     .+       ..++..+.+||.+||+.||++|||+.||+++|+++..
T Consensus       256 --~~~~~i~~~~~~~-----~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         256 --KFYKMIKEGFRML-----SP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             --HHHHHHHHTCCCC-----CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHhcCCCCC-----Cc-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence              1122222221111     10       1345678999999999999999999999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=394.87  Aligned_cols=247  Identities=25%  Similarity=0.415  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc---hHhHHHHHHHHHHHH-hCCCCCceeEeeeeeccCceEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN---FKRIEQFMNEVEILT-KLQHPNLVKLYGCTSRQSRELLL  184 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~l  184 (438)
                      ++|.+.+.||+|+||+||+|..+ +|+.||||++....   ....+.+..|..++. .++|||||++++++... +.+|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeE
Confidence            57889999999999999999986 69999999997542   233456777777765 68999999999977665 47999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTD  264 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~  264 (438)
                      |||||++|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        81 vmEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999987664    899999999999999999999999999999999999999999999999999865443


Q ss_pred             ccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccccccCcC
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNELVDPSL  344 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (438)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       .....+..+..      .+
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~~------~~  222 (320)
T d1xjda_         157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNP------FY  222 (320)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------CC
T ss_pred             cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCC------CC
Confidence            22 234457999999999999999999999999999999999999999754321       12222322211      11


Q ss_pred             CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 013686          345 GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMK-EVLE  382 (438)
Q Consensus       345 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  382 (438)
                      +       ..++..+.+|+.+||+.||++|||+. |+++
T Consensus       223 p-------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 P-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C-------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1       23466789999999999999999995 7765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=391.72  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=195.1

Q ss_pred             CCcccccCceEEEEEEEc-CCcEEEEEEeeccchHh-----HHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          115 SKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKR-----IEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      +++||+|+||+||+|..+ +|+.||||++.......     .+.+.+|+.+|++++|||||++++++..+ +.+|+||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-~~~~ivmE~   81 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDF   81 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-Cceeehhhh
Confidence            578999999999999975 69999999986543221     24688999999999999999999977665 479999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcccc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTHV  268 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~  268 (438)
                      +.++++..++....    .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          82 METDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             CSEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             hcchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            98887776665433    3889999999999999999999999999999999999999999999999999876544322 


Q ss_pred             ccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccccccc---
Q 013686          269 STAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALNELVD---  341 (438)
Q Consensus       269 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---  341 (438)
                      .....||+.|+|||.+.+ ..|+.++|||||||++|||+||.+||......+..   .........   ........   
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccch
Confidence            234579999999998865 46799999999999999999999999765432111   001111100   00000000   


Q ss_pred             ----CcC-CCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          342 ----PSL-GFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       342 ----~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                          ... ...........++.+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence                000 001111122456789999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-52  Score=391.56  Aligned_cols=268  Identities=26%  Similarity=0.424  Sum_probs=214.5

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEc------CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeee
Q 013686          104 ELEEATDNFNSSKQLGDGGFGAVYLGILR------DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTS  176 (438)
Q Consensus       104 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  176 (438)
                      +++...++|++.+.||+|+||+||+|.++      +++.||||+++.. .......|.+|++++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34444578899999999999999999864      2578999999754 3344567899999999999999999999776


Q ss_pred             ccCceEEEEEeccCCCCHHHHhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeE
Q 013686          177 RQSRELLLVYEYIPNGTVADHLHNRQ------PNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRV  250 (438)
Q Consensus       177 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~  250 (438)
                      .+ ...++|||||++|+|.+++....      .....+++..+..++.|+++||.|||+++|+||||||+|||++.++++
T Consensus        94 ~~-~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          94 QG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SS-SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             cC-CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            55 47899999999999999987532      112347899999999999999999999999999999999999999999


Q ss_pred             EEeeeCcccccCCCccc-cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCC-CCcccCCcccccchhHHHH
Q 013686          251 KVADFGLSRLFPTDVTH-VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGL-EAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       251 kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~-~p~~~~~~~~~~~~~~~~~  328 (438)
                      ||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+||. +||......      . ..
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~-~~  245 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VL  245 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HH
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H-HH
Confidence            99999999876443332 233446899999999999999999999999999999999985 677543221      1 11


Q ss_pred             HHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhccC
Q 013686          329 NKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKDSN  391 (438)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  391 (438)
                      ..+..+.....            +..++..+.+++.+||+.||++|||++||+++|++..+..
T Consensus       246 ~~i~~~~~~~~------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         246 RFVMEGGLLDK------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             HHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             HHHHhCCCCCC------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            22323222111            1235567999999999999999999999999998775533

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=385.97  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=207.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEcC--------CcEEEEEEeeccc-hHhHHHHHHHHHHHHhC-CCCCceeEeeeeecc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILRD--------GRIVAVKRLYENN-FKRIEQFMNEVEILTKL-QHPNLVKLYGCTSRQ  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  178 (438)
                      .++|.+.+.||+|+||.||+|....        +..||||++.... .....++.+|...+.++ +|||||++++++..+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4678889999999999999998642        2479999997653 34457888999999888 799999999988765


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPN------------SCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN  246 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~  246 (438)
                       +..++|||||++|+|.+++......            ...+++..++.++.||+.||+|||+++||||||||+|||++.
T Consensus        92 -~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          92 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             -SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             -CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence             4799999999999999999865421            235899999999999999999999999999999999999999


Q ss_pred             CCeEEEeeeCcccccCCCcc-ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHh-CCCCcccCCcccccchh
Q 013686          247 NFRVKVADFGLSRLFPTDVT-HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELIS-GLEAVDTSRHRHDINLS  324 (438)
Q Consensus       247 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-G~~p~~~~~~~~~~~~~  324 (438)
                      ++.+||+|||+++....... .......+++.|+|||.+.+..|+.++|||||||++|||++ |.+||......      
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~------  244 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------  244 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH------
Confidence            99999999999986644322 22334568999999999999999999999999999999998 68888754321      


Q ss_pred             HHHHHHHhcCcccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          325 NMATNKIQNGALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                       .....+..+.....     +       ..+++.+.+|+.+||+.||++|||+.||++.|+++..
T Consensus       245 -~~~~~i~~~~~~~~-----p-------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 -ELFKLLKEGHRMDK-----P-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -HHHHHHHTTCCCCC-----C-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHcCCCCCC-----C-------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence             12223333221111     1       2356679999999999999999999999999988753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=386.91  Aligned_cols=266  Identities=23%  Similarity=0.375  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.....  ...+.+.+|+++|++++|||||++++++... ..+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEEE
Confidence            57999999999999999999975 699999999865432  2346789999999999999999999987665 5799999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      ||+.+ ++.+++......  .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.......
T Consensus        81 e~~~~-~~~~~~~~~~~~--~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             eecCC-chhhhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99965 555555443322  399999999999999999999999999999999999999999999999999987654332


Q ss_pred             ccccCCCCCCCccCccccccCC-CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHh---cCccccc---
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQ---NGALNEL---  339 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---  339 (438)
                       ......||+.|+|||.+.... ++.++|||||||++|||++|+.||.........  .. ......   +......   
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FR-IFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGGS
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HH-HHHhcCCCchhhccccccc
Confidence             234457999999999887665 578999999999999999999999754322110  00 000000   0000000   


Q ss_pred             ------ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          340 ------VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       340 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                            ...............++..+.+|+.+||..||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                  00000011111223456788999999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-51  Score=384.23  Aligned_cols=265  Identities=23%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccch--HhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEe
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF--KRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYE  187 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  187 (438)
                      ++|++.++||+|+||+||+|.+++|+.||||++.....  ...+.+.+|+.+|++++||||+++++++...+ ..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEEEE
Confidence            57899999999999999999999999999999865432  23578999999999999999999999777654 7999999


Q ss_pred             ccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCccc
Q 013686          188 YIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVTH  267 (438)
Q Consensus       188 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~  267 (438)
                      |+.++.+..+......    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        81 ~~~~~~~~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             CCSEEHHHHHHTSTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             eehhhhHHHHHhhcCC----cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            9987777666654433    999999999999999999999999999999999999999999999999999876543222


Q ss_pred             cccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---C---------
Q 013686          268 VSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---G---------  334 (438)
Q Consensus       268 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~---------  334 (438)
                       .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.........  .. .......   .         
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MR-IFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGGST
T ss_pred             -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HH-HHHhhCCCChhhccchhhhh
Confidence             2334689999999998754 5689999999999999999999999754322110  00 0000000   0         


Q ss_pred             cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ....................+++.+.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000000111111223456778999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=384.50  Aligned_cols=267  Identities=22%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-C-CcEEEEEEeeccchH--hHHHHHHHHHHHHhC---CCCCceeEeeeeec----
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-D-GRIVAVKRLYENNFK--RIEQFMNEVEILTKL---QHPNLVKLYGCTSR----  177 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----  177 (438)
                      .++|++++.||+|+||+||+|.+. + ++.||||++......  ....+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            578999999999999999999974 4 678999998654221  223456777777665   79999999997642    


Q ss_pred             cCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCc
Q 013686          178 QSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGL  257 (438)
Q Consensus       178 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  257 (438)
                      .....+++|||++++++.........   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence            33478999999988776555443332   389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---C
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---G  334 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~  334 (438)
                      ++.....  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.........   .........   .
T Consensus       163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~  237 (305)
T d1blxa_         163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEE  237 (305)
T ss_dssp             CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCGG
T ss_pred             hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCchh
Confidence            9865433  2334567999999999999999999999999999999999999999765432111   000010000   0


Q ss_pred             ccc-------ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 ALN-------ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 ~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .+.       ..................++.+.+|+.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000       0000000111111123456678899999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-51  Score=380.70  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=197.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccch------HhHHHHHHHHHHHHhCC--CCCceeEeeeeeccC
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNF------KRIEQFMNEVEILTKLQ--HPNLVKLYGCTSRQS  179 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  179 (438)
                      .++|++.+.||+|+||+||+|... +|+.||||++.....      ....++.+|+.++++++  |||||++++++... 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            357999999999999999999976 689999999865321      11234678999999986  89999999977665 


Q ss_pred             ceEEEEEeccCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-CCeEEEeeeCc
Q 013686          180 RELLLVYEYIPN-GTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-NFRVKVADFGL  257 (438)
Q Consensus       180 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl  257 (438)
                      +..++||||+.+ +++.+++.....    +++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~----l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CeEEEEEEeccCcchHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence            479999999975 688888877654    999999999999999999999999999999999999985 57999999999


Q ss_pred             ccccCCCccccccCCCCCCCccCccccccCCC-CChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc
Q 013686          258 SRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKL-TDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL  336 (438)
Q Consensus       258 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (438)
                      ++......   .....||+.|+|||.+.+..+ +.++|||||||++|||+||+.||....             .+..+..
T Consensus       158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~  221 (273)
T d1xwsa_         158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV  221 (273)
T ss_dssp             CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCC
T ss_pred             ceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhccc
Confidence            98754332   344579999999999987765 567899999999999999999997421             1111111


Q ss_pred             cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                        .+.           ..+++++.+|+.+||+.||++|||++|++++
T Consensus       222 --~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 --FFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --CCS-----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CCC-----------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              011           1245678999999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-49  Score=374.84  Aligned_cols=261  Identities=20%  Similarity=0.262  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEEec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVYEY  188 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  188 (438)
                      ++|++.+.||+|+||+||+|.+. +|+.||||.+.....  .+.+.+|+++++.++|+|++..+..+...+...++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999975 689999998765432  245788999999998887776666555566689999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEec---CCCeEEEeeeCcccccCCCc
Q 013686          189 IPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLD---NNFRVKVADFGLSRLFPTDV  265 (438)
Q Consensus       189 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgla~~~~~~~  265 (438)
                      + +++|.+.+.....   .+++..+..++.|++.||+|||++||+||||||+|||++   .+..+||+|||+++.+....
T Consensus        85 ~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 6677777665433   389999999999999999999999999999999999985   45579999999999765432


Q ss_pred             c------ccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccccc
Q 013686          266 T------HVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNEL  339 (438)
Q Consensus       266 ~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (438)
                      .      .......||+.|||||.+.+..++.++|||||||++|||+||+.||.......................    
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~----  236 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----  236 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC----
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC----
Confidence            2      122345799999999999999999999999999999999999999976544322221111111100000    


Q ss_pred             ccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 013686          340 VDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETK  388 (438)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  388 (438)
                              ......++++++.+++.+||+.||++||++.++.+.|+.+.
T Consensus       237 --------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         237 --------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             --------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             --------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                    11112346678999999999999999999999999888764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=382.19  Aligned_cols=267  Identities=18%  Similarity=0.267  Sum_probs=198.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc-chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC---ceEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN-NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS---RELL  183 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~  183 (438)
                      .++|++++.||+|+||+||+|..+ +|+.||||++... .....+.+++|+++|+.++||||+++++++....   ...+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457899999999999999999975 7999999999654 3344678899999999999999999999765432   1234


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCC
Q 013686          184 LVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPT  263 (438)
Q Consensus       184 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~  263 (438)
                      ++++|+.+|+|.+++....     +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~~-----l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            4455666999999997642     89999999999999999999999999999999999999999999999999986543


Q ss_pred             Cccc--cccCCCCCCCccCccccc-cCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcc----
Q 013686          264 DVTH--VSTAPQGTPGYVDPDYFQ-CYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGAL----  336 (438)
Q Consensus       264 ~~~~--~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  336 (438)
                      ....  ......||+.|+|||.+. +..++.++||||+||++|||++|+.||............   .........    
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~  238 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQEDLN  238 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHHH
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhhhh
Confidence            3221  234456999999999985 456789999999999999999999999765432111100   000000000    


Q ss_pred             ----------cccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          337 ----------NELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       337 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                                ...................+..+.+|+.+||+.||.+|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      00000000111111223445678999999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=374.73  Aligned_cols=269  Identities=19%  Similarity=0.277  Sum_probs=197.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-------
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-------  178 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  178 (438)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....  ....+.+.+|+++|++++||||+++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999975 79999999985442  22346788999999999999999999966442       


Q ss_pred             CceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcc
Q 013686          179 SRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLS  258 (438)
Q Consensus       179 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  258 (438)
                      ....|+||||+.++.+........    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence            236899999997776665544333    3899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc---ccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc-
Q 013686          259 RLFPTDVT---HVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN-  333 (438)
Q Consensus       259 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-  333 (438)
                      +.......   .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........   ......... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~~  241 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSI  241 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCCC
Confidence            86653222   122334699999999998765 6899999999999999999999999754322111   111111100 


Q ss_pred             --Cccccc--------ccCcCCCCcc----HHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 013686          334 --GALNEL--------VDPSLGFEKD----YAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEIL  384 (438)
Q Consensus       334 --~~~~~~--------~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  384 (438)
                        ......        ..........    .........+.+|+.+||+.||++|||++|++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence              000000        0000000000    01122345678999999999999999999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-48  Score=363.59  Aligned_cols=262  Identities=16%  Similarity=0.222  Sum_probs=206.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC-CCceeEeeeeeccCceEEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH-PNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~  186 (438)
                      .++|++.+.||+|+||+||+|.+. +|+.||||.+.....  .+.+.+|++.++.+.| +|++.+++++... ...++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-CccEEEE
Confidence            357899999999999999999976 689999998755432  2356789999999975 8999999866554 5789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecC-----CCeEEEeeeCccccc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDN-----NFRVKVADFGLSRLF  261 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfgla~~~  261 (438)
                      ||+ +++|.+++.....   .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+++.+
T Consensus        81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 7899999876543   3899999999999999999999999999999999999964     578999999999876


Q ss_pred             CCCccc------cccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCc
Q 013686          262 PTDVTH------VSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGA  335 (438)
Q Consensus       262 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (438)
                      ......      ......||+.|||||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            433211      22345699999999999999999999999999999999999999986544322211111111111111


Q ss_pred             ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 013686          336 LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEILRETKD  389 (438)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  389 (438)
                      .            .....++++++.+++..|+..+|++||+++.+.+.|+++.+
T Consensus       237 ~------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         237 L------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             H------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             h------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            1            11113456789999999999999999999999998887654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-49  Score=378.15  Aligned_cols=271  Identities=24%  Similarity=0.315  Sum_probs=195.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-----CceEEE
Q 013686          111 NFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-----SRELLL  184 (438)
Q Consensus       111 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~l  184 (438)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|+++|++++||||+++++++...     ...+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777899999999999999986 699999999865432    234699999999999999999976432     235789


Q ss_pred             EEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCC-eEEEeeeCcccccCC
Q 013686          185 VYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNF-RVKVADFGLSRLFPT  263 (438)
Q Consensus       185 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~  263 (438)
                      |||||+++ +.+.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus        97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            99999765 4444432211223499999999999999999999999999999999999999775 899999999987644


Q ss_pred             CccccccCCCCCCCccCcccccc-CCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchh--------HHHHHHHhcC
Q 013686          264 DVTHVSTAPQGTPGYVDPDYFQC-YKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLS--------NMATNKIQNG  334 (438)
Q Consensus       264 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~--------~~~~~~~~~~  334 (438)
                      ...  .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||............        ..........
T Consensus       176 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         176 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             Ccc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            322  234579999999998765 57899999999999999999999999765432111000        0000000000


Q ss_pred             cccccccCcCCCC--ccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 013686          335 ALNELVDPSLGFE--KDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI--LRETKD  389 (438)
Q Consensus       335 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~  389 (438)
                       .....-+.....  ........++.+.+|+.+||..||++|||+.|++++  ++++.+
T Consensus       254 -~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         254 -YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             -hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence             000000000000  000112356678999999999999999999999975  455543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=379.14  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=196.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeeccC-----c
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQS-----R  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  180 (438)
                      .++|++++.||+|+||+||+|..+ +|+.||||++...  .....+.+.+|+++|+.++|||||++++++...+     .
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999976 6999999999753  3344578899999999999999999999775543     2


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|+||||+ +.+|..+++...     +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 678888776532     99999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHH-----HHHhcC
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT-----NKIQNG  334 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~-----~~~~~~  334 (438)
                      ....    .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||................     ..+...
T Consensus       171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            6443    2345699999999998764 56899999999999999999999997654221110000000     000000


Q ss_pred             c------ccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 A------LNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 ~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      .      ..................+.++.+.+|+.+||..||.+|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0      000000000000011112345678899999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=371.14  Aligned_cols=254  Identities=29%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc----CCcEEEEEEeeccc----hHhHHHHHHHHHHHHhCCC-CCceeEeeeeeccC
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR----DGRIVAVKRLYENN----FKRIEQFMNEVEILTKLQH-PNLVKLYGCTSRQS  179 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  179 (438)
                      .++|++.+.||+|+||+||+|...    +|+.||||.+....    ....+.+.+|++++++++| |||+++++++... 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            367999999999999999999852    47899999986432    2234568889999999976 8999999977655 


Q ss_pred             ceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          180 RELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       180 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                      ...+++|||+.+|+|.+++.....    +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             CceeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            479999999999999999988765    7889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCCCccCccccccC--CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCccc
Q 013686          260 LFPTDVTHVSTAPQGTPGYVDPDYFQCY--KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALN  337 (438)
Q Consensus       260 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (438)
                      .+............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.........   ...........  
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~--  252 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSE--  252 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCC--
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCC--
Confidence            7755444444556799999999999754  4788999999999999999999999865433221   11111111111  


Q ss_pred             ccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 013686          338 ELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRP-----TMKEVLEI  383 (438)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  383 (438)
                          +.+       +..++..+.+|+.+||+.||++||     |++|++++
T Consensus       253 ----~~~-------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         253 ----PPY-------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----CCC-------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----CCC-------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                011       123567899999999999999999     47888864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=362.49  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccc--hHhHHHHHHHHHHHHhCCCCCceeEeeeeeccCceEEEEE
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENN--FKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQSRELLLVY  186 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  186 (438)
                      ++|++++.||+|+||+||+|.+. +|+.||||+++...  ....+.+.+|+.+|+.++||||+++++++... ...++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-cceeEEe
Confidence            57899999999999999999975 68999999986442  33457899999999999999999999977665 4789999


Q ss_pred             eccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccccCCCcc
Q 013686          187 EYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLFPTDVT  266 (438)
Q Consensus       187 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  266 (438)
                      |++.+++|..++...+.    +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......
T Consensus        81 ~~~~~~~l~~~~~~~~~----~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSEEHHHHHHHTTTC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eeccccccccccccccc----cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99999999888876543    89999999999999999999999999999999999999999999999999987654332


Q ss_pred             ccccCCCCCCCccCccccccCC-CCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhc---Cccc-----
Q 013686          267 HVSTAPQGTPGYVDPDYFQCYK-LTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQN---GALN-----  337 (438)
Q Consensus       267 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-----  337 (438)
                       ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.......+  ...........   ....     
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhc
Confidence             233445788999999987665 68999999999999999999988753322111  00100110000   0000     


Q ss_pred             -cccc---CcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          338 -ELVD---PSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       338 -~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       +...   .............++..+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0000   000001111123456678999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=369.98  Aligned_cols=266  Identities=20%  Similarity=0.271  Sum_probs=194.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc-----Cc
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ-----SR  180 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  180 (438)
                      .++|++.++||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999976 6999999999754  334456789999999999999999999977532     35


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          181 ELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       181 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                      .+|+|||||.+ ++.+.+..      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.
T Consensus        96 ~~~iv~Ey~~~-~l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eeEEEEeccch-HHHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence            78999999965 45555532      289999999999999999999999999999999999999999999999999886


Q ss_pred             cCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccch----------------h
Q 013686          261 FPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINL----------------S  324 (438)
Q Consensus       261 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~----------------~  324 (438)
                      .....  ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...........                .
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            54432  23345689999999999999999999999999999999999999975432111000                0


Q ss_pred             HHHHHHHhcC------cccccccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          325 NMATNKIQNG------ALNELVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       325 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                      ..........      .....................+..+.+|+.+||..||++|||++|+|++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000000      0000111111111223445678889999999999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8e-48  Score=367.52  Aligned_cols=263  Identities=21%  Similarity=0.308  Sum_probs=198.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeec-cCceEEEE
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSR-QSRELLLV  185 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~~~~~lv  185 (438)
                      .++|+++++||+|+||+||+|... +|+.||||+++...   .+.+.+|+++|+.++ ||||+++++++.. ....+++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            367999999999999999999975 69999999987543   356888999999995 9999999997754 34568999


Q ss_pred             EeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCC-CeEEEeeeCcccccCCC
Q 013686          186 YEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNN-FRVKVADFGLSRLFPTD  264 (438)
Q Consensus       186 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~~~~~  264 (438)
                      ||||++++|..+.+       .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999977642       28999999999999999999999999999999999999865 46999999999876543


Q ss_pred             ccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhH-------HHHHHHhcC--
Q 013686          265 VTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSN-------MATNKIQNG--  334 (438)
Q Consensus       265 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~-------~~~~~~~~~--  334 (438)
                      ..  .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.............       .........  
T Consensus       184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            22  2445689999999998765 47999999999999999999999997544321110000       000000000  


Q ss_pred             -c---ccccccCcCC-----CCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          335 -A---LNELVDPSLG-----FEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       335 -~---~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                       .   ..........     .........+++++.+|+.+||..||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0   0000000000     00001123456778999999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=368.30  Aligned_cols=262  Identities=19%  Similarity=0.311  Sum_probs=196.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeecc--chHhHHHHHHHHHHHHhCCCCCceeEeeeeecc----Cce
Q 013686          109 TDNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN--NFKRIEQFMNEVEILTKLQHPNLVKLYGCTSRQ----SRE  181 (438)
Q Consensus       109 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~  181 (438)
                      .++|++.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|+++|++++|||||++++++...    ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999975 6999999998654  334456789999999999999999999976432    223


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEeeeCccccc
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVADFGLSRLF  261 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  261 (438)
                      .+++|+|+.+|+|.+++...+     +++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~-----l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhccccc-----ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence            466677788999999996542     999999999999999999999999999999999999999999999999999764


Q ss_pred             CCCccccccCCCCCCCccCccccccC-CCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHHHHHhcCcccc--
Q 013686          262 PTDVTHVSTAPQGTPGYVDPDYFQCY-KLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMATNKIQNGALNE--  338 (438)
Q Consensus       262 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  338 (438)
                      ...    .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||..........   ....... ....+  
T Consensus       172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~-~~~~~~~  243 (348)
T d2gfsa1         172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVG-TPGAELL  243 (348)
T ss_dssp             TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHC-CCCHHHH
T ss_pred             Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcC-CCChHHh
Confidence            322    3345689999999987665 46889999999999999999999997643221110   0000000 00000  


Q ss_pred             -------------cccCcCCCCccHHHHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 013686          339 -------------LVDPSLGFEKDYAVRNMVTSVAELAFRCVQQDRDMRPTMKEVLEI  383 (438)
Q Consensus       339 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  383 (438)
                                   ...............+++..+.+||.+||+.||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                         000000000111122456778999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-41  Score=326.95  Aligned_cols=267  Identities=18%  Similarity=0.247  Sum_probs=188.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEc-CCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-----------CCCceeEeeeeec
Q 013686          110 DNFNSSKQLGDGGFGAVYLGILR-DGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-----------HPNLVKLYGCTSR  177 (438)
Q Consensus       110 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  177 (438)
                      .+|+++++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35899999999999999999975 699999999976533 2467788999888775           5789999986643


Q ss_pred             -cCceEEEEEeccCCCCHH-HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEecCCC------
Q 013686          178 -QSRELLLVYEYIPNGTVA-DHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHA-SDVIHRDVKSNNILLDNNF------  248 (438)
Q Consensus       178 -~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~Dlkp~Nill~~~~------  248 (438)
                       .....+++|+++..+... .......  ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence             234566677766554433 3332222  2348899999999999999999998 8999999999999998654      


Q ss_pred             eEEEeeeCcccccCCCccccccCCCCCCCccCccccccCCCCChhhHHHHHHHHHHHHhCCCCcccCCcccccchhHHHH
Q 013686          249 RVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYFQCYKLTDKSDVYSFGVVLIELISGLEAVDTSRHRHDINLSNMAT  328 (438)
Q Consensus       249 ~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~  328 (438)
                      .++++|||.+......    .....||+.|+|||.+.+..++.++||||+||+++||++|+.||................
T Consensus       170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            4999999999865332    234569999999999999999999999999999999999999997644322111111111


Q ss_pred             HHH-----------hcCcc-ccccc-----CcCCC----Cc-------cHHHHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 013686          329 NKI-----------QNGAL-NELVD-----PSLGF----EK-------DYAVRNMVTSVAELAFRCVQQDRDMRPTMKEV  380 (438)
Q Consensus       329 ~~~-----------~~~~~-~~~~~-----~~~~~----~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  380 (438)
                      ..+           ..... ....+     ..+..    ..       .......+..+.+|+.+||..||++|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            000           00000 00000     00000    00       00124567889999999999999999999999


Q ss_pred             HHH
Q 013686          381 LEI  383 (438)
Q Consensus       381 l~~  383 (438)
                      |++
T Consensus       326 L~H  328 (362)
T d1q8ya_         326 VNH  328 (362)
T ss_dssp             HTC
T ss_pred             hcC
Confidence            875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.8e-26  Score=201.38  Aligned_cols=164  Identities=18%  Similarity=0.152  Sum_probs=120.7

Q ss_pred             CCCCcccccCceEEEEEEEcCCcEEEEEEeeccch------------------HhHHHHHHHHHHHHhCCCCCceeEeee
Q 013686          113 NSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNF------------------KRIEQFMNEVEILTKLQHPNLVKLYGC  174 (438)
Q Consensus       113 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~  174 (438)
                      .+.+.||+|+||+||+|...+|+.||||.++....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35789999999999999988899999998643211                  011335578899999999999988763


Q ss_pred             eeccCceEEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEecCCCeEEEee
Q 013686          175 TSRQSRELLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHASDVIHRDVKSNNILLDNNFRVKVAD  254 (438)
Q Consensus       175 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~Dlkp~Nill~~~~~~kl~D  254 (438)
                      .     ..+++|||+++..+.+           ++......++.|++++|.|||++||+||||||+|||++++ .++|+|
T Consensus        83 ~-----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E-----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E-----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             c-----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence            2     1379999998765433           3334456889999999999999999999999999999966 489999


Q ss_pred             eCcccccCCCccccccCCCCCCCccCc------cccccCCCCChhhHHHHHHHHH
Q 013686          255 FGLSRLFPTDVTHVSTAPQGTPGYVDP------DYFQCYKLTDKSDVYSFGVVLI  303 (438)
Q Consensus       255 fgla~~~~~~~~~~~~~~~g~~~y~aP------E~~~~~~~~~~~Dvws~Gv~l~  303 (438)
                      ||+|.....+...         .|...      +.+ .+.|+.++|+||+.--+.
T Consensus       146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence            9999765322111         11111      111 356788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.74  E-value=2.6e-08  Score=89.03  Aligned_cols=147  Identities=14%  Similarity=0.099  Sum_probs=95.8

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-CCCceeEeeeeeccCce
Q 013686          103 SELEEATDNFNSSKQLGDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-HPNLVKLYGCTSRQSRE  181 (438)
Q Consensus       103 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  181 (438)
                      .++....+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+-+++.+...+ +.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC-Cc
Confidence            45666677777766655566679999865 46678889876554433445677888888774 32244555544333 46


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 013686          182 LLLVYEYIPNGTVADHLHNRQPNSCLLPWPVRLSIAIETAGALAYLHAS-------------------------------  230 (438)
Q Consensus       182 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------  230 (438)
                      .++||++++|.++.+......      .   ...++.++++.+..||+.                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEecccccccccccccc------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            899999999988765432211      1   112333344444444421                               


Q ss_pred             ----------------------------CccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          231 ----------------------------DVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       231 ----------------------------~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                                                  .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                        278999999999999877777999997753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.26  E-value=1.2e-06  Score=77.38  Aligned_cols=140  Identities=21%  Similarity=0.218  Sum_probs=80.8

Q ss_pred             cccccCc-eEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC--CCceeEeeeeeccCceEEEEEeccCCCC
Q 013686          117 QLGDGGF-GAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH--PNLVKLYGCTSRQSRELLLVYEYIPNGT  193 (438)
Q Consensus       117 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~g~  193 (438)
                      .+..|.. +.||+....++..+++|.......   ..+..|...++.+..  -.+.+++++.... +..++||+|++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccc-cceEEEEEeeeccc
Confidence            3455554 689999887788889997654432   245668888877742  2244556644443 46899999998866


Q ss_pred             HHHH-----------------hhccCCCCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhC----
Q 013686          194 VADH-----------------LHNRQPNSCLL--PWPVRLSIA--------------------IETAGALAYLHAS----  230 (438)
Q Consensus       194 L~~~-----------------l~~~~~~~~~l--~~~~~~~i~--------------------~~i~~~l~~LH~~----  230 (438)
                      +.+.                 |+........+  .......-.                    ......+..+...    
T Consensus        93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  172 (255)
T d1nd4a_          93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG  172 (255)
T ss_dssp             TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred             cccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence            5331                 11100000000  000000000                    0012223333322    


Q ss_pred             ---CccccCCCCCCEEecCCCeEEEeeeCcccc
Q 013686          231 ---DVIHRDVKSNNILLDNNFRVKVADFGLSRL  260 (438)
Q Consensus       231 ---~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  260 (438)
                         .++|+|+.|.|||++++..+-|+||+.+..
T Consensus       173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence               379999999999999887778999997753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.89  E-value=1.2e-05  Score=75.73  Aligned_cols=76  Identities=16%  Similarity=0.198  Sum_probs=47.2

Q ss_pred             CCcccccCceEEEEEEEc-CCcEEEEEEeecc------c-hHhHHHHHHHHHHHHhCC-C--CCceeEeeeeeccCceEE
Q 013686          115 SKQLGDGGFGAVYLGILR-DGRIVAVKRLYEN------N-FKRIEQFMNEVEILTKLQ-H--PNLVKLYGCTSRQSRELL  183 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~  183 (438)
                      .+.||.|....||++... +++.|+||.-...      . ....++...|.+.|+.+. +  ..+.+++.+. ..  ..+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~--~~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TE--MAV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TT--TTE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CC--CCE
Confidence            457899999999999865 4678999964321      1 112344556888887663 2  3344555432 22  357


Q ss_pred             EEEeccCCCC
Q 013686          184 LVYEYIPNGT  193 (438)
Q Consensus       184 lv~e~~~~g~  193 (438)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            9999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.63  E-value=5.1e-05  Score=69.34  Aligned_cols=69  Identities=17%  Similarity=0.155  Sum_probs=44.0

Q ss_pred             ceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCCC-----CCceeEee-eeeccCceEEEEEeccCCC
Q 013686          123 FGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQH-----PNLVKLYG-CTSRQSRELLLVYEYIPNG  192 (438)
Q Consensus       123 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~~~~-~~~~~~~~~~lv~e~~~~g  192 (438)
                      --.||++...+|+.|++|....... ..+++..|...+..|..     +..+..-+ .........+.++++++|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            4589999998999999998765432 23567778888887742     22222111 1111234578899999764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.13  E-value=0.0018  Score=58.19  Aligned_cols=157  Identities=11%  Similarity=0.056  Sum_probs=81.8

Q ss_pred             cChHHHHHHhcCCCCCCcc-----cccCceEEEEEEEcCCcEEEEEEeeccchHhHHHHHHHHHHHHhCC-----CCCce
Q 013686          100 FSCSELEEATDNFNSSKQL-----GDGGFGAVYLGILRDGRIVAVKRLYENNFKRIEQFMNEVEILTKLQ-----HPNLV  169 (438)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  169 (438)
                      .+.++++....+|.+++..     ..|---+.|+....+| .+++|+.....  ..+++..|++++..|.     -|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            3557788888888776544     3566678899987665 48899875431  1234455677777663     22222


Q ss_pred             eEee--eeeccCceEEEEEeccCCCCHHH--------------HhhccCCC-----CCCCCHH-----------------
Q 013686          170 KLYG--CTSRQSRELLLVYEYIPNGTVAD--------------HLHNRQPN-----SCLLPWP-----------------  211 (438)
Q Consensus       170 ~~~~--~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~-----~~~l~~~-----------------  211 (438)
                      ...+  ....-......++.++.+.....              .++.....     .......                 
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2211  01111224556666665532211              11100000     0000000                 


Q ss_pred             -HHHHHHHHHHHHHHHHHh----CCccccCCCCCCEEecCCCeEEEeeeCccc
Q 013686          212 -VRLSIAIETAGALAYLHA----SDVIHRDVKSNNILLDNNFRVKVADFGLSR  259 (438)
Q Consensus       212 -~~~~i~~~i~~~l~~LH~----~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  259 (438)
                       .....+..+...+...+.    .|+||+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             011122222233333332    379999999999999998777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.05  E-value=0.00064  Score=63.55  Aligned_cols=73  Identities=25%  Similarity=0.315  Sum_probs=47.2

Q ss_pred             CCcccccCceEEEEEEEcCC--------cEEEEEEeeccchHhHHHHHHHHHHHHhCCCCCc-eeEeeeeeccCceEEEE
Q 013686          115 SKQLGDGGFGAVYLGILRDG--------RIVAVKRLYENNFKRIEQFMNEVEILTKLQHPNL-VKLYGCTSRQSRELLLV  185 (438)
Q Consensus       115 ~~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv  185 (438)
                      ++.|+.|-.-.+|++...++        +.|.++... ... ..-...+|..+++.+.-.++ .++++++ .+    .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~-~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIF-SG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEE-TT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEc-CC----ceE
Confidence            46788899999999986542        456666543 222 22345679999888853344 3566644 22    589


Q ss_pred             EeccCCCCH
Q 013686          186 YEYIPNGTV  194 (438)
Q Consensus       186 ~e~~~~g~L  194 (438)
                      |||++|.+|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544